data_1rjj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rjj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 4' ' ' SER . 8.9 t -63.48 -45.57 90.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.149 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 3' ' ' THR . 19.9 m -139.64 -100.5 0.16 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.22 148.48 34.43 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.689 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.544 ' CZ ' ' OD1' ' A' ' 97' ' ' ASP . 34.6 t80 -114.93 128.09 56.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.268 -1.137 . . . . 0.0 108.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.535 ' HZ1' ' CD1' ' A' ' 9' ' ' LEU . 3.7 ttpp -113.51 142.35 46.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.919 -1.113 . . . . 0.0 112.83 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -132.79 133.42 43.38 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.535 ' CD1' ' HZ1' ' A' ' 7' ' ' LYS . 6.6 tt -136.63 145.84 45.33 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 109.461 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.14 133.43 68.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.47 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.19 129.03 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.45 167.53 19.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.733 -1.587 . . . . 0.0 113.024 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 19.0 tptp -132.85 152.29 51.87 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' N ' ' HG3' ' A' ' 13' ' ' LYS . 39.7 p90 -108.68 149.61 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.877 -1.139 . . . . 0.0 111.576 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -129.29 -22.09 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.7 mt-10 -89.27 -57.11 3.0 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.0 t0 153.83 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 64.6 m -50.93 105.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.104 0.954 . . . . 0.0 112.814 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -75.56 88.16 2.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.61 -38.57 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.557 -0.714 . . . . 0.0 110.524 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 82.9 m-20 -66.1 -44.63 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.425 -0.797 . . . . 0.0 110.572 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.96 -31.39 72.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 23' ' ' ILE . 13.3 mt -69.62 -37.44 74.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 13.9 tp -53.22 -37.86 62.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -34.53 74.23 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.02 -53.54 36.41 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -46.82 -47.73 20.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.497 -1.002 . . . . 0.0 108.832 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.49 -44.54 65.7 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -68.59 -49.05 62.33 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.39 -47.81 37.27 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.7 t -49.76 -26.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.268 -0.895 . . . . 0.0 108.887 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 47.0 t -41.64 -42.69 2.57 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.663 HE22 ' CG ' ' A' ' 76' ' ' HIS . 15.2 mm100 -61.23 -11.17 8.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.483 -0.76 . . . . 0.0 111.499 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.444 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 41.8 mm -81.92 26.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 119.985 -1.697 . . . . 0.0 110.604 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 36' ' ' THR . 31.1 p-10 -67.38 -26.38 66.43 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.708 ' O ' ' N ' ' A' ' 38' ' ' LYS . 7.5 t -79.21 1.99 22.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.968 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 21.1 m 37.83 21.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.081 -1.012 . . . . 0.0 109.187 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' A' ' 36' ' ' THR . 83.0 mttt -120.81 41.26 3.33 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -158.12 154.75 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.503 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 98.5 m-85 -144.46 154.43 42.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.543 -1.348 . . . . 0.0 111.949 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 81.1 mt-10 -160.88 130.46 4.9 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.335 0.588 . . . . 0.0 110.223 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -130.01 175.27 9.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.8 154.0 21.97 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.574 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 17.8 mt-10 -151.1 141.85 22.77 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -1.146 . . . . 0.0 109.401 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 8.5 p30 -116.02 148.53 40.07 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.622 ' HD3' ' N ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -68.5 80.82 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.481 -1.387 . . . . 0.0 109.809 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 45' ' ' ASP . 78.2 mm-40 -96.91 54.66 1.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.298 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 49' ' ' HIS . 29.7 t -134.14 -138.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -0.934 . . . . 0.0 110.23 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.54 ' N ' ' OG ' ' A' ' 48' ' ' SER . 74.1 m80 -107.37 142.94 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -42.83 -41.11 3.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 0.0 110.798 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 ttt -71.54 -29.37 64.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.016 -1.053 . . . . 0.0 110.703 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' B' ' 95' ' ' LEU . 52.1 mt -98.25 -18.38 18.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.745 -1.222 . . . . 0.0 109.277 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.669 ' C ' ' H ' ' A' ' 55' ' ' GLY . 55.0 mtp180 -73.43 0.58 11.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 111.212 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 55.9 -4.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.797 -1.189 . . . . 0.0 110.197 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 82.53 -18.36 15.2 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.884 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CZ ' ' NZ ' ' A' ' 92' ' ' LYS . 12.0 m-85 -59.26 -128.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.246 -1.738 . . . . 0.0 109.922 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.622 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 2.5 t -164.99 -36.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.34 -0.85 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.7 t60 -169.9 153.68 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.166 . . . . 0.0 110.225 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.653 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.18 168.76 18.98 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.261 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 88.1 m-85 -129.03 126.07 38.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 109.073 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.25 14.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 mtt -104.84 117.83 35.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.172 -0.955 . . . . 0.0 110.82 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -120.31 143.24 48.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.28 159.66 23.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.691 -1.255 . . . . 0.0 110.069 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.54 -27.45 62.23 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -173.75 -174.57 0.97 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.35 -27.17 65.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 111.445 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 29.1 p-10 -58.04 -37.89 75.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.813 -1.18 . . . . 0.0 110.532 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -68.98 -37.59 83.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' ' CG2' ' A' ' 74' ' ' THR . 71.0 t80 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.507 -0.996 . . . . 0.0 110.498 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.376 -1.453 . . . . 0.0 108.677 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.91 2.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.59 ' CZ ' ' CG ' ' A' ' 79' ' ' HIS . 35.8 t80 -45.98 -35.71 4.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.9 . . . . 0.0 111.127 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -86.02 -27.25 24.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.75 -1.219 . . . . 0.0 110.332 -178.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -66.81 12.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.989 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.663 ' CG ' HE22 ' A' ' 33' ' ' GLN . 16.5 m80 -124.76 152.7 69.88 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.787 -1.195 . . . . 0.0 109.636 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.73 -6.63 15.35 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.675 2.25 . . . . 0.0 112.434 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.412 HD12 HD22 ' A' ' 29' ' ' ASN . 5.8 tp -73.22 -28.01 61.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.837 . . . . 0.0 111.223 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.59 ' CG ' ' CZ ' ' A' ' 73' ' ' PHE . 2.9 t60 -82.08 -35.45 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.052 . . . . 0.0 110.281 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.53 -60.01 3.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.989 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -56.64 -38.65 72.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.612 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.41 -41.86 72.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.849 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.3 t -61.73 -39.2 90.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.167 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.31 77.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.1 -39.72 78.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.461 ' C ' ' O ' ' A' ' 85' ' ' ALA . 28.3 t80 -45.19 -29.53 0.97 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.613 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 1.2 p -83.46 -62.26 1.63 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.613 ' H ' ' HG1' ' A' ' 87' ' ' THR . . . -40.09 -27.94 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.705 -0.622 . . . . 0.0 110.084 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 p -100.95 14.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.819 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 22.5 mm -128.69 161.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.682 -1.261 . . . . 0.0 110.444 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 62.8 t0 -104.37 -35.23 8.01 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.625 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 19.8 ptmt -145.63 146.03 31.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -125.69 123.43 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.626 -1.296 . . . . 0.0 109.799 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.65 132.4 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -138.6 135.41 34.92 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.262 -1.524 . . . . 0.0 111.766 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.457 HD13 ' H ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -121.06 124.53 45.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.638 -0.664 . . . . 0.0 109.363 176.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.544 ' OD1' ' CZ ' ' A' ' 6' ' ' PHE . 20.2 t0 -126.27 133.65 51.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.053 -1.029 . . . . 0.0 108.951 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CE1' ' CD ' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -156.62 157.77 31.07 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.109 -0.995 . . . . 0.0 110.516 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.79 127.77 13.41 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.321 2.014 . . . . 0.0 112.209 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -106.99 128.7 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -108.47 94.48 5.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.47 -0.768 . . . . 0.0 109.625 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.46 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' A' ' 101' ' ' ALA . 10.2 m -148.36 -26.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 106' ' ' SER . 25.2 mmtt -38.45 -28.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 103' ' ' VAL . 5.7 p -57.69 70.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.131 -0.98 . . . . 0.0 108.941 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 104' ' ' LYS . 8.0 t -111.21 109.82 20.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.466 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.26 148.39 34.25 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.406 -1.378 . . . . 0.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.54 ' CZ ' ' OD1' ' B' ' 97' ' ' ASP . 34.4 t80 -114.77 128.2 56.17 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.249 -1.148 . . . . 0.0 108.02 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.536 ' HZ1' ' CD1' ' B' ' 9' ' ' LEU . 3.6 ttpp -113.55 142.4 46.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 112.822 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -132.86 133.36 43.21 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.536 ' CD1' ' HZ1' ' B' ' 7' ' ' LYS . 6.5 tt -136.58 145.86 45.45 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.728 -1.233 . . . . 0.0 109.458 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.18 133.34 68.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.04 129.16 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.61 167.5 19.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.017 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 19.1 tptp -132.74 152.34 51.77 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.442 ' N ' ' HG3' ' B' ' 13' ' ' LYS . 39.7 p90 -108.77 149.47 28.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.85 -1.156 . . . . 0.0 111.606 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -129.11 -22.08 3.2 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.6 mt-10 -89.29 -57.12 3.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 7.9 t0 153.75 64.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 63.7 m -50.73 105.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.136 0.97 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -75.62 88.22 2.73 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.63 -38.55 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.612 -0.68 . . . . 0.0 110.471 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' B' ' 24' ' ' LEU . 82.7 m-20 -66.19 -44.56 83.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 110.564 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -66.07 -31.47 72.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.446 HG21 HD12 ' B' ' 23' ' ' ILE . 13.4 mt -69.53 -37.35 74.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' B' ' 21' ' ' ASP . 13.9 tp -53.3 -37.83 62.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -34.64 74.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.98 -53.54 36.54 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.77 -47.64 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.982 . . . . 0.0 108.797 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -52.6 -44.55 66.06 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.3 OUTLIER -68.66 -49.04 62.27 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.47 -47.6 38.32 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 32' ' ' SER . 53.7 t -49.96 -26.06 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.309 -0.869 . . . . 0.0 108.832 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.3 t -42.0 -42.61 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.669 HE22 ' CG ' ' B' ' 76' ' ' HIS . 15.3 mm100 -61.07 -11.3 8.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.443 -0.786 . . . . 0.0 111.509 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.445 ' O ' ' CG2' ' B' ' 34' ' ' ILE . 42.1 mm -81.78 26.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 119.99 -1.693 . . . . 0.0 110.559 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 36' ' ' THR . 31.6 p-10 -67.51 -26.3 66.27 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.723 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.4 t -79.25 1.85 23.33 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.942 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 36' ' ' THR . 21.1 m 37.93 21.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 36' ' ' THR . 83.3 mttt -120.82 41.36 3.31 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -158.2 154.71 27.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 98.5 m-85 -144.47 154.53 43.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.545 -1.347 . . . . 0.0 111.99 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 80.8 mt-10 -160.97 130.45 4.83 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.345 0.593 . . . . 0.0 110.2 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -130.09 175.22 9.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.75 154.07 21.99 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.828 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.568 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 17.9 mt-10 -151.12 141.72 22.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 8.1 p30 -115.91 148.67 39.77 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' B' ' 57' ' ' THR . 0.0 OUTLIER -68.59 80.89 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.394 -1.441 . . . . 0.0 109.788 -176.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 45' ' ' ASP . 78.2 mm-40 -96.95 54.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.646 . . . . 0.0 109.315 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' B' ' 49' ' ' HIS . 29.6 t -134.14 -138.22 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.511 ' N ' ' OG ' ' B' ' 48' ' ' SER . 74.1 m80 -107.24 142.92 36.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.134 -0.979 . . . . 0.0 109.699 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -42.78 -41.25 3.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.78 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.9 ttt -71.42 -29.29 64.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 95' ' ' LEU . 51.5 mt -98.26 -18.46 18.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.72 -1.238 . . . . 0.0 109.279 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.672 ' C ' ' H ' ' B' ' 55' ' ' GLY . 55.0 mtp180 -73.42 0.58 11.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -0.844 . . . . 0.0 111.271 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 55.87 -4.06 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.832 -1.168 . . . . 0.0 110.18 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 82.77 -18.89 13.22 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.454 -0.778 . . . . 0.0 112.861 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.624 ' CZ ' ' NZ ' ' B' ' 92' ' ' LYS . 12.2 m-85 -58.92 -128.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.288 -1.713 . . . . 0.0 109.902 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.614 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 2.5 t -164.9 -36.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.299 -0.876 . . . . 0.0 110.992 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.652 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.7 t60 -169.91 153.77 4.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.826 -1.171 . . . . 0.0 110.214 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.652 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.21 168.77 18.95 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.461 -0.774 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.532 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 88.2 m-85 -129.01 126.12 38.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.513 -0.742 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.24 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 34.6 mtt -104.92 117.9 35.2 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.24 -0.913 . . . . 0.0 110.731 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 99.9 m -120.38 143.27 48.52 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -119.28 159.69 23.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.715 -1.241 . . . . 0.0 110.073 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.6 -27.57 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -173.57 -174.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.39 -27.33 65.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 111.422 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 29.0 p-10 -57.9 -38.03 75.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.817 -1.177 . . . . 0.0 110.574 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -68.75 -37.6 84.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.507 ' O ' ' CG2' ' B' ' 74' ' ' THR . 71.5 t80 -62.36 -46.76 87.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.574 -0.956 . . . . 0.0 110.445 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.94 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.377 -1.452 . . . . 0.0 108.732 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.585 ' CZ ' ' CG ' ' B' ' 79' ' ' HIS . 35.8 t80 -45.75 -35.76 4.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.932 . . . . 0.0 111.107 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.2 OUTLIER -86.08 -27.29 24.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.808 -1.183 . . . . 0.0 110.316 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -66.66 12.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.066 -1.021 . . . . 0.0 110.986 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.669 ' CG ' HE22 ' B' ' 33' ' ' GLN . 16.8 m80 -124.81 152.56 69.88 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 109.547 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.58 -6.63 15.48 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.644 2.229 . . . . 0.0 112.453 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.407 HD12 HD22 ' B' ' 29' ' ' ASN . 5.8 tp -73.09 -28.23 62.17 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.236 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.585 ' CG ' ' CZ ' ' B' ' 73' ' ' PHE . 2.9 t60 -81.98 -35.44 28.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.48 -60.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.987 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' B' ' 82' ' ' PHE . 22.4 pt-20 -56.59 -38.77 72.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' B' ' 81' ' ' GLU . 73.1 t80 -70.26 -41.86 72.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 17.4 t -61.62 -39.42 91.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.1 -1.0 . . . . 0.0 110.15 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -49.39 77.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 108.68 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.93 -39.8 79.37 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.466 ' C ' ' O ' ' B' ' 85' ' ' ALA . 28.4 t80 -45.12 -29.5 0.93 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.59 ' HG1' ' H ' ' B' ' 88' ' ' ALA . 1.2 p -83.5 -62.36 1.6 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.59 ' H ' ' HG1' ' B' ' 87' ' ' THR . . . -40.01 -27.98 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.742 -0.599 . . . . 0.0 110.084 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' B' ' 87' ' ' THR . 3.9 p -100.86 14.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.234 -0.916 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 22.4 mm -128.63 161.19 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.664 -1.273 . . . . 0.0 110.421 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 62.6 t0 -104.55 -35.33 7.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.624 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 19.8 ptmt -145.53 146.14 31.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -125.78 123.32 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.597 -1.314 . . . . 0.0 109.767 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 132.38 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.4 OUTLIER -138.59 135.3 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.314 -1.491 . . . . 0.0 111.737 -178.278 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.461 ' H ' HD13 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -121.0 124.62 45.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 176.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' B' ' 6' ' ' PHE . 21.1 t0 -126.39 133.62 51.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.034 -1.041 . . . . 0.0 108.923 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -156.6 157.67 31.04 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.065 -1.022 . . . . 0.0 110.516 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.7 127.93 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.268 1.979 . . . . 0.0 112.227 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.14 128.66 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.957 . . . . 0.0 110.042 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -108.56 94.46 5.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.491 -0.756 . . . . 0.0 109.609 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.39 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.564 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.658 ' N ' ' O ' ' B' ' 101' ' ' ALA . 10.4 m -148.33 -26.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 109.23 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.4 mmtt -38.6 -28.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 103' ' ' VAL . 5.7 p -57.77 70.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.135 -0.978 . . . . 0.0 108.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.705 ' N ' ' O ' ' B' ' 104' ' ' LYS . 8.0 t -111.15 109.83 20.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--N 1.302 -1.48 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.465 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.472 ' CG2' ' N ' ' A' ' 4' ' ' SER . 7.6 t -147.64 -49.07 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.102 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.472 ' N ' ' CG2' ' A' ' 3' ' ' THR . 29.6 m -124.05 -103.76 0.37 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.01 45.24 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.737 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -136.36 135.02 38.47 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.218 -1.166 . . . . 0.0 108.036 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -99.94 127.0 46.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.93 -1.107 . . . . 0.0 112.822 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.507 ' ND1' ' OD1' ' A' ' 97' ' ' ASP . 86.3 t60 -122.61 121.18 35.84 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.6 tt -135.08 144.11 47.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.714 -1.241 . . . . 0.0 109.474 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 10.7 p -127.64 134.32 65.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.547 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.52 127.93 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.429 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.4 m -141.6 159.92 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 117.785 -1.566 . . . . 0.0 113.042 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -130.41 155.2 46.81 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.543 ' H ' HG22 ' A' ' 57' ' ' THR . 11.9 p90 -111.11 153.69 25.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.13 . . . . 0.0 111.606 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -19.14 3.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 17' ' ' ASP . 13.5 tm-20 -92.63 -56.82 2.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 3.1 m-20 155.24 62.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.8 m -49.04 105.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.082 0.944 . . . . 0.0 112.849 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.752 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.98 85.5 0.7 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' LEU . 33.0 m -64.95 -41.02 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.527 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 36.4 p-10 -66.51 -46.54 75.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.4 -0.812 . . . . 0.0 110.553 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.8 mp0 -66.14 -30.25 70.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mt -72.4 -41.79 64.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.4 tp -56.1 -38.59 70.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.47 -34.03 76.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.591 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -68.16 -53.3 22.86 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -44.93 -42.68 8.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.547 -0.972 . . . . 0.0 108.793 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -53.24 -42.69 66.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.674 ' ND2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -58.84 -45.2 90.63 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.674 ' N ' ' ND2' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -49.24 -45.12 44.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' ILE . 16.0 t -58.08 -20.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 108.827 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 46.8 t -44.0 -38.3 3.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -10.74 50.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 111.39 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 36' ' ' THR . 5.4 mm -86.06 21.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.075 -1.64 . . . . 0.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 36' ' ' THR . 51.6 p30 -58.91 -9.43 1.84 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.642 ' O ' ' C ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -80.2 -1.1 39.02 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.895 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.642 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.4 m 30.26 45.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 109.217 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.644 ' HZ1' ' CA ' ' A' ' 69' ' ' GLY . 11.4 ptmm? -121.03 39.86 3.7 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 75.7 m -173.36 179.08 2.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -145.56 154.74 42.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.608 -1.308 . . . . 0.0 111.936 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -154.64 123.25 6.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.395 0.617 . . . . 0.0 110.234 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.532 ' CG ' ' N ' ' A' ' 43' ' ' GLY . 67.0 t-105 -135.83 175.03 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' N ' ' CG ' ' A' ' 42' ' ' TRP . . . -132.28 160.97 23.85 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 118.711 -1.709 . . . . 0.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 41.8 mp0 -148.84 139.63 22.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -1.151 . . . . 0.0 109.336 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 47' ' ' GLU . 85.6 m-20 -113.75 147.08 38.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.671 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.5 81.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.435 -1.416 . . . . 0.0 109.806 -178.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.0 mt-10 -122.06 59.2 1.01 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' A' ' 49' ' ' HIS . 43.9 p -158.49 73.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' A' ' 48' ' ' SER . 55.9 m80 54.34 125.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -44.79 -31.51 1.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 110.757 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -30.79 52.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.992 -1.068 . . . . 0.0 110.763 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 48' ' ' SER . 40.6 mt -100.62 -27.63 13.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.784 -1.198 . . . . 0.0 109.336 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 46' ' ' LYS . 8.7 ptm180 -87.0 -2.45 58.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.326 -0.859 . . . . 0.0 111.25 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER 49.21 13.71 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.839 -1.163 . . . . 0.0 110.167 178.388 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 57.06 -2.89 0.07 OUTLIER Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.441 -0.787 . . . . 0.0 112.89 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 56' ' ' PHE . 45.8 p90 -57.1 124.08 17.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.233 -1.745 . . . . 0.0 109.977 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' ND1' ' A' ' 58' ' ' HIS . 72.1 p -54.2 -44.11 71.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 111.002 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 36.0 p-80 -170.21 154.94 5.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.826 -1.171 . . . . 0.0 110.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.48 17.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.283 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.91 126.77 38.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.494 -0.754 . . . . 0.0 109.078 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -96.09 96.24 8.71 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 8' ' ' HIS . 67.4 mtt -101.83 119.11 38.26 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.165 -0.959 . . . . 0.0 110.809 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 m -125.67 145.31 50.22 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -121.59 163.74 18.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.701 -1.249 . . . . 0.0 110.088 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 4' ' ' SER . 85.4 tt0 -85.49 -30.9 23.09 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -157.56 164.06 37.71 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.484 ' CB ' ' HZ1' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -57.6 -24.29 55.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 0.0 111.478 -179.178 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -57.18 -40.03 76.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.796 -1.19 . . . . 0.0 110.608 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.644 ' CA ' ' HZ1' ' A' ' 38' ' ' LYS . . . -68.63 -40.79 85.64 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -60.54 -46.79 88.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.988 . . . . 0.0 110.454 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.1 m -70.72 -28.97 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.396 -1.44 . . . . 0.0 108.677 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.02 -60.95 2.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -56.77 -39.44 74.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 111.173 -176.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -80.84 -34.08 34.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.764 -1.21 . . . . 0.0 110.295 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 74.1 m -68.12 -32.9 73.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 110.973 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.61 ' N ' ' HD1' ' A' ' 76' ' ' HIS . 0.3 OUTLIER -69.62 126.0 92.32 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.899 -1.125 . . . . 0.0 109.635 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.78 -7.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.726 2.284 . . . . 0.0 112.364 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.1 tt -72.31 -30.99 65.3 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.363 -0.836 . . . . 0.0 111.198 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 10.9 t-160 -82.89 -29.19 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.966 -1.084 . . . . 0.0 110.275 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.53 -58.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.018 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -56.45 -38.17 71.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -71.64 -42.19 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -62.18 -39.72 93.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.102 -0.999 . . . . 0.0 110.146 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.49 77.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.955 -1.091 . . . . 0.0 108.69 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.08 -40.67 87.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 85' ' ' ALA . 15.9 t80 -45.29 -29.35 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 89' ' ' VAL . 12.2 m -81.79 -62.12 1.73 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -38.85 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.7 -0.625 . . . . 0.0 110.111 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.5 m -106.47 11.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.791 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 26.4 mm -130.53 163.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.685 -1.26 . . . . 0.0 110.41 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.541 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 22.6 t0 -124.22 -34.52 2.92 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -126.99 125.17 41.02 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.0 tp -123.54 123.14 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.691 -1.256 . . . . 0.0 109.786 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 43.7 t -130.28 133.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -137.48 135.26 36.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.278 -1.514 . . . . 0.0 111.781 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 1.1 mp -114.67 117.01 29.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.688 -0.632 . . . . 0.0 109.339 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.507 ' OD1' ' ND1' ' A' ' 8' ' ' HIS . 79.2 m-20 -114.63 121.77 44.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.092 -1.005 . . . . 0.0 108.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 63.1 t80 -154.61 137.22 10.03 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.077 -1.014 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 39.7 Cg_endo -63.86 141.94 80.19 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.311 2.007 . . . . 0.0 112.228 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.1 t -122.41 141.97 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 109.979 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -112.46 96.93 6.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.88 76.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 101' ' ' ALA . 8.6 m -148.11 120.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.385 -0.822 . . . . 0.0 109.155 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.32 115.71 24.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.346 -0.846 . . . . 0.0 109.325 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 106' ' ' SER . 22.1 m -69.88 -45.38 67.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 108.914 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' SER . 6.1 t 43.19 52.42 5.56 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.354 -0.841 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.61 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.443 ' O ' ' O ' ' B' ' 65' ' ' GLU . 28.2 m . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.4 175.0 45.64 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.43 134.81 38.11 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.207 -1.172 . . . . 0.0 108.075 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -99.76 126.9 45.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.929 -1.107 . . . . 0.0 112.837 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' B' ' 97' ' ' ASP . 86.3 t60 -122.66 121.21 35.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.6 tt -135.07 144.07 47.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.694 -1.253 . . . . 0.0 109.454 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 10.6 p -127.62 134.41 65.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.512 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.64 127.95 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.425 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.4 m -141.6 159.76 21.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.019 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -130.29 155.26 46.62 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 12.0 p90 -111.23 153.66 25.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.827 -1.17 . . . . 0.0 111.558 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 -19.2 3.2 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 17' ' ' ASP . 13.5 tm-20 -92.49 -56.92 2.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.519 ' N ' ' OE1' ' B' ' 16' ' ' GLU . 3.1 m-20 155.21 62.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 90.2 m -49.31 105.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.095 0.95 . . . . 0.0 112.882 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.738 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -70.95 85.33 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' B' ' 24' ' ' LEU . 32.9 m -64.84 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.616 -0.677 . . . . 0.0 110.539 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 36.0 p-10 -66.59 -46.41 76.05 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 110.569 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 3.9 mp0 -66.25 -30.25 70.65 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.35 -41.78 65.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -56.08 -38.6 70.9 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.34 -34.28 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.596 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -67.96 -53.43 22.98 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.88 -42.59 8.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.466 -1.02 . . . . 0.0 108.801 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -53.43 -42.54 67.19 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' N ' ' B' ' 30' ' ' LEU . 0.0 OUTLIER -58.91 -45.21 90.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.68 ' N ' ' ND2' ' B' ' 29' ' ' ASN . 0.5 OUTLIER -49.18 -45.28 43.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' B' ' 34' ' ' ILE . 15.8 t -57.88 -20.35 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.278 -0.889 . . . . 0.0 108.806 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.0 t -43.86 -38.41 3.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -10.97 50.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.502 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' B' ' 36' ' ' THR . 5.3 mm -85.85 21.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 119.933 -1.73 . . . . 0.0 110.588 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 36' ' ' THR . 51.1 p30 -59.01 -9.5 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -80.18 -1.01 38.56 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.878 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.6 m 30.33 45.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.03 -1.044 . . . . 0.0 109.17 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.646 ' HZ1' ' CA ' ' B' ' 69' ' ' GLY . 11.4 ptmm? -121.12 40.0 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.568 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 74.9 m -173.39 179.17 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.61 154.73 42.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.469 -1.394 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -154.6 123.33 6.19 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.471 0.653 . . . . 0.0 110.218 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.533 ' CG ' ' N ' ' B' ' 43' ' ' GLY . 66.7 t-105 -135.75 175.08 9.92 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' B' ' 42' ' ' TRP . . . -132.2 161.07 23.84 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.772 -1.68 . . . . 0.0 110.791 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 41.6 mp0 -148.9 139.48 22.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -1.162 . . . . 0.0 109.358 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 47' ' ' GLU . 85.2 m-20 -113.46 147.14 38.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.66 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -65.54 81.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.483 -1.385 . . . . 0.0 109.832 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.1 mt-10 -122.12 59.28 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.712 -0.618 . . . . 0.0 109.398 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' B' ' 49' ' ' HIS . 41.7 p -158.42 73.25 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' B' ' 48' ' ' SER . 55.9 m80 54.24 125.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -44.6 -31.62 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.44 -30.89 53.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.724 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' B' ' 48' ' ' SER . 41.4 mt -100.76 -27.47 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.782 -1.199 . . . . 0.0 109.247 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' O ' ' B' ' 46' ' ' LYS . 8.7 ptm180 -87.11 -2.48 58.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 111.204 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' B' ' 56' ' ' PHE . 0.8 OUTLIER 49.32 13.64 0.08 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.782 -1.199 . . . . 0.0 110.217 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 57.18 -3.13 0.07 OUTLIER Glycine 0 N--CA 1.498 2.797 0 O-C-N 121.47 -0.769 . . . . 0.0 112.852 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 45.9 p90 -56.96 124.17 17.72 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.279 -1.718 . . . . 0.0 109.977 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.546 ' OG1' ' ND1' ' B' ' 58' ' ' HIS . 72.1 p -54.19 -44.19 71.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.988 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.623 ' HA ' ' O ' ' B' ' 44' ' ' GLU . 36.0 p-80 -170.21 154.82 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.119 . . . . 0.0 110.197 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.95 169.46 17.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.414 -0.804 . . . . 0.0 109.24 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.81 126.87 39.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.348 -0.845 . . . . 0.0 109.081 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 66.0 m -96.1 96.3 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' MET . . . . . 0.401 ' O ' ' N ' ' B' ' 8' ' ' HIS . 67.4 mtt -101.81 119.07 38.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.23 -0.919 . . . . 0.0 110.81 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -125.71 145.33 50.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.63 163.64 18.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.661 -1.274 . . . . 0.0 110.054 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 4' ' ' SER . 85.4 tt0 -85.45 -30.92 23.14 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.43 164.13 37.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.495 ' CB ' ' HZ1' ' B' ' 67' ' ' LYS . 0.5 OUTLIER -57.6 -24.39 56.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 111.467 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.96 -40.23 76.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.727 -1.233 . . . . 0.0 110.563 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.646 ' CA ' ' HZ1' ' B' ' 38' ' ' LYS . . . -68.6 -40.55 85.91 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.77 -46.69 89.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.636 -0.92 . . . . 0.0 110.522 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.98 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.322 -1.486 . . . . 0.0 108.665 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.461 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.03 -60.85 2.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.788 . . . . 0.0 109.387 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.425 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.75 -39.43 73.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.889 . . . . 0.0 111.079 -177.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.425 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 4.9 t -80.97 -33.84 33.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.763 -1.21 . . . . 0.0 110.371 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 74.5 m -68.36 -32.82 73.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.955 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.601 ' N ' ' HD1' ' B' ' 76' ' ' HIS . 0.3 OUTLIER -69.58 126.04 92.35 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.807 -1.183 . . . . 0.0 109.605 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -43.78 -7.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.642 2.228 . . . . 0.0 112.48 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.2 tt -72.51 -30.93 64.93 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.42 -0.8 . . . . 0.0 111.214 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.457 ' O ' ' CD2' ' B' ' 79' ' ' HIS . 10.9 t-160 -82.93 -29.11 29.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.956 -1.09 . . . . 0.0 110.317 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.54 -58.71 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 110.004 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -56.54 -38.2 71.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 0.0 109.531 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -71.5 -42.25 68.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 0.0 109.905 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -62.27 -39.64 93.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.0 . . . . 0.0 110.124 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.5 77.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 0.0 108.609 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.18 -40.64 86.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.446 ' C ' ' O ' ' B' ' 85' ' ' ALA . 16.0 t80 -45.31 -29.3 1.0 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 12.3 m -81.8 -62.08 1.74 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.99 -26.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.643 -0.661 . . . . 0.0 110.093 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.7 m -106.58 11.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.28 -0.888 . . . . 0.0 110.828 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 26.4 mm -130.59 163.91 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.616 -1.302 . . . . 0.0 110.494 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.538 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 22.6 t0 -124.25 -34.55 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -127.03 125.13 40.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.0 tp -123.63 123.15 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.617 -1.302 . . . . 0.0 109.715 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 43.2 t -130.27 133.01 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.1 OUTLIER -137.43 135.19 36.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.251 -1.531 . . . . 0.0 111.796 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 1.2 mp -114.68 116.96 29.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 109.317 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' B' ' 8' ' ' HIS . 79.8 m-20 -114.67 121.78 44.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.156 -0.965 . . . . 0.0 108.884 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 63.3 t80 -154.56 137.18 10.01 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 39.7 Cg_endo -63.93 141.89 79.53 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.27 1.98 . . . . 0.0 112.299 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 71.4 t -122.37 141.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 110.05 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -112.53 96.99 6.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.439 -0.788 . . . . 0.0 109.548 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.9 76.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.091 -1.005 . . . . 0.0 109.561 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' B' ' 101' ' ' ALA . 9.4 m -148.03 120.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.227 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.27 115.72 24.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.409 ' O ' ' C ' ' B' ' 106' ' ' SER . 23.2 m -69.78 -45.67 67.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.138 -0.976 . . . . 0.0 108.917 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.4 t 43.48 52.23 6.03 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.365 -0.834 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.575 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.489 ' CG2' ' N ' ' A' ' 4' ' ' SER . 10.2 t -65.85 -45.7 81.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.174 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 3' ' ' THR . 19.7 m -136.23 -97.02 0.23 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.61 170.06 41.79 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.731 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.2 131.27 43.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.283 -1.127 . . . . 0.0 108.011 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -99.87 125.75 45.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.925 -1.109 . . . . 0.0 112.824 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 62' ' ' MET . 74.5 m80 -120.09 121.41 38.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.42 143.21 43.82 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.696 -1.252 . . . . 0.0 109.486 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.67 136.12 60.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.635 -0.666 . . . . 0.0 109.492 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.07 126.58 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.09 154.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.813 -1.555 . . . . 0.0 113.064 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -126.61 154.85 43.4 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 16.6 p90 -111.28 152.54 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.817 -1.177 . . . . 0.0 111.641 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -128.23 -18.48 4.08 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.6 mt-10 -90.48 -56.83 3.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 4.8 p30 153.05 58.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 78.8 m -47.05 107.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.051 0.929 . . . . 0.0 112.815 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.75 87.67 2.79 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 175.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -57.97 -34.87 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.725 . . . . 0.0 110.527 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.45 -40.25 89.32 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 88.3 mt-10 -68.27 -33.33 74.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.1 mp -63.9 -44.08 97.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.48 -34.62 61.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.51 -34.33 75.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.38 -44.92 8.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -58.09 9.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.538 -0.978 . . . . 0.0 108.81 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.76 -40.82 73.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 38.7 t30 -61.23 -45.34 94.95 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 26' ' ' GLY . 2.8 tm? -53.91 -46.08 71.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 32' ' ' SER . 59.5 t -55.91 -33.8 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 108.825 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 31' ' ' VAL . 4.7 m -45.47 -39.8 7.61 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 35' ' ' ASP . 21.3 tp60 -69.34 -53.98 16.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.439 -0.788 . . . . 0.0 111.469 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.661 ' C ' ' H ' ' A' ' 36' ' ' THR . 17.4 mt -61.2 41.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.039 -1.663 . . . . 0.0 110.626 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.662 ' N ' ' O ' ' A' ' 33' ' ' GLN . 58.9 t0 -60.41 -3.81 0.74 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.661 ' H ' ' C ' ' A' ' 34' ' ' ILE . 45.3 p -76.9 -0.96 26.09 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.942 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 36' ' ' THR . 19.1 m 31.21 47.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 36' ' ' THR . 13.9 ptpt -124.46 42.45 3.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 63' ' ' THR . 28.2 t -175.63 179.45 1.41 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.414 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 93.0 m-85 -145.75 155.28 42.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.566 -1.334 . . . . 0.0 111.958 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 40' ' ' PHE . 71.2 mt-10 -157.06 126.52 6.08 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.356 0.598 . . . . 0.0 110.246 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.6 ' CD1' ' NZ ' ' B' ' 104' ' ' LYS . 0.1 OUTLIER -142.34 178.02 7.86 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' CE3' ' A' ' 42' ' ' TRP . . . -142.83 169.1 25.74 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.46 145.97 27.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -1.137 . . . . 0.0 109.369 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 86.5 m-20 -124.25 147.02 48.39 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.852 ' HD2' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -146.19 136.36 23.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.437 -1.414 . . . . 0.0 109.808 -174.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.73 ' O ' ' O ' ' A' ' 48' ' ' SER . 96.2 mt-10 -131.13 -0.7 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.707 -0.621 . . . . 0.0 109.343 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.73 ' O ' ' O ' ' A' ' 47' ' ' GLU . 29.7 t -49.01 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.514 ' N ' ' OG ' ' A' ' 48' ' ' SER . 76.0 m80 -70.7 152.59 43.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.461 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 88.2 m-20 -66.98 -41.65 86.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.481 ' O ' ' SD ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -69.2 -33.95 74.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.007 -1.058 . . . . 0.0 110.789 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' B' ' 95' ' ' LEU . 70.4 mt -87.26 -56.34 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.722 -1.236 . . . . 0.0 109.33 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.706 ' C ' ' H ' ' A' ' 55' ' ' GLY . 10.0 ptt180 -59.4 4.75 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 111.149 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.603 ' NE2' ' CD1' ' B' ' 96' ' ' LEU . 2.5 mt-30 59.64 -18.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.86 -1.15 . . . . 0.0 110.196 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.706 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 83.12 -17.27 23.89 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 121.434 -0.791 . . . . 0.0 112.921 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.852 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 6.1 p90 -60.47 117.02 4.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.275 -1.721 . . . . 0.0 109.897 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.562 ' OG1' ' NE2' ' A' ' 58' ' ' HIS . 70.1 p -51.68 -33.72 35.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.295 -0.878 . . . . 0.0 110.984 -175.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.562 ' NE2' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -175.44 159.93 2.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.847 -1.158 . . . . 0.0 110.114 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.51 169.28 17.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.347 -0.846 . . . . 0.0 109.249 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.36 127.5 37.72 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.484 -0.76 . . . . 0.0 109.094 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -93.15 98.49 11.33 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 8' ' ' HIS . 69.9 mtm -101.54 113.63 26.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.166 -0.958 . . . . 0.0 110.775 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' OG ' ' A' ' 39' ' ' SER . 34.2 m -123.03 141.99 51.35 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.87 162.05 19.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.698 -1.252 . . . . 0.0 110.118 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -81.97 -30.41 31.67 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -168.13 175.36 6.63 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -65.07 -24.84 67.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 111.419 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -61.38 -44.88 96.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.777 -1.202 . . . . 0.0 110.573 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.25 -34.3 74.93 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -65.98 -46.2 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.479 -1.012 . . . . 0.0 110.485 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 75' ' ' SER . 20.9 m -70.75 -28.93 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.345 -1.472 . . . . 0.0 108.668 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.12 -60.88 2.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 0.0 109.326 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -60.96 -55.86 27.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 111.177 -177.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.7 ' N ' ' CD2' ' A' ' 73' ' ' PHE . 12.8 t -57.09 -34.71 68.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.729 -1.232 . . . . 0.0 110.287 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 68.8 p -69.35 -26.44 64.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -0.955 . . . . 0.0 110.967 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 72' ' ' ALA . 41.9 m80 -65.1 151.46 93.6 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.843 -1.161 . . . . 0.0 109.648 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.74 -12.7 26.73 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.641 2.227 . . . . 0.0 112.439 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.32 -28.9 63.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.361 -0.837 . . . . 0.0 111.208 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.464 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 46.1 t60 -83.23 -32.8 26.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.017 -1.052 . . . . 0.0 110.227 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.84 -60.44 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.047 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.05 -37.6 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.14 -40.26 74.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.3 t -62.6 -41.09 98.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.21 74.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.972 -1.08 . . . . 0.0 108.706 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.63 -41.26 79.69 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.467 ' C ' ' O ' ' A' ' 85' ' ' ALA . 20.0 t80 -44.6 -31.26 1.09 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.3 m -82.53 -61.68 1.82 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.17 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.712 -0.617 . . . . 0.0 110.09 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.1 m -100.53 16.35 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 110.847 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.616 ' N ' ' O ' ' A' ' 87' ' ' THR . 41.1 mt -126.68 159.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.659 -1.276 . . . . 0.0 110.409 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.517 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 52.7 t0 -102.31 -31.91 10.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -151.9 149.44 28.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -125.06 124.23 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.653 -1.279 . . . . 0.0 109.73 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.42 HG12 HE21 ' B' ' 54' ' ' GLN . 46.3 t -126.95 131.33 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.8 138.17 32.05 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.34 -1.475 . . . . 0.0 111.741 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.673 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.16 125.72 49.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 31.4 p-10 -120.38 124.56 45.83 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.045 . . . . 0.0 108.907 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 86.3 t80 -154.05 123.74 3.26 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.1 -1.0 . . . . 0.0 110.531 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.03 136.22 14.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.345 2.03 . . . . 0.0 112.186 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.9 t -120.77 140.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.997 . . . . 0.0 110.028 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -113.46 96.97 6.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.34 76.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.018 . . . . 0.0 109.599 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 101' ' ' ALA . 13.2 m -148.42 118.85 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 0.0 109.176 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.591 ' NZ ' ' CD1' ' B' ' 42' ' ' TRP . 23.4 mmtm -144.73 -11.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.467 ' C ' ' O ' ' A' ' 104' ' ' LYS . 87.5 p -42.15 -24.5 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 108.93 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 104' ' ' LYS . 34.5 t -53.04 -83.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.36 -0.838 . . . . 0.0 109.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 106' ' ' SER . 44.2 t . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.84 170.03 41.29 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.748 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.99 131.24 44.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.29 -1.123 . . . . 0.0 108.064 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -99.77 125.86 45.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.946 -1.096 . . . . 0.0 112.854 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' B' ' 62' ' ' MET . 74.4 m80 -120.22 121.09 37.95 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 tt -136.19 143.34 44.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.736 -1.227 . . . . 0.0 109.399 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -128.69 136.22 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.505 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.16 126.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.24 153.9 27.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 117.757 -1.577 . . . . 0.0 113.016 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -126.4 154.68 43.27 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.519 ' H ' HG23 ' B' ' 57' ' ' THR . 17.1 p90 -111.17 152.58 26.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.923 -1.11 . . . . 0.0 111.589 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -128.18 -18.83 4.03 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.3 mt-10 -90.12 -56.94 3.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 4.8 p30 153.13 58.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 73.0 m -47.04 107.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.131 0.967 . . . . 0.0 112.821 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.515 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.88 87.72 2.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -57.91 -34.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.567 -0.708 . . . . 0.0 110.533 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.4 p-10 -66.76 -40.08 88.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 110.51 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 88.3 mt-10 -68.28 -33.15 73.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.446 HD13 ' N ' ' B' ' 23' ' ' ILE . 1.1 mp -64.26 -43.96 97.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.27 -34.92 61.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.36 -34.43 75.29 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.26 -44.75 8.58 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -57.98 10.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.555 -0.967 . . . . 0.0 108.799 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.8 -40.66 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.45 ' H ' ' HG3' ' B' ' 28' ' ' GLU . 38.7 t30 -61.41 -45.35 94.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' B' ' 26' ' ' GLY . 2.8 tm? -53.87 -46.06 71.18 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' B' ' 32' ' ' SER . 60.2 t -55.69 -34.01 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.301 -0.874 . . . . 0.0 108.839 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 31' ' ' VAL . 4.7 m -45.37 -39.77 7.21 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.667 ' O ' ' N ' ' B' ' 35' ' ' ASP . 21.5 tp60 -69.49 -53.88 16.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.493 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' B' ' 36' ' ' THR . 17.4 mt -61.31 41.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 119.939 -1.725 . . . . 0.0 110.588 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.667 ' N ' ' O ' ' B' ' 33' ' ' GLN . 60.6 t0 -60.55 -4.26 0.87 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.673 ' H ' ' C ' ' B' ' 34' ' ' ILE . 45.6 p -76.44 -1.4 26.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.62 ' C ' ' O ' ' B' ' 36' ' ' THR . 19.0 m 31.66 47.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.015 -1.053 . . . . 0.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' B' ' 36' ' ' THR . 13.9 ptpt -124.56 42.48 3.25 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' B' ' 63' ' ' THR . 28.5 t -175.56 179.39 1.44 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.408 ' O ' ' HG2' ' B' ' 41' ' ' GLU . 93.1 m-85 -145.8 155.28 42.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.582 -1.324 . . . . 0.0 111.93 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' B' ' 40' ' ' PHE . 71.7 mt-10 -157.1 126.43 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.783 -0.573 . . . . 0.0 110.272 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.591 ' CD1' ' NZ ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -142.23 177.95 7.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' B' ' 42' ' ' TRP . . . -142.74 168.89 25.79 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -149.31 145.65 27.14 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -1.128 . . . . 0.0 109.409 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 86.6 m-20 -123.84 147.05 47.94 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.852 ' HD2' ' O ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -146.15 136.44 23.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.349 -1.47 . . . . 0.0 109.737 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.714 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.9 mt-10 -131.1 -0.63 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.701 -0.624 . . . . 0.0 109.353 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.714 ' O ' ' O ' ' B' ' 47' ' ' GLU . 29.5 t -49.32 -151.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.204 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.513 ' N ' ' OG ' ' B' ' 48' ' ' SER . 76.1 m80 -70.63 152.41 43.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -0.994 . . . . 0.0 109.641 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.453 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 87.9 m-20 -66.69 -41.82 87.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.349 -0.844 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.482 ' O ' ' SD ' ' B' ' 51' ' ' MET . 0.4 OUTLIER -69.03 -33.95 74.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' B' ' 54' ' ' GLN . 70.9 mt -87.26 -56.46 3.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.778 -1.201 . . . . 0.0 109.197 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.732 ' C ' ' H ' ' B' ' 55' ' ' GLY . 9.8 ptt180 -59.33 4.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 111.266 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.611 ' NE2' ' CD1' ' A' ' 96' ' ' LEU . 2.3 mt-30 59.4 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.828 -1.17 . . . . 0.0 110.219 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.732 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 83.07 -17.18 24.13 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.379 -0.826 . . . . 0.0 112.856 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.852 ' O ' ' HD2' ' B' ' 46' ' ' LYS . 6.0 p90 -60.48 117.12 4.88 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.292 -1.711 . . . . 0.0 109.951 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.563 ' OG1' ' NE2' ' B' ' 58' ' ' HIS . 69.8 p -51.73 -33.53 35.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.258 -0.901 . . . . 0.0 111.002 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.563 ' NE2' ' OG1' ' B' ' 57' ' ' THR . 0.1 OUTLIER -175.61 159.71 2.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.787 -1.196 . . . . 0.0 110.183 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.3 169.39 17.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.504 -0.747 . . . . 0.0 109.294 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -131.3 127.7 38.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.433 -0.792 . . . . 0.0 109.093 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t -93.23 98.24 11.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' MET . . . . . 0.512 ' O ' ' N ' ' B' ' 8' ' ' HIS . 70.2 mtm -101.35 113.59 26.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.834 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.494 ' O ' ' OG ' ' B' ' 39' ' ' SER . 35.8 m -122.98 142.38 50.9 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -119.16 162.0 19.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.69 -1.257 . . . . 0.0 110.035 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -82.15 -30.08 31.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -168.43 175.22 6.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -65.05 -24.61 67.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 111.474 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -61.66 -44.84 96.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.803 -1.186 . . . . 0.0 110.647 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.99 -34.31 76.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -66.14 -46.17 78.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.565 -0.962 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.71 -28.92 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.382 -1.449 . . . . 0.0 108.666 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.08 -60.83 2.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.435 -0.791 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -60.97 -55.96 26.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 111.116 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.687 ' N ' ' CD2' ' B' ' 73' ' ' PHE . 13.0 t -57.05 -34.77 68.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.702 -1.249 . . . . 0.0 110.34 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 69.1 p -69.31 -26.25 64.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.088 -1.008 . . . . 0.0 110.965 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 72' ' ' ALA . 41.3 m80 -65.33 151.6 93.73 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.876 -1.14 . . . . 0.0 109.651 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.02 -12.24 25.82 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.678 2.252 . . . . 0.0 112.491 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -28.6 62.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.436 -0.79 . . . . 0.0 111.22 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.454 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 46.2 t60 -83.26 -32.84 26.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.943 -1.098 . . . . 0.0 110.249 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 66.6 t -62.91 -60.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.999 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.11 -37.52 61.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -70.21 -40.17 74.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.172 -0.955 . . . . 0.0 109.883 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.8 t -62.59 -41.2 98.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.29 74.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.973 -1.079 . . . . 0.0 108.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.52 -41.35 80.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.469 ' C ' ' O ' ' B' ' 85' ' ' ALA . 19.9 t80 -44.54 -31.37 1.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.593 ' O ' ' N ' ' B' ' 90' ' ' ILE . 6.5 m -82.53 -61.84 1.77 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.0 -29.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.681 -0.637 . . . . 0.0 110.086 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.2 m -100.67 16.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.161 -0.962 . . . . 0.0 110.843 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' B' ' 87' ' ' THR . 41.5 mt -126.73 159.23 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 0.0 110.474 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 51.9 t0 -102.48 -31.81 10.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -152.04 149.72 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -125.43 124.05 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.594 -1.316 . . . . 0.0 109.76 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.422 HG12 HE21 ' A' ' 54' ' ' GLN . 45.9 t -126.82 131.4 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.572 ' N ' ' CD1' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.273 -1.517 . . . . 0.0 111.79 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.668 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.0 OUTLIER -119.21 125.76 49.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.664 -0.648 . . . . 0.0 109.33 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 30.0 p-10 -120.43 124.3 45.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.065 -1.022 . . . . 0.0 108.961 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 86.1 t80 -153.79 123.91 3.36 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.091 -1.005 . . . . 0.0 110.547 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.22 136.08 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.358 2.039 . . . . 0.0 112.221 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.56 140.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 0.0 110.094 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -113.65 96.86 6.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 0.0 109.584 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.32 76.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' B' ' 101' ' ' ALA . 13.2 m -148.49 118.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.234 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.6 ' NZ ' ' CD1' ' A' ' 42' ' ' TRP . 23.1 mmtm -144.55 -11.97 0.6 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.478 ' C ' ' O ' ' B' ' 104' ' ' LYS . 85.6 p -42.2 -24.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.152 -0.968 . . . . 0.0 108.999 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.525 ' N ' ' O ' ' B' ' 104' ' ' LYS . 33.5 t -52.93 -83.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' B' ' 106' ' ' SER . 44.8 t . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.534 ' CG2' ' N ' ' A' ' 4' ' ' SER . 10.1 t -153.24 -48.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.937 . . . . 0.0 109.124 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.534 ' N ' ' CG2' ' A' ' 3' ' ' THR . 15.2 m -59.63 -69.05 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.18 -163.63 15.4 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.76 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -110.64 135.39 51.33 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.315 -1.109 . . . . 0.0 108.015 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 5.1 ttpm? -100.44 129.43 46.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.962 -1.086 . . . . 0.0 112.88 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' MET . 78.2 t60 -121.9 120.47 34.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -132.12 141.93 49.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.702 -1.249 . . . . 0.0 109.446 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.47 139.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.654 -0.654 . . . . 0.0 109.475 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.64 133.74 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.3 155.95 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.069 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.704 ' HZ1' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -119.8 152.26 37.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.56 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 8.9 p90 -107.88 151.51 25.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.835 -1.166 . . . . 0.0 111.565 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.13 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.6 tt0 -90.14 -56.48 3.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.8 m-20 152.63 66.86 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 65.1 m -52.46 107.0 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.087 0.946 . . . . 0.0 112.841 -176.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.531 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -72.72 85.55 1.21 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -54.63 -37.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.3 p-10 -63.42 -36.61 84.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 110.591 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 81.6 mt-10 -72.67 -37.61 67.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' GLY . 1.8 mm -58.46 -45.28 90.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -48.87 -36.25 16.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.35 -38.24 76.82 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -73.4 -25.11 73.63 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.1 tt -75.12 -60.18 2.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -1.025 . . . . 0.0 108.804 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -49.95 -31.58 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 32' ' ' SER . 75.0 m-20 -65.62 -43.5 89.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -47.22 -53.34 13.5 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.3 t -49.8 -30.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 108.856 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 10.6 t -45.15 -50.77 11.11 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.445 ' NE2' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -83.54 -9.04 59.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 111.393 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 36' ' ' THR . 12.3 mt -91.72 28.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.012 -1.68 . . . . 0.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.44 -9.39 2.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 34' ' ' ILE . 10.1 t -67.55 -7.71 28.19 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.959 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.6 m 34.99 34.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.12 -0.987 . . . . 0.0 109.173 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' THR . 32.5 mtmt -123.03 47.83 1.91 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 63' ' ' THR . 15.9 t -174.35 175.05 2.69 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.17 159.05 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.522 -1.361 . . . . 0.0 112.013 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -152.11 117.25 5.23 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.306 0.574 . . . . 0.0 110.22 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -105.74 167.16 9.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 150.27 17.13 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.73 -1.7 . . . . 0.0 110.851 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 78.0 mt-10 -152.1 143.81 23.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -1.167 . . . . 0.0 109.368 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.67 ' HA ' ' O ' ' A' ' 57' ' ' THR . 59.6 t0 -170.36 95.98 0.25 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.647 ' HZ1' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -84.34 156.54 21.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.484 -1.385 . . . . 0.0 109.853 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 48' ' ' SER . 84.7 mt-10 -158.91 82.2 0.79 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.587 ' HG ' ' CE1' ' A' ' 49' ' ' HIS . 1.1 t 160.82 151.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.189 -0.944 . . . . 0.0 110.222 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.587 ' CE1' ' HG ' ' A' ' 48' ' ' SER . 28.8 m80 62.56 105.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.927 . . . . 0.0 109.718 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -49.8 -43.61 48.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.377 -0.827 . . . . 0.0 110.775 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.552 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 24.8 ttt -60.16 -35.58 75.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.04 -1.037 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.64 -9.62 51.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.828 -1.17 . . . . 0.0 109.283 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.951 ' O ' ' N ' ' A' ' 55' ' ' GLY . 33.2 ttp180 -84.86 36.65 0.62 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.0 111.207 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 51' ' ' MET . 78.8 mm-40 -32.66 -10.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.77 -1.206 . . . . 0.0 110.173 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.951 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 102.72 -39.74 2.67 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 121.49 -0.756 . . . . 0.0 112.911 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -52.3 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.228 -1.748 . . . . 0.0 109.903 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 70.1 p -56.84 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 110.927 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.542 ' NE2' ' CG2' ' A' ' 12' ' ' VAL . 17.6 p-80 -122.0 152.36 39.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.826 -1.171 . . . . 0.0 110.085 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.6 168.77 19.38 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -138.28 133.46 33.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.433 -0.792 . . . . 0.0 109.095 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -100.43 96.11 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 8' ' ' HIS . 53.6 mtm -96.34 121.32 38.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.111 -0.993 . . . . 0.0 110.801 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.459 ' O ' ' OG ' ' A' ' 39' ' ' SER . 30.0 m -124.74 148.07 48.28 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -125.61 155.91 40.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.795 -1.191 . . . . 0.0 110.045 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 41.4 tp10 -78.12 -26.97 48.22 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.7 m-20 -163.66 171.0 16.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -59.95 -22.17 62.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.281 -0.887 . . . . 0.0 111.438 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -58.78 -39.0 79.76 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.716 -1.24 . . . . 0.0 110.524 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.47 71.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -66.64 -44.27 82.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.561 -0.964 . . . . 0.0 110.465 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.79 -28.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.372 -1.455 . . . . 0.0 108.671 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.488 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.06 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.559 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 1.4 t80 -52.74 -38.7 61.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.1 t -84.16 -31.42 25.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.719 -1.238 . . . . 0.0 110.267 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 71.2 m -67.48 -33.03 74.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 111.005 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.601 ' N ' ' HD1' ' A' ' 76' ' ' HIS . 0.9 OUTLIER -75.36 128.02 85.14 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.898 -1.126 . . . . 0.0 109.659 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -43.67 -7.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.9 tp -64.83 -29.53 70.5 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.395 -0.815 . . . . 0.0 111.247 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -84.34 -37.11 22.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.996 -1.065 . . . . 0.0 110.239 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.73 -61.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.949 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.81 -39.15 84.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.267 -0.895 . . . . 0.0 109.559 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.32 -45.01 70.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.795 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 t -62.39 -35.02 77.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.125 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.25 65.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 108.712 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -70.83 -42.16 70.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.456 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 18.9 t80 -45.73 -29.08 1.17 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' ' C ' ' A' ' 88' ' ' ALA . 11.2 m -82.31 -63.47 1.37 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.06 -32.34 0.09 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.624 -0.672 . . . . 0.0 110.012 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' THR . 19.3 m -98.84 13.01 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.927 . . . . 0.0 110.829 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 91' ' ' ASP . 1.1 mp -122.32 156.96 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.657 -1.277 . . . . 0.0 110.451 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 90' ' ' ILE . 59.4 t0 -103.57 -36.35 7.97 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.704 ' NZ ' ' HZ1' ' A' ' 13' ' ' LYS . 30.2 pttt -147.52 147.36 30.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' A' ' 93' ' ' ILE . 6.1 tp -123.42 117.73 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.608 -1.307 . . . . 0.0 109.791 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.78 127.1 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -133.79 129.2 36.24 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.365 -1.459 . . . . 0.0 111.761 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.69 119.36 35.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.332 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 61.3 t0 -125.1 131.67 53.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 108.899 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 51.9 t80 -169.26 135.36 1.4 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.06 -1.025 . . . . 0.0 110.548 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.9 Cg_exo -41.22 120.25 1.12 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.363 2.042 . . . . 0.0 112.128 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.3 143.18 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 110.019 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.12 67.78 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.682 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.03 98.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.054 -1.029 . . . . 0.0 109.53 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.72 128.59 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 109.136 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.654 ' O ' ' N ' ' A' ' 106' ' ' SER . 5.6 mptt -111.89 -32.29 6.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.342 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 106' ' ' SER . 1.2 m 63.42 -53.01 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 108.938 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 104' ' ' LYS . 1.4 p 73.12 148.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.0 109.348 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.477 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.57 -163.55 15.55 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.727 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -110.75 135.04 51.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.327 -1.102 . . . . 0.0 108.035 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 5.2 ttpm? -100.05 129.46 46.1 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.33 1.062 . . . . 0.0 112.778 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 77.7 t60 -121.88 120.53 34.76 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.04 142.05 49.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.762 -1.211 . . . . 0.0 109.467 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.48 139.32 51.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.83 133.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.538 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.23 156.3 21.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.048 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.694 ' HZ1' ' NZ ' ' B' ' 92' ' ' LYS . 0.0 OUTLIER -119.95 152.33 37.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 178.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 9.0 p90 -107.94 151.45 25.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.838 -1.164 . . . . 0.0 111.645 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.14 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -90.07 -56.53 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.7 m-20 152.68 66.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.429 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 64.4 m -52.35 107.09 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.991 0.901 . . . . 0.0 112.841 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.529 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -72.82 85.73 1.24 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.9 m -54.87 -37.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 110.441 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.9 p-10 -63.36 -36.45 83.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.485 -0.76 . . . . 0.0 110.549 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 81.1 mt-10 -72.96 -37.77 66.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' B' ' 26' ' ' GLY . 1.8 mm -58.31 -44.96 89.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -49.13 -36.21 18.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -58.16 -38.49 76.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -73.08 -25.34 73.77 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.1 tt -74.94 -60.13 2.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.948 . . . . 0.0 108.772 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -50.2 -31.26 13.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 32' ' ' SER . 75.3 m-20 -65.86 -43.49 88.26 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER -47.25 -53.1 14.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' B' ' 32' ' ' SER . 79.4 t -50.08 -30.4 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.363 -0.835 . . . . 0.0 108.811 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 11.2 t -45.36 -50.78 11.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.437 ' NE2' ' N ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -83.44 -9.25 59.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.79 . . . . 0.0 111.518 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.596 ' C ' ' H ' ' B' ' 36' ' ' THR . 12.7 mt -91.45 28.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.967 -1.708 . . . . 0.0 110.639 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -59.43 -9.2 2.21 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.596 ' H ' ' C ' ' B' ' 34' ' ' ILE . 9.6 t -67.56 -7.87 29.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.028 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.7 m 35.31 33.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.128 -0.983 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' B' ' 36' ' ' THR . 32.3 mtmt -122.86 47.79 1.9 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' B' ' 63' ' ' THR . 15.9 t -174.46 174.87 2.67 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.05 159.17 44.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.51 -1.369 . . . . 0.0 111.972 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -152.23 117.22 5.17 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.379 0.609 . . . . 0.0 110.225 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -105.72 167.2 9.93 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.84 150.48 17.15 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 118.734 -1.698 . . . . 0.0 110.835 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 77.6 mt-10 -152.23 143.75 23.45 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -1.105 . . . . 0.0 109.425 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' B' ' 57' ' ' THR . 59.5 t0 -170.11 95.82 0.26 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.625 ' HZ1' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -84.2 156.51 22.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.422 -1.424 . . . . 0.0 109.807 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' B' ' 48' ' ' SER . 84.3 mt-10 -158.94 82.06 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.591 ' HG ' ' CE1' ' B' ' 49' ' ' HIS . 1.1 t 160.94 151.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.176 -0.953 . . . . 0.0 110.192 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.591 ' CE1' ' HG ' ' B' ' 48' ' ' SER . 28.8 m80 62.8 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.682 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -49.62 -44.02 47.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.818 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.553 ' O ' ' NE2' ' B' ' 54' ' ' GLN . 24.8 ttt -59.78 -35.76 75.31 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.763 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 19.3 mt -88.65 -9.5 51.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.718 -1.239 . . . . 0.0 109.312 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.954 ' O ' ' N ' ' B' ' 55' ' ' GLY . 33.6 ttp180 -84.8 36.37 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 111.232 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' B' ' 51' ' ' MET . 78.8 mm-40 -32.48 -10.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 110.215 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.954 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 102.51 -39.63 2.71 Favored Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.425 -0.797 . . . . 0.0 112.805 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -52.34 101.57 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.554 1.677 . . . . 0.0 109.907 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 71.4 p -56.99 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 110.95 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.538 ' NE2' ' CG2' ' B' ' 12' ' ' VAL . 18.1 p-80 -121.97 152.12 40.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.908 -1.12 . . . . 0.0 110.127 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.38 168.72 19.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.0 109.301 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -138.24 133.69 33.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.042 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -100.56 96.19 7.2 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 53.5 mtm -96.5 121.43 38.31 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.172 -0.955 . . . . 0.0 110.73 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.456 ' O ' ' OG ' ' B' ' 39' ' ' SER . 28.5 m -125.03 147.64 48.87 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.23 156.19 38.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.724 -1.235 . . . . 0.0 110.081 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 41.8 tp10 -78.48 -26.82 46.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.7 m-20 -163.78 170.79 16.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -59.82 -21.82 61.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 111.501 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -59.13 -38.68 80.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 110.57 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.38 69.87 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.59 -44.42 82.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.618 -0.93 . . . . 0.0 110.433 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.73 -28.91 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.451 -1.405 . . . . 0.0 108.707 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.491 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.09 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.297 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 1.4 t80 -52.59 -38.94 61.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 111.123 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 4.1 t -84.07 -31.32 25.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.726 -1.234 . . . . 0.0 110.281 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 71.9 m -67.53 -32.85 73.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.974 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.585 ' N ' ' HD1' ' B' ' 76' ' ' HIS . 0.9 OUTLIER -75.53 128.09 84.7 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.885 -1.134 . . . . 0.0 109.602 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.77 -7.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 112.508 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.9 tp -64.84 -29.61 70.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.397 -0.815 . . . . 0.0 111.199 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -84.29 -37.14 22.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.238 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.68 -61.65 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 110.045 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.63 -39.21 83.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.33 -44.95 70.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.812 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 28.9 t -62.38 -35.18 78.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.1 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.29 65.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.675 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -70.79 -42.34 70.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.449 ' C ' ' O ' ' B' ' 85' ' ' ALA . 19.2 t80 -45.81 -28.86 1.16 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.452 ' O ' ' C ' ' B' ' 88' ' ' ALA . 11.1 m -82.37 -63.37 1.39 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.11 -32.36 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.708 -0.62 . . . . 0.0 110.122 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' B' ' 87' ' ' THR . 19.1 m -98.84 12.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.874 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.493 HG23 ' N ' ' B' ' 91' ' ' ASP . 1.1 mp -122.0 157.26 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 0.0 110.477 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.493 ' N ' HG23 ' B' ' 90' ' ' ILE . 59.1 t0 -103.89 -36.21 7.88 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.694 ' NZ ' ' HZ1' ' B' ' 13' ' ' LYS . 30.6 pttt -147.65 147.22 29.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' B' ' 93' ' ' ILE . 6.2 tp -123.42 117.87 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.517 -1.364 . . . . 0.0 109.721 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.86 127.24 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -133.99 129.16 35.77 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.258 -1.526 . . . . 0.0 111.73 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.64 119.37 35.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.652 -0.655 . . . . 0.0 109.328 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 62.0 t0 -125.04 131.78 53.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 108.929 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 52.1 t80 -169.36 135.25 1.37 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.105 -0.997 . . . . 0.0 110.53 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 87.6 Cg_exo -41.2 120.1 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.264 1.976 . . . . 0.0 112.247 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.16 143.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 110.025 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.16 68.0 0.67 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.514 -0.741 . . . . 0.0 109.581 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.12 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.623 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.52 128.49 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 109.237 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.646 ' O ' ' N ' ' B' ' 106' ' ' SER . 5.6 mptt -111.7 -32.43 6.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' B' ' 106' ' ' SER . 1.2 m 63.55 -53.21 0.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.13 -0.982 . . . . 0.0 108.892 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.646 ' N ' ' O ' ' B' ' 104' ' ' LYS . 1.4 p 73.24 148.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--N 1.302 -1.474 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.543 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.4 ' O ' ' OG ' ' A' ' 4' ' ' SER . 6.1 t -95.79 3.44 53.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 3' ' ' THR . 69.0 m -168.95 -89.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.28 168.68 18.35 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.671 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.62 131.57 55.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.242 -1.152 . . . . 0.0 108.022 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 25.2 ttpt -104.22 131.9 51.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.917 -1.114 . . . . 0.0 112.777 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 62' ' ' MET . 61.1 m80 -126.34 127.46 45.56 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.2 tt -135.72 142.53 45.05 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.767 -1.208 . . . . 0.0 109.496 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 4.3 p -130.66 140.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.547 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.74 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.654 ' O ' ' O ' ' A' ' 56' ' ' PHE . 3.4 m -132.38 143.39 40.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.104 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.458 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 14.2 mmtt -107.43 152.6 23.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.511 ' HB2' ' H ' ' A' ' 18' ' ' THR . 15.8 p90 -114.53 148.71 37.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.769 -1.207 . . . . 0.0 111.585 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.89 -23.43 4.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -93.05 -53.89 3.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.2 t0 150.1 67.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.3 m -49.03 105.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.13 0.967 . . . . 0.0 112.802 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -72.82 84.77 1.22 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.34 -37.72 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.549 -0.72 . . . . 0.0 110.456 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 34.1 p-10 -65.29 -38.33 89.89 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.479 -0.763 . . . . 0.0 110.544 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -70.08 -34.07 72.7 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.87 -44.07 97.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.31 -35.8 51.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -61.45 -34.59 75.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.46 -44.11 8.88 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -59.24 5.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.996 . . . . 0.0 108.856 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 22.1 pt-20 -52.17 -45.41 65.1 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.533 ' N ' ' CG ' ' A' ' 28' ' ' GLU . 3.8 t30 -58.15 -43.87 87.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -49.59 -44.25 46.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 34' ' ' ILE . 20.6 t -52.4 -22.35 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.221 -0.924 . . . . 0.0 108.888 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 34.3 t -40.62 -39.53 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.55 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 62.3 mm-40 -76.26 -23.81 54.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 111.461 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 36' ' ' THR . 75.8 mt -81.75 20.85 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.018 -1.676 . . . . 0.0 110.544 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -57.4 -6.47 0.45 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.676 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.3 t -87.93 2.96 50.33 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.943 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.9 m 35.31 35.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.073 -1.017 . . . . 0.0 109.195 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.9 mttt -115.34 39.87 2.84 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 71.0 m -173.04 175.84 3.14 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -147.3 157.41 43.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.966 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -154.41 120.3 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.436 0.636 . . . . 0.0 110.246 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 42' ' ' TRP . 1.1 m95 -123.37 170.27 10.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 164.4 24.92 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 118.695 -1.717 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 50.8 tt0 -154.72 148.1 25.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -113.17 141.3 47.1 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -139.39 108.08 5.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.41 -1.431 . . . . 0.0 109.829 -178.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.5 45.81 0.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.64 -0.663 . . . . 0.0 109.287 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.475 ' CB ' HH11 ' A' ' 53' ' ' ARG . 1.4 t -144.58 121.67 11.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.131 -0.98 . . . . 0.0 110.191 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.422 ' ND1' ' C ' ' A' ' 48' ' ' SER . 7.2 m80 65.97 118.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 109.753 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.15 -29.07 70.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.81 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -85.31 -36.05 21.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.01 -1.056 . . . . 0.0 110.712 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' B' ' 95' ' ' LEU . 27.0 mt -79.66 -72.87 0.38 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.729 -1.232 . . . . 0.0 109.273 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.86 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -73.15 4.67 4.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 111.252 -176.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 53' ' ' ARG . 15.4 mm100 39.1 6.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.819 -1.176 . . . . 0.0 110.204 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 50.79 2.87 0.04 OUTLIER Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.544 -0.722 . . . . 0.0 112.933 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.763 ' O ' ' CB ' ' A' ' 57' ' ' THR . 34.4 m-85 -39.12 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.189 -1.771 . . . . 0.0 109.976 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.763 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 16.8 m 99.8 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.287 -0.883 . . . . 0.0 110.938 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.526 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 18.5 t60 -164.56 152.08 11.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.885 -1.134 . . . . 0.0 110.173 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.19 167.28 22.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.31 -0.869 . . . . 0.0 109.249 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 95.2 m-85 -135.26 130.5 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.062 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.65 96.98 8.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.488 ' O ' ' N ' ' A' ' 8' ' ' HIS . 74.2 mtm -98.02 117.86 33.31 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.188 -0.945 . . . . 0.0 110.844 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -122.78 144.64 49.04 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.31 159.12 28.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.702 -1.249 . . . . 0.0 110.068 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 41.6 tp10 -82.7 -31.47 28.52 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 65' ' ' GLU . 80.6 m-20 -161.73 169.37 21.58 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.51 ' CB ' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -55.18 -21.66 14.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 111.437 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -56.52 -40.48 75.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.788 -1.195 . . . . 0.0 110.611 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.17 -37.59 72.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -62.63 -45.12 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.623 -0.928 . . . . 0.0 110.522 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.368 -1.457 . . . . 0.0 108.653 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' CD2' ' A' ' 76' ' ' HIS . . . -65.07 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.381 -0.825 . . . . 0.0 109.381 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.488 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -51.68 -37.74 51.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 111.134 -177.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -84.99 -33.97 22.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.802 -1.186 . . . . 0.0 110.299 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.4 t -71.34 -25.6 62.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 0.0 110.95 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.55 ' CD2' ' OE1' ' A' ' 33' ' ' GLN . 84.1 m-70 -81.01 121.35 80.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.852 -1.155 . . . . 0.0 109.604 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.36 -13.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.638 2.225 . . . . 0.0 112.457 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -64.0 -26.97 68.81 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.346 -0.846 . . . . 0.0 111.277 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.488 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 7.4 t-160 -81.66 -30.45 32.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.06 . . . . 0.0 110.236 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' ' OG ' ' A' ' 83' ' ' SER . 68.9 t -61.09 -60.21 3.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.66 -40.24 62.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -66.6 -33.52 75.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.83 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 80' ' ' VAL . 57.4 p -61.33 -43.79 98.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.105 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.48 -37.06 67.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 108.714 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.588 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -72.18 -40.53 67.87 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.606 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.28 -40.96 0.37 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' VAL . 24.3 m -81.94 -60.36 2.26 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.59 -10.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.669 -0.644 . . . . 0.0 110.047 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 10.5 m -124.8 -7.86 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.191 -0.943 . . . . 0.0 110.853 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 65.4 mt -131.1 162.99 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.588 -1.32 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.512 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 12.0 t0 -121.44 -24.01 5.51 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.73 139.02 32.76 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 tp -128.97 127.31 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.596 -1.315 . . . . 0.0 109.83 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 t -128.38 132.36 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -137.58 132.55 33.28 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.315 -1.49 . . . . 0.0 111.75 -178.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.8 121.36 42.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.723 -0.611 . . . . 0.0 109.364 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.674 ' O ' ' NE ' ' B' ' 53' ' ' ARG . 59.7 m-20 -123.75 128.3 49.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.081 -1.012 . . . . 0.0 108.869 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 99' ' ' PRO . 63.6 t80 -165.48 131.67 2.09 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.519 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 88.7 Cg_exo -47.52 133.41 20.83 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.288 1.992 . . . . 0.0 112.25 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.47 141.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.034 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -103.11 70.96 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.25 82.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.578 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 101' ' ' ALA . 29.1 m -127.53 -15.96 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 106' ' ' SER . 4.7 mptt 44.61 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -65.43 53.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 108.942 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 104' ' ' LYS . 6.3 t -83.98 38.89 0.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.636 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.11 168.88 18.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.726 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.77 131.7 55.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 25.1 ttpt -104.43 131.65 51.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.938 -1.101 . . . . 0.0 112.881 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 62' ' ' MET . 60.9 m80 -126.13 127.57 45.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.2 tt -135.77 142.56 44.96 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.741 -1.225 . . . . 0.0 109.385 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 4.2 p -130.69 140.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.56 -0.712 . . . . 0.0 109.528 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.77 132.85 70.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.645 ' O ' ' O ' ' B' ' 56' ' ' PHE . 3.5 m -132.73 143.18 40.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 117.762 -1.575 . . . . 0.0 112.993 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 14.2 mmtt -107.25 152.22 24.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.502 ' HB2' ' H ' ' B' ' 18' ' ' THR . 15.8 p90 -114.03 149.12 35.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.187 . . . . 0.0 111.58 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -124.0 -23.59 4.58 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.4 mt-10 -92.88 -53.96 3.94 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.1 t0 150.17 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.502 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.7 m -48.99 105.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.105 0.955 . . . . 0.0 112.887 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.481 ' HD3' ' H ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -72.79 84.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -58.41 -37.53 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 34.4 p-10 -65.52 -38.29 89.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.514 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.498 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 0.4 OUTLIER -70.05 -33.99 72.65 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.84 -44.11 98.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.27 -35.7 50.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -61.56 -34.71 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.31 -43.71 9.32 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.43 -59.01 5.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.944 . . . . 0.0 108.809 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 22.3 pt-20 -52.37 -45.23 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.527 ' N ' ' CG ' ' B' ' 28' ' ' GLU . 3.8 t30 -58.22 -43.93 87.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -49.76 -43.92 48.35 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' B' ' 34' ' ' ILE . 20.8 t -52.61 -22.33 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 36.4 t -40.65 -39.48 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.552 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 62.0 mm-40 -76.28 -23.73 54.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.765 . . . . 0.0 111.497 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.665 ' C ' ' H ' ' B' ' 36' ' ' THR . 75.9 mt -81.85 20.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.014 -1.679 . . . . 0.0 110.585 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.5 p30 -57.45 -6.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.665 ' H ' ' C ' ' B' ' 34' ' ' ILE . 1.3 t -87.89 3.0 50.15 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.986 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.566 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.0 m 35.43 35.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.101 -1.0 . . . . 0.0 109.154 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 36' ' ' THR . 64.8 mttt -115.17 40.11 2.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 73.2 m -173.4 175.72 3.0 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -147.18 157.53 43.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.478 -1.389 . . . . 0.0 111.972 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -154.54 120.5 5.25 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.356 0.598 . . . . 0.0 110.235 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.635 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 1.1 m95 -123.63 170.15 10.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.58 164.26 24.91 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 50.9 tt0 -154.48 148.07 25.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.254 -1.145 . . . . 0.0 109.354 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -113.19 141.02 47.44 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.56 ' CD ' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -139.35 108.04 5.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.357 -1.464 . . . . 0.0 109.889 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.38 45.54 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.689 -0.632 . . . . 0.0 109.395 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.467 ' CB ' HH11 ' B' ' 53' ' ' ARG . 1.4 t -144.24 121.94 11.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 110.166 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.417 ' ND1' ' C ' ' B' ' 48' ' ' SER . 7.2 m80 65.66 118.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.207 -0.933 . . . . 0.0 109.728 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -62.23 -29.33 70.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.332 -0.855 . . . . 0.0 110.781 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 89.5 mtp -85.23 -35.89 21.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.03 -1.044 . . . . 0.0 110.768 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' A' ' 95' ' ' LEU . 27.2 mt -79.7 -72.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.755 -1.216 . . . . 0.0 109.291 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.852 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.6 OUTLIER -73.2 4.51 4.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 111.22 -176.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.474 ' C ' ' O ' ' B' ' 53' ' ' ARG . 15.4 mm100 39.15 6.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.804 -1.185 . . . . 0.0 110.213 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.852 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 50.46 2.91 0.04 OUTLIER Glycine 0 N--CA 1.499 2.835 0 O-C-N 121.515 -0.74 . . . . 0.0 112.909 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' CB ' ' B' ' 57' ' ' THR . 33.7 m-85 -39.04 -25.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.274 -1.721 . . . . 0.0 110.004 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.768 ' CB ' ' O ' ' B' ' 56' ' ' PHE . 16.1 m 99.7 -62.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.281 -0.887 . . . . 0.0 110.982 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.52 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 18.6 t60 -164.31 152.04 12.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.862 -1.148 . . . . 0.0 110.127 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.468 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.19 167.13 22.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.536 -0.727 . . . . 0.0 109.301 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.52 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 95.2 m-85 -135.01 130.71 36.11 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.485 -0.759 . . . . 0.0 109.08 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.66 97.06 8.71 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' MET . . . . . 0.448 ' O ' ' N ' ' B' ' 8' ' ' HIS . 74.6 mtm -98.12 117.82 33.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.175 -0.953 . . . . 0.0 110.741 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -122.84 144.44 49.2 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.12 159.04 27.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.75 -1.219 . . . . 0.0 110.062 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' B' ' 66' ' ' ASN . 42.1 tp10 -82.57 -31.33 29.06 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' B' ' 65' ' ' GLU . 80.7 m-20 -161.93 169.6 20.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.511 ' CB ' ' NZ ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -55.25 -21.73 15.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.493 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.4 -40.76 75.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.789 -1.195 . . . . 0.0 110.534 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.89 -37.84 75.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -62.28 -45.47 93.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.592 -0.946 . . . . 0.0 110.374 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.67 -28.94 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.455 -1.403 . . . . 0.0 108.732 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' B' ' 76' ' ' HIS . . . -65.12 -60.86 2.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.315 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.491 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.1 OUTLIER -51.35 -38.1 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.86 . . . . 0.0 111.146 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -84.74 -33.99 22.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.732 -1.23 . . . . 0.0 110.324 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 36.3 t -71.29 -25.97 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.942 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.552 ' CD2' ' OE1' ' B' ' 33' ' ' GLN . 83.7 m-70 -80.63 121.32 81.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.796 -1.19 . . . . 0.0 109.557 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.39 -13.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.69 2.26 . . . . 0.0 112.413 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' B' ' 76' ' ' HIS . 0.6 OUTLIER -63.65 -27.32 69.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.776 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.491 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 7.4 t-160 -81.47 -30.32 33.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 110.301 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.421 ' O ' ' OG ' ' B' ' 83' ' ' SER . 68.9 t -61.18 -60.24 3.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.76 -40.06 62.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.518 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -66.56 -33.78 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.93 . . . . 0.0 109.877 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 80' ' ' VAL . 56.6 p -61.06 -43.9 98.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.1 -1.0 . . . . 0.0 110.134 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.31 -37.26 67.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.034 -1.042 . . . . 0.0 108.72 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.582 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -72.04 -40.72 68.18 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.606 ' O ' ' HB ' ' B' ' 90' ' ' ILE . 0.0 OUTLIER -37.1 -40.89 0.33 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.548 ' C ' ' H ' ' B' ' 89' ' ' VAL . 24.6 m -82.16 -60.34 2.25 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.52 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.783 -0.573 . . . . 0.0 110.103 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' B' ' 87' ' ' THR . 10.4 m -124.94 -7.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 110.855 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 66.2 mt -131.04 162.89 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.618 -1.301 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.519 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 12.0 t0 -121.28 -24.33 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.58 139.22 33.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 tp -129.28 127.34 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.542 -1.349 . . . . 0.0 109.755 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 60.7 t -128.35 132.52 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -137.71 132.48 32.91 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.254 -1.528 . . . . 0.0 111.783 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.404 HD11 ' H ' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -115.66 121.49 42.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.68 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 60.3 m-20 -123.73 128.23 49.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.066 -1.021 . . . . 0.0 108.934 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 99' ' ' PRO . 63.7 t80 -165.31 131.65 2.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.55 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . 0.514 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 88.2 Cg_exo -47.59 133.15 21.13 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.256 1.971 . . . . 0.0 112.225 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.22 141.28 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.049 -1.032 . . . . 0.0 110.064 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -102.88 71.11 1.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.487 -0.758 . . . . 0.0 109.602 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.46 82.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.123 -0.985 . . . . 0.0 109.574 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' B' ' 101' ' ' ALA . 29.1 m -127.65 -15.92 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.18 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' B' ' 106' ' ' SER . 4.7 mptt 44.73 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.353 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -65.34 53.97 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -0.976 . . . . 0.0 108.959 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.557 ' N ' ' O ' ' B' ' 104' ' ' LYS . 6.3 t -84.07 38.95 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.57 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.382 0.611 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 4' ' ' SER . 6.7 t -67.3 -51.49 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.5 ' N ' ' CG2' ' A' ' 3' ' ' THR . 9.7 m -140.85 -117.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.25 142.62 46.6 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.641 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -113.59 128.83 56.58 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.297 -1.119 . . . . 0.0 108.011 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -110.07 138.87 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.929 -1.107 . . . . 0.0 112.776 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.27 129.74 43.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -135.46 143.39 45.86 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.698 -1.251 . . . . 0.0 109.522 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 10.4 p -128.5 138.05 55.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.642 -0.661 . . . . 0.0 109.508 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.97 130.67 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -136.96 165.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.78 -1.568 . . . . 0.0 113.07 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 39.2 tptt -130.43 151.4 50.96 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 10.0 p90 -108.87 150.16 28.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.838 -1.164 . . . . 0.0 111.615 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.37 -22.64 5.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.9 mt-10 -91.26 -53.68 4.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.8 t0 149.39 69.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.454 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.2 m -55.85 109.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.082 0.944 . . . . 0.0 112.857 -177.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.633 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.73 91.11 5.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -61.36 -33.45 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 110.453 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.8 p-10 -68.3 -41.52 80.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.451 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.677 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 70.3 tt0 -66.72 -28.32 68.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 23' ' ' ILE . 13.1 mt -74.46 -39.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.7 -40.41 79.42 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -60.51 -26.11 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . -81.26 -45.29 7.56 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 tt -49.0 -51.92 27.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.484 -1.01 . . . . 0.0 108.809 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 17.1 pt-20 -53.06 -43.29 66.57 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -57.41 -43.52 83.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -46.91 -45.35 20.49 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 34' ' ' ILE . 23.0 t -51.6 -23.37 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 108.933 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 41.9 t -42.86 -46.55 5.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.534 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 82.0 mm-40 -74.55 -20.47 59.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.374 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 36' ' ' THR . 58.0 mt -82.62 22.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.05 -1.656 . . . . 0.0 110.643 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.8 p30 -59.46 -8.78 1.98 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 34' ' ' ILE . 36.2 p -82.64 -0.97 49.66 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.981 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.6 m 35.59 31.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' THR . 42.0 mttm -117.66 40.76 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.6 p -173.11 173.96 3.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.72 159.12 44.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -153.96 121.04 5.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.395 0.617 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.401 ' CD1' ' NZ ' ' B' ' 104' ' ' LYS . 9.5 m-90 -124.03 167.02 14.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 44' ' ' GLU . . . -125.48 157.98 19.73 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.756 -1.688 . . . . 0.0 110.823 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.659 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 73.9 mm-40 -148.35 136.9 21.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.247 -1.149 . . . . 0.0 109.397 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -111.09 141.02 45.14 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.851 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -143.42 117.26 9.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.454 -1.404 . . . . 0.0 109.763 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -153.56 -15.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 49' ' ' HIS . 0.7 OUTLIER -69.57 122.0 18.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 0.0 110.177 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.494 ' O ' ' O ' ' A' ' 48' ' ' SER . 48.1 m80 59.36 126.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.985 . . . . 0.0 109.678 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -67.02 -34.89 78.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.816 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.523 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -77.44 -37.94 50.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 0.0 110.687 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' B' ' 95' ' ' LEU . 19.3 mt -78.79 -71.15 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.74 -1.225 . . . . 0.0 109.266 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.566 ' C ' ' H ' ' A' ' 55' ' ' GLY . 3.7 mmt-85 -72.25 12.63 0.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.901 . . . . 0.0 111.258 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.417 ' C ' ' H ' ' A' ' 56' ' ' PHE . 76.1 mt-30 50.67 7.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.765 -1.209 . . . . 0.0 110.171 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.674 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 55.87 -0.42 0.12 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.361 -0.837 . . . . 0.0 112.891 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.674 ' O ' ' O ' ' A' ' 55' ' ' GLY . 4.8 m-85 -53.19 -142.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.157 -1.79 . . . . 0.0 109.914 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.503 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 35.3 m -135.82 -47.49 0.67 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.659 ' CE1' ' H ' ' A' ' 44' ' ' GLU . 27.4 t60 -172.76 160.06 4.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.96 -1.087 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.611 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.55 163.01 34.08 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.46 -0.775 . . . . 0.0 109.231 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 82.6 m-85 -133.42 129.59 37.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.499 -0.751 . . . . 0.0 109.121 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.29 98.7 8.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.6 mtt -98.68 119.68 37.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.234 -0.916 . . . . 0.0 110.76 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -119.37 140.62 50.06 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.07 125.83 44.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.083 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -50.87 -32.14 19.51 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -156.03 162.28 40.33 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -60.59 -21.83 63.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 111.493 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 34.0 p-10 -55.94 -36.43 67.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.773 -1.204 . . . . 0.0 110.532 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.18 -31.99 63.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -67.79 -44.36 77.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.973 . . . . 0.0 110.436 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 75' ' ' SER . 20.9 m -70.76 -28.95 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.404 -1.435 . . . . 0.0 108.686 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.05 -60.89 2.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.373 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 73' ' ' PHE . 1.6 t80 -56.59 -60.13 3.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.11 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 t -52.29 -34.46 46.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.734 -1.228 . . . . 0.0 110.3 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 66.3 m -77.96 -16.22 58.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.959 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 78' ' ' LEU . 22.6 m80 -79.24 132.18 63.72 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.152 . . . . 0.0 109.57 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -42.22 -12.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.697 2.264 . . . . 0.0 112.394 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.5 tp -74.44 -27.28 60.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.423 -0.798 . . . . 0.0 111.292 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.83 -45.13 21.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.957 -1.09 . . . . 0.0 110.206 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.2 p -59.44 -58.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 110.01 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.593 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 15.2 tm-20 -51.01 -36.65 40.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.92 -32.02 73.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.758 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.05 -44.23 94.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.44 -33.28 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.921 -1.112 . . . . 0.0 108.73 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.566 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -79.42 -46.37 17.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.699 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -38.81 -40.15 0.59 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' VAL . 20.3 m -82.17 -62.53 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.86 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.676 -0.64 . . . . 0.0 110.097 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' THR . 9.1 m -117.46 -1.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 0.0 110.771 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 68.4 mt -132.93 164.02 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 110.512 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.538 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 38.4 t0 -124.14 -26.82 3.94 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 18.9 ttpt -133.81 131.17 38.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -126.32 125.59 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.596 -1.315 . . . . 0.0 109.768 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 t -132.2 134.5 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -136.47 131.65 34.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.294 -1.503 . . . . 0.0 111.764 -178.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -116.05 122.57 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.645 -0.659 . . . . 0.0 109.391 177.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.549 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 38.5 p-10 -126.11 132.49 51.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -159.81 128.72 3.08 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.087 -1.008 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 131.46 12.67 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.37 2.046 . . . . 0.0 112.186 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.9 t -113.42 135.37 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.96 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -107.96 88.3 2.7 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.451 -0.781 . . . . 0.0 109.56 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.469 ' O ' ' CG1' ' A' ' 103' ' ' VAL . . . -57.71 73.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.647 ' N ' ' O ' ' A' ' 101' ' ' ALA . 4.5 m -161.01 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.099 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 106' ' ' SER . 24.0 mmtm -97.7 4.57 49.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.412 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.35 -53.53 0.27 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 108.879 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 104' ' ' LYS . 20.1 m 47.17 45.01 16.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t . . . . . 0 C--N 1.301 -1.509 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.721 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.22 142.69 46.52 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.693 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -113.67 128.74 56.54 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.218 -1.166 . . . . 0.0 108.033 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -109.91 138.63 46.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.862 -1.149 . . . . 0.0 112.822 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.09 129.68 43.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.0 tt -135.35 143.45 46.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.433 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 10.3 p -128.34 137.97 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.478 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.92 130.79 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.04 165.49 27.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.663 -1.615 . . . . 0.0 113.028 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.497 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 39.1 tptt -130.39 151.41 50.91 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 9.9 p90 -108.84 150.11 28.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.795 -1.191 . . . . 0.0 111.558 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.36 -22.82 4.98 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.9 mt-10 -91.03 -53.77 4.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.7 t0 149.47 69.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.459 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -56.0 109.76 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.129 0.966 . . . . 0.0 112.778 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.627 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.87 91.31 5.97 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.38 -33.55 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.647 . . . . 0.0 110.495 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.6 p-10 -68.13 -41.56 81.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.542 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.667 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 70.7 tt0 -66.85 -28.09 68.07 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.409 HG21 HD12 ' B' ' 23' ' ' ILE . 12.9 mt -74.7 -39.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.62 -40.57 79.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.1 OUTLIER -60.36 -26.19 66.42 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' B' ' 25' ' ' LYS . . . -81.06 -45.47 7.56 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 tt -48.91 -51.98 27.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -1.032 . . . . 0.0 108.855 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 17.0 pt-20 -53.09 -43.33 66.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.0 OUTLIER -57.34 -43.47 83.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -47.1 -45.34 22.05 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 34' ' ' ILE . 23.2 t -51.47 -23.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.299 -0.876 . . . . 0.0 108.767 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 41.7 t -42.74 -46.47 5.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.527 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 81.9 mm-40 -74.57 -20.47 59.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 111.533 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' B' ' 36' ' ' THR . 58.1 mt -82.65 22.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.972 -1.705 . . . . 0.0 110.563 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.1 p30 -59.5 -8.88 2.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.6 ' H ' ' C ' ' B' ' 34' ' ' ILE . 36.3 p -82.52 -0.98 49.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.953 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.9 m 35.53 31.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.063 -1.023 . . . . 0.0 109.187 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.597 ' N ' ' O ' ' B' ' 36' ' ' THR . 42.2 mttm -117.64 40.73 3.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 95.6 p -173.07 173.94 3.56 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.525 -0.735 . . . . 0.0 109.031 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.73 158.99 44.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.521 -1.362 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -153.82 120.95 5.72 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.314 0.578 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.4 ' CD1' ' NZ ' ' A' ' 104' ' ' LYS . 9.4 m-90 -124.0 166.77 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' B' ' 44' ' ' GLU . . . -125.43 157.94 19.68 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.754 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.658 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 74.1 mm-40 -148.26 136.97 21.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.253 -1.146 . . . . 0.0 109.42 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -111.11 141.05 45.12 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.848 ' HG2' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -143.4 117.29 9.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.384 -1.448 . . . . 0.0 109.785 -178.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -153.62 -15.25 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.33 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.492 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 0.7 OUTLIER -69.62 121.87 17.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' B' ' 48' ' ' SER . 48.0 m80 59.55 126.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.076 -1.015 . . . . 0.0 109.701 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -67.07 -34.87 78.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.402 -0.811 . . . . 0.0 110.823 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.527 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -77.45 -37.89 50.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 110.749 -178.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' A' ' 95' ' ' LEU . 19.1 mt -78.75 -71.35 0.44 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.699 -1.25 . . . . 0.0 109.307 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.553 ' C ' ' H ' ' B' ' 55' ' ' GLY . 3.7 mmt-85 -72.06 12.59 0.4 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 111.268 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' B' ' 56' ' ' PHE . 76.0 mt-30 50.65 7.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.826 -1.171 . . . . 0.0 110.167 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.676 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 56.01 -0.38 0.13 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.468 -0.77 . . . . 0.0 112.865 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.676 ' O ' ' O ' ' B' ' 55' ' ' GLY . 4.7 m-85 -53.31 -142.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.323 -1.692 . . . . 0.0 109.985 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.501 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 37.5 m -135.55 -47.46 0.69 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.852 . . . . 0.0 111.003 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.658 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 27.2 t60 -172.78 160.32 4.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.624 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.81 163.07 33.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.449 -0.782 . . . . 0.0 109.282 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 82.3 m-85 -133.43 129.7 37.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.529 -0.732 . . . . 0.0 109.076 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.32 98.73 8.82 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.7 mtt -98.77 119.71 37.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.234 -0.916 . . . . 0.0 110.793 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.5 m -119.48 140.77 49.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -125.3 125.67 43.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.704 -1.247 . . . . 0.0 110.058 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.82 -32.07 19.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -156.01 162.39 40.33 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.73 -21.67 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 111.451 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 33.6 p-10 -56.06 -36.36 67.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.722 -1.236 . . . . 0.0 110.569 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -72.09 -31.99 63.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -67.78 -44.37 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.955 . . . . 0.0 110.506 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.2 m -70.78 -28.9 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.431 -1.418 . . . . 0.0 108.691 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.532 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.465 -0.772 . . . . 0.0 109.348 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' B' ' 73' ' ' PHE . 1.6 t80 -56.59 -60.35 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.125 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 10.2 t -52.03 -34.49 43.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.715 -1.24 . . . . 0.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 66.5 m -78.01 -16.28 58.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 0.0 110.9 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' B' ' 78' ' ' LEU . 22.8 m80 -79.23 132.15 63.8 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.874 -1.141 . . . . 0.0 109.621 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.401 ' O ' HG13 ' B' ' 80' ' ' VAL . 64.2 Cg_exo -42.12 -12.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.625 2.217 . . . . 0.0 112.435 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.5 tp -74.38 -27.27 60.58 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.372 -0.83 . . . . 0.0 111.236 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.87 -44.99 21.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.029 -1.044 . . . . 0.0 110.307 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.594 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.2 p -59.55 -58.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.594 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 15.2 tm-20 -50.91 -36.72 39.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.26 -0.9 . . . . 0.0 109.602 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.88 -31.96 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.853 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.0 -44.34 94.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.029 . . . . 0.0 110.118 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.15 70.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.928 -1.108 . . . . 0.0 108.685 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.555 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -79.39 -46.43 17.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.702 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -38.96 -40.01 0.6 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 21.0 m -82.24 -62.42 1.63 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.77 -16.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.767 -0.583 . . . . 0.0 110.126 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.0 m -117.25 -1.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.166 -0.959 . . . . 0.0 110.835 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 68.4 mt -132.99 163.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.67 -1.268 . . . . 0.0 110.457 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 38.5 t0 -124.04 -27.0 3.94 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.644 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 18.9 ttpt -133.77 131.16 39.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -126.41 125.62 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.568 -1.333 . . . . 0.0 109.735 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 12.0 t -132.22 134.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -136.56 131.57 34.0 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.188 -1.57 . . . . 0.0 111.814 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.476 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -116.02 122.69 45.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.701 -0.624 . . . . 0.0 109.317 177.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.551 ' O ' ' CZ ' ' A' ' 53' ' ' ARG . 38.7 p-10 -126.3 132.47 51.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.097 -1.002 . . . . 0.0 108.948 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -159.83 128.68 3.06 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.005 . . . . 0.0 110.529 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.79 131.37 13.2 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.283 1.988 . . . . 0.0 112.257 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.18 135.38 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -107.89 88.31 2.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 109.636 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . 0.465 ' O ' ' CG1' ' B' ' 103' ' ' VAL . . . -57.63 73.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.617 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.66 ' N ' ' O ' ' B' ' 101' ' ' ALA . 4.6 m -160.99 99.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 0.0 109.189 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.624 ' O ' ' N ' ' B' ' 106' ' ' SER . 24.1 mmtm -97.74 4.56 49.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.325 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.38 -53.46 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.147 -0.97 . . . . 0.0 108.93 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.624 ' N ' ' O ' ' B' ' 104' ' ' LYS . 20.6 m 47.13 45.04 15.94 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.338 -0.851 . . . . 0.0 109.385 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 72.2 t . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.625 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.445 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 70.35 -26.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.145 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.63 ' H ' ' C ' ' A' ' 2' ' ' ALA . 43.4 p -143.37 -136.85 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.37 168.56 26.96 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.73 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 131.6 47.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.173 -1.193 . . . . 0.0 108.0 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 19.7 ttpt -110.15 139.04 45.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 112.745 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -129.4 127.81 41.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.9 tt -136.47 146.3 46.15 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.761 -1.212 . . . . 0.0 109.48 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 p -127.8 134.76 64.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.501 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.68 127.35 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.34 159.62 32.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.041 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 17.8 tptt -129.46 152.98 48.4 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 8.0 p90 -106.24 148.85 27.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.906 -1.121 . . . . 0.0 111.626 -177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.62 -22.92 3.52 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 85.0 tt0 -89.47 -58.17 2.62 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.3 t0 155.94 72.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 44.8 m -66.15 109.75 2.73 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 112.834 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.613 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.72 92.2 5.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' LEU . 15.7 m -61.55 -35.97 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.1 p-10 -68.1 -41.65 81.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 65.5 tt0 -71.47 -32.68 68.57 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.22 -36.94 69.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' VAL . 12.8 tp -52.72 -39.98 62.58 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -39.58 84.2 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 29' ' ' ASN . . . -61.59 -54.36 36.37 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 48.5 mt -52.63 -47.85 66.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.551 -0.97 . . . . 0.0 108.769 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.66 -39.43 61.84 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -63.18 -42.52 99.38 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.0 mm? -49.93 -46.75 52.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 34' ' ' ILE . 22.0 t -48.77 -25.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.283 -0.886 . . . . 0.0 108.846 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 68.5 m -42.83 -40.61 2.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.44 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 98.1 mm-40 -71.1 -17.98 62.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 111.478 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 89.1 mt -80.59 18.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.024 -1.672 . . . . 0.0 110.588 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.5 -12.8 4.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 38' ' ' LYS . 4.0 t -89.28 0.52 56.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.586 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 34.24 34.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.987 -1.071 . . . . 0.0 109.157 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.0 mttt -117.54 41.75 2.76 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -177.87 179.12 0.9 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -148.33 159.84 43.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.566 -1.334 . . . . 0.0 111.955 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.492 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 76.3 mt-10 -155.96 123.76 5.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.394 0.616 . . . . 0.0 110.165 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 24.1 m95 -125.29 165.88 17.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 44' ' ' GLU . . . -161.45 150.7 20.56 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.793 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 43' ' ' GLY . 7.5 tp10 -163.66 175.19 10.83 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 11.3 p-10 -118.34 170.0 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -61.26 84.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.409 -1.432 . . . . 0.0 109.847 -178.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.6 mt-10 -107.03 42.5 1.29 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.345 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 97' ' ' ASP . 0.7 OUTLIER -139.87 -142.66 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.994 . . . . 0.0 110.193 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 50' ' ' ASP . 78.9 m80 -95.99 136.97 35.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.218 -0.927 . . . . 0.0 109.675 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' HIS . 90.8 m-20 -41.52 -35.73 0.77 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.0 110.789 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -79.02 -29.19 43.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 0.0 110.733 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.8 mt -94.31 -22.77 18.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.697 -1.252 . . . . 0.0 109.275 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 55' ' ' GLY . 2.7 ptt180 -96.08 4.01 52.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.327 -0.858 . . . . 0.0 111.218 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 53' ' ' ARG . 35.3 tt0 40.71 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.733 -1.229 . . . . 0.0 110.171 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 57.53 1.12 0.45 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 121.39 -0.819 . . . . 0.0 112.816 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 56' ' ' PHE . 32.1 p90 -55.29 129.36 38.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.281 -1.717 . . . . 0.0 109.976 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 52.8 m -54.53 -47.55 73.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.4 ' CG ' ' N ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -164.3 150.93 11.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -179.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 58' ' ' HIS . . . -130.07 147.77 51.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.391 -0.818 . . . . 0.0 109.283 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 42' ' ' TRP . 2.4 t80 -126.71 122.93 36.29 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.069 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -106.9 102.7 12.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.3 mtm -102.5 124.74 48.61 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.24 -0.913 . . . . 0.0 110.797 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.8 m -122.29 144.58 48.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.37 160.59 29.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.771 -1.206 . . . . 0.0 110.011 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 77.0 mt-10 -82.97 -30.84 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 29.6 m120 -150.96 160.0 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -58.21 -24.55 59.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 111.389 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -53.62 -35.42 60.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.89 85.45 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -62.39 -46.55 88.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.566 -0.961 . . . . 0.0 110.459 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.394 -1.441 . . . . 0.0 108.649 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.94 2.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -48.62 -36.79 16.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 111.103 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.406 ' H ' HG21 ' A' ' 74' ' ' THR . 2.2 t -82.47 -27.14 32.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.759 -1.213 . . . . 0.0 110.311 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.2 p -69.34 -22.01 63.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.04 -1.038 . . . . 0.0 110.983 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.622 ' C ' ' H ' ' A' ' 78' ' ' LEU . 78.4 m80 -85.33 130.76 50.39 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.847 -1.158 . . . . 0.0 109.579 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.415 ' O ' HG13 ' A' ' 80' ' ' VAL . 80.3 Cg_exo -45.69 -2.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.67 2.247 . . . . 0.0 112.392 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.622 ' H ' ' C ' ' A' ' 76' ' ' HIS . 8.5 tp -77.16 -31.1 55.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.423 -0.798 . . . . 0.0 111.24 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -76.9 -39.18 51.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.989 -1.069 . . . . 0.0 110.219 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.515 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 4.0 p -62.26 -56.56 16.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.988 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.515 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 84.4 tt0 -49.48 -37.76 27.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.4 -29.42 70.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.256 -0.903 . . . . 0.0 109.886 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 80' ' ' VAL . 59.8 p -61.87 -44.87 95.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 110.149 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.83 69.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.729 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.607 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -83.33 -45.39 13.81 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.703 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -36.37 -44.01 0.4 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.635 ' CG2' ' H ' ' A' ' 88' ' ' ALA . 3.3 t -83.36 -60.14 2.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.635 ' H ' ' CG2' ' A' ' 87' ' ' THR . . . -47.22 -14.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.744 -0.598 . . . . 0.0 110.093 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.1 m -120.17 -1.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.232 -0.918 . . . . 0.0 110.809 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 61.1 mt -128.55 160.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.649 -1.282 . . . . 0.0 110.434 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 40.3 t0 -110.34 -31.97 7.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.51 142.66 31.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.2 tp -124.35 121.11 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.62 -1.3 . . . . 0.0 109.759 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.422 ' CG1' ' CD ' ' B' ' 54' ' ' GLN . 9.0 t -127.57 132.25 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -137.15 132.98 34.73 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.319 -1.488 . . . . 0.0 111.767 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.61 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.66 119.7 36.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.636 -0.665 . . . . 0.0 109.379 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.459 ' O ' ' OG ' ' B' ' 48' ' ' SER . 49.9 t0 -125.61 133.24 52.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.0 108.913 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 31.4 p90 -158.06 138.11 8.81 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.102 -0.999 . . . . 0.0 110.52 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.7 122.92 6.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.596 ' O ' ' OG ' ' A' ' 4' ' ' SER . 56.7 t -85.6 109.28 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.995 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.29 89.71 3.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.42 -0.8 . . . . 0.0 109.613 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.85 71.06 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.511 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.47 ' O ' ' CG2' ' A' ' 103' ' ' VAL . 33.7 m -153.02 86.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.265 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 106' ' ' SER . 29.3 mmtp -95.92 4.45 52.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.342 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t 63.43 -53.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.68 ' N ' ' O ' ' A' ' 104' ' ' LYS . 7.6 t 44.32 50.51 7.81 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.649 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.596 ' OG ' ' O ' ' B' ' 100' ' ' VAL . 46.0 p . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' B' ' 100' ' ' VAL . . . -95.7 168.65 26.56 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.63 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.28 131.52 46.99 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -1.143 . . . . 0.0 108.012 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 19.7 ttpt -110.01 138.97 45.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.903 -1.123 . . . . 0.0 112.793 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -129.2 128.19 42.84 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.9 tt -136.86 145.91 44.95 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.724 -1.235 . . . . 0.0 109.509 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 p -127.57 134.64 65.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.587 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.62 127.22 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.23 159.73 32.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.707 -1.597 . . . . 0.0 112.983 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.541 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 18.1 tptt -129.48 153.17 48.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 7.9 p90 -106.43 148.76 27.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.893 -1.129 . . . . 0.0 111.621 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -23.11 3.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 85.1 tt0 -89.22 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.3 t0 155.8 73.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 47.6 m -66.55 109.67 2.87 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.083 0.944 . . . . 0.0 112.862 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.597 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -79.46 92.27 5.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 175.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.8 -35.73 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.539 -0.725 . . . . 0.0 110.445 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 28.9 p-10 -68.23 -41.5 81.14 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.58 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 64.6 tt0 -71.69 -32.47 67.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.36 -36.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.11 -39.96 63.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -39.72 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' B' ' 29' ' ' ASN . . . -61.39 -54.57 35.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 47.8 mt -52.49 -47.74 66.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.525 -0.986 . . . . 0.0 108.87 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.64 -39.63 61.95 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.518 ' O ' ' OG ' ' B' ' 32' ' ' SER . 0.1 OUTLIER -62.98 -42.64 99.89 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.0 mm? -49.98 -46.65 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' B' ' 34' ' ' ILE . 22.0 t -49.05 -25.17 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.867 . . . . 0.0 108.816 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 68.4 m -43.05 -40.63 3.18 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.448 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 98.1 mm-40 -70.98 -18.08 62.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.453 -0.779 . . . . 0.0 111.526 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.571 ' O ' ' CG2' ' B' ' 34' ' ' ILE . 89.6 mt -80.47 18.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 119.978 -1.702 . . . . 0.0 110.568 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.64 -12.83 4.57 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.589 ' O ' ' N ' ' B' ' 38' ' ' LYS . 3.9 t -89.16 0.53 56.66 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.887 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.57 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.5 m 34.32 33.9 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.194 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' B' ' 36' ' ' THR . 65.5 mttt -117.59 42.09 2.68 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 55.6 p -177.93 179.19 0.88 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -148.34 159.65 43.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.554 -1.341 . . . . 0.0 111.95 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.502 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 77.1 mt-10 -155.79 123.84 5.74 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.335 0.588 . . . . 0.0 110.229 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' B' ' 60' ' ' PHE . 23.9 m95 -125.22 166.03 17.22 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' B' ' 44' ' ' GLU . . . -161.55 150.56 20.25 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 118.716 -1.707 . . . . 0.0 110.839 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 43' ' ' GLY . 7.6 tp10 -163.57 175.2 10.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 109.352 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 11.7 p-10 -118.44 169.92 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -61.32 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.322 -1.487 . . . . 0.0 109.809 -178.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.8 mt-10 -106.96 42.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.316 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -139.74 -142.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.138 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' B' ' 50' ' ' ASP . 79.1 m80 -95.97 136.87 35.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 49' ' ' HIS . 90.4 m-20 -41.34 -36.01 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.324 -0.86 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.5 OUTLIER -78.81 -29.35 44.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.731 -178.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.28 -22.83 18.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.691 -1.256 . . . . 0.0 109.257 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' B' ' 55' ' ' GLY . 2.7 ptt180 -95.98 4.04 52.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -0.834 . . . . 0.0 111.235 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' B' ' 53' ' ' ARG . 35.5 tt0 40.55 21.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.812 -1.18 . . . . 0.0 110.15 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 57.27 1.26 0.41 Allowed Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.356 -0.84 . . . . 0.0 112.796 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 31.5 p90 -55.45 129.47 38.87 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 119.595 1.697 . . . . 0.0 109.941 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -54.66 -47.57 73.41 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.301 -0.874 . . . . 0.0 110.946 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 151.06 11.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.895 -1.128 . . . . 0.0 110.17 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.18 147.77 51.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.0 109.262 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' B' ' 42' ' ' TRP . 2.4 t80 -126.65 122.97 36.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.488 -0.757 . . . . 0.0 109.075 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -107.07 102.56 11.89 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.26 124.99 48.81 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.134 -0.979 . . . . 0.0 110.759 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -122.51 144.65 48.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.47 160.92 28.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.738 -1.226 . . . . 0.0 110.025 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.528 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 77.9 mt-10 -83.31 -30.73 27.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 29.6 m120 -151.01 160.21 44.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -58.27 -25.04 61.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 111.411 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -53.06 -35.75 59.86 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.816 -1.177 . . . . 0.0 110.585 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -37.1 87.71 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -62.4 -46.55 88.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.978 . . . . 0.0 110.439 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.72 -28.98 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.37 -1.456 . . . . 0.0 108.623 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.0 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -48.54 -36.58 15.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 111.186 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 2.1 t -82.74 -27.08 31.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.744 -1.222 . . . . 0.0 110.329 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -69.49 -21.81 63.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 0.0 111.027 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.613 ' C ' ' H ' ' B' ' 78' ' ' LEU . 78.3 m80 -85.35 130.81 50.17 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.861 -1.149 . . . . 0.0 109.596 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.409 ' O ' HG13 ' B' ' 80' ' ' VAL . 82.7 Cg_exo -45.71 -2.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.599 2.199 . . . . 0.0 112.433 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' B' ' 76' ' ' HIS . 8.3 tp -77.31 -31.1 54.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -76.84 -39.18 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.0 110.296 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.516 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 4.0 p -62.41 -56.3 18.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.972 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.516 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 84.2 tt0 -49.89 -37.37 31.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.62 -29.27 69.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.85 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 80' ' ' VAL . 59.9 p -62.03 -44.99 95.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.71 68.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.998 -1.063 . . . . 0.0 108.641 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.591 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -83.55 -45.33 13.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.705 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -36.52 -43.91 0.42 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.629 ' CG2' ' H ' ' B' ' 88' ' ' ALA . 3.3 t -83.32 -60.4 2.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.629 ' H ' ' CG2' ' B' ' 87' ' ' THR . . . -47.04 -14.9 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.3 m -119.9 -1.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -0.904 . . . . 0.0 110.835 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 61.0 mt -128.33 160.68 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.672 -1.267 . . . . 0.0 110.448 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.505 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 40.7 t0 -110.54 -31.89 7.09 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.63 142.35 30.99 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 tp -124.03 121.45 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.579 -1.326 . . . . 0.0 109.661 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.431 ' CG1' ' CD ' ' A' ' 54' ' ' GLN . 9.3 t -127.83 132.42 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.4 OUTLIER -137.37 132.67 33.87 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.246 -1.534 . . . . 0.0 111.777 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.43 119.78 37.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.683 -0.636 . . . . 0.0 109.294 177.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' B' ' 98' ' ' PHE . 50.2 t0 -125.69 133.23 52.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.067 -1.021 . . . . 0.0 108.861 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.581 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 31.2 p90 -158.04 137.79 8.6 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 110.555 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.37 123.1 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.313 2.008 . . . . 0.0 112.221 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . 0.596 ' O ' ' OG ' ' B' ' 4' ' ' SER . 58.9 t -85.79 109.21 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.21 89.8 3.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.82 71.17 0.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.099 -1.001 . . . . 0.0 109.599 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' B' ' 103' ' ' VAL . 33.8 m -153.29 85.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -0.843 . . . . 0.0 109.235 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.67 ' O ' ' N ' ' B' ' 106' ' ' SER . 29.2 mmtp -95.61 4.62 52.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.415 ' O ' ' C ' ' B' ' 106' ' ' SER . 1.8 t 63.34 -53.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 108.879 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.67 ' N ' ' O ' ' B' ' 104' ' ' LYS . 7.6 t 44.68 50.43 8.51 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.592 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.427 0.632 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.406 ' O ' ' OG ' ' A' ' 4' ' ' SER . 8.8 t -111.5 0.21 16.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 3' ' ' THR . 17.3 m -167.25 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.1 178.15 18.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.66 127.04 55.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.276 -1.132 . . . . 0.0 107.973 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.551 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.4 ttpt -97.95 128.03 44.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.916 -1.115 . . . . 0.0 112.841 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 70' ' ' TYR . 51.6 m-70 -121.06 119.2 31.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 5.9 tt -128.71 139.44 52.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.716 -1.24 . . . . 0.0 109.496 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.9 137.48 56.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.641 -0.662 . . . . 0.0 109.536 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.48 133.8 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 1.5 m -141.42 162.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.047 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -127.59 152.64 47.38 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 12.7 p90 -109.82 151.8 26.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.799 -1.188 . . . . 0.0 111.607 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.31 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 48.3 tp10 -92.84 -54.93 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.8 t0 152.86 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 89.4 m -50.22 107.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.14 0.972 . . . . 0.0 112.859 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -71.61 83.36 0.85 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 24' ' ' LEU . 27.8 m -62.83 -41.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.546 -0.721 . . . . 0.0 110.481 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.401 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 90.3 m-20 -64.96 -44.64 88.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 110.498 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.7 -31.77 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 23' ' ' ILE . 11.2 mt -70.84 -43.61 76.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.2 tp -54.01 -40.04 66.66 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.92 -38.04 81.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -62.57 -51.27 57.3 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 4.7 tt -45.22 -44.03 10.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.461 -1.023 . . . . 0.0 108.848 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -49.87 -35.01 21.81 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 26' ' ' GLY . 14.3 m-20 -65.39 -44.32 87.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 1.4 mm? -48.39 -50.76 29.6 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 34' ' ' ILE . 54.8 t -46.94 -35.7 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 108.733 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.1 t -45.36 -50.55 12.13 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -69.21 -9.15 51.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 111.47 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 31' ' ' VAL . 21.9 mm -101.35 29.07 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.04 -1.663 . . . . 0.0 110.589 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.19 -19.08 61.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.585 ' O ' ' C ' ' A' ' 37' ' ' VAL . 16.8 p -69.84 -6.85 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.585 ' C ' ' O ' ' A' ' 36' ' ' THR . 34.7 m 35.08 36.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.104 -0.998 . . . . 0.0 109.106 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -118.0 41.55 2.87 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.5 p -174.01 178.09 2.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 97.6 m-85 -145.47 153.81 41.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.594 -1.316 . . . . 0.0 111.951 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 40' ' ' PHE . 54.1 mp0 -156.99 125.41 5.68 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.421 0.629 . . . . 0.0 110.162 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -134.58 176.05 8.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.612 ' H ' ' NZ ' ' B' ' 104' ' ' LYS . . . -133.56 158.82 23.42 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.55 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 77.4 mt-10 -149.06 140.79 23.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -1.145 . . . . 0.0 109.368 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.538 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 32.4 p30 -120.62 145.36 47.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -148.62 128.84 13.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.437 -1.414 . . . . 0.0 109.794 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -161.98 51.2 0.21 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.641 -0.662 . . . . 0.0 109.32 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.2 t -91.12 -98.65 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.203 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.4 m-70 -100.69 144.67 29.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.155 -0.965 . . . . 0.0 109.708 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 87.8 m-20 -50.09 -42.97 51.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.301 -0.875 . . . . 0.0 110.674 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.3 ttt -73.55 -32.77 64.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.084 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 68.9 mt -88.67 -51.65 5.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.741 -1.224 . . . . 0.0 109.245 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.721 ' O ' ' N ' ' A' ' 55' ' ' GLY . 13.8 ptt180 -71.08 5.45 2.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 111.275 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 46.07 3.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.729 -1.232 . . . . 0.0 110.197 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.21 -10.07 11.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.488 -0.758 . . . . 0.0 112.864 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 55' ' ' GLY . 20.9 m-85 -59.1 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.226 -1.749 . . . . 0.0 109.99 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.537 ' OG1' ' ND1' ' A' ' 58' ' ' HIS . 81.1 p -152.86 -41.9 0.1 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.962 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.618 ' NE2' ' CG2' ' A' ' 12' ' ' VAL . 27.3 p-80 -174.33 157.81 2.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.836 -1.165 . . . . 0.0 110.145 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.69 170.91 14.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 109.287 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.05 131.67 37.29 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.128 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 t -101.67 102.15 12.78 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.9 mtt -108.08 125.1 51.18 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.146 -0.971 . . . . 0.0 110.799 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.8 m -128.4 149.36 50.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.06 131.71 45.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 110.03 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 71.7 mm-40 -52.48 -32.52 40.36 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 33.0 m120 -155.64 160.46 40.43 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -57.66 -17.93 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.99 -39.83 79.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.844 -1.16 . . . . 0.0 110.589 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.26 -33.46 73.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.615 ' CE1' ' CE1' ' A' ' 8' ' ' HIS . 76.4 t80 -67.12 -44.38 80.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.495 -1.003 . . . . 0.0 110.451 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -28.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.381 -1.45 . . . . 0.0 108.673 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.367 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 2.5 t80 -45.66 -34.17 3.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 111.141 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -83.41 -24.9 31.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.744 -1.223 . . . . 0.0 110.249 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.6 m -67.47 -26.0 66.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.994 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -85.47 156.0 59.42 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.878 -1.139 . . . . 0.0 109.664 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.21 3.86 2.27 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.66 2.24 . . . . 0.0 112.469 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.5 tp -77.87 -31.1 51.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.77 . . . . 0.0 111.322 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -77.7 -41.61 37.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 0.0 110.211 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.592 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.5 p -62.58 -58.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.592 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 84.8 tt0 -51.77 -38.72 56.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 109.638 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -69.89 -32.02 70.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 109.883 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.5 -45.06 95.16 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.48 85.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.879 -1.138 . . . . 0.0 108.751 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.549 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -77.55 -44.76 27.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.652 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -39.28 -38.78 0.55 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.3 m -81.46 -61.0 2.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.34 -13.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.63 -0.669 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 87' ' ' THR . 13.1 m -119.27 -2.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 110.859 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -120.66 155.98 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.595 -1.316 . . . . 0.0 110.473 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.466 ' N ' HG21 ' A' ' 90' ' ' ILE . 36.4 t0 -104.35 -31.58 9.47 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' H ' HG21 ' A' ' 90' ' ' ILE . 21.5 pttt -149.98 150.61 32.06 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' A' ' 93' ' ' ILE . 6.0 tp -127.31 125.25 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.627 -1.295 . . . . 0.0 109.751 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.2 t -123.45 128.57 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.25 138.43 33.25 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.249 -1.532 . . . . 0.0 111.838 -178.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.25 123.96 42.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.637 . . . . 0.0 109.326 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -125.85 135.59 52.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.011 -1.056 . . . . 0.0 108.919 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -165.67 158.55 13.14 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 0.0 110.522 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.595 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 39.9 Cg_exo -58.78 114.84 2.17 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.298 1.999 . . . . 0.0 112.176 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 132.97 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.923 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.8 79.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.83 93.97 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.114 -0.991 . . . . 0.0 109.535 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.754 ' O ' ' C ' ' A' ' 104' ' ' LYS . 14.7 m -155.9 -16.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.201 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.754 ' C ' ' O ' ' A' ' 103' ' ' VAL . 31.5 mmtm -8.14 -105.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.71 -5.52 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 108.911 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.599 ' H ' ' C ' ' A' ' 104' ' ' LYS . 45.1 t -59.71 140.56 56.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.778 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.19 178.12 18.44 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.433 -1.365 . . . . 0.0 109.697 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -111.76 126.69 55.33 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.276 -1.132 . . . . 0.0 107.993 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.55 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.3 ttpt -97.53 128.23 44.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.937 -1.102 . . . . 0.0 112.863 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.601 ' CE1' ' CE1' ' B' ' 70' ' ' TYR . 51.3 m-70 -121.29 119.02 31.01 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 5.9 tt -128.56 139.53 52.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.743 -1.223 . . . . 0.0 109.451 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.83 137.67 56.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.498 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.77 133.86 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.623 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 1.5 m -141.5 162.04 21.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 117.745 -1.582 . . . . 0.0 113.039 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -127.57 152.66 47.35 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 12.6 p90 -109.88 151.73 26.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.798 -1.189 . . . . 0.0 111.562 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.14 3.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 48.4 tp10 -92.96 -55.04 3.5 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.7 t0 152.99 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 89.3 m -50.27 107.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.082 0.944 . . . . 0.0 112.868 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HD3' ' H ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -71.51 83.23 0.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' B' ' 21' ' ' ASP . 26.9 m -62.77 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.631 -0.668 . . . . 0.0 110.473 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.41 ' N ' ' CG2' ' B' ' 20' ' ' VAL . 90.0 m-20 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.456 -0.777 . . . . 0.0 110.576 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -65.5 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.432 HD11 HG21 ' B' ' 23' ' ' ILE . 11.2 mt -70.96 -43.43 76.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.13 -40.02 67.01 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.98 -38.13 81.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -62.22 -51.59 55.61 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 4.7 tt -45.04 -44.08 9.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.533 -0.981 . . . . 0.0 108.795 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -49.89 -34.94 21.78 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' B' ' 26' ' ' GLY . 14.3 m-20 -65.4 -44.31 87.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 1.4 mm? -48.37 -50.82 29.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' B' ' 34' ' ' ILE . 54.9 t -46.93 -35.47 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.915 . . . . 0.0 108.79 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 8.2 t -45.65 -50.48 13.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -69.28 -8.99 51.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 111.475 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' B' ' 31' ' ' VAL . 21.9 mm -101.58 29.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.019 -1.675 . . . . 0.0 110.645 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -61.23 -19.27 61.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.571 ' O ' ' C ' ' B' ' 37' ' ' VAL . 16.8 p -69.59 -6.85 33.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.961 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.6 m 35.04 36.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.022 -1.049 . . . . 0.0 109.132 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.3 OUTLIER -118.09 41.68 2.86 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p -174.2 177.99 2.17 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.519 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 97.7 m-85 -145.47 153.7 41.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.58 -1.325 . . . . 0.0 111.967 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' B' ' 40' ' ' PHE . 53.9 mp0 -156.92 125.11 5.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -134.2 176.18 8.83 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.631 ' H ' ' NZ ' ' A' ' 104' ' ' LYS . . . -133.74 158.74 23.42 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 118.703 -1.713 . . . . 0.0 110.782 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.551 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 77.3 mt-10 -148.98 140.83 23.66 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 32.2 p30 -120.71 145.39 47.53 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.66 128.69 13.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.404 -1.435 . . . . 0.0 109.834 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -161.91 51.36 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.622 . . . . 0.0 109.339 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -91.18 -98.83 0.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ARG . 90.4 m-70 -100.59 144.5 29.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.093 -1.004 . . . . 0.0 109.676 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' B' ' 53' ' ' ARG . 88.6 m-20 -49.92 -42.92 49.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 110.849 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.1 ttt -73.76 -32.46 63.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.029 -1.044 . . . . 0.0 110.756 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 95' ' ' LEU . 68.9 mt -88.82 -51.76 5.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.731 ' O ' ' N ' ' B' ' 55' ' ' GLY . 13.8 ptt180 -70.91 5.36 2.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.344 -0.848 . . . . 0.0 111.249 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 46.19 3.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.855 -1.153 . . . . 0.0 110.244 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.32 -10.12 11.96 Favored Glycine 0 N--CA 1.499 2.882 0 O-C-N 121.437 -0.79 . . . . 0.0 112.812 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' B' ' 55' ' ' GLY . 21.4 m-85 -59.19 -141.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.284 -1.715 . . . . 0.0 109.946 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.54 ' OG1' ' ND1' ' B' ' 58' ' ' HIS . 80.6 p -152.76 -41.85 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.319 -0.863 . . . . 0.0 111.024 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.623 ' NE2' ' CG2' ' B' ' 12' ' ' VAL . 27.5 p-80 -174.45 157.7 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.854 -1.154 . . . . 0.0 110.167 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.72 170.9 14.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.489 -0.757 . . . . 0.0 109.219 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.01 131.67 37.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 21.1 t -101.61 102.23 12.91 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 125.31 51.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.931 . . . . 0.0 110.733 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.7 m -128.59 149.28 50.7 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.05 131.64 45.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 110.095 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 72.0 mm-40 -52.17 -32.82 37.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 32.9 m120 -155.5 160.51 40.62 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -57.76 -17.87 18.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 111.466 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -57.85 -40.11 79.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.885 -1.134 . . . . 0.0 110.551 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.93 -33.6 75.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.601 ' CE1' ' CE1' ' B' ' 8' ' ' HIS . 76.2 t80 -66.99 -44.55 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.661 -0.905 . . . . 0.0 110.473 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.67 -28.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.704 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.88 2.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 2.5 t80 -45.66 -34.08 3.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.148 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.1 OUTLIER -83.34 -24.99 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 0.0 110.304 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -67.41 -25.86 66.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 111.032 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -85.65 156.0 58.92 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.83 -1.169 . . . . 0.0 109.579 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.17 3.91 2.23 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 112.433 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 44.5 tp -77.98 -31.31 50.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.429 -0.794 . . . . 0.0 111.218 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -77.41 -41.79 38.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.961 -1.087 . . . . 0.0 110.289 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.598 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.6 p -62.39 -58.24 8.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.054 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.598 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 85.0 tt0 -51.71 -38.73 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 0.0 109.593 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -69.98 -31.96 69.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.838 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.4 t -60.35 -45.36 93.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.142 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.42 85.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.987 -1.071 . . . . 0.0 108.685 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -77.53 -44.79 27.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.657 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -39.33 -38.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.593 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.3 m -81.41 -61.1 2.04 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.12 -13.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.079 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' B' ' 87' ' ' THR . 13.1 m -119.21 -2.77 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.237 -0.915 . . . . 0.0 110.875 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -120.7 156.05 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.701 -1.249 . . . . 0.0 110.465 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.473 ' N ' HG21 ' B' ' 90' ' ' ILE . 35.9 t0 -104.47 -31.63 9.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.425 ' H ' HG21 ' B' ' 90' ' ' ILE . 21.6 pttt -150.04 150.37 31.65 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' B' ' 93' ' ' ILE . 6.0 tp -127.07 125.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.491 -1.381 . . . . 0.0 109.733 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.8 t -123.55 128.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.33 138.54 33.18 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.302 -1.499 . . . . 0.0 111.791 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.25 123.83 42.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -125.77 135.67 52.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.064 -1.023 . . . . 0.0 108.87 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.591 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 0.5 OUTLIER -165.62 158.52 13.21 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.132 -0.98 . . . . 0.0 110.587 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . 0.591 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 41.1 Cg_exo -58.76 114.73 2.12 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.305 2.003 . . . . 0.0 112.265 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 133.04 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.004 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 78.87 1.16 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.502 -0.749 . . . . 0.0 109.58 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.58 94.08 2.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.12 -0.987 . . . . 0.0 109.657 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.784 ' O ' ' C ' ' B' ' 104' ' ' LYS . 14.6 m -156.0 -16.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.362 -0.836 . . . . 0.0 109.219 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.784 ' C ' ' O ' ' B' ' 103' ' ' VAL . 31.3 mmtm -8.28 -105.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.373 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.66 -5.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.935 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.572 ' H ' ' C ' ' B' ' 104' ' ' LYS . 44.4 t -59.53 140.61 56.12 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.291 -0.881 . . . . 0.0 109.419 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.302 -1.475 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.792 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.404 0.621 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.444 ' O ' ' OG ' ' A' ' 4' ' ' SER . 12.1 t -107.68 0.77 22.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.089 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.9 m -173.32 -107.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.8 -178.26 20.55 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.399 -1.382 . . . . 0.0 109.694 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -130.11 130.13 44.42 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 1.3 ttpm? -104.48 133.84 48.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.874 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -127.21 125.7 41.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.51 142.45 48.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.745 -1.222 . . . . 0.0 109.507 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 140.32 48.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.506 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.22 134.02 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -137.53 162.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 117.79 -1.564 . . . . 0.0 113.014 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 14' ' ' PHE . 20.7 tptp -132.21 152.8 51.14 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.496 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 36.3 p90 -111.65 149.44 31.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.886 -1.134 . . . . 0.0 111.597 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.45 -19.68 3.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.5 mt-10 -91.69 -56.5 3.08 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.9 t0 154.48 64.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 86.8 m -49.77 105.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.126 0.965 . . . . 0.0 112.794 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.796 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -68.65 83.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 24' ' ' LEU . 28.9 m -61.59 -42.96 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.52 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.0 p-10 -65.97 -43.27 88.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 0.0 110.571 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 97.4 mt-10 -70.7 -34.12 71.61 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -67.32 -44.61 87.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' VAL . 15.7 tp -52.88 -38.0 61.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.08 75.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -60.63 -54.23 38.81 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 4.4 tt -45.83 -43.91 13.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.497 -1.002 . . . . 0.0 108.838 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' B' ' 106' ' ' SER . 71.8 mm-40 -50.86 -33.33 23.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.0 m-20 -66.54 -44.39 82.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.1 mm? -49.3 -48.28 46.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 32' ' ' SER . 94.6 t -46.97 -31.91 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.908 . . . . 0.0 108.844 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 73.7 p -45.59 -49.25 14.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 70.6 mm-40 -72.79 -12.15 60.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 111.457 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.525 ' C ' ' N ' ' A' ' 36' ' ' THR . 21.1 mm -96.69 24.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.043 -1.661 . . . . 0.0 110.589 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.06 -12.43 4.81 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.2 p -74.86 -1.28 21.6 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.995 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.576 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.1 m 34.61 33.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 32.1 mtmt -119.55 42.36 2.9 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 58.4 m -171.88 174.54 4.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -146.71 157.4 43.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.639 -1.288 . . . . 0.0 111.957 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -155.27 121.5 5.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.362 0.601 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -123.95 170.2 10.85 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.97 160.0 23.72 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.72 -1.705 . . . . 0.0 110.852 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 24.1 mt-10 -150.5 145.21 25.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.251 -1.147 . . . . 0.0 109.394 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 22.5 t70 -126.53 148.03 49.77 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -145.37 122.99 11.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.417 -1.427 . . . . 0.0 109.799 -178.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 48' ' ' SER . 95.4 mt-10 -133.93 3.4 3.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 47' ' ' GLU . 99.2 p -56.99 -140.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.953 . . . . 0.0 110.17 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.755 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 57.4 t-80 -74.62 160.15 31.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.678 ' N ' HH21 ' A' ' 53' ' ' ARG . 77.9 m-20 -61.2 -44.23 97.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.659 ' H ' ' HD1' ' A' ' 49' ' ' HIS . 1.8 tpt -67.76 -33.43 74.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.013 -1.054 . . . . 0.0 110.746 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' B' ' 95' ' ' LEU . 38.0 mt -89.23 -54.43 4.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.702 -1.249 . . . . 0.0 109.323 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.755 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.3 ptp180 -64.41 2.97 0.52 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.0 111.195 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.607 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER 57.19 -12.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.75 -1.219 . . . . 0.0 110.14 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 85.24 -21.81 11.69 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.408 -0.808 . . . . 0.0 112.847 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.634 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 3.7 m-85 -57.79 -129.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.267 -1.725 . . . . 0.0 109.988 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.46 ' HA ' ' HZ1' ' A' ' 46' ' ' LYS . 2.8 t -162.2 -33.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.629 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 15.0 t60 -172.05 154.49 3.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.104 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.629 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.9 168.01 20.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.414 -0.804 . . . . 0.0 109.251 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 96.8 m-85 -134.74 130.98 37.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.475 -0.766 . . . . 0.0 109.067 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.6 99.24 8.84 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.0 mtm -100.07 124.8 45.86 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.149 -0.97 . . . . 0.0 110.851 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.46 142.94 50.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' GLU . 94.2 m-85 -122.01 126.8 49.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.736 -1.228 . . . . 0.0 110.092 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 64' ' ' PHE . 33.6 tt0 -46.93 -30.7 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -165.81 170.59 13.74 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -57.79 -22.35 46.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 111.46 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -56.24 -40.22 73.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.822 -1.174 . . . . 0.0 110.673 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.09 62.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -63.13 -44.59 95.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.984 . . . . 0.0 110.467 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.421 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.75 -28.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.388 -1.445 . . . . 0.0 108.692 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -60.99 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -56.74 -42.57 79.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 111.09 -177.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.457 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 10.0 t -75.95 -33.19 59.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.787 -1.195 . . . . 0.0 110.31 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 63.5 m -63.39 -32.76 74.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.996 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.522 ' CE1' ' OE1' ' A' ' 33' ' ' GLN . 54.5 m80 -72.03 151.91 92.76 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.861 -1.15 . . . . 0.0 109.604 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.14 4.1 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.669 2.246 . . . . 0.0 112.42 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 tp -76.57 -28.62 56.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.384 -0.822 . . . . 0.0 111.267 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.518 ' CD2' ' OG ' ' A' ' 83' ' ' SER . 11.2 t-160 -81.59 -41.82 20.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.987 -1.07 . . . . 0.0 110.245 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.604 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.5 p -63.12 -58.9 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 110.023 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.604 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 48.3 tp10 -58.46 -39.61 80.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.197 -0.94 . . . . 0.0 109.627 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 85.6 t80 -69.69 -43.49 72.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.518 ' OG ' ' CD2' ' A' ' 79' ' ' HIS . 49.8 m -59.24 -36.63 75.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.113 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.22 60.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.972 -1.08 . . . . 0.0 108.666 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.9 -41.59 74.49 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.492 ' C ' ' O ' ' A' ' 85' ' ' ALA . 11.9 t80 -43.06 -30.82 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.3 m -83.21 -60.98 1.97 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.41 -24.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.682 -0.636 . . . . 0.0 110.049 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' THR . 9.0 m -105.32 11.92 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.213 -0.93 . . . . 0.0 110.834 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 47.1 mt -124.68 158.77 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.278 . . . . 0.0 110.474 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.508 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 57.5 t0 -100.05 -34.32 10.12 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.477 ' NZ ' ' CD1' ' A' ' 56' ' ' PHE . 38.4 pttt -149.08 147.62 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.88 131.4 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.619 -1.301 . . . . 0.0 109.744 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.0 139.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -139.44 135.18 33.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.245 -1.534 . . . . 0.0 111.739 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.613 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -117.99 123.87 46.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.382 178.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 65.7 t0 -125.47 131.15 52.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.041 -1.037 . . . . 0.0 108.939 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' B' ' 45' ' ' ASP . 44.8 t80 -160.93 138.72 7.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.036 -1.04 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.82 120.33 2.8 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.34 2.026 . . . . 0.0 112.205 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.82 144.04 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.06 125.77 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 109.609 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.06 73.55 9.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.539 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 103' ' ' VAL . 18.1 m -150.25 98.06 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.162 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.685 ' C ' ' H ' ' A' ' 106' ' ' SER . 41.4 mmtm -134.27 -112.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.57 -12.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 108.868 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.685 ' H ' ' C ' ' A' ' 104' ' ' LYS . 30.1 t -53.58 139.75 30.75 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.269 -0.895 . . . . 0.0 109.404 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.301 -1.511 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.83 -178.81 20.51 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.632 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.62 130.2 45.33 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.302 -1.117 . . . . 0.0 108.011 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 1.2 ttpm? -104.47 134.04 48.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.337 1.065 . . . . 0.0 112.841 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -127.41 125.63 40.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 tt -133.43 142.59 48.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 109.375 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.87 140.31 49.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.574 -0.704 . . . . 0.0 109.493 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.13 134.14 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -137.5 162.8 32.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 117.758 -1.577 . . . . 0.0 113.016 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.514 ' HD2' ' H ' ' B' ' 14' ' ' PHE . 20.6 tptp -132.17 152.96 51.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.514 ' H ' ' HD2' ' B' ' 13' ' ' LYS . 36.4 p90 -111.76 149.51 31.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.78 -1.2 . . . . 0.0 111.598 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.65 -19.44 3.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.4 mt-10 -92.14 -56.17 3.16 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 8.7 t0 154.25 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 87.1 m -49.67 105.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.148 0.975 . . . . 0.0 112.876 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.803 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -68.76 83.59 0.3 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' B' ' 21' ' ' ASP . 29.6 m -61.84 -42.89 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 110.513 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.4 p-10 -65.95 -43.2 88.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.547 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 97.2 mt-10 -70.7 -34.17 71.66 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -67.29 -44.51 87.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' B' ' 20' ' ' VAL . 15.7 tp -52.87 -37.94 60.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.05 75.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -60.71 -54.13 39.54 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 4.4 tt -45.92 -43.63 14.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 108.828 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 106' ' ' SER . 71.6 mm-40 -51.35 -33.2 28.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 26' ' ' GLY . 11.5 m-20 -66.34 -44.75 82.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.1 mm? -48.9 -48.4 42.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 94.4 t -46.9 -32.09 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 108.815 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 69.6 p -45.57 -49.37 14.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.518 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 71.1 mm-40 -72.49 -12.07 60.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 111.527 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.508 ' C ' ' N ' ' B' ' 36' ' ' THR . 21.2 mm -96.97 24.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.017 -1.677 . . . . 0.0 110.568 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.35 -12.02 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.575 ' O ' ' N ' ' B' ' 38' ' ' LYS . 52.6 p -75.29 -1.11 22.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.96 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 34.63 33.57 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.998 -1.064 . . . . 0.0 109.135 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' B' ' 36' ' ' THR . 32.1 mtmt -119.6 42.53 2.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.524 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 58.5 m -172.03 174.58 4.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -146.78 157.46 43.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.497 -1.377 . . . . 0.0 111.934 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -155.24 121.51 5.23 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.428 0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -123.86 170.27 10.74 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.18 159.67 23.65 Favored Glycine 0 N--CA 1.499 2.836 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.847 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 24.2 mt-10 -150.3 145.0 25.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.181 -1.188 . . . . 0.0 109.387 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 22.3 t70 -126.38 147.9 49.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.641 ' NZ ' ' O ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -145.17 123.12 12.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 0.0 109.858 -178.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.4 mt-10 -134.08 3.9 3.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.694 -0.629 . . . . 0.0 109.367 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.536 ' O ' ' O ' ' B' ' 47' ' ' GLU . 95.1 p -57.21 -140.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.179 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.734 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 57.3 t-80 -74.54 160.18 31.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 109.742 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.685 ' N ' HH21 ' B' ' 53' ' ' ARG . 77.7 m-20 -61.2 -44.2 97.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.0 110.837 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.656 ' H ' ' HD1' ' B' ' 49' ' ' HIS . 1.7 tpt -67.81 -33.28 74.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.005 . . . . 0.0 110.726 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 95' ' ' LEU . 38.9 mt -89.32 -54.46 4.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.715 -1.24 . . . . 0.0 109.307 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.734 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.4 ptp180 -64.37 2.89 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 111.231 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.599 ' NE2' ' CZ ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER 57.33 -12.38 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.811 -1.18 . . . . 0.0 110.282 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.719 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 85.61 -22.04 12.3 Favored Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.43 -0.794 . . . . 0.0 112.789 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.641 ' O ' ' NZ ' ' B' ' 46' ' ' LYS . 3.6 m-85 -57.82 -129.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.327 -1.69 . . . . 0.0 109.973 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.466 ' HA ' ' HZ1' ' B' ' 46' ' ' LYS . 2.6 t -162.37 -33.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 110.985 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.617 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 15.2 t60 -171.93 154.61 3.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.832 -1.168 . . . . 0.0 110.162 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.617 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.95 167.99 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.439 -0.788 . . . . 0.0 109.341 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 96.7 m-85 -134.61 131.04 37.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 109.137 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.55 99.1 8.72 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -99.9 124.77 45.58 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.204 -0.935 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 88.4 m -123.58 143.06 50.45 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' B' ' 65' ' ' GLU . 94.3 m-85 -122.22 126.65 48.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.751 -1.218 . . . . 0.0 110.081 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' B' ' 64' ' ' PHE . 32.8 tt0 -46.62 -30.79 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -166.01 170.6 13.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.85 -22.4 47.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.886 . . . . 0.0 111.402 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -56.18 -40.26 73.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.81 -1.181 . . . . 0.0 110.653 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.57 -36.08 62.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.07 -44.78 94.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.532 -0.981 . . . . 0.0 110.49 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.75 -28.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.351 -1.468 . . . . 0.0 108.684 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -60.83 2.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.344 -0.847 . . . . 0.0 109.292 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.69 -42.46 79.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 111.124 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.453 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 10.0 t -76.09 -33.14 59.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.779 -1.2 . . . . 0.0 110.381 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 65.4 m -63.47 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.062 -1.024 . . . . 0.0 110.912 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.518 ' CE1' ' OE1' ' B' ' 33' ' ' GLN . 54.1 m80 -72.34 151.63 92.06 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.82 -1.175 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.79 3.91 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.701 2.267 . . . . 0.0 112.425 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 tp -76.48 -28.93 56.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.373 -0.83 . . . . 0.0 111.233 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.506 ' CD2' ' OG ' ' B' ' 83' ' ' SER . 11.2 t-160 -81.37 -41.6 21.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.041 -1.037 . . . . 0.0 110.266 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.613 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.7 p -63.35 -59.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.998 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.613 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 49.1 tp10 -58.23 -39.65 79.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.862 . . . . 0.0 109.625 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 85.5 t80 -69.43 -43.66 72.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' SER . . . . . 0.506 ' OG ' ' CD2' ' B' ' 79' ' ' HIS . 50.9 m -59.14 -36.54 75.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.027 -1.046 . . . . 0.0 110.147 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.21 -52.98 63.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.65 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -69.99 -41.93 73.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' B' ' 85' ' ' ALA . 11.8 t80 -42.89 -30.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.545 ' O ' ' N ' ' B' ' 89' ' ' VAL . 9.4 m -83.3 -60.79 2.03 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.65 -24.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.702 -0.624 . . . . 0.0 110.06 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.0 m -105.8 12.04 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.78 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 48.0 mt -124.63 158.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.711 -1.243 . . . . 0.0 110.423 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.509 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 57.1 t0 -100.06 -34.53 10.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.468 ' NZ ' ' CD1' ' B' ' 56' ' ' PHE . 38.5 pttt -148.76 147.67 29.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.81 131.48 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.583 -1.323 . . . . 0.0 109.764 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.93 139.51 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -139.68 135.05 32.82 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.276 -1.515 . . . . 0.0 111.773 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.622 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -117.8 124.05 47.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.7 t0 -125.64 131.56 52.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.037 -1.04 . . . . 0.0 108.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 45' ' ' ASP . 44.7 t80 -161.41 138.68 6.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.025 -1.047 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -44.69 120.35 2.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.299 2.0 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.86 143.92 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.05 125.78 25.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 109.6 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.03 73.37 9.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.039 -1.038 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' B' ' 103' ' ' VAL . 18.2 m -149.95 98.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.219 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.673 ' C ' ' H ' ' B' ' 106' ' ' SER . 41.1 mmtm -134.52 -113.3 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.272 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.97 -13.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 108.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.673 ' H ' ' C ' ' B' ' 104' ' ' LYS . 31.1 t -53.03 139.75 27.17 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.219 -0.925 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.465 ' O ' ' OG ' ' A' ' 4' ' ' SER . 7.6 t -116.06 1.11 13.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.141 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 3' ' ' THR . 28.9 m -175.34 -126.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.24 173.14 31.2 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.709 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -135.78 136.36 40.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.289 -1.124 . . . . 0.0 108.005 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' B' ' 44' ' ' GLU . 20.7 ttpt -114.61 142.63 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.0 112.844 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -130.59 129.21 42.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -137.24 145.98 44.25 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.71 -1.244 . . . . 0.0 109.442 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 p -131.18 136.58 57.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.64 -0.663 . . . . 0.0 109.5 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.53 131.14 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.57 162.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 117.808 -1.557 . . . . 0.0 113.043 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HZ2' ' HG1' ' A' ' 57' ' ' THR . 13.9 tptp -127.55 155.32 43.99 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.511 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 11.5 p90 -108.18 149.54 28.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.842 -1.162 . . . . 0.0 111.638 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -127.02 -19.28 4.43 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -90.68 -56.76 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 10.1 t0 153.51 58.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 71.9 m -46.53 106.92 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.173 0.987 . . . . 0.0 112.795 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.475 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.39 89.13 1.6 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.8 m -61.2 -39.19 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.752 . . . . 0.0 110.467 -176.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.58 -45.4 94.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.554 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 21.8 mp0 -73.97 -37.82 64.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -66.79 -48.88 78.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.678 ' N ' ' O ' ' A' ' 20' ' ' VAL . 2.1 tm? -58.22 -41.34 83.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.61 -25.71 68.35 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.697 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -65.37 -55.48 20.73 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.499 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 7.0 tt -47.5 -35.75 9.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.514 -0.992 . . . . 0.0 108.826 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -53.52 -42.94 67.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -59.97 -42.32 93.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -52.7 -46.29 67.25 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 32' ' ' SER . 38.7 t -51.97 -23.95 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.248 -0.908 . . . . 0.0 108.843 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 44.3 t -44.34 -37.26 3.21 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.532 HE21 ' CG ' ' A' ' 76' ' ' HIS . 8.6 mm100 -79.87 -4.02 50.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.792 . . . . 0.0 111.457 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 6.5 mm -88.42 23.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.107 -1.62 . . . . 0.0 110.652 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.38 -16.8 16.18 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.598 ' O ' ' C ' ' A' ' 37' ' ' VAL . 43.7 p -68.27 -2.65 8.68 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.937 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 36' ' ' THR . 31.2 m 30.32 41.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.049 -1.032 . . . . 0.0 109.185 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' THR . 4.2 mtmm -122.46 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 63' ' ' THR . 28.8 t -72.74 -176.07 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' LYS . 82.3 m-85 -153.0 167.51 28.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.629 -1.294 . . . . 0.0 111.925 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.514 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 80.6 mt-10 -159.42 127.61 5.0 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.398 0.618 . . . . 0.0 110.193 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -129.54 171.36 12.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.15 24.46 Favored Glycine 0 N--CA 1.499 2.874 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.845 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.541 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 63.9 mt-10 -151.24 147.02 26.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -1.096 . . . . 0.0 109.391 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.6 t0 -130.85 157.58 42.49 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -61.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.405 -1.434 . . . . 0.0 109.813 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.8 mt-10 -126.69 40.62 3.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.683 -0.636 . . . . 0.0 109.333 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 49' ' ' HIS . 5.3 t -147.99 76.05 1.36 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.978 . . . . 0.0 110.219 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.522 ' HD1' ' N ' ' A' ' 50' ' ' ASP . 1.4 t-80 56.83 114.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.767 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.522 ' N ' ' HD1' ' A' ' 49' ' ' HIS . 57.2 t0 -45.13 -34.87 2.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.0 110.783 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.508 ' H ' ' ND1' ' A' ' 49' ' ' HIS . 93.0 mmm -75.74 -34.04 60.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' B' ' 95' ' ' LEU . 63.3 mt -89.7 -18.5 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.706 -1.246 . . . . 0.0 109.291 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' GLY . 18.0 ptt180 -101.8 7.94 41.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.244 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 53' ' ' ARG . 68.3 mm-40 38.68 27.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.789 -1.195 . . . . 0.0 110.138 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 53.37 2.71 0.12 Allowed Glycine 0 N--CA 1.499 2.836 0 O-C-N 121.416 -0.803 . . . . 0.0 112.85 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 20.4 p90 -47.82 132.07 14.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.206 -1.761 . . . . 0.0 109.936 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.489 ' HG1' ' HZ2' ' A' ' 13' ' ' LYS . 98.6 m -58.18 -55.05 40.02 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.928 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.637 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 17.0 t60 -167.85 153.89 7.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.926 -1.109 . . . . 0.0 110.188 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.559 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.62 162.15 35.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.206 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 57.8 m-85 -129.2 126.17 38.58 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.493 -0.755 . . . . 0.0 109.062 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -104.57 102.91 12.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.5 mtt -102.42 120.73 41.0 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.177 -0.952 . . . . 0.0 110.816 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.459 ' O ' ' OG ' ' A' ' 39' ' ' SER . 37.0 m -112.02 133.66 54.05 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -119.46 121.04 38.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.689 -1.257 . . . . 0.0 110.084 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 66' ' ' ASN . 0.6 OUTLIER -47.88 -31.55 5.22 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.588 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 18.2 t-20 -157.34 162.4 39.1 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.9 -24.26 64.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 111.465 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.24 -38.39 68.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 0.0 110.573 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.525 ' O ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.63 -33.59 84.93 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.502 ' O ' ' CG2' ' A' ' 74' ' ' THR . 77.7 t80 -66.56 -46.98 74.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.548 -0.972 . . . . 0.0 110.489 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.93 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.427 -1.421 . . . . 0.0 108.651 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -60.64 -34.85 74.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 111.147 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 41.8 p -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.712 -1.243 . . . . 0.0 110.295 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -65.38 -24.15 67.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.18 -0.95 . . . . 0.0 110.986 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.665 ' C ' ' H ' ' A' ' 78' ' ' LEU . 57.5 m80 -79.86 124.58 83.21 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.81 -1.181 . . . . 0.0 109.603 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.59 2.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.665 ' H ' ' C ' ' A' ' 76' ' ' HIS . 6.7 tp -76.37 -34.41 58.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.307 -0.871 . . . . 0.0 111.24 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 58.0 t-80 -82.66 -33.44 27.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 0.0 110.327 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.93 -60.25 2.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.79 -42.97 65.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 17.6 m-85 -72.17 -34.14 68.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.754 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 67.0 m -60.87 -43.04 98.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 110.13 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -41.96 97.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.978 -1.076 . . . . 0.0 108.673 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.4 -43.08 78.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.477 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 2.7 m-85 -44.8 -30.25 0.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.1 p -82.26 -62.2 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.578 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -38.64 -28.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.654 -0.654 . . . . 0.0 110.052 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' THR . 23.3 m -106.35 14.58 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 110.767 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 1.2 mp -124.81 160.2 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.672 -1.268 . . . . 0.0 110.467 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.551 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 58.7 t0 -105.53 -35.95 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -145.95 145.29 30.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 93' ' ' ILE . 3.0 tp -126.11 124.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.672 -1.267 . . . . 0.0 109.744 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.24 130.07 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -130.98 127.22 37.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.325 -1.485 . . . . 0.0 111.759 -178.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.428 ' H ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -118.8 122.46 42.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.653 -0.654 . . . . 0.0 109.358 177.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.447 ' OD2' ' OG ' ' B' ' 48' ' ' SER . 23.1 p-10 -130.2 138.94 50.84 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.11 -0.994 . . . . 0.0 108.864 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 32.3 t80 -159.43 134.71 5.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.075 -1.015 . . . . 0.0 110.52 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 94.9 Cg_exo -42.46 125.57 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.318 2.012 . . . . 0.0 112.19 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.6 t -89.99 116.05 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.29 82.81 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.368 -0.832 . . . . 0.0 109.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.492 ' O ' ' CG1' ' A' ' 103' ' ' VAL . . . -74.37 72.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 5.3 m -161.91 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 25.9 mmtp -92.98 141.57 28.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.1 p -67.65 -25.3 65.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 108.958 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 106' ' ' SER . 5.9 p 61.85 50.88 4.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 100' ' ' VAL . . . -95.39 172.96 30.83 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.368 -1.396 . . . . 0.0 109.703 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -135.52 136.43 41.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.283 -1.128 . . . . 0.0 108.07 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.54 ' NZ ' ' OE2' ' A' ' 44' ' ' GLU . 20.7 ttpt -114.72 142.61 46.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.075 . . . . 0.0 112.809 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -130.5 129.29 42.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.1 tt -137.29 145.94 44.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.821 -1.175 . . . . 0.0 109.439 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.2 136.66 57.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.64 131.16 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.68 162.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.08 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.48 ' HZ2' ' HG1' ' B' ' 57' ' ' THR . 14.0 tptp -127.6 155.27 44.11 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 11.5 p90 -108.2 149.48 28.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.827 -1.17 . . . . 0.0 111.59 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -127.03 -19.41 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.2 mt-10 -90.64 -56.65 3.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 9.7 t0 153.29 58.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.471 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 68.2 m -46.59 106.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.03 0.919 . . . . 0.0 112.89 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.482 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -73.42 89.35 1.63 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.8 m -61.56 -38.91 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 110.465 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -61.66 -45.4 94.2 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 110.512 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 21.6 mp0 -74.15 -37.59 63.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -67.07 -48.94 77.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' B' ' 20' ' ' VAL . 2.1 tm? -58.0 -41.65 83.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.4 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.703 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -65.34 -55.54 20.46 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.492 ' CD1' ' CD1' ' B' ' 60' ' ' PHE . 7.0 tt -47.42 -35.73 8.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.541 -0.976 . . . . 0.0 108.811 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -53.49 -43.22 68.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.8 p30 -59.83 -42.23 93.06 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.61 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -52.84 -46.15 67.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' B' ' 32' ' ' SER . 38.7 t -52.0 -23.93 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.292 -0.88 . . . . 0.0 108.859 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 43.5 t -44.33 -37.39 3.28 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.538 HE21 ' CG ' ' B' ' 76' ' ' HIS . 8.6 mm100 -79.71 -4.29 51.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 111.466 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.499 ' C ' ' N ' ' B' ' 36' ' ' THR . 6.3 mm -88.24 23.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 119.947 -1.721 . . . . 0.0 110.61 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.44 -16.65 15.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' B' ' 37' ' ' VAL . 44.1 p -68.28 -2.82 9.04 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.932 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' B' ' 36' ' ' THR . 31.3 m 30.55 41.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' B' ' 40' ' ' PHE . 4.1 mtmm -122.4 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' B' ' 63' ' ' THR . 28.9 t -72.62 -176.16 1.87 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' B' ' 38' ' ' LYS . 82.4 m-85 -152.99 167.47 29.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.542 -1.349 . . . . 0.0 111.991 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.487 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 81.0 mt-10 -159.36 127.44 4.98 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.298 0.57 . . . . 0.0 110.227 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -129.46 171.49 12.5 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.2 162.13 24.49 Favored Glycine 0 N--CA 1.5 2.961 0 C-N-CA 118.689 -1.72 . . . . 0.0 110.768 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.544 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 63.1 mt-10 -151.3 146.84 26.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.294 -1.121 . . . . 0.0 109.392 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' B' ' 47' ' ' GLU . 63.3 t0 -130.71 157.47 42.71 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.529 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.07 80.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.378 -1.451 . . . . 0.0 109.825 -177.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -126.68 40.51 3.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.503 ' O ' ' O ' ' B' ' 49' ' ' HIS . 5.4 t -147.85 76.45 1.39 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.169 -0.957 . . . . 0.0 110.173 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.522 ' HD1' ' N ' ' B' ' 50' ' ' ASP . 1.4 t-80 56.59 114.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.195 -0.941 . . . . 0.0 109.676 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.522 ' N ' ' HD1' ' B' ' 49' ' ' HIS . 57.9 t0 -45.14 -34.88 2.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.513 ' H ' ' ND1' ' B' ' 49' ' ' HIS . 93.0 mmm -75.65 -33.9 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.7 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 95' ' ' LEU . 62.6 mt -89.69 -18.7 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.776 -1.202 . . . . 0.0 109.253 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' B' ' 55' ' ' GLY . 18.0 ptt180 -101.78 7.91 41.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.847 . . . . 0.0 111.26 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' B' ' 53' ' ' ARG . 68.8 mm-40 38.68 27.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.803 -1.186 . . . . 0.0 110.214 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 53.31 2.79 0.11 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.37 -0.831 . . . . 0.0 112.791 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 20.1 p90 -47.96 132.08 15.28 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.193 -1.769 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.48 ' HG1' ' HZ2' ' B' ' 13' ' ' LYS . 99.7 m -57.98 -55.27 37.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.325 -0.859 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 17.3 t60 -167.77 153.9 7.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.887 -1.133 . . . . 0.0 110.193 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.543 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.62 162.07 35.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.477 -0.764 . . . . 0.0 109.287 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 57.8 m-85 -129.05 126.05 38.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.11 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -104.48 102.68 12.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 39.7 mtt -102.36 120.9 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 110.673 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.458 ' O ' ' OG ' ' B' ' 39' ' ' SER . 37.9 m -112.02 134.13 53.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' B' ' 64' ' ' PHE . 2.2 m-85 -119.81 121.37 38.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.741 -1.224 . . . . 0.0 109.999 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' B' ' 66' ' ' ASN . 0.6 OUTLIER -48.26 -31.47 5.96 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.592 ' H ' ' CD ' ' B' ' 65' ' ' GLU . 18.0 t-20 -157.32 162.25 39.13 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.7 -24.43 63.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.512 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -55.04 -38.67 68.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.597 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' B' ' 73' ' ' PHE . . . -66.22 -33.7 85.94 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.496 ' O ' ' CG2' ' B' ' 74' ' ' THR . 77.8 t80 -66.61 -47.04 73.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.566 -0.961 . . . . 0.0 110.495 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.73 -28.99 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.356 -1.465 . . . . 0.0 108.67 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.0 -60.86 2.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.338 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -60.57 -34.92 74.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.245 -0.909 . . . . 0.0 111.088 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 42.0 p -73.86 -33.32 64.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.776 -1.203 . . . . 0.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -65.56 -24.31 67.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.0 111.053 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.665 ' C ' ' H ' ' B' ' 78' ' ' LEU . 57.6 m80 -79.58 124.62 83.68 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.829 -1.169 . . . . 0.0 109.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -46.77 2.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.609 2.206 . . . . 0.0 112.446 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.665 ' H ' ' C ' ' B' ' 76' ' ' HIS . 6.7 tp -76.42 -34.51 58.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.348 -0.845 . . . . 0.0 111.238 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.512 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 57.9 t-80 -82.47 -33.47 28.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.037 -1.039 . . . . 0.0 110.324 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.04 -60.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.92 -42.7 65.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.64 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 17.6 m-85 -72.29 -34.23 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' SER . . . . . 0.512 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 65.3 m -60.86 -42.99 98.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.048 . . . . 0.0 110.098 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.08 97.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 108.661 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.39 -42.93 78.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.477 ' O ' ' CD1' ' B' ' 90' ' ' ILE . 2.7 m-85 -44.9 -30.22 0.96 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.1 p -82.26 -62.21 1.69 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.577 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -38.66 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.691 -0.63 . . . . 0.0 110.099 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' B' ' 87' ' ' THR . 23.1 m -106.22 14.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.207 -0.933 . . . . 0.0 110.829 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 1.2 mp -124.63 160.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.7 -1.25 . . . . 0.0 110.467 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 58.3 t0 -105.46 -36.02 7.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -145.93 145.24 30.6 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' B' ' 93' ' ' ILE . 3.0 tp -126.15 124.1 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.571 -1.331 . . . . 0.0 109.798 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 t -127.29 130.2 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -131.06 126.9 37.08 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.244 -1.535 . . . . 0.0 111.809 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.42 ' H ' HD11 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -118.55 122.72 43.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.443 ' OD2' ' OG ' ' A' ' 48' ' ' SER . 23.0 p-10 -130.43 138.85 50.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.175 -0.953 . . . . 0.0 108.853 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 32.2 t80 -159.42 134.6 5.75 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.048 -1.032 . . . . 0.0 110.541 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 96.5 Cg_exo -42.36 125.67 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.29 1.993 . . . . 0.0 112.244 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 5' ' ' GLY . 27.4 t -89.96 116.11 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.44 82.85 2.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . 0.481 ' O ' ' CG1' ' B' ' 103' ' ' VAL . . . -74.27 71.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.602 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' B' ' 102' ' ' ALA . 5.5 m -161.58 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.33 -0.856 . . . . 0.0 109.263 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 41' ' ' GLU . 25.8 mmtp -92.88 141.6 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' B' ' 106' ' ' SER . 85.9 p -67.44 -25.58 65.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 108.944 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' B' ' 106' ' ' SER . 6.1 p 62.06 50.73 3.91 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.32 -0.863 . . . . 0.0 109.355 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.402 0.62 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 t -98.32 -12.24 21.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.141 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.659 ' HG ' ' H ' ' A' ' 102' ' ' ALA . 17.7 m -127.79 -81.94 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.08 -168.91 16.91 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.664 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -114.43 130.76 56.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.241 -1.152 . . . . 0.0 108.09 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 21.9 ttpt -101.09 129.66 47.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.908 -1.12 . . . . 0.0 112.824 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -121.59 119.86 33.13 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 173.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 tt -132.51 141.57 48.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.679 -1.263 . . . . 0.0 109.48 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -129.35 136.11 60.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.614 -0.679 . . . . 0.0 109.523 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.27 131.0 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' CG2' ' CD2' ' A' ' 58' ' ' HIS . 35.8 m -139.32 150.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.816 -1.554 . . . . 0.0 113.095 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -127.83 154.74 45.1 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.522 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 16.2 p90 -113.04 156.8 22.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.814 -1.178 . . . . 0.0 111.615 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.36 -18.62 3.58 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.8 mt-10 -91.81 -53.49 4.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.1 t0 149.12 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -53.98 111.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.059 0.933 . . . . 0.0 112.814 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -74.07 86.36 1.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 24' ' ' LEU . 33.2 m -61.55 -42.59 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.553 -0.717 . . . . 0.0 110.547 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -63.45 -45.16 92.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.539 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -68.79 -34.01 74.82 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -67.94 -42.02 85.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.5 tp -58.95 -39.36 81.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -61.15 -35.48 77.21 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.656 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.44 -53.23 40.54 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -44.09 -41.44 5.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.517 -0.99 . . . . 0.0 108.821 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -51.98 -39.12 58.87 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -63.59 -44.49 93.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.584 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -47.15 -48.42 23.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 32' ' ' SER . 86.3 t -55.47 -24.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 0.0 108.873 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 32.2 t -43.44 -43.4 5.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.05 -10.06 48.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 111.433 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 36' ' ' THR . 64.5 mt -92.5 29.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.024 -1.672 . . . . 0.0 110.626 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.91 -8.08 2.04 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.614 ' H ' ' C ' ' A' ' 34' ' ' ILE . 68.2 p -67.5 -10.24 49.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.939 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.55 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 35.3 34.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 109.219 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.3 mttt -118.17 43.94 2.33 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.478 ' HG ' ' H ' ' A' ' 40' ' ' PHE . 14.2 t -176.22 177.59 1.52 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.478 ' H ' ' HG ' ' A' ' 39' ' ' SER . 21.0 t80 -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 0.0 111.914 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 64.2 mt-10 -154.33 124.07 6.66 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.366 0.603 . . . . 0.0 110.207 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.532 ' CE2' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -127.39 169.17 13.89 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.45 138.44 6.42 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.794 -1.67 . . . . 0.0 110.838 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.532 ' OE2' ' CE2' ' A' ' 42' ' ' TRP . 4.4 mp0 -124.92 172.63 9.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.209 -1.171 . . . . 0.0 109.323 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 57' ' ' THR . 57.0 t0 -167.58 94.61 0.43 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.613 ' HZ1' ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.15 170.89 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.471 -1.393 . . . . 0.0 109.78 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 48' ' ' SER . 2.4 mt-10 -172.77 90.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER 163.14 147.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 0.0 110.138 -179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 48' ' ' SER . 57.5 m170 57.95 113.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.204 -0.935 . . . . 0.0 109.7 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 51' ' ' MET . 29.0 p-10 -52.53 -43.41 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.313 -0.867 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 23.2 ttt -62.56 -35.03 78.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 17.2 mt -89.08 -20.03 24.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.763 -1.211 . . . . 0.0 109.305 177.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.97 ' O ' ' N ' ' A' ' 55' ' ' GLY . 34.0 ttt-85 -83.83 42.54 0.86 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.384 -0.823 . . . . 0.0 111.217 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.613 ' N ' ' HZ1' ' A' ' 46' ' ' LYS . 34.6 tt0 -31.41 -12.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.739 -1.225 . . . . 0.0 110.195 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.97 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 105.66 -35.79 4.83 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.385 -0.822 . . . . 0.0 112.93 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -55.39 102.82 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.294 -1.709 . . . . 0.0 109.956 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.616 ' OG1' ' ND1' ' A' ' 58' ' ' HIS . 49.1 p -61.99 -34.48 76.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.952 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.616 ' ND1' ' OG1' ' A' ' 57' ' ' THR . 34.7 p-80 -171.74 149.9 2.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.853 -1.154 . . . . 0.0 110.182 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.35 170.87 14.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.434 -0.791 . . . . 0.0 109.26 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -138.64 134.96 34.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.441 ' HB2' ' HE1' ' A' ' 42' ' ' TRP . 10.2 t -111.22 106.24 15.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.539 ' N ' ' O ' ' A' ' 8' ' ' HIS . 67.6 mtt -95.67 119.98 35.12 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.826 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.0 m -116.59 141.78 47.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -121.29 152.46 38.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.742 -1.224 . . . . 0.0 110.073 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -86.27 -23.92 26.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.0 OUTLIER -162.47 165.86 25.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -69.15 -24.73 64.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 0.0 111.446 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.1 -40.61 98.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.825 -1.172 . . . . 0.0 110.602 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . -72.1 -33.44 62.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -66.32 -43.0 87.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.589 -0.948 . . . . 0.0 110.51 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.84 -28.89 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.449 -1.407 . . . . 0.0 108.658 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 69' ' ' GLY . 1.1 m-85 -54.72 -35.42 63.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -0.897 . . . . 0.0 111.084 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.407 ' H ' HG21 ' A' ' 74' ' ' THR . 4.9 t -85.57 -28.93 24.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.739 -1.226 . . . . 0.0 110.327 -177.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -66.21 -34.64 78.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.997 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -61.31 151.53 76.18 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.76 -1.213 . . . . 0.0 109.61 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.07 -7.75 20.74 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.652 2.235 . . . . 0.0 112.407 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tt -76.97 -27.92 54.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.395 -0.816 . . . . 0.0 111.218 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -81.73 -35.53 29.62 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.541 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 6.7 p -70.2 -56.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.006 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.541 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.96 84.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.619 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -59.17 -42.78 91.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.804 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.7 p -65.73 -30.63 71.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 110.106 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.85 -55.19 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 108.687 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.426 ' C ' ' N ' ' A' ' 87' ' ' THR . . . -66.62 -39.35 88.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' ALA . 23.8 t80 -46.47 -25.42 0.67 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 90' ' ' ILE . 5.4 m -83.56 -63.62 1.32 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.01 -33.39 0.31 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.719 -0.613 . . . . 0.0 110.067 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.66 14.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -0.897 . . . . 0.0 110.815 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 26.5 mm -132.35 163.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.609 -1.307 . . . . 0.0 110.412 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 34.7 t0 -113.9 -33.73 5.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -132.87 129.54 38.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.0 tp -128.79 130.44 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.579 -1.326 . . . . 0.0 109.762 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.95 148.07 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.85 129.86 33.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.276 -1.515 . . . . 0.0 111.804 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.631 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -112.73 119.57 38.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.669 -0.644 . . . . 0.0 109.346 178.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.53 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 54.1 t0 -128.33 135.76 50.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.052 -1.03 . . . . 0.0 108.847 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.511 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 36.3 t80 -166.76 140.64 3.24 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 110.54 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.03 106.99 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.266 1.978 . . . . 0.0 112.249 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.49 128.8 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 109.952 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.76 94.71 4.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.654 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.659 ' H ' ' HG ' ' A' ' 4' ' ' SER . . . -156.45 150.59 25.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.091 -1.006 . . . . 0.0 109.562 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 -21.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 109.133 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.736 ' C ' ' H ' ' A' ' 106' ' ' SER . 18.0 mmtp 54.03 -141.74 0.84 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.366 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.97 -12.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 108.961 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.736 ' H ' ' C ' ' A' ' 104' ' ' LYS . 83.7 p -52.46 152.64 3.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.66 ' HG ' ' H ' ' B' ' 102' ' ' ALA . 16.8 m . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.94 -168.98 16.89 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.684 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.5 130.52 56.75 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -1.149 . . . . 0.0 108.014 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 22.1 ttpt -100.91 129.71 46.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.975 -1.078 . . . . 0.0 112.838 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' B' ' 97' ' ' ASP . 0.3 OUTLIER -121.52 119.56 32.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.07 141.67 49.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.713 -1.242 . . . . 0.0 109.56 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -129.25 136.34 59.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.485 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.4 131.02 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.416 ' CG2' ' CD2' ' B' ' 58' ' ' HIS . 35.9 m -139.22 150.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 117.706 -1.597 . . . . 0.0 113.046 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -127.91 154.98 44.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.521 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 15.4 p90 -113.34 156.68 22.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.815 -1.178 . . . . 0.0 111.596 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.27 -18.8 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.6 mt-10 -91.73 -53.65 4.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.4 t0 149.2 65.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.8 m -54.14 112.02 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.114 0.959 . . . . 0.0 112.825 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.486 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.11 86.47 1.87 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' B' ' 24' ' ' LEU . 33.0 m -61.86 -42.42 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.622 -0.674 . . . . 0.0 110.477 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.412 ' N ' ' CG2' ' B' ' 20' ' ' VAL . 87.5 m-20 -63.5 -45.03 92.57 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 110.535 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -68.87 -34.43 75.43 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -67.49 -42.11 86.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' B' ' 20' ' ' VAL . 16.5 tp -58.89 -39.51 81.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -60.87 -35.67 77.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.66 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -63.29 -53.32 40.39 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 26' ' ' GLY . 5.9 tt -44.11 -41.28 5.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.989 . . . . 0.0 108.846 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -51.99 -39.07 58.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 0.7 OUTLIER -63.82 -44.17 94.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.568 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.5 OUTLIER -47.59 -47.91 28.35 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 32' ' ' SER . 84.4 t -55.84 -24.47 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 32.5 t -43.65 -43.38 5.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.07 -9.83 49.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.436 -0.79 . . . . 0.0 111.479 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' B' ' 36' ' ' THR . 62.8 mt -92.59 28.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.003 -1.685 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.84 -8.01 1.95 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.6 ' H ' ' C ' ' B' ' 34' ' ' ILE . 66.1 p -67.61 -10.2 49.89 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.945 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.58 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.6 m 35.27 35.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.032 -1.043 . . . . 0.0 109.181 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 36' ' ' THR . 66.4 mttt -118.22 43.99 2.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.477 ' HG ' ' H ' ' B' ' 40' ' ' PHE . 14.4 t -176.27 177.7 1.48 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.477 ' H ' ' HG ' ' B' ' 39' ' ' SER . 21.2 t80 -148.02 156.0 42.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.541 -1.349 . . . . 0.0 112.007 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.452 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 63.8 mt-10 -154.09 124.23 6.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.354 0.597 . . . . 0.0 110.259 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.54 ' CE2' ' OE2' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -127.51 168.92 14.27 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.26 138.34 6.4 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.75 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.54 ' OE2' ' CE2' ' B' ' 42' ' ' TRP . 4.4 mp0 -124.71 173.16 8.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.233 -1.157 . . . . 0.0 109.434 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.577 ' HA ' ' O ' ' B' ' 57' ' ' THR . 57.1 t0 -168.12 94.55 0.39 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.622 ' HZ1' ' N ' ' B' ' 54' ' ' GLN . 0.0 OUTLIER -89.0 170.73 10.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.446 -1.409 . . . . 0.0 109.825 179.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' B' ' 48' ' ' SER . 2.3 mt-10 -172.58 90.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER 163.46 148.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' B' ' 48' ' ' SER . 57.9 m170 57.7 113.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 109.693 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 51' ' ' MET . 28.7 p-10 -52.49 -43.53 65.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.781 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 23.3 ttt -62.34 -35.17 78.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 110.723 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.519 ' O ' ' NZ ' ' B' ' 46' ' ' LYS . 17.0 mt -89.04 -19.91 25.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.336 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.953 ' O ' ' N ' ' B' ' 55' ' ' GLY . 34.1 ttt-85 -83.99 42.65 0.88 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -0.854 . . . . 0.0 111.194 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.622 ' N ' ' HZ1' ' B' ' 46' ' ' LYS . 34.8 tt0 -31.53 -12.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.862 -1.149 . . . . 0.0 110.274 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.953 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 105.88 -36.11 4.62 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.454 -0.779 . . . . 0.0 112.857 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.809 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 0.7 OUTLIER -55.04 102.8 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.302 -1.705 . . . . 0.0 109.987 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.61 ' OG1' ' ND1' ' B' ' 58' ' ' HIS . 49.2 p -61.78 -34.81 76.55 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.307 -0.871 . . . . 0.0 111.015 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.61 ' ND1' ' OG1' ' B' ' 57' ' ' THR . 33.9 p-80 -171.35 150.3 2.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 110.148 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.65 170.8 15.16 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.262 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -138.59 134.9 34.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.439 -0.788 . . . . 0.0 109.128 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.441 ' HB2' ' HE1' ' B' ' 42' ' ' TRP . 10.0 t -111.16 106.24 15.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' MET . . . . . 0.475 ' N ' ' O ' ' B' ' 8' ' ' HIS . 67.7 mtt -95.57 120.33 35.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.149 -0.97 . . . . 0.0 110.833 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m -116.96 141.72 47.87 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -121.27 152.1 39.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.695 -1.253 . . . . 0.0 110.047 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -85.94 -23.76 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.484 ' N ' HD21 ' B' ' 66' ' ' ASN . 0.0 OUTLIER -162.65 166.08 24.98 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -69.35 -24.66 63.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 111.453 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.44 -40.29 96.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.865 -1.147 . . . . 0.0 110.604 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.553 ' O ' ' CE2' ' B' ' 73' ' ' PHE . . . -71.99 -33.78 62.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -66.15 -43.05 88.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.512 -0.993 . . . . 0.0 110.426 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.83 -28.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.412 -1.43 . . . . 0.0 108.626 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.99 2.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.358 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.553 ' CE2' ' O ' ' B' ' 69' ' ' GLY . 1.1 m-85 -54.6 -35.56 63.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.287 -0.883 . . . . 0.0 111.089 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -85.49 -29.0 24.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.822 -1.174 . . . . 0.0 110.347 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 73.8 m -66.11 -34.78 78.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.982 . . . . 0.0 111.056 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -61.11 151.81 73.91 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.24 -7.86 21.23 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.611 2.207 . . . . 0.0 112.499 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tt -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -0.797 . . . . 0.0 111.202 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -81.37 -35.65 30.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 110.281 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 6.9 p -70.26 -56.67 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.545 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.89 84.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.15 -42.77 91.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.849 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 88.0 p -65.82 -30.55 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.991 . . . . 0.0 110.069 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.85 36.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 0.0 108.705 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.427 ' C ' ' N ' ' B' ' 87' ' ' THR . . . -66.96 -39.24 87.2 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' B' ' 85' ' ' ALA . 24.0 t80 -46.73 -25.05 0.66 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.427 ' N ' ' C ' ' B' ' 85' ' ' ALA . 5.7 m -83.91 -63.48 1.34 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.07 -33.18 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.771 -0.581 . . . . 0.0 110.086 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 7.0 m -92.89 14.83 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.173 -0.954 . . . . 0.0 110.811 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 26.2 mm -132.43 164.16 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.651 -1.281 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 34.8 t0 -114.07 -33.71 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -132.94 129.58 38.47 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 7.1 tp -128.83 130.56 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.516 -1.365 . . . . 0.0 109.757 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.06 147.94 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.86 130.03 33.27 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.237 -1.54 . . . . 0.0 111.759 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.63 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.1 OUTLIER -112.85 119.42 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.325 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' B' ' 8' ' ' HIS . 54.7 t0 -128.24 135.7 50.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.107 -0.996 . . . . 0.0 108.918 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.492 ' N ' ' OD1' ' B' ' 97' ' ' ASP . 36.1 t80 -166.7 140.65 3.28 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.111 -0.993 . . . . 0.0 110.49 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.95 106.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.273 1.982 . . . . 0.0 112.264 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.38 128.67 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.121 -0.987 . . . . 0.0 110.079 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.65 94.74 4.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.511 -0.743 . . . . 0.0 109.554 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . 0.66 ' H ' ' HG ' ' B' ' 4' ' ' SER . . . -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 0.0 109.62 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.52 -21.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.21 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.717 ' C ' ' H ' ' B' ' 106' ' ' SER . 18.1 mmtp 54.45 -141.87 0.83 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.28 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.89 -12.7 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.143 -0.973 . . . . 0.0 108.916 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.717 ' H ' ' C ' ' B' ' 104' ' ' LYS . 83.5 p -52.49 152.44 3.57 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.921 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.546 ' O ' HG21 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.546 HG21 ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 74.77 -2.81 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.116 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.3 m -174.65 -129.13 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.94 168.59 26.19 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.653 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.91 128.14 47.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -1.15 . . . . 0.0 108.028 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.509 ' NZ ' ' CD ' ' B' ' 44' ' ' GLU . 4.3 ttpm? -106.5 134.66 49.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 112.885 -177.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -126.17 124.48 40.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -131.76 142.03 49.65 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.678 -1.264 . . . . 0.0 109.526 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.08 138.21 53.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.482 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.83 131.69 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.19 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 117.88 -1.528 . . . . 0.0 113.071 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -127.49 147.74 50.31 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.8 ' CB ' ' H ' ' A' ' 18' ' ' THR . 17.7 t80 -111.31 158.88 18.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.0 111.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.701 ' HG3' ' H ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.42 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.701 ' H ' ' HG3' ' A' ' 15' ' ' LYS . 83.6 mt-10 -85.95 -49.99 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.5 t0 160.31 98.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.8 ' H ' ' CB ' ' A' ' 14' ' ' PHE . 3.4 m -51.43 153.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.121 0.963 . . . . 0.0 112.84 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 18' ' ' THR . 0.0 OUTLIER -77.84 87.69 4.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.32 -33.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.507 -0.746 . . . . 0.0 110.517 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.74 -42.02 86.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.443 -0.785 . . . . 0.0 110.508 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 70.7 mm-40 -67.64 -30.31 69.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mm -70.9 -37.46 68.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -54.12 -36.87 63.71 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -35.46 80.37 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.95 -54.58 17.18 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -47.96 41.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.5 -1.0 . . . . 0.0 108.883 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.08 -43.61 70.48 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.647 ' ND2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -65.0 -47.52 77.23 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.27 -44.64 44.0 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 34' ' ' ILE . 78.7 t -55.62 -25.02 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.28 -0.887 . . . . 0.0 108.866 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 51.0 m -43.27 -39.09 2.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.425 ' OE1' ' CG ' ' A' ' 76' ' ' HIS . 99.5 mm-40 -67.55 0.89 2.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 111.425 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 36' ' ' THR . 72.2 mt -108.17 26.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.074 -1.641 . . . . 0.0 110.607 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -60.42 -8.42 2.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.609 ' O ' ' C ' ' A' ' 37' ' ' VAL . 29.4 p -84.21 0.23 49.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.964 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.609 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.3 m 30.26 38.99 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.29 3.59 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 63' ' ' THR . 18.4 t -174.07 178.27 2.16 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 91.9 m-85 -144.53 154.49 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 111.993 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 81.0 mt-10 -158.01 127.46 5.86 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.342 0.591 . . . . 0.0 110.267 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -133.43 172.59 12.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' B' ' 98' ' ' PHE . . . -131.89 163.87 23.75 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.816 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.677 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 18.9 mt-10 -149.49 142.54 24.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.247 -1.149 . . . . 0.0 109.34 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 47' ' ' GLU . 42.2 m-20 -125.63 155.79 40.22 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 81.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.395 -1.44 . . . . 0.0 109.771 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.7 mt-10 -103.04 39.33 1.57 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' B' ' 97' ' ' ASP . 11.7 m -142.75 168.33 19.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 0.0 110.129 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ARG . 78.0 m80 -48.37 140.79 7.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.134 -0.979 . . . . 0.0 109.757 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 78.7 m-20 -44.48 -46.4 9.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.759 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 110.732 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 43.5 mt -102.0 -19.12 15.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.713 -1.242 . . . . 0.0 109.241 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.761 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -72.25 -5.34 35.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.905 . . . . 0.0 111.217 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.62 -8.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.827 -1.17 . . . . 0.0 110.149 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.761 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 72.77 -13.16 3.23 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.386 -0.821 . . . . 0.0 112.844 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 3.5 p90 -59.54 129.9 44.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.308 -1.701 . . . . 0.0 109.985 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.9 p -54.07 -43.04 69.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.88 . . . . 0.0 111.008 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.677 ' CE1' ' H ' ' A' ' 44' ' ' GLU . 19.0 t60 -173.36 159.4 3.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.143 . . . . 0.0 110.147 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.649 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.07 167.9 21.0 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 0.0 109.208 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 81.0 m-85 -132.94 129.48 38.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.114 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.2 m -106.6 100.72 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.9 mtm -104.79 129.14 53.1 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.19 -0.944 . . . . 0.0 110.745 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 39' ' ' SER . 52.3 m -126.48 143.44 51.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 65' ' ' GLU . 93.1 m-85 -124.5 130.13 51.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.679 -1.263 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' PHE . 84.6 tt0 -47.93 -33.82 8.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.545 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -161.54 166.37 27.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -55.27 -22.47 18.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 111.459 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD2' ' NZ ' ' A' ' 38' ' ' LYS . 22.9 t70 -53.63 -40.49 65.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.791 -1.193 . . . . 0.0 110.651 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.01 -36.16 64.55 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -64.39 -44.16 92.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.631 -0.923 . . . . 0.0 110.472 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.77 -28.9 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.331 -1.481 . . . . 0.0 108.68 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.86 2.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -59.12 -46.7 87.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 111.08 -177.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.62 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 11.6 t -69.84 -36.13 75.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.747 -1.22 . . . . 0.0 110.307 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.0 p -65.43 -27.21 68.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -0.98 . . . . 0.0 110.941 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 55.3 m80 -72.17 151.29 92.41 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.836 -1.165 . . . . 0.0 109.562 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.98 -5.35 16.13 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 5.6 tp -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 111.198 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 83' ' ' SER . 11.1 t-160 -82.61 -40.75 20.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.074 -1.016 . . . . 0.0 110.241 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.35 -61.72 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.998 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -53.16 -38.07 62.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.612 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.647 ' CZ ' ' ND2' ' A' ' 29' ' ' ASN . 8.1 m-85 -74.37 -33.62 63.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.838 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' HIS . 21.2 t -61.23 -44.09 97.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 110.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.35 96.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.99 -1.069 . . . . 0.0 108.667 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.19 -43.42 78.14 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.22 -31.64 0.64 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 89' ' ' VAL . 22.3 m -80.43 -62.25 1.73 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.97 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.3 m -113.95 7.26 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 86' ' ' PHE . 60.9 mt -123.5 157.72 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.656 -1.277 . . . . 0.0 110.452 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.472 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 22.5 t70 -108.37 -30.28 8.4 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -145.59 142.98 29.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 tp -125.39 123.51 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.635 -1.29 . . . . 0.0 109.852 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 t -126.05 131.59 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -138.3 133.24 32.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.207 -1.558 . . . . 0.0 111.793 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.16 126.58 50.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.307 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.454 ' O ' ' OG ' ' B' ' 48' ' ' SER . 64.8 t0 -124.69 130.43 52.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.085 -1.009 . . . . 0.0 108.952 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.648 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -157.65 124.23 2.55 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.035 -1.041 . . . . 0.0 110.501 -179.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.648 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 79.8 Cg_exo -45.01 133.68 11.03 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.287 1.991 . . . . 0.0 112.235 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.2 t -110.35 133.3 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 110.001 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -110.9 94.05 4.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.463 -0.773 . . . . 0.0 109.634 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.27 69.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 109.516 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 101' ' ' ALA . 21.7 m -151.45 110.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.134 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.686 ' C ' ' H ' ' A' ' 106' ' ' SER . 24.6 mmtp -125.41 1.46 7.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.44 -23.38 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 104' ' ' LYS . 1.7 m 61.15 54.62 3.24 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.257 -0.902 . . . . 0.0 109.35 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.774 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.0 m . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.87 168.44 26.19 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.688 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.85 128.25 47.34 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 4.3 ttpm? -106.39 134.77 49.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.989 -1.07 . . . . 0.0 112.823 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -126.25 124.5 40.52 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.85 141.98 49.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.7 -1.25 . . . . 0.0 109.491 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 138.22 54.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.612 -0.68 . . . . 0.0 109.542 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.75 131.69 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.28 146.31 29.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 117.702 -1.599 . . . . 0.0 113.04 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -127.65 147.75 50.37 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.798 ' CB ' ' H ' ' B' ' 18' ' ' THR . 17.5 t80 -111.37 158.83 18.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.867 -1.146 . . . . 0.0 111.596 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.699 ' HG3' ' H ' ' B' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.699 ' H ' ' HG3' ' B' ' 15' ' ' LYS . 83.6 mt-10 -86.05 -49.95 7.41 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.5 t0 160.35 98.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' B' ' 14' ' ' PHE . 3.4 m -51.28 153.77 1.94 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.062 0.935 . . . . 0.0 112.909 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.517 ' N ' ' CG2' ' B' ' 18' ' ' THR . 0.0 OUTLIER -78.01 87.6 4.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -64.24 -33.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.605 -0.684 . . . . 0.0 110.562 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 29.7 p-10 -66.71 -42.1 86.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.793 . . . . 0.0 110.56 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 70.5 mm-40 -67.64 -30.28 69.8 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mm -70.78 -37.48 69.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -54.28 -36.64 63.86 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -35.54 80.66 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.02 -54.39 17.9 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.86 -47.7 42.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.633 -0.922 . . . . 0.0 108.855 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.44 -43.59 71.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.642 ' ND2' ' CZ ' ' B' ' 82' ' ' PHE . 0.2 OUTLIER -64.95 -47.5 77.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.046 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.25 -44.71 43.93 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' B' ' 32' ' ' SER . 77.4 t -55.51 -25.11 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.273 -0.892 . . . . 0.0 108.789 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 50.9 m -43.12 -39.25 2.72 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' B' ' 76' ' ' HIS . 99.5 mm-40 -67.37 0.88 2.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 111.536 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.559 ' C ' ' H ' ' B' ' 36' ' ' THR . 72.1 mt -108.18 26.64 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.043 -1.661 . . . . 0.0 110.581 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.8 p30 -60.47 -8.49 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.625 ' O ' ' C ' ' B' ' 37' ' ' VAL . 29.6 p -84.1 0.14 49.6 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.966 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.625 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.5 m 30.32 38.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.093 -1.004 . . . . 0.0 109.149 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.33 3.58 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' B' ' 63' ' ' THR . 20.4 t -174.19 178.29 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 91.9 m-85 -144.59 154.39 42.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.555 -1.341 . . . . 0.0 112.002 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.533 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 81.7 mt-10 -158.01 127.57 5.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.441 0.639 . . . . 0.0 110.192 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -133.62 172.54 12.6 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 98' ' ' PHE . . . -131.93 163.8 23.78 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.725 -1.702 . . . . 0.0 110.854 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.687 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 18.4 mt-10 -149.4 142.48 24.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -1.158 . . . . 0.0 109.35 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' B' ' 47' ' ' GLU . 42.3 m-20 -125.53 155.76 40.11 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 81.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.354 -1.466 . . . . 0.0 109.743 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -103.11 39.14 1.61 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 97' ' ' ASP . 11.9 m -142.82 168.21 20.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 110.164 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' B' ' 53' ' ' ARG . 78.0 m80 -48.26 140.78 7.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.686 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 78.1 m-20 -44.57 -46.27 9.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.773 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.4 ttt -61.76 -28.85 69.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.718 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 95' ' ' LEU . 43.3 mt -102.14 -18.98 15.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.748 ' CG ' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -72.36 -5.28 35.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 111.238 -177.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.82 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.827 -1.17 . . . . 0.0 110.204 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.748 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 73.04 -13.32 3.37 Favored Glycine 0 N--CA 1.498 2.82 0 O-C-N 121.433 -0.792 . . . . 0.0 112.83 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 3.4 p90 -59.44 129.9 44.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.328 -1.689 . . . . 0.0 109.908 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 28.8 p -53.99 -43.2 69.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 111.039 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.687 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 18.9 t60 -173.17 159.6 3.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.903 -1.123 . . . . 0.0 110.175 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.662 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.22 167.74 21.41 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.507 -0.746 . . . . 0.0 109.282 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.402 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 80.9 m-85 -132.84 129.55 38.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.443 -0.785 . . . . 0.0 109.104 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -106.55 100.95 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 56.7 mtm -105.13 129.15 53.6 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.467 ' O ' ' OG ' ' B' ' 39' ' ' SER . 50.4 m -126.53 143.52 51.18 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' B' ' 65' ' ' GLU . 93.3 m-85 -124.6 130.0 51.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 0.0 110.014 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 64' ' ' PHE . 84.4 tt0 -47.88 -33.67 7.84 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.546 ' N ' ' OD1' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -161.71 166.41 26.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -55.39 -22.7 20.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 111.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.492 ' OD2' ' NZ ' ' B' ' 38' ' ' LYS . 22.6 t70 -53.23 -40.69 64.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.704 -1.248 . . . . 0.0 110.574 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.17 65.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -64.19 -44.43 91.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.921 . . . . 0.0 110.47 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.77 -28.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.331 -1.481 . . . . 0.0 108.704 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -60.94 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.309 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -58.76 -46.74 86.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 0.0 111.191 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.621 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 11.6 t -69.9 -36.13 75.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.706 -1.246 . . . . 0.0 110.308 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 77.9 p -65.51 -27.08 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -0.993 . . . . 0.0 110.924 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.423 ' CG ' ' OE1' ' B' ' 33' ' ' GLN . 55.0 m80 -72.22 151.18 92.29 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.8 -1.187 . . . . 0.0 109.559 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.87 -5.12 15.52 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.632 2.221 . . . . 0.0 112.517 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' B' ' 82' ' ' PHE . 5.6 tp -73.22 -28.67 62.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.323 -0.861 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 83' ' ' SER . 11.0 t-160 -82.56 -40.69 20.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.031 -1.043 . . . . 0.0 110.226 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.45 -61.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.33 -38.02 62.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.642 ' CZ ' ' ND2' ' B' ' 29' ' ' ASN . 8.2 m-85 -74.39 -33.54 63.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 109.873 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' SER . . . . . 0.438 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.1 t -61.32 -44.08 97.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.0 110.084 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.89 96.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.001 -1.062 . . . . 0.0 108.685 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.72 -43.13 76.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.45 -31.58 0.72 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.542 ' O ' ' N ' ' B' ' 89' ' ' VAL . 22.0 m -80.36 -62.2 1.75 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.18 -21.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.754 -0.591 . . . . 0.0 110.078 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.4 m -114.32 7.36 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.224 -0.922 . . . . 0.0 110.83 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 61.8 mt -123.5 157.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.659 -1.276 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 22.2 t70 -108.33 -30.45 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -145.63 142.97 29.56 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 tp -125.38 123.51 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.535 -1.353 . . . . 0.0 109.753 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 t -125.99 131.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -138.32 133.25 32.78 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.207 -1.558 . . . . 0.0 111.707 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.07 126.7 50.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.695 -0.628 . . . . 0.0 109.308 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.465 ' O ' ' OG ' ' A' ' 48' ' ' SER . 65.1 t0 -124.8 130.34 52.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 108.943 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.658 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 0.1 OUTLIER -157.49 124.15 2.57 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.048 -1.033 . . . . 0.0 110.539 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . 0.658 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 79.7 Cg_exo -44.85 133.73 10.57 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.179 1.919 . . . . 0.0 112.274 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -110.44 133.2 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -110.74 94.19 4.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.448 -0.783 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.37 69.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.018 . . . . 0.0 109.558 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' B' ' 101' ' ' ALA . 21.7 m -151.44 110.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 0.0 109.246 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.688 ' C ' ' H ' ' B' ' 106' ' ' SER . 24.7 mmtp -125.45 1.39 7.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 109.381 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.48 -23.41 0.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.938 . . . . 0.0 108.94 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.688 ' H ' ' C ' ' B' ' 104' ' ' LYS . 1.8 m 61.22 54.39 3.26 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.823 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.443 0.639 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.508 HG21 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER 73.09 -39.61 0.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.126 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 2' ' ' ALA . 75.1 m -91.64 -132.13 0.12 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.02 177.13 20.82 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.332 -1.413 . . . . 0.0 109.655 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -114.17 131.77 56.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -107.03 137.63 44.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.908 -1.12 . . . . 0.0 112.827 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -129.95 129.13 43.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -134.33 145.04 48.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.766 -1.209 . . . . 0.0 109.498 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.04 133.55 68.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.436 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.28 128.89 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 m -139.0 161.85 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 117.779 -1.568 . . . . 0.0 113.053 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 18.3 tptm -125.2 152.22 44.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.455 ' N ' ' HG3' ' A' ' 13' ' ' LYS . 41.6 p90 -111.04 152.55 26.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.857 -1.152 . . . . 0.0 111.574 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -127.5 -24.71 3.28 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 63.2 tt0 -89.7 -53.61 4.44 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.4 t0 147.57 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.2 m -54.84 111.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.095 0.95 . . . . 0.0 112.889 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.623 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.07 86.41 5.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.5 m -57.82 -33.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.551 -0.718 . . . . 0.0 110.456 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -66.19 -37.57 85.93 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -70.8 -35.85 72.73 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.27 -40.82 89.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.22 -35.79 60.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -56.94 -30.12 63.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -76.68 -44.93 14.13 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 tt -49.47 -56.34 10.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.568 -0.96 . . . . 0.0 108.835 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 8.0 pt-20 -51.49 -35.44 40.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 51.7 m-20 -67.2 -46.58 73.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 4.1 mm? -47.71 -51.43 21.97 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.6 t -48.91 -34.12 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 108.888 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.3 m -45.15 -50.24 11.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.79 -1.55 2.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.475 -0.766 . . . . 0.0 111.419 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 36' ' ' THR . 6.3 mt -112.37 34.06 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.997 -1.689 . . . . 0.0 110.626 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -56.31 -10.48 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.618 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.2 t -85.88 -1.57 57.4 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.03 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 35.4 m 35.6 39.96 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.034 -1.041 . . . . 0.0 109.167 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' O ' ' OG ' ' A' ' 39' ' ' SER . 59.2 mttt -116.87 43.21 2.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 38.6 m -174.27 175.07 2.73 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' C ' ' CD ' ' A' ' 41' ' ' GLU . 77.3 m-85 -147.95 157.18 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.524 -1.36 . . . . 0.0 112.002 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' CD ' ' C ' ' A' ' 40' ' ' PHE . 58.7 mp0 -156.28 123.85 5.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.452 0.644 . . . . 0.0 110.172 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.52 172.25 9.85 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.97 155.56 21.04 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.798 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.582 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 76.6 mm-40 -149.12 136.65 20.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -1.127 . . . . 0.0 109.345 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 88.6 m-20 -111.43 142.87 43.12 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HZ3' ' C ' ' A' ' 58' ' ' HIS . 9.9 pttm -141.54 109.39 5.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.369 -1.457 . . . . 0.0 109.826 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -147.0 45.33 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.679 -0.638 . . . . 0.0 109.305 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 49' ' ' HIS . 10.1 t -133.16 124.44 27.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 48' ' ' SER . 58.1 m-70 60.97 116.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -60.34 -38.28 83.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.364 -0.835 . . . . 0.0 110.827 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -71.18 -35.53 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.031 -1.043 . . . . 0.0 110.729 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 54' ' ' GLN . 26.5 mt -80.68 -58.27 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.806 -1.184 . . . . 0.0 109.292 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.6 ptt180 -63.53 14.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.242 -0.911 . . . . 0.0 111.209 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.569 ' H ' ' C ' ' A' ' 52' ' ' LEU . 24.9 mt-30 43.56 4.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.789 -1.194 . . . . 0.0 110.187 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 84.5 -16.94 32.32 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.478 -0.764 . . . . 0.0 112.844 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.507 ' CE2' ' NZ ' ' A' ' 92' ' ' LYS . 48.2 m-85 -61.94 -134.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.253 -1.733 . . . . 0.0 109.998 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -162.89 -34.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.284 -0.885 . . . . 0.0 111.027 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.658 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 8.5 t60 -168.47 153.59 6.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 110.125 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.658 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.56 169.1 18.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.385 -0.822 . . . . 0.0 109.283 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.653 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 90.0 m-85 -132.06 128.43 38.21 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 0.0 109.083 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -100.18 99.76 10.5 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -103.07 123.08 45.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.766 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.9 m -123.12 145.62 48.43 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' ASN . 92.2 m-85 -120.92 120.33 35.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.722 -1.237 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -50.92 -24.46 3.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 64' ' ' PHE . 42.2 t-20 -171.26 171.26 5.71 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -58.91 -20.42 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 111.446 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -58.67 -41.95 87.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.835 -1.166 . . . . 0.0 110.574 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.68 -32.93 66.93 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -66.86 -44.11 81.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.927 . . . . 0.0 110.538 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.322 -1.486 . . . . 0.0 108.649 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.91 2.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.349 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -50.57 -34.78 27.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -0.871 . . . . 0.0 111.182 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 76' ' ' HIS . 3.7 t -85.63 -30.15 23.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.824 -1.172 . . . . 0.0 110.294 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 t -67.41 16.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.126 -0.984 . . . . 0.0 110.971 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.519 ' H ' ' C ' ' A' ' 74' ' ' THR . 56.1 m80 -133.06 152.05 79.0 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 0.0 109.602 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.84 1.44 8.12 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.669 2.246 . . . . 0.0 112.507 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.26 -31.77 72.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.369 -0.832 . . . . 0.0 111.256 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 83' ' ' SER . 75.2 t60 -84.85 -31.84 23.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.117 -0.989 . . . . 0.0 110.237 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.13 -62.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.993 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.1 -42.46 72.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -75.13 -32.91 61.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 79' ' ' HIS . 13.7 t -63.25 -42.92 99.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.158 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.34 99.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.978 -1.076 . . . . 0.0 108.686 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -65.21 -41.8 94.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.465 ' O ' HG12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -44.66 -31.13 1.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' VAL . 18.7 m -81.68 -63.14 1.45 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.18 -28.74 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.718 -0.614 . . . . 0.0 110.057 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 87' ' ' THR . 5.3 m -103.99 6.95 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.122 -0.986 . . . . 0.0 110.848 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 28.4 mm -129.57 161.92 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.64 -1.287 . . . . 0.0 110.436 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.508 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 61.4 t0 -121.85 -30.01 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.507 ' NZ ' ' CE2' ' A' ' 56' ' ' PHE . 18.1 ttpt -131.04 129.06 41.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 93' ' ' ILE . 3.4 tp -123.69 121.44 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.643 -1.286 . . . . 0.0 109.799 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 t -131.17 134.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -143.17 141.27 31.1 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.273 -1.517 . . . . 0.0 111.755 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.93 118.92 33.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.649 -0.657 . . . . 0.0 109.311 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 39.3 p30 -128.26 136.46 51.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.059 -1.026 . . . . 0.0 108.983 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 9.3 p90 -172.48 156.14 3.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 110.481 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.19 124.87 15.16 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.293 1.995 . . . . 0.0 112.187 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.5 t -109.66 136.05 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 110.022 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.58 104.02 9.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.501 -0.75 . . . . 0.0 109.612 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.46 160.28 13.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.001 . . . . 0.0 109.579 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.02 -10.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 109.238 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.843 ' C ' ' H ' ' A' ' 106' ' ' SER . 3.7 mmpp? 54.94 -145.72 0.61 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.322 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.53 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 108.904 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.843 ' H ' ' C ' ' A' ' 104' ' ' LYS . 75.2 m -61.62 124.64 21.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.36 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.529 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.03 176.75 21.07 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.727 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -113.85 131.99 56.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.301 -1.117 . . . . 0.0 108.029 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -107.41 137.5 45.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.988 -1.07 . . . . 0.0 112.809 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -130.03 129.18 43.34 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -134.36 145.03 48.6 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.702 -1.248 . . . . 0.0 109.53 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 p -126.09 133.69 68.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.45 128.63 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 m -138.92 161.56 29.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.741 -1.584 . . . . 0.0 113.026 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 18.2 tptm -124.73 152.34 43.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.455 ' N ' ' HG3' ' B' ' 13' ' ' LYS . 41.5 p90 -111.16 152.42 27.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.818 -1.176 . . . . 0.0 111.589 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -127.46 -24.73 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 62.8 tt0 -89.77 -53.64 4.42 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.5 t0 147.5 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 28.3 m -54.77 111.32 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.11 0.957 . . . . 0.0 112.857 -177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.619 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.4 86.13 5.78 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.32 -33.51 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.554 -0.716 . . . . 0.0 110.443 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.19 -37.77 86.41 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -70.54 -35.97 73.43 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.28 -40.71 88.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.26 -35.84 60.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' B' ' 28' ' ' GLU . 0.0 OUTLIER -56.94 -30.01 63.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -76.76 -44.78 14.15 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 1.2 tt -49.52 -56.37 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.5 -1.0 . . . . 0.0 108.824 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 8.1 pt-20 -51.49 -35.52 40.54 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 51.6 m-20 -67.17 -46.54 73.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 4.1 mm? -47.72 -51.39 22.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 32' ' ' SER . 52.1 t -48.98 -34.13 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.251 -0.906 . . . . 0.0 108.824 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 7.3 m -45.27 -49.95 12.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -64.79 -1.62 2.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 111.553 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' B' ' 36' ' ' THR . 6.1 mt -112.32 34.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.079 -1.638 . . . . 0.0 110.625 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -56.54 -10.61 1.01 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.618 ' H ' ' C ' ' B' ' 34' ' ' ILE . 1.2 t -85.81 -1.84 57.64 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.4 m 35.97 39.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.053 -1.029 . . . . 0.0 109.23 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.533 ' O ' ' OG ' ' B' ' 39' ' ' SER . 58.5 mttt -116.72 43.33 2.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.533 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 38.2 m -174.17 175.48 2.69 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.492 ' C ' ' CD ' ' B' ' 41' ' ' GLU . 77.1 m-85 -148.18 157.4 43.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.531 -1.356 . . . . 0.0 111.959 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.492 ' CD ' ' C ' ' B' ' 40' ' ' PHE . 58.5 mp0 -156.48 123.82 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.439 0.638 . . . . 0.0 110.194 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.5 172.11 9.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.74 155.54 20.97 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.768 -1.682 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.577 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 76.7 mm-40 -149.19 136.61 20.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -1.202 . . . . 0.0 109.392 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 90.4 m-20 -111.51 142.8 43.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.494 ' HZ3' ' C ' ' B' ' 58' ' ' HIS . 10.0 pttm -141.6 109.33 5.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.419 -1.426 . . . . 0.0 109.785 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -146.98 45.46 1.17 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.625 -0.672 . . . . 0.0 109.293 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' B' ' 49' ' ' HIS . 10.0 t -133.11 124.42 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.183 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.414 ' CD2' ' OG ' ' B' ' 48' ' ' SER . 58.2 m-70 60.88 116.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.166 -0.959 . . . . 0.0 109.664 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -60.93 -38.07 84.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.747 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -71.02 -35.5 72.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.753 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' B' ' 54' ' ' GLN . 26.5 mt -80.93 -58.42 3.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.704 -1.247 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.756 ' O ' ' N ' ' B' ' 55' ' ' GLY . 17.3 ptt180 -63.33 14.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 0.0 111.222 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.579 ' H ' ' C ' ' B' ' 52' ' ' LEU . 24.7 mt-30 43.76 4.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.814 -1.179 . . . . 0.0 110.157 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 84.71 -16.91 33.51 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.357 -0.84 . . . . 0.0 112.861 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.496 ' CE2' ' NZ ' ' B' ' 92' ' ' LYS . 47.9 m-85 -62.08 -134.08 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.884 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -163.01 -34.39 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.249 -0.907 . . . . 0.0 111.014 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.671 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 8.0 t60 -168.68 153.67 6.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.846 -1.159 . . . . 0.0 110.164 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.671 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.57 169.08 18.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.483 -0.761 . . . . 0.0 109.262 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.656 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 89.8 m-85 -131.98 128.5 38.53 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.112 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 30.0 t -100.29 99.59 10.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 64.1 mtt -103.07 123.08 45.96 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.771 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 46.3 m -123.0 145.83 48.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.14 120.27 34.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.744 -1.223 . . . . 0.0 110.048 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -51.06 -24.47 3.9 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -171.07 171.55 5.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -59.29 -20.23 52.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.363 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -58.8 -41.74 87.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.804 -1.185 . . . . 0.0 110.583 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.91 -33.11 65.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -66.56 -44.31 82.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.941 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.8 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.426 -1.421 . . . . 0.0 108.731 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.12 -60.89 2.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -50.29 -35.32 26.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.258 -0.901 . . . . 0.0 111.161 -177.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.9 t -85.21 -30.44 23.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.721 -1.237 . . . . 0.0 110.353 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -67.18 16.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.115 -0.991 . . . . 0.0 110.97 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' B' ' 74' ' ' THR . 56.3 m80 -133.48 152.28 78.88 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.813 -1.179 . . . . 0.0 109.602 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.15 1.64 8.05 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.697 2.264 . . . . 0.0 112.445 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.5 -31.66 71.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.408 -0.808 . . . . 0.0 111.231 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' B' ' 83' ' ' SER . 75.8 t60 -84.98 -31.69 23.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.1 . . . . 0.0 110.312 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.31 -61.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.33 -42.78 74.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.573 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -74.83 -32.85 62.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 79' ' ' HIS . 13.7 t -63.41 -43.05 98.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.21 98.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 108.698 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -65.64 -41.57 92.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.455 ' O ' HG12 ' B' ' 90' ' ' ILE . 1.0 OUTLIER -44.87 -31.16 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.418 ' O ' ' C ' ' B' ' 88' ' ' ALA . 18.4 m -81.47 -63.08 1.47 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.0 -29.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.657 -0.652 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 87' ' ' THR . 5.3 m -103.83 7.21 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.139 -0.976 . . . . 0.0 110.805 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 28.0 mm -129.64 161.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.605 -1.309 . . . . 0.0 110.419 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 62.0 t0 -121.87 -30.0 4.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.496 ' NZ ' ' CE2' ' B' ' 56' ' ' PHE . 17.5 ttpt -131.24 129.01 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' B' ' 93' ' ' ILE . 3.4 tp -123.58 121.61 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 109.709 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.0 t -131.36 134.71 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -143.1 141.18 31.17 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.349 -1.469 . . . . 0.0 111.765 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.76 119.05 33.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.363 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 40.6 p30 -128.51 136.39 50.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.094 -1.003 . . . . 0.0 108.896 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 9.3 p90 -172.32 156.23 3.61 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.015 -1.053 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.29 124.85 15.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.316 2.011 . . . . 0.0 112.248 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.72 136.14 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 110.038 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.55 103.89 9.25 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.52 160.23 12.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.559 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.03 -10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.823 ' C ' ' H ' ' B' ' 106' ' ' SER . 3.7 mmpp? 54.89 -145.6 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.347 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.54 -26.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 108.908 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.823 ' H ' ' C ' ' B' ' 104' ' ' LYS . 75.6 m -61.51 124.87 21.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.439 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 t -100.1 0.45 40.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.162 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -162.85 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.53 174.18 19.82 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.367 -1.397 . . . . 0.0 109.696 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.5 131.52 56.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.313 -1.11 . . . . 0.0 108.014 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 10.6 ttpt -105.29 133.11 50.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.935 -1.103 . . . . 0.0 112.837 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 97' ' ' ASP . 60.5 m80 -125.6 125.97 44.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.888 -1.894 . . . . 0.0 105.888 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -136.0 143.41 44.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.43 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.9 p -127.69 136.69 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.637 -0.665 . . . . 0.0 109.486 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.2 128.12 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.08 159.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 117.848 -1.541 . . . . 0.0 113.083 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 91' ' ' ASP . 11.1 mtpt -121.16 153.87 36.96 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 17.1 p90 -102.61 144.03 31.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.818 -1.176 . . . . 0.0 111.604 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -116.03 -29.61 6.27 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.7 tt0 -88.54 -55.18 3.83 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.564 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 13.6 m-20 152.19 74.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 39.3 m -62.24 109.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.103 0.954 . . . . 0.0 112.876 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.638 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.14 92.22 5.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.6 m -57.59 -35.27 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 110.475 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.1 p-10 -66.46 -39.58 88.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 110.554 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 96.4 mt-10 -70.67 -32.64 69.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.63 -42.48 83.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.49 -39.26 70.2 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -60.07 -24.73 64.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.621 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -82.42 -45.84 6.75 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.5 tt -49.05 -52.45 25.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.488 -1.007 . . . . 0.0 108.838 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 18.7 pt-20 -52.83 -40.28 63.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.1 m-20 -58.62 -43.9 89.79 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -47.33 -46.75 25.7 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' SER . 37.8 t -49.14 -27.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 108.842 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 37.4 t -42.93 -48.16 5.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.773 HE22 ' NE2' ' A' ' 76' ' ' HIS . 8.9 mm100 -72.8 -23.25 60.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 111.481 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.555 ' C ' ' H ' ' A' ' 36' ' ' THR . 73.2 mt -82.63 23.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.043 -1.661 . . . . 0.0 110.636 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.63 -10.89 2.53 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 43.9 p -79.94 -1.0 37.46 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.6 m 35.4 32.61 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 109.117 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 20.1 mtmm -120.02 42.71 2.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' THR . 27.7 t -172.76 171.98 4.26 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -148.83 160.98 42.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.645 -1.284 . . . . 0.0 111.943 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 63.2 mt-10 -151.91 116.71 5.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.393 0.616 . . . . 0.0 110.2 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.486 ' C ' ' NZ ' ' B' ' 104' ' ' LYS . 11.4 t-105 -104.66 159.2 15.96 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.435 ' N ' ' HZ3' ' B' ' 104' ' ' LYS . . . -118.81 151.49 17.69 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.736 -1.697 . . . . 0.0 110.803 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.518 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 70.9 mt-10 -150.84 133.47 15.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.211 -1.17 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.6 p-10 -155.46 86.56 1.08 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HZ1' ' C ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -78.81 155.42 29.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.398 -1.439 . . . . 0.0 109.81 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.4 mt-10 -155.52 59.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.67 -0.644 . . . . 0.0 109.331 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 49' ' ' HIS . 54.6 p -172.37 138.2 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.131 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 m80 60.82 113.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.14 -0.975 . . . . 0.0 109.688 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -55.44 -44.03 75.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 110.797 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.2 mtt -60.32 -35.74 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.746 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' B' ' 96' ' ' LEU . 12.2 mt -93.3 -28.97 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.74 -1.225 . . . . 0.0 109.283 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 1.065 ' O ' ' N ' ' A' ' 55' ' ' GLY . 39.6 ttt-85 -79.07 2.86 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.299 -0.876 . . . . 0.0 111.296 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.627 HE21 ' CG1' ' B' ' 94' ' ' VAL . 8.7 mt-30 33.72 2.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.709 -1.244 . . . . 0.0 110.212 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 1.065 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.54 -24.82 1.43 Allowed Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.379 -0.826 . . . . 0.0 112.877 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.513 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 6.5 m-85 -59.24 -142.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.26 -1.73 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.522 ' OG1' ' ND1' ' A' ' 58' ' ' HIS . 66.4 p -142.71 -48.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -0.848 . . . . 0.0 110.999 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.522 ' ND1' ' OG1' ' A' ' 57' ' ' THR . 35.7 p-80 -173.6 159.63 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.0 110.105 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.14 172.32 13.61 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.395 -0.815 . . . . 0.0 109.221 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -138.5 133.83 33.17 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.416 -0.803 . . . . 0.0 109.12 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.6 t -110.17 102.22 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.64 125.99 44.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.269 -0.894 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 39' ' ' SER . 31.7 m -120.55 142.83 48.99 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.26 130.59 46.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.717 -1.239 . . . . 0.0 110.066 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -55.7 -31.04 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -153.84 160.48 42.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.79 -19.7 43.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.957 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.55 -39.1 72.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.813 -1.18 . . . . 0.0 110.594 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.65 77.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.447 ' O ' ' CG2' ' A' ' 74' ' ' THR . 75.7 t80 -69.17 -45.68 69.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.969 . . . . 0.0 110.432 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.81 -28.91 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.355 -1.466 . . . . 0.0 108.645 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.355 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 3.5 t80 -54.46 -32.05 56.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 30.9 p -75.42 -31.21 60.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.762 -1.211 . . . . 0.0 110.303 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.7 t -82.34 -0.73 47.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.115 -0.991 . . . . 0.0 110.961 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.773 ' NE2' HE22 ' A' ' 33' ' ' GLN . 62.1 m80 -97.8 126.36 41.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.758 -1.214 . . . . 0.0 109.61 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -41.51 -14.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.0 112.418 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.2 tp -68.73 -29.26 67.63 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 111.228 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.517 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 81.6 t60 -79.88 -42.77 23.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.046 -1.034 . . . . 0.0 110.226 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.38 -60.68 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.005 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.89 -39.2 77.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -73.24 -42.49 62.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.847 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 66.8 m -62.17 -39.86 94.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.39 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 108.69 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -70.34 -41.99 72.47 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 25.6 t80 -45.96 -30.63 1.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 89' ' ' VAL . 17.6 m -80.77 -62.73 1.58 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.93 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.69 -0.631 . . . . 0.0 110.045 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 87' ' ' THR . 19.4 m -103.84 10.38 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.163 -0.96 . . . . 0.0 110.786 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 91' ' ' ASP . 1.1 mp -119.9 154.5 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.667 -1.271 . . . . 0.0 110.426 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 13' ' ' LYS . 63.8 t0 -101.37 -34.65 9.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.58 148.7 31.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -126.88 125.27 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.619 -1.3 . . . . 0.0 109.786 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.631 ' CG1' HE21 ' B' ' 54' ' ' GLN . 5.3 t -134.25 136.53 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -138.74 137.91 37.18 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.279 -1.513 . . . . 0.0 111.779 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.641 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -112.13 118.09 34.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.632 -0.667 . . . . 0.0 109.333 176.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 56.7 t0 -123.74 126.72 47.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.044 -1.035 . . . . 0.0 108.924 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 55.3 t80 -167.86 137.72 2.17 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.019 -1.051 . . . . 0.0 110.487 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.0 Cg_exo -47.7 124.45 9.73 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.26 1.973 . . . . 0.0 112.199 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.427 HG13 ' HE1' ' B' ' 42' ' ' TRP . 76.1 t -114.19 140.44 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.939 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -109.81 78.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 109.617 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.13 88.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.541 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 101' ' ' ALA . 13.1 m -149.17 116.12 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.828 . . . . 0.0 109.163 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 105' ' ' SER . 5.8 ptmt -176.43 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.362 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 107' ' ' VAL . 0.3 OUTLIER 162.05 -44.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 108.965 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.3 t -64.75 44.33 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.286 -0.884 . . . . 0.0 109.395 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' SER . 3.5 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.62 174.22 19.84 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.423 -1.37 . . . . 0.0 109.697 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.49 131.45 56.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.272 -1.134 . . . . 0.0 108.013 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.518 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 10.6 ttpt -105.08 133.14 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.894 -1.129 . . . . 0.0 112.821 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' B' ' 97' ' ' ASP . 60.5 m80 -125.72 126.04 43.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.4 tt -136.12 143.43 44.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.836 -1.165 . . . . 0.0 109.45 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 11.8 p -127.62 136.68 59.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.485 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.09 128.17 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.2 159.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 117.706 -1.598 . . . . 0.0 113.043 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' B' ' 91' ' ' ASP . 11.2 mtpt -121.13 153.81 37.0 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.528 ' HB2' ' H ' ' B' ' 18' ' ' THR . 17.3 p90 -102.61 143.96 31.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.94 -1.1 . . . . 0.0 111.585 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -115.97 -29.58 6.3 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 78.7 tt0 -88.65 -55.07 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 13.6 m-20 152.03 74.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 39.5 m -62.34 109.56 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.122 0.963 . . . . 0.0 112.862 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.672 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.2 92.21 5.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' B' ' 24' ' ' LEU . 8.6 m -57.71 -35.1 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 110.413 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.5 p-10 -66.54 -39.63 88.68 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 110.563 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 96.4 mt-10 -70.71 -32.6 69.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.66 -42.43 83.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' B' ' 20' ' ' VAL . 7.3 tp -55.6 -39.2 70.43 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.2 OUTLIER -60.02 -24.86 64.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -82.16 -45.93 6.82 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.5 tt -49.0 -52.43 25.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.968 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 18.6 pt-20 -52.96 -40.24 63.54 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 40.5 m-20 -58.59 -44.01 89.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -47.28 -46.71 25.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' B' ' 32' ' ' SER . 37.6 t -49.16 -27.77 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.91 . . . . 0.0 108.775 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 37.0 t -42.85 -48.29 5.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.781 HE22 ' NE2' ' B' ' 76' ' ' HIS . 8.8 mm100 -72.52 -23.45 61.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.461 -0.774 . . . . 0.0 111.509 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.564 ' C ' ' H ' ' B' ' 36' ' ' THR . 73.4 mt -82.57 23.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.009 -1.682 . . . . 0.0 110.558 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.6 -10.91 2.52 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' N ' ' B' ' 38' ' ' LYS . 44.1 p -79.93 -0.93 37.15 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.97 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.7 m 35.43 32.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.177 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' B' ' 36' ' ' THR . 20.1 mtmm -119.93 43.01 2.78 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.4 t -172.98 171.79 4.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -148.92 160.87 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.562 -1.336 . . . . 0.0 112.002 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.499 ' C ' ' HZ2' ' A' ' 104' ' ' LYS . 63.0 mt-10 -151.85 116.7 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.369 0.604 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.485 ' C ' ' NZ ' ' A' ' 104' ' ' LYS . 11.4 t-105 -104.62 159.27 15.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.437 ' N ' ' HZ3' ' A' ' 104' ' ' LYS . . . -118.91 151.44 17.68 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 118.695 -1.716 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.528 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 71.7 mt-10 -150.84 133.46 15.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.27 -1.136 . . . . 0.0 109.379 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 43.1 p-10 -155.47 86.62 1.08 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.547 ' HZ1' ' C ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -78.91 155.35 29.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.365 -1.459 . . . . 0.0 109.872 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.5 mt-10 -155.51 59.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.646 -0.659 . . . . 0.0 109.338 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.415 ' O ' ' O ' ' B' ' 49' ' ' HIS . 54.1 p -172.53 138.04 0.86 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 110.142 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' B' ' 53' ' ' ARG . 43.7 m80 61.03 113.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.684 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -55.33 -44.09 75.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.821 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.42 -35.56 76.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 12.2 mt -93.46 -28.93 15.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.724 -1.235 . . . . 0.0 109.244 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 1.066 ' O ' ' N ' ' B' ' 55' ' ' GLY . 39.8 ttt-85 -79.07 2.82 19.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.394 -0.816 . . . . 0.0 111.246 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.631 HE21 ' CG1' ' A' ' 94' ' ' VAL . 8.7 mt-30 33.7 2.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.77 -1.206 . . . . 0.0 110.206 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 1.066 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.41 -24.76 1.39 Allowed Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.449 -0.782 . . . . 0.0 112.865 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 6.5 m-85 -59.23 -142.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.292 -1.711 . . . . 0.0 109.928 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.518 ' OG1' ' ND1' ' B' ' 58' ' ' HIS . 64.6 p -142.73 -48.3 0.33 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.518 ' ND1' ' OG1' ' B' ' 57' ' ' THR . 35.8 p-80 -173.72 159.45 3.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.891 -1.131 . . . . 0.0 110.186 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.8 172.37 13.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 109.283 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -138.54 133.77 33.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.479 -0.763 . . . . 0.0 109.132 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -110.04 102.28 11.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.68 125.83 44.11 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.198 -0.939 . . . . 0.0 110.782 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.1 m -120.33 142.97 48.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -129.38 130.55 46.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.746 -1.221 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -55.56 -31.17 61.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -153.74 160.64 42.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.97 -19.66 45.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 111.421 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.61 -39.02 72.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.839 -1.163 . . . . 0.0 110.611 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.59 77.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.435 ' O ' ' CG2' ' B' ' 74' ' ' THR . 75.7 t80 -69.07 -45.89 69.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.645 -0.915 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.92 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.354 -1.466 . . . . 0.0 108.745 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.457 -0.777 . . . . 0.0 109.365 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.54 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 3.5 t80 -54.22 -32.16 55.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 111.118 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 30.9 p -75.31 -31.34 60.63 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.761 -1.212 . . . . 0.0 110.372 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t -82.21 -0.85 47.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.097 -1.002 . . . . 0.0 110.894 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.781 ' NE2' HE22 ' B' ' 33' ' ' GLN . 62.3 m80 -97.66 126.49 40.91 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.829 -1.169 . . . . 0.0 109.595 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -41.64 -14.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.65 2.234 . . . . 0.0 112.454 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' B' ' 76' ' ' HIS . 8.3 tp -68.79 -29.39 67.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.422 -0.799 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 81.5 t60 -79.59 -42.83 24.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.088 . . . . 0.0 110.324 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.46 -60.69 2.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.981 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.79 -39.38 77.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.245 -0.909 . . . . 0.0 109.616 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -73.04 -42.58 62.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 66.6 m -62.15 -39.87 94.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.172 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.59 77.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.673 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -70.22 -41.88 73.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' B' ' 90' ' ' ILE . 26.2 t80 -46.1 -30.54 1.94 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' B' ' 89' ' ' VAL . 17.6 m -80.77 -62.72 1.59 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.07 -29.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.717 -0.615 . . . . 0.0 110.084 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 87' ' ' THR . 19.5 m -103.99 10.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.225 -0.922 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.471 HG23 ' N ' ' B' ' 91' ' ' ASP . 1.1 mp -119.9 154.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.593 -1.317 . . . . 0.0 110.481 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' B' ' 13' ' ' LYS . 64.2 t0 -101.41 -34.75 9.46 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -147.59 148.53 31.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -126.82 125.29 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.569 -1.332 . . . . 0.0 109.688 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.627 ' CG1' HE21 ' A' ' 54' ' ' GLN . 5.1 t -134.17 136.5 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.1 OUTLIER -138.69 137.98 37.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.359 -1.463 . . . . 0.0 111.854 -178.347 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.621 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.8 OUTLIER -112.1 118.08 34.39 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 8' ' ' HIS . 56.1 t0 -123.75 126.71 46.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.16 -0.962 . . . . 0.0 108.883 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 55.9 t80 -167.71 137.79 2.24 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . 0.525 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 88.6 Cg_exo -47.74 124.49 9.83 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.267 1.978 . . . . 0.0 112.21 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . 0.412 HG13 ' HE1' ' A' ' 42' ' ' TRP . 76.2 t -114.24 140.38 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.99 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.86 78.6 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.06 88.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.003 . . . . 0.0 109.581 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' B' ' 101' ' ' ALA . 13.3 m -149.11 116.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.827 . . . . 0.0 109.153 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' B' ' 105' ' ' SER . 5.9 ptmt -176.5 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' B' ' 104' ' ' LYS . 0.3 OUTLIER 162.06 -44.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 8.2 t -64.59 44.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.253 -0.905 . . . . 0.0 109.456 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 105' ' ' SER . 3.5 t . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.596 ' O ' ' CB ' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.596 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 81.86 -4.3 1.53 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.163 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.4 t -137.55 -98.38 0.2 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.91 175.77 20.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.722 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.51 128.94 56.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -1.115 . . . . 0.0 108.064 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.49 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -102.72 131.04 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.947 -1.096 . . . . 0.0 112.857 -177.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -125.22 123.59 39.89 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -131.16 140.04 49.87 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.716 -1.24 . . . . 0.0 109.481 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 70.5 t -126.22 132.67 70.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.545 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.0 130.53 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.18 167.17 27.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.775 -1.57 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 91' ' ' ASP . 2.2 mmmt -137.41 151.24 48.33 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.641 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 7.7 m-85 -108.07 147.3 31.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 111.637 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -127.83 -28.06 2.73 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 75.6 tt0 -87.77 -59.11 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.5 m-20 153.14 69.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 14' ' ' PHE . 31.8 m -60.02 111.71 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.063 0.935 . . . . 0.0 112.844 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.677 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.3 87.3 5.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 176.197 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.92 -32.6 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 110.487 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.3 p-10 -65.32 -37.32 86.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 96.3 mt-10 -69.79 -35.31 74.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.2 mm -62.81 -45.22 99.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -50.24 -37.29 34.92 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -59.9 -36.29 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -78.82 -42.87 12.2 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.38 -59.36 4.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -1.001 . . . . 0.0 108.837 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.28 -34.89 59.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.75 -45.48 92.1 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -50.26 -44.86 53.82 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' ILE . 48.3 t -45.13 -35.41 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.243 -0.91 . . . . 0.0 108.889 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' VAL . 20.1 m -42.2 -45.86 4.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.466 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 22.4 mp0 -70.89 -23.58 62.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 111.496 176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 36' ' ' THR . 22.1 mt -85.86 28.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 119.967 -1.708 . . . . 0.0 110.667 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.3 p30 -62.22 -7.2 3.84 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 38' ' ' LYS . 2.0 t -86.44 1.89 49.75 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.971 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.5 m 37.45 28.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.083 -1.011 . . . . 0.0 109.198 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 36' ' ' THR . 78.9 mttt -118.42 39.43 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.17 157.03 30.06 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.514 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 99.3 m-85 -143.95 154.0 42.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.624 -1.297 . . . . 0.0 112.013 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 40' ' ' PHE . 55.5 mp0 -158.83 125.26 4.61 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.379 0.609 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 43' ' ' GLY . 53.1 t-105 -124.02 174.33 7.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -132.63 153.31 20.58 Favored Glycine 0 N--CA 1.499 2.837 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 72.8 mt-10 -147.48 137.88 23.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.204 -1.174 . . . . 0.0 109.319 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.41 144.18 48.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -149.13 122.51 9.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.502 -1.374 . . . . 0.0 109.769 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 56' ' ' PHE . 65.1 mm-40 -151.5 45.46 0.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.692 . . . . 0.0 109.335 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -124.23 121.87 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.186 -0.946 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.413 ' HD1' ' CG ' ' A' ' 51' ' ' MET . 0.2 OUTLIER 62.84 119.89 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.16 -0.963 . . . . 0.0 109.658 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.496 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 80.9 m-20 -56.38 -41.53 76.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 0.0 110.805 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.413 ' CG ' ' HD1' ' A' ' 49' ' ' HIS . 5.0 ptp -71.66 -32.01 67.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.084 . . . . 0.0 110.751 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.53 ' C ' ' H ' ' A' ' 54' ' ' GLN . 83.7 mt -86.96 -52.54 5.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.157 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.749 ' C ' ' H ' ' A' ' 55' ' ' GLY . 15.3 ptt180 -61.93 7.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 0.0 111.219 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.53 ' H ' ' C ' ' A' ' 52' ' ' LEU . 4.7 mm-40 53.5 -8.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.702 -1.249 . . . . 0.0 110.207 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.749 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 86.88 -21.64 18.37 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.846 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.428 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 3.2 m-85 -66.23 -128.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.247 -1.737 . . . . 0.0 109.91 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -164.85 -33.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.84 . . . . 0.0 111.002 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.645 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.8 t60 -171.77 154.25 3.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.645 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.56 171.4 14.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.218 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.32 121.26 35.36 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.365 -0.834 . . . . 0.0 109.087 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m -96.71 101.41 13.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.4 mtt -109.81 123.4 49.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 110.828 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.0 m -124.38 148.11 47.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.64 156.06 39.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.694 -1.254 . . . . 0.0 110.118 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 48.8 tp10 -82.91 -28.31 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 15.3 m120 -164.65 169.23 17.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.5 ' CB ' ' NZ ' ' A' ' 67' ' ' LYS . 8.3 mtmp? -58.9 -18.94 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 111.432 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 25.4 p-10 -59.52 -40.66 87.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.771 -1.205 . . . . 0.0 110.562 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -71.3 -32.89 64.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -67.4 -44.7 78.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.522 -0.987 . . . . 0.0 110.498 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.9 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.336 -1.478 . . . . 0.0 108.657 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.88 2.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.261 -0.899 . . . . 0.0 109.345 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.2 -35.49 59.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 111.112 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -84.23 -30.11 25.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.704 -1.247 . . . . 0.0 110.29 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.6 p -68.52 -29.57 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.965 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' A' ' 78' ' ' LEU . 16.4 m-70 -76.81 127.4 84.11 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 0.0 109.562 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.3 -7.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.4 tp -70.87 -26.19 63.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.351 -0.843 . . . . 0.0 111.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.417 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.5 t60 -80.93 -42.62 21.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.049 . . . . 0.0 110.218 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 3.7 p -64.92 -57.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.529 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 93.2 mt-10 -58.89 -42.73 90.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 81.3 t80 -66.45 -43.36 85.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.863 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -59.89 -33.23 71.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.131 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.63 53.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.935 -1.103 . . . . 0.0 108.681 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -72.22 -43.45 64.43 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 85' ' ' ALA . 26.5 t80 -42.77 -29.02 0.28 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 89' ' ' VAL . 5.8 m -84.52 -61.49 1.78 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.16 -28.73 0.06 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.706 -0.621 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.489 ' O ' ' OG1' ' A' ' 18' ' ' THR . 8.9 m -97.45 13.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.196 -0.94 . . . . 0.0 110.816 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' A' ' 86' ' ' PHE . 74.3 mt -123.19 156.03 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.628 -1.295 . . . . 0.0 110.45 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.0 t0 -98.64 -35.4 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -147.63 146.04 29.19 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.85 126.25 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.62 -1.3 . . . . 0.0 109.727 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t -132.07 135.44 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -139.06 134.97 33.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.303 -1.498 . . . . 0.0 111.751 -178.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 1.6 mp -113.82 119.08 36.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.681 -0.637 . . . . 0.0 109.303 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.37 130.29 50.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.023 -1.048 . . . . 0.0 108.96 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -172.0 140.03 1.1 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.057 -1.027 . . . . 0.0 110.486 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.91 121.38 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.296 1.998 . . . . 0.0 112.173 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.4 t -109.05 138.11 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.992 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.19 107.55 10.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.376 -0.828 . . . . 0.0 109.639 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.88 149.63 26.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.51 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -154.91 147.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.247 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 65.77 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.348 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 106' ' ' SER . 23.2 m -51.67 -23.42 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.15 -0.969 . . . . 0.0 108.944 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' SER . 1.4 p 76.22 144.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.388 -0.82 . . . . 0.0 109.336 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.684 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.96 175.97 20.27 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.374 -1.393 . . . . 0.0 109.698 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -114.69 129.09 56.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.44 ' O ' ' NZ ' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -102.97 130.87 50.21 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.319 1.057 . . . . 0.0 112.851 -177.274 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -124.99 123.59 40.2 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.3 tt -131.14 140.06 49.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.762 -1.211 . . . . 0.0 109.444 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 70.0 t -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.586 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.27 130.41 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.17 167.25 26.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 117.723 -1.591 . . . . 0.0 113.058 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' B' ' 91' ' ' ASP . 2.2 mmmt -137.47 151.01 48.02 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD1' ' OG1' ' B' ' 18' ' ' THR . 7.6 m-85 -107.88 147.37 31.05 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.785 -1.197 . . . . 0.0 111.57 -178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -127.99 -27.76 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 75.2 tt0 -88.19 -58.93 2.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.4 m-20 153.07 69.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.639 ' OG1' ' CD1' ' B' ' 14' ' ' PHE . 32.5 m -60.15 111.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.034 0.921 . . . . 0.0 112.927 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.676 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.28 87.34 5.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.02 -32.42 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.661 . . . . 0.0 110.433 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -65.34 -37.43 87.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.56 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 96.3 mt-10 -69.76 -35.37 74.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' B' ' 26' ' ' GLY . 3.3 mm -62.6 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -50.35 -37.04 34.9 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -60.1 -35.88 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -79.3 -42.7 11.48 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -54.31 -59.39 4.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.545 -0.973 . . . . 0.0 108.85 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.41 -34.89 59.51 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -45.56 91.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' B' ' 31' ' ' VAL . 0.4 OUTLIER -50.15 -44.99 52.85 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' B' ' 34' ' ' ILE . 48.4 t -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.245 -0.909 . . . . 0.0 108.792 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.433 ' C ' ' O ' ' B' ' 31' ' ' VAL . 20.4 m -42.37 -45.64 4.38 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' B' ' 33' ' ' GLN . 22.3 mp0 -71.1 -23.55 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 111.535 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' B' ' 36' ' ' THR . 22.2 mt -85.79 28.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.006 -1.684 . . . . 0.0 110.571 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.4 p30 -62.36 -7.14 3.91 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.612 ' O ' ' N ' ' B' ' 38' ' ' LYS . 1.9 t -86.55 2.08 49.37 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.874 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.515 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.5 m 37.47 28.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 109.167 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' B' ' 36' ' ' THR . 78.5 mttt -118.3 39.88 3.32 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 156.72 28.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.505 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 99.3 m-85 -143.75 153.83 42.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.497 -1.377 . . . . 0.0 111.946 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' B' ' 40' ' ' PHE . 56.1 mp0 -158.76 125.23 4.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.407 0.622 . . . . 0.0 110.208 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.558 ' CD1' ' N ' ' B' ' 43' ' ' GLY . 53.0 t-105 -124.01 174.69 7.44 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.558 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -133.28 152.91 20.55 Favored Glycine 0 N--CA 1.498 2.82 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.839 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.562 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 71.2 mt-10 -147.2 137.87 23.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.46 143.95 48.24 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.92 122.84 9.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.386 -1.446 . . . . 0.0 109.816 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' B' ' 56' ' ' PHE . 64.9 mm-40 -151.79 45.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.665 -0.647 . . . . 0.0 109.388 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -124.12 121.7 35.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 110.172 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.42 ' HD1' ' CG ' ' B' ' 51' ' ' MET . 0.2 OUTLIER 62.92 119.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.484 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 79.4 m-20 -56.3 -41.52 76.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.838 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.42 ' CG ' ' HD1' ' B' ' 49' ' ' HIS . 4.9 ptp -71.8 -31.91 67.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.034 . . . . 0.0 110.726 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' B' ' 54' ' ' GLN . 84.0 mt -86.95 -52.45 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.712 -1.243 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.733 ' C ' ' H ' ' B' ' 55' ' ' GLY . 15.4 ptt180 -62.02 7.94 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 111.307 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' B' ' 52' ' ' LEU . 4.6 mm-40 53.53 -8.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.832 -1.168 . . . . 0.0 110.225 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.733 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 87.12 -21.48 20.17 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.468 -0.77 . . . . 0.0 112.864 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.442 ' O ' ' OE2' ' B' ' 47' ' ' GLU . 3.2 m-85 -66.39 -128.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.278 -1.719 . . . . 0.0 109.915 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.8 t -164.46 -34.15 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.276 -0.89 . . . . 0.0 111.0 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.648 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.9 t60 -171.61 154.56 3.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.803 -1.186 . . . . 0.0 110.231 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.648 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.98 171.09 14.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.02 121.26 35.64 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -96.65 101.48 13.1 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 38.8 mtt -109.9 123.6 49.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 110.782 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 97.1 m -124.71 147.93 48.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.53 156.03 39.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.668 -1.27 . . . . 0.0 110.058 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 50.2 tp10 -82.7 -28.64 30.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 15.6 m120 -164.31 169.74 17.09 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.493 ' CB ' ' NZ ' ' B' ' 67' ' ' LYS . 8.2 mtmp? -59.14 -19.09 41.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 0.0 111.406 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 26.5 p-10 -59.51 -40.67 87.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.905 -1.122 . . . . 0.0 110.55 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -71.22 -32.79 65.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -67.41 -44.87 77.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.644 -0.915 . . . . 0.0 110.445 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.8 -28.88 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.352 -1.468 . . . . 0.0 108.671 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.84 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -35.25 59.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 111.141 -176.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -84.51 -30.01 25.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.744 -1.223 . . . . 0.0 110.339 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 95.0 p -68.43 -29.56 68.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.12 -0.988 . . . . 0.0 110.964 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 78' ' ' LEU . 16.4 m-70 -76.97 127.53 83.54 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.4 -7.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.598 2.199 . . . . 0.0 112.48 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.4 tp -70.82 -26.38 63.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.408 -0.808 . . . . 0.0 111.178 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -80.86 -42.7 21.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 110.276 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.533 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 3.6 p -64.8 -57.61 10.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 110.024 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.533 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 93.2 mt-10 -58.9 -42.67 90.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.299 -0.876 . . . . 0.0 109.587 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 81.1 t80 -66.48 -43.48 85.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.818 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -59.71 -33.36 71.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.111 -0.993 . . . . 0.0 110.149 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.93 49.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 108.644 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -71.81 -43.54 65.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.477 ' O ' ' CD1' ' B' ' 90' ' ' ILE . 26.4 t80 -42.75 -29.2 0.29 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.471 ' O ' ' N ' ' B' ' 89' ' ' VAL . 5.4 m -84.32 -61.62 1.76 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.98 -28.67 0.06 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.681 -0.637 . . . . 0.0 110.098 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.492 ' O ' ' OG1' ' B' ' 18' ' ' THR . 9.2 m -97.69 13.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.477 ' CD1' ' O ' ' B' ' 86' ' ' PHE . 73.4 mt -123.39 156.1 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.651 -1.281 . . . . 0.0 110.437 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' B' ' 13' ' ' LYS . 61.8 t0 -98.54 -35.45 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -147.66 145.71 29.04 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.46 126.06 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.556 -1.34 . . . . 0.0 109.727 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 22.3 t -131.74 135.68 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.613 ' N ' ' CD1' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -139.11 135.04 33.69 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.256 -1.527 . . . . 0.0 111.798 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.606 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 1.7 mp -113.86 119.04 35.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 109.33 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.22 130.48 51.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.102 -0.999 . . . . 0.0 108.97 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -171.98 140.08 1.1 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.126 -0.984 . . . . 0.0 110.538 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.86 121.18 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.308 2.005 . . . . 0.0 112.194 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 63.4 t -108.77 138.29 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 110.037 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.4 107.79 10.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.581 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.13 149.62 26.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -155.03 147.72 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.377 -0.827 . . . . 0.0 109.233 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 65.53 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.373 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' B' ' 106' ' ' SER . 24.4 m -51.31 -23.83 4.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' B' ' 105' ' ' SER . 1.4 p 76.53 144.83 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.367 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t . . . . . 0 C--N 1.303 -1.441 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.605 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.421 0.629 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.625 ' O ' ' CB ' ' A' ' 4' ' ' SER . 1.0 OUTLIER 155.25 -62.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.133 -178.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 3' ' ' THR . 2.5 t 152.35 -100.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 4' ' ' SER . . . -81.09 170.42 52.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.24 132.92 42.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 108.027 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 5.2 ttpm? -100.3 127.01 46.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 112.813 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' MET . 56.4 m80 -117.12 116.46 27.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -131.59 140.96 49.56 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.734 -1.229 . . . . 0.0 109.408 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.02 138.51 52.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.6 -0.687 . . . . 0.0 109.458 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.13 130.38 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.439 ' O ' ' OG1' ' A' ' 57' ' ' THR . 3.9 m -135.02 148.95 28.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 117.74 -1.584 . . . . 0.0 113.028 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.716 ' HZ2' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -120.15 151.99 38.28 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.578 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 9.2 p90 -113.32 152.94 29.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.81 -1.181 . . . . 0.0 111.601 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -128.67 -18.05 3.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.2 mm-40 -90.33 -57.28 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 12.1 m-20 154.09 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 51.7 m -51.59 112.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.098 0.951 . . . . 0.0 112.84 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.87 90.66 2.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 24' ' ' LEU . 29.1 m -62.85 -41.91 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.504 -0.747 . . . . 0.0 110.512 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.43 -45.13 92.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.559 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -70.29 -33.05 71.09 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.34 -40.29 79.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.5 tp -58.84 -38.77 79.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.68 -35.07 76.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.93 -53.55 36.69 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 5.8 tt -48.08 -43.84 31.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.511 -0.993 . . . . 0.0 108.813 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -54.71 -46.42 74.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.537 ' ND2' ' CE2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -47.7 -41.67 23.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 32' ' ' SER . 19.3 t -54.74 -20.5 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.236 -0.915 . . . . 0.0 108.902 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' ASN . 74.5 m -44.63 -42.28 7.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.542 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 46.2 mm-40 -83.84 -9.77 58.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 111.398 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.632 ' C ' ' H ' ' A' ' 36' ' ' THR . 45.0 mm -91.23 23.56 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 119.976 -1.702 . . . . 0.0 110.716 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.77 -8.92 1.05 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.632 ' H ' ' C ' ' A' ' 34' ' ' ILE . 33.6 p -79.15 -2.82 42.59 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.972 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.614 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.8 m 32.13 41.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.08 -1.012 . . . . 0.0 109.135 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.0 ptmt -122.32 41.93 3.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -173.67 178.18 2.33 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 87.3 m-85 -147.01 155.0 41.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.546 -1.346 . . . . 0.0 111.929 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 46.5 mp0 -152.46 121.18 6.48 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.657 ' N ' ' CD1' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -126.5 168.71 13.87 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.12 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.01 159.28 21.16 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.827 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.573 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 49.4 mp0 -147.78 140.59 24.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.331 -1.1 . . . . 0.0 109.392 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.3 t0 -128.46 155.7 44.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -60.22 80.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.461 -1.4 . . . . 0.0 109.747 -177.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.3 mt-10 -105.04 42.65 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.67 -0.644 . . . . 0.0 109.272 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.554 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 3.4 m -150.09 179.38 8.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.47 150.01 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' MET . 32.2 p-10 -43.94 -44.05 6.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.787 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.517 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 83.2 mmm -67.19 -28.96 68.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.942 -1.099 . . . . 0.0 110.713 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 95' ' ' LEU . 33.9 mt -98.29 -30.18 12.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.772 -1.205 . . . . 0.0 109.292 -178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.655 ' O ' ' N ' ' A' ' 55' ' ' GLY . 3.2 ptm180 -86.46 -1.73 57.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.827 . . . . 0.0 111.225 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' A' ' 56' ' ' PHE . 6.4 tt0 45.96 10.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.73 -1.231 . . . . 0.0 110.149 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 58.77 -5.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.424 -0.797 . . . . 0.0 112.89 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 54' ' ' GLN . 11.8 p90 -57.0 131.11 48.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.204 -1.762 . . . . 0.0 109.93 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.622 ' HG1' ' N ' ' A' ' 58' ' ' HIS . 71.3 p -54.15 -48.1 71.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.0 110.995 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 23.7 t60 -173.0 159.19 3.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.109 . . . . 0.0 110.165 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.612 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -144.83 169.53 17.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -0.805 . . . . 0.0 109.219 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 76.6 m-85 -135.12 130.64 35.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.484 -0.76 . . . . 0.0 109.075 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 98.18 8.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.2 mtp -98.9 118.89 36.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.165 -0.96 . . . . 0.0 110.849 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -123.29 142.43 50.95 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.94 162.58 18.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.829 -1.17 . . . . 0.0 110.078 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.57 -29.97 29.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -169.76 175.0 5.44 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -58.38 -22.52 54.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 111.415 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.84 -37.56 71.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.809 -1.182 . . . . 0.0 110.617 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.08 76.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -67.14 -44.18 80.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.956 . . . . 0.0 110.417 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.76 -28.93 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.38 -1.45 . . . . 0.0 108.696 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . -64.98 -61.0 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.73 -60.22 3.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.207 -0.933 . . . . 0.0 111.115 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -49.46 -37.22 25.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.752 -1.218 . . . . 0.0 110.357 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 72' ' ' ALA . 63.7 p -65.97 -11.95 51.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 0.0 111.014 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 78' ' ' LEU . 65.2 m-70 -92.64 125.99 53.66 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.25 -4.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.675 2.25 . . . . 0.0 112.489 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.3 tp -74.39 -25.87 59.75 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.297 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -77.84 -45.4 24.44 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.086 -1.009 . . . . 0.0 110.247 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.594 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.2 p -63.37 -57.94 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.993 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.594 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 84.3 tt0 -53.59 -36.45 61.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 6.4 m-85 -74.39 -36.18 63.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.875 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -62.09 -42.9 99.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.61 -44.14 97.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 108.656 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.87 -44.19 73.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.482 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.03 -30.18 0.41 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' VAL . 10.9 m -82.36 -64.17 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -43.3 -24.83 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 110.099 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.9 m -107.4 9.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 110.723 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 28.9 mm -131.44 164.37 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.6 -1.313 . . . . 0.0 110.504 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.546 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 52.2 t0 -109.42 -33.41 6.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.716 ' NZ ' ' HZ2' ' A' ' 13' ' ' LYS . 29.2 pttt -147.84 147.57 29.94 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 93' ' ' ILE . 4.1 tp -128.86 123.81 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.637 -1.289 . . . . 0.0 109.785 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.7 132.64 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -142.05 138.37 31.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.269 -1.519 . . . . 0.0 111.748 -178.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -116.5 119.28 35.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.719 -0.613 . . . . 0.0 109.355 177.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' B' ' 48' ' ' SER . 62.2 t0 -111.21 117.5 33.38 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -0.989 . . . . 0.0 108.971 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 54.7 t80 -141.37 137.65 16.8 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.01 . . . . 0.0 110.465 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.55 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 31.0 Cg_endo -61.02 127.81 23.42 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.257 1.972 . . . . 0.0 112.229 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 5' ' ' GLY . 99.6 t -92.61 117.3 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.009 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -109.35 95.29 5.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.546 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.45 69.74 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' A' ' 103' ' ' VAL . 21.9 m -152.88 95.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.243 -178.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' SER . 7.7 ptmm? -175.19 -126.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.396 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.96 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 108.899 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' LYS . 4.4 m -115.84 71.04 0.76 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.276 -0.89 . . . . 0.0 109.339 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.532 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' B' ' 5' ' ' GLY . 2.5 t . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' B' ' 4' ' ' SER . . . -81.19 170.41 52.59 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.02 133.16 42.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.281 -1.129 . . . . 0.0 108.043 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.421 ' HB3' ' NZ ' ' B' ' 7' ' ' LYS . 5.1 ttpm? -100.51 126.93 46.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.937 -1.102 . . . . 0.0 112.843 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 62' ' ' MET . 56.0 m80 -117.11 116.2 26.86 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -131.28 141.13 49.93 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.657 -1.277 . . . . 0.0 109.474 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.05 138.64 52.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 130.3 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.441 ' O ' ' OG1' ' B' ' 57' ' ' THR . 3.9 m -134.94 148.77 28.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.818 -1.553 . . . . 0.0 113.051 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.703 ' HZ2' ' NZ ' ' B' ' 92' ' ' LYS . 0.0 OUTLIER -120.11 151.91 38.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.565 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 9.4 p90 -113.35 152.96 29.28 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.828 -1.17 . . . . 0.0 111.545 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -128.77 -18.0 3.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CG ' ' B' ' 17' ' ' ASP . 77.5 mm-40 -90.32 -57.08 2.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CG ' ' O ' ' B' ' 16' ' ' GLU . 12.7 m-20 153.73 58.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 58.6 m -52.45 112.35 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.147 0.975 . . . . 0.0 112.846 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.483 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.6 90.46 2.79 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' B' ' 24' ' ' LEU . 29.8 m -62.7 -41.93 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.683 -0.636 . . . . 0.0 110.474 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -63.45 -45.01 92.84 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.447 -0.783 . . . . 0.0 110.563 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -70.3 -33.26 71.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.26 -40.19 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -58.99 -38.65 79.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.52 -35.03 76.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.44 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -64.44 -53.07 38.08 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.441 ' CD1' ' CD1' ' B' ' 60' ' ' PHE . 5.8 tt -48.21 -43.97 32.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.577 -0.955 . . . . 0.0 108.799 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -54.49 -46.77 73.51 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' B' ' 82' ' ' PHE . 0.0 OUTLIER -52.79 -41.34 64.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -47.98 -41.35 24.98 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' B' ' 32' ' ' SER . 19.3 t -54.99 -20.21 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.311 -0.868 . . . . 0.0 108.829 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.47 ' N ' ' O ' ' B' ' 29' ' ' ASN . 73.6 m -44.87 -42.34 7.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.551 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 46.1 mm-40 -83.85 -9.55 58.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.449 -0.782 . . . . 0.0 111.523 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.634 ' C ' ' H ' ' B' ' 36' ' ' THR . 44.9 mm -91.29 23.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.031 -1.668 . . . . 0.0 110.641 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -57.65 -8.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.634 ' H ' ' C ' ' B' ' 34' ' ' ILE . 34.2 p -79.06 -2.68 41.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.984 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.592 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.0 m 32.13 41.84 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.121 -0.987 . . . . 0.0 109.194 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.1 ptmt -122.24 42.15 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 89.2 p -173.82 177.97 2.32 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 86.5 m-85 -146.91 155.06 42.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.52 -1.362 . . . . 0.0 111.944 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' B' ' 41' ' ' GLU . 46.4 mp0 -152.42 121.11 6.47 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.364 0.602 . . . . 0.0 110.194 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.642 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.7 OUTLIER -126.48 168.83 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.09 159.48 21.22 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.807 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.582 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 49.8 mp0 -148.13 140.65 24.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.407 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' B' ' 47' ' ' GLU . 61.9 t0 -128.49 155.64 44.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.521 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -60.17 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.44 -1.413 . . . . 0.0 109.773 -177.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.5 mt-10 -104.65 42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.676 -0.64 . . . . 0.0 109.358 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 3.6 m -150.04 179.58 7.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.139 -0.975 . . . . 0.0 110.243 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.62 150.29 41.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.945 . . . . 0.0 109.701 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.3 p-10 -44.14 -43.77 7.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.858 . . . . 0.0 110.8 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.53 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 83.4 mmm -67.57 -28.95 68.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.14 -0.975 . . . . 0.0 110.75 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 95' ' ' LEU . 34.6 mt -98.32 -29.76 12.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.747 -1.221 . . . . 0.0 109.265 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' B' ' 55' ' ' GLY . 3.2 ptm180 -86.89 -1.66 57.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.394 -0.816 . . . . 0.0 111.243 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.428 ' C ' ' H ' ' B' ' 56' ' ' PHE . 6.4 tt0 45.99 10.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.807 -1.183 . . . . 0.0 110.194 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 59.3 -5.81 0.08 OUTLIER Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.428 -0.795 . . . . 0.0 112.881 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' B' ' 54' ' ' GLN . 11.7 p90 -56.64 131.11 47.98 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.259 -1.73 . . . . 0.0 109.899 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.616 ' HG1' ' N ' ' B' ' 58' ' ' HIS . 69.9 p -54.19 -47.9 71.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.279 -0.888 . . . . 0.0 110.995 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.64 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 23.6 t60 -173.13 159.61 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.9 -1.125 . . . . 0.0 110.165 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -145.39 169.28 18.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.542 -0.724 . . . . 0.0 109.292 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 76.6 m-85 -134.91 130.64 36.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.512 -0.742 . . . . 0.0 109.081 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 97.81 8.55 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' MET . . . . . 0.515 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.8 mtp -98.62 119.1 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.198 -0.939 . . . . 0.0 110.77 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -123.43 142.63 50.79 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.0 162.99 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 110.038 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -82.98 -29.84 28.69 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -169.73 175.44 5.28 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -58.72 -22.46 57.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 111.45 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -57.08 -37.57 72.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.804 -1.185 . . . . 0.0 110.565 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 -33.1 77.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -67.01 -44.55 80.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.947 . . . . 0.0 110.405 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.81 -28.87 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.329 -1.482 . . . . 0.0 108.669 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.1 -60.91 2.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 73' ' ' PHE . 2.7 t80 -63.22 -60.48 3.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 111.136 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 14.9 t -49.47 -37.18 25.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 63.9 p -65.92 -12.04 51.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.982 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' B' ' 78' ' ' LEU . 65.2 m-70 -92.6 126.27 52.71 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.898 -1.126 . . . . 0.0 109.544 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -44.6 -4.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.686 2.257 . . . . 0.0 112.424 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.3 tp -74.44 -26.22 59.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.366 -0.834 . . . . 0.0 111.18 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -77.72 -45.25 25.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.95 -1.094 . . . . 0.0 110.321 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.597 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.1 p -63.19 -58.21 8.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.597 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 84.0 tt0 -53.56 -36.36 61.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 6.4 m-85 -74.38 -36.4 63.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.872 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 87.5 p -61.79 -43.05 99.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.052 -1.03 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.97 97.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 108.622 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.485 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -69.13 -43.99 73.28 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.485 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.22 -30.0 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.6 m -82.48 -64.15 1.23 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -43.26 -24.94 0.1 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.76 -0.588 . . . . 0.0 110.12 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.438 ' O ' ' OG1' ' B' ' 18' ' ' THR . 4.9 m -107.34 9.89 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 110.838 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 28.3 mm -131.68 164.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.628 -1.295 . . . . 0.0 110.462 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.537 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 52.0 t0 -109.28 -33.49 6.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.703 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 28.2 pttt -147.86 147.67 30.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' B' ' 93' ' ' ILE . 4.2 tp -128.98 123.67 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.569 -1.332 . . . . 0.0 109.711 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.52 132.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -141.95 138.5 32.0 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.266 -1.521 . . . . 0.0 111.774 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 1.0 OUTLIER -116.55 119.27 35.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.708 -0.62 . . . . 0.0 109.334 177.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.432 ' O ' ' OG ' ' A' ' 48' ' ' SER . 62.4 t0 -111.19 117.14 32.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.04 -1.037 . . . . 0.0 108.889 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 55.6 t80 -140.87 137.89 17.62 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.057 -1.027 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 31.3 Cg_endo -61.18 127.91 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.286 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 5' ' ' GLY . 99.2 t -92.76 117.41 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 109.974 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.45 95.05 5.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 109.609 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.36 70.05 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' B' ' 103' ' ' VAL . 21.9 m -153.15 95.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' B' ' 106' ' ' SER . 7.6 ptmm? -175.09 -127.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.331 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.6 m 64.16 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 108.922 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.504 ' N ' ' O ' ' B' ' 104' ' ' LYS . 4.4 m -115.76 70.6 0.75 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.301 -1.506 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.38 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.376 0.608 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -101.15 -7.82 22.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.111 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.7 t -145.93 -80.91 0.15 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.16 -158.97 7.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -135.76 138.15 42.38 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.164 -1.198 . . . . 0.0 108.09 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.452 ' CD ' ' CZ2' ' B' ' 42' ' ' TRP . 1.1 ttpm? -113.32 141.31 47.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.906 -1.121 . . . . 0.0 112.801 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -130.02 130.05 44.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.3 tt -135.17 144.67 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.7 -1.25 . . . . 0.0 109.485 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -128.47 135.56 62.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.434 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.38 128.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 177.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.81 157.0 32.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 117.766 -1.574 . . . . 0.0 112.994 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 91' ' ' ASP . 20.6 tptm -122.34 152.1 40.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.468 ' HB2' ' H ' ' A' ' 18' ' ' THR . 29.9 p90 -105.29 147.17 28.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.942 -1.099 . . . . 0.0 111.643 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -120.75 -24.91 5.58 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.0 mt-10 -89.38 -54.98 3.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.5 t0 150.58 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.468 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 61.0 m -58.91 110.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.112 0.958 . . . . 0.0 112.851 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.64 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -81.29 92.67 6.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.675 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 m -58.72 -32.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.551 -0.718 . . . . 0.0 110.473 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.6 p-10 -66.41 -39.2 88.84 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 78.0 mm-40 -67.74 -34.2 76.38 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.463 HG23 HD11 ' A' ' 23' ' ' ILE . 6.6 mt -65.71 -44.36 93.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.4 tp -53.89 -37.15 63.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.85 -32.12 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -81.9 -43.76 8.08 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -58.27 8.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.482 -1.011 . . . . 0.0 108.777 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 9.3 pt-20 -51.68 -43.95 62.92 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.581 HD22 ' CD1' ' A' ' 78' ' ' LEU . 13.7 t30 -61.56 -43.38 98.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER -49.95 -43.73 50.24 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.027 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 34' ' ' ILE . 39.8 t -50.8 -27.86 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.315 -0.866 . . . . 0.0 108.874 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' VAL . 46.9 t -40.61 -42.89 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.528 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 29.9 mm100 -75.75 -23.15 55.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.495 -0.753 . . . . 0.0 111.462 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 36' ' ' THR . 30.9 mm -85.69 25.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.068 -1.645 . . . . 0.0 110.648 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 36' ' ' THR . 54.3 p30 -60.74 -9.01 3.39 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 38' ' ' LYS . 59.5 p -73.88 -3.2 27.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.896 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.5 m 35.65 30.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.16 -0.963 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 36' ' ' THR . 75.1 mttt -118.94 39.5 3.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 63' ' ' THR . 12.4 t -170.9 170.92 6.18 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -147.42 157.48 43.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.595 -1.316 . . . . 0.0 112.006 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.573 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 58.1 mt-10 -151.59 120.26 6.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.417 0.627 . . . . 0.0 110.169 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.709 ' CD1' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.49 164.55 24.58 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.709 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -134.45 174.1 21.13 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.733 -1.699 . . . . 0.0 110.766 -178.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.657 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -152.69 141.21 20.77 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -1.174 . . . . 0.0 109.371 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -105.12 140.72 37.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -135.24 103.59 5.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.374 -1.454 . . . . 0.0 109.749 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -146.97 25.6 1.13 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.651 -0.656 . . . . 0.0 109.312 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.444 ' H ' ' CB ' ' A' ' 53' ' ' ARG . 11.6 p -89.09 -106.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 m80 -92.61 148.07 22.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 51' ' ' MET . 31.5 p-10 -53.45 -43.07 67.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.365 -0.834 . . . . 0.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.522 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.9 tpt -75.42 -32.05 60.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.0 110.745 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 54' ' ' GLN . 48.9 mt -90.14 -54.53 3.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.732 -1.23 . . . . 0.0 109.305 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.76 ' C ' ' H ' ' A' ' 55' ' ' GLY . 12.5 ptt180 -62.59 1.23 0.39 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER 56.11 -17.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.803 -1.185 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.76 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 88.05 -23.16 15.29 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.511 -0.743 . . . . 0.0 112.905 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.5 ' CE1' ' NZ ' ' A' ' 92' ' ' LYS . 3.5 m-85 -61.23 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.212 -1.758 . . . . 0.0 109.903 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 58' ' ' HIS . 3.2 t -161.5 -35.99 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.315 -0.866 . . . . 0.0 110.996 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 35.1 t-80 -166.89 149.46 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.937 -1.102 . . . . 0.0 110.19 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.603 ' N ' ' HD1' ' A' ' 58' ' ' HIS . . . -142.72 167.63 21.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 58' ' ' HIS . 91.3 m-85 -138.15 134.87 35.12 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.494 -0.754 . . . . 0.0 109.073 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.548 ' OG ' ' CZ3' ' A' ' 42' ' ' TRP . 1.4 m -116.45 104.64 11.64 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.7 mtt -95.32 125.45 39.96 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.143 -0.973 . . . . 0.0 110.79 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.462 ' O ' ' OG ' ' A' ' 39' ' ' SER . 38.7 m -118.89 140.87 49.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -127.2 128.1 45.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.742 -1.224 . . . . 0.0 110.036 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -50.96 -26.36 5.85 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -171.43 172.9 4.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.9 -19.17 60.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 111.361 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.92 -40.71 89.8 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.859 -1.15 . . . . 0.0 110.613 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.84 -29.25 59.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -66.1 -42.59 89.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.917 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.407 -1.433 . . . . 0.0 108.669 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.96 2.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.304 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.45 -39.39 64.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 111.159 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 t -79.78 -29.62 40.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.746 -1.221 . . . . 0.0 110.338 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -65.44 -25.56 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 111.023 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HD1' ' H ' ' A' ' 78' ' ' LEU . 56.8 t-80 -79.04 125.33 83.95 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.833 -1.167 . . . . 0.0 109.661 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.43 -6.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.661 ' H ' ' HD1' ' A' ' 76' ' ' HIS . 6.1 tp -75.84 -25.38 56.19 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 111.203 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.6 t60 -76.57 -43.0 40.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.018 -1.051 . . . . 0.0 110.241 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.554 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 11.3 p -64.4 -54.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.554 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 78.7 mm-40 -50.43 -30.83 13.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' CD1' ' A' ' 86' ' ' PHE . 4.2 m-85 -72.97 -37.34 67.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.879 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.6 m -63.46 -42.33 98.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.0 110.14 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.48 67.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.965 -1.084 . . . . 0.0 108.751 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.0 -43.43 82.93 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 82' ' ' PHE . 2.5 m-85 -45.0 -31.06 1.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.1 m -78.94 -63.31 1.45 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.03 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.72 -0.612 . . . . 0.0 110.064 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.4 m -111.92 6.91 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.18 -0.95 . . . . 0.0 110.803 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 34.5 mt -120.11 154.64 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.647 -1.283 . . . . 0.0 110.444 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.9 t0 -103.52 -31.42 9.96 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.5 ' NZ ' ' CE1' ' A' ' 56' ' ' PHE . 37.9 pttt -150.44 149.3 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -125.24 121.94 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.615 -1.303 . . . . 0.0 109.852 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.76 133.52 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -139.49 136.86 34.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.241 -1.537 . . . . 0.0 111.752 -178.145 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.643 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.94 121.44 42.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.655 -0.653 . . . . 0.0 109.383 176.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 68.2 t0 -123.12 128.35 49.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.017 . . . . 0.0 108.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -164.08 139.68 4.93 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.096 -1.003 . . . . 0.0 110.505 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.03 120.68 4.4 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.292 1.995 . . . . 0.0 112.202 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -105.55 135.73 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.93 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.78 75.51 0.93 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.87 113.3 24.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.457 ' CG2' ' H ' ' A' ' 104' ' ' LYS . 16.9 m -134.42 -54.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.171 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.564 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 26.0 mmtm 60.19 -129.75 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 0.0 109.339 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 104' ' ' LYS . 0.9 OUTLIER 72.52 -18.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.181 -0.949 . . . . 0.0 108.978 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 104' ' ' LYS . 2.0 t 168.75 -42.04 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 109.346 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.675 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.98 -158.47 7.6 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.694 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.36 137.68 40.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.279 -1.13 . . . . 0.0 108.015 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.458 ' CD ' ' CZ2' ' A' ' 42' ' ' TRP . 1.1 ttpm? -112.89 141.22 46.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.864 -1.147 . . . . 0.0 112.787 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -129.99 130.13 44.63 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.4 tt -135.45 144.54 46.51 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.798 -1.189 . . . . 0.0 109.479 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -128.45 135.41 62.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.629 -0.669 . . . . 0.0 109.537 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.25 128.27 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.07 156.9 31.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 117.769 -1.572 . . . . 0.0 113.011 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' B' ' 91' ' ' ASP . 20.7 tptm -122.4 151.73 40.93 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.468 ' HB2' ' H ' ' B' ' 18' ' ' THR . 30.0 p90 -105.07 147.3 28.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.863 -1.148 . . . . 0.0 111.555 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -120.82 -25.07 5.5 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 94.9 mt-10 -89.21 -55.06 3.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.4 t0 150.5 72.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.468 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.9 m -59.11 110.3 1.02 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.105 0.955 . . . . 0.0 112.85 -176.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.652 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -81.4 92.46 6.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 175.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.7 m -58.37 -32.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.609 -0.682 . . . . 0.0 110.43 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -66.49 -39.23 88.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.533 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 77.6 mm-40 -67.75 -34.07 76.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.74 -44.49 93.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -53.63 -37.16 62.8 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.93 -31.95 70.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -81.96 -43.7 8.08 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.82 -58.04 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.589 -0.947 . . . . 0.0 108.832 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.536 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 9.4 pt-20 -51.68 -44.31 63.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.599 HD22 ' CD1' ' B' ' 78' ' ' LEU . 14.7 t30 -61.22 -43.31 99.08 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' B' ' 26' ' ' GLY . 1.0 OUTLIER -50.13 -43.61 51.93 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' B' ' 34' ' ' ILE . 40.6 t -51.05 -27.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.266 -0.896 . . . . 0.0 108.847 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.474 ' C ' ' O ' ' B' ' 31' ' ' VAL . 48.0 t -40.59 -43.34 1.87 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.525 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 29.9 mm100 -75.3 -23.35 57.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.425 -0.797 . . . . 0.0 111.517 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.558 ' C ' ' H ' ' B' ' 36' ' ' THR . 30.0 mm -85.45 25.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 119.995 -1.69 . . . . 0.0 110.605 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.3 p30 -60.63 -8.91 3.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' B' ' 38' ' ' LYS . 64.8 p -74.04 -3.43 29.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.963 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.554 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.6 m 36.03 30.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.13 -0.981 . . . . 0.0 109.135 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' B' ' 36' ' ' THR . 74.2 mttt -118.77 39.7 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 63' ' ' THR . 13.1 t -171.18 170.79 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -147.51 157.37 43.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.521 -1.362 . . . . 0.0 111.934 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.564 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 57.1 mt-10 -151.69 119.89 6.32 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.349 0.595 . . . . 0.0 110.282 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.702 ' CD1' ' N ' ' B' ' 43' ' ' GLY . 0.0 OUTLIER -130.03 164.55 24.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.07 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . 0.702 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -134.32 174.24 21.03 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.749 -1.691 . . . . 0.0 110.885 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 0.2 OUTLIER -152.92 140.92 20.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -1.142 . . . . 0.0 109.387 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -104.99 140.42 38.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.529 ' CD ' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -135.0 103.78 5.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.388 -1.445 . . . . 0.0 109.769 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -147.07 25.68 1.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.322 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.449 ' H ' ' HB2' ' B' ' 53' ' ' ARG . 11.7 p -89.18 -106.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.932 . . . . 0.0 110.107 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' B' ' 53' ' ' ARG . 76.4 m80 -92.22 147.98 22.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.157 -0.964 . . . . 0.0 109.699 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.1 p-10 -53.36 -43.29 67.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 110.799 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 1.9 tpt -75.02 -32.34 61.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.732 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' B' ' 54' ' ' GLN . 46.2 mt -90.05 -54.58 3.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.682 -1.261 . . . . 0.0 109.324 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.775 ' C ' ' H ' ' B' ' 55' ' ' GLY . 12.9 ptt180 -62.47 1.33 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.354 -0.841 . . . . 0.0 111.247 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER 56.01 -17.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.821 -1.174 . . . . 0.0 110.194 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.775 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 88.07 -22.84 16.69 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.455 -0.778 . . . . 0.0 112.795 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.503 ' CE1' ' NZ ' ' B' ' 92' ' ' LYS . 3.5 m-85 -61.52 -133.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.272 -1.723 . . . . 0.0 109.962 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' B' ' 58' ' ' HIS . 3.0 t -161.56 -36.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.194 -0.941 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.644 ' HA ' ' O ' ' B' ' 44' ' ' GLU . 34.9 t-80 -166.6 149.52 6.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 0.0 110.206 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.599 ' N ' ' HD1' ' B' ' 58' ' ' HIS . . . -142.68 167.76 21.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.764 . . . . 0.0 109.272 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' B' ' 58' ' ' HIS . 92.0 m-85 -138.28 134.84 34.85 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.446 -0.784 . . . . 0.0 109.094 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.541 ' OG ' ' CZ3' ' B' ' 42' ' ' TRP . 1.4 m -116.5 104.91 11.9 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 61.6 mtt -95.49 125.79 40.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.209 -0.932 . . . . 0.0 110.73 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.451 ' O ' ' OG ' ' B' ' 39' ' ' SER . 39.2 m -119.18 140.6 49.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -126.87 127.86 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.247 . . . . 0.0 110.029 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -50.54 -26.44 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -171.52 173.02 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.98 -19.16 60.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 111.435 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.84 90.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.827 -1.171 . . . . 0.0 110.571 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.56 59.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -65.59 -42.94 91.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.594 -0.945 . . . . 0.0 110.425 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.69 -28.99 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.38 -1.45 . . . . 0.0 108.671 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 109.356 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.0 OUTLIER -53.67 -39.23 64.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 111.221 -177.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 5.0 t -79.67 -29.64 40.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.779 -1.201 . . . . 0.0 110.341 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.6 m -65.59 -25.29 67.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.987 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.688 ' HD1' ' H ' ' B' ' 78' ' ' LEU . 57.5 t-80 -79.19 125.08 84.12 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.406 ' O ' HG12 ' B' ' 80' ' ' VAL . 74.9 Cg_exo -44.29 -6.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.696 2.264 . . . . 0.0 112.433 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.688 ' H ' ' HD1' ' B' ' 76' ' ' HIS . 6.1 tp -75.62 -25.42 56.91 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.369 -0.832 . . . . 0.0 111.233 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 2.8 t60 -76.87 -42.68 38.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.978 -1.076 . . . . 0.0 110.29 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.558 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 11.6 p -64.52 -54.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.558 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 79.0 mm-40 -50.4 -30.95 13.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.618 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' B' ' 86' ' ' PHE . 4.3 m-85 -72.81 -37.08 67.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.849 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.8 m -63.83 -42.28 97.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.128 -0.982 . . . . 0.0 110.082 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -50.39 67.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.029 . . . . 0.0 108.673 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.14 -43.38 82.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' B' ' 82' ' ' PHE . 2.5 m-85 -45.11 -31.01 1.24 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.539 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.7 m -78.9 -63.31 1.45 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -40.0 -24.14 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.645 -0.659 . . . . 0.0 110.074 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.3 m -111.88 7.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.198 -0.939 . . . . 0.0 110.807 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 34.5 mt -120.34 154.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.642 -1.286 . . . . 0.0 110.458 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' B' ' 13' ' ' LYS . 62.2 t0 -103.34 -31.58 9.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.503 ' NZ ' ' CE1' ' B' ' 56' ' ' PHE . 38.1 pttt -150.41 149.41 30.0 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.9 tp -125.42 122.21 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.647 -1.283 . . . . 0.0 109.727 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.98 133.69 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.4 OUTLIER -139.6 136.83 34.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.291 -1.505 . . . . 0.0 111.73 -178.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.645 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.92 121.09 41.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.335 176.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 68.3 t0 -122.88 128.38 50.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 108.928 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -164.13 139.61 4.87 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.574 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.11 121.01 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.231 1.954 . . . . 0.0 112.294 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 18.6 t -105.96 135.57 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.002 . . . . 0.0 110.036 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.68 75.29 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.73 113.33 24.96 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.452 ' CG2' ' H ' ' B' ' 104' ' ' LYS . 16.8 m -134.37 -54.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.284 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.573 ' NZ ' ' O ' ' A' ' 41' ' ' GLU . 25.9 mmtm 59.91 -129.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.396 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' B' ' 104' ' ' LYS . 0.9 OUTLIER 72.32 -18.23 0.34 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.217 -0.927 . . . . 0.0 109.02 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.557 ' H ' ' C ' ' B' ' 104' ' ' LYS . 2.0 t 168.55 -41.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.552 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.398 0.618 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.509 ' CG2' ' N ' ' A' ' 4' ' ' SER . 9.8 t -63.02 -49.8 73.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.181 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 3' ' ' THR . 32.0 t -144.22 -95.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.04 154.05 40.61 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.635 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.05 127.27 53.26 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -1.14 . . . . 0.0 108.037 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.529 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.8 ttpm? -108.39 137.83 45.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 112.769 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -124.49 123.21 39.63 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.41 142.27 49.21 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 109.478 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -129.81 134.74 62.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.42 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.41 129.08 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 m -134.44 161.85 39.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 117.771 -1.572 . . . . 0.0 113.036 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.54 151.24 51.74 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' HB2' ' H ' ' A' ' 18' ' ' THR . 22.5 p90 -109.72 146.99 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.899 -1.125 . . . . 0.0 111.529 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -130.17 -20.24 3.08 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 79.4 mm-40 -91.18 -58.01 2.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.8 m-20 156.52 65.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 90.5 m -57.4 108.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.075 0.941 . . . . 0.0 112.835 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.65 87.12 3.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -61.61 -37.73 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.524 -0.735 . . . . 0.0 110.493 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -66.41 -42.16 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.62 -32.48 73.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.423 HD11 HG23 ' A' ' 23' ' ' ILE . 4.2 mt -66.14 -38.99 83.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.65 -35.25 60.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.37 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -60.56 -54.4 37.44 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.8 tt -51.33 -47.9 62.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.548 -0.972 . . . . 0.0 108.764 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.14 -37.26 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -61.94 -44.21 97.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 3.0 mm? -50.07 -47.2 53.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.4 t -50.65 -26.32 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.252 -0.905 . . . . 0.0 108.883 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 27.2 t -47.38 -44.23 24.07 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.754 HE21 ' HE2' ' A' ' 76' ' ' HIS . 12.8 pm0 -92.98 -24.32 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 36' ' ' THR . 9.3 mt -71.55 26.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 119.983 -1.698 . . . . 0.0 110.631 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 33' ' ' GLN . 88.9 m-20 -62.84 -7.33 4.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' LYS . 50.8 p -71.93 -5.83 37.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.949 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.59 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.7 m 33.51 31.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.63 ' N ' ' O ' ' A' ' 36' ' ' THR . 6.0 mtmp? -117.35 38.61 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 72.8 m -173.63 177.29 2.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.434 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.3 m-85 -146.88 155.94 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.574 -1.329 . . . . 0.0 112.016 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 85.4 mt-10 -158.69 129.26 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.43 0.633 . . . . 0.0 110.17 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.54 177.29 8.57 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.8 162.26 22.37 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.727 -1.701 . . . . 0.0 110.816 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.675 ' H ' ' NE2' ' A' ' 58' ' ' HIS . 72.3 mt-10 -145.93 138.18 25.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -1.168 . . . . 0.0 109.438 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.14 149.28 43.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' H ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.99 81.16 0.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.396 -1.44 . . . . 0.0 109.824 -176.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -115.37 56.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.643 -0.661 . . . . 0.0 109.33 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 49' ' ' HIS . 38.5 t -150.95 83.59 1.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.203 -0.935 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.684 ' N ' HH21 ' A' ' 53' ' ' ARG . 79.1 m-70 56.83 118.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 96.6 m-20 -44.61 -33.88 1.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.339 -0.85 . . . . 0.0 110.726 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -76.94 -32.0 57.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.026 . . . . 0.0 110.714 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 95' ' ' LEU . 62.9 mt -96.32 -12.38 24.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.732 -1.23 . . . . 0.0 109.333 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.684 HH21 ' N ' ' A' ' 49' ' ' HIS . 5.9 ptp180 -95.78 2.15 53.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.311 -0.868 . . . . 0.0 111.263 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' PHE . 95.1 mm-40 44.13 19.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.82 -1.175 . . . . 0.0 110.169 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.757 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 48.75 3.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.759 0 O-C-N 121.424 -0.797 . . . . 0.0 112.914 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.757 ' O ' ' O ' ' A' ' 55' ' ' GLY . 33.2 m-85 -49.94 -143.73 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.229 -1.748 . . . . 0.0 109.987 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 93.0 m -135.93 -55.88 0.77 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.951 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.675 ' NE2' ' H ' ' A' ' 44' ' ' GLU . 13.0 t60 -168.41 152.88 6.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.879 -1.138 . . . . 0.0 110.156 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.549 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.06 115.86 10.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.231 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.29 131.67 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.118 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -121.8 122.0 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 110.749 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -122.7 143.2 49.95 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -117.73 159.81 22.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.788 -1.195 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.69 -28.91 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -174.53 -178.1 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.94 -27.09 67.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 111.453 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.02 -43.98 97.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.78 -1.2 . . . . 0.0 110.548 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.44 67.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -67.02 -45.2 78.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.982 . . . . 0.0 110.467 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.75 -28.97 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.36 -1.462 . . . . 0.0 108.671 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . -65.06 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.347 -0.845 . . . . 0.0 109.331 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.609 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.06 -50.15 73.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 111.108 -177.274 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 8.6 t -62.63 -28.17 69.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.805 -1.184 . . . . 0.0 110.304 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 72' ' ' ALA . 84.3 p -61.95 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.0 110.897 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.754 ' HE2' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -121.94 151.19 57.63 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.787 -1.196 . . . . 0.0 109.578 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.43 12.53 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.575 2.184 . . . . 0.0 112.433 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.505 HD22 HE22 ' A' ' 33' ' ' GLN . 0.7 OUTLIER -75.98 -29.71 58.32 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 111.251 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' SER . 35.6 t-80 -85.22 -41.65 15.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.952 -1.093 . . . . 0.0 110.282 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.622 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.2 p -57.88 -58.46 6.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.961 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.622 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 14.9 tm-20 -58.01 -39.33 78.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.137 -0.977 . . . . 0.0 109.593 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.91 -40.74 71.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.915 . . . . 0.0 109.879 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' HIS . 86.8 p -61.56 -38.16 86.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 110.218 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.93 63.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.973 -1.079 . . . . 0.0 108.725 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.26 -40.82 77.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.464 ' C ' ' O ' ' A' ' 85' ' ' ALA . 24.8 t80 -44.53 -30.49 0.9 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.0 m -83.31 -61.84 1.74 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -36.87 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.741 -0.6 . . . . 0.0 110.07 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 87' ' ' THR . 12.6 m -101.93 16.53 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 110.819 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 87' ' ' THR . 73.7 mt -124.43 159.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.655 -1.278 . . . . 0.0 110.51 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.486 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 62.8 t0 -102.32 -34.53 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -145.78 143.71 29.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 tp -121.54 122.06 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.649 -1.282 . . . . 0.0 109.774 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.78 130.43 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.0 OUTLIER -135.34 131.75 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.258 -1.526 . . . . 0.0 111.811 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.616 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -122.75 126.97 48.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.377 177.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -125.81 133.35 52.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.098 -1.001 . . . . 0.0 108.899 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 63.8 t80 -155.42 128.73 4.38 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.108 -0.995 . . . . 0.0 110.476 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.533 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 81.8 Cg_exo -46.08 133.58 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.308 2.006 . . . . 0.0 112.176 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.61 129.33 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -101.39 82.14 2.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.435 -0.79 . . . . 0.0 109.585 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.25 76.69 0.06 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.177 -0.952 . . . . 0.0 109.568 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.763 ' O ' ' C ' ' A' ' 104' ' ' LYS . 16.3 m -154.26 -28.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.436 -0.79 . . . . 0.0 109.271 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.763 ' C ' ' O ' ' A' ' 103' ' ' VAL . 55.2 mmtt -4.52 -106.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 0.0 109.396 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 104' ' ' LYS . 3.5 m 67.04 -8.99 0.4 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.095 -1.003 . . . . 0.0 108.891 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 104' ' ' LYS . 25.5 t -55.76 133.5 50.99 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.4 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.552 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.84 154.23 41.24 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.26 127.13 52.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.203 -1.175 . . . . 0.0 108.021 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.534 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.8 ttpm? -108.14 137.93 45.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.96 -1.087 . . . . 0.0 112.816 -177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -124.7 123.19 39.48 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.39 142.27 49.22 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 109.475 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -129.7 134.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.629 -0.67 . . . . 0.0 109.523 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.23 129.08 68.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.37 162.09 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.001 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.79 151.06 51.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.428 ' HB2' ' H ' ' B' ' 18' ' ' THR . 22.3 p90 -109.56 146.92 33.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.867 -1.146 . . . . 0.0 111.583 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.04 -20.37 3.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 79.3 mm-40 -91.08 -57.92 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.8 m-20 156.39 65.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -57.12 108.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.088 0.947 . . . . 0.0 112.86 -176.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.476 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -76.82 87.13 3.41 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 175.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.75 -37.58 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.573 -0.704 . . . . 0.0 110.518 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -66.32 -42.31 88.41 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 110.552 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.59 -32.44 73.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.421 HG23 HD11 ' B' ' 23' ' ' ILE . 4.2 mt -66.15 -39.0 83.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 tp -53.71 -35.19 60.89 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.43 74.96 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -60.52 -54.34 37.94 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 1.8 tt -51.34 -47.85 62.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -55.24 -37.03 66.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -62.15 -44.04 97.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 3.0 mm? -50.21 -47.09 54.97 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 32' ' ' SER . 86.3 t -50.71 -26.26 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.326 -0.858 . . . . 0.0 108.879 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 27.9 t -47.34 -44.48 23.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.733 HE21 ' HE2' ' B' ' 76' ' ' HIS . 12.9 pm0 -92.75 -24.35 18.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.812 . . . . 0.0 111.54 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' B' ' 36' ' ' THR . 9.6 mt -71.66 26.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 119.976 -1.703 . . . . 0.0 110.541 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' B' ' 33' ' ' GLN . 89.6 m-20 -63.02 -7.22 4.93 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.627 ' O ' ' N ' ' B' ' 38' ' ' LYS . 49.9 p -71.83 -6.11 39.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.987 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.574 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.8 m 33.72 31.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.012 -1.055 . . . . 0.0 109.189 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' B' ' 36' ' ' THR . 5.9 mtmp? -117.39 38.65 3.51 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.584 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 72.7 m -173.66 177.26 2.55 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.6 m-85 -147.06 155.77 42.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.555 -1.341 . . . . 0.0 111.912 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 85.6 mt-10 -158.58 129.1 6.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.332 0.587 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.36 177.48 8.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.93 162.35 22.45 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 118.69 -1.719 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.679 ' H ' ' NE2' ' B' ' 58' ' ' HIS . 71.7 mt-10 -145.97 138.24 25.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -1.134 . . . . 0.0 109.34 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -121.07 149.33 42.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.483 ' H ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -71.05 81.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.412 -1.43 . . . . 0.0 109.809 -177.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -115.35 56.93 0.74 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.539 ' O ' ' O ' ' B' ' 49' ' ' HIS . 39.8 t -151.1 83.63 1.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.949 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.682 ' N ' HH21 ' B' ' 53' ' ' ARG . 78.6 m-70 56.86 118.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.121 -0.987 . . . . 0.0 109.702 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.545 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 97.4 m-20 -44.68 -33.89 2.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 110.847 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -76.86 -32.0 57.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.063 -1.023 . . . . 0.0 110.751 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 95' ' ' LEU . 63.0 mt -96.29 -12.41 24.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.709 -1.245 . . . . 0.0 109.258 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.682 HH21 ' N ' ' B' ' 49' ' ' HIS . 6.1 ptp180 -95.76 1.97 53.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 111.281 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' B' ' 56' ' ' PHE . 94.9 mm-40 44.37 19.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.8 -1.187 . . . . 0.0 110.168 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.768 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 48.9 3.26 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.477 -0.764 . . . . 0.0 112.893 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' O ' ' B' ' 55' ' ' GLY . 33.0 m-85 -49.91 -143.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.252 -1.734 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.435 ' H ' ' HB3' ' B' ' 56' ' ' PHE . 93.0 m -135.8 -55.87 0.78 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.312 -0.868 . . . . 0.0 110.964 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.679 ' NE2' ' H ' ' B' ' 44' ' ' GLU . 13.0 t60 -168.39 153.22 6.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.203 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.36 116.06 10.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.509 -0.744 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -89.42 131.68 35.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.069 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -121.89 121.3 36.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -114.95 134.66 54.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.218 -0.926 . . . . 0.0 110.757 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 32.6 m -122.88 143.34 49.94 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -117.83 159.59 22.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.693 -1.254 . . . . 0.0 110.036 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.46 -29.24 46.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -174.22 -178.17 1.4 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.83 -27.12 67.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.949 . . . . 0.0 111.469 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -61.92 -44.02 97.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.782 -1.199 . . . . 0.0 110.593 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.27 -32.7 68.65 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -66.7 -45.38 78.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.939 . . . . 0.0 110.459 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.81 -28.92 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.411 -1.43 . . . . 0.0 108.697 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.08 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.325 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.596 ' O ' ' CE1' ' B' ' 76' ' ' HIS . 0.0 OUTLIER -57.06 -49.98 74.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.224 -0.923 . . . . 0.0 111.107 -177.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.594 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 8.6 t -62.85 -28.13 69.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 110.311 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 84.5 p -62.05 16.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.96 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.733 ' HE2' HE21 ' B' ' 33' ' ' GLN . 0.0 OUTLIER -121.83 150.97 56.95 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.868 -1.145 . . . . 0.0 109.585 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.19 12.6 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.604 2.203 . . . . 0.0 112.48 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.526 HD22 HE22 ' B' ' 33' ' ' GLN . 0.7 OUTLIER -76.08 -29.72 58.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.435 -0.79 . . . . 0.0 111.22 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' B' ' 83' ' ' SER . 35.4 t-80 -85.21 -41.71 15.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.935 -1.103 . . . . 0.0 110.22 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.628 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.2 p -57.9 -58.56 5.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 110.031 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.628 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 14.9 tm-20 -57.84 -39.4 77.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.544 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.8 -40.89 72.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 109.894 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' SER . . . . . 0.437 ' N ' ' O ' ' B' ' 79' ' ' HIS . 87.2 p -61.5 -38.14 86.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.24 60.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.011 -1.056 . . . . 0.0 108.675 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -41.18 78.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' B' ' 85' ' ' ALA . 24.6 t80 -44.24 -30.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 89' ' ' VAL . 6.1 m -83.35 -61.77 1.76 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.06 -26.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.604 . . . . 0.0 110.061 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' B' ' 87' ' ' THR . 12.7 m -102.15 16.27 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.18 -0.95 . . . . 0.0 110.769 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' B' ' 87' ' ' THR . 73.4 mt -124.32 159.17 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.643 -1.285 . . . . 0.0 110.417 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.49 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 63.0 t0 -102.3 -34.47 9.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 29.2 pttt -145.94 143.55 29.6 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 tp -121.4 122.2 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.64 -1.287 . . . . 0.0 109.772 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.93 130.44 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -135.37 131.67 36.64 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.307 -1.495 . . . . 0.0 111.76 -178.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.625 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.0 OUTLIER -122.73 127.24 48.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -126.05 133.3 51.76 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.078 -1.014 . . . . 0.0 108.91 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 64.2 t80 -155.24 128.74 4.44 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . 0.531 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 80.5 Cg_exo -46.18 133.39 15.22 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.314 2.009 . . . . 0.0 112.241 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 74.8 t -107.42 129.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 110.007 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -101.5 81.94 2.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 109.577 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 76.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.783 ' O ' ' C ' ' B' ' 104' ' ' LYS . 16.2 m -154.22 -28.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.783 ' C ' ' O ' ' B' ' 103' ' ' VAL . 54.5 mmtt -4.54 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' B' ' 104' ' ' LYS . 3.6 m 67.22 -8.97 0.42 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.149 -0.969 . . . . 0.0 108.949 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.574 ' H ' ' C ' ' B' ' 104' ' ' LYS . 26.2 t -55.83 133.27 51.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.444 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 t -103.38 -9.85 19.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.109 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.408 ' HB3' ' H ' ' A' ' 5' ' ' GLY . 22.1 t -152.78 -86.36 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 4' ' ' SER . . . -140.48 -159.29 7.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.703 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -142.56 142.38 32.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -1.13 . . . . 0.0 108.051 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.44 141.89 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 112.831 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -126.73 128.95 47.46 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.0 tt -135.37 142.77 45.78 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.755 -1.216 . . . . 0.0 109.436 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 12.7 p -131.11 139.5 50.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.05 127.34 72.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.05 144.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.825 -1.55 . . . . 0.0 113.068 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 37.2 tptt -111.76 150.5 30.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 18.4 p90 -107.0 147.5 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.823 -1.173 . . . . 0.0 111.607 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.76 -26.36 4.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 65.0 tt0 -88.19 -56.94 3.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.0 p30 152.63 70.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 41.8 m -55.12 106.88 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.142 0.972 . . . . 0.0 112.821 -177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.95 88.56 1.86 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.5 m -59.53 -40.95 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.705 . . . . 0.0 110.458 -176.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -61.01 -44.24 97.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.411 -0.806 . . . . 0.0 110.557 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.48 -39.12 62.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.5 -50.71 70.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.683 ' N ' ' O ' ' A' ' 20' ' ' VAL . 2.2 tm? -56.48 -42.61 78.53 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -60.13 -25.05 65.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.68 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -69.21 -54.82 11.89 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' GLY . 6.8 tt -44.33 -38.33 3.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.512 -0.993 . . . . 0.0 108.818 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -52.87 -41.82 64.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -57.41 -42.43 82.29 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.641 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -50.22 -46.29 54.48 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 34' ' ' ILE . 34.4 t -48.91 -24.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.332 -0.855 . . . . 0.0 108.908 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 42.4 t -43.24 -43.15 4.65 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 97.0 mm-40 -76.18 -22.42 55.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 111.464 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 36' ' ' THR . 71.9 mt -79.73 20.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.033 -1.667 . . . . 0.0 110.645 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.47 -10.47 1.46 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 34' ' ' ILE . 35.0 p -82.24 0.44 41.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.963 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.577 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.3 m 34.94 33.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.046 -1.034 . . . . 0.0 109.117 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 mtmp? -119.61 42.01 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 63' ' ' THR . 30.1 t -175.97 175.5 1.94 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.4 m-85 -150.53 159.72 44.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.591 -1.318 . . . . 0.0 111.99 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 86.1 mt-10 -159.24 130.82 6.28 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.364 0.602 . . . . 0.0 110.2 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.696 ' N ' ' CD1' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -133.78 171.61 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' GLU . . . -134.45 168.21 23.57 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 118.672 -1.728 . . . . 0.0 110.793 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.618 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 87.4 mt-10 -156.82 152.5 26.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -1.114 . . . . 0.0 109.341 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.871 ' HA ' ' O ' ' A' ' 57' ' ' THR . 23.9 t0 -157.16 87.5 0.99 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HZ2' ' N ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -90.35 170.01 10.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.393 -1.442 . . . . 0.0 109.882 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.699 -0.625 . . . . 0.0 109.317 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.413 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 4.2 t -78.75 -125.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.0 110.164 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -77.63 153.9 32.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.721 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.47 -41.57 69.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 110.759 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.516 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.17 -40.61 90.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.969 -1.082 . . . . 0.0 110.737 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' B' ' 95' ' ' LEU . 44.8 mt -75.86 -64.62 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.745 -1.222 . . . . 0.0 109.303 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -67.72 18.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 0.0 111.233 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 52' ' ' LEU . 1.7 mm100 45.33 8.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.701 -1.249 . . . . 0.0 110.164 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 70.3 -11.54 2.12 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.503 -0.748 . . . . 0.0 112.936 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.656 ' O ' ' O ' ' A' ' 55' ' ' GLY . 49.4 m-85 -53.92 -136.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.288 -1.713 . . . . 0.0 109.92 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.871 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 6.1 t -163.28 -51.45 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 110.903 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 60' ' ' PHE . 6.3 t60 -148.37 142.5 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 0.0 110.149 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.69 163.06 33.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 0.0 109.231 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 58' ' ' HIS . 94.9 m-85 -133.78 131.17 39.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.083 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' A' ' 42' ' ' TRP . 1.6 m -116.59 110.39 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.13 132.38 53.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.209 -0.932 . . . . 0.0 110.838 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.437 ' O ' ' OG ' ' A' ' 39' ' ' SER . 62.8 m -119.01 141.44 48.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.24 158.5 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.689 -1.257 . . . . 0.0 110.097 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -75.66 -26.42 57.67 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -175.39 -177.34 1.01 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -66.61 -23.73 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 111.355 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.7 -41.04 97.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.763 -1.21 . . . . 0.0 110.577 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.57 65.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -69.39 -43.22 73.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.496 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.523 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.82 -28.89 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.423 -1.423 . . . . 0.0 108.642 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.08 -60.9 2.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.299 -0.876 . . . . 0.0 109.358 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.72 -57.74 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.875 . . . . 0.0 111.145 -178.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.64 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 9.2 t -57.27 -35.57 69.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.775 -1.203 . . . . 0.0 110.293 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 58.4 m -66.69 -32.94 74.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.0 110.964 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 78' ' ' LEU . 59.3 m80 -68.43 128.76 93.03 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.83 -1.169 . . . . 0.0 109.601 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.34 -8.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 112.443 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.7 tp -66.77 -28.41 68.37 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.34 -0.85 . . . . 0.0 111.291 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.75 -35.32 24.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.012 . . . . 0.0 110.247 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.97 -61.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -58.62 -38.66 78.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.604 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 78.0 t80 -68.48 -44.28 75.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.872 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 t -59.87 -35.48 74.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.968 -1.082 . . . . 0.0 108.682 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.75 -42.14 77.94 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 85' ' ' ALA . 6.5 t80 -43.53 -30.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.4 m -83.05 -61.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.84 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.639 -0.663 . . . . 0.0 110.008 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.7 m -102.69 11.37 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.19 -0.944 . . . . 0.0 110.746 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 44.8 mt -125.74 158.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.596 -1.315 . . . . 0.0 110.53 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 60.6 t0 -104.22 -32.33 9.17 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -148.87 147.0 28.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.43 127.58 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.579 -1.326 . . . . 0.0 109.763 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 48.3 t -132.18 135.51 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -135.6 130.28 34.19 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 111.759 -178.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.72 127.34 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.65 -0.656 . . . . 0.0 109.387 177.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 54.6 m-20 -123.06 125.08 44.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 108.908 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.748 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -146.7 127.26 7.01 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.053 -1.029 . . . . 0.0 110.501 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.42 123.61 9.44 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.31 2.007 . . . . 0.0 112.22 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.47 132.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.62 80.51 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 84.51 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.632 ' O ' ' O ' ' A' ' 104' ' ' LYS . 17.2 m -147.11 -22.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.177 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.632 ' O ' ' O ' ' A' ' 103' ' ' VAL . 24.8 mtmt 41.33 102.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.328 -0.858 . . . . 0.0 109.358 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -50.74 -50.8 54.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.15 -0.969 . . . . 0.0 108.934 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.1 t 45.78 29.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.385 -0.822 . . . . 0.0 109.378 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.75 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.49 -159.06 7.79 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.687 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -142.81 142.37 31.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -1.136 . . . . 0.0 108.029 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.61 141.64 47.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.932 -1.105 . . . . 0.0 112.819 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.5 128.91 47.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.0 tt -135.42 142.75 45.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.789 -1.195 . . . . 0.0 109.439 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 12.5 p -131.01 139.53 50.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.627 -0.671 . . . . 0.0 109.523 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.09 127.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.03 144.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 117.738 -1.585 . . . . 0.0 113.019 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 36.8 tptt -111.92 150.42 30.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 18.4 p90 -106.91 147.36 29.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 111.575 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.6 -26.39 4.55 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 65.4 tt0 -88.18 -56.83 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.1 p30 152.45 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 40.1 m -55.38 106.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.059 0.933 . . . . 0.0 112.901 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.499 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.01 88.4 1.88 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.679 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.4 m -59.52 -40.65 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 110.434 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.22 -44.42 97.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 110.54 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -74.23 -38.99 63.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.79 -50.37 71.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' B' ' 20' ' ' VAL . 2.2 tm? -56.86 -42.5 79.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -60.11 -25.15 65.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.688 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -69.15 -54.62 12.9 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' B' ' 26' ' ' GLY . 6.8 tt -44.43 -38.29 3.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.551 -0.97 . . . . 0.0 108.831 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -52.96 -41.87 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.688 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.7 p30 -57.28 -42.57 81.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.638 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -50.07 -46.62 53.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' B' ' 34' ' ' ILE . 33.6 t -48.53 -24.74 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 44.2 t -43.15 -43.31 4.52 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.477 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 97.0 mm-40 -75.91 -22.74 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.429 -0.795 . . . . 0.0 111.52 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' B' ' 36' ' ' THR . 72.5 mt -79.3 20.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.955 -1.715 . . . . 0.0 110.586 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.57 -10.58 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.588 ' H ' ' C ' ' B' ' 34' ' ' ILE . 34.6 p -82.09 0.36 40.97 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 35.17 33.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.079 -1.013 . . . . 0.0 109.24 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.8 mtmp? -119.72 42.13 2.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 63' ' ' THR . 30.8 t -176.04 175.21 1.96 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.454 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.9 m-85 -150.41 159.26 44.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.511 -1.368 . . . . 0.0 111.953 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 86.1 mt-10 -158.84 130.78 6.59 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.315 0.578 . . . . 0.0 110.221 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . 0.688 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.0 OUTLIER -133.7 171.6 13.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.46 168.41 23.49 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.666 -1.731 . . . . 0.0 110.751 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.615 ' O ' ' CG ' ' B' ' 58' ' ' HIS . 87.1 mt-10 -156.94 152.42 26.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -1.202 . . . . 0.0 109.41 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.876 ' HA ' ' O ' ' B' ' 57' ' ' THR . 24.4 t0 -156.99 87.85 1.01 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.596 ' HZ2' ' N ' ' B' ' 57' ' ' THR . 0.0 OUTLIER -90.83 170.15 10.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.368 -1.457 . . . . 0.0 109.818 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.09 0.43 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.402 ' N ' ' HG3' ' B' ' 53' ' ' ARG . 4.7 t -78.55 -125.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 110.118 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -78.18 153.73 31.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.17 -41.79 69.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 110.822 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -66.1 -40.42 90.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.033 . . . . 0.0 110.768 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 95' ' ' LEU . 45.5 mt -76.09 -64.31 1.12 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.729 -1.232 . . . . 0.0 109.295 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.4 OUTLIER -68.12 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.38 -0.825 . . . . 0.0 111.218 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' B' ' 52' ' ' LEU . 1.7 mm100 45.13 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.735 -1.228 . . . . 0.0 110.195 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.669 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 70.42 -12.05 2.01 Favored Glycine 0 N--CA 1.5 2.914 0 O-C-N 121.496 -0.753 . . . . 0.0 112.811 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.669 ' O ' ' O ' ' B' ' 55' ' ' GLY . 49.8 m-85 -53.66 -136.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.242 -1.74 . . . . 0.0 109.916 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.876 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 6.3 t -163.0 -51.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.641 ' CD2' ' CZ ' ' B' ' 60' ' ' PHE . 6.2 t60 -148.44 142.45 25.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.938 -1.101 . . . . 0.0 110.175 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.52 163.1 33.85 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.487 -0.758 . . . . 0.0 109.294 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' B' ' 58' ' ' HIS . 95.2 m-85 -133.71 131.02 38.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.151 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' B' ' 42' ' ' TRP . 1.6 m -116.39 110.6 18.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.56 132.51 53.18 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 110.743 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.437 ' O ' ' OG ' ' B' ' 39' ' ' SER . 62.8 m -119.05 141.42 48.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.28 158.49 26.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.736 -1.228 . . . . 0.0 110.013 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -75.76 -26.48 57.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -175.28 -177.42 1.03 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.43 -23.74 66.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.69 -41.2 97.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.814 -1.179 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.28 -31.71 65.9 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -69.07 -43.53 74.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.56 -0.965 . . . . 0.0 110.474 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.508 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.88 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.47 -1.394 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.51 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.1 -60.85 2.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.632 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -57.43 -57.94 10.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 111.146 -178.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.632 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 9.1 t -57.33 -35.21 69.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.368 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.508 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 58.5 m -66.93 -32.97 74.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' B' ' 78' ' ' LEU . 59.4 m80 -68.44 128.55 93.05 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.887 -1.133 . . . . 0.0 109.629 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -42.98 -8.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.644 2.229 . . . . 0.0 112.513 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.6 tp -66.56 -28.59 68.64 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.387 -0.821 . . . . 0.0 111.211 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -83.65 -35.31 24.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 110.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.05 -61.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.014 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -58.58 -38.72 78.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 77.9 t80 -68.27 -44.54 75.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.838 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -59.77 -35.24 74.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.163 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.16 60.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.978 -1.076 . . . . 0.0 108.742 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -42.15 77.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.474 ' C ' ' O ' ' B' ' 85' ' ' ALA . 6.6 t80 -43.55 -30.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.503 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.0 m -82.98 -61.87 1.75 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.78 -26.92 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.697 -0.627 . . . . 0.0 110.049 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.7 m -102.71 11.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.233 -0.917 . . . . 0.0 110.797 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 43.8 mt -126.0 158.85 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.646 -1.284 . . . . 0.0 110.384 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 60.3 t0 -104.4 -32.25 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -149.0 147.1 28.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.67 127.48 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.526 -1.358 . . . . 0.0 109.746 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 48.4 t -132.12 135.28 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -135.4 130.24 34.56 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.254 -1.529 . . . . 0.0 111.792 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.537 ' H ' HD13 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -118.69 127.11 53.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.645 -0.66 . . . . 0.0 109.343 177.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.573 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 55.3 m-20 -122.85 124.87 44.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.031 -1.043 . . . . 0.0 108.85 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.794 ' N ' ' CD1' ' B' ' 98' ' ' PHE . 0.0 OUTLIER -146.37 127.45 7.29 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.097 -1.002 . . . . 0.0 110.502 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.55 123.65 9.65 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.229 1.953 . . . . 0.0 112.248 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.34 132.83 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.69 80.53 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.99 84.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -0.98 . . . . 0.0 109.557 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.627 ' O ' ' O ' ' B' ' 104' ' ' LYS . 17.2 m -147.26 -22.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.196 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.627 ' O ' ' O ' ' B' ' 103' ' ' VAL . 24.5 mtmt 41.02 102.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.344 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.408 ' O ' ' C ' ' B' ' 106' ' ' SER . 15.1 m -50.89 -50.8 56.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.112 -0.993 . . . . 0.0 108.957 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.408 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.0 t 45.94 29.91 0.82 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.362 -0.836 . . . . 0.0 109.413 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 C--N 1.302 -1.482 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.85 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.44 0.638 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -113.51 4.27 16.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.15 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 100' ' ' VAL . 4.3 p -175.84 -113.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.27 173.75 19.12 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.71 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -124.92 128.99 49.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.188 -1.184 . . . . 0.0 108.07 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 20.1 ttpt -104.1 134.26 47.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.057 . . . . 0.0 112.837 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 62' ' ' MET . 85.3 t60 -127.14 125.03 40.47 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.725 -1.234 . . . . 0.0 109.454 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.46 138.05 54.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.6 -0.687 . . . . 0.0 109.444 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 t -119.4 131.64 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -136.52 156.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 117.787 -1.565 . . . . 0.0 113.071 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -123.33 153.09 40.77 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' HB2' ' H ' ' A' ' 18' ' ' THR . 23.7 p90 -110.99 146.61 36.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -21.14 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.5 tt0 -92.82 -57.37 2.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.5 m-20 157.55 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.9 m -50.95 103.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.045 0.926 . . . . 0.0 112.854 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.791 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -71.1 82.55 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 24' ' ' LEU . 28.8 m -62.37 -40.07 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.635 -0.666 . . . . 0.0 110.458 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -66.21 -45.59 80.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 0.0 110.515 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 29.2 mp0 -68.29 -34.09 75.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.11 -43.29 88.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 20' ' ' VAL . 17.9 tp -54.29 -35.92 63.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.28 -33.9 72.99 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -61.33 -52.49 51.24 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.2 tt -46.91 -44.14 19.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.493 -1.004 . . . . 0.0 108.774 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -55.21 -37.65 67.4 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 2.0 m-80 -62.85 -46.04 89.75 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 3.4 mm? -48.45 -46.49 37.92 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 32' ' ' SER . 63.1 t -51.3 -26.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.287 -0.883 . . . . 0.0 108.837 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 30.9 t -46.38 -47.97 18.65 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.651 ' NE2' ' O ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -86.94 -23.7 25.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 0.0 111.467 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.55 ' C ' ' H ' ' A' ' 36' ' ' THR . 4.6 mm -73.25 23.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.036 -1.665 . . . . 0.0 110.618 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.0 p30 -61.8 -9.31 6.28 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' A' ' 37' ' ' VAL . 64.1 p -71.52 -4.86 29.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.971 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.4 m 32.64 36.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 ptmt -121.96 41.97 3.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 40' ' ' PHE . 26.9 t -174.6 179.07 1.8 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.567 ' N ' ' HG ' ' A' ' 39' ' ' SER . 97.6 m-85 -143.98 153.4 42.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.554 -1.341 . . . . 0.0 111.998 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 61' ' ' SER . 75.5 mt-10 -156.41 124.26 5.57 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.355 0.598 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -134.74 174.15 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.24 145.42 11.7 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 118.777 -1.678 . . . . 0.0 110.832 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.573 ' O ' ' CD2' ' A' ' 58' ' ' HIS . 56.2 mp0 -148.31 164.81 32.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.233 -1.157 . . . . 0.0 109.388 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 57' ' ' THR . 21.4 t70 -113.78 161.1 17.95 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.658 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 3.0 ptmm? -62.01 83.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.43 -1.419 . . . . 0.0 109.771 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.2 mt-10 -128.79 46.87 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.622 -0.674 . . . . 0.0 109.259 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' B' ' 97' ' ' ASP . 5.9 t -142.2 78.71 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.75 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 56.2 m80 56.58 107.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.927 . . . . 0.0 109.678 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -45.66 -35.16 3.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -0.851 . . . . 0.0 110.818 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -71.4 -35.34 70.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.961 -1.087 . . . . 0.0 110.682 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' B' ' 95' ' ' LEU . 84.5 mt -78.76 -51.1 10.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.763 -1.211 . . . . 0.0 109.314 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.75 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.1 ptp180 -64.35 13.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 0.0 111.274 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 52' ' ' LEU . 82.2 mm-40 37.76 32.19 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.82 -1.175 . . . . 0.0 110.129 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.777 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 59.16 1.83 1.16 Allowed Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.439 -0.788 . . . . 0.0 112.815 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.777 ' O ' ' O ' ' A' ' 55' ' ' GLY . 46.1 m-85 -48.82 -148.15 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.221 -1.753 . . . . 0.0 109.884 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 50.4 m -143.37 -56.72 0.4 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.331 -0.855 . . . . 0.0 110.957 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.632 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 15.2 t-80 -158.21 145.98 18.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.116 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -132.04 148.91 52.53 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.264 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 58' ' ' HIS . 34.8 m-85 -118.91 119.71 35.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.48 -0.762 . . . . 0.0 109.04 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 7.1 t -88.94 95.35 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.0 mtp -102.37 110.62 22.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.228 -0.92 . . . . 0.0 110.813 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.473 ' O ' ' OG ' ' A' ' 39' ' ' SER . 4.2 m -125.63 145.87 49.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.6 160.52 21.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.17 . . . . 0.0 110.068 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 85.5 tt0 -81.99 -31.95 30.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.4 m-20 -163.18 174.32 12.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.63 -27.14 62.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 111.417 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 71' ' ' VAL . 91.6 m-20 -55.49 -36.73 66.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.869 -1.144 . . . . 0.0 110.538 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.74 -35.35 73.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.68 -44.34 97.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.508 -0.995 . . . . 0.0 110.5 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 68' ' ' ASP . 21.1 m -70.78 -28.88 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.379 -1.451 . . . . 0.0 108.661 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.94 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.365 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.59 -39.94 58.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 111.129 -177.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.619 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.5 t -80.79 -29.81 36.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.725 -1.234 . . . . 0.0 110.264 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.2 t -58.13 -33.64 69.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.984 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 73' ' ' PHE . 13.9 p80 -87.84 141.91 32.0 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.632 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 10.86 1.49 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.652 2.234 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.594 ' H ' ' HD1' ' A' ' 76' ' ' HIS . 3.6 tt -73.04 -26.86 61.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.801 . . . . 0.0 111.256 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 83' ' ' SER . 9.3 t-80 -85.0 -43.41 13.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.0 110.249 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.517 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 2.8 p -56.62 -58.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.517 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 93.5 mt-10 -58.39 -42.27 86.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.94 -39.37 72.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' HIS . 23.6 t -59.83 -38.07 81.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.142 -0.974 . . . . 0.0 110.151 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.55 72.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.923 -1.111 . . . . 0.0 108.65 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.84 -41.59 78.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 85' ' ' ALA . 22.5 t80 -45.04 -30.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 90' ' ' ILE . 3.8 m -84.68 -63.6 1.31 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.09 -27.35 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.65 -0.657 . . . . 0.0 110.089 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 87' ' ' THR . 5.4 p -98.53 16.57 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 23.0 mm -130.64 164.02 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.683 -1.26 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.567 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 40.9 t0 -103.41 -36.76 7.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -146.96 146.42 30.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.37 127.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.6 -1.313 . . . . 0.0 109.707 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.2 133.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.65 36.22 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.292 -1.505 . . . . 0.0 111.804 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -125.69 128.99 48.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.675 . . . . 0.0 109.379 177.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.593 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 42.8 t0 -120.01 124.61 46.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.021 -1.049 . . . . 0.0 108.893 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 97' ' ' ASP . 25.1 m-85 -142.31 148.96 49.8 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.986 -1.071 . . . . 0.0 110.531 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.83 130.12 16.4 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.244 1.963 . . . . 0.0 112.201 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.551 ' O ' ' OG ' ' A' ' 4' ' ' SER . 9.9 t -95.22 117.09 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.96 . . . . 0.0 109.994 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -91.31 75.45 6.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.21 71.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.114 -0.992 . . . . 0.0 109.563 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' SER . 29.1 m -149.78 -32.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.266 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 106' ' ' SER . 25.3 mtmt 37.68 -93.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER 66.58 -42.53 0.4 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 108.978 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 104' ' ' LYS . 9.5 m -44.4 104.18 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.277 -0.89 . . . . 0.0 109.336 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.323 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' B' ' 100' ' ' VAL . 4.2 p . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.28 173.7 19.07 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -124.8 129.11 49.8 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.205 -1.174 . . . . 0.0 108.01 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' B' ' 97' ' ' ASP . 20.2 ttpt -104.23 134.27 47.74 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.311 1.053 . . . . 0.0 112.822 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' B' ' 62' ' ' MET . 85.4 t60 -127.08 125.07 40.66 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.1 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.747 -1.22 . . . . 0.0 109.487 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -130.47 138.02 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.545 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.42 131.52 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.49 156.19 35.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 117.732 -1.587 . . . . 0.0 113.053 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -123.2 153.07 40.58 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.501 ' HB2' ' H ' ' B' ' 18' ' ' THR . 23.7 p90 -111.01 146.54 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 0.0 111.663 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 -21.18 2.9 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -92.96 -57.36 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.5 m-20 157.47 65.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.501 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.3 m -50.79 103.32 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.117 0.961 . . . . 0.0 112.844 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.776 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -71.29 82.47 0.75 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' B' ' 24' ' ' LEU . 28.4 m -62.15 -40.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.585 -0.697 . . . . 0.0 110.433 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -66.36 -45.41 80.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.559 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' B' ' 22' ' ' GLU . 28.8 mp0 -68.43 -34.1 75.39 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.04 -43.31 89.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 20' ' ' VAL . 17.9 tp -54.14 -36.24 63.09 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.02 -34.03 72.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -61.42 -52.22 52.79 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.2 tt -47.12 -43.85 20.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.533 -0.98 . . . . 0.0 108.83 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -55.54 -37.47 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 2.1 m-80 -62.9 -46.13 89.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 3.4 mm? -48.31 -46.62 36.48 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' B' ' 32' ' ' SER . 62.8 t -51.19 -26.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 108.821 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 31.0 t -46.33 -48.05 18.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.654 ' NE2' ' O ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -86.97 -23.68 24.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.448 -0.782 . . . . 0.0 111.553 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.537 ' C ' ' H ' ' B' ' 36' ' ' THR . 4.6 mm -73.16 23.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 119.984 -1.697 . . . . 0.0 110.591 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' B' ' 33' ' ' GLN . 55.2 p30 -61.7 -9.44 6.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' THR . . . . . 0.604 ' O ' ' N ' ' B' ' 38' ' ' LYS . 63.0 p -71.46 -4.73 28.2 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.948 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.596 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.3 m 32.61 36.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.044 -1.035 . . . . 0.0 109.144 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.9 ptmt -122.26 42.01 3.25 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.543 ' HG ' ' N ' ' B' ' 40' ' ' PHE . 27.6 t -174.51 179.14 1.82 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.543 ' N ' ' HG ' ' B' ' 39' ' ' SER . 97.6 m-85 -144.1 153.24 41.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.525 -1.359 . . . . 0.0 112.001 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' B' ' 61' ' ' SER . 74.9 mt-10 -156.3 124.18 5.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.746 -0.596 . . . . 0.0 110.302 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -134.87 174.15 10.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.3 145.54 11.86 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 118.691 -1.719 . . . . 0.0 110.819 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.575 ' O ' ' CD2' ' B' ' 58' ' ' HIS . 56.8 mp0 -148.35 164.72 33.21 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -1.149 . . . . 0.0 109.408 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' B' ' 57' ' ' THR . 21.6 t70 -113.57 161.15 17.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.66 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 3.0 ptmm? -62.03 83.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.421 -1.424 . . . . 0.0 109.805 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.0 mt-10 -128.73 46.75 2.56 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 97' ' ' ASP . 6.1 t -142.13 78.9 1.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 110.179 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.749 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 56.0 m80 56.4 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 109.694 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -45.86 -35.01 4.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.38 -0.825 . . . . 0.0 110.784 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -71.49 -35.2 70.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 0.0 110.739 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' A' ' 95' ' ' LEU . 84.1 mt -78.88 -50.99 10.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.691 -1.256 . . . . 0.0 109.329 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.749 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.1 ptp180 -64.29 13.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 111.291 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' B' ' 52' ' ' LEU . 82.2 mm-40 37.92 31.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.787 -1.196 . . . . 0.0 110.175 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.775 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 59.49 1.47 1.21 Allowed Glycine 0 N--CA 1.499 2.833 0 O-C-N 121.393 -0.817 . . . . 0.0 112.82 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' PHE . . . . . 0.775 ' O ' ' O ' ' B' ' 55' ' ' GLY . 46.6 m-85 -48.58 -148.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.296 -1.708 . . . . 0.0 109.979 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 49.3 m -143.44 -56.69 0.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.342 -0.849 . . . . 0.0 110.925 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' HIS . . . . . 0.63 ' CE1' ' CE1' ' B' ' 60' ' ' PHE . 14.8 t-80 -158.37 146.21 18.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.91 -1.119 . . . . 0.0 110.157 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.582 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -132.25 148.97 52.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CE1' ' B' ' 58' ' ' HIS . 35.6 m-85 -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.461 -0.775 . . . . 0.0 109.08 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 6.9 t -88.9 95.31 10.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' MET . . . . . 0.479 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.5 mtp -102.41 110.55 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.195 -0.94 . . . . 0.0 110.787 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' B' ' 39' ' ' SER . 4.2 m -125.56 145.99 49.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -117.73 160.58 21.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.726 -1.234 . . . . 0.0 110.051 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 85.6 tt0 -82.06 -31.86 30.64 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.3 m-20 -163.29 174.2 12.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.58 -27.11 62.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.292 -0.88 . . . . 0.0 111.407 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.403 ' O ' HG21 ' B' ' 71' ' ' VAL . 91.2 m-20 -55.37 -36.89 66.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.75 -35.43 73.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -61.49 -44.66 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.604 -0.939 . . . . 0.0 110.455 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.403 HG21 ' O ' ' B' ' 68' ' ' ASP . 20.8 m -70.69 -29.01 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.348 -1.47 . . . . 0.0 108.695 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.379 -0.826 . . . . 0.0 109.323 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -51.22 -40.21 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -0.921 . . . . 0.0 111.131 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' THR . . . . . 0.62 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.5 t -80.58 -29.96 36.95 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.742 -1.224 . . . . 0.0 110.256 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 38.5 t -57.97 -33.84 69.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.961 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.63 ' HD1' ' H ' ' B' ' 78' ' ' LEU . 13.8 p80 -87.76 141.94 32.17 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.161 . . . . 0.0 109.564 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.68 10.91 1.47 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.662 2.241 . . . . 0.0 112.427 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.63 ' H ' ' HD1' ' B' ' 76' ' ' HIS . 3.5 tt -73.0 -27.01 61.53 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.342 -0.849 . . . . 0.0 111.243 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' SER . 9.3 t-80 -84.96 -43.26 14.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.019 -1.051 . . . . 0.0 110.25 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.512 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 2.7 p -56.83 -58.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 110.041 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.512 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 93.5 mt-10 -58.36 -42.49 87.09 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.643 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -70.63 -39.47 73.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.827 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' SER . . . . . 0.481 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.7 t -59.72 -38.25 81.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 110.108 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.63 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 108.654 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.76 -41.59 78.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' B' ' 85' ' ' ALA . 22.4 t80 -45.02 -30.88 1.14 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.495 ' O ' ' N ' ' B' ' 90' ' ' ILE . 3.8 m -84.44 -63.73 1.29 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.94 -27.51 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 110.07 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 87' ' ' THR . 5.4 p -98.57 16.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.224 -0.923 . . . . 0.0 110.818 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 22.8 mm -130.86 164.1 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.618 -1.301 . . . . 0.0 110.497 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . 0.553 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 41.9 t0 -103.44 -36.89 7.83 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -146.95 146.39 30.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.32 127.56 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.555 -1.341 . . . . 0.0 109.658 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.38 133.11 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.8 36.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.269 -1.52 . . . . 0.0 111.768 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.628 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.0 OUTLIER -125.73 129.06 48.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.629 . . . . 0.0 109.312 177.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' ASP . . . . . 0.596 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 43.3 t0 -119.99 124.6 46.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' PHE . . . . . 0.596 ' CD1' ' O ' ' B' ' 97' ' ' ASP . 24.9 m-85 -142.29 148.91 49.7 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.098 -1.001 . . . . 0.0 110.504 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 130.05 16.41 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.28 1.987 . . . . 0.0 112.187 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . 0.551 ' O ' ' OG ' ' B' ' 4' ' ' SER . 9.5 t -95.15 117.05 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 110.054 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -91.32 75.48 6.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 109.54 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.23 71.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.566 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' B' ' 105' ' ' SER . 29.2 m -149.84 -32.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.577 ' C ' ' H ' ' B' ' 106' ' ' SER . 25.5 mtmt 37.71 -93.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.579 ' N ' ' O ' ' B' ' 103' ' ' VAL . 0.9 OUTLIER 66.59 -42.69 0.41 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.968 . . . . 0.0 108.941 -178.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.577 ' H ' ' C ' ' B' ' 104' ' ' LYS . 10.2 m -44.22 104.08 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.35 -0.844 . . . . 0.0 109.386 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.492 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' ' C ' ' A' ' 2' ' ' ALA . 74.6 mmm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 41.28 55.03 3.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.325 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 4' ' ' SER . 8.9 t -63.48 -45.57 90.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.149 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 3' ' ' THR . 19.9 m -139.64 -100.5 0.16 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.22 148.48 34.43 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.689 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.544 ' CZ ' ' OD1' ' A' ' 97' ' ' ASP . 34.6 t80 -114.93 128.09 56.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.268 -1.137 . . . . 0.0 108.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.535 ' HZ1' ' CD1' ' A' ' 9' ' ' LEU . 3.7 ttpp -113.51 142.35 46.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.919 -1.113 . . . . 0.0 112.83 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -132.79 133.42 43.38 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.535 ' CD1' ' HZ1' ' A' ' 7' ' ' LYS . 6.6 tt -136.63 145.84 45.33 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 109.461 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.14 133.43 68.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.47 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.19 129.03 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -139.45 167.53 19.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.733 -1.587 . . . . 0.0 113.024 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 19.0 tptp -132.85 152.29 51.87 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' N ' ' HG3' ' A' ' 13' ' ' LYS . 39.7 p90 -108.68 149.61 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.877 -1.139 . . . . 0.0 111.576 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -129.29 -22.09 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.7 mt-10 -89.27 -57.11 3.0 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.0 t0 153.83 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 64.6 m -50.93 105.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.104 0.954 . . . . 0.0 112.814 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -75.56 88.16 2.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.61 -38.57 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.557 -0.714 . . . . 0.0 110.524 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 82.9 m-20 -66.1 -44.63 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.425 -0.797 . . . . 0.0 110.572 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.96 -31.39 72.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 23' ' ' ILE . 13.3 mt -69.62 -37.44 74.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 13.9 tp -53.22 -37.86 62.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -34.53 74.23 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.02 -53.54 36.41 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -46.82 -47.73 20.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.497 -1.002 . . . . 0.0 108.832 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.49 -44.54 65.7 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -68.59 -49.05 62.33 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.39 -47.81 37.27 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.7 t -49.76 -26.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.268 -0.895 . . . . 0.0 108.887 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 47.0 t -41.64 -42.69 2.57 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.663 HE22 ' CG ' ' A' ' 76' ' ' HIS . 15.2 mm100 -61.23 -11.17 8.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.483 -0.76 . . . . 0.0 111.499 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.444 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 41.8 mm -81.92 26.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 119.985 -1.697 . . . . 0.0 110.604 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 36' ' ' THR . 31.1 p-10 -67.38 -26.38 66.43 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.708 ' O ' ' N ' ' A' ' 38' ' ' LYS . 7.5 t -79.21 1.99 22.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.968 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 21.1 m 37.83 21.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.081 -1.012 . . . . 0.0 109.187 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' A' ' 36' ' ' THR . 83.0 mttt -120.81 41.26 3.33 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -158.12 154.75 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.503 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 98.5 m-85 -144.46 154.43 42.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.543 -1.348 . . . . 0.0 111.949 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 81.1 mt-10 -160.88 130.46 4.9 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.335 0.588 . . . . 0.0 110.223 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -130.01 175.27 9.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.8 154.0 21.97 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.574 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 17.8 mt-10 -151.1 141.85 22.77 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -1.146 . . . . 0.0 109.401 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 8.5 p30 -116.02 148.53 40.07 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.622 ' HD3' ' N ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -68.5 80.82 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.481 -1.387 . . . . 0.0 109.809 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 45' ' ' ASP . 78.2 mm-40 -96.91 54.66 1.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.298 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 49' ' ' HIS . 29.7 t -134.14 -138.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -0.934 . . . . 0.0 110.23 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.54 ' N ' ' OG ' ' A' ' 48' ' ' SER . 74.1 m80 -107.37 142.94 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -42.83 -41.11 3.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 0.0 110.798 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 ttt -71.54 -29.37 64.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.016 -1.053 . . . . 0.0 110.703 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' B' ' 95' ' ' LEU . 52.1 mt -98.25 -18.38 18.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.745 -1.222 . . . . 0.0 109.277 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.669 ' C ' ' H ' ' A' ' 55' ' ' GLY . 55.0 mtp180 -73.43 0.58 11.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 111.212 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 55.9 -4.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.797 -1.189 . . . . 0.0 110.197 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 82.53 -18.36 15.2 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.884 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CZ ' ' NZ ' ' A' ' 92' ' ' LYS . 12.0 m-85 -59.26 -128.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.246 -1.738 . . . . 0.0 109.922 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.622 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 2.5 t -164.99 -36.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.34 -0.85 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.7 t60 -169.9 153.68 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.166 . . . . 0.0 110.225 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.653 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.18 168.76 18.98 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.261 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 88.1 m-85 -129.03 126.07 38.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 109.073 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.25 14.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 mtt -104.84 117.83 35.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.172 -0.955 . . . . 0.0 110.82 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -120.31 143.24 48.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.28 159.66 23.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.691 -1.255 . . . . 0.0 110.069 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.54 -27.45 62.23 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -173.75 -174.57 0.97 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.35 -27.17 65.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 111.445 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 29.1 p-10 -58.04 -37.89 75.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.813 -1.18 . . . . 0.0 110.532 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -68.98 -37.59 83.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' ' CG2' ' A' ' 74' ' ' THR . 71.0 t80 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.507 -0.996 . . . . 0.0 110.498 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.376 -1.453 . . . . 0.0 108.677 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.91 2.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.59 ' CZ ' ' CG ' ' A' ' 79' ' ' HIS . 35.8 t80 -45.98 -35.71 4.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.9 . . . . 0.0 111.127 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -86.02 -27.25 24.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.75 -1.219 . . . . 0.0 110.332 -178.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -66.81 12.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.989 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.663 ' CG ' HE22 ' A' ' 33' ' ' GLN . 16.5 m80 -124.76 152.7 69.88 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.787 -1.195 . . . . 0.0 109.636 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.73 -6.63 15.35 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.675 2.25 . . . . 0.0 112.434 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.412 HD12 HD22 ' A' ' 29' ' ' ASN . 5.8 tp -73.22 -28.01 61.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.837 . . . . 0.0 111.223 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.59 ' CG ' ' CZ ' ' A' ' 73' ' ' PHE . 2.9 t60 -82.08 -35.45 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.052 . . . . 0.0 110.281 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.53 -60.01 3.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.989 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -56.64 -38.65 72.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.612 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.41 -41.86 72.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.849 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.3 t -61.73 -39.2 90.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.167 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.31 77.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.1 -39.72 78.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.461 ' C ' ' O ' ' A' ' 85' ' ' ALA . 28.3 t80 -45.19 -29.53 0.97 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.613 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 1.2 p -83.46 -62.26 1.63 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.613 ' H ' ' HG1' ' A' ' 87' ' ' THR . . . -40.09 -27.94 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.705 -0.622 . . . . 0.0 110.084 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 p -100.95 14.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.819 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 22.5 mm -128.69 161.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.682 -1.261 . . . . 0.0 110.444 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 62.8 t0 -104.37 -35.23 8.01 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.625 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 19.8 ptmt -145.63 146.03 31.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -125.69 123.43 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.626 -1.296 . . . . 0.0 109.799 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.65 132.4 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -138.6 135.41 34.92 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.262 -1.524 . . . . 0.0 111.766 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.457 HD13 ' H ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -121.06 124.53 45.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.638 -0.664 . . . . 0.0 109.363 176.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.544 ' OD1' ' CZ ' ' A' ' 6' ' ' PHE . 20.2 t0 -126.27 133.65 51.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.053 -1.029 . . . . 0.0 108.951 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CE1' ' CD ' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -156.62 157.77 31.07 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.109 -0.995 . . . . 0.0 110.516 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.79 127.77 13.41 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.321 2.014 . . . . 0.0 112.209 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -106.99 128.7 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -108.47 94.48 5.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.47 -0.768 . . . . 0.0 109.625 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.46 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' A' ' 101' ' ' ALA . 10.2 m -148.36 -26.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 106' ' ' SER . 25.2 mmtt -38.45 -28.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 103' ' ' VAL . 5.7 p -57.69 70.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.131 -0.98 . . . . 0.0 108.941 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 104' ' ' LYS . 8.0 t -111.21 109.82 20.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 p -91.73 30.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.27 141.36 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.538 -0.726 . . . . 0.0 109.533 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.82 132.17 32.2 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 p -70.73 152.55 95.18 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.891 -1.131 . . . . 0.0 109.617 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 C-N-CA 122.776 2.317 . . . . 0.0 112.238 179.652 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.455 ' O ' ' C ' ' B' ' 2' ' ' ALA . 74.3 mmm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' B' ' 1' ' ' MET . . . 41.39 55.06 3.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' B' ' 4' ' ' SER . 8.9 t -63.49 -45.72 89.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.179 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.484 ' N ' ' CG2' ' B' ' 3' ' ' THR . 20.1 m -139.47 -100.51 0.16 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.26 148.39 34.25 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.406 -1.378 . . . . 0.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.54 ' CZ ' ' OD1' ' B' ' 97' ' ' ASP . 34.4 t80 -114.77 128.2 56.17 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.249 -1.148 . . . . 0.0 108.02 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.536 ' HZ1' ' CD1' ' B' ' 9' ' ' LEU . 3.6 ttpp -113.55 142.4 46.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 112.822 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -132.86 133.36 43.21 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.536 ' CD1' ' HZ1' ' B' ' 7' ' ' LYS . 6.5 tt -136.58 145.86 45.45 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.728 -1.233 . . . . 0.0 109.458 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.18 133.34 68.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.04 129.16 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.61 167.5 19.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.017 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 19.1 tptp -132.74 152.34 51.77 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.442 ' N ' ' HG3' ' B' ' 13' ' ' LYS . 39.7 p90 -108.77 149.47 28.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.85 -1.156 . . . . 0.0 111.606 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -129.11 -22.08 3.2 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.6 mt-10 -89.29 -57.12 3.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 7.9 t0 153.75 64.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 63.7 m -50.73 105.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.136 0.97 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -75.62 88.22 2.73 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.63 -38.55 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.612 -0.68 . . . . 0.0 110.471 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' B' ' 24' ' ' LEU . 82.7 m-20 -66.19 -44.56 83.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 110.564 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -66.07 -31.47 72.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.446 HG21 HD12 ' B' ' 23' ' ' ILE . 13.4 mt -69.53 -37.35 74.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' B' ' 21' ' ' ASP . 13.9 tp -53.3 -37.83 62.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -34.64 74.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.98 -53.54 36.54 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.77 -47.64 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.982 . . . . 0.0 108.797 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -52.6 -44.55 66.06 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.3 OUTLIER -68.66 -49.04 62.27 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.47 -47.6 38.32 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 32' ' ' SER . 53.7 t -49.96 -26.06 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.309 -0.869 . . . . 0.0 108.832 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.3 t -42.0 -42.61 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.669 HE22 ' CG ' ' B' ' 76' ' ' HIS . 15.3 mm100 -61.07 -11.3 8.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.443 -0.786 . . . . 0.0 111.509 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.445 ' O ' ' CG2' ' B' ' 34' ' ' ILE . 42.1 mm -81.78 26.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 119.99 -1.693 . . . . 0.0 110.559 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 36' ' ' THR . 31.6 p-10 -67.51 -26.3 66.27 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.723 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.4 t -79.25 1.85 23.33 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.942 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 36' ' ' THR . 21.1 m 37.93 21.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 36' ' ' THR . 83.3 mttt -120.82 41.36 3.31 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -158.2 154.71 27.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 98.5 m-85 -144.47 154.53 43.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.545 -1.347 . . . . 0.0 111.99 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 80.8 mt-10 -160.97 130.45 4.83 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.345 0.593 . . . . 0.0 110.2 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -130.09 175.22 9.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.75 154.07 21.99 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.828 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.568 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 17.9 mt-10 -151.12 141.72 22.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 8.1 p30 -115.91 148.67 39.77 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' B' ' 57' ' ' THR . 0.0 OUTLIER -68.59 80.89 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.394 -1.441 . . . . 0.0 109.788 -176.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 45' ' ' ASP . 78.2 mm-40 -96.95 54.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.646 . . . . 0.0 109.315 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' B' ' 49' ' ' HIS . 29.6 t -134.14 -138.22 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.511 ' N ' ' OG ' ' B' ' 48' ' ' SER . 74.1 m80 -107.24 142.92 36.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.134 -0.979 . . . . 0.0 109.699 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -42.78 -41.25 3.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.78 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.9 ttt -71.42 -29.29 64.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 95' ' ' LEU . 51.5 mt -98.26 -18.46 18.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.72 -1.238 . . . . 0.0 109.279 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.672 ' C ' ' H ' ' B' ' 55' ' ' GLY . 55.0 mtp180 -73.42 0.58 11.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -0.844 . . . . 0.0 111.271 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 55.87 -4.06 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.832 -1.168 . . . . 0.0 110.18 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 82.77 -18.89 13.22 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.454 -0.778 . . . . 0.0 112.861 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.624 ' CZ ' ' NZ ' ' B' ' 92' ' ' LYS . 12.2 m-85 -58.92 -128.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.288 -1.713 . . . . 0.0 109.902 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.614 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 2.5 t -164.9 -36.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.299 -0.876 . . . . 0.0 110.992 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.652 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.7 t60 -169.91 153.77 4.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.826 -1.171 . . . . 0.0 110.214 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.652 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.21 168.77 18.95 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.461 -0.774 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.532 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 88.2 m-85 -129.01 126.12 38.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.513 -0.742 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.24 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 34.6 mtt -104.92 117.9 35.2 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.24 -0.913 . . . . 0.0 110.731 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 99.9 m -120.38 143.27 48.52 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -119.28 159.69 23.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.715 -1.241 . . . . 0.0 110.073 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.6 -27.57 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -173.57 -174.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.39 -27.33 65.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 111.422 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 29.0 p-10 -57.9 -38.03 75.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.817 -1.177 . . . . 0.0 110.574 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -68.75 -37.6 84.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.507 ' O ' ' CG2' ' B' ' 74' ' ' THR . 71.5 t80 -62.36 -46.76 87.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.574 -0.956 . . . . 0.0 110.445 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.94 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.377 -1.452 . . . . 0.0 108.732 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.585 ' CZ ' ' CG ' ' B' ' 79' ' ' HIS . 35.8 t80 -45.75 -35.76 4.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.932 . . . . 0.0 111.107 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.2 OUTLIER -86.08 -27.29 24.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.808 -1.183 . . . . 0.0 110.316 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -66.66 12.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.066 -1.021 . . . . 0.0 110.986 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.669 ' CG ' HE22 ' B' ' 33' ' ' GLN . 16.8 m80 -124.81 152.56 69.88 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 109.547 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.58 -6.63 15.48 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.644 2.229 . . . . 0.0 112.453 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.407 HD12 HD22 ' B' ' 29' ' ' ASN . 5.8 tp -73.09 -28.23 62.17 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.236 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.585 ' CG ' ' CZ ' ' B' ' 73' ' ' PHE . 2.9 t60 -81.98 -35.44 28.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.48 -60.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.987 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' B' ' 82' ' ' PHE . 22.4 pt-20 -56.59 -38.77 72.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' B' ' 81' ' ' GLU . 73.1 t80 -70.26 -41.86 72.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 17.4 t -61.62 -39.42 91.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.1 -1.0 . . . . 0.0 110.15 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -49.39 77.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 108.68 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.93 -39.8 79.37 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.466 ' C ' ' O ' ' B' ' 85' ' ' ALA . 28.4 t80 -45.12 -29.5 0.93 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.59 ' HG1' ' H ' ' B' ' 88' ' ' ALA . 1.2 p -83.5 -62.36 1.6 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.59 ' H ' ' HG1' ' B' ' 87' ' ' THR . . . -40.01 -27.98 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.742 -0.599 . . . . 0.0 110.084 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' B' ' 87' ' ' THR . 3.9 p -100.86 14.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.234 -0.916 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 22.4 mm -128.63 161.19 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.664 -1.273 . . . . 0.0 110.421 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.516 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 62.6 t0 -104.55 -35.33 7.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.624 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 19.8 ptmt -145.53 146.14 31.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -125.78 123.32 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.597 -1.314 . . . . 0.0 109.767 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 132.38 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.4 OUTLIER -138.59 135.3 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.314 -1.491 . . . . 0.0 111.737 -178.278 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.461 ' H ' HD13 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -121.0 124.62 45.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 176.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' B' ' 6' ' ' PHE . 21.1 t0 -126.39 133.62 51.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.034 -1.041 . . . . 0.0 108.923 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -156.6 157.67 31.04 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.065 -1.022 . . . . 0.0 110.516 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.7 127.93 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.268 1.979 . . . . 0.0 112.227 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.14 128.66 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.957 . . . . 0.0 110.042 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -108.56 94.46 5.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.491 -0.756 . . . . 0.0 109.609 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.39 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.564 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.658 ' N ' ' O ' ' B' ' 101' ' ' ALA . 10.4 m -148.33 -26.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 109.23 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.4 mmtt -38.6 -28.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 103' ' ' VAL . 5.7 p -57.77 70.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.135 -0.978 . . . . 0.0 108.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.705 ' N ' ' O ' ' B' ' 104' ' ' LYS . 8.0 t -111.15 109.83 20.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 p -91.76 30.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.38 141.43 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.437 -0.79 . . . . 0.0 109.498 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.93 132.0 31.74 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -70.48 152.71 95.37 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 120.89 -1.131 . . . . 0.0 109.663 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.308 -1.604 0 C-N-CA 122.736 2.291 . . . . 0.0 112.272 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' O ' ' C ' ' A' ' 2' ' ' ALA . 61.1 mtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.346 0.593 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -38.25 110.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 109.339 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.472 ' CG2' ' N ' ' A' ' 4' ' ' SER . 7.6 t -147.64 -49.07 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.102 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.472 ' N ' ' CG2' ' A' ' 3' ' ' THR . 29.6 m -124.05 -103.76 0.37 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.01 45.24 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.737 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -136.36 135.02 38.47 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.218 -1.166 . . . . 0.0 108.036 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -99.94 127.0 46.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.93 -1.107 . . . . 0.0 112.822 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.507 ' ND1' ' OD1' ' A' ' 97' ' ' ASP . 86.3 t60 -122.61 121.18 35.84 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.6 tt -135.08 144.11 47.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.714 -1.241 . . . . 0.0 109.474 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 10.7 p -127.64 134.32 65.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.547 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.52 127.93 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.429 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.4 m -141.6 159.92 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 117.785 -1.566 . . . . 0.0 113.042 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -130.41 155.2 46.81 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.543 ' H ' HG22 ' A' ' 57' ' ' THR . 11.9 p90 -111.11 153.69 25.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.13 . . . . 0.0 111.606 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -19.14 3.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 17' ' ' ASP . 13.5 tm-20 -92.63 -56.82 2.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 3.1 m-20 155.24 62.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.8 m -49.04 105.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.082 0.944 . . . . 0.0 112.849 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.752 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.98 85.5 0.7 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' LEU . 33.0 m -64.95 -41.02 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.527 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 36.4 p-10 -66.51 -46.54 75.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.4 -0.812 . . . . 0.0 110.553 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.8 mp0 -66.14 -30.25 70.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mt -72.4 -41.79 64.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.4 tp -56.1 -38.59 70.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' NZ ' ' C ' ' B' ' 111' ' ' PRO . 3.3 ttpt -63.47 -34.03 76.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.591 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -68.16 -53.3 22.86 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -44.93 -42.68 8.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.547 -0.972 . . . . 0.0 108.793 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -53.24 -42.69 66.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.674 ' ND2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -58.84 -45.2 90.63 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.674 ' N ' ' ND2' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -49.24 -45.12 44.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' ILE . 16.0 t -58.08 -20.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 108.827 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 46.8 t -44.0 -38.3 3.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -10.74 50.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 111.39 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 36' ' ' THR . 5.4 mm -86.06 21.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.075 -1.64 . . . . 0.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 36' ' ' THR . 51.6 p30 -58.91 -9.43 1.84 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.642 ' O ' ' C ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -80.2 -1.1 39.02 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.895 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.642 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.4 m 30.26 45.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 109.217 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.644 ' HZ1' ' CA ' ' A' ' 69' ' ' GLY . 11.4 ptmm? -121.03 39.86 3.7 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 75.7 m -173.36 179.08 2.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -145.56 154.74 42.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.608 -1.308 . . . . 0.0 111.936 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -154.64 123.25 6.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.395 0.617 . . . . 0.0 110.234 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.532 ' CG ' ' N ' ' A' ' 43' ' ' GLY . 67.0 t-105 -135.83 175.03 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' N ' ' CG ' ' A' ' 42' ' ' TRP . . . -132.28 160.97 23.85 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 118.711 -1.709 . . . . 0.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 41.8 mp0 -148.84 139.63 22.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -1.151 . . . . 0.0 109.336 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 47' ' ' GLU . 85.6 m-20 -113.75 147.08 38.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.671 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.5 81.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.435 -1.416 . . . . 0.0 109.806 -178.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.0 mt-10 -122.06 59.2 1.01 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' A' ' 49' ' ' HIS . 43.9 p -158.49 73.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' A' ' 48' ' ' SER . 55.9 m80 54.34 125.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -44.79 -31.51 1.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 110.757 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -30.79 52.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.992 -1.068 . . . . 0.0 110.763 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 48' ' ' SER . 40.6 mt -100.62 -27.63 13.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.784 -1.198 . . . . 0.0 109.336 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 46' ' ' LYS . 8.7 ptm180 -87.0 -2.45 58.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.326 -0.859 . . . . 0.0 111.25 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER 49.21 13.71 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.839 -1.163 . . . . 0.0 110.167 178.388 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 57.06 -2.89 0.07 OUTLIER Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.441 -0.787 . . . . 0.0 112.89 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 56' ' ' PHE . 45.8 p90 -57.1 124.08 17.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.233 -1.745 . . . . 0.0 109.977 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' ND1' ' A' ' 58' ' ' HIS . 72.1 p -54.2 -44.11 71.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 111.002 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 36.0 p-80 -170.21 154.94 5.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.826 -1.171 . . . . 0.0 110.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.48 17.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.283 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.91 126.77 38.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.494 -0.754 . . . . 0.0 109.078 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -96.09 96.24 8.71 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 8' ' ' HIS . 67.4 mtt -101.83 119.11 38.26 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.165 -0.959 . . . . 0.0 110.809 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 m -125.67 145.31 50.22 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -121.59 163.74 18.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.701 -1.249 . . . . 0.0 110.088 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 4' ' ' SER . 85.4 tt0 -85.49 -30.9 23.09 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -157.56 164.06 37.71 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' CB ' ' HZ1' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -57.6 -24.29 55.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 0.0 111.478 -179.178 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -57.18 -40.03 76.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.796 -1.19 . . . . 0.0 110.608 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.644 ' CA ' ' HZ1' ' A' ' 38' ' ' LYS . . . -68.63 -40.79 85.64 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -60.54 -46.79 88.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.988 . . . . 0.0 110.454 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.1 m -70.72 -28.97 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.396 -1.44 . . . . 0.0 108.677 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.02 -60.95 2.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -56.77 -39.44 74.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 111.173 -176.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -80.84 -34.08 34.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.764 -1.21 . . . . 0.0 110.295 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 74.1 m -68.12 -32.9 73.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 110.973 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.61 ' N ' ' HD1' ' A' ' 76' ' ' HIS . 0.3 OUTLIER -69.62 126.0 92.32 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.899 -1.125 . . . . 0.0 109.635 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.78 -7.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.726 2.284 . . . . 0.0 112.364 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.1 tt -72.31 -30.99 65.3 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.363 -0.836 . . . . 0.0 111.198 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 10.9 t-160 -82.89 -29.19 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.966 -1.084 . . . . 0.0 110.275 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.53 -58.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.018 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -56.45 -38.17 71.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -71.64 -42.19 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -62.18 -39.72 93.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.102 -0.999 . . . . 0.0 110.146 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.49 77.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.955 -1.091 . . . . 0.0 108.69 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.08 -40.67 87.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 85' ' ' ALA . 15.9 t80 -45.29 -29.35 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 89' ' ' VAL . 12.2 m -81.79 -62.12 1.73 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -38.85 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.7 -0.625 . . . . 0.0 110.111 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.5 m -106.47 11.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.791 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 26.4 mm -130.53 163.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.685 -1.26 . . . . 0.0 110.41 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.541 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 22.6 t0 -124.22 -34.52 2.92 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -126.99 125.17 41.02 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.0 tp -123.54 123.14 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.691 -1.256 . . . . 0.0 109.786 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 43.7 t -130.28 133.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -137.48 135.26 36.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.278 -1.514 . . . . 0.0 111.781 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 1.1 mp -114.67 117.01 29.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.688 -0.632 . . . . 0.0 109.339 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.507 ' OD1' ' ND1' ' A' ' 8' ' ' HIS . 79.2 m-20 -114.63 121.77 44.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.092 -1.005 . . . . 0.0 108.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 63.1 t80 -154.61 137.22 10.03 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.077 -1.014 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 39.7 Cg_endo -63.86 141.94 80.19 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.311 2.007 . . . . 0.0 112.228 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.1 t -122.41 141.97 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 109.979 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -112.46 96.93 6.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.88 76.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 101' ' ' ALA . 8.6 m -148.11 120.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.385 -0.822 . . . . 0.0 109.155 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.32 115.71 24.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.346 -0.846 . . . . 0.0 109.325 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 106' ' ' SER . 22.1 m -69.88 -45.38 67.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 108.914 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' SER . 6.1 t 43.19 52.42 5.56 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.354 -0.841 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -177.19 51.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 108' ' ' VAL . 8.6 p -168.06 43.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.567 -0.708 . . . . 0.0 109.465 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.03 75.99 0.66 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.427 ' H ' ' HG1' ' A' ' 110' ' ' THR . 1.7 p -76.28 153.56 84.16 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 120.921 -1.112 . . . . 0.0 109.661 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.47 ' C ' ' NZ ' ' B' ' 25' ' ' LYS . 75.3 Cg_endo . . . . . 0 C--N 1.309 -1.546 0 C-N-CA 122.736 2.291 . . . . 0.0 112.255 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.481 ' O ' ' C ' ' B' ' 2' ' ' ALA . 61.5 mtt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.289 0.566 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' B' ' 1' ' ' MET . . . -38.3 110.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -0.927 . . . . 0.0 109.288 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' B' ' 4' ' ' SER . 7.7 t -147.82 -48.83 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 109.143 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.474 ' N ' ' CG2' ' B' ' 3' ' ' THR . 28.2 m -124.36 -103.97 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.4 175.0 45.64 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.43 134.81 38.11 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.207 -1.172 . . . . 0.0 108.075 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -99.76 126.9 45.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.929 -1.107 . . . . 0.0 112.837 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' B' ' 97' ' ' ASP . 86.3 t60 -122.66 121.21 35.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.6 tt -135.07 144.07 47.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.694 -1.253 . . . . 0.0 109.454 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 10.6 p -127.62 134.41 65.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.512 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.64 127.95 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.425 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.4 m -141.6 159.76 21.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.019 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -130.29 155.26 46.62 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 12.0 p90 -111.23 153.66 25.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.827 -1.17 . . . . 0.0 111.558 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 -19.2 3.2 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 17' ' ' ASP . 13.5 tm-20 -92.49 -56.92 2.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.519 ' N ' ' OE1' ' B' ' 16' ' ' GLU . 3.1 m-20 155.21 62.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 90.2 m -49.31 105.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.095 0.95 . . . . 0.0 112.882 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.738 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -70.95 85.33 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' B' ' 24' ' ' LEU . 32.9 m -64.84 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.616 -0.677 . . . . 0.0 110.539 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 36.0 p-10 -66.59 -46.41 76.05 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 110.569 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 3.9 mp0 -66.25 -30.25 70.65 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.35 -41.78 65.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -56.08 -38.6 70.9 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.47 ' NZ ' ' C ' ' A' ' 111' ' ' PRO . 3.3 ttpt -63.34 -34.28 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.596 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -67.96 -53.43 22.98 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.88 -42.59 8.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.466 -1.02 . . . . 0.0 108.801 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -53.43 -42.54 67.19 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' N ' ' B' ' 30' ' ' LEU . 0.0 OUTLIER -58.91 -45.21 90.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.68 ' N ' ' ND2' ' B' ' 29' ' ' ASN . 0.5 OUTLIER -49.18 -45.28 43.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' B' ' 34' ' ' ILE . 15.8 t -57.88 -20.35 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.278 -0.889 . . . . 0.0 108.806 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.0 t -43.86 -38.41 3.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -10.97 50.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.502 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' B' ' 36' ' ' THR . 5.3 mm -85.85 21.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 119.933 -1.73 . . . . 0.0 110.588 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 36' ' ' THR . 51.1 p30 -59.01 -9.5 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -80.18 -1.01 38.56 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.878 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.6 m 30.33 45.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.03 -1.044 . . . . 0.0 109.17 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.646 ' HZ1' ' CA ' ' B' ' 69' ' ' GLY . 11.4 ptmm? -121.12 40.0 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.568 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 74.9 m -173.39 179.17 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.61 154.73 42.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.469 -1.394 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -154.6 123.33 6.19 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.471 0.653 . . . . 0.0 110.218 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.533 ' CG ' ' N ' ' B' ' 43' ' ' GLY . 66.7 t-105 -135.75 175.08 9.92 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' B' ' 42' ' ' TRP . . . -132.2 161.07 23.84 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.772 -1.68 . . . . 0.0 110.791 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 41.6 mp0 -148.9 139.48 22.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -1.162 . . . . 0.0 109.358 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 47' ' ' GLU . 85.2 m-20 -113.46 147.14 38.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.66 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -65.54 81.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.483 -1.385 . . . . 0.0 109.832 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.1 mt-10 -122.12 59.28 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.712 -0.618 . . . . 0.0 109.398 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' B' ' 49' ' ' HIS . 41.7 p -158.42 73.25 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' B' ' 48' ' ' SER . 55.9 m80 54.24 125.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -44.6 -31.62 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.44 -30.89 53.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.724 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' B' ' 48' ' ' SER . 41.4 mt -100.76 -27.47 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.782 -1.199 . . . . 0.0 109.247 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' O ' ' B' ' 46' ' ' LYS . 8.7 ptm180 -87.11 -2.48 58.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 111.204 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' B' ' 56' ' ' PHE . 0.8 OUTLIER 49.32 13.64 0.08 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.782 -1.199 . . . . 0.0 110.217 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 57.18 -3.13 0.07 OUTLIER Glycine 0 N--CA 1.498 2.797 0 O-C-N 121.47 -0.769 . . . . 0.0 112.852 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 45.9 p90 -56.96 124.17 17.72 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.279 -1.718 . . . . 0.0 109.977 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.546 ' OG1' ' ND1' ' B' ' 58' ' ' HIS . 72.1 p -54.19 -44.19 71.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.988 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.623 ' HA ' ' O ' ' B' ' 44' ' ' GLU . 36.0 p-80 -170.21 154.82 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.119 . . . . 0.0 110.197 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.95 169.46 17.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.414 -0.804 . . . . 0.0 109.24 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.81 126.87 39.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.348 -0.845 . . . . 0.0 109.081 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 66.0 m -96.1 96.3 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' MET . . . . . 0.401 ' O ' ' N ' ' B' ' 8' ' ' HIS . 67.4 mtt -101.81 119.07 38.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.23 -0.919 . . . . 0.0 110.81 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -125.71 145.33 50.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.63 163.64 18.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.661 -1.274 . . . . 0.0 110.054 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 4' ' ' SER . 85.4 tt0 -85.45 -30.92 23.14 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.43 164.13 37.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.495 ' CB ' ' HZ1' ' B' ' 67' ' ' LYS . 0.5 OUTLIER -57.6 -24.39 56.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 111.467 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.96 -40.23 76.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.727 -1.233 . . . . 0.0 110.563 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.646 ' CA ' ' HZ1' ' B' ' 38' ' ' LYS . . . -68.6 -40.55 85.91 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.77 -46.69 89.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.636 -0.92 . . . . 0.0 110.522 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.98 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.322 -1.486 . . . . 0.0 108.665 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.461 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.03 -60.85 2.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.788 . . . . 0.0 109.387 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.425 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.75 -39.43 73.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.889 . . . . 0.0 111.079 -177.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.425 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 4.9 t -80.97 -33.84 33.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.763 -1.21 . . . . 0.0 110.371 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 74.5 m -68.36 -32.82 73.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.955 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.601 ' N ' ' HD1' ' B' ' 76' ' ' HIS . 0.3 OUTLIER -69.58 126.04 92.35 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.807 -1.183 . . . . 0.0 109.605 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -43.78 -7.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.642 2.228 . . . . 0.0 112.48 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.2 tt -72.51 -30.93 64.93 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.42 -0.8 . . . . 0.0 111.214 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.457 ' O ' ' CD2' ' B' ' 79' ' ' HIS . 10.9 t-160 -82.93 -29.11 29.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.956 -1.09 . . . . 0.0 110.317 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.54 -58.71 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 110.004 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -56.54 -38.2 71.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 0.0 109.531 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -71.5 -42.25 68.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 0.0 109.905 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -62.27 -39.64 93.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.0 . . . . 0.0 110.124 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.5 77.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 0.0 108.609 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.18 -40.64 86.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.446 ' C ' ' O ' ' B' ' 85' ' ' ALA . 16.0 t80 -45.31 -29.3 1.0 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 12.3 m -81.8 -62.08 1.74 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.99 -26.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.643 -0.661 . . . . 0.0 110.093 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.7 m -106.58 11.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.28 -0.888 . . . . 0.0 110.828 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 26.4 mm -130.59 163.91 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.616 -1.302 . . . . 0.0 110.494 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.538 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 22.6 t0 -124.25 -34.55 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -127.03 125.13 40.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.0 tp -123.63 123.15 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.617 -1.302 . . . . 0.0 109.715 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 43.2 t -130.27 133.01 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.1 OUTLIER -137.43 135.19 36.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.251 -1.531 . . . . 0.0 111.796 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 1.2 mp -114.68 116.96 29.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 109.317 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' B' ' 8' ' ' HIS . 79.8 m-20 -114.67 121.78 44.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.156 -0.965 . . . . 0.0 108.884 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 63.3 t80 -154.56 137.18 10.01 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 39.7 Cg_endo -63.93 141.89 79.53 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.27 1.98 . . . . 0.0 112.299 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 71.4 t -122.37 141.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 110.05 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.605 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -112.53 96.99 6.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.439 -0.788 . . . . 0.0 109.548 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.9 76.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.091 -1.005 . . . . 0.0 109.561 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' B' ' 101' ' ' ALA . 9.4 m -148.03 120.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.227 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.27 115.72 24.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.409 ' O ' ' C ' ' B' ' 106' ' ' SER . 23.2 m -69.78 -45.67 67.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.138 -0.976 . . . . 0.0 108.917 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.4 t 43.48 52.23 6.03 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.365 -0.834 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 9.5 p -177.09 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.462 ' O ' ' CG2' ' B' ' 108' ' ' VAL . 8.5 p -167.94 43.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.509 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.9 75.9 0.63 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.285 -0.884 . . . . 0.0 108.636 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 1.7 p -76.28 153.57 84.17 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 120.864 -1.148 . . . . 0.0 109.625 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.468 ' C ' ' NZ ' ' A' ' 25' ' ' LYS . 74.9 Cg_endo . . . . . 0 C--N 1.308 -1.571 0 C-N-CA 122.731 2.287 . . . . 0.0 112.228 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' O ' ' C ' ' A' ' 2' ' ' ALA . 25.4 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.303 0.573 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 44.57 64.1 1.46 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.362 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.489 ' CG2' ' N ' ' A' ' 4' ' ' SER . 10.2 t -65.85 -45.7 81.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.174 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 3' ' ' THR . 19.7 m -136.23 -97.02 0.23 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.61 170.06 41.79 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.731 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.2 131.27 43.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.283 -1.127 . . . . 0.0 108.011 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -99.87 125.75 45.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.925 -1.109 . . . . 0.0 112.824 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 62' ' ' MET . 74.5 m80 -120.09 121.41 38.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.42 143.21 43.82 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.696 -1.252 . . . . 0.0 109.486 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.67 136.12 60.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.635 -0.666 . . . . 0.0 109.492 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.07 126.58 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.09 154.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.813 -1.555 . . . . 0.0 113.064 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -126.61 154.85 43.4 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 16.6 p90 -111.28 152.54 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.817 -1.177 . . . . 0.0 111.641 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -128.23 -18.48 4.08 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.6 mt-10 -90.48 -56.83 3.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 4.8 p30 153.05 58.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 78.8 m -47.05 107.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.051 0.929 . . . . 0.0 112.815 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.75 87.67 2.79 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 175.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -57.97 -34.87 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.725 . . . . 0.0 110.527 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.45 -40.25 89.32 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 88.3 mt-10 -68.27 -33.33 74.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.1 mp -63.9 -44.08 97.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.48 -34.62 61.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.51 -34.33 75.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.38 -44.92 8.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -58.09 9.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.538 -0.978 . . . . 0.0 108.81 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.76 -40.82 73.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 38.7 t30 -61.23 -45.34 94.95 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 26' ' ' GLY . 2.8 tm? -53.91 -46.08 71.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 32' ' ' SER . 59.5 t -55.91 -33.8 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 108.825 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 31' ' ' VAL . 4.7 m -45.47 -39.8 7.61 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 35' ' ' ASP . 21.3 tp60 -69.34 -53.98 16.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.439 -0.788 . . . . 0.0 111.469 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.661 ' C ' ' H ' ' A' ' 36' ' ' THR . 17.4 mt -61.2 41.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.039 -1.663 . . . . 0.0 110.626 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.662 ' N ' ' O ' ' A' ' 33' ' ' GLN . 58.9 t0 -60.41 -3.81 0.74 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.661 ' H ' ' C ' ' A' ' 34' ' ' ILE . 45.3 p -76.9 -0.96 26.09 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.942 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 36' ' ' THR . 19.1 m 31.21 47.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 36' ' ' THR . 13.9 ptpt -124.46 42.45 3.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 63' ' ' THR . 28.2 t -175.63 179.45 1.41 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.414 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 93.0 m-85 -145.75 155.28 42.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.566 -1.334 . . . . 0.0 111.958 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 40' ' ' PHE . 71.2 mt-10 -157.06 126.52 6.08 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.356 0.598 . . . . 0.0 110.246 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.6 ' CD1' ' NZ ' ' B' ' 104' ' ' LYS . 0.1 OUTLIER -142.34 178.02 7.86 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' CE3' ' A' ' 42' ' ' TRP . . . -142.83 169.1 25.74 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.46 145.97 27.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -1.137 . . . . 0.0 109.369 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 86.5 m-20 -124.25 147.02 48.39 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.852 ' HD2' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -146.19 136.36 23.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.437 -1.414 . . . . 0.0 109.808 -174.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.73 ' O ' ' O ' ' A' ' 48' ' ' SER . 96.2 mt-10 -131.13 -0.7 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.707 -0.621 . . . . 0.0 109.343 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.73 ' O ' ' O ' ' A' ' 47' ' ' GLU . 29.7 t -49.01 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.514 ' N ' ' OG ' ' A' ' 48' ' ' SER . 76.0 m80 -70.7 152.59 43.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.461 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 88.2 m-20 -66.98 -41.65 86.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.481 ' O ' ' SD ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -69.2 -33.95 74.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.007 -1.058 . . . . 0.0 110.789 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' B' ' 95' ' ' LEU . 70.4 mt -87.26 -56.34 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.722 -1.236 . . . . 0.0 109.33 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.706 ' C ' ' H ' ' A' ' 55' ' ' GLY . 10.0 ptt180 -59.4 4.75 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 111.149 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.603 ' NE2' ' CD1' ' B' ' 96' ' ' LEU . 2.5 mt-30 59.64 -18.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.86 -1.15 . . . . 0.0 110.196 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.706 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 83.12 -17.27 23.89 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 121.434 -0.791 . . . . 0.0 112.921 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.852 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 6.1 p90 -60.47 117.02 4.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.275 -1.721 . . . . 0.0 109.897 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.562 ' OG1' ' NE2' ' A' ' 58' ' ' HIS . 70.1 p -51.68 -33.72 35.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.295 -0.878 . . . . 0.0 110.984 -175.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.562 ' NE2' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -175.44 159.93 2.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.847 -1.158 . . . . 0.0 110.114 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.51 169.28 17.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.347 -0.846 . . . . 0.0 109.249 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.36 127.5 37.72 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.484 -0.76 . . . . 0.0 109.094 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -93.15 98.49 11.33 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 8' ' ' HIS . 69.9 mtm -101.54 113.63 26.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.166 -0.958 . . . . 0.0 110.775 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' OG ' ' A' ' 39' ' ' SER . 34.2 m -123.03 141.99 51.35 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.87 162.05 19.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.698 -1.252 . . . . 0.0 110.118 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -81.97 -30.41 31.67 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -168.13 175.36 6.63 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -65.07 -24.84 67.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 111.419 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -61.38 -44.88 96.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.777 -1.202 . . . . 0.0 110.573 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.25 -34.3 74.93 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -65.98 -46.2 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.479 -1.012 . . . . 0.0 110.485 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 75' ' ' SER . 20.9 m -70.75 -28.93 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.345 -1.472 . . . . 0.0 108.668 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.12 -60.88 2.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 0.0 109.326 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -60.96 -55.86 27.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 111.177 -177.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.7 ' N ' ' CD2' ' A' ' 73' ' ' PHE . 12.8 t -57.09 -34.71 68.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.729 -1.232 . . . . 0.0 110.287 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 68.8 p -69.35 -26.44 64.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -0.955 . . . . 0.0 110.967 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 72' ' ' ALA . 41.9 m80 -65.1 151.46 93.6 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.843 -1.161 . . . . 0.0 109.648 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.74 -12.7 26.73 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.641 2.227 . . . . 0.0 112.439 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.32 -28.9 63.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.361 -0.837 . . . . 0.0 111.208 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.464 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 46.1 t60 -83.23 -32.8 26.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.017 -1.052 . . . . 0.0 110.227 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.84 -60.44 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.047 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.05 -37.6 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.14 -40.26 74.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.3 t -62.6 -41.09 98.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.21 74.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.972 -1.08 . . . . 0.0 108.706 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.63 -41.26 79.69 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.467 ' C ' ' O ' ' A' ' 85' ' ' ALA . 20.0 t80 -44.6 -31.26 1.09 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.3 m -82.53 -61.68 1.82 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.17 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.712 -0.617 . . . . 0.0 110.09 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.1 m -100.53 16.35 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 110.847 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.616 ' N ' ' O ' ' A' ' 87' ' ' THR . 41.1 mt -126.68 159.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.659 -1.276 . . . . 0.0 110.409 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.517 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 52.7 t0 -102.31 -31.91 10.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -151.9 149.44 28.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -125.06 124.23 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.653 -1.279 . . . . 0.0 109.73 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.42 HG12 HE21 ' B' ' 54' ' ' GLN . 46.3 t -126.95 131.33 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.8 138.17 32.05 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.34 -1.475 . . . . 0.0 111.741 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.673 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.16 125.72 49.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 31.4 p-10 -120.38 124.56 45.83 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.045 . . . . 0.0 108.907 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 86.3 t80 -154.05 123.74 3.26 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.1 -1.0 . . . . 0.0 110.531 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.03 136.22 14.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.345 2.03 . . . . 0.0 112.186 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.9 t -120.77 140.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.997 . . . . 0.0 110.028 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -113.46 96.97 6.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.34 76.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.018 . . . . 0.0 109.599 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 101' ' ' ALA . 13.2 m -148.42 118.85 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 0.0 109.176 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.591 ' NZ ' ' CD1' ' B' ' 42' ' ' TRP . 23.4 mmtm -144.73 -11.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.467 ' C ' ' O ' ' A' ' 104' ' ' LYS . 87.5 p -42.15 -24.5 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 108.93 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 104' ' ' LYS . 34.5 t -53.04 -83.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.36 -0.838 . . . . 0.0 109.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 106' ' ' SER . 44.2 t 42.9 87.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' B' ' 28' ' ' GLU . 78.9 t -129.89 119.1 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.612 -0.68 . . . . 0.0 109.49 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.96 157.54 33.09 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.6 151.2 96.67 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 120.839 -1.163 . . . . 0.0 109.634 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo . . . . . 0 C--N 1.307 -1.641 0 C-N-CA 122.843 2.362 . . . . 0.0 112.259 179.909 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.04 64.26 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' B' ' 4' ' ' SER . 10.4 t -65.99 -45.98 79.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.895 . . . . 0.0 109.147 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.491 ' N ' ' CG2' ' B' ' 3' ' ' THR . 19.9 m -135.92 -96.92 0.23 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.84 170.03 41.29 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.748 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.99 131.24 44.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.29 -1.123 . . . . 0.0 108.064 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -99.77 125.86 45.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.946 -1.096 . . . . 0.0 112.854 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' B' ' 62' ' ' MET . 74.4 m80 -120.22 121.09 37.95 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 tt -136.19 143.34 44.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.736 -1.227 . . . . 0.0 109.399 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -128.69 136.22 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.505 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.16 126.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.24 153.9 27.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 117.757 -1.577 . . . . 0.0 113.016 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -126.4 154.68 43.27 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.519 ' H ' HG23 ' B' ' 57' ' ' THR . 17.1 p90 -111.17 152.58 26.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.923 -1.11 . . . . 0.0 111.589 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -128.18 -18.83 4.03 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.3 mt-10 -90.12 -56.94 3.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 4.8 p30 153.13 58.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 73.0 m -47.04 107.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.131 0.967 . . . . 0.0 112.821 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.515 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.88 87.72 2.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -57.91 -34.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.567 -0.708 . . . . 0.0 110.533 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.4 p-10 -66.76 -40.08 88.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 110.51 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 88.3 mt-10 -68.28 -33.15 73.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.446 HD13 ' N ' ' B' ' 23' ' ' ILE . 1.1 mp -64.26 -43.96 97.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.27 -34.92 61.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.36 -34.43 75.29 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.26 -44.75 8.58 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -57.98 10.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.555 -0.967 . . . . 0.0 108.799 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.8 -40.66 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.45 ' H ' ' HG3' ' B' ' 28' ' ' GLU . 38.7 t30 -61.41 -45.35 94.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' B' ' 26' ' ' GLY . 2.8 tm? -53.87 -46.06 71.18 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' B' ' 32' ' ' SER . 60.2 t -55.69 -34.01 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.301 -0.874 . . . . 0.0 108.839 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 31' ' ' VAL . 4.7 m -45.37 -39.77 7.21 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.667 ' O ' ' N ' ' B' ' 35' ' ' ASP . 21.5 tp60 -69.49 -53.88 16.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.493 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' B' ' 36' ' ' THR . 17.4 mt -61.31 41.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 119.939 -1.725 . . . . 0.0 110.588 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.667 ' N ' ' O ' ' B' ' 33' ' ' GLN . 60.6 t0 -60.55 -4.26 0.87 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.673 ' H ' ' C ' ' B' ' 34' ' ' ILE . 45.6 p -76.44 -1.4 26.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.62 ' C ' ' O ' ' B' ' 36' ' ' THR . 19.0 m 31.66 47.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.015 -1.053 . . . . 0.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' B' ' 36' ' ' THR . 13.9 ptpt -124.56 42.48 3.25 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' B' ' 63' ' ' THR . 28.5 t -175.56 179.39 1.44 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.408 ' O ' ' HG2' ' B' ' 41' ' ' GLU . 93.1 m-85 -145.8 155.28 42.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.582 -1.324 . . . . 0.0 111.93 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' B' ' 40' ' ' PHE . 71.7 mt-10 -157.1 126.43 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.783 -0.573 . . . . 0.0 110.272 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.591 ' CD1' ' NZ ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -142.23 177.95 7.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' B' ' 42' ' ' TRP . . . -142.74 168.89 25.79 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -149.31 145.65 27.14 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -1.128 . . . . 0.0 109.409 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 86.6 m-20 -123.84 147.05 47.94 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.852 ' HD2' ' O ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -146.15 136.44 23.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.349 -1.47 . . . . 0.0 109.737 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.714 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.9 mt-10 -131.1 -0.63 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.701 -0.624 . . . . 0.0 109.353 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.714 ' O ' ' O ' ' B' ' 47' ' ' GLU . 29.5 t -49.32 -151.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.204 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.513 ' N ' ' OG ' ' B' ' 48' ' ' SER . 76.1 m80 -70.63 152.41 43.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -0.994 . . . . 0.0 109.641 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.453 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 87.9 m-20 -66.69 -41.82 87.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.349 -0.844 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.482 ' O ' ' SD ' ' B' ' 51' ' ' MET . 0.4 OUTLIER -69.03 -33.95 74.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' B' ' 54' ' ' GLN . 70.9 mt -87.26 -56.46 3.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.778 -1.201 . . . . 0.0 109.197 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.732 ' C ' ' H ' ' B' ' 55' ' ' GLY . 9.8 ptt180 -59.33 4.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 111.266 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.611 ' NE2' ' CD1' ' A' ' 96' ' ' LEU . 2.3 mt-30 59.4 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.828 -1.17 . . . . 0.0 110.219 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.732 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 83.07 -17.18 24.13 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.379 -0.826 . . . . 0.0 112.856 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.852 ' O ' ' HD2' ' B' ' 46' ' ' LYS . 6.0 p90 -60.48 117.12 4.88 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.292 -1.711 . . . . 0.0 109.951 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.563 ' OG1' ' NE2' ' B' ' 58' ' ' HIS . 69.8 p -51.73 -33.53 35.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.258 -0.901 . . . . 0.0 111.002 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.563 ' NE2' ' OG1' ' B' ' 57' ' ' THR . 0.1 OUTLIER -175.61 159.71 2.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.787 -1.196 . . . . 0.0 110.183 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.3 169.39 17.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.504 -0.747 . . . . 0.0 109.294 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -131.3 127.7 38.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.433 -0.792 . . . . 0.0 109.093 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t -93.23 98.24 11.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' MET . . . . . 0.512 ' O ' ' N ' ' B' ' 8' ' ' HIS . 70.2 mtm -101.35 113.59 26.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.834 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.494 ' O ' ' OG ' ' B' ' 39' ' ' SER . 35.8 m -122.98 142.38 50.9 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -119.16 162.0 19.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.69 -1.257 . . . . 0.0 110.035 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -82.15 -30.08 31.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -168.43 175.22 6.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -65.05 -24.61 67.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 111.474 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -61.66 -44.84 96.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.803 -1.186 . . . . 0.0 110.647 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.99 -34.31 76.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -66.14 -46.17 78.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.565 -0.962 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.71 -28.92 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.382 -1.449 . . . . 0.0 108.666 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.08 -60.83 2.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.435 -0.791 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -60.97 -55.96 26.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 111.116 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.687 ' N ' ' CD2' ' B' ' 73' ' ' PHE . 13.0 t -57.05 -34.77 68.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.702 -1.249 . . . . 0.0 110.34 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 69.1 p -69.31 -26.25 64.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.088 -1.008 . . . . 0.0 110.965 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 72' ' ' ALA . 41.3 m80 -65.33 151.6 93.73 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.876 -1.14 . . . . 0.0 109.651 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.02 -12.24 25.82 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.678 2.252 . . . . 0.0 112.491 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -28.6 62.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.436 -0.79 . . . . 0.0 111.22 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.454 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 46.2 t60 -83.26 -32.84 26.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.943 -1.098 . . . . 0.0 110.249 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 66.6 t -62.91 -60.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.999 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.11 -37.52 61.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -70.21 -40.17 74.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.172 -0.955 . . . . 0.0 109.883 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.8 t -62.59 -41.2 98.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.29 74.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.973 -1.079 . . . . 0.0 108.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.52 -41.35 80.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.469 ' C ' ' O ' ' B' ' 85' ' ' ALA . 19.9 t80 -44.54 -31.37 1.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.593 ' O ' ' N ' ' B' ' 90' ' ' ILE . 6.5 m -82.53 -61.84 1.77 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.0 -29.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.681 -0.637 . . . . 0.0 110.086 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.2 m -100.67 16.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.161 -0.962 . . . . 0.0 110.843 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' B' ' 87' ' ' THR . 41.5 mt -126.73 159.23 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 0.0 110.474 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 51.9 t0 -102.48 -31.81 10.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -152.04 149.72 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -125.43 124.05 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.594 -1.316 . . . . 0.0 109.76 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.422 HG12 HE21 ' A' ' 54' ' ' GLN . 45.9 t -126.82 131.4 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.572 ' N ' ' CD1' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.273 -1.517 . . . . 0.0 111.79 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.668 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.0 OUTLIER -119.21 125.76 49.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.664 -0.648 . . . . 0.0 109.33 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 30.0 p-10 -120.43 124.3 45.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.065 -1.022 . . . . 0.0 108.961 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 86.1 t80 -153.79 123.91 3.36 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.091 -1.005 . . . . 0.0 110.547 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.22 136.08 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.358 2.039 . . . . 0.0 112.221 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.56 140.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 0.0 110.094 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -113.65 96.86 6.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 0.0 109.584 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.32 76.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' B' ' 101' ' ' ALA . 13.2 m -148.49 118.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.234 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.6 ' NZ ' ' CD1' ' A' ' 42' ' ' TRP . 23.1 mmtm -144.55 -11.97 0.6 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.478 ' C ' ' O ' ' B' ' 104' ' ' LYS . 85.6 p -42.2 -24.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.152 -0.968 . . . . 0.0 108.999 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.525 ' N ' ' O ' ' B' ' 104' ' ' LYS . 33.5 t -52.93 -83.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' B' ' 106' ' ' SER . 44.8 t 42.9 87.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.441 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 79.0 t -129.93 119.2 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 109.49 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.09 157.55 33.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.6 150.93 96.74 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 120.799 -1.188 . . . . 0.0 109.706 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo . . . . . 0 C--N 1.307 -1.611 0 C-N-CA 122.759 2.306 . . . . 0.0 112.213 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.266 0.555 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 176.02 69.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 109.341 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.534 ' CG2' ' N ' ' A' ' 4' ' ' SER . 10.1 t -153.24 -48.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.937 . . . . 0.0 109.124 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.534 ' N ' ' CG2' ' A' ' 3' ' ' THR . 15.2 m -59.63 -69.05 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.18 -163.63 15.4 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.76 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -110.64 135.39 51.33 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.315 -1.109 . . . . 0.0 108.015 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 5.1 ttpm? -100.44 129.43 46.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.962 -1.086 . . . . 0.0 112.88 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' MET . 78.2 t60 -121.9 120.47 34.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -132.12 141.93 49.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.702 -1.249 . . . . 0.0 109.446 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.47 139.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.654 -0.654 . . . . 0.0 109.475 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.64 133.74 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.3 155.95 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.069 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.704 ' HZ1' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -119.8 152.26 37.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.56 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 8.9 p90 -107.88 151.51 25.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.835 -1.166 . . . . 0.0 111.565 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.13 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.6 tt0 -90.14 -56.48 3.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.8 m-20 152.63 66.86 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 65.1 m -52.46 107.0 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.087 0.946 . . . . 0.0 112.841 -176.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.531 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -72.72 85.55 1.21 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -54.63 -37.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.3 p-10 -63.42 -36.61 84.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 110.591 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 81.6 mt-10 -72.67 -37.61 67.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' GLY . 1.8 mm -58.46 -45.28 90.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -48.87 -36.25 16.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.35 -38.24 76.82 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -73.4 -25.11 73.63 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.1 tt -75.12 -60.18 2.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -1.025 . . . . 0.0 108.804 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' B' ' 110' ' ' THR . 24.2 pt-20 -49.95 -31.58 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 32' ' ' SER . 75.0 m-20 -65.62 -43.5 89.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -47.22 -53.34 13.5 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.3 t -49.8 -30.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 108.856 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 10.6 t -45.15 -50.77 11.11 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.445 ' NE2' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -83.54 -9.04 59.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 111.393 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 36' ' ' THR . 12.3 mt -91.72 28.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.012 -1.68 . . . . 0.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.44 -9.39 2.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 34' ' ' ILE . 10.1 t -67.55 -7.71 28.19 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.959 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.6 m 34.99 34.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.12 -0.987 . . . . 0.0 109.173 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' THR . 32.5 mtmt -123.03 47.83 1.91 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 63' ' ' THR . 15.9 t -174.35 175.05 2.69 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.17 159.05 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.522 -1.361 . . . . 0.0 112.013 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -152.11 117.25 5.23 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.306 0.574 . . . . 0.0 110.22 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -105.74 167.16 9.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 150.27 17.13 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.73 -1.7 . . . . 0.0 110.851 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 78.0 mt-10 -152.1 143.81 23.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -1.167 . . . . 0.0 109.368 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.67 ' HA ' ' O ' ' A' ' 57' ' ' THR . 59.6 t0 -170.36 95.98 0.25 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.647 ' HZ1' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -84.34 156.54 21.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.484 -1.385 . . . . 0.0 109.853 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 48' ' ' SER . 84.7 mt-10 -158.91 82.2 0.79 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.587 ' HG ' ' CE1' ' A' ' 49' ' ' HIS . 1.1 t 160.82 151.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.189 -0.944 . . . . 0.0 110.222 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.587 ' CE1' ' HG ' ' A' ' 48' ' ' SER . 28.8 m80 62.56 105.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.927 . . . . 0.0 109.718 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -49.8 -43.61 48.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.377 -0.827 . . . . 0.0 110.775 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.552 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 24.8 ttt -60.16 -35.58 75.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.04 -1.037 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.64 -9.62 51.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.828 -1.17 . . . . 0.0 109.283 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.951 ' O ' ' N ' ' A' ' 55' ' ' GLY . 33.2 ttp180 -84.86 36.65 0.62 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.0 111.207 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 51' ' ' MET . 78.8 mm-40 -32.66 -10.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.77 -1.206 . . . . 0.0 110.173 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.951 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 102.72 -39.74 2.67 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 121.49 -0.756 . . . . 0.0 112.911 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -52.3 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.228 -1.748 . . . . 0.0 109.903 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 70.1 p -56.84 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 110.927 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.542 ' NE2' ' CG2' ' A' ' 12' ' ' VAL . 17.6 p-80 -122.0 152.36 39.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.826 -1.171 . . . . 0.0 110.085 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.6 168.77 19.38 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -138.28 133.46 33.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.433 -0.792 . . . . 0.0 109.095 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -100.43 96.11 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 8' ' ' HIS . 53.6 mtm -96.34 121.32 38.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.111 -0.993 . . . . 0.0 110.801 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.459 ' O ' ' OG ' ' A' ' 39' ' ' SER . 30.0 m -124.74 148.07 48.28 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -125.61 155.91 40.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.795 -1.191 . . . . 0.0 110.045 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 41.4 tp10 -78.12 -26.97 48.22 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.7 m-20 -163.66 171.0 16.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -59.95 -22.17 62.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.281 -0.887 . . . . 0.0 111.438 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -58.78 -39.0 79.76 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.716 -1.24 . . . . 0.0 110.524 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.47 71.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -66.64 -44.27 82.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.561 -0.964 . . . . 0.0 110.465 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.79 -28.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.372 -1.455 . . . . 0.0 108.671 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.488 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.06 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.559 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 1.4 t80 -52.74 -38.7 61.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.1 t -84.16 -31.42 25.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.719 -1.238 . . . . 0.0 110.267 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 71.2 m -67.48 -33.03 74.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 111.005 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.601 ' N ' ' HD1' ' A' ' 76' ' ' HIS . 0.9 OUTLIER -75.36 128.02 85.14 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.898 -1.126 . . . . 0.0 109.659 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -43.67 -7.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.9 tp -64.83 -29.53 70.5 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.395 -0.815 . . . . 0.0 111.247 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -84.34 -37.11 22.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.996 -1.065 . . . . 0.0 110.239 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.73 -61.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.949 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.81 -39.15 84.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.267 -0.895 . . . . 0.0 109.559 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.32 -45.01 70.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.795 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 t -62.39 -35.02 77.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.125 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.25 65.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 108.712 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -70.83 -42.16 70.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.456 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 18.9 t80 -45.73 -29.08 1.17 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' ' C ' ' A' ' 88' ' ' ALA . 11.2 m -82.31 -63.47 1.37 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.06 -32.34 0.09 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.624 -0.672 . . . . 0.0 110.012 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' THR . 19.3 m -98.84 13.01 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.927 . . . . 0.0 110.829 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 91' ' ' ASP . 1.1 mp -122.32 156.96 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.657 -1.277 . . . . 0.0 110.451 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 90' ' ' ILE . 59.4 t0 -103.57 -36.35 7.97 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.704 ' NZ ' ' HZ1' ' A' ' 13' ' ' LYS . 30.2 pttt -147.52 147.36 30.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' A' ' 93' ' ' ILE . 6.1 tp -123.42 117.73 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.608 -1.307 . . . . 0.0 109.791 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.78 127.1 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -133.79 129.2 36.24 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.365 -1.459 . . . . 0.0 111.761 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.69 119.36 35.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.332 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 61.3 t0 -125.1 131.67 53.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 108.899 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 51.9 t80 -169.26 135.36 1.4 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.06 -1.025 . . . . 0.0 110.548 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.9 Cg_exo -41.22 120.25 1.12 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.363 2.042 . . . . 0.0 112.128 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.3 143.18 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 110.019 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.12 67.78 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.682 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.03 98.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.054 -1.029 . . . . 0.0 109.53 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.72 128.59 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 109.136 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.654 ' O ' ' N ' ' A' ' 106' ' ' SER . 5.6 mptt -111.89 -32.29 6.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.342 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 106' ' ' SER . 1.2 m 63.42 -53.01 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 108.938 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 104' ' ' LYS . 1.4 p 73.12 148.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.0 109.348 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.3 t 49.65 66.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.48 152.1 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.735 . . . . 0.0 109.425 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.36 137.68 40.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.498 ' N ' ' OE2' ' B' ' 28' ' ' GLU . 29.5 m -132.92 71.53 77.95 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 120.843 -1.161 . . . . 0.0 109.63 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 C--N 1.308 -1.559 0 C-N-CA 122.769 2.313 . . . . 0.0 112.225 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.303 0.573 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 175.93 69.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 109.354 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' B' ' 4' ' ' SER . 10.2 t -153.29 -48.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.065 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.53 ' N ' ' CG2' ' B' ' 3' ' ' THR . 15.6 m -59.78 -68.68 0.26 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.57 -163.55 15.55 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.727 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -110.75 135.04 51.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.327 -1.102 . . . . 0.0 108.035 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 5.2 ttpm? -100.05 129.46 46.1 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.33 1.062 . . . . 0.0 112.778 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 77.7 t60 -121.88 120.53 34.76 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.04 142.05 49.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.762 -1.211 . . . . 0.0 109.467 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.48 139.32 51.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.83 133.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.538 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.23 156.3 21.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.048 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.694 ' HZ1' ' NZ ' ' B' ' 92' ' ' LYS . 0.0 OUTLIER -119.95 152.33 37.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 178.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 9.0 p90 -107.94 151.45 25.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.838 -1.164 . . . . 0.0 111.645 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.14 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -90.07 -56.53 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.7 m-20 152.68 66.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.429 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 64.4 m -52.35 107.09 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.991 0.901 . . . . 0.0 112.841 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.529 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -72.82 85.73 1.24 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.9 m -54.87 -37.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 110.441 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.9 p-10 -63.36 -36.45 83.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.485 -0.76 . . . . 0.0 110.549 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 81.1 mt-10 -72.96 -37.77 66.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' B' ' 26' ' ' GLY . 1.8 mm -58.31 -44.96 89.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -49.13 -36.21 18.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -58.16 -38.49 76.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -73.08 -25.34 73.77 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.1 tt -74.94 -60.13 2.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.948 . . . . 0.0 108.772 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.498 ' OE2' ' N ' ' A' ' 110' ' ' THR . 24.4 pt-20 -50.2 -31.26 13.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 32' ' ' SER . 75.3 m-20 -65.86 -43.49 88.26 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER -47.25 -53.1 14.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' B' ' 32' ' ' SER . 79.4 t -50.08 -30.4 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.363 -0.835 . . . . 0.0 108.811 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 11.2 t -45.36 -50.78 11.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.437 ' NE2' ' N ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -83.44 -9.25 59.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.79 . . . . 0.0 111.518 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.596 ' C ' ' H ' ' B' ' 36' ' ' THR . 12.7 mt -91.45 28.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.967 -1.708 . . . . 0.0 110.639 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -59.43 -9.2 2.21 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.596 ' H ' ' C ' ' B' ' 34' ' ' ILE . 9.6 t -67.56 -7.87 29.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.028 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.7 m 35.31 33.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.128 -0.983 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' B' ' 36' ' ' THR . 32.3 mtmt -122.86 47.79 1.9 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' B' ' 63' ' ' THR . 15.9 t -174.46 174.87 2.67 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.05 159.17 44.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.51 -1.369 . . . . 0.0 111.972 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -152.23 117.22 5.17 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.379 0.609 . . . . 0.0 110.225 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -105.72 167.2 9.93 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.84 150.48 17.15 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 118.734 -1.698 . . . . 0.0 110.835 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 77.6 mt-10 -152.23 143.75 23.45 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -1.105 . . . . 0.0 109.425 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' B' ' 57' ' ' THR . 59.5 t0 -170.11 95.82 0.26 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.625 ' HZ1' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -84.2 156.51 22.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.422 -1.424 . . . . 0.0 109.807 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' B' ' 48' ' ' SER . 84.3 mt-10 -158.94 82.06 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.591 ' HG ' ' CE1' ' B' ' 49' ' ' HIS . 1.1 t 160.94 151.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.176 -0.953 . . . . 0.0 110.192 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.591 ' CE1' ' HG ' ' B' ' 48' ' ' SER . 28.8 m80 62.8 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.682 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -49.62 -44.02 47.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.818 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.553 ' O ' ' NE2' ' B' ' 54' ' ' GLN . 24.8 ttt -59.78 -35.76 75.31 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.763 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 19.3 mt -88.65 -9.5 51.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.718 -1.239 . . . . 0.0 109.312 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.954 ' O ' ' N ' ' B' ' 55' ' ' GLY . 33.6 ttp180 -84.8 36.37 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 111.232 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' B' ' 51' ' ' MET . 78.8 mm-40 -32.48 -10.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 110.215 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.954 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 102.51 -39.63 2.71 Favored Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.425 -0.797 . . . . 0.0 112.805 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -52.34 101.57 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.554 1.677 . . . . 0.0 109.907 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 71.4 p -56.99 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 110.95 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.538 ' NE2' ' CG2' ' B' ' 12' ' ' VAL . 18.1 p-80 -121.97 152.12 40.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.908 -1.12 . . . . 0.0 110.127 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.38 168.72 19.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.0 109.301 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -138.24 133.69 33.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.042 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -100.56 96.19 7.2 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 53.5 mtm -96.5 121.43 38.31 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.172 -0.955 . . . . 0.0 110.73 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.456 ' O ' ' OG ' ' B' ' 39' ' ' SER . 28.5 m -125.03 147.64 48.87 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.23 156.19 38.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.724 -1.235 . . . . 0.0 110.081 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 41.8 tp10 -78.48 -26.82 46.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.7 m-20 -163.78 170.79 16.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -59.82 -21.82 61.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 111.501 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -59.13 -38.68 80.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 110.57 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.38 69.87 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.59 -44.42 82.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.618 -0.93 . . . . 0.0 110.433 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.73 -28.91 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.451 -1.405 . . . . 0.0 108.707 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.491 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.09 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.297 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 1.4 t80 -52.59 -38.94 61.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 111.123 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 4.1 t -84.07 -31.32 25.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.726 -1.234 . . . . 0.0 110.281 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 71.9 m -67.53 -32.85 73.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.974 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.585 ' N ' ' HD1' ' B' ' 76' ' ' HIS . 0.9 OUTLIER -75.53 128.09 84.7 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.885 -1.134 . . . . 0.0 109.602 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.77 -7.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 112.508 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.9 tp -64.84 -29.61 70.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.397 -0.815 . . . . 0.0 111.199 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -84.29 -37.14 22.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.238 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.68 -61.65 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 110.045 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.63 -39.21 83.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.33 -44.95 70.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.812 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 28.9 t -62.38 -35.18 78.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.1 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.29 65.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.675 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -70.79 -42.34 70.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.449 ' C ' ' O ' ' B' ' 85' ' ' ALA . 19.2 t80 -45.81 -28.86 1.16 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.452 ' O ' ' C ' ' B' ' 88' ' ' ALA . 11.1 m -82.37 -63.37 1.39 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.11 -32.36 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.708 -0.62 . . . . 0.0 110.122 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' B' ' 87' ' ' THR . 19.1 m -98.84 12.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.874 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.493 HG23 ' N ' ' B' ' 91' ' ' ASP . 1.1 mp -122.0 157.26 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 0.0 110.477 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.493 ' N ' HG23 ' B' ' 90' ' ' ILE . 59.1 t0 -103.89 -36.21 7.88 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.694 ' NZ ' ' HZ1' ' B' ' 13' ' ' LYS . 30.6 pttt -147.65 147.22 29.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' B' ' 93' ' ' ILE . 6.2 tp -123.42 117.87 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.517 -1.364 . . . . 0.0 109.721 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.86 127.24 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -133.99 129.16 35.77 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.258 -1.526 . . . . 0.0 111.73 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.64 119.37 35.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.652 -0.655 . . . . 0.0 109.328 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 62.0 t0 -125.04 131.78 53.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 108.929 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 52.1 t80 -169.36 135.25 1.37 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.105 -0.997 . . . . 0.0 110.53 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 87.6 Cg_exo -41.2 120.1 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.264 1.976 . . . . 0.0 112.247 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.16 143.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 110.025 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.16 68.0 0.67 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.514 -0.741 . . . . 0.0 109.581 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.12 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.623 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 24.3 m -144.52 128.49 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 109.237 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.646 ' O ' ' N ' ' B' ' 106' ' ' SER . 5.6 mptt -111.7 -32.43 6.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' B' ' 106' ' ' SER . 1.2 m 63.55 -53.21 0.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.13 -0.982 . . . . 0.0 108.892 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.646 ' N ' ' O ' ' B' ' 104' ' ' LYS . 1.4 p 73.24 148.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t 49.5 66.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.34 152.23 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.513 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.46 137.64 40.61 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.484 ' N ' ' OE2' ' A' ' 28' ' ' GLU . 28.7 m -132.79 71.41 78.4 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 120.821 -1.175 . . . . 0.0 109.657 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 C--N 1.308 -1.564 0 C-N-CA 122.785 2.323 . . . . 0.0 112.233 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.288 0.566 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.77 64.97 1.65 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 109.38 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.4 ' O ' ' OG ' ' A' ' 4' ' ' SER . 6.1 t -95.79 3.44 53.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 3' ' ' THR . 69.0 m -168.95 -89.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.28 168.68 18.35 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.671 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.62 131.57 55.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.242 -1.152 . . . . 0.0 108.022 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 25.2 ttpt -104.22 131.9 51.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.917 -1.114 . . . . 0.0 112.777 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 62' ' ' MET . 61.1 m80 -126.34 127.46 45.56 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.2 tt -135.72 142.53 45.05 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.767 -1.208 . . . . 0.0 109.496 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 4.3 p -130.66 140.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.547 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.74 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.654 ' O ' ' O ' ' A' ' 56' ' ' PHE . 3.4 m -132.38 143.39 40.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.104 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.458 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 14.2 mmtt -107.43 152.6 23.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.511 ' HB2' ' H ' ' A' ' 18' ' ' THR . 15.8 p90 -114.53 148.71 37.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.769 -1.207 . . . . 0.0 111.585 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.89 -23.43 4.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -93.05 -53.89 3.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.2 t0 150.1 67.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.3 m -49.03 105.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.13 0.967 . . . . 0.0 112.802 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -72.82 84.77 1.22 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.34 -37.72 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.549 -0.72 . . . . 0.0 110.456 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 34.1 p-10 -65.29 -38.33 89.89 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.479 -0.763 . . . . 0.0 110.544 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -70.08 -34.07 72.7 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.87 -44.07 97.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.31 -35.8 51.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -61.45 -34.59 75.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.46 -44.11 8.88 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -59.24 5.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.996 . . . . 0.0 108.856 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 22.1 pt-20 -52.17 -45.41 65.1 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.533 ' N ' ' CG ' ' A' ' 28' ' ' GLU . 3.8 t30 -58.15 -43.87 87.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -49.59 -44.25 46.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 34' ' ' ILE . 20.6 t -52.4 -22.35 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.221 -0.924 . . . . 0.0 108.888 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 34.3 t -40.62 -39.53 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 62.3 mm-40 -76.26 -23.81 54.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 111.461 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 36' ' ' THR . 75.8 mt -81.75 20.85 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.018 -1.676 . . . . 0.0 110.544 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -57.4 -6.47 0.45 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.676 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.3 t -87.93 2.96 50.33 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.943 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.9 m 35.31 35.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.073 -1.017 . . . . 0.0 109.195 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.9 mttt -115.34 39.87 2.84 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 71.0 m -173.04 175.84 3.14 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -147.3 157.41 43.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.966 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -154.41 120.3 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.436 0.636 . . . . 0.0 110.246 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 42' ' ' TRP . 1.1 m95 -123.37 170.27 10.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 164.4 24.92 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 118.695 -1.717 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 50.8 tt0 -154.72 148.1 25.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -113.17 141.3 47.1 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -139.39 108.08 5.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.41 -1.431 . . . . 0.0 109.829 -178.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.5 45.81 0.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.64 -0.663 . . . . 0.0 109.287 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.475 ' CB ' HH11 ' A' ' 53' ' ' ARG . 1.4 t -144.58 121.67 11.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.131 -0.98 . . . . 0.0 110.191 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.422 ' ND1' ' C ' ' A' ' 48' ' ' SER . 7.2 m80 65.97 118.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 109.753 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.15 -29.07 70.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.81 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -85.31 -36.05 21.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.01 -1.056 . . . . 0.0 110.712 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' B' ' 95' ' ' LEU . 27.0 mt -79.66 -72.87 0.38 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.729 -1.232 . . . . 0.0 109.273 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.86 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -73.15 4.67 4.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 111.252 -176.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 53' ' ' ARG . 15.4 mm100 39.1 6.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.819 -1.176 . . . . 0.0 110.204 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 50.79 2.87 0.04 OUTLIER Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.544 -0.722 . . . . 0.0 112.933 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.763 ' O ' ' CB ' ' A' ' 57' ' ' THR . 34.4 m-85 -39.12 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.189 -1.771 . . . . 0.0 109.976 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.763 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 16.8 m 99.8 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.287 -0.883 . . . . 0.0 110.938 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.526 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 18.5 t60 -164.56 152.08 11.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.885 -1.134 . . . . 0.0 110.173 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.19 167.28 22.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.31 -0.869 . . . . 0.0 109.249 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 95.2 m-85 -135.26 130.5 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.062 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.65 96.98 8.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.488 ' O ' ' N ' ' A' ' 8' ' ' HIS . 74.2 mtm -98.02 117.86 33.31 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.188 -0.945 . . . . 0.0 110.844 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -122.78 144.64 49.04 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.31 159.12 28.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.702 -1.249 . . . . 0.0 110.068 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 41.6 tp10 -82.7 -31.47 28.52 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 65' ' ' GLU . 80.6 m-20 -161.73 169.37 21.58 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.51 ' CB ' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -55.18 -21.66 14.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 111.437 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -56.52 -40.48 75.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.788 -1.195 . . . . 0.0 110.611 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.17 -37.59 72.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -62.63 -45.12 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.623 -0.928 . . . . 0.0 110.522 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.368 -1.457 . . . . 0.0 108.653 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' CD2' ' A' ' 76' ' ' HIS . . . -65.07 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.381 -0.825 . . . . 0.0 109.381 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.488 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -51.68 -37.74 51.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 111.134 -177.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -84.99 -33.97 22.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.802 -1.186 . . . . 0.0 110.299 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.4 t -71.34 -25.6 62.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 0.0 110.95 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.55 ' CD2' ' OE1' ' A' ' 33' ' ' GLN . 84.1 m-70 -81.01 121.35 80.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.852 -1.155 . . . . 0.0 109.604 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.36 -13.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.638 2.225 . . . . 0.0 112.457 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -64.0 -26.97 68.81 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.346 -0.846 . . . . 0.0 111.277 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.488 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 7.4 t-160 -81.66 -30.45 32.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.06 . . . . 0.0 110.236 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' ' OG ' ' A' ' 83' ' ' SER . 68.9 t -61.09 -60.21 3.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.66 -40.24 62.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -66.6 -33.52 75.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.83 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 80' ' ' VAL . 57.4 p -61.33 -43.79 98.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.105 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.48 -37.06 67.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 108.714 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.588 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -72.18 -40.53 67.87 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.606 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.28 -40.96 0.37 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' VAL . 24.3 m -81.94 -60.36 2.26 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.59 -10.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.669 -0.644 . . . . 0.0 110.047 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 10.5 m -124.8 -7.86 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.191 -0.943 . . . . 0.0 110.853 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 65.4 mt -131.1 162.99 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.588 -1.32 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.512 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 12.0 t0 -121.44 -24.01 5.51 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.73 139.02 32.76 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 tp -128.97 127.31 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.596 -1.315 . . . . 0.0 109.83 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 t -128.38 132.36 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -137.58 132.55 33.28 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.315 -1.49 . . . . 0.0 111.75 -178.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.8 121.36 42.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.723 -0.611 . . . . 0.0 109.364 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.674 ' O ' ' NE ' ' B' ' 53' ' ' ARG . 59.7 m-20 -123.75 128.3 49.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.081 -1.012 . . . . 0.0 108.869 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 99' ' ' PRO . 63.6 t80 -165.48 131.67 2.09 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.519 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 88.7 Cg_exo -47.52 133.41 20.83 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.288 1.992 . . . . 0.0 112.25 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.47 141.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.034 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -103.11 70.96 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.25 82.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.578 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 101' ' ' ALA . 29.1 m -127.53 -15.96 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 106' ' ' SER . 4.7 mptt 44.61 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -65.43 53.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 108.942 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 104' ' ' LYS . 6.3 t -83.98 38.89 0.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 108' ' ' VAL . 9.7 p -91.44 -44.22 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.497 ' N ' ' CG1' ' A' ' 107' ' ' VAL . 7.1 p -144.38 140.72 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.553 -0.717 . . . . 0.0 109.519 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.94 119.5 38.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -77.78 152.73 80.47 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 120.937 -1.102 . . . . 0.0 109.629 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.813 2.342 . . . . 0.0 112.245 179.695 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.314 0.578 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.8 65.14 1.6 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.88 . . . . 0.0 109.33 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.425 ' O ' ' OG ' ' B' ' 4' ' ' SER . 6.0 t -95.92 3.74 53.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 109.166 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' B' ' 3' ' ' THR . 68.1 m -169.37 -89.95 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.11 168.88 18.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.726 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.77 131.7 55.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 25.1 ttpt -104.43 131.65 51.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.938 -1.101 . . . . 0.0 112.881 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 62' ' ' MET . 60.9 m80 -126.13 127.57 45.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.2 tt -135.77 142.56 44.96 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.741 -1.225 . . . . 0.0 109.385 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 4.2 p -130.69 140.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.56 -0.712 . . . . 0.0 109.528 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.77 132.85 70.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.645 ' O ' ' O ' ' B' ' 56' ' ' PHE . 3.5 m -132.73 143.18 40.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 117.762 -1.575 . . . . 0.0 112.993 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 14.2 mmtt -107.25 152.22 24.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.502 ' HB2' ' H ' ' B' ' 18' ' ' THR . 15.8 p90 -114.03 149.12 35.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.187 . . . . 0.0 111.58 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -124.0 -23.59 4.58 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.4 mt-10 -92.88 -53.96 3.94 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.1 t0 150.17 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.502 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.7 m -48.99 105.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.105 0.955 . . . . 0.0 112.887 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.481 ' HD3' ' H ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -72.79 84.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -58.41 -37.53 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 34.4 p-10 -65.52 -38.29 89.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.514 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.498 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 0.4 OUTLIER -70.05 -33.99 72.65 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.84 -44.11 98.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.27 -35.7 50.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -61.56 -34.71 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.31 -43.71 9.32 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.43 -59.01 5.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.944 . . . . 0.0 108.809 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 22.3 pt-20 -52.37 -45.23 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.527 ' N ' ' CG ' ' B' ' 28' ' ' GLU . 3.8 t30 -58.22 -43.93 87.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -49.76 -43.92 48.35 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' B' ' 34' ' ' ILE . 20.8 t -52.61 -22.33 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 36.4 t -40.65 -39.48 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.552 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 62.0 mm-40 -76.28 -23.73 54.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.765 . . . . 0.0 111.497 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.665 ' C ' ' H ' ' B' ' 36' ' ' THR . 75.9 mt -81.85 20.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.014 -1.679 . . . . 0.0 110.585 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.5 p30 -57.45 -6.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.665 ' H ' ' C ' ' B' ' 34' ' ' ILE . 1.3 t -87.89 3.0 50.15 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.986 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.566 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.0 m 35.43 35.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.101 -1.0 . . . . 0.0 109.154 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 36' ' ' THR . 64.8 mttt -115.17 40.11 2.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 73.2 m -173.4 175.72 3.0 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -147.18 157.53 43.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.478 -1.389 . . . . 0.0 111.972 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -154.54 120.5 5.25 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.356 0.598 . . . . 0.0 110.235 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.635 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 1.1 m95 -123.63 170.15 10.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.58 164.26 24.91 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 50.9 tt0 -154.48 148.07 25.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.254 -1.145 . . . . 0.0 109.354 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -113.19 141.02 47.44 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.56 ' CD ' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -139.35 108.04 5.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.357 -1.464 . . . . 0.0 109.889 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.38 45.54 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.689 -0.632 . . . . 0.0 109.395 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.467 ' CB ' HH11 ' B' ' 53' ' ' ARG . 1.4 t -144.24 121.94 11.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 110.166 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.417 ' ND1' ' C ' ' B' ' 48' ' ' SER . 7.2 m80 65.66 118.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.207 -0.933 . . . . 0.0 109.728 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -62.23 -29.33 70.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.332 -0.855 . . . . 0.0 110.781 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 89.5 mtp -85.23 -35.89 21.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.03 -1.044 . . . . 0.0 110.768 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' A' ' 95' ' ' LEU . 27.2 mt -79.7 -72.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.755 -1.216 . . . . 0.0 109.291 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.852 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.6 OUTLIER -73.2 4.51 4.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 111.22 -176.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.474 ' C ' ' O ' ' B' ' 53' ' ' ARG . 15.4 mm100 39.15 6.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.804 -1.185 . . . . 0.0 110.213 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.852 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 50.46 2.91 0.04 OUTLIER Glycine 0 N--CA 1.499 2.835 0 O-C-N 121.515 -0.74 . . . . 0.0 112.909 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' CB ' ' B' ' 57' ' ' THR . 33.7 m-85 -39.04 -25.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.274 -1.721 . . . . 0.0 110.004 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.768 ' CB ' ' O ' ' B' ' 56' ' ' PHE . 16.1 m 99.7 -62.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.281 -0.887 . . . . 0.0 110.982 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.52 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 18.6 t60 -164.31 152.04 12.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.862 -1.148 . . . . 0.0 110.127 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.468 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.19 167.13 22.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.536 -0.727 . . . . 0.0 109.301 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.52 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 95.2 m-85 -135.01 130.71 36.11 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.485 -0.759 . . . . 0.0 109.08 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.66 97.06 8.71 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' MET . . . . . 0.448 ' O ' ' N ' ' B' ' 8' ' ' HIS . 74.6 mtm -98.12 117.82 33.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.175 -0.953 . . . . 0.0 110.741 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -122.84 144.44 49.2 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.12 159.04 27.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.75 -1.219 . . . . 0.0 110.062 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' B' ' 66' ' ' ASN . 42.1 tp10 -82.57 -31.33 29.06 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' B' ' 65' ' ' GLU . 80.7 m-20 -161.93 169.6 20.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.511 ' CB ' ' NZ ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -55.25 -21.73 15.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.493 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.4 -40.76 75.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.789 -1.195 . . . . 0.0 110.534 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.89 -37.84 75.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -62.28 -45.47 93.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.592 -0.946 . . . . 0.0 110.374 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.67 -28.94 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.455 -1.403 . . . . 0.0 108.732 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' B' ' 76' ' ' HIS . . . -65.12 -60.86 2.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.315 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.491 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.1 OUTLIER -51.35 -38.1 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.86 . . . . 0.0 111.146 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -84.74 -33.99 22.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.732 -1.23 . . . . 0.0 110.324 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 36.3 t -71.29 -25.97 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.942 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.552 ' CD2' ' OE1' ' B' ' 33' ' ' GLN . 83.7 m-70 -80.63 121.32 81.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.796 -1.19 . . . . 0.0 109.557 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.39 -13.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.69 2.26 . . . . 0.0 112.413 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' B' ' 76' ' ' HIS . 0.6 OUTLIER -63.65 -27.32 69.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.776 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.491 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 7.4 t-160 -81.47 -30.32 33.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 110.301 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.421 ' O ' ' OG ' ' B' ' 83' ' ' SER . 68.9 t -61.18 -60.24 3.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.76 -40.06 62.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.518 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -66.56 -33.78 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.93 . . . . 0.0 109.877 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 80' ' ' VAL . 56.6 p -61.06 -43.9 98.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.1 -1.0 . . . . 0.0 110.134 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.31 -37.26 67.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.034 -1.042 . . . . 0.0 108.72 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.582 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -72.04 -40.72 68.18 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.606 ' O ' ' HB ' ' B' ' 90' ' ' ILE . 0.0 OUTLIER -37.1 -40.89 0.33 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.548 ' C ' ' H ' ' B' ' 89' ' ' VAL . 24.6 m -82.16 -60.34 2.25 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.52 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.783 -0.573 . . . . 0.0 110.103 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' B' ' 87' ' ' THR . 10.4 m -124.94 -7.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 110.855 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 66.2 mt -131.04 162.89 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.618 -1.301 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.519 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 12.0 t0 -121.28 -24.33 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.58 139.22 33.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 tp -129.28 127.34 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.542 -1.349 . . . . 0.0 109.755 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 60.7 t -128.35 132.52 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -137.71 132.48 32.91 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.254 -1.528 . . . . 0.0 111.783 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.404 HD11 ' H ' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -115.66 121.49 42.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.68 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 60.3 m-20 -123.73 128.23 49.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.066 -1.021 . . . . 0.0 108.934 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 99' ' ' PRO . 63.7 t80 -165.31 131.65 2.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.55 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . 0.514 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 88.2 Cg_exo -47.59 133.15 21.13 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.256 1.971 . . . . 0.0 112.225 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.22 141.28 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.049 -1.032 . . . . 0.0 110.064 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -102.88 71.11 1.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.487 -0.758 . . . . 0.0 109.602 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.46 82.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.123 -0.985 . . . . 0.0 109.574 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' B' ' 101' ' ' ALA . 29.1 m -127.65 -15.92 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.18 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' B' ' 106' ' ' SER . 4.7 mptt 44.73 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.353 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -65.34 53.97 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -0.976 . . . . 0.0 108.959 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.557 ' N ' ' O ' ' B' ' 104' ' ' LYS . 6.3 t -84.07 38.95 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' B' ' 108' ' ' VAL . 9.8 p -91.49 -44.18 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.496 ' N ' ' CG1' ' B' ' 107' ' ' VAL . 7.2 p -144.45 140.62 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.508 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.71 119.6 39.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -77.71 152.76 80.68 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 120.841 -1.162 . . . . 0.0 109.613 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.775 2.317 . . . . 0.0 112.262 179.765 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.91 62.84 2.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.979 . . . . 0.0 109.423 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 4' ' ' SER . 6.7 t -67.3 -51.49 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.5 ' N ' ' CG2' ' A' ' 3' ' ' THR . 9.7 m -140.85 -117.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.25 142.62 46.6 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.641 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -113.59 128.83 56.58 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.297 -1.119 . . . . 0.0 108.011 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -110.07 138.87 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.929 -1.107 . . . . 0.0 112.776 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.27 129.74 43.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -135.46 143.39 45.86 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.698 -1.251 . . . . 0.0 109.522 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 10.4 p -128.5 138.05 55.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.642 -0.661 . . . . 0.0 109.508 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.97 130.67 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -136.96 165.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.78 -1.568 . . . . 0.0 113.07 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 39.2 tptt -130.43 151.4 50.96 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 10.0 p90 -108.87 150.16 28.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.838 -1.164 . . . . 0.0 111.615 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.37 -22.64 5.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.9 mt-10 -91.26 -53.68 4.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.8 t0 149.39 69.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.454 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.2 m -55.85 109.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.082 0.944 . . . . 0.0 112.857 -177.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.633 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.73 91.11 5.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -61.36 -33.45 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 110.453 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.8 p-10 -68.3 -41.52 80.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.451 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.677 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 70.3 tt0 -66.72 -28.32 68.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 23' ' ' ILE . 13.1 mt -74.46 -39.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.7 -40.41 79.42 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -60.51 -26.11 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . -81.26 -45.29 7.56 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 tt -49.0 -51.92 27.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.484 -1.01 . . . . 0.0 108.809 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 17.1 pt-20 -53.06 -43.29 66.57 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -57.41 -43.52 83.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -46.91 -45.35 20.49 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 34' ' ' ILE . 23.0 t -51.6 -23.37 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 108.933 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 41.9 t -42.86 -46.55 5.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.534 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 82.0 mm-40 -74.55 -20.47 59.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.374 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 36' ' ' THR . 58.0 mt -82.62 22.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.05 -1.656 . . . . 0.0 110.643 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.8 p30 -59.46 -8.78 1.98 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 34' ' ' ILE . 36.2 p -82.64 -0.97 49.66 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.981 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.6 m 35.59 31.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' THR . 42.0 mttm -117.66 40.76 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.6 p -173.11 173.96 3.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.72 159.12 44.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -153.96 121.04 5.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.395 0.617 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.401 ' CD1' ' NZ ' ' B' ' 104' ' ' LYS . 9.5 m-90 -124.03 167.02 14.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 44' ' ' GLU . . . -125.48 157.98 19.73 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.756 -1.688 . . . . 0.0 110.823 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.659 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 73.9 mm-40 -148.35 136.9 21.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.247 -1.149 . . . . 0.0 109.397 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -111.09 141.02 45.14 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.851 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -143.42 117.26 9.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.454 -1.404 . . . . 0.0 109.763 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -153.56 -15.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 49' ' ' HIS . 0.7 OUTLIER -69.57 122.0 18.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 0.0 110.177 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.494 ' O ' ' O ' ' A' ' 48' ' ' SER . 48.1 m80 59.36 126.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.985 . . . . 0.0 109.678 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -67.02 -34.89 78.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.816 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.523 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -77.44 -37.94 50.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 0.0 110.687 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' B' ' 95' ' ' LEU . 19.3 mt -78.79 -71.15 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.74 -1.225 . . . . 0.0 109.266 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.566 ' C ' ' H ' ' A' ' 55' ' ' GLY . 3.7 mmt-85 -72.25 12.63 0.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.901 . . . . 0.0 111.258 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.417 ' C ' ' H ' ' A' ' 56' ' ' PHE . 76.1 mt-30 50.67 7.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.765 -1.209 . . . . 0.0 110.171 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.674 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 55.87 -0.42 0.12 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.361 -0.837 . . . . 0.0 112.891 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.674 ' O ' ' O ' ' A' ' 55' ' ' GLY . 4.8 m-85 -53.19 -142.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.157 -1.79 . . . . 0.0 109.914 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.503 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 35.3 m -135.82 -47.49 0.67 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.659 ' CE1' ' H ' ' A' ' 44' ' ' GLU . 27.4 t60 -172.76 160.06 4.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.96 -1.087 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.611 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.55 163.01 34.08 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.46 -0.775 . . . . 0.0 109.231 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 82.6 m-85 -133.42 129.59 37.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.499 -0.751 . . . . 0.0 109.121 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.29 98.7 8.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.6 mtt -98.68 119.68 37.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.234 -0.916 . . . . 0.0 110.76 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -119.37 140.62 50.06 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.07 125.83 44.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.083 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -50.87 -32.14 19.51 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -156.03 162.28 40.33 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -60.59 -21.83 63.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 111.493 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 34.0 p-10 -55.94 -36.43 67.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.773 -1.204 . . . . 0.0 110.532 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.18 -31.99 63.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -67.79 -44.36 77.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.973 . . . . 0.0 110.436 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 75' ' ' SER . 20.9 m -70.76 -28.95 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.404 -1.435 . . . . 0.0 108.686 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.05 -60.89 2.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.373 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 73' ' ' PHE . 1.6 t80 -56.59 -60.13 3.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.11 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 t -52.29 -34.46 46.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.734 -1.228 . . . . 0.0 110.3 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 66.3 m -77.96 -16.22 58.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.959 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 78' ' ' LEU . 22.6 m80 -79.24 132.18 63.72 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.152 . . . . 0.0 109.57 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -42.22 -12.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.697 2.264 . . . . 0.0 112.394 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.5 tp -74.44 -27.28 60.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.423 -0.798 . . . . 0.0 111.292 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.83 -45.13 21.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.957 -1.09 . . . . 0.0 110.206 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.2 p -59.44 -58.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 110.01 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.593 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 15.2 tm-20 -51.01 -36.65 40.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.92 -32.02 73.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.758 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.05 -44.23 94.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.44 -33.28 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.921 -1.112 . . . . 0.0 108.73 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.566 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -79.42 -46.37 17.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.699 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -38.81 -40.15 0.59 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' VAL . 20.3 m -82.17 -62.53 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.86 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.676 -0.64 . . . . 0.0 110.097 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' THR . 9.1 m -117.46 -1.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 0.0 110.771 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 68.4 mt -132.93 164.02 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 110.512 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.538 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 38.4 t0 -124.14 -26.82 3.94 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 18.9 ttpt -133.81 131.17 38.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -126.32 125.59 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.596 -1.315 . . . . 0.0 109.768 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 t -132.2 134.5 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -136.47 131.65 34.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.294 -1.503 . . . . 0.0 111.764 -178.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -116.05 122.57 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.645 -0.659 . . . . 0.0 109.391 177.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.549 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 38.5 p-10 -126.11 132.49 51.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -159.81 128.72 3.08 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.087 -1.008 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 131.46 12.67 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.37 2.046 . . . . 0.0 112.186 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.9 t -113.42 135.37 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.96 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -107.96 88.3 2.7 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.451 -0.781 . . . . 0.0 109.56 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.469 ' O ' ' CG1' ' A' ' 103' ' ' VAL . . . -57.71 73.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.647 ' N ' ' O ' ' A' ' 101' ' ' ALA . 4.5 m -161.01 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.099 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 106' ' ' SER . 24.0 mmtm -97.7 4.57 49.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.412 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.35 -53.53 0.27 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 108.879 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 104' ' ' LYS . 20.1 m 47.17 45.01 16.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -84.83 -41.62 16.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.3 m -112.4 49.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.573 -0.704 . . . . 0.0 109.508 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.78 83.88 3.38 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.39 161.79 48.3 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 120.901 -1.124 . . . . 0.0 109.671 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 C--N 1.308 -1.576 0 C-N-CA 122.707 2.271 . . . . 0.0 112.277 179.651 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.322 0.582 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.05 62.86 2.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.302 -0.874 . . . . 0.0 109.366 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' B' ' 4' ' ' SER . 6.7 t -67.36 -51.52 51.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -0.859 . . . . 0.0 109.138 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.491 ' N ' ' CG2' ' B' ' 3' ' ' THR . 9.5 m -140.82 -117.35 0.12 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.22 142.69 46.52 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.693 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -113.67 128.74 56.54 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.218 -1.166 . . . . 0.0 108.033 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -109.91 138.63 46.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.862 -1.149 . . . . 0.0 112.822 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.09 129.68 43.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.0 tt -135.35 143.45 46.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.433 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 10.3 p -128.34 137.97 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.478 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.92 130.79 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.04 165.49 27.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.663 -1.615 . . . . 0.0 113.028 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.497 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 39.1 tptt -130.39 151.41 50.91 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 9.9 p90 -108.84 150.11 28.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.795 -1.191 . . . . 0.0 111.558 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.36 -22.82 4.98 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.9 mt-10 -91.03 -53.77 4.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.7 t0 149.47 69.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.459 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -56.0 109.76 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.129 0.966 . . . . 0.0 112.778 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.627 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.87 91.31 5.97 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.38 -33.55 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.647 . . . . 0.0 110.495 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.6 p-10 -68.13 -41.56 81.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.542 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.667 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 70.7 tt0 -66.85 -28.09 68.07 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.409 HG21 HD12 ' B' ' 23' ' ' ILE . 12.9 mt -74.7 -39.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.62 -40.57 79.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.1 OUTLIER -60.36 -26.19 66.42 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' B' ' 25' ' ' LYS . . . -81.06 -45.47 7.56 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 tt -48.91 -51.98 27.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -1.032 . . . . 0.0 108.855 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 17.0 pt-20 -53.09 -43.33 66.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.0 OUTLIER -57.34 -43.47 83.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -47.1 -45.34 22.05 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 34' ' ' ILE . 23.2 t -51.47 -23.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.299 -0.876 . . . . 0.0 108.767 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 41.7 t -42.74 -46.47 5.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.527 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 81.9 mm-40 -74.57 -20.47 59.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 111.533 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' B' ' 36' ' ' THR . 58.1 mt -82.65 22.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.972 -1.705 . . . . 0.0 110.563 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.1 p30 -59.5 -8.88 2.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.6 ' H ' ' C ' ' B' ' 34' ' ' ILE . 36.3 p -82.52 -0.98 49.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.953 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.9 m 35.53 31.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.063 -1.023 . . . . 0.0 109.187 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.597 ' N ' ' O ' ' B' ' 36' ' ' THR . 42.2 mttm -117.64 40.73 3.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 95.6 p -173.07 173.94 3.56 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.525 -0.735 . . . . 0.0 109.031 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.73 158.99 44.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.521 -1.362 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -153.82 120.95 5.72 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.314 0.578 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.4 ' CD1' ' NZ ' ' A' ' 104' ' ' LYS . 9.4 m-90 -124.0 166.77 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' B' ' 44' ' ' GLU . . . -125.43 157.94 19.68 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.754 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.658 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 74.1 mm-40 -148.26 136.97 21.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.253 -1.146 . . . . 0.0 109.42 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -111.11 141.05 45.12 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.848 ' HG2' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -143.4 117.29 9.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.384 -1.448 . . . . 0.0 109.785 -178.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -153.62 -15.25 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.33 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.492 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 0.7 OUTLIER -69.62 121.87 17.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' B' ' 48' ' ' SER . 48.0 m80 59.55 126.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.076 -1.015 . . . . 0.0 109.701 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -67.07 -34.87 78.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.402 -0.811 . . . . 0.0 110.823 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.527 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -77.45 -37.89 50.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 110.749 -178.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' A' ' 95' ' ' LEU . 19.1 mt -78.75 -71.35 0.44 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.699 -1.25 . . . . 0.0 109.307 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.553 ' C ' ' H ' ' B' ' 55' ' ' GLY . 3.7 mmt-85 -72.06 12.59 0.4 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 111.268 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' B' ' 56' ' ' PHE . 76.0 mt-30 50.65 7.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.826 -1.171 . . . . 0.0 110.167 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.676 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 56.01 -0.38 0.13 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.468 -0.77 . . . . 0.0 112.865 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.676 ' O ' ' O ' ' B' ' 55' ' ' GLY . 4.7 m-85 -53.31 -142.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.323 -1.692 . . . . 0.0 109.985 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.501 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 37.5 m -135.55 -47.46 0.69 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.852 . . . . 0.0 111.003 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.658 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 27.2 t60 -172.78 160.32 4.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.624 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.81 163.07 33.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.449 -0.782 . . . . 0.0 109.282 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 82.3 m-85 -133.43 129.7 37.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.529 -0.732 . . . . 0.0 109.076 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.32 98.73 8.82 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.7 mtt -98.77 119.71 37.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.234 -0.916 . . . . 0.0 110.793 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.5 m -119.48 140.77 49.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -125.3 125.67 43.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.704 -1.247 . . . . 0.0 110.058 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.82 -32.07 19.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -156.01 162.39 40.33 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.73 -21.67 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 111.451 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 33.6 p-10 -56.06 -36.36 67.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.722 -1.236 . . . . 0.0 110.569 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -72.09 -31.99 63.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -67.78 -44.37 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.955 . . . . 0.0 110.506 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.2 m -70.78 -28.9 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.431 -1.418 . . . . 0.0 108.691 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.532 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.465 -0.772 . . . . 0.0 109.348 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' B' ' 73' ' ' PHE . 1.6 t80 -56.59 -60.35 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.125 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 10.2 t -52.03 -34.49 43.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.715 -1.24 . . . . 0.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 66.5 m -78.01 -16.28 58.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 0.0 110.9 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' B' ' 78' ' ' LEU . 22.8 m80 -79.23 132.15 63.8 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.874 -1.141 . . . . 0.0 109.621 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.401 ' O ' HG13 ' B' ' 80' ' ' VAL . 64.2 Cg_exo -42.12 -12.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.625 2.217 . . . . 0.0 112.435 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.5 tp -74.38 -27.27 60.58 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.372 -0.83 . . . . 0.0 111.236 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.87 -44.99 21.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.029 -1.044 . . . . 0.0 110.307 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.594 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.2 p -59.55 -58.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.594 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 15.2 tm-20 -50.91 -36.72 39.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.26 -0.9 . . . . 0.0 109.602 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.88 -31.96 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.853 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.0 -44.34 94.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.029 . . . . 0.0 110.118 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.15 70.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.928 -1.108 . . . . 0.0 108.685 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.555 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -79.39 -46.43 17.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.702 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -38.96 -40.01 0.6 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 21.0 m -82.24 -62.42 1.63 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.77 -16.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.767 -0.583 . . . . 0.0 110.126 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.0 m -117.25 -1.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.166 -0.959 . . . . 0.0 110.835 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 68.4 mt -132.99 163.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.67 -1.268 . . . . 0.0 110.457 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.55 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 38.5 t0 -124.04 -27.0 3.94 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.644 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 18.9 ttpt -133.77 131.16 39.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -126.41 125.62 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.568 -1.333 . . . . 0.0 109.735 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 12.0 t -132.22 134.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -136.56 131.57 34.0 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.188 -1.57 . . . . 0.0 111.814 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.476 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -116.02 122.69 45.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.701 -0.624 . . . . 0.0 109.317 177.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.551 ' O ' ' CZ ' ' A' ' 53' ' ' ARG . 38.7 p-10 -126.3 132.47 51.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.097 -1.002 . . . . 0.0 108.948 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -159.83 128.68 3.06 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.005 . . . . 0.0 110.529 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.79 131.37 13.2 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.283 1.988 . . . . 0.0 112.257 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.18 135.38 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -107.89 88.31 2.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 109.636 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . 0.465 ' O ' ' CG1' ' B' ' 103' ' ' VAL . . . -57.63 73.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.617 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.66 ' N ' ' O ' ' B' ' 101' ' ' ALA . 4.6 m -160.99 99.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 0.0 109.189 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.624 ' O ' ' N ' ' B' ' 106' ' ' SER . 24.1 mmtm -97.74 4.56 49.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.325 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.38 -53.46 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.147 -0.97 . . . . 0.0 108.93 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.624 ' N ' ' O ' ' B' ' 104' ' ' LYS . 20.6 m 47.13 45.04 15.94 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.338 -0.851 . . . . 0.0 109.385 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 72.2 t -84.95 -41.67 15.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 9.7 m -112.3 49.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.472 -0.768 . . . . 0.0 109.53 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.82 83.81 3.41 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.35 161.74 48.66 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.853 -1.154 . . . . 0.0 109.609 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 C-N-CA 122.775 2.317 . . . . 0.0 112.252 179.688 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.277 0.561 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 4' ' ' SER . . . 66.11 -138.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 109.365 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.445 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 70.35 -26.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.145 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.63 ' H ' ' C ' ' A' ' 2' ' ' ALA . 43.4 p -143.37 -136.85 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.37 168.56 26.96 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.73 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 131.6 47.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.173 -1.193 . . . . 0.0 108.0 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 19.7 ttpt -110.15 139.04 45.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 112.745 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -129.4 127.81 41.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.9 tt -136.47 146.3 46.15 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.761 -1.212 . . . . 0.0 109.48 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 p -127.8 134.76 64.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.501 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.68 127.35 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.34 159.62 32.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.041 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 17.8 tptt -129.46 152.98 48.4 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 8.0 p90 -106.24 148.85 27.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.906 -1.121 . . . . 0.0 111.626 -177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.62 -22.92 3.52 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 85.0 tt0 -89.47 -58.17 2.62 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.3 t0 155.94 72.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 44.8 m -66.15 109.75 2.73 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 112.834 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.613 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.72 92.2 5.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' LEU . 15.7 m -61.55 -35.97 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.1 p-10 -68.1 -41.65 81.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 65.5 tt0 -71.47 -32.68 68.57 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.22 -36.94 69.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' VAL . 12.8 tp -52.72 -39.98 62.58 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -39.58 84.2 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 29' ' ' ASN . . . -61.59 -54.36 36.37 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 48.5 mt -52.63 -47.85 66.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.551 -0.97 . . . . 0.0 108.769 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.66 -39.43 61.84 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -63.18 -42.52 99.38 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.0 mm? -49.93 -46.75 52.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 34' ' ' ILE . 22.0 t -48.77 -25.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.283 -0.886 . . . . 0.0 108.846 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 68.5 m -42.83 -40.61 2.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.44 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 98.1 mm-40 -71.1 -17.98 62.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 111.478 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 89.1 mt -80.59 18.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.024 -1.672 . . . . 0.0 110.588 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.5 -12.8 4.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 38' ' ' LYS . 4.0 t -89.28 0.52 56.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.586 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 34.24 34.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.987 -1.071 . . . . 0.0 109.157 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.0 mttt -117.54 41.75 2.76 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -177.87 179.12 0.9 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -148.33 159.84 43.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.566 -1.334 . . . . 0.0 111.955 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.492 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 76.3 mt-10 -155.96 123.76 5.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.394 0.616 . . . . 0.0 110.165 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 24.1 m95 -125.29 165.88 17.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 44' ' ' GLU . . . -161.45 150.7 20.56 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.793 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 43' ' ' GLY . 7.5 tp10 -163.66 175.19 10.83 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 11.3 p-10 -118.34 170.0 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -61.26 84.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.409 -1.432 . . . . 0.0 109.847 -178.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.6 mt-10 -107.03 42.5 1.29 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.345 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 97' ' ' ASP . 0.7 OUTLIER -139.87 -142.66 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.994 . . . . 0.0 110.193 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 50' ' ' ASP . 78.9 m80 -95.99 136.97 35.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.218 -0.927 . . . . 0.0 109.675 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' HIS . 90.8 m-20 -41.52 -35.73 0.77 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.0 110.789 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -79.02 -29.19 43.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 0.0 110.733 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.8 mt -94.31 -22.77 18.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.697 -1.252 . . . . 0.0 109.275 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 55' ' ' GLY . 2.7 ptt180 -96.08 4.01 52.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.327 -0.858 . . . . 0.0 111.218 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 53' ' ' ARG . 35.3 tt0 40.71 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.733 -1.229 . . . . 0.0 110.171 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 57.53 1.12 0.45 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 121.39 -0.819 . . . . 0.0 112.816 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 56' ' ' PHE . 32.1 p90 -55.29 129.36 38.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.281 -1.717 . . . . 0.0 109.976 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 52.8 m -54.53 -47.55 73.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.4 ' CG ' ' N ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -164.3 150.93 11.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -179.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 58' ' ' HIS . . . -130.07 147.77 51.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.391 -0.818 . . . . 0.0 109.283 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 42' ' ' TRP . 2.4 t80 -126.71 122.93 36.29 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.069 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -106.9 102.7 12.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.3 mtm -102.5 124.74 48.61 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.24 -0.913 . . . . 0.0 110.797 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.8 m -122.29 144.58 48.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.37 160.59 29.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.771 -1.206 . . . . 0.0 110.011 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 77.0 mt-10 -82.97 -30.84 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 29.6 m120 -150.96 160.0 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -58.21 -24.55 59.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 111.389 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -53.62 -35.42 60.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.89 85.45 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -62.39 -46.55 88.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.566 -0.961 . . . . 0.0 110.459 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.394 -1.441 . . . . 0.0 108.649 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.94 2.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -48.62 -36.79 16.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 111.103 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.406 ' H ' HG21 ' A' ' 74' ' ' THR . 2.2 t -82.47 -27.14 32.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.759 -1.213 . . . . 0.0 110.311 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.2 p -69.34 -22.01 63.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.04 -1.038 . . . . 0.0 110.983 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.622 ' C ' ' H ' ' A' ' 78' ' ' LEU . 78.4 m80 -85.33 130.76 50.39 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.847 -1.158 . . . . 0.0 109.579 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' O ' HG13 ' A' ' 80' ' ' VAL . 80.3 Cg_exo -45.69 -2.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.67 2.247 . . . . 0.0 112.392 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.622 ' H ' ' C ' ' A' ' 76' ' ' HIS . 8.5 tp -77.16 -31.1 55.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.423 -0.798 . . . . 0.0 111.24 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -76.9 -39.18 51.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.989 -1.069 . . . . 0.0 110.219 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.515 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 4.0 p -62.26 -56.56 16.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.988 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.515 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 84.4 tt0 -49.48 -37.76 27.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.4 -29.42 70.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.256 -0.903 . . . . 0.0 109.886 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 80' ' ' VAL . 59.8 p -61.87 -44.87 95.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 110.149 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.83 69.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.729 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.607 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -83.33 -45.39 13.81 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.703 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -36.37 -44.01 0.4 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.635 ' CG2' ' H ' ' A' ' 88' ' ' ALA . 3.3 t -83.36 -60.14 2.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.635 ' H ' ' CG2' ' A' ' 87' ' ' THR . . . -47.22 -14.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.744 -0.598 . . . . 0.0 110.093 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.1 m -120.17 -1.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.232 -0.918 . . . . 0.0 110.809 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 61.1 mt -128.55 160.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.649 -1.282 . . . . 0.0 110.434 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 40.3 t0 -110.34 -31.97 7.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.51 142.66 31.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.2 tp -124.35 121.11 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.62 -1.3 . . . . 0.0 109.759 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.422 ' CG1' ' CD ' ' B' ' 54' ' ' GLN . 9.0 t -127.57 132.25 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -137.15 132.98 34.73 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.319 -1.488 . . . . 0.0 111.767 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.61 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.66 119.7 36.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.636 -0.665 . . . . 0.0 109.379 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.459 ' O ' ' OG ' ' B' ' 48' ' ' SER . 49.9 t0 -125.61 133.24 52.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.0 108.913 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 31.4 p90 -158.06 138.11 8.81 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.102 -0.999 . . . . 0.0 110.52 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.7 122.92 6.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.596 ' O ' ' OG ' ' A' ' 4' ' ' SER . 56.7 t -85.6 109.28 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.995 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.29 89.71 3.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.42 -0.8 . . . . 0.0 109.613 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.85 71.06 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.511 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.47 ' O ' ' CG2' ' A' ' 103' ' ' VAL . 33.7 m -153.02 86.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.265 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 106' ' ' SER . 29.3 mmtp -95.92 4.45 52.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.342 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t 63.43 -53.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.68 ' N ' ' O ' ' A' ' 104' ' ' LYS . 7.6 t 44.32 50.51 7.81 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.83 -38.55 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.86 141.59 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.544 -0.722 . . . . 0.0 109.487 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.46 108.05 19.24 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.3 p -71.1 150.91 94.8 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 120.9 -1.125 . . . . 0.0 109.659 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo . . . . . 0 C--N 1.308 -1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 112.215 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' B' ' 4' ' ' SER . . . 65.79 -138.03 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.269 -0.894 . . . . 0.0 109.366 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.409 ' CB ' ' O ' ' B' ' 2' ' ' ALA . 0.4 OUTLIER 70.41 -26.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.619 ' H ' ' C ' ' B' ' 2' ' ' ALA . 46.0 p -143.47 -136.57 0.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' B' ' 100' ' ' VAL . . . -95.7 168.65 26.56 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.63 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.28 131.52 46.99 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -1.143 . . . . 0.0 108.012 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 19.7 ttpt -110.01 138.97 45.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.903 -1.123 . . . . 0.0 112.793 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -129.2 128.19 42.84 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.9 tt -136.86 145.91 44.95 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.724 -1.235 . . . . 0.0 109.509 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 p -127.57 134.64 65.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.587 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.62 127.22 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.23 159.73 32.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.707 -1.597 . . . . 0.0 112.983 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.541 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 18.1 tptt -129.48 153.17 48.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 7.9 p90 -106.43 148.76 27.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.893 -1.129 . . . . 0.0 111.621 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -23.11 3.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 85.1 tt0 -89.22 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.3 t0 155.8 73.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 47.6 m -66.55 109.67 2.87 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.083 0.944 . . . . 0.0 112.862 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.597 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -79.46 92.27 5.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 175.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.8 -35.73 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.539 -0.725 . . . . 0.0 110.445 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 28.9 p-10 -68.23 -41.5 81.14 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.58 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 64.6 tt0 -71.69 -32.47 67.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.36 -36.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.11 -39.96 63.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -39.72 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' B' ' 29' ' ' ASN . . . -61.39 -54.57 35.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 47.8 mt -52.49 -47.74 66.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.525 -0.986 . . . . 0.0 108.87 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.64 -39.63 61.95 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.518 ' O ' ' OG ' ' B' ' 32' ' ' SER . 0.1 OUTLIER -62.98 -42.64 99.89 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.0 mm? -49.98 -46.65 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' B' ' 34' ' ' ILE . 22.0 t -49.05 -25.17 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.867 . . . . 0.0 108.816 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 68.4 m -43.05 -40.63 3.18 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.448 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 98.1 mm-40 -70.98 -18.08 62.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.453 -0.779 . . . . 0.0 111.526 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.571 ' O ' ' CG2' ' B' ' 34' ' ' ILE . 89.6 mt -80.47 18.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 119.978 -1.702 . . . . 0.0 110.568 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.64 -12.83 4.57 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.589 ' O ' ' N ' ' B' ' 38' ' ' LYS . 3.9 t -89.16 0.53 56.66 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.887 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.57 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.5 m 34.32 33.9 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.194 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' B' ' 36' ' ' THR . 65.5 mttt -117.59 42.09 2.68 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 55.6 p -177.93 179.19 0.88 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -148.34 159.65 43.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.554 -1.341 . . . . 0.0 111.95 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.502 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 77.1 mt-10 -155.79 123.84 5.74 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.335 0.588 . . . . 0.0 110.229 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' B' ' 60' ' ' PHE . 23.9 m95 -125.22 166.03 17.22 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' B' ' 44' ' ' GLU . . . -161.55 150.56 20.25 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 118.716 -1.707 . . . . 0.0 110.839 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 43' ' ' GLY . 7.6 tp10 -163.57 175.2 10.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 109.352 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 11.7 p-10 -118.44 169.92 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -61.32 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.322 -1.487 . . . . 0.0 109.809 -178.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.8 mt-10 -106.96 42.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.316 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -139.74 -142.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.138 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' B' ' 50' ' ' ASP . 79.1 m80 -95.97 136.87 35.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 49' ' ' HIS . 90.4 m-20 -41.34 -36.01 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.324 -0.86 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.5 OUTLIER -78.81 -29.35 44.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.731 -178.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.28 -22.83 18.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.691 -1.256 . . . . 0.0 109.257 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' B' ' 55' ' ' GLY . 2.7 ptt180 -95.98 4.04 52.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -0.834 . . . . 0.0 111.235 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' B' ' 53' ' ' ARG . 35.5 tt0 40.55 21.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.812 -1.18 . . . . 0.0 110.15 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 57.27 1.26 0.41 Allowed Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.356 -0.84 . . . . 0.0 112.796 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 31.5 p90 -55.45 129.47 38.87 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 119.595 1.697 . . . . 0.0 109.941 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -54.66 -47.57 73.41 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.301 -0.874 . . . . 0.0 110.946 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 151.06 11.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.895 -1.128 . . . . 0.0 110.17 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.18 147.77 51.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.0 109.262 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' B' ' 42' ' ' TRP . 2.4 t80 -126.65 122.97 36.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.488 -0.757 . . . . 0.0 109.075 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -107.07 102.56 11.89 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.26 124.99 48.81 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.134 -0.979 . . . . 0.0 110.759 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -122.51 144.65 48.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.47 160.92 28.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.738 -1.226 . . . . 0.0 110.025 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.528 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 77.9 mt-10 -83.31 -30.73 27.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 29.6 m120 -151.01 160.21 44.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -58.27 -25.04 61.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 111.411 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -53.06 -35.75 59.86 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.816 -1.177 . . . . 0.0 110.585 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -37.1 87.71 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -62.4 -46.55 88.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.978 . . . . 0.0 110.439 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.72 -28.98 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.37 -1.456 . . . . 0.0 108.623 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.0 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -48.54 -36.58 15.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 111.186 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 2.1 t -82.74 -27.08 31.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.744 -1.222 . . . . 0.0 110.329 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -69.49 -21.81 63.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 0.0 111.027 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.613 ' C ' ' H ' ' B' ' 78' ' ' LEU . 78.3 m80 -85.35 130.81 50.17 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.861 -1.149 . . . . 0.0 109.596 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.409 ' O ' HG13 ' B' ' 80' ' ' VAL . 82.7 Cg_exo -45.71 -2.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.599 2.199 . . . . 0.0 112.433 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' B' ' 76' ' ' HIS . 8.3 tp -77.31 -31.1 54.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -76.84 -39.18 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.0 110.296 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.516 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 4.0 p -62.41 -56.3 18.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.972 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.516 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 84.2 tt0 -49.89 -37.37 31.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.62 -29.27 69.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.85 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 80' ' ' VAL . 59.9 p -62.03 -44.99 95.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.71 68.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.998 -1.063 . . . . 0.0 108.641 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.591 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -83.55 -45.33 13.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.705 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -36.52 -43.91 0.42 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.629 ' CG2' ' H ' ' B' ' 88' ' ' ALA . 3.3 t -83.32 -60.4 2.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.629 ' H ' ' CG2' ' B' ' 87' ' ' THR . . . -47.04 -14.9 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.3 m -119.9 -1.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -0.904 . . . . 0.0 110.835 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 61.0 mt -128.33 160.68 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.672 -1.267 . . . . 0.0 110.448 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.505 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 40.7 t0 -110.54 -31.89 7.09 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.63 142.35 30.99 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 tp -124.03 121.45 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.579 -1.326 . . . . 0.0 109.661 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.431 ' CG1' ' CD ' ' A' ' 54' ' ' GLN . 9.3 t -127.83 132.42 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.4 OUTLIER -137.37 132.67 33.87 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.246 -1.534 . . . . 0.0 111.777 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.43 119.78 37.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.683 -0.636 . . . . 0.0 109.294 177.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' B' ' 98' ' ' PHE . 50.2 t0 -125.69 133.23 52.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.067 -1.021 . . . . 0.0 108.861 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.581 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 31.2 p90 -158.04 137.79 8.6 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 110.555 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.37 123.1 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.313 2.008 . . . . 0.0 112.221 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . 0.596 ' O ' ' OG ' ' B' ' 4' ' ' SER . 58.9 t -85.79 109.21 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.21 89.8 3.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.82 71.17 0.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.099 -1.001 . . . . 0.0 109.599 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' B' ' 103' ' ' VAL . 33.8 m -153.29 85.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -0.843 . . . . 0.0 109.235 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.67 ' O ' ' N ' ' B' ' 106' ' ' SER . 29.2 mmtp -95.61 4.62 52.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.415 ' O ' ' C ' ' B' ' 106' ' ' SER . 1.8 t 63.34 -53.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 108.879 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.67 ' N ' ' O ' ' B' ' 104' ' ' LYS . 7.6 t 44.68 50.43 8.51 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' B' ' 108' ' ' VAL . 11.8 p -104.96 -38.26 4.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.405 ' N ' ' CG1' ' B' ' 107' ' ' VAL . 12.3 p -144.08 141.59 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 109.434 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.45 107.99 19.16 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.2 p -71.14 151.0 94.71 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.844 -1.16 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo . . . . . 0 C--N 1.308 -1.584 0 C-N-CA 122.743 2.295 . . . . 0.0 112.255 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.732 ' O ' ' C ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.314 0.578 . . . . 0.0 109.511 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.732 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -15.44 91.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.168 -0.957 . . . . 0.0 109.336 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 1' ' ' MET . 8.8 t -111.5 0.21 16.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 3' ' ' THR . 17.3 m -167.25 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.1 178.15 18.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.66 127.04 55.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.276 -1.132 . . . . 0.0 107.973 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.551 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.4 ttpt -97.95 128.03 44.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.916 -1.115 . . . . 0.0 112.841 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 70' ' ' TYR . 51.6 m-70 -121.06 119.2 31.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 5.9 tt -128.71 139.44 52.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.716 -1.24 . . . . 0.0 109.496 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.9 137.48 56.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.641 -0.662 . . . . 0.0 109.536 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.48 133.8 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 1.5 m -141.42 162.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.047 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -127.59 152.64 47.38 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 12.7 p90 -109.82 151.8 26.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.799 -1.188 . . . . 0.0 111.607 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.31 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 48.3 tp10 -92.84 -54.93 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.8 t0 152.86 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 89.4 m -50.22 107.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.14 0.972 . . . . 0.0 112.859 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -71.61 83.36 0.85 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 24' ' ' LEU . 27.8 m -62.83 -41.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.546 -0.721 . . . . 0.0 110.481 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 90.3 m-20 -64.96 -44.64 88.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 110.498 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.7 -31.77 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 23' ' ' ILE . 11.2 mt -70.84 -43.61 76.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.2 tp -54.01 -40.04 66.66 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.92 -38.04 81.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -62.57 -51.27 57.3 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 4.7 tt -45.22 -44.03 10.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.461 -1.023 . . . . 0.0 108.848 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -49.87 -35.01 21.81 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 26' ' ' GLY . 14.3 m-20 -65.39 -44.32 87.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 1.4 mm? -48.39 -50.76 29.6 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 34' ' ' ILE . 54.8 t -46.94 -35.7 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 108.733 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.1 t -45.36 -50.55 12.13 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -69.21 -9.15 51.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 111.47 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 31' ' ' VAL . 21.9 mm -101.35 29.07 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.04 -1.663 . . . . 0.0 110.589 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.19 -19.08 61.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.585 ' O ' ' C ' ' A' ' 37' ' ' VAL . 16.8 p -69.84 -6.85 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.585 ' C ' ' O ' ' A' ' 36' ' ' THR . 34.7 m 35.08 36.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.104 -0.998 . . . . 0.0 109.106 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -118.0 41.55 2.87 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.5 p -174.01 178.09 2.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 97.6 m-85 -145.47 153.81 41.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.594 -1.316 . . . . 0.0 111.951 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 40' ' ' PHE . 54.1 mp0 -156.99 125.41 5.68 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.421 0.629 . . . . 0.0 110.162 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -134.58 176.05 8.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.612 ' H ' ' NZ ' ' B' ' 104' ' ' LYS . . . -133.56 158.82 23.42 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.55 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 77.4 mt-10 -149.06 140.79 23.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -1.145 . . . . 0.0 109.368 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 32.4 p30 -120.62 145.36 47.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -148.62 128.84 13.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.437 -1.414 . . . . 0.0 109.794 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -161.98 51.2 0.21 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.641 -0.662 . . . . 0.0 109.32 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.2 t -91.12 -98.65 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.203 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.4 m-70 -100.69 144.67 29.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.155 -0.965 . . . . 0.0 109.708 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 87.8 m-20 -50.09 -42.97 51.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.301 -0.875 . . . . 0.0 110.674 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.3 ttt -73.55 -32.77 64.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.084 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 68.9 mt -88.67 -51.65 5.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.741 -1.224 . . . . 0.0 109.245 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.721 ' O ' ' N ' ' A' ' 55' ' ' GLY . 13.8 ptt180 -71.08 5.45 2.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 111.275 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 46.07 3.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.729 -1.232 . . . . 0.0 110.197 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.21 -10.07 11.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.488 -0.758 . . . . 0.0 112.864 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 55' ' ' GLY . 20.9 m-85 -59.1 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.226 -1.749 . . . . 0.0 109.99 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.537 ' OG1' ' ND1' ' A' ' 58' ' ' HIS . 81.1 p -152.86 -41.9 0.1 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.962 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.618 ' NE2' ' CG2' ' A' ' 12' ' ' VAL . 27.3 p-80 -174.33 157.81 2.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.836 -1.165 . . . . 0.0 110.145 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.69 170.91 14.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 109.287 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.05 131.67 37.29 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.128 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 t -101.67 102.15 12.78 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.9 mtt -108.08 125.1 51.18 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.146 -0.971 . . . . 0.0 110.799 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.8 m -128.4 149.36 50.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.06 131.71 45.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 110.03 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 71.7 mm-40 -52.48 -32.52 40.36 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 33.0 m120 -155.64 160.46 40.43 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -57.66 -17.93 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.99 -39.83 79.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.844 -1.16 . . . . 0.0 110.589 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.26 -33.46 73.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.615 ' CE1' ' CE1' ' A' ' 8' ' ' HIS . 76.4 t80 -67.12 -44.38 80.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.495 -1.003 . . . . 0.0 110.451 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -28.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.381 -1.45 . . . . 0.0 108.673 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.367 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 2.5 t80 -45.66 -34.17 3.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 111.141 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -83.41 -24.9 31.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.744 -1.223 . . . . 0.0 110.249 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.6 m -67.47 -26.0 66.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.994 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -85.47 156.0 59.42 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.878 -1.139 . . . . 0.0 109.664 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.21 3.86 2.27 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.66 2.24 . . . . 0.0 112.469 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.5 tp -77.87 -31.1 51.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.77 . . . . 0.0 111.322 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -77.7 -41.61 37.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 0.0 110.211 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.592 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.5 p -62.58 -58.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.592 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 84.8 tt0 -51.77 -38.72 56.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 109.638 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -69.89 -32.02 70.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 109.883 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.5 -45.06 95.16 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.48 85.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.879 -1.138 . . . . 0.0 108.751 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.549 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -77.55 -44.76 27.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.652 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -39.28 -38.78 0.55 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.3 m -81.46 -61.0 2.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.34 -13.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.63 -0.669 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 87' ' ' THR . 13.1 m -119.27 -2.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 110.859 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -120.66 155.98 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.595 -1.316 . . . . 0.0 110.473 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.466 ' N ' HG21 ' A' ' 90' ' ' ILE . 36.4 t0 -104.35 -31.58 9.47 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' H ' HG21 ' A' ' 90' ' ' ILE . 21.5 pttt -149.98 150.61 32.06 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' A' ' 93' ' ' ILE . 6.0 tp -127.31 125.25 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.627 -1.295 . . . . 0.0 109.751 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.2 t -123.45 128.57 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.25 138.43 33.25 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.249 -1.532 . . . . 0.0 111.838 -178.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.25 123.96 42.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.637 . . . . 0.0 109.326 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -125.85 135.59 52.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.011 -1.056 . . . . 0.0 108.919 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -165.67 158.55 13.14 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 0.0 110.522 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.595 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 39.9 Cg_exo -58.78 114.84 2.17 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.298 1.999 . . . . 0.0 112.176 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 132.97 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.923 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.8 79.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.83 93.97 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.114 -0.991 . . . . 0.0 109.535 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.754 ' O ' ' C ' ' A' ' 104' ' ' LYS . 14.7 m -155.9 -16.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.201 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.754 ' C ' ' O ' ' A' ' 103' ' ' VAL . 31.5 mmtm -8.14 -105.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.71 -5.52 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 108.911 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.599 ' H ' ' C ' ' A' ' 104' ' ' LYS . 45.1 t -59.71 140.56 56.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -148.71 42.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.91 151.03 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.0 109.445 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.34 163.04 26.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.5 p -142.67 68.67 19.79 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 120.82 -1.175 . . . . 0.0 109.599 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo . . . . . 0 C--N 1.308 -1.575 0 C-N-CA 122.763 2.309 . . . . 0.0 112.226 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.745 ' O ' ' C ' ' B' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.745 ' C ' ' O ' ' B' ' 1' ' ' MET . . . -15.51 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 109.311 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.572 ' N ' ' O ' ' B' ' 1' ' ' MET . 8.9 t -111.56 0.17 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.226 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -167.36 -87.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.19 178.12 18.44 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.433 -1.365 . . . . 0.0 109.697 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -111.76 126.69 55.33 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.276 -1.132 . . . . 0.0 107.993 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.55 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.3 ttpt -97.53 128.23 44.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.937 -1.102 . . . . 0.0 112.863 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.601 ' CE1' ' CE1' ' B' ' 70' ' ' TYR . 51.3 m-70 -121.29 119.02 31.01 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 5.9 tt -128.56 139.53 52.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.743 -1.223 . . . . 0.0 109.451 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.83 137.67 56.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.498 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.77 133.86 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.623 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 1.5 m -141.5 162.04 21.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 117.745 -1.582 . . . . 0.0 113.039 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -127.57 152.66 47.35 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 12.6 p90 -109.88 151.73 26.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.798 -1.189 . . . . 0.0 111.562 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.14 3.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 48.4 tp10 -92.96 -55.04 3.5 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.7 t0 152.99 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 89.3 m -50.27 107.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.082 0.944 . . . . 0.0 112.868 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HD3' ' H ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -71.51 83.23 0.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.41 ' CG2' ' N ' ' B' ' 21' ' ' ASP . 26.9 m -62.77 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.631 -0.668 . . . . 0.0 110.473 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.41 ' N ' ' CG2' ' B' ' 20' ' ' VAL . 90.0 m-20 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.456 -0.777 . . . . 0.0 110.576 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -65.5 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.432 HD11 HG21 ' B' ' 23' ' ' ILE . 11.2 mt -70.96 -43.43 76.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.13 -40.02 67.01 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.98 -38.13 81.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -62.22 -51.59 55.61 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 4.7 tt -45.04 -44.08 9.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.533 -0.981 . . . . 0.0 108.795 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -49.89 -34.94 21.78 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' B' ' 26' ' ' GLY . 14.3 m-20 -65.4 -44.31 87.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 1.4 mm? -48.37 -50.82 29.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' B' ' 34' ' ' ILE . 54.9 t -46.93 -35.47 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.915 . . . . 0.0 108.79 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 8.2 t -45.65 -50.48 13.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -69.28 -8.99 51.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 111.475 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' B' ' 31' ' ' VAL . 21.9 mm -101.58 29.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.019 -1.675 . . . . 0.0 110.645 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -61.23 -19.27 61.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.571 ' O ' ' C ' ' B' ' 37' ' ' VAL . 16.8 p -69.59 -6.85 33.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.961 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.6 m 35.04 36.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.022 -1.049 . . . . 0.0 109.132 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.3 OUTLIER -118.09 41.68 2.86 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p -174.2 177.99 2.17 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.519 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 97.7 m-85 -145.47 153.7 41.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.58 -1.325 . . . . 0.0 111.967 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' B' ' 40' ' ' PHE . 53.9 mp0 -156.92 125.11 5.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -134.2 176.18 8.83 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.631 ' H ' ' NZ ' ' A' ' 104' ' ' LYS . . . -133.74 158.74 23.42 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 118.703 -1.713 . . . . 0.0 110.782 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.551 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 77.3 mt-10 -148.98 140.83 23.66 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 32.2 p30 -120.71 145.39 47.53 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.66 128.69 13.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.404 -1.435 . . . . 0.0 109.834 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -161.91 51.36 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.622 . . . . 0.0 109.339 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -91.18 -98.83 0.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ARG . 90.4 m-70 -100.59 144.5 29.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.093 -1.004 . . . . 0.0 109.676 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' B' ' 53' ' ' ARG . 88.6 m-20 -49.92 -42.92 49.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 110.849 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.1 ttt -73.76 -32.46 63.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.029 -1.044 . . . . 0.0 110.756 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 95' ' ' LEU . 68.9 mt -88.82 -51.76 5.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.731 ' O ' ' N ' ' B' ' 55' ' ' GLY . 13.8 ptt180 -70.91 5.36 2.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.344 -0.848 . . . . 0.0 111.249 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 46.19 3.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.855 -1.153 . . . . 0.0 110.244 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.32 -10.12 11.96 Favored Glycine 0 N--CA 1.499 2.882 0 O-C-N 121.437 -0.79 . . . . 0.0 112.812 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' B' ' 55' ' ' GLY . 21.4 m-85 -59.19 -141.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.284 -1.715 . . . . 0.0 109.946 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.54 ' OG1' ' ND1' ' B' ' 58' ' ' HIS . 80.6 p -152.76 -41.85 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.319 -0.863 . . . . 0.0 111.024 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.623 ' NE2' ' CG2' ' B' ' 12' ' ' VAL . 27.5 p-80 -174.45 157.7 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.854 -1.154 . . . . 0.0 110.167 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.72 170.9 14.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.489 -0.757 . . . . 0.0 109.219 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.01 131.67 37.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 21.1 t -101.61 102.23 12.91 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 125.31 51.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.931 . . . . 0.0 110.733 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.7 m -128.59 149.28 50.7 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.05 131.64 45.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 110.095 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 72.0 mm-40 -52.17 -32.82 37.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 32.9 m120 -155.5 160.51 40.62 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -57.76 -17.87 18.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 111.466 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -57.85 -40.11 79.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.885 -1.134 . . . . 0.0 110.551 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.93 -33.6 75.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.601 ' CE1' ' CE1' ' B' ' 8' ' ' HIS . 76.2 t80 -66.99 -44.55 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.661 -0.905 . . . . 0.0 110.473 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.67 -28.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.704 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.88 2.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 2.5 t80 -45.66 -34.08 3.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.148 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.1 OUTLIER -83.34 -24.99 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 0.0 110.304 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -67.41 -25.86 66.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 111.032 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -85.65 156.0 58.92 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.83 -1.169 . . . . 0.0 109.579 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.17 3.91 2.23 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 112.433 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 44.5 tp -77.98 -31.31 50.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.429 -0.794 . . . . 0.0 111.218 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -77.41 -41.79 38.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.961 -1.087 . . . . 0.0 110.289 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.598 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.6 p -62.39 -58.24 8.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.054 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.598 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 85.0 tt0 -51.71 -38.73 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 0.0 109.593 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -69.98 -31.96 69.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.838 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.4 t -60.35 -45.36 93.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.142 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.42 85.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.987 -1.071 . . . . 0.0 108.685 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -77.53 -44.79 27.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.657 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -39.33 -38.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.593 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.3 m -81.41 -61.1 2.04 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.12 -13.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.079 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' B' ' 87' ' ' THR . 13.1 m -119.21 -2.77 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.237 -0.915 . . . . 0.0 110.875 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -120.7 156.05 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.701 -1.249 . . . . 0.0 110.465 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.473 ' N ' HG21 ' B' ' 90' ' ' ILE . 35.9 t0 -104.47 -31.63 9.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.425 ' H ' HG21 ' B' ' 90' ' ' ILE . 21.6 pttt -150.04 150.37 31.65 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' B' ' 93' ' ' ILE . 6.0 tp -127.07 125.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.491 -1.381 . . . . 0.0 109.733 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 12.8 t -123.55 128.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.33 138.54 33.18 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.302 -1.499 . . . . 0.0 111.791 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.25 123.83 42.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -125.77 135.67 52.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.064 -1.023 . . . . 0.0 108.87 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.591 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 0.5 OUTLIER -165.62 158.52 13.21 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.132 -0.98 . . . . 0.0 110.587 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . 0.591 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 41.1 Cg_exo -58.76 114.73 2.12 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.305 2.003 . . . . 0.0 112.265 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 133.04 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.004 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 78.87 1.16 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.502 -0.749 . . . . 0.0 109.58 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.58 94.08 2.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.12 -0.987 . . . . 0.0 109.657 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.784 ' O ' ' C ' ' B' ' 104' ' ' LYS . 14.6 m -156.0 -16.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.362 -0.836 . . . . 0.0 109.219 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.784 ' C ' ' O ' ' B' ' 103' ' ' VAL . 31.3 mmtm -8.28 -105.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.373 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.66 -5.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.935 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.572 ' H ' ' C ' ' B' ' 104' ' ' LYS . 44.4 t -59.53 140.61 56.12 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.291 -0.881 . . . . 0.0 109.419 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p -148.78 42.95 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.95 151.07 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.48 -0.762 . . . . 0.0 109.452 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.3 163.16 26.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 6.6 p -142.82 68.56 18.98 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 120.874 -1.142 . . . . 0.0 109.658 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo . . . . . 0 C--N 1.308 -1.575 0 C-N-CA 122.731 2.287 . . . . 0.0 112.234 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.301 0.572 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.26 66.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.368 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.444 ' O ' ' OG ' ' A' ' 4' ' ' SER . 12.1 t -107.68 0.77 22.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.089 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.9 m -173.32 -107.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.8 -178.26 20.55 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.399 -1.382 . . . . 0.0 109.694 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -130.11 130.13 44.42 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 1.3 ttpm? -104.48 133.84 48.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.874 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -127.21 125.7 41.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.51 142.45 48.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.745 -1.222 . . . . 0.0 109.507 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 140.32 48.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.506 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.22 134.02 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -137.53 162.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 117.79 -1.564 . . . . 0.0 113.014 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 14' ' ' PHE . 20.7 tptp -132.21 152.8 51.14 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.496 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 36.3 p90 -111.65 149.44 31.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.886 -1.134 . . . . 0.0 111.597 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.45 -19.68 3.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.5 mt-10 -91.69 -56.5 3.08 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.9 t0 154.48 64.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 86.8 m -49.77 105.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.126 0.965 . . . . 0.0 112.794 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.796 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -68.65 83.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 24' ' ' LEU . 28.9 m -61.59 -42.96 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.52 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.0 p-10 -65.97 -43.27 88.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 0.0 110.571 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 97.4 mt-10 -70.7 -34.12 71.61 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -67.32 -44.61 87.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' VAL . 15.7 tp -52.88 -38.0 61.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.08 75.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -60.63 -54.23 38.81 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 4.4 tt -45.83 -43.91 13.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.497 -1.002 . . . . 0.0 108.838 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' B' ' 106' ' ' SER . 71.8 mm-40 -50.86 -33.33 23.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.0 m-20 -66.54 -44.39 82.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.1 mm? -49.3 -48.28 46.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 32' ' ' SER . 94.6 t -46.97 -31.91 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.908 . . . . 0.0 108.844 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 73.7 p -45.59 -49.25 14.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 70.6 mm-40 -72.79 -12.15 60.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 111.457 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.525 ' C ' ' N ' ' A' ' 36' ' ' THR . 21.1 mm -96.69 24.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.043 -1.661 . . . . 0.0 110.589 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.06 -12.43 4.81 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.2 p -74.86 -1.28 21.6 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.995 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.576 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.1 m 34.61 33.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 32.1 mtmt -119.55 42.36 2.9 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 58.4 m -171.88 174.54 4.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -146.71 157.4 43.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.639 -1.288 . . . . 0.0 111.957 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -155.27 121.5 5.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.362 0.601 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -123.95 170.2 10.85 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.97 160.0 23.72 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.72 -1.705 . . . . 0.0 110.852 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 24.1 mt-10 -150.5 145.21 25.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.251 -1.147 . . . . 0.0 109.394 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 22.5 t70 -126.53 148.03 49.77 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -145.37 122.99 11.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.417 -1.427 . . . . 0.0 109.799 -178.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 48' ' ' SER . 95.4 mt-10 -133.93 3.4 3.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 47' ' ' GLU . 99.2 p -56.99 -140.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.953 . . . . 0.0 110.17 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.755 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 57.4 t-80 -74.62 160.15 31.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.678 ' N ' HH21 ' A' ' 53' ' ' ARG . 77.9 m-20 -61.2 -44.23 97.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.659 ' H ' ' HD1' ' A' ' 49' ' ' HIS . 1.8 tpt -67.76 -33.43 74.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.013 -1.054 . . . . 0.0 110.746 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' B' ' 95' ' ' LEU . 38.0 mt -89.23 -54.43 4.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.702 -1.249 . . . . 0.0 109.323 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.755 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.3 ptp180 -64.41 2.97 0.52 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.0 111.195 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.607 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER 57.19 -12.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.75 -1.219 . . . . 0.0 110.14 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 85.24 -21.81 11.69 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.408 -0.808 . . . . 0.0 112.847 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.634 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 3.7 m-85 -57.79 -129.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.267 -1.725 . . . . 0.0 109.988 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.46 ' HA ' ' HZ1' ' A' ' 46' ' ' LYS . 2.8 t -162.2 -33.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.629 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 15.0 t60 -172.05 154.49 3.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.104 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.629 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.9 168.01 20.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.414 -0.804 . . . . 0.0 109.251 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 96.8 m-85 -134.74 130.98 37.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.475 -0.766 . . . . 0.0 109.067 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.6 99.24 8.84 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.0 mtm -100.07 124.8 45.86 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.149 -0.97 . . . . 0.0 110.851 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.46 142.94 50.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' GLU . 94.2 m-85 -122.01 126.8 49.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.736 -1.228 . . . . 0.0 110.092 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 64' ' ' PHE . 33.6 tt0 -46.93 -30.7 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -165.81 170.59 13.74 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -57.79 -22.35 46.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 111.46 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -56.24 -40.22 73.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.822 -1.174 . . . . 0.0 110.673 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.09 62.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -63.13 -44.59 95.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.984 . . . . 0.0 110.467 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.421 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.75 -28.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.388 -1.445 . . . . 0.0 108.692 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -60.99 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -56.74 -42.57 79.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 111.09 -177.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.457 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 10.0 t -75.95 -33.19 59.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.787 -1.195 . . . . 0.0 110.31 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 63.5 m -63.39 -32.76 74.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.996 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.522 ' CE1' ' OE1' ' A' ' 33' ' ' GLN . 54.5 m80 -72.03 151.91 92.76 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.861 -1.15 . . . . 0.0 109.604 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.14 4.1 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.669 2.246 . . . . 0.0 112.42 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 tp -76.57 -28.62 56.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.384 -0.822 . . . . 0.0 111.267 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.518 ' CD2' ' OG ' ' A' ' 83' ' ' SER . 11.2 t-160 -81.59 -41.82 20.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.987 -1.07 . . . . 0.0 110.245 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.604 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.5 p -63.12 -58.9 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 110.023 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.604 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 48.3 tp10 -58.46 -39.61 80.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.197 -0.94 . . . . 0.0 109.627 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 85.6 t80 -69.69 -43.49 72.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.518 ' OG ' ' CD2' ' A' ' 79' ' ' HIS . 49.8 m -59.24 -36.63 75.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.113 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.22 60.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.972 -1.08 . . . . 0.0 108.666 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.9 -41.59 74.49 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.492 ' C ' ' O ' ' A' ' 85' ' ' ALA . 11.9 t80 -43.06 -30.82 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.3 m -83.21 -60.98 1.97 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.41 -24.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.682 -0.636 . . . . 0.0 110.049 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' THR . 9.0 m -105.32 11.92 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.213 -0.93 . . . . 0.0 110.834 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 47.1 mt -124.68 158.77 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.278 . . . . 0.0 110.474 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.508 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 57.5 t0 -100.05 -34.32 10.12 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.477 ' NZ ' ' CD1' ' A' ' 56' ' ' PHE . 38.4 pttt -149.08 147.62 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.88 131.4 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.619 -1.301 . . . . 0.0 109.744 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.0 139.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -139.44 135.18 33.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.245 -1.534 . . . . 0.0 111.739 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.613 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -117.99 123.87 46.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.382 178.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 65.7 t0 -125.47 131.15 52.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.041 -1.037 . . . . 0.0 108.939 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' B' ' 45' ' ' ASP . 44.8 t80 -160.93 138.72 7.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.036 -1.04 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.82 120.33 2.8 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.34 2.026 . . . . 0.0 112.205 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.82 144.04 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.06 125.77 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 109.609 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.06 73.55 9.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.539 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 103' ' ' VAL . 18.1 m -150.25 98.06 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.162 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.685 ' C ' ' H ' ' A' ' 106' ' ' SER . 41.4 mmtm -134.27 -112.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.57 -12.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 108.868 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.685 ' H ' ' C ' ' A' ' 104' ' ' LYS . 30.1 t -53.58 139.75 30.75 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.269 -0.895 . . . . 0.0 109.404 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.93 138.38 53.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 108' ' ' VAL . 5.8 p 178.47 59.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.465 -0.772 . . . . 0.0 109.495 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.9 109.36 17.52 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.9 m -135.87 70.15 64.56 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 120.84 -1.162 . . . . 0.0 109.641 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--N 1.309 -1.549 0 C-N-CA 122.782 2.322 . . . . 0.0 112.223 179.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.86 67.26 1.03 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 109.357 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.449 ' O ' ' OG ' ' B' ' 4' ' ' SER . 11.8 t -108.02 0.82 22.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 109.047 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' B' ' 3' ' ' THR . 38.2 m -173.55 -107.35 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.83 -178.81 20.51 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.632 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.62 130.2 45.33 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.302 -1.117 . . . . 0.0 108.011 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 1.2 ttpm? -104.47 134.04 48.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.337 1.065 . . . . 0.0 112.841 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -127.41 125.63 40.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 tt -133.43 142.59 48.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 109.375 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.87 140.31 49.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.574 -0.704 . . . . 0.0 109.493 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.13 134.14 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -137.5 162.8 32.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 117.758 -1.577 . . . . 0.0 113.016 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.514 ' HD2' ' H ' ' B' ' 14' ' ' PHE . 20.6 tptp -132.17 152.96 51.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.514 ' H ' ' HD2' ' B' ' 13' ' ' LYS . 36.4 p90 -111.76 149.51 31.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.78 -1.2 . . . . 0.0 111.598 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.65 -19.44 3.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.4 mt-10 -92.14 -56.17 3.16 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 8.7 t0 154.25 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 87.1 m -49.67 105.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.148 0.975 . . . . 0.0 112.876 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.803 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -68.76 83.59 0.3 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' B' ' 21' ' ' ASP . 29.6 m -61.84 -42.89 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 110.513 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.4 p-10 -65.95 -43.2 88.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.547 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 97.2 mt-10 -70.7 -34.17 71.66 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -67.29 -44.51 87.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' B' ' 20' ' ' VAL . 15.7 tp -52.87 -37.94 60.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.05 75.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -60.71 -54.13 39.54 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 4.4 tt -45.92 -43.63 14.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 108.828 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 106' ' ' SER . 71.6 mm-40 -51.35 -33.2 28.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 26' ' ' GLY . 11.5 m-20 -66.34 -44.75 82.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.1 mm? -48.9 -48.4 42.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 94.4 t -46.9 -32.09 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 108.815 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 69.6 p -45.57 -49.37 14.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.518 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 71.1 mm-40 -72.49 -12.07 60.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 111.527 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.508 ' C ' ' N ' ' B' ' 36' ' ' THR . 21.2 mm -96.97 24.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.017 -1.677 . . . . 0.0 110.568 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.35 -12.02 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.575 ' O ' ' N ' ' B' ' 38' ' ' LYS . 52.6 p -75.29 -1.11 22.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.96 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 34.63 33.57 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.998 -1.064 . . . . 0.0 109.135 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' B' ' 36' ' ' THR . 32.1 mtmt -119.6 42.53 2.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.524 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 58.5 m -172.03 174.58 4.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -146.78 157.46 43.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.497 -1.377 . . . . 0.0 111.934 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -155.24 121.51 5.23 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.428 0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -123.86 170.27 10.74 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.18 159.67 23.65 Favored Glycine 0 N--CA 1.499 2.836 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.847 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 24.2 mt-10 -150.3 145.0 25.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.181 -1.188 . . . . 0.0 109.387 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 22.3 t70 -126.38 147.9 49.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.641 ' NZ ' ' O ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -145.17 123.12 12.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 0.0 109.858 -178.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.4 mt-10 -134.08 3.9 3.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.694 -0.629 . . . . 0.0 109.367 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.536 ' O ' ' O ' ' B' ' 47' ' ' GLU . 95.1 p -57.21 -140.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.179 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.734 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 57.3 t-80 -74.54 160.18 31.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 109.742 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.685 ' N ' HH21 ' B' ' 53' ' ' ARG . 77.7 m-20 -61.2 -44.2 97.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.0 110.837 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.656 ' H ' ' HD1' ' B' ' 49' ' ' HIS . 1.7 tpt -67.81 -33.28 74.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.005 . . . . 0.0 110.726 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 95' ' ' LEU . 38.9 mt -89.32 -54.46 4.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.715 -1.24 . . . . 0.0 109.307 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.734 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.4 ptp180 -64.37 2.89 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 111.231 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.599 ' NE2' ' CZ ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER 57.33 -12.38 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.811 -1.18 . . . . 0.0 110.282 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.719 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 85.61 -22.04 12.3 Favored Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.43 -0.794 . . . . 0.0 112.789 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.641 ' O ' ' NZ ' ' B' ' 46' ' ' LYS . 3.6 m-85 -57.82 -129.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.327 -1.69 . . . . 0.0 109.973 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.466 ' HA ' ' HZ1' ' B' ' 46' ' ' LYS . 2.6 t -162.37 -33.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 110.985 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.617 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 15.2 t60 -171.93 154.61 3.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.832 -1.168 . . . . 0.0 110.162 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.617 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.95 167.99 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.439 -0.788 . . . . 0.0 109.341 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 96.7 m-85 -134.61 131.04 37.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 109.137 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.55 99.1 8.72 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -99.9 124.77 45.58 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.204 -0.935 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 88.4 m -123.58 143.06 50.45 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' B' ' 65' ' ' GLU . 94.3 m-85 -122.22 126.65 48.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.751 -1.218 . . . . 0.0 110.081 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' B' ' 64' ' ' PHE . 32.8 tt0 -46.62 -30.79 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -166.01 170.6 13.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.85 -22.4 47.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.886 . . . . 0.0 111.402 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -56.18 -40.26 73.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.81 -1.181 . . . . 0.0 110.653 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.57 -36.08 62.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.07 -44.78 94.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.532 -0.981 . . . . 0.0 110.49 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.75 -28.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.351 -1.468 . . . . 0.0 108.684 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -60.83 2.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.344 -0.847 . . . . 0.0 109.292 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.69 -42.46 79.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 111.124 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.453 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 10.0 t -76.09 -33.14 59.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.779 -1.2 . . . . 0.0 110.381 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 65.4 m -63.47 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.062 -1.024 . . . . 0.0 110.912 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.518 ' CE1' ' OE1' ' B' ' 33' ' ' GLN . 54.1 m80 -72.34 151.63 92.06 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.82 -1.175 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.79 3.91 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.701 2.267 . . . . 0.0 112.425 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 tp -76.48 -28.93 56.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.373 -0.83 . . . . 0.0 111.233 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.506 ' CD2' ' OG ' ' B' ' 83' ' ' SER . 11.2 t-160 -81.37 -41.6 21.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.041 -1.037 . . . . 0.0 110.266 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.613 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.7 p -63.35 -59.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.998 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.613 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 49.1 tp10 -58.23 -39.65 79.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.862 . . . . 0.0 109.625 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 85.5 t80 -69.43 -43.66 72.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.506 ' OG ' ' CD2' ' B' ' 79' ' ' HIS . 50.9 m -59.14 -36.54 75.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.027 -1.046 . . . . 0.0 110.147 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.21 -52.98 63.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.65 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -69.99 -41.93 73.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' B' ' 85' ' ' ALA . 11.8 t80 -42.89 -30.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.545 ' O ' ' N ' ' B' ' 89' ' ' VAL . 9.4 m -83.3 -60.79 2.03 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.65 -24.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.702 -0.624 . . . . 0.0 110.06 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.0 m -105.8 12.04 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.78 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 48.0 mt -124.63 158.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.711 -1.243 . . . . 0.0 110.423 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.509 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 57.1 t0 -100.06 -34.53 10.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.468 ' NZ ' ' CD1' ' B' ' 56' ' ' PHE . 38.5 pttt -148.76 147.67 29.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.81 131.48 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.583 -1.323 . . . . 0.0 109.764 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.93 139.51 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -139.68 135.05 32.82 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.276 -1.515 . . . . 0.0 111.773 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.622 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -117.8 124.05 47.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.7 t0 -125.64 131.56 52.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.037 -1.04 . . . . 0.0 108.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 45' ' ' ASP . 44.7 t80 -161.41 138.68 6.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.025 -1.047 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -44.69 120.35 2.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.299 2.0 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.86 143.92 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.05 125.78 25.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 109.6 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.03 73.37 9.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.039 -1.038 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' B' ' 103' ' ' VAL . 18.2 m -149.95 98.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.219 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.673 ' C ' ' H ' ' B' ' 106' ' ' SER . 41.1 mmtm -134.52 -113.3 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.272 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.97 -13.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 108.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.673 ' H ' ' C ' ' B' ' 104' ' ' LYS . 31.1 t -53.03 139.75 27.17 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.219 -0.925 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -130.88 138.37 53.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' B' ' 108' ' ' VAL . 5.6 p 178.41 59.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.544 -0.723 . . . . 0.0 109.463 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.96 109.38 17.58 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 20.5 m -135.83 70.11 64.82 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 120.86 -1.15 . . . . 0.0 109.567 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 C--N 1.307 -1.62 0 C-N-CA 122.768 2.312 . . . . 0.0 112.248 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.277 0.56 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.77 58.04 4.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.347 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.465 ' O ' ' OG ' ' A' ' 4' ' ' SER . 7.6 t -116.06 1.11 13.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.141 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 3' ' ' THR . 28.9 m -175.34 -126.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.24 173.14 31.2 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.709 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -135.78 136.36 40.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.289 -1.124 . . . . 0.0 108.005 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' B' ' 44' ' ' GLU . 20.7 ttpt -114.61 142.63 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.0 112.844 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -130.59 129.21 42.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -137.24 145.98 44.25 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.71 -1.244 . . . . 0.0 109.442 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 p -131.18 136.58 57.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.64 -0.663 . . . . 0.0 109.5 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.53 131.14 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.57 162.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 117.808 -1.557 . . . . 0.0 113.043 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HZ2' ' HG1' ' A' ' 57' ' ' THR . 13.9 tptp -127.55 155.32 43.99 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.511 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 11.5 p90 -108.18 149.54 28.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.842 -1.162 . . . . 0.0 111.638 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -127.02 -19.28 4.43 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -90.68 -56.76 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 10.1 t0 153.51 58.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 71.9 m -46.53 106.92 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.173 0.987 . . . . 0.0 112.795 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.475 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.39 89.13 1.6 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.8 m -61.2 -39.19 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.752 . . . . 0.0 110.467 -176.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.58 -45.4 94.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.554 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 21.8 mp0 -73.97 -37.82 64.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -66.79 -48.88 78.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.678 ' N ' ' O ' ' A' ' 20' ' ' VAL . 2.1 tm? -58.22 -41.34 83.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.61 -25.71 68.35 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.697 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -65.37 -55.48 20.73 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.499 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 7.0 tt -47.5 -35.75 9.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.514 -0.992 . . . . 0.0 108.826 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -53.52 -42.94 67.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -59.97 -42.32 93.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -52.7 -46.29 67.25 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 32' ' ' SER . 38.7 t -51.97 -23.95 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.248 -0.908 . . . . 0.0 108.843 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 44.3 t -44.34 -37.26 3.21 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.532 HE21 ' CG ' ' A' ' 76' ' ' HIS . 8.6 mm100 -79.87 -4.02 50.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.792 . . . . 0.0 111.457 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 6.5 mm -88.42 23.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.107 -1.62 . . . . 0.0 110.652 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.38 -16.8 16.18 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.598 ' O ' ' C ' ' A' ' 37' ' ' VAL . 43.7 p -68.27 -2.65 8.68 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.937 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 36' ' ' THR . 31.2 m 30.32 41.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.049 -1.032 . . . . 0.0 109.185 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' THR . 4.2 mtmm -122.46 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 63' ' ' THR . 28.8 t -72.74 -176.07 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' LYS . 82.3 m-85 -153.0 167.51 28.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.629 -1.294 . . . . 0.0 111.925 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.514 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 80.6 mt-10 -159.42 127.61 5.0 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.398 0.618 . . . . 0.0 110.193 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -129.54 171.36 12.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.15 24.46 Favored Glycine 0 N--CA 1.499 2.874 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.845 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.541 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 63.9 mt-10 -151.24 147.02 26.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -1.096 . . . . 0.0 109.391 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.6 t0 -130.85 157.58 42.49 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -61.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.405 -1.434 . . . . 0.0 109.813 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.8 mt-10 -126.69 40.62 3.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.683 -0.636 . . . . 0.0 109.333 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 49' ' ' HIS . 5.3 t -147.99 76.05 1.36 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.978 . . . . 0.0 110.219 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.522 ' HD1' ' N ' ' A' ' 50' ' ' ASP . 1.4 t-80 56.83 114.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.767 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.522 ' N ' ' HD1' ' A' ' 49' ' ' HIS . 57.2 t0 -45.13 -34.87 2.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.0 110.783 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.508 ' H ' ' ND1' ' A' ' 49' ' ' HIS . 93.0 mmm -75.74 -34.04 60.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' B' ' 95' ' ' LEU . 63.3 mt -89.7 -18.5 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.706 -1.246 . . . . 0.0 109.291 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' GLY . 18.0 ptt180 -101.8 7.94 41.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.244 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 53' ' ' ARG . 68.3 mm-40 38.68 27.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.789 -1.195 . . . . 0.0 110.138 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 53.37 2.71 0.12 Allowed Glycine 0 N--CA 1.499 2.836 0 O-C-N 121.416 -0.803 . . . . 0.0 112.85 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 20.4 p90 -47.82 132.07 14.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.206 -1.761 . . . . 0.0 109.936 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.489 ' HG1' ' HZ2' ' A' ' 13' ' ' LYS . 98.6 m -58.18 -55.05 40.02 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.928 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.637 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 17.0 t60 -167.85 153.89 7.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.926 -1.109 . . . . 0.0 110.188 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.559 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.62 162.15 35.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.206 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 57.8 m-85 -129.2 126.17 38.58 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.493 -0.755 . . . . 0.0 109.062 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -104.57 102.91 12.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.5 mtt -102.42 120.73 41.0 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.177 -0.952 . . . . 0.0 110.816 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.459 ' O ' ' OG ' ' A' ' 39' ' ' SER . 37.0 m -112.02 133.66 54.05 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -119.46 121.04 38.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.689 -1.257 . . . . 0.0 110.084 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 66' ' ' ASN . 0.6 OUTLIER -47.88 -31.55 5.22 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.588 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 18.2 t-20 -157.34 162.4 39.1 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.9 -24.26 64.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 111.465 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.24 -38.39 68.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 0.0 110.573 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.525 ' O ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.63 -33.59 84.93 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.502 ' O ' ' CG2' ' A' ' 74' ' ' THR . 77.7 t80 -66.56 -46.98 74.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.548 -0.972 . . . . 0.0 110.489 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.93 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.427 -1.421 . . . . 0.0 108.651 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -60.64 -34.85 74.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 111.147 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 41.8 p -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.712 -1.243 . . . . 0.0 110.295 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -65.38 -24.15 67.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.18 -0.95 . . . . 0.0 110.986 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.665 ' C ' ' H ' ' A' ' 78' ' ' LEU . 57.5 m80 -79.86 124.58 83.21 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.81 -1.181 . . . . 0.0 109.603 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.59 2.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.665 ' H ' ' C ' ' A' ' 76' ' ' HIS . 6.7 tp -76.37 -34.41 58.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.307 -0.871 . . . . 0.0 111.24 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 58.0 t-80 -82.66 -33.44 27.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 0.0 110.327 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.93 -60.25 2.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.79 -42.97 65.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 17.6 m-85 -72.17 -34.14 68.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.754 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 67.0 m -60.87 -43.04 98.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 110.13 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -41.96 97.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.978 -1.076 . . . . 0.0 108.673 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.4 -43.08 78.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.477 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 2.7 m-85 -44.8 -30.25 0.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.1 p -82.26 -62.2 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.578 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -38.64 -28.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.654 -0.654 . . . . 0.0 110.052 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' THR . 23.3 m -106.35 14.58 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 110.767 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 1.2 mp -124.81 160.2 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.672 -1.268 . . . . 0.0 110.467 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.551 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 58.7 t0 -105.53 -35.95 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -145.95 145.29 30.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 93' ' ' ILE . 3.0 tp -126.11 124.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.672 -1.267 . . . . 0.0 109.744 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.24 130.07 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -130.98 127.22 37.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.325 -1.485 . . . . 0.0 111.759 -178.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.428 ' H ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -118.8 122.46 42.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.653 -0.654 . . . . 0.0 109.358 177.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.447 ' OD2' ' OG ' ' B' ' 48' ' ' SER . 23.1 p-10 -130.2 138.94 50.84 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.11 -0.994 . . . . 0.0 108.864 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 32.3 t80 -159.43 134.71 5.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.075 -1.015 . . . . 0.0 110.52 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 94.9 Cg_exo -42.46 125.57 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.318 2.012 . . . . 0.0 112.19 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.6 t -89.99 116.05 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.29 82.81 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.368 -0.832 . . . . 0.0 109.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.492 ' O ' ' CG1' ' A' ' 103' ' ' VAL . . . -74.37 72.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 5.3 m -161.91 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 25.9 mmtp -92.98 141.57 28.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.1 p -67.65 -25.3 65.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 108.958 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 106' ' ' SER . 5.9 p 61.85 50.88 4.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.83 135.88 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.0 t -51.54 140.47 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.533 -0.73 . . . . 0.0 109.467 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.76 100.48 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.2 p -134.53 69.75 72.52 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.918 -1.114 . . . . 0.0 109.611 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo . . . . . 0 C--N 1.307 -1.606 0 C-N-CA 122.812 2.342 . . . . 0.0 112.283 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.95 57.8 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.365 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.466 ' O ' ' OG ' ' B' ' 4' ' ' SER . 7.4 t -115.86 0.69 13.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.133 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' B' ' 3' ' ' THR . 31.2 m -175.07 -126.23 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 100' ' ' VAL . . . -95.39 172.96 30.83 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.368 -1.396 . . . . 0.0 109.703 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -135.52 136.43 41.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.283 -1.128 . . . . 0.0 108.07 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.54 ' NZ ' ' OE2' ' A' ' 44' ' ' GLU . 20.7 ttpt -114.72 142.61 46.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.075 . . . . 0.0 112.809 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -130.5 129.29 42.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.1 tt -137.29 145.94 44.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.821 -1.175 . . . . 0.0 109.439 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.2 136.66 57.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.64 131.16 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.68 162.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.08 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.48 ' HZ2' ' HG1' ' B' ' 57' ' ' THR . 14.0 tptp -127.6 155.27 44.11 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 11.5 p90 -108.2 149.48 28.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.827 -1.17 . . . . 0.0 111.59 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -127.03 -19.41 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.2 mt-10 -90.64 -56.65 3.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 9.7 t0 153.29 58.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.471 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 68.2 m -46.59 106.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.03 0.919 . . . . 0.0 112.89 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.482 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -73.42 89.35 1.63 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.8 m -61.56 -38.91 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 110.465 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -61.66 -45.4 94.2 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 110.512 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 21.6 mp0 -74.15 -37.59 63.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -67.07 -48.94 77.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' B' ' 20' ' ' VAL . 2.1 tm? -58.0 -41.65 83.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.4 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.703 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -65.34 -55.54 20.46 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.492 ' CD1' ' CD1' ' B' ' 60' ' ' PHE . 7.0 tt -47.42 -35.73 8.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.541 -0.976 . . . . 0.0 108.811 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -53.49 -43.22 68.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.8 p30 -59.83 -42.23 93.06 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.61 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -52.84 -46.15 67.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' B' ' 32' ' ' SER . 38.7 t -52.0 -23.93 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.292 -0.88 . . . . 0.0 108.859 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 43.5 t -44.33 -37.39 3.28 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.538 HE21 ' CG ' ' B' ' 76' ' ' HIS . 8.6 mm100 -79.71 -4.29 51.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 111.466 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.499 ' C ' ' N ' ' B' ' 36' ' ' THR . 6.3 mm -88.24 23.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 119.947 -1.721 . . . . 0.0 110.61 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.44 -16.65 15.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' B' ' 37' ' ' VAL . 44.1 p -68.28 -2.82 9.04 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.932 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' B' ' 36' ' ' THR . 31.3 m 30.55 41.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' B' ' 40' ' ' PHE . 4.1 mtmm -122.4 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' B' ' 63' ' ' THR . 28.9 t -72.62 -176.16 1.87 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' B' ' 38' ' ' LYS . 82.4 m-85 -152.99 167.47 29.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.542 -1.349 . . . . 0.0 111.991 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.487 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 81.0 mt-10 -159.36 127.44 4.98 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.298 0.57 . . . . 0.0 110.227 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -129.46 171.49 12.5 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.2 162.13 24.49 Favored Glycine 0 N--CA 1.5 2.961 0 C-N-CA 118.689 -1.72 . . . . 0.0 110.768 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.544 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 63.1 mt-10 -151.3 146.84 26.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.294 -1.121 . . . . 0.0 109.392 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' B' ' 47' ' ' GLU . 63.3 t0 -130.71 157.47 42.71 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.529 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.07 80.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.378 -1.451 . . . . 0.0 109.825 -177.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -126.68 40.51 3.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.503 ' O ' ' O ' ' B' ' 49' ' ' HIS . 5.4 t -147.85 76.45 1.39 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.169 -0.957 . . . . 0.0 110.173 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.522 ' HD1' ' N ' ' B' ' 50' ' ' ASP . 1.4 t-80 56.59 114.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.195 -0.941 . . . . 0.0 109.676 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.522 ' N ' ' HD1' ' B' ' 49' ' ' HIS . 57.9 t0 -45.14 -34.88 2.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.513 ' H ' ' ND1' ' B' ' 49' ' ' HIS . 93.0 mmm -75.65 -33.9 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.7 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 95' ' ' LEU . 62.6 mt -89.69 -18.7 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.776 -1.202 . . . . 0.0 109.253 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' B' ' 55' ' ' GLY . 18.0 ptt180 -101.78 7.91 41.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.847 . . . . 0.0 111.26 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' B' ' 53' ' ' ARG . 68.8 mm-40 38.68 27.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.803 -1.186 . . . . 0.0 110.214 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 53.31 2.79 0.11 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.37 -0.831 . . . . 0.0 112.791 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 20.1 p90 -47.96 132.08 15.28 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.193 -1.769 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.48 ' HG1' ' HZ2' ' B' ' 13' ' ' LYS . 99.7 m -57.98 -55.27 37.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.325 -0.859 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 17.3 t60 -167.77 153.9 7.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.887 -1.133 . . . . 0.0 110.193 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.543 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.62 162.07 35.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.477 -0.764 . . . . 0.0 109.287 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 57.8 m-85 -129.05 126.05 38.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.11 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -104.48 102.68 12.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 39.7 mtt -102.36 120.9 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 110.673 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.458 ' O ' ' OG ' ' B' ' 39' ' ' SER . 37.9 m -112.02 134.13 53.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' B' ' 64' ' ' PHE . 2.2 m-85 -119.81 121.37 38.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.741 -1.224 . . . . 0.0 109.999 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' B' ' 66' ' ' ASN . 0.6 OUTLIER -48.26 -31.47 5.96 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.592 ' H ' ' CD ' ' B' ' 65' ' ' GLU . 18.0 t-20 -157.32 162.25 39.13 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.7 -24.43 63.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.512 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -55.04 -38.67 68.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.597 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' B' ' 73' ' ' PHE . . . -66.22 -33.7 85.94 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.496 ' O ' ' CG2' ' B' ' 74' ' ' THR . 77.8 t80 -66.61 -47.04 73.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.566 -0.961 . . . . 0.0 110.495 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.73 -28.99 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.356 -1.465 . . . . 0.0 108.67 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.0 -60.86 2.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.338 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -60.57 -34.92 74.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.245 -0.909 . . . . 0.0 111.088 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 42.0 p -73.86 -33.32 64.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.776 -1.203 . . . . 0.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -65.56 -24.31 67.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.0 111.053 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.665 ' C ' ' H ' ' B' ' 78' ' ' LEU . 57.6 m80 -79.58 124.62 83.68 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.829 -1.169 . . . . 0.0 109.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -46.77 2.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.609 2.206 . . . . 0.0 112.446 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.665 ' H ' ' C ' ' B' ' 76' ' ' HIS . 6.7 tp -76.42 -34.51 58.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.348 -0.845 . . . . 0.0 111.238 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.512 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 57.9 t-80 -82.47 -33.47 28.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.037 -1.039 . . . . 0.0 110.324 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.04 -60.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.92 -42.7 65.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.64 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 17.6 m-85 -72.29 -34.23 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.512 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 65.3 m -60.86 -42.99 98.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.048 . . . . 0.0 110.098 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.08 97.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 108.661 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.39 -42.93 78.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.477 ' O ' ' CD1' ' B' ' 90' ' ' ILE . 2.7 m-85 -44.9 -30.22 0.96 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.1 p -82.26 -62.21 1.69 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.577 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -38.66 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.691 -0.63 . . . . 0.0 110.099 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' B' ' 87' ' ' THR . 23.1 m -106.22 14.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.207 -0.933 . . . . 0.0 110.829 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 1.2 mp -124.63 160.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.7 -1.25 . . . . 0.0 110.467 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 58.3 t0 -105.46 -36.02 7.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -145.93 145.24 30.6 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' B' ' 93' ' ' ILE . 3.0 tp -126.15 124.1 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.571 -1.331 . . . . 0.0 109.798 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 t -127.29 130.2 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -131.06 126.9 37.08 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.244 -1.535 . . . . 0.0 111.809 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.42 ' H ' HD11 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -118.55 122.72 43.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.443 ' OD2' ' OG ' ' A' ' 48' ' ' SER . 23.0 p-10 -130.43 138.85 50.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.175 -0.953 . . . . 0.0 108.853 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 32.2 t80 -159.42 134.6 5.75 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.048 -1.032 . . . . 0.0 110.541 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 96.5 Cg_exo -42.36 125.67 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.29 1.993 . . . . 0.0 112.244 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 5' ' ' GLY . 27.4 t -89.96 116.11 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.44 82.85 2.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . 0.481 ' O ' ' CG1' ' B' ' 103' ' ' VAL . . . -74.27 71.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.602 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' B' ' 102' ' ' ALA . 5.5 m -161.58 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.33 -0.856 . . . . 0.0 109.263 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 41' ' ' GLU . 25.8 mmtp -92.88 141.6 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' B' ' 106' ' ' SER . 85.9 p -67.44 -25.58 65.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 108.944 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' B' ' 106' ' ' SER . 6.1 p 62.06 50.73 3.91 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.32 -0.863 . . . . 0.0 109.355 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.78 136.15 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 t -51.92 140.52 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.429 -0.794 . . . . 0.0 109.501 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.69 100.39 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 17.2 p -134.47 69.64 72.8 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.82 -1.175 . . . . 0.0 109.634 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo . . . . . 0 C--N 1.308 -1.582 0 C-N-CA 122.76 2.307 . . . . 0.0 112.219 179.938 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.279 0.562 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.54 57.53 6.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 109.375 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 t -98.32 -12.24 21.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.141 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.659 ' HG ' ' H ' ' A' ' 102' ' ' ALA . 17.7 m -127.79 -81.94 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.08 -168.91 16.91 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.664 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -114.43 130.76 56.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.241 -1.152 . . . . 0.0 108.09 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 21.9 ttpt -101.09 129.66 47.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.908 -1.12 . . . . 0.0 112.824 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -121.59 119.86 33.13 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 173.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 tt -132.51 141.57 48.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.679 -1.263 . . . . 0.0 109.48 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -129.35 136.11 60.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.614 -0.679 . . . . 0.0 109.523 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.27 131.0 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' CG2' ' CD2' ' A' ' 58' ' ' HIS . 35.8 m -139.32 150.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.816 -1.554 . . . . 0.0 113.095 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -127.83 154.74 45.1 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.522 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 16.2 p90 -113.04 156.8 22.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.814 -1.178 . . . . 0.0 111.615 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.36 -18.62 3.58 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.8 mt-10 -91.81 -53.49 4.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.1 t0 149.12 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -53.98 111.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.059 0.933 . . . . 0.0 112.814 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -74.07 86.36 1.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 24' ' ' LEU . 33.2 m -61.55 -42.59 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.553 -0.717 . . . . 0.0 110.547 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -63.45 -45.16 92.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.539 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -68.79 -34.01 74.82 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -67.94 -42.02 85.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.5 tp -58.95 -39.36 81.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -61.15 -35.48 77.21 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.656 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.44 -53.23 40.54 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -44.09 -41.44 5.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.517 -0.99 . . . . 0.0 108.821 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -51.98 -39.12 58.87 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -63.59 -44.49 93.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.584 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -47.15 -48.42 23.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 32' ' ' SER . 86.3 t -55.47 -24.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 0.0 108.873 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 32.2 t -43.44 -43.4 5.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.05 -10.06 48.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 111.433 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 36' ' ' THR . 64.5 mt -92.5 29.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.024 -1.672 . . . . 0.0 110.626 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.91 -8.08 2.04 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.614 ' H ' ' C ' ' A' ' 34' ' ' ILE . 68.2 p -67.5 -10.24 49.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.939 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.55 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 35.3 34.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 109.219 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.3 mttt -118.17 43.94 2.33 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.478 ' HG ' ' H ' ' A' ' 40' ' ' PHE . 14.2 t -176.22 177.59 1.52 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.478 ' H ' ' HG ' ' A' ' 39' ' ' SER . 21.0 t80 -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 0.0 111.914 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 64.2 mt-10 -154.33 124.07 6.66 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.366 0.603 . . . . 0.0 110.207 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.532 ' CE2' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -127.39 169.17 13.89 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.45 138.44 6.42 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.794 -1.67 . . . . 0.0 110.838 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' OE2' ' CE2' ' A' ' 42' ' ' TRP . 4.4 mp0 -124.92 172.63 9.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.209 -1.171 . . . . 0.0 109.323 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 57' ' ' THR . 57.0 t0 -167.58 94.61 0.43 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.613 ' HZ1' ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.15 170.89 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.471 -1.393 . . . . 0.0 109.78 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 48' ' ' SER . 2.4 mt-10 -172.77 90.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER 163.14 147.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 0.0 110.138 -179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 48' ' ' SER . 57.5 m170 57.95 113.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.204 -0.935 . . . . 0.0 109.7 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 51' ' ' MET . 29.0 p-10 -52.53 -43.41 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.313 -0.867 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 23.2 ttt -62.56 -35.03 78.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 17.2 mt -89.08 -20.03 24.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.763 -1.211 . . . . 0.0 109.305 177.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.97 ' O ' ' N ' ' A' ' 55' ' ' GLY . 34.0 ttt-85 -83.83 42.54 0.86 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.384 -0.823 . . . . 0.0 111.217 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.613 ' N ' ' HZ1' ' A' ' 46' ' ' LYS . 34.6 tt0 -31.41 -12.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.739 -1.225 . . . . 0.0 110.195 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.97 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 105.66 -35.79 4.83 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.385 -0.822 . . . . 0.0 112.93 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -55.39 102.82 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.294 -1.709 . . . . 0.0 109.956 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.616 ' OG1' ' ND1' ' A' ' 58' ' ' HIS . 49.1 p -61.99 -34.48 76.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.952 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.616 ' ND1' ' OG1' ' A' ' 57' ' ' THR . 34.7 p-80 -171.74 149.9 2.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.853 -1.154 . . . . 0.0 110.182 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.35 170.87 14.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.434 -0.791 . . . . 0.0 109.26 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -138.64 134.96 34.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.441 ' HB2' ' HE1' ' A' ' 42' ' ' TRP . 10.2 t -111.22 106.24 15.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.539 ' N ' ' O ' ' A' ' 8' ' ' HIS . 67.6 mtt -95.67 119.98 35.12 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.826 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.0 m -116.59 141.78 47.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -121.29 152.46 38.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.742 -1.224 . . . . 0.0 110.073 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -86.27 -23.92 26.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.0 OUTLIER -162.47 165.86 25.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -69.15 -24.73 64.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 0.0 111.446 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.1 -40.61 98.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.825 -1.172 . . . . 0.0 110.602 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . -72.1 -33.44 62.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -66.32 -43.0 87.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.589 -0.948 . . . . 0.0 110.51 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.84 -28.89 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.449 -1.407 . . . . 0.0 108.658 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 69' ' ' GLY . 1.1 m-85 -54.72 -35.42 63.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -0.897 . . . . 0.0 111.084 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.407 ' H ' HG21 ' A' ' 74' ' ' THR . 4.9 t -85.57 -28.93 24.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.739 -1.226 . . . . 0.0 110.327 -177.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -66.21 -34.64 78.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.997 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -61.31 151.53 76.18 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.76 -1.213 . . . . 0.0 109.61 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.07 -7.75 20.74 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.652 2.235 . . . . 0.0 112.407 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tt -76.97 -27.92 54.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.395 -0.816 . . . . 0.0 111.218 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -81.73 -35.53 29.62 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.541 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 6.7 p -70.2 -56.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.006 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.541 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.96 84.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.619 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -59.17 -42.78 91.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.804 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.7 p -65.73 -30.63 71.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 110.106 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.85 -55.19 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 108.687 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.426 ' C ' ' N ' ' A' ' 87' ' ' THR . . . -66.62 -39.35 88.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' ALA . 23.8 t80 -46.47 -25.42 0.67 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 90' ' ' ILE . 5.4 m -83.56 -63.62 1.32 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.01 -33.39 0.31 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.719 -0.613 . . . . 0.0 110.067 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.66 14.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -0.897 . . . . 0.0 110.815 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 26.5 mm -132.35 163.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.609 -1.307 . . . . 0.0 110.412 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 34.7 t0 -113.9 -33.73 5.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -132.87 129.54 38.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.0 tp -128.79 130.44 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.579 -1.326 . . . . 0.0 109.762 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.95 148.07 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.85 129.86 33.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.276 -1.515 . . . . 0.0 111.804 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.631 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -112.73 119.57 38.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.669 -0.644 . . . . 0.0 109.346 178.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.53 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 54.1 t0 -128.33 135.76 50.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.052 -1.03 . . . . 0.0 108.847 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.511 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 36.3 t80 -166.76 140.64 3.24 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 110.54 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.03 106.99 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.266 1.978 . . . . 0.0 112.249 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.49 128.8 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 109.952 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.76 94.71 4.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.654 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.659 ' H ' ' HG ' ' A' ' 4' ' ' SER . . . -156.45 150.59 25.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.091 -1.006 . . . . 0.0 109.562 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 -21.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 109.133 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.736 ' C ' ' H ' ' A' ' 106' ' ' SER . 18.0 mmtp 54.03 -141.74 0.84 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.366 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.97 -12.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 108.961 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.736 ' H ' ' C ' ' A' ' 104' ' ' LYS . 83.7 p -52.46 152.64 3.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.559 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.4 p -140.29 166.03 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 108' ' ' VAL . 5.1 p 32.53 72.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.733 . . . . 0.0 109.545 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.8 174.01 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.6 m -70.72 132.78 86.89 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 120.848 -1.158 . . . . 0.0 109.673 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 C--N 1.308 -1.574 0 C-N-CA 122.795 2.33 . . . . 0.0 112.228 179.659 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.32 0.581 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.43 57.67 5.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 0.0 109.339 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.5 t -98.48 -12.26 21.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.106 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.66 ' HG ' ' H ' ' B' ' 102' ' ' ALA . 16.8 m -127.76 -82.02 0.6 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.94 -168.98 16.89 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.684 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.5 130.52 56.75 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -1.149 . . . . 0.0 108.014 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 22.1 ttpt -100.91 129.71 46.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.975 -1.078 . . . . 0.0 112.838 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' B' ' 97' ' ' ASP . 0.3 OUTLIER -121.52 119.56 32.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.07 141.67 49.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.713 -1.242 . . . . 0.0 109.56 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -129.25 136.34 59.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.485 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.4 131.02 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.416 ' CG2' ' CD2' ' B' ' 58' ' ' HIS . 35.9 m -139.22 150.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 117.706 -1.597 . . . . 0.0 113.046 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -127.91 154.98 44.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.521 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 15.4 p90 -113.34 156.68 22.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.815 -1.178 . . . . 0.0 111.596 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.27 -18.8 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.6 mt-10 -91.73 -53.65 4.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.4 t0 149.2 65.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.8 m -54.14 112.02 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.114 0.959 . . . . 0.0 112.825 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.486 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.11 86.47 1.87 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' B' ' 24' ' ' LEU . 33.0 m -61.86 -42.42 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.622 -0.674 . . . . 0.0 110.477 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.412 ' N ' ' CG2' ' B' ' 20' ' ' VAL . 87.5 m-20 -63.5 -45.03 92.57 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 110.535 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -68.87 -34.43 75.43 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -67.49 -42.11 86.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' B' ' 20' ' ' VAL . 16.5 tp -58.89 -39.51 81.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -60.87 -35.67 77.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.66 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -63.29 -53.32 40.39 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 26' ' ' GLY . 5.9 tt -44.11 -41.28 5.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.989 . . . . 0.0 108.846 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -51.99 -39.07 58.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 0.7 OUTLIER -63.82 -44.17 94.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.568 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.5 OUTLIER -47.59 -47.91 28.35 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 32' ' ' SER . 84.4 t -55.84 -24.47 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 32.5 t -43.65 -43.38 5.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.07 -9.83 49.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.436 -0.79 . . . . 0.0 111.479 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' B' ' 36' ' ' THR . 62.8 mt -92.59 28.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.003 -1.685 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.84 -8.01 1.95 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.6 ' H ' ' C ' ' B' ' 34' ' ' ILE . 66.1 p -67.61 -10.2 49.89 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.945 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.58 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.6 m 35.27 35.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.032 -1.043 . . . . 0.0 109.181 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 36' ' ' THR . 66.4 mttt -118.22 43.99 2.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.477 ' HG ' ' H ' ' B' ' 40' ' ' PHE . 14.4 t -176.27 177.7 1.48 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.477 ' H ' ' HG ' ' B' ' 39' ' ' SER . 21.2 t80 -148.02 156.0 42.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.541 -1.349 . . . . 0.0 112.007 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.452 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 63.8 mt-10 -154.09 124.23 6.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.354 0.597 . . . . 0.0 110.259 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.54 ' CE2' ' OE2' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -127.51 168.92 14.27 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.26 138.34 6.4 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.75 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.54 ' OE2' ' CE2' ' B' ' 42' ' ' TRP . 4.4 mp0 -124.71 173.16 8.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.233 -1.157 . . . . 0.0 109.434 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.577 ' HA ' ' O ' ' B' ' 57' ' ' THR . 57.1 t0 -168.12 94.55 0.39 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.622 ' HZ1' ' N ' ' B' ' 54' ' ' GLN . 0.0 OUTLIER -89.0 170.73 10.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.446 -1.409 . . . . 0.0 109.825 179.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' B' ' 48' ' ' SER . 2.3 mt-10 -172.58 90.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER 163.46 148.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' B' ' 48' ' ' SER . 57.9 m170 57.7 113.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 109.693 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 51' ' ' MET . 28.7 p-10 -52.49 -43.53 65.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.781 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 23.3 ttt -62.34 -35.17 78.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 110.723 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.519 ' O ' ' NZ ' ' B' ' 46' ' ' LYS . 17.0 mt -89.04 -19.91 25.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.336 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.953 ' O ' ' N ' ' B' ' 55' ' ' GLY . 34.1 ttt-85 -83.99 42.65 0.88 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -0.854 . . . . 0.0 111.194 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.622 ' N ' ' HZ1' ' B' ' 46' ' ' LYS . 34.8 tt0 -31.53 -12.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.862 -1.149 . . . . 0.0 110.274 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.953 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 105.88 -36.11 4.62 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.454 -0.779 . . . . 0.0 112.857 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.809 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 0.7 OUTLIER -55.04 102.8 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.302 -1.705 . . . . 0.0 109.987 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.61 ' OG1' ' ND1' ' B' ' 58' ' ' HIS . 49.2 p -61.78 -34.81 76.55 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.307 -0.871 . . . . 0.0 111.015 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.61 ' ND1' ' OG1' ' B' ' 57' ' ' THR . 33.9 p-80 -171.35 150.3 2.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 110.148 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.65 170.8 15.16 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.262 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -138.59 134.9 34.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.439 -0.788 . . . . 0.0 109.128 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.441 ' HB2' ' HE1' ' B' ' 42' ' ' TRP . 10.0 t -111.16 106.24 15.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' MET . . . . . 0.475 ' N ' ' O ' ' B' ' 8' ' ' HIS . 67.7 mtt -95.57 120.33 35.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.149 -0.97 . . . . 0.0 110.833 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m -116.96 141.72 47.87 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -121.27 152.1 39.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.695 -1.253 . . . . 0.0 110.047 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -85.94 -23.76 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.484 ' N ' HD21 ' B' ' 66' ' ' ASN . 0.0 OUTLIER -162.65 166.08 24.98 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -69.35 -24.66 63.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 111.453 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.44 -40.29 96.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.865 -1.147 . . . . 0.0 110.604 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.553 ' O ' ' CE2' ' B' ' 73' ' ' PHE . . . -71.99 -33.78 62.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -66.15 -43.05 88.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.512 -0.993 . . . . 0.0 110.426 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.83 -28.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.412 -1.43 . . . . 0.0 108.626 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.99 2.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.358 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.553 ' CE2' ' O ' ' B' ' 69' ' ' GLY . 1.1 m-85 -54.6 -35.56 63.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.287 -0.883 . . . . 0.0 111.089 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -85.49 -29.0 24.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.822 -1.174 . . . . 0.0 110.347 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 73.8 m -66.11 -34.78 78.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.982 . . . . 0.0 111.056 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -61.11 151.81 73.91 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.24 -7.86 21.23 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.611 2.207 . . . . 0.0 112.499 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 tt -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -0.797 . . . . 0.0 111.202 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -81.37 -35.65 30.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 110.281 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.545 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 6.9 p -70.26 -56.67 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.545 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.89 84.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.15 -42.77 91.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.849 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 88.0 p -65.82 -30.55 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.991 . . . . 0.0 110.069 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.85 36.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 0.0 108.705 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.427 ' C ' ' N ' ' B' ' 87' ' ' THR . . . -66.96 -39.24 87.2 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' B' ' 85' ' ' ALA . 24.0 t80 -46.73 -25.05 0.66 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.427 ' N ' ' C ' ' B' ' 85' ' ' ALA . 5.7 m -83.91 -63.48 1.34 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.07 -33.18 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.771 -0.581 . . . . 0.0 110.086 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 7.0 m -92.89 14.83 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.173 -0.954 . . . . 0.0 110.811 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 26.2 mm -132.43 164.16 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.651 -1.281 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 34.8 t0 -114.07 -33.71 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -132.94 129.58 38.47 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 7.1 tp -128.83 130.56 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.516 -1.365 . . . . 0.0 109.757 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.06 147.94 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.86 130.03 33.27 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.237 -1.54 . . . . 0.0 111.759 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.63 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.1 OUTLIER -112.85 119.42 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.325 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' B' ' 8' ' ' HIS . 54.7 t0 -128.24 135.7 50.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.107 -0.996 . . . . 0.0 108.918 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.492 ' N ' ' OD1' ' B' ' 97' ' ' ASP . 36.1 t80 -166.7 140.65 3.28 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.111 -0.993 . . . . 0.0 110.49 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.95 106.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.273 1.982 . . . . 0.0 112.264 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.38 128.67 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.121 -0.987 . . . . 0.0 110.079 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.65 94.74 4.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.511 -0.743 . . . . 0.0 109.554 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . 0.66 ' H ' ' HG ' ' B' ' 4' ' ' SER . . . -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 0.0 109.62 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.52 -21.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.21 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.717 ' C ' ' H ' ' B' ' 106' ' ' SER . 18.1 mmtp 54.45 -141.87 0.83 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.28 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.89 -12.7 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.143 -0.973 . . . . 0.0 108.916 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.717 ' H ' ' C ' ' B' ' 104' ' ' LYS . 83.5 p -52.49 152.44 3.57 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.537 ' O ' ' C ' ' B' ' 108' ' ' VAL . 7.4 p -140.16 165.57 21.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.558 ' O ' HG12 ' B' ' 108' ' ' VAL . 5.0 p 32.96 72.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.61 174.26 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.293 -0.879 . . . . 0.0 108.635 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 22.0 m -71.07 132.69 86.27 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 120.8 -1.187 . . . . 0.0 109.606 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 0 C--N 1.307 -1.623 0 C-N-CA 122.796 2.33 . . . . 0.0 112.267 179.708 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.686 ' O ' ' N ' ' A' ' 3' ' ' THR . 7.4 ptp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.31 0.576 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.546 ' O ' HG21 ' A' ' 3' ' ' THR . . . 60.0 -62.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.362 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.686 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.5 OUTLIER 74.77 -2.81 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.116 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.3 m -174.65 -129.13 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.94 168.59 26.19 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.653 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.91 128.14 47.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -1.15 . . . . 0.0 108.028 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' NZ ' ' CD ' ' B' ' 44' ' ' GLU . 4.3 ttpm? -106.5 134.66 49.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 112.885 -177.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -126.17 124.48 40.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -131.76 142.03 49.65 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.678 -1.264 . . . . 0.0 109.526 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.08 138.21 53.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.482 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.83 131.69 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.19 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 117.88 -1.528 . . . . 0.0 113.071 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -127.49 147.74 50.31 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.8 ' CB ' ' H ' ' A' ' 18' ' ' THR . 17.7 t80 -111.31 158.88 18.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.0 111.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.701 ' HG3' ' H ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.42 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.701 ' H ' ' HG3' ' A' ' 15' ' ' LYS . 83.6 mt-10 -85.95 -49.99 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.5 t0 160.31 98.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.8 ' H ' ' CB ' ' A' ' 14' ' ' PHE . 3.4 m -51.43 153.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.121 0.963 . . . . 0.0 112.84 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 18' ' ' THR . 0.0 OUTLIER -77.84 87.69 4.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.32 -33.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.507 -0.746 . . . . 0.0 110.517 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.74 -42.02 86.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.443 -0.785 . . . . 0.0 110.508 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 70.7 mm-40 -67.64 -30.31 69.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mm -70.9 -37.46 68.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -54.12 -36.87 63.71 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -35.46 80.37 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.95 -54.58 17.18 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -47.96 41.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.5 -1.0 . . . . 0.0 108.883 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.08 -43.61 70.48 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.647 ' ND2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -65.0 -47.52 77.23 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.27 -44.64 44.0 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 34' ' ' ILE . 78.7 t -55.62 -25.02 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.28 -0.887 . . . . 0.0 108.866 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 51.0 m -43.27 -39.09 2.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.425 ' OE1' ' CG ' ' A' ' 76' ' ' HIS . 99.5 mm-40 -67.55 0.89 2.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 111.425 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 36' ' ' THR . 72.2 mt -108.17 26.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.074 -1.641 . . . . 0.0 110.607 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -60.42 -8.42 2.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.609 ' O ' ' C ' ' A' ' 37' ' ' VAL . 29.4 p -84.21 0.23 49.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.964 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.609 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.3 m 30.26 38.99 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.29 3.59 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 63' ' ' THR . 18.4 t -174.07 178.27 2.16 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 91.9 m-85 -144.53 154.49 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 111.993 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 81.0 mt-10 -158.01 127.46 5.86 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.342 0.591 . . . . 0.0 110.267 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -133.43 172.59 12.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' B' ' 98' ' ' PHE . . . -131.89 163.87 23.75 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.816 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.677 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 18.9 mt-10 -149.49 142.54 24.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.247 -1.149 . . . . 0.0 109.34 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 47' ' ' GLU . 42.2 m-20 -125.63 155.79 40.22 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 81.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.395 -1.44 . . . . 0.0 109.771 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.7 mt-10 -103.04 39.33 1.57 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' B' ' 97' ' ' ASP . 11.7 m -142.75 168.33 19.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 0.0 110.129 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ARG . 78.0 m80 -48.37 140.79 7.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.134 -0.979 . . . . 0.0 109.757 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 78.7 m-20 -44.48 -46.4 9.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.759 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 110.732 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 43.5 mt -102.0 -19.12 15.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.713 -1.242 . . . . 0.0 109.241 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.761 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -72.25 -5.34 35.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.905 . . . . 0.0 111.217 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.62 -8.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.827 -1.17 . . . . 0.0 110.149 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.761 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 72.77 -13.16 3.23 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.386 -0.821 . . . . 0.0 112.844 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 3.5 p90 -59.54 129.9 44.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.308 -1.701 . . . . 0.0 109.985 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.9 p -54.07 -43.04 69.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.88 . . . . 0.0 111.008 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.677 ' CE1' ' H ' ' A' ' 44' ' ' GLU . 19.0 t60 -173.36 159.4 3.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.143 . . . . 0.0 110.147 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.649 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.07 167.9 21.0 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 0.0 109.208 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 81.0 m-85 -132.94 129.48 38.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.114 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.2 m -106.6 100.72 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.9 mtm -104.79 129.14 53.1 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.19 -0.944 . . . . 0.0 110.745 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 39' ' ' SER . 52.3 m -126.48 143.44 51.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 65' ' ' GLU . 93.1 m-85 -124.5 130.13 51.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.679 -1.263 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' PHE . 84.6 tt0 -47.93 -33.82 8.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.545 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -161.54 166.37 27.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -55.27 -22.47 18.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 111.459 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD2' ' NZ ' ' A' ' 38' ' ' LYS . 22.9 t70 -53.63 -40.49 65.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.791 -1.193 . . . . 0.0 110.651 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.01 -36.16 64.55 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -64.39 -44.16 92.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.631 -0.923 . . . . 0.0 110.472 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.77 -28.9 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.331 -1.481 . . . . 0.0 108.68 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.86 2.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -59.12 -46.7 87.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 111.08 -177.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.62 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 11.6 t -69.84 -36.13 75.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.747 -1.22 . . . . 0.0 110.307 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.0 p -65.43 -27.21 68.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -0.98 . . . . 0.0 110.941 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 55.3 m80 -72.17 151.29 92.41 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.836 -1.165 . . . . 0.0 109.562 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.98 -5.35 16.13 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 5.6 tp -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 111.198 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 83' ' ' SER . 11.1 t-160 -82.61 -40.75 20.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.074 -1.016 . . . . 0.0 110.241 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.35 -61.72 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.998 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -53.16 -38.07 62.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.612 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.647 ' CZ ' ' ND2' ' A' ' 29' ' ' ASN . 8.1 m-85 -74.37 -33.62 63.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.838 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' HIS . 21.2 t -61.23 -44.09 97.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 110.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.35 96.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.99 -1.069 . . . . 0.0 108.667 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.19 -43.42 78.14 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.22 -31.64 0.64 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 89' ' ' VAL . 22.3 m -80.43 -62.25 1.73 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.97 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.3 m -113.95 7.26 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 86' ' ' PHE . 60.9 mt -123.5 157.72 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.656 -1.277 . . . . 0.0 110.452 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.472 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 22.5 t70 -108.37 -30.28 8.4 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -145.59 142.98 29.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 tp -125.39 123.51 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.635 -1.29 . . . . 0.0 109.852 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 t -126.05 131.59 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -138.3 133.24 32.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.207 -1.558 . . . . 0.0 111.793 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.16 126.58 50.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.307 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.454 ' O ' ' OG ' ' B' ' 48' ' ' SER . 64.8 t0 -124.69 130.43 52.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.085 -1.009 . . . . 0.0 108.952 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.648 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -157.65 124.23 2.55 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.035 -1.041 . . . . 0.0 110.501 -179.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.648 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 79.8 Cg_exo -45.01 133.68 11.03 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.287 1.991 . . . . 0.0 112.235 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.2 t -110.35 133.3 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 110.001 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -110.9 94.05 4.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.463 -0.773 . . . . 0.0 109.634 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.27 69.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 109.516 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 101' ' ' ALA . 21.7 m -151.45 110.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.134 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.686 ' C ' ' H ' ' A' ' 106' ' ' SER . 24.6 mmtp -125.41 1.46 7.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.44 -23.38 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 104' ' ' LYS . 1.7 m 61.15 54.62 3.24 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.257 -0.902 . . . . 0.0 109.35 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t -142.31 -123.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.703 ' CG1' ' H ' ' A' ' 109' ' ' ALA . 2.8 p -140.05 -103.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 109.5 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.703 ' H ' ' CG1' ' A' ' 108' ' ' VAL . . . -136.39 157.13 47.52 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.36 154.51 91.88 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 120.876 -1.14 . . . . 0.0 109.639 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.781 2.321 . . . . 0.0 112.29 179.63 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.677 ' O ' ' N ' ' B' ' 3' ' ' THR . 7.3 ptp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.547 ' O ' HG21 ' B' ' 3' ' ' THR . . . 59.89 -62.22 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.677 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.5 OUTLIER 74.8 -2.94 2.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.877 . . . . 0.0 109.149 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' B' ' 3' ' ' THR . 40.0 m -174.48 -129.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.87 168.44 26.19 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.688 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.85 128.25 47.34 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 4.3 ttpm? -106.39 134.77 49.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.989 -1.07 . . . . 0.0 112.823 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -126.25 124.5 40.52 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.85 141.98 49.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.7 -1.25 . . . . 0.0 109.491 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 138.22 54.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.612 -0.68 . . . . 0.0 109.542 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.75 131.69 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.28 146.31 29.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 117.702 -1.599 . . . . 0.0 113.04 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -127.65 147.75 50.37 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.798 ' CB ' ' H ' ' B' ' 18' ' ' THR . 17.5 t80 -111.37 158.83 18.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.867 -1.146 . . . . 0.0 111.596 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.699 ' HG3' ' H ' ' B' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.699 ' H ' ' HG3' ' B' ' 15' ' ' LYS . 83.6 mt-10 -86.05 -49.95 7.41 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.5 t0 160.35 98.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' B' ' 14' ' ' PHE . 3.4 m -51.28 153.77 1.94 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.062 0.935 . . . . 0.0 112.909 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.517 ' N ' ' CG2' ' B' ' 18' ' ' THR . 0.0 OUTLIER -78.01 87.6 4.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -64.24 -33.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.605 -0.684 . . . . 0.0 110.562 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 29.7 p-10 -66.71 -42.1 86.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.793 . . . . 0.0 110.56 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 70.5 mm-40 -67.64 -30.28 69.8 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mm -70.78 -37.48 69.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -54.28 -36.64 63.86 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -35.54 80.66 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.02 -54.39 17.9 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.86 -47.7 42.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.633 -0.922 . . . . 0.0 108.855 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.44 -43.59 71.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.642 ' ND2' ' CZ ' ' B' ' 82' ' ' PHE . 0.2 OUTLIER -64.95 -47.5 77.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.046 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.25 -44.71 43.93 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' B' ' 32' ' ' SER . 77.4 t -55.51 -25.11 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.273 -0.892 . . . . 0.0 108.789 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 50.9 m -43.12 -39.25 2.72 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' B' ' 76' ' ' HIS . 99.5 mm-40 -67.37 0.88 2.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 111.536 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.559 ' C ' ' H ' ' B' ' 36' ' ' THR . 72.1 mt -108.18 26.64 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.043 -1.661 . . . . 0.0 110.581 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.8 p30 -60.47 -8.49 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.625 ' O ' ' C ' ' B' ' 37' ' ' VAL . 29.6 p -84.1 0.14 49.6 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.966 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.625 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.5 m 30.32 38.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.093 -1.004 . . . . 0.0 109.149 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.33 3.58 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' B' ' 63' ' ' THR . 20.4 t -174.19 178.29 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 91.9 m-85 -144.59 154.39 42.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.555 -1.341 . . . . 0.0 112.002 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.533 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 81.7 mt-10 -158.01 127.57 5.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.441 0.639 . . . . 0.0 110.192 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -133.62 172.54 12.6 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 98' ' ' PHE . . . -131.93 163.8 23.78 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.725 -1.702 . . . . 0.0 110.854 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.687 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 18.4 mt-10 -149.4 142.48 24.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -1.158 . . . . 0.0 109.35 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' B' ' 47' ' ' GLU . 42.3 m-20 -125.53 155.76 40.11 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 81.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.354 -1.466 . . . . 0.0 109.743 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -103.11 39.14 1.61 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 97' ' ' ASP . 11.9 m -142.82 168.21 20.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 110.164 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' B' ' 53' ' ' ARG . 78.0 m80 -48.26 140.78 7.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.686 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 78.1 m-20 -44.57 -46.27 9.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.773 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.4 ttt -61.76 -28.85 69.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.718 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 95' ' ' LEU . 43.3 mt -102.14 -18.98 15.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.748 ' CG ' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -72.36 -5.28 35.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 111.238 -177.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.82 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.827 -1.17 . . . . 0.0 110.204 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.748 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 73.04 -13.32 3.37 Favored Glycine 0 N--CA 1.498 2.82 0 O-C-N 121.433 -0.792 . . . . 0.0 112.83 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 3.4 p90 -59.44 129.9 44.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.328 -1.689 . . . . 0.0 109.908 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 28.8 p -53.99 -43.2 69.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 111.039 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.687 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 18.9 t60 -173.17 159.6 3.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.903 -1.123 . . . . 0.0 110.175 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.662 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.22 167.74 21.41 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.507 -0.746 . . . . 0.0 109.282 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.402 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 80.9 m-85 -132.84 129.55 38.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.443 -0.785 . . . . 0.0 109.104 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -106.55 100.95 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 56.7 mtm -105.13 129.15 53.6 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.467 ' O ' ' OG ' ' B' ' 39' ' ' SER . 50.4 m -126.53 143.52 51.18 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' B' ' 65' ' ' GLU . 93.3 m-85 -124.6 130.0 51.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 0.0 110.014 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 64' ' ' PHE . 84.4 tt0 -47.88 -33.67 7.84 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.546 ' N ' ' OD1' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -161.71 166.41 26.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -55.39 -22.7 20.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 111.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.492 ' OD2' ' NZ ' ' B' ' 38' ' ' LYS . 22.6 t70 -53.23 -40.69 64.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.704 -1.248 . . . . 0.0 110.574 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.17 65.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -64.19 -44.43 91.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.921 . . . . 0.0 110.47 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.77 -28.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.331 -1.481 . . . . 0.0 108.704 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -60.94 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.309 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -58.76 -46.74 86.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 0.0 111.191 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.621 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 11.6 t -69.9 -36.13 75.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.706 -1.246 . . . . 0.0 110.308 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 77.9 p -65.51 -27.08 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -0.993 . . . . 0.0 110.924 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.423 ' CG ' ' OE1' ' B' ' 33' ' ' GLN . 55.0 m80 -72.22 151.18 92.29 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.8 -1.187 . . . . 0.0 109.559 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.87 -5.12 15.52 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.632 2.221 . . . . 0.0 112.517 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' B' ' 82' ' ' PHE . 5.6 tp -73.22 -28.67 62.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.323 -0.861 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 83' ' ' SER . 11.0 t-160 -82.56 -40.69 20.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.031 -1.043 . . . . 0.0 110.226 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.45 -61.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.33 -38.02 62.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.642 ' CZ ' ' ND2' ' B' ' 29' ' ' ASN . 8.2 m-85 -74.39 -33.54 63.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 109.873 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.438 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.1 t -61.32 -44.08 97.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.0 110.084 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.89 96.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.001 -1.062 . . . . 0.0 108.685 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.72 -43.13 76.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.45 -31.58 0.72 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.542 ' O ' ' N ' ' B' ' 89' ' ' VAL . 22.0 m -80.36 -62.2 1.75 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.18 -21.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.754 -0.591 . . . . 0.0 110.078 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.4 m -114.32 7.36 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.224 -0.922 . . . . 0.0 110.83 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 61.8 mt -123.5 157.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.659 -1.276 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 22.2 t70 -108.33 -30.45 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -145.63 142.97 29.56 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 tp -125.38 123.51 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.535 -1.353 . . . . 0.0 109.753 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 t -125.99 131.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -138.32 133.25 32.78 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.207 -1.558 . . . . 0.0 111.707 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.07 126.7 50.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.695 -0.628 . . . . 0.0 109.308 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.465 ' O ' ' OG ' ' A' ' 48' ' ' SER . 65.1 t0 -124.8 130.34 52.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 108.943 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.658 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 0.1 OUTLIER -157.49 124.15 2.57 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.048 -1.033 . . . . 0.0 110.539 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . 0.658 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 79.7 Cg_exo -44.85 133.73 10.57 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.179 1.919 . . . . 0.0 112.274 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -110.44 133.2 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -110.74 94.19 4.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.448 -0.783 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.37 69.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.018 . . . . 0.0 109.558 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' B' ' 101' ' ' ALA . 21.7 m -151.44 110.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 0.0 109.246 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.688 ' C ' ' H ' ' B' ' 106' ' ' SER . 24.7 mmtp -125.45 1.39 7.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 109.381 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.48 -23.41 0.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.938 . . . . 0.0 108.94 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.688 ' H ' ' C ' ' B' ' 104' ' ' LYS . 1.8 m 61.22 54.39 3.26 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 5.2 t -142.16 -123.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.736 ' CG1' ' H ' ' B' ' 109' ' ' ALA . 2.8 p -139.97 -103.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.474 -0.766 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . 0.736 ' H ' ' CG1' ' B' ' 108' ' ' VAL . . . -136.42 157.28 47.16 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.48 154.68 91.64 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 120.926 -1.109 . . . . 0.0 109.583 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 C-N-CA 122.786 2.324 . . . . 0.0 112.223 179.641 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 24.1 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 4' ' ' SER . . . 76.9 -155.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 109.339 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.508 HG21 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER 73.09 -39.61 0.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.126 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 2' ' ' ALA . 75.1 m -91.64 -132.13 0.12 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.02 177.13 20.82 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.332 -1.413 . . . . 0.0 109.655 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -114.17 131.77 56.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -107.03 137.63 44.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.908 -1.12 . . . . 0.0 112.827 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -129.95 129.13 43.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -134.33 145.04 48.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.766 -1.209 . . . . 0.0 109.498 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.04 133.55 68.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.436 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.28 128.89 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 m -139.0 161.85 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 117.779 -1.568 . . . . 0.0 113.053 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 18.3 tptm -125.2 152.22 44.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.455 ' N ' ' HG3' ' A' ' 13' ' ' LYS . 41.6 p90 -111.04 152.55 26.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.857 -1.152 . . . . 0.0 111.574 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -127.5 -24.71 3.28 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 63.2 tt0 -89.7 -53.61 4.44 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.4 t0 147.57 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.2 m -54.84 111.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.095 0.95 . . . . 0.0 112.889 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.623 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.07 86.41 5.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.5 m -57.82 -33.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.551 -0.718 . . . . 0.0 110.456 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -66.19 -37.57 85.93 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -70.8 -35.85 72.73 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.27 -40.82 89.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.22 -35.79 60.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -56.94 -30.12 63.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -76.68 -44.93 14.13 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 tt -49.47 -56.34 10.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.568 -0.96 . . . . 0.0 108.835 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 8.0 pt-20 -51.49 -35.44 40.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 51.7 m-20 -67.2 -46.58 73.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 4.1 mm? -47.71 -51.43 21.97 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.6 t -48.91 -34.12 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 108.888 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.3 m -45.15 -50.24 11.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.79 -1.55 2.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.475 -0.766 . . . . 0.0 111.419 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 36' ' ' THR . 6.3 mt -112.37 34.06 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.997 -1.689 . . . . 0.0 110.626 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -56.31 -10.48 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.618 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.2 t -85.88 -1.57 57.4 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.03 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 35.4 m 35.6 39.96 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.034 -1.041 . . . . 0.0 109.167 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' O ' ' OG ' ' A' ' 39' ' ' SER . 59.2 mttt -116.87 43.21 2.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 38.6 m -174.27 175.07 2.73 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' C ' ' CD ' ' A' ' 41' ' ' GLU . 77.3 m-85 -147.95 157.18 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.524 -1.36 . . . . 0.0 112.002 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' CD ' ' C ' ' A' ' 40' ' ' PHE . 58.7 mp0 -156.28 123.85 5.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.452 0.644 . . . . 0.0 110.172 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.52 172.25 9.85 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.97 155.56 21.04 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.798 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.582 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 76.6 mm-40 -149.12 136.65 20.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -1.127 . . . . 0.0 109.345 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 88.6 m-20 -111.43 142.87 43.12 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HZ3' ' C ' ' A' ' 58' ' ' HIS . 9.9 pttm -141.54 109.39 5.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.369 -1.457 . . . . 0.0 109.826 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -147.0 45.33 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.679 -0.638 . . . . 0.0 109.305 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 49' ' ' HIS . 10.1 t -133.16 124.44 27.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 48' ' ' SER . 58.1 m-70 60.97 116.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -60.34 -38.28 83.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.364 -0.835 . . . . 0.0 110.827 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -71.18 -35.53 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.031 -1.043 . . . . 0.0 110.729 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 54' ' ' GLN . 26.5 mt -80.68 -58.27 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.806 -1.184 . . . . 0.0 109.292 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.6 ptt180 -63.53 14.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.242 -0.911 . . . . 0.0 111.209 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.569 ' H ' ' C ' ' A' ' 52' ' ' LEU . 24.9 mt-30 43.56 4.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.789 -1.194 . . . . 0.0 110.187 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 84.5 -16.94 32.32 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.478 -0.764 . . . . 0.0 112.844 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.507 ' CE2' ' NZ ' ' A' ' 92' ' ' LYS . 48.2 m-85 -61.94 -134.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.253 -1.733 . . . . 0.0 109.998 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -162.89 -34.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.284 -0.885 . . . . 0.0 111.027 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.658 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 8.5 t60 -168.47 153.59 6.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 110.125 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.658 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.56 169.1 18.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.385 -0.822 . . . . 0.0 109.283 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.653 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 90.0 m-85 -132.06 128.43 38.21 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 0.0 109.083 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -100.18 99.76 10.5 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -103.07 123.08 45.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.766 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.9 m -123.12 145.62 48.43 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' ASN . 92.2 m-85 -120.92 120.33 35.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.722 -1.237 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -50.92 -24.46 3.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 64' ' ' PHE . 42.2 t-20 -171.26 171.26 5.71 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -58.91 -20.42 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 111.446 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -58.67 -41.95 87.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.835 -1.166 . . . . 0.0 110.574 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.68 -32.93 66.93 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -66.86 -44.11 81.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.927 . . . . 0.0 110.538 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.322 -1.486 . . . . 0.0 108.649 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.91 2.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.349 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -50.57 -34.78 27.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -0.871 . . . . 0.0 111.182 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 76' ' ' HIS . 3.7 t -85.63 -30.15 23.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.824 -1.172 . . . . 0.0 110.294 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 t -67.41 16.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.126 -0.984 . . . . 0.0 110.971 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.519 ' H ' ' C ' ' A' ' 74' ' ' THR . 56.1 m80 -133.06 152.05 79.0 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 0.0 109.602 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.84 1.44 8.12 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.669 2.246 . . . . 0.0 112.507 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.26 -31.77 72.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.369 -0.832 . . . . 0.0 111.256 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 83' ' ' SER . 75.2 t60 -84.85 -31.84 23.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.117 -0.989 . . . . 0.0 110.237 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.13 -62.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.993 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.1 -42.46 72.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -75.13 -32.91 61.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 79' ' ' HIS . 13.7 t -63.25 -42.92 99.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.158 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.34 99.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.978 -1.076 . . . . 0.0 108.686 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -65.21 -41.8 94.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.465 ' O ' HG12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -44.66 -31.13 1.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' VAL . 18.7 m -81.68 -63.14 1.45 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.18 -28.74 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.718 -0.614 . . . . 0.0 110.057 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 87' ' ' THR . 5.3 m -103.99 6.95 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.122 -0.986 . . . . 0.0 110.848 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 28.4 mm -129.57 161.92 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.64 -1.287 . . . . 0.0 110.436 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.508 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 61.4 t0 -121.85 -30.01 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.507 ' NZ ' ' CE2' ' A' ' 56' ' ' PHE . 18.1 ttpt -131.04 129.06 41.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 93' ' ' ILE . 3.4 tp -123.69 121.44 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.643 -1.286 . . . . 0.0 109.799 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 t -131.17 134.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -143.17 141.27 31.1 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.273 -1.517 . . . . 0.0 111.755 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.93 118.92 33.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.649 -0.657 . . . . 0.0 109.311 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 39.3 p30 -128.26 136.46 51.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.059 -1.026 . . . . 0.0 108.983 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 9.3 p90 -172.48 156.14 3.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 110.481 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.19 124.87 15.16 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.293 1.995 . . . . 0.0 112.187 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.5 t -109.66 136.05 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 110.022 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.58 104.02 9.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.501 -0.75 . . . . 0.0 109.612 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.46 160.28 13.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.001 . . . . 0.0 109.579 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.02 -10.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 109.238 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.843 ' C ' ' H ' ' A' ' 106' ' ' SER . 3.7 mmpp? 54.94 -145.72 0.61 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.322 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.53 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 108.904 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.843 ' H ' ' C ' ' A' ' 104' ' ' LYS . 75.2 m -61.62 124.64 21.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.36 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.562 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.7 p -129.71 140.45 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 107' ' ' VAL . 2.3 p 160.97 77.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.518 -0.739 . . . . 0.0 109.401 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.1 116.77 23.66 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 p -70.35 150.89 95.81 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 120.898 -1.126 . . . . 0.0 109.675 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 122.873 2.382 . . . . 0.0 112.231 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.515 ' O ' ' CB ' ' B' ' 2' ' ' ALA . 24.1 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.324 0.583 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' B' ' 4' ' ' SER . . . 76.8 -155.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 109.313 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.506 HG21 ' N ' ' B' ' 4' ' ' SER . 0.4 OUTLIER 73.09 -39.68 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.141 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.525 ' H ' ' C ' ' B' ' 2' ' ' ALA . 74.9 m -91.66 -132.25 0.12 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.03 176.75 21.07 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.727 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -113.85 131.99 56.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.301 -1.117 . . . . 0.0 108.029 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -107.41 137.5 45.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.988 -1.07 . . . . 0.0 112.809 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -130.03 129.18 43.34 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -134.36 145.03 48.6 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.702 -1.248 . . . . 0.0 109.53 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 p -126.09 133.69 68.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.45 128.63 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 m -138.92 161.56 29.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.741 -1.584 . . . . 0.0 113.026 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 18.2 tptm -124.73 152.34 43.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.455 ' N ' ' HG3' ' B' ' 13' ' ' LYS . 41.5 p90 -111.16 152.42 27.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.818 -1.176 . . . . 0.0 111.589 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -127.46 -24.73 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 62.8 tt0 -89.77 -53.64 4.42 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.5 t0 147.5 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 28.3 m -54.77 111.32 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.11 0.957 . . . . 0.0 112.857 -177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.619 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.4 86.13 5.78 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.32 -33.51 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.554 -0.716 . . . . 0.0 110.443 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.19 -37.77 86.41 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -70.54 -35.97 73.43 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.28 -40.71 88.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.26 -35.84 60.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' B' ' 28' ' ' GLU . 0.0 OUTLIER -56.94 -30.01 63.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -76.76 -44.78 14.15 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 1.2 tt -49.52 -56.37 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.5 -1.0 . . . . 0.0 108.824 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 8.1 pt-20 -51.49 -35.52 40.54 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 51.6 m-20 -67.17 -46.54 73.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 4.1 mm? -47.72 -51.39 22.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 32' ' ' SER . 52.1 t -48.98 -34.13 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.251 -0.906 . . . . 0.0 108.824 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 7.3 m -45.27 -49.95 12.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -64.79 -1.62 2.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 111.553 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' B' ' 36' ' ' THR . 6.1 mt -112.32 34.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.079 -1.638 . . . . 0.0 110.625 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -56.54 -10.61 1.01 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.618 ' H ' ' C ' ' B' ' 34' ' ' ILE . 1.2 t -85.81 -1.84 57.64 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.4 m 35.97 39.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.053 -1.029 . . . . 0.0 109.23 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.533 ' O ' ' OG ' ' B' ' 39' ' ' SER . 58.5 mttt -116.72 43.33 2.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.533 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 38.2 m -174.17 175.48 2.69 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.492 ' C ' ' CD ' ' B' ' 41' ' ' GLU . 77.1 m-85 -148.18 157.4 43.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.531 -1.356 . . . . 0.0 111.959 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.492 ' CD ' ' C ' ' B' ' 40' ' ' PHE . 58.5 mp0 -156.48 123.82 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.439 0.638 . . . . 0.0 110.194 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.5 172.11 9.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.74 155.54 20.97 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.768 -1.682 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.577 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 76.7 mm-40 -149.19 136.61 20.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -1.202 . . . . 0.0 109.392 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 90.4 m-20 -111.51 142.8 43.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.494 ' HZ3' ' C ' ' B' ' 58' ' ' HIS . 10.0 pttm -141.6 109.33 5.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.419 -1.426 . . . . 0.0 109.785 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -146.98 45.46 1.17 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.625 -0.672 . . . . 0.0 109.293 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' B' ' 49' ' ' HIS . 10.0 t -133.11 124.42 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.183 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.414 ' CD2' ' OG ' ' B' ' 48' ' ' SER . 58.2 m-70 60.88 116.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.166 -0.959 . . . . 0.0 109.664 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -60.93 -38.07 84.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.747 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -71.02 -35.5 72.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.753 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' B' ' 54' ' ' GLN . 26.5 mt -80.93 -58.42 3.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.704 -1.247 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.756 ' O ' ' N ' ' B' ' 55' ' ' GLY . 17.3 ptt180 -63.33 14.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 0.0 111.222 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.579 ' H ' ' C ' ' B' ' 52' ' ' LEU . 24.7 mt-30 43.76 4.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.814 -1.179 . . . . 0.0 110.157 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 84.71 -16.91 33.51 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.357 -0.84 . . . . 0.0 112.861 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.496 ' CE2' ' NZ ' ' B' ' 92' ' ' LYS . 47.9 m-85 -62.08 -134.08 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.884 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -163.01 -34.39 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.249 -0.907 . . . . 0.0 111.014 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.671 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 8.0 t60 -168.68 153.67 6.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.846 -1.159 . . . . 0.0 110.164 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.671 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.57 169.08 18.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.483 -0.761 . . . . 0.0 109.262 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.656 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 89.8 m-85 -131.98 128.5 38.53 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.112 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 30.0 t -100.29 99.59 10.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 64.1 mtt -103.07 123.08 45.96 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.771 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 46.3 m -123.0 145.83 48.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.14 120.27 34.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.744 -1.223 . . . . 0.0 110.048 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -51.06 -24.47 3.9 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -171.07 171.55 5.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -59.29 -20.23 52.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.363 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -58.8 -41.74 87.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.804 -1.185 . . . . 0.0 110.583 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.91 -33.11 65.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -66.56 -44.31 82.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.941 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.8 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.426 -1.421 . . . . 0.0 108.731 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.12 -60.89 2.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -50.29 -35.32 26.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.258 -0.901 . . . . 0.0 111.161 -177.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.9 t -85.21 -30.44 23.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.721 -1.237 . . . . 0.0 110.353 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -67.18 16.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.115 -0.991 . . . . 0.0 110.97 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' B' ' 74' ' ' THR . 56.3 m80 -133.48 152.28 78.88 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.813 -1.179 . . . . 0.0 109.602 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.15 1.64 8.05 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.697 2.264 . . . . 0.0 112.445 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.5 -31.66 71.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.408 -0.808 . . . . 0.0 111.231 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' B' ' 83' ' ' SER . 75.8 t60 -84.98 -31.69 23.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.1 . . . . 0.0 110.312 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.31 -61.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.33 -42.78 74.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.573 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -74.83 -32.85 62.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 79' ' ' HIS . 13.7 t -63.41 -43.05 98.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.21 98.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 108.698 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -65.64 -41.57 92.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.455 ' O ' HG12 ' B' ' 90' ' ' ILE . 1.0 OUTLIER -44.87 -31.16 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.418 ' O ' ' C ' ' B' ' 88' ' ' ALA . 18.4 m -81.47 -63.08 1.47 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.0 -29.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.657 -0.652 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 87' ' ' THR . 5.3 m -103.83 7.21 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.139 -0.976 . . . . 0.0 110.805 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 28.0 mm -129.64 161.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.605 -1.309 . . . . 0.0 110.419 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 62.0 t0 -121.87 -30.0 4.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.496 ' NZ ' ' CE2' ' B' ' 56' ' ' PHE . 17.5 ttpt -131.24 129.01 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' B' ' 93' ' ' ILE . 3.4 tp -123.58 121.61 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 109.709 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 8.0 t -131.36 134.71 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -143.1 141.18 31.17 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.349 -1.469 . . . . 0.0 111.765 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.76 119.05 33.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.363 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 40.6 p30 -128.51 136.39 50.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.094 -1.003 . . . . 0.0 108.896 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 9.3 p90 -172.32 156.23 3.61 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.015 -1.053 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.29 124.85 15.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.316 2.011 . . . . 0.0 112.248 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.72 136.14 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 110.038 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.55 103.89 9.25 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -167.52 160.23 12.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.559 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.03 -10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.823 ' C ' ' H ' ' B' ' 106' ' ' SER . 3.7 mmpp? 54.89 -145.6 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.347 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.54 -26.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 108.908 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.823 ' H ' ' C ' ' B' ' 104' ' ' LYS . 75.6 m -61.51 124.87 21.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' B' ' 108' ' ' VAL . 7.3 p -129.98 140.5 48.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' B' ' 107' ' ' VAL . 2.3 p 160.9 77.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.533 -0.729 . . . . 0.0 109.52 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.84 116.92 23.57 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.3 p -70.6 151.06 95.5 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 120.804 -1.185 . . . . 0.0 109.676 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo . . . . . 0 C--N 1.307 -1.637 0 C-N-CA 122.775 2.317 . . . . 0.0 112.279 179.674 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.25 77.22 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.967 . . . . 0.0 109.319 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 t -100.1 0.45 40.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.162 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -162.85 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.53 174.18 19.82 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.367 -1.397 . . . . 0.0 109.696 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.5 131.52 56.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.313 -1.11 . . . . 0.0 108.014 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 10.6 ttpt -105.29 133.11 50.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.935 -1.103 . . . . 0.0 112.837 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 97' ' ' ASP . 60.5 m80 -125.6 125.97 44.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.888 -1.894 . . . . 0.0 105.888 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -136.0 143.41 44.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.43 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.9 p -127.69 136.69 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.637 -0.665 . . . . 0.0 109.486 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.2 128.12 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.08 159.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 117.848 -1.541 . . . . 0.0 113.083 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 91' ' ' ASP . 11.1 mtpt -121.16 153.87 36.96 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 14' ' ' PHE . 17.1 p90 -102.61 144.03 31.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.818 -1.176 . . . . 0.0 111.604 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -116.03 -29.61 6.27 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.7 tt0 -88.54 -55.18 3.83 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.564 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 13.6 m-20 152.19 74.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 39.3 m -62.24 109.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.103 0.954 . . . . 0.0 112.876 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.638 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.14 92.22 5.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.6 m -57.59 -35.27 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 110.475 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.1 p-10 -66.46 -39.58 88.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 110.554 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 96.4 mt-10 -70.67 -32.64 69.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.63 -42.48 83.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.49 -39.26 70.2 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -60.07 -24.73 64.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.621 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -82.42 -45.84 6.75 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.5 tt -49.05 -52.45 25.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.488 -1.007 . . . . 0.0 108.838 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 18.7 pt-20 -52.83 -40.28 63.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.1 m-20 -58.62 -43.9 89.79 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -47.33 -46.75 25.7 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' SER . 37.8 t -49.14 -27.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 108.842 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 37.4 t -42.93 -48.16 5.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.773 HE22 ' NE2' ' A' ' 76' ' ' HIS . 8.9 mm100 -72.8 -23.25 60.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 111.481 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.555 ' C ' ' H ' ' A' ' 36' ' ' THR . 73.2 mt -82.63 23.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.043 -1.661 . . . . 0.0 110.636 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.63 -10.89 2.53 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 43.9 p -79.94 -1.0 37.46 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.6 m 35.4 32.61 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 109.117 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 20.1 mtmm -120.02 42.71 2.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' THR . 27.7 t -172.76 171.98 4.26 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -148.83 160.98 42.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.645 -1.284 . . . . 0.0 111.943 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 63.2 mt-10 -151.91 116.71 5.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.393 0.616 . . . . 0.0 110.2 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.486 ' C ' ' NZ ' ' B' ' 104' ' ' LYS . 11.4 t-105 -104.66 159.2 15.96 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.435 ' N ' ' HZ3' ' B' ' 104' ' ' LYS . . . -118.81 151.49 17.69 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.736 -1.697 . . . . 0.0 110.803 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 70.9 mt-10 -150.84 133.47 15.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.211 -1.17 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.6 p-10 -155.46 86.56 1.08 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HZ1' ' C ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -78.81 155.42 29.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.398 -1.439 . . . . 0.0 109.81 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.4 mt-10 -155.52 59.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.67 -0.644 . . . . 0.0 109.331 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 49' ' ' HIS . 54.6 p -172.37 138.2 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.131 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 m80 60.82 113.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.14 -0.975 . . . . 0.0 109.688 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -55.44 -44.03 75.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 110.797 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.2 mtt -60.32 -35.74 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.746 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' B' ' 96' ' ' LEU . 12.2 mt -93.3 -28.97 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.74 -1.225 . . . . 0.0 109.283 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 1.065 ' O ' ' N ' ' A' ' 55' ' ' GLY . 39.6 ttt-85 -79.07 2.86 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.299 -0.876 . . . . 0.0 111.296 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.627 HE21 ' CG1' ' B' ' 94' ' ' VAL . 8.7 mt-30 33.72 2.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.709 -1.244 . . . . 0.0 110.212 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 1.065 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.54 -24.82 1.43 Allowed Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.379 -0.826 . . . . 0.0 112.877 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.513 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 6.5 m-85 -59.24 -142.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.26 -1.73 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.522 ' OG1' ' ND1' ' A' ' 58' ' ' HIS . 66.4 p -142.71 -48.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -0.848 . . . . 0.0 110.999 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.522 ' ND1' ' OG1' ' A' ' 57' ' ' THR . 35.7 p-80 -173.6 159.63 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.0 110.105 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.14 172.32 13.61 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.395 -0.815 . . . . 0.0 109.221 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -138.5 133.83 33.17 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.416 -0.803 . . . . 0.0 109.12 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.6 t -110.17 102.22 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.64 125.99 44.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.269 -0.894 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 39' ' ' SER . 31.7 m -120.55 142.83 48.99 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.26 130.59 46.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.717 -1.239 . . . . 0.0 110.066 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -55.7 -31.04 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -153.84 160.48 42.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.79 -19.7 43.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.957 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.55 -39.1 72.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.813 -1.18 . . . . 0.0 110.594 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.65 77.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.447 ' O ' ' CG2' ' A' ' 74' ' ' THR . 75.7 t80 -69.17 -45.68 69.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.969 . . . . 0.0 110.432 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.81 -28.91 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.355 -1.466 . . . . 0.0 108.645 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.355 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 3.5 t80 -54.46 -32.05 56.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 30.9 p -75.42 -31.21 60.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.762 -1.211 . . . . 0.0 110.303 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.7 t -82.34 -0.73 47.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.115 -0.991 . . . . 0.0 110.961 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.773 ' NE2' HE22 ' A' ' 33' ' ' GLN . 62.1 m80 -97.8 126.36 41.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.758 -1.214 . . . . 0.0 109.61 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -41.51 -14.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.0 112.418 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.2 tp -68.73 -29.26 67.63 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 111.228 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.517 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 81.6 t60 -79.88 -42.77 23.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.046 -1.034 . . . . 0.0 110.226 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.38 -60.68 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.005 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.89 -39.2 77.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -73.24 -42.49 62.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.847 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 66.8 m -62.17 -39.86 94.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.39 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 108.69 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -70.34 -41.99 72.47 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 25.6 t80 -45.96 -30.63 1.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 89' ' ' VAL . 17.6 m -80.77 -62.73 1.58 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.93 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.69 -0.631 . . . . 0.0 110.045 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 87' ' ' THR . 19.4 m -103.84 10.38 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.163 -0.96 . . . . 0.0 110.786 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 91' ' ' ASP . 1.1 mp -119.9 154.5 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.667 -1.271 . . . . 0.0 110.426 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 13' ' ' LYS . 63.8 t0 -101.37 -34.65 9.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.58 148.7 31.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -126.88 125.27 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.619 -1.3 . . . . 0.0 109.786 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.631 ' CG1' HE21 ' B' ' 54' ' ' GLN . 5.3 t -134.25 136.53 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -138.74 137.91 37.18 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.279 -1.513 . . . . 0.0 111.779 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.641 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -112.13 118.09 34.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.632 -0.667 . . . . 0.0 109.333 176.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 56.7 t0 -123.74 126.72 47.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.044 -1.035 . . . . 0.0 108.924 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 55.3 t80 -167.86 137.72 2.17 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.019 -1.051 . . . . 0.0 110.487 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.0 Cg_exo -47.7 124.45 9.73 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.26 1.973 . . . . 0.0 112.199 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.427 HG13 ' HE1' ' B' ' 42' ' ' TRP . 76.1 t -114.19 140.44 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.939 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -109.81 78.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 109.617 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.13 88.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.541 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 101' ' ' ALA . 13.1 m -149.17 116.12 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.828 . . . . 0.0 109.163 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 105' ' ' SER . 5.8 ptmt -176.43 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.362 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 107' ' ' VAL . 0.3 OUTLIER 162.05 -44.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 108.965 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.3 t -64.75 44.33 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.286 -0.884 . . . . 0.0 109.395 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' SER . 3.5 t -139.77 -135.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.519 ' H ' ' CG1' ' A' ' 107' ' ' VAL . 11.6 p -149.89 151.16 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 109.487 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.2 115.65 26.86 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.4 m -133.29 73.2 74.43 Favored Pre-proline 0 C--N 1.303 -1.43 0 O-C-N 120.848 -1.158 . . . . 0.0 109.623 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.308 -1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 112.287 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.326 0.584 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.94 77.4 0.31 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.379 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -100.22 0.28 40.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.15 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -162.55 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.62 174.22 19.84 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.423 -1.37 . . . . 0.0 109.697 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.49 131.45 56.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.272 -1.134 . . . . 0.0 108.013 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.518 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 10.6 ttpt -105.08 133.14 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.894 -1.129 . . . . 0.0 112.821 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' B' ' 97' ' ' ASP . 60.5 m80 -125.72 126.04 43.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.4 tt -136.12 143.43 44.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.836 -1.165 . . . . 0.0 109.45 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 11.8 p -127.62 136.68 59.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.485 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.09 128.17 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.2 159.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 117.706 -1.598 . . . . 0.0 113.043 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' B' ' 91' ' ' ASP . 11.2 mtpt -121.13 153.81 37.0 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.528 ' HB2' ' H ' ' B' ' 18' ' ' THR . 17.3 p90 -102.61 143.96 31.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.94 -1.1 . . . . 0.0 111.585 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -115.97 -29.58 6.3 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 78.7 tt0 -88.65 -55.07 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 13.6 m-20 152.03 74.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 39.5 m -62.34 109.56 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.122 0.963 . . . . 0.0 112.862 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.672 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.2 92.21 5.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' B' ' 24' ' ' LEU . 8.6 m -57.71 -35.1 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 110.413 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.5 p-10 -66.54 -39.63 88.68 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 110.563 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 96.4 mt-10 -70.71 -32.6 69.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.66 -42.43 83.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' B' ' 20' ' ' VAL . 7.3 tp -55.6 -39.2 70.43 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.2 OUTLIER -60.02 -24.86 64.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -82.16 -45.93 6.82 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.5 tt -49.0 -52.43 25.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.968 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 18.6 pt-20 -52.96 -40.24 63.54 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 40.5 m-20 -58.59 -44.01 89.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -47.28 -46.71 25.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' B' ' 32' ' ' SER . 37.6 t -49.16 -27.77 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.91 . . . . 0.0 108.775 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 37.0 t -42.85 -48.29 5.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.781 HE22 ' NE2' ' B' ' 76' ' ' HIS . 8.8 mm100 -72.52 -23.45 61.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.461 -0.774 . . . . 0.0 111.509 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.564 ' C ' ' H ' ' B' ' 36' ' ' THR . 73.4 mt -82.57 23.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.009 -1.682 . . . . 0.0 110.558 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.6 -10.91 2.52 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' N ' ' B' ' 38' ' ' LYS . 44.1 p -79.93 -0.93 37.15 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.97 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.7 m 35.43 32.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.177 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' B' ' 36' ' ' THR . 20.1 mtmm -119.93 43.01 2.78 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.4 t -172.98 171.79 4.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -148.92 160.87 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.562 -1.336 . . . . 0.0 112.002 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.499 ' C ' ' HZ2' ' A' ' 104' ' ' LYS . 63.0 mt-10 -151.85 116.7 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.369 0.604 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.485 ' C ' ' NZ ' ' A' ' 104' ' ' LYS . 11.4 t-105 -104.62 159.27 15.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.437 ' N ' ' HZ3' ' A' ' 104' ' ' LYS . . . -118.91 151.44 17.68 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 118.695 -1.716 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.528 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 71.7 mt-10 -150.84 133.46 15.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.27 -1.136 . . . . 0.0 109.379 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 43.1 p-10 -155.47 86.62 1.08 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.547 ' HZ1' ' C ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -78.91 155.35 29.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.365 -1.459 . . . . 0.0 109.872 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.5 mt-10 -155.51 59.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.646 -0.659 . . . . 0.0 109.338 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.415 ' O ' ' O ' ' B' ' 49' ' ' HIS . 54.1 p -172.53 138.04 0.86 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 110.142 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' B' ' 53' ' ' ARG . 43.7 m80 61.03 113.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.684 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -55.33 -44.09 75.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.821 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.42 -35.56 76.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 12.2 mt -93.46 -28.93 15.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.724 -1.235 . . . . 0.0 109.244 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 1.066 ' O ' ' N ' ' B' ' 55' ' ' GLY . 39.8 ttt-85 -79.07 2.82 19.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.394 -0.816 . . . . 0.0 111.246 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.631 HE21 ' CG1' ' A' ' 94' ' ' VAL . 8.7 mt-30 33.7 2.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.77 -1.206 . . . . 0.0 110.206 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 1.066 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.41 -24.76 1.39 Allowed Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.449 -0.782 . . . . 0.0 112.865 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 6.5 m-85 -59.23 -142.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.292 -1.711 . . . . 0.0 109.928 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.518 ' OG1' ' ND1' ' B' ' 58' ' ' HIS . 64.6 p -142.73 -48.3 0.33 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.518 ' ND1' ' OG1' ' B' ' 57' ' ' THR . 35.8 p-80 -173.72 159.45 3.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.891 -1.131 . . . . 0.0 110.186 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.8 172.37 13.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 109.283 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -138.54 133.77 33.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.479 -0.763 . . . . 0.0 109.132 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -110.04 102.28 11.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.68 125.83 44.11 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.198 -0.939 . . . . 0.0 110.782 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.1 m -120.33 142.97 48.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -129.38 130.55 46.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.746 -1.221 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -55.56 -31.17 61.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -153.74 160.64 42.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.97 -19.66 45.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 111.421 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.61 -39.02 72.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.839 -1.163 . . . . 0.0 110.611 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.59 77.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.435 ' O ' ' CG2' ' B' ' 74' ' ' THR . 75.7 t80 -69.07 -45.89 69.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.645 -0.915 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.92 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.354 -1.466 . . . . 0.0 108.745 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.457 -0.777 . . . . 0.0 109.365 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.54 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 3.5 t80 -54.22 -32.16 55.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 111.118 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 30.9 p -75.31 -31.34 60.63 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.761 -1.212 . . . . 0.0 110.372 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t -82.21 -0.85 47.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.097 -1.002 . . . . 0.0 110.894 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.781 ' NE2' HE22 ' B' ' 33' ' ' GLN . 62.3 m80 -97.66 126.49 40.91 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.829 -1.169 . . . . 0.0 109.595 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -41.64 -14.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.65 2.234 . . . . 0.0 112.454 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' B' ' 76' ' ' HIS . 8.3 tp -68.79 -29.39 67.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.422 -0.799 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 81.5 t60 -79.59 -42.83 24.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.088 . . . . 0.0 110.324 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.46 -60.69 2.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.981 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.79 -39.38 77.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.245 -0.909 . . . . 0.0 109.616 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -73.04 -42.58 62.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 66.6 m -62.15 -39.87 94.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.172 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.59 77.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.673 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -70.22 -41.88 73.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' B' ' 90' ' ' ILE . 26.2 t80 -46.1 -30.54 1.94 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' B' ' 89' ' ' VAL . 17.6 m -80.77 -62.72 1.59 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.07 -29.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.717 -0.615 . . . . 0.0 110.084 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 87' ' ' THR . 19.5 m -103.99 10.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.225 -0.922 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.471 HG23 ' N ' ' B' ' 91' ' ' ASP . 1.1 mp -119.9 154.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.593 -1.317 . . . . 0.0 110.481 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' B' ' 13' ' ' LYS . 64.2 t0 -101.41 -34.75 9.46 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -147.59 148.53 31.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 tp -126.82 125.29 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.569 -1.332 . . . . 0.0 109.688 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.627 ' CG1' HE21 ' A' ' 54' ' ' GLN . 5.1 t -134.17 136.5 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.1 OUTLIER -138.69 137.98 37.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.359 -1.463 . . . . 0.0 111.854 -178.347 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.621 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.8 OUTLIER -112.1 118.08 34.39 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 8' ' ' HIS . 56.1 t0 -123.75 126.71 46.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.16 -0.962 . . . . 0.0 108.883 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 55.9 t80 -167.71 137.79 2.24 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . 0.525 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 88.6 Cg_exo -47.74 124.49 9.83 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.267 1.978 . . . . 0.0 112.21 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . 0.412 HG13 ' HE1' ' A' ' 42' ' ' TRP . 76.2 t -114.24 140.38 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.99 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.86 78.6 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.06 88.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.003 . . . . 0.0 109.581 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' B' ' 101' ' ' ALA . 13.3 m -149.11 116.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.827 . . . . 0.0 109.153 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' B' ' 105' ' ' SER . 5.9 ptmt -176.5 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' B' ' 104' ' ' LYS . 0.3 OUTLIER 162.06 -44.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 8.2 t -64.59 44.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.253 -0.905 . . . . 0.0 109.456 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 105' ' ' SER . 3.5 t -139.8 -135.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.526 ' H ' ' CG1' ' B' ' 107' ' ' VAL . 11.7 p -149.8 151.31 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -0.795 . . . . 0.0 109.503 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.3 115.6 26.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 18.8 m -133.26 73.35 74.31 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.859 -1.15 . . . . 0.0 109.666 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 C--N 1.308 -1.577 0 C-N-CA 122.815 2.344 . . . . 0.0 112.235 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.339 0.59 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.596 ' O ' ' CB ' ' A' ' 3' ' ' THR . . . 56.89 -148.34 0.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.317 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.596 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 81.86 -4.3 1.53 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.163 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.4 t -137.55 -98.38 0.2 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.91 175.77 20.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.722 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.51 128.94 56.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -1.115 . . . . 0.0 108.064 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -102.72 131.04 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.947 -1.096 . . . . 0.0 112.857 -177.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -125.22 123.59 39.89 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -131.16 140.04 49.87 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.716 -1.24 . . . . 0.0 109.481 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 70.5 t -126.22 132.67 70.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.545 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.0 130.53 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.18 167.17 27.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.775 -1.57 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 91' ' ' ASP . 2.2 mmmt -137.41 151.24 48.33 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.641 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 7.7 m-85 -108.07 147.3 31.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 111.637 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -127.83 -28.06 2.73 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 75.6 tt0 -87.77 -59.11 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.5 m-20 153.14 69.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 14' ' ' PHE . 31.8 m -60.02 111.71 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.063 0.935 . . . . 0.0 112.844 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.677 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.3 87.3 5.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 176.197 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.92 -32.6 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 110.487 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.3 p-10 -65.32 -37.32 86.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 96.3 mt-10 -69.79 -35.31 74.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.2 mm -62.81 -45.22 99.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -50.24 -37.29 34.92 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -59.9 -36.29 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -78.82 -42.87 12.2 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.38 -59.36 4.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -1.001 . . . . 0.0 108.837 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.28 -34.89 59.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.75 -45.48 92.1 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -50.26 -44.86 53.82 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' ILE . 48.3 t -45.13 -35.41 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.243 -0.91 . . . . 0.0 108.889 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' VAL . 20.1 m -42.2 -45.86 4.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.466 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 22.4 mp0 -70.89 -23.58 62.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 111.496 176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 36' ' ' THR . 22.1 mt -85.86 28.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 119.967 -1.708 . . . . 0.0 110.667 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.3 p30 -62.22 -7.2 3.84 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 38' ' ' LYS . 2.0 t -86.44 1.89 49.75 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.971 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.5 m 37.45 28.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.083 -1.011 . . . . 0.0 109.198 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 36' ' ' THR . 78.9 mttt -118.42 39.43 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.17 157.03 30.06 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.514 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 99.3 m-85 -143.95 154.0 42.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.624 -1.297 . . . . 0.0 112.013 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 40' ' ' PHE . 55.5 mp0 -158.83 125.26 4.61 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.379 0.609 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 43' ' ' GLY . 53.1 t-105 -124.02 174.33 7.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -132.63 153.31 20.58 Favored Glycine 0 N--CA 1.499 2.837 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 72.8 mt-10 -147.48 137.88 23.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.204 -1.174 . . . . 0.0 109.319 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.41 144.18 48.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -149.13 122.51 9.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.502 -1.374 . . . . 0.0 109.769 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 56' ' ' PHE . 65.1 mm-40 -151.5 45.46 0.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.692 . . . . 0.0 109.335 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -124.23 121.87 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.186 -0.946 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.413 ' HD1' ' CG ' ' A' ' 51' ' ' MET . 0.2 OUTLIER 62.84 119.89 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.16 -0.963 . . . . 0.0 109.658 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.496 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 80.9 m-20 -56.38 -41.53 76.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 0.0 110.805 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.413 ' CG ' ' HD1' ' A' ' 49' ' ' HIS . 5.0 ptp -71.66 -32.01 67.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.084 . . . . 0.0 110.751 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.53 ' C ' ' H ' ' A' ' 54' ' ' GLN . 83.7 mt -86.96 -52.54 5.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.157 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.749 ' C ' ' H ' ' A' ' 55' ' ' GLY . 15.3 ptt180 -61.93 7.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 0.0 111.219 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.53 ' H ' ' C ' ' A' ' 52' ' ' LEU . 4.7 mm-40 53.5 -8.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.702 -1.249 . . . . 0.0 110.207 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.749 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 86.88 -21.64 18.37 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.846 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.428 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 3.2 m-85 -66.23 -128.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.247 -1.737 . . . . 0.0 109.91 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -164.85 -33.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.84 . . . . 0.0 111.002 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.645 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.8 t60 -171.77 154.25 3.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.645 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.56 171.4 14.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.218 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.32 121.26 35.36 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.365 -0.834 . . . . 0.0 109.087 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m -96.71 101.41 13.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.4 mtt -109.81 123.4 49.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 110.828 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.0 m -124.38 148.11 47.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.64 156.06 39.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.694 -1.254 . . . . 0.0 110.118 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 48.8 tp10 -82.91 -28.31 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 15.3 m120 -164.65 169.23 17.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.5 ' CB ' ' NZ ' ' A' ' 67' ' ' LYS . 8.3 mtmp? -58.9 -18.94 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 111.432 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 25.4 p-10 -59.52 -40.66 87.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.771 -1.205 . . . . 0.0 110.562 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -71.3 -32.89 64.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -67.4 -44.7 78.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.522 -0.987 . . . . 0.0 110.498 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.9 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.336 -1.478 . . . . 0.0 108.657 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.88 2.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.261 -0.899 . . . . 0.0 109.345 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.2 -35.49 59.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 111.112 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -84.23 -30.11 25.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.704 -1.247 . . . . 0.0 110.29 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.6 p -68.52 -29.57 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.965 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' A' ' 78' ' ' LEU . 16.4 m-70 -76.81 127.4 84.11 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 0.0 109.562 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.3 -7.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.4 tp -70.87 -26.19 63.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.351 -0.843 . . . . 0.0 111.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.417 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.5 t60 -80.93 -42.62 21.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.049 . . . . 0.0 110.218 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 3.7 p -64.92 -57.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.529 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 93.2 mt-10 -58.89 -42.73 90.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 81.3 t80 -66.45 -43.36 85.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.863 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -59.89 -33.23 71.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.131 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.63 53.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.935 -1.103 . . . . 0.0 108.681 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -72.22 -43.45 64.43 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 85' ' ' ALA . 26.5 t80 -42.77 -29.02 0.28 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 89' ' ' VAL . 5.8 m -84.52 -61.49 1.78 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.16 -28.73 0.06 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.706 -0.621 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.489 ' O ' ' OG1' ' A' ' 18' ' ' THR . 8.9 m -97.45 13.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.196 -0.94 . . . . 0.0 110.816 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' A' ' 86' ' ' PHE . 74.3 mt -123.19 156.03 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.628 -1.295 . . . . 0.0 110.45 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.0 t0 -98.64 -35.4 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -147.63 146.04 29.19 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.85 126.25 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.62 -1.3 . . . . 0.0 109.727 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t -132.07 135.44 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -139.06 134.97 33.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.303 -1.498 . . . . 0.0 111.751 -178.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 1.6 mp -113.82 119.08 36.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.681 -0.637 . . . . 0.0 109.303 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.37 130.29 50.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.023 -1.048 . . . . 0.0 108.96 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -172.0 140.03 1.1 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.057 -1.027 . . . . 0.0 110.486 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.91 121.38 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.296 1.998 . . . . 0.0 112.173 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.4 t -109.05 138.11 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.992 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.19 107.55 10.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.376 -0.828 . . . . 0.0 109.639 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.88 149.63 26.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.51 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -154.91 147.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.247 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 65.77 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.348 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 106' ' ' SER . 23.2 m -51.67 -23.42 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.15 -0.969 . . . . 0.0 108.944 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' SER . 1.4 p 76.22 144.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.388 -0.82 . . . . 0.0 109.336 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.6 t 52.45 67.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 108' ' ' VAL . 13.3 p -145.16 30.65 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.55 -0.719 . . . . 0.0 109.468 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.13 161.14 0.9 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.38 151.99 95.6 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 120.823 -1.173 . . . . 0.0 109.678 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo . . . . . 0 C--N 1.308 -1.599 0 C-N-CA 122.788 2.325 . . . . 0.0 112.26 179.702 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.3 0.572 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.6 ' O ' ' CB ' ' B' ' 3' ' ' THR . . . 56.95 -148.32 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 109.382 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.6 ' CB ' ' O ' ' B' ' 2' ' ' ALA . 0.5 OUTLIER 81.78 -3.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 109.09 179.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t -137.73 -98.36 0.19 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.96 175.97 20.27 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.374 -1.393 . . . . 0.0 109.698 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -114.69 129.09 56.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.44 ' O ' ' NZ ' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -102.97 130.87 50.21 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.319 1.057 . . . . 0.0 112.851 -177.274 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -124.99 123.59 40.2 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.3 tt -131.14 140.06 49.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.762 -1.211 . . . . 0.0 109.444 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 70.0 t -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.586 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.27 130.41 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.17 167.25 26.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 117.723 -1.591 . . . . 0.0 113.058 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' B' ' 91' ' ' ASP . 2.2 mmmt -137.47 151.01 48.02 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD1' ' OG1' ' B' ' 18' ' ' THR . 7.6 m-85 -107.88 147.37 31.05 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.785 -1.197 . . . . 0.0 111.57 -178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -127.99 -27.76 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 75.2 tt0 -88.19 -58.93 2.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.4 m-20 153.07 69.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.639 ' OG1' ' CD1' ' B' ' 14' ' ' PHE . 32.5 m -60.15 111.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.034 0.921 . . . . 0.0 112.927 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.676 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.28 87.34 5.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.02 -32.42 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.661 . . . . 0.0 110.433 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -65.34 -37.43 87.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.56 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 96.3 mt-10 -69.76 -35.37 74.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' B' ' 26' ' ' GLY . 3.3 mm -62.6 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -50.35 -37.04 34.9 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -60.1 -35.88 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -79.3 -42.7 11.48 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -54.31 -59.39 4.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.545 -0.973 . . . . 0.0 108.85 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.41 -34.89 59.51 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -45.56 91.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' B' ' 31' ' ' VAL . 0.4 OUTLIER -50.15 -44.99 52.85 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' B' ' 34' ' ' ILE . 48.4 t -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.245 -0.909 . . . . 0.0 108.792 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.433 ' C ' ' O ' ' B' ' 31' ' ' VAL . 20.4 m -42.37 -45.64 4.38 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' B' ' 33' ' ' GLN . 22.3 mp0 -71.1 -23.55 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 111.535 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' B' ' 36' ' ' THR . 22.2 mt -85.79 28.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.006 -1.684 . . . . 0.0 110.571 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.4 p30 -62.36 -7.14 3.91 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.612 ' O ' ' N ' ' B' ' 38' ' ' LYS . 1.9 t -86.55 2.08 49.37 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.874 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.515 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.5 m 37.47 28.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 109.167 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' B' ' 36' ' ' THR . 78.5 mttt -118.3 39.88 3.32 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 156.72 28.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.505 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 99.3 m-85 -143.75 153.83 42.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.497 -1.377 . . . . 0.0 111.946 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' B' ' 40' ' ' PHE . 56.1 mp0 -158.76 125.23 4.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.407 0.622 . . . . 0.0 110.208 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.558 ' CD1' ' N ' ' B' ' 43' ' ' GLY . 53.0 t-105 -124.01 174.69 7.44 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.558 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -133.28 152.91 20.55 Favored Glycine 0 N--CA 1.498 2.82 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.839 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.562 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 71.2 mt-10 -147.2 137.87 23.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.46 143.95 48.24 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.92 122.84 9.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.386 -1.446 . . . . 0.0 109.816 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' B' ' 56' ' ' PHE . 64.9 mm-40 -151.79 45.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.665 -0.647 . . . . 0.0 109.388 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -124.12 121.7 35.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 110.172 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.42 ' HD1' ' CG ' ' B' ' 51' ' ' MET . 0.2 OUTLIER 62.92 119.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.484 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 79.4 m-20 -56.3 -41.52 76.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.838 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.42 ' CG ' ' HD1' ' B' ' 49' ' ' HIS . 4.9 ptp -71.8 -31.91 67.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.034 . . . . 0.0 110.726 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' B' ' 54' ' ' GLN . 84.0 mt -86.95 -52.45 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.712 -1.243 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.733 ' C ' ' H ' ' B' ' 55' ' ' GLY . 15.4 ptt180 -62.02 7.94 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 111.307 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' B' ' 52' ' ' LEU . 4.6 mm-40 53.53 -8.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.832 -1.168 . . . . 0.0 110.225 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.733 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 87.12 -21.48 20.17 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.468 -0.77 . . . . 0.0 112.864 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.442 ' O ' ' OE2' ' B' ' 47' ' ' GLU . 3.2 m-85 -66.39 -128.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.278 -1.719 . . . . 0.0 109.915 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.8 t -164.46 -34.15 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.276 -0.89 . . . . 0.0 111.0 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.648 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.9 t60 -171.61 154.56 3.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.803 -1.186 . . . . 0.0 110.231 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.648 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.98 171.09 14.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.02 121.26 35.64 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -96.65 101.48 13.1 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 38.8 mtt -109.9 123.6 49.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 110.782 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 97.1 m -124.71 147.93 48.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.53 156.03 39.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.668 -1.27 . . . . 0.0 110.058 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 50.2 tp10 -82.7 -28.64 30.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 15.6 m120 -164.31 169.74 17.09 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.493 ' CB ' ' NZ ' ' B' ' 67' ' ' LYS . 8.2 mtmp? -59.14 -19.09 41.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 0.0 111.406 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 26.5 p-10 -59.51 -40.67 87.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.905 -1.122 . . . . 0.0 110.55 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -71.22 -32.79 65.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -67.41 -44.87 77.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.644 -0.915 . . . . 0.0 110.445 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.8 -28.88 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.352 -1.468 . . . . 0.0 108.671 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.84 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -35.25 59.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 111.141 -176.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -84.51 -30.01 25.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.744 -1.223 . . . . 0.0 110.339 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 95.0 p -68.43 -29.56 68.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.12 -0.988 . . . . 0.0 110.964 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 78' ' ' LEU . 16.4 m-70 -76.97 127.53 83.54 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.4 -7.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.598 2.199 . . . . 0.0 112.48 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.4 tp -70.82 -26.38 63.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.408 -0.808 . . . . 0.0 111.178 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -80.86 -42.7 21.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 110.276 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.533 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 3.6 p -64.8 -57.61 10.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 110.024 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.533 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 93.2 mt-10 -58.9 -42.67 90.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.299 -0.876 . . . . 0.0 109.587 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 81.1 t80 -66.48 -43.48 85.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.818 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -59.71 -33.36 71.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.111 -0.993 . . . . 0.0 110.149 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.93 49.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 108.644 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -71.81 -43.54 65.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.477 ' O ' ' CD1' ' B' ' 90' ' ' ILE . 26.4 t80 -42.75 -29.2 0.29 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.471 ' O ' ' N ' ' B' ' 89' ' ' VAL . 5.4 m -84.32 -61.62 1.76 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.98 -28.67 0.06 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.681 -0.637 . . . . 0.0 110.098 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.492 ' O ' ' OG1' ' B' ' 18' ' ' THR . 9.2 m -97.69 13.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.477 ' CD1' ' O ' ' B' ' 86' ' ' PHE . 73.4 mt -123.39 156.1 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.651 -1.281 . . . . 0.0 110.437 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' B' ' 13' ' ' LYS . 61.8 t0 -98.54 -35.45 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -147.66 145.71 29.04 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 tp -124.46 126.06 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.556 -1.34 . . . . 0.0 109.727 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 22.3 t -131.74 135.68 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.613 ' N ' ' CD1' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -139.11 135.04 33.69 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.256 -1.527 . . . . 0.0 111.798 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.606 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 1.7 mp -113.86 119.04 35.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 109.33 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.22 130.48 51.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.102 -0.999 . . . . 0.0 108.97 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -171.98 140.08 1.1 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.126 -0.984 . . . . 0.0 110.538 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.86 121.18 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.308 2.005 . . . . 0.0 112.194 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 63.4 t -108.77 138.29 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 110.037 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.4 107.79 10.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.581 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.13 149.62 26.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 m -155.03 147.72 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.377 -0.827 . . . . 0.0 109.233 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 65.53 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.373 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' B' ' 106' ' ' SER . 24.4 m -51.31 -23.83 4.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' B' ' 105' ' ' SER . 1.4 p 76.53 144.83 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.367 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t 52.53 67.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' B' ' 108' ' ' VAL . 13.3 p -145.16 30.59 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.52 -0.737 . . . . 0.0 109.524 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.91 161.17 0.82 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.4 151.83 95.61 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 120.89 -1.131 . . . . 0.0 109.659 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.721 2.281 . . . . 0.0 112.256 179.735 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 mmm . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.306 0.574 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 3' ' ' THR . . . -139.25 95.41 2.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.625 ' O ' ' CB ' ' A' ' 4' ' ' SER . 1.0 OUTLIER 155.25 -62.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.133 -178.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 3' ' ' THR . 2.5 t 152.35 -100.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 4' ' ' SER . . . -81.09 170.42 52.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.24 132.92 42.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 108.027 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 5.2 ttpm? -100.3 127.01 46.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 112.813 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' MET . 56.4 m80 -117.12 116.46 27.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -131.59 140.96 49.56 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.734 -1.229 . . . . 0.0 109.408 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.02 138.51 52.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.6 -0.687 . . . . 0.0 109.458 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.13 130.38 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.439 ' O ' ' OG1' ' A' ' 57' ' ' THR . 3.9 m -135.02 148.95 28.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 117.74 -1.584 . . . . 0.0 113.028 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.716 ' HZ2' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -120.15 151.99 38.28 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.578 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 9.2 p90 -113.32 152.94 29.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.81 -1.181 . . . . 0.0 111.601 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -128.67 -18.05 3.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.2 mm-40 -90.33 -57.28 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 12.1 m-20 154.09 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 51.7 m -51.59 112.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.098 0.951 . . . . 0.0 112.84 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.87 90.66 2.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 24' ' ' LEU . 29.1 m -62.85 -41.91 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.504 -0.747 . . . . 0.0 110.512 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.43 -45.13 92.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.559 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -70.29 -33.05 71.09 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.34 -40.29 79.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.5 tp -58.84 -38.77 79.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.68 -35.07 76.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.93 -53.55 36.69 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 5.8 tt -48.08 -43.84 31.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.511 -0.993 . . . . 0.0 108.813 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -54.71 -46.42 74.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.537 ' ND2' ' CE2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -47.7 -41.67 23.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 32' ' ' SER . 19.3 t -54.74 -20.5 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.236 -0.915 . . . . 0.0 108.902 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' ASN . 74.5 m -44.63 -42.28 7.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.542 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 46.2 mm-40 -83.84 -9.77 58.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 111.398 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.632 ' C ' ' H ' ' A' ' 36' ' ' THR . 45.0 mm -91.23 23.56 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 119.976 -1.702 . . . . 0.0 110.716 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.77 -8.92 1.05 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.632 ' H ' ' C ' ' A' ' 34' ' ' ILE . 33.6 p -79.15 -2.82 42.59 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.972 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.614 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.8 m 32.13 41.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.08 -1.012 . . . . 0.0 109.135 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.0 ptmt -122.32 41.93 3.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -173.67 178.18 2.33 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 87.3 m-85 -147.01 155.0 41.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.546 -1.346 . . . . 0.0 111.929 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 46.5 mp0 -152.46 121.18 6.48 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -126.5 168.71 13.87 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.12 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.01 159.28 21.16 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.827 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.573 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 49.4 mp0 -147.78 140.59 24.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.331 -1.1 . . . . 0.0 109.392 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.3 t0 -128.46 155.7 44.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -60.22 80.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.461 -1.4 . . . . 0.0 109.747 -177.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.3 mt-10 -105.04 42.65 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.67 -0.644 . . . . 0.0 109.272 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.554 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 3.4 m -150.09 179.38 8.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.47 150.01 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' MET . 32.2 p-10 -43.94 -44.05 6.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.787 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.517 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 83.2 mmm -67.19 -28.96 68.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.942 -1.099 . . . . 0.0 110.713 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 95' ' ' LEU . 33.9 mt -98.29 -30.18 12.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.772 -1.205 . . . . 0.0 109.292 -178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.655 ' O ' ' N ' ' A' ' 55' ' ' GLY . 3.2 ptm180 -86.46 -1.73 57.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.827 . . . . 0.0 111.225 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' A' ' 56' ' ' PHE . 6.4 tt0 45.96 10.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.73 -1.231 . . . . 0.0 110.149 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 58.77 -5.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.424 -0.797 . . . . 0.0 112.89 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 54' ' ' GLN . 11.8 p90 -57.0 131.11 48.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.204 -1.762 . . . . 0.0 109.93 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.622 ' HG1' ' N ' ' A' ' 58' ' ' HIS . 71.3 p -54.15 -48.1 71.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.0 110.995 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 23.7 t60 -173.0 159.19 3.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.109 . . . . 0.0 110.165 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.612 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -144.83 169.53 17.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -0.805 . . . . 0.0 109.219 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 76.6 m-85 -135.12 130.64 35.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.484 -0.76 . . . . 0.0 109.075 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 98.18 8.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.2 mtp -98.9 118.89 36.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.165 -0.96 . . . . 0.0 110.849 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -123.29 142.43 50.95 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.94 162.58 18.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.829 -1.17 . . . . 0.0 110.078 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.57 -29.97 29.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -169.76 175.0 5.44 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -58.38 -22.52 54.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 111.415 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.84 -37.56 71.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.809 -1.182 . . . . 0.0 110.617 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.08 76.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -67.14 -44.18 80.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.956 . . . . 0.0 110.417 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.76 -28.93 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.38 -1.45 . . . . 0.0 108.696 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . -64.98 -61.0 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.73 -60.22 3.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.207 -0.933 . . . . 0.0 111.115 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -49.46 -37.22 25.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.752 -1.218 . . . . 0.0 110.357 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 72' ' ' ALA . 63.7 p -65.97 -11.95 51.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 0.0 111.014 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 78' ' ' LEU . 65.2 m-70 -92.64 125.99 53.66 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.25 -4.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.675 2.25 . . . . 0.0 112.489 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.3 tp -74.39 -25.87 59.75 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.297 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -77.84 -45.4 24.44 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.086 -1.009 . . . . 0.0 110.247 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.594 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.2 p -63.37 -57.94 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.993 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.594 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 84.3 tt0 -53.59 -36.45 61.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 6.4 m-85 -74.39 -36.18 63.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.875 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -62.09 -42.9 99.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.61 -44.14 97.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 108.656 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.87 -44.19 73.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.482 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.03 -30.18 0.41 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' VAL . 10.9 m -82.36 -64.17 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -43.3 -24.83 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 110.099 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.9 m -107.4 9.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 110.723 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 28.9 mm -131.44 164.37 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.6 -1.313 . . . . 0.0 110.504 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.546 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 52.2 t0 -109.42 -33.41 6.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.716 ' NZ ' ' HZ2' ' A' ' 13' ' ' LYS . 29.2 pttt -147.84 147.57 29.94 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 93' ' ' ILE . 4.1 tp -128.86 123.81 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.637 -1.289 . . . . 0.0 109.785 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.7 132.64 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -142.05 138.37 31.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.269 -1.519 . . . . 0.0 111.748 -178.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -116.5 119.28 35.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.719 -0.613 . . . . 0.0 109.355 177.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' B' ' 48' ' ' SER . 62.2 t0 -111.21 117.5 33.38 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -0.989 . . . . 0.0 108.971 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 54.7 t80 -141.37 137.65 16.8 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.01 . . . . 0.0 110.465 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.55 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 31.0 Cg_endo -61.02 127.81 23.42 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.257 1.972 . . . . 0.0 112.229 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 5' ' ' GLY . 99.6 t -92.61 117.3 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.009 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -109.35 95.29 5.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.546 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.45 69.74 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 103' ' ' VAL . 21.9 m -152.88 95.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.243 -178.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' SER . 7.7 ptmm? -175.19 -126.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.396 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.96 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 108.899 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' LYS . 4.4 m -115.84 71.04 0.76 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.276 -0.89 . . . . 0.0 109.339 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.3 p -119.94 -4.9 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 9.6 p -176.58 53.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.591 -0.693 . . . . 0.0 109.447 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 108' ' ' VAL . . . -54.24 -177.53 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.5 p -134.55 69.71 72.46 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 120.865 -1.147 . . . . 0.0 109.685 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 C--N 1.308 -1.585 0 C-N-CA 122.795 2.33 . . . . 0.0 112.266 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.4 mmm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' B' ' 3' ' ' THR . . . -139.97 95.08 2.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 109.409 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.631 ' O ' ' CB ' ' B' ' 4' ' ' SER . 1.0 OUTLIER 155.5 -62.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.111 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.631 ' CB ' ' O ' ' B' ' 3' ' ' THR . 2.5 t 152.24 -100.89 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' B' ' 4' ' ' SER . . . -81.19 170.41 52.59 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.02 133.16 42.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.281 -1.129 . . . . 0.0 108.043 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' B' ' 7' ' ' LYS . 5.1 ttpm? -100.51 126.93 46.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.937 -1.102 . . . . 0.0 112.843 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 62' ' ' MET . 56.0 m80 -117.11 116.2 26.86 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -131.28 141.13 49.93 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.657 -1.277 . . . . 0.0 109.474 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.05 138.64 52.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 130.3 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.441 ' O ' ' OG1' ' B' ' 57' ' ' THR . 3.9 m -134.94 148.77 28.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.818 -1.553 . . . . 0.0 113.051 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.703 ' HZ2' ' NZ ' ' B' ' 92' ' ' LYS . 0.0 OUTLIER -120.11 151.91 38.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.565 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 9.4 p90 -113.35 152.96 29.28 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.828 -1.17 . . . . 0.0 111.545 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -128.77 -18.0 3.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CG ' ' B' ' 17' ' ' ASP . 77.5 mm-40 -90.32 -57.08 2.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CG ' ' O ' ' B' ' 16' ' ' GLU . 12.7 m-20 153.73 58.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' B' ' 89' ' ' VAL . 58.6 m -52.45 112.35 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.147 0.975 . . . . 0.0 112.846 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.483 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.6 90.46 2.79 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' B' ' 24' ' ' LEU . 29.8 m -62.7 -41.93 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.683 -0.636 . . . . 0.0 110.474 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -63.45 -45.01 92.84 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.447 -0.783 . . . . 0.0 110.563 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -70.3 -33.26 71.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.26 -40.19 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -58.99 -38.65 79.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.52 -35.03 76.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.44 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -64.44 -53.07 38.08 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.441 ' CD1' ' CD1' ' B' ' 60' ' ' PHE . 5.8 tt -48.21 -43.97 32.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.577 -0.955 . . . . 0.0 108.799 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -54.49 -46.77 73.51 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' B' ' 82' ' ' PHE . 0.0 OUTLIER -52.79 -41.34 64.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -47.98 -41.35 24.98 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' B' ' 32' ' ' SER . 19.3 t -54.99 -20.21 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.311 -0.868 . . . . 0.0 108.829 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.47 ' N ' ' O ' ' B' ' 29' ' ' ASN . 73.6 m -44.87 -42.34 7.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.551 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 46.1 mm-40 -83.85 -9.55 58.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.449 -0.782 . . . . 0.0 111.523 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.634 ' C ' ' H ' ' B' ' 36' ' ' THR . 44.9 mm -91.29 23.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.031 -1.668 . . . . 0.0 110.641 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -57.65 -8.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.634 ' H ' ' C ' ' B' ' 34' ' ' ILE . 34.2 p -79.06 -2.68 41.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.984 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.592 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.0 m 32.13 41.84 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.121 -0.987 . . . . 0.0 109.194 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.1 ptmt -122.24 42.15 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 89.2 p -173.82 177.97 2.32 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 86.5 m-85 -146.91 155.06 42.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.52 -1.362 . . . . 0.0 111.944 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' B' ' 41' ' ' GLU . 46.4 mp0 -152.42 121.11 6.47 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.364 0.602 . . . . 0.0 110.194 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.642 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.7 OUTLIER -126.48 168.83 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.09 159.48 21.22 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.807 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.582 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 49.8 mp0 -148.13 140.65 24.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.407 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' B' ' 47' ' ' GLU . 61.9 t0 -128.49 155.64 44.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.521 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -60.17 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.44 -1.413 . . . . 0.0 109.773 -177.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.5 mt-10 -104.65 42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.676 -0.64 . . . . 0.0 109.358 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 3.6 m -150.04 179.58 7.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.139 -0.975 . . . . 0.0 110.243 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.62 150.29 41.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.945 . . . . 0.0 109.701 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.3 p-10 -44.14 -43.77 7.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.858 . . . . 0.0 110.8 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.53 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 83.4 mmm -67.57 -28.95 68.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.14 -0.975 . . . . 0.0 110.75 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 95' ' ' LEU . 34.6 mt -98.32 -29.76 12.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.747 -1.221 . . . . 0.0 109.265 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' B' ' 55' ' ' GLY . 3.2 ptm180 -86.89 -1.66 57.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.394 -0.816 . . . . 0.0 111.243 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.428 ' C ' ' H ' ' B' ' 56' ' ' PHE . 6.4 tt0 45.99 10.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.807 -1.183 . . . . 0.0 110.194 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 59.3 -5.81 0.08 OUTLIER Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.428 -0.795 . . . . 0.0 112.881 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' B' ' 54' ' ' GLN . 11.7 p90 -56.64 131.11 47.98 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.259 -1.73 . . . . 0.0 109.899 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.616 ' HG1' ' N ' ' B' ' 58' ' ' HIS . 69.9 p -54.19 -47.9 71.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.279 -0.888 . . . . 0.0 110.995 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.64 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 23.6 t60 -173.13 159.61 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.9 -1.125 . . . . 0.0 110.165 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -145.39 169.28 18.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.542 -0.724 . . . . 0.0 109.292 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 76.6 m-85 -134.91 130.64 36.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.512 -0.742 . . . . 0.0 109.081 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 97.81 8.55 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' MET . . . . . 0.515 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.8 mtp -98.62 119.1 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.198 -0.939 . . . . 0.0 110.77 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -123.43 142.63 50.79 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.0 162.99 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 110.038 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -82.98 -29.84 28.69 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -169.73 175.44 5.28 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -58.72 -22.46 57.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 111.45 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -57.08 -37.57 72.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.804 -1.185 . . . . 0.0 110.565 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 -33.1 77.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -67.01 -44.55 80.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.947 . . . . 0.0 110.405 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.81 -28.87 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.329 -1.482 . . . . 0.0 108.669 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.1 -60.91 2.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 73' ' ' PHE . 2.7 t80 -63.22 -60.48 3.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 111.136 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 14.9 t -49.47 -37.18 25.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 63.9 p -65.92 -12.04 51.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.982 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' B' ' 78' ' ' LEU . 65.2 m-70 -92.6 126.27 52.71 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.898 -1.126 . . . . 0.0 109.544 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -44.6 -4.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.686 2.257 . . . . 0.0 112.424 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.3 tp -74.44 -26.22 59.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.366 -0.834 . . . . 0.0 111.18 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -77.72 -45.25 25.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.95 -1.094 . . . . 0.0 110.321 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.597 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.1 p -63.19 -58.21 8.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.597 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 84.0 tt0 -53.56 -36.36 61.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 6.4 m-85 -74.38 -36.4 63.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.872 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 87.5 p -61.79 -43.05 99.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.052 -1.03 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.97 97.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 108.622 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.485 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -69.13 -43.99 73.28 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.485 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.22 -30.0 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.6 m -82.48 -64.15 1.23 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -43.26 -24.94 0.1 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.76 -0.588 . . . . 0.0 110.12 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.438 ' O ' ' OG1' ' B' ' 18' ' ' THR . 4.9 m -107.34 9.89 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 110.838 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 28.3 mm -131.68 164.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.628 -1.295 . . . . 0.0 110.462 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.537 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 52.0 t0 -109.28 -33.49 6.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.703 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 28.2 pttt -147.86 147.67 30.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' B' ' 93' ' ' ILE . 4.2 tp -128.98 123.67 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.569 -1.332 . . . . 0.0 109.711 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.52 132.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -141.95 138.5 32.0 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.266 -1.521 . . . . 0.0 111.774 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 1.0 OUTLIER -116.55 119.27 35.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.708 -0.62 . . . . 0.0 109.334 177.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.432 ' O ' ' OG ' ' A' ' 48' ' ' SER . 62.4 t0 -111.19 117.14 32.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.04 -1.037 . . . . 0.0 108.889 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 55.6 t80 -140.87 137.89 17.62 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.057 -1.027 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 31.3 Cg_endo -61.18 127.91 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.286 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 5' ' ' GLY . 99.2 t -92.76 117.41 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 109.974 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.45 95.05 5.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 109.609 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.36 70.05 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' B' ' 103' ' ' VAL . 21.9 m -153.15 95.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' B' ' 106' ' ' SER . 7.6 ptmm? -175.09 -127.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.331 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.6 m 64.16 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 108.922 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.504 ' N ' ' O ' ' B' ' 104' ' ' LYS . 4.4 m -115.76 70.6 0.75 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -119.56 -5.05 10.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' B' ' 109' ' ' ALA . 9.7 p -176.57 53.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 109.569 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' B' ' 108' ' ' VAL . . . -54.15 -177.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 46.6 p -134.45 70.26 72.61 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.846 -1.159 . . . . 0.0 109.678 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.74 2.293 . . . . 0.0 112.267 -179.938 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.283 0.563 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.29 38.56 13.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 109.413 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -101.15 -7.82 22.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.111 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.7 t -145.93 -80.91 0.15 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.16 -158.97 7.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -135.76 138.15 42.38 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.164 -1.198 . . . . 0.0 108.09 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.452 ' CD ' ' CZ2' ' B' ' 42' ' ' TRP . 1.1 ttpm? -113.32 141.31 47.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.906 -1.121 . . . . 0.0 112.801 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -130.02 130.05 44.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.3 tt -135.17 144.67 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.7 -1.25 . . . . 0.0 109.485 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -128.47 135.56 62.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.434 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.38 128.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 177.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.81 157.0 32.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 117.766 -1.574 . . . . 0.0 112.994 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 91' ' ' ASP . 20.6 tptm -122.34 152.1 40.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.468 ' HB2' ' H ' ' A' ' 18' ' ' THR . 29.9 p90 -105.29 147.17 28.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.942 -1.099 . . . . 0.0 111.643 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -120.75 -24.91 5.58 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.0 mt-10 -89.38 -54.98 3.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.5 t0 150.58 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.468 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 61.0 m -58.91 110.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.112 0.958 . . . . 0.0 112.851 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.64 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -81.29 92.67 6.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.675 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 m -58.72 -32.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.551 -0.718 . . . . 0.0 110.473 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.6 p-10 -66.41 -39.2 88.84 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 78.0 mm-40 -67.74 -34.2 76.38 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.463 HG23 HD11 ' A' ' 23' ' ' ILE . 6.6 mt -65.71 -44.36 93.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.573 ' CD2' ' H ' ' B' ' 110' ' ' THR . 7.4 tp -53.89 -37.15 63.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.85 -32.12 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -81.9 -43.76 8.08 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -58.27 8.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.482 -1.011 . . . . 0.0 108.777 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 9.3 pt-20 -51.68 -43.95 62.92 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.581 HD22 ' CD1' ' A' ' 78' ' ' LEU . 13.7 t30 -61.56 -43.38 98.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER -49.95 -43.73 50.24 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.027 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 34' ' ' ILE . 39.8 t -50.8 -27.86 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.315 -0.866 . . . . 0.0 108.874 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' VAL . 46.9 t -40.61 -42.89 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.528 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 29.9 mm100 -75.75 -23.15 55.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.495 -0.753 . . . . 0.0 111.462 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 36' ' ' THR . 30.9 mm -85.69 25.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.068 -1.645 . . . . 0.0 110.648 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 36' ' ' THR . 54.3 p30 -60.74 -9.01 3.39 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 38' ' ' LYS . 59.5 p -73.88 -3.2 27.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.896 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.5 m 35.65 30.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.16 -0.963 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 36' ' ' THR . 75.1 mttt -118.94 39.5 3.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 63' ' ' THR . 12.4 t -170.9 170.92 6.18 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -147.42 157.48 43.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.595 -1.316 . . . . 0.0 112.006 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.573 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 58.1 mt-10 -151.59 120.26 6.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.417 0.627 . . . . 0.0 110.169 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.709 ' CD1' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.49 164.55 24.58 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.709 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -134.45 174.1 21.13 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.733 -1.699 . . . . 0.0 110.766 -178.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.657 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -152.69 141.21 20.77 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -1.174 . . . . 0.0 109.371 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -105.12 140.72 37.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -135.24 103.59 5.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.374 -1.454 . . . . 0.0 109.749 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -146.97 25.6 1.13 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.651 -0.656 . . . . 0.0 109.312 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.444 ' H ' ' CB ' ' A' ' 53' ' ' ARG . 11.6 p -89.09 -106.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 m80 -92.61 148.07 22.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 51' ' ' MET . 31.5 p-10 -53.45 -43.07 67.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.365 -0.834 . . . . 0.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.522 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.9 tpt -75.42 -32.05 60.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.0 110.745 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 54' ' ' GLN . 48.9 mt -90.14 -54.53 3.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.732 -1.23 . . . . 0.0 109.305 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.76 ' C ' ' H ' ' A' ' 55' ' ' GLY . 12.5 ptt180 -62.59 1.23 0.39 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER 56.11 -17.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.803 -1.185 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.76 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 88.05 -23.16 15.29 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.511 -0.743 . . . . 0.0 112.905 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.5 ' CE1' ' NZ ' ' A' ' 92' ' ' LYS . 3.5 m-85 -61.23 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.212 -1.758 . . . . 0.0 109.903 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 58' ' ' HIS . 3.2 t -161.5 -35.99 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.315 -0.866 . . . . 0.0 110.996 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 35.1 t-80 -166.89 149.46 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.937 -1.102 . . . . 0.0 110.19 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.603 ' N ' ' HD1' ' A' ' 58' ' ' HIS . . . -142.72 167.63 21.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 58' ' ' HIS . 91.3 m-85 -138.15 134.87 35.12 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.494 -0.754 . . . . 0.0 109.073 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.548 ' OG ' ' CZ3' ' A' ' 42' ' ' TRP . 1.4 m -116.45 104.64 11.64 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.7 mtt -95.32 125.45 39.96 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.143 -0.973 . . . . 0.0 110.79 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.462 ' O ' ' OG ' ' A' ' 39' ' ' SER . 38.7 m -118.89 140.87 49.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -127.2 128.1 45.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.742 -1.224 . . . . 0.0 110.036 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -50.96 -26.36 5.85 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -171.43 172.9 4.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.9 -19.17 60.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 111.361 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.92 -40.71 89.8 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.859 -1.15 . . . . 0.0 110.613 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.84 -29.25 59.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -66.1 -42.59 89.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.917 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.407 -1.433 . . . . 0.0 108.669 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.96 2.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.304 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.45 -39.39 64.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 111.159 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 t -79.78 -29.62 40.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.746 -1.221 . . . . 0.0 110.338 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -65.44 -25.56 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 111.023 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HD1' ' H ' ' A' ' 78' ' ' LEU . 56.8 t-80 -79.04 125.33 83.95 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.833 -1.167 . . . . 0.0 109.661 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.43 -6.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.661 ' H ' ' HD1' ' A' ' 76' ' ' HIS . 6.1 tp -75.84 -25.38 56.19 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 111.203 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.6 t60 -76.57 -43.0 40.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.018 -1.051 . . . . 0.0 110.241 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.554 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 11.3 p -64.4 -54.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.554 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 78.7 mm-40 -50.43 -30.83 13.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' CD1' ' A' ' 86' ' ' PHE . 4.2 m-85 -72.97 -37.34 67.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.879 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.6 m -63.46 -42.33 98.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.0 110.14 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.48 67.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.965 -1.084 . . . . 0.0 108.751 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.0 -43.43 82.93 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 82' ' ' PHE . 2.5 m-85 -45.0 -31.06 1.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.1 m -78.94 -63.31 1.45 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.03 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.72 -0.612 . . . . 0.0 110.064 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.4 m -111.92 6.91 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.18 -0.95 . . . . 0.0 110.803 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 34.5 mt -120.11 154.64 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.647 -1.283 . . . . 0.0 110.444 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.9 t0 -103.52 -31.42 9.96 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.5 ' NZ ' ' CE1' ' A' ' 56' ' ' PHE . 37.9 pttt -150.44 149.3 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -125.24 121.94 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.615 -1.303 . . . . 0.0 109.852 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.76 133.52 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -139.49 136.86 34.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.241 -1.537 . . . . 0.0 111.752 -178.145 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.643 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.94 121.44 42.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.655 -0.653 . . . . 0.0 109.383 176.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 68.2 t0 -123.12 128.35 49.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.017 . . . . 0.0 108.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -164.08 139.68 4.93 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.096 -1.003 . . . . 0.0 110.505 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.03 120.68 4.4 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.292 1.995 . . . . 0.0 112.202 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -105.55 135.73 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.93 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.78 75.51 0.93 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.87 113.3 24.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.457 ' CG2' ' H ' ' A' ' 104' ' ' LYS . 16.9 m -134.42 -54.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.171 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.564 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 26.0 mmtm 60.19 -129.75 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 0.0 109.339 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 104' ' ' LYS . 0.9 OUTLIER 72.52 -18.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.181 -0.949 . . . . 0.0 108.978 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 104' ' ' LYS . 2.0 t 168.75 -42.04 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 109.346 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -145.11 145.25 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.9 p -122.13 13.49 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.07 136.79 57.23 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.571 ' H ' ' CD2' ' B' ' 24' ' ' LEU . 25.8 m -132.58 71.44 78.84 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 120.841 -1.162 . . . . 0.0 109.636 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo . . . . . 0 C--N 1.308 -1.595 0 C-N-CA 122.805 2.336 . . . . 0.0 112.178 -179.905 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.7 38.79 11.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 0.0 109.355 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 5.5 t -101.34 -7.84 22.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.0 109.086 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t -145.94 -81.12 0.15 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.98 -158.47 7.6 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.694 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.36 137.68 40.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.279 -1.13 . . . . 0.0 108.015 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.458 ' CD ' ' CZ2' ' A' ' 42' ' ' TRP . 1.1 ttpm? -112.89 141.22 46.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.864 -1.147 . . . . 0.0 112.787 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -129.99 130.13 44.63 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.4 tt -135.45 144.54 46.51 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.798 -1.189 . . . . 0.0 109.479 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -128.45 135.41 62.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.629 -0.669 . . . . 0.0 109.537 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.25 128.27 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.07 156.9 31.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 117.769 -1.572 . . . . 0.0 113.011 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' B' ' 91' ' ' ASP . 20.7 tptm -122.4 151.73 40.93 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.468 ' HB2' ' H ' ' B' ' 18' ' ' THR . 30.0 p90 -105.07 147.3 28.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.863 -1.148 . . . . 0.0 111.555 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -120.82 -25.07 5.5 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 94.9 mt-10 -89.21 -55.06 3.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.4 t0 150.5 72.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.468 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.9 m -59.11 110.3 1.02 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.105 0.955 . . . . 0.0 112.85 -176.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.652 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -81.4 92.46 6.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 175.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.7 m -58.37 -32.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.609 -0.682 . . . . 0.0 110.43 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -66.49 -39.23 88.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.533 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 77.6 mm-40 -67.75 -34.07 76.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.74 -44.49 93.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.571 ' CD2' ' H ' ' A' ' 110' ' ' THR . 7.5 tp -53.63 -37.16 62.8 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.93 -31.95 70.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -81.96 -43.7 8.08 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.82 -58.04 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.589 -0.947 . . . . 0.0 108.832 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.536 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 9.4 pt-20 -51.68 -44.31 63.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.599 HD22 ' CD1' ' B' ' 78' ' ' LEU . 14.7 t30 -61.22 -43.31 99.08 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' B' ' 26' ' ' GLY . 1.0 OUTLIER -50.13 -43.61 51.93 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' B' ' 34' ' ' ILE . 40.6 t -51.05 -27.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.266 -0.896 . . . . 0.0 108.847 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.474 ' C ' ' O ' ' B' ' 31' ' ' VAL . 48.0 t -40.59 -43.34 1.87 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.525 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 29.9 mm100 -75.3 -23.35 57.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.425 -0.797 . . . . 0.0 111.517 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.558 ' C ' ' H ' ' B' ' 36' ' ' THR . 30.0 mm -85.45 25.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 119.995 -1.69 . . . . 0.0 110.605 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.3 p30 -60.63 -8.91 3.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' B' ' 38' ' ' LYS . 64.8 p -74.04 -3.43 29.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.963 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.554 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.6 m 36.03 30.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.13 -0.981 . . . . 0.0 109.135 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' B' ' 36' ' ' THR . 74.2 mttt -118.77 39.7 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 63' ' ' THR . 13.1 t -171.18 170.79 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -147.51 157.37 43.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.521 -1.362 . . . . 0.0 111.934 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.564 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 57.1 mt-10 -151.69 119.89 6.32 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.349 0.595 . . . . 0.0 110.282 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.702 ' CD1' ' N ' ' B' ' 43' ' ' GLY . 0.0 OUTLIER -130.03 164.55 24.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.07 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.702 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -134.32 174.24 21.03 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.749 -1.691 . . . . 0.0 110.885 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 0.2 OUTLIER -152.92 140.92 20.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -1.142 . . . . 0.0 109.387 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -104.99 140.42 38.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.529 ' CD ' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -135.0 103.78 5.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.388 -1.445 . . . . 0.0 109.769 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -147.07 25.68 1.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.322 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.449 ' H ' ' HB2' ' B' ' 53' ' ' ARG . 11.7 p -89.18 -106.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.932 . . . . 0.0 110.107 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' B' ' 53' ' ' ARG . 76.4 m80 -92.22 147.98 22.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.157 -0.964 . . . . 0.0 109.699 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.1 p-10 -53.36 -43.29 67.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 110.799 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 1.9 tpt -75.02 -32.34 61.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.732 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' B' ' 54' ' ' GLN . 46.2 mt -90.05 -54.58 3.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.682 -1.261 . . . . 0.0 109.324 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.775 ' C ' ' H ' ' B' ' 55' ' ' GLY . 12.9 ptt180 -62.47 1.33 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.354 -0.841 . . . . 0.0 111.247 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER 56.01 -17.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.821 -1.174 . . . . 0.0 110.194 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.775 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 88.07 -22.84 16.69 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.455 -0.778 . . . . 0.0 112.795 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.503 ' CE1' ' NZ ' ' B' ' 92' ' ' LYS . 3.5 m-85 -61.52 -133.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.272 -1.723 . . . . 0.0 109.962 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' B' ' 58' ' ' HIS . 3.0 t -161.56 -36.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.194 -0.941 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.644 ' HA ' ' O ' ' B' ' 44' ' ' GLU . 34.9 t-80 -166.6 149.52 6.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 0.0 110.206 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.599 ' N ' ' HD1' ' B' ' 58' ' ' HIS . . . -142.68 167.76 21.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.764 . . . . 0.0 109.272 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' B' ' 58' ' ' HIS . 92.0 m-85 -138.28 134.84 34.85 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.446 -0.784 . . . . 0.0 109.094 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.541 ' OG ' ' CZ3' ' B' ' 42' ' ' TRP . 1.4 m -116.5 104.91 11.9 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 61.6 mtt -95.49 125.79 40.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.209 -0.932 . . . . 0.0 110.73 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.451 ' O ' ' OG ' ' B' ' 39' ' ' SER . 39.2 m -119.18 140.6 49.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -126.87 127.86 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.247 . . . . 0.0 110.029 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -50.54 -26.44 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -171.52 173.02 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.98 -19.16 60.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 111.435 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.84 90.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.827 -1.171 . . . . 0.0 110.571 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.56 59.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -65.59 -42.94 91.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.594 -0.945 . . . . 0.0 110.425 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.69 -28.99 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.38 -1.45 . . . . 0.0 108.671 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 109.356 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.0 OUTLIER -53.67 -39.23 64.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 111.221 -177.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 5.0 t -79.67 -29.64 40.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.779 -1.201 . . . . 0.0 110.341 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.6 m -65.59 -25.29 67.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.987 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.688 ' HD1' ' H ' ' B' ' 78' ' ' LEU . 57.5 t-80 -79.19 125.08 84.12 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.406 ' O ' HG12 ' B' ' 80' ' ' VAL . 74.9 Cg_exo -44.29 -6.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.696 2.264 . . . . 0.0 112.433 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.688 ' H ' ' HD1' ' B' ' 76' ' ' HIS . 6.1 tp -75.62 -25.42 56.91 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.369 -0.832 . . . . 0.0 111.233 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 2.8 t60 -76.87 -42.68 38.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.978 -1.076 . . . . 0.0 110.29 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.558 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 11.6 p -64.52 -54.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.558 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 79.0 mm-40 -50.4 -30.95 13.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.618 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' B' ' 86' ' ' PHE . 4.3 m-85 -72.81 -37.08 67.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.849 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.8 m -63.83 -42.28 97.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.128 -0.982 . . . . 0.0 110.082 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -50.39 67.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.029 . . . . 0.0 108.673 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.14 -43.38 82.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' B' ' 82' ' ' PHE . 2.5 m-85 -45.11 -31.01 1.24 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.539 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.7 m -78.9 -63.31 1.45 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -40.0 -24.14 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.645 -0.659 . . . . 0.0 110.074 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.3 m -111.88 7.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.198 -0.939 . . . . 0.0 110.807 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 34.5 mt -120.34 154.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.642 -1.286 . . . . 0.0 110.458 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' B' ' 13' ' ' LYS . 62.2 t0 -103.34 -31.58 9.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.503 ' NZ ' ' CE1' ' B' ' 56' ' ' PHE . 38.1 pttt -150.41 149.41 30.0 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.9 tp -125.42 122.21 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.647 -1.283 . . . . 0.0 109.727 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.98 133.69 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' B' ' 9' ' ' LEU . 0.4 OUTLIER -139.6 136.83 34.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.291 -1.505 . . . . 0.0 111.73 -178.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.645 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.92 121.09 41.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.335 176.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 68.3 t0 -122.88 128.38 50.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 108.928 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -164.13 139.61 4.87 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.574 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.11 121.01 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.231 1.954 . . . . 0.0 112.294 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 18.6 t -105.96 135.57 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.002 . . . . 0.0 110.036 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.68 75.29 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.73 113.33 24.96 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.452 ' CG2' ' H ' ' B' ' 104' ' ' LYS . 16.8 m -134.37 -54.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.284 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.573 ' NZ ' ' O ' ' A' ' 41' ' ' GLU . 25.9 mmtm 59.91 -129.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.396 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' B' ' 104' ' ' LYS . 0.9 OUTLIER 72.32 -18.23 0.34 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.217 -0.927 . . . . 0.0 109.02 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.557 ' H ' ' C ' ' B' ' 104' ' ' LYS . 2.0 t 168.55 -41.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 55.1 t -145.37 144.99 21.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 1.9 p -122.01 13.49 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.782 . . . . 0.0 109.449 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.09 136.44 57.19 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.573 ' H ' ' CD2' ' A' ' 24' ' ' LEU . 26.5 m -132.25 71.94 79.13 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 120.894 -1.129 . . . . 0.0 109.625 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 C--N 1.308 -1.554 0 C-N-CA 122.712 2.275 . . . . 0.0 112.288 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.45 59.77 3.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.509 ' CG2' ' N ' ' A' ' 4' ' ' SER . 9.8 t -63.02 -49.8 73.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.181 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 3' ' ' THR . 32.0 t -144.22 -95.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.04 154.05 40.61 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.635 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.05 127.27 53.26 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -1.14 . . . . 0.0 108.037 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.529 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.8 ttpm? -108.39 137.83 45.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 112.769 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -124.49 123.21 39.63 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.41 142.27 49.21 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 109.478 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -129.81 134.74 62.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.42 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.41 129.08 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 m -134.44 161.85 39.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 117.771 -1.572 . . . . 0.0 113.036 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.54 151.24 51.74 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' HB2' ' H ' ' A' ' 18' ' ' THR . 22.5 p90 -109.72 146.99 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.899 -1.125 . . . . 0.0 111.529 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -130.17 -20.24 3.08 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 79.4 mm-40 -91.18 -58.01 2.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.8 m-20 156.52 65.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 90.5 m -57.4 108.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.075 0.941 . . . . 0.0 112.835 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.65 87.12 3.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -61.61 -37.73 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.524 -0.735 . . . . 0.0 110.493 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -66.41 -42.16 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.62 -32.48 73.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.423 HD11 HG23 ' A' ' 23' ' ' ILE . 4.2 mt -66.14 -38.99 83.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.65 -35.25 60.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.37 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -60.56 -54.4 37.44 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.8 tt -51.33 -47.9 62.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.548 -0.972 . . . . 0.0 108.764 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.14 -37.26 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -61.94 -44.21 97.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 3.0 mm? -50.07 -47.2 53.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.4 t -50.65 -26.32 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.252 -0.905 . . . . 0.0 108.883 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 27.2 t -47.38 -44.23 24.07 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.754 HE21 ' HE2' ' A' ' 76' ' ' HIS . 12.8 pm0 -92.98 -24.32 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 36' ' ' THR . 9.3 mt -71.55 26.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 119.983 -1.698 . . . . 0.0 110.631 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 33' ' ' GLN . 88.9 m-20 -62.84 -7.33 4.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' LYS . 50.8 p -71.93 -5.83 37.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.949 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.59 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.7 m 33.51 31.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.63 ' N ' ' O ' ' A' ' 36' ' ' THR . 6.0 mtmp? -117.35 38.61 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 72.8 m -173.63 177.29 2.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.434 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.3 m-85 -146.88 155.94 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.574 -1.329 . . . . 0.0 112.016 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 85.4 mt-10 -158.69 129.26 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.43 0.633 . . . . 0.0 110.17 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.54 177.29 8.57 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.8 162.26 22.37 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.727 -1.701 . . . . 0.0 110.816 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.675 ' H ' ' NE2' ' A' ' 58' ' ' HIS . 72.3 mt-10 -145.93 138.18 25.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -1.168 . . . . 0.0 109.438 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.14 149.28 43.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' H ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.99 81.16 0.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.396 -1.44 . . . . 0.0 109.824 -176.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -115.37 56.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.643 -0.661 . . . . 0.0 109.33 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 49' ' ' HIS . 38.5 t -150.95 83.59 1.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.203 -0.935 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.684 ' N ' HH21 ' A' ' 53' ' ' ARG . 79.1 m-70 56.83 118.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 96.6 m-20 -44.61 -33.88 1.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.339 -0.85 . . . . 0.0 110.726 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -76.94 -32.0 57.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.026 . . . . 0.0 110.714 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 95' ' ' LEU . 62.9 mt -96.32 -12.38 24.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.732 -1.23 . . . . 0.0 109.333 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.684 HH21 ' N ' ' A' ' 49' ' ' HIS . 5.9 ptp180 -95.78 2.15 53.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.311 -0.868 . . . . 0.0 111.263 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' PHE . 95.1 mm-40 44.13 19.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.82 -1.175 . . . . 0.0 110.169 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.757 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 48.75 3.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.759 0 O-C-N 121.424 -0.797 . . . . 0.0 112.914 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.757 ' O ' ' O ' ' A' ' 55' ' ' GLY . 33.2 m-85 -49.94 -143.73 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.229 -1.748 . . . . 0.0 109.987 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 93.0 m -135.93 -55.88 0.77 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.951 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.675 ' NE2' ' H ' ' A' ' 44' ' ' GLU . 13.0 t60 -168.41 152.88 6.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.879 -1.138 . . . . 0.0 110.156 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.549 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.06 115.86 10.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.231 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.29 131.67 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.118 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -121.8 122.0 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 110.749 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -122.7 143.2 49.95 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -117.73 159.81 22.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.788 -1.195 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.69 -28.91 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -174.53 -178.1 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.94 -27.09 67.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 111.453 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.02 -43.98 97.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.78 -1.2 . . . . 0.0 110.548 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.44 67.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -67.02 -45.2 78.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.982 . . . . 0.0 110.467 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.75 -28.97 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.36 -1.462 . . . . 0.0 108.671 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . -65.06 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.347 -0.845 . . . . 0.0 109.331 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.609 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.06 -50.15 73.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 111.108 -177.274 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 8.6 t -62.63 -28.17 69.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.805 -1.184 . . . . 0.0 110.304 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 72' ' ' ALA . 84.3 p -61.95 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.0 110.897 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.754 ' HE2' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -121.94 151.19 57.63 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.787 -1.196 . . . . 0.0 109.578 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.43 12.53 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.575 2.184 . . . . 0.0 112.433 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD22 HE22 ' A' ' 33' ' ' GLN . 0.7 OUTLIER -75.98 -29.71 58.32 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 111.251 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' SER . 35.6 t-80 -85.22 -41.65 15.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.952 -1.093 . . . . 0.0 110.282 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.622 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 7.2 p -57.88 -58.46 6.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.961 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.622 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 14.9 tm-20 -58.01 -39.33 78.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.137 -0.977 . . . . 0.0 109.593 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.91 -40.74 71.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.915 . . . . 0.0 109.879 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' HIS . 86.8 p -61.56 -38.16 86.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 110.218 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.93 63.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.973 -1.079 . . . . 0.0 108.725 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.26 -40.82 77.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.464 ' C ' ' O ' ' A' ' 85' ' ' ALA . 24.8 t80 -44.53 -30.49 0.9 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.0 m -83.31 -61.84 1.74 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -36.87 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.741 -0.6 . . . . 0.0 110.07 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 87' ' ' THR . 12.6 m -101.93 16.53 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 110.819 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 87' ' ' THR . 73.7 mt -124.43 159.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.655 -1.278 . . . . 0.0 110.51 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.486 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 62.8 t0 -102.32 -34.53 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -145.78 143.71 29.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 tp -121.54 122.06 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.649 -1.282 . . . . 0.0 109.774 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.78 130.43 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.0 OUTLIER -135.34 131.75 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.258 -1.526 . . . . 0.0 111.811 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.616 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -122.75 126.97 48.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.377 177.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -125.81 133.35 52.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.098 -1.001 . . . . 0.0 108.899 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 63.8 t80 -155.42 128.73 4.38 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.108 -0.995 . . . . 0.0 110.476 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.533 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 81.8 Cg_exo -46.08 133.58 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.308 2.006 . . . . 0.0 112.176 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.61 129.33 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -101.39 82.14 2.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.435 -0.79 . . . . 0.0 109.585 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.25 76.69 0.06 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.177 -0.952 . . . . 0.0 109.568 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.763 ' O ' ' C ' ' A' ' 104' ' ' LYS . 16.3 m -154.26 -28.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.436 -0.79 . . . . 0.0 109.271 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.763 ' C ' ' O ' ' A' ' 103' ' ' VAL . 55.2 mmtt -4.52 -106.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 0.0 109.396 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 104' ' ' LYS . 3.5 m 67.04 -8.99 0.4 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.095 -1.003 . . . . 0.0 108.891 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 104' ' ' LYS . 25.5 t -55.76 133.5 50.99 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.4 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.76 40.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.37 138.97 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.51 -0.744 . . . . 0.0 109.486 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.2 177.33 7.9 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 110' ' ' THR . 16.1 p -137.49 70.02 53.36 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.937 -1.102 . . . . 0.0 109.642 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 C--N 1.307 -1.621 0 C-N-CA 122.814 2.343 . . . . 0.0 112.248 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.306 0.574 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.36 59.89 3.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 109.434 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.51 ' CG2' ' N ' ' B' ' 4' ' ' SER . 9.8 t -63.16 -49.88 72.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.163 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.51 ' N ' ' CG2' ' B' ' 3' ' ' THR . 31.9 t -144.08 -95.65 0.11 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.84 154.23 41.24 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.26 127.13 52.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.203 -1.175 . . . . 0.0 108.021 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.534 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.8 ttpm? -108.14 137.93 45.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.96 -1.087 . . . . 0.0 112.816 -177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -124.7 123.19 39.48 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.39 142.27 49.22 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 109.475 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -129.7 134.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.629 -0.67 . . . . 0.0 109.523 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.23 129.08 68.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.37 162.09 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.001 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.79 151.06 51.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.428 ' HB2' ' H ' ' B' ' 18' ' ' THR . 22.3 p90 -109.56 146.92 33.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.867 -1.146 . . . . 0.0 111.583 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.04 -20.37 3.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 79.3 mm-40 -91.08 -57.92 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.8 m-20 156.39 65.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -57.12 108.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.088 0.947 . . . . 0.0 112.86 -176.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.476 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -76.82 87.13 3.41 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 175.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.75 -37.58 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.573 -0.704 . . . . 0.0 110.518 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -66.32 -42.31 88.41 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 110.552 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.59 -32.44 73.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.421 HG23 HD11 ' B' ' 23' ' ' ILE . 4.2 mt -66.15 -39.0 83.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 tp -53.71 -35.19 60.89 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.43 74.96 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -60.52 -54.34 37.94 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 1.8 tt -51.34 -47.85 62.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -55.24 -37.03 66.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -62.15 -44.04 97.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 3.0 mm? -50.21 -47.09 54.97 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 32' ' ' SER . 86.3 t -50.71 -26.26 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.326 -0.858 . . . . 0.0 108.879 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 27.9 t -47.34 -44.48 23.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.733 HE21 ' HE2' ' B' ' 76' ' ' HIS . 12.9 pm0 -92.75 -24.35 18.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.812 . . . . 0.0 111.54 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' B' ' 36' ' ' THR . 9.6 mt -71.66 26.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 119.976 -1.703 . . . . 0.0 110.541 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' B' ' 33' ' ' GLN . 89.6 m-20 -63.02 -7.22 4.93 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.627 ' O ' ' N ' ' B' ' 38' ' ' LYS . 49.9 p -71.83 -6.11 39.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.987 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.574 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.8 m 33.72 31.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.012 -1.055 . . . . 0.0 109.189 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' B' ' 36' ' ' THR . 5.9 mtmp? -117.39 38.65 3.51 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.584 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 72.7 m -173.66 177.26 2.55 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.6 m-85 -147.06 155.77 42.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.555 -1.341 . . . . 0.0 111.912 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 85.6 mt-10 -158.58 129.1 6.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.332 0.587 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.36 177.48 8.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.93 162.35 22.45 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 118.69 -1.719 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.679 ' H ' ' NE2' ' B' ' 58' ' ' HIS . 71.7 mt-10 -145.97 138.24 25.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -1.134 . . . . 0.0 109.34 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -121.07 149.33 42.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.483 ' H ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -71.05 81.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.412 -1.43 . . . . 0.0 109.809 -177.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -115.35 56.93 0.74 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.539 ' O ' ' O ' ' B' ' 49' ' ' HIS . 39.8 t -151.1 83.63 1.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.949 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.682 ' N ' HH21 ' B' ' 53' ' ' ARG . 78.6 m-70 56.86 118.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.121 -0.987 . . . . 0.0 109.702 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.545 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 97.4 m-20 -44.68 -33.89 2.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 110.847 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -76.86 -32.0 57.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.063 -1.023 . . . . 0.0 110.751 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 95' ' ' LEU . 63.0 mt -96.29 -12.41 24.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.709 -1.245 . . . . 0.0 109.258 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.682 HH21 ' N ' ' B' ' 49' ' ' HIS . 6.1 ptp180 -95.76 1.97 53.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 111.281 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' B' ' 56' ' ' PHE . 94.9 mm-40 44.37 19.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.8 -1.187 . . . . 0.0 110.168 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.768 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 48.9 3.26 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.477 -0.764 . . . . 0.0 112.893 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' O ' ' B' ' 55' ' ' GLY . 33.0 m-85 -49.91 -143.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.252 -1.734 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.435 ' H ' ' HB3' ' B' ' 56' ' ' PHE . 93.0 m -135.8 -55.87 0.78 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.312 -0.868 . . . . 0.0 110.964 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.679 ' NE2' ' H ' ' B' ' 44' ' ' GLU . 13.0 t60 -168.39 153.22 6.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.203 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.36 116.06 10.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.509 -0.744 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -89.42 131.68 35.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.069 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -121.89 121.3 36.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -114.95 134.66 54.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.218 -0.926 . . . . 0.0 110.757 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 32.6 m -122.88 143.34 49.94 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -117.83 159.59 22.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.693 -1.254 . . . . 0.0 110.036 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.46 -29.24 46.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -174.22 -178.17 1.4 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.83 -27.12 67.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.949 . . . . 0.0 111.469 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -61.92 -44.02 97.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.782 -1.199 . . . . 0.0 110.593 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.27 -32.7 68.65 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -66.7 -45.38 78.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.939 . . . . 0.0 110.459 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.81 -28.92 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.411 -1.43 . . . . 0.0 108.697 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.08 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.325 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.596 ' O ' ' CE1' ' B' ' 76' ' ' HIS . 0.0 OUTLIER -57.06 -49.98 74.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.224 -0.923 . . . . 0.0 111.107 -177.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.594 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 8.6 t -62.85 -28.13 69.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 110.311 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 84.5 p -62.05 16.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.96 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.733 ' HE2' HE21 ' B' ' 33' ' ' GLN . 0.0 OUTLIER -121.83 150.97 56.95 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.868 -1.145 . . . . 0.0 109.585 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.19 12.6 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.604 2.203 . . . . 0.0 112.48 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.526 HD22 HE22 ' B' ' 33' ' ' GLN . 0.7 OUTLIER -76.08 -29.72 58.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.435 -0.79 . . . . 0.0 111.22 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' B' ' 83' ' ' SER . 35.4 t-80 -85.21 -41.71 15.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.935 -1.103 . . . . 0.0 110.22 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.628 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 7.2 p -57.9 -58.56 5.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 110.031 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.628 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 14.9 tm-20 -57.84 -39.4 77.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.544 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.8 -40.89 72.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 109.894 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.437 ' N ' ' O ' ' B' ' 79' ' ' HIS . 87.2 p -61.5 -38.14 86.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.24 60.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.011 -1.056 . . . . 0.0 108.675 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -41.18 78.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.462 ' C ' ' O ' ' B' ' 85' ' ' ALA . 24.6 t80 -44.24 -30.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 89' ' ' VAL . 6.1 m -83.35 -61.77 1.76 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.06 -26.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.604 . . . . 0.0 110.061 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' B' ' 87' ' ' THR . 12.7 m -102.15 16.27 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.18 -0.95 . . . . 0.0 110.769 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' B' ' 87' ' ' THR . 73.4 mt -124.32 159.17 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.643 -1.285 . . . . 0.0 110.417 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.49 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 63.0 t0 -102.3 -34.47 9.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 29.2 pttt -145.94 143.55 29.6 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 4.0 tp -121.4 122.2 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.64 -1.287 . . . . 0.0 109.772 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.93 130.44 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -135.37 131.67 36.64 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.307 -1.495 . . . . 0.0 111.76 -178.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.625 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.0 OUTLIER -122.73 127.24 48.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -126.05 133.3 51.76 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.078 -1.014 . . . . 0.0 108.91 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 64.2 t80 -155.24 128.74 4.44 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . 0.531 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 80.5 Cg_exo -46.18 133.39 15.22 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.314 2.009 . . . . 0.0 112.241 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 74.8 t -107.42 129.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 110.007 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -101.5 81.94 2.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 109.577 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 76.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.783 ' O ' ' C ' ' B' ' 104' ' ' LYS . 16.2 m -154.22 -28.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.783 ' C ' ' O ' ' B' ' 103' ' ' VAL . 54.5 mmtt -4.54 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' B' ' 104' ' ' LYS . 3.6 m 67.22 -8.97 0.42 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.149 -0.969 . . . . 0.0 108.949 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.574 ' H ' ' C ' ' B' ' 104' ' ' LYS . 26.2 t -55.83 133.27 51.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.51 40.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.41 139.02 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.5 -0.75 . . . . 0.0 109.518 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.33 177.24 7.89 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' B' ' 110' ' ' THR . 15.9 p -137.44 69.92 53.8 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.864 -1.147 . . . . 0.0 109.64 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.733 2.288 . . . . 0.0 112.225 -179.905 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.5 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.18 52.87 2.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 109.355 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 t -103.38 -9.85 19.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.109 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.408 ' HB3' ' H ' ' A' ' 5' ' ' GLY . 22.1 t -152.78 -86.36 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 4' ' ' SER . . . -140.48 -159.29 7.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.703 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -142.56 142.38 32.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -1.13 . . . . 0.0 108.051 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.44 141.89 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 112.831 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -126.73 128.95 47.46 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.0 tt -135.37 142.77 45.78 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.755 -1.216 . . . . 0.0 109.436 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 12.7 p -131.11 139.5 50.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.05 127.34 72.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.05 144.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.825 -1.55 . . . . 0.0 113.068 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 37.2 tptt -111.76 150.5 30.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 18.4 p90 -107.0 147.5 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.823 -1.173 . . . . 0.0 111.607 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.76 -26.36 4.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 65.0 tt0 -88.19 -56.94 3.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.0 p30 152.63 70.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 41.8 m -55.12 106.88 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.142 0.972 . . . . 0.0 112.821 -177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.95 88.56 1.86 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.5 m -59.53 -40.95 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.705 . . . . 0.0 110.458 -176.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -61.01 -44.24 97.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.411 -0.806 . . . . 0.0 110.557 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.48 -39.12 62.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.5 -50.71 70.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.683 ' N ' ' O ' ' A' ' 20' ' ' VAL . 2.2 tm? -56.48 -42.61 78.53 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -60.13 -25.05 65.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.68 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -69.21 -54.82 11.89 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' GLY . 6.8 tt -44.33 -38.33 3.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.512 -0.993 . . . . 0.0 108.818 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -52.87 -41.82 64.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -57.41 -42.43 82.29 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.641 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -50.22 -46.29 54.48 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 34' ' ' ILE . 34.4 t -48.91 -24.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.332 -0.855 . . . . 0.0 108.908 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 42.4 t -43.24 -43.15 4.65 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 97.0 mm-40 -76.18 -22.42 55.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 111.464 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 36' ' ' THR . 71.9 mt -79.73 20.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.033 -1.667 . . . . 0.0 110.645 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.47 -10.47 1.46 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 34' ' ' ILE . 35.0 p -82.24 0.44 41.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.963 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.577 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.3 m 34.94 33.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.046 -1.034 . . . . 0.0 109.117 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 mtmp? -119.61 42.01 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 63' ' ' THR . 30.1 t -175.97 175.5 1.94 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.4 m-85 -150.53 159.72 44.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.591 -1.318 . . . . 0.0 111.99 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 86.1 mt-10 -159.24 130.82 6.28 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.364 0.602 . . . . 0.0 110.2 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.696 ' N ' ' CD1' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -133.78 171.61 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' GLU . . . -134.45 168.21 23.57 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 118.672 -1.728 . . . . 0.0 110.793 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.618 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 87.4 mt-10 -156.82 152.5 26.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -1.114 . . . . 0.0 109.341 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.871 ' HA ' ' O ' ' A' ' 57' ' ' THR . 23.9 t0 -157.16 87.5 0.99 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HZ2' ' N ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -90.35 170.01 10.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.393 -1.442 . . . . 0.0 109.882 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.699 -0.625 . . . . 0.0 109.317 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.413 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 4.2 t -78.75 -125.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.0 110.164 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -77.63 153.9 32.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.721 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.47 -41.57 69.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 110.759 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.516 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.17 -40.61 90.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.969 -1.082 . . . . 0.0 110.737 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' B' ' 95' ' ' LEU . 44.8 mt -75.86 -64.62 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.745 -1.222 . . . . 0.0 109.303 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -67.72 18.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 0.0 111.233 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 52' ' ' LEU . 1.7 mm100 45.33 8.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.701 -1.249 . . . . 0.0 110.164 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 70.3 -11.54 2.12 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.503 -0.748 . . . . 0.0 112.936 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' O ' ' O ' ' A' ' 55' ' ' GLY . 49.4 m-85 -53.92 -136.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.288 -1.713 . . . . 0.0 109.92 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.871 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 6.1 t -163.28 -51.45 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 110.903 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 60' ' ' PHE . 6.3 t60 -148.37 142.5 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 0.0 110.149 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.69 163.06 33.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 0.0 109.231 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 58' ' ' HIS . 94.9 m-85 -133.78 131.17 39.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.083 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' A' ' 42' ' ' TRP . 1.6 m -116.59 110.39 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.13 132.38 53.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.209 -0.932 . . . . 0.0 110.838 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.437 ' O ' ' OG ' ' A' ' 39' ' ' SER . 62.8 m -119.01 141.44 48.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.24 158.5 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.689 -1.257 . . . . 0.0 110.097 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -75.66 -26.42 57.67 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -175.39 -177.34 1.01 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -66.61 -23.73 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 111.355 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.7 -41.04 97.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.763 -1.21 . . . . 0.0 110.577 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.57 65.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -69.39 -43.22 73.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.496 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.523 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.82 -28.89 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.423 -1.423 . . . . 0.0 108.642 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.08 -60.9 2.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.299 -0.876 . . . . 0.0 109.358 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.72 -57.74 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.875 . . . . 0.0 111.145 -178.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.64 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 9.2 t -57.27 -35.57 69.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.775 -1.203 . . . . 0.0 110.293 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 58.4 m -66.69 -32.94 74.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.0 110.964 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 78' ' ' LEU . 59.3 m80 -68.43 128.76 93.03 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.83 -1.169 . . . . 0.0 109.601 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.34 -8.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 112.443 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.7 tp -66.77 -28.41 68.37 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.34 -0.85 . . . . 0.0 111.291 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.75 -35.32 24.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.012 . . . . 0.0 110.247 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.97 -61.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -58.62 -38.66 78.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.604 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 78.0 t80 -68.48 -44.28 75.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.872 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 t -59.87 -35.48 74.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.968 -1.082 . . . . 0.0 108.682 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.75 -42.14 77.94 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 85' ' ' ALA . 6.5 t80 -43.53 -30.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.4 m -83.05 -61.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.84 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.639 -0.663 . . . . 0.0 110.008 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.7 m -102.69 11.37 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.19 -0.944 . . . . 0.0 110.746 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 44.8 mt -125.74 158.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.596 -1.315 . . . . 0.0 110.53 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 60.6 t0 -104.22 -32.33 9.17 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -148.87 147.0 28.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.43 127.58 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.579 -1.326 . . . . 0.0 109.763 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 48.3 t -132.18 135.51 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -135.6 130.28 34.19 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 111.759 -178.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.72 127.34 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.65 -0.656 . . . . 0.0 109.387 177.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 54.6 m-20 -123.06 125.08 44.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 108.908 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.748 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -146.7 127.26 7.01 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.053 -1.029 . . . . 0.0 110.501 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.42 123.61 9.44 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.31 2.007 . . . . 0.0 112.22 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.47 132.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.62 80.51 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 84.51 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.632 ' O ' ' O ' ' A' ' 104' ' ' LYS . 17.2 m -147.11 -22.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.177 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.632 ' O ' ' O ' ' A' ' 103' ' ' VAL . 24.8 mtmt 41.33 102.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.328 -0.858 . . . . 0.0 109.358 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -50.74 -50.8 54.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.15 -0.969 . . . . 0.0 108.934 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.1 t 45.78 29.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.385 -0.822 . . . . 0.0 109.378 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.3 t -72.32 -56.0 11.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.01 140.97 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.546 -0.721 . . . . 0.0 109.505 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -104.58 120.28 40.92 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.19 155.16 61.78 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 120.802 -1.186 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.307 -1.626 0 C-N-CA 122.825 2.35 . . . . 0.0 112.219 179.562 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.38 53.22 2.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 109.358 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 13.7 t -103.47 -10.36 18.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.85 . . . . 0.0 109.153 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t -152.44 -86.4 0.07 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.49 -159.06 7.79 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.687 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -142.81 142.37 31.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -1.136 . . . . 0.0 108.029 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.61 141.64 47.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.932 -1.105 . . . . 0.0 112.819 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.5 128.91 47.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.0 tt -135.42 142.75 45.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.789 -1.195 . . . . 0.0 109.439 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 12.5 p -131.01 139.53 50.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.627 -0.671 . . . . 0.0 109.523 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.09 127.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.03 144.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 117.738 -1.585 . . . . 0.0 113.019 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 36.8 tptt -111.92 150.42 30.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 18.4 p90 -106.91 147.36 29.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 111.575 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.6 -26.39 4.55 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 65.4 tt0 -88.18 -56.83 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.1 p30 152.45 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 40.1 m -55.38 106.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.059 0.933 . . . . 0.0 112.901 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.499 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.01 88.4 1.88 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.679 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.4 m -59.52 -40.65 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 110.434 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.22 -44.42 97.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 110.54 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -74.23 -38.99 63.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.79 -50.37 71.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' B' ' 20' ' ' VAL . 2.2 tm? -56.86 -42.5 79.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -60.11 -25.15 65.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.688 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -69.15 -54.62 12.9 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' B' ' 26' ' ' GLY . 6.8 tt -44.43 -38.29 3.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.551 -0.97 . . . . 0.0 108.831 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -52.96 -41.87 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.688 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.7 p30 -57.28 -42.57 81.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.638 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -50.07 -46.62 53.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' B' ' 34' ' ' ILE . 33.6 t -48.53 -24.74 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 44.2 t -43.15 -43.31 4.52 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.477 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 97.0 mm-40 -75.91 -22.74 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.429 -0.795 . . . . 0.0 111.52 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' B' ' 36' ' ' THR . 72.5 mt -79.3 20.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.955 -1.715 . . . . 0.0 110.586 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.57 -10.58 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.588 ' H ' ' C ' ' B' ' 34' ' ' ILE . 34.6 p -82.09 0.36 40.97 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 35.17 33.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.079 -1.013 . . . . 0.0 109.24 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.8 mtmp? -119.72 42.13 2.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 63' ' ' THR . 30.8 t -176.04 175.21 1.96 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.454 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.9 m-85 -150.41 159.26 44.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.511 -1.368 . . . . 0.0 111.953 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 86.1 mt-10 -158.84 130.78 6.59 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.315 0.578 . . . . 0.0 110.221 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . 0.688 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.0 OUTLIER -133.7 171.6 13.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.46 168.41 23.49 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.666 -1.731 . . . . 0.0 110.751 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.615 ' O ' ' CG ' ' B' ' 58' ' ' HIS . 87.1 mt-10 -156.94 152.42 26.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -1.202 . . . . 0.0 109.41 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.876 ' HA ' ' O ' ' B' ' 57' ' ' THR . 24.4 t0 -156.99 87.85 1.01 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.596 ' HZ2' ' N ' ' B' ' 57' ' ' THR . 0.0 OUTLIER -90.83 170.15 10.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.368 -1.457 . . . . 0.0 109.818 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.09 0.43 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.402 ' N ' ' HG3' ' B' ' 53' ' ' ARG . 4.7 t -78.55 -125.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 110.118 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -78.18 153.73 31.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.17 -41.79 69.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 110.822 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -66.1 -40.42 90.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.033 . . . . 0.0 110.768 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 95' ' ' LEU . 45.5 mt -76.09 -64.31 1.12 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.729 -1.232 . . . . 0.0 109.295 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.4 OUTLIER -68.12 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.38 -0.825 . . . . 0.0 111.218 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' B' ' 52' ' ' LEU . 1.7 mm100 45.13 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.735 -1.228 . . . . 0.0 110.195 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.669 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 70.42 -12.05 2.01 Favored Glycine 0 N--CA 1.5 2.914 0 O-C-N 121.496 -0.753 . . . . 0.0 112.811 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.669 ' O ' ' O ' ' B' ' 55' ' ' GLY . 49.8 m-85 -53.66 -136.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.242 -1.74 . . . . 0.0 109.916 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.876 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 6.3 t -163.0 -51.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.641 ' CD2' ' CZ ' ' B' ' 60' ' ' PHE . 6.2 t60 -148.44 142.45 25.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.938 -1.101 . . . . 0.0 110.175 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.52 163.1 33.85 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.487 -0.758 . . . . 0.0 109.294 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' B' ' 58' ' ' HIS . 95.2 m-85 -133.71 131.02 38.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.151 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' B' ' 42' ' ' TRP . 1.6 m -116.39 110.6 18.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.56 132.51 53.18 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 110.743 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.437 ' O ' ' OG ' ' B' ' 39' ' ' SER . 62.8 m -119.05 141.42 48.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.28 158.49 26.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.736 -1.228 . . . . 0.0 110.013 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -75.76 -26.48 57.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -175.28 -177.42 1.03 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.43 -23.74 66.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.69 -41.2 97.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.814 -1.179 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.28 -31.71 65.9 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -69.07 -43.53 74.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.56 -0.965 . . . . 0.0 110.474 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.508 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.88 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.47 -1.394 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.51 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.1 -60.85 2.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.632 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -57.43 -57.94 10.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 111.146 -178.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.632 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 9.1 t -57.33 -35.21 69.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.368 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.508 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 58.5 m -66.93 -32.97 74.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' B' ' 78' ' ' LEU . 59.4 m80 -68.44 128.55 93.05 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.887 -1.133 . . . . 0.0 109.629 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -42.98 -8.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.644 2.229 . . . . 0.0 112.513 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.6 tp -66.56 -28.59 68.64 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.387 -0.821 . . . . 0.0 111.211 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -83.65 -35.31 24.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 110.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.05 -61.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.014 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -58.58 -38.72 78.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 77.9 t80 -68.27 -44.54 75.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.838 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -59.77 -35.24 74.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.163 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.16 60.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.978 -1.076 . . . . 0.0 108.742 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -42.15 77.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.474 ' C ' ' O ' ' B' ' 85' ' ' ALA . 6.6 t80 -43.55 -30.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.503 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.0 m -82.98 -61.87 1.75 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.78 -26.92 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.697 -0.627 . . . . 0.0 110.049 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.7 m -102.71 11.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.233 -0.917 . . . . 0.0 110.797 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 43.8 mt -126.0 158.85 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.646 -1.284 . . . . 0.0 110.384 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 60.3 t0 -104.4 -32.25 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -149.0 147.1 28.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.67 127.48 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.526 -1.358 . . . . 0.0 109.746 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 48.4 t -132.12 135.28 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -135.4 130.24 34.56 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.254 -1.529 . . . . 0.0 111.792 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.537 ' H ' HD13 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -118.69 127.11 53.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.645 -0.66 . . . . 0.0 109.343 177.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.573 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 55.3 m-20 -122.85 124.87 44.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.031 -1.043 . . . . 0.0 108.85 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.794 ' N ' ' CD1' ' B' ' 98' ' ' PHE . 0.0 OUTLIER -146.37 127.45 7.29 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.097 -1.002 . . . . 0.0 110.502 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.55 123.65 9.65 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.229 1.953 . . . . 0.0 112.248 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.34 132.83 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.69 80.53 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.99 84.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -0.98 . . . . 0.0 109.557 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.627 ' O ' ' O ' ' B' ' 104' ' ' LYS . 17.2 m -147.26 -22.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.196 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.627 ' O ' ' O ' ' B' ' 103' ' ' VAL . 24.5 mtmt 41.02 102.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.344 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.408 ' O ' ' C ' ' B' ' 106' ' ' SER . 15.1 m -50.89 -50.8 56.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.112 -0.993 . . . . 0.0 108.957 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.408 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.0 t 45.94 29.91 0.82 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.362 -0.836 . . . . 0.0 109.413 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t -72.29 -56.1 11.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.87 141.35 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 109.532 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -104.81 120.26 40.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.24 155.19 61.59 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 120.816 -1.177 . . . . 0.0 109.652 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 C--N 1.309 -1.54 0 C-N-CA 122.674 2.249 . . . . 0.0 112.245 179.623 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.43 64.02 1.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.381 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -113.51 4.27 16.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.15 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 100' ' ' VAL . 4.3 p -175.84 -113.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.27 173.75 19.12 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.71 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -124.92 128.99 49.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.188 -1.184 . . . . 0.0 108.07 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 20.1 ttpt -104.1 134.26 47.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.057 . . . . 0.0 112.837 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 62' ' ' MET . 85.3 t60 -127.14 125.03 40.47 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.725 -1.234 . . . . 0.0 109.454 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.46 138.05 54.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.6 -0.687 . . . . 0.0 109.444 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 t -119.4 131.64 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -136.52 156.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 117.787 -1.565 . . . . 0.0 113.071 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -123.33 153.09 40.77 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' HB2' ' H ' ' A' ' 18' ' ' THR . 23.7 p90 -110.99 146.61 36.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -21.14 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.5 tt0 -92.82 -57.37 2.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.5 m-20 157.55 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.9 m -50.95 103.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.045 0.926 . . . . 0.0 112.854 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.791 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -71.1 82.55 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 24' ' ' LEU . 28.8 m -62.37 -40.07 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.635 -0.666 . . . . 0.0 110.458 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -66.21 -45.59 80.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 0.0 110.515 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 29.2 mp0 -68.29 -34.09 75.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.11 -43.29 88.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 20' ' ' VAL . 17.9 tp -54.29 -35.92 63.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.28 -33.9 72.99 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -61.33 -52.49 51.24 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.2 tt -46.91 -44.14 19.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.493 -1.004 . . . . 0.0 108.774 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -55.21 -37.65 67.4 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 2.0 m-80 -62.85 -46.04 89.75 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 3.4 mm? -48.45 -46.49 37.92 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 32' ' ' SER . 63.1 t -51.3 -26.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.287 -0.883 . . . . 0.0 108.837 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 30.9 t -46.38 -47.97 18.65 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.651 ' NE2' ' O ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -86.94 -23.7 25.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 0.0 111.467 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.55 ' C ' ' H ' ' A' ' 36' ' ' THR . 4.6 mm -73.25 23.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.036 -1.665 . . . . 0.0 110.618 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.0 p30 -61.8 -9.31 6.28 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' A' ' 37' ' ' VAL . 64.1 p -71.52 -4.86 29.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.971 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.4 m 32.64 36.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 ptmt -121.96 41.97 3.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 40' ' ' PHE . 26.9 t -174.6 179.07 1.8 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.567 ' N ' ' HG ' ' A' ' 39' ' ' SER . 97.6 m-85 -143.98 153.4 42.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.554 -1.341 . . . . 0.0 111.998 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 61' ' ' SER . 75.5 mt-10 -156.41 124.26 5.57 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.355 0.598 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -134.74 174.15 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.24 145.42 11.7 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 118.777 -1.678 . . . . 0.0 110.832 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.573 ' O ' ' CD2' ' A' ' 58' ' ' HIS . 56.2 mp0 -148.31 164.81 32.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.233 -1.157 . . . . 0.0 109.388 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 57' ' ' THR . 21.4 t70 -113.78 161.1 17.95 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.658 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 3.0 ptmm? -62.01 83.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.43 -1.419 . . . . 0.0 109.771 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.2 mt-10 -128.79 46.87 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.622 -0.674 . . . . 0.0 109.259 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' B' ' 97' ' ' ASP . 5.9 t -142.2 78.71 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.75 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 56.2 m80 56.58 107.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.927 . . . . 0.0 109.678 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -45.66 -35.16 3.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -0.851 . . . . 0.0 110.818 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -71.4 -35.34 70.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.961 -1.087 . . . . 0.0 110.682 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' B' ' 95' ' ' LEU . 84.5 mt -78.76 -51.1 10.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.763 -1.211 . . . . 0.0 109.314 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.75 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.1 ptp180 -64.35 13.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 0.0 111.274 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 52' ' ' LEU . 82.2 mm-40 37.76 32.19 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.82 -1.175 . . . . 0.0 110.129 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.777 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 59.16 1.83 1.16 Allowed Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.439 -0.788 . . . . 0.0 112.815 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.777 ' O ' ' O ' ' A' ' 55' ' ' GLY . 46.1 m-85 -48.82 -148.15 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.221 -1.753 . . . . 0.0 109.884 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 50.4 m -143.37 -56.72 0.4 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.331 -0.855 . . . . 0.0 110.957 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.632 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 15.2 t-80 -158.21 145.98 18.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.116 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -132.04 148.91 52.53 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.264 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 58' ' ' HIS . 34.8 m-85 -118.91 119.71 35.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.48 -0.762 . . . . 0.0 109.04 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 7.1 t -88.94 95.35 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.0 mtp -102.37 110.62 22.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.228 -0.92 . . . . 0.0 110.813 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.473 ' O ' ' OG ' ' A' ' 39' ' ' SER . 4.2 m -125.63 145.87 49.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.6 160.52 21.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.17 . . . . 0.0 110.068 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 85.5 tt0 -81.99 -31.95 30.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.4 m-20 -163.18 174.32 12.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.63 -27.14 62.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 111.417 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 71' ' ' VAL . 91.6 m-20 -55.49 -36.73 66.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.869 -1.144 . . . . 0.0 110.538 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.74 -35.35 73.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.68 -44.34 97.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.508 -0.995 . . . . 0.0 110.5 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 68' ' ' ASP . 21.1 m -70.78 -28.88 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.379 -1.451 . . . . 0.0 108.661 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.94 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.365 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.59 -39.94 58.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 111.129 -177.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.619 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.5 t -80.79 -29.81 36.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.725 -1.234 . . . . 0.0 110.264 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.2 t -58.13 -33.64 69.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.984 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 73' ' ' PHE . 13.9 p80 -87.84 141.91 32.0 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.632 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 10.86 1.49 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.652 2.234 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.594 ' H ' ' HD1' ' A' ' 76' ' ' HIS . 3.6 tt -73.04 -26.86 61.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.801 . . . . 0.0 111.256 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 83' ' ' SER . 9.3 t-80 -85.0 -43.41 13.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.0 110.249 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.517 ' CG1' ' H ' ' A' ' 81' ' ' GLU . 2.8 p -56.62 -58.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.517 ' H ' ' CG1' ' A' ' 80' ' ' VAL . 93.5 mt-10 -58.39 -42.27 86.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.94 -39.37 72.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' HIS . 23.6 t -59.83 -38.07 81.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.142 -0.974 . . . . 0.0 110.151 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.55 72.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.923 -1.111 . . . . 0.0 108.65 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.84 -41.59 78.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 85' ' ' ALA . 22.5 t80 -45.04 -30.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 90' ' ' ILE . 3.8 m -84.68 -63.6 1.31 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.09 -27.35 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.65 -0.657 . . . . 0.0 110.089 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 87' ' ' THR . 5.4 p -98.53 16.57 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 23.0 mm -130.64 164.02 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.683 -1.26 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.567 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 40.9 t0 -103.41 -36.76 7.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -146.96 146.42 30.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.37 127.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.6 -1.313 . . . . 0.0 109.707 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.2 133.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.65 36.22 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.292 -1.505 . . . . 0.0 111.804 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -125.69 128.99 48.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.675 . . . . 0.0 109.379 177.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.593 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 42.8 t0 -120.01 124.61 46.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.021 -1.049 . . . . 0.0 108.893 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 97' ' ' ASP . 25.1 m-85 -142.31 148.96 49.8 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.986 -1.071 . . . . 0.0 110.531 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.83 130.12 16.4 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.244 1.963 . . . . 0.0 112.201 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.551 ' O ' ' OG ' ' A' ' 4' ' ' SER . 9.9 t -95.22 117.09 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.96 . . . . 0.0 109.994 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -91.31 75.45 6.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.21 71.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.114 -0.992 . . . . 0.0 109.563 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' SER . 29.1 m -149.78 -32.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.266 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 106' ' ' SER . 25.3 mtmt 37.68 -93.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER 66.58 -42.53 0.4 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 108.978 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 104' ' ' LYS . 9.5 m -44.4 104.18 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.277 -0.89 . . . . 0.0 109.336 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.593 ' CG2' ' H ' ' A' ' 108' ' ' VAL . 7.6 p -80.64 -176.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.593 ' H ' ' CG2' ' A' ' 107' ' ' VAL . 8.6 p -42.26 142.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.399 -0.813 . . . . 0.0 109.401 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.87 93.34 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -70.75 152.09 95.21 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 120.824 -1.172 . . . . 0.0 109.671 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo . . . . . 0 C--N 1.307 -1.637 0 C-N-CA 122.76 2.306 . . . . 0.0 112.24 179.776 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.607 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.42 63.83 1.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 109.428 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -113.38 3.99 16.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.101 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' B' ' 100' ' ' VAL . 4.2 p -175.64 -113.27 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.28 173.7 19.07 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -124.8 129.11 49.8 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.205 -1.174 . . . . 0.0 108.01 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' B' ' 97' ' ' ASP . 20.2 ttpt -104.23 134.27 47.74 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.311 1.053 . . . . 0.0 112.822 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' B' ' 62' ' ' MET . 85.4 t60 -127.08 125.07 40.66 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.1 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.747 -1.22 . . . . 0.0 109.487 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -130.47 138.02 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.545 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.42 131.52 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.49 156.19 35.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 117.732 -1.587 . . . . 0.0 113.053 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -123.2 153.07 40.58 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.501 ' HB2' ' H ' ' B' ' 18' ' ' THR . 23.7 p90 -111.01 146.54 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 0.0 111.663 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 -21.18 2.9 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -92.96 -57.36 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.5 m-20 157.47 65.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.501 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.3 m -50.79 103.32 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.117 0.961 . . . . 0.0 112.844 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.776 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -71.29 82.47 0.75 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' B' ' 24' ' ' LEU . 28.4 m -62.15 -40.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.585 -0.697 . . . . 0.0 110.433 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -66.36 -45.41 80.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.559 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' B' ' 22' ' ' GLU . 28.8 mp0 -68.43 -34.1 75.39 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.04 -43.31 89.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 20' ' ' VAL . 17.9 tp -54.14 -36.24 63.09 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.02 -34.03 72.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -61.42 -52.22 52.79 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.2 tt -47.12 -43.85 20.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.533 -0.98 . . . . 0.0 108.83 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -55.54 -37.47 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 2.1 m-80 -62.9 -46.13 89.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 3.4 mm? -48.31 -46.62 36.48 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' B' ' 32' ' ' SER . 62.8 t -51.19 -26.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 108.821 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 31.0 t -46.33 -48.05 18.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.654 ' NE2' ' O ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -86.97 -23.68 24.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.448 -0.782 . . . . 0.0 111.553 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.537 ' C ' ' H ' ' B' ' 36' ' ' THR . 4.6 mm -73.16 23.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 119.984 -1.697 . . . . 0.0 110.591 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' B' ' 33' ' ' GLN . 55.2 p30 -61.7 -9.44 6.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' THR . . . . . 0.604 ' O ' ' N ' ' B' ' 38' ' ' LYS . 63.0 p -71.46 -4.73 28.2 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.948 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.596 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.3 m 32.61 36.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.044 -1.035 . . . . 0.0 109.144 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.9 ptmt -122.26 42.01 3.25 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.543 ' HG ' ' N ' ' B' ' 40' ' ' PHE . 27.6 t -174.51 179.14 1.82 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.543 ' N ' ' HG ' ' B' ' 39' ' ' SER . 97.6 m-85 -144.1 153.24 41.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.525 -1.359 . . . . 0.0 112.001 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' B' ' 61' ' ' SER . 74.9 mt-10 -156.3 124.18 5.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.746 -0.596 . . . . 0.0 110.302 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -134.87 174.15 10.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.3 145.54 11.86 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 118.691 -1.719 . . . . 0.0 110.819 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.575 ' O ' ' CD2' ' B' ' 58' ' ' HIS . 56.8 mp0 -148.35 164.72 33.21 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -1.149 . . . . 0.0 109.408 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' B' ' 57' ' ' THR . 21.6 t70 -113.57 161.15 17.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.66 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 3.0 ptmm? -62.03 83.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.421 -1.424 . . . . 0.0 109.805 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.0 mt-10 -128.73 46.75 2.56 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 97' ' ' ASP . 6.1 t -142.13 78.9 1.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 110.179 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.749 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 56.0 m80 56.4 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 109.694 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -45.86 -35.01 4.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.38 -0.825 . . . . 0.0 110.784 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -71.49 -35.2 70.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 0.0 110.739 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' A' ' 95' ' ' LEU . 84.1 mt -78.88 -50.99 10.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.691 -1.256 . . . . 0.0 109.329 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.749 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.1 ptp180 -64.29 13.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 111.291 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' B' ' 52' ' ' LEU . 82.2 mm-40 37.92 31.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.787 -1.196 . . . . 0.0 110.175 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.775 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 59.49 1.47 1.21 Allowed Glycine 0 N--CA 1.499 2.833 0 O-C-N 121.393 -0.817 . . . . 0.0 112.82 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' PHE . . . . . 0.775 ' O ' ' O ' ' B' ' 55' ' ' GLY . 46.6 m-85 -48.58 -148.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.296 -1.708 . . . . 0.0 109.979 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 49.3 m -143.44 -56.69 0.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.342 -0.849 . . . . 0.0 110.925 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' HIS . . . . . 0.63 ' CE1' ' CE1' ' B' ' 60' ' ' PHE . 14.8 t-80 -158.37 146.21 18.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.91 -1.119 . . . . 0.0 110.157 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.582 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -132.25 148.97 52.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CE1' ' B' ' 58' ' ' HIS . 35.6 m-85 -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.461 -0.775 . . . . 0.0 109.08 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 6.9 t -88.9 95.31 10.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' MET . . . . . 0.479 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.5 mtp -102.41 110.55 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.195 -0.94 . . . . 0.0 110.787 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' B' ' 39' ' ' SER . 4.2 m -125.56 145.99 49.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -117.73 160.58 21.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.726 -1.234 . . . . 0.0 110.051 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 85.6 tt0 -82.06 -31.86 30.64 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.3 m-20 -163.29 174.2 12.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.58 -27.11 62.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.292 -0.88 . . . . 0.0 111.407 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.403 ' O ' HG21 ' B' ' 71' ' ' VAL . 91.2 m-20 -55.37 -36.89 66.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.75 -35.43 73.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -61.49 -44.66 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.604 -0.939 . . . . 0.0 110.455 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.403 HG21 ' O ' ' B' ' 68' ' ' ASP . 20.8 m -70.69 -29.01 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.348 -1.47 . . . . 0.0 108.695 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.379 -0.826 . . . . 0.0 109.323 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -51.22 -40.21 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -0.921 . . . . 0.0 111.131 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.62 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.5 t -80.58 -29.96 36.95 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.742 -1.224 . . . . 0.0 110.256 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 38.5 t -57.97 -33.84 69.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.961 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.63 ' HD1' ' H ' ' B' ' 78' ' ' LEU . 13.8 p80 -87.76 141.94 32.17 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.161 . . . . 0.0 109.564 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.68 10.91 1.47 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.662 2.241 . . . . 0.0 112.427 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.63 ' H ' ' HD1' ' B' ' 76' ' ' HIS . 3.5 tt -73.0 -27.01 61.53 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.342 -0.849 . . . . 0.0 111.243 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' SER . 9.3 t-80 -84.96 -43.26 14.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.019 -1.051 . . . . 0.0 110.25 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.512 ' CG1' ' H ' ' B' ' 81' ' ' GLU . 2.7 p -56.83 -58.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 110.041 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.512 ' H ' ' CG1' ' B' ' 80' ' ' VAL . 93.5 mt-10 -58.36 -42.49 87.09 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.643 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -70.63 -39.47 73.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.827 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.481 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.7 t -59.72 -38.25 81.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 110.108 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.63 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 108.654 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.76 -41.59 78.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' B' ' 85' ' ' ALA . 22.4 t80 -45.02 -30.88 1.14 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.495 ' O ' ' N ' ' B' ' 90' ' ' ILE . 3.8 m -84.44 -63.73 1.29 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.94 -27.51 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 110.07 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 87' ' ' THR . 5.4 p -98.57 16.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.224 -0.923 . . . . 0.0 110.818 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 22.8 mm -130.86 164.1 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.618 -1.301 . . . . 0.0 110.497 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . 0.553 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 41.9 t0 -103.44 -36.89 7.83 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -146.95 146.39 30.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.32 127.56 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.555 -1.341 . . . . 0.0 109.658 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.38 133.11 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.8 36.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.269 -1.52 . . . . 0.0 111.768 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.628 ' N ' ' CD1' ' B' ' 96' ' ' LEU . 0.0 OUTLIER -125.73 129.06 48.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.629 . . . . 0.0 109.312 177.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.596 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 43.3 t0 -119.99 124.6 46.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . 0.596 ' CD1' ' O ' ' B' ' 97' ' ' ASP . 24.9 m-85 -142.29 148.91 49.7 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.098 -1.001 . . . . 0.0 110.504 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 130.05 16.41 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.28 1.987 . . . . 0.0 112.187 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . 0.551 ' O ' ' OG ' ' B' ' 4' ' ' SER . 9.5 t -95.15 117.05 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 110.054 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -91.32 75.48 6.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 109.54 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.23 71.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.566 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' B' ' 105' ' ' SER . 29.2 m -149.84 -32.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.577 ' C ' ' H ' ' B' ' 106' ' ' SER . 25.5 mtmt 37.71 -93.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.579 ' N ' ' O ' ' B' ' 103' ' ' VAL . 0.9 OUTLIER 66.59 -42.69 0.41 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.968 . . . . 0.0 108.941 -178.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.577 ' H ' ' C ' ' B' ' 104' ' ' LYS . 10.2 m -44.22 104.08 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.35 -0.844 . . . . 0.0 109.386 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.589 ' CG2' ' H ' ' B' ' 108' ' ' VAL . 7.5 p -80.49 -176.72 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.589 ' H ' ' CG2' ' B' ' 107' ' ' VAL . 8.5 p -41.88 142.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.408 -0.807 . . . . 0.0 109.484 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.92 93.41 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 108' ' ' VAL . 0.1 OUTLIER -70.74 152.17 95.21 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 120.881 -1.137 . . . . 0.0 109.667 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo . . . . . 0 C--N 1.307 -1.61 0 C-N-CA 122.704 2.269 . . . . 0.0 112.362 179.757 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.628 HG23 ' N ' ' A' ' 4' ' ' SER . 8.9 t -63.48 -45.57 90.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.149 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.628 ' N ' HG23 ' A' ' 3' ' ' THR . 19.9 m -139.64 -100.5 0.16 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.22 148.48 34.43 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.689 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.544 ' CZ ' ' OD1' ' A' ' 97' ' ' ASP . 34.6 t80 -114.93 128.09 56.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.268 -1.137 . . . . 0.0 108.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.695 ' HZ3' HD12 ' A' ' 9' ' ' LEU . 3.7 ttpp -113.51 142.35 46.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.919 -1.113 . . . . 0.0 112.83 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -132.79 133.42 43.38 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.695 HD12 ' HZ3' ' A' ' 7' ' ' LYS . 6.6 tt -136.63 145.84 45.33 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 109.461 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.2 p -127.14 133.43 68.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.566 HG12 ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -116.19 129.03 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 57' ' ' THR . 6.4 m -139.45 167.53 19.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.733 -1.587 . . . . 0.0 113.024 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 19.0 tptp -132.85 152.29 51.87 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.473 ' HB2' ' H ' ' A' ' 18' ' ' THR . 39.7 p90 -108.68 149.61 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.877 -1.139 . . . . 0.0 111.576 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -129.29 -22.09 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.7 mt-10 -89.27 -57.11 3.0 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.0 t0 153.83 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.473 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 64.6 m -50.93 105.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.104 0.954 . . . . 0.0 112.814 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -75.56 88.16 2.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 21' ' ' ASP . 34.7 m -64.61 -38.57 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.557 -0.714 . . . . 0.0 110.524 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 20' ' ' VAL . 82.9 m-20 -66.1 -44.63 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.425 -0.797 . . . . 0.0 110.572 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.96 -31.39 72.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mt -69.62 -37.44 74.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 13.9 tp -53.22 -37.86 62.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -34.53 74.23 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.02 -53.54 36.41 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -46.82 -47.73 20.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.497 -1.002 . . . . 0.0 108.832 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.49 -44.54 65.7 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -68.59 -49.05 62.33 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.269 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.39 -47.81 37.27 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.7 t -49.76 -26.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.268 -0.895 . . . . 0.0 108.887 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 47.0 t -41.64 -42.69 2.57 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.663 HE22 ' CE1' ' A' ' 76' ' ' HIS . 26.4 mm-40 -61.23 -11.17 8.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.483 -0.76 . . . . 0.0 111.499 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 34' ' ' ILE . 41.8 mm -81.92 26.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 119.985 -1.697 . . . . 0.0 110.604 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 36' ' ' THR . 31.1 p-10 -67.38 -26.38 66.43 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.711 HG23 ' H ' ' A' ' 38' ' ' LYS . 7.5 t -79.21 1.99 22.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.968 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 21.1 m 37.83 21.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.081 -1.012 . . . . 0.0 109.187 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.711 ' H ' HG23 ' A' ' 36' ' ' THR . 83.0 mttt -120.81 41.26 3.33 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.4 m -158.12 154.75 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.503 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 98.5 m-85 -144.46 154.43 42.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.543 -1.348 . . . . 0.0 111.949 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 81.1 mt-10 -160.88 130.46 4.9 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.335 0.588 . . . . 0.0 110.223 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -130.01 175.27 9.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.8 154.0 21.97 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.574 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 17.8 mt-10 -151.1 141.85 22.77 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -1.146 . . . . 0.0 109.401 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 8.5 p30 -116.02 148.53 40.07 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.64 ' HD3' ' N ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -68.5 80.82 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.481 -1.387 . . . . 0.0 109.809 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 45' ' ' ASP . 78.2 mm-40 -96.91 54.66 1.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.298 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 49' ' ' HIS . 29.7 t -134.14 -138.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -0.934 . . . . 0.0 110.23 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.54 ' N ' ' OG ' ' A' ' 48' ' ' SER . 74.1 m80 -107.37 142.94 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -42.83 -41.11 3.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 0.0 110.798 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 ttt -71.54 -29.37 64.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.016 -1.053 . . . . 0.0 110.703 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' B' ' 95' ' ' LEU . 52.1 mt -98.25 -18.38 18.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.745 -1.222 . . . . 0.0 109.277 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.636 ' C ' ' H ' ' A' ' 55' ' ' GLY . 55.0 mtp180 -73.43 0.58 11.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 111.212 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.9 -4.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.797 -1.189 . . . . 0.0 110.197 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 82.53 -18.36 15.2 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.884 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CD2' HG12 ' A' ' 11' ' ' VAL . 12.0 m-85 -59.26 -128.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.246 -1.738 . . . . 0.0 109.922 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.64 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 2.5 t -164.99 -36.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.34 -0.85 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.7 t60 -169.9 153.68 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.166 . . . . 0.0 110.225 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.653 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.18 168.76 18.98 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.261 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 88.1 m-85 -129.03 126.07 38.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 109.073 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.25 14.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 mtt -104.84 117.83 35.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.172 -0.955 . . . . 0.0 110.82 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -120.31 143.24 48.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.28 159.66 23.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.691 -1.255 . . . . 0.0 110.069 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.54 -27.45 62.23 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -173.75 -174.57 0.97 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.35 -27.17 65.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 111.445 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 29.1 p-10 -58.04 -37.89 75.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.813 -1.18 . . . . 0.0 110.532 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -68.98 -37.59 83.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' ' CG2' ' A' ' 74' ' ' THR . 71.0 t80 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.507 -0.996 . . . . 0.0 110.498 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.376 -1.453 . . . . 0.0 108.677 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.91 2.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.59 ' CZ ' ' CG ' ' A' ' 79' ' ' HIS . 35.8 t80 -45.98 -35.71 4.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.9 . . . . 0.0 111.127 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -86.02 -27.25 24.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.75 -1.219 . . . . 0.0 110.332 -178.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -66.81 12.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.989 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.663 ' CE1' HE22 ' A' ' 33' ' ' GLN . 10.2 m-70 -124.76 152.7 69.88 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.787 -1.195 . . . . 0.0 109.636 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.73 -6.63 15.35 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.675 2.25 . . . . 0.0 112.434 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 29' ' ' ASN . 5.8 tp -73.22 -28.01 61.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.837 . . . . 0.0 111.223 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.59 ' CG ' ' CZ ' ' A' ' 73' ' ' PHE . 2.9 t60 -82.08 -35.45 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.052 . . . . 0.0 110.281 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.53 -60.01 3.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.989 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -56.64 -38.65 72.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.612 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.41 -41.86 72.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.849 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 87' ' ' THR . 17.3 t -61.73 -39.2 90.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.167 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.31 77.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.1 -39.72 78.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 90' ' ' ILE . 28.3 t80 -45.19 -29.53 0.97 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.2 p -83.46 -62.26 1.63 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.588 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -40.09 -27.94 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.705 -0.622 . . . . 0.0 110.084 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 p -100.95 14.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.819 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 91' ' ' ASP . 22.5 mm -128.69 161.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.682 -1.261 . . . . 0.0 110.444 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 90' ' ' ILE . 62.8 t0 -104.37 -35.23 8.01 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.483 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 19.8 ptmt -145.63 146.03 31.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -125.69 123.43 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.626 -1.296 . . . . 0.0 109.799 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.65 132.4 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -138.6 135.41 34.92 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.262 -1.524 . . . . 0.0 111.766 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -121.06 124.53 45.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.638 -0.664 . . . . 0.0 109.363 176.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.544 ' OD1' ' CZ ' ' A' ' 6' ' ' PHE . 20.2 t0 -126.27 133.65 51.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.053 -1.029 . . . . 0.0 108.951 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CE1' ' CD ' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -156.62 157.77 31.07 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.109 -0.995 . . . . 0.0 110.516 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.79 127.77 13.41 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.321 2.014 . . . . 0.0 112.209 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -106.99 128.7 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -108.47 94.48 5.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.47 -0.768 . . . . 0.0 109.625 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.46 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' A' ' 101' ' ' ALA . 10.2 m -148.36 -26.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 106' ' ' SER . 25.2 mmtt -38.45 -28.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 103' ' ' VAL . 5.7 p -57.69 70.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.131 -0.98 . . . . 0.0 108.941 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 104' ' ' LYS . 8.0 t -111.21 109.82 20.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 107' ' ' VAL . 11.3 p . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.26 148.39 34.25 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.406 -1.378 . . . . 0.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.54 ' CZ ' ' OD1' ' B' ' 97' ' ' ASP . 34.4 t80 -114.77 128.2 56.17 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.249 -1.148 . . . . 0.0 108.02 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.627 ' HZ3' HD12 ' B' ' 9' ' ' LEU . 3.6 ttpp -113.55 142.4 46.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 112.822 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.406 ' HD1' ' HB2' ' B' ' 97' ' ' ASP . 70.4 t60 -132.86 133.36 43.21 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.627 HD12 ' HZ3' ' B' ' 7' ' ' LYS . 6.5 tt -136.58 145.86 45.45 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.728 -1.233 . . . . 0.0 109.458 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.45 HG13 ' O ' ' B' ' 10' ' ' VAL . 12.1 p -127.18 133.34 68.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.6 OUTLIER -116.04 129.16 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.487 ' O ' HG22 ' B' ' 57' ' ' THR . 6.3 m -139.61 167.5 19.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.017 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 19.1 tptp -132.74 152.34 51.77 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.48 ' HB2' ' H ' ' B' ' 18' ' ' THR . 39.7 p90 -108.77 149.47 28.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.85 -1.156 . . . . 0.0 111.606 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -129.11 -22.08 3.2 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.6 mt-10 -89.29 -57.12 3.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 7.9 t0 153.75 64.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 63.7 m -50.73 105.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.136 0.97 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.526 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -75.62 88.22 2.73 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.497 HG23 ' N ' ' B' ' 21' ' ' ASP . 34.9 m -64.63 -38.55 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.612 -0.68 . . . . 0.0 110.471 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' HG23 ' B' ' 20' ' ' VAL . 82.7 m-20 -66.19 -44.56 83.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 110.564 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -66.07 -31.47 72.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 mt -69.53 -37.35 74.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' B' ' 21' ' ' ASP . 13.9 tp -53.3 -37.83 62.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -34.64 74.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -63.98 -53.54 36.54 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.77 -47.64 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.982 . . . . 0.0 108.797 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -52.6 -44.55 66.06 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.3 OUTLIER -68.66 -49.04 62.27 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.33 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.51 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -48.47 -47.6 38.32 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 32' ' ' SER . 53.7 t -49.96 -26.06 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.309 -0.869 . . . . 0.0 108.832 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.3 t -42.0 -42.61 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.69 HE22 ' CG ' ' B' ' 76' ' ' HIS . 15.3 mm100 -61.07 -11.3 8.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.443 -0.786 . . . . 0.0 111.509 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.683 HG22 ' O ' ' B' ' 34' ' ' ILE . 42.1 mm -81.78 26.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 119.99 -1.693 . . . . 0.0 110.559 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 36' ' ' THR . 31.6 p-10 -67.51 -26.3 66.27 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.723 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.4 t -79.25 1.85 23.33 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.942 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 36' ' ' THR . 21.1 m 37.93 21.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 36' ' ' THR . 83.3 mttt -120.82 41.36 3.31 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.422 ' O ' HD12 ' B' ' 34' ' ' ILE . 1.4 m -158.2 154.71 27.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 98.5 m-85 -144.47 154.53 43.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.545 -1.347 . . . . 0.0 111.99 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 80.8 mt-10 -160.97 130.45 4.83 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.345 0.593 . . . . 0.0 110.2 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -130.09 175.22 9.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.75 154.07 21.99 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.828 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.568 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 17.9 mt-10 -151.12 141.72 22.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 8.1 p30 -115.91 148.67 39.77 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.633 ' HD3' ' N ' ' B' ' 57' ' ' THR . 0.0 OUTLIER -68.59 80.89 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.394 -1.441 . . . . 0.0 109.788 -176.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 45' ' ' ASP . 78.2 mm-40 -96.95 54.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.646 . . . . 0.0 109.315 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' B' ' 49' ' ' HIS . 29.6 t -134.14 -138.22 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.531 ' N ' ' OG ' ' B' ' 48' ' ' SER . 74.1 m80 -107.24 142.92 36.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.134 -0.979 . . . . 0.0 109.699 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -42.78 -41.25 3.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.78 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.9 ttt -71.42 -29.29 64.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 95' ' ' LEU . 51.5 mt -98.26 -18.46 18.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.72 -1.238 . . . . 0.0 109.279 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' B' ' 55' ' ' GLY . 55.0 mtp180 -73.42 0.58 11.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -0.844 . . . . 0.0 111.271 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.87 -4.06 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.832 -1.168 . . . . 0.0 110.18 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.641 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 82.77 -18.89 13.22 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.454 -0.778 . . . . 0.0 112.861 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' B' ' 11' ' ' VAL . 12.2 m-85 -58.92 -128.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.288 -1.713 . . . . 0.0 109.902 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.633 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 2.5 t -164.9 -36.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.299 -0.876 . . . . 0.0 110.992 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.652 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.7 t60 -169.91 153.77 4.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.826 -1.171 . . . . 0.0 110.214 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.652 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.21 168.77 18.95 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.461 -0.774 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.532 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 88.2 m-85 -129.01 126.12 38.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.513 -0.742 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.24 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 34.6 mtt -104.92 117.9 35.2 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.24 -0.913 . . . . 0.0 110.731 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 99.9 m -120.38 143.27 48.52 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -119.28 159.69 23.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.715 -1.241 . . . . 0.0 110.073 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.6 -27.57 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -173.57 -174.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.39 -27.33 65.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 111.422 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 29.0 p-10 -57.9 -38.03 75.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.817 -1.177 . . . . 0.0 110.574 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -68.75 -37.6 84.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.507 ' O ' ' CG2' ' B' ' 74' ' ' THR . 71.5 t80 -62.36 -46.76 87.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.574 -0.956 . . . . 0.0 110.445 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.94 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.377 -1.452 . . . . 0.0 108.732 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.585 ' CZ ' ' CG ' ' B' ' 79' ' ' HIS . 35.8 t80 -45.75 -35.76 4.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.932 . . . . 0.0 111.107 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.2 OUTLIER -86.08 -27.29 24.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.808 -1.183 . . . . 0.0 110.316 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -66.66 12.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.066 -1.021 . . . . 0.0 110.986 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.69 ' CG ' HE22 ' B' ' 33' ' ' GLN . 16.8 m80 -124.81 152.56 69.88 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 109.547 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.58 -6.63 15.48 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.644 2.229 . . . . 0.0 112.453 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.451 HD23 HD22 ' B' ' 30' ' ' LEU . 5.8 tp -73.09 -28.23 62.17 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.236 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.585 ' CG ' ' CZ ' ' B' ' 73' ' ' PHE . 2.9 t60 -81.98 -35.44 28.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.48 -60.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.987 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' B' ' 82' ' ' PHE . 22.4 pt-20 -56.59 -38.77 72.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' B' ' 81' ' ' GLU . 73.1 t80 -70.26 -41.86 72.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' SER . . . . . 0.531 ' O ' HG23 ' B' ' 87' ' ' THR . 17.4 t -61.62 -39.42 91.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.1 -1.0 . . . . 0.0 110.15 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -49.39 77.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 108.68 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.93 -39.8 79.37 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.467 ' O ' HG12 ' B' ' 90' ' ' ILE . 28.4 t80 -45.12 -29.5 0.93 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.2 p -83.5 -62.36 1.6 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -40.01 -27.98 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.742 -0.599 . . . . 0.0 110.084 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' B' ' 87' ' ' THR . 3.9 p -100.86 14.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.234 -0.916 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 91' ' ' ASP . 22.4 mm -128.63 161.19 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.664 -1.273 . . . . 0.0 110.421 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.564 ' N ' HG22 ' B' ' 90' ' ' ILE . 62.6 t0 -104.55 -35.33 7.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.468 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 19.8 ptmt -145.53 146.14 31.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -125.78 123.32 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.597 -1.314 . . . . 0.0 109.767 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 132.38 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.519 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -138.59 135.3 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.314 -1.491 . . . . 0.0 111.737 -178.278 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.564 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -121.0 124.62 45.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 176.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' B' ' 6' ' ' PHE . 21.1 t0 -126.39 133.62 51.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.034 -1.041 . . . . 0.0 108.923 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -156.6 157.67 31.04 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.065 -1.022 . . . . 0.0 110.516 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.7 127.93 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.268 1.979 . . . . 0.0 112.227 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.14 128.66 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.957 . . . . 0.0 110.042 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -108.56 94.46 5.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.491 -0.756 . . . . 0.0 109.609 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.39 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.564 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.658 ' N ' ' O ' ' B' ' 101' ' ' ALA . 10.4 m -148.33 -26.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 109.23 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.4 mmtt -38.6 -28.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 103' ' ' VAL . 5.7 p -57.77 70.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.135 -0.978 . . . . 0.0 108.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.705 ' N ' ' O ' ' B' ' 104' ' ' LYS . 8.0 t -111.15 109.83 20.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.575 HG22 ' O ' ' B' ' 107' ' ' VAL . 11.3 p . . . . . 0 C--N 1.302 -1.48 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.663 HG23 ' N ' ' A' ' 4' ' ' SER . 7.6 t -147.64 -49.07 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.102 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.663 ' N ' HG23 ' A' ' 3' ' ' THR . 29.6 m -124.05 -103.76 0.37 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.01 45.24 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.737 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -136.36 135.02 38.47 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.218 -1.166 . . . . 0.0 108.036 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -99.94 127.0 46.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.93 -1.107 . . . . 0.0 112.822 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.507 ' ND1' ' OD1' ' A' ' 97' ' ' ASP . 86.3 t60 -122.61 121.18 35.84 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.6 tt -135.08 144.11 47.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.714 -1.241 . . . . 0.0 109.474 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.7 p -127.64 134.32 65.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.547 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.52 127.93 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.429 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.4 m -141.6 159.92 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 117.785 -1.566 . . . . 0.0 113.042 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -130.41 155.2 46.81 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.605 ' CD2' HG21 ' A' ' 57' ' ' THR . 11.9 p90 -111.11 153.69 25.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.13 . . . . 0.0 111.606 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -19.14 3.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 17' ' ' ASP . 13.5 tm-20 -92.63 -56.82 2.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 3.1 m-20 155.24 62.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.522 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.8 m -49.04 105.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.082 0.944 . . . . 0.0 112.849 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.85 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.98 85.5 0.7 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 21' ' ' ASP . 33.0 m -64.95 -41.02 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.527 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.547 ' N ' HG23 ' A' ' 20' ' ' VAL . 36.4 p-10 -66.51 -46.54 75.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.4 -0.812 . . . . 0.0 110.553 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.8 mp0 -66.14 -30.25 70.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mt -72.4 -41.79 64.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.4 tp -56.1 -38.59 70.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.47 -34.03 76.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -68.16 -53.3 22.86 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -44.93 -42.68 8.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.547 -0.972 . . . . 0.0 108.793 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -53.24 -42.69 66.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.674 ' ND2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -58.84 -45.2 90.63 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.674 ' N ' ' ND2' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -49.24 -45.12 44.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' ILE . 16.0 t -58.08 -20.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 108.827 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 46.8 t -44.0 -38.3 3.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.659 ' OE1' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.64 -10.74 50.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 111.39 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.659 HD13 ' OE1' ' A' ' 33' ' ' GLN . 5.4 mm -86.06 21.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.075 -1.64 . . . . 0.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 36' ' ' THR . 51.6 p30 -58.91 -9.43 1.84 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.642 ' O ' ' C ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -80.2 -1.1 39.02 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.895 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.642 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.4 m 30.26 45.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 109.217 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HZ1' ' H ' ' A' ' 69' ' ' GLY . 11.4 ptmm? -121.03 39.86 3.7 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 75.7 m -173.36 179.08 2.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -145.56 154.74 42.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.608 -1.308 . . . . 0.0 111.936 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -154.64 123.25 6.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.395 0.617 . . . . 0.0 110.234 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.615 ' CH2' ' HB3' ' B' ' 101' ' ' ALA . 67.0 t-105 -135.83 175.03 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' N ' ' CG ' ' A' ' 42' ' ' TRP . . . -132.28 160.97 23.85 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 118.711 -1.709 . . . . 0.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 41.8 mp0 -148.84 139.63 22.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -1.151 . . . . 0.0 109.336 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 47' ' ' GLU . 85.6 m-20 -113.75 147.08 38.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.671 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.5 81.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.435 -1.416 . . . . 0.0 109.806 -178.302 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.0 mt-10 -122.06 59.2 1.01 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' A' ' 49' ' ' HIS . 43.9 p -158.49 73.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' A' ' 48' ' ' SER . 55.9 m80 54.34 125.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -44.79 -31.51 1.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 110.757 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -30.79 52.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.992 -1.068 . . . . 0.0 110.763 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' SER . 40.6 mt -100.62 -27.63 13.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.784 -1.198 . . . . 0.0 109.336 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 46' ' ' LYS . 8.7 ptm180 -87.0 -2.45 58.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.326 -0.859 . . . . 0.0 111.25 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 49.21 13.71 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.839 -1.163 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.584 ' H ' ' HG3' ' A' ' 53' ' ' ARG . . . 57.06 -2.89 0.07 OUTLIER Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.441 -0.787 . . . . 0.0 112.89 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.525 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 45.8 p90 -57.1 124.08 17.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.233 -1.745 . . . . 0.0 109.977 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.675 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 72.1 p -54.2 -44.11 71.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 111.002 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.675 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 36.0 p-80 -170.21 154.94 5.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.826 -1.171 . . . . 0.0 110.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.48 17.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.283 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.91 126.77 38.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.494 -0.754 . . . . 0.0 109.078 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -96.09 96.24 8.71 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtt -101.83 119.11 38.26 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.165 -0.959 . . . . 0.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 m -125.67 145.31 50.22 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -121.59 163.74 18.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.701 -1.249 . . . . 0.0 110.088 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 4' ' ' SER . 85.4 tt0 -85.49 -30.9 23.09 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -157.56 164.06 37.71 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -24.29 55.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -57.18 -40.03 76.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.796 -1.19 . . . . 0.0 110.608 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.617 ' H ' ' HZ1' ' A' ' 38' ' ' LYS . . . -68.63 -40.79 85.64 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' HG22 ' A' ' 74' ' ' THR . 72.9 t80 -60.54 -46.79 88.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.988 . . . . 0.0 110.454 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.72 -28.97 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.396 -1.44 . . . . 0.0 108.677 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.02 -60.95 2.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -56.77 -39.44 74.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 111.173 -176.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.82 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.9 t -80.84 -34.08 34.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.764 -1.21 . . . . 0.0 110.295 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.1 m -68.12 -32.9 73.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 110.973 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -69.62 126.0 92.32 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.899 -1.125 . . . . 0.0 109.635 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.78 -7.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.726 2.284 . . . . 0.0 112.364 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 30' ' ' LEU . 6.1 tt -72.31 -30.99 65.3 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.363 -0.836 . . . . 0.0 111.198 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 10.9 t-160 -82.89 -29.19 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.966 -1.084 . . . . 0.0 110.275 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.53 -58.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.018 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -56.45 -38.17 71.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -71.64 -42.19 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -62.18 -39.72 93.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.102 -0.999 . . . . 0.0 110.146 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.49 77.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.955 -1.091 . . . . 0.0 108.69 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.08 -40.67 87.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 85' ' ' ALA . 15.9 t80 -45.29 -29.35 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 89' ' ' VAL . 12.2 m -81.79 -62.12 1.73 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -38.85 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.7 -0.625 . . . . 0.0 110.111 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.5 m -106.47 11.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.791 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 91' ' ' ASP . 26.4 mm -130.53 163.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.685 -1.26 . . . . 0.0 110.41 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.618 ' N ' HG22 ' A' ' 90' ' ' ILE . 22.6 t0 -124.22 -34.52 2.92 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -126.99 125.17 41.02 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.0 tp -123.54 123.14 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.691 -1.256 . . . . 0.0 109.786 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 43.7 t -130.28 133.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -137.48 135.26 36.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.278 -1.514 . . . . 0.0 111.781 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.867 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.1 mp -114.67 117.01 29.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.688 -0.632 . . . . 0.0 109.339 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.507 ' OD1' ' ND1' ' A' ' 8' ' ' HIS . 79.2 m-20 -114.63 121.77 44.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.092 -1.005 . . . . 0.0 108.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 63.1 t80 -154.61 137.22 10.03 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.077 -1.014 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 39.7 Cg_endo -63.86 141.94 80.19 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.311 2.007 . . . . 0.0 112.228 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' B' ' 42' ' ' TRP . 71.1 t -122.41 141.97 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 109.979 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.607 ' HB3' ' CH2' ' B' ' 42' ' ' TRP . . . -112.46 96.93 6.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.88 76.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.6 m -148.11 120.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.385 -0.822 . . . . 0.0 109.155 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.32 115.71 24.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.346 -0.846 . . . . 0.0 109.325 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.556 ' O ' HG12 ' A' ' 107' ' ' VAL . 22.1 m -69.88 -45.38 67.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 108.914 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' SER . 6.1 t 43.19 52.42 5.56 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.354 -0.841 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 107' ' ' VAL . 9.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.443 ' O ' ' O ' ' B' ' 65' ' ' GLU . 28.2 m . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.4 175.0 45.64 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.43 134.81 38.11 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.207 -1.172 . . . . 0.0 108.075 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -99.76 126.9 45.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.929 -1.107 . . . . 0.0 112.837 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' B' ' 97' ' ' ASP . 86.3 t60 -122.66 121.21 35.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.6 tt -135.07 144.07 47.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.694 -1.253 . . . . 0.0 109.454 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.444 HG13 ' O ' ' B' ' 10' ' ' VAL . 10.6 p -127.62 134.41 65.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.512 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.64 127.95 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.425 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.4 m -141.6 159.76 21.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.019 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -130.29 155.26 46.62 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.604 ' CD2' HG21 ' B' ' 57' ' ' THR . 12.0 p90 -111.23 153.66 25.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.827 -1.17 . . . . 0.0 111.558 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 -19.2 3.2 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 17' ' ' ASP . 13.5 tm-20 -92.49 -56.92 2.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.519 ' N ' ' OE1' ' B' ' 16' ' ' GLU . 3.1 m-20 155.21 62.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.509 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 90.2 m -49.31 105.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.095 0.95 . . . . 0.0 112.882 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.838 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -70.95 85.33 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.552 HG23 ' N ' ' B' ' 21' ' ' ASP . 32.9 m -64.84 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.616 -0.677 . . . . 0.0 110.539 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' HG23 ' B' ' 20' ' ' VAL . 36.0 p-10 -66.59 -46.41 76.05 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 110.569 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 3.9 mp0 -66.25 -30.25 70.65 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.35 -41.78 65.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -56.08 -38.6 70.9 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.34 -34.28 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.596 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -67.96 -53.43 22.98 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -44.88 -42.59 8.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.466 -1.02 . . . . 0.0 108.801 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -53.43 -42.54 67.19 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' N ' ' B' ' 30' ' ' LEU . 0.0 OUTLIER -58.91 -45.21 90.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.68 ' N ' ' ND2' ' B' ' 29' ' ' ASN . 0.5 OUTLIER -49.18 -45.28 43.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' B' ' 34' ' ' ILE . 15.8 t -57.88 -20.35 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.278 -0.889 . . . . 0.0 108.806 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.0 t -43.86 -38.41 3.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.652 ' OE1' HD13 ' B' ' 34' ' ' ILE . 0.0 OUTLIER -87.53 -10.97 50.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.502 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.652 HD13 ' OE1' ' B' ' 33' ' ' GLN . 5.3 mm -85.85 21.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 119.933 -1.73 . . . . 0.0 110.588 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 36' ' ' THR . 51.1 p30 -59.01 -9.5 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -80.18 -1.01 38.56 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.878 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.6 m 30.33 45.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.03 -1.044 . . . . 0.0 109.17 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.652 ' HZ2' ' CA ' ' B' ' 69' ' ' GLY . 11.4 ptmm? -121.12 40.0 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 74.9 m -173.39 179.17 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.61 154.73 42.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.469 -1.394 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -154.6 123.33 6.19 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.471 0.653 . . . . 0.0 110.218 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.607 ' CH2' ' HB3' ' A' ' 101' ' ' ALA . 66.7 t-105 -135.75 175.08 9.92 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' B' ' 42' ' ' TRP . . . -132.2 161.07 23.84 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.772 -1.68 . . . . 0.0 110.791 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 41.6 mp0 -148.9 139.48 22.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -1.162 . . . . 0.0 109.358 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 47' ' ' GLU . 85.2 m-20 -113.46 147.14 38.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.66 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -65.54 81.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.483 -1.385 . . . . 0.0 109.832 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.1 mt-10 -122.12 59.28 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.712 -0.618 . . . . 0.0 109.398 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' B' ' 49' ' ' HIS . 41.7 p -158.42 73.25 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' B' ' 48' ' ' SER . 55.9 m80 54.24 125.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -44.6 -31.62 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.44 -30.89 53.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.724 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' B' ' 48' ' ' SER . 41.4 mt -100.76 -27.47 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.782 -1.199 . . . . 0.0 109.247 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' O ' ' B' ' 46' ' ' LYS . 8.7 ptm180 -87.11 -2.48 58.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 111.204 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 49.32 13.64 0.08 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.782 -1.199 . . . . 0.0 110.217 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.592 ' H ' ' HG3' ' B' ' 53' ' ' ARG . . . 57.18 -3.13 0.07 OUTLIER Glycine 0 N--CA 1.498 2.797 0 O-C-N 121.47 -0.769 . . . . 0.0 112.852 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 45.9 p90 -56.96 124.17 17.72 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.279 -1.718 . . . . 0.0 109.977 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.64 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 72.1 p -54.19 -44.19 71.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.988 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.64 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 36.0 p-80 -170.21 154.82 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.119 . . . . 0.0 110.197 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.95 169.46 17.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.414 -0.804 . . . . 0.0 109.24 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.81 126.87 39.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.348 -0.845 . . . . 0.0 109.081 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 66.0 m -96.1 96.3 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtt -101.81 119.07 38.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.23 -0.919 . . . . 0.0 110.81 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -125.71 145.33 50.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.63 163.64 18.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.661 -1.274 . . . . 0.0 110.054 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 4' ' ' SER . 85.4 tt0 -85.45 -30.92 23.14 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.43 164.13 37.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -24.39 56.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 111.467 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.96 -40.23 76.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.727 -1.233 . . . . 0.0 110.563 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.652 ' CA ' ' HZ2' ' B' ' 38' ' ' LYS . . . -68.6 -40.55 85.91 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.817 ' O ' HG22 ' B' ' 74' ' ' THR . 73.4 t80 -60.77 -46.69 89.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.636 -0.92 . . . . 0.0 110.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.98 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.322 -1.486 . . . . 0.0 108.665 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.461 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.03 -60.85 2.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.788 . . . . 0.0 109.387 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.425 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.75 -39.43 73.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.889 . . . . 0.0 111.079 -177.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.817 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.9 t -80.97 -33.84 33.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.763 -1.21 . . . . 0.0 110.371 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 74.5 m -68.36 -32.82 73.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.955 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.565 ' O ' ' N ' ' B' ' 78' ' ' LEU . 0.3 OUTLIER -69.58 126.04 92.35 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.807 -1.183 . . . . 0.0 109.605 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -43.78 -7.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.642 2.228 . . . . 0.0 112.48 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.566 ' CD2' HD22 ' B' ' 30' ' ' LEU . 6.2 tt -72.51 -30.93 64.93 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.42 -0.8 . . . . 0.0 111.214 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.457 ' CD2' ' O ' ' B' ' 79' ' ' HIS . 10.9 t-160 -82.93 -29.11 29.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.956 -1.09 . . . . 0.0 110.317 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.54 -58.71 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 110.004 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -56.54 -38.2 71.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 0.0 109.531 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -71.5 -42.25 68.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 0.0 109.905 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -62.27 -39.64 93.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.0 . . . . 0.0 110.124 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.5 77.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 0.0 108.609 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.18 -40.64 86.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.456 ' O ' HG12 ' B' ' 90' ' ' ILE . 16.0 t80 -45.31 -29.3 1.0 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 12.3 m -81.8 -62.08 1.74 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.99 -26.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.643 -0.661 . . . . 0.0 110.093 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.7 m -106.58 11.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.28 -0.888 . . . . 0.0 110.828 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.62 HG22 ' N ' ' B' ' 91' ' ' ASP . 26.4 mm -130.59 163.91 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.616 -1.302 . . . . 0.0 110.494 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.62 ' N ' HG22 ' B' ' 90' ' ' ILE . 22.6 t0 -124.25 -34.55 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -127.03 125.13 40.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.0 tp -123.63 123.15 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.617 -1.302 . . . . 0.0 109.715 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 43.2 t -130.27 133.01 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.494 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -137.43 135.19 36.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.251 -1.531 . . . . 0.0 111.796 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.859 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.2 mp -114.68 116.96 29.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 109.317 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' B' ' 8' ' ' HIS . 79.8 m-20 -114.67 121.78 44.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.156 -0.965 . . . . 0.0 108.884 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 63.3 t80 -154.56 137.18 10.01 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 39.7 Cg_endo -63.93 141.89 79.53 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.27 1.98 . . . . 0.0 112.299 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' A' ' 42' ' ' TRP . 71.4 t -122.37 141.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 110.05 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.615 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . . . -112.53 96.99 6.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.439 -0.788 . . . . 0.0 109.548 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.9 76.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.091 -1.005 . . . . 0.0 109.561 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 103' ' ' VAL . 9.4 m -148.03 120.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.227 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.27 115.72 24.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.552 ' O ' HG12 ' B' ' 107' ' ' VAL . 23.2 m -69.78 -45.67 67.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.138 -0.976 . . . . 0.0 108.917 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.4 t 43.48 52.23 6.03 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.365 -0.834 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 107' ' ' VAL . 9.5 p . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.81 HG21 ' HB2' ' A' ' 101' ' ' ALA . 10.2 t -65.85 -45.7 81.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.174 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.625 ' N ' HG23 ' A' ' 3' ' ' THR . 19.7 m -136.23 -97.02 0.23 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.61 170.06 41.79 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.731 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.2 131.27 43.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.283 -1.127 . . . . 0.0 108.011 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -99.87 125.75 45.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.925 -1.109 . . . . 0.0 112.824 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 62' ' ' MET . 74.5 m80 -120.09 121.41 38.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.42 143.21 43.82 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.696 -1.252 . . . . 0.0 109.486 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 95' ' ' LEU . 14.7 p -128.67 136.12 60.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.635 -0.666 . . . . 0.0 109.492 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -114.07 126.58 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 178.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' A' ' 10' ' ' VAL . 2.1 m -138.09 154.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.813 -1.555 . . . . 0.0 113.064 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 57' ' ' THR . 43.7 mtpt -126.61 154.85 43.4 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.669 ' CD2' HG21 ' A' ' 57' ' ' THR . 16.6 p90 -111.28 152.54 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.817 -1.177 . . . . 0.0 111.641 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -128.23 -18.48 4.08 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.6 mt-10 -90.48 -56.83 3.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 4.8 p30 153.05 58.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 78.8 m -47.05 107.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.051 0.929 . . . . 0.0 112.815 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.75 87.67 2.79 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 175.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -57.97 -34.87 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.725 . . . . 0.0 110.527 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.45 -40.25 89.32 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 88.3 mt-10 -68.27 -33.33 74.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 19' ' ' LYS . 1.1 mp -63.9 -44.08 97.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.48 -34.62 61.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.51 -34.33 75.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.38 -44.92 8.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.56 -58.09 9.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.538 -0.978 . . . . 0.0 108.81 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.76 -40.82 73.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.425 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 13.4 t-20 -61.23 -45.34 94.95 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.687 HD13 ' O ' ' A' ' 30' ' ' LEU . 2.8 tm? -53.91 -46.08 71.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG11 HG21 ' B' ' 107' ' ' VAL . 59.5 t -55.91 -33.8 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 108.825 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 31' ' ' VAL . 4.7 m -45.47 -39.8 7.61 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 35' ' ' ASP . 21.3 tp60 -69.34 -53.98 16.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.439 -0.788 . . . . 0.0 111.469 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.633 ' C ' ' H ' ' A' ' 36' ' ' THR . 17.4 mt -61.2 41.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.039 -1.663 . . . . 0.0 110.626 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.662 ' N ' ' O ' ' A' ' 33' ' ' GLN . 58.9 t0 -60.41 -3.81 0.74 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' A' ' 37' ' ' VAL . 45.3 p -76.9 -0.96 26.09 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.942 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 36' ' ' THR . 19.1 m 31.21 47.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 36' ' ' THR . 13.9 ptpt -124.46 42.45 3.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 t -175.63 179.45 1.41 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 93.0 m-85 -145.75 155.28 42.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.566 -1.334 . . . . 0.0 111.958 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' PHE . 71.2 mt-10 -157.06 126.52 6.08 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.356 0.598 . . . . 0.0 110.246 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.545 ' CD1' ' NZ ' ' B' ' 104' ' ' LYS . 0.1 OUTLIER -142.34 178.02 7.86 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' CE3' ' A' ' 42' ' ' TRP . . . -142.83 169.1 25.74 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.46 145.97 27.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -1.137 . . . . 0.0 109.369 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 86.5 m-20 -124.25 147.02 48.39 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.855 ' HD2' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -146.19 136.36 23.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.437 -1.414 . . . . 0.0 109.808 -174.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.73 ' O ' ' O ' ' A' ' 48' ' ' SER . 96.2 mt-10 -131.13 -0.7 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.707 -0.621 . . . . 0.0 109.343 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.73 ' O ' ' O ' ' A' ' 47' ' ' GLU . 29.7 t -49.01 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.543 ' N ' ' OG ' ' A' ' 48' ' ' SER . 76.0 m80 -70.7 152.59 43.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.461 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 88.2 m-20 -66.98 -41.65 86.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.481 ' SD ' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -69.2 -33.95 74.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.007 -1.058 . . . . 0.0 110.789 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' B' ' 95' ' ' LEU . 70.4 mt -87.26 -56.34 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.722 -1.236 . . . . 0.0 109.33 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.697 ' C ' ' H ' ' A' ' 55' ' ' GLY . 10.0 ptt180 -59.4 4.75 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 111.149 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.749 ' OE1' HD11 ' B' ' 96' ' ' LEU . 1.2 mt-30 59.64 -18.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.86 -1.15 . . . . 0.0 110.196 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.697 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 83.12 -17.27 23.89 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 121.434 -0.791 . . . . 0.0 112.921 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.855 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 6.1 p90 -60.47 117.02 4.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.275 -1.721 . . . . 0.0 109.897 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.791 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 70.1 p -51.68 -33.72 35.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.295 -0.878 . . . . 0.0 110.984 -175.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.791 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -175.44 159.93 2.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.847 -1.158 . . . . 0.0 110.114 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.51 169.28 17.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.347 -0.846 . . . . 0.0 109.249 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.36 127.5 37.72 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.484 -0.76 . . . . 0.0 109.094 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -93.15 98.49 11.33 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 8' ' ' HIS . 69.9 mtm -101.54 113.63 26.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.166 -0.958 . . . . 0.0 110.775 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.2 m -123.03 141.99 51.35 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.87 162.05 19.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.698 -1.252 . . . . 0.0 110.118 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -81.97 -30.41 31.67 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -168.13 175.36 6.63 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -65.07 -24.84 67.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 111.419 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -61.38 -44.88 96.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.777 -1.202 . . . . 0.0 110.573 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.25 -34.3 74.93 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.748 ' O ' HG22 ' A' ' 74' ' ' THR . 74.0 t80 -65.98 -46.2 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.479 -1.012 . . . . 0.0 110.485 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 75' ' ' SER . 20.9 m -70.75 -28.93 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.345 -1.472 . . . . 0.0 108.668 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.12 -60.88 2.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 0.0 109.326 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -60.96 -55.86 27.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 111.177 -177.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.748 HG22 ' O ' ' A' ' 70' ' ' TYR . 12.8 t -57.09 -34.71 68.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.729 -1.232 . . . . 0.0 110.287 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 68.8 p -69.35 -26.44 64.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -0.955 . . . . 0.0 110.967 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 72' ' ' ALA . 41.9 m80 -65.1 151.46 93.6 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.843 -1.161 . . . . 0.0 109.648 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.74 -12.7 26.73 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.641 2.227 . . . . 0.0 112.439 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.32 -28.9 63.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.361 -0.837 . . . . 0.0 111.208 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.464 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 46.1 t60 -83.23 -32.8 26.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.017 -1.052 . . . . 0.0 110.227 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.84 -60.44 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.047 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.05 -37.6 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.14 -40.26 74.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.3 t -62.6 -41.09 98.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.21 74.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.972 -1.08 . . . . 0.0 108.706 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.63 -41.26 79.69 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.467 ' C ' ' O ' ' A' ' 85' ' ' ALA . 20.0 t80 -44.6 -31.26 1.09 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.3 m -82.53 -61.68 1.82 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.17 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.712 -0.617 . . . . 0.0 110.09 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.1 m -100.53 16.35 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 110.847 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.616 ' N ' ' O ' ' A' ' 87' ' ' THR . 41.1 mt -126.68 159.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.659 -1.276 . . . . 0.0 110.409 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.517 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 52.7 t0 -102.31 -31.91 10.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.456 ' N ' HG22 ' A' ' 90' ' ' ILE . 32.2 pttt -151.9 149.44 28.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.8 tp -125.06 124.23 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.653 -1.279 . . . . 0.0 109.73 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 46.3 t -126.95 131.33 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.8 138.17 32.05 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.34 -1.475 . . . . 0.0 111.741 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.959 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.16 125.72 49.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 31.4 p-10 -120.38 124.56 45.83 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.045 . . . . 0.0 108.907 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 86.3 t80 -154.05 123.74 3.26 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.1 -1.0 . . . . 0.0 110.531 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.03 136.22 14.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.345 2.03 . . . . 0.0 112.186 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.9 t -120.77 140.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.997 . . . . 0.0 110.028 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.81 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -113.46 96.97 6.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.34 76.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.018 . . . . 0.0 109.599 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 103' ' ' VAL . 13.2 m -148.42 118.85 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 0.0 109.176 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 106' ' ' SER . 23.4 mmtm -144.73 -11.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.467 ' C ' ' O ' ' A' ' 104' ' ' LYS . 87.5 p -42.15 -24.5 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 108.93 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 104' ' ' LYS . 34.5 t -53.04 -83.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.36 -0.838 . . . . 0.0 109.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 104' ' ' LYS . 44.2 t . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.84 170.03 41.29 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.748 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.99 131.24 44.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.29 -1.123 . . . . 0.0 108.064 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -99.77 125.86 45.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.946 -1.096 . . . . 0.0 112.854 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' B' ' 62' ' ' MET . 74.4 m80 -120.22 121.09 37.95 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 tt -136.19 143.34 44.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.736 -1.227 . . . . 0.0 109.399 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' B' ' 95' ' ' LEU . 15.0 p -128.69 136.22 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.505 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' B' ' 56' ' ' PHE . 0.2 OUTLIER -114.16 126.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.431 ' CG1' HG22 ' B' ' 10' ' ' VAL . 2.1 m -138.24 153.9 27.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 117.757 -1.577 . . . . 0.0 113.016 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.434 ' HD3' ' HZ2' ' B' ' 92' ' ' LYS . 43.7 mtpt -126.4 154.68 43.27 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.674 ' CD2' HG21 ' B' ' 57' ' ' THR . 17.1 p90 -111.17 152.58 26.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.923 -1.11 . . . . 0.0 111.589 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -128.18 -18.83 4.03 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.3 mt-10 -90.12 -56.94 3.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 4.8 p30 153.13 58.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 73.0 m -47.04 107.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.131 0.967 . . . . 0.0 112.821 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.618 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.88 87.72 2.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -57.91 -34.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.567 -0.708 . . . . 0.0 110.533 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.4 p-10 -66.76 -40.08 88.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 110.51 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 88.3 mt-10 -68.28 -33.15 73.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.41 HD13 ' O ' ' B' ' 19' ' ' LYS . 1.1 mp -64.26 -43.96 97.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.27 -34.92 61.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.36 -34.43 75.29 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.26 -44.75 8.58 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -56.96 -57.98 10.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.555 -0.967 . . . . 0.0 108.799 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.8 -40.66 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.423 ' H ' ' HG3' ' B' ' 28' ' ' GLU . 13.4 t-20 -61.41 -45.35 94.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.677 HD13 ' O ' ' B' ' 30' ' ' LEU . 2.8 tm? -53.87 -46.06 71.18 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 107' ' ' VAL . 60.2 t -55.69 -34.01 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.301 -0.874 . . . . 0.0 108.839 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 31' ' ' VAL . 4.7 m -45.37 -39.77 7.21 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.667 ' O ' ' N ' ' B' ' 35' ' ' ASP . 21.5 tp60 -69.49 -53.88 16.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.493 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.624 ' C ' ' H ' ' B' ' 36' ' ' THR . 17.4 mt -61.31 41.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 119.939 -1.725 . . . . 0.0 110.588 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.667 ' N ' ' O ' ' B' ' 33' ' ' GLN . 60.6 t0 -60.55 -4.26 0.87 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.624 ' H ' ' C ' ' B' ' 34' ' ' ILE . 45.6 p -76.44 -1.4 26.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.62 ' C ' ' O ' ' B' ' 36' ' ' THR . 19.0 m 31.66 47.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.015 -1.053 . . . . 0.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.444 ' HG2' ' OG1' ' B' ' 36' ' ' THR . 13.9 ptpt -124.56 42.48 3.25 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.5 t -175.56 179.39 1.44 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.434 ' O ' ' HG2' ' B' ' 41' ' ' GLU . 93.1 m-85 -145.8 155.28 42.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.582 -1.324 . . . . 0.0 111.93 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 40' ' ' PHE . 71.7 mt-10 -157.1 126.43 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.783 -0.573 . . . . 0.0 110.272 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' B' ' 43' ' ' GLY . 0.1 OUTLIER -142.23 177.95 7.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' B' ' 42' ' ' TRP . . . -142.74 168.89 25.79 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -149.31 145.65 27.14 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -1.128 . . . . 0.0 109.409 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 86.6 m-20 -123.84 147.05 47.94 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.851 ' HD2' ' O ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -146.15 136.44 23.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.349 -1.47 . . . . 0.0 109.737 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.714 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.9 mt-10 -131.1 -0.63 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.701 -0.624 . . . . 0.0 109.353 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.714 ' O ' ' O ' ' B' ' 47' ' ' GLU . 29.5 t -49.32 -151.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.204 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.513 ' N ' ' OG ' ' B' ' 48' ' ' SER . 76.1 m80 -70.63 152.41 43.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -0.994 . . . . 0.0 109.641 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.453 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 87.9 m-20 -66.69 -41.82 87.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.349 -0.844 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.482 ' SD ' ' O ' ' B' ' 51' ' ' MET . 0.4 OUTLIER -69.03 -33.95 74.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 95' ' ' LEU . 70.9 mt -87.26 -56.46 3.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.778 -1.201 . . . . 0.0 109.197 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.705 ' C ' ' H ' ' B' ' 55' ' ' GLY . 9.8 ptt180 -59.33 4.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 111.266 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.762 ' OE1' HD11 ' A' ' 96' ' ' LEU . 1.2 mt-30 59.4 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.828 -1.17 . . . . 0.0 110.219 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.705 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 83.07 -17.18 24.13 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.379 -0.826 . . . . 0.0 112.856 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.851 ' O ' ' HD2' ' B' ' 46' ' ' LYS . 6.0 p90 -60.48 117.12 4.88 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.292 -1.711 . . . . 0.0 109.951 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.74 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 69.8 p -51.73 -33.53 35.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.258 -0.901 . . . . 0.0 111.002 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.74 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 0.1 OUTLIER -175.61 159.71 2.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.787 -1.196 . . . . 0.0 110.183 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.3 169.39 17.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.504 -0.747 . . . . 0.0 109.294 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -131.3 127.7 38.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.433 -0.792 . . . . 0.0 109.093 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t -93.23 98.24 11.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' MET . . . . . 0.415 ' O ' ' N ' ' B' ' 8' ' ' HIS . 70.2 mtm -101.35 113.59 26.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.834 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 35.8 m -122.98 142.38 50.9 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -119.16 162.0 19.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.69 -1.257 . . . . 0.0 110.035 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -82.15 -30.08 31.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -168.43 175.22 6.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -65.05 -24.61 67.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 111.474 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -61.66 -44.84 96.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.803 -1.186 . . . . 0.0 110.647 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.99 -34.31 76.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.735 ' O ' HG22 ' B' ' 74' ' ' THR . 72.9 t80 -66.14 -46.17 78.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.565 -0.962 . . . . 0.0 110.504 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.71 -28.92 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.382 -1.449 . . . . 0.0 108.666 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.08 -60.83 2.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.435 -0.791 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -60.97 -55.96 26.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 111.116 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.735 HG22 ' O ' ' B' ' 70' ' ' TYR . 13.0 t -57.05 -34.77 68.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.702 -1.249 . . . . 0.0 110.34 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 69.1 p -69.31 -26.25 64.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.088 -1.008 . . . . 0.0 110.965 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 72' ' ' ALA . 41.3 m80 -65.33 151.6 93.73 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.876 -1.14 . . . . 0.0 109.651 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.02 -12.24 25.82 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.678 2.252 . . . . 0.0 112.491 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -28.6 62.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.436 -0.79 . . . . 0.0 111.22 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.454 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 46.2 t60 -83.26 -32.84 26.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.943 -1.098 . . . . 0.0 110.249 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 66.6 t -62.91 -60.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.999 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.11 -37.52 61.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -70.21 -40.17 74.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.172 -0.955 . . . . 0.0 109.883 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.8 t -62.59 -41.2 98.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.29 74.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.973 -1.079 . . . . 0.0 108.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.52 -41.35 80.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.469 ' C ' ' O ' ' B' ' 85' ' ' ALA . 19.9 t80 -44.54 -31.37 1.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.561 ' O ' ' N ' ' B' ' 90' ' ' ILE . 6.5 m -82.53 -61.84 1.77 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.0 -29.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.681 -0.637 . . . . 0.0 110.086 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.2 m -100.67 16.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.161 -0.962 . . . . 0.0 110.843 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' B' ' 87' ' ' THR . 41.5 mt -126.73 159.23 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 0.0 110.474 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 51.9 t0 -102.48 -31.81 10.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.449 ' N ' HG22 ' B' ' 90' ' ' ILE . 32.4 pttt -152.04 149.72 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.463 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.8 tp -125.43 124.05 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.594 -1.316 . . . . 0.0 109.76 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 45.9 t -126.82 131.4 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.824 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.273 -1.517 . . . . 0.0 111.79 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.959 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -119.21 125.76 49.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.664 -0.648 . . . . 0.0 109.33 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 30.0 p-10 -120.43 124.3 45.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.065 -1.022 . . . . 0.0 108.961 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 86.1 t80 -153.79 123.91 3.36 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.091 -1.005 . . . . 0.0 110.547 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.22 136.08 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.358 2.039 . . . . 0.0 112.221 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.56 140.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 0.0 110.094 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -113.65 96.86 6.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 0.0 109.584 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.32 76.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.622 HG23 ' O ' ' B' ' 103' ' ' VAL . 13.2 m -148.49 118.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.234 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.545 ' NZ ' ' CD1' ' A' ' 42' ' ' TRP . 23.1 mmtm -144.55 -11.97 0.6 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.478 ' C ' ' O ' ' B' ' 104' ' ' LYS . 85.6 p -42.2 -24.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.152 -0.968 . . . . 0.0 108.999 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.525 ' N ' ' O ' ' B' ' 104' ' ' LYS . 33.5 t -52.93 -83.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 104' ' ' LYS . 44.8 t . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.685 HG23 ' N ' ' A' ' 4' ' ' SER . 10.1 t -153.24 -48.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.937 . . . . 0.0 109.124 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.685 ' N ' HG23 ' A' ' 3' ' ' THR . 15.2 m -59.63 -69.05 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.18 -163.63 15.4 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.76 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -110.64 135.39 51.33 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.315 -1.109 . . . . 0.0 108.015 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 5.1 ttpm? -100.44 129.43 46.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.962 -1.086 . . . . 0.0 112.88 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' MET . 78.2 t60 -121.9 120.47 34.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -132.12 141.93 49.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.702 -1.249 . . . . 0.0 109.446 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.47 139.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.654 -0.654 . . . . 0.0 109.475 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.444 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -126.64 133.74 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.3 155.95 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.069 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.701 ' HB2' ' HZ2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.8 152.26 37.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CD2' HG21 ' A' ' 57' ' ' THR . 8.9 p90 -107.88 151.51 25.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.835 -1.166 . . . . 0.0 111.565 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.13 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.6 tt0 -90.14 -56.48 3.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.8 m-20 152.63 66.86 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 65.1 m -52.46 107.0 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.087 0.946 . . . . 0.0 112.841 -176.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.629 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -72.72 85.55 1.21 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 21' ' ' ASP . 17.7 m -54.63 -37.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.3 p-10 -63.42 -36.61 84.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 110.591 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 81.6 mt-10 -72.67 -37.61 67.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.447 HD11 HG21 ' A' ' 89' ' ' VAL . 1.8 mm -58.46 -45.28 90.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -48.87 -36.25 16.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.35 -38.24 76.82 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -73.4 -25.11 73.63 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.1 tt -75.12 -60.18 2.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -1.025 . . . . 0.0 108.804 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -49.95 -31.58 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 32' ' ' SER . 75.0 m-20 -65.62 -43.5 89.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.844 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -47.22 -53.34 13.5 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.3 t -49.8 -30.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 108.856 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 10.6 t -45.15 -50.77 11.11 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.445 ' NE2' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -83.54 -9.04 59.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 111.393 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.537 ' C ' ' N ' ' A' ' 36' ' ' THR . 12.3 mt -91.72 28.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.012 -1.68 . . . . 0.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.44 -9.39 2.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 38' ' ' LYS . 10.1 t -67.55 -7.71 28.19 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.959 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.6 m 34.99 34.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.12 -0.987 . . . . 0.0 109.173 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.702 ' H ' HG23 ' A' ' 36' ' ' THR . 32.5 mtmt -123.03 47.83 1.91 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -174.35 175.05 2.69 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.17 159.05 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.522 -1.361 . . . . 0.0 112.013 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -152.11 117.25 5.23 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.306 0.574 . . . . 0.0 110.22 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' B' ' 102' ' ' ALA . 3.6 t-105 -105.74 167.16 9.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 150.27 17.13 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.73 -1.7 . . . . 0.0 110.851 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 78.0 mt-10 -152.1 143.81 23.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -1.167 . . . . 0.0 109.368 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.694 ' HA ' ' O ' ' A' ' 57' ' ' THR . 59.6 t0 -170.36 95.98 0.25 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HZ1' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -84.34 156.54 21.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.484 -1.385 . . . . 0.0 109.853 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 48' ' ' SER . 84.7 mt-10 -158.91 82.2 0.79 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.1 t 160.82 151.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.189 -0.944 . . . . 0.0 110.222 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.516 ' ND1' ' OG ' ' A' ' 48' ' ' SER . 28.8 m80 62.56 105.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.927 . . . . 0.0 109.718 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -49.8 -43.61 48.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.377 -0.827 . . . . 0.0 110.775 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.552 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 24.8 ttt -60.16 -35.58 75.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.04 -1.037 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.64 -9.62 51.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.828 -1.17 . . . . 0.0 109.283 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.951 ' O ' ' N ' ' A' ' 55' ' ' GLY . 33.2 ttp180 -84.86 36.65 0.62 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.0 111.207 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 51' ' ' MET . 78.8 mm-40 -32.66 -10.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.77 -1.206 . . . . 0.0 110.173 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.951 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 102.72 -39.74 2.67 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 121.49 -0.756 . . . . 0.0 112.911 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -52.3 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.228 -1.748 . . . . 0.0 109.903 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 70.1 p -56.84 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 110.927 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.542 ' NE2' ' CG2' ' A' ' 12' ' ' VAL . 17.6 p-80 -122.0 152.36 39.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.826 -1.171 . . . . 0.0 110.085 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB2' HG13 ' A' ' 11' ' ' VAL . . . -144.6 168.77 19.38 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -138.28 133.46 33.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.433 -0.792 . . . . 0.0 109.095 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -100.43 96.11 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 8' ' ' HIS . 53.6 mtm -96.34 121.32 38.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.111 -0.993 . . . . 0.0 110.801 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -124.74 148.07 48.28 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -125.61 155.91 40.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.795 -1.191 . . . . 0.0 110.045 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 41.4 tp10 -78.12 -26.97 48.22 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.7 m-20 -163.66 171.0 16.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -59.95 -22.17 62.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.281 -0.887 . . . . 0.0 111.438 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -58.78 -39.0 79.76 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.716 -1.24 . . . . 0.0 110.524 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.47 71.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.701 ' O ' HG22 ' A' ' 74' ' ' THR . 70.5 t80 -66.64 -44.27 82.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.561 -0.964 . . . . 0.0 110.465 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.79 -28.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.372 -1.455 . . . . 0.0 108.671 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.488 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.06 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.844 ' CE1' HD11 ' A' ' 30' ' ' LEU . 1.4 t80 -52.74 -38.7 61.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.1 t -84.16 -31.42 25.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.719 -1.238 . . . . 0.0 110.267 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 71.2 m -67.48 -33.03 74.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 111.005 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -75.36 128.02 85.14 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.898 -1.126 . . . . 0.0 109.659 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -43.67 -7.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.9 tp -64.83 -29.53 70.5 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.395 -0.815 . . . . 0.0 111.247 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -84.34 -37.11 22.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.996 -1.065 . . . . 0.0 110.239 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.73 -61.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.949 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.81 -39.15 84.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.267 -0.895 . . . . 0.0 109.559 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.32 -45.01 70.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.795 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 t -62.39 -35.02 77.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.125 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.25 65.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 108.712 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -70.83 -42.16 70.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.911 ' O ' HD13 ' A' ' 90' ' ' ILE . 18.9 t80 -45.73 -29.08 1.17 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' ' C ' ' A' ' 88' ' ' ALA . 11.2 m -82.31 -63.47 1.37 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.06 -32.34 0.09 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.624 -0.672 . . . . 0.0 110.012 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 85' ' ' ALA . 19.3 m -98.84 13.01 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.927 . . . . 0.0 110.829 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.911 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.1 mp -122.32 156.96 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.657 -1.277 . . . . 0.0 110.451 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.482 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 59.4 t0 -103.57 -36.35 7.97 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' NZ ' ' NZ ' ' A' ' 13' ' ' LYS . 30.2 pttt -147.52 147.36 30.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 93' ' ' ILE . 6.1 tp -123.42 117.73 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.608 -1.307 . . . . 0.0 109.791 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.78 127.1 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -133.79 129.2 36.24 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.365 -1.459 . . . . 0.0 111.761 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -115.69 119.36 35.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.332 176.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 61.3 t0 -125.1 131.67 53.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 108.899 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 51.9 t80 -169.26 135.36 1.4 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.06 -1.025 . . . . 0.0 110.548 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.9 Cg_exo -41.22 120.25 1.12 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.363 2.042 . . . . 0.0 112.128 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.3 143.18 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 110.019 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.12 67.78 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.682 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB2' ' CE2' ' B' ' 42' ' ' TRP . . . -56.03 98.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.054 -1.029 . . . . 0.0 109.53 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 103' ' ' VAL . 24.5 m -144.72 128.59 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 109.136 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 106' ' ' SER . 5.6 mptt -111.89 -32.29 6.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.342 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 106' ' ' SER . 1.2 m 63.42 -53.01 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 108.938 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 104' ' ' LYS . 1.4 p 73.12 148.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.0 109.348 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.477 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.57 -163.55 15.55 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.727 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -110.75 135.04 51.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.327 -1.102 . . . . 0.0 108.035 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 5.2 ttpm? -100.05 129.46 46.1 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.33 1.062 . . . . 0.0 112.778 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 77.7 t60 -121.88 120.53 34.76 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.04 142.05 49.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.762 -1.211 . . . . 0.0 109.467 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.48 139.32 51.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -126.83 133.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.538 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.23 156.3 21.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.048 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.671 ' HB2' ' HZ2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -119.95 152.33 37.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 178.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' B' ' 57' ' ' THR . 9.0 p90 -107.94 151.45 25.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.838 -1.164 . . . . 0.0 111.645 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.14 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -90.07 -56.53 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.7 m-20 152.68 66.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 64.4 m -52.35 107.09 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.991 0.901 . . . . 0.0 112.841 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.626 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -72.82 85.73 1.24 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.421 HG23 ' N ' ' B' ' 21' ' ' ASP . 17.9 m -54.87 -37.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 110.441 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.9 p-10 -63.36 -36.45 83.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.485 -0.76 . . . . 0.0 110.549 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 81.1 mt-10 -72.96 -37.77 66.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.445 HD11 HG21 ' B' ' 89' ' ' VAL . 1.8 mm -58.31 -44.96 89.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -49.13 -36.21 18.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -58.16 -38.49 76.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -73.08 -25.34 73.77 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.1 tt -74.94 -60.13 2.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.948 . . . . 0.0 108.772 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -50.2 -31.26 13.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 32' ' ' SER . 75.3 m-20 -65.86 -43.49 88.26 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.839 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.5 OUTLIER -47.25 -53.1 14.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' B' ' 32' ' ' SER . 79.4 t -50.08 -30.4 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.363 -0.835 . . . . 0.0 108.811 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 11.2 t -45.36 -50.78 11.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.441 HE22 ' CB ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -83.44 -9.25 59.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.79 . . . . 0.0 111.518 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' B' ' 36' ' ' THR . 12.7 mt -91.45 28.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.967 -1.708 . . . . 0.0 110.639 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -59.43 -9.2 2.21 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.726 HG23 ' H ' ' B' ' 38' ' ' LYS . 9.6 t -67.56 -7.87 29.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.028 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.7 m 35.31 33.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.128 -0.983 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.726 ' H ' HG23 ' B' ' 36' ' ' THR . 32.3 mtmt -122.86 47.79 1.9 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' B' ' 63' ' ' THR . 15.9 t -174.46 174.87 2.67 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.05 159.17 44.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.51 -1.369 . . . . 0.0 111.972 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -152.23 117.22 5.17 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.379 0.609 . . . . 0.0 110.225 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 102' ' ' ALA . 3.7 t-105 -105.72 167.2 9.93 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.84 150.48 17.15 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 118.734 -1.698 . . . . 0.0 110.835 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 77.6 mt-10 -152.23 143.75 23.45 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -1.105 . . . . 0.0 109.425 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' B' ' 57' ' ' THR . 59.5 t0 -170.11 95.82 0.26 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.713 ' HZ1' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -84.2 156.51 22.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.422 -1.424 . . . . 0.0 109.807 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' B' ' 48' ' ' SER . 84.3 mt-10 -158.94 82.06 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.1 t 160.94 151.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.176 -0.953 . . . . 0.0 110.192 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.516 ' ND1' ' OG ' ' B' ' 48' ' ' SER . 28.8 m80 62.8 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.682 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -49.62 -44.02 47.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.818 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.553 ' O ' ' NE2' ' B' ' 54' ' ' GLN . 24.8 ttt -59.78 -35.76 75.31 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.763 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 19.3 mt -88.65 -9.5 51.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.718 -1.239 . . . . 0.0 109.312 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.954 ' O ' ' N ' ' B' ' 55' ' ' GLY . 33.6 ttp180 -84.8 36.37 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 111.232 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' B' ' 51' ' ' MET . 78.8 mm-40 -32.48 -10.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 110.215 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.954 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 102.51 -39.63 2.71 Favored Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.425 -0.797 . . . . 0.0 112.805 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -52.34 101.57 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.554 1.677 . . . . 0.0 109.907 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 71.4 p -56.99 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 110.95 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.576 ' H ' ' HG1' ' B' ' 57' ' ' THR . 18.1 p-80 -121.97 152.12 40.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.908 -1.12 . . . . 0.0 110.127 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' B' ' 11' ' ' VAL . . . -144.38 168.72 19.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -138.24 133.69 33.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.042 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -100.56 96.19 7.2 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 53.5 mtm -96.5 121.43 38.31 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.172 -0.955 . . . . 0.0 110.73 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' B' ' 39' ' ' SER . 28.5 m -125.03 147.64 48.87 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.23 156.19 38.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.724 -1.235 . . . . 0.0 110.081 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 41.8 tp10 -78.48 -26.82 46.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.7 m-20 -163.78 170.79 16.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -59.82 -21.82 61.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 111.501 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -59.13 -38.68 80.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 110.57 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.38 69.87 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.697 ' O ' HG22 ' B' ' 74' ' ' THR . 70.6 t80 -66.59 -44.42 82.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.618 -0.93 . . . . 0.0 110.433 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.417 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.73 -28.91 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.451 -1.405 . . . . 0.0 108.707 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.491 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.09 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.297 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.839 ' CE1' HD11 ' B' ' 30' ' ' LEU . 1.4 t80 -52.59 -38.94 61.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 111.123 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.697 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.1 t -84.07 -31.32 25.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.726 -1.234 . . . . 0.0 110.281 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 71.9 m -67.53 -32.85 73.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.974 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' B' ' 78' ' ' LEU . 0.9 OUTLIER -75.53 128.09 84.7 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.885 -1.134 . . . . 0.0 109.602 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.77 -7.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 112.508 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.9 tp -64.84 -29.61 70.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.397 -0.815 . . . . 0.0 111.199 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -84.29 -37.14 22.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.238 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.68 -61.65 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 110.045 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.63 -39.21 83.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.33 -44.95 70.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.812 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 28.9 t -62.38 -35.18 78.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.1 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.29 65.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.675 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.684 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -70.79 -42.34 70.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.888 ' O ' HD13 ' B' ' 90' ' ' ILE . 19.2 t80 -45.81 -28.86 1.16 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.452 ' O ' ' C ' ' B' ' 88' ' ' ALA . 11.1 m -82.37 -63.37 1.39 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.11 -32.36 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.708 -0.62 . . . . 0.0 110.122 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.684 HG22 ' O ' ' B' ' 85' ' ' ALA . 19.1 m -98.84 12.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.874 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.888 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.1 mp -122.0 157.26 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 0.0 110.477 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 59.1 t0 -103.89 -36.21 7.88 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.435 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 30.6 pttt -147.65 147.22 29.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.554 HG23 ' O ' ' B' ' 93' ' ' ILE . 6.2 tp -123.42 117.87 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.517 -1.364 . . . . 0.0 109.721 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.86 127.24 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.59 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -133.99 129.16 35.77 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.258 -1.526 . . . . 0.0 111.73 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.462 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.5 OUTLIER -115.64 119.37 35.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.652 -0.655 . . . . 0.0 109.328 176.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 62.0 t0 -125.04 131.78 53.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 108.929 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 52.1 t80 -169.36 135.25 1.37 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.105 -0.997 . . . . 0.0 110.53 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 87.6 Cg_exo -41.2 120.1 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.264 1.976 . . . . 0.0 112.247 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.16 143.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 110.025 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.16 68.0 0.67 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.514 -0.741 . . . . 0.0 109.581 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . . . -56.12 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.623 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 103' ' ' VAL . 24.3 m -144.52 128.49 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 106' ' ' SER . 5.6 mptt -111.7 -32.43 6.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' B' ' 106' ' ' SER . 1.2 m 63.55 -53.21 0.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.13 -0.982 . . . . 0.0 108.892 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.685 ' N ' ' O ' ' B' ' 104' ' ' LYS . 1.4 p 73.24 148.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--N 1.302 -1.474 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.543 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 t -95.79 3.44 53.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -168.95 -89.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.28 168.68 18.35 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.671 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.62 131.57 55.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.242 -1.152 . . . . 0.0 108.022 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 25.2 ttpt -104.22 131.9 51.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.917 -1.114 . . . . 0.0 112.777 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 62' ' ' MET . 43.4 m-70 -126.34 127.46 45.56 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.2 tt -135.72 142.53 45.05 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.767 -1.208 . . . . 0.0 109.496 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 4.3 p -130.66 140.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.547 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.74 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.654 ' O ' ' O ' ' A' ' 56' ' ' PHE . 3.4 m -132.38 143.39 40.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.104 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 14.2 mmtt -107.43 152.6 23.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.565 ' HB2' ' H ' ' A' ' 18' ' ' THR . 15.8 p90 -114.53 148.71 37.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.769 -1.207 . . . . 0.0 111.585 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.89 -23.43 4.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -93.05 -53.89 3.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.2 t0 150.1 67.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.565 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.3 m -49.03 105.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.13 0.967 . . . . 0.0 112.802 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.551 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -72.82 84.77 1.22 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 21' ' ' ASP . 27.8 m -58.34 -37.72 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.549 -0.72 . . . . 0.0 110.456 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 34.1 p-10 -65.29 -38.33 89.89 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.479 -0.763 . . . . 0.0 110.544 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -70.08 -34.07 72.7 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.034 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.881 HD11 HG21 ' A' ' 89' ' ' VAL . 1.4 mm -63.87 -44.07 97.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.31 -35.8 51.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -61.45 -34.59 75.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.46 -44.11 8.88 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.94 -59.24 5.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.996 . . . . 0.0 108.856 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 22.1 pt-20 -52.17 -45.41 65.1 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.533 ' N ' ' CG ' ' A' ' 28' ' ' GLU . 3.8 t30 -58.15 -43.87 87.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -49.59 -44.25 46.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 34' ' ' ILE . 20.6 t -52.4 -22.35 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.221 -0.924 . . . . 0.0 108.888 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 34.3 t -40.62 -39.53 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -76.26 -23.81 54.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 111.461 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 34' ' ' ILE . 75.8 mt -81.75 20.85 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.018 -1.676 . . . . 0.0 110.544 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -57.4 -6.47 0.45 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.659 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.3 t -87.93 2.96 50.33 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.943 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.9 m 35.31 35.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.073 -1.017 . . . . 0.0 109.195 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.57 ' O ' ' OG ' ' A' ' 39' ' ' SER . 65.9 mttt -115.34 39.87 2.84 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 71.0 m -173.04 175.84 3.14 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -147.3 157.41 43.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.966 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' SER . 67.6 mt-10 -154.41 120.3 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.436 0.636 . . . . 0.0 110.246 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 1.1 m95 -123.37 170.27 10.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 164.4 24.92 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 118.695 -1.717 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 50.8 tt0 -154.72 148.1 25.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -113.17 141.3 47.1 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -139.39 108.08 5.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.41 -1.431 . . . . 0.0 109.829 -178.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.5 45.81 0.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.64 -0.663 . . . . 0.0 109.287 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.483 ' CB ' HH11 ' A' ' 53' ' ' ARG . 1.4 t -144.58 121.67 11.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.131 -0.98 . . . . 0.0 110.191 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.537 ' CG ' HD12 ' A' ' 52' ' ' LEU . 7.2 m80 65.97 118.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 109.753 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.15 -29.07 70.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.81 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -85.31 -36.05 21.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.01 -1.056 . . . . 0.0 110.712 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' B' ' 95' ' ' LEU . 27.0 mt -79.66 -72.87 0.38 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.729 -1.232 . . . . 0.0 109.273 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.86 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -73.15 4.67 4.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 111.252 -176.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 53' ' ' ARG . 15.4 mm100 39.1 6.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.819 -1.176 . . . . 0.0 110.204 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 50.79 2.87 0.04 OUTLIER Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.544 -0.722 . . . . 0.0 112.933 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.763 ' O ' ' CB ' ' A' ' 57' ' ' THR . 34.4 m-85 -39.12 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.189 -1.771 . . . . 0.0 109.976 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.763 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 16.8 m 99.8 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.287 -0.883 . . . . 0.0 110.938 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.526 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 18.5 t60 -164.56 152.08 11.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.885 -1.134 . . . . 0.0 110.173 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.19 167.28 22.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.31 -0.869 . . . . 0.0 109.249 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 95.2 m-85 -135.26 130.5 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.062 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -97.65 96.98 8.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 8' ' ' HIS . 74.2 mtm -98.02 117.86 33.31 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.188 -0.945 . . . . 0.0 110.844 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -122.78 144.64 49.04 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.31 159.12 28.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.702 -1.249 . . . . 0.0 110.068 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 41.6 tp10 -82.7 -31.47 28.52 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 65' ' ' GLU . 80.6 m-20 -161.73 169.37 21.58 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.51 ' NZ ' ' CB ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -55.18 -21.66 14.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 111.437 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -56.52 -40.48 75.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.788 -1.195 . . . . 0.0 110.611 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.17 -37.59 72.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' THR . 75.1 t80 -62.63 -45.12 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.623 -0.928 . . . . 0.0 110.522 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.368 -1.457 . . . . 0.0 108.653 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.381 -0.825 . . . . 0.0 109.381 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.488 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -51.68 -37.74 51.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 111.134 -177.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.6 t -84.99 -33.97 22.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.802 -1.186 . . . . 0.0 110.299 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.4 t -71.34 -25.6 62.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 0.0 110.95 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 78' ' ' LEU . 38.4 m80 -81.01 121.35 80.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.852 -1.155 . . . . 0.0 109.604 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.36 -13.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.638 2.225 . . . . 0.0 112.457 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 HD22 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -64.0 -26.97 68.81 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.346 -0.846 . . . . 0.0 111.277 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.488 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 3.8 t60 -81.66 -30.45 32.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.06 . . . . 0.0 110.236 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.09 -60.21 3.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.66 -40.24 62.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -66.6 -33.52 75.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.83 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 p -61.33 -43.79 98.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.105 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.48 -37.06 67.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 108.714 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.941 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -72.18 -40.53 67.87 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.613 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.28 -40.96 0.37 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.027 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' VAL . 24.3 m -81.94 -60.36 2.26 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.59 -10.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.669 -0.644 . . . . 0.0 110.047 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.941 HG22 ' O ' ' A' ' 85' ' ' ALA . 10.5 m -124.8 -7.86 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.191 -0.943 . . . . 0.0 110.853 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.652 HG13 HG23 ' A' ' 89' ' ' VAL . 65.4 mt -131.1 162.99 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.588 -1.32 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 90' ' ' ILE . 12.0 t0 -121.44 -24.01 5.51 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.73 139.02 32.76 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.4 tp -128.97 127.31 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.596 -1.315 . . . . 0.0 109.83 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 t -128.38 132.36 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -137.58 132.55 33.28 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.315 -1.49 . . . . 0.0 111.75 -178.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -115.8 121.36 42.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.723 -0.611 . . . . 0.0 109.364 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.674 ' O ' ' NE ' ' B' ' 53' ' ' ARG . 59.7 m-20 -123.75 128.3 49.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.081 -1.012 . . . . 0.0 108.869 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 99' ' ' PRO . 63.6 t80 -165.48 131.67 2.09 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.519 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 88.7 Cg_exo -47.52 133.41 20.83 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.288 1.992 . . . . 0.0 112.25 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.47 141.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.034 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -103.11 70.96 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.25 82.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.578 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 101' ' ' ALA . 29.1 m -127.53 -15.96 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 106' ' ' SER . 4.7 mptt 44.61 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -65.43 53.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 108.942 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 104' ' ' LYS . 6.3 t -83.98 38.89 0.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.636 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.11 168.88 18.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.726 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.77 131.7 55.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 25.1 ttpt -104.43 131.65 51.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.938 -1.101 . . . . 0.0 112.881 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 62' ' ' MET . 43.3 m-70 -126.13 127.57 45.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.2 tt -135.77 142.56 44.96 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.741 -1.225 . . . . 0.0 109.385 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 4.2 p -130.69 140.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.56 -0.712 . . . . 0.0 109.528 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -124.77 132.85 70.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.645 ' O ' ' O ' ' B' ' 56' ' ' PHE . 3.5 m -132.73 143.18 40.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 117.762 -1.575 . . . . 0.0 112.993 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 14.2 mmtt -107.25 152.22 24.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.553 ' HB2' ' H ' ' B' ' 18' ' ' THR . 15.8 p90 -114.03 149.12 35.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.187 . . . . 0.0 111.58 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -124.0 -23.59 4.58 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.4 mt-10 -92.88 -53.96 3.94 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.1 t0 150.17 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.553 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.7 m -48.99 105.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.105 0.955 . . . . 0.0 112.887 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.562 ' H ' ' HD3' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -72.79 84.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.463 HG23 ' N ' ' B' ' 21' ' ' ASP . 27.9 m -58.41 -37.53 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 34.4 p-10 -65.52 -38.29 89.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.514 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.498 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 0.4 OUTLIER -70.05 -33.99 72.65 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.88 HD11 HG21 ' B' ' 89' ' ' VAL . 1.4 mm -63.84 -44.11 98.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.27 -35.7 50.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -61.56 -34.71 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.31 -43.71 9.32 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -57.43 -59.01 5.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.944 . . . . 0.0 108.809 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 22.3 pt-20 -52.37 -45.23 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.527 ' N ' ' CG ' ' B' ' 28' ' ' GLU . 3.8 t30 -58.22 -43.93 87.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.576 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -49.76 -43.92 48.35 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' B' ' 34' ' ' ILE . 20.8 t -52.61 -22.33 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 36.4 t -40.65 -39.48 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -76.28 -23.73 54.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.765 . . . . 0.0 111.497 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.79 HG22 ' O ' ' B' ' 34' ' ' ILE . 75.9 mt -81.85 20.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.014 -1.679 . . . . 0.0 110.585 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.5 p30 -57.45 -6.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.634 ' H ' ' C ' ' B' ' 34' ' ' ILE . 1.3 t -87.89 3.0 50.15 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.986 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.566 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.0 m 35.43 35.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.101 -1.0 . . . . 0.0 109.154 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.569 ' O ' ' OG ' ' B' ' 39' ' ' SER . 64.8 mttt -115.17 40.11 2.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.569 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 73.2 m -173.4 175.72 3.0 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -147.18 157.53 43.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.478 -1.389 . . . . 0.0 111.972 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' B' ' 61' ' ' SER . 67.7 mt-10 -154.54 120.5 5.25 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.356 0.598 . . . . 0.0 110.235 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.635 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 1.1 m95 -123.63 170.15 10.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.58 164.26 24.91 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 50.9 tt0 -154.48 148.07 25.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.254 -1.145 . . . . 0.0 109.354 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -113.19 141.02 47.44 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -139.35 108.04 5.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.357 -1.464 . . . . 0.0 109.889 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.38 45.54 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.689 -0.632 . . . . 0.0 109.395 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.476 ' CB ' HH11 ' B' ' 53' ' ' ARG . 1.4 t -144.24 121.94 11.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 110.166 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.533 ' CG ' HD12 ' B' ' 52' ' ' LEU . 7.2 m80 65.66 118.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.207 -0.933 . . . . 0.0 109.728 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -62.23 -29.33 70.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.332 -0.855 . . . . 0.0 110.781 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 89.5 mtp -85.23 -35.89 21.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.03 -1.044 . . . . 0.0 110.768 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' A' ' 95' ' ' LEU . 27.2 mt -79.7 -72.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.755 -1.216 . . . . 0.0 109.291 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.852 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.6 OUTLIER -73.2 4.51 4.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 111.22 -176.017 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.474 ' C ' ' O ' ' B' ' 53' ' ' ARG . 15.4 mm100 39.15 6.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.804 -1.185 . . . . 0.0 110.213 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.852 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 50.46 2.91 0.04 OUTLIER Glycine 0 N--CA 1.499 2.835 0 O-C-N 121.515 -0.74 . . . . 0.0 112.909 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' CB ' ' B' ' 57' ' ' THR . 33.7 m-85 -39.04 -25.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.274 -1.721 . . . . 0.0 110.004 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.768 ' CB ' ' O ' ' B' ' 56' ' ' PHE . 16.1 m 99.7 -62.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.281 -0.887 . . . . 0.0 110.982 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.52 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 18.6 t60 -164.31 152.04 12.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.862 -1.148 . . . . 0.0 110.127 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.468 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.19 167.13 22.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.536 -0.727 . . . . 0.0 109.301 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.52 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 95.2 m-85 -135.01 130.71 36.11 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.485 -0.759 . . . . 0.0 109.08 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 0.1 OUTLIER -97.66 97.06 8.71 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 62' ' ' MET . . . . . 0.448 ' O ' ' N ' ' B' ' 8' ' ' HIS . 74.6 mtm -98.12 117.82 33.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.175 -0.953 . . . . 0.0 110.741 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -122.84 144.44 49.2 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.12 159.04 27.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.75 -1.219 . . . . 0.0 110.062 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' B' ' 66' ' ' ASN . 42.1 tp10 -82.57 -31.33 29.06 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' B' ' 65' ' ' GLU . 80.7 m-20 -161.93 169.6 20.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -55.25 -21.73 15.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.493 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.4 -40.76 75.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.789 -1.195 . . . . 0.0 110.534 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.89 -37.84 75.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.544 ' O ' HG22 ' B' ' 74' ' ' THR . 75.4 t80 -62.28 -45.47 93.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.592 -0.946 . . . . 0.0 110.374 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.67 -28.94 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.455 -1.403 . . . . 0.0 108.732 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.12 -60.86 2.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.315 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.491 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.1 OUTLIER -51.35 -38.1 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.86 . . . . 0.0 111.146 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.544 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.6 t -84.74 -33.99 22.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.732 -1.23 . . . . 0.0 110.324 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 36.3 t -71.29 -25.97 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.942 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' B' ' 78' ' ' LEU . 38.5 m80 -80.63 121.32 81.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.796 -1.19 . . . . 0.0 109.557 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.39 -13.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.69 2.26 . . . . 0.0 112.413 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.544 HD23 HD22 ' B' ' 30' ' ' LEU . 0.6 OUTLIER -63.65 -27.32 69.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.776 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.491 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 4.1 t60 -81.47 -30.32 33.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 110.301 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.18 -60.24 3.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.76 -40.06 62.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.518 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -66.56 -33.78 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.93 . . . . 0.0 109.877 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 56.6 p -61.06 -43.9 98.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.1 -1.0 . . . . 0.0 110.134 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.31 -37.26 67.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.034 -1.042 . . . . 0.0 108.72 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.926 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -72.04 -40.72 68.18 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.614 ' O ' ' HB ' ' B' ' 90' ' ' ILE . 0.0 OUTLIER -37.1 -40.89 0.33 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.541 ' O ' ' N ' ' B' ' 89' ' ' VAL . 24.6 m -82.16 -60.34 2.25 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.52 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.783 -0.573 . . . . 0.0 110.103 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.926 HG22 ' O ' ' B' ' 85' ' ' ALA . 10.4 m -124.94 -7.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 110.855 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.657 HG13 HG23 ' B' ' 89' ' ' VAL . 66.2 mt -131.04 162.89 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.618 -1.301 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.603 ' N ' HG22 ' B' ' 90' ' ' ILE . 12.0 t0 -121.28 -24.33 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.58 139.22 33.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.418 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.4 tp -129.28 127.34 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.542 -1.349 . . . . 0.0 109.755 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 60.7 t -128.35 132.52 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -137.71 132.48 32.91 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.254 -1.528 . . . . 0.0 111.783 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.443 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.4 OUTLIER -115.66 121.49 42.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.68 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 60.3 m-20 -123.73 128.23 49.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.066 -1.021 . . . . 0.0 108.934 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 99' ' ' PRO . 63.7 t80 -165.31 131.65 2.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.55 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' PRO . . . . . 0.514 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 88.2 Cg_exo -47.59 133.15 21.13 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.256 1.971 . . . . 0.0 112.225 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.22 141.28 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.049 -1.032 . . . . 0.0 110.064 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -102.88 71.11 1.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.487 -0.758 . . . . 0.0 109.602 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.46 82.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.123 -0.985 . . . . 0.0 109.574 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' B' ' 101' ' ' ALA . 29.1 m -127.65 -15.92 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.18 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' B' ' 106' ' ' SER . 4.7 mptt 44.73 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.353 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -65.34 53.97 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -0.976 . . . . 0.0 108.959 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.589 ' N ' ' O ' ' B' ' 104' ' ' LYS . 6.3 t -84.07 38.95 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.57 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.382 0.611 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.699 HG23 ' N ' ' A' ' 4' ' ' SER . 6.7 t -67.3 -51.49 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.699 ' N ' HG23 ' A' ' 3' ' ' THR . 9.7 m -140.85 -117.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.25 142.62 46.6 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.641 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -113.59 128.83 56.58 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.297 -1.119 . . . . 0.0 108.011 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -110.07 138.87 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.929 -1.107 . . . . 0.0 112.776 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.27 129.74 43.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -135.46 143.39 45.86 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.698 -1.251 . . . . 0.0 109.522 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 10.4 p -128.5 138.05 55.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.642 -0.661 . . . . 0.0 109.508 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.97 130.67 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -136.96 165.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.78 -1.568 . . . . 0.0 113.07 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 39.2 tptt -130.43 151.4 50.96 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 10.0 p90 -108.87 150.16 28.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.838 -1.164 . . . . 0.0 111.615 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.37 -22.64 5.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.9 mt-10 -91.26 -53.68 4.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.8 t0 149.39 69.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.2 m -55.85 109.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.082 0.944 . . . . 0.0 112.857 -177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.712 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.73 91.11 5.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -61.36 -33.45 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 110.453 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.8 p-10 -68.3 -41.52 80.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.451 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.703 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 70.3 tt0 -66.72 -28.32 68.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -74.46 -39.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.7 -40.41 79.42 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.703 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -60.51 -26.11 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . -81.26 -45.29 7.56 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.6 tt -49.0 -51.92 27.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.484 -1.01 . . . . 0.0 108.809 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 17.1 pt-20 -53.06 -43.29 66.57 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -57.41 -43.52 83.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -46.91 -45.35 20.49 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 34' ' ' ILE . 23.0 t -51.6 -23.37 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 108.933 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 41.9 t -42.86 -46.55 5.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.534 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 82.0 mm-40 -74.55 -20.47 59.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.374 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 34' ' ' ILE . 58.0 mt -82.62 22.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.05 -1.656 . . . . 0.0 110.643 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.8 p30 -59.46 -8.78 1.98 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 36.2 p -82.64 -0.97 49.66 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.981 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.6 m 35.59 31.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' THR . 42.0 mttm -117.66 40.76 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 34' ' ' ILE . 95.6 p -173.11 173.96 3.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.72 159.12 44.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -153.96 121.04 5.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.395 0.617 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -124.03 167.02 14.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 44' ' ' GLU . . . -125.48 157.98 19.73 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.756 -1.688 . . . . 0.0 110.823 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.654 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 73.9 mm-40 -148.35 136.9 21.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.247 -1.149 . . . . 0.0 109.397 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -111.09 141.02 45.14 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.842 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -143.42 117.26 9.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.454 -1.404 . . . . 0.0 109.763 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -153.56 -15.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.544 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -69.57 122.0 18.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 0.0 110.177 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.494 ' O ' ' O ' ' A' ' 48' ' ' SER . 48.1 m80 59.36 126.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.985 . . . . 0.0 109.678 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -67.02 -34.89 78.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.816 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.523 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -77.44 -37.94 50.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 0.0 110.687 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' B' ' 95' ' ' LEU . 19.3 mt -78.79 -71.15 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.74 -1.225 . . . . 0.0 109.266 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' A' ' 53' ' ' ARG . 3.7 mmt-85 -72.25 12.63 0.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.901 . . . . 0.0 111.258 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.53 ' CD ' HD21 ' B' ' 96' ' ' LEU . 22.1 mt-30 50.67 7.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.765 -1.209 . . . . 0.0 110.171 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.674 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 55.87 -0.42 0.12 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.361 -0.837 . . . . 0.0 112.891 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.674 ' O ' ' O ' ' A' ' 55' ' ' GLY . 4.8 m-85 -53.19 -142.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.157 -1.79 . . . . 0.0 109.914 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 35.3 m -135.82 -47.49 0.67 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.654 ' CE1' ' H ' ' A' ' 44' ' ' GLU . 27.4 t60 -172.76 160.06 4.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.96 -1.087 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.611 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.55 163.01 34.08 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.46 -0.775 . . . . 0.0 109.231 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 82.6 m-85 -133.42 129.59 37.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.499 -0.751 . . . . 0.0 109.121 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.29 98.7 8.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.6 mtt -98.68 119.68 37.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.234 -0.916 . . . . 0.0 110.76 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -119.37 140.62 50.06 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.07 125.83 44.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.083 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -50.87 -32.14 19.51 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -156.03 162.28 40.33 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -60.59 -21.83 63.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 111.493 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 34.0 p-10 -55.94 -36.43 67.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.773 -1.204 . . . . 0.0 110.532 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.18 -31.99 63.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.699 ' O ' HG22 ' A' ' 74' ' ' THR . 76.9 t80 -67.79 -44.36 77.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.973 . . . . 0.0 110.436 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.76 -28.95 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.404 -1.435 . . . . 0.0 108.686 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.05 -60.89 2.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.373 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.539 ' CE1' HD11 ' A' ' 30' ' ' LEU . 1.6 t80 -56.59 -60.13 3.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.11 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.699 HG22 ' O ' ' A' ' 70' ' ' TYR . 10.1 t -52.29 -34.46 46.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.734 -1.228 . . . . 0.0 110.3 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.3 m -77.96 -16.22 58.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.959 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 78' ' ' LEU . 22.6 m80 -79.24 132.18 63.72 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.152 . . . . 0.0 109.57 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -42.22 -12.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.697 2.264 . . . . 0.0 112.394 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.5 tp -74.44 -27.28 60.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.423 -0.798 . . . . 0.0 111.292 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.83 -45.13 21.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.957 -1.09 . . . . 0.0 110.206 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.774 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -59.44 -58.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 110.01 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.774 ' H ' HG13 ' A' ' 80' ' ' VAL . 15.2 tm-20 -51.01 -36.65 40.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.92 -32.02 73.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.758 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.05 -44.23 94.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.44 -33.28 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.921 -1.112 . . . . 0.0 108.73 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.939 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -79.42 -46.37 17.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.699 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -38.81 -40.15 0.59 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' VAL . 20.3 m -82.17 -62.53 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.86 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.676 -0.64 . . . . 0.0 110.097 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.939 HG22 ' O ' ' A' ' 85' ' ' ALA . 9.1 m -117.46 -1.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 0.0 110.771 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 91' ' ' ASP . 68.4 mt -132.93 164.02 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 110.512 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 90' ' ' ILE . 38.4 t0 -124.14 -26.82 3.94 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.422 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 18.9 ttpt -133.81 131.17 38.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -126.32 125.59 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.596 -1.315 . . . . 0.0 109.768 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 t -132.2 134.5 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -136.47 131.65 34.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.294 -1.503 . . . . 0.0 111.764 -178.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.546 HD21 ' CD ' ' B' ' 54' ' ' GLN . 0.2 OUTLIER -116.05 122.57 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.645 -0.659 . . . . 0.0 109.391 177.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.549 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 38.5 p-10 -126.11 132.49 51.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -159.81 128.72 3.08 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.087 -1.008 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 131.46 12.67 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.37 2.046 . . . . 0.0 112.186 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.553 HG22 ' OE2' ' B' ' 44' ' ' GLU . 96.9 t -113.42 135.37 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.96 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -107.96 88.3 2.7 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.451 -0.781 . . . . 0.0 109.56 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -57.71 73.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 102' ' ' ALA . 4.5 m -161.01 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.099 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 106' ' ' SER . 24.0 mmtm -97.7 4.57 49.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.412 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.35 -53.53 0.27 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 108.879 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 104' ' ' LYS . 20.1 m 47.17 45.01 16.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t . . . . . 0 C--N 1.301 -1.509 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.721 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.22 142.69 46.52 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.693 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -113.67 128.74 56.54 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.218 -1.166 . . . . 0.0 108.033 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -109.91 138.63 46.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.862 -1.149 . . . . 0.0 112.822 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.09 129.68 43.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.0 tt -135.35 143.45 46.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.433 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 10.3 p -128.34 137.97 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.478 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.6 OUTLIER -120.92 130.79 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 178.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.04 165.49 27.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.663 -1.615 . . . . 0.0 113.028 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 39.1 tptt -130.39 151.41 50.91 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.511 ' HB2' ' H ' ' B' ' 18' ' ' THR . 9.9 p90 -108.84 150.11 28.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.795 -1.191 . . . . 0.0 111.558 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.36 -22.82 4.98 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.9 mt-10 -91.03 -53.77 4.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.7 t0 149.47 69.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -56.0 109.76 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.129 0.966 . . . . 0.0 112.778 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.713 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.87 91.31 5.97 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.403 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.38 -33.55 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.647 . . . . 0.0 110.495 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.6 p-10 -68.13 -41.56 81.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.542 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.695 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 70.7 tt0 -66.85 -28.09 68.07 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -74.7 -39.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.62 -40.57 79.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.1 OUTLIER -60.36 -26.19 66.42 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' B' ' 25' ' ' LYS . . . -81.06 -45.47 7.56 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.502 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.6 tt -48.91 -51.98 27.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -1.032 . . . . 0.0 108.855 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 17.0 pt-20 -53.09 -43.33 66.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.0 OUTLIER -57.34 -43.47 83.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.299 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.538 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -47.1 -45.34 22.05 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 34' ' ' ILE . 23.2 t -51.47 -23.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.299 -0.876 . . . . 0.0 108.767 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 41.7 t -42.74 -46.47 5.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.527 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 81.9 mm-40 -74.57 -20.47 59.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 111.533 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.714 HG22 ' O ' ' B' ' 34' ' ' ILE . 58.1 mt -82.65 22.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.972 -1.705 . . . . 0.0 110.563 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.1 p30 -59.5 -8.88 2.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.597 ' O ' ' N ' ' B' ' 38' ' ' LYS . 36.3 p -82.52 -0.98 49.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.953 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.9 m 35.53 31.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.063 -1.023 . . . . 0.0 109.187 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.597 ' N ' ' O ' ' B' ' 36' ' ' THR . 42.2 mttm -117.64 40.73 3.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.551 ' OG ' HG23 ' B' ' 34' ' ' ILE . 95.6 p -173.07 173.94 3.56 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.525 -0.735 . . . . 0.0 109.031 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.73 158.99 44.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.521 -1.362 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -153.82 120.95 5.72 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.314 0.578 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -124.0 166.77 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' B' ' 44' ' ' GLU . . . -125.43 157.94 19.68 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.754 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.655 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 74.1 mm-40 -148.26 136.97 21.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.253 -1.146 . . . . 0.0 109.42 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -111.11 141.05 45.12 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.839 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -143.4 117.29 9.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.384 -1.448 . . . . 0.0 109.785 -178.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -153.62 -15.25 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.33 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.551 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 0.7 OUTLIER -69.62 121.87 17.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' B' ' 48' ' ' SER . 48.0 m80 59.55 126.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.076 -1.015 . . . . 0.0 109.701 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -67.07 -34.87 78.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.402 -0.811 . . . . 0.0 110.823 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.527 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -77.45 -37.89 50.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 110.749 -178.098 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' A' ' 95' ' ' LEU . 19.1 mt -78.75 -71.35 0.44 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.699 -1.25 . . . . 0.0 109.307 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' B' ' 53' ' ' ARG . 3.7 mmt-85 -72.06 12.59 0.4 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 111.268 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.546 ' CD ' HD21 ' A' ' 96' ' ' LEU . 22.0 mt-30 50.65 7.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.826 -1.171 . . . . 0.0 110.167 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.676 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 56.01 -0.38 0.13 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.468 -0.77 . . . . 0.0 112.865 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.676 ' O ' ' O ' ' B' ' 55' ' ' GLY . 4.7 m-85 -53.31 -142.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.323 -1.692 . . . . 0.0 109.985 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.511 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 37.5 m -135.55 -47.46 0.69 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.852 . . . . 0.0 111.003 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.655 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 27.2 t60 -172.78 160.32 4.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.624 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.81 163.07 33.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.449 -0.782 . . . . 0.0 109.282 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 82.3 m-85 -133.43 129.7 37.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.529 -0.732 . . . . 0.0 109.076 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.32 98.73 8.82 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.7 mtt -98.77 119.71 37.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.234 -0.916 . . . . 0.0 110.793 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.5 m -119.48 140.77 49.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -125.3 125.67 43.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.704 -1.247 . . . . 0.0 110.058 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.82 -32.07 19.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -156.01 162.39 40.33 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.73 -21.67 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 111.451 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 33.6 p-10 -56.06 -36.36 67.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.722 -1.236 . . . . 0.0 110.569 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -72.09 -31.99 63.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.693 ' O ' HG22 ' B' ' 74' ' ' THR . 76.6 t80 -67.78 -44.37 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.955 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.78 -28.9 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.431 -1.418 . . . . 0.0 108.691 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.532 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.465 -0.772 . . . . 0.0 109.348 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' B' ' 30' ' ' LEU . 1.6 t80 -56.59 -60.35 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.125 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 70' ' ' TYR . 10.2 t -52.03 -34.49 43.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.715 -1.24 . . . . 0.0 110.322 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 66.5 m -78.01 -16.28 58.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 0.0 110.9 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' B' ' 78' ' ' LEU . 22.8 m80 -79.23 132.15 63.8 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.874 -1.141 . . . . 0.0 109.621 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -42.12 -12.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.625 2.217 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.5 tp -74.38 -27.27 60.58 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.372 -0.83 . . . . 0.0 111.236 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.87 -44.99 21.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.029 -1.044 . . . . 0.0 110.307 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.775 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.2 p -59.55 -58.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.775 ' H ' HG13 ' B' ' 80' ' ' VAL . 15.2 tm-20 -50.91 -36.72 39.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.26 -0.9 . . . . 0.0 109.602 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.88 -31.96 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.853 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.0 -44.34 94.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.029 . . . . 0.0 110.118 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.15 70.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.928 -1.108 . . . . 0.0 108.685 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.924 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -79.39 -46.43 17.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.702 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -38.96 -40.01 0.6 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.559 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 21.0 m -82.24 -62.42 1.63 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.77 -16.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.767 -0.583 . . . . 0.0 110.126 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.924 HG22 ' O ' ' B' ' 85' ' ' ALA . 9.0 m -117.25 -1.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.166 -0.959 . . . . 0.0 110.835 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.622 HG22 ' N ' ' B' ' 91' ' ' ASP . 68.4 mt -132.99 163.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.67 -1.268 . . . . 0.0 110.457 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.622 ' N ' HG22 ' B' ' 90' ' ' ILE . 38.5 t0 -124.04 -27.0 3.94 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.495 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 18.9 ttpt -133.77 131.16 39.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.437 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -126.41 125.62 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.568 -1.333 . . . . 0.0 109.735 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 12.0 t -132.22 134.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -136.56 131.57 34.0 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.188 -1.57 . . . . 0.0 111.814 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.53 HD21 ' CD ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -116.02 122.69 45.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.701 -0.624 . . . . 0.0 109.317 177.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.551 ' O ' ' CZ ' ' A' ' 53' ' ' ARG . 38.7 p-10 -126.3 132.47 51.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.097 -1.002 . . . . 0.0 108.948 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -159.83 128.68 3.06 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.005 . . . . 0.0 110.529 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.79 131.37 13.2 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.283 1.988 . . . . 0.0 112.257 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.547 HG22 ' OE2' ' A' ' 44' ' ' GLU . 97.4 t -113.18 135.38 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -107.89 88.31 2.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 109.636 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ALA . . . . . 0.667 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -57.63 73.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.617 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.667 HG13 ' O ' ' B' ' 102' ' ' ALA . 4.6 m -160.99 99.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 0.0 109.189 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' B' ' 106' ' ' SER . 24.1 mmtm -97.74 4.56 49.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.325 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.38 -53.46 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.147 -0.97 . . . . 0.0 108.93 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.655 ' N ' ' O ' ' B' ' 104' ' ' LYS . 20.6 m 47.13 45.04 15.94 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.338 -0.851 . . . . 0.0 109.385 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 72.2 t . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.625 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.605 ' C ' ' H ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.445 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 70.35 -26.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.145 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 2' ' ' ALA . 43.4 p -143.37 -136.85 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.37 168.56 26.96 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.73 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 131.6 47.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.173 -1.193 . . . . 0.0 108.0 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 19.7 ttpt -110.15 139.04 45.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 112.745 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -129.4 127.81 41.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.9 tt -136.47 146.3 46.15 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.761 -1.212 . . . . 0.0 109.48 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 10' ' ' VAL . 11.7 p -127.8 134.76 64.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.501 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.68 127.35 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.34 159.62 32.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.041 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 17.8 tptt -129.46 152.98 48.4 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 8.0 p90 -106.24 148.85 27.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.906 -1.121 . . . . 0.0 111.626 -177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.62 -22.92 3.52 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 85.0 tt0 -89.47 -58.17 2.62 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.3 t0 155.94 72.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.434 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m -66.15 109.75 2.73 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 112.834 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.72 92.2 5.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 20' ' ' VAL . 15.7 m -61.55 -35.97 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.1 p-10 -68.1 -41.65 81.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 65.5 tt0 -71.47 -32.68 68.57 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.22 -36.94 69.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' VAL . 12.8 tp -52.72 -39.98 62.58 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -39.58 84.2 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 29' ' ' ASN . . . -61.59 -54.36 36.37 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 60' ' ' PHE . 48.5 mt -52.63 -47.85 66.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.551 -0.97 . . . . 0.0 108.769 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.66 -39.43 61.84 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.642 ' OD1' HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.18 -42.52 99.38 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.0 mm? -49.93 -46.75 52.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.706 HG13 HD12 ' A' ' 34' ' ' ILE . 22.0 t -48.77 -25.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.283 -0.886 . . . . 0.0 108.846 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 68.5 m -42.83 -40.61 2.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.44 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 98.1 mm-40 -71.1 -17.98 62.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 111.478 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 34' ' ' ILE . 89.1 mt -80.59 18.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.024 -1.672 . . . . 0.0 110.588 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.5 -12.8 4.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 38' ' ' LYS . 4.0 t -89.28 0.52 56.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.586 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 34.24 34.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.987 -1.071 . . . . 0.0 109.157 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.0 mttt -117.54 41.75 2.76 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -177.87 179.12 0.9 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -148.33 159.84 43.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.566 -1.334 . . . . 0.0 111.955 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 76.3 mt-10 -155.96 123.76 5.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.394 0.616 . . . . 0.0 110.165 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 24.1 m95 -125.29 165.88 17.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 44' ' ' GLU . . . -161.45 150.7 20.56 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.793 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 43' ' ' GLY . 7.5 tp10 -163.66 175.19 10.83 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 11.3 p-10 -118.34 170.0 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -61.26 84.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.409 -1.432 . . . . 0.0 109.847 -178.595 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.6 mt-10 -107.03 42.5 1.29 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.345 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.87 -142.66 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.994 . . . . 0.0 110.193 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 50' ' ' ASP . 78.9 m80 -95.99 136.97 35.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.218 -0.927 . . . . 0.0 109.675 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' HIS . 90.8 m-20 -41.52 -35.73 0.77 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.0 110.789 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -79.02 -29.19 43.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 0.0 110.733 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.8 mt -94.31 -22.77 18.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.697 -1.252 . . . . 0.0 109.275 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 55' ' ' GLY . 2.7 ptt180 -96.08 4.01 52.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.327 -0.858 . . . . 0.0 111.218 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 53' ' ' ARG . 35.3 tt0 40.71 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.733 -1.229 . . . . 0.0 110.171 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 57.53 1.12 0.45 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 121.39 -0.819 . . . . 0.0 112.816 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 32.1 p90 -55.29 129.36 38.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.281 -1.717 . . . . 0.0 109.976 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 52.8 m -54.53 -47.55 73.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.4 ' CG ' ' N ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -164.3 150.93 11.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -179.174 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 58' ' ' HIS . . . -130.07 147.77 51.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.391 -0.818 . . . . 0.0 109.283 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.948 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 2.4 t80 -126.71 122.93 36.29 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.069 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -106.9 102.7 12.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.3 mtm -102.5 124.74 48.61 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.24 -0.913 . . . . 0.0 110.797 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.8 m -122.29 144.58 48.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.37 160.59 29.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.771 -1.206 . . . . 0.0 110.011 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -82.97 -30.84 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -150.96 160.0 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -58.21 -24.55 59.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 111.389 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -53.62 -35.42 60.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.89 85.45 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 74' ' ' THR . 71.6 t80 -62.39 -46.55 88.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.566 -0.961 . . . . 0.0 110.459 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.394 -1.441 . . . . 0.0 108.649 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.94 2.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 33' ' ' GLN . 3.8 m-85 -48.62 -36.79 16.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 111.103 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 70' ' ' TYR . 2.2 t -82.47 -27.14 32.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.759 -1.213 . . . . 0.0 110.311 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.2 p -69.34 -22.01 63.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.04 -1.038 . . . . 0.0 110.983 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 78' ' ' LEU . 78.4 m80 -85.33 130.76 50.39 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.847 -1.158 . . . . 0.0 109.579 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -45.69 -2.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.67 2.247 . . . . 0.0 112.392 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.642 HD11 ' OD1' ' A' ' 29' ' ' ASN . 8.5 tp -77.16 -31.1 55.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.423 -0.798 . . . . 0.0 111.24 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -76.9 -39.18 51.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.989 -1.069 . . . . 0.0 110.219 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.735 HG13 ' H ' ' A' ' 81' ' ' GLU . 4.0 p -62.26 -56.56 16.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.988 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.735 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.4 tt0 -49.48 -37.76 27.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.4 -29.42 70.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.256 -0.903 . . . . 0.0 109.886 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -61.87 -44.87 95.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.83 69.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.729 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.93 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -83.33 -45.39 13.81 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.703 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -36.37 -44.01 0.4 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.849 HG23 ' H ' ' A' ' 88' ' ' ALA . 3.3 t -83.36 -60.14 2.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.849 ' H ' HG23 ' A' ' 87' ' ' THR . . . -47.22 -14.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.744 -0.598 . . . . 0.0 110.093 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 85' ' ' ALA . 6.1 m -120.17 -1.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.232 -0.918 . . . . 0.0 110.809 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.565 HG13 HG23 ' A' ' 89' ' ' VAL . 61.1 mt -128.55 160.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.649 -1.282 . . . . 0.0 110.434 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.525 ' N ' HG22 ' A' ' 90' ' ' ILE . 40.3 t0 -110.34 -31.97 7.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.51 142.66 31.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.2 tp -124.35 121.11 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.62 -1.3 . . . . 0.0 109.759 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.422 ' CG1' ' CD ' ' B' ' 54' ' ' GLN . 9.0 t -127.57 132.25 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -137.15 132.98 34.73 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.319 -1.488 . . . . 0.0 111.767 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.89 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.66 119.7 36.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.636 -0.665 . . . . 0.0 109.379 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 49.9 t0 -125.61 133.24 52.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.0 108.913 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 31.4 p90 -158.06 138.11 8.81 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.102 -0.999 . . . . 0.0 110.52 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.7 122.92 6.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.594 ' O ' ' OG ' ' A' ' 4' ' ' SER . 56.7 t -85.6 109.28 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.995 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.29 89.71 3.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.42 -0.8 . . . . 0.0 109.613 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' HG13 ' A' ' 103' ' ' VAL . . . -69.85 71.06 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.511 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 103' ' ' VAL . 33.7 m -153.02 86.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.265 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 106' ' ' SER . 29.3 mmtp -95.92 4.45 52.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.342 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t 63.43 -53.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.68 ' N ' ' O ' ' A' ' 104' ' ' LYS . 7.6 t 44.32 50.51 7.81 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.649 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.596 ' OG ' ' O ' ' B' ' 100' ' ' VAL . 46.0 p . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 168.65 26.56 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.63 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.28 131.52 46.99 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -1.143 . . . . 0.0 108.012 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 19.7 ttpt -110.01 138.97 45.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.903 -1.123 . . . . 0.0 112.793 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -129.2 128.19 42.84 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.9 tt -136.86 145.91 44.95 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.724 -1.235 . . . . 0.0 109.509 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.436 HG13 ' O ' ' B' ' 10' ' ' VAL . 11.7 p -127.57 134.64 65.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.587 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.62 127.22 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.23 159.73 32.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.707 -1.597 . . . . 0.0 112.983 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 18.1 tptt -129.48 153.17 48.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 7.9 p90 -106.43 148.76 27.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.893 -1.129 . . . . 0.0 111.621 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -23.11 3.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 85.1 tt0 -89.22 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.3 t0 155.8 73.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 47.6 m -66.55 109.67 2.87 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.083 0.944 . . . . 0.0 112.862 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.678 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -79.46 92.27 5.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 175.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.427 ' H ' HG22 ' B' ' 20' ' ' VAL . 15.8 m -61.8 -35.73 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.539 -0.725 . . . . 0.0 110.445 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 28.9 p-10 -68.23 -41.5 81.14 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.58 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 64.6 tt0 -71.69 -32.47 67.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.36 -36.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.11 -39.96 63.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -39.72 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' B' ' 29' ' ' ASN . . . -61.39 -54.57 35.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.952 HD22 ' CZ ' ' B' ' 60' ' ' PHE . 47.8 mt -52.49 -47.74 66.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.525 -0.986 . . . . 0.0 108.87 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.64 -39.63 61.95 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.648 ' OD1' HD11 ' B' ' 78' ' ' LEU . 0.1 OUTLIER -62.98 -42.64 99.89 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.0 mm? -49.98 -46.65 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.708 HG13 HD12 ' B' ' 34' ' ' ILE . 22.0 t -49.05 -25.17 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.867 . . . . 0.0 108.816 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 68.4 m -43.05 -40.63 3.18 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.448 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 98.1 mm-40 -70.98 -18.08 62.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.453 -0.779 . . . . 0.0 111.526 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.828 HG22 ' O ' ' B' ' 34' ' ' ILE . 89.6 mt -80.47 18.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 119.978 -1.702 . . . . 0.0 110.568 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.64 -12.83 4.57 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.589 ' O ' ' N ' ' B' ' 38' ' ' LYS . 3.9 t -89.16 0.53 56.66 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.887 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.57 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.5 m 34.32 33.9 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.194 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' B' ' 36' ' ' THR . 65.5 mttt -117.59 42.09 2.68 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 55.6 p -177.93 179.19 0.88 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -148.34 159.65 43.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.554 -1.341 . . . . 0.0 111.95 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.502 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 77.1 mt-10 -155.79 123.84 5.74 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.335 0.588 . . . . 0.0 110.229 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' B' ' 60' ' ' PHE . 23.9 m95 -125.22 166.03 17.22 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' B' ' 44' ' ' GLU . . . -161.55 150.56 20.25 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 118.716 -1.707 . . . . 0.0 110.839 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 43' ' ' GLY . 7.6 tp10 -163.57 175.2 10.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 109.352 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 11.7 p-10 -118.44 169.92 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -61.32 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.322 -1.487 . . . . 0.0 109.809 -178.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.8 mt-10 -106.96 42.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.316 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -139.74 -142.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.138 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' B' ' 50' ' ' ASP . 79.1 m80 -95.97 136.87 35.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 49' ' ' HIS . 90.4 m-20 -41.34 -36.01 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.324 -0.86 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.5 OUTLIER -78.81 -29.35 44.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.731 -178.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.28 -22.83 18.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.691 -1.256 . . . . 0.0 109.257 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' B' ' 55' ' ' GLY . 2.7 ptt180 -95.98 4.04 52.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -0.834 . . . . 0.0 111.235 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' B' ' 53' ' ' ARG . 35.5 tt0 40.55 21.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.812 -1.18 . . . . 0.0 110.15 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 57.27 1.26 0.41 Allowed Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.356 -0.84 . . . . 0.0 112.796 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 31.5 p90 -55.45 129.47 38.87 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 119.595 1.697 . . . . 0.0 109.941 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 55.2 m -54.66 -47.57 73.41 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.301 -0.874 . . . . 0.0 110.946 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 151.06 11.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.895 -1.128 . . . . 0.0 110.17 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.18 147.77 51.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.0 109.262 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.952 ' CZ ' HD22 ' B' ' 27' ' ' LEU . 2.4 t80 -126.65 122.97 36.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.488 -0.757 . . . . 0.0 109.075 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -107.07 102.56 11.89 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.26 124.99 48.81 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.134 -0.979 . . . . 0.0 110.759 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -122.51 144.65 48.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.47 160.92 28.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.738 -1.226 . . . . 0.0 110.025 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -83.31 -30.73 27.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -151.01 160.21 44.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -58.27 -25.04 61.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 111.411 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -53.06 -35.75 59.86 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.816 -1.177 . . . . 0.0 110.585 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -37.1 87.71 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.458 ' O ' HG22 ' B' ' 74' ' ' THR . 71.7 t80 -62.4 -46.55 88.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.978 . . . . 0.0 110.439 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.72 -28.98 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.37 -1.456 . . . . 0.0 108.623 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.0 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' B' ' 33' ' ' GLN . 3.8 m-85 -48.54 -36.58 15.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 111.186 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.458 HG22 ' O ' ' B' ' 70' ' ' TYR . 2.1 t -82.74 -27.08 31.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.744 -1.222 . . . . 0.0 110.329 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -69.49 -21.81 63.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 0.0 111.027 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' B' ' 78' ' ' LEU . 78.3 m80 -85.35 130.81 50.17 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.861 -1.149 . . . . 0.0 109.596 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.71 -2.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.599 2.199 . . . . 0.0 112.433 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.648 HD11 ' OD1' ' B' ' 29' ' ' ASN . 8.3 tp -77.31 -31.1 54.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -76.84 -39.18 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.0 110.296 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.719 HG13 ' H ' ' B' ' 81' ' ' GLU . 4.0 p -62.41 -56.3 18.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.972 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.719 ' H ' HG13 ' B' ' 80' ' ' VAL . 84.2 tt0 -49.89 -37.37 31.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.62 -29.27 69.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.85 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 59.9 p -62.03 -44.99 95.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.71 68.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.998 -1.063 . . . . 0.0 108.641 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.956 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -83.55 -45.33 13.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.705 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -36.52 -43.91 0.42 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.836 HG23 ' H ' ' B' ' 88' ' ' ALA . 3.3 t -83.32 -60.4 2.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.836 ' H ' HG23 ' B' ' 87' ' ' THR . . . -47.04 -14.9 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.956 HG22 ' O ' ' B' ' 85' ' ' ALA . 6.3 m -119.9 -1.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -0.904 . . . . 0.0 110.835 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 61.0 mt -128.33 160.68 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.672 -1.267 . . . . 0.0 110.448 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.545 ' N ' HG22 ' B' ' 90' ' ' ILE . 40.7 t0 -110.54 -31.89 7.09 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.63 142.35 30.99 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.516 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.1 tp -124.03 121.45 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.579 -1.326 . . . . 0.0 109.661 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.431 ' CG1' ' CD ' ' A' ' 54' ' ' GLN . 9.3 t -127.83 132.42 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.553 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -137.37 132.67 33.87 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.246 -1.534 . . . . 0.0 111.777 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.891 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.43 119.78 37.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.683 -0.636 . . . . 0.0 109.294 177.273 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' B' ' 98' ' ' PHE . 50.2 t0 -125.69 133.23 52.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.067 -1.021 . . . . 0.0 108.861 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' B' ' 98' ' ' PHE . 31.2 p90 -158.04 137.79 8.6 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 110.555 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.37 123.1 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.313 2.008 . . . . 0.0 112.221 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.596 ' O ' ' OG ' ' B' ' 4' ' ' SER . 58.9 t -85.79 109.21 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.21 89.8 3.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ALA . . . . . 0.41 ' C ' HG13 ' B' ' 103' ' ' VAL . . . -69.82 71.17 0.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.099 -1.001 . . . . 0.0 109.599 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.742 HG23 ' O ' ' B' ' 103' ' ' VAL . 33.8 m -153.29 85.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -0.843 . . . . 0.0 109.235 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.67 ' O ' ' N ' ' B' ' 106' ' ' SER . 29.2 mmtp -95.61 4.62 52.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.415 ' O ' ' C ' ' B' ' 106' ' ' SER . 1.8 t 63.34 -53.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 108.879 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.67 ' N ' ' O ' ' B' ' 104' ' ' LYS . 7.6 t 44.68 50.43 8.51 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.592 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.427 0.632 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 101' ' ' ALA . 8.8 t -111.5 0.21 16.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -167.25 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.1 178.15 18.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.66 127.04 55.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.276 -1.132 . . . . 0.0 107.973 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.4 ttpt -97.95 128.03 44.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.916 -1.115 . . . . 0.0 112.841 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 70' ' ' TYR . 51.6 m-70 -121.06 119.2 31.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.71 139.44 52.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.716 -1.24 . . . . 0.0 109.496 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.9 137.48 56.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.641 -0.662 . . . . 0.0 109.536 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -124.48 133.8 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 1.5 m -141.42 162.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.047 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -127.59 152.64 47.38 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 12.7 p90 -109.82 151.8 26.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.799 -1.188 . . . . 0.0 111.607 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.31 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 48.3 tp10 -92.84 -54.93 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.8 t0 152.86 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.536 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.4 m -50.22 107.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.14 0.972 . . . . 0.0 112.859 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -71.61 83.36 0.85 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 21' ' ' ASP . 27.8 m -62.83 -41.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.546 -0.721 . . . . 0.0 110.481 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.57 ' N ' HG23 ' A' ' 20' ' ' VAL . 90.3 m-20 -64.96 -44.64 88.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 110.498 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.7 -31.77 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -70.84 -43.61 76.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.2 tp -54.01 -40.04 66.66 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.92 -38.04 81.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -62.57 -51.27 57.3 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.7 tt -45.22 -44.03 10.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.461 -1.023 . . . . 0.0 108.848 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -49.87 -35.01 21.81 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 26' ' ' GLY . 14.3 m-20 -65.39 -44.32 87.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.668 HD11 ' CE1' ' A' ' 73' ' ' PHE . 1.4 mm? -48.39 -50.76 29.6 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' SER . 54.8 t -46.94 -35.7 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 108.733 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.1 t -45.36 -50.55 12.13 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -69.21 -9.15 51.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 111.47 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 34' ' ' ILE . 21.9 mm -101.35 29.07 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.04 -1.663 . . . . 0.0 110.589 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.19 -19.08 61.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.585 ' O ' ' C ' ' A' ' 37' ' ' VAL . 16.8 p -69.84 -6.85 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.585 ' C ' ' O ' ' A' ' 36' ' ' THR . 34.7 m 35.08 36.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.104 -0.998 . . . . 0.0 109.106 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -118.0 41.55 2.87 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.444 ' OG ' HG23 ' A' ' 34' ' ' ILE . 60.5 p -174.01 178.09 2.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 97.6 m-85 -145.47 153.81 41.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.594 -1.316 . . . . 0.0 111.951 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 40' ' ' PHE . 54.1 mp0 -156.99 125.41 5.68 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.421 0.629 . . . . 0.0 110.162 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -134.58 176.05 8.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.636 ' H ' ' NZ ' ' B' ' 104' ' ' LYS . . . -133.56 158.82 23.42 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 77.4 mt-10 -149.06 140.79 23.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -1.145 . . . . 0.0 109.368 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.538 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 32.4 p30 -120.62 145.36 47.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -148.62 128.84 13.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.437 -1.414 . . . . 0.0 109.794 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -161.98 51.2 0.21 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.641 -0.662 . . . . 0.0 109.32 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.2 t -91.12 -98.65 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.203 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.44 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.4 m-70 -100.69 144.67 29.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.155 -0.965 . . . . 0.0 109.708 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 87.8 m-20 -50.09 -42.97 51.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.301 -0.875 . . . . 0.0 110.674 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.3 ttt -73.55 -32.77 64.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.084 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 68.9 mt -88.67 -51.65 5.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.741 -1.224 . . . . 0.0 109.245 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.721 ' O ' ' N ' ' A' ' 55' ' ' GLY . 13.8 ptt180 -71.08 5.45 2.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 111.275 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.404 ' CD ' HG13 ' B' ' 94' ' ' VAL . 85.2 mm-40 46.07 3.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.729 -1.232 . . . . 0.0 110.197 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.21 -10.07 11.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.488 -0.758 . . . . 0.0 112.864 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 55' ' ' GLY . 20.9 m-85 -59.1 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.226 -1.749 . . . . 0.0 109.99 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.724 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 81.1 p -152.86 -41.9 0.1 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.962 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.724 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 27.3 p-80 -174.33 157.81 2.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.836 -1.165 . . . . 0.0 110.145 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG13 ' A' ' 11' ' ' VAL . . . -143.69 170.91 14.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 109.287 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.05 131.67 37.29 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.128 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 t -101.67 102.15 12.78 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.9 mtt -108.08 125.1 51.18 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.146 -0.971 . . . . 0.0 110.799 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.8 m -128.4 149.36 50.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.06 131.71 45.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 110.03 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 71.7 mm-40 -52.48 -32.52 40.36 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 33.0 m120 -155.64 160.46 40.43 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -57.66 -17.93 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.99 -39.83 79.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.844 -1.16 . . . . 0.0 110.589 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.26 -33.46 73.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.615 ' CE1' ' CE1' ' A' ' 8' ' ' HIS . 76.4 t80 -67.12 -44.38 80.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.495 -1.003 . . . . 0.0 110.451 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -28.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.381 -1.45 . . . . 0.0 108.673 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.367 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.668 ' CE1' HD11 ' A' ' 30' ' ' LEU . 2.5 t80 -45.66 -34.17 3.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 111.141 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -83.41 -24.9 31.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.744 -1.223 . . . . 0.0 110.249 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.6 m -67.47 -26.0 66.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.994 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -85.47 156.0 59.42 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.878 -1.139 . . . . 0.0 109.664 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.21 3.86 2.27 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.66 2.24 . . . . 0.0 112.469 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' CD2' HD22 ' A' ' 30' ' ' LEU . 44.5 tp -77.87 -31.1 51.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.77 . . . . 0.0 111.322 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -77.7 -41.61 37.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 0.0 110.211 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.765 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.5 p -62.58 -58.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.765 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.8 tt0 -51.77 -38.72 56.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 109.638 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -69.89 -32.02 70.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 109.883 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.5 -45.06 95.16 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.48 85.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.879 -1.138 . . . . 0.0 108.751 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.829 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -77.55 -44.76 27.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -39.28 -38.78 0.55 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.3 m -81.46 -61.0 2.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.34 -13.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.63 -0.669 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 85' ' ' ALA . 13.1 m -119.27 -2.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 110.859 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -120.66 155.98 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.595 -1.316 . . . . 0.0 110.473 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.444 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 36.4 t0 -104.35 -31.58 9.47 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.433 ' H ' HG23 ' A' ' 90' ' ' ILE . 21.5 pttt -149.98 150.61 32.06 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 86' ' ' PHE . 6.0 tp -127.31 125.25 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.627 -1.295 . . . . 0.0 109.751 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.424 HG13 ' CD ' ' B' ' 54' ' ' GLN . 13.2 t -123.45 128.57 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.841 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.25 138.43 33.25 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.249 -1.532 . . . . 0.0 111.838 -178.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -122.25 123.96 42.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.637 . . . . 0.0 109.326 176.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -125.85 135.59 52.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.011 -1.056 . . . . 0.0 108.919 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -165.67 158.55 13.14 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 0.0 110.522 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.595 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 39.9 Cg_exo -58.78 114.84 2.17 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.298 1.999 . . . . 0.0 112.176 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 132.97 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.923 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -109.8 79.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -73.83 93.97 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.114 -0.991 . . . . 0.0 109.535 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.754 ' O ' ' C ' ' A' ' 104' ' ' LYS . 14.7 m -155.9 -16.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.201 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.754 ' C ' ' O ' ' A' ' 103' ' ' VAL . 31.5 mmtm -8.14 -105.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.71 -5.52 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 108.911 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 104' ' ' LYS . 45.1 t -59.71 140.56 56.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.6 p . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.19 178.12 18.44 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.433 -1.365 . . . . 0.0 109.697 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -111.76 126.69 55.33 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.276 -1.132 . . . . 0.0 107.993 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.3 ttpt -97.53 128.23 44.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.937 -1.102 . . . . 0.0 112.863 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.601 ' CE1' ' CE1' ' B' ' 70' ' ' TYR . 51.3 m-70 -121.29 119.02 31.01 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 5.9 tt -128.56 139.53 52.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.743 -1.223 . . . . 0.0 109.451 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.83 137.67 56.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.498 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.3 OUTLIER -124.77 133.86 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.623 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 1.5 m -141.5 162.04 21.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 117.745 -1.582 . . . . 0.0 113.039 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -127.57 152.66 47.35 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 12.6 p90 -109.88 151.73 26.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.798 -1.189 . . . . 0.0 111.562 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.14 3.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 48.4 tp10 -92.96 -55.04 3.5 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.7 t0 152.99 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.531 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 89.3 m -50.27 107.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.082 0.944 . . . . 0.0 112.868 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -71.51 83.23 0.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.575 HG23 ' N ' ' B' ' 21' ' ' ASP . 26.9 m -62.77 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.631 -0.668 . . . . 0.0 110.473 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.575 ' N ' HG23 ' B' ' 20' ' ' VAL . 90.0 m-20 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.456 -0.777 . . . . 0.0 110.576 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -65.5 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -70.96 -43.43 76.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.13 -40.02 67.01 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.98 -38.13 81.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -62.22 -51.59 55.61 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.544 ' O ' HD23 ' B' ' 27' ' ' LEU . 4.7 tt -45.04 -44.08 9.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.533 -0.981 . . . . 0.0 108.795 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -49.89 -34.94 21.78 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' B' ' 26' ' ' GLY . 14.3 m-20 -65.4 -44.31 87.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.664 HD11 ' CE1' ' B' ' 73' ' ' PHE . 1.4 mm? -48.37 -50.82 29.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 32' ' ' SER . 54.9 t -46.93 -35.47 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.915 . . . . 0.0 108.79 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 8.2 t -45.65 -50.48 13.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -69.28 -8.99 51.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 111.475 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 34' ' ' ILE . 21.9 mm -101.58 29.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.019 -1.675 . . . . 0.0 110.645 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -61.23 -19.27 61.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.571 ' O ' ' C ' ' B' ' 37' ' ' VAL . 16.8 p -69.59 -6.85 33.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.961 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.6 m 35.04 36.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.022 -1.049 . . . . 0.0 109.132 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.3 OUTLIER -118.09 41.68 2.86 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.445 ' OG ' HG23 ' B' ' 34' ' ' ILE . 60.3 p -174.2 177.99 2.17 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 97.7 m-85 -145.47 153.7 41.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.58 -1.325 . . . . 0.0 111.967 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' B' ' 40' ' ' PHE . 53.9 mp0 -156.92 125.11 5.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -134.2 176.18 8.83 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.648 ' H ' ' NZ ' ' A' ' 104' ' ' LYS . . . -133.74 158.74 23.42 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 118.703 -1.713 . . . . 0.0 110.782 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 77.3 mt-10 -148.98 140.83 23.66 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 32.2 p30 -120.71 145.39 47.53 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.66 128.69 13.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.404 -1.435 . . . . 0.0 109.834 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -161.91 51.36 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.622 . . . . 0.0 109.339 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -91.18 -98.83 0.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ARG . 90.4 m-70 -100.59 144.5 29.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.093 -1.004 . . . . 0.0 109.676 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' B' ' 53' ' ' ARG . 88.6 m-20 -49.92 -42.92 49.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 110.849 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.1 ttt -73.76 -32.46 63.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.029 -1.044 . . . . 0.0 110.756 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 95' ' ' LEU . 68.9 mt -88.82 -51.76 5.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.731 ' O ' ' N ' ' B' ' 55' ' ' GLY . 13.8 ptt180 -70.91 5.36 2.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.344 -0.848 . . . . 0.0 111.249 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.424 ' CD ' HG13 ' A' ' 94' ' ' VAL . 85.5 mm-40 46.19 3.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.855 -1.153 . . . . 0.0 110.244 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.32 -10.12 11.96 Favored Glycine 0 N--CA 1.499 2.882 0 O-C-N 121.437 -0.79 . . . . 0.0 112.812 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' B' ' 55' ' ' GLY . 21.4 m-85 -59.19 -141.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.284 -1.715 . . . . 0.0 109.946 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.706 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 80.6 p -152.76 -41.85 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.319 -0.863 . . . . 0.0 111.024 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.706 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 27.5 p-80 -174.45 157.7 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.854 -1.154 . . . . 0.0 110.167 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.53 ' HB2' HG13 ' B' ' 11' ' ' VAL . . . -143.72 170.9 14.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.489 -0.757 . . . . 0.0 109.219 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.01 131.67 37.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 21.1 t -101.61 102.23 12.91 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 125.31 51.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.931 . . . . 0.0 110.733 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.7 m -128.59 149.28 50.7 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.05 131.64 45.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 110.095 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 72.0 mm-40 -52.17 -32.82 37.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 32.9 m120 -155.5 160.51 40.62 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -57.76 -17.87 18.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 111.466 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -57.85 -40.11 79.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.885 -1.134 . . . . 0.0 110.551 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.93 -33.6 75.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.601 ' CE1' ' CE1' ' B' ' 8' ' ' HIS . 76.2 t80 -66.99 -44.55 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.661 -0.905 . . . . 0.0 110.473 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.67 -28.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.704 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.88 2.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.664 ' CE1' HD11 ' B' ' 30' ' ' LEU . 2.5 t80 -45.66 -34.08 3.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.148 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.1 OUTLIER -83.34 -24.99 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 0.0 110.304 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -67.41 -25.86 66.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 111.032 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -85.65 156.0 58.92 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.83 -1.169 . . . . 0.0 109.579 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.17 3.91 2.23 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 112.433 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.513 ' CD2' HD22 ' B' ' 30' ' ' LEU . 44.5 tp -77.98 -31.31 50.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.429 -0.794 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -77.41 -41.79 38.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.961 -1.087 . . . . 0.0 110.289 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.781 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.6 p -62.39 -58.24 8.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.054 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.781 ' H ' HG13 ' B' ' 80' ' ' VAL . 85.0 tt0 -51.71 -38.73 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 0.0 109.593 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -69.98 -31.96 69.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.838 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.4 t -60.35 -45.36 93.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.142 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.42 85.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.987 -1.071 . . . . 0.0 108.685 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.801 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -77.53 -44.79 27.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.698 ' CE1' HD13 ' B' ' 93' ' ' ILE . 0.0 OUTLIER -39.33 -38.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.593 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.3 m -81.41 -61.1 2.04 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.12 -13.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.079 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.801 HG22 ' O ' ' B' ' 85' ' ' ALA . 13.1 m -119.21 -2.77 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.237 -0.915 . . . . 0.0 110.875 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -120.7 156.05 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.701 -1.249 . . . . 0.0 110.465 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.455 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 35.9 t0 -104.47 -31.63 9.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.435 ' H ' HG23 ' B' ' 90' ' ' ILE . 21.6 pttt -150.04 150.37 31.65 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.698 HD13 ' CE1' ' B' ' 86' ' ' PHE . 6.0 tp -127.07 125.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.491 -1.381 . . . . 0.0 109.733 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.404 HG13 ' CD ' ' A' ' 54' ' ' GLN . 12.8 t -123.55 128.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.847 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.33 138.54 33.18 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.302 -1.499 . . . . 0.0 111.791 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.4 HD12 ' N ' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -122.25 123.83 42.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -125.77 135.67 52.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.064 -1.023 . . . . 0.0 108.87 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.591 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 0.5 OUTLIER -165.62 158.52 13.21 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.132 -0.98 . . . . 0.0 110.587 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 99' ' ' PRO . . . . . 0.591 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 41.1 Cg_exo -58.76 114.73 2.12 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.305 2.003 . . . . 0.0 112.265 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 133.04 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.004 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 78.87 1.16 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.502 -0.749 . . . . 0.0 109.58 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ALA . . . . . 0.471 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -73.58 94.08 2.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.12 -0.987 . . . . 0.0 109.657 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.784 ' O ' ' C ' ' B' ' 104' ' ' LYS . 14.6 m -156.0 -16.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.362 -0.836 . . . . 0.0 109.219 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.784 ' C ' ' O ' ' B' ' 103' ' ' VAL . 31.3 mmtm -8.28 -105.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.373 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.66 -5.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.935 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.557 ' H ' ' C ' ' B' ' 104' ' ' LYS . 44.4 t -59.53 140.61 56.12 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.291 -0.881 . . . . 0.0 109.419 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.538 ' O ' HG13 ' B' ' 107' ' ' VAL . 10.7 p . . . . . 0 C--N 1.302 -1.475 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.404 0.621 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 4' ' ' SER . 12.1 t -107.68 0.77 22.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.089 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.9 m -173.32 -107.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.8 -178.26 20.55 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.399 -1.382 . . . . 0.0 109.694 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -130.11 130.13 44.42 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 1.3 ttpm? -104.48 133.84 48.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.874 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -127.21 125.7 41.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.51 142.45 48.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.745 -1.222 . . . . 0.0 109.507 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 140.32 48.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.506 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.22 134.02 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.491 ' O ' HG22 ' A' ' 57' ' ' THR . 2.6 m -137.53 162.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 117.79 -1.564 . . . . 0.0 113.014 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 14' ' ' PHE . 20.7 tptp -132.21 152.8 51.14 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 18' ' ' THR . 36.3 p90 -111.65 149.44 31.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.886 -1.134 . . . . 0.0 111.597 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.45 -19.68 3.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.5 mt-10 -91.69 -56.5 3.08 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.9 t0 154.48 64.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 86.8 m -49.77 105.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.126 0.965 . . . . 0.0 112.794 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.898 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -68.65 83.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.405 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 21' ' ' ASP . 28.9 m -61.59 -42.96 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.52 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' N ' HG23 ' A' ' 20' ' ' VAL . 29.0 p-10 -65.97 -43.27 88.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 0.0 110.571 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 97.4 mt-10 -70.7 -34.12 71.61 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 89' ' ' VAL . 1.8 mm -67.32 -44.61 87.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' VAL . 15.7 tp -52.88 -38.0 61.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.08 75.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -60.63 -54.23 38.81 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.4 tt -45.83 -43.91 13.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.497 -1.002 . . . . 0.0 108.838 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' B' ' 106' ' ' SER . 71.8 mm-40 -50.86 -33.33 23.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.0 m-20 -66.54 -44.39 82.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.1 mm? -49.3 -48.28 46.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 32' ' ' SER . 94.6 t -46.97 -31.91 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.908 . . . . 0.0 108.844 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 73.7 p -45.59 -49.25 14.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 70.6 mm-40 -72.79 -12.15 60.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 111.457 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 34' ' ' ILE . 21.1 mm -96.69 24.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.043 -1.661 . . . . 0.0 110.589 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.06 -12.43 4.81 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.2 p -74.86 -1.28 21.6 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.995 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.576 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.1 m 34.61 33.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 32.1 mtmt -119.55 42.36 2.9 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 58.4 m -171.88 174.54 4.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -146.71 157.4 43.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.639 -1.288 . . . . 0.0 111.957 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.479 ' OE1' HD21 ' A' ' 27' ' ' LEU . 72.5 mt-10 -155.27 121.5 5.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.362 0.601 . . . . 0.0 110.231 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -123.95 170.2 10.85 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.97 160.0 23.72 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.72 -1.705 . . . . 0.0 110.852 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 24.1 mt-10 -150.5 145.21 25.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.251 -1.147 . . . . 0.0 109.394 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 22.5 t70 -126.53 148.03 49.77 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.877 ' HZ2' ' C ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -145.37 122.99 11.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.417 -1.427 . . . . 0.0 109.799 -178.13 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 48' ' ' SER . 95.4 mt-10 -133.93 3.4 3.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 47' ' ' GLU . 99.2 p -56.99 -140.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.953 . . . . 0.0 110.17 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.786 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 57.4 t-80 -74.62 160.15 31.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.691 ' N ' HH21 ' A' ' 53' ' ' ARG . 77.9 m-20 -61.2 -44.23 97.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 tpt -67.76 -33.43 74.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.013 -1.054 . . . . 0.0 110.746 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' B' ' 95' ' ' LEU . 38.0 mt -89.23 -54.43 4.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.702 -1.249 . . . . 0.0 109.323 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.786 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.3 ptp180 -64.41 2.97 0.52 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.0 111.195 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.515 HE21 ' HB ' ' B' ' 94' ' ' VAL . 2.5 mm-40 57.19 -12.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.75 -1.219 . . . . 0.0 110.14 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.739 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 85.24 -21.81 11.69 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.408 -0.808 . . . . 0.0 112.847 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.877 ' C ' ' HZ2' ' A' ' 46' ' ' LYS . 3.7 m-85 -57.79 -129.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.267 -1.725 . . . . 0.0 109.988 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.8 t -162.2 -33.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.629 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 15.0 t60 -172.05 154.49 3.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.104 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.629 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.9 168.01 20.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.414 -0.804 . . . . 0.0 109.251 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 96.8 m-85 -134.74 130.98 37.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.475 -0.766 . . . . 0.0 109.067 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.6 99.24 8.84 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.0 mtm -100.07 124.8 45.86 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.149 -0.97 . . . . 0.0 110.851 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.46 142.94 50.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' GLU . 94.2 m-85 -122.01 126.8 49.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.736 -1.228 . . . . 0.0 110.092 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 64' ' ' PHE . 33.6 tt0 -46.93 -30.7 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -165.81 170.59 13.74 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -57.79 -22.35 46.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 111.46 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -56.24 -40.22 73.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.822 -1.174 . . . . 0.0 110.673 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.09 62.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.645 ' O ' HG22 ' A' ' 74' ' ' THR . 71.7 t80 -63.13 -44.59 95.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.984 . . . . 0.0 110.467 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.75 -28.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.388 -1.445 . . . . 0.0 108.692 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -60.99 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -56.74 -42.57 79.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 111.09 -177.279 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 70' ' ' TYR . 10.0 t -75.95 -33.19 59.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.787 -1.195 . . . . 0.0 110.31 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 63.5 m -63.39 -32.76 74.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.996 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.522 ' CE1' ' OE1' ' A' ' 33' ' ' GLN . 54.5 m80 -72.03 151.91 92.76 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.861 -1.15 . . . . 0.0 109.604 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.14 4.1 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.669 2.246 . . . . 0.0 112.42 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.482 ' CD2' HD22 ' A' ' 30' ' ' LEU . 28.5 tp -76.57 -28.62 56.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.384 -0.822 . . . . 0.0 111.267 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.518 ' CD2' ' OG ' ' A' ' 83' ' ' SER . 11.2 t-160 -81.59 -41.82 20.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.987 -1.07 . . . . 0.0 110.245 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.775 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.5 p -63.12 -58.9 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 110.023 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.775 ' H ' HG13 ' A' ' 80' ' ' VAL . 48.3 tp10 -58.46 -39.61 80.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.197 -0.94 . . . . 0.0 109.627 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 85.6 t80 -69.69 -43.49 72.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.518 ' OG ' ' CD2' ' A' ' 79' ' ' HIS . 49.8 m -59.24 -36.63 75.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.113 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.22 60.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.972 -1.08 . . . . 0.0 108.666 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.9 -41.59 74.49 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.492 ' C ' ' O ' ' A' ' 85' ' ' ALA . 11.9 t80 -43.06 -30.82 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.3 m -83.21 -60.98 1.97 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.41 -24.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.682 -0.636 . . . . 0.0 110.049 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' THR . 9.0 m -105.32 11.92 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.213 -0.93 . . . . 0.0 110.834 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 47.1 mt -124.68 158.77 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.278 . . . . 0.0 110.474 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.508 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 57.5 t0 -100.05 -34.32 10.12 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 90' ' ' ILE . 38.4 pttt -149.08 147.62 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.88 131.4 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.619 -1.301 . . . . 0.0 109.744 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.513 ' HB ' HE21 ' B' ' 54' ' ' GLN . 2.3 m -137.0 139.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -139.44 135.18 33.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.245 -1.534 . . . . 0.0 111.739 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.898 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -117.99 123.87 46.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.382 178.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 65.7 t0 -125.47 131.15 52.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.041 -1.037 . . . . 0.0 108.939 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' B' ' 45' ' ' ASP . 44.8 t80 -160.93 138.72 7.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.036 -1.04 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.82 120.33 2.8 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.34 2.026 . . . . 0.0 112.205 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.82 144.04 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.06 125.77 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 109.609 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.06 73.55 9.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.539 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 103' ' ' VAL . 18.1 m -150.25 98.06 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.162 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 106' ' ' SER . 41.4 mmtm -134.27 -112.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.57 -12.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 108.868 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 104' ' ' LYS . 30.1 t -53.58 139.75 30.75 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.269 -0.895 . . . . 0.0 109.404 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.301 -1.511 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.83 -178.81 20.51 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.632 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.62 130.2 45.33 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.302 -1.117 . . . . 0.0 108.011 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 1.2 ttpm? -104.47 134.04 48.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.337 1.065 . . . . 0.0 112.841 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -127.41 125.63 40.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 tt -133.43 142.59 48.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 109.375 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.87 140.31 49.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.574 -0.704 . . . . 0.0 109.493 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.408 ' O ' HG22 ' B' ' 94' ' ' VAL . 0.1 OUTLIER -121.13 134.14 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.489 ' O ' HG22 ' B' ' 57' ' ' THR . 2.6 m -137.5 162.8 32.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 117.758 -1.577 . . . . 0.0 113.016 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.503 ' HD2' ' H ' ' B' ' 14' ' ' PHE . 20.6 tptp -132.17 152.96 51.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.515 ' HB2' ' H ' ' B' ' 18' ' ' THR . 36.4 p90 -111.76 149.51 31.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.78 -1.2 . . . . 0.0 111.598 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.65 -19.44 3.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.4 mt-10 -92.14 -56.17 3.16 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 8.7 t0 154.25 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.515 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 87.1 m -49.67 105.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.148 0.975 . . . . 0.0 112.876 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.887 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -68.76 83.59 0.3 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.591 HG23 ' N ' ' B' ' 21' ' ' ASP . 29.6 m -61.84 -42.89 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 110.513 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.591 ' N ' HG23 ' B' ' 20' ' ' VAL . 30.4 p-10 -65.95 -43.2 88.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.547 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 97.2 mt-10 -70.7 -34.17 71.66 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.46 HD11 HG21 ' B' ' 89' ' ' VAL . 1.8 mm -67.29 -44.51 87.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' B' ' 20' ' ' VAL . 15.7 tp -52.87 -37.94 60.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.05 75.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -60.71 -54.13 39.54 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.559 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.4 tt -45.92 -43.63 14.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 108.828 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 106' ' ' SER . 71.6 mm-40 -51.35 -33.2 28.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 26' ' ' GLY . 11.5 m-20 -66.34 -44.75 82.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.1 mm? -48.9 -48.4 42.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 94.4 t -46.9 -32.09 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 108.815 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 69.6 p -45.57 -49.37 14.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.518 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 71.1 mm-40 -72.49 -12.07 60.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 111.527 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 34' ' ' ILE . 21.2 mm -96.97 24.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.017 -1.677 . . . . 0.0 110.568 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.35 -12.02 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.575 ' O ' ' N ' ' B' ' 38' ' ' LYS . 52.6 p -75.29 -1.11 22.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.96 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 34.63 33.57 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.998 -1.064 . . . . 0.0 109.135 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' B' ' 36' ' ' THR . 32.1 mtmt -119.6 42.53 2.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 58.5 m -172.03 174.58 4.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -146.78 157.46 43.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.497 -1.377 . . . . 0.0 111.934 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.472 ' OE1' HD21 ' B' ' 27' ' ' LEU . 72.5 mt-10 -155.24 121.51 5.23 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.428 0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -123.86 170.27 10.74 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.18 159.67 23.65 Favored Glycine 0 N--CA 1.499 2.836 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.847 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 24.2 mt-10 -150.3 145.0 25.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.181 -1.188 . . . . 0.0 109.387 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 22.3 t70 -126.38 147.9 49.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.857 ' HZ2' ' C ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -145.17 123.12 12.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 0.0 109.858 -178.211 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.4 mt-10 -134.08 3.9 3.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.694 -0.629 . . . . 0.0 109.367 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.536 ' O ' ' O ' ' B' ' 47' ' ' GLU . 95.1 p -57.21 -140.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.179 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.762 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 57.3 t-80 -74.54 160.18 31.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 109.742 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.701 ' N ' HH21 ' B' ' 53' ' ' ARG . 77.7 m-20 -61.2 -44.2 97.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.0 110.837 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.7 tpt -67.81 -33.28 74.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.005 . . . . 0.0 110.726 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 95' ' ' LEU . 38.9 mt -89.32 -54.46 4.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.715 -1.24 . . . . 0.0 109.307 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.762 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.4 ptp180 -64.37 2.89 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 111.231 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.513 HE21 ' HB ' ' A' ' 94' ' ' VAL . 2.5 mm-40 57.33 -12.38 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.811 -1.18 . . . . 0.0 110.282 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.738 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 85.61 -22.04 12.3 Favored Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.43 -0.794 . . . . 0.0 112.789 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.857 ' C ' ' HZ2' ' B' ' 46' ' ' LYS . 3.6 m-85 -57.82 -129.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.327 -1.69 . . . . 0.0 109.973 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.489 HG22 ' O ' ' B' ' 12' ' ' VAL . 2.6 t -162.37 -33.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 110.985 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.617 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 15.2 t60 -171.93 154.61 3.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.832 -1.168 . . . . 0.0 110.162 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.617 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.95 167.99 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.439 -0.788 . . . . 0.0 109.341 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 96.7 m-85 -134.61 131.04 37.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 109.137 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.55 99.1 8.72 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -99.9 124.77 45.58 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.204 -0.935 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 88.4 m -123.58 143.06 50.45 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' B' ' 65' ' ' GLU . 94.3 m-85 -122.22 126.65 48.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.751 -1.218 . . . . 0.0 110.081 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' B' ' 64' ' ' PHE . 32.8 tt0 -46.62 -30.79 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -166.01 170.6 13.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.85 -22.4 47.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.886 . . . . 0.0 111.402 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -56.18 -40.26 73.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.81 -1.181 . . . . 0.0 110.653 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.57 -36.08 62.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.63 ' O ' HG22 ' B' ' 74' ' ' THR . 72.5 t80 -63.07 -44.78 94.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.532 -0.981 . . . . 0.0 110.49 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.75 -28.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.351 -1.468 . . . . 0.0 108.684 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -60.83 2.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.344 -0.847 . . . . 0.0 109.292 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.69 -42.46 79.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 111.124 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.63 HG22 ' O ' ' B' ' 70' ' ' TYR . 10.0 t -76.09 -33.14 59.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.779 -1.2 . . . . 0.0 110.381 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 65.4 m -63.47 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.062 -1.024 . . . . 0.0 110.912 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.518 ' CE1' ' OE1' ' B' ' 33' ' ' GLN . 54.1 m80 -72.34 151.63 92.06 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.82 -1.175 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.79 3.91 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.701 2.267 . . . . 0.0 112.425 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.473 ' CD2' HD22 ' B' ' 30' ' ' LEU . 28.5 tp -76.48 -28.93 56.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.373 -0.83 . . . . 0.0 111.233 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.506 ' CD2' ' OG ' ' B' ' 83' ' ' SER . 11.2 t-160 -81.37 -41.6 21.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.041 -1.037 . . . . 0.0 110.266 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.796 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.7 p -63.35 -59.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.998 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.796 ' H ' HG13 ' B' ' 80' ' ' VAL . 49.1 tp10 -58.23 -39.65 79.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.862 . . . . 0.0 109.625 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 85.5 t80 -69.43 -43.66 72.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' SER . . . . . 0.506 ' OG ' ' CD2' ' B' ' 79' ' ' HIS . 50.9 m -59.14 -36.54 75.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.027 -1.046 . . . . 0.0 110.147 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.21 -52.98 63.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.65 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -69.99 -41.93 73.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' B' ' 85' ' ' ALA . 11.8 t80 -42.89 -30.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.545 ' O ' ' N ' ' B' ' 89' ' ' VAL . 9.4 m -83.3 -60.79 2.03 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.65 -24.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.702 -0.624 . . . . 0.0 110.06 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.0 m -105.8 12.04 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.78 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 48.0 mt -124.63 158.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.711 -1.243 . . . . 0.0 110.423 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.509 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 57.1 t0 -100.06 -34.53 10.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.445 ' N ' HG22 ' B' ' 90' ' ' ILE . 38.5 pttt -148.76 147.67 29.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.81 131.48 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.583 -1.323 . . . . 0.0 109.764 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.515 ' HB ' HE21 ' A' ' 54' ' ' GLN . 2.3 m -136.93 139.51 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -139.68 135.05 32.82 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.276 -1.515 . . . . 0.0 111.773 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.885 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -117.8 124.05 47.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.7 t0 -125.64 131.56 52.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.037 -1.04 . . . . 0.0 108.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 45' ' ' ASP . 44.7 t80 -161.41 138.68 6.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.025 -1.047 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -44.69 120.35 2.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.299 2.0 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.86 143.92 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.05 125.78 25.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 109.6 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.03 73.37 9.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.039 -1.038 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.8 HG23 ' O ' ' B' ' 103' ' ' VAL . 18.2 m -149.95 98.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.219 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.635 ' C ' ' H ' ' B' ' 106' ' ' SER . 41.1 mmtm -134.52 -113.3 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.272 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.97 -13.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 108.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.635 ' H ' ' C ' ' B' ' 104' ' ' LYS . 31.1 t -53.03 139.75 27.17 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.219 -0.925 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -116.06 1.11 13.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.141 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 m -175.34 -126.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.24 173.14 31.2 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.709 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -135.78 136.36 40.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.289 -1.124 . . . . 0.0 108.005 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' B' ' 44' ' ' GLU . 20.7 ttpt -114.61 142.63 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.0 112.844 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -130.59 129.21 42.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -137.24 145.98 44.25 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.71 -1.244 . . . . 0.0 109.442 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.1 p -131.18 136.58 57.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.64 -0.663 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.53 131.14 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.46 ' CG1' HD12 ' A' ' 93' ' ' ILE . 2.1 m -142.57 162.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 117.808 -1.557 . . . . 0.0 113.043 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 91' ' ' ASP . 13.9 tptp -127.55 155.32 43.99 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.527 ' HB2' ' H ' ' A' ' 18' ' ' THR . 11.5 p90 -108.18 149.54 28.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.842 -1.162 . . . . 0.0 111.638 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -127.02 -19.28 4.43 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -90.68 -56.76 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 10.1 t0 153.51 58.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.527 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 71.9 m -46.53 106.92 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.173 0.987 . . . . 0.0 112.795 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.567 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.39 89.13 1.6 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.8 m -61.2 -39.19 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.752 . . . . 0.0 110.467 -176.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 20' ' ' VAL . 89.3 m-20 -61.58 -45.4 94.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.554 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 21.8 mp0 -73.97 -37.82 64.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.528 HD11 HG21 ' A' ' 89' ' ' VAL . 1.9 mm -66.79 -48.88 78.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.1 tm? -58.22 -41.34 83.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.61 -25.71 68.35 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.697 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -65.37 -55.48 20.73 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 27' ' ' LEU . 7.0 tt -47.5 -35.75 9.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.514 -0.992 . . . . 0.0 108.826 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -53.52 -42.94 67.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -59.97 -42.32 93.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -52.7 -46.29 67.25 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 32' ' ' SER . 38.7 t -51.97 -23.95 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.248 -0.908 . . . . 0.0 108.843 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 44.3 t -44.34 -37.26 3.21 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.552 HE21 ' CG ' ' A' ' 76' ' ' HIS . 8.6 mm100 -79.87 -4.02 50.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.792 . . . . 0.0 111.457 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 34' ' ' ILE . 6.5 mm -88.42 23.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.107 -1.62 . . . . 0.0 110.652 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.38 -16.8 16.18 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.598 ' O ' ' C ' ' A' ' 37' ' ' VAL . 43.7 p -68.27 -2.65 8.68 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.937 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 36' ' ' THR . 31.2 m 30.32 41.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.049 -1.032 . . . . 0.0 109.185 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' THR . 4.2 mtmm -122.46 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 40' ' ' PHE . 28.8 t -72.74 -176.07 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' LYS . 82.3 m-85 -153.0 167.51 28.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.629 -1.294 . . . . 0.0 111.925 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.482 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 80.6 mt-10 -159.42 127.61 5.0 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.398 0.618 . . . . 0.0 110.193 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -129.54 171.36 12.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.15 24.46 Favored Glycine 0 N--CA 1.499 2.874 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.845 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.539 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 63.9 mt-10 -151.24 147.02 26.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -1.096 . . . . 0.0 109.391 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.6 t0 -130.85 157.58 42.49 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -61.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.405 -1.434 . . . . 0.0 109.813 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.8 mt-10 -126.69 40.62 3.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.683 -0.636 . . . . 0.0 109.333 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 49' ' ' HIS . 5.3 t -147.99 76.05 1.36 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.978 . . . . 0.0 110.219 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 48' ' ' SER . 1.4 t-80 56.83 114.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.767 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 57.2 t0 -45.13 -34.87 2.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.0 110.783 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.0 mmm -75.74 -34.04 60.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' B' ' 95' ' ' LEU . 63.3 mt -89.7 -18.5 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.706 -1.246 . . . . 0.0 109.291 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' GLY . 18.0 ptt180 -101.8 7.94 41.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.244 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 53' ' ' ARG . 68.3 mm-40 38.68 27.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.789 -1.195 . . . . 0.0 110.138 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 53.37 2.71 0.12 Allowed Glycine 0 N--CA 1.499 2.836 0 O-C-N 121.416 -0.803 . . . . 0.0 112.85 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 20.4 p90 -47.82 132.07 14.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.206 -1.761 . . . . 0.0 109.936 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 98.6 m -58.18 -55.05 40.02 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.928 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.637 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 17.0 t60 -167.85 153.89 7.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.926 -1.109 . . . . 0.0 110.188 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.559 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.62 162.15 35.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.206 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 57.8 m-85 -129.2 126.17 38.58 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.493 -0.755 . . . . 0.0 109.062 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -104.57 102.91 12.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.5 mtt -102.42 120.73 41.0 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.177 -0.952 . . . . 0.0 110.816 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 m -112.02 133.66 54.05 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -119.46 121.04 38.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.689 -1.257 . . . . 0.0 110.084 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 66' ' ' ASN . 0.6 OUTLIER -47.88 -31.55 5.22 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.587 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 18.2 t-20 -157.34 162.4 39.1 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.9 -24.26 64.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 111.465 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.24 -38.39 68.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 0.0 110.573 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.525 ' O ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.63 -33.59 84.93 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.881 ' O ' HG23 ' A' ' 74' ' ' THR . 77.7 t80 -66.56 -46.98 74.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.548 -0.972 . . . . 0.0 110.489 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.93 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.427 -1.421 . . . . 0.0 108.651 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -60.64 -34.85 74.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 111.147 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 70' ' ' TYR . 41.8 p -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.712 -1.243 . . . . 0.0 110.295 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -65.38 -24.15 67.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.18 -0.95 . . . . 0.0 110.986 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.636 ' C ' ' H ' ' A' ' 78' ' ' LEU . 57.5 m80 -79.86 124.58 83.21 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.81 -1.181 . . . . 0.0 109.603 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.59 2.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.636 ' H ' ' C ' ' A' ' 76' ' ' HIS . 6.7 tp -76.37 -34.41 58.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.307 -0.871 . . . . 0.0 111.24 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 58.0 t-80 -82.66 -33.44 27.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 0.0 110.327 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.93 -60.25 2.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.79 -42.97 65.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 17.6 m-85 -72.17 -34.14 68.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.754 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 67.0 m -60.87 -43.04 98.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 110.13 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -41.96 97.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.978 -1.076 . . . . 0.0 108.673 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.666 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -68.4 -43.08 78.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.933 ' O ' HD13 ' A' ' 90' ' ' ILE . 2.7 m-85 -44.8 -30.25 0.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.1 p -82.26 -62.2 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.578 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -38.64 -28.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.654 -0.654 . . . . 0.0 110.052 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 85' ' ' ALA . 23.3 m -106.35 14.58 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 110.767 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.933 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -124.81 160.2 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.672 -1.268 . . . . 0.0 110.467 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.551 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 58.7 t0 -105.53 -35.95 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -145.95 145.29 30.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' A' ' 12' ' ' VAL . 3.0 tp -126.11 124.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.672 -1.267 . . . . 0.0 109.744 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t -127.24 130.07 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -130.98 127.22 37.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.325 -1.485 . . . . 0.0 111.759 -178.183 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -118.8 122.46 42.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.653 -0.654 . . . . 0.0 109.358 177.043 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASP . 23.1 p-10 -130.2 138.94 50.84 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.11 -0.994 . . . . 0.0 108.864 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 32.3 t80 -159.43 134.71 5.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.075 -1.015 . . . . 0.0 110.52 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 94.9 Cg_exo -42.46 125.57 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.318 2.012 . . . . 0.0 112.19 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.6 t -89.99 116.05 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.29 82.81 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.368 -0.832 . . . . 0.0 109.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -74.37 72.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 102' ' ' ALA . 5.3 m -161.91 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 25.9 mmtp -92.98 141.57 28.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.1 p -67.65 -25.3 65.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 108.958 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 106' ' ' SER . 5.9 p 61.85 50.88 4.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 100' ' ' VAL . . . -95.39 172.96 30.83 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.368 -1.396 . . . . 0.0 109.703 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -135.52 136.43 41.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.283 -1.128 . . . . 0.0 108.07 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 44' ' ' GLU . 20.7 ttpt -114.72 142.61 46.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.075 . . . . 0.0 112.809 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -130.5 129.29 42.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.1 tt -137.29 145.94 44.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.821 -1.175 . . . . 0.0 109.439 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.409 HG13 ' O ' ' B' ' 10' ' ' VAL . 11.0 p -131.2 136.66 57.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.467 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.64 131.16 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.46 ' CG1' HD12 ' B' ' 93' ' ' ILE . 2.1 m -142.68 162.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.08 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -127.6 155.27 44.11 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.545 ' HB2' ' H ' ' B' ' 18' ' ' THR . 11.5 p90 -108.2 149.48 28.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.827 -1.17 . . . . 0.0 111.59 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -127.03 -19.41 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.2 mt-10 -90.64 -56.65 3.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 9.7 t0 153.29 58.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.545 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 68.2 m -46.59 106.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.03 0.919 . . . . 0.0 112.89 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -73.42 89.35 1.63 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.8 m -61.56 -38.91 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 110.465 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.512 ' N ' HG23 ' B' ' 20' ' ' VAL . 90.6 m-20 -61.66 -45.4 94.2 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 110.512 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 21.6 mp0 -74.15 -37.59 63.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.536 HD11 HG21 ' B' ' 89' ' ' VAL . 1.9 mm -67.07 -48.94 77.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.858 ' C ' HD13 ' B' ' 24' ' ' LEU . 2.1 tm? -58.0 -41.65 83.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.4 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.703 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -65.34 -55.54 20.46 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.655 HD23 ' O ' ' B' ' 27' ' ' LEU . 7.0 tt -47.42 -35.73 8.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.541 -0.976 . . . . 0.0 108.811 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -53.49 -43.22 68.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.8 p30 -59.83 -42.23 93.06 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.61 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -52.84 -46.15 67.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' B' ' 32' ' ' SER . 38.7 t -52.0 -23.93 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.292 -0.88 . . . . 0.0 108.859 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 43.5 t -44.33 -37.39 3.28 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.558 HE21 ' CG ' ' B' ' 76' ' ' HIS . 8.6 mm100 -79.71 -4.29 51.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 111.466 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.716 HG22 ' O ' ' B' ' 34' ' ' ILE . 6.3 mm -88.24 23.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 119.947 -1.721 . . . . 0.0 110.61 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.44 -16.65 15.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' B' ' 37' ' ' VAL . 44.1 p -68.28 -2.82 9.04 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.932 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' B' ' 36' ' ' THR . 31.3 m 30.55 41.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' B' ' 40' ' ' PHE . 4.1 mtmm -122.4 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' B' ' 40' ' ' PHE . 28.9 t -72.62 -176.16 1.87 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' B' ' 38' ' ' LYS . 82.4 m-85 -152.99 167.47 29.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.542 -1.349 . . . . 0.0 111.991 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 81.0 mt-10 -159.36 127.44 4.98 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.298 0.57 . . . . 0.0 110.227 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.404 ' HE1' ' HA ' ' A' ' 102' ' ' ALA . 16.7 m-90 -129.46 171.49 12.5 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.2 162.13 24.49 Favored Glycine 0 N--CA 1.5 2.961 0 C-N-CA 118.689 -1.72 . . . . 0.0 110.768 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.544 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 63.1 mt-10 -151.3 146.84 26.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.294 -1.121 . . . . 0.0 109.392 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' B' ' 47' ' ' GLU . 63.3 t0 -130.71 157.47 42.71 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.529 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.07 80.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.378 -1.451 . . . . 0.0 109.825 -177.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -126.68 40.51 3.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.503 ' O ' ' O ' ' B' ' 49' ' ' HIS . 5.4 t -147.85 76.45 1.39 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.169 -0.957 . . . . 0.0 110.173 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.503 ' O ' ' O ' ' B' ' 48' ' ' SER . 1.4 t-80 56.59 114.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.195 -0.941 . . . . 0.0 109.676 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' NE ' ' B' ' 53' ' ' ARG . 57.9 t0 -45.14 -34.88 2.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 93.0 mmm -75.65 -33.9 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.7 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 95' ' ' LEU . 62.6 mt -89.69 -18.7 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.776 -1.202 . . . . 0.0 109.253 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' B' ' 55' ' ' GLY . 18.0 ptt180 -101.78 7.91 41.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.847 . . . . 0.0 111.26 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' B' ' 53' ' ' ARG . 68.8 mm-40 38.68 27.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.803 -1.186 . . . . 0.0 110.214 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 53.31 2.79 0.11 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.37 -0.831 . . . . 0.0 112.791 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 20.1 p90 -47.96 132.08 15.28 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.193 -1.769 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 99.7 m -57.98 -55.27 37.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.325 -0.859 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 17.3 t60 -167.77 153.9 7.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.887 -1.133 . . . . 0.0 110.193 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.543 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.62 162.07 35.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.477 -0.764 . . . . 0.0 109.287 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 57.8 m-85 -129.05 126.05 38.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.11 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -104.48 102.68 12.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 39.7 mtt -102.36 120.9 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 110.673 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 37.9 m -112.02 134.13 53.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' B' ' 64' ' ' PHE . 2.2 m-85 -119.81 121.37 38.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.741 -1.224 . . . . 0.0 109.999 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' B' ' 66' ' ' ASN . 0.6 OUTLIER -48.26 -31.47 5.96 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ASN . . . . . 0.581 ' H ' ' CD ' ' B' ' 65' ' ' GLU . 18.0 t-20 -157.32 162.25 39.13 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.7 -24.43 63.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.512 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -55.04 -38.67 68.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.597 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' B' ' 73' ' ' PHE . . . -66.22 -33.7 85.94 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.882 ' O ' HG23 ' B' ' 74' ' ' THR . 77.8 t80 -66.61 -47.04 73.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.566 -0.961 . . . . 0.0 110.495 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.73 -28.99 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.356 -1.465 . . . . 0.0 108.67 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.0 -60.86 2.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.338 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -60.57 -34.92 74.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.245 -0.909 . . . . 0.0 111.088 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.882 HG23 ' O ' ' B' ' 70' ' ' TYR . 42.0 p -73.86 -33.32 64.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.776 -1.203 . . . . 0.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -65.56 -24.31 67.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.0 111.053 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.635 ' C ' ' H ' ' B' ' 78' ' ' LEU . 57.6 m80 -79.58 124.62 83.68 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.829 -1.169 . . . . 0.0 109.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -46.77 2.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.609 2.206 . . . . 0.0 112.446 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.635 ' H ' ' C ' ' B' ' 76' ' ' HIS . 6.7 tp -76.42 -34.51 58.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.348 -0.845 . . . . 0.0 111.238 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.512 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 57.9 t-80 -82.47 -33.47 28.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.037 -1.039 . . . . 0.0 110.324 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.04 -60.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.92 -42.7 65.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.64 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 17.6 m-85 -72.29 -34.23 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' SER . . . . . 0.512 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 65.3 m -60.86 -42.99 98.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.048 . . . . 0.0 110.098 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.08 97.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 108.661 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.681 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -68.39 -42.93 78.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.939 ' O ' HD13 ' B' ' 90' ' ' ILE . 2.7 m-85 -44.9 -30.22 0.96 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.1 p -82.26 -62.21 1.69 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.577 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -38.66 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.691 -0.63 . . . . 0.0 110.099 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.681 HG22 ' O ' ' B' ' 85' ' ' ALA . 23.1 m -106.22 14.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.207 -0.933 . . . . 0.0 110.829 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.939 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -124.63 160.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.7 -1.25 . . . . 0.0 110.467 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 58.3 t0 -105.46 -36.02 7.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -145.93 145.24 30.6 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' B' ' 12' ' ' VAL . 3.0 tp -126.15 124.1 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.571 -1.331 . . . . 0.0 109.798 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 14.4 t -127.29 130.2 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -131.06 126.9 37.08 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.244 -1.535 . . . . 0.0 111.809 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.554 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -118.55 122.72 43.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.083 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.443 ' OD2' ' OG ' ' A' ' 48' ' ' SER . 23.0 p-10 -130.43 138.85 50.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.175 -0.953 . . . . 0.0 108.853 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 32.2 t80 -159.42 134.6 5.75 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.048 -1.032 . . . . 0.0 110.541 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 96.5 Cg_exo -42.36 125.67 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.29 1.993 . . . . 0.0 112.244 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 5' ' ' GLY . 27.4 t -89.96 116.11 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.44 82.85 2.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ALA . . . . . 0.675 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -74.27 71.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.602 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.675 HG13 ' O ' ' B' ' 102' ' ' ALA . 5.5 m -161.58 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.33 -0.856 . . . . 0.0 109.263 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -92.88 141.6 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 85.9 p -67.44 -25.58 65.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 108.944 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' B' ' 106' ' ' SER . 6.1 p 62.06 50.73 3.91 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.32 -0.863 . . . . 0.0 109.355 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.402 0.62 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 t -98.32 -12.24 21.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.141 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.7 m -127.79 -81.94 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.08 -168.91 16.91 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.664 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -114.43 130.76 56.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.241 -1.152 . . . . 0.0 108.09 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HZ3' ' HB3' ' B' ' 44' ' ' GLU . 21.9 ttpt -101.09 129.66 47.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.908 -1.12 . . . . 0.0 112.824 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.725 ' CE1' ' OD2' ' A' ' 97' ' ' ASP . 0.3 OUTLIER -121.59 119.86 33.13 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 173.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 96' ' ' LEU . 6.6 tt -132.51 141.57 48.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.679 -1.263 . . . . 0.0 109.48 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 10' ' ' VAL . 9.5 p -129.35 136.11 60.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.614 -0.679 . . . . 0.0 109.523 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.27 131.0 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.843 HG12 HD12 ' A' ' 93' ' ' ILE . 35.8 m -139.32 150.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.816 -1.554 . . . . 0.0 113.095 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -127.83 154.74 45.1 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CD2' HG21 ' A' ' 57' ' ' THR . 16.2 p90 -113.04 156.8 22.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.814 -1.178 . . . . 0.0 111.615 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.36 -18.62 3.58 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.8 mt-10 -91.81 -53.49 4.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.1 t0 149.12 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -53.98 111.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.059 0.933 . . . . 0.0 112.814 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.587 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -74.07 86.36 1.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.043 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 21' ' ' ASP . 33.2 m -61.55 -42.59 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.553 -0.717 . . . . 0.0 110.547 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' N ' HG23 ' A' ' 20' ' ' VAL . 87.3 m-20 -63.45 -45.16 92.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.539 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -68.79 -34.01 74.82 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -67.94 -42.02 85.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.5 tp -58.95 -39.36 81.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -61.15 -35.48 77.21 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.656 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.44 -53.23 40.54 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -44.09 -41.44 5.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.517 -0.99 . . . . 0.0 108.821 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -51.98 -39.12 58.87 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -63.59 -44.49 93.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.554 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.649 HD22 ' CD2' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -47.15 -48.42 23.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.466 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 32' ' ' SER . 86.3 t -55.47 -24.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 0.0 108.873 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 32.2 t -43.44 -43.4 5.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.05 -10.06 48.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 111.433 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.726 HG22 ' O ' ' A' ' 34' ' ' ILE . 64.5 mt -92.5 29.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.024 -1.672 . . . . 0.0 110.626 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.91 -8.08 2.04 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.579 ' H ' ' C ' ' A' ' 34' ' ' ILE . 68.2 p -67.5 -10.24 49.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.939 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.55 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 35.3 34.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 109.219 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.3 mttt -118.17 43.94 2.33 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 63' ' ' THR . 14.2 t -176.22 177.59 1.52 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 0.0 111.914 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 64.2 mt-10 -154.33 124.07 6.66 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.366 0.603 . . . . 0.0 110.207 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.532 ' CE2' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -127.39 169.17 13.89 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.001 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.45 138.44 6.42 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.794 -1.67 . . . . 0.0 110.838 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.532 ' OE2' ' CE2' ' A' ' 42' ' ' TRP . 4.4 mp0 -124.92 172.63 9.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.209 -1.171 . . . . 0.0 109.323 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 57' ' ' THR . 57.0 t0 -167.58 94.61 0.43 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HZ1' ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.15 170.89 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.471 -1.393 . . . . 0.0 109.78 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 48' ' ' SER . 2.4 mt-10 -172.77 90.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER 163.14 147.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 0.0 110.138 -179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 48' ' ' SER . 57.5 m170 57.95 113.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.204 -0.935 . . . . 0.0 109.7 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 51' ' ' MET . 29.0 p-10 -52.53 -43.41 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.313 -0.867 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 23.2 ttt -62.56 -35.03 78.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 17.2 mt -89.08 -20.03 24.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.763 -1.211 . . . . 0.0 109.305 177.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.97 ' O ' ' N ' ' A' ' 55' ' ' GLY . 34.0 ttt-85 -83.83 42.54 0.86 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.384 -0.823 . . . . 0.0 111.217 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.559 ' C ' ' O ' ' A' ' 53' ' ' ARG . 6.6 tt0 -31.41 -12.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.739 -1.225 . . . . 0.0 110.195 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.97 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 105.66 -35.79 4.83 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.385 -0.822 . . . . 0.0 112.93 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -55.39 102.82 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.294 -1.709 . . . . 0.0 109.956 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.636 HG21 ' CD2' ' A' ' 14' ' ' PHE . 49.1 p -61.99 -34.48 76.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.952 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.596 ' ND1' ' OG1' ' A' ' 57' ' ' THR . 34.7 p-80 -171.74 149.9 2.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.853 -1.154 . . . . 0.0 110.182 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.35 170.87 14.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.434 -0.791 . . . . 0.0 109.26 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -138.64 134.96 34.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.494 ' HB2' ' HE1' ' A' ' 42' ' ' TRP . 10.2 t -111.22 106.24 15.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' HIS . 67.6 mtt -95.67 119.98 35.12 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.826 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.467 ' O ' ' OG ' ' A' ' 39' ' ' SER . 32.0 m -116.59 141.78 47.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -121.29 152.46 38.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.742 -1.224 . . . . 0.0 110.073 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -86.27 -23.92 26.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -162.47 165.86 25.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -69.15 -24.73 64.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 0.0 111.446 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.1 -40.61 98.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.825 -1.172 . . . . 0.0 110.602 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . -72.1 -33.44 62.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.655 ' O ' HG22 ' A' ' 74' ' ' THR . 25.1 t80 -66.32 -43.0 87.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.589 -0.948 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.1 m -70.84 -28.89 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.449 -1.407 . . . . 0.0 108.658 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 69' ' ' GLY . 1.1 m-85 -54.72 -35.42 63.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -0.897 . . . . 0.0 111.084 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.9 t -85.57 -28.93 24.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.739 -1.226 . . . . 0.0 110.327 -177.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 73.6 m -66.21 -34.64 78.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.997 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -61.31 151.53 76.18 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.76 -1.213 . . . . 0.0 109.61 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.07 -7.75 20.74 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.652 2.235 . . . . 0.0 112.407 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 30' ' ' LEU . 7.3 tt -76.97 -27.92 54.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.395 -0.816 . . . . 0.0 111.218 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -81.73 -35.53 29.62 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 81' ' ' GLU . 6.7 p -70.2 -56.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.006 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.726 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.96 84.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.619 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -59.17 -42.78 91.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.804 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.7 p -65.73 -30.63 71.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 110.106 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.85 -55.19 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 108.687 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.468 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -66.62 -39.35 88.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.428 ' O ' HG12 ' A' ' 90' ' ' ILE . 23.8 t80 -46.47 -25.42 0.67 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.4 m -83.56 -63.62 1.32 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.01 -33.39 0.31 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.719 -0.613 . . . . 0.0 110.067 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 85' ' ' ALA . 6.8 m -92.66 14.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -0.897 . . . . 0.0 110.815 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.636 HD12 ' HB ' ' A' ' 12' ' ' VAL . 26.5 mm -132.35 163.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.609 -1.307 . . . . 0.0 110.412 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 90' ' ' ILE . 34.7 t0 -113.9 -33.73 5.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -132.87 129.54 38.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.843 HD12 HG12 ' A' ' 12' ' ' VAL . 7.0 tp -128.79 130.44 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.579 -1.326 . . . . 0.0 109.762 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.403 HG11 ' OE1' ' B' ' 54' ' ' GLN . 14.4 p -146.95 148.07 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -135.85 129.86 33.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.276 -1.515 . . . . 0.0 111.804 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.901 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -112.73 119.57 38.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.669 -0.644 . . . . 0.0 109.346 178.311 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.725 ' OD2' ' CE1' ' A' ' 8' ' ' HIS . 54.1 t0 -128.33 135.76 50.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.052 -1.03 . . . . 0.0 108.847 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.511 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 36.3 t80 -166.76 140.64 3.24 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 110.54 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.03 106.99 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.266 1.978 . . . . 0.0 112.249 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 100' ' ' VAL . 1.9 p -88.49 128.8 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 109.952 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.76 94.71 4.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.654 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.45 150.59 25.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.091 -1.006 . . . . 0.0 109.562 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 -21.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 109.133 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.696 ' C ' ' H ' ' A' ' 106' ' ' SER . 18.0 mmtp 54.03 -141.74 0.84 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.366 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.97 -12.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 108.961 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.696 ' H ' ' C ' ' A' ' 104' ' ' LYS . 83.7 p -52.46 152.64 3.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.94 -168.98 16.89 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.684 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.5 130.52 56.75 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -1.149 . . . . 0.0 108.014 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 22.1 ttpt -100.91 129.71 46.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.975 -1.078 . . . . 0.0 112.838 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.721 ' CE1' ' OD2' ' B' ' 97' ' ' ASP . 0.3 OUTLIER -121.52 119.56 32.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.66 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.535 HD22 HD13 ' B' ' 96' ' ' LEU . 6.5 tt -132.07 141.67 49.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.713 -1.242 . . . . 0.0 109.56 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.412 ' O ' HG13 ' B' ' 10' ' ' VAL . 9.7 p -129.25 136.34 59.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.485 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.4 131.02 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.848 HG12 HD12 ' B' ' 93' ' ' ILE . 35.9 m -139.22 150.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 117.706 -1.597 . . . . 0.0 113.046 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -127.91 154.98 44.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD2' HG21 ' B' ' 57' ' ' THR . 15.4 p90 -113.34 156.68 22.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.815 -1.178 . . . . 0.0 111.596 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.27 -18.8 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.6 mt-10 -91.73 -53.65 4.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.4 t0 149.2 65.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.8 m -54.14 112.02 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.114 0.959 . . . . 0.0 112.825 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.575 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.11 86.47 1.87 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.577 HG23 ' N ' ' B' ' 21' ' ' ASP . 33.0 m -61.86 -42.42 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.622 -0.674 . . . . 0.0 110.477 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.577 ' N ' HG23 ' B' ' 20' ' ' VAL . 87.5 m-20 -63.5 -45.03 92.57 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 110.535 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -68.87 -34.43 75.43 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -67.49 -42.11 86.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' B' ' 20' ' ' VAL . 16.5 tp -58.89 -39.51 81.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -60.87 -35.67 77.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.66 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -63.29 -53.32 40.39 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 26' ' ' GLY . 5.9 tt -44.11 -41.28 5.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.989 . . . . 0.0 108.846 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -51.99 -39.07 58.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 0.7 OUTLIER -63.82 -44.17 94.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.59 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.64 HD22 ' CD2' ' B' ' 78' ' ' LEU . 0.5 OUTLIER -47.59 -47.91 28.35 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 32' ' ' SER . 84.4 t -55.84 -24.47 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 32.5 t -43.65 -43.38 5.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.07 -9.83 49.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.436 -0.79 . . . . 0.0 111.479 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.733 HG22 ' O ' ' B' ' 34' ' ' ILE . 62.8 mt -92.59 28.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.003 -1.685 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.84 -8.01 1.95 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' C ' ' B' ' 37' ' ' VAL . 66.1 p -67.61 -10.2 49.89 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.945 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.58 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.6 m 35.27 35.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.032 -1.043 . . . . 0.0 109.181 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 36' ' ' THR . 66.4 mttt -118.22 43.99 2.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' B' ' 63' ' ' THR . 14.4 t -176.27 177.7 1.48 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.02 156.0 42.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.541 -1.349 . . . . 0.0 112.007 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.452 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 63.8 mt-10 -154.09 124.23 6.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.354 0.597 . . . . 0.0 110.259 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.54 ' CE2' ' OE2' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -127.51 168.92 14.27 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.26 138.34 6.4 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.75 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.54 ' OE2' ' CE2' ' B' ' 42' ' ' TRP . 4.4 mp0 -124.71 173.16 8.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.233 -1.157 . . . . 0.0 109.434 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' B' ' 57' ' ' THR . 57.1 t0 -168.12 94.55 0.39 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HZ2' ' HA ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -89.0 170.73 10.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.446 -1.409 . . . . 0.0 109.825 179.115 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' B' ' 48' ' ' SER . 2.3 mt-10 -172.58 90.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER 163.46 148.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' B' ' 48' ' ' SER . 57.9 m170 57.7 113.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 109.693 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 28.7 p-10 -52.49 -43.53 65.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.781 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 23.3 ttt -62.34 -35.17 78.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 110.723 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' NZ ' ' B' ' 46' ' ' LYS . 17.0 mt -89.04 -19.91 25.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.336 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.953 ' O ' ' N ' ' B' ' 55' ' ' GLY . 34.1 ttt-85 -83.99 42.65 0.88 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -0.854 . . . . 0.0 111.194 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.56 ' C ' ' O ' ' B' ' 53' ' ' ARG . 6.7 tt0 -31.53 -12.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.862 -1.149 . . . . 0.0 110.274 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.953 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 105.88 -36.11 4.62 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.454 -0.779 . . . . 0.0 112.857 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.809 ' CG ' ' O ' ' B' ' 56' ' ' PHE . 0.7 OUTLIER -55.04 102.8 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.302 -1.705 . . . . 0.0 109.987 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.639 HG21 ' CD2' ' B' ' 14' ' ' PHE . 49.2 p -61.78 -34.81 76.55 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.307 -0.871 . . . . 0.0 111.015 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.575 ' HE2' HD11 ' B' ' 90' ' ' ILE . 33.9 p-80 -171.35 150.3 2.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 110.148 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.65 170.8 15.16 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.262 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -138.59 134.9 34.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.439 -0.788 . . . . 0.0 109.128 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.498 ' HB2' ' HE1' ' B' ' 42' ' ' TRP . 10.0 t -111.16 106.24 15.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' MET . . . . . 0.475 ' N ' ' O ' ' B' ' 8' ' ' HIS . 67.7 mtt -95.57 120.33 35.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.149 -0.97 . . . . 0.0 110.833 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.507 ' O ' ' OG ' ' B' ' 39' ' ' SER . 32.5 m -116.96 141.72 47.87 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -121.27 152.1 39.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.695 -1.253 . . . . 0.0 110.047 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -85.94 -23.76 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -162.65 166.08 24.98 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -69.35 -24.66 63.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 111.453 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.44 -40.29 96.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.865 -1.147 . . . . 0.0 110.604 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.553 ' O ' ' CE2' ' B' ' 73' ' ' PHE . . . -71.99 -33.78 62.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.648 ' O ' HG22 ' B' ' 74' ' ' THR . 25.2 t80 -66.15 -43.05 88.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.512 -0.993 . . . . 0.0 110.426 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.3 m -70.83 -28.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.412 -1.43 . . . . 0.0 108.626 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.99 2.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.358 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.553 ' CE2' ' O ' ' B' ' 69' ' ' GLY . 1.1 m-85 -54.6 -35.56 63.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.287 -0.883 . . . . 0.0 111.089 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.648 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.9 t -85.49 -29.0 24.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.822 -1.174 . . . . 0.0 110.347 -177.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 73.8 m -66.11 -34.78 78.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.982 . . . . 0.0 111.056 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -61.11 151.81 73.91 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.24 -7.86 21.23 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.611 2.207 . . . . 0.0 112.499 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.64 ' CD2' HD22 ' B' ' 30' ' ' LEU . 7.3 tt -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -0.797 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -81.37 -35.65 30.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 110.281 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.726 HG13 ' H ' ' B' ' 81' ' ' GLU . 6.9 p -70.26 -56.67 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.726 ' H ' HG13 ' B' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.89 84.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.15 -42.77 91.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.849 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 88.0 p -65.82 -30.55 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.991 . . . . 0.0 110.069 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.85 36.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 0.0 108.705 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.479 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -66.96 -39.24 87.2 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' B' ' 85' ' ' ALA . 24.0 t80 -46.73 -25.05 0.66 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.427 ' N ' ' C ' ' B' ' 85' ' ' ALA . 5.7 m -83.91 -63.48 1.34 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.07 -33.18 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.771 -0.581 . . . . 0.0 110.086 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 85' ' ' ALA . 7.0 m -92.89 14.83 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.173 -0.954 . . . . 0.0 110.811 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.625 HG22 ' N ' ' B' ' 91' ' ' ASP . 26.2 mm -132.43 164.16 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.651 -1.281 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.625 ' N ' HG22 ' B' ' 90' ' ' ILE . 34.8 t0 -114.07 -33.71 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -132.94 129.58 38.47 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.848 HD12 HG12 ' B' ' 12' ' ' VAL . 7.1 tp -128.83 130.56 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.516 -1.365 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.401 HG11 ' OE1' ' A' ' 54' ' ' GLN . 14.4 p -147.06 147.94 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.501 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -135.86 130.03 33.27 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.237 -1.54 . . . . 0.0 111.759 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.898 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.1 OUTLIER -112.85 119.42 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.325 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.721 ' OD2' ' CE1' ' B' ' 8' ' ' HIS . 54.7 t0 -128.24 135.7 50.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.107 -0.996 . . . . 0.0 108.918 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.492 ' N ' ' OD1' ' B' ' 97' ' ' ASP . 36.1 t80 -166.7 140.65 3.28 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.111 -0.993 . . . . 0.0 110.49 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.95 106.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.273 1.982 . . . . 0.0 112.264 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.441 ' H ' HG12 ' B' ' 100' ' ' VAL . 1.9 p -88.38 128.67 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.121 -0.987 . . . . 0.0 110.079 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.65 94.74 4.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.511 -0.743 . . . . 0.0 109.554 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 0.0 109.62 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.52 -21.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.21 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.703 ' C ' ' H ' ' B' ' 106' ' ' SER . 18.1 mmtp 54.45 -141.87 0.83 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.28 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.89 -12.7 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.143 -0.973 . . . . 0.0 108.916 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.703 ' H ' ' C ' ' B' ' 104' ' ' LYS . 83.5 p -52.49 152.44 3.57 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.921 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.681 ' O ' HG22 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.681 HG22 ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 74.77 -2.81 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.116 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.3 m -174.65 -129.13 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.94 168.59 26.19 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.653 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.91 128.14 47.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -1.15 . . . . 0.0 108.028 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 4.3 ttpm? -106.5 134.66 49.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 112.885 -177.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -126.17 124.48 40.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -131.76 142.03 49.65 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.678 -1.264 . . . . 0.0 109.526 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.08 138.21 53.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.482 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.83 131.69 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.19 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 117.88 -1.528 . . . . 0.0 113.071 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -127.49 147.74 50.31 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.798 ' CB ' ' H ' ' A' ' 18' ' ' THR . 17.7 t80 -111.31 158.88 18.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.0 111.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.694 ' HG3' ' H ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.42 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.694 ' H ' ' HG3' ' A' ' 15' ' ' LYS . 83.6 mt-10 -85.95 -49.99 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.457 ' H ' ' HD2' ' A' ' 14' ' ' PHE . 6.5 t0 160.31 98.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' A' ' 14' ' ' PHE . 3.4 m -51.43 153.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.121 0.963 . . . . 0.0 112.84 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.561 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -77.84 87.69 4.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.32 -33.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.507 -0.746 . . . . 0.0 110.517 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.74 -42.02 86.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.443 -0.785 . . . . 0.0 110.508 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 70.7 mm-40 -67.64 -30.31 69.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 89' ' ' VAL . 1.3 mm -70.9 -37.46 68.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -54.12 -36.87 63.71 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -35.46 80.37 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.95 -54.58 17.18 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -47.96 41.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.5 -1.0 . . . . 0.0 108.883 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.08 -43.61 70.48 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.647 ' ND2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -65.0 -47.52 77.23 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -49.27 -44.64 44.0 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.7 t -55.62 -25.02 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.28 -0.887 . . . . 0.0 108.866 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 51.0 m -43.27 -39.09 2.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.425 ' OE1' ' CG ' ' A' ' 76' ' ' HIS . 99.5 mm-40 -67.55 0.89 2.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 111.425 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 34' ' ' ILE . 72.2 mt -108.17 26.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.074 -1.641 . . . . 0.0 110.607 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -60.42 -8.42 2.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.609 ' O ' ' C ' ' A' ' 37' ' ' VAL . 29.4 p -84.21 0.23 49.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.964 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.609 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.3 m 30.26 38.99 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.29 3.59 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 t -174.07 178.27 2.16 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 91.9 m-85 -144.53 154.49 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 111.993 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.499 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 81.0 mt-10 -158.01 127.46 5.86 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.342 0.591 . . . . 0.0 110.267 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -133.43 172.59 12.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' B' ' 98' ' ' PHE . . . -131.89 163.87 23.75 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.816 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.668 ' N ' ' CE1' ' A' ' 58' ' ' HIS . 18.9 mt-10 -149.49 142.54 24.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.247 -1.149 . . . . 0.0 109.34 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.587 ' CG ' ' HD1' ' A' ' 58' ' ' HIS . 42.2 m-20 -125.63 155.79 40.22 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 81.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.395 -1.44 . . . . 0.0 109.771 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.7 mt-10 -103.04 39.33 1.57 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 97' ' ' ASP . 11.7 m -142.75 168.33 19.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 0.0 110.129 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ARG . 78.0 m80 -48.37 140.79 7.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.134 -0.979 . . . . 0.0 109.757 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 78.7 m-20 -44.48 -46.4 9.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.759 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 110.732 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 43.5 mt -102.0 -19.12 15.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.713 -1.242 . . . . 0.0 109.241 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.832 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -72.25 -5.34 35.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.905 . . . . 0.0 111.217 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.62 -8.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.827 -1.17 . . . . 0.0 110.149 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.832 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 72.77 -13.16 3.23 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.386 -0.821 . . . . 0.0 112.844 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 3.5 p90 -59.54 129.9 44.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.308 -1.701 . . . . 0.0 109.985 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.9 p -54.07 -43.04 69.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.88 . . . . 0.0 111.008 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.668 ' CE1' ' N ' ' A' ' 44' ' ' GLU . 19.0 t60 -173.36 159.4 3.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.143 . . . . 0.0 110.147 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.649 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.07 167.9 21.0 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 0.0 109.208 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 81.0 m-85 -132.94 129.48 38.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.114 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.2 m -106.6 100.72 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.9 mtm -104.79 129.14 53.1 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.19 -0.944 . . . . 0.0 110.745 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -126.48 143.44 51.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 65' ' ' GLU . 93.1 m-85 -124.5 130.13 51.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.679 -1.263 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' PHE . 84.6 tt0 -47.93 -33.82 8.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -161.54 166.37 27.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -55.27 -22.47 18.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 111.459 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD2' ' NZ ' ' A' ' 38' ' ' LYS . 22.9 t70 -53.63 -40.49 65.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.791 -1.193 . . . . 0.0 110.651 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.01 -36.16 64.55 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.647 ' O ' HG22 ' A' ' 74' ' ' THR . 56.6 t80 -64.39 -44.16 92.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.631 -0.923 . . . . 0.0 110.472 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.77 -28.9 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.331 -1.481 . . . . 0.0 108.68 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.86 2.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -59.12 -46.7 87.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 111.08 -177.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 70' ' ' TYR . 11.6 t -69.84 -36.13 75.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.747 -1.22 . . . . 0.0 110.307 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.413 ' N ' HG23 ' A' ' 74' ' ' THR . 78.0 p -65.43 -27.21 68.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -0.98 . . . . 0.0 110.941 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 55.3 m80 -72.17 151.29 92.41 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.836 -1.165 . . . . 0.0 109.562 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.98 -5.35 16.13 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 5.6 tp -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 111.198 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 83' ' ' SER . 11.1 t-160 -82.61 -40.75 20.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.074 -1.016 . . . . 0.0 110.241 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.35 -61.72 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.998 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -53.16 -38.07 62.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.612 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.647 ' CZ ' ' ND2' ' A' ' 29' ' ' ASN . 8.1 m-85 -74.37 -33.62 63.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.838 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' HIS . 21.2 t -61.23 -44.09 97.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 110.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.35 96.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.99 -1.069 . . . . 0.0 108.667 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.19 -43.42 78.14 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.22 -31.64 0.64 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 89' ' ' VAL . 22.3 m -80.43 -62.25 1.73 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.97 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.3 m -113.95 7.26 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 91' ' ' ASP . 60.9 mt -123.5 157.72 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.656 -1.277 . . . . 0.0 110.452 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.483 ' N ' HG22 ' A' ' 90' ' ' ILE . 22.5 t70 -108.37 -30.28 8.4 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -145.59 142.98 29.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' ILE . 4.0 tp -125.39 123.51 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.635 -1.29 . . . . 0.0 109.852 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 t -126.05 131.59 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -138.3 133.24 32.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.207 -1.558 . . . . 0.0 111.793 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -121.16 126.58 50.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.307 178.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 64.8 t0 -124.69 130.43 52.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.085 -1.009 . . . . 0.0 108.952 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.648 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -157.65 124.23 2.55 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.035 -1.041 . . . . 0.0 110.501 -179.178 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.648 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 79.8 Cg_exo -45.01 133.68 11.03 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.287 1.991 . . . . 0.0 112.235 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 4' ' ' SER . 37.2 t -110.35 133.3 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 110.001 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -110.9 94.05 4.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.463 -0.773 . . . . 0.0 109.634 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.27 69.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 109.516 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.7 m -151.45 110.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.134 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.652 ' C ' ' H ' ' A' ' 106' ' ' SER . 24.6 mmtp -125.41 1.46 7.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.44 -23.38 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.652 ' H ' ' C ' ' A' ' 104' ' ' LYS . 1.7 m 61.15 54.62 3.24 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.257 -0.902 . . . . 0.0 109.35 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.774 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' B' ' 100' ' ' VAL . 40.0 m . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.87 168.44 26.19 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.688 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.85 128.25 47.34 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.538 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 4.3 ttpm? -106.39 134.77 49.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.989 -1.07 . . . . 0.0 112.823 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -126.25 124.5 40.52 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.85 141.98 49.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.7 -1.25 . . . . 0.0 109.491 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 138.22 54.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.612 -0.68 . . . . 0.0 109.542 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.75 131.69 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.28 146.31 29.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 117.702 -1.599 . . . . 0.0 113.04 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -127.65 147.75 50.37 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.807 ' CB ' ' H ' ' B' ' 18' ' ' THR . 17.5 t80 -111.37 158.83 18.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.867 -1.146 . . . . 0.0 111.596 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.674 ' HG3' ' H ' ' B' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.674 ' H ' ' HG3' ' B' ' 15' ' ' LYS . 83.6 mt-10 -86.05 -49.95 7.41 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.466 ' H ' ' HD2' ' B' ' 14' ' ' PHE . 6.5 t0 160.35 98.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.807 ' H ' ' CB ' ' B' ' 14' ' ' PHE . 3.4 m -51.28 153.77 1.94 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.062 0.935 . . . . 0.0 112.909 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.561 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -78.01 87.6 4.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -64.24 -33.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.605 -0.684 . . . . 0.0 110.562 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 29.7 p-10 -66.71 -42.1 86.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.793 . . . . 0.0 110.56 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 70.5 mm-40 -67.64 -30.28 69.8 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.475 HD11 HG21 ' B' ' 89' ' ' VAL . 1.3 mm -70.78 -37.48 69.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -54.28 -36.64 63.86 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -35.54 80.66 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.02 -54.39 17.9 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.86 -47.7 42.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.633 -0.922 . . . . 0.0 108.855 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.44 -43.59 71.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.642 ' ND2' ' CZ ' ' B' ' 82' ' ' PHE . 0.2 OUTLIER -64.95 -47.5 77.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.046 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.6 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -49.25 -44.71 43.93 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' B' ' 32' ' ' SER . 77.4 t -55.51 -25.11 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.273 -0.892 . . . . 0.0 108.789 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 50.9 m -43.12 -39.25 2.72 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' B' ' 76' ' ' HIS . 99.5 mm-40 -67.37 0.88 2.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 111.536 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.766 HG22 ' O ' ' B' ' 34' ' ' ILE . 72.1 mt -108.18 26.64 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.043 -1.661 . . . . 0.0 110.581 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.8 p30 -60.47 -8.49 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.625 ' O ' ' C ' ' B' ' 37' ' ' VAL . 29.6 p -84.1 0.14 49.6 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.966 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.625 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.5 m 30.32 38.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.093 -1.004 . . . . 0.0 109.149 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.33 3.58 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -174.19 178.29 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 91.9 m-85 -144.59 154.39 42.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.555 -1.341 . . . . 0.0 112.002 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 81.7 mt-10 -158.01 127.57 5.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.441 0.639 . . . . 0.0 110.192 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -133.62 172.54 12.6 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 98' ' ' PHE . . . -131.93 163.8 23.78 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.725 -1.702 . . . . 0.0 110.854 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.684 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 18.4 mt-10 -149.4 142.48 24.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -1.158 . . . . 0.0 109.35 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.583 ' CG ' ' HD1' ' B' ' 58' ' ' HIS . 42.3 m-20 -125.53 155.76 40.11 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 81.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.354 -1.466 . . . . 0.0 109.743 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -103.11 39.14 1.61 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 11.9 m -142.82 168.21 20.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 110.164 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' B' ' 53' ' ' ARG . 78.0 m80 -48.26 140.78 7.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.686 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 78.1 m-20 -44.57 -46.27 9.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.773 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.4 ttt -61.76 -28.85 69.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.718 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 95' ' ' LEU . 43.3 mt -102.14 -18.98 15.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.814 ' CG ' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -72.36 -5.28 35.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 111.238 -177.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.82 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.827 -1.17 . . . . 0.0 110.204 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.814 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 73.04 -13.32 3.37 Favored Glycine 0 N--CA 1.498 2.82 0 O-C-N 121.433 -0.792 . . . . 0.0 112.83 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 3.4 p90 -59.44 129.9 44.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.328 -1.689 . . . . 0.0 109.908 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 28.8 p -53.99 -43.2 69.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 111.039 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.684 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 18.9 t60 -173.17 159.6 3.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.903 -1.123 . . . . 0.0 110.175 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.662 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.22 167.74 21.41 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.507 -0.746 . . . . 0.0 109.282 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.402 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 80.9 m-85 -132.84 129.55 38.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.443 -0.785 . . . . 0.0 109.104 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -106.55 100.95 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 56.7 mtm -105.13 129.15 53.6 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 50.4 m -126.53 143.52 51.18 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' B' ' 65' ' ' GLU . 93.3 m-85 -124.6 130.0 51.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 0.0 110.014 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 64' ' ' PHE . 84.4 tt0 -47.88 -33.67 7.84 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -161.71 166.41 26.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -55.39 -22.7 20.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 111.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.492 ' OD2' ' NZ ' ' B' ' 38' ' ' LYS . 22.6 t70 -53.23 -40.69 64.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.704 -1.248 . . . . 0.0 110.574 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.17 65.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.649 ' O ' HG22 ' B' ' 74' ' ' THR . 56.8 t80 -64.19 -44.43 91.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.921 . . . . 0.0 110.47 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.77 -28.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.331 -1.481 . . . . 0.0 108.704 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -60.94 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.309 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -58.76 -46.74 86.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 0.0 111.191 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 70' ' ' TYR . 11.6 t -69.9 -36.13 75.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.706 -1.246 . . . . 0.0 110.308 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.426 ' N ' HG23 ' B' ' 74' ' ' THR . 77.9 p -65.51 -27.08 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -0.993 . . . . 0.0 110.924 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.423 ' CG ' ' OE1' ' B' ' 33' ' ' GLN . 55.0 m80 -72.22 151.18 92.29 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.8 -1.187 . . . . 0.0 109.559 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.87 -5.12 15.52 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.632 2.221 . . . . 0.0 112.517 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' B' ' 82' ' ' PHE . 5.6 tp -73.22 -28.67 62.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.323 -0.861 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 83' ' ' SER . 11.0 t-160 -82.56 -40.69 20.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.031 -1.043 . . . . 0.0 110.226 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.45 -61.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.33 -38.02 62.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.642 ' CZ ' ' ND2' ' B' ' 29' ' ' ASN . 8.2 m-85 -74.39 -33.54 63.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 109.873 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' SER . . . . . 0.438 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.1 t -61.32 -44.08 97.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.0 110.084 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.89 96.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.001 -1.062 . . . . 0.0 108.685 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.72 -43.13 76.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.45 -31.58 0.72 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.542 ' O ' ' N ' ' B' ' 89' ' ' VAL . 22.0 m -80.36 -62.2 1.75 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.18 -21.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.754 -0.591 . . . . 0.0 110.078 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.4 m -114.32 7.36 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.224 -0.922 . . . . 0.0 110.83 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 61.8 mt -123.5 157.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.659 -1.276 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 22.2 t70 -108.33 -30.45 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -145.63 142.97 29.56 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.472 ' O ' HG23 ' B' ' 93' ' ' ILE . 4.0 tp -125.38 123.51 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.535 -1.353 . . . . 0.0 109.753 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 t -125.99 131.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.609 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.3 OUTLIER -138.32 133.25 32.78 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.207 -1.558 . . . . 0.0 111.707 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.438 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.4 OUTLIER -121.07 126.7 50.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.695 -0.628 . . . . 0.0 109.308 178.192 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.1 t0 -124.8 130.34 52.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 108.943 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.658 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 0.1 OUTLIER -157.49 124.15 2.57 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.048 -1.033 . . . . 0.0 110.539 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 99' ' ' PRO . . . . . 0.658 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 79.7 Cg_exo -44.85 133.73 10.57 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.179 1.919 . . . . 0.0 112.274 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' B' ' 4' ' ' SER . 37.1 t -110.44 133.2 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -110.74 94.19 4.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.448 -0.783 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.37 69.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.018 . . . . 0.0 109.558 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.686 HG23 ' O ' ' B' ' 103' ' ' VAL . 21.7 m -151.44 110.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 0.0 109.246 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.637 ' C ' ' H ' ' B' ' 106' ' ' SER . 24.7 mmtp -125.45 1.39 7.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 109.381 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.48 -23.41 0.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.938 . . . . 0.0 108.94 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 104' ' ' LYS . 1.8 m 61.22 54.39 3.26 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.823 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.443 0.639 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER 73.09 -39.61 0.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.126 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.518 ' N ' HG22 ' A' ' 3' ' ' THR . 75.1 m -91.64 -132.13 0.12 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.02 177.13 20.82 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.332 -1.413 . . . . 0.0 109.655 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -114.17 131.77 56.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -107.03 137.63 44.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.908 -1.12 . . . . 0.0 112.827 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -129.95 129.13 43.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -134.33 145.04 48.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.766 -1.209 . . . . 0.0 109.498 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.3 p -126.04 133.55 68.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.436 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.28 128.89 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 57' ' ' THR . 11.5 m -139.0 161.85 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 117.779 -1.568 . . . . 0.0 113.053 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 18.3 tptm -125.2 152.22 44.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.455 ' N ' ' HG3' ' A' ' 13' ' ' LYS . 41.6 p90 -111.04 152.55 26.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.857 -1.152 . . . . 0.0 111.574 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -127.5 -24.71 3.28 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 63.2 tt0 -89.7 -53.61 4.44 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.4 t0 147.57 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 29.2 m -54.84 111.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.095 0.95 . . . . 0.0 112.889 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.698 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.07 86.41 5.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.5 m -57.82 -33.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.551 -0.718 . . . . 0.0 110.456 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -66.19 -37.57 85.93 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -70.8 -35.85 72.73 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.27 -40.82 89.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.22 -35.79 60.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HA ' ' HZ3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -56.94 -30.12 63.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -76.68 -44.93 14.13 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 tt -49.47 -56.34 10.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.568 -0.96 . . . . 0.0 108.835 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 8.0 pt-20 -51.49 -35.44 40.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 51.7 m-20 -67.2 -46.58 73.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 4.1 mm? -47.71 -51.43 21.97 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.6 t -48.91 -34.12 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 108.888 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.3 m -45.15 -50.24 11.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.79 -1.55 2.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.475 -0.766 . . . . 0.0 111.419 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 36' ' ' THR . 6.3 mt -112.37 34.06 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.997 -1.689 . . . . 0.0 110.626 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -56.31 -10.48 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.577 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.2 t -85.88 -1.57 57.4 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.03 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 35.4 m 35.6 39.96 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.034 -1.041 . . . . 0.0 109.167 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' OG ' ' A' ' 39' ' ' SER . 59.2 mttt -116.87 43.21 2.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 38.6 m -174.27 175.07 2.73 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' C ' ' CD ' ' A' ' 41' ' ' GLU . 77.3 m-85 -147.95 157.18 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.524 -1.36 . . . . 0.0 112.002 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' CD ' ' C ' ' A' ' 40' ' ' PHE . 58.7 mp0 -156.28 123.85 5.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.452 0.644 . . . . 0.0 110.172 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.52 172.25 9.85 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.97 155.56 21.04 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.798 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.582 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 76.6 mm-40 -149.12 136.65 20.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -1.127 . . . . 0.0 109.345 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 88.6 m-20 -111.43 142.87 43.12 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HZ1' ' C ' ' A' ' 58' ' ' HIS . 9.9 pttm -141.54 109.39 5.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.369 -1.457 . . . . 0.0 109.826 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -147.0 45.33 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.679 -0.638 . . . . 0.0 109.305 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 49' ' ' HIS . 10.1 t -133.16 124.44 27.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 48' ' ' SER . 27.6 m80 60.97 116.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -60.34 -38.28 83.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.364 -0.835 . . . . 0.0 110.827 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -71.18 -35.53 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.031 -1.043 . . . . 0.0 110.729 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 54' ' ' GLN . 26.5 mt -80.68 -58.27 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.806 -1.184 . . . . 0.0 109.292 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.6 ptt180 -63.53 14.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.242 -0.911 . . . . 0.0 111.209 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 52' ' ' LEU . 24.9 mt-30 43.56 4.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.789 -1.194 . . . . 0.0 110.187 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 84.5 -16.94 32.32 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.478 -0.764 . . . . 0.0 112.844 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.482 ' CE2' ' NZ ' ' A' ' 92' ' ' LYS . 48.2 m-85 -61.94 -134.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.253 -1.733 . . . . 0.0 109.998 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 12' ' ' VAL . 4.6 t -162.89 -34.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.284 -0.885 . . . . 0.0 111.027 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.658 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 8.5 t60 -168.47 153.59 6.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 110.125 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.658 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.56 169.1 18.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.385 -0.822 . . . . 0.0 109.283 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.653 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 90.0 m-85 -132.06 128.43 38.21 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 0.0 109.083 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -100.18 99.76 10.5 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -103.07 123.08 45.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.766 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.9 m -123.12 145.62 48.43 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' ASN . 92.2 m-85 -120.92 120.33 35.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.722 -1.237 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -50.92 -24.46 3.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 64' ' ' PHE . 42.2 t-20 -171.26 171.26 5.71 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -58.91 -20.42 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 111.446 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -58.67 -41.95 87.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.835 -1.166 . . . . 0.0 110.574 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.68 -32.93 66.93 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.484 ' O ' HG22 ' A' ' 74' ' ' THR . 78.5 t80 -66.86 -44.11 81.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.927 . . . . 0.0 110.538 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.322 -1.486 . . . . 0.0 108.649 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.91 2.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.349 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -50.57 -34.78 27.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -0.871 . . . . 0.0 111.182 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.7 t -85.63 -30.15 23.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.824 -1.172 . . . . 0.0 110.294 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 t -67.41 16.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.126 -0.984 . . . . 0.0 110.971 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.474 ' H ' ' C ' ' A' ' 74' ' ' THR . 56.1 m80 -133.06 152.05 79.0 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 0.0 109.602 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.84 1.44 8.12 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.669 2.246 . . . . 0.0 112.507 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.26 -31.77 72.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.369 -0.832 . . . . 0.0 111.256 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 83' ' ' SER . 75.2 t60 -84.85 -31.84 23.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.117 -0.989 . . . . 0.0 110.237 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.13 -62.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.993 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.1 -42.46 72.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -75.13 -32.91 61.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 79' ' ' HIS . 13.7 t -63.25 -42.92 99.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.158 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.34 99.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.978 -1.076 . . . . 0.0 108.686 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -65.21 -41.8 94.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -44.66 -31.13 1.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.562 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' VAL . 18.7 m -81.68 -63.14 1.45 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.18 -28.74 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.718 -0.614 . . . . 0.0 110.057 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 85' ' ' ALA . 5.3 m -103.99 6.95 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.122 -0.986 . . . . 0.0 110.848 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 91' ' ' ASP . 28.4 mm -129.57 161.92 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.64 -1.287 . . . . 0.0 110.436 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.559 ' N ' HG22 ' A' ' 90' ' ' ILE . 61.4 t0 -121.85 -30.01 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.482 ' NZ ' ' CE2' ' A' ' 56' ' ' PHE . 18.1 ttpt -131.04 129.06 41.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' ILE . 3.4 tp -123.69 121.44 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.643 -1.286 . . . . 0.0 109.799 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.435 ' C ' HD12 ' A' ' 95' ' ' LEU . 7.5 t -131.17 134.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.823 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -143.17 141.27 31.1 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.273 -1.517 . . . . 0.0 111.755 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -117.93 118.92 33.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.649 -0.657 . . . . 0.0 109.311 177.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 39.3 p30 -128.26 136.46 51.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.059 -1.026 . . . . 0.0 108.983 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 9.3 p90 -172.48 156.14 3.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 110.481 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.19 124.87 15.16 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.293 1.995 . . . . 0.0 112.187 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.5 t -109.66 136.05 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 110.022 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.58 104.02 9.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.501 -0.75 . . . . 0.0 109.612 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.437 ' HB1' ' HZ2' ' A' ' 104' ' ' LYS . . . -167.46 160.28 13.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.001 . . . . 0.0 109.579 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.02 -10.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 109.238 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.802 ' C ' ' H ' ' A' ' 106' ' ' SER . 3.7 mmpp? 54.94 -145.72 0.61 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.322 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.53 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 108.904 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.802 ' H ' ' C ' ' A' ' 104' ' ' LYS . 75.2 m -61.62 124.64 21.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.36 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.529 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.03 176.75 21.07 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.727 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -113.85 131.99 56.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.301 -1.117 . . . . 0.0 108.029 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -107.41 137.5 45.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.988 -1.07 . . . . 0.0 112.809 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -130.03 129.18 43.34 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -134.36 145.03 48.6 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.702 -1.248 . . . . 0.0 109.53 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 10' ' ' VAL . 12.2 p -126.09 133.69 68.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.403 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.9 OUTLIER -117.45 128.63 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.5 ' O ' HG22 ' B' ' 57' ' ' THR . 11.3 m -138.92 161.56 29.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.741 -1.584 . . . . 0.0 113.026 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 18.2 tptm -124.73 152.34 43.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.452 ' N ' ' HG3' ' B' ' 13' ' ' LYS . 41.5 p90 -111.16 152.42 27.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.818 -1.176 . . . . 0.0 111.589 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -127.46 -24.73 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 62.8 tt0 -89.77 -53.64 4.42 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.5 t0 147.5 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 28.3 m -54.77 111.32 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.11 0.957 . . . . 0.0 112.857 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.704 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.4 86.13 5.78 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.32 -33.51 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.554 -0.716 . . . . 0.0 110.443 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.19 -37.77 86.41 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -70.54 -35.97 73.43 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.28 -40.71 88.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.26 -35.84 60.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' B' ' 28' ' ' GLU . 0.0 OUTLIER -56.94 -30.01 63.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -76.76 -44.78 14.15 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 1.2 tt -49.52 -56.37 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.5 -1.0 . . . . 0.0 108.824 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 8.1 pt-20 -51.49 -35.52 40.54 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 51.6 m-20 -67.17 -46.54 73.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 4.1 mm? -47.72 -51.39 22.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 32' ' ' SER . 52.1 t -48.98 -34.13 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.251 -0.906 . . . . 0.0 108.824 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 7.3 m -45.27 -49.95 12.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -64.79 -1.62 2.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 111.553 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.581 ' C ' ' N ' ' B' ' 36' ' ' THR . 6.1 mt -112.32 34.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.079 -1.638 . . . . 0.0 110.625 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -56.54 -10.61 1.01 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.581 ' N ' ' C ' ' B' ' 34' ' ' ILE . 1.2 t -85.81 -1.84 57.64 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.4 m 35.97 39.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.053 -1.029 . . . . 0.0 109.23 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.54 ' O ' ' OG ' ' B' ' 39' ' ' SER . 58.5 mttt -116.72 43.33 2.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.54 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 38.2 m -174.17 175.48 2.69 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.492 ' C ' ' CD ' ' B' ' 41' ' ' GLU . 77.1 m-85 -148.18 157.4 43.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.531 -1.356 . . . . 0.0 111.959 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.492 ' CD ' ' C ' ' B' ' 40' ' ' PHE . 58.5 mp0 -156.48 123.82 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.439 0.638 . . . . 0.0 110.194 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.5 172.11 9.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.74 155.54 20.97 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.768 -1.682 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.577 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 76.7 mm-40 -149.19 136.61 20.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -1.202 . . . . 0.0 109.392 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 90.4 m-20 -111.51 142.8 43.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.513 ' HZ1' ' C ' ' B' ' 58' ' ' HIS . 10.0 pttm -141.6 109.33 5.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.419 -1.426 . . . . 0.0 109.785 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -146.98 45.46 1.17 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.625 -0.672 . . . . 0.0 109.293 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.0 t -133.11 124.42 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.183 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 27.6 m80 60.88 116.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.166 -0.959 . . . . 0.0 109.664 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -60.93 -38.07 84.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.747 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -71.02 -35.5 72.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.753 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' B' ' 54' ' ' GLN . 26.5 mt -80.93 -58.42 3.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.704 -1.247 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.756 ' O ' ' N ' ' B' ' 55' ' ' GLY . 17.3 ptt180 -63.33 14.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 0.0 111.222 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' B' ' 52' ' ' LEU . 24.7 mt-30 43.76 4.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.814 -1.179 . . . . 0.0 110.157 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 84.71 -16.91 33.51 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.357 -0.84 . . . . 0.0 112.861 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.486 ' CE2' ' NZ ' ' B' ' 92' ' ' LYS . 47.9 m-85 -62.08 -134.08 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.884 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.5 HG22 ' O ' ' B' ' 12' ' ' VAL . 4.6 t -163.01 -34.39 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.249 -0.907 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.671 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 8.0 t60 -168.68 153.67 6.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.846 -1.159 . . . . 0.0 110.164 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.671 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.57 169.08 18.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.483 -0.761 . . . . 0.0 109.262 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.656 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 89.8 m-85 -131.98 128.5 38.53 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.112 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 30.0 t -100.29 99.59 10.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 64.1 mtt -103.07 123.08 45.96 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.771 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 46.3 m -123.0 145.83 48.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.14 120.27 34.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.744 -1.223 . . . . 0.0 110.048 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -51.06 -24.47 3.9 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -171.07 171.55 5.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -59.29 -20.23 52.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.363 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -58.8 -41.74 87.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.804 -1.185 . . . . 0.0 110.583 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.91 -33.11 65.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.473 ' O ' HG22 ' B' ' 74' ' ' THR . 78.6 t80 -66.56 -44.31 82.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.941 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.8 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.426 -1.421 . . . . 0.0 108.731 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.12 -60.89 2.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -50.29 -35.32 26.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.258 -0.901 . . . . 0.0 111.161 -177.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.9 t -85.21 -30.44 23.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.721 -1.237 . . . . 0.0 110.353 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -67.18 16.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.115 -0.991 . . . . 0.0 110.97 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.483 ' H ' ' C ' ' B' ' 74' ' ' THR . 56.3 m80 -133.48 152.28 78.88 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.813 -1.179 . . . . 0.0 109.602 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.15 1.64 8.05 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.697 2.264 . . . . 0.0 112.445 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.5 -31.66 71.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.408 -0.808 . . . . 0.0 111.231 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' B' ' 83' ' ' SER . 75.8 t60 -84.98 -31.69 23.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.1 . . . . 0.0 110.312 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.31 -61.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.33 -42.78 74.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.573 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -74.83 -32.85 62.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 79' ' ' HIS . 13.7 t -63.41 -43.05 98.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.21 98.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 108.698 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -65.64 -41.57 92.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.468 ' O ' HG12 ' B' ' 90' ' ' ILE . 1.0 OUTLIER -44.87 -31.16 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.418 ' O ' ' C ' ' B' ' 88' ' ' ALA . 18.4 m -81.47 -63.08 1.47 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.0 -29.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.657 -0.652 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.612 HG22 ' O ' ' B' ' 85' ' ' ALA . 5.3 m -103.83 7.21 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.139 -0.976 . . . . 0.0 110.805 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.573 HG22 ' N ' ' B' ' 91' ' ' ASP . 28.0 mm -129.64 161.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.605 -1.309 . . . . 0.0 110.419 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.573 ' N ' HG22 ' B' ' 90' ' ' ILE . 62.0 t0 -121.87 -30.0 4.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.486 ' NZ ' ' CE2' ' B' ' 56' ' ' PHE . 17.5 ttpt -131.24 129.01 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.49 HG23 ' O ' ' B' ' 93' ' ' ILE . 3.4 tp -123.58 121.61 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 109.709 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.436 ' C ' HD12 ' B' ' 95' ' ' LEU . 8.0 t -131.36 134.71 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.801 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -143.1 141.18 31.17 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.349 -1.469 . . . . 0.0 111.765 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.425 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.6 OUTLIER -117.76 119.05 33.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.363 177.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 40.6 p30 -128.51 136.39 50.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.094 -1.003 . . . . 0.0 108.896 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 9.3 p90 -172.32 156.23 3.61 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.015 -1.053 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.29 124.85 15.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.316 2.011 . . . . 0.0 112.248 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.72 136.14 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 110.038 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.55 103.89 9.25 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' ALA . . . . . 0.433 ' HB1' ' NZ ' ' B' ' 104' ' ' LYS . . . -167.52 160.23 12.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.559 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.03 -10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.805 ' C ' ' H ' ' B' ' 106' ' ' SER . 3.7 mmpp? 54.89 -145.6 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.347 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.54 -26.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 108.908 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.805 ' H ' ' C ' ' B' ' 104' ' ' LYS . 75.6 m -61.51 124.87 21.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.439 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 t -100.1 0.45 40.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.162 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -162.85 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.53 174.18 19.82 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.367 -1.397 . . . . 0.0 109.696 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.5 131.52 56.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.313 -1.11 . . . . 0.0 108.014 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 10.6 ttpt -105.29 133.11 50.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.935 -1.103 . . . . 0.0 112.837 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 97' ' ' ASP . 60.5 m80 -125.6 125.97 44.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.888 -1.894 . . . . 0.0 105.888 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -136.0 143.41 44.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.43 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.9 p -127.69 136.69 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.637 -0.665 . . . . 0.0 109.486 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.2 128.12 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.08 159.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 117.848 -1.541 . . . . 0.0 113.083 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 91' ' ' ASP . 11.1 mtpt -121.16 153.87 36.96 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.566 ' HB2' ' H ' ' A' ' 18' ' ' THR . 17.1 p90 -102.61 144.03 31.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.818 -1.176 . . . . 0.0 111.604 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -116.03 -29.61 6.27 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.7 tt0 -88.54 -55.18 3.83 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.564 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 13.6 m-20 152.19 74.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.566 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 39.3 m -62.24 109.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.103 0.954 . . . . 0.0 112.876 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.694 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.14 92.22 5.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 20' ' ' VAL . 8.6 m -57.59 -35.27 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 110.475 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.1 p-10 -66.46 -39.58 88.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 110.554 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 96.4 mt-10 -70.67 -32.64 69.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.63 -42.48 83.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.49 -39.26 70.2 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -60.07 -24.73 64.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -82.42 -45.84 6.75 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.455 HD21 ' OE1' ' A' ' 41' ' ' GLU . 2.5 tt -49.05 -52.45 25.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.488 -1.007 . . . . 0.0 108.838 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 18.7 pt-20 -52.83 -40.28 63.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.1 m-20 -58.62 -43.9 89.79 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.694 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -47.33 -46.75 25.7 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.53 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' SER . 37.8 t -49.14 -27.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 108.842 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 37.4 t -42.93 -48.16 5.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.63 ' NE2' ' CE1' ' A' ' 76' ' ' HIS . 8.9 mm100 -72.8 -23.25 60.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 111.481 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.76 HG22 ' O ' ' A' ' 34' ' ' ILE . 73.2 mt -82.63 23.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.043 -1.661 . . . . 0.0 110.636 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.63 -10.89 2.53 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 43.9 p -79.94 -1.0 37.46 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.6 m 35.4 32.61 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 109.117 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 20.1 mtmm -120.02 42.71 2.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' THR . 27.7 t -172.76 171.98 4.26 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -148.83 160.98 42.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.645 -1.284 . . . . 0.0 111.943 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.526 ' C ' ' HZ3' ' B' ' 104' ' ' LYS . 63.2 mt-10 -151.91 116.71 5.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.393 0.616 . . . . 0.0 110.2 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.697 ' HE1' HG11 ' B' ' 100' ' ' VAL . 11.4 t-105 -104.66 159.2 15.96 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' HZ2' ' B' ' 104' ' ' LYS . . . -118.81 151.49 17.69 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.736 -1.697 . . . . 0.0 110.803 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' B' ' 7' ' ' LYS . 70.9 mt-10 -150.84 133.47 15.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.211 -1.17 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.6 p-10 -155.46 86.56 1.08 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -78.81 155.42 29.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.398 -1.439 . . . . 0.0 109.81 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.4 mt-10 -155.52 59.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.67 -0.644 . . . . 0.0 109.331 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 49' ' ' HIS . 54.6 p -172.37 138.2 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.131 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 m80 60.82 113.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.14 -0.975 . . . . 0.0 109.688 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -55.44 -44.03 75.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 110.797 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.2 mtt -60.32 -35.74 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.746 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' B' ' 96' ' ' LEU . 12.2 mt -93.3 -28.97 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.74 -1.225 . . . . 0.0 109.283 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.065 ' O ' ' N ' ' A' ' 55' ' ' GLY . 39.6 ttt-85 -79.07 2.86 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.299 -0.876 . . . . 0.0 111.296 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 1.059 ' NE2' HD21 ' B' ' 96' ' ' LEU . 3.4 mt-30 33.72 2.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.709 -1.244 . . . . 0.0 110.212 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 1.065 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.54 -24.82 1.43 Allowed Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.379 -0.826 . . . . 0.0 112.877 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.513 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 6.5 m-85 -59.24 -142.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.26 -1.73 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.698 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 66.4 p -142.71 -48.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -0.848 . . . . 0.0 110.999 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.698 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 35.7 p-80 -173.6 159.63 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.0 110.105 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.14 172.32 13.61 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.395 -0.815 . . . . 0.0 109.221 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -138.5 133.83 33.17 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.416 -0.803 . . . . 0.0 109.12 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.6 t -110.17 102.22 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.64 125.99 44.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.269 -0.894 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 39' ' ' SER . 31.7 m -120.55 142.83 48.99 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.26 130.59 46.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.717 -1.239 . . . . 0.0 110.066 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -55.7 -31.04 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -153.84 160.48 42.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.79 -19.7 43.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.957 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.55 -39.1 72.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.813 -1.18 . . . . 0.0 110.594 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.65 77.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 74' ' ' THR . 75.7 t80 -69.17 -45.68 69.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.969 . . . . 0.0 110.432 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.81 -28.91 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.355 -1.466 . . . . 0.0 108.645 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.355 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.694 ' CE1' HD11 ' A' ' 30' ' ' LEU . 3.5 t80 -54.46 -32.05 56.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 70' ' ' TYR . 30.9 p -75.42 -31.21 60.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.762 -1.211 . . . . 0.0 110.303 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.7 t -82.34 -0.73 47.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.115 -0.991 . . . . 0.0 110.961 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.63 ' CE1' ' NE2' ' A' ' 33' ' ' GLN . 62.1 m80 -97.8 126.36 41.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.758 -1.214 . . . . 0.0 109.61 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -41.51 -14.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.0 112.418 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.2 tp -68.73 -29.26 67.63 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 111.228 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.517 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 81.6 t60 -79.88 -42.77 23.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.046 -1.034 . . . . 0.0 110.226 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.38 -60.68 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.005 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.89 -39.2 77.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -73.24 -42.49 62.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.847 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 66.8 m -62.17 -39.86 94.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.39 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 108.69 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -70.34 -41.99 72.47 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.894 ' O ' HD13 ' A' ' 90' ' ' ILE . 25.6 t80 -45.96 -30.63 1.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 89' ' ' VAL . 17.6 m -80.77 -62.73 1.58 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.93 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.69 -0.631 . . . . 0.0 110.045 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 85' ' ' ALA . 19.4 m -103.84 10.38 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.163 -0.96 . . . . 0.0 110.786 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.894 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.1 mp -119.9 154.5 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.667 -1.271 . . . . 0.0 110.426 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' LYS . 63.8 t0 -101.37 -34.65 9.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.58 148.7 31.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -126.88 125.27 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.619 -1.3 . . . . 0.0 109.786 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 5.3 t -134.25 136.53 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -138.74 137.91 37.18 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.279 -1.513 . . . . 0.0 111.779 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.069 HD21 ' NE2' ' B' ' 54' ' ' GLN . 0.8 OUTLIER -112.13 118.09 34.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.632 -0.667 . . . . 0.0 109.333 176.277 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 56.7 t0 -123.74 126.72 47.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.044 -1.035 . . . . 0.0 108.924 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 55.3 t80 -167.86 137.72 2.17 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.019 -1.051 . . . . 0.0 110.487 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.0 Cg_exo -47.7 124.45 9.73 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.26 1.973 . . . . 0.0 112.199 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.702 HG11 ' HE1' ' B' ' 42' ' ' TRP . 76.1 t -114.19 140.44 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.939 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -109.81 78.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 109.617 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.534 ' HB2' ' CZ2' ' B' ' 42' ' ' TRP . . . -49.13 88.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.541 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.671 ' O ' HG23 ' A' ' 103' ' ' VAL . 13.1 m -149.17 116.12 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.828 . . . . 0.0 109.163 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 105' ' ' SER . 5.8 ptmt -176.43 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.362 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 107' ' ' VAL . 0.3 OUTLIER 162.05 -44.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 108.965 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.3 t -64.75 44.33 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.286 -0.884 . . . . 0.0 109.395 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 105' ' ' SER . 3.5 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' H ' ' B' ' 5' ' ' GLY . 15.7 m . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' B' ' 4' ' ' SER . . . -130.62 174.22 19.84 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.423 -1.37 . . . . 0.0 109.697 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.49 131.45 56.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.272 -1.134 . . . . 0.0 108.013 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 44' ' ' GLU . 10.6 ttpt -105.08 133.14 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.894 -1.129 . . . . 0.0 112.821 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' B' ' 97' ' ' ASP . 60.5 m80 -125.72 126.04 43.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.4 tt -136.12 143.43 44.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.836 -1.165 . . . . 0.0 109.45 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 11.8 p -127.62 136.68 59.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.485 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.09 128.17 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.2 159.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 117.706 -1.598 . . . . 0.0 113.043 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' B' ' 91' ' ' ASP . 11.2 mtpt -121.13 153.81 37.0 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.571 ' HB2' ' H ' ' B' ' 18' ' ' THR . 17.3 p90 -102.61 143.96 31.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.94 -1.1 . . . . 0.0 111.585 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -115.97 -29.58 6.3 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 78.7 tt0 -88.65 -55.07 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 13.6 m-20 152.03 74.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.571 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 39.5 m -62.34 109.56 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.122 0.963 . . . . 0.0 112.862 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.2 92.21 5.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.417 ' H ' HG22 ' B' ' 20' ' ' VAL . 8.6 m -57.71 -35.1 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 110.413 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.5 p-10 -66.54 -39.63 88.68 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 110.563 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.622 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 96.4 mt-10 -70.71 -32.6 69.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.66 -42.43 83.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.6 -39.2 70.43 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.2 OUTLIER -60.02 -24.86 64.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -82.16 -45.93 6.82 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.449 HD21 ' OE1' ' B' ' 41' ' ' GLU . 2.5 tt -49.0 -52.43 25.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.968 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 18.6 pt-20 -52.96 -40.24 63.54 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 40.5 m-20 -58.59 -44.01 89.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.1 OUTLIER -47.28 -46.71 25.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' B' ' 32' ' ' SER . 37.6 t -49.16 -27.77 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.91 . . . . 0.0 108.775 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 37.0 t -42.85 -48.29 5.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.63 ' NE2' ' CE1' ' B' ' 76' ' ' HIS . 8.8 mm100 -72.52 -23.45 61.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.461 -0.774 . . . . 0.0 111.509 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.779 HG22 ' O ' ' B' ' 34' ' ' ILE . 73.4 mt -82.57 23.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.009 -1.682 . . . . 0.0 110.558 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.6 -10.91 2.52 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' N ' ' B' ' 38' ' ' LYS . 44.1 p -79.93 -0.93 37.15 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.97 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.7 m 35.43 32.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.177 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' B' ' 36' ' ' THR . 20.1 mtmm -119.93 43.01 2.78 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.4 t -172.98 171.79 4.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -148.92 160.87 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.562 -1.336 . . . . 0.0 112.002 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.507 ' C ' ' HZ3' ' A' ' 104' ' ' LYS . 63.0 mt-10 -151.85 116.7 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.369 0.604 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.702 ' HE1' HG11 ' A' ' 100' ' ' VAL . 11.4 t-105 -104.62 159.27 15.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.438 ' N ' ' HZ2' ' A' ' 104' ' ' LYS . . . -118.91 151.44 17.68 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 118.695 -1.716 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.528 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 71.7 mt-10 -150.84 133.46 15.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.27 -1.136 . . . . 0.0 109.379 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 43.1 p-10 -155.47 86.62 1.08 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -78.91 155.35 29.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.365 -1.459 . . . . 0.0 109.872 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.5 mt-10 -155.51 59.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.646 -0.659 . . . . 0.0 109.338 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.415 ' O ' ' O ' ' B' ' 49' ' ' HIS . 54.1 p -172.53 138.04 0.86 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 110.142 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' B' ' 53' ' ' ARG . 43.7 m80 61.03 113.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.684 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -55.33 -44.09 75.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.821 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.42 -35.56 76.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 12.2 mt -93.46 -28.93 15.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.724 -1.235 . . . . 0.0 109.244 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 1.066 ' O ' ' N ' ' B' ' 55' ' ' GLY . 39.8 ttt-85 -79.07 2.82 19.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.394 -0.816 . . . . 0.0 111.246 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 1.069 ' NE2' HD21 ' A' ' 96' ' ' LEU . 3.3 mt-30 33.7 2.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.77 -1.206 . . . . 0.0 110.206 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 1.066 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.41 -24.76 1.39 Allowed Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.449 -0.782 . . . . 0.0 112.865 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 6.5 m-85 -59.23 -142.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.292 -1.711 . . . . 0.0 109.928 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.618 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 64.6 p -142.73 -48.3 0.33 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.618 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 35.8 p-80 -173.72 159.45 3.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.891 -1.131 . . . . 0.0 110.186 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.8 172.37 13.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 109.283 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -138.54 133.77 33.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.479 -0.763 . . . . 0.0 109.132 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -110.04 102.28 11.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.68 125.83 44.11 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.198 -0.939 . . . . 0.0 110.782 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.1 m -120.33 142.97 48.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -129.38 130.55 46.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.746 -1.221 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -55.56 -31.17 61.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -153.74 160.64 42.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.97 -19.66 45.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 111.421 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.61 -39.02 72.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.839 -1.163 . . . . 0.0 110.611 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.59 77.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.896 ' O ' HG23 ' B' ' 74' ' ' THR . 75.7 t80 -69.07 -45.89 69.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.645 -0.915 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.92 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.354 -1.466 . . . . 0.0 108.745 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.457 -0.777 . . . . 0.0 109.365 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' B' ' 30' ' ' LEU . 3.5 t80 -54.22 -32.16 55.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 111.118 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.896 HG23 ' O ' ' B' ' 70' ' ' TYR . 30.9 p -75.31 -31.34 60.63 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.761 -1.212 . . . . 0.0 110.372 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t -82.21 -0.85 47.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.097 -1.002 . . . . 0.0 110.894 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.63 ' CE1' ' NE2' ' B' ' 33' ' ' GLN . 62.3 m80 -97.66 126.49 40.91 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.829 -1.169 . . . . 0.0 109.595 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -41.64 -14.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.65 2.234 . . . . 0.0 112.454 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' B' ' 76' ' ' HIS . 8.3 tp -68.79 -29.39 67.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.422 -0.799 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 81.5 t60 -79.59 -42.83 24.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.088 . . . . 0.0 110.324 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.46 -60.69 2.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.981 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.79 -39.38 77.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.245 -0.909 . . . . 0.0 109.616 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -73.04 -42.58 62.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 66.6 m -62.15 -39.87 94.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.172 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.59 77.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.673 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.652 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -70.22 -41.88 73.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.884 ' O ' HD13 ' B' ' 90' ' ' ILE . 26.2 t80 -46.1 -30.54 1.94 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' B' ' 89' ' ' VAL . 17.6 m -80.77 -62.72 1.59 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.07 -29.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.717 -0.615 . . . . 0.0 110.084 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.652 HG22 ' O ' ' B' ' 85' ' ' ALA . 19.5 m -103.99 10.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.225 -0.922 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.884 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.1 mp -119.9 154.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.593 -1.317 . . . . 0.0 110.481 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' B' ' 13' ' ' LYS . 64.2 t0 -101.41 -34.75 9.46 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -147.59 148.53 31.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.447 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -126.82 125.29 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.569 -1.332 . . . . 0.0 109.688 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 5.1 t -134.17 136.5 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.542 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -138.69 137.98 37.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.359 -1.463 . . . . 0.0 111.854 -178.347 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 1.059 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -112.1 118.08 34.39 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.239 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 8' ' ' HIS . 56.1 t0 -123.75 126.71 46.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.16 -0.962 . . . . 0.0 108.883 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 55.9 t80 -167.71 137.79 2.24 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' PRO . . . . . 0.525 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 88.6 Cg_exo -47.74 124.49 9.83 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.267 1.978 . . . . 0.0 112.21 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.697 HG11 ' HE1' ' A' ' 42' ' ' TRP . 76.2 t -114.24 140.38 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.99 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.86 78.6 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' ALA . . . . . 0.529 ' HB2' ' CZ2' ' A' ' 42' ' ' TRP . . . -49.06 88.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.003 . . . . 0.0 109.581 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.654 HG23 ' O ' ' B' ' 103' ' ' VAL . 13.3 m -149.11 116.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.827 . . . . 0.0 109.153 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' B' ' 105' ' ' SER . 5.9 ptmt -176.5 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 107' ' ' VAL . 0.3 OUTLIER 162.06 -44.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 8.2 t -64.59 44.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.253 -0.905 . . . . 0.0 109.456 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' B' ' 105' ' ' SER . 3.5 t . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.745 ' O ' HG22 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 81.86 -4.3 1.53 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.163 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.4 t -137.55 -98.38 0.2 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.91 175.77 20.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.722 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.51 128.94 56.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -1.115 . . . . 0.0 108.064 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HB2' HG21 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -102.72 131.04 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.947 -1.096 . . . . 0.0 112.857 -177.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -125.22 123.59 39.89 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -131.16 140.04 49.87 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.716 -1.24 . . . . 0.0 109.481 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 70.5 t -126.22 132.67 70.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.545 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 59' ' ' ALA . 1.4 t -113.0 130.53 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.18 167.17 27.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.775 -1.57 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 91' ' ' ASP . 2.2 mmmt -137.41 151.24 48.33 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.641 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 7.7 m-85 -108.07 147.3 31.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 111.637 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -127.83 -28.06 2.73 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 75.6 tt0 -87.77 -59.11 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.5 m-20 153.14 69.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 14' ' ' PHE . 31.8 m -60.02 111.71 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.063 0.935 . . . . 0.0 112.844 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.743 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.3 87.3 5.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 176.197 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.92 -32.6 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 110.487 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.3 p-10 -65.32 -37.32 86.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 96.3 mt-10 -69.79 -35.31 74.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 23' ' ' ILE . 3.2 mm -62.81 -45.22 99.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -50.24 -37.29 34.92 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -59.9 -36.29 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -78.82 -42.87 12.2 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -54.38 -59.36 4.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -1.001 . . . . 0.0 108.837 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.28 -34.89 59.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.75 -45.48 92.1 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -50.26 -44.86 53.82 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' ILE . 48.3 t -45.13 -35.41 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.243 -0.91 . . . . 0.0 108.889 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' VAL . 20.1 m -42.2 -45.86 4.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.466 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 22.4 mp0 -70.89 -23.58 62.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 111.496 176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.543 ' C ' ' H ' ' A' ' 36' ' ' THR . 22.1 mt -85.86 28.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 119.967 -1.708 . . . . 0.0 110.667 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.3 p30 -62.22 -7.2 3.84 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 38' ' ' LYS . 2.0 t -86.44 1.89 49.75 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.971 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.5 m 37.45 28.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.083 -1.011 . . . . 0.0 109.198 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 36' ' ' THR . 78.9 mttt -118.42 39.43 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.17 157.03 30.06 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.508 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 99.3 m-85 -143.95 154.0 42.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.624 -1.297 . . . . 0.0 112.013 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 55.5 mp0 -158.83 125.26 4.61 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.379 0.609 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.601 ' HE1' HG11 ' B' ' 100' ' ' VAL . 53.1 t-105 -124.02 174.33 7.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -132.63 153.31 20.58 Favored Glycine 0 N--CA 1.499 2.837 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.765 ' O ' ' CD2' ' A' ' 58' ' ' HIS . 72.8 mt-10 -147.48 137.88 23.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.204 -1.174 . . . . 0.0 109.319 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.41 144.18 48.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.568 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -149.13 122.51 9.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.502 -1.374 . . . . 0.0 109.769 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 56' ' ' PHE . 65.1 mm-40 -151.5 45.46 0.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.692 . . . . 0.0 109.335 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -124.23 121.87 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.186 -0.946 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.84 119.89 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.16 -0.963 . . . . 0.0 109.658 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.496 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 80.9 m-20 -56.38 -41.53 76.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 0.0 110.805 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG2' ' H ' ' A' ' 51' ' ' MET . 5.0 ptp -71.66 -32.01 67.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.084 . . . . 0.0 110.751 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 54' ' ' GLN . 83.7 mt -86.96 -52.54 5.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.157 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.736 ' C ' ' H ' ' A' ' 55' ' ' GLY . 15.3 ptt180 -61.93 7.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 0.0 111.219 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.54 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 3.3 mm100 53.5 -8.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.702 -1.249 . . . . 0.0 110.207 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.736 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 86.88 -21.64 18.37 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.846 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CZ ' ' NE2' ' A' ' 54' ' ' GLN . 3.2 m-85 -66.23 -128.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.247 -1.737 . . . . 0.0 109.91 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.418 HG21 ' CE2' ' A' ' 14' ' ' PHE . 4.9 t -164.85 -33.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.84 . . . . 0.0 111.002 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.765 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 5.4 t-80 -171.77 154.25 3.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.701 ' O ' ' CE1' ' A' ' 58' ' ' HIS . . . -141.56 171.4 14.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.218 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.32 121.26 35.36 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.365 -0.834 . . . . 0.0 109.087 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m -96.71 101.41 13.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.4 mtt -109.81 123.4 49.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 110.828 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.0 m -124.38 148.11 47.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.64 156.06 39.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.694 -1.254 . . . . 0.0 110.118 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.446 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 48.8 tp10 -82.91 -28.31 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 75.6 m-20 -164.65 169.23 17.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.5 ' NZ ' ' CB ' ' A' ' 67' ' ' LYS . 8.3 mtmp? -58.9 -18.94 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 111.432 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 25.4 p-10 -59.52 -40.66 87.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.771 -1.205 . . . . 0.0 110.562 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -71.3 -32.89 64.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' O ' HG22 ' A' ' 74' ' ' THR . 70.5 t80 -67.4 -44.7 78.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.522 -0.987 . . . . 0.0 110.498 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.9 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.336 -1.478 . . . . 0.0 108.657 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.88 2.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.261 -0.899 . . . . 0.0 109.345 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.2 -35.49 59.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 111.112 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.2 t -84.23 -30.11 25.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.704 -1.247 . . . . 0.0 110.29 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.6 p -68.52 -29.57 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.965 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' A' ' 78' ' ' LEU . 16.4 m-70 -76.81 127.4 84.11 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 0.0 109.562 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.3 -7.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.4 tp -70.87 -26.19 63.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.351 -0.843 . . . . 0.0 111.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.417 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.5 t60 -80.93 -42.62 21.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.049 . . . . 0.0 110.218 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.772 HG13 ' H ' ' A' ' 81' ' ' GLU . 3.7 p -64.92 -57.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.772 ' H ' HG13 ' A' ' 80' ' ' VAL . 93.2 mt-10 -58.89 -42.73 90.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 81.3 t80 -66.45 -43.36 85.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.863 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -59.89 -33.23 71.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.131 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.63 53.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.935 -1.103 . . . . 0.0 108.681 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -72.22 -43.45 64.43 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.534 ' O ' HD12 ' A' ' 90' ' ' ILE . 26.5 t80 -42.77 -29.02 0.28 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 90' ' ' ILE . 5.8 m -84.52 -61.49 1.78 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.16 -28.73 0.06 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.706 -0.621 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 87' ' ' THR . 8.9 m -97.45 13.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.196 -0.94 . . . . 0.0 110.816 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 86' ' ' PHE . 74.3 mt -123.19 156.03 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.628 -1.295 . . . . 0.0 110.45 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.0 t0 -98.64 -35.4 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' N ' HG22 ' A' ' 90' ' ' ILE . 11.1 pttp -147.63 146.04 29.19 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.7 tp -124.85 126.25 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.62 -1.3 . . . . 0.0 109.727 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t -132.07 135.44 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -139.06 134.97 33.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.303 -1.498 . . . . 0.0 111.751 -178.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.6 mp -113.82 119.08 36.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.681 -0.637 . . . . 0.0 109.303 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.37 130.29 50.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.023 -1.048 . . . . 0.0 108.96 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -172.0 140.03 1.1 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.057 -1.027 . . . . 0.0 110.486 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.91 121.38 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.296 1.998 . . . . 0.0 112.173 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' A' ' 7' ' ' LYS . 65.4 t -109.05 138.11 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.992 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.19 107.55 10.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.376 -0.828 . . . . 0.0 109.639 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -154.88 149.63 26.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.51 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 102' ' ' ALA . 3.2 m -154.91 147.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.247 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -130.27 65.77 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.348 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 106' ' ' SER . 23.2 m -51.67 -23.42 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.15 -0.969 . . . . 0.0 108.944 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' SER . 1.4 p 76.22 144.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.388 -0.82 . . . . 0.0 109.336 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.684 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.96 175.97 20.27 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.374 -1.393 . . . . 0.0 109.698 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -114.69 129.09 56.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.654 ' HB2' HG21 ' B' ' 100' ' ' VAL . 0.0 OUTLIER -102.97 130.87 50.21 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.319 1.057 . . . . 0.0 112.851 -177.274 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -124.99 123.59 40.2 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.3 tt -131.14 140.06 49.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.762 -1.211 . . . . 0.0 109.444 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 70.0 t -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.586 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' B' ' 59' ' ' ALA . 1.4 t -113.27 130.41 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.17 167.25 26.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 117.723 -1.591 . . . . 0.0 113.058 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' B' ' 91' ' ' ASP . 2.2 mmmt -137.47 151.01 48.02 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD1' ' OG1' ' B' ' 18' ' ' THR . 7.6 m-85 -107.88 147.37 31.05 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.785 -1.197 . . . . 0.0 111.57 -178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -127.99 -27.76 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 75.2 tt0 -88.19 -58.93 2.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.4 m-20 153.07 69.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.639 ' OG1' ' CD1' ' B' ' 14' ' ' PHE . 32.5 m -60.15 111.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.034 0.921 . . . . 0.0 112.927 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.753 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.28 87.34 5.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.02 -32.42 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.661 . . . . 0.0 110.433 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -65.34 -37.43 87.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.56 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 96.3 mt-10 -69.76 -35.37 74.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' B' ' 26' ' ' GLY . 3.3 mm -62.6 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -50.35 -37.04 34.9 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -60.1 -35.88 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -79.3 -42.7 11.48 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.434 HD13 ' C ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -54.31 -59.39 4.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.545 -0.973 . . . . 0.0 108.85 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.41 -34.89 59.51 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -45.56 91.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 30' ' ' LEU . 0.4 OUTLIER -50.15 -44.99 52.85 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' B' ' 34' ' ' ILE . 48.4 t -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.245 -0.909 . . . . 0.0 108.792 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.433 ' C ' ' O ' ' B' ' 31' ' ' VAL . 20.4 m -42.37 -45.64 4.38 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' B' ' 33' ' ' GLN . 22.3 mp0 -71.1 -23.55 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 111.535 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.549 HG22 ' O ' ' B' ' 34' ' ' ILE . 22.2 mt -85.79 28.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.006 -1.684 . . . . 0.0 110.571 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.4 p30 -62.36 -7.14 3.91 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.612 ' O ' ' N ' ' B' ' 38' ' ' LYS . 1.9 t -86.55 2.08 49.37 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.874 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.515 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.5 m 37.47 28.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 109.167 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' B' ' 36' ' ' THR . 78.5 mttt -118.3 39.88 3.32 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 156.72 28.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.498 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 99.3 m-85 -143.75 153.83 42.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.497 -1.377 . . . . 0.0 111.946 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.504 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 56.1 mp0 -158.76 125.23 4.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.407 0.622 . . . . 0.0 110.208 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.601 ' HE1' HG11 ' A' ' 100' ' ' VAL . 53.0 t-105 -124.01 174.69 7.44 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.558 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -133.28 152.91 20.55 Favored Glycine 0 N--CA 1.498 2.82 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.839 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.757 ' O ' ' CD2' ' B' ' 58' ' ' HIS . 71.2 mt-10 -147.2 137.87 23.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.46 143.95 48.24 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.92 122.84 9.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.386 -1.446 . . . . 0.0 109.816 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' B' ' 56' ' ' PHE . 64.9 mm-40 -151.79 45.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.665 -0.647 . . . . 0.0 109.388 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -124.12 121.7 35.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 110.172 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.92 119.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.484 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 79.4 m-20 -56.3 -41.52 76.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.838 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 4.9 ptp -71.8 -31.91 67.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.034 . . . . 0.0 110.726 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' B' ' 54' ' ' GLN . 84.0 mt -86.95 -52.45 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.712 -1.243 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.698 ' C ' ' H ' ' B' ' 55' ' ' GLY . 15.4 ptt180 -62.02 7.94 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 111.307 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.534 ' NE2' ' CZ ' ' B' ' 56' ' ' PHE . 3.3 mm100 53.53 -8.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.832 -1.168 . . . . 0.0 110.225 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.698 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 87.12 -21.48 20.17 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.468 -0.77 . . . . 0.0 112.864 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.534 ' CZ ' ' NE2' ' B' ' 54' ' ' GLN . 3.2 m-85 -66.39 -128.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.278 -1.719 . . . . 0.0 109.915 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.422 HG21 ' CE2' ' B' ' 14' ' ' PHE . 4.8 t -164.46 -34.15 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.276 -0.89 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.757 ' CD2' ' O ' ' B' ' 44' ' ' GLU . 5.4 t-80 -171.61 154.56 3.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.803 -1.186 . . . . 0.0 110.231 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.694 ' O ' ' CE1' ' B' ' 58' ' ' HIS . . . -141.98 171.09 14.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.02 121.26 35.64 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -96.65 101.48 13.1 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 38.8 mtt -109.9 123.6 49.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 110.782 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 97.1 m -124.71 147.93 48.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.53 156.03 39.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.668 -1.27 . . . . 0.0 110.058 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 50.2 tp10 -82.7 -28.64 30.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 75.5 m-20 -164.31 169.74 17.09 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.493 ' NZ ' ' CB ' ' B' ' 67' ' ' LYS . 8.2 mtmp? -59.14 -19.09 41.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 0.0 111.406 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 26.5 p-10 -59.51 -40.67 87.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.905 -1.122 . . . . 0.0 110.55 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -71.22 -32.79 65.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.505 ' O ' HG22 ' B' ' 74' ' ' THR . 71.0 t80 -67.41 -44.87 77.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.644 -0.915 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.8 -28.88 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.352 -1.468 . . . . 0.0 108.671 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.84 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -35.25 59.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 111.141 -176.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.505 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.2 t -84.51 -30.01 25.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.744 -1.223 . . . . 0.0 110.339 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 95.0 p -68.43 -29.56 68.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.12 -0.988 . . . . 0.0 110.964 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 78' ' ' LEU . 16.4 m-70 -76.97 127.53 83.54 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.4 -7.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.598 2.199 . . . . 0.0 112.48 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.4 tp -70.82 -26.38 63.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.408 -0.808 . . . . 0.0 111.178 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -80.86 -42.7 21.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 110.276 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.77 HG13 ' H ' ' B' ' 81' ' ' GLU . 3.6 p -64.8 -57.61 10.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 110.024 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.77 ' H ' HG13 ' B' ' 80' ' ' VAL . 93.2 mt-10 -58.9 -42.67 90.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.299 -0.876 . . . . 0.0 109.587 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 81.1 t80 -66.48 -43.48 85.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.818 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -59.71 -33.36 71.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.111 -0.993 . . . . 0.0 110.149 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.93 49.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 108.644 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -71.81 -43.54 65.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.548 ' O ' HD12 ' B' ' 90' ' ' ILE . 26.4 t80 -42.75 -29.2 0.29 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.471 ' O ' ' N ' ' B' ' 89' ' ' VAL . 5.4 m -84.32 -61.62 1.76 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.98 -28.67 0.06 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.681 -0.637 . . . . 0.0 110.098 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.2 m -97.69 13.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.548 HD12 ' O ' ' B' ' 86' ' ' PHE . 73.4 mt -123.39 156.1 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.651 -1.281 . . . . 0.0 110.437 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' B' ' 13' ' ' LYS . 61.8 t0 -98.54 -35.45 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.453 ' N ' HG22 ' B' ' 90' ' ' ILE . 11.2 pttp -147.66 145.71 29.04 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.43 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.7 tp -124.46 126.06 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.556 -1.34 . . . . 0.0 109.727 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 22.3 t -131.74 135.68 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.868 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -139.11 135.04 33.69 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.256 -1.527 . . . . 0.0 111.798 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.885 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.7 mp -113.86 119.04 35.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 109.33 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.22 130.48 51.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.102 -0.999 . . . . 0.0 108.97 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -171.98 140.08 1.1 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.126 -0.984 . . . . 0.0 110.538 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.86 121.18 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.308 2.005 . . . . 0.0 112.194 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' B' ' 7' ' ' LYS . 63.4 t -108.77 138.29 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 110.037 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.4 107.79 10.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.581 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' ALA . . . . . 0.486 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -155.13 149.62 26.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.486 HG13 ' O ' ' B' ' 102' ' ' ALA . 3.2 m -155.03 147.72 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.377 -0.827 . . . . 0.0 109.233 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -130.27 65.53 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.373 -179.179 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' B' ' 106' ' ' SER . 24.4 m -51.31 -23.83 4.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' B' ' 105' ' ' SER . 1.4 p 76.53 144.83 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.367 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t . . . . . 0 C--N 1.303 -1.441 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.605 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.421 0.629 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.675 HG23 ' HB2' ' A' ' 101' ' ' ALA . 1.0 OUTLIER 155.25 -62.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.133 -178.327 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 3' ' ' THR . 2.5 t 152.35 -100.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 4' ' ' SER . . . -81.09 170.42 52.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.24 132.92 42.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 108.027 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 5.2 ttpm? -100.3 127.01 46.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 112.813 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 62' ' ' MET . 56.4 m80 -117.12 116.46 27.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -131.59 140.96 49.56 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.734 -1.229 . . . . 0.0 109.408 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.02 138.51 52.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.6 -0.687 . . . . 0.0 109.458 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.13 130.38 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.655 ' HB ' HD12 ' A' ' 90' ' ' ILE . 3.9 m -135.02 148.95 28.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 117.74 -1.584 . . . . 0.0 113.028 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.665 ' HZ2' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -120.15 151.99 38.28 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.113 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.616 ' CD2' HG21 ' A' ' 57' ' ' THR . 9.2 p90 -113.32 152.94 29.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.81 -1.181 . . . . 0.0 111.601 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -128.67 -18.05 3.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.2 mm-40 -90.33 -57.28 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 12.1 m-20 154.09 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 51.7 m -51.59 112.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.098 0.951 . . . . 0.0 112.84 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.569 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.87 90.66 2.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LEU . 29.1 m -62.85 -41.91 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.504 -0.747 . . . . 0.0 110.512 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' HG23 ' A' ' 20' ' ' VAL . 87.1 m-20 -63.43 -45.13 92.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.559 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -70.29 -33.05 71.09 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.34 -40.29 79.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.5 tp -58.84 -38.77 79.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.68 -35.07 76.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.93 -53.55 36.69 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 27' ' ' LEU . 5.8 tt -48.08 -43.84 31.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.511 -0.993 . . . . 0.0 108.813 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -54.71 -46.42 74.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.537 ' ND2' ' CE2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.66 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -47.7 -41.67 23.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.555 HG21 ' HA ' ' B' ' 105' ' ' SER . 19.3 t -54.74 -20.5 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.236 -0.915 . . . . 0.0 108.902 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 74.5 m -44.63 -42.28 7.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.533 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 46.2 mm-40 -83.84 -9.77 58.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 111.398 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 34' ' ' ILE . 45.0 mm -91.23 23.56 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 119.976 -1.702 . . . . 0.0 110.716 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.77 -8.92 1.05 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 37' ' ' VAL . 33.6 p -79.15 -2.82 42.59 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.972 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.614 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.8 m 32.13 41.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.08 -1.012 . . . . 0.0 109.135 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.0 ptmt -122.32 41.93 3.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.569 ' OG ' HD12 ' A' ' 34' ' ' ILE . 87.6 p -173.67 178.18 2.33 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 87.3 m-85 -147.01 155.0 41.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.546 -1.346 . . . . 0.0 111.929 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 46.5 mp0 -152.46 121.18 6.48 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -126.5 168.71 13.87 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.12 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.01 159.28 21.16 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.827 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.57 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 49.4 mp0 -147.78 140.59 24.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.331 -1.1 . . . . 0.0 109.392 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.3 t0 -128.46 155.7 44.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -60.22 80.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.461 -1.4 . . . . 0.0 109.747 -177.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.3 mt-10 -105.04 42.65 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.67 -0.644 . . . . 0.0 109.272 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.554 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 3.4 m -150.09 179.38 8.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.47 150.01 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 51' ' ' MET . 32.2 p-10 -43.94 -44.05 6.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.787 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.527 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 83.2 mmm -67.19 -28.96 68.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.942 -1.099 . . . . 0.0 110.713 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 95' ' ' LEU . 33.9 mt -98.29 -30.18 12.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.772 -1.205 . . . . 0.0 109.292 -178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.662 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 3.2 ptm180 -86.46 -1.73 57.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.827 . . . . 0.0 111.225 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 53' ' ' ARG . 17.0 tt0 45.96 10.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.73 -1.231 . . . . 0.0 110.149 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.662 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 58.77 -5.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.424 -0.797 . . . . 0.0 112.89 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 11.8 p90 -57.0 131.11 48.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.204 -1.762 . . . . 0.0 109.93 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.616 HG21 ' CD2' ' A' ' 14' ' ' PHE . 71.3 p -54.15 -48.1 71.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.0 110.995 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 23.7 t60 -173.0 159.19 3.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.109 . . . . 0.0 110.165 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.612 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -144.83 169.53 17.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -0.805 . . . . 0.0 109.219 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 76.6 m-85 -135.12 130.64 35.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.484 -0.76 . . . . 0.0 109.075 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 98.18 8.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.511 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.2 mtp -98.9 118.89 36.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.165 -0.96 . . . . 0.0 110.849 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -123.29 142.43 50.95 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.94 162.58 18.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.829 -1.17 . . . . 0.0 110.078 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.57 -29.97 29.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -169.76 175.0 5.44 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -58.38 -22.52 54.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 111.415 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.84 -37.56 71.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.809 -1.182 . . . . 0.0 110.617 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.08 76.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.747 ' O ' HG22 ' A' ' 74' ' ' THR . 74.0 t80 -67.14 -44.18 80.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.956 . . . . 0.0 110.417 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.76 -28.93 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.38 -1.45 . . . . 0.0 108.696 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . -64.98 -61.0 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CE1' HD11 ' A' ' 30' ' ' LEU . 2.7 t80 -63.73 -60.22 3.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.207 -0.933 . . . . 0.0 111.115 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 70' ' ' TYR . 14.8 t -49.46 -37.22 25.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.752 -1.218 . . . . 0.0 110.357 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 74' ' ' THR . 63.7 p -65.97 -11.95 51.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 0.0 111.014 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 78' ' ' LEU . 23.1 m80 -92.64 125.99 53.66 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.25 -4.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.675 2.25 . . . . 0.0 112.489 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.3 tp -74.39 -25.87 59.75 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.297 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -77.84 -45.4 24.44 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.086 -1.009 . . . . 0.0 110.247 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.756 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -63.37 -57.94 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.993 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.756 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.3 tt0 -53.59 -36.45 61.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 6.4 m-85 -74.39 -36.18 63.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.875 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -62.09 -42.9 99.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.61 -44.14 97.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 108.656 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -68.87 -44.19 73.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.482 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.03 -30.18 0.41 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' VAL . 10.9 m -82.36 -64.17 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -43.3 -24.83 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 110.099 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 85' ' ' ALA . 4.9 m -107.4 9.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 110.723 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.655 HD12 ' HB ' ' A' ' 12' ' ' VAL . 28.9 mm -131.44 164.37 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.6 -1.313 . . . . 0.0 110.504 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 90' ' ' ILE . 52.2 t0 -109.42 -33.41 6.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' NZ ' ' NZ ' ' A' ' 13' ' ' LYS . 29.2 pttt -147.84 147.57 29.94 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.605 HD12 HG12 ' A' ' 12' ' ' VAL . 4.1 tp -128.86 123.81 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.637 -1.289 . . . . 0.0 109.785 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.7 132.64 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -142.05 138.37 31.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.269 -1.519 . . . . 0.0 111.748 -178.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.875 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -116.5 119.28 35.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.719 -0.613 . . . . 0.0 109.355 177.216 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.403 ' O ' ' OG ' ' B' ' 48' ' ' SER . 62.2 t0 -111.21 117.5 33.38 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -0.989 . . . . 0.0 108.971 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 54.7 t80 -141.37 137.65 16.8 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.01 . . . . 0.0 110.465 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.55 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 31.0 Cg_endo -61.02 127.81 23.42 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.257 1.972 . . . . 0.0 112.229 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.61 117.3 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.009 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.675 ' HB2' HG23 ' A' ' 3' ' ' THR . . . -109.35 95.29 5.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.546 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.422 ' C ' HG13 ' A' ' 103' ' ' VAL . . . -65.45 69.74 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.9 m -152.88 95.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.243 -178.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' SER . 7.7 ptmm? -175.19 -126.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.396 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.578 ' HA ' HG21 ' B' ' 31' ' ' VAL . 1.5 m 63.96 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 108.899 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' LYS . 4.4 m -115.84 71.04 0.76 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.276 -0.89 . . . . 0.0 109.339 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 107' ' ' VAL . 14.3 p . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' B' ' 5' ' ' GLY . 2.5 t . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' B' ' 4' ' ' SER . . . -81.19 170.41 52.59 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.02 133.16 42.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.281 -1.129 . . . . 0.0 108.043 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' B' ' 7' ' ' LYS . 5.1 ttpm? -100.51 126.93 46.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.937 -1.102 . . . . 0.0 112.843 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 62' ' ' MET . 56.0 m80 -117.11 116.2 26.86 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -131.28 141.13 49.93 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.657 -1.277 . . . . 0.0 109.474 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.05 138.64 52.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 130.3 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.657 ' HB ' HD12 ' B' ' 90' ' ' ILE . 3.9 m -134.94 148.77 28.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.818 -1.553 . . . . 0.0 113.051 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.64 ' HZ2' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -120.11 151.91 38.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.61 ' CD2' HG21 ' B' ' 57' ' ' THR . 9.4 p90 -113.35 152.96 29.28 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.828 -1.17 . . . . 0.0 111.545 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -128.77 -18.0 3.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CG ' ' B' ' 17' ' ' ASP . 77.5 mm-40 -90.32 -57.08 2.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CG ' ' O ' ' B' ' 16' ' ' GLU . 12.7 m-20 153.73 58.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.447 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 58.6 m -52.45 112.35 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.147 0.975 . . . . 0.0 112.846 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.582 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.6 90.46 2.79 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' B' ' 24' ' ' LEU . 29.8 m -62.7 -41.93 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.683 -0.636 . . . . 0.0 110.474 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.524 ' N ' HG23 ' B' ' 20' ' ' VAL . 86.2 m-20 -63.45 -45.01 92.84 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.447 -0.783 . . . . 0.0 110.563 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -70.3 -33.26 71.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.26 -40.19 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -58.99 -38.65 79.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.52 -35.03 76.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.44 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -64.44 -53.07 38.08 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.685 HD23 ' O ' ' B' ' 27' ' ' LEU . 5.8 tt -48.21 -43.97 32.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.577 -0.955 . . . . 0.0 108.799 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -54.49 -46.77 73.51 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' B' ' 82' ' ' PHE . 0.0 OUTLIER -52.79 -41.34 64.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.555 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -47.98 -41.35 24.98 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 105' ' ' SER . 19.3 t -54.99 -20.21 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.311 -0.868 . . . . 0.0 108.829 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.47 ' N ' ' O ' ' B' ' 29' ' ' ASN . 73.6 m -44.87 -42.34 7.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.534 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 46.1 mm-40 -83.85 -9.55 58.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.449 -0.782 . . . . 0.0 111.523 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.769 HG22 ' O ' ' B' ' 34' ' ' ILE . 44.9 mm -91.29 23.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.031 -1.668 . . . . 0.0 110.641 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -57.65 -8.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.592 ' O ' ' C ' ' B' ' 37' ' ' VAL . 34.2 p -79.06 -2.68 41.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.984 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.592 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.0 m 32.13 41.84 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.121 -0.987 . . . . 0.0 109.194 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.1 ptmt -122.24 42.15 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.573 ' OG ' HD12 ' B' ' 34' ' ' ILE . 89.2 p -173.82 177.97 2.32 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 86.5 m-85 -146.91 155.06 42.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.52 -1.362 . . . . 0.0 111.944 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' B' ' 41' ' ' GLU . 46.4 mp0 -152.42 121.11 6.47 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.364 0.602 . . . . 0.0 110.194 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.642 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.7 OUTLIER -126.48 168.83 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.09 159.48 21.22 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.807 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.584 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 49.8 mp0 -148.13 140.65 24.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.407 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' B' ' 47' ' ' GLU . 61.9 t0 -128.49 155.64 44.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.521 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -60.17 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.44 -1.413 . . . . 0.0 109.773 -177.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.5 mt-10 -104.65 42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.676 -0.64 . . . . 0.0 109.358 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 3.6 m -150.04 179.58 7.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.139 -0.975 . . . . 0.0 110.243 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.62 150.29 41.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.945 . . . . 0.0 109.701 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.3 p-10 -44.14 -43.77 7.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.858 . . . . 0.0 110.8 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.53 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 83.4 mmm -67.57 -28.95 68.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.14 -0.975 . . . . 0.0 110.75 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 95' ' ' LEU . 34.6 mt -98.32 -29.76 12.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.747 -1.221 . . . . 0.0 109.265 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' B' ' 55' ' ' GLY . 3.2 ptm180 -86.89 -1.66 57.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.394 -0.816 . . . . 0.0 111.243 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 45.99 10.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.807 -1.183 . . . . 0.0 110.194 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 59.3 -5.81 0.08 OUTLIER Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.428 -0.795 . . . . 0.0 112.881 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 11.7 p90 -56.64 131.11 47.98 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.259 -1.73 . . . . 0.0 109.899 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.61 HG21 ' CD2' ' B' ' 14' ' ' PHE . 69.9 p -54.19 -47.9 71.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.279 -0.888 . . . . 0.0 110.995 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.64 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 23.6 t60 -173.13 159.61 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.9 -1.125 . . . . 0.0 110.165 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -145.39 169.28 18.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.542 -0.724 . . . . 0.0 109.292 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 76.6 m-85 -134.91 130.64 36.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.512 -0.742 . . . . 0.0 109.081 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 97.81 8.55 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' MET . . . . . 0.515 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.8 mtp -98.62 119.1 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.198 -0.939 . . . . 0.0 110.77 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -123.43 142.63 50.79 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.0 162.99 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 110.038 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -82.98 -29.84 28.69 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -169.73 175.44 5.28 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -58.72 -22.46 57.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 111.45 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -57.08 -37.57 72.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.804 -1.185 . . . . 0.0 110.565 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 -33.1 77.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.748 ' O ' HG22 ' B' ' 74' ' ' THR . 74.5 t80 -67.01 -44.55 80.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.947 . . . . 0.0 110.405 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.81 -28.87 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.329 -1.482 . . . . 0.0 108.669 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.1 -60.91 2.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.673 ' CE1' HD11 ' B' ' 30' ' ' LEU . 2.7 t80 -63.22 -60.48 3.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 111.136 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.748 HG22 ' O ' ' B' ' 70' ' ' TYR . 14.9 t -49.47 -37.18 25.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 63.9 p -65.92 -12.04 51.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.982 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' B' ' 78' ' ' LEU . 23.1 m80 -92.6 126.27 52.71 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.898 -1.126 . . . . 0.0 109.544 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -44.6 -4.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.686 2.257 . . . . 0.0 112.424 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.3 tp -74.44 -26.22 59.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.366 -0.834 . . . . 0.0 111.18 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -77.72 -45.25 25.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.95 -1.094 . . . . 0.0 110.321 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.767 HG13 ' N ' ' B' ' 81' ' ' GLU . 7.1 p -63.19 -58.21 8.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.767 ' N ' HG13 ' B' ' 80' ' ' VAL . 84.0 tt0 -53.56 -36.36 61.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 6.4 m-85 -74.38 -36.4 63.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.872 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 87.5 p -61.79 -43.05 99.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.052 -1.03 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.97 97.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 108.622 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.632 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -69.13 -43.99 73.28 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.485 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.22 -30.0 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.6 m -82.48 -64.15 1.23 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -43.26 -24.94 0.1 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.76 -0.588 . . . . 0.0 110.12 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.632 HG22 ' O ' ' B' ' 85' ' ' ALA . 4.9 m -107.34 9.89 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 110.838 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.657 HD12 ' HB ' ' B' ' 12' ' ' VAL . 28.3 mm -131.68 164.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.628 -1.295 . . . . 0.0 110.462 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.628 ' N ' HG22 ' B' ' 90' ' ' ILE . 52.0 t0 -109.28 -33.49 6.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.491 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 28.2 pttt -147.86 147.67 30.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.608 HD12 HG12 ' B' ' 12' ' ' VAL . 4.2 tp -128.98 123.67 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.569 -1.332 . . . . 0.0 109.711 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.52 132.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.844 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -141.95 138.5 32.0 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.266 -1.521 . . . . 0.0 111.774 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.871 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.0 OUTLIER -116.55 119.27 35.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.708 -0.62 . . . . 0.0 109.334 177.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.408 ' O ' ' OG ' ' A' ' 48' ' ' SER . 62.4 t0 -111.19 117.14 32.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.04 -1.037 . . . . 0.0 108.889 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 55.6 t80 -140.87 137.89 17.62 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.057 -1.027 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 31.3 Cg_endo -61.18 127.91 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.286 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 5' ' ' GLY . 99.2 t -92.76 117.41 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 109.974 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.45 95.05 5.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 109.609 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' ALA . . . . . 0.424 ' C ' HG13 ' B' ' 103' ' ' VAL . . . -65.36 70.05 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.784 HG23 ' O ' ' B' ' 103' ' ' VAL . 21.9 m -153.15 95.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' B' ' 106' ' ' SER . 7.6 ptmm? -175.09 -127.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.331 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.555 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.6 m 64.16 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 108.922 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.504 ' N ' ' O ' ' B' ' 104' ' ' LYS . 4.4 m -115.76 70.6 0.75 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.43 HG22 ' O ' ' B' ' 107' ' ' VAL . 13.9 p . . . . . 0 C--N 1.301 -1.506 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.376 0.608 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -101.15 -7.82 22.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.111 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.7 t -145.93 -80.91 0.15 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.16 -158.97 7.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -135.76 138.15 42.38 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.164 -1.198 . . . . 0.0 108.09 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.452 ' CD ' ' CZ2' ' B' ' 42' ' ' TRP . 1.1 ttpm? -113.32 141.31 47.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.906 -1.121 . . . . 0.0 112.801 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -130.02 130.05 44.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.3 tt -135.17 144.67 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.7 -1.25 . . . . 0.0 109.485 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.8 p -128.47 135.56 62.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.434 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.38 128.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.81 157.0 32.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 117.766 -1.574 . . . . 0.0 112.994 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 91' ' ' ASP . 20.6 tptm -122.34 152.1 40.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' HB2' ' H ' ' A' ' 18' ' ' THR . 29.9 p90 -105.29 147.17 28.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.942 -1.099 . . . . 0.0 111.643 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -120.75 -24.91 5.58 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.0 mt-10 -89.38 -54.98 3.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.5 t0 150.58 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.497 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 61.0 m -58.91 110.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.112 0.958 . . . . 0.0 112.851 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.724 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -81.29 92.67 6.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.675 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 20' ' ' VAL . 11.5 m -58.72 -32.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.551 -0.718 . . . . 0.0 110.473 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.6 p-10 -66.41 -39.2 88.84 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 78.0 mm-40 -67.74 -34.2 76.38 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.71 -44.36 93.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.4 tp -53.89 -37.15 63.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.85 -32.12 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -81.9 -43.76 8.08 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.67 -58.27 8.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.482 -1.011 . . . . 0.0 108.777 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 9.3 pt-20 -51.68 -43.95 62.92 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' ' CG ' ' A' ' 28' ' ' GLU . 14.9 t-20 -61.56 -43.38 98.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.755 HD22 HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -49.95 -43.73 50.24 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.027 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 34' ' ' ILE . 39.8 t -50.8 -27.86 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.315 -0.866 . . . . 0.0 108.874 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' VAL . 46.9 t -40.61 -42.89 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.528 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 29.9 mm100 -75.75 -23.15 55.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.495 -0.753 . . . . 0.0 111.462 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.651 ' O ' HG22 ' A' ' 34' ' ' ILE . 30.9 mm -85.69 25.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.068 -1.645 . . . . 0.0 110.648 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 36' ' ' THR . 54.3 p30 -60.74 -9.01 3.39 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 38' ' ' LYS . 59.5 p -73.88 -3.2 27.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.896 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.5 m 35.65 30.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.16 -0.963 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 36' ' ' THR . 75.1 mttt -118.94 39.5 3.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 t -170.9 170.92 6.18 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -147.42 157.48 43.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.595 -1.316 . . . . 0.0 112.006 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.562 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 58.1 mt-10 -151.59 120.26 6.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.417 0.627 . . . . 0.0 110.169 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.709 ' CD1' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.49 164.55 24.58 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.709 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -134.45 174.1 21.13 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.733 -1.699 . . . . 0.0 110.766 -178.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -152.69 141.21 20.77 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -1.174 . . . . 0.0 109.371 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -105.12 140.72 37.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -135.24 103.59 5.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.374 -1.454 . . . . 0.0 109.749 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -146.97 25.6 1.13 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.651 -0.656 . . . . 0.0 109.312 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.476 ' H ' ' CB ' ' A' ' 53' ' ' ARG . 11.6 p -89.09 -106.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 m80 -92.61 148.07 22.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 51' ' ' MET . 31.5 p-10 -53.45 -43.07 67.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.365 -0.834 . . . . 0.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.522 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.9 tpt -75.42 -32.05 60.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.0 110.745 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 95' ' ' LEU . 48.9 mt -90.14 -54.53 3.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.732 -1.23 . . . . 0.0 109.305 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.76 ' C ' ' H ' ' A' ' 55' ' ' GLY . 12.5 ptt180 -62.59 1.23 0.39 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.492 ' NE2' HG11 ' B' ' 94' ' ' VAL . 0.4 OUTLIER 56.11 -17.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.803 -1.185 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.76 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 88.05 -23.16 15.29 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.511 -0.743 . . . . 0.0 112.905 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' GLY . 3.5 m-85 -61.23 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.212 -1.758 . . . . 0.0 109.903 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 58' ' ' HIS . 3.2 t -161.5 -35.99 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.315 -0.866 . . . . 0.0 110.996 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.667 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 35.1 t-80 -166.89 149.46 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.937 -1.102 . . . . 0.0 110.19 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -142.72 167.63 21.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 58' ' ' HIS . 91.3 m-85 -138.15 134.87 35.12 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.494 -0.754 . . . . 0.0 109.073 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.546 ' OG ' ' CZ3' ' A' ' 42' ' ' TRP . 1.4 m -116.45 104.64 11.64 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.7 mtt -95.32 125.45 39.96 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.143 -0.973 . . . . 0.0 110.79 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 m -118.89 140.87 49.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -127.2 128.1 45.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.742 -1.224 . . . . 0.0 110.036 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -50.96 -26.36 5.85 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -171.43 172.9 4.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.9 -19.17 60.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 111.361 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.92 -40.71 89.8 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.859 -1.15 . . . . 0.0 110.613 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.84 -29.25 59.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 74' ' ' THR . 73.5 t80 -66.1 -42.59 89.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.917 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.407 -1.433 . . . . 0.0 108.669 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.96 2.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.304 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.45 -39.39 64.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 111.159 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.0 t -79.78 -29.62 40.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.746 -1.221 . . . . 0.0 110.338 -177.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -65.44 -25.56 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 111.023 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' A' ' 78' ' ' LEU . 56.8 t-80 -79.04 125.33 83.95 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.833 -1.167 . . . . 0.0 109.661 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.43 -6.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.755 HD23 HD22 ' A' ' 30' ' ' LEU . 6.1 tp -75.84 -25.38 56.19 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 111.203 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.6 t60 -76.57 -43.0 40.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.018 -1.051 . . . . 0.0 110.241 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.733 HG13 ' N ' ' A' ' 81' ' ' GLU . 11.3 p -64.4 -54.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.733 ' N ' HG13 ' A' ' 80' ' ' VAL . 78.7 mm-40 -50.43 -30.83 13.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' CD1' ' A' ' 86' ' ' PHE . 4.2 m-85 -72.97 -37.34 67.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.879 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.6 m -63.46 -42.33 98.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.0 110.14 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.48 67.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.965 -1.084 . . . . 0.0 108.751 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.0 -43.43 82.93 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 82' ' ' PHE . 2.5 m-85 -45.0 -31.06 1.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.1 m -78.94 -63.31 1.45 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.03 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.72 -0.612 . . . . 0.0 110.064 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.4 m -111.92 6.91 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.18 -0.95 . . . . 0.0 110.803 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 34.5 mt -120.11 154.64 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.647 -1.283 . . . . 0.0 110.444 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.9 t0 -103.52 -31.42 9.96 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' NZ ' ' CE1' ' A' ' 56' ' ' PHE . 37.9 pttt -150.44 149.3 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 93' ' ' ILE . 3.8 tp -125.24 121.94 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.615 -1.303 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.496 HG11 ' NE2' ' B' ' 54' ' ' GLN . 48.8 t -129.76 133.52 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -139.49 136.86 34.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.241 -1.537 . . . . 0.0 111.752 -178.145 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.95 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.94 121.44 42.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.655 -0.653 . . . . 0.0 109.383 176.175 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 68.2 t0 -123.12 128.35 49.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.017 . . . . 0.0 108.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -164.08 139.68 4.93 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.096 -1.003 . . . . 0.0 110.505 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.03 120.68 4.4 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.292 1.995 . . . . 0.0 112.202 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -105.55 135.73 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.93 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.78 75.51 0.93 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.87 113.3 24.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 104' ' ' LYS . 16.9 m -134.42 -54.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.171 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.694 ' H ' HG23 ' A' ' 103' ' ' VAL . 26.0 mmtm 60.19 -129.75 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 0.0 109.339 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 104' ' ' LYS . 0.9 OUTLIER 72.52 -18.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.181 -0.949 . . . . 0.0 108.978 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 104' ' ' LYS . 2.0 t 168.75 -42.04 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 109.346 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.675 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.98 -158.47 7.6 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.694 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.36 137.68 40.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.279 -1.13 . . . . 0.0 108.015 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.458 ' CD ' ' CZ2' ' A' ' 42' ' ' TRP . 1.1 ttpm? -112.89 141.22 46.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.864 -1.147 . . . . 0.0 112.787 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -129.99 130.13 44.63 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.4 tt -135.45 144.54 46.51 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.798 -1.189 . . . . 0.0 109.479 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.418 ' O ' HG13 ' B' ' 10' ' ' VAL . 11.0 p -128.45 135.41 62.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.629 -0.669 . . . . 0.0 109.537 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.25 128.27 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.07 156.9 31.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 117.769 -1.572 . . . . 0.0 113.011 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' B' ' 91' ' ' ASP . 20.7 tptm -122.4 151.73 40.93 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.518 ' HB2' ' H ' ' B' ' 18' ' ' THR . 30.0 p90 -105.07 147.3 28.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.863 -1.148 . . . . 0.0 111.555 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -120.82 -25.07 5.5 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 94.9 mt-10 -89.21 -55.06 3.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.4 t0 150.5 72.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.518 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.9 m -59.11 110.3 1.02 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.105 0.955 . . . . 0.0 112.85 -176.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.729 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -81.4 92.46 6.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 175.676 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' H ' HG22 ' B' ' 20' ' ' VAL . 11.7 m -58.37 -32.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.609 -0.682 . . . . 0.0 110.43 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -66.49 -39.23 88.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.533 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 77.6 mm-40 -67.75 -34.07 76.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.74 -44.49 93.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -53.63 -37.16 62.8 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.93 -31.95 70.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -81.96 -43.7 8.08 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -56.82 -58.04 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.589 -0.947 . . . . 0.0 108.832 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.536 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 9.4 pt-20 -51.68 -44.31 63.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.536 ' N ' ' CG ' ' B' ' 28' ' ' GLU . 15.1 t-20 -61.22 -43.31 99.08 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.761 HD22 HD23 ' B' ' 78' ' ' LEU . 1.0 OUTLIER -50.13 -43.61 51.93 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.093 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' B' ' 34' ' ' ILE . 40.6 t -51.05 -27.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.266 -0.896 . . . . 0.0 108.847 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.474 ' C ' ' O ' ' B' ' 31' ' ' VAL . 48.0 t -40.59 -43.34 1.87 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.525 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 29.9 mm100 -75.3 -23.35 57.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.425 -0.797 . . . . 0.0 111.517 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.656 HG22 ' O ' ' B' ' 34' ' ' ILE . 30.0 mm -85.45 25.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 119.995 -1.69 . . . . 0.0 110.605 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.3 p30 -60.63 -8.91 3.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' B' ' 38' ' ' LYS . 64.8 p -74.04 -3.43 29.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.963 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.554 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.6 m 36.03 30.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.13 -0.981 . . . . 0.0 109.135 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' B' ' 36' ' ' THR . 74.2 mttt -118.77 39.7 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 13.1 t -171.18 170.79 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -147.51 157.37 43.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.521 -1.362 . . . . 0.0 111.934 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.564 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 57.1 mt-10 -151.69 119.89 6.32 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.349 0.595 . . . . 0.0 110.282 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.702 ' CD1' ' N ' ' B' ' 43' ' ' GLY . 0.0 OUTLIER -130.03 164.55 24.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.07 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLY . . . . . 0.702 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -134.32 174.24 21.03 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.749 -1.691 . . . . 0.0 110.885 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 0.2 OUTLIER -152.92 140.92 20.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -1.142 . . . . 0.0 109.387 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -104.99 140.42 38.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.529 ' CD ' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -135.0 103.78 5.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.388 -1.445 . . . . 0.0 109.769 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -147.07 25.68 1.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.322 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.468 ' H ' ' CB ' ' B' ' 53' ' ' ARG . 11.7 p -89.18 -106.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.932 . . . . 0.0 110.107 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' B' ' 53' ' ' ARG . 76.4 m80 -92.22 147.98 22.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.157 -0.964 . . . . 0.0 109.699 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.1 p-10 -53.36 -43.29 67.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 110.799 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 1.9 tpt -75.02 -32.34 61.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.732 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 95' ' ' LEU . 46.2 mt -90.05 -54.58 3.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.682 -1.261 . . . . 0.0 109.324 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.742 ' C ' ' H ' ' B' ' 55' ' ' GLY . 12.9 ptt180 -62.47 1.33 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.354 -0.841 . . . . 0.0 111.247 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.496 ' NE2' HG11 ' A' ' 94' ' ' VAL . 0.4 OUTLIER 56.01 -17.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.821 -1.174 . . . . 0.0 110.194 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.742 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 88.07 -22.84 16.69 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.455 -0.778 . . . . 0.0 112.795 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' B' ' 55' ' ' GLY . 3.5 m-85 -61.52 -133.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.272 -1.723 . . . . 0.0 109.962 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' B' ' 58' ' ' HIS . 3.0 t -161.56 -36.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.194 -0.941 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.651 ' HA ' ' O ' ' B' ' 44' ' ' GLU . 34.9 t-80 -166.6 149.52 6.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 0.0 110.206 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.535 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -142.68 167.76 21.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.764 . . . . 0.0 109.272 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' B' ' 58' ' ' HIS . 92.0 m-85 -138.28 134.84 34.85 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.446 -0.784 . . . . 0.0 109.094 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.539 ' OG ' ' CZ3' ' B' ' 42' ' ' TRP . 1.4 m -116.5 104.91 11.9 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 61.6 mtt -95.49 125.79 40.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.209 -0.932 . . . . 0.0 110.73 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 39.2 m -119.18 140.6 49.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -126.87 127.86 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.247 . . . . 0.0 110.029 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -50.54 -26.44 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -171.52 173.02 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.98 -19.16 60.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 111.435 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.84 90.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.827 -1.171 . . . . 0.0 110.571 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.56 59.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.594 ' O ' HG22 ' B' ' 74' ' ' THR . 74.3 t80 -65.59 -42.94 91.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.594 -0.945 . . . . 0.0 110.425 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.69 -28.99 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.38 -1.45 . . . . 0.0 108.671 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 109.356 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.0 OUTLIER -53.67 -39.23 64.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 111.221 -177.085 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.594 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.0 t -79.67 -29.64 40.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.779 -1.201 . . . . 0.0 110.341 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.6 m -65.59 -25.29 67.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.987 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' B' ' 78' ' ' LEU . 57.5 t-80 -79.19 125.08 84.12 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.29 -6.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.696 2.264 . . . . 0.0 112.433 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.761 HD23 HD22 ' B' ' 30' ' ' LEU . 6.1 tp -75.62 -25.42 56.91 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.369 -0.832 . . . . 0.0 111.233 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 2.8 t60 -76.87 -42.68 38.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.978 -1.076 . . . . 0.0 110.29 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.728 HG13 ' N ' ' B' ' 81' ' ' GLU . 11.6 p -64.52 -54.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.728 ' N ' HG13 ' B' ' 80' ' ' VAL . 79.0 mm-40 -50.4 -30.95 13.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.618 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' B' ' 86' ' ' PHE . 4.3 m-85 -72.81 -37.08 67.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.849 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.8 m -63.83 -42.28 97.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.128 -0.982 . . . . 0.0 110.082 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -50.39 67.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.029 . . . . 0.0 108.673 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.14 -43.38 82.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' B' ' 82' ' ' PHE . 2.5 m-85 -45.11 -31.01 1.24 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.539 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.7 m -78.9 -63.31 1.45 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -40.0 -24.14 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.645 -0.659 . . . . 0.0 110.074 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.3 m -111.88 7.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.198 -0.939 . . . . 0.0 110.807 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 34.5 mt -120.34 154.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.642 -1.286 . . . . 0.0 110.458 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' B' ' 13' ' ' LYS . 62.2 t0 -103.34 -31.58 9.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.447 ' NZ ' ' CE1' ' B' ' 56' ' ' PHE . 38.1 pttt -150.41 149.41 30.0 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.489 HG23 ' O ' ' B' ' 93' ' ' ILE . 3.9 tp -125.42 122.21 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.647 -1.283 . . . . 0.0 109.727 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.492 HG11 ' NE2' ' A' ' 54' ' ' GLN . 49.8 t -129.98 133.69 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.578 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -139.6 136.83 34.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.291 -1.505 . . . . 0.0 111.73 -178.149 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.929 HD12 ' N ' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.92 121.09 41.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.335 176.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 68.3 t0 -122.88 128.38 50.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 108.928 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -164.13 139.61 4.87 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.574 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.11 121.01 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.231 1.954 . . . . 0.0 112.294 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 18.6 t -105.96 135.57 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.002 . . . . 0.0 110.036 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.68 75.29 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.73 113.33 24.96 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.677 HG23 ' H ' ' B' ' 104' ' ' LYS . 16.8 m -134.37 -54.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.284 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.677 ' H ' HG23 ' B' ' 103' ' ' VAL . 25.9 mmtm 59.91 -129.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.396 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' B' ' 104' ' ' LYS . 0.9 OUTLIER 72.32 -18.23 0.34 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.217 -0.927 . . . . 0.0 109.02 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.518 ' H ' ' C ' ' B' ' 104' ' ' LYS . 2.0 t 168.55 -41.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.552 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.398 0.618 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.692 HG23 ' N ' ' A' ' 4' ' ' SER . 9.8 t -63.02 -49.8 73.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.181 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.692 ' N ' HG23 ' A' ' 3' ' ' THR . 32.0 t -144.22 -95.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.04 154.05 40.61 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.635 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.05 127.27 53.26 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -1.14 . . . . 0.0 108.037 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.8 ttpm? -108.39 137.83 45.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 112.769 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -124.49 123.21 39.63 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.41 142.27 49.21 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 109.478 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.4 p -129.81 134.74 62.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.42 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.41 129.08 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 m -134.44 161.85 39.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 117.771 -1.572 . . . . 0.0 113.036 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.54 151.24 51.74 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' HB2' ' H ' ' A' ' 18' ' ' THR . 22.5 p90 -109.72 146.99 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.899 -1.125 . . . . 0.0 111.529 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -130.17 -20.24 3.08 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 79.4 mm-40 -91.18 -58.01 2.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.8 m-20 156.52 65.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.5 m -57.4 108.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.075 0.941 . . . . 0.0 112.835 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.65 87.12 3.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.034 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 21' ' ' ASP . 26.8 m -61.61 -37.73 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.524 -0.735 . . . . 0.0 110.493 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.465 ' N ' HG23 ' A' ' 20' ' ' VAL . 81.5 m-20 -66.41 -42.16 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.62 -32.48 73.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.14 -38.99 83.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.65 -35.25 60.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.37 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -60.56 -54.4 37.44 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.8 tt -51.33 -47.9 62.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.548 -0.972 . . . . 0.0 108.764 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.14 -37.26 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -61.94 -44.21 97.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.846 HD13 ' NE2' ' A' ' 33' ' ' GLN . 3.0 mm? -50.07 -47.2 53.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.4 t -50.65 -26.32 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.252 -0.905 . . . . 0.0 108.883 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 27.2 t -47.38 -44.23 24.07 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.846 ' NE2' HD13 ' A' ' 30' ' ' LEU . 12.8 pm0 -92.98 -24.32 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.541 ' C ' ' H ' ' A' ' 36' ' ' THR . 9.3 mt -71.55 26.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 119.983 -1.698 . . . . 0.0 110.631 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' GLN . 88.9 m-20 -62.84 -7.33 4.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' LYS . 50.8 p -71.93 -5.83 37.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.949 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.59 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.7 m 33.51 31.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.63 ' N ' ' O ' ' A' ' 36' ' ' THR . 6.0 mtmp? -117.35 38.61 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 72.8 m -173.63 177.29 2.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.434 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.3 m-85 -146.88 155.94 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.574 -1.329 . . . . 0.0 112.016 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 85.4 mt-10 -158.69 129.26 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.43 0.633 . . . . 0.0 110.17 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.54 177.29 8.57 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.8 162.26 22.37 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.727 -1.701 . . . . 0.0 110.816 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.628 ' N ' ' CE1' ' A' ' 58' ' ' HIS . 72.3 mt-10 -145.93 138.18 25.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -1.168 . . . . 0.0 109.438 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.14 149.28 43.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' H ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.99 81.16 0.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.396 -1.44 . . . . 0.0 109.824 -176.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -115.37 56.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.643 -0.661 . . . . 0.0 109.33 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 49' ' ' HIS . 38.5 t -150.95 83.59 1.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.203 -0.935 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.701 ' N ' HH21 ' A' ' 53' ' ' ARG . 79.1 m-70 56.83 118.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 96.6 m-20 -44.61 -33.88 1.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.339 -0.85 . . . . 0.0 110.726 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -76.94 -32.0 57.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.026 . . . . 0.0 110.714 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 95' ' ' LEU . 62.9 mt -96.32 -12.38 24.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.732 -1.23 . . . . 0.0 109.333 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.701 HH21 ' N ' ' A' ' 49' ' ' HIS . 5.9 ptp180 -95.78 2.15 53.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.311 -0.868 . . . . 0.0 111.263 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' PHE . 95.1 mm-40 44.13 19.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.82 -1.175 . . . . 0.0 110.169 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.757 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 48.75 3.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.759 0 O-C-N 121.424 -0.797 . . . . 0.0 112.914 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.757 ' O ' ' O ' ' A' ' 55' ' ' GLY . 33.2 m-85 -49.94 -143.73 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.229 -1.748 . . . . 0.0 109.987 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 93.0 m -135.93 -55.88 0.77 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.951 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.628 ' CE1' ' N ' ' A' ' 44' ' ' GLU . 13.0 t60 -168.41 152.88 6.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.879 -1.138 . . . . 0.0 110.156 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.549 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.06 115.86 10.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.231 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.29 131.67 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.118 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -121.8 122.0 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 110.749 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -122.7 143.2 49.95 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -117.73 159.81 22.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.788 -1.195 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.69 -28.91 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -174.53 -178.1 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.94 -27.09 67.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 111.453 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.02 -43.98 97.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.78 -1.2 . . . . 0.0 110.548 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.44 67.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.597 ' O ' HG22 ' A' ' 74' ' ' THR . 71.2 t80 -67.02 -45.2 78.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.982 . . . . 0.0 110.467 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.75 -28.97 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.36 -1.462 . . . . 0.0 108.671 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.347 -0.845 . . . . 0.0 109.331 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.609 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.06 -50.15 73.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 111.108 -177.274 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 8.6 t -62.63 -28.17 69.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.805 -1.184 . . . . 0.0 110.304 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -61.95 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.0 110.897 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.626 ' NE2' ' NE2' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -121.94 151.19 57.63 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.787 -1.196 . . . . 0.0 109.578 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.43 12.53 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.575 2.184 . . . . 0.0 112.433 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.685 HD22 HE22 ' A' ' 33' ' ' GLN . 0.7 OUTLIER -75.98 -29.71 58.32 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 111.251 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' SER . 35.6 t-80 -85.22 -41.65 15.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.952 -1.093 . . . . 0.0 110.282 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -57.88 -58.46 6.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.961 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.762 ' H ' HG13 ' A' ' 80' ' ' VAL . 14.9 tm-20 -58.01 -39.33 78.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.137 -0.977 . . . . 0.0 109.593 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.91 -40.74 71.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.915 . . . . 0.0 109.879 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' HIS . 86.8 p -61.56 -38.16 86.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 110.218 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.93 63.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.973 -1.079 . . . . 0.0 108.725 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.26 -40.82 77.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.476 ' O ' HD12 ' A' ' 90' ' ' ILE . 24.8 t80 -44.53 -30.49 0.9 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.0 m -83.31 -61.84 1.74 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -36.87 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.741 -0.6 . . . . 0.0 110.07 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 87' ' ' THR . 12.6 m -101.93 16.53 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 110.819 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 87' ' ' THR . 73.7 mt -124.43 159.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.655 -1.278 . . . . 0.0 110.51 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 90' ' ' ILE . 62.8 t0 -102.32 -34.53 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.462 ' N ' HG22 ' A' ' 90' ' ' ILE . 29.4 pttt -145.78 143.71 29.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 93' ' ' ILE . 4.0 tp -121.54 122.06 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.649 -1.282 . . . . 0.0 109.774 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.78 130.43 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -135.34 131.75 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.258 -1.526 . . . . 0.0 111.811 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -122.75 126.97 48.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.377 177.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -125.81 133.35 52.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.098 -1.001 . . . . 0.0 108.899 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 63.8 t80 -155.42 128.73 4.38 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.108 -0.995 . . . . 0.0 110.476 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.533 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 81.8 Cg_exo -46.08 133.58 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.308 2.006 . . . . 0.0 112.176 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.61 129.33 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -101.39 82.14 2.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.435 -0.79 . . . . 0.0 109.585 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -65.25 76.69 0.06 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.177 -0.952 . . . . 0.0 109.568 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.763 ' O ' ' C ' ' A' ' 104' ' ' LYS . 16.3 m -154.26 -28.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.436 -0.79 . . . . 0.0 109.271 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.763 ' C ' ' O ' ' A' ' 103' ' ' VAL . 55.2 mmtt -4.52 -106.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 0.0 109.396 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m 67.04 -8.99 0.4 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.095 -1.003 . . . . 0.0 108.891 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 104' ' ' LYS . 25.5 t -55.76 133.5 50.99 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.4 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 107' ' ' VAL . 14.6 p . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.84 154.23 41.24 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.26 127.13 52.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.203 -1.175 . . . . 0.0 108.021 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.534 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.8 ttpm? -108.14 137.93 45.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.96 -1.087 . . . . 0.0 112.816 -177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -124.7 123.19 39.48 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.39 142.27 49.22 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 109.475 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.436 HG13 ' O ' ' B' ' 10' ' ' VAL . 10.3 p -129.7 134.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.629 -0.67 . . . . 0.0 109.523 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.23 129.08 68.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.37 162.09 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.001 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.79 151.06 51.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.489 ' HB2' ' H ' ' B' ' 18' ' ' THR . 22.3 p90 -109.56 146.92 33.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.867 -1.146 . . . . 0.0 111.583 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.04 -20.37 3.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 79.3 mm-40 -91.08 -57.92 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.8 m-20 156.39 65.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.489 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -57.12 108.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.088 0.947 . . . . 0.0 112.86 -176.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.566 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -76.82 87.13 3.41 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 175.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.472 HG23 ' N ' ' B' ' 21' ' ' ASP . 27.1 m -61.75 -37.58 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.573 -0.704 . . . . 0.0 110.518 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.472 ' N ' HG23 ' B' ' 20' ' ' VAL . 80.7 m-20 -66.32 -42.31 88.41 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 110.552 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.59 -32.44 73.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.15 -39.0 83.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 tp -53.71 -35.19 60.89 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.43 74.96 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -60.52 -54.34 37.94 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.584 HD23 ' O ' ' B' ' 27' ' ' LEU . 1.8 tt -51.34 -47.85 62.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -55.24 -37.03 66.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -62.15 -44.04 97.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.865 HD13 ' NE2' ' B' ' 33' ' ' GLN . 3.0 mm? -50.21 -47.09 54.97 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 32' ' ' SER . 86.3 t -50.71 -26.26 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.326 -0.858 . . . . 0.0 108.879 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 27.9 t -47.34 -44.48 23.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.865 ' NE2' HD13 ' B' ' 30' ' ' LEU . 12.9 pm0 -92.75 -24.35 18.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.812 . . . . 0.0 111.54 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' B' ' 36' ' ' THR . 9.6 mt -71.66 26.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 119.976 -1.703 . . . . 0.0 110.541 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' B' ' 33' ' ' GLN . 89.6 m-20 -63.02 -7.22 4.93 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.627 ' O ' ' N ' ' B' ' 38' ' ' LYS . 49.9 p -71.83 -6.11 39.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.987 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.574 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.8 m 33.72 31.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.012 -1.055 . . . . 0.0 109.189 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' B' ' 36' ' ' THR . 5.9 mtmp? -117.39 38.65 3.51 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.541 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 72.7 m -173.66 177.26 2.55 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.6 m-85 -147.06 155.77 42.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.555 -1.341 . . . . 0.0 111.912 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 85.6 mt-10 -158.58 129.1 6.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.332 0.587 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.36 177.48 8.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.93 162.35 22.45 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 118.69 -1.719 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.637 ' N ' ' CE1' ' B' ' 58' ' ' HIS . 71.7 mt-10 -145.97 138.24 25.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -1.134 . . . . 0.0 109.34 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -121.07 149.33 42.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.568 ' H ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -71.05 81.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.412 -1.43 . . . . 0.0 109.809 -177.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -115.35 56.93 0.74 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.539 ' O ' ' O ' ' B' ' 49' ' ' HIS . 39.8 t -151.1 83.63 1.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.949 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.699 ' N ' HH21 ' B' ' 53' ' ' ARG . 78.6 m-70 56.86 118.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.121 -0.987 . . . . 0.0 109.702 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.545 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 97.4 m-20 -44.68 -33.89 2.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 110.847 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.401 ' HG2' ' H ' ' B' ' 51' ' ' MET . 2.7 ptt? -76.86 -32.0 57.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.063 -1.023 . . . . 0.0 110.751 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 95' ' ' LEU . 63.0 mt -96.29 -12.41 24.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.709 -1.245 . . . . 0.0 109.258 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.699 HH21 ' N ' ' B' ' 49' ' ' HIS . 6.1 ptp180 -95.76 1.97 53.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 111.281 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' B' ' 56' ' ' PHE . 94.9 mm-40 44.37 19.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.8 -1.187 . . . . 0.0 110.168 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.768 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 48.9 3.26 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.477 -0.764 . . . . 0.0 112.893 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' O ' ' B' ' 55' ' ' GLY . 33.0 m-85 -49.91 -143.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.252 -1.734 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 93.0 m -135.8 -55.87 0.78 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.312 -0.868 . . . . 0.0 110.964 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.637 ' CE1' ' N ' ' B' ' 44' ' ' GLU . 13.0 t60 -168.39 153.22 6.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.203 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.36 116.06 10.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.509 -0.744 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -89.42 131.68 35.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.069 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -121.89 121.3 36.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -114.95 134.66 54.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.218 -0.926 . . . . 0.0 110.757 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 40' ' ' PHE . 32.6 m -122.88 143.34 49.94 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -117.83 159.59 22.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.693 -1.254 . . . . 0.0 110.036 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.46 -29.24 46.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -174.22 -178.17 1.4 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.83 -27.12 67.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.949 . . . . 0.0 111.469 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -61.92 -44.02 97.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.782 -1.199 . . . . 0.0 110.593 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.27 -32.7 68.65 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.585 ' O ' HG22 ' B' ' 74' ' ' THR . 71.6 t80 -66.7 -45.38 78.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.939 . . . . 0.0 110.459 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.81 -28.92 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.411 -1.43 . . . . 0.0 108.697 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.421 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.08 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.325 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.596 ' O ' ' CE1' ' B' ' 76' ' ' HIS . 0.0 OUTLIER -57.06 -49.98 74.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.224 -0.923 . . . . 0.0 111.107 -177.323 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.594 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 8.6 t -62.85 -28.13 69.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 110.311 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 84.5 p -62.05 16.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.96 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.626 ' NE2' ' NE2' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -121.83 150.97 56.95 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.868 -1.145 . . . . 0.0 109.585 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.19 12.6 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.604 2.203 . . . . 0.0 112.48 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.663 HD22 HE22 ' B' ' 33' ' ' GLN . 0.7 OUTLIER -76.08 -29.72 58.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.435 -0.79 . . . . 0.0 111.22 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' B' ' 83' ' ' SER . 35.4 t-80 -85.21 -41.71 15.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.935 -1.103 . . . . 0.0 110.22 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.778 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.2 p -57.9 -58.56 5.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 110.031 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.778 ' H ' HG13 ' B' ' 80' ' ' VAL . 14.9 tm-20 -57.84 -39.4 77.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.544 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.8 -40.89 72.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 109.894 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' SER . . . . . 0.437 ' N ' ' O ' ' B' ' 79' ' ' HIS . 87.2 p -61.5 -38.14 86.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.24 60.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.011 -1.056 . . . . 0.0 108.675 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -41.18 78.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.466 ' O ' HD12 ' B' ' 90' ' ' ILE . 24.6 t80 -44.24 -30.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 89' ' ' VAL . 6.1 m -83.35 -61.77 1.76 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.06 -26.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.604 . . . . 0.0 110.061 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' B' ' 87' ' ' THR . 12.7 m -102.15 16.27 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.18 -0.95 . . . . 0.0 110.769 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' B' ' 87' ' ' THR . 73.4 mt -124.32 159.17 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.643 -1.285 . . . . 0.0 110.417 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.521 ' N ' HG22 ' B' ' 90' ' ' ILE . 63.0 t0 -102.3 -34.47 9.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.458 ' N ' HG22 ' B' ' 90' ' ' ILE . 29.2 pttt -145.94 143.55 29.6 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.49 ' O ' HG23 ' B' ' 93' ' ' ILE . 4.0 tp -121.4 122.2 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.64 -1.287 . . . . 0.0 109.772 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.93 130.44 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.461 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -135.37 131.67 36.64 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.307 -1.495 . . . . 0.0 111.76 -178.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.881 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -122.73 127.24 48.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.333 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -126.05 133.3 51.76 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.078 -1.014 . . . . 0.0 108.91 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 64.2 t80 -155.24 128.74 4.44 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' PRO . . . . . 0.531 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 80.5 Cg_exo -46.18 133.39 15.22 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.314 2.009 . . . . 0.0 112.241 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 74.8 t -107.42 129.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 110.007 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -101.5 81.94 2.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 109.577 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 76.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.783 ' O ' ' C ' ' B' ' 104' ' ' LYS . 16.2 m -154.22 -28.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.783 ' C ' ' O ' ' B' ' 103' ' ' VAL . 54.5 mmtt -4.54 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m 67.22 -8.97 0.42 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.149 -0.969 . . . . 0.0 108.949 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.544 ' H ' ' C ' ' B' ' 104' ' ' LYS . 26.2 t -55.83 133.27 51.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.603 HG22 ' O ' ' B' ' 107' ' ' VAL . 14.7 p . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 t -103.38 -9.85 19.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.109 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -152.78 -86.36 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.48 -159.29 7.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -142.56 142.38 32.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -1.13 . . . . 0.0 108.051 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.44 141.89 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 112.831 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -126.73 128.95 47.46 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.0 tt -135.37 142.77 45.78 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.755 -1.216 . . . . 0.0 109.436 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 12.7 p -131.11 139.5 50.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.05 127.34 72.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.05 144.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.825 -1.55 . . . . 0.0 113.068 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 37.2 tptt -111.76 150.5 30.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HB2' ' H ' ' A' ' 18' ' ' THR . 18.4 p90 -107.0 147.5 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.823 -1.173 . . . . 0.0 111.607 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.76 -26.36 4.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 65.0 tt0 -88.19 -56.94 3.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.0 p30 152.63 70.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 41.8 m -55.12 106.88 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.142 0.972 . . . . 0.0 112.821 -177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.589 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.95 88.56 1.86 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.5 m -59.53 -40.95 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.705 . . . . 0.0 110.458 -176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.551 ' N ' HG23 ' A' ' 20' ' ' VAL . 92.4 m-20 -61.01 -44.24 97.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.411 -0.806 . . . . 0.0 110.557 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.48 -39.12 62.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.5 -50.71 70.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.86 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.2 tm? -56.48 -42.61 78.53 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 24' ' ' LEU . 5.1 ttpt -60.13 -25.05 65.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.68 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -69.21 -54.82 11.89 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 27' ' ' LEU . 6.8 tt -44.33 -38.33 3.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.512 -0.993 . . . . 0.0 108.818 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -52.87 -41.82 64.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -57.41 -42.43 82.29 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.641 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -50.22 -46.29 54.48 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.849 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' SER . 34.4 t -48.91 -24.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.332 -0.855 . . . . 0.0 108.908 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 42.4 t -43.24 -43.15 4.65 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 97.0 mm-40 -76.18 -22.42 55.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 111.464 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.756 HG22 ' O ' ' A' ' 34' ' ' ILE . 71.9 mt -79.73 20.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.033 -1.667 . . . . 0.0 110.645 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.47 -10.47 1.46 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.581 ' N ' ' C ' ' A' ' 34' ' ' ILE . 35.0 p -82.24 0.44 41.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.963 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.577 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.3 m 34.94 33.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.046 -1.034 . . . . 0.0 109.117 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 mtmp? -119.61 42.01 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' PHE . 30.1 t -175.97 175.5 1.94 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.4 m-85 -150.53 159.72 44.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.591 -1.318 . . . . 0.0 111.99 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 86.1 mt-10 -159.24 130.82 6.28 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.364 0.602 . . . . 0.0 110.2 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -133.78 171.61 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' GLU . . . -134.45 168.21 23.57 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 118.672 -1.728 . . . . 0.0 110.793 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.618 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 87.4 mt-10 -156.82 152.5 26.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -1.114 . . . . 0.0 109.341 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.893 ' HA ' ' O ' ' A' ' 57' ' ' THR . 23.9 t0 -157.16 87.5 0.99 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -90.35 170.01 10.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.393 -1.442 . . . . 0.0 109.882 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.699 -0.625 . . . . 0.0 109.317 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.426 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 4.2 t -78.75 -125.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.0 110.164 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -77.63 153.9 32.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.721 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.47 -41.57 69.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 110.759 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.516 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.17 -40.61 90.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.969 -1.082 . . . . 0.0 110.737 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' B' ' 95' ' ' LEU . 44.8 mt -75.86 -64.62 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.745 -1.222 . . . . 0.0 109.303 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -67.72 18.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 0.0 111.233 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' A' ' 52' ' ' LEU . 1.7 mm100 45.33 8.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.701 -1.249 . . . . 0.0 110.164 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 70.3 -11.54 2.12 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.503 -0.748 . . . . 0.0 112.936 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.656 ' O ' ' O ' ' A' ' 55' ' ' GLY . 49.4 m-85 -53.92 -136.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.288 -1.713 . . . . 0.0 109.92 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.893 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 6.1 t -163.28 -51.45 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 110.903 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 60' ' ' PHE . 6.3 t60 -148.37 142.5 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 0.0 110.149 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.69 163.06 33.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 0.0 109.231 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 58' ' ' HIS . 94.9 m-85 -133.78 131.17 39.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.083 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' A' ' 42' ' ' TRP . 1.6 m -116.59 110.39 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.13 132.38 53.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.209 -0.932 . . . . 0.0 110.838 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -119.01 141.44 48.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.24 158.5 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.689 -1.257 . . . . 0.0 110.097 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -75.66 -26.42 57.67 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -175.39 -177.34 1.01 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -66.61 -23.73 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 111.355 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.7 -41.04 97.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.763 -1.21 . . . . 0.0 110.577 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.57 65.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.805 ' O ' HG22 ' A' ' 74' ' ' THR . 76.0 t80 -69.39 -43.22 73.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.496 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.82 -28.89 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.423 -1.423 . . . . 0.0 108.642 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.08 -60.9 2.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.299 -0.876 . . . . 0.0 109.358 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.72 -57.74 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.875 . . . . 0.0 111.145 -178.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 70' ' ' TYR . 9.2 t -57.27 -35.57 69.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.775 -1.203 . . . . 0.0 110.293 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 58.4 m -66.69 -32.94 74.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.0 110.964 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 78' ' ' LEU . 59.3 m80 -68.43 128.76 93.03 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.83 -1.169 . . . . 0.0 109.601 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.34 -8.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 112.443 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.7 tp -66.77 -28.41 68.37 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.34 -0.85 . . . . 0.0 111.291 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.75 -35.32 24.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.012 . . . . 0.0 110.247 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.97 -61.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -58.62 -38.66 78.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.604 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 78.0 t80 -68.48 -44.28 75.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.872 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 t -59.87 -35.48 74.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.968 -1.082 . . . . 0.0 108.682 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.75 -42.14 77.94 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 85' ' ' ALA . 6.5 t80 -43.53 -30.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.4 m -83.05 -61.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.84 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.639 -0.663 . . . . 0.0 110.008 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.7 m -102.69 11.37 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.19 -0.944 . . . . 0.0 110.746 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 44.8 mt -125.74 158.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.596 -1.315 . . . . 0.0 110.53 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 60.6 t0 -104.22 -32.33 9.17 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 13' ' ' LYS . 9.1 pttp -148.87 147.0 28.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.8 tp -127.43 127.58 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.579 -1.326 . . . . 0.0 109.763 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 48.3 t -132.18 135.51 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -135.6 130.28 34.19 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 111.759 -178.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.584 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.72 127.34 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.65 -0.656 . . . . 0.0 109.387 177.373 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 54.6 m-20 -123.06 125.08 44.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 108.908 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -146.7 127.26 7.01 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.053 -1.029 . . . . 0.0 110.501 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.42 123.61 9.44 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.31 2.007 . . . . 0.0 112.22 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.47 132.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.62 80.51 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 84.51 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.632 ' O ' ' O ' ' A' ' 104' ' ' LYS . 17.2 m -147.11 -22.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.177 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.632 ' O ' ' O ' ' A' ' 103' ' ' VAL . 24.8 mtmt 41.33 102.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.328 -0.858 . . . . 0.0 109.358 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -50.74 -50.8 54.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.15 -0.969 . . . . 0.0 108.934 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.1 t 45.78 29.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.385 -0.822 . . . . 0.0 109.378 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.75 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.49 -159.06 7.79 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.687 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -142.81 142.37 31.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -1.136 . . . . 0.0 108.029 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.61 141.64 47.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.932 -1.105 . . . . 0.0 112.819 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.5 128.91 47.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.0 tt -135.42 142.75 45.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.789 -1.195 . . . . 0.0 109.439 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 12.5 p -131.01 139.53 50.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.627 -0.671 . . . . 0.0 109.523 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.09 127.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.03 144.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 117.738 -1.585 . . . . 0.0 113.019 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 36.8 tptt -111.92 150.42 30.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 18.4 p90 -106.91 147.36 29.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 111.575 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.6 -26.39 4.55 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 65.4 tt0 -88.18 -56.83 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.1 p30 152.45 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.459 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 40.1 m -55.38 106.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.059 0.933 . . . . 0.0 112.901 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.6 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.01 88.4 1.88 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.4 m -59.52 -40.65 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 110.434 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.528 ' N ' HG23 ' B' ' 20' ' ' VAL . 92.0 m-20 -61.22 -44.42 97.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 110.54 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -74.23 -38.99 63.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.79 -50.37 71.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.858 ' C ' HD13 ' B' ' 24' ' ' LEU . 2.2 tm? -56.86 -42.5 79.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -60.11 -25.15 65.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.688 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -69.15 -54.62 12.9 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.711 HD23 ' O ' ' B' ' 27' ' ' LEU . 6.8 tt -44.43 -38.29 3.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.551 -0.97 . . . . 0.0 108.831 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -52.96 -41.87 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.688 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.7 p30 -57.28 -42.57 81.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.638 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -50.07 -46.62 53.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' B' ' 34' ' ' ILE . 33.6 t -48.53 -24.74 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 44.2 t -43.15 -43.31 4.52 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.477 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 97.0 mm-40 -75.91 -22.74 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.429 -0.795 . . . . 0.0 111.52 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.766 HG22 ' O ' ' B' ' 34' ' ' ILE . 72.5 mt -79.3 20.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.955 -1.715 . . . . 0.0 110.586 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.57 -10.58 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.568 ' O ' ' N ' ' B' ' 38' ' ' LYS . 34.6 p -82.09 0.36 40.97 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 35.17 33.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.079 -1.013 . . . . 0.0 109.24 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.8 mtmp? -119.72 42.13 2.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.425 ' O ' ' CG ' ' B' ' 40' ' ' PHE . 30.8 t -176.04 175.21 1.96 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.454 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.9 m-85 -150.41 159.26 44.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.511 -1.368 . . . . 0.0 111.953 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 86.1 mt-10 -158.84 130.78 6.59 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.315 0.578 . . . . 0.0 110.221 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' TRP . . . . . 0.688 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.0 OUTLIER -133.7 171.6 13.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.46 168.41 23.49 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.666 -1.731 . . . . 0.0 110.751 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.615 ' O ' ' CG ' ' B' ' 58' ' ' HIS . 87.1 mt-10 -156.94 152.42 26.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -1.202 . . . . 0.0 109.41 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.888 ' HA ' ' O ' ' B' ' 57' ' ' THR . 24.4 t0 -156.99 87.85 1.01 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' H ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -90.83 170.15 10.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.368 -1.457 . . . . 0.0 109.818 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.09 0.43 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.425 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 4.7 t -78.55 -125.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 110.118 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -78.18 153.73 31.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.17 -41.79 69.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 110.822 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -66.1 -40.42 90.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.033 . . . . 0.0 110.768 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 95' ' ' LEU . 45.5 mt -76.09 -64.31 1.12 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.729 -1.232 . . . . 0.0 109.295 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.4 OUTLIER -68.12 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.38 -0.825 . . . . 0.0 111.218 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' B' ' 52' ' ' LEU . 1.7 mm100 45.13 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.735 -1.228 . . . . 0.0 110.195 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.669 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 70.42 -12.05 2.01 Favored Glycine 0 N--CA 1.5 2.914 0 O-C-N 121.496 -0.753 . . . . 0.0 112.811 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.669 ' O ' ' O ' ' B' ' 55' ' ' GLY . 49.8 m-85 -53.66 -136.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.242 -1.74 . . . . 0.0 109.916 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.888 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 6.3 t -163.0 -51.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.641 ' CD2' ' CZ ' ' B' ' 60' ' ' PHE . 6.2 t60 -148.44 142.45 25.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.938 -1.101 . . . . 0.0 110.175 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.52 163.1 33.85 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.487 -0.758 . . . . 0.0 109.294 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' B' ' 58' ' ' HIS . 95.2 m-85 -133.71 131.02 38.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.151 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' B' ' 42' ' ' TRP . 1.6 m -116.39 110.6 18.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.56 132.51 53.18 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 110.743 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -119.05 141.42 48.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.28 158.49 26.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.736 -1.228 . . . . 0.0 110.013 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -75.76 -26.48 57.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -175.28 -177.42 1.03 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.43 -23.74 66.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.69 -41.2 97.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.814 -1.179 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.28 -31.71 65.9 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.816 ' O ' HG22 ' B' ' 74' ' ' THR . 76.6 t80 -69.07 -43.53 74.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.56 -0.965 . . . . 0.0 110.474 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.88 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.47 -1.394 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.51 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.1 -60.85 2.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.632 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -57.43 -57.94 10.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 111.146 -178.538 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.816 HG22 ' O ' ' B' ' 70' ' ' TYR . 9.1 t -57.33 -35.21 69.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.368 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 58.5 m -66.93 -32.97 74.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' B' ' 78' ' ' LEU . 59.4 m80 -68.44 128.55 93.05 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.887 -1.133 . . . . 0.0 109.629 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -42.98 -8.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.644 2.229 . . . . 0.0 112.513 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.6 tp -66.56 -28.59 68.64 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.387 -0.821 . . . . 0.0 111.211 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -83.65 -35.31 24.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 110.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.05 -61.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.014 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -58.58 -38.72 78.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 77.9 t80 -68.27 -44.54 75.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.838 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -59.77 -35.24 74.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.163 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.16 60.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.978 -1.076 . . . . 0.0 108.742 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -42.15 77.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.474 ' C ' ' O ' ' B' ' 85' ' ' ALA . 6.6 t80 -43.55 -30.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.503 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.0 m -82.98 -61.87 1.75 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.78 -26.92 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.697 -0.627 . . . . 0.0 110.049 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.7 m -102.71 11.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.233 -0.917 . . . . 0.0 110.797 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 43.8 mt -126.0 158.85 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.646 -1.284 . . . . 0.0 110.384 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 60.3 t0 -104.4 -32.25 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' B' ' 13' ' ' LYS . 8.9 pttp -149.0 147.1 28.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.412 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.8 tp -127.67 127.48 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.526 -1.358 . . . . 0.0 109.746 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 48.4 t -132.12 135.28 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -135.4 130.24 34.56 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.254 -1.529 . . . . 0.0 111.792 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.599 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -118.69 127.11 53.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.645 -0.66 . . . . 0.0 109.343 177.411 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.573 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 55.3 m-20 -122.85 124.87 44.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.031 -1.043 . . . . 0.0 108.85 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.794 ' CD1' ' N ' ' B' ' 98' ' ' PHE . 0.0 OUTLIER -146.37 127.45 7.29 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.097 -1.002 . . . . 0.0 110.502 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.55 123.65 9.65 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.229 1.953 . . . . 0.0 112.248 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.34 132.83 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.69 80.53 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.99 84.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -0.98 . . . . 0.0 109.557 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.627 ' O ' ' O ' ' B' ' 104' ' ' LYS . 17.2 m -147.26 -22.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.196 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.627 ' O ' ' O ' ' B' ' 103' ' ' VAL . 24.5 mtmt 41.02 102.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.344 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.408 ' O ' ' C ' ' B' ' 106' ' ' SER . 15.1 m -50.89 -50.8 56.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.112 -0.993 . . . . 0.0 108.957 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.408 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.0 t 45.94 29.91 0.82 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.362 -0.836 . . . . 0.0 109.413 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 C--N 1.302 -1.482 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.85 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.44 0.638 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -113.51 4.27 16.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.15 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 100' ' ' VAL . 4.3 p -175.84 -113.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.27 173.75 19.12 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.71 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -124.92 128.99 49.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.188 -1.184 . . . . 0.0 108.07 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 20.1 ttpt -104.1 134.26 47.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.057 . . . . 0.0 112.837 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 62' ' ' MET . 85.3 t60 -127.14 125.03 40.47 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.725 -1.234 . . . . 0.0 109.454 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.46 138.05 54.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.6 -0.687 . . . . 0.0 109.444 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 t -119.4 131.64 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 93' ' ' ILE . 5.1 m -136.52 156.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 117.787 -1.565 . . . . 0.0 113.071 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -123.33 153.09 40.77 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.57 ' HB2' ' H ' ' A' ' 18' ' ' THR . 23.7 p90 -110.99 146.61 36.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -21.14 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.5 tt0 -92.82 -57.37 2.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.5 m-20 157.55 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.57 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.9 m -50.95 103.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.045 0.926 . . . . 0.0 112.854 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.89 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -71.1 82.55 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.517 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 21' ' ' ASP . 28.8 m -62.37 -40.07 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.635 -0.666 . . . . 0.0 110.458 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 20' ' ' VAL . 91.0 m-20 -66.21 -45.59 80.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 0.0 110.515 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 29.2 mp0 -68.29 -34.09 75.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.11 -43.29 88.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 20' ' ' VAL . 17.9 tp -54.29 -35.92 63.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.28 -33.9 72.99 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -61.33 -52.49 51.24 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.2 tt -46.91 -44.14 19.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.493 -1.004 . . . . 0.0 108.774 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -55.21 -37.65 67.4 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 2.0 m-80 -62.85 -46.04 89.75 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 78' ' ' LEU . 3.4 mm? -48.45 -46.49 37.92 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 32' ' ' SER . 63.1 t -51.3 -26.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.287 -0.883 . . . . 0.0 108.837 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 30.9 t -46.38 -47.97 18.65 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.652 ' NE2' HD13 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -86.94 -23.7 25.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 0.0 111.467 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.652 HD13 ' NE2' ' A' ' 33' ' ' GLN . 4.6 mm -73.25 23.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.036 -1.665 . . . . 0.0 110.618 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.0 p30 -61.8 -9.31 6.28 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' A' ' 37' ' ' VAL . 64.1 p -71.52 -4.86 29.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.971 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.4 m 32.64 36.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 ptmt -121.96 41.97 3.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 t -174.6 179.07 1.8 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 97.6 m-85 -143.98 153.4 42.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.554 -1.341 . . . . 0.0 111.998 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 61' ' ' SER . 75.5 mt-10 -156.41 124.26 5.57 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.355 0.598 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -134.74 174.15 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.24 145.42 11.7 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 118.777 -1.678 . . . . 0.0 110.832 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.573 ' O ' ' CD2' ' A' ' 58' ' ' HIS . 56.2 mp0 -148.31 164.81 32.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.233 -1.157 . . . . 0.0 109.388 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 57' ' ' THR . 21.4 t70 -113.78 161.1 17.95 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.658 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 3.0 ptmm? -62.01 83.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.43 -1.419 . . . . 0.0 109.771 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.2 mt-10 -128.79 46.87 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.622 -0.674 . . . . 0.0 109.259 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' B' ' 97' ' ' ASP . 5.9 t -142.2 78.71 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.794 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 56.2 m80 56.58 107.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.927 . . . . 0.0 109.678 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -45.66 -35.16 3.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -0.851 . . . . 0.0 110.818 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -71.4 -35.34 70.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.961 -1.087 . . . . 0.0 110.682 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' B' ' 95' ' ' LEU . 84.5 mt -78.76 -51.1 10.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.763 -1.211 . . . . 0.0 109.314 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.794 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.1 ptp180 -64.35 13.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 0.0 111.274 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.513 ' C ' ' O ' ' A' ' 53' ' ' ARG . 82.2 mm-40 37.76 32.19 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.82 -1.175 . . . . 0.0 110.129 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.777 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 59.16 1.83 1.16 Allowed Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.439 -0.788 . . . . 0.0 112.815 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.777 ' O ' ' O ' ' A' ' 55' ' ' GLY . 46.1 m-85 -48.82 -148.15 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.221 -1.753 . . . . 0.0 109.884 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 50.4 m -143.37 -56.72 0.4 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.331 -0.855 . . . . 0.0 110.957 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.632 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 15.2 t-80 -158.21 145.98 18.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.116 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -132.04 148.91 52.53 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.264 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 58' ' ' HIS . 34.8 m-85 -118.91 119.71 35.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.48 -0.762 . . . . 0.0 109.04 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 7.1 t -88.94 95.35 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.0 mtp -102.37 110.62 22.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.228 -0.92 . . . . 0.0 110.813 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -125.63 145.87 49.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.6 160.52 21.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.17 . . . . 0.0 110.068 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 85.5 tt0 -81.99 -31.95 30.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.4 m-20 -163.18 174.32 12.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.63 -27.14 62.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 111.417 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.49 -36.73 66.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.869 -1.144 . . . . 0.0 110.538 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.74 -35.35 73.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.612 ' O ' HG22 ' A' ' 74' ' ' THR . 70.4 t80 -61.68 -44.34 97.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.508 -0.995 . . . . 0.0 110.5 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.88 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.379 -1.451 . . . . 0.0 108.661 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.94 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.365 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.59 -39.94 58.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 111.129 -177.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.619 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.5 t -80.79 -29.81 36.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.725 -1.234 . . . . 0.0 110.264 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.2 t -58.13 -33.64 69.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.984 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 73' ' ' PHE . 13.9 p80 -87.84 141.91 32.0 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.632 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 10.86 1.49 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.652 2.234 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' CD2' HD22 ' A' ' 30' ' ' LEU . 3.6 tt -73.04 -26.86 61.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.801 . . . . 0.0 111.256 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 83' ' ' SER . 9.3 t-80 -85.0 -43.41 13.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.0 110.249 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.787 HG13 ' H ' ' A' ' 81' ' ' GLU . 2.8 p -56.62 -58.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.787 ' H ' HG13 ' A' ' 80' ' ' VAL . 93.5 mt-10 -58.39 -42.27 86.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.94 -39.37 72.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' HIS . 23.6 t -59.83 -38.07 81.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.142 -0.974 . . . . 0.0 110.151 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.55 72.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.923 -1.111 . . . . 0.0 108.65 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.84 -41.59 78.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 85' ' ' ALA . 22.5 t80 -45.04 -30.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 90' ' ' ILE . 3.8 m -84.68 -63.6 1.31 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.09 -27.35 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.65 -0.657 . . . . 0.0 110.089 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 87' ' ' THR . 5.4 p -98.53 16.57 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 91' ' ' ASP . 23.0 mm -130.64 164.02 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.683 -1.26 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.592 ' N ' HG22 ' A' ' 90' ' ' ILE . 40.9 t0 -103.41 -36.76 7.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 90' ' ' ILE . 21.2 pttt -146.96 146.42 30.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.65 HD12 HG12 ' A' ' 12' ' ' VAL . 4.8 tp -128.37 127.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.6 -1.313 . . . . 0.0 109.707 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.2 133.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.65 36.22 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.292 -1.505 . . . . 0.0 111.804 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -125.69 128.99 48.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.675 . . . . 0.0 109.379 177.12 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.593 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 42.8 t0 -120.01 124.61 46.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.021 -1.049 . . . . 0.0 108.893 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 97' ' ' ASP . 25.1 m-85 -142.31 148.96 49.8 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.986 -1.071 . . . . 0.0 110.531 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.83 130.12 16.4 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.244 1.963 . . . . 0.0 112.201 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.537 ' O ' ' OG ' ' A' ' 4' ' ' SER . 9.9 t -95.22 117.09 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.96 . . . . 0.0 109.994 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -91.31 75.45 6.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.21 71.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.114 -0.992 . . . . 0.0 109.563 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' SER . 29.1 m -149.78 -32.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.266 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 106' ' ' SER . 25.3 mtmt 37.68 -93.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER 66.58 -42.53 0.4 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 108.978 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 104' ' ' LYS . 9.5 m -44.4 104.18 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.277 -0.89 . . . . 0.0 109.336 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.323 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' B' ' 100' ' ' VAL . 4.2 p . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.28 173.7 19.07 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -124.8 129.11 49.8 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.205 -1.174 . . . . 0.0 108.01 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 97' ' ' ASP . 20.2 ttpt -104.23 134.27 47.74 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.311 1.053 . . . . 0.0 112.822 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 85.4 t60 -127.08 125.07 40.66 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.1 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.747 -1.22 . . . . 0.0 109.487 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -130.47 138.02 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.545 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.42 131.52 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.636 HG12 HD12 ' B' ' 93' ' ' ILE . 5.2 m -136.49 156.19 35.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 117.732 -1.587 . . . . 0.0 113.053 -177.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -123.2 153.07 40.58 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.564 ' HB2' ' H ' ' B' ' 18' ' ' THR . 23.7 p90 -111.01 146.54 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 0.0 111.663 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 -21.18 2.9 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -92.96 -57.36 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.5 m-20 157.47 65.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.3 m -50.79 103.32 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.117 0.961 . . . . 0.0 112.844 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.875 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -71.29 82.47 0.75 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.527 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.535 HG23 ' N ' ' B' ' 21' ' ' ASP . 28.4 m -62.15 -40.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.585 -0.697 . . . . 0.0 110.433 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.535 ' N ' HG23 ' B' ' 20' ' ' VAL . 91.6 m-20 -66.36 -45.41 80.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.559 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 28.8 mp0 -68.43 -34.1 75.39 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.04 -43.31 89.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 20' ' ' VAL . 17.9 tp -54.14 -36.24 63.09 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.02 -34.03 72.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.582 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -61.42 -52.22 52.79 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.639 HD23 ' O ' ' B' ' 27' ' ' LEU . 2.2 tt -47.12 -43.85 20.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.533 -0.98 . . . . 0.0 108.83 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -55.54 -37.47 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 2.1 m-80 -62.9 -46.13 89.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' B' ' 78' ' ' LEU . 3.4 mm? -48.31 -46.62 36.48 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' B' ' 32' ' ' SER . 62.8 t -51.19 -26.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 108.821 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 31.0 t -46.33 -48.05 18.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.666 ' NE2' HD13 ' B' ' 34' ' ' ILE . 0.6 OUTLIER -86.97 -23.68 24.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.448 -0.782 . . . . 0.0 111.553 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.666 HD13 ' NE2' ' B' ' 33' ' ' GLN . 4.6 mm -73.16 23.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 119.984 -1.697 . . . . 0.0 110.591 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.2 p30 -61.7 -9.44 6.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.604 ' O ' ' N ' ' B' ' 38' ' ' LYS . 63.0 p -71.46 -4.73 28.2 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.948 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.596 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.3 m 32.61 36.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.044 -1.035 . . . . 0.0 109.144 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.9 ptmt -122.26 42.01 3.25 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -174.51 179.14 1.82 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.1 153.24 41.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.525 -1.359 . . . . 0.0 112.001 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 61' ' ' SER . 74.9 mt-10 -156.3 124.18 5.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.746 -0.596 . . . . 0.0 110.302 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -134.87 174.15 10.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.3 145.54 11.86 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 118.691 -1.719 . . . . 0.0 110.819 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.575 ' O ' ' CD2' ' B' ' 58' ' ' HIS . 56.8 mp0 -148.35 164.72 33.21 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -1.149 . . . . 0.0 109.408 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' B' ' 57' ' ' THR . 21.6 t70 -113.57 161.15 17.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.66 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 3.0 ptmm? -62.03 83.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.421 -1.424 . . . . 0.0 109.805 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.0 mt-10 -128.73 46.75 2.56 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 97' ' ' ASP . 6.1 t -142.13 78.9 1.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 110.179 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.787 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 56.0 m80 56.4 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 109.694 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -45.86 -35.01 4.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.38 -0.825 . . . . 0.0 110.784 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -71.49 -35.2 70.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 0.0 110.739 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' A' ' 95' ' ' LEU . 84.1 mt -78.88 -50.99 10.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.691 -1.256 . . . . 0.0 109.329 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.787 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.1 ptp180 -64.29 13.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 111.291 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' GLN . . . . . 0.514 ' C ' ' O ' ' B' ' 53' ' ' ARG . 82.2 mm-40 37.92 31.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.787 -1.196 . . . . 0.0 110.175 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.775 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 59.49 1.47 1.21 Allowed Glycine 0 N--CA 1.499 2.833 0 O-C-N 121.393 -0.817 . . . . 0.0 112.82 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' PHE . . . . . 0.775 ' O ' ' O ' ' B' ' 55' ' ' GLY . 46.6 m-85 -48.58 -148.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.296 -1.708 . . . . 0.0 109.979 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 49.3 m -143.44 -56.69 0.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.342 -0.849 . . . . 0.0 110.925 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' HIS . . . . . 0.63 ' CE1' ' CE1' ' B' ' 60' ' ' PHE . 14.8 t-80 -158.37 146.21 18.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.91 -1.119 . . . . 0.0 110.157 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.582 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -132.25 148.97 52.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CE1' ' B' ' 58' ' ' HIS . 35.6 m-85 -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.461 -0.775 . . . . 0.0 109.08 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 6.9 t -88.9 95.31 10.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.5 mtp -102.41 110.55 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.195 -0.94 . . . . 0.0 110.787 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -125.56 145.99 49.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -117.73 160.58 21.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.726 -1.234 . . . . 0.0 110.051 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 85.6 tt0 -82.06 -31.86 30.64 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.3 m-20 -163.29 174.2 12.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.58 -27.11 62.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.292 -0.88 . . . . 0.0 111.407 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -55.37 -36.89 66.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.75 -35.43 73.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.609 ' O ' HG22 ' B' ' 74' ' ' THR . 71.3 t80 -61.49 -44.66 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.604 -0.939 . . . . 0.0 110.455 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.69 -29.01 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.348 -1.47 . . . . 0.0 108.695 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.379 -0.826 . . . . 0.0 109.323 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -51.22 -40.21 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -0.921 . . . . 0.0 111.131 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 74' ' ' THR . . . . . 0.62 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.5 t -80.58 -29.96 36.95 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.742 -1.224 . . . . 0.0 110.256 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 38.5 t -57.97 -33.84 69.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.961 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.608 ' NE2' ' O ' ' B' ' 73' ' ' PHE . 13.8 p80 -87.76 141.94 32.17 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.161 . . . . 0.0 109.564 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.68 10.91 1.47 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.662 2.241 . . . . 0.0 112.427 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' B' ' 30' ' ' LEU . 3.5 tt -73.0 -27.01 61.53 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.342 -0.849 . . . . 0.0 111.243 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' SER . 9.3 t-80 -84.96 -43.26 14.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.019 -1.051 . . . . 0.0 110.25 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.777 HG13 ' H ' ' B' ' 81' ' ' GLU . 2.7 p -56.83 -58.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 110.041 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.777 ' H ' HG13 ' B' ' 80' ' ' VAL . 93.5 mt-10 -58.36 -42.49 87.09 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.643 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -70.63 -39.47 73.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.827 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' SER . . . . . 0.481 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.7 t -59.72 -38.25 81.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 110.108 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.63 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 108.654 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.76 -41.59 78.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' B' ' 85' ' ' ALA . 22.4 t80 -45.02 -30.88 1.14 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.495 ' O ' ' N ' ' B' ' 90' ' ' ILE . 3.8 m -84.44 -63.73 1.29 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.94 -27.51 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 110.07 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 87' ' ' THR . 5.4 p -98.57 16.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.224 -0.923 . . . . 0.0 110.818 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' ILE . . . . . 0.601 HG22 ' N ' ' B' ' 91' ' ' ASP . 22.8 mm -130.86 164.1 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.618 -1.301 . . . . 0.0 110.497 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ASP . . . . . 0.601 ' N ' HG22 ' B' ' 90' ' ' ILE . 41.9 t0 -103.44 -36.89 7.83 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.468 ' N ' HG22 ' B' ' 90' ' ' ILE . 21.1 pttt -146.95 146.39 30.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' ILE . . . . . 0.636 HD12 HG12 ' B' ' 12' ' ' VAL . 4.8 tp -128.32 127.56 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.555 -1.341 . . . . 0.0 109.658 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.38 133.11 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.8 36.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.269 -1.52 . . . . 0.0 111.768 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.888 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -125.73 129.06 48.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.629 . . . . 0.0 109.312 177.199 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 97' ' ' ASP . . . . . 0.596 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 43.3 t0 -119.99 124.6 46.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 98' ' ' PHE . . . . . 0.596 ' CD1' ' O ' ' B' ' 97' ' ' ASP . 24.9 m-85 -142.29 148.91 49.7 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.098 -1.001 . . . . 0.0 110.504 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 130.05 16.41 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.28 1.987 . . . . 0.0 112.187 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.55 ' O ' ' OG ' ' B' ' 4' ' ' SER . 9.5 t -95.15 117.05 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 110.054 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -91.32 75.48 6.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 109.54 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.23 71.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.566 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' B' ' 105' ' ' SER . 29.2 m -149.84 -32.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.5 mtmt 37.71 -93.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.579 ' N ' ' O ' ' B' ' 103' ' ' VAL . 0.9 OUTLIER 66.59 -42.69 0.41 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.968 . . . . 0.0 108.941 -178.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.561 ' N ' ' O ' ' B' ' 104' ' ' LYS . 10.2 m -44.22 104.08 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.35 -0.844 . . . . 0.0 109.386 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.492 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' ' C ' ' A' ' 2' ' ' ALA . 74.6 mmm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 41.28 55.03 3.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.325 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.628 HG23 ' N ' ' A' ' 4' ' ' SER . 8.9 t -63.48 -45.57 90.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.149 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.628 ' N ' HG23 ' A' ' 3' ' ' THR . 19.9 m -139.64 -100.5 0.16 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.22 148.48 34.43 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.689 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.544 ' CZ ' ' OD1' ' A' ' 97' ' ' ASP . 34.6 t80 -114.93 128.09 56.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.268 -1.137 . . . . 0.0 108.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.695 ' HZ3' HD12 ' A' ' 9' ' ' LEU . 3.7 ttpp -113.51 142.35 46.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.919 -1.113 . . . . 0.0 112.83 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -132.79 133.42 43.38 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.695 HD12 ' HZ3' ' A' ' 7' ' ' LYS . 6.6 tt -136.63 145.84 45.33 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 109.461 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.2 p -127.14 133.43 68.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.566 HG12 ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -116.19 129.03 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 57' ' ' THR . 6.4 m -139.45 167.53 19.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.733 -1.587 . . . . 0.0 113.024 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 19.0 tptp -132.85 152.29 51.87 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.473 ' HB2' ' H ' ' A' ' 18' ' ' THR . 39.7 p90 -108.68 149.61 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.877 -1.139 . . . . 0.0 111.576 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -129.29 -22.09 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.7 mt-10 -89.27 -57.11 3.0 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.0 t0 153.83 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.473 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 64.6 m -50.93 105.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.104 0.954 . . . . 0.0 112.814 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -75.56 88.16 2.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 21' ' ' ASP . 34.7 m -64.61 -38.57 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.557 -0.714 . . . . 0.0 110.524 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 20' ' ' VAL . 82.9 m-20 -66.1 -44.63 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.425 -0.797 . . . . 0.0 110.572 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.96 -31.39 72.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mt -69.62 -37.44 74.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 13.9 tp -53.22 -37.86 62.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -34.53 74.23 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.02 -53.54 36.41 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -46.82 -47.73 20.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.497 -1.002 . . . . 0.0 108.832 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.49 -44.54 65.7 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -68.59 -49.05 62.33 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.39 -47.81 37.27 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.7 t -49.76 -26.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.268 -0.895 . . . . 0.0 108.887 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 47.0 t -41.64 -42.69 2.57 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.663 HE22 ' CE1' ' A' ' 76' ' ' HIS . 26.4 mm-40 -61.23 -11.17 8.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.483 -0.76 . . . . 0.0 111.499 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 34' ' ' ILE . 41.8 mm -81.92 26.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 119.985 -1.697 . . . . 0.0 110.604 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 36' ' ' THR . 31.1 p-10 -67.38 -26.38 66.43 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.711 HG23 ' H ' ' A' ' 38' ' ' LYS . 7.5 t -79.21 1.99 22.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.968 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 21.1 m 37.83 21.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.081 -1.012 . . . . 0.0 109.187 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.711 ' H ' HG23 ' A' ' 36' ' ' THR . 83.0 mttt -120.81 41.26 3.33 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.4 m -158.12 154.75 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.503 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 98.5 m-85 -144.46 154.43 42.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.543 -1.348 . . . . 0.0 111.949 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 81.1 mt-10 -160.88 130.46 4.9 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.335 0.588 . . . . 0.0 110.223 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -130.01 175.27 9.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.8 154.0 21.97 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.574 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 17.8 mt-10 -151.1 141.85 22.77 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -1.146 . . . . 0.0 109.401 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 8.5 p30 -116.02 148.53 40.07 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.64 ' HD3' ' N ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -68.5 80.82 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.481 -1.387 . . . . 0.0 109.809 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 45' ' ' ASP . 78.2 mm-40 -96.91 54.66 1.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.298 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 49' ' ' HIS . 29.7 t -134.14 -138.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -0.934 . . . . 0.0 110.23 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.54 ' N ' ' OG ' ' A' ' 48' ' ' SER . 74.1 m80 -107.37 142.94 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -42.83 -41.11 3.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 0.0 110.798 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 ttt -71.54 -29.37 64.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.016 -1.053 . . . . 0.0 110.703 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' B' ' 95' ' ' LEU . 52.1 mt -98.25 -18.38 18.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.745 -1.222 . . . . 0.0 109.277 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.636 ' C ' ' H ' ' A' ' 55' ' ' GLY . 55.0 mtp180 -73.43 0.58 11.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 111.212 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.9 -4.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.797 -1.189 . . . . 0.0 110.197 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 82.53 -18.36 15.2 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.884 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CD2' HG12 ' A' ' 11' ' ' VAL . 12.0 m-85 -59.26 -128.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.246 -1.738 . . . . 0.0 109.922 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.64 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 2.5 t -164.99 -36.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.34 -0.85 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.7 t60 -169.9 153.68 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.166 . . . . 0.0 110.225 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.653 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.18 168.76 18.98 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.261 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 88.1 m-85 -129.03 126.07 38.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 109.073 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.25 14.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 mtt -104.84 117.83 35.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.172 -0.955 . . . . 0.0 110.82 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -120.31 143.24 48.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.28 159.66 23.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.691 -1.255 . . . . 0.0 110.069 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.54 -27.45 62.23 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -173.75 -174.57 0.97 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.35 -27.17 65.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 111.445 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 29.1 p-10 -58.04 -37.89 75.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.813 -1.18 . . . . 0.0 110.532 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -68.98 -37.59 83.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' ' CG2' ' A' ' 74' ' ' THR . 71.0 t80 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.507 -0.996 . . . . 0.0 110.498 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.376 -1.453 . . . . 0.0 108.677 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.91 2.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.59 ' CZ ' ' CG ' ' A' ' 79' ' ' HIS . 35.8 t80 -45.98 -35.71 4.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.9 . . . . 0.0 111.127 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -86.02 -27.25 24.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.75 -1.219 . . . . 0.0 110.332 -178.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -66.81 12.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.989 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.663 ' CE1' HE22 ' A' ' 33' ' ' GLN . 10.2 m-70 -124.76 152.7 69.88 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.787 -1.195 . . . . 0.0 109.636 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.73 -6.63 15.35 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.675 2.25 . . . . 0.0 112.434 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 29' ' ' ASN . 5.8 tp -73.22 -28.01 61.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.837 . . . . 0.0 111.223 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.59 ' CG ' ' CZ ' ' A' ' 73' ' ' PHE . 2.9 t60 -82.08 -35.45 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.052 . . . . 0.0 110.281 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.53 -60.01 3.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.989 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -56.64 -38.65 72.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.612 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.41 -41.86 72.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.849 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 87' ' ' THR . 17.3 t -61.73 -39.2 90.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.167 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.31 77.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.1 -39.72 78.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 90' ' ' ILE . 28.3 t80 -45.19 -29.53 0.97 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.2 p -83.46 -62.26 1.63 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.588 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -40.09 -27.94 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.705 -0.622 . . . . 0.0 110.084 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 p -100.95 14.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.819 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 91' ' ' ASP . 22.5 mm -128.69 161.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.682 -1.261 . . . . 0.0 110.444 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 90' ' ' ILE . 62.8 t0 -104.37 -35.23 8.01 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.483 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 19.8 ptmt -145.63 146.03 31.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -125.69 123.43 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.626 -1.296 . . . . 0.0 109.799 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.65 132.4 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -138.6 135.41 34.92 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.262 -1.524 . . . . 0.0 111.766 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -121.06 124.53 45.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.638 -0.664 . . . . 0.0 109.363 176.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.544 ' OD1' ' CZ ' ' A' ' 6' ' ' PHE . 20.2 t0 -126.27 133.65 51.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.053 -1.029 . . . . 0.0 108.951 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CE1' ' CD ' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -156.62 157.77 31.07 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.109 -0.995 . . . . 0.0 110.516 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 58.9 Cg_endo -71.79 127.77 13.41 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.321 2.014 . . . . 0.0 112.209 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -106.99 128.7 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -108.47 94.48 5.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.47 -0.768 . . . . 0.0 109.625 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.46 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' A' ' 101' ' ' ALA . 10.2 m -148.36 -26.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 106' ' ' SER . 25.2 mmtt -38.45 -28.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 103' ' ' VAL . 5.7 p -57.69 70.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.131 -0.98 . . . . 0.0 108.941 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 104' ' ' LYS . 8.0 t -111.21 109.82 20.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 107' ' ' VAL . 11.3 p -91.73 30.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.27 141.36 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.538 -0.726 . . . . 0.0 109.533 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.82 132.17 32.2 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 p -70.73 152.55 95.18 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.891 -1.131 . . . . 0.0 109.617 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 C-N-CA 122.776 2.317 . . . . 0.0 112.238 179.652 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.455 ' O ' ' C ' ' B' ' 2' ' ' ALA . 74.3 mmm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' B' ' 1' ' ' MET . . . 41.39 55.06 3.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.618 HG23 ' N ' ' B' ' 4' ' ' SER . 8.9 t -63.49 -45.72 89.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.179 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.618 ' N ' HG23 ' B' ' 3' ' ' THR . 20.1 m -139.47 -100.51 0.16 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.26 148.39 34.25 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.406 -1.378 . . . . 0.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.54 ' CZ ' ' OD1' ' B' ' 97' ' ' ASP . 34.4 t80 -114.77 128.2 56.17 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.249 -1.148 . . . . 0.0 108.02 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.627 ' HZ3' HD12 ' B' ' 9' ' ' LEU . 3.6 ttpp -113.55 142.4 46.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 112.822 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.406 ' HD1' ' HB2' ' B' ' 97' ' ' ASP . 70.4 t60 -132.86 133.36 43.21 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.627 HD12 ' HZ3' ' B' ' 7' ' ' LYS . 6.5 tt -136.58 145.86 45.45 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.728 -1.233 . . . . 0.0 109.458 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.45 HG13 ' O ' ' B' ' 10' ' ' VAL . 12.1 p -127.18 133.34 68.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.6 OUTLIER -116.04 129.16 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.487 ' O ' HG22 ' B' ' 57' ' ' THR . 6.3 m -139.61 167.5 19.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.017 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 19.1 tptp -132.74 152.34 51.77 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.48 ' HB2' ' H ' ' B' ' 18' ' ' THR . 39.7 p90 -108.77 149.47 28.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.85 -1.156 . . . . 0.0 111.606 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -129.11 -22.08 3.2 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.6 mt-10 -89.29 -57.12 3.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 7.9 t0 153.75 64.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 63.7 m -50.73 105.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.136 0.97 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.526 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -75.62 88.22 2.73 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.497 HG23 ' N ' ' B' ' 21' ' ' ASP . 34.9 m -64.63 -38.55 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.612 -0.68 . . . . 0.0 110.471 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' HG23 ' B' ' 20' ' ' VAL . 82.7 m-20 -66.19 -44.56 83.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 110.564 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -66.07 -31.47 72.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 mt -69.53 -37.35 74.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' B' ' 21' ' ' ASP . 13.9 tp -53.3 -37.83 62.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -34.64 74.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -63.98 -53.54 36.54 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.77 -47.64 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.982 . . . . 0.0 108.797 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -52.6 -44.55 66.06 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.3 OUTLIER -68.66 -49.04 62.27 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.51 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -48.47 -47.6 38.32 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 32' ' ' SER . 53.7 t -49.96 -26.06 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.309 -0.869 . . . . 0.0 108.832 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.3 t -42.0 -42.61 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.69 HE22 ' CG ' ' B' ' 76' ' ' HIS . 15.3 mm100 -61.07 -11.3 8.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.443 -0.786 . . . . 0.0 111.509 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.683 HG22 ' O ' ' B' ' 34' ' ' ILE . 42.1 mm -81.78 26.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 119.99 -1.693 . . . . 0.0 110.559 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 36' ' ' THR . 31.6 p-10 -67.51 -26.3 66.27 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.723 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.4 t -79.25 1.85 23.33 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.942 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 36' ' ' THR . 21.1 m 37.93 21.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 36' ' ' THR . 83.3 mttt -120.82 41.36 3.31 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.422 ' O ' HD12 ' B' ' 34' ' ' ILE . 1.4 m -158.2 154.71 27.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 98.5 m-85 -144.47 154.53 43.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.545 -1.347 . . . . 0.0 111.99 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 80.8 mt-10 -160.97 130.45 4.83 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.345 0.593 . . . . 0.0 110.2 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -130.09 175.22 9.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.75 154.07 21.99 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.828 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.568 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 17.9 mt-10 -151.12 141.72 22.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 8.1 p30 -115.91 148.67 39.77 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.633 ' HD3' ' N ' ' B' ' 57' ' ' THR . 0.0 OUTLIER -68.59 80.89 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.394 -1.441 . . . . 0.0 109.788 -176.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 45' ' ' ASP . 78.2 mm-40 -96.95 54.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.646 . . . . 0.0 109.315 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' B' ' 49' ' ' HIS . 29.6 t -134.14 -138.22 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.531 ' N ' ' OG ' ' B' ' 48' ' ' SER . 74.1 m80 -107.24 142.92 36.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.134 -0.979 . . . . 0.0 109.699 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -42.78 -41.25 3.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.78 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.9 ttt -71.42 -29.29 64.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 95' ' ' LEU . 51.5 mt -98.26 -18.46 18.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.72 -1.238 . . . . 0.0 109.279 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' B' ' 55' ' ' GLY . 55.0 mtp180 -73.42 0.58 11.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -0.844 . . . . 0.0 111.271 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.87 -4.06 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.832 -1.168 . . . . 0.0 110.18 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.641 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 82.77 -18.89 13.22 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.454 -0.778 . . . . 0.0 112.861 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' B' ' 11' ' ' VAL . 12.2 m-85 -58.92 -128.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.288 -1.713 . . . . 0.0 109.902 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.633 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 2.5 t -164.9 -36.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.299 -0.876 . . . . 0.0 110.992 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.652 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.7 t60 -169.91 153.77 4.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.826 -1.171 . . . . 0.0 110.214 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.652 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.21 168.77 18.95 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.461 -0.774 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.532 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 88.2 m-85 -129.01 126.12 38.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.513 -0.742 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.24 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 34.6 mtt -104.92 117.9 35.2 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.24 -0.913 . . . . 0.0 110.731 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 99.9 m -120.38 143.27 48.52 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -119.28 159.69 23.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.715 -1.241 . . . . 0.0 110.073 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.6 -27.57 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -173.57 -174.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.39 -27.33 65.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 111.422 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 29.0 p-10 -57.9 -38.03 75.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.817 -1.177 . . . . 0.0 110.574 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -68.75 -37.6 84.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.507 ' O ' ' CG2' ' B' ' 74' ' ' THR . 71.5 t80 -62.36 -46.76 87.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.574 -0.956 . . . . 0.0 110.445 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.94 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.377 -1.452 . . . . 0.0 108.732 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.585 ' CZ ' ' CG ' ' B' ' 79' ' ' HIS . 35.8 t80 -45.75 -35.76 4.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.932 . . . . 0.0 111.107 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.2 OUTLIER -86.08 -27.29 24.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.808 -1.183 . . . . 0.0 110.316 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -66.66 12.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.066 -1.021 . . . . 0.0 110.986 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.69 ' CG ' HE22 ' B' ' 33' ' ' GLN . 16.8 m80 -124.81 152.56 69.88 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 109.547 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.58 -6.63 15.48 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.644 2.229 . . . . 0.0 112.453 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.451 HD23 HD22 ' B' ' 30' ' ' LEU . 5.8 tp -73.09 -28.23 62.17 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.236 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.585 ' CG ' ' CZ ' ' B' ' 73' ' ' PHE . 2.9 t60 -81.98 -35.44 28.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.48 -60.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.987 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' B' ' 82' ' ' PHE . 22.4 pt-20 -56.59 -38.77 72.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' B' ' 81' ' ' GLU . 73.1 t80 -70.26 -41.86 72.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.531 ' O ' HG23 ' B' ' 87' ' ' THR . 17.4 t -61.62 -39.42 91.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.1 -1.0 . . . . 0.0 110.15 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -49.39 77.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 108.68 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.93 -39.8 79.37 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.467 ' O ' HG12 ' B' ' 90' ' ' ILE . 28.4 t80 -45.12 -29.5 0.93 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.2 p -83.5 -62.36 1.6 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -40.01 -27.98 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.742 -0.599 . . . . 0.0 110.084 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' B' ' 87' ' ' THR . 3.9 p -100.86 14.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.234 -0.916 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 91' ' ' ASP . 22.4 mm -128.63 161.19 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.664 -1.273 . . . . 0.0 110.421 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.564 ' N ' HG22 ' B' ' 90' ' ' ILE . 62.6 t0 -104.55 -35.33 7.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.468 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 19.8 ptmt -145.53 146.14 31.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -125.78 123.32 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.597 -1.314 . . . . 0.0 109.767 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 132.38 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.519 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -138.59 135.3 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.314 -1.491 . . . . 0.0 111.737 -178.278 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.564 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -121.0 124.62 45.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 176.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' B' ' 6' ' ' PHE . 21.1 t0 -126.39 133.62 51.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.034 -1.041 . . . . 0.0 108.923 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -156.6 157.67 31.04 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.065 -1.022 . . . . 0.0 110.516 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 2' ' ' ALA . 58.9 Cg_endo -71.7 127.93 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.268 1.979 . . . . 0.0 112.227 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.14 128.66 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.957 . . . . 0.0 110.042 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -108.56 94.46 5.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.491 -0.756 . . . . 0.0 109.609 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.39 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.564 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.658 ' N ' ' O ' ' B' ' 101' ' ' ALA . 10.4 m -148.33 -26.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 109.23 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.4 mmtt -38.6 -28.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 103' ' ' VAL . 5.7 p -57.77 70.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.135 -0.978 . . . . 0.0 108.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.705 ' N ' ' O ' ' B' ' 104' ' ' LYS . 8.0 t -111.15 109.83 20.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.575 HG22 ' O ' ' B' ' 107' ' ' VAL . 11.3 p -91.76 30.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.38 141.43 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.437 -0.79 . . . . 0.0 109.498 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.93 132.0 31.74 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -70.48 152.71 95.37 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 120.89 -1.131 . . . . 0.0 109.663 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.308 -1.604 0 C-N-CA 122.736 2.291 . . . . 0.0 112.272 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.504 ' O ' ' C ' ' A' ' 2' ' ' ALA . 61.1 mtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.346 0.593 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -38.25 110.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 109.339 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.663 HG23 ' N ' ' A' ' 4' ' ' SER . 7.6 t -147.64 -49.07 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.102 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.663 ' N ' HG23 ' A' ' 3' ' ' THR . 29.6 m -124.05 -103.76 0.37 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.01 45.24 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.737 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -136.36 135.02 38.47 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.218 -1.166 . . . . 0.0 108.036 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -99.94 127.0 46.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.93 -1.107 . . . . 0.0 112.822 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.507 ' ND1' ' OD1' ' A' ' 97' ' ' ASP . 86.3 t60 -122.61 121.18 35.84 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.6 tt -135.08 144.11 47.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.714 -1.241 . . . . 0.0 109.474 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.7 p -127.64 134.32 65.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.547 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.52 127.93 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.429 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.4 m -141.6 159.92 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 117.785 -1.566 . . . . 0.0 113.042 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -130.41 155.2 46.81 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.605 ' CD2' HG21 ' A' ' 57' ' ' THR . 11.9 p90 -111.11 153.69 25.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.13 . . . . 0.0 111.606 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -19.14 3.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 17' ' ' ASP . 13.5 tm-20 -92.63 -56.82 2.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 3.1 m-20 155.24 62.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.522 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.8 m -49.04 105.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.082 0.944 . . . . 0.0 112.849 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.85 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.98 85.5 0.7 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 21' ' ' ASP . 33.0 m -64.95 -41.02 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.527 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.547 ' N ' HG23 ' A' ' 20' ' ' VAL . 36.4 p-10 -66.51 -46.54 75.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.4 -0.812 . . . . 0.0 110.553 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.8 mp0 -66.14 -30.25 70.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mt -72.4 -41.79 64.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.4 tp -56.1 -38.59 70.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' NZ ' ' C ' ' B' ' 111' ' ' PRO . 3.3 ttpt -63.47 -34.03 76.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -68.16 -53.3 22.86 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -44.93 -42.68 8.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.547 -0.972 . . . . 0.0 108.793 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -53.24 -42.69 66.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.674 ' ND2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -58.84 -45.2 90.63 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.674 ' N ' ' ND2' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -49.24 -45.12 44.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' ILE . 16.0 t -58.08 -20.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 108.827 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 46.8 t -44.0 -38.3 3.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.659 ' OE1' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.64 -10.74 50.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 111.39 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.659 HD13 ' OE1' ' A' ' 33' ' ' GLN . 5.4 mm -86.06 21.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.075 -1.64 . . . . 0.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 36' ' ' THR . 51.6 p30 -58.91 -9.43 1.84 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.642 ' O ' ' C ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -80.2 -1.1 39.02 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.895 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.642 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.4 m 30.26 45.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 109.217 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HZ1' ' H ' ' A' ' 69' ' ' GLY . 11.4 ptmm? -121.03 39.86 3.7 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 75.7 m -173.36 179.08 2.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -145.56 154.74 42.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.608 -1.308 . . . . 0.0 111.936 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -154.64 123.25 6.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.395 0.617 . . . . 0.0 110.234 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.615 ' CH2' ' HB3' ' B' ' 101' ' ' ALA . 67.0 t-105 -135.83 175.03 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' N ' ' CG ' ' A' ' 42' ' ' TRP . . . -132.28 160.97 23.85 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 118.711 -1.709 . . . . 0.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 41.8 mp0 -148.84 139.63 22.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -1.151 . . . . 0.0 109.336 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 47' ' ' GLU . 85.6 m-20 -113.75 147.08 38.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.671 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.5 81.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.435 -1.416 . . . . 0.0 109.806 -178.302 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.0 mt-10 -122.06 59.2 1.01 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' A' ' 49' ' ' HIS . 43.9 p -158.49 73.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' A' ' 48' ' ' SER . 55.9 m80 54.34 125.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -44.79 -31.51 1.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 110.757 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -30.79 52.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.992 -1.068 . . . . 0.0 110.763 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' SER . 40.6 mt -100.62 -27.63 13.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.784 -1.198 . . . . 0.0 109.336 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 46' ' ' LYS . 8.7 ptm180 -87.0 -2.45 58.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.326 -0.859 . . . . 0.0 111.25 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 49.21 13.71 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.839 -1.163 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.584 ' H ' ' HG3' ' A' ' 53' ' ' ARG . . . 57.06 -2.89 0.07 OUTLIER Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.441 -0.787 . . . . 0.0 112.89 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.525 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 45.8 p90 -57.1 124.08 17.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.233 -1.745 . . . . 0.0 109.977 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.675 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 72.1 p -54.2 -44.11 71.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 111.002 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.675 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 36.0 p-80 -170.21 154.94 5.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.826 -1.171 . . . . 0.0 110.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.48 17.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.283 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.91 126.77 38.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.494 -0.754 . . . . 0.0 109.078 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -96.09 96.24 8.71 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtt -101.83 119.11 38.26 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.165 -0.959 . . . . 0.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 m -125.67 145.31 50.22 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -121.59 163.74 18.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.701 -1.249 . . . . 0.0 110.088 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 4' ' ' SER . 85.4 tt0 -85.49 -30.9 23.09 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -157.56 164.06 37.71 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -24.29 55.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -57.18 -40.03 76.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.796 -1.19 . . . . 0.0 110.608 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.617 ' H ' ' HZ1' ' A' ' 38' ' ' LYS . . . -68.63 -40.79 85.64 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' HG22 ' A' ' 74' ' ' THR . 72.9 t80 -60.54 -46.79 88.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.988 . . . . 0.0 110.454 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.72 -28.97 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.396 -1.44 . . . . 0.0 108.677 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.02 -60.95 2.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -56.77 -39.44 74.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 111.173 -176.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.82 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.9 t -80.84 -34.08 34.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.764 -1.21 . . . . 0.0 110.295 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.1 m -68.12 -32.9 73.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 110.973 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -69.62 126.0 92.32 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.899 -1.125 . . . . 0.0 109.635 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.78 -7.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.726 2.284 . . . . 0.0 112.364 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 30' ' ' LEU . 6.1 tt -72.31 -30.99 65.3 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.363 -0.836 . . . . 0.0 111.198 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 10.9 t-160 -82.89 -29.19 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.966 -1.084 . . . . 0.0 110.275 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.53 -58.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.018 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -56.45 -38.17 71.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -71.64 -42.19 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -62.18 -39.72 93.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.102 -0.999 . . . . 0.0 110.146 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.49 77.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.955 -1.091 . . . . 0.0 108.69 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.08 -40.67 87.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 85' ' ' ALA . 15.9 t80 -45.29 -29.35 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 89' ' ' VAL . 12.2 m -81.79 -62.12 1.73 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -38.85 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.7 -0.625 . . . . 0.0 110.111 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.5 m -106.47 11.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.791 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 91' ' ' ASP . 26.4 mm -130.53 163.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.685 -1.26 . . . . 0.0 110.41 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.618 ' N ' HG22 ' A' ' 90' ' ' ILE . 22.6 t0 -124.22 -34.52 2.92 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -126.99 125.17 41.02 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.0 tp -123.54 123.14 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.691 -1.256 . . . . 0.0 109.786 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 43.7 t -130.28 133.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -137.48 135.26 36.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.278 -1.514 . . . . 0.0 111.781 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.867 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.1 mp -114.67 117.01 29.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.688 -0.632 . . . . 0.0 109.339 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.507 ' OD1' ' ND1' ' A' ' 8' ' ' HIS . 79.2 m-20 -114.63 121.77 44.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.092 -1.005 . . . . 0.0 108.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 63.1 t80 -154.61 137.22 10.03 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.077 -1.014 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 39.7 Cg_endo -63.86 141.94 80.19 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.311 2.007 . . . . 0.0 112.228 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' B' ' 42' ' ' TRP . 71.1 t -122.41 141.97 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 109.979 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.607 ' HB3' ' CH2' ' B' ' 42' ' ' TRP . . . -112.46 96.93 6.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.88 76.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.6 m -148.11 120.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.385 -0.822 . . . . 0.0 109.155 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.32 115.71 24.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.346 -0.846 . . . . 0.0 109.325 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.556 ' O ' HG12 ' A' ' 107' ' ' VAL . 22.1 m -69.88 -45.38 67.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 108.914 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' SER . 6.1 t 43.19 52.42 5.56 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.354 -0.841 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 107' ' ' VAL . 9.7 p -177.19 51.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 108' ' ' VAL . 8.6 p -168.06 43.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.567 -0.708 . . . . 0.0 109.465 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.03 75.99 0.66 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 p -76.28 153.56 84.16 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 120.921 -1.112 . . . . 0.0 109.661 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.47 ' C ' ' NZ ' ' B' ' 25' ' ' LYS . 75.3 Cg_endo . . . . . 0 C--N 1.309 -1.546 0 C-N-CA 122.736 2.291 . . . . 0.0 112.255 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.481 ' O ' ' C ' ' B' ' 2' ' ' ALA . 61.5 mtt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.289 0.566 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' B' ' 1' ' ' MET . . . -38.3 110.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -0.927 . . . . 0.0 109.288 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.665 HG23 ' N ' ' B' ' 4' ' ' SER . 7.7 t -147.82 -48.83 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 109.143 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.665 ' N ' HG23 ' B' ' 3' ' ' THR . 28.2 m -124.36 -103.97 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.4 175.0 45.64 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.43 134.81 38.11 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.207 -1.172 . . . . 0.0 108.075 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -99.76 126.9 45.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.929 -1.107 . . . . 0.0 112.837 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' B' ' 97' ' ' ASP . 86.3 t60 -122.66 121.21 35.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.6 tt -135.07 144.07 47.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.694 -1.253 . . . . 0.0 109.454 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.444 HG13 ' O ' ' B' ' 10' ' ' VAL . 10.6 p -127.62 134.41 65.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.512 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.64 127.95 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.425 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.4 m -141.6 159.76 21.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.019 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -130.29 155.26 46.62 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.604 ' CD2' HG21 ' B' ' 57' ' ' THR . 12.0 p90 -111.23 153.66 25.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.827 -1.17 . . . . 0.0 111.558 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 -19.2 3.2 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 17' ' ' ASP . 13.5 tm-20 -92.49 -56.92 2.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.519 ' N ' ' OE1' ' B' ' 16' ' ' GLU . 3.1 m-20 155.21 62.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.509 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 90.2 m -49.31 105.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.095 0.95 . . . . 0.0 112.882 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.838 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -70.95 85.33 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.552 HG23 ' N ' ' B' ' 21' ' ' ASP . 32.9 m -64.84 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.616 -0.677 . . . . 0.0 110.539 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' HG23 ' B' ' 20' ' ' VAL . 36.0 p-10 -66.59 -46.41 76.05 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 110.569 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 3.9 mp0 -66.25 -30.25 70.65 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.35 -41.78 65.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -56.08 -38.6 70.9 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.47 ' NZ ' ' C ' ' A' ' 111' ' ' PRO . 3.3 ttpt -63.34 -34.28 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.596 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -67.96 -53.43 22.98 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -44.88 -42.59 8.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.466 -1.02 . . . . 0.0 108.801 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -53.43 -42.54 67.19 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' N ' ' B' ' 30' ' ' LEU . 0.0 OUTLIER -58.91 -45.21 90.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.68 ' N ' ' ND2' ' B' ' 29' ' ' ASN . 0.5 OUTLIER -49.18 -45.28 43.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' B' ' 34' ' ' ILE . 15.8 t -57.88 -20.35 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.278 -0.889 . . . . 0.0 108.806 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.0 t -43.86 -38.41 3.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.652 ' OE1' HD13 ' B' ' 34' ' ' ILE . 0.0 OUTLIER -87.53 -10.97 50.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.502 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.652 HD13 ' OE1' ' B' ' 33' ' ' GLN . 5.3 mm -85.85 21.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 119.933 -1.73 . . . . 0.0 110.588 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 36' ' ' THR . 51.1 p30 -59.01 -9.5 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -80.18 -1.01 38.56 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.878 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.6 m 30.33 45.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.03 -1.044 . . . . 0.0 109.17 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.652 ' HZ2' ' CA ' ' B' ' 69' ' ' GLY . 11.4 ptmm? -121.12 40.0 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 74.9 m -173.39 179.17 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.61 154.73 42.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.469 -1.394 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -154.6 123.33 6.19 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.471 0.653 . . . . 0.0 110.218 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.607 ' CH2' ' HB3' ' A' ' 101' ' ' ALA . 66.7 t-105 -135.75 175.08 9.92 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' B' ' 42' ' ' TRP . . . -132.2 161.07 23.84 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.772 -1.68 . . . . 0.0 110.791 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 41.6 mp0 -148.9 139.48 22.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -1.162 . . . . 0.0 109.358 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 47' ' ' GLU . 85.2 m-20 -113.46 147.14 38.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.66 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -65.54 81.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.483 -1.385 . . . . 0.0 109.832 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.1 mt-10 -122.12 59.28 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.712 -0.618 . . . . 0.0 109.398 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' B' ' 49' ' ' HIS . 41.7 p -158.42 73.25 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' B' ' 48' ' ' SER . 55.9 m80 54.24 125.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -44.6 -31.62 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.44 -30.89 53.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.724 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' B' ' 48' ' ' SER . 41.4 mt -100.76 -27.47 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.782 -1.199 . . . . 0.0 109.247 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' O ' ' B' ' 46' ' ' LYS . 8.7 ptm180 -87.11 -2.48 58.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 111.204 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 49.32 13.64 0.08 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.782 -1.199 . . . . 0.0 110.217 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.592 ' H ' ' HG3' ' B' ' 53' ' ' ARG . . . 57.18 -3.13 0.07 OUTLIER Glycine 0 N--CA 1.498 2.797 0 O-C-N 121.47 -0.769 . . . . 0.0 112.852 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 45.9 p90 -56.96 124.17 17.72 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.279 -1.718 . . . . 0.0 109.977 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.64 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 72.1 p -54.19 -44.19 71.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.988 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.64 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 36.0 p-80 -170.21 154.82 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.119 . . . . 0.0 110.197 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.95 169.46 17.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.414 -0.804 . . . . 0.0 109.24 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.81 126.87 39.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.348 -0.845 . . . . 0.0 109.081 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 66.0 m -96.1 96.3 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtt -101.81 119.07 38.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.23 -0.919 . . . . 0.0 110.81 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -125.71 145.33 50.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.63 163.64 18.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.661 -1.274 . . . . 0.0 110.054 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 4' ' ' SER . 85.4 tt0 -85.45 -30.92 23.14 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.43 164.13 37.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -24.39 56.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 111.467 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.96 -40.23 76.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.727 -1.233 . . . . 0.0 110.563 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.652 ' CA ' ' HZ2' ' B' ' 38' ' ' LYS . . . -68.6 -40.55 85.91 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.817 ' O ' HG22 ' B' ' 74' ' ' THR . 73.4 t80 -60.77 -46.69 89.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.636 -0.92 . . . . 0.0 110.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.98 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.322 -1.486 . . . . 0.0 108.665 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.461 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.03 -60.85 2.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.788 . . . . 0.0 109.387 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.425 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.75 -39.43 73.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.889 . . . . 0.0 111.079 -177.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.817 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.9 t -80.97 -33.84 33.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.763 -1.21 . . . . 0.0 110.371 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 74.5 m -68.36 -32.82 73.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.955 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.565 ' O ' ' N ' ' B' ' 78' ' ' LEU . 0.3 OUTLIER -69.58 126.04 92.35 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.807 -1.183 . . . . 0.0 109.605 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -43.78 -7.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.642 2.228 . . . . 0.0 112.48 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.566 ' CD2' HD22 ' B' ' 30' ' ' LEU . 6.2 tt -72.51 -30.93 64.93 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.42 -0.8 . . . . 0.0 111.214 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.457 ' CD2' ' O ' ' B' ' 79' ' ' HIS . 10.9 t-160 -82.93 -29.11 29.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.956 -1.09 . . . . 0.0 110.317 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.54 -58.71 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 110.004 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -56.54 -38.2 71.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 0.0 109.531 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -71.5 -42.25 68.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 0.0 109.905 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -62.27 -39.64 93.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.0 . . . . 0.0 110.124 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.5 77.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 0.0 108.609 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.18 -40.64 86.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.456 ' O ' HG12 ' B' ' 90' ' ' ILE . 16.0 t80 -45.31 -29.3 1.0 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 12.3 m -81.8 -62.08 1.74 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.99 -26.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.643 -0.661 . . . . 0.0 110.093 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.7 m -106.58 11.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.28 -0.888 . . . . 0.0 110.828 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.62 HG22 ' N ' ' B' ' 91' ' ' ASP . 26.4 mm -130.59 163.91 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.616 -1.302 . . . . 0.0 110.494 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.62 ' N ' HG22 ' B' ' 90' ' ' ILE . 22.6 t0 -124.25 -34.55 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -127.03 125.13 40.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.0 tp -123.63 123.15 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.617 -1.302 . . . . 0.0 109.715 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 43.2 t -130.27 133.01 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.494 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -137.43 135.19 36.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.251 -1.531 . . . . 0.0 111.796 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.859 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.2 mp -114.68 116.96 29.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 109.317 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' B' ' 8' ' ' HIS . 79.8 m-20 -114.67 121.78 44.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.156 -0.965 . . . . 0.0 108.884 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 63.3 t80 -154.56 137.18 10.01 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 39.7 Cg_endo -63.93 141.89 79.53 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.27 1.98 . . . . 0.0 112.299 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' A' ' 42' ' ' TRP . 71.4 t -122.37 141.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 110.05 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.615 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . . . -112.53 96.99 6.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.439 -0.788 . . . . 0.0 109.548 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.9 76.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.091 -1.005 . . . . 0.0 109.561 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 103' ' ' VAL . 9.4 m -148.03 120.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.227 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.27 115.72 24.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.552 ' O ' HG12 ' B' ' 107' ' ' VAL . 23.2 m -69.78 -45.67 67.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.138 -0.976 . . . . 0.0 108.917 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.4 t 43.48 52.23 6.03 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.365 -0.834 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 107' ' ' VAL . 9.5 p -177.09 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.73 ' O ' HG22 ' B' ' 108' ' ' VAL . 8.5 p -167.94 43.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.509 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.9 75.9 0.63 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.285 -0.884 . . . . 0.0 108.636 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 1.7 p -76.28 153.57 84.17 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 120.864 -1.148 . . . . 0.0 109.625 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.468 ' C ' ' NZ ' ' A' ' 25' ' ' LYS . 74.9 Cg_endo . . . . . 0 C--N 1.308 -1.571 0 C-N-CA 122.731 2.287 . . . . 0.0 112.228 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' O ' ' C ' ' A' ' 2' ' ' ALA . 25.4 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.303 0.573 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 44.57 64.1 1.46 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.362 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.81 HG21 ' HB2' ' A' ' 101' ' ' ALA . 10.2 t -65.85 -45.7 81.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.174 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.625 ' N ' HG23 ' A' ' 3' ' ' THR . 19.7 m -136.23 -97.02 0.23 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.61 170.06 41.79 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.731 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.2 131.27 43.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.283 -1.127 . . . . 0.0 108.011 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -99.87 125.75 45.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.925 -1.109 . . . . 0.0 112.824 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 62' ' ' MET . 74.5 m80 -120.09 121.41 38.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.42 143.21 43.82 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.696 -1.252 . . . . 0.0 109.486 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 95' ' ' LEU . 14.7 p -128.67 136.12 60.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.635 -0.666 . . . . 0.0 109.492 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -114.07 126.58 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 178.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' A' ' 10' ' ' VAL . 2.1 m -138.09 154.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.813 -1.555 . . . . 0.0 113.064 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 57' ' ' THR . 43.7 mtpt -126.61 154.85 43.4 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.669 ' CD2' HG21 ' A' ' 57' ' ' THR . 16.6 p90 -111.28 152.54 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.817 -1.177 . . . . 0.0 111.641 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -128.23 -18.48 4.08 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.6 mt-10 -90.48 -56.83 3.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 4.8 p30 153.05 58.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 78.8 m -47.05 107.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.051 0.929 . . . . 0.0 112.815 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.75 87.67 2.79 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 175.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -57.97 -34.87 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.725 . . . . 0.0 110.527 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.45 -40.25 89.32 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 88.3 mt-10 -68.27 -33.33 74.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 19' ' ' LYS . 1.1 mp -63.9 -44.08 97.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.48 -34.62 61.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.51 -34.33 75.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.38 -44.92 8.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.56 -58.09 9.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.538 -0.978 . . . . 0.0 108.81 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' B' ' 108' ' ' VAL . 0.7 OUTLIER -55.76 -40.82 73.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 13.4 t-20 -61.23 -45.34 94.95 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.687 HD13 ' O ' ' A' ' 30' ' ' LEU . 2.8 tm? -53.91 -46.08 71.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG11 HG21 ' B' ' 107' ' ' VAL . 59.5 t -55.91 -33.8 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 108.825 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 31' ' ' VAL . 4.7 m -45.47 -39.8 7.61 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 35' ' ' ASP . 21.3 tp60 -69.34 -53.98 16.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.439 -0.788 . . . . 0.0 111.469 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.633 ' C ' ' H ' ' A' ' 36' ' ' THR . 17.4 mt -61.2 41.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.039 -1.663 . . . . 0.0 110.626 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.662 ' N ' ' O ' ' A' ' 33' ' ' GLN . 58.9 t0 -60.41 -3.81 0.74 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' A' ' 37' ' ' VAL . 45.3 p -76.9 -0.96 26.09 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.942 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 36' ' ' THR . 19.1 m 31.21 47.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 36' ' ' THR . 13.9 ptpt -124.46 42.45 3.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 t -175.63 179.45 1.41 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 93.0 m-85 -145.75 155.28 42.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.566 -1.334 . . . . 0.0 111.958 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' PHE . 71.2 mt-10 -157.06 126.52 6.08 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.356 0.598 . . . . 0.0 110.246 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.545 ' CD1' ' NZ ' ' B' ' 104' ' ' LYS . 0.1 OUTLIER -142.34 178.02 7.86 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' CE3' ' A' ' 42' ' ' TRP . . . -142.83 169.1 25.74 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.46 145.97 27.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -1.137 . . . . 0.0 109.369 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 86.5 m-20 -124.25 147.02 48.39 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.855 ' HD2' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -146.19 136.36 23.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.437 -1.414 . . . . 0.0 109.808 -174.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.73 ' O ' ' O ' ' A' ' 48' ' ' SER . 96.2 mt-10 -131.13 -0.7 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.707 -0.621 . . . . 0.0 109.343 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.73 ' O ' ' O ' ' A' ' 47' ' ' GLU . 29.7 t -49.01 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.543 ' N ' ' OG ' ' A' ' 48' ' ' SER . 76.0 m80 -70.7 152.59 43.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.461 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 88.2 m-20 -66.98 -41.65 86.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.481 ' SD ' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -69.2 -33.95 74.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.007 -1.058 . . . . 0.0 110.789 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' B' ' 95' ' ' LEU . 70.4 mt -87.26 -56.34 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.722 -1.236 . . . . 0.0 109.33 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.697 ' C ' ' H ' ' A' ' 55' ' ' GLY . 10.0 ptt180 -59.4 4.75 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 111.149 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.749 ' OE1' HD11 ' B' ' 96' ' ' LEU . 1.2 mt-30 59.64 -18.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.86 -1.15 . . . . 0.0 110.196 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.697 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 83.12 -17.27 23.89 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 121.434 -0.791 . . . . 0.0 112.921 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.855 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 6.1 p90 -60.47 117.02 4.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.275 -1.721 . . . . 0.0 109.897 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.791 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 70.1 p -51.68 -33.72 35.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.295 -0.878 . . . . 0.0 110.984 -175.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.791 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -175.44 159.93 2.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.847 -1.158 . . . . 0.0 110.114 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.51 169.28 17.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.347 -0.846 . . . . 0.0 109.249 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.36 127.5 37.72 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.484 -0.76 . . . . 0.0 109.094 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -93.15 98.49 11.33 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 8' ' ' HIS . 69.9 mtm -101.54 113.63 26.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.166 -0.958 . . . . 0.0 110.775 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.2 m -123.03 141.99 51.35 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.87 162.05 19.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.698 -1.252 . . . . 0.0 110.118 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -81.97 -30.41 31.67 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -168.13 175.36 6.63 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -65.07 -24.84 67.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 111.419 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -61.38 -44.88 96.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.777 -1.202 . . . . 0.0 110.573 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.25 -34.3 74.93 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.748 ' O ' HG22 ' A' ' 74' ' ' THR . 74.0 t80 -65.98 -46.2 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.479 -1.012 . . . . 0.0 110.485 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 75' ' ' SER . 20.9 m -70.75 -28.93 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.345 -1.472 . . . . 0.0 108.668 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.12 -60.88 2.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 0.0 109.326 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -60.96 -55.86 27.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 111.177 -177.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.748 HG22 ' O ' ' A' ' 70' ' ' TYR . 12.8 t -57.09 -34.71 68.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.729 -1.232 . . . . 0.0 110.287 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 68.8 p -69.35 -26.44 64.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -0.955 . . . . 0.0 110.967 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 72' ' ' ALA . 41.9 m80 -65.1 151.46 93.6 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.843 -1.161 . . . . 0.0 109.648 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.74 -12.7 26.73 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.641 2.227 . . . . 0.0 112.439 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.32 -28.9 63.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.361 -0.837 . . . . 0.0 111.208 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.464 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 46.1 t60 -83.23 -32.8 26.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.017 -1.052 . . . . 0.0 110.227 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.84 -60.44 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.047 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.05 -37.6 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.14 -40.26 74.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.3 t -62.6 -41.09 98.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.21 74.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.972 -1.08 . . . . 0.0 108.706 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.63 -41.26 79.69 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.467 ' C ' ' O ' ' A' ' 85' ' ' ALA . 20.0 t80 -44.6 -31.26 1.09 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.3 m -82.53 -61.68 1.82 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.17 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.712 -0.617 . . . . 0.0 110.09 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.1 m -100.53 16.35 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 110.847 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.616 ' N ' ' O ' ' A' ' 87' ' ' THR . 41.1 mt -126.68 159.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.659 -1.276 . . . . 0.0 110.409 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.517 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 52.7 t0 -102.31 -31.91 10.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' N ' HG22 ' A' ' 90' ' ' ILE . 32.2 pttt -151.9 149.44 28.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.8 tp -125.06 124.23 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.653 -1.279 . . . . 0.0 109.73 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 46.3 t -126.95 131.33 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.8 138.17 32.05 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.34 -1.475 . . . . 0.0 111.741 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.959 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.16 125.72 49.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 31.4 p-10 -120.38 124.56 45.83 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.045 . . . . 0.0 108.907 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 86.3 t80 -154.05 123.74 3.26 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.1 -1.0 . . . . 0.0 110.531 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.03 136.22 14.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.345 2.03 . . . . 0.0 112.186 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.9 t -120.77 140.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.997 . . . . 0.0 110.028 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.81 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -113.46 96.97 6.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.34 76.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.018 . . . . 0.0 109.599 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 103' ' ' VAL . 13.2 m -148.42 118.85 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 0.0 109.176 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 106' ' ' SER . 23.4 mmtm -144.73 -11.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.467 ' C ' ' O ' ' A' ' 104' ' ' LYS . 87.5 p -42.15 -24.5 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 108.93 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 104' ' ' LYS . 34.5 t -53.04 -83.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.36 -0.838 . . . . 0.0 109.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 104' ' ' LYS . 44.2 t 42.9 87.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' B' ' 28' ' ' GLU . 78.9 t -129.89 119.1 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.612 -0.68 . . . . 0.0 109.49 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.96 157.54 33.09 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -69.6 151.2 96.67 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 120.839 -1.163 . . . . 0.0 109.634 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo . . . . . 0 C--N 1.307 -1.641 0 C-N-CA 122.843 2.362 . . . . 0.0 112.259 179.909 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.04 64.26 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.804 HG21 ' HB2' ' B' ' 101' ' ' ALA . 10.4 t -65.99 -45.98 79.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.895 . . . . 0.0 109.147 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.624 ' N ' HG23 ' B' ' 3' ' ' THR . 19.9 m -135.92 -96.92 0.23 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.84 170.03 41.29 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.748 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.99 131.24 44.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.29 -1.123 . . . . 0.0 108.064 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -99.77 125.86 45.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.946 -1.096 . . . . 0.0 112.854 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' B' ' 62' ' ' MET . 74.4 m80 -120.22 121.09 37.95 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 tt -136.19 143.34 44.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.736 -1.227 . . . . 0.0 109.399 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' B' ' 95' ' ' LEU . 15.0 p -128.69 136.22 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.505 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' B' ' 56' ' ' PHE . 0.2 OUTLIER -114.16 126.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.431 ' CG1' HG22 ' B' ' 10' ' ' VAL . 2.1 m -138.24 153.9 27.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 117.757 -1.577 . . . . 0.0 113.016 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.434 ' HD3' ' HZ2' ' B' ' 92' ' ' LYS . 43.7 mtpt -126.4 154.68 43.27 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.674 ' CD2' HG21 ' B' ' 57' ' ' THR . 17.1 p90 -111.17 152.58 26.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.923 -1.11 . . . . 0.0 111.589 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -128.18 -18.83 4.03 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.3 mt-10 -90.12 -56.94 3.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 4.8 p30 153.13 58.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 73.0 m -47.04 107.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.131 0.967 . . . . 0.0 112.821 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.618 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.88 87.72 2.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -57.91 -34.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.567 -0.708 . . . . 0.0 110.533 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.4 p-10 -66.76 -40.08 88.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 110.51 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 88.3 mt-10 -68.28 -33.15 73.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.41 HD13 ' O ' ' B' ' 19' ' ' LYS . 1.1 mp -64.26 -43.96 97.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.27 -34.92 61.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.36 -34.43 75.29 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.26 -44.75 8.58 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -56.96 -57.98 10.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.555 -0.967 . . . . 0.0 108.799 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 108' ' ' VAL . 0.7 OUTLIER -55.8 -40.66 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.423 ' H ' ' HG3' ' B' ' 28' ' ' GLU . 13.4 t-20 -61.41 -45.35 94.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.677 HD13 ' O ' ' B' ' 30' ' ' LEU . 2.8 tm? -53.87 -46.06 71.18 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 107' ' ' VAL . 60.2 t -55.69 -34.01 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.301 -0.874 . . . . 0.0 108.839 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 31' ' ' VAL . 4.7 m -45.37 -39.77 7.21 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.667 ' O ' ' N ' ' B' ' 35' ' ' ASP . 21.5 tp60 -69.49 -53.88 16.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.493 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.624 ' C ' ' H ' ' B' ' 36' ' ' THR . 17.4 mt -61.31 41.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 119.939 -1.725 . . . . 0.0 110.588 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.667 ' N ' ' O ' ' B' ' 33' ' ' GLN . 60.6 t0 -60.55 -4.26 0.87 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.624 ' H ' ' C ' ' B' ' 34' ' ' ILE . 45.6 p -76.44 -1.4 26.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.62 ' C ' ' O ' ' B' ' 36' ' ' THR . 19.0 m 31.66 47.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.015 -1.053 . . . . 0.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.444 ' HG2' ' OG1' ' B' ' 36' ' ' THR . 13.9 ptpt -124.56 42.48 3.25 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.5 t -175.56 179.39 1.44 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.434 ' O ' ' HG2' ' B' ' 41' ' ' GLU . 93.1 m-85 -145.8 155.28 42.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.582 -1.324 . . . . 0.0 111.93 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 40' ' ' PHE . 71.7 mt-10 -157.1 126.43 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.783 -0.573 . . . . 0.0 110.272 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' B' ' 43' ' ' GLY . 0.1 OUTLIER -142.23 177.95 7.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' B' ' 42' ' ' TRP . . . -142.74 168.89 25.79 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -149.31 145.65 27.14 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -1.128 . . . . 0.0 109.409 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 86.6 m-20 -123.84 147.05 47.94 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.851 ' HD2' ' O ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -146.15 136.44 23.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.349 -1.47 . . . . 0.0 109.737 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.714 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.9 mt-10 -131.1 -0.63 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.701 -0.624 . . . . 0.0 109.353 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.714 ' O ' ' O ' ' B' ' 47' ' ' GLU . 29.5 t -49.32 -151.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.204 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.513 ' N ' ' OG ' ' B' ' 48' ' ' SER . 76.1 m80 -70.63 152.41 43.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -0.994 . . . . 0.0 109.641 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.453 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 87.9 m-20 -66.69 -41.82 87.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.349 -0.844 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.482 ' SD ' ' O ' ' B' ' 51' ' ' MET . 0.4 OUTLIER -69.03 -33.95 74.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 95' ' ' LEU . 70.9 mt -87.26 -56.46 3.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.778 -1.201 . . . . 0.0 109.197 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.705 ' C ' ' H ' ' B' ' 55' ' ' GLY . 9.8 ptt180 -59.33 4.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 111.266 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.762 ' OE1' HD11 ' A' ' 96' ' ' LEU . 1.2 mt-30 59.4 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.828 -1.17 . . . . 0.0 110.219 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.705 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 83.07 -17.18 24.13 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.379 -0.826 . . . . 0.0 112.856 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.851 ' O ' ' HD2' ' B' ' 46' ' ' LYS . 6.0 p90 -60.48 117.12 4.88 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.292 -1.711 . . . . 0.0 109.951 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.74 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 69.8 p -51.73 -33.53 35.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.258 -0.901 . . . . 0.0 111.002 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.74 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 0.1 OUTLIER -175.61 159.71 2.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.787 -1.196 . . . . 0.0 110.183 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.3 169.39 17.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.504 -0.747 . . . . 0.0 109.294 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -131.3 127.7 38.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.433 -0.792 . . . . 0.0 109.093 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t -93.23 98.24 11.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' MET . . . . . 0.415 ' O ' ' N ' ' B' ' 8' ' ' HIS . 70.2 mtm -101.35 113.59 26.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.834 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 35.8 m -122.98 142.38 50.9 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -119.16 162.0 19.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.69 -1.257 . . . . 0.0 110.035 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -82.15 -30.08 31.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -168.43 175.22 6.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -65.05 -24.61 67.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 111.474 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -61.66 -44.84 96.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.803 -1.186 . . . . 0.0 110.647 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.99 -34.31 76.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.735 ' O ' HG22 ' B' ' 74' ' ' THR . 72.9 t80 -66.14 -46.17 78.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.565 -0.962 . . . . 0.0 110.504 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.71 -28.92 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.382 -1.449 . . . . 0.0 108.666 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.08 -60.83 2.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.435 -0.791 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -60.97 -55.96 26.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 111.116 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.735 HG22 ' O ' ' B' ' 70' ' ' TYR . 13.0 t -57.05 -34.77 68.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.702 -1.249 . . . . 0.0 110.34 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 69.1 p -69.31 -26.25 64.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.088 -1.008 . . . . 0.0 110.965 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 72' ' ' ALA . 41.3 m80 -65.33 151.6 93.73 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.876 -1.14 . . . . 0.0 109.651 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.02 -12.24 25.82 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.678 2.252 . . . . 0.0 112.491 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -28.6 62.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.436 -0.79 . . . . 0.0 111.22 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.454 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 46.2 t60 -83.26 -32.84 26.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.943 -1.098 . . . . 0.0 110.249 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 66.6 t -62.91 -60.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.999 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.11 -37.52 61.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -70.21 -40.17 74.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.172 -0.955 . . . . 0.0 109.883 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.8 t -62.59 -41.2 98.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.29 74.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.973 -1.079 . . . . 0.0 108.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.52 -41.35 80.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.469 ' C ' ' O ' ' B' ' 85' ' ' ALA . 19.9 t80 -44.54 -31.37 1.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.561 ' O ' ' N ' ' B' ' 90' ' ' ILE . 6.5 m -82.53 -61.84 1.77 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.0 -29.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.681 -0.637 . . . . 0.0 110.086 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.2 m -100.67 16.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.161 -0.962 . . . . 0.0 110.843 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' B' ' 87' ' ' THR . 41.5 mt -126.73 159.23 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 0.0 110.474 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 51.9 t0 -102.48 -31.81 10.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.449 ' N ' HG22 ' B' ' 90' ' ' ILE . 32.4 pttt -152.04 149.72 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.463 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.8 tp -125.43 124.05 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.594 -1.316 . . . . 0.0 109.76 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 45.9 t -126.82 131.4 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.824 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.273 -1.517 . . . . 0.0 111.79 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.959 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -119.21 125.76 49.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.664 -0.648 . . . . 0.0 109.33 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 30.0 p-10 -120.43 124.3 45.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.065 -1.022 . . . . 0.0 108.961 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 86.1 t80 -153.79 123.91 3.36 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.091 -1.005 . . . . 0.0 110.547 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.22 136.08 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.358 2.039 . . . . 0.0 112.221 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.56 140.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 0.0 110.094 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.804 ' HB2' HG21 ' B' ' 3' ' ' THR . . . -113.65 96.86 6.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 0.0 109.584 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.32 76.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.622 HG23 ' O ' ' B' ' 103' ' ' VAL . 13.2 m -148.49 118.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.234 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.545 ' NZ ' ' CD1' ' A' ' 42' ' ' TRP . 23.1 mmtm -144.55 -11.97 0.6 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.478 ' C ' ' O ' ' B' ' 104' ' ' LYS . 85.6 p -42.2 -24.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.152 -0.968 . . . . 0.0 108.999 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.525 ' N ' ' O ' ' B' ' 104' ' ' LYS . 33.5 t -52.93 -83.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 104' ' ' LYS . 44.8 t 42.9 87.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.441 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 79.0 t -129.93 119.2 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 109.49 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.09 157.55 33.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.452 HG22 ' H ' ' B' ' 110' ' ' THR . 0.0 OUTLIER -69.6 150.93 96.74 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 120.799 -1.188 . . . . 0.0 109.706 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo . . . . . 0 C--N 1.307 -1.611 0 C-N-CA 122.759 2.306 . . . . 0.0 112.213 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' H2 ' ' N ' ' A' ' 101' ' ' ALA . 65.1 mtt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.266 0.555 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 176.02 69.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 109.341 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.685 HG23 ' N ' ' A' ' 4' ' ' SER . 10.1 t -153.24 -48.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.937 . . . . 0.0 109.124 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.685 ' N ' HG23 ' A' ' 3' ' ' THR . 15.2 m -59.63 -69.05 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.18 -163.63 15.4 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.76 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -110.64 135.39 51.33 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.315 -1.109 . . . . 0.0 108.015 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 5.1 ttpm? -100.44 129.43 46.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.962 -1.086 . . . . 0.0 112.88 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' MET . 78.2 t60 -121.9 120.47 34.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -132.12 141.93 49.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.702 -1.249 . . . . 0.0 109.446 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.47 139.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.654 -0.654 . . . . 0.0 109.475 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.444 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -126.64 133.74 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.3 155.95 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.069 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.701 ' HB2' ' HZ2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.8 152.26 37.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CD2' HG21 ' A' ' 57' ' ' THR . 8.9 p90 -107.88 151.51 25.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.835 -1.166 . . . . 0.0 111.565 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.13 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.6 tt0 -90.14 -56.48 3.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.8 m-20 152.63 66.86 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 65.1 m -52.46 107.0 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.087 0.946 . . . . 0.0 112.841 -176.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.629 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -72.72 85.55 1.21 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 21' ' ' ASP . 17.7 m -54.63 -37.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.3 p-10 -63.42 -36.61 84.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 110.591 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 81.6 mt-10 -72.67 -37.61 67.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.447 HD11 HG21 ' A' ' 89' ' ' VAL . 1.8 mm -58.46 -45.28 90.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -48.87 -36.25 16.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.35 -38.24 76.82 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -73.4 -25.11 73.63 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.1 tt -75.12 -60.18 2.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -1.025 . . . . 0.0 108.804 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' B' ' 110' ' ' THR . 24.2 pt-20 -49.95 -31.58 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 32' ' ' SER . 75.0 m-20 -65.62 -43.5 89.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.844 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -47.22 -53.34 13.5 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.3 t -49.8 -30.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 108.856 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 10.6 t -45.15 -50.77 11.11 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.445 ' NE2' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -83.54 -9.04 59.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 111.393 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.537 ' C ' ' N ' ' A' ' 36' ' ' THR . 12.3 mt -91.72 28.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.012 -1.68 . . . . 0.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.44 -9.39 2.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 38' ' ' LYS . 10.1 t -67.55 -7.71 28.19 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.959 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.6 m 34.99 34.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.12 -0.987 . . . . 0.0 109.173 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.702 ' H ' HG23 ' A' ' 36' ' ' THR . 32.5 mtmt -123.03 47.83 1.91 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -174.35 175.05 2.69 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.17 159.05 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.522 -1.361 . . . . 0.0 112.013 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -152.11 117.25 5.23 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.306 0.574 . . . . 0.0 110.22 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' B' ' 102' ' ' ALA . 3.6 t-105 -105.74 167.16 9.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 150.27 17.13 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.73 -1.7 . . . . 0.0 110.851 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 78.0 mt-10 -152.1 143.81 23.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -1.167 . . . . 0.0 109.368 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.694 ' HA ' ' O ' ' A' ' 57' ' ' THR . 59.6 t0 -170.36 95.98 0.25 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HZ1' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -84.34 156.54 21.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.484 -1.385 . . . . 0.0 109.853 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 48' ' ' SER . 84.7 mt-10 -158.91 82.2 0.79 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.1 t 160.82 151.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.189 -0.944 . . . . 0.0 110.222 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.516 ' ND1' ' OG ' ' A' ' 48' ' ' SER . 28.8 m80 62.56 105.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.927 . . . . 0.0 109.718 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -49.8 -43.61 48.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.377 -0.827 . . . . 0.0 110.775 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.552 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 24.8 ttt -60.16 -35.58 75.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.04 -1.037 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.64 -9.62 51.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.828 -1.17 . . . . 0.0 109.283 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.951 ' O ' ' N ' ' A' ' 55' ' ' GLY . 33.2 ttp180 -84.86 36.65 0.62 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.0 111.207 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 51' ' ' MET . 78.8 mm-40 -32.66 -10.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.77 -1.206 . . . . 0.0 110.173 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.951 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 102.72 -39.74 2.67 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 121.49 -0.756 . . . . 0.0 112.911 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -52.3 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.228 -1.748 . . . . 0.0 109.903 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 70.1 p -56.84 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 110.927 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.542 ' NE2' ' CG2' ' A' ' 12' ' ' VAL . 17.6 p-80 -122.0 152.36 39.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.826 -1.171 . . . . 0.0 110.085 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB2' HG13 ' A' ' 11' ' ' VAL . . . -144.6 168.77 19.38 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -138.28 133.46 33.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.433 -0.792 . . . . 0.0 109.095 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -100.43 96.11 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 8' ' ' HIS . 53.6 mtm -96.34 121.32 38.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.111 -0.993 . . . . 0.0 110.801 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -124.74 148.07 48.28 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -125.61 155.91 40.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.795 -1.191 . . . . 0.0 110.045 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 41.4 tp10 -78.12 -26.97 48.22 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.7 m-20 -163.66 171.0 16.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -59.95 -22.17 62.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.281 -0.887 . . . . 0.0 111.438 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -58.78 -39.0 79.76 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.716 -1.24 . . . . 0.0 110.524 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.47 71.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.701 ' O ' HG22 ' A' ' 74' ' ' THR . 70.5 t80 -66.64 -44.27 82.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.561 -0.964 . . . . 0.0 110.465 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.79 -28.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.372 -1.455 . . . . 0.0 108.671 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.488 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.06 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.844 ' CE1' HD11 ' A' ' 30' ' ' LEU . 1.4 t80 -52.74 -38.7 61.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.1 t -84.16 -31.42 25.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.719 -1.238 . . . . 0.0 110.267 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 71.2 m -67.48 -33.03 74.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 111.005 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -75.36 128.02 85.14 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.898 -1.126 . . . . 0.0 109.659 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -43.67 -7.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.9 tp -64.83 -29.53 70.5 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.395 -0.815 . . . . 0.0 111.247 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -84.34 -37.11 22.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.996 -1.065 . . . . 0.0 110.239 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.73 -61.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.949 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.81 -39.15 84.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.267 -0.895 . . . . 0.0 109.559 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.32 -45.01 70.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.795 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 t -62.39 -35.02 77.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.125 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.25 65.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 108.712 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -70.83 -42.16 70.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.911 ' O ' HD13 ' A' ' 90' ' ' ILE . 18.9 t80 -45.73 -29.08 1.17 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' ' C ' ' A' ' 88' ' ' ALA . 11.2 m -82.31 -63.47 1.37 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.06 -32.34 0.09 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.624 -0.672 . . . . 0.0 110.012 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 85' ' ' ALA . 19.3 m -98.84 13.01 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.927 . . . . 0.0 110.829 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.911 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.1 mp -122.32 156.96 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.657 -1.277 . . . . 0.0 110.451 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.482 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 59.4 t0 -103.57 -36.35 7.97 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' NZ ' ' NZ ' ' A' ' 13' ' ' LYS . 30.2 pttt -147.52 147.36 30.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 93' ' ' ILE . 6.1 tp -123.42 117.73 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.608 -1.307 . . . . 0.0 109.791 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.78 127.1 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -133.79 129.2 36.24 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.365 -1.459 . . . . 0.0 111.761 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -115.69 119.36 35.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.332 176.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 61.3 t0 -125.1 131.67 53.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 108.899 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 51.9 t80 -169.26 135.36 1.4 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.06 -1.025 . . . . 0.0 110.548 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.9 Cg_exo -41.22 120.25 1.12 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.363 2.042 . . . . 0.0 112.128 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.3 143.18 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 110.019 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.507 ' N ' ' H2 ' ' A' ' 1' ' ' MET . . . -113.12 67.78 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.682 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB2' ' CE2' ' B' ' 42' ' ' TRP . . . -56.03 98.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.054 -1.029 . . . . 0.0 109.53 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 103' ' ' VAL . 24.5 m -144.72 128.59 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 109.136 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 106' ' ' SER . 5.6 mptt -111.89 -32.29 6.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.342 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 106' ' ' SER . 1.2 m 63.42 -53.01 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 108.938 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 104' ' ' LYS . 1.4 p 73.12 148.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.0 109.348 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.3 t 49.65 66.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.48 152.1 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.735 . . . . 0.0 109.425 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.36 137.68 40.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.498 ' N ' ' OE2' ' B' ' 28' ' ' GLU . 29.5 m -132.92 71.53 77.95 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 120.843 -1.161 . . . . 0.0 109.63 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 C--N 1.308 -1.559 0 C-N-CA 122.769 2.313 . . . . 0.0 112.225 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.521 ' H3 ' ' HB3' ' B' ' 101' ' ' ALA . 64.8 mtt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.303 0.573 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' B' ' 1' ' ' MET . . . 175.93 69.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 109.354 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.671 HG23 ' N ' ' B' ' 4' ' ' SER . 10.2 t -153.29 -48.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.065 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.671 ' N ' HG23 ' B' ' 3' ' ' THR . 15.6 m -59.78 -68.68 0.26 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.57 -163.55 15.55 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.727 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -110.75 135.04 51.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.327 -1.102 . . . . 0.0 108.035 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 5.2 ttpm? -100.05 129.46 46.1 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.33 1.062 . . . . 0.0 112.778 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 77.7 t60 -121.88 120.53 34.76 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.04 142.05 49.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.762 -1.211 . . . . 0.0 109.467 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.48 139.32 51.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -126.83 133.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.538 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.23 156.3 21.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.048 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.671 ' HB2' ' HZ2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -119.95 152.33 37.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 178.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' B' ' 57' ' ' THR . 9.0 p90 -107.94 151.45 25.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.838 -1.164 . . . . 0.0 111.645 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.14 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -90.07 -56.53 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.7 m-20 152.68 66.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 64.4 m -52.35 107.09 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.991 0.901 . . . . 0.0 112.841 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.626 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -72.82 85.73 1.24 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.421 HG23 ' N ' ' B' ' 21' ' ' ASP . 17.9 m -54.87 -37.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 110.441 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.9 p-10 -63.36 -36.45 83.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.485 -0.76 . . . . 0.0 110.549 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 81.1 mt-10 -72.96 -37.77 66.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.445 HD11 HG21 ' B' ' 89' ' ' VAL . 1.8 mm -58.31 -44.96 89.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -49.13 -36.21 18.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -58.16 -38.49 76.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -73.08 -25.34 73.77 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.1 tt -74.94 -60.13 2.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.948 . . . . 0.0 108.772 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.498 ' OE2' ' N ' ' A' ' 110' ' ' THR . 24.4 pt-20 -50.2 -31.26 13.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 32' ' ' SER . 75.3 m-20 -65.86 -43.49 88.26 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.839 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.5 OUTLIER -47.25 -53.1 14.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' B' ' 32' ' ' SER . 79.4 t -50.08 -30.4 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.363 -0.835 . . . . 0.0 108.811 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 11.2 t -45.36 -50.78 11.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.441 HE22 ' CB ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -83.44 -9.25 59.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.79 . . . . 0.0 111.518 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' B' ' 36' ' ' THR . 12.7 mt -91.45 28.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.967 -1.708 . . . . 0.0 110.639 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -59.43 -9.2 2.21 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.726 HG23 ' H ' ' B' ' 38' ' ' LYS . 9.6 t -67.56 -7.87 29.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.028 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.7 m 35.31 33.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.128 -0.983 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.726 ' H ' HG23 ' B' ' 36' ' ' THR . 32.3 mtmt -122.86 47.79 1.9 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' B' ' 63' ' ' THR . 15.9 t -174.46 174.87 2.67 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.05 159.17 44.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.51 -1.369 . . . . 0.0 111.972 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -152.23 117.22 5.17 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.379 0.609 . . . . 0.0 110.225 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 102' ' ' ALA . 3.7 t-105 -105.72 167.2 9.93 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.84 150.48 17.15 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 118.734 -1.698 . . . . 0.0 110.835 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 77.6 mt-10 -152.23 143.75 23.45 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -1.105 . . . . 0.0 109.425 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' B' ' 57' ' ' THR . 59.5 t0 -170.11 95.82 0.26 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.713 ' HZ1' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -84.2 156.51 22.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.422 -1.424 . . . . 0.0 109.807 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' B' ' 48' ' ' SER . 84.3 mt-10 -158.94 82.06 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.1 t 160.94 151.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.176 -0.953 . . . . 0.0 110.192 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.516 ' ND1' ' OG ' ' B' ' 48' ' ' SER . 28.8 m80 62.8 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.682 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -49.62 -44.02 47.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.818 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.553 ' O ' ' NE2' ' B' ' 54' ' ' GLN . 24.8 ttt -59.78 -35.76 75.31 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.763 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 19.3 mt -88.65 -9.5 51.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.718 -1.239 . . . . 0.0 109.312 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.954 ' O ' ' N ' ' B' ' 55' ' ' GLY . 33.6 ttp180 -84.8 36.37 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 111.232 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' B' ' 51' ' ' MET . 78.8 mm-40 -32.48 -10.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 110.215 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.954 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 102.51 -39.63 2.71 Favored Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.425 -0.797 . . . . 0.0 112.805 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -52.34 101.57 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.554 1.677 . . . . 0.0 109.907 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 71.4 p -56.99 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 110.95 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.576 ' H ' ' HG1' ' B' ' 57' ' ' THR . 18.1 p-80 -121.97 152.12 40.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.908 -1.12 . . . . 0.0 110.127 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' B' ' 11' ' ' VAL . . . -144.38 168.72 19.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -138.24 133.69 33.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.042 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -100.56 96.19 7.2 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 53.5 mtm -96.5 121.43 38.31 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.172 -0.955 . . . . 0.0 110.73 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' B' ' 39' ' ' SER . 28.5 m -125.03 147.64 48.87 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.23 156.19 38.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.724 -1.235 . . . . 0.0 110.081 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 41.8 tp10 -78.48 -26.82 46.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.7 m-20 -163.78 170.79 16.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -59.82 -21.82 61.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 111.501 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -59.13 -38.68 80.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 110.57 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.38 69.87 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.697 ' O ' HG22 ' B' ' 74' ' ' THR . 70.6 t80 -66.59 -44.42 82.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.618 -0.93 . . . . 0.0 110.433 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.417 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.73 -28.91 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.451 -1.405 . . . . 0.0 108.707 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.491 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.09 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.297 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.839 ' CE1' HD11 ' B' ' 30' ' ' LEU . 1.4 t80 -52.59 -38.94 61.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 111.123 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.697 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.1 t -84.07 -31.32 25.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.726 -1.234 . . . . 0.0 110.281 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 71.9 m -67.53 -32.85 73.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.974 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' B' ' 78' ' ' LEU . 0.9 OUTLIER -75.53 128.09 84.7 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.885 -1.134 . . . . 0.0 109.602 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.77 -7.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 112.508 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.9 tp -64.84 -29.61 70.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.397 -0.815 . . . . 0.0 111.199 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -84.29 -37.14 22.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.238 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.68 -61.65 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 110.045 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.63 -39.21 83.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.33 -44.95 70.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.812 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 28.9 t -62.38 -35.18 78.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.1 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.29 65.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.675 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.684 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -70.79 -42.34 70.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.888 ' O ' HD13 ' B' ' 90' ' ' ILE . 19.2 t80 -45.81 -28.86 1.16 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.452 ' O ' ' C ' ' B' ' 88' ' ' ALA . 11.1 m -82.37 -63.37 1.39 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.11 -32.36 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.708 -0.62 . . . . 0.0 110.122 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.684 HG22 ' O ' ' B' ' 85' ' ' ALA . 19.1 m -98.84 12.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.874 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.888 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.1 mp -122.0 157.26 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 0.0 110.477 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 59.1 t0 -103.89 -36.21 7.88 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.435 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 30.6 pttt -147.65 147.22 29.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.554 HG23 ' O ' ' B' ' 93' ' ' ILE . 6.2 tp -123.42 117.87 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.517 -1.364 . . . . 0.0 109.721 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.86 127.24 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.59 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -133.99 129.16 35.77 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.258 -1.526 . . . . 0.0 111.73 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.462 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.5 OUTLIER -115.64 119.37 35.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.652 -0.655 . . . . 0.0 109.328 176.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 62.0 t0 -125.04 131.78 53.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 108.929 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 52.1 t80 -169.36 135.25 1.37 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.105 -0.997 . . . . 0.0 110.53 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 87.6 Cg_exo -41.2 120.1 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.264 1.976 . . . . 0.0 112.247 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.16 143.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 110.025 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.521 ' HB3' ' H3 ' ' B' ' 1' ' ' MET . . . -113.16 68.0 0.67 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.514 -0.741 . . . . 0.0 109.581 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . . . -56.12 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.623 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 103' ' ' VAL . 24.3 m -144.52 128.49 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 106' ' ' SER . 5.6 mptt -111.7 -32.43 6.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' B' ' 106' ' ' SER . 1.2 m 63.55 -53.21 0.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.13 -0.982 . . . . 0.0 108.892 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.685 ' N ' ' O ' ' B' ' 104' ' ' LYS . 1.4 p 73.24 148.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t 49.5 66.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.34 152.23 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.513 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.46 137.64 40.61 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.484 ' N ' ' OE2' ' A' ' 28' ' ' GLU . 28.7 m -132.79 71.41 78.4 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 120.821 -1.175 . . . . 0.0 109.657 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 C--N 1.308 -1.564 0 C-N-CA 122.785 2.323 . . . . 0.0 112.233 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.288 0.566 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.77 64.97 1.65 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 109.38 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 t -95.79 3.44 53.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -168.95 -89.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.28 168.68 18.35 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.671 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.62 131.57 55.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.242 -1.152 . . . . 0.0 108.022 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 25.2 ttpt -104.22 131.9 51.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.917 -1.114 . . . . 0.0 112.777 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 62' ' ' MET . 43.4 m-70 -126.34 127.46 45.56 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.2 tt -135.72 142.53 45.05 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.767 -1.208 . . . . 0.0 109.496 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 4.3 p -130.66 140.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.547 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.74 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.654 ' O ' ' O ' ' A' ' 56' ' ' PHE . 3.4 m -132.38 143.39 40.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.104 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 14.2 mmtt -107.43 152.6 23.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.565 ' HB2' ' H ' ' A' ' 18' ' ' THR . 15.8 p90 -114.53 148.71 37.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.769 -1.207 . . . . 0.0 111.585 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.89 -23.43 4.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -93.05 -53.89 3.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.2 t0 150.1 67.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.565 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.3 m -49.03 105.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.13 0.967 . . . . 0.0 112.802 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.551 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -72.82 84.77 1.22 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 21' ' ' ASP . 27.8 m -58.34 -37.72 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.549 -0.72 . . . . 0.0 110.456 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 34.1 p-10 -65.29 -38.33 89.89 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.479 -0.763 . . . . 0.0 110.544 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -70.08 -34.07 72.7 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.881 HD11 HG21 ' A' ' 89' ' ' VAL . 1.4 mm -63.87 -44.07 97.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.31 -35.8 51.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -61.45 -34.59 75.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.46 -44.11 8.88 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.94 -59.24 5.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.996 . . . . 0.0 108.856 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 22.1 pt-20 -52.17 -45.41 65.1 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.533 ' N ' ' CG ' ' A' ' 28' ' ' GLU . 3.8 t30 -58.15 -43.87 87.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -49.59 -44.25 46.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 34' ' ' ILE . 20.6 t -52.4 -22.35 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.221 -0.924 . . . . 0.0 108.888 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 34.3 t -40.62 -39.53 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -76.26 -23.81 54.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 111.461 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 34' ' ' ILE . 75.8 mt -81.75 20.85 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.018 -1.676 . . . . 0.0 110.544 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -57.4 -6.47 0.45 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.659 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.3 t -87.93 2.96 50.33 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.943 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.9 m 35.31 35.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.073 -1.017 . . . . 0.0 109.195 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.57 ' O ' ' OG ' ' A' ' 39' ' ' SER . 65.9 mttt -115.34 39.87 2.84 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 71.0 m -173.04 175.84 3.14 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -147.3 157.41 43.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.966 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' SER . 67.6 mt-10 -154.41 120.3 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.436 0.636 . . . . 0.0 110.246 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 1.1 m95 -123.37 170.27 10.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 164.4 24.92 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 118.695 -1.717 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 50.8 tt0 -154.72 148.1 25.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -113.17 141.3 47.1 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -139.39 108.08 5.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.41 -1.431 . . . . 0.0 109.829 -178.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.5 45.81 0.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.64 -0.663 . . . . 0.0 109.287 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.483 ' CB ' HH11 ' A' ' 53' ' ' ARG . 1.4 t -144.58 121.67 11.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.131 -0.98 . . . . 0.0 110.191 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.537 ' CG ' HD12 ' A' ' 52' ' ' LEU . 7.2 m80 65.97 118.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 109.753 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.15 -29.07 70.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.81 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -85.31 -36.05 21.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.01 -1.056 . . . . 0.0 110.712 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' B' ' 95' ' ' LEU . 27.0 mt -79.66 -72.87 0.38 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.729 -1.232 . . . . 0.0 109.273 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.86 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -73.15 4.67 4.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 111.252 -176.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 53' ' ' ARG . 15.4 mm100 39.1 6.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.819 -1.176 . . . . 0.0 110.204 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 50.79 2.87 0.04 OUTLIER Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.544 -0.722 . . . . 0.0 112.933 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.763 ' O ' ' CB ' ' A' ' 57' ' ' THR . 34.4 m-85 -39.12 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.189 -1.771 . . . . 0.0 109.976 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.763 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 16.8 m 99.8 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.287 -0.883 . . . . 0.0 110.938 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.526 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 18.5 t60 -164.56 152.08 11.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.885 -1.134 . . . . 0.0 110.173 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.19 167.28 22.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.31 -0.869 . . . . 0.0 109.249 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 95.2 m-85 -135.26 130.5 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.062 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -97.65 96.98 8.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 8' ' ' HIS . 74.2 mtm -98.02 117.86 33.31 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.188 -0.945 . . . . 0.0 110.844 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -122.78 144.64 49.04 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.31 159.12 28.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.702 -1.249 . . . . 0.0 110.068 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 41.6 tp10 -82.7 -31.47 28.52 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 65' ' ' GLU . 80.6 m-20 -161.73 169.37 21.58 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.51 ' NZ ' ' CB ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -55.18 -21.66 14.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 111.437 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -56.52 -40.48 75.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.788 -1.195 . . . . 0.0 110.611 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.17 -37.59 72.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' THR . 75.1 t80 -62.63 -45.12 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.623 -0.928 . . . . 0.0 110.522 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.368 -1.457 . . . . 0.0 108.653 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.381 -0.825 . . . . 0.0 109.381 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.488 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -51.68 -37.74 51.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 111.134 -177.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.6 t -84.99 -33.97 22.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.802 -1.186 . . . . 0.0 110.299 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.4 t -71.34 -25.6 62.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 0.0 110.95 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 78' ' ' LEU . 38.4 m80 -81.01 121.35 80.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.852 -1.155 . . . . 0.0 109.604 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.36 -13.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.638 2.225 . . . . 0.0 112.457 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 HD22 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -64.0 -26.97 68.81 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.346 -0.846 . . . . 0.0 111.277 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.488 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 3.8 t60 -81.66 -30.45 32.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.06 . . . . 0.0 110.236 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.09 -60.21 3.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.66 -40.24 62.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -66.6 -33.52 75.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.83 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 p -61.33 -43.79 98.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.105 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.48 -37.06 67.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 108.714 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.941 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -72.18 -40.53 67.87 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.613 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.28 -40.96 0.37 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.027 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' VAL . 24.3 m -81.94 -60.36 2.26 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.59 -10.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.669 -0.644 . . . . 0.0 110.047 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.941 HG22 ' O ' ' A' ' 85' ' ' ALA . 10.5 m -124.8 -7.86 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.191 -0.943 . . . . 0.0 110.853 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.652 HG13 HG23 ' A' ' 89' ' ' VAL . 65.4 mt -131.1 162.99 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.588 -1.32 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 90' ' ' ILE . 12.0 t0 -121.44 -24.01 5.51 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.73 139.02 32.76 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.4 tp -128.97 127.31 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.596 -1.315 . . . . 0.0 109.83 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 t -128.38 132.36 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -137.58 132.55 33.28 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.315 -1.49 . . . . 0.0 111.75 -178.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -115.8 121.36 42.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.723 -0.611 . . . . 0.0 109.364 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.674 ' O ' ' NE ' ' B' ' 53' ' ' ARG . 59.7 m-20 -123.75 128.3 49.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.081 -1.012 . . . . 0.0 108.869 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 99' ' ' PRO . 63.6 t80 -165.48 131.67 2.09 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.519 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 88.7 Cg_exo -47.52 133.41 20.83 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.288 1.992 . . . . 0.0 112.25 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.47 141.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.034 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -103.11 70.96 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.25 82.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.578 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 101' ' ' ALA . 29.1 m -127.53 -15.96 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 106' ' ' SER . 4.7 mptt 44.61 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -65.43 53.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 108.942 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 104' ' ' LYS . 6.3 t -83.98 38.89 0.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 108' ' ' VAL . 9.7 p -91.44 -44.22 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.593 ' N ' HG13 ' A' ' 107' ' ' VAL . 7.1 p -144.38 140.72 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.553 -0.717 . . . . 0.0 109.519 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.94 119.5 38.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -77.78 152.73 80.47 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 120.937 -1.102 . . . . 0.0 109.629 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.813 2.342 . . . . 0.0 112.245 179.695 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.314 0.578 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.8 65.14 1.6 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.88 . . . . 0.0 109.33 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -95.92 3.74 53.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 109.166 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m -169.37 -89.95 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.11 168.88 18.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.726 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.77 131.7 55.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 25.1 ttpt -104.43 131.65 51.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.938 -1.101 . . . . 0.0 112.881 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 62' ' ' MET . 43.3 m-70 -126.13 127.57 45.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.2 tt -135.77 142.56 44.96 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.741 -1.225 . . . . 0.0 109.385 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 4.2 p -130.69 140.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.56 -0.712 . . . . 0.0 109.528 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -124.77 132.85 70.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.645 ' O ' ' O ' ' B' ' 56' ' ' PHE . 3.5 m -132.73 143.18 40.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 117.762 -1.575 . . . . 0.0 112.993 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 14.2 mmtt -107.25 152.22 24.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.553 ' HB2' ' H ' ' B' ' 18' ' ' THR . 15.8 p90 -114.03 149.12 35.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.187 . . . . 0.0 111.58 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -124.0 -23.59 4.58 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.4 mt-10 -92.88 -53.96 3.94 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.1 t0 150.17 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.553 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.7 m -48.99 105.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.105 0.955 . . . . 0.0 112.887 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.562 ' H ' ' HD3' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -72.79 84.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.463 HG23 ' N ' ' B' ' 21' ' ' ASP . 27.9 m -58.41 -37.53 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 34.4 p-10 -65.52 -38.29 89.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.514 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.498 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 0.4 OUTLIER -70.05 -33.99 72.65 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.88 HD11 HG21 ' B' ' 89' ' ' VAL . 1.4 mm -63.84 -44.11 98.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.27 -35.7 50.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -61.56 -34.71 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.31 -43.71 9.32 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -57.43 -59.01 5.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.944 . . . . 0.0 108.809 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 22.3 pt-20 -52.37 -45.23 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.527 ' N ' ' CG ' ' B' ' 28' ' ' GLU . 3.8 t30 -58.22 -43.93 87.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.576 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -49.76 -43.92 48.35 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' B' ' 34' ' ' ILE . 20.8 t -52.61 -22.33 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 36.4 t -40.65 -39.48 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -76.28 -23.73 54.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.765 . . . . 0.0 111.497 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.79 HG22 ' O ' ' B' ' 34' ' ' ILE . 75.9 mt -81.85 20.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.014 -1.679 . . . . 0.0 110.585 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.5 p30 -57.45 -6.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.634 ' H ' ' C ' ' B' ' 34' ' ' ILE . 1.3 t -87.89 3.0 50.15 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.986 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.566 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.0 m 35.43 35.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.101 -1.0 . . . . 0.0 109.154 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.569 ' O ' ' OG ' ' B' ' 39' ' ' SER . 64.8 mttt -115.17 40.11 2.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.569 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 73.2 m -173.4 175.72 3.0 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -147.18 157.53 43.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.478 -1.389 . . . . 0.0 111.972 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' B' ' 61' ' ' SER . 67.7 mt-10 -154.54 120.5 5.25 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.356 0.598 . . . . 0.0 110.235 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.635 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 1.1 m95 -123.63 170.15 10.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.58 164.26 24.91 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 50.9 tt0 -154.48 148.07 25.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.254 -1.145 . . . . 0.0 109.354 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -113.19 141.02 47.44 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -139.35 108.04 5.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.357 -1.464 . . . . 0.0 109.889 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.38 45.54 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.689 -0.632 . . . . 0.0 109.395 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.476 ' CB ' HH11 ' B' ' 53' ' ' ARG . 1.4 t -144.24 121.94 11.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 110.166 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.533 ' CG ' HD12 ' B' ' 52' ' ' LEU . 7.2 m80 65.66 118.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.207 -0.933 . . . . 0.0 109.728 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -62.23 -29.33 70.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.332 -0.855 . . . . 0.0 110.781 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 89.5 mtp -85.23 -35.89 21.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.03 -1.044 . . . . 0.0 110.768 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' A' ' 95' ' ' LEU . 27.2 mt -79.7 -72.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.755 -1.216 . . . . 0.0 109.291 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.852 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.6 OUTLIER -73.2 4.51 4.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 111.22 -176.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.474 ' C ' ' O ' ' B' ' 53' ' ' ARG . 15.4 mm100 39.15 6.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.804 -1.185 . . . . 0.0 110.213 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.852 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 50.46 2.91 0.04 OUTLIER Glycine 0 N--CA 1.499 2.835 0 O-C-N 121.515 -0.74 . . . . 0.0 112.909 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' CB ' ' B' ' 57' ' ' THR . 33.7 m-85 -39.04 -25.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.274 -1.721 . . . . 0.0 110.004 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.768 ' CB ' ' O ' ' B' ' 56' ' ' PHE . 16.1 m 99.7 -62.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.281 -0.887 . . . . 0.0 110.982 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.52 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 18.6 t60 -164.31 152.04 12.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.862 -1.148 . . . . 0.0 110.127 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.468 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.19 167.13 22.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.536 -0.727 . . . . 0.0 109.301 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.52 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 95.2 m-85 -135.01 130.71 36.11 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.485 -0.759 . . . . 0.0 109.08 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 0.1 OUTLIER -97.66 97.06 8.71 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 62' ' ' MET . . . . . 0.448 ' O ' ' N ' ' B' ' 8' ' ' HIS . 74.6 mtm -98.12 117.82 33.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.175 -0.953 . . . . 0.0 110.741 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -122.84 144.44 49.2 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.12 159.04 27.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.75 -1.219 . . . . 0.0 110.062 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' B' ' 66' ' ' ASN . 42.1 tp10 -82.57 -31.33 29.06 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' B' ' 65' ' ' GLU . 80.7 m-20 -161.93 169.6 20.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -55.25 -21.73 15.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.493 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.4 -40.76 75.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.789 -1.195 . . . . 0.0 110.534 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.89 -37.84 75.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.544 ' O ' HG22 ' B' ' 74' ' ' THR . 75.4 t80 -62.28 -45.47 93.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.592 -0.946 . . . . 0.0 110.374 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.67 -28.94 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.455 -1.403 . . . . 0.0 108.732 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.12 -60.86 2.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.315 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.491 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.1 OUTLIER -51.35 -38.1 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.86 . . . . 0.0 111.146 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.544 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.6 t -84.74 -33.99 22.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.732 -1.23 . . . . 0.0 110.324 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 36.3 t -71.29 -25.97 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.942 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' B' ' 78' ' ' LEU . 38.5 m80 -80.63 121.32 81.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.796 -1.19 . . . . 0.0 109.557 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.39 -13.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.69 2.26 . . . . 0.0 112.413 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.544 HD23 HD22 ' B' ' 30' ' ' LEU . 0.6 OUTLIER -63.65 -27.32 69.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.776 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.491 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 4.1 t60 -81.47 -30.32 33.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 110.301 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.18 -60.24 3.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.76 -40.06 62.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.518 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -66.56 -33.78 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.93 . . . . 0.0 109.877 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 56.6 p -61.06 -43.9 98.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.1 -1.0 . . . . 0.0 110.134 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.31 -37.26 67.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.034 -1.042 . . . . 0.0 108.72 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.926 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -72.04 -40.72 68.18 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.614 ' O ' ' HB ' ' B' ' 90' ' ' ILE . 0.0 OUTLIER -37.1 -40.89 0.33 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.541 ' O ' ' N ' ' B' ' 89' ' ' VAL . 24.6 m -82.16 -60.34 2.25 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.52 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.783 -0.573 . . . . 0.0 110.103 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.926 HG22 ' O ' ' B' ' 85' ' ' ALA . 10.4 m -124.94 -7.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 110.855 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.657 HG13 HG23 ' B' ' 89' ' ' VAL . 66.2 mt -131.04 162.89 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.618 -1.301 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.603 ' N ' HG22 ' B' ' 90' ' ' ILE . 12.0 t0 -121.28 -24.33 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.58 139.22 33.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.418 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.4 tp -129.28 127.34 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.542 -1.349 . . . . 0.0 109.755 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 60.7 t -128.35 132.52 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -137.71 132.48 32.91 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.254 -1.528 . . . . 0.0 111.783 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.443 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.4 OUTLIER -115.66 121.49 42.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.68 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 60.3 m-20 -123.73 128.23 49.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.066 -1.021 . . . . 0.0 108.934 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 99' ' ' PRO . 63.7 t80 -165.31 131.65 2.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.55 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.514 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 88.2 Cg_exo -47.59 133.15 21.13 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.256 1.971 . . . . 0.0 112.225 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.22 141.28 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.049 -1.032 . . . . 0.0 110.064 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -102.88 71.11 1.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.487 -0.758 . . . . 0.0 109.602 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.46 82.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.123 -0.985 . . . . 0.0 109.574 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' B' ' 101' ' ' ALA . 29.1 m -127.65 -15.92 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.18 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' B' ' 106' ' ' SER . 4.7 mptt 44.73 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.353 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -65.34 53.97 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -0.976 . . . . 0.0 108.959 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.589 ' N ' ' O ' ' B' ' 104' ' ' LYS . 6.3 t -84.07 38.95 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.583 HG13 ' N ' ' B' ' 108' ' ' VAL . 9.8 p -91.49 -44.18 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.583 ' N ' HG13 ' B' ' 107' ' ' VAL . 7.2 p -144.45 140.62 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.508 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.71 119.6 39.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -77.71 152.76 80.68 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 120.841 -1.162 . . . . 0.0 109.613 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.775 2.317 . . . . 0.0 112.262 179.765 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.536 ' H3 ' ' HG2' ' A' ' 99' ' ' PRO . 7.9 ptp . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.483 ' H ' ' HG3' ' A' ' 99' ' ' PRO . . . 46.91 62.84 2.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.979 . . . . 0.0 109.423 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.699 HG23 ' N ' ' A' ' 4' ' ' SER . 6.7 t -67.3 -51.49 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.699 ' N ' HG23 ' A' ' 3' ' ' THR . 9.7 m -140.85 -117.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.25 142.62 46.6 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.641 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -113.59 128.83 56.58 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.297 -1.119 . . . . 0.0 108.011 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -110.07 138.87 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.929 -1.107 . . . . 0.0 112.776 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.27 129.74 43.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -135.46 143.39 45.86 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.698 -1.251 . . . . 0.0 109.522 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 10.4 p -128.5 138.05 55.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.642 -0.661 . . . . 0.0 109.508 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.97 130.67 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -136.96 165.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.78 -1.568 . . . . 0.0 113.07 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 39.2 tptt -130.43 151.4 50.96 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 10.0 p90 -108.87 150.16 28.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.838 -1.164 . . . . 0.0 111.615 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.37 -22.64 5.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.9 mt-10 -91.26 -53.68 4.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.8 t0 149.39 69.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.2 m -55.85 109.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.082 0.944 . . . . 0.0 112.857 -177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.712 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.73 91.11 5.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -61.36 -33.45 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 110.453 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.8 p-10 -68.3 -41.52 80.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.451 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.703 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 70.3 tt0 -66.72 -28.32 68.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -74.46 -39.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.7 -40.41 79.42 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.703 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -60.51 -26.11 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . -81.26 -45.29 7.56 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.6 tt -49.0 -51.92 27.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.484 -1.01 . . . . 0.0 108.809 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 17.1 pt-20 -53.06 -43.29 66.57 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -57.41 -43.52 83.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -46.91 -45.35 20.49 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 34' ' ' ILE . 23.0 t -51.6 -23.37 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 108.933 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 41.9 t -42.86 -46.55 5.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.534 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 82.0 mm-40 -74.55 -20.47 59.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.374 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 34' ' ' ILE . 58.0 mt -82.62 22.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.05 -1.656 . . . . 0.0 110.643 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.8 p30 -59.46 -8.78 1.98 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 36.2 p -82.64 -0.97 49.66 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.981 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.6 m 35.59 31.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' THR . 42.0 mttm -117.66 40.76 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 34' ' ' ILE . 95.6 p -173.11 173.96 3.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.72 159.12 44.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -153.96 121.04 5.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.395 0.617 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -124.03 167.02 14.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 44' ' ' GLU . . . -125.48 157.98 19.73 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.756 -1.688 . . . . 0.0 110.823 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.654 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 73.9 mm-40 -148.35 136.9 21.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.247 -1.149 . . . . 0.0 109.397 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -111.09 141.02 45.14 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.842 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -143.42 117.26 9.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.454 -1.404 . . . . 0.0 109.763 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -153.56 -15.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.544 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -69.57 122.0 18.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 0.0 110.177 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.494 ' O ' ' O ' ' A' ' 48' ' ' SER . 48.1 m80 59.36 126.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.985 . . . . 0.0 109.678 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -67.02 -34.89 78.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.816 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.523 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -77.44 -37.94 50.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 0.0 110.687 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' B' ' 95' ' ' LEU . 19.3 mt -78.79 -71.15 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.74 -1.225 . . . . 0.0 109.266 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' A' ' 53' ' ' ARG . 3.7 mmt-85 -72.25 12.63 0.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.901 . . . . 0.0 111.258 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.53 ' CD ' HD21 ' B' ' 96' ' ' LEU . 22.1 mt-30 50.67 7.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.765 -1.209 . . . . 0.0 110.171 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.674 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 55.87 -0.42 0.12 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.361 -0.837 . . . . 0.0 112.891 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.674 ' O ' ' O ' ' A' ' 55' ' ' GLY . 4.8 m-85 -53.19 -142.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.157 -1.79 . . . . 0.0 109.914 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 35.3 m -135.82 -47.49 0.67 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.654 ' CE1' ' H ' ' A' ' 44' ' ' GLU . 27.4 t60 -172.76 160.06 4.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.96 -1.087 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.611 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.55 163.01 34.08 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.46 -0.775 . . . . 0.0 109.231 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 82.6 m-85 -133.42 129.59 37.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.499 -0.751 . . . . 0.0 109.121 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.29 98.7 8.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.6 mtt -98.68 119.68 37.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.234 -0.916 . . . . 0.0 110.76 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -119.37 140.62 50.06 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.07 125.83 44.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.083 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -50.87 -32.14 19.51 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -156.03 162.28 40.33 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -60.59 -21.83 63.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 111.493 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 34.0 p-10 -55.94 -36.43 67.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.773 -1.204 . . . . 0.0 110.532 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.18 -31.99 63.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.699 ' O ' HG22 ' A' ' 74' ' ' THR . 76.9 t80 -67.79 -44.36 77.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.973 . . . . 0.0 110.436 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.76 -28.95 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.404 -1.435 . . . . 0.0 108.686 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.05 -60.89 2.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.373 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.539 ' CE1' HD11 ' A' ' 30' ' ' LEU . 1.6 t80 -56.59 -60.13 3.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.11 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.699 HG22 ' O ' ' A' ' 70' ' ' TYR . 10.1 t -52.29 -34.46 46.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.734 -1.228 . . . . 0.0 110.3 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.3 m -77.96 -16.22 58.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.959 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 78' ' ' LEU . 22.6 m80 -79.24 132.18 63.72 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.152 . . . . 0.0 109.57 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -42.22 -12.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.697 2.264 . . . . 0.0 112.394 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.5 tp -74.44 -27.28 60.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.423 -0.798 . . . . 0.0 111.292 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.83 -45.13 21.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.957 -1.09 . . . . 0.0 110.206 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.774 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -59.44 -58.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 110.01 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.774 ' H ' HG13 ' A' ' 80' ' ' VAL . 15.2 tm-20 -51.01 -36.65 40.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.92 -32.02 73.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.758 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.05 -44.23 94.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.44 -33.28 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.921 -1.112 . . . . 0.0 108.73 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.939 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -79.42 -46.37 17.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.699 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -38.81 -40.15 0.59 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' VAL . 20.3 m -82.17 -62.53 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.86 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.676 -0.64 . . . . 0.0 110.097 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.939 HG22 ' O ' ' A' ' 85' ' ' ALA . 9.1 m -117.46 -1.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 0.0 110.771 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 91' ' ' ASP . 68.4 mt -132.93 164.02 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 110.512 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 90' ' ' ILE . 38.4 t0 -124.14 -26.82 3.94 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 18.9 ttpt -133.81 131.17 38.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -126.32 125.59 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.596 -1.315 . . . . 0.0 109.768 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 12.0 t -132.2 134.5 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -136.47 131.65 34.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.294 -1.503 . . . . 0.0 111.764 -178.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.546 HD21 ' CD ' ' B' ' 54' ' ' GLN . 0.2 OUTLIER -116.05 122.57 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.645 -0.659 . . . . 0.0 109.391 177.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.549 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 38.5 p-10 -126.11 132.49 51.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -159.81 128.72 3.08 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.087 -1.008 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.536 ' HG2' ' H3 ' ' A' ' 1' ' ' MET . 80.5 Cg_exo -45.61 131.46 12.67 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.37 2.046 . . . . 0.0 112.186 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.553 HG22 ' OE2' ' B' ' 44' ' ' GLU . 96.9 t -113.42 135.37 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.96 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -107.96 88.3 2.7 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.451 -0.781 . . . . 0.0 109.56 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -57.71 73.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 102' ' ' ALA . 4.5 m -161.01 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.099 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 106' ' ' SER . 24.0 mmtm -97.7 4.57 49.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.412 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.35 -53.53 0.27 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 108.879 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 104' ' ' LYS . 20.1 m 47.17 45.01 16.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -84.83 -41.62 16.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.3 m -112.4 49.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.573 -0.704 . . . . 0.0 109.508 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.78 83.88 3.38 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.39 161.79 48.3 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 120.901 -1.124 . . . . 0.0 109.671 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 C--N 1.308 -1.576 0 C-N-CA 122.707 2.271 . . . . 0.0 112.277 179.651 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.556 ' H3 ' ' HG2' ' B' ' 99' ' ' PRO . 7.9 ptp . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.322 0.582 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.472 ' H ' ' HG3' ' B' ' 99' ' ' PRO . . . 47.05 62.86 2.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.302 -0.874 . . . . 0.0 109.366 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.69 HG23 ' N ' ' B' ' 4' ' ' SER . 6.7 t -67.36 -51.52 51.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -0.859 . . . . 0.0 109.138 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.69 ' N ' HG23 ' B' ' 3' ' ' THR . 9.5 m -140.82 -117.35 0.12 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.22 142.69 46.52 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.693 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -113.67 128.74 56.54 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.218 -1.166 . . . . 0.0 108.033 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -109.91 138.63 46.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.862 -1.149 . . . . 0.0 112.822 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.09 129.68 43.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.0 tt -135.35 143.45 46.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.433 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 10.3 p -128.34 137.97 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.478 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.6 OUTLIER -120.92 130.79 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 178.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.04 165.49 27.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.663 -1.615 . . . . 0.0 113.028 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 39.1 tptt -130.39 151.41 50.91 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.511 ' HB2' ' H ' ' B' ' 18' ' ' THR . 9.9 p90 -108.84 150.11 28.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.795 -1.191 . . . . 0.0 111.558 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.36 -22.82 4.98 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.9 mt-10 -91.03 -53.77 4.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.7 t0 149.47 69.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -56.0 109.76 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.129 0.966 . . . . 0.0 112.778 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.713 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.87 91.31 5.97 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.38 -33.55 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.647 . . . . 0.0 110.495 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.6 p-10 -68.13 -41.56 81.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.542 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.695 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 70.7 tt0 -66.85 -28.09 68.07 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -74.7 -39.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.62 -40.57 79.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.1 OUTLIER -60.36 -26.19 66.42 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' B' ' 25' ' ' LYS . . . -81.06 -45.47 7.56 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.502 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.6 tt -48.91 -51.98 27.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -1.032 . . . . 0.0 108.855 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 17.0 pt-20 -53.09 -43.33 66.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.0 OUTLIER -57.34 -43.47 83.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.538 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -47.1 -45.34 22.05 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 34' ' ' ILE . 23.2 t -51.47 -23.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.299 -0.876 . . . . 0.0 108.767 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 41.7 t -42.74 -46.47 5.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.527 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 81.9 mm-40 -74.57 -20.47 59.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 111.533 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.714 HG22 ' O ' ' B' ' 34' ' ' ILE . 58.1 mt -82.65 22.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.972 -1.705 . . . . 0.0 110.563 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.1 p30 -59.5 -8.88 2.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.597 ' O ' ' N ' ' B' ' 38' ' ' LYS . 36.3 p -82.52 -0.98 49.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.953 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.9 m 35.53 31.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.063 -1.023 . . . . 0.0 109.187 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.597 ' N ' ' O ' ' B' ' 36' ' ' THR . 42.2 mttm -117.64 40.73 3.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.551 ' OG ' HG23 ' B' ' 34' ' ' ILE . 95.6 p -173.07 173.94 3.56 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.525 -0.735 . . . . 0.0 109.031 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.73 158.99 44.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.521 -1.362 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -153.82 120.95 5.72 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.314 0.578 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -124.0 166.77 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' B' ' 44' ' ' GLU . . . -125.43 157.94 19.68 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.754 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.655 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 74.1 mm-40 -148.26 136.97 21.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.253 -1.146 . . . . 0.0 109.42 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -111.11 141.05 45.12 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.839 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -143.4 117.29 9.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.384 -1.448 . . . . 0.0 109.785 -178.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -153.62 -15.25 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.33 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.551 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 0.7 OUTLIER -69.62 121.87 17.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' B' ' 48' ' ' SER . 48.0 m80 59.55 126.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.076 -1.015 . . . . 0.0 109.701 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -67.07 -34.87 78.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.402 -0.811 . . . . 0.0 110.823 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.527 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -77.45 -37.89 50.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 110.749 -178.098 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' A' ' 95' ' ' LEU . 19.1 mt -78.75 -71.35 0.44 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.699 -1.25 . . . . 0.0 109.307 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' B' ' 53' ' ' ARG . 3.7 mmt-85 -72.06 12.59 0.4 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 111.268 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.546 ' CD ' HD21 ' A' ' 96' ' ' LEU . 22.0 mt-30 50.65 7.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.826 -1.171 . . . . 0.0 110.167 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.676 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 56.01 -0.38 0.13 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.468 -0.77 . . . . 0.0 112.865 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.676 ' O ' ' O ' ' B' ' 55' ' ' GLY . 4.7 m-85 -53.31 -142.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.323 -1.692 . . . . 0.0 109.985 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.511 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 37.5 m -135.55 -47.46 0.69 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.852 . . . . 0.0 111.003 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.655 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 27.2 t60 -172.78 160.32 4.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.624 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.81 163.07 33.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.449 -0.782 . . . . 0.0 109.282 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 82.3 m-85 -133.43 129.7 37.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.529 -0.732 . . . . 0.0 109.076 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.32 98.73 8.82 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.7 mtt -98.77 119.71 37.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.234 -0.916 . . . . 0.0 110.793 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.5 m -119.48 140.77 49.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -125.3 125.67 43.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.704 -1.247 . . . . 0.0 110.058 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.82 -32.07 19.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -156.01 162.39 40.33 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.73 -21.67 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 111.451 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 33.6 p-10 -56.06 -36.36 67.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.722 -1.236 . . . . 0.0 110.569 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -72.09 -31.99 63.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.693 ' O ' HG22 ' B' ' 74' ' ' THR . 76.6 t80 -67.78 -44.37 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.955 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.78 -28.9 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.431 -1.418 . . . . 0.0 108.691 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.532 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.465 -0.772 . . . . 0.0 109.348 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' B' ' 30' ' ' LEU . 1.6 t80 -56.59 -60.35 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.125 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 70' ' ' TYR . 10.2 t -52.03 -34.49 43.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.715 -1.24 . . . . 0.0 110.322 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 66.5 m -78.01 -16.28 58.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 0.0 110.9 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' B' ' 78' ' ' LEU . 22.8 m80 -79.23 132.15 63.8 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.874 -1.141 . . . . 0.0 109.621 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -42.12 -12.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.625 2.217 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.5 tp -74.38 -27.27 60.58 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.372 -0.83 . . . . 0.0 111.236 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.87 -44.99 21.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.029 -1.044 . . . . 0.0 110.307 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.775 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.2 p -59.55 -58.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.775 ' H ' HG13 ' B' ' 80' ' ' VAL . 15.2 tm-20 -50.91 -36.72 39.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.26 -0.9 . . . . 0.0 109.602 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.88 -31.96 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.853 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.0 -44.34 94.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.029 . . . . 0.0 110.118 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.15 70.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.928 -1.108 . . . . 0.0 108.685 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.924 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -79.39 -46.43 17.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.702 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -38.96 -40.01 0.6 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.559 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 21.0 m -82.24 -62.42 1.63 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.77 -16.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.767 -0.583 . . . . 0.0 110.126 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.924 HG22 ' O ' ' B' ' 85' ' ' ALA . 9.0 m -117.25 -1.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.166 -0.959 . . . . 0.0 110.835 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.622 HG22 ' N ' ' B' ' 91' ' ' ASP . 68.4 mt -132.99 163.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.67 -1.268 . . . . 0.0 110.457 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.622 ' N ' HG22 ' B' ' 90' ' ' ILE . 38.5 t0 -124.04 -27.0 3.94 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.495 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 18.9 ttpt -133.77 131.16 39.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.437 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -126.41 125.62 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.568 -1.333 . . . . 0.0 109.735 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 12.0 t -132.22 134.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -136.56 131.57 34.0 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.188 -1.57 . . . . 0.0 111.814 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.53 HD21 ' CD ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -116.02 122.69 45.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.701 -0.624 . . . . 0.0 109.317 177.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.551 ' O ' ' CZ ' ' A' ' 53' ' ' ARG . 38.7 p-10 -126.3 132.47 51.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.097 -1.002 . . . . 0.0 108.948 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -159.83 128.68 3.06 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.005 . . . . 0.0 110.529 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.556 ' HG2' ' H3 ' ' B' ' 1' ' ' MET . 80.1 Cg_exo -45.79 131.37 13.2 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.283 1.988 . . . . 0.0 112.257 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.547 HG22 ' OE2' ' A' ' 44' ' ' GLU . 97.4 t -113.18 135.38 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -107.89 88.31 2.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 109.636 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ALA . . . . . 0.667 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -57.63 73.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.617 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.667 HG13 ' O ' ' B' ' 102' ' ' ALA . 4.6 m -160.99 99.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 0.0 109.189 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' B' ' 106' ' ' SER . 24.1 mmtm -97.74 4.56 49.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.325 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.38 -53.46 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.147 -0.97 . . . . 0.0 108.93 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.655 ' N ' ' O ' ' B' ' 104' ' ' LYS . 20.6 m 47.13 45.04 15.94 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.338 -0.851 . . . . 0.0 109.385 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 72.2 t -84.95 -41.67 15.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 9.7 m -112.3 49.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.472 -0.768 . . . . 0.0 109.53 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.82 83.81 3.41 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.35 161.74 48.66 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.853 -1.154 . . . . 0.0 109.609 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 C-N-CA 122.775 2.317 . . . . 0.0 112.252 179.688 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.542 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 7.3 ptm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.277 0.561 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.605 ' C ' ' H ' ' A' ' 4' ' ' SER . . . 66.11 -138.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 109.365 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.445 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 70.35 -26.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.145 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 2' ' ' ALA . 43.4 p -143.37 -136.85 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.37 168.56 26.96 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.73 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.463 ' HZ ' ' H2 ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -129.22 131.6 47.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.173 -1.193 . . . . 0.0 108.0 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 19.7 ttpt -110.15 139.04 45.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 112.745 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -129.4 127.81 41.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.9 tt -136.47 146.3 46.15 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.761 -1.212 . . . . 0.0 109.48 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 10' ' ' VAL . 11.7 p -127.8 134.76 64.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.501 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.68 127.35 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.34 159.62 32.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.041 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 17.8 tptt -129.46 152.98 48.4 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 8.0 p90 -106.24 148.85 27.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.906 -1.121 . . . . 0.0 111.626 -177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.62 -22.92 3.52 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 85.0 tt0 -89.47 -58.17 2.62 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.3 t0 155.94 72.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.434 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m -66.15 109.75 2.73 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 112.834 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.72 92.2 5.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 20' ' ' VAL . 15.7 m -61.55 -35.97 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.1 p-10 -68.1 -41.65 81.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 65.5 tt0 -71.47 -32.68 68.57 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.22 -36.94 69.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' VAL . 12.8 tp -52.72 -39.98 62.58 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -39.58 84.2 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 29' ' ' ASN . . . -61.59 -54.36 36.37 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 60' ' ' PHE . 48.5 mt -52.63 -47.85 66.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.551 -0.97 . . . . 0.0 108.769 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.66 -39.43 61.84 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.642 ' OD1' HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.18 -42.52 99.38 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.0 mm? -49.93 -46.75 52.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.706 HG13 HD12 ' A' ' 34' ' ' ILE . 22.0 t -48.77 -25.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.283 -0.886 . . . . 0.0 108.846 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 68.5 m -42.83 -40.61 2.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.44 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 98.1 mm-40 -71.1 -17.98 62.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 111.478 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 34' ' ' ILE . 89.1 mt -80.59 18.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.024 -1.672 . . . . 0.0 110.588 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.5 -12.8 4.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 38' ' ' LYS . 4.0 t -89.28 0.52 56.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.586 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 34.24 34.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.987 -1.071 . . . . 0.0 109.157 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.0 mttt -117.54 41.75 2.76 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -177.87 179.12 0.9 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -148.33 159.84 43.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.566 -1.334 . . . . 0.0 111.955 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 76.3 mt-10 -155.96 123.76 5.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.394 0.616 . . . . 0.0 110.165 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 24.1 m95 -125.29 165.88 17.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 44' ' ' GLU . . . -161.45 150.7 20.56 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.793 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 43' ' ' GLY . 7.5 tp10 -163.66 175.19 10.83 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 11.3 p-10 -118.34 170.0 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -61.26 84.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.409 -1.432 . . . . 0.0 109.847 -178.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.6 mt-10 -107.03 42.5 1.29 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.345 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.87 -142.66 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.994 . . . . 0.0 110.193 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 50' ' ' ASP . 78.9 m80 -95.99 136.97 35.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.218 -0.927 . . . . 0.0 109.675 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' HIS . 90.8 m-20 -41.52 -35.73 0.77 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.0 110.789 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -79.02 -29.19 43.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 0.0 110.733 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.8 mt -94.31 -22.77 18.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.697 -1.252 . . . . 0.0 109.275 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 55' ' ' GLY . 2.7 ptt180 -96.08 4.01 52.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.327 -0.858 . . . . 0.0 111.218 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 53' ' ' ARG . 35.3 tt0 40.71 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.733 -1.229 . . . . 0.0 110.171 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 57.53 1.12 0.45 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 121.39 -0.819 . . . . 0.0 112.816 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 32.1 p90 -55.29 129.36 38.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.281 -1.717 . . . . 0.0 109.976 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 52.8 m -54.53 -47.55 73.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.4 ' CG ' ' N ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -164.3 150.93 11.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -179.174 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 58' ' ' HIS . . . -130.07 147.77 51.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.391 -0.818 . . . . 0.0 109.283 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.948 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 2.4 t80 -126.71 122.93 36.29 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.069 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -106.9 102.7 12.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.3 mtm -102.5 124.74 48.61 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.24 -0.913 . . . . 0.0 110.797 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.8 m -122.29 144.58 48.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.37 160.59 29.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.771 -1.206 . . . . 0.0 110.011 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -82.97 -30.84 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -150.96 160.0 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -58.21 -24.55 59.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 111.389 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -53.62 -35.42 60.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.89 85.45 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 74' ' ' THR . 71.6 t80 -62.39 -46.55 88.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.566 -0.961 . . . . 0.0 110.459 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.394 -1.441 . . . . 0.0 108.649 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.94 2.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 33' ' ' GLN . 3.8 m-85 -48.62 -36.79 16.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 111.103 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 70' ' ' TYR . 2.2 t -82.47 -27.14 32.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.759 -1.213 . . . . 0.0 110.311 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.2 p -69.34 -22.01 63.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.04 -1.038 . . . . 0.0 110.983 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 78' ' ' LEU . 78.4 m80 -85.33 130.76 50.39 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.847 -1.158 . . . . 0.0 109.579 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -45.69 -2.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.67 2.247 . . . . 0.0 112.392 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.642 HD11 ' OD1' ' A' ' 29' ' ' ASN . 8.5 tp -77.16 -31.1 55.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.423 -0.798 . . . . 0.0 111.24 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -76.9 -39.18 51.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.989 -1.069 . . . . 0.0 110.219 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.735 HG13 ' H ' ' A' ' 81' ' ' GLU . 4.0 p -62.26 -56.56 16.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.988 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.735 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.4 tt0 -49.48 -37.76 27.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.4 -29.42 70.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.256 -0.903 . . . . 0.0 109.886 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -61.87 -44.87 95.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.83 69.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.729 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.93 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -83.33 -45.39 13.81 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.703 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -36.37 -44.01 0.4 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.849 HG23 ' H ' ' A' ' 88' ' ' ALA . 3.3 t -83.36 -60.14 2.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.849 ' H ' HG23 ' A' ' 87' ' ' THR . . . -47.22 -14.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.744 -0.598 . . . . 0.0 110.093 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 85' ' ' ALA . 6.1 m -120.17 -1.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.232 -0.918 . . . . 0.0 110.809 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.565 HG13 HG23 ' A' ' 89' ' ' VAL . 61.1 mt -128.55 160.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.649 -1.282 . . . . 0.0 110.434 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.525 ' N ' HG22 ' A' ' 90' ' ' ILE . 40.3 t0 -110.34 -31.97 7.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.51 142.66 31.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.2 tp -124.35 121.11 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.62 -1.3 . . . . 0.0 109.759 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.422 ' CG1' ' CD ' ' B' ' 54' ' ' GLN . 9.0 t -127.57 132.25 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -137.15 132.98 34.73 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.319 -1.488 . . . . 0.0 111.767 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.89 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.66 119.7 36.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.636 -0.665 . . . . 0.0 109.379 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 49.9 t0 -125.61 133.24 52.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.0 108.913 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 31.4 p90 -158.06 138.11 8.81 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.102 -0.999 . . . . 0.0 110.52 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.7 122.92 6.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.594 ' O ' ' OG ' ' A' ' 4' ' ' SER . 56.7 t -85.6 109.28 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.995 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.29 89.71 3.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.42 -0.8 . . . . 0.0 109.613 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' HG13 ' A' ' 103' ' ' VAL . . . -69.85 71.06 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.511 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 103' ' ' VAL . 33.7 m -153.02 86.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.265 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 106' ' ' SER . 29.3 mmtp -95.92 4.45 52.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.342 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t 63.43 -53.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.68 ' N ' ' O ' ' A' ' 104' ' ' LYS . 7.6 t 44.32 50.51 7.81 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 108' ' ' VAL . 11.6 p -104.83 -38.55 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.48 ' N ' HG13 ' A' ' 107' ' ' VAL . 12.3 p -143.86 141.59 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.544 -0.722 . . . . 0.0 109.487 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' HB2' ' OG ' ' B' ' 32' ' ' SER . . . -102.46 108.05 19.24 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.3 p -71.1 150.91 94.8 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 120.9 -1.125 . . . . 0.0 109.659 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo . . . . . 0 C--N 1.308 -1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 112.215 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.535 ' O ' ' HB3' ' B' ' 2' ' ' ALA . 7.3 ptm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' B' ' 4' ' ' SER . . . 65.79 -138.03 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.269 -0.894 . . . . 0.0 109.366 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.409 ' CB ' ' O ' ' B' ' 2' ' ' ALA . 0.4 OUTLIER 70.41 -26.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.599 ' H ' ' C ' ' B' ' 2' ' ' ALA . 46.0 p -143.47 -136.57 0.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 168.65 26.56 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.63 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.467 ' HZ ' ' H2 ' ' B' ' 1' ' ' MET . 0.2 OUTLIER -129.28 131.52 46.99 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -1.143 . . . . 0.0 108.012 178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 19.7 ttpt -110.01 138.97 45.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.903 -1.123 . . . . 0.0 112.793 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -129.2 128.19 42.84 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.9 tt -136.86 145.91 44.95 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.724 -1.235 . . . . 0.0 109.509 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.436 HG13 ' O ' ' B' ' 10' ' ' VAL . 11.7 p -127.57 134.64 65.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.587 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.62 127.22 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.23 159.73 32.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.707 -1.597 . . . . 0.0 112.983 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 18.1 tptt -129.48 153.17 48.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 7.9 p90 -106.43 148.76 27.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.893 -1.129 . . . . 0.0 111.621 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -23.11 3.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 85.1 tt0 -89.22 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.3 t0 155.8 73.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 47.6 m -66.55 109.67 2.87 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.083 0.944 . . . . 0.0 112.862 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.678 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -79.46 92.27 5.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 175.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.427 ' H ' HG22 ' B' ' 20' ' ' VAL . 15.8 m -61.8 -35.73 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.539 -0.725 . . . . 0.0 110.445 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 28.9 p-10 -68.23 -41.5 81.14 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.58 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 64.6 tt0 -71.69 -32.47 67.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.36 -36.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.11 -39.96 63.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -39.72 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' B' ' 29' ' ' ASN . . . -61.39 -54.57 35.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.952 HD22 ' CZ ' ' B' ' 60' ' ' PHE . 47.8 mt -52.49 -47.74 66.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.525 -0.986 . . . . 0.0 108.87 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.64 -39.63 61.95 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.648 ' OD1' HD11 ' B' ' 78' ' ' LEU . 0.1 OUTLIER -62.98 -42.64 99.89 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.0 mm? -49.98 -46.65 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.708 HG13 HD12 ' B' ' 34' ' ' ILE . 22.0 t -49.05 -25.17 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.867 . . . . 0.0 108.816 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 68.4 m -43.05 -40.63 3.18 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.448 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 98.1 mm-40 -70.98 -18.08 62.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.453 -0.779 . . . . 0.0 111.526 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.828 HG22 ' O ' ' B' ' 34' ' ' ILE . 89.6 mt -80.47 18.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 119.978 -1.702 . . . . 0.0 110.568 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.64 -12.83 4.57 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.589 ' O ' ' N ' ' B' ' 38' ' ' LYS . 3.9 t -89.16 0.53 56.66 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.887 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.57 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.5 m 34.32 33.9 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.194 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' B' ' 36' ' ' THR . 65.5 mttt -117.59 42.09 2.68 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 55.6 p -177.93 179.19 0.88 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -148.34 159.65 43.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.554 -1.341 . . . . 0.0 111.95 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.502 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 77.1 mt-10 -155.79 123.84 5.74 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.335 0.588 . . . . 0.0 110.229 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' B' ' 60' ' ' PHE . 23.9 m95 -125.22 166.03 17.22 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' B' ' 44' ' ' GLU . . . -161.55 150.56 20.25 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 118.716 -1.707 . . . . 0.0 110.839 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 43' ' ' GLY . 7.6 tp10 -163.57 175.2 10.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 109.352 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 11.7 p-10 -118.44 169.92 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -61.32 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.322 -1.487 . . . . 0.0 109.809 -178.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.8 mt-10 -106.96 42.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.316 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -139.74 -142.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.138 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' B' ' 50' ' ' ASP . 79.1 m80 -95.97 136.87 35.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 49' ' ' HIS . 90.4 m-20 -41.34 -36.01 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.324 -0.86 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.5 OUTLIER -78.81 -29.35 44.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.731 -178.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.28 -22.83 18.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.691 -1.256 . . . . 0.0 109.257 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' B' ' 55' ' ' GLY . 2.7 ptt180 -95.98 4.04 52.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -0.834 . . . . 0.0 111.235 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' B' ' 53' ' ' ARG . 35.5 tt0 40.55 21.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.812 -1.18 . . . . 0.0 110.15 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 57.27 1.26 0.41 Allowed Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.356 -0.84 . . . . 0.0 112.796 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 31.5 p90 -55.45 129.47 38.87 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 119.595 1.697 . . . . 0.0 109.941 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 55.2 m -54.66 -47.57 73.41 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.301 -0.874 . . . . 0.0 110.946 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 151.06 11.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.895 -1.128 . . . . 0.0 110.17 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.18 147.77 51.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.0 109.262 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.952 ' CZ ' HD22 ' B' ' 27' ' ' LEU . 2.4 t80 -126.65 122.97 36.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.488 -0.757 . . . . 0.0 109.075 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -107.07 102.56 11.89 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.26 124.99 48.81 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.134 -0.979 . . . . 0.0 110.759 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -122.51 144.65 48.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.47 160.92 28.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.738 -1.226 . . . . 0.0 110.025 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -83.31 -30.73 27.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -151.01 160.21 44.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -58.27 -25.04 61.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 111.411 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -53.06 -35.75 59.86 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.816 -1.177 . . . . 0.0 110.585 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -37.1 87.71 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.458 ' O ' HG22 ' B' ' 74' ' ' THR . 71.7 t80 -62.4 -46.55 88.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.978 . . . . 0.0 110.439 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.72 -28.98 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.37 -1.456 . . . . 0.0 108.623 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.0 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' B' ' 33' ' ' GLN . 3.8 m-85 -48.54 -36.58 15.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 111.186 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.458 HG22 ' O ' ' B' ' 70' ' ' TYR . 2.1 t -82.74 -27.08 31.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.744 -1.222 . . . . 0.0 110.329 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -69.49 -21.81 63.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 0.0 111.027 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' B' ' 78' ' ' LEU . 78.3 m80 -85.35 130.81 50.17 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.861 -1.149 . . . . 0.0 109.596 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.71 -2.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.599 2.199 . . . . 0.0 112.433 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.648 HD11 ' OD1' ' B' ' 29' ' ' ASN . 8.3 tp -77.31 -31.1 54.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -76.84 -39.18 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.0 110.296 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.719 HG13 ' H ' ' B' ' 81' ' ' GLU . 4.0 p -62.41 -56.3 18.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.972 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.719 ' H ' HG13 ' B' ' 80' ' ' VAL . 84.2 tt0 -49.89 -37.37 31.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.62 -29.27 69.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.85 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 59.9 p -62.03 -44.99 95.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.71 68.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.998 -1.063 . . . . 0.0 108.641 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.956 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -83.55 -45.33 13.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.705 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -36.52 -43.91 0.42 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.836 HG23 ' H ' ' B' ' 88' ' ' ALA . 3.3 t -83.32 -60.4 2.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.836 ' H ' HG23 ' B' ' 87' ' ' THR . . . -47.04 -14.9 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.956 HG22 ' O ' ' B' ' 85' ' ' ALA . 6.3 m -119.9 -1.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -0.904 . . . . 0.0 110.835 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 61.0 mt -128.33 160.68 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.672 -1.267 . . . . 0.0 110.448 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.545 ' N ' HG22 ' B' ' 90' ' ' ILE . 40.7 t0 -110.54 -31.89 7.09 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.63 142.35 30.99 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.516 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.1 tp -124.03 121.45 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.579 -1.326 . . . . 0.0 109.661 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.431 ' CG1' ' CD ' ' A' ' 54' ' ' GLN . 9.3 t -127.83 132.42 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.553 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -137.37 132.67 33.87 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.246 -1.534 . . . . 0.0 111.777 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.891 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.43 119.78 37.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.683 -0.636 . . . . 0.0 109.294 177.273 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' B' ' 98' ' ' PHE . 50.2 t0 -125.69 133.23 52.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.067 -1.021 . . . . 0.0 108.861 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' B' ' 98' ' ' PHE . 31.2 p90 -158.04 137.79 8.6 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 110.555 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.37 123.1 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.313 2.008 . . . . 0.0 112.221 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.596 ' O ' ' OG ' ' B' ' 4' ' ' SER . 58.9 t -85.79 109.21 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.21 89.8 3.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ALA . . . . . 0.41 ' C ' HG13 ' B' ' 103' ' ' VAL . . . -69.82 71.17 0.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.099 -1.001 . . . . 0.0 109.599 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.742 HG23 ' O ' ' B' ' 103' ' ' VAL . 33.8 m -153.29 85.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -0.843 . . . . 0.0 109.235 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.67 ' O ' ' N ' ' B' ' 106' ' ' SER . 29.2 mmtp -95.61 4.62 52.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.415 ' O ' ' C ' ' B' ' 106' ' ' SER . 1.8 t 63.34 -53.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 108.879 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.67 ' N ' ' O ' ' B' ' 104' ' ' LYS . 7.6 t 44.68 50.43 8.51 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.48 HG13 ' N ' ' B' ' 108' ' ' VAL . 11.8 p -104.96 -38.26 4.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.48 ' N ' HG13 ' B' ' 107' ' ' VAL . 12.3 p -144.08 141.59 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 109.434 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.45 107.99 19.16 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.2 p -71.14 151.0 94.71 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.844 -1.16 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo . . . . . 0 C--N 1.308 -1.584 0 C-N-CA 122.743 2.295 . . . . 0.0 112.255 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.732 ' O ' ' C ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.314 0.578 . . . . 0.0 109.511 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.732 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -15.44 91.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.168 -0.957 . . . . 0.0 109.336 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 1' ' ' MET . 8.8 t -111.5 0.21 16.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -167.25 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.1 178.15 18.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.66 127.04 55.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.276 -1.132 . . . . 0.0 107.973 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.4 ttpt -97.95 128.03 44.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.916 -1.115 . . . . 0.0 112.841 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 70' ' ' TYR . 51.6 m-70 -121.06 119.2 31.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.71 139.44 52.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.716 -1.24 . . . . 0.0 109.496 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.9 137.48 56.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.641 -0.662 . . . . 0.0 109.536 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -124.48 133.8 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 1.5 m -141.42 162.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.047 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -127.59 152.64 47.38 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 12.7 p90 -109.82 151.8 26.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.799 -1.188 . . . . 0.0 111.607 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.31 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 48.3 tp10 -92.84 -54.93 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.8 t0 152.86 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.536 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.4 m -50.22 107.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.14 0.972 . . . . 0.0 112.859 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -71.61 83.36 0.85 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 21' ' ' ASP . 27.8 m -62.83 -41.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.546 -0.721 . . . . 0.0 110.481 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.57 ' N ' HG23 ' A' ' 20' ' ' VAL . 90.3 m-20 -64.96 -44.64 88.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 110.498 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.7 -31.77 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -70.84 -43.61 76.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.2 tp -54.01 -40.04 66.66 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.92 -38.04 81.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -62.57 -51.27 57.3 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.7 tt -45.22 -44.03 10.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.461 -1.023 . . . . 0.0 108.848 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -49.87 -35.01 21.81 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 26' ' ' GLY . 14.3 m-20 -65.39 -44.32 87.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.668 HD11 ' CE1' ' A' ' 73' ' ' PHE . 1.4 mm? -48.39 -50.76 29.6 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' SER . 54.8 t -46.94 -35.7 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 108.733 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.1 t -45.36 -50.55 12.13 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -69.21 -9.15 51.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 111.47 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 34' ' ' ILE . 21.9 mm -101.35 29.07 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.04 -1.663 . . . . 0.0 110.589 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.19 -19.08 61.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.585 ' O ' ' C ' ' A' ' 37' ' ' VAL . 16.8 p -69.84 -6.85 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.585 ' C ' ' O ' ' A' ' 36' ' ' THR . 34.7 m 35.08 36.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.104 -0.998 . . . . 0.0 109.106 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -118.0 41.55 2.87 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.444 ' OG ' HG23 ' A' ' 34' ' ' ILE . 60.5 p -174.01 178.09 2.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 97.6 m-85 -145.47 153.81 41.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.594 -1.316 . . . . 0.0 111.951 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 40' ' ' PHE . 54.1 mp0 -156.99 125.41 5.68 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.421 0.629 . . . . 0.0 110.162 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -134.58 176.05 8.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.636 ' H ' ' NZ ' ' B' ' 104' ' ' LYS . . . -133.56 158.82 23.42 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 77.4 mt-10 -149.06 140.79 23.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -1.145 . . . . 0.0 109.368 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 32.4 p30 -120.62 145.36 47.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' CD ' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -148.62 128.84 13.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.437 -1.414 . . . . 0.0 109.794 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -161.98 51.2 0.21 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.641 -0.662 . . . . 0.0 109.32 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.2 t -91.12 -98.65 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.203 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.44 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.4 m-70 -100.69 144.67 29.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.155 -0.965 . . . . 0.0 109.708 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 87.8 m-20 -50.09 -42.97 51.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.301 -0.875 . . . . 0.0 110.674 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.3 ttt -73.55 -32.77 64.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.084 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 68.9 mt -88.67 -51.65 5.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.741 -1.224 . . . . 0.0 109.245 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.721 ' O ' ' N ' ' A' ' 55' ' ' GLY . 13.8 ptt180 -71.08 5.45 2.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 111.275 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.404 ' CD ' HG13 ' B' ' 94' ' ' VAL . 85.2 mm-40 46.07 3.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.729 -1.232 . . . . 0.0 110.197 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.21 -10.07 11.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.488 -0.758 . . . . 0.0 112.864 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 55' ' ' GLY . 20.9 m-85 -59.1 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.226 -1.749 . . . . 0.0 109.99 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.724 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 81.1 p -152.86 -41.9 0.1 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.962 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.724 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 27.3 p-80 -174.33 157.81 2.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.836 -1.165 . . . . 0.0 110.145 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG13 ' A' ' 11' ' ' VAL . . . -143.69 170.91 14.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 109.287 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.05 131.67 37.29 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.128 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 t -101.67 102.15 12.78 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.9 mtt -108.08 125.1 51.18 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.146 -0.971 . . . . 0.0 110.799 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.8 m -128.4 149.36 50.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.06 131.71 45.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 110.03 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 71.7 mm-40 -52.48 -32.52 40.36 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 33.0 m120 -155.64 160.46 40.43 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -57.66 -17.93 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.99 -39.83 79.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.844 -1.16 . . . . 0.0 110.589 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.26 -33.46 73.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.615 ' CE1' ' CE1' ' A' ' 8' ' ' HIS . 76.4 t80 -67.12 -44.38 80.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.495 -1.003 . . . . 0.0 110.451 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -28.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.381 -1.45 . . . . 0.0 108.673 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.367 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.668 ' CE1' HD11 ' A' ' 30' ' ' LEU . 2.5 t80 -45.66 -34.17 3.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 111.141 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -83.41 -24.9 31.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.744 -1.223 . . . . 0.0 110.249 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.6 m -67.47 -26.0 66.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.994 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -85.47 156.0 59.42 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.878 -1.139 . . . . 0.0 109.664 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.21 3.86 2.27 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.66 2.24 . . . . 0.0 112.469 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' CD2' HD22 ' A' ' 30' ' ' LEU . 44.5 tp -77.87 -31.1 51.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.77 . . . . 0.0 111.322 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -77.7 -41.61 37.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 0.0 110.211 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.765 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.5 p -62.58 -58.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.765 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.8 tt0 -51.77 -38.72 56.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 109.638 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -69.89 -32.02 70.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 109.883 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.5 -45.06 95.16 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.48 85.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.879 -1.138 . . . . 0.0 108.751 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.829 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -77.55 -44.76 27.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -39.28 -38.78 0.55 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.3 m -81.46 -61.0 2.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.34 -13.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.63 -0.669 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 85' ' ' ALA . 13.1 m -119.27 -2.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 110.859 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -120.66 155.98 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.595 -1.316 . . . . 0.0 110.473 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.444 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 36.4 t0 -104.35 -31.58 9.47 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.433 ' H ' HG23 ' A' ' 90' ' ' ILE . 21.5 pttt -149.98 150.61 32.06 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 86' ' ' PHE . 6.0 tp -127.31 125.25 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.627 -1.295 . . . . 0.0 109.751 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.424 HG13 ' CD ' ' B' ' 54' ' ' GLN . 13.2 t -123.45 128.57 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.841 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.25 138.43 33.25 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.249 -1.532 . . . . 0.0 111.838 -178.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -122.25 123.96 42.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.637 . . . . 0.0 109.326 176.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -125.85 135.59 52.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.011 -1.056 . . . . 0.0 108.919 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -165.67 158.55 13.14 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 0.0 110.522 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.595 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 39.9 Cg_exo -58.78 114.84 2.17 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.298 1.999 . . . . 0.0 112.176 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 132.97 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.923 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -109.8 79.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -73.83 93.97 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.114 -0.991 . . . . 0.0 109.535 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.754 ' O ' ' C ' ' A' ' 104' ' ' LYS . 14.7 m -155.9 -16.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.201 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.754 ' C ' ' O ' ' A' ' 103' ' ' VAL . 31.5 mmtm -8.14 -105.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.71 -5.52 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 108.911 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 104' ' ' LYS . 45.1 t -59.71 140.56 56.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 107' ' ' VAL . 10.6 p -148.71 42.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.91 151.03 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.0 109.445 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.34 163.04 26.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 110' ' ' THR . 6.5 p -142.67 68.67 19.79 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 120.82 -1.175 . . . . 0.0 109.599 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo . . . . . 0 C--N 1.308 -1.575 0 C-N-CA 122.763 2.309 . . . . 0.0 112.226 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.745 ' O ' ' C ' ' B' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.745 ' C ' ' O ' ' B' ' 1' ' ' MET . . . -15.51 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 109.311 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.572 ' N ' ' O ' ' B' ' 1' ' ' MET . 8.9 t -111.56 0.17 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.226 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -167.36 -87.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.19 178.12 18.44 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.433 -1.365 . . . . 0.0 109.697 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -111.76 126.69 55.33 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.276 -1.132 . . . . 0.0 107.993 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.3 ttpt -97.53 128.23 44.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.937 -1.102 . . . . 0.0 112.863 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.601 ' CE1' ' CE1' ' B' ' 70' ' ' TYR . 51.3 m-70 -121.29 119.02 31.01 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 5.9 tt -128.56 139.53 52.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.743 -1.223 . . . . 0.0 109.451 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.83 137.67 56.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.498 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.3 OUTLIER -124.77 133.86 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.623 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 1.5 m -141.5 162.04 21.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 117.745 -1.582 . . . . 0.0 113.039 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -127.57 152.66 47.35 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 12.6 p90 -109.88 151.73 26.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.798 -1.189 . . . . 0.0 111.562 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.14 3.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 48.4 tp10 -92.96 -55.04 3.5 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.7 t0 152.99 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.531 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 89.3 m -50.27 107.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.082 0.944 . . . . 0.0 112.868 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -71.51 83.23 0.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.575 HG23 ' N ' ' B' ' 21' ' ' ASP . 26.9 m -62.77 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.631 -0.668 . . . . 0.0 110.473 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.575 ' N ' HG23 ' B' ' 20' ' ' VAL . 90.0 m-20 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.456 -0.777 . . . . 0.0 110.576 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -65.5 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -70.96 -43.43 76.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.13 -40.02 67.01 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.98 -38.13 81.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -62.22 -51.59 55.61 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.544 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.7 tt -45.04 -44.08 9.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.533 -0.981 . . . . 0.0 108.795 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -49.89 -34.94 21.78 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' B' ' 26' ' ' GLY . 14.3 m-20 -65.4 -44.31 87.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.664 HD11 ' CE1' ' B' ' 73' ' ' PHE . 1.4 mm? -48.37 -50.82 29.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 32' ' ' SER . 54.9 t -46.93 -35.47 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.915 . . . . 0.0 108.79 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 8.2 t -45.65 -50.48 13.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -69.28 -8.99 51.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 111.475 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 34' ' ' ILE . 21.9 mm -101.58 29.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.019 -1.675 . . . . 0.0 110.645 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -61.23 -19.27 61.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.571 ' O ' ' C ' ' B' ' 37' ' ' VAL . 16.8 p -69.59 -6.85 33.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.961 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.6 m 35.04 36.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.022 -1.049 . . . . 0.0 109.132 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.3 OUTLIER -118.09 41.68 2.86 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.445 ' OG ' HG23 ' B' ' 34' ' ' ILE . 60.3 p -174.2 177.99 2.17 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 97.7 m-85 -145.47 153.7 41.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.58 -1.325 . . . . 0.0 111.967 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' B' ' 40' ' ' PHE . 53.9 mp0 -156.92 125.11 5.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -134.2 176.18 8.83 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.648 ' H ' ' NZ ' ' A' ' 104' ' ' LYS . . . -133.74 158.74 23.42 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 118.703 -1.713 . . . . 0.0 110.782 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 77.3 mt-10 -148.98 140.83 23.66 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 32.2 p30 -120.71 145.39 47.53 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.66 128.69 13.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.404 -1.435 . . . . 0.0 109.834 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -161.91 51.36 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.622 . . . . 0.0 109.339 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -91.18 -98.83 0.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ARG . 90.4 m-70 -100.59 144.5 29.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.093 -1.004 . . . . 0.0 109.676 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' B' ' 53' ' ' ARG . 88.6 m-20 -49.92 -42.92 49.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 110.849 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.1 ttt -73.76 -32.46 63.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.029 -1.044 . . . . 0.0 110.756 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 95' ' ' LEU . 68.9 mt -88.82 -51.76 5.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.731 ' O ' ' N ' ' B' ' 55' ' ' GLY . 13.8 ptt180 -70.91 5.36 2.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.344 -0.848 . . . . 0.0 111.249 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.424 ' CD ' HG13 ' A' ' 94' ' ' VAL . 85.5 mm-40 46.19 3.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.855 -1.153 . . . . 0.0 110.244 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.32 -10.12 11.96 Favored Glycine 0 N--CA 1.499 2.882 0 O-C-N 121.437 -0.79 . . . . 0.0 112.812 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' B' ' 55' ' ' GLY . 21.4 m-85 -59.19 -141.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.284 -1.715 . . . . 0.0 109.946 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.706 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 80.6 p -152.76 -41.85 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.319 -0.863 . . . . 0.0 111.024 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.706 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 27.5 p-80 -174.45 157.7 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.854 -1.154 . . . . 0.0 110.167 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.53 ' HB2' HG13 ' B' ' 11' ' ' VAL . . . -143.72 170.9 14.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.489 -0.757 . . . . 0.0 109.219 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.01 131.67 37.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 21.1 t -101.61 102.23 12.91 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 125.31 51.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.931 . . . . 0.0 110.733 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.7 m -128.59 149.28 50.7 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.05 131.64 45.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 110.095 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 72.0 mm-40 -52.17 -32.82 37.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 32.9 m120 -155.5 160.51 40.62 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -57.76 -17.87 18.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 111.466 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -57.85 -40.11 79.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.885 -1.134 . . . . 0.0 110.551 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.93 -33.6 75.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.601 ' CE1' ' CE1' ' B' ' 8' ' ' HIS . 76.2 t80 -66.99 -44.55 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.661 -0.905 . . . . 0.0 110.473 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.67 -28.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.704 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.88 2.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.664 ' CE1' HD11 ' B' ' 30' ' ' LEU . 2.5 t80 -45.66 -34.08 3.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.148 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.1 OUTLIER -83.34 -24.99 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 0.0 110.304 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -67.41 -25.86 66.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 111.032 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -85.65 156.0 58.92 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.83 -1.169 . . . . 0.0 109.579 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.17 3.91 2.23 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 112.433 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.513 ' CD2' HD22 ' B' ' 30' ' ' LEU . 44.5 tp -77.98 -31.31 50.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.429 -0.794 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -77.41 -41.79 38.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.961 -1.087 . . . . 0.0 110.289 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.781 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.6 p -62.39 -58.24 8.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.054 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.781 ' H ' HG13 ' B' ' 80' ' ' VAL . 85.0 tt0 -51.71 -38.73 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 0.0 109.593 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -69.98 -31.96 69.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.838 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.4 t -60.35 -45.36 93.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.142 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.42 85.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.987 -1.071 . . . . 0.0 108.685 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.801 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -77.53 -44.79 27.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.698 ' CE1' HD13 ' B' ' 93' ' ' ILE . 0.0 OUTLIER -39.33 -38.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.593 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.3 m -81.41 -61.1 2.04 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.12 -13.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.079 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.801 HG22 ' O ' ' B' ' 85' ' ' ALA . 13.1 m -119.21 -2.77 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.237 -0.915 . . . . 0.0 110.875 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -120.7 156.05 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.701 -1.249 . . . . 0.0 110.465 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.455 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 35.9 t0 -104.47 -31.63 9.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.435 ' H ' HG23 ' B' ' 90' ' ' ILE . 21.6 pttt -150.04 150.37 31.65 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.698 HD13 ' CE1' ' B' ' 86' ' ' PHE . 6.0 tp -127.07 125.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.491 -1.381 . . . . 0.0 109.733 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.404 HG13 ' CD ' ' A' ' 54' ' ' GLN . 12.8 t -123.55 128.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.847 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.33 138.54 33.18 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.302 -1.499 . . . . 0.0 111.791 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.4 HD12 ' N ' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -122.25 123.83 42.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -125.77 135.67 52.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.064 -1.023 . . . . 0.0 108.87 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.591 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 0.5 OUTLIER -165.62 158.52 13.21 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.132 -0.98 . . . . 0.0 110.587 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.591 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 41.1 Cg_exo -58.76 114.73 2.12 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.305 2.003 . . . . 0.0 112.265 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 133.04 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.004 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' B' ' 3' ' ' THR . . . -109.87 78.87 1.16 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.502 -0.749 . . . . 0.0 109.58 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ALA . . . . . 0.471 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -73.58 94.08 2.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.12 -0.987 . . . . 0.0 109.657 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.784 ' O ' ' C ' ' B' ' 104' ' ' LYS . 14.6 m -156.0 -16.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.362 -0.836 . . . . 0.0 109.219 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.784 ' C ' ' O ' ' B' ' 103' ' ' VAL . 31.3 mmtm -8.28 -105.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.373 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.66 -5.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.935 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.557 ' H ' ' C ' ' B' ' 104' ' ' LYS . 44.4 t -59.53 140.61 56.12 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.291 -0.881 . . . . 0.0 109.419 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.538 ' O ' HG13 ' B' ' 107' ' ' VAL . 10.7 p -148.78 42.95 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.95 151.07 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.48 -0.762 . . . . 0.0 109.452 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.3 163.16 26.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.466 ' O ' ' OG1' ' B' ' 110' ' ' THR . 6.6 p -142.82 68.56 18.98 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 120.874 -1.142 . . . . 0.0 109.658 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo . . . . . 0 C--N 1.308 -1.575 0 C-N-CA 122.731 2.287 . . . . 0.0 112.234 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.301 0.572 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.26 66.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.368 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 4' ' ' SER . 12.1 t -107.68 0.77 22.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.089 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.9 m -173.32 -107.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.8 -178.26 20.55 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.399 -1.382 . . . . 0.0 109.694 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -130.11 130.13 44.42 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 1.3 ttpm? -104.48 133.84 48.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.874 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -127.21 125.7 41.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.51 142.45 48.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.745 -1.222 . . . . 0.0 109.507 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 140.32 48.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.506 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.22 134.02 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.491 ' O ' HG22 ' A' ' 57' ' ' THR . 2.6 m -137.53 162.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 117.79 -1.564 . . . . 0.0 113.014 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 14' ' ' PHE . 20.7 tptp -132.21 152.8 51.14 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 18' ' ' THR . 36.3 p90 -111.65 149.44 31.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.886 -1.134 . . . . 0.0 111.597 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.45 -19.68 3.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.5 mt-10 -91.69 -56.5 3.08 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.9 t0 154.48 64.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 86.8 m -49.77 105.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.126 0.965 . . . . 0.0 112.794 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.898 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -68.65 83.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 21' ' ' ASP . 28.9 m -61.59 -42.96 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.52 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' N ' HG23 ' A' ' 20' ' ' VAL . 29.0 p-10 -65.97 -43.27 88.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 0.0 110.571 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 97.4 mt-10 -70.7 -34.12 71.61 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 89' ' ' VAL . 1.8 mm -67.32 -44.61 87.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' VAL . 15.7 tp -52.88 -38.0 61.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.08 75.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -60.63 -54.23 38.81 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.4 tt -45.83 -43.91 13.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.497 -1.002 . . . . 0.0 108.838 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' B' ' 106' ' ' SER . 71.8 mm-40 -50.86 -33.33 23.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.0 m-20 -66.54 -44.39 82.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.1 mm? -49.3 -48.28 46.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 32' ' ' SER . 94.6 t -46.97 -31.91 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.908 . . . . 0.0 108.844 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 73.7 p -45.59 -49.25 14.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 70.6 mm-40 -72.79 -12.15 60.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 111.457 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 34' ' ' ILE . 21.1 mm -96.69 24.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.043 -1.661 . . . . 0.0 110.589 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.06 -12.43 4.81 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.2 p -74.86 -1.28 21.6 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.995 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.576 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.1 m 34.61 33.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 32.1 mtmt -119.55 42.36 2.9 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 58.4 m -171.88 174.54 4.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -146.71 157.4 43.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.639 -1.288 . . . . 0.0 111.957 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.479 ' OE1' HD21 ' A' ' 27' ' ' LEU . 72.5 mt-10 -155.27 121.5 5.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.362 0.601 . . . . 0.0 110.231 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -123.95 170.2 10.85 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.97 160.0 23.72 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.72 -1.705 . . . . 0.0 110.852 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 24.1 mt-10 -150.5 145.21 25.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.251 -1.147 . . . . 0.0 109.394 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 22.5 t70 -126.53 148.03 49.77 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.877 ' HZ2' ' C ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -145.37 122.99 11.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.417 -1.427 . . . . 0.0 109.799 -178.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 48' ' ' SER . 95.4 mt-10 -133.93 3.4 3.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 47' ' ' GLU . 99.2 p -56.99 -140.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.953 . . . . 0.0 110.17 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.786 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 57.4 t-80 -74.62 160.15 31.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.691 ' N ' HH21 ' A' ' 53' ' ' ARG . 77.9 m-20 -61.2 -44.23 97.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 tpt -67.76 -33.43 74.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.013 -1.054 . . . . 0.0 110.746 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' B' ' 95' ' ' LEU . 38.0 mt -89.23 -54.43 4.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.702 -1.249 . . . . 0.0 109.323 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.786 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.3 ptp180 -64.41 2.97 0.52 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.0 111.195 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.515 HE21 ' HB ' ' B' ' 94' ' ' VAL . 2.5 mm-40 57.19 -12.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.75 -1.219 . . . . 0.0 110.14 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.739 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 85.24 -21.81 11.69 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.408 -0.808 . . . . 0.0 112.847 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.877 ' C ' ' HZ2' ' A' ' 46' ' ' LYS . 3.7 m-85 -57.79 -129.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.267 -1.725 . . . . 0.0 109.988 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.8 t -162.2 -33.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.629 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 15.0 t60 -172.05 154.49 3.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.104 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.629 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.9 168.01 20.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.414 -0.804 . . . . 0.0 109.251 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 96.8 m-85 -134.74 130.98 37.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.475 -0.766 . . . . 0.0 109.067 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.6 99.24 8.84 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.0 mtm -100.07 124.8 45.86 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.149 -0.97 . . . . 0.0 110.851 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.46 142.94 50.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' GLU . 94.2 m-85 -122.01 126.8 49.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.736 -1.228 . . . . 0.0 110.092 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 64' ' ' PHE . 33.6 tt0 -46.93 -30.7 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -165.81 170.59 13.74 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -57.79 -22.35 46.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 111.46 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -56.24 -40.22 73.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.822 -1.174 . . . . 0.0 110.673 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.09 62.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.645 ' O ' HG22 ' A' ' 74' ' ' THR . 71.7 t80 -63.13 -44.59 95.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.984 . . . . 0.0 110.467 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.75 -28.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.388 -1.445 . . . . 0.0 108.692 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -60.99 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -56.74 -42.57 79.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 111.09 -177.279 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 70' ' ' TYR . 10.0 t -75.95 -33.19 59.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.787 -1.195 . . . . 0.0 110.31 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 63.5 m -63.39 -32.76 74.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.996 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.522 ' CE1' ' OE1' ' A' ' 33' ' ' GLN . 54.5 m80 -72.03 151.91 92.76 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.861 -1.15 . . . . 0.0 109.604 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.14 4.1 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.669 2.246 . . . . 0.0 112.42 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.482 ' CD2' HD22 ' A' ' 30' ' ' LEU . 28.5 tp -76.57 -28.62 56.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.384 -0.822 . . . . 0.0 111.267 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.518 ' CD2' ' OG ' ' A' ' 83' ' ' SER . 11.2 t-160 -81.59 -41.82 20.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.987 -1.07 . . . . 0.0 110.245 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.775 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.5 p -63.12 -58.9 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 110.023 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.775 ' H ' HG13 ' A' ' 80' ' ' VAL . 48.3 tp10 -58.46 -39.61 80.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.197 -0.94 . . . . 0.0 109.627 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 85.6 t80 -69.69 -43.49 72.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.518 ' OG ' ' CD2' ' A' ' 79' ' ' HIS . 49.8 m -59.24 -36.63 75.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.113 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.22 60.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.972 -1.08 . . . . 0.0 108.666 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.9 -41.59 74.49 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.492 ' C ' ' O ' ' A' ' 85' ' ' ALA . 11.9 t80 -43.06 -30.82 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.3 m -83.21 -60.98 1.97 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.41 -24.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.682 -0.636 . . . . 0.0 110.049 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' THR . 9.0 m -105.32 11.92 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.213 -0.93 . . . . 0.0 110.834 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 47.1 mt -124.68 158.77 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.278 . . . . 0.0 110.474 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.508 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 57.5 t0 -100.05 -34.32 10.12 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 90' ' ' ILE . 38.4 pttt -149.08 147.62 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.88 131.4 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.619 -1.301 . . . . 0.0 109.744 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.513 ' HB ' HE21 ' B' ' 54' ' ' GLN . 2.3 m -137.0 139.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -139.44 135.18 33.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.245 -1.534 . . . . 0.0 111.739 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.898 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -117.99 123.87 46.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.382 178.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 65.7 t0 -125.47 131.15 52.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.041 -1.037 . . . . 0.0 108.939 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' B' ' 45' ' ' ASP . 44.8 t80 -160.93 138.72 7.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.036 -1.04 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.82 120.33 2.8 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.34 2.026 . . . . 0.0 112.205 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.82 144.04 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.06 125.77 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 109.609 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.06 73.55 9.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.539 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 103' ' ' VAL . 18.1 m -150.25 98.06 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.162 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 106' ' ' SER . 41.4 mmtm -134.27 -112.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.57 -12.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 108.868 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 104' ' ' LYS . 30.1 t -53.58 139.75 30.75 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.269 -0.895 . . . . 0.0 109.404 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.93 138.38 53.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 108' ' ' VAL . 5.8 p 178.47 59.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.465 -0.772 . . . . 0.0 109.495 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.455 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . . . -83.9 109.36 17.52 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.9 m -135.87 70.15 64.56 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 120.84 -1.162 . . . . 0.0 109.641 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--N 1.309 -1.549 0 C-N-CA 122.782 2.322 . . . . 0.0 112.223 179.963 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.86 67.26 1.03 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 109.357 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -108.02 0.82 22.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 109.047 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 38.2 m -173.55 -107.35 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.83 -178.81 20.51 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.632 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.62 130.2 45.33 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.302 -1.117 . . . . 0.0 108.011 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 1.2 ttpm? -104.47 134.04 48.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.337 1.065 . . . . 0.0 112.841 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -127.41 125.63 40.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 tt -133.43 142.59 48.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 109.375 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.87 140.31 49.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.574 -0.704 . . . . 0.0 109.493 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.408 ' O ' HG22 ' B' ' 94' ' ' VAL . 0.1 OUTLIER -121.13 134.14 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.489 ' O ' HG22 ' B' ' 57' ' ' THR . 2.6 m -137.5 162.8 32.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 117.758 -1.577 . . . . 0.0 113.016 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.503 ' HD2' ' H ' ' B' ' 14' ' ' PHE . 20.6 tptp -132.17 152.96 51.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.515 ' HB2' ' H ' ' B' ' 18' ' ' THR . 36.4 p90 -111.76 149.51 31.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.78 -1.2 . . . . 0.0 111.598 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.65 -19.44 3.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.4 mt-10 -92.14 -56.17 3.16 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 8.7 t0 154.25 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.515 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 87.1 m -49.67 105.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.148 0.975 . . . . 0.0 112.876 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.887 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -68.76 83.59 0.3 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.591 HG23 ' N ' ' B' ' 21' ' ' ASP . 29.6 m -61.84 -42.89 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 110.513 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.591 ' N ' HG23 ' B' ' 20' ' ' VAL . 30.4 p-10 -65.95 -43.2 88.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.547 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 97.2 mt-10 -70.7 -34.17 71.66 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.46 HD11 HG21 ' B' ' 89' ' ' VAL . 1.8 mm -67.29 -44.51 87.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' B' ' 20' ' ' VAL . 15.7 tp -52.87 -37.94 60.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.05 75.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -60.71 -54.13 39.54 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.559 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.4 tt -45.92 -43.63 14.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 108.828 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 106' ' ' SER . 71.6 mm-40 -51.35 -33.2 28.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 26' ' ' GLY . 11.5 m-20 -66.34 -44.75 82.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.1 mm? -48.9 -48.4 42.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 94.4 t -46.9 -32.09 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 108.815 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 69.6 p -45.57 -49.37 14.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.518 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 71.1 mm-40 -72.49 -12.07 60.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 111.527 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 34' ' ' ILE . 21.2 mm -96.97 24.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.017 -1.677 . . . . 0.0 110.568 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.35 -12.02 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.575 ' O ' ' N ' ' B' ' 38' ' ' LYS . 52.6 p -75.29 -1.11 22.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.96 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 34.63 33.57 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.998 -1.064 . . . . 0.0 109.135 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' B' ' 36' ' ' THR . 32.1 mtmt -119.6 42.53 2.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 58.5 m -172.03 174.58 4.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -146.78 157.46 43.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.497 -1.377 . . . . 0.0 111.934 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.472 ' OE1' HD21 ' B' ' 27' ' ' LEU . 72.5 mt-10 -155.24 121.51 5.23 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.428 0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -123.86 170.27 10.74 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.18 159.67 23.65 Favored Glycine 0 N--CA 1.499 2.836 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.847 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 24.2 mt-10 -150.3 145.0 25.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.181 -1.188 . . . . 0.0 109.387 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 22.3 t70 -126.38 147.9 49.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.857 ' HZ2' ' C ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -145.17 123.12 12.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 0.0 109.858 -178.211 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.4 mt-10 -134.08 3.9 3.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.694 -0.629 . . . . 0.0 109.367 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.536 ' O ' ' O ' ' B' ' 47' ' ' GLU . 95.1 p -57.21 -140.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.179 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.762 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 57.3 t-80 -74.54 160.18 31.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 109.742 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.701 ' N ' HH21 ' B' ' 53' ' ' ARG . 77.7 m-20 -61.2 -44.2 97.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.0 110.837 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.7 tpt -67.81 -33.28 74.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.005 . . . . 0.0 110.726 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 95' ' ' LEU . 38.9 mt -89.32 -54.46 4.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.715 -1.24 . . . . 0.0 109.307 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.762 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.4 ptp180 -64.37 2.89 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 111.231 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.513 HE21 ' HB ' ' A' ' 94' ' ' VAL . 2.5 mm-40 57.33 -12.38 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.811 -1.18 . . . . 0.0 110.282 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.738 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 85.61 -22.04 12.3 Favored Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.43 -0.794 . . . . 0.0 112.789 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.857 ' C ' ' HZ2' ' B' ' 46' ' ' LYS . 3.6 m-85 -57.82 -129.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.327 -1.69 . . . . 0.0 109.973 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.489 HG22 ' O ' ' B' ' 12' ' ' VAL . 2.6 t -162.37 -33.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 110.985 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.617 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 15.2 t60 -171.93 154.61 3.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.832 -1.168 . . . . 0.0 110.162 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.617 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.95 167.99 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.439 -0.788 . . . . 0.0 109.341 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 96.7 m-85 -134.61 131.04 37.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 109.137 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.55 99.1 8.72 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -99.9 124.77 45.58 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.204 -0.935 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 88.4 m -123.58 143.06 50.45 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' B' ' 65' ' ' GLU . 94.3 m-85 -122.22 126.65 48.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.751 -1.218 . . . . 0.0 110.081 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' B' ' 64' ' ' PHE . 32.8 tt0 -46.62 -30.79 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -166.01 170.6 13.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.85 -22.4 47.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.886 . . . . 0.0 111.402 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -56.18 -40.26 73.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.81 -1.181 . . . . 0.0 110.653 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.57 -36.08 62.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.63 ' O ' HG22 ' B' ' 74' ' ' THR . 72.5 t80 -63.07 -44.78 94.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.532 -0.981 . . . . 0.0 110.49 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.75 -28.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.351 -1.468 . . . . 0.0 108.684 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -60.83 2.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.344 -0.847 . . . . 0.0 109.292 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.69 -42.46 79.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 111.124 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.63 HG22 ' O ' ' B' ' 70' ' ' TYR . 10.0 t -76.09 -33.14 59.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.779 -1.2 . . . . 0.0 110.381 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 65.4 m -63.47 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.062 -1.024 . . . . 0.0 110.912 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.518 ' CE1' ' OE1' ' B' ' 33' ' ' GLN . 54.1 m80 -72.34 151.63 92.06 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.82 -1.175 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.79 3.91 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.701 2.267 . . . . 0.0 112.425 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.473 ' CD2' HD22 ' B' ' 30' ' ' LEU . 28.5 tp -76.48 -28.93 56.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.373 -0.83 . . . . 0.0 111.233 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.506 ' CD2' ' OG ' ' B' ' 83' ' ' SER . 11.2 t-160 -81.37 -41.6 21.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.041 -1.037 . . . . 0.0 110.266 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.796 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.7 p -63.35 -59.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.998 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.796 ' H ' HG13 ' B' ' 80' ' ' VAL . 49.1 tp10 -58.23 -39.65 79.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.862 . . . . 0.0 109.625 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 85.5 t80 -69.43 -43.66 72.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.506 ' OG ' ' CD2' ' B' ' 79' ' ' HIS . 50.9 m -59.14 -36.54 75.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.027 -1.046 . . . . 0.0 110.147 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.21 -52.98 63.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.65 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -69.99 -41.93 73.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' B' ' 85' ' ' ALA . 11.8 t80 -42.89 -30.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.545 ' O ' ' N ' ' B' ' 89' ' ' VAL . 9.4 m -83.3 -60.79 2.03 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.65 -24.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.702 -0.624 . . . . 0.0 110.06 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.0 m -105.8 12.04 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.78 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 48.0 mt -124.63 158.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.711 -1.243 . . . . 0.0 110.423 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.509 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 57.1 t0 -100.06 -34.53 10.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.445 ' N ' HG22 ' B' ' 90' ' ' ILE . 38.5 pttt -148.76 147.67 29.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.81 131.48 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.583 -1.323 . . . . 0.0 109.764 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.515 ' HB ' HE21 ' A' ' 54' ' ' GLN . 2.3 m -136.93 139.51 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -139.68 135.05 32.82 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.276 -1.515 . . . . 0.0 111.773 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.885 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -117.8 124.05 47.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.7 t0 -125.64 131.56 52.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.037 -1.04 . . . . 0.0 108.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 45' ' ' ASP . 44.7 t80 -161.41 138.68 6.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.025 -1.047 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -44.69 120.35 2.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.299 2.0 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.86 143.92 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.05 125.78 25.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 109.6 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.03 73.37 9.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.039 -1.038 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.8 HG23 ' O ' ' B' ' 103' ' ' VAL . 18.2 m -149.95 98.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.219 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.635 ' C ' ' H ' ' B' ' 106' ' ' SER . 41.1 mmtm -134.52 -113.3 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.272 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.97 -13.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 108.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.635 ' H ' ' C ' ' B' ' 104' ' ' LYS . 31.1 t -53.03 139.75 27.17 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.219 -0.925 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -130.88 138.37 53.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.699 ' O ' HG22 ' B' ' 108' ' ' VAL . 5.6 p 178.41 59.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.544 -0.723 . . . . 0.0 109.463 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ALA . . . . . 0.453 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . . . -83.96 109.38 17.58 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 20.5 m -135.83 70.11 64.82 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 120.86 -1.15 . . . . 0.0 109.567 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 C--N 1.307 -1.62 0 C-N-CA 122.768 2.312 . . . . 0.0 112.248 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.277 0.56 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.77 58.04 4.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.347 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -116.06 1.11 13.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.141 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 m -175.34 -126.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.24 173.14 31.2 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.709 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -135.78 136.36 40.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.289 -1.124 . . . . 0.0 108.005 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' B' ' 44' ' ' GLU . 20.7 ttpt -114.61 142.63 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.0 112.844 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -130.59 129.21 42.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -137.24 145.98 44.25 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.71 -1.244 . . . . 0.0 109.442 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.1 p -131.18 136.58 57.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.64 -0.663 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.53 131.14 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.46 ' CG1' HD12 ' A' ' 93' ' ' ILE . 2.1 m -142.57 162.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 117.808 -1.557 . . . . 0.0 113.043 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 91' ' ' ASP . 13.9 tptp -127.55 155.32 43.99 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.527 ' HB2' ' H ' ' A' ' 18' ' ' THR . 11.5 p90 -108.18 149.54 28.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.842 -1.162 . . . . 0.0 111.638 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -127.02 -19.28 4.43 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -90.68 -56.76 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 10.1 t0 153.51 58.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.527 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 71.9 m -46.53 106.92 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.173 0.987 . . . . 0.0 112.795 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.567 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.39 89.13 1.6 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.8 m -61.2 -39.19 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.752 . . . . 0.0 110.467 -176.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 20' ' ' VAL . 89.3 m-20 -61.58 -45.4 94.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.554 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 21.8 mp0 -73.97 -37.82 64.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.528 HD11 HG21 ' A' ' 89' ' ' VAL . 1.9 mm -66.79 -48.88 78.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.1 tm? -58.22 -41.34 83.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.61 -25.71 68.35 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.697 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -65.37 -55.48 20.73 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 27' ' ' LEU . 7.0 tt -47.5 -35.75 9.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.514 -0.992 . . . . 0.0 108.826 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -53.52 -42.94 67.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -59.97 -42.32 93.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -52.7 -46.29 67.25 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 32' ' ' SER . 38.7 t -51.97 -23.95 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.248 -0.908 . . . . 0.0 108.843 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 44.3 t -44.34 -37.26 3.21 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.552 HE21 ' CG ' ' A' ' 76' ' ' HIS . 8.6 mm100 -79.87 -4.02 50.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.792 . . . . 0.0 111.457 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 34' ' ' ILE . 6.5 mm -88.42 23.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.107 -1.62 . . . . 0.0 110.652 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.38 -16.8 16.18 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.598 ' O ' ' C ' ' A' ' 37' ' ' VAL . 43.7 p -68.27 -2.65 8.68 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.937 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 36' ' ' THR . 31.2 m 30.32 41.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.049 -1.032 . . . . 0.0 109.185 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' THR . 4.2 mtmm -122.46 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 40' ' ' PHE . 28.8 t -72.74 -176.07 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' LYS . 82.3 m-85 -153.0 167.51 28.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.629 -1.294 . . . . 0.0 111.925 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.482 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 80.6 mt-10 -159.42 127.61 5.0 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.398 0.618 . . . . 0.0 110.193 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -129.54 171.36 12.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.15 24.46 Favored Glycine 0 N--CA 1.499 2.874 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.845 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.539 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 63.9 mt-10 -151.24 147.02 26.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -1.096 . . . . 0.0 109.391 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.6 t0 -130.85 157.58 42.49 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -61.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.405 -1.434 . . . . 0.0 109.813 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.8 mt-10 -126.69 40.62 3.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.683 -0.636 . . . . 0.0 109.333 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 49' ' ' HIS . 5.3 t -147.99 76.05 1.36 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.978 . . . . 0.0 110.219 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 48' ' ' SER . 1.4 t-80 56.83 114.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.767 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 57.2 t0 -45.13 -34.87 2.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.0 110.783 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.0 mmm -75.74 -34.04 60.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' B' ' 95' ' ' LEU . 63.3 mt -89.7 -18.5 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.706 -1.246 . . . . 0.0 109.291 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' GLY . 18.0 ptt180 -101.8 7.94 41.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.244 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 53' ' ' ARG . 68.3 mm-40 38.68 27.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.789 -1.195 . . . . 0.0 110.138 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 53.37 2.71 0.12 Allowed Glycine 0 N--CA 1.499 2.836 0 O-C-N 121.416 -0.803 . . . . 0.0 112.85 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 20.4 p90 -47.82 132.07 14.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.206 -1.761 . . . . 0.0 109.936 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 98.6 m -58.18 -55.05 40.02 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.928 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.637 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 17.0 t60 -167.85 153.89 7.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.926 -1.109 . . . . 0.0 110.188 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.559 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.62 162.15 35.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.206 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 57.8 m-85 -129.2 126.17 38.58 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.493 -0.755 . . . . 0.0 109.062 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -104.57 102.91 12.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.5 mtt -102.42 120.73 41.0 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.177 -0.952 . . . . 0.0 110.816 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 m -112.02 133.66 54.05 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -119.46 121.04 38.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.689 -1.257 . . . . 0.0 110.084 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 66' ' ' ASN . 0.6 OUTLIER -47.88 -31.55 5.22 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.587 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 18.2 t-20 -157.34 162.4 39.1 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.9 -24.26 64.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 111.465 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.24 -38.39 68.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 0.0 110.573 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.525 ' O ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.63 -33.59 84.93 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.881 ' O ' HG23 ' A' ' 74' ' ' THR . 77.7 t80 -66.56 -46.98 74.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.548 -0.972 . . . . 0.0 110.489 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.93 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.427 -1.421 . . . . 0.0 108.651 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -60.64 -34.85 74.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 111.147 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 70' ' ' TYR . 41.8 p -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.712 -1.243 . . . . 0.0 110.295 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -65.38 -24.15 67.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.18 -0.95 . . . . 0.0 110.986 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.636 ' C ' ' H ' ' A' ' 78' ' ' LEU . 57.5 m80 -79.86 124.58 83.21 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.81 -1.181 . . . . 0.0 109.603 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.59 2.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.636 ' H ' ' C ' ' A' ' 76' ' ' HIS . 6.7 tp -76.37 -34.41 58.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.307 -0.871 . . . . 0.0 111.24 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 58.0 t-80 -82.66 -33.44 27.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 0.0 110.327 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.93 -60.25 2.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.79 -42.97 65.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 17.6 m-85 -72.17 -34.14 68.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.754 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 67.0 m -60.87 -43.04 98.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 110.13 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -41.96 97.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.978 -1.076 . . . . 0.0 108.673 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.666 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -68.4 -43.08 78.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.933 ' O ' HD13 ' A' ' 90' ' ' ILE . 2.7 m-85 -44.8 -30.25 0.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.1 p -82.26 -62.2 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.578 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -38.64 -28.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.654 -0.654 . . . . 0.0 110.052 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 85' ' ' ALA . 23.3 m -106.35 14.58 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 110.767 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.933 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -124.81 160.2 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.672 -1.268 . . . . 0.0 110.467 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.551 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 58.7 t0 -105.53 -35.95 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -145.95 145.29 30.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' A' ' 12' ' ' VAL . 3.0 tp -126.11 124.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.672 -1.267 . . . . 0.0 109.744 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t -127.24 130.07 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -130.98 127.22 37.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.325 -1.485 . . . . 0.0 111.759 -178.183 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -118.8 122.46 42.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.653 -0.654 . . . . 0.0 109.358 177.043 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASP . 23.1 p-10 -130.2 138.94 50.84 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.11 -0.994 . . . . 0.0 108.864 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 32.3 t80 -159.43 134.71 5.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.075 -1.015 . . . . 0.0 110.52 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 94.9 Cg_exo -42.46 125.57 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.318 2.012 . . . . 0.0 112.19 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.6 t -89.99 116.05 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.29 82.81 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.368 -0.832 . . . . 0.0 109.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -74.37 72.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 102' ' ' ALA . 5.3 m -161.91 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 25.9 mmtp -92.98 141.57 28.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.1 p -67.65 -25.3 65.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 108.958 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 106' ' ' SER . 5.9 p 61.85 50.88 4.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.83 135.88 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.0 t -51.54 140.47 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.533 -0.73 . . . . 0.0 109.467 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.76 100.48 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.2 p -134.53 69.75 72.52 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.918 -1.114 . . . . 0.0 109.611 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo . . . . . 0 C--N 1.307 -1.606 0 C-N-CA 122.812 2.342 . . . . 0.0 112.283 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.95 57.8 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.365 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.408 ' O ' ' OG ' ' B' ' 4' ' ' SER . 7.4 t -115.86 0.69 13.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.133 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 3' ' ' THR . 31.2 m -175.07 -126.23 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 100' ' ' VAL . . . -95.39 172.96 30.83 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.368 -1.396 . . . . 0.0 109.703 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -135.52 136.43 41.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.283 -1.128 . . . . 0.0 108.07 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 44' ' ' GLU . 20.7 ttpt -114.72 142.61 46.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.075 . . . . 0.0 112.809 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -130.5 129.29 42.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.1 tt -137.29 145.94 44.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.821 -1.175 . . . . 0.0 109.439 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.409 HG13 ' O ' ' B' ' 10' ' ' VAL . 11.0 p -131.2 136.66 57.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.467 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.64 131.16 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.46 ' CG1' HD12 ' B' ' 93' ' ' ILE . 2.1 m -142.68 162.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.08 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -127.6 155.27 44.11 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.545 ' HB2' ' H ' ' B' ' 18' ' ' THR . 11.5 p90 -108.2 149.48 28.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.827 -1.17 . . . . 0.0 111.59 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -127.03 -19.41 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.2 mt-10 -90.64 -56.65 3.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 9.7 t0 153.29 58.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.545 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 68.2 m -46.59 106.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.03 0.919 . . . . 0.0 112.89 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -73.42 89.35 1.63 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.8 m -61.56 -38.91 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 110.465 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.512 ' N ' HG23 ' B' ' 20' ' ' VAL . 90.6 m-20 -61.66 -45.4 94.2 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 110.512 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 21.6 mp0 -74.15 -37.59 63.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.536 HD11 HG21 ' B' ' 89' ' ' VAL . 1.9 mm -67.07 -48.94 77.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.858 ' C ' HD13 ' B' ' 24' ' ' LEU . 2.1 tm? -58.0 -41.65 83.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.4 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.703 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -65.34 -55.54 20.46 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.655 HD23 ' O ' ' B' ' 27' ' ' LEU . 7.0 tt -47.42 -35.73 8.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.541 -0.976 . . . . 0.0 108.811 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -53.49 -43.22 68.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.8 p30 -59.83 -42.23 93.06 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.61 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -52.84 -46.15 67.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' B' ' 32' ' ' SER . 38.7 t -52.0 -23.93 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.292 -0.88 . . . . 0.0 108.859 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 43.5 t -44.33 -37.39 3.28 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.558 HE21 ' CG ' ' B' ' 76' ' ' HIS . 8.6 mm100 -79.71 -4.29 51.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 111.466 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.716 HG22 ' O ' ' B' ' 34' ' ' ILE . 6.3 mm -88.24 23.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 119.947 -1.721 . . . . 0.0 110.61 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.44 -16.65 15.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' B' ' 37' ' ' VAL . 44.1 p -68.28 -2.82 9.04 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.932 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' B' ' 36' ' ' THR . 31.3 m 30.55 41.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' B' ' 40' ' ' PHE . 4.1 mtmm -122.4 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' B' ' 40' ' ' PHE . 28.9 t -72.62 -176.16 1.87 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' B' ' 38' ' ' LYS . 82.4 m-85 -152.99 167.47 29.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.542 -1.349 . . . . 0.0 111.991 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 81.0 mt-10 -159.36 127.44 4.98 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.298 0.57 . . . . 0.0 110.227 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.404 ' HE1' ' HA ' ' A' ' 102' ' ' ALA . 16.7 m-90 -129.46 171.49 12.5 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.2 162.13 24.49 Favored Glycine 0 N--CA 1.5 2.961 0 C-N-CA 118.689 -1.72 . . . . 0.0 110.768 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.544 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 63.1 mt-10 -151.3 146.84 26.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.294 -1.121 . . . . 0.0 109.392 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' B' ' 47' ' ' GLU . 63.3 t0 -130.71 157.47 42.71 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.529 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.07 80.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.378 -1.451 . . . . 0.0 109.825 -177.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -126.68 40.51 3.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.503 ' O ' ' O ' ' B' ' 49' ' ' HIS . 5.4 t -147.85 76.45 1.39 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.169 -0.957 . . . . 0.0 110.173 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.503 ' O ' ' O ' ' B' ' 48' ' ' SER . 1.4 t-80 56.59 114.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.195 -0.941 . . . . 0.0 109.676 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' NE ' ' B' ' 53' ' ' ARG . 57.9 t0 -45.14 -34.88 2.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 93.0 mmm -75.65 -33.9 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.7 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 95' ' ' LEU . 62.6 mt -89.69 -18.7 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.776 -1.202 . . . . 0.0 109.253 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' B' ' 55' ' ' GLY . 18.0 ptt180 -101.78 7.91 41.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.847 . . . . 0.0 111.26 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' B' ' 53' ' ' ARG . 68.8 mm-40 38.68 27.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.803 -1.186 . . . . 0.0 110.214 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 53.31 2.79 0.11 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.37 -0.831 . . . . 0.0 112.791 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 20.1 p90 -47.96 132.08 15.28 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.193 -1.769 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 99.7 m -57.98 -55.27 37.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.325 -0.859 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 17.3 t60 -167.77 153.9 7.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.887 -1.133 . . . . 0.0 110.193 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.543 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.62 162.07 35.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.477 -0.764 . . . . 0.0 109.287 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 57.8 m-85 -129.05 126.05 38.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.11 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -104.48 102.68 12.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 39.7 mtt -102.36 120.9 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 110.673 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 37.9 m -112.02 134.13 53.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' B' ' 64' ' ' PHE . 2.2 m-85 -119.81 121.37 38.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.741 -1.224 . . . . 0.0 109.999 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' B' ' 66' ' ' ASN . 0.6 OUTLIER -48.26 -31.47 5.96 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.581 ' H ' ' CD ' ' B' ' 65' ' ' GLU . 18.0 t-20 -157.32 162.25 39.13 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.7 -24.43 63.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.512 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -55.04 -38.67 68.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.597 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' B' ' 73' ' ' PHE . . . -66.22 -33.7 85.94 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.882 ' O ' HG23 ' B' ' 74' ' ' THR . 77.8 t80 -66.61 -47.04 73.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.566 -0.961 . . . . 0.0 110.495 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.73 -28.99 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.356 -1.465 . . . . 0.0 108.67 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.0 -60.86 2.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.338 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -60.57 -34.92 74.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.245 -0.909 . . . . 0.0 111.088 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.882 HG23 ' O ' ' B' ' 70' ' ' TYR . 42.0 p -73.86 -33.32 64.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.776 -1.203 . . . . 0.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -65.56 -24.31 67.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.0 111.053 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.635 ' C ' ' H ' ' B' ' 78' ' ' LEU . 57.6 m80 -79.58 124.62 83.68 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.829 -1.169 . . . . 0.0 109.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -46.77 2.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.609 2.206 . . . . 0.0 112.446 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.635 ' H ' ' C ' ' B' ' 76' ' ' HIS . 6.7 tp -76.42 -34.51 58.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.348 -0.845 . . . . 0.0 111.238 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.512 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 57.9 t-80 -82.47 -33.47 28.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.037 -1.039 . . . . 0.0 110.324 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.04 -60.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.92 -42.7 65.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.64 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 17.6 m-85 -72.29 -34.23 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.512 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 65.3 m -60.86 -42.99 98.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.048 . . . . 0.0 110.098 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.08 97.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 108.661 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.681 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -68.39 -42.93 78.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.939 ' O ' HD13 ' B' ' 90' ' ' ILE . 2.7 m-85 -44.9 -30.22 0.96 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.1 p -82.26 -62.21 1.69 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.577 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -38.66 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.691 -0.63 . . . . 0.0 110.099 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.681 HG22 ' O ' ' B' ' 85' ' ' ALA . 23.1 m -106.22 14.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.207 -0.933 . . . . 0.0 110.829 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.939 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -124.63 160.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.7 -1.25 . . . . 0.0 110.467 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 58.3 t0 -105.46 -36.02 7.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -145.93 145.24 30.6 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' B' ' 12' ' ' VAL . 3.0 tp -126.15 124.1 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.571 -1.331 . . . . 0.0 109.798 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 14.4 t -127.29 130.2 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -131.06 126.9 37.08 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.244 -1.535 . . . . 0.0 111.809 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.554 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -118.55 122.72 43.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.083 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.443 ' OD2' ' OG ' ' A' ' 48' ' ' SER . 23.0 p-10 -130.43 138.85 50.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.175 -0.953 . . . . 0.0 108.853 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 32.2 t80 -159.42 134.6 5.75 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.048 -1.032 . . . . 0.0 110.541 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 96.5 Cg_exo -42.36 125.67 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.29 1.993 . . . . 0.0 112.244 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 5' ' ' GLY . 27.4 t -89.96 116.11 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.44 82.85 2.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ALA . . . . . 0.675 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -74.27 71.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.602 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.675 HG13 ' O ' ' B' ' 102' ' ' ALA . 5.5 m -161.58 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.33 -0.856 . . . . 0.0 109.263 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -92.88 141.6 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 85.9 p -67.44 -25.58 65.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 108.944 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' B' ' 106' ' ' SER . 6.1 p 62.06 50.73 3.91 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.32 -0.863 . . . . 0.0 109.355 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.78 136.15 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.442 ' H ' HG23 ' B' ' 108' ' ' VAL . 15.5 t -51.92 140.52 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.429 -0.794 . . . . 0.0 109.501 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.69 100.39 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 17.2 p -134.47 69.64 72.8 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.82 -1.175 . . . . 0.0 109.634 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo . . . . . 0 C--N 1.308 -1.582 0 C-N-CA 122.76 2.307 . . . . 0.0 112.219 179.938 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.279 0.562 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.54 57.53 6.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 109.375 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 t -98.32 -12.24 21.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.141 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.7 m -127.79 -81.94 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.08 -168.91 16.91 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.664 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -114.43 130.76 56.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.241 -1.152 . . . . 0.0 108.09 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HZ3' ' HB3' ' B' ' 44' ' ' GLU . 21.9 ttpt -101.09 129.66 47.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.908 -1.12 . . . . 0.0 112.824 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.725 ' CE1' ' OD2' ' A' ' 97' ' ' ASP . 0.3 OUTLIER -121.59 119.86 33.13 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 173.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 96' ' ' LEU . 6.6 tt -132.51 141.57 48.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.679 -1.263 . . . . 0.0 109.48 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 10' ' ' VAL . 9.5 p -129.35 136.11 60.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.614 -0.679 . . . . 0.0 109.523 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.27 131.0 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.843 HG12 HD12 ' A' ' 93' ' ' ILE . 35.8 m -139.32 150.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.816 -1.554 . . . . 0.0 113.095 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -127.83 154.74 45.1 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CD2' HG21 ' A' ' 57' ' ' THR . 16.2 p90 -113.04 156.8 22.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.814 -1.178 . . . . 0.0 111.615 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.36 -18.62 3.58 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.8 mt-10 -91.81 -53.49 4.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.1 t0 149.12 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -53.98 111.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.059 0.933 . . . . 0.0 112.814 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.587 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -74.07 86.36 1.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.043 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 21' ' ' ASP . 33.2 m -61.55 -42.59 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.553 -0.717 . . . . 0.0 110.547 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' N ' HG23 ' A' ' 20' ' ' VAL . 87.3 m-20 -63.45 -45.16 92.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.539 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -68.79 -34.01 74.82 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -67.94 -42.02 85.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.5 tp -58.95 -39.36 81.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -61.15 -35.48 77.21 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.656 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.44 -53.23 40.54 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -44.09 -41.44 5.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.517 -0.99 . . . . 0.0 108.821 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -51.98 -39.12 58.87 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -63.59 -44.49 93.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.649 HD22 ' CD2' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -47.15 -48.42 23.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.466 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 32' ' ' SER . 86.3 t -55.47 -24.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 0.0 108.873 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 32.2 t -43.44 -43.4 5.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.05 -10.06 48.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 111.433 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.726 HG22 ' O ' ' A' ' 34' ' ' ILE . 64.5 mt -92.5 29.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.024 -1.672 . . . . 0.0 110.626 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.91 -8.08 2.04 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.579 ' H ' ' C ' ' A' ' 34' ' ' ILE . 68.2 p -67.5 -10.24 49.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.939 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.55 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 35.3 34.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 109.219 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.3 mttt -118.17 43.94 2.33 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 63' ' ' THR . 14.2 t -176.22 177.59 1.52 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 0.0 111.914 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 64.2 mt-10 -154.33 124.07 6.66 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.366 0.603 . . . . 0.0 110.207 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.532 ' CE2' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -127.39 169.17 13.89 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.001 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.45 138.44 6.42 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.794 -1.67 . . . . 0.0 110.838 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' OE2' ' CE2' ' A' ' 42' ' ' TRP . 4.4 mp0 -124.92 172.63 9.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.209 -1.171 . . . . 0.0 109.323 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 57' ' ' THR . 57.0 t0 -167.58 94.61 0.43 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HZ1' ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.15 170.89 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.471 -1.393 . . . . 0.0 109.78 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 48' ' ' SER . 2.4 mt-10 -172.77 90.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER 163.14 147.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 0.0 110.138 -179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 48' ' ' SER . 57.5 m170 57.95 113.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.204 -0.935 . . . . 0.0 109.7 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 51' ' ' MET . 29.0 p-10 -52.53 -43.41 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.313 -0.867 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 23.2 ttt -62.56 -35.03 78.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 17.2 mt -89.08 -20.03 24.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.763 -1.211 . . . . 0.0 109.305 177.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.97 ' O ' ' N ' ' A' ' 55' ' ' GLY . 34.0 ttt-85 -83.83 42.54 0.86 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.384 -0.823 . . . . 0.0 111.217 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.559 ' C ' ' O ' ' A' ' 53' ' ' ARG . 6.6 tt0 -31.41 -12.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.739 -1.225 . . . . 0.0 110.195 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.97 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 105.66 -35.79 4.83 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.385 -0.822 . . . . 0.0 112.93 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -55.39 102.82 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.294 -1.709 . . . . 0.0 109.956 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.636 HG21 ' CD2' ' A' ' 14' ' ' PHE . 49.1 p -61.99 -34.48 76.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.952 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.596 ' ND1' ' OG1' ' A' ' 57' ' ' THR . 34.7 p-80 -171.74 149.9 2.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.853 -1.154 . . . . 0.0 110.182 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.35 170.87 14.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.434 -0.791 . . . . 0.0 109.26 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -138.64 134.96 34.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.494 ' HB2' ' HE1' ' A' ' 42' ' ' TRP . 10.2 t -111.22 106.24 15.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' HIS . 67.6 mtt -95.67 119.98 35.12 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.826 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.467 ' O ' ' OG ' ' A' ' 39' ' ' SER . 32.0 m -116.59 141.78 47.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -121.29 152.46 38.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.742 -1.224 . . . . 0.0 110.073 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -86.27 -23.92 26.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -162.47 165.86 25.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -69.15 -24.73 64.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 0.0 111.446 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.1 -40.61 98.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.825 -1.172 . . . . 0.0 110.602 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . -72.1 -33.44 62.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.655 ' O ' HG22 ' A' ' 74' ' ' THR . 25.1 t80 -66.32 -43.0 87.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.589 -0.948 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.1 m -70.84 -28.89 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.449 -1.407 . . . . 0.0 108.658 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 69' ' ' GLY . 1.1 m-85 -54.72 -35.42 63.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -0.897 . . . . 0.0 111.084 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.9 t -85.57 -28.93 24.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.739 -1.226 . . . . 0.0 110.327 -177.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 73.6 m -66.21 -34.64 78.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.997 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -61.31 151.53 76.18 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.76 -1.213 . . . . 0.0 109.61 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.07 -7.75 20.74 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.652 2.235 . . . . 0.0 112.407 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 30' ' ' LEU . 7.3 tt -76.97 -27.92 54.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.395 -0.816 . . . . 0.0 111.218 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -81.73 -35.53 29.62 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 81' ' ' GLU . 6.7 p -70.2 -56.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.006 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.726 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.96 84.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.619 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -59.17 -42.78 91.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.804 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.7 p -65.73 -30.63 71.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 110.106 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.85 -55.19 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 108.687 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.468 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -66.62 -39.35 88.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.428 ' O ' HG12 ' A' ' 90' ' ' ILE . 23.8 t80 -46.47 -25.42 0.67 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.4 m -83.56 -63.62 1.32 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.01 -33.39 0.31 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.719 -0.613 . . . . 0.0 110.067 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 85' ' ' ALA . 6.8 m -92.66 14.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -0.897 . . . . 0.0 110.815 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.636 HD12 ' HB ' ' A' ' 12' ' ' VAL . 26.5 mm -132.35 163.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.609 -1.307 . . . . 0.0 110.412 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 90' ' ' ILE . 34.7 t0 -113.9 -33.73 5.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -132.87 129.54 38.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.843 HD12 HG12 ' A' ' 12' ' ' VAL . 7.0 tp -128.79 130.44 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.579 -1.326 . . . . 0.0 109.762 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.403 HG11 ' OE1' ' B' ' 54' ' ' GLN . 14.4 p -146.95 148.07 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -135.85 129.86 33.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.276 -1.515 . . . . 0.0 111.804 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.901 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -112.73 119.57 38.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.669 -0.644 . . . . 0.0 109.346 178.311 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.725 ' OD2' ' CE1' ' A' ' 8' ' ' HIS . 54.1 t0 -128.33 135.76 50.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.052 -1.03 . . . . 0.0 108.847 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.511 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 36.3 t80 -166.76 140.64 3.24 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 110.54 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.03 106.99 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.266 1.978 . . . . 0.0 112.249 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 100' ' ' VAL . 1.9 p -88.49 128.8 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 109.952 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.76 94.71 4.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.654 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.45 150.59 25.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.091 -1.006 . . . . 0.0 109.562 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 -21.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 109.133 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.696 ' C ' ' H ' ' A' ' 106' ' ' SER . 18.0 mmtp 54.03 -141.74 0.84 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.366 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.97 -12.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 108.961 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.696 ' H ' ' C ' ' A' ' 104' ' ' LYS . 83.7 p -52.46 152.64 3.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.756 HG13 HG12 ' A' ' 108' ' ' VAL . 7.4 p -140.29 166.03 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.756 HG12 HG13 ' A' ' 107' ' ' VAL . 5.1 p 32.53 72.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.733 . . . . 0.0 109.545 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.8 174.01 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.6 m -70.72 132.78 86.89 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 120.848 -1.158 . . . . 0.0 109.673 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 C--N 1.308 -1.574 0 C-N-CA 122.795 2.33 . . . . 0.0 112.228 179.659 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.32 0.581 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.43 57.67 5.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 0.0 109.339 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.5 t -98.48 -12.26 21.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.106 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m -127.76 -82.02 0.6 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.94 -168.98 16.89 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.684 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.5 130.52 56.75 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -1.149 . . . . 0.0 108.014 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 22.1 ttpt -100.91 129.71 46.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.975 -1.078 . . . . 0.0 112.838 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.721 ' CE1' ' OD2' ' B' ' 97' ' ' ASP . 0.3 OUTLIER -121.52 119.56 32.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.535 HD22 HD13 ' B' ' 96' ' ' LEU . 6.5 tt -132.07 141.67 49.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.713 -1.242 . . . . 0.0 109.56 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.412 ' O ' HG13 ' B' ' 10' ' ' VAL . 9.7 p -129.25 136.34 59.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.485 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.4 131.02 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.848 HG12 HD12 ' B' ' 93' ' ' ILE . 35.9 m -139.22 150.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 117.706 -1.597 . . . . 0.0 113.046 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -127.91 154.98 44.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD2' HG21 ' B' ' 57' ' ' THR . 15.4 p90 -113.34 156.68 22.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.815 -1.178 . . . . 0.0 111.596 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.27 -18.8 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.6 mt-10 -91.73 -53.65 4.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.4 t0 149.2 65.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.8 m -54.14 112.02 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.114 0.959 . . . . 0.0 112.825 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.575 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.11 86.47 1.87 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.577 HG23 ' N ' ' B' ' 21' ' ' ASP . 33.0 m -61.86 -42.42 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.622 -0.674 . . . . 0.0 110.477 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.577 ' N ' HG23 ' B' ' 20' ' ' VAL . 87.5 m-20 -63.5 -45.03 92.57 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 110.535 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -68.87 -34.43 75.43 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -67.49 -42.11 86.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' B' ' 20' ' ' VAL . 16.5 tp -58.89 -39.51 81.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -60.87 -35.67 77.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.66 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -63.29 -53.32 40.39 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 26' ' ' GLY . 5.9 tt -44.11 -41.28 5.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.989 . . . . 0.0 108.846 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -51.99 -39.07 58.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 0.7 OUTLIER -63.82 -44.17 94.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.59 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.64 HD22 ' CD2' ' B' ' 78' ' ' LEU . 0.5 OUTLIER -47.59 -47.91 28.35 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 32' ' ' SER . 84.4 t -55.84 -24.47 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 32.5 t -43.65 -43.38 5.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.07 -9.83 49.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.436 -0.79 . . . . 0.0 111.479 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.733 HG22 ' O ' ' B' ' 34' ' ' ILE . 62.8 mt -92.59 28.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.003 -1.685 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.84 -8.01 1.95 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' C ' ' B' ' 37' ' ' VAL . 66.1 p -67.61 -10.2 49.89 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.945 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.58 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.6 m 35.27 35.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.032 -1.043 . . . . 0.0 109.181 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 36' ' ' THR . 66.4 mttt -118.22 43.99 2.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' B' ' 63' ' ' THR . 14.4 t -176.27 177.7 1.48 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.02 156.0 42.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.541 -1.349 . . . . 0.0 112.007 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.452 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 63.8 mt-10 -154.09 124.23 6.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.354 0.597 . . . . 0.0 110.259 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.54 ' CE2' ' OE2' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -127.51 168.92 14.27 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.26 138.34 6.4 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.75 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.54 ' OE2' ' CE2' ' B' ' 42' ' ' TRP . 4.4 mp0 -124.71 173.16 8.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.233 -1.157 . . . . 0.0 109.434 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' B' ' 57' ' ' THR . 57.1 t0 -168.12 94.55 0.39 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HZ2' ' HA ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -89.0 170.73 10.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.446 -1.409 . . . . 0.0 109.825 179.115 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' B' ' 48' ' ' SER . 2.3 mt-10 -172.58 90.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER 163.46 148.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' B' ' 48' ' ' SER . 57.9 m170 57.7 113.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 109.693 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 28.7 p-10 -52.49 -43.53 65.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.781 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 23.3 ttt -62.34 -35.17 78.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 110.723 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' NZ ' ' B' ' 46' ' ' LYS . 17.0 mt -89.04 -19.91 25.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.336 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.953 ' O ' ' N ' ' B' ' 55' ' ' GLY . 34.1 ttt-85 -83.99 42.65 0.88 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -0.854 . . . . 0.0 111.194 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.56 ' C ' ' O ' ' B' ' 53' ' ' ARG . 6.7 tt0 -31.53 -12.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.862 -1.149 . . . . 0.0 110.274 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.953 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 105.88 -36.11 4.62 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.454 -0.779 . . . . 0.0 112.857 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.809 ' CG ' ' O ' ' B' ' 56' ' ' PHE . 0.7 OUTLIER -55.04 102.8 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.302 -1.705 . . . . 0.0 109.987 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.639 HG21 ' CD2' ' B' ' 14' ' ' PHE . 49.2 p -61.78 -34.81 76.55 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.307 -0.871 . . . . 0.0 111.015 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.575 ' HE2' HD11 ' B' ' 90' ' ' ILE . 33.9 p-80 -171.35 150.3 2.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 110.148 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.65 170.8 15.16 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.262 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -138.59 134.9 34.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.439 -0.788 . . . . 0.0 109.128 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.498 ' HB2' ' HE1' ' B' ' 42' ' ' TRP . 10.0 t -111.16 106.24 15.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' MET . . . . . 0.475 ' N ' ' O ' ' B' ' 8' ' ' HIS . 67.7 mtt -95.57 120.33 35.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.149 -0.97 . . . . 0.0 110.833 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.507 ' O ' ' OG ' ' B' ' 39' ' ' SER . 32.5 m -116.96 141.72 47.87 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -121.27 152.1 39.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.695 -1.253 . . . . 0.0 110.047 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -85.94 -23.76 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -162.65 166.08 24.98 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -69.35 -24.66 63.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 111.453 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.44 -40.29 96.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.865 -1.147 . . . . 0.0 110.604 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.553 ' O ' ' CE2' ' B' ' 73' ' ' PHE . . . -71.99 -33.78 62.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.648 ' O ' HG22 ' B' ' 74' ' ' THR . 25.2 t80 -66.15 -43.05 88.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.512 -0.993 . . . . 0.0 110.426 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.3 m -70.83 -28.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.412 -1.43 . . . . 0.0 108.626 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.99 2.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.358 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.553 ' CE2' ' O ' ' B' ' 69' ' ' GLY . 1.1 m-85 -54.6 -35.56 63.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.287 -0.883 . . . . 0.0 111.089 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.648 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.9 t -85.49 -29.0 24.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.822 -1.174 . . . . 0.0 110.347 -177.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 73.8 m -66.11 -34.78 78.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.982 . . . . 0.0 111.056 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -61.11 151.81 73.91 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.24 -7.86 21.23 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.611 2.207 . . . . 0.0 112.499 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.64 ' CD2' HD22 ' B' ' 30' ' ' LEU . 7.3 tt -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -0.797 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -81.37 -35.65 30.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 110.281 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.726 HG13 ' H ' ' B' ' 81' ' ' GLU . 6.9 p -70.26 -56.67 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.726 ' H ' HG13 ' B' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.89 84.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.15 -42.77 91.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.849 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 88.0 p -65.82 -30.55 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.991 . . . . 0.0 110.069 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.85 36.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 0.0 108.705 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.479 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -66.96 -39.24 87.2 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' B' ' 85' ' ' ALA . 24.0 t80 -46.73 -25.05 0.66 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.427 ' N ' ' C ' ' B' ' 85' ' ' ALA . 5.7 m -83.91 -63.48 1.34 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.07 -33.18 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.771 -0.581 . . . . 0.0 110.086 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 85' ' ' ALA . 7.0 m -92.89 14.83 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.173 -0.954 . . . . 0.0 110.811 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.625 HG22 ' N ' ' B' ' 91' ' ' ASP . 26.2 mm -132.43 164.16 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.651 -1.281 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.625 ' N ' HG22 ' B' ' 90' ' ' ILE . 34.8 t0 -114.07 -33.71 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -132.94 129.58 38.47 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.848 HD12 HG12 ' B' ' 12' ' ' VAL . 7.1 tp -128.83 130.56 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.516 -1.365 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.401 HG11 ' OE1' ' A' ' 54' ' ' GLN . 14.4 p -147.06 147.94 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.501 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -135.86 130.03 33.27 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.237 -1.54 . . . . 0.0 111.759 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.898 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.1 OUTLIER -112.85 119.42 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.325 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.721 ' OD2' ' CE1' ' B' ' 8' ' ' HIS . 54.7 t0 -128.24 135.7 50.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.107 -0.996 . . . . 0.0 108.918 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.492 ' N ' ' OD1' ' B' ' 97' ' ' ASP . 36.1 t80 -166.7 140.65 3.28 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.111 -0.993 . . . . 0.0 110.49 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.95 106.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.273 1.982 . . . . 0.0 112.264 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.441 ' H ' HG12 ' B' ' 100' ' ' VAL . 1.9 p -88.38 128.67 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.121 -0.987 . . . . 0.0 110.079 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.65 94.74 4.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.511 -0.743 . . . . 0.0 109.554 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 0.0 109.62 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.52 -21.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.21 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.703 ' C ' ' H ' ' B' ' 106' ' ' SER . 18.1 mmtp 54.45 -141.87 0.83 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.28 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.89 -12.7 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.143 -0.973 . . . . 0.0 108.916 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.703 ' H ' ' C ' ' B' ' 104' ' ' LYS . 83.5 p -52.49 152.44 3.57 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.738 HG13 HG12 ' B' ' 108' ' ' VAL . 7.4 p -140.16 165.57 21.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.738 HG12 HG13 ' B' ' 107' ' ' VAL . 5.0 p 32.96 72.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.61 174.26 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.293 -0.879 . . . . 0.0 108.635 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 22.0 m -71.07 132.69 86.27 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 120.8 -1.187 . . . . 0.0 109.606 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 0 C--N 1.307 -1.623 0 C-N-CA 122.796 2.33 . . . . 0.0 112.267 179.708 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.686 ' O ' ' N ' ' A' ' 3' ' ' THR . 7.4 ptp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.31 0.576 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.681 ' O ' HG22 ' A' ' 3' ' ' THR . . . 60.0 -62.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.362 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.686 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.5 OUTLIER 74.77 -2.81 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.116 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.3 m -174.65 -129.13 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.94 168.59 26.19 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.653 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.91 128.14 47.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -1.15 . . . . 0.0 108.028 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 4.3 ttpm? -106.5 134.66 49.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 112.885 -177.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -126.17 124.48 40.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -131.76 142.03 49.65 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.678 -1.264 . . . . 0.0 109.526 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.08 138.21 53.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.482 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.83 131.69 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.19 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 117.88 -1.528 . . . . 0.0 113.071 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -127.49 147.74 50.31 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.798 ' CB ' ' H ' ' A' ' 18' ' ' THR . 17.7 t80 -111.31 158.88 18.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.0 111.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.694 ' HG3' ' H ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.42 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.694 ' H ' ' HG3' ' A' ' 15' ' ' LYS . 83.6 mt-10 -85.95 -49.99 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.457 ' H ' ' HD2' ' A' ' 14' ' ' PHE . 6.5 t0 160.31 98.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' A' ' 14' ' ' PHE . 3.4 m -51.43 153.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.121 0.963 . . . . 0.0 112.84 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.561 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -77.84 87.69 4.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.32 -33.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.507 -0.746 . . . . 0.0 110.517 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.74 -42.02 86.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.443 -0.785 . . . . 0.0 110.508 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 70.7 mm-40 -67.64 -30.31 69.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 89' ' ' VAL . 1.3 mm -70.9 -37.46 68.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -54.12 -36.87 63.71 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -35.46 80.37 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.95 -54.58 17.18 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -47.96 41.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.5 -1.0 . . . . 0.0 108.883 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.08 -43.61 70.48 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.647 ' ND2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -65.0 -47.52 77.23 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -49.27 -44.64 44.0 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.7 t -55.62 -25.02 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.28 -0.887 . . . . 0.0 108.866 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 51.0 m -43.27 -39.09 2.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.425 ' OE1' ' CG ' ' A' ' 76' ' ' HIS . 99.5 mm-40 -67.55 0.89 2.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 111.425 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 34' ' ' ILE . 72.2 mt -108.17 26.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.074 -1.641 . . . . 0.0 110.607 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -60.42 -8.42 2.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.609 ' O ' ' C ' ' A' ' 37' ' ' VAL . 29.4 p -84.21 0.23 49.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.964 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.609 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.3 m 30.26 38.99 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.29 3.59 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 t -174.07 178.27 2.16 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 91.9 m-85 -144.53 154.49 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 111.993 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.499 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 81.0 mt-10 -158.01 127.46 5.86 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.342 0.591 . . . . 0.0 110.267 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -133.43 172.59 12.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' B' ' 98' ' ' PHE . . . -131.89 163.87 23.75 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.816 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.668 ' N ' ' CE1' ' A' ' 58' ' ' HIS . 18.9 mt-10 -149.49 142.54 24.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.247 -1.149 . . . . 0.0 109.34 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.587 ' CG ' ' HD1' ' A' ' 58' ' ' HIS . 42.2 m-20 -125.63 155.79 40.22 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 81.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.395 -1.44 . . . . 0.0 109.771 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.7 mt-10 -103.04 39.33 1.57 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 97' ' ' ASP . 11.7 m -142.75 168.33 19.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 0.0 110.129 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ARG . 78.0 m80 -48.37 140.79 7.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.134 -0.979 . . . . 0.0 109.757 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 78.7 m-20 -44.48 -46.4 9.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.759 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 110.732 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 43.5 mt -102.0 -19.12 15.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.713 -1.242 . . . . 0.0 109.241 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.832 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -72.25 -5.34 35.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.905 . . . . 0.0 111.217 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.62 -8.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.827 -1.17 . . . . 0.0 110.149 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.832 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 72.77 -13.16 3.23 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.386 -0.821 . . . . 0.0 112.844 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 3.5 p90 -59.54 129.9 44.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.308 -1.701 . . . . 0.0 109.985 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.9 p -54.07 -43.04 69.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.88 . . . . 0.0 111.008 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.668 ' CE1' ' N ' ' A' ' 44' ' ' GLU . 19.0 t60 -173.36 159.4 3.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.143 . . . . 0.0 110.147 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.649 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.07 167.9 21.0 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 0.0 109.208 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 81.0 m-85 -132.94 129.48 38.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.114 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.2 m -106.6 100.72 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.9 mtm -104.79 129.14 53.1 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.19 -0.944 . . . . 0.0 110.745 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -126.48 143.44 51.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 65' ' ' GLU . 93.1 m-85 -124.5 130.13 51.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.679 -1.263 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' PHE . 84.6 tt0 -47.93 -33.82 8.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -161.54 166.37 27.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -55.27 -22.47 18.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 111.459 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD2' ' NZ ' ' A' ' 38' ' ' LYS . 22.9 t70 -53.63 -40.49 65.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.791 -1.193 . . . . 0.0 110.651 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.01 -36.16 64.55 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.647 ' O ' HG22 ' A' ' 74' ' ' THR . 56.6 t80 -64.39 -44.16 92.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.631 -0.923 . . . . 0.0 110.472 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.77 -28.9 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.331 -1.481 . . . . 0.0 108.68 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.86 2.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -59.12 -46.7 87.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 111.08 -177.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 70' ' ' TYR . 11.6 t -69.84 -36.13 75.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.747 -1.22 . . . . 0.0 110.307 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.413 ' N ' HG23 ' A' ' 74' ' ' THR . 78.0 p -65.43 -27.21 68.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -0.98 . . . . 0.0 110.941 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 55.3 m80 -72.17 151.29 92.41 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.836 -1.165 . . . . 0.0 109.562 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.98 -5.35 16.13 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 5.6 tp -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 111.198 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 83' ' ' SER . 11.1 t-160 -82.61 -40.75 20.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.074 -1.016 . . . . 0.0 110.241 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.35 -61.72 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.998 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -53.16 -38.07 62.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.612 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.647 ' CZ ' ' ND2' ' A' ' 29' ' ' ASN . 8.1 m-85 -74.37 -33.62 63.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.838 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' HIS . 21.2 t -61.23 -44.09 97.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 110.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.35 96.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.99 -1.069 . . . . 0.0 108.667 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.19 -43.42 78.14 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.22 -31.64 0.64 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 89' ' ' VAL . 22.3 m -80.43 -62.25 1.73 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.97 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.3 m -113.95 7.26 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 91' ' ' ASP . 60.9 mt -123.5 157.72 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.656 -1.277 . . . . 0.0 110.452 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.483 ' N ' HG22 ' A' ' 90' ' ' ILE . 22.5 t70 -108.37 -30.28 8.4 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -145.59 142.98 29.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' ILE . 4.0 tp -125.39 123.51 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.635 -1.29 . . . . 0.0 109.852 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 t -126.05 131.59 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -138.3 133.24 32.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.207 -1.558 . . . . 0.0 111.793 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -121.16 126.58 50.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.307 178.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 64.8 t0 -124.69 130.43 52.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.085 -1.009 . . . . 0.0 108.952 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.648 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -157.65 124.23 2.55 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.035 -1.041 . . . . 0.0 110.501 -179.178 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.648 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 79.8 Cg_exo -45.01 133.68 11.03 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.287 1.991 . . . . 0.0 112.235 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 4' ' ' SER . 37.2 t -110.35 133.3 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 110.001 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -110.9 94.05 4.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.463 -0.773 . . . . 0.0 109.634 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.27 69.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 109.516 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.7 m -151.45 110.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.134 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.652 ' C ' ' H ' ' A' ' 106' ' ' SER . 24.6 mmtp -125.41 1.46 7.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.44 -23.38 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.652 ' H ' ' C ' ' A' ' 104' ' ' LYS . 1.7 m 61.15 54.62 3.24 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.257 -0.902 . . . . 0.0 109.35 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.656 HG12 HG12 ' A' ' 108' ' ' VAL . 5.4 t -142.31 -123.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.934 HG13 ' H ' ' A' ' 109' ' ' ALA . 2.8 p -140.05 -103.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 109.5 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.934 ' H ' HG13 ' A' ' 108' ' ' VAL . . . -136.39 157.13 47.52 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -72.36 154.51 91.88 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 120.876 -1.14 . . . . 0.0 109.639 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.781 2.321 . . . . 0.0 112.29 179.63 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.677 ' O ' ' N ' ' B' ' 3' ' ' THR . 7.3 ptp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.677 ' O ' HG22 ' B' ' 3' ' ' THR . . . 59.89 -62.22 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.677 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.5 OUTLIER 74.8 -2.94 2.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.877 . . . . 0.0 109.149 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' B' ' 3' ' ' THR . 40.0 m -174.48 -129.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.87 168.44 26.19 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.688 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.85 128.25 47.34 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.538 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 4.3 ttpm? -106.39 134.77 49.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.989 -1.07 . . . . 0.0 112.823 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -126.25 124.5 40.52 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.85 141.98 49.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.7 -1.25 . . . . 0.0 109.491 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 138.22 54.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.612 -0.68 . . . . 0.0 109.542 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.75 131.69 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.28 146.31 29.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 117.702 -1.599 . . . . 0.0 113.04 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -127.65 147.75 50.37 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.807 ' CB ' ' H ' ' B' ' 18' ' ' THR . 17.5 t80 -111.37 158.83 18.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.867 -1.146 . . . . 0.0 111.596 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.674 ' HG3' ' H ' ' B' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.674 ' H ' ' HG3' ' B' ' 15' ' ' LYS . 83.6 mt-10 -86.05 -49.95 7.41 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.466 ' H ' ' HD2' ' B' ' 14' ' ' PHE . 6.5 t0 160.35 98.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.807 ' H ' ' CB ' ' B' ' 14' ' ' PHE . 3.4 m -51.28 153.77 1.94 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.062 0.935 . . . . 0.0 112.909 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.561 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -78.01 87.6 4.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -64.24 -33.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.605 -0.684 . . . . 0.0 110.562 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 29.7 p-10 -66.71 -42.1 86.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.793 . . . . 0.0 110.56 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 70.5 mm-40 -67.64 -30.28 69.8 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.475 HD11 HG21 ' B' ' 89' ' ' VAL . 1.3 mm -70.78 -37.48 69.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -54.28 -36.64 63.86 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -35.54 80.66 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.02 -54.39 17.9 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.86 -47.7 42.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.633 -0.922 . . . . 0.0 108.855 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.44 -43.59 71.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.642 ' ND2' ' CZ ' ' B' ' 82' ' ' PHE . 0.2 OUTLIER -64.95 -47.5 77.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.046 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.6 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -49.25 -44.71 43.93 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' B' ' 32' ' ' SER . 77.4 t -55.51 -25.11 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.273 -0.892 . . . . 0.0 108.789 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 50.9 m -43.12 -39.25 2.72 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' B' ' 76' ' ' HIS . 99.5 mm-40 -67.37 0.88 2.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 111.536 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.766 HG22 ' O ' ' B' ' 34' ' ' ILE . 72.1 mt -108.18 26.64 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.043 -1.661 . . . . 0.0 110.581 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.8 p30 -60.47 -8.49 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.625 ' O ' ' C ' ' B' ' 37' ' ' VAL . 29.6 p -84.1 0.14 49.6 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.966 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.625 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.5 m 30.32 38.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.093 -1.004 . . . . 0.0 109.149 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.33 3.58 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -174.19 178.29 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 91.9 m-85 -144.59 154.39 42.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.555 -1.341 . . . . 0.0 112.002 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 81.7 mt-10 -158.01 127.57 5.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.441 0.639 . . . . 0.0 110.192 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -133.62 172.54 12.6 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 98' ' ' PHE . . . -131.93 163.8 23.78 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.725 -1.702 . . . . 0.0 110.854 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.684 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 18.4 mt-10 -149.4 142.48 24.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -1.158 . . . . 0.0 109.35 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.583 ' CG ' ' HD1' ' B' ' 58' ' ' HIS . 42.3 m-20 -125.53 155.76 40.11 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 81.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.354 -1.466 . . . . 0.0 109.743 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -103.11 39.14 1.61 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 11.9 m -142.82 168.21 20.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 110.164 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' B' ' 53' ' ' ARG . 78.0 m80 -48.26 140.78 7.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.686 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 78.1 m-20 -44.57 -46.27 9.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.773 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.4 ttt -61.76 -28.85 69.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.718 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 95' ' ' LEU . 43.3 mt -102.14 -18.98 15.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.814 ' CG ' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -72.36 -5.28 35.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 111.238 -177.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.82 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.827 -1.17 . . . . 0.0 110.204 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.814 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 73.04 -13.32 3.37 Favored Glycine 0 N--CA 1.498 2.82 0 O-C-N 121.433 -0.792 . . . . 0.0 112.83 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 3.4 p90 -59.44 129.9 44.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.328 -1.689 . . . . 0.0 109.908 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 28.8 p -53.99 -43.2 69.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 111.039 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.684 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 18.9 t60 -173.17 159.6 3.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.903 -1.123 . . . . 0.0 110.175 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.662 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.22 167.74 21.41 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.507 -0.746 . . . . 0.0 109.282 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.402 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 80.9 m-85 -132.84 129.55 38.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.443 -0.785 . . . . 0.0 109.104 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -106.55 100.95 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 56.7 mtm -105.13 129.15 53.6 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 50.4 m -126.53 143.52 51.18 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' B' ' 65' ' ' GLU . 93.3 m-85 -124.6 130.0 51.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 0.0 110.014 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 64' ' ' PHE . 84.4 tt0 -47.88 -33.67 7.84 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -161.71 166.41 26.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -55.39 -22.7 20.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 111.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.492 ' OD2' ' NZ ' ' B' ' 38' ' ' LYS . 22.6 t70 -53.23 -40.69 64.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.704 -1.248 . . . . 0.0 110.574 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.17 65.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.649 ' O ' HG22 ' B' ' 74' ' ' THR . 56.8 t80 -64.19 -44.43 91.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.921 . . . . 0.0 110.47 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.77 -28.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.331 -1.481 . . . . 0.0 108.704 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -60.94 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.309 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -58.76 -46.74 86.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 0.0 111.191 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 70' ' ' TYR . 11.6 t -69.9 -36.13 75.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.706 -1.246 . . . . 0.0 110.308 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.426 ' N ' HG23 ' B' ' 74' ' ' THR . 77.9 p -65.51 -27.08 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -0.993 . . . . 0.0 110.924 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.423 ' CG ' ' OE1' ' B' ' 33' ' ' GLN . 55.0 m80 -72.22 151.18 92.29 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.8 -1.187 . . . . 0.0 109.559 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.87 -5.12 15.52 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.632 2.221 . . . . 0.0 112.517 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' B' ' 82' ' ' PHE . 5.6 tp -73.22 -28.67 62.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.323 -0.861 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 83' ' ' SER . 11.0 t-160 -82.56 -40.69 20.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.031 -1.043 . . . . 0.0 110.226 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.45 -61.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.33 -38.02 62.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.642 ' CZ ' ' ND2' ' B' ' 29' ' ' ASN . 8.2 m-85 -74.39 -33.54 63.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 109.873 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.438 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.1 t -61.32 -44.08 97.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.0 110.084 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.89 96.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.001 -1.062 . . . . 0.0 108.685 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.72 -43.13 76.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.45 -31.58 0.72 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.542 ' O ' ' N ' ' B' ' 89' ' ' VAL . 22.0 m -80.36 -62.2 1.75 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.18 -21.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.754 -0.591 . . . . 0.0 110.078 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.4 m -114.32 7.36 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.224 -0.922 . . . . 0.0 110.83 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 61.8 mt -123.5 157.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.659 -1.276 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 22.2 t70 -108.33 -30.45 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -145.63 142.97 29.56 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.472 ' O ' HG23 ' B' ' 93' ' ' ILE . 4.0 tp -125.38 123.51 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.535 -1.353 . . . . 0.0 109.753 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 t -125.99 131.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.609 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.3 OUTLIER -138.32 133.25 32.78 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.207 -1.558 . . . . 0.0 111.707 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.438 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.4 OUTLIER -121.07 126.7 50.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.695 -0.628 . . . . 0.0 109.308 178.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.1 t0 -124.8 130.34 52.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 108.943 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.658 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 0.1 OUTLIER -157.49 124.15 2.57 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.048 -1.033 . . . . 0.0 110.539 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.658 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 79.7 Cg_exo -44.85 133.73 10.57 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.179 1.919 . . . . 0.0 112.274 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' B' ' 4' ' ' SER . 37.1 t -110.44 133.2 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -110.74 94.19 4.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.448 -0.783 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.37 69.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.018 . . . . 0.0 109.558 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.686 HG23 ' O ' ' B' ' 103' ' ' VAL . 21.7 m -151.44 110.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 0.0 109.246 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.637 ' C ' ' H ' ' B' ' 106' ' ' SER . 24.7 mmtp -125.45 1.39 7.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 109.381 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.48 -23.41 0.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.938 . . . . 0.0 108.94 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 104' ' ' LYS . 1.8 m 61.22 54.39 3.26 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.643 HG12 HG12 ' B' ' 108' ' ' VAL . 5.2 t -142.16 -123.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.938 HG13 ' H ' ' B' ' 109' ' ' ALA . 2.8 p -139.97 -103.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.474 -0.766 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ALA . . . . . 0.938 ' H ' HG13 ' B' ' 108' ' ' VAL . . . -136.42 157.28 47.16 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.427 HG22 ' H ' ' B' ' 110' ' ' THR . 0.1 OUTLIER -72.48 154.68 91.64 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 120.926 -1.109 . . . . 0.0 109.583 -179.495 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 C-N-CA 122.786 2.324 . . . . 0.0 112.223 179.641 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.719 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 24.1 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 76.9 -155.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 109.339 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER 73.09 -39.61 0.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.126 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.518 ' N ' HG22 ' A' ' 3' ' ' THR . 75.1 m -91.64 -132.13 0.12 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.02 177.13 20.82 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.332 -1.413 . . . . 0.0 109.655 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -114.17 131.77 56.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -107.03 137.63 44.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.908 -1.12 . . . . 0.0 112.827 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -129.95 129.13 43.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -134.33 145.04 48.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.766 -1.209 . . . . 0.0 109.498 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.3 p -126.04 133.55 68.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.436 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.28 128.89 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 57' ' ' THR . 11.5 m -139.0 161.85 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 117.779 -1.568 . . . . 0.0 113.053 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 18.3 tptm -125.2 152.22 44.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.455 ' N ' ' HG3' ' A' ' 13' ' ' LYS . 41.6 p90 -111.04 152.55 26.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.857 -1.152 . . . . 0.0 111.574 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -127.5 -24.71 3.28 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 63.2 tt0 -89.7 -53.61 4.44 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.4 t0 147.57 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 29.2 m -54.84 111.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.095 0.95 . . . . 0.0 112.889 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.698 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.07 86.41 5.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.5 m -57.82 -33.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.551 -0.718 . . . . 0.0 110.456 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -66.19 -37.57 85.93 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -70.8 -35.85 72.73 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.27 -40.82 89.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.22 -35.79 60.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HA ' ' HZ3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -56.94 -30.12 63.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -76.68 -44.93 14.13 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 tt -49.47 -56.34 10.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.568 -0.96 . . . . 0.0 108.835 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 8.0 pt-20 -51.49 -35.44 40.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 51.7 m-20 -67.2 -46.58 73.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 4.1 mm? -47.71 -51.43 21.97 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.6 t -48.91 -34.12 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 108.888 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.3 m -45.15 -50.24 11.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.79 -1.55 2.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.475 -0.766 . . . . 0.0 111.419 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 36' ' ' THR . 6.3 mt -112.37 34.06 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.997 -1.689 . . . . 0.0 110.626 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -56.31 -10.48 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.577 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.2 t -85.88 -1.57 57.4 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.03 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 35.4 m 35.6 39.96 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.034 -1.041 . . . . 0.0 109.167 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' OG ' ' A' ' 39' ' ' SER . 59.2 mttt -116.87 43.21 2.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 38.6 m -174.27 175.07 2.73 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' C ' ' CD ' ' A' ' 41' ' ' GLU . 77.3 m-85 -147.95 157.18 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.524 -1.36 . . . . 0.0 112.002 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' CD ' ' C ' ' A' ' 40' ' ' PHE . 58.7 mp0 -156.28 123.85 5.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.452 0.644 . . . . 0.0 110.172 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.52 172.25 9.85 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.97 155.56 21.04 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.798 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.582 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 76.6 mm-40 -149.12 136.65 20.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -1.127 . . . . 0.0 109.345 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 88.6 m-20 -111.43 142.87 43.12 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HZ1' ' C ' ' A' ' 58' ' ' HIS . 9.9 pttm -141.54 109.39 5.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.369 -1.457 . . . . 0.0 109.826 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -147.0 45.33 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.679 -0.638 . . . . 0.0 109.305 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 49' ' ' HIS . 10.1 t -133.16 124.44 27.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 48' ' ' SER . 27.6 m80 60.97 116.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -60.34 -38.28 83.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.364 -0.835 . . . . 0.0 110.827 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -71.18 -35.53 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.031 -1.043 . . . . 0.0 110.729 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 54' ' ' GLN . 26.5 mt -80.68 -58.27 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.806 -1.184 . . . . 0.0 109.292 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.6 ptt180 -63.53 14.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.242 -0.911 . . . . 0.0 111.209 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 52' ' ' LEU . 24.9 mt-30 43.56 4.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.789 -1.194 . . . . 0.0 110.187 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 84.5 -16.94 32.32 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.478 -0.764 . . . . 0.0 112.844 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.482 ' CE2' ' NZ ' ' A' ' 92' ' ' LYS . 48.2 m-85 -61.94 -134.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.253 -1.733 . . . . 0.0 109.998 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 12' ' ' VAL . 4.6 t -162.89 -34.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.284 -0.885 . . . . 0.0 111.027 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.658 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 8.5 t60 -168.47 153.59 6.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 110.125 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.658 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.56 169.1 18.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.385 -0.822 . . . . 0.0 109.283 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.653 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 90.0 m-85 -132.06 128.43 38.21 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 0.0 109.083 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -100.18 99.76 10.5 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -103.07 123.08 45.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.766 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.9 m -123.12 145.62 48.43 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' ASN . 92.2 m-85 -120.92 120.33 35.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.722 -1.237 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -50.92 -24.46 3.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 64' ' ' PHE . 42.2 t-20 -171.26 171.26 5.71 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -58.91 -20.42 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 111.446 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -58.67 -41.95 87.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.835 -1.166 . . . . 0.0 110.574 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.68 -32.93 66.93 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.484 ' O ' HG22 ' A' ' 74' ' ' THR . 78.5 t80 -66.86 -44.11 81.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.927 . . . . 0.0 110.538 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.322 -1.486 . . . . 0.0 108.649 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.91 2.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.349 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -50.57 -34.78 27.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -0.871 . . . . 0.0 111.182 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.7 t -85.63 -30.15 23.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.824 -1.172 . . . . 0.0 110.294 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 t -67.41 16.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.126 -0.984 . . . . 0.0 110.971 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.474 ' H ' ' C ' ' A' ' 74' ' ' THR . 56.1 m80 -133.06 152.05 79.0 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 0.0 109.602 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.84 1.44 8.12 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.669 2.246 . . . . 0.0 112.507 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.26 -31.77 72.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.369 -0.832 . . . . 0.0 111.256 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 83' ' ' SER . 75.2 t60 -84.85 -31.84 23.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.117 -0.989 . . . . 0.0 110.237 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.13 -62.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.993 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.1 -42.46 72.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -75.13 -32.91 61.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 79' ' ' HIS . 13.7 t -63.25 -42.92 99.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.158 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.34 99.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.978 -1.076 . . . . 0.0 108.686 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -65.21 -41.8 94.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -44.66 -31.13 1.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.562 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' VAL . 18.7 m -81.68 -63.14 1.45 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.18 -28.74 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.718 -0.614 . . . . 0.0 110.057 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 85' ' ' ALA . 5.3 m -103.99 6.95 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.122 -0.986 . . . . 0.0 110.848 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 91' ' ' ASP . 28.4 mm -129.57 161.92 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.64 -1.287 . . . . 0.0 110.436 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.559 ' N ' HG22 ' A' ' 90' ' ' ILE . 61.4 t0 -121.85 -30.01 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.482 ' NZ ' ' CE2' ' A' ' 56' ' ' PHE . 18.1 ttpt -131.04 129.06 41.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' ILE . 3.4 tp -123.69 121.44 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.643 -1.286 . . . . 0.0 109.799 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.435 ' C ' HD12 ' A' ' 95' ' ' LEU . 7.5 t -131.17 134.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.823 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -143.17 141.27 31.1 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.273 -1.517 . . . . 0.0 111.755 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -117.93 118.92 33.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.649 -0.657 . . . . 0.0 109.311 177.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 39.3 p30 -128.26 136.46 51.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.059 -1.026 . . . . 0.0 108.983 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 9.3 p90 -172.48 156.14 3.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 110.481 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.19 124.87 15.16 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.293 1.995 . . . . 0.0 112.187 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.5 t -109.66 136.05 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 110.022 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.58 104.02 9.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.501 -0.75 . . . . 0.0 109.612 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' HB1' ' HZ2' ' A' ' 104' ' ' LYS . . . -167.46 160.28 13.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.001 . . . . 0.0 109.579 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.02 -10.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 109.238 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.802 ' C ' ' H ' ' A' ' 106' ' ' SER . 3.7 mmpp? 54.94 -145.72 0.61 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.322 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.53 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 108.904 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.802 ' H ' ' C ' ' A' ' 104' ' ' LYS . 75.2 m -61.62 124.64 21.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.36 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.7 p -129.71 140.45 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.672 ' O ' HG22 ' A' ' 108' ' ' VAL . 2.3 p 160.97 77.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.518 -0.739 . . . . 0.0 109.401 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.1 116.77 23.66 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 p -70.35 150.89 95.81 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 120.898 -1.126 . . . . 0.0 109.675 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 122.873 2.382 . . . . 0.0 112.231 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.712 ' O ' ' HB3' ' B' ' 2' ' ' ALA . 24.1 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.324 0.583 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' B' ' 1' ' ' MET . . . 76.8 -155.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 109.313 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.528 HG22 ' N ' ' B' ' 4' ' ' SER . 0.4 OUTLIER 73.09 -39.68 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.141 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.528 ' N ' HG22 ' B' ' 3' ' ' THR . 74.9 m -91.66 -132.25 0.12 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.03 176.75 21.07 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.727 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -113.85 131.99 56.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.301 -1.117 . . . . 0.0 108.029 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -107.41 137.5 45.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.988 -1.07 . . . . 0.0 112.809 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -130.03 129.18 43.34 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -134.36 145.03 48.6 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.702 -1.248 . . . . 0.0 109.53 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 10' ' ' VAL . 12.2 p -126.09 133.69 68.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.403 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.9 OUTLIER -117.45 128.63 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.5 ' O ' HG22 ' B' ' 57' ' ' THR . 11.3 m -138.92 161.56 29.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.741 -1.584 . . . . 0.0 113.026 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 18.2 tptm -124.73 152.34 43.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.452 ' N ' ' HG3' ' B' ' 13' ' ' LYS . 41.5 p90 -111.16 152.42 27.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.818 -1.176 . . . . 0.0 111.589 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -127.46 -24.73 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 62.8 tt0 -89.77 -53.64 4.42 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.5 t0 147.5 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 28.3 m -54.77 111.32 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.11 0.957 . . . . 0.0 112.857 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.704 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.4 86.13 5.78 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.32 -33.51 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.554 -0.716 . . . . 0.0 110.443 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.19 -37.77 86.41 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -70.54 -35.97 73.43 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.28 -40.71 88.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.26 -35.84 60.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' B' ' 28' ' ' GLU . 0.0 OUTLIER -56.94 -30.01 63.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -76.76 -44.78 14.15 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 1.2 tt -49.52 -56.37 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.5 -1.0 . . . . 0.0 108.824 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 8.1 pt-20 -51.49 -35.52 40.54 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 51.6 m-20 -67.17 -46.54 73.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 4.1 mm? -47.72 -51.39 22.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 32' ' ' SER . 52.1 t -48.98 -34.13 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.251 -0.906 . . . . 0.0 108.824 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 7.3 m -45.27 -49.95 12.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -64.79 -1.62 2.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 111.553 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.581 ' C ' ' N ' ' B' ' 36' ' ' THR . 6.1 mt -112.32 34.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.079 -1.638 . . . . 0.0 110.625 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -56.54 -10.61 1.01 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.581 ' N ' ' C ' ' B' ' 34' ' ' ILE . 1.2 t -85.81 -1.84 57.64 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.4 m 35.97 39.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.053 -1.029 . . . . 0.0 109.23 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.54 ' O ' ' OG ' ' B' ' 39' ' ' SER . 58.5 mttt -116.72 43.33 2.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.54 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 38.2 m -174.17 175.48 2.69 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.492 ' C ' ' CD ' ' B' ' 41' ' ' GLU . 77.1 m-85 -148.18 157.4 43.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.531 -1.356 . . . . 0.0 111.959 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.492 ' CD ' ' C ' ' B' ' 40' ' ' PHE . 58.5 mp0 -156.48 123.82 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.439 0.638 . . . . 0.0 110.194 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.5 172.11 9.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.74 155.54 20.97 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.768 -1.682 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.577 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 76.7 mm-40 -149.19 136.61 20.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -1.202 . . . . 0.0 109.392 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 90.4 m-20 -111.51 142.8 43.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.513 ' HZ1' ' C ' ' B' ' 58' ' ' HIS . 10.0 pttm -141.6 109.33 5.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.419 -1.426 . . . . 0.0 109.785 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -146.98 45.46 1.17 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.625 -0.672 . . . . 0.0 109.293 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.0 t -133.11 124.42 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.183 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 27.6 m80 60.88 116.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.166 -0.959 . . . . 0.0 109.664 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -60.93 -38.07 84.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.747 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -71.02 -35.5 72.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.753 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' B' ' 54' ' ' GLN . 26.5 mt -80.93 -58.42 3.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.704 -1.247 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.756 ' O ' ' N ' ' B' ' 55' ' ' GLY . 17.3 ptt180 -63.33 14.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 0.0 111.222 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' B' ' 52' ' ' LEU . 24.7 mt-30 43.76 4.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.814 -1.179 . . . . 0.0 110.157 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 84.71 -16.91 33.51 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.357 -0.84 . . . . 0.0 112.861 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.486 ' CE2' ' NZ ' ' B' ' 92' ' ' LYS . 47.9 m-85 -62.08 -134.08 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.884 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.5 HG22 ' O ' ' B' ' 12' ' ' VAL . 4.6 t -163.01 -34.39 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.249 -0.907 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.671 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 8.0 t60 -168.68 153.67 6.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.846 -1.159 . . . . 0.0 110.164 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.671 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.57 169.08 18.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.483 -0.761 . . . . 0.0 109.262 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.656 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 89.8 m-85 -131.98 128.5 38.53 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.112 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 30.0 t -100.29 99.59 10.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 64.1 mtt -103.07 123.08 45.96 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.771 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 46.3 m -123.0 145.83 48.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.14 120.27 34.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.744 -1.223 . . . . 0.0 110.048 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -51.06 -24.47 3.9 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -171.07 171.55 5.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -59.29 -20.23 52.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.363 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -58.8 -41.74 87.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.804 -1.185 . . . . 0.0 110.583 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.91 -33.11 65.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.473 ' O ' HG22 ' B' ' 74' ' ' THR . 78.6 t80 -66.56 -44.31 82.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.941 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.8 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.426 -1.421 . . . . 0.0 108.731 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.12 -60.89 2.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -50.29 -35.32 26.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.258 -0.901 . . . . 0.0 111.161 -177.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.9 t -85.21 -30.44 23.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.721 -1.237 . . . . 0.0 110.353 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -67.18 16.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.115 -0.991 . . . . 0.0 110.97 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.483 ' H ' ' C ' ' B' ' 74' ' ' THR . 56.3 m80 -133.48 152.28 78.88 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.813 -1.179 . . . . 0.0 109.602 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.15 1.64 8.05 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.697 2.264 . . . . 0.0 112.445 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.5 -31.66 71.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.408 -0.808 . . . . 0.0 111.231 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' B' ' 83' ' ' SER . 75.8 t60 -84.98 -31.69 23.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.1 . . . . 0.0 110.312 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.31 -61.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.33 -42.78 74.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.573 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -74.83 -32.85 62.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 79' ' ' HIS . 13.7 t -63.41 -43.05 98.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.21 98.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 108.698 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -65.64 -41.57 92.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.468 ' O ' HG12 ' B' ' 90' ' ' ILE . 1.0 OUTLIER -44.87 -31.16 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.418 ' O ' ' C ' ' B' ' 88' ' ' ALA . 18.4 m -81.47 -63.08 1.47 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.0 -29.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.657 -0.652 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.612 HG22 ' O ' ' B' ' 85' ' ' ALA . 5.3 m -103.83 7.21 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.139 -0.976 . . . . 0.0 110.805 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.573 HG22 ' N ' ' B' ' 91' ' ' ASP . 28.0 mm -129.64 161.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.605 -1.309 . . . . 0.0 110.419 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.573 ' N ' HG22 ' B' ' 90' ' ' ILE . 62.0 t0 -121.87 -30.0 4.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.486 ' NZ ' ' CE2' ' B' ' 56' ' ' PHE . 17.5 ttpt -131.24 129.01 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.49 HG23 ' O ' ' B' ' 93' ' ' ILE . 3.4 tp -123.58 121.61 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 109.709 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.436 ' C ' HD12 ' B' ' 95' ' ' LEU . 8.0 t -131.36 134.71 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.801 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -143.1 141.18 31.17 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.349 -1.469 . . . . 0.0 111.765 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.425 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.6 OUTLIER -117.76 119.05 33.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.363 177.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 40.6 p30 -128.51 136.39 50.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.094 -1.003 . . . . 0.0 108.896 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 9.3 p90 -172.32 156.23 3.61 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.015 -1.053 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.29 124.85 15.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.316 2.011 . . . . 0.0 112.248 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.72 136.14 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 110.038 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.55 103.89 9.25 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' ALA . . . . . 0.433 ' HB1' ' NZ ' ' B' ' 104' ' ' LYS . . . -167.52 160.23 12.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.559 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.03 -10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.805 ' C ' ' H ' ' B' ' 106' ' ' SER . 3.7 mmpp? 54.89 -145.6 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.347 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.54 -26.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 108.908 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.805 ' H ' ' C ' ' B' ' 104' ' ' LYS . 75.6 m -61.51 124.87 21.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.567 ' O ' ' HB ' ' B' ' 108' ' ' VAL . 7.3 p -129.98 140.5 48.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.684 HG22 ' O ' ' B' ' 108' ' ' VAL . 2.3 p 160.9 77.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.533 -0.729 . . . . 0.0 109.52 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.84 116.92 23.57 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.3 p -70.6 151.06 95.5 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 120.804 -1.185 . . . . 0.0 109.676 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo . . . . . 0 C--N 1.307 -1.637 0 C-N-CA 122.775 2.317 . . . . 0.0 112.279 179.674 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.25 77.22 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.967 . . . . 0.0 109.319 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 t -100.1 0.45 40.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.162 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -162.85 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.53 174.18 19.82 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.367 -1.397 . . . . 0.0 109.696 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.5 131.52 56.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.313 -1.11 . . . . 0.0 108.014 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 10.6 ttpt -105.29 133.11 50.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.935 -1.103 . . . . 0.0 112.837 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 97' ' ' ASP . 60.5 m80 -125.6 125.97 44.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.888 -1.894 . . . . 0.0 105.888 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -136.0 143.41 44.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.43 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.9 p -127.69 136.69 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.637 -0.665 . . . . 0.0 109.486 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.2 128.12 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.08 159.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 117.848 -1.541 . . . . 0.0 113.083 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 91' ' ' ASP . 11.1 mtpt -121.16 153.87 36.96 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.566 ' HB2' ' H ' ' A' ' 18' ' ' THR . 17.1 p90 -102.61 144.03 31.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.818 -1.176 . . . . 0.0 111.604 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -116.03 -29.61 6.27 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.7 tt0 -88.54 -55.18 3.83 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.564 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 13.6 m-20 152.19 74.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.566 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 39.3 m -62.24 109.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.103 0.954 . . . . 0.0 112.876 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.694 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.14 92.22 5.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 20' ' ' VAL . 8.6 m -57.59 -35.27 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 110.475 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.1 p-10 -66.46 -39.58 88.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 110.554 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 96.4 mt-10 -70.67 -32.64 69.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.63 -42.48 83.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.49 -39.26 70.2 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -60.07 -24.73 64.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -82.42 -45.84 6.75 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.455 HD21 ' OE1' ' A' ' 41' ' ' GLU . 2.5 tt -49.05 -52.45 25.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.488 -1.007 . . . . 0.0 108.838 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 18.7 pt-20 -52.83 -40.28 63.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.1 m-20 -58.62 -43.9 89.79 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.694 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -47.33 -46.75 25.7 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' SER . 37.8 t -49.14 -27.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 108.842 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 37.4 t -42.93 -48.16 5.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.63 ' NE2' ' CE1' ' A' ' 76' ' ' HIS . 8.9 mm100 -72.8 -23.25 60.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 111.481 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.76 HG22 ' O ' ' A' ' 34' ' ' ILE . 73.2 mt -82.63 23.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.043 -1.661 . . . . 0.0 110.636 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.63 -10.89 2.53 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 43.9 p -79.94 -1.0 37.46 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.6 m 35.4 32.61 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 109.117 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 20.1 mtmm -120.02 42.71 2.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' THR . 27.7 t -172.76 171.98 4.26 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -148.83 160.98 42.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.645 -1.284 . . . . 0.0 111.943 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.526 ' C ' ' HZ3' ' B' ' 104' ' ' LYS . 63.2 mt-10 -151.91 116.71 5.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.393 0.616 . . . . 0.0 110.2 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.697 ' HE1' HG11 ' B' ' 100' ' ' VAL . 11.4 t-105 -104.66 159.2 15.96 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' HZ2' ' B' ' 104' ' ' LYS . . . -118.81 151.49 17.69 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.736 -1.697 . . . . 0.0 110.803 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' B' ' 7' ' ' LYS . 70.9 mt-10 -150.84 133.47 15.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.211 -1.17 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.6 p-10 -155.46 86.56 1.08 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -78.81 155.42 29.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.398 -1.439 . . . . 0.0 109.81 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.4 mt-10 -155.52 59.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.67 -0.644 . . . . 0.0 109.331 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 49' ' ' HIS . 54.6 p -172.37 138.2 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.131 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 m80 60.82 113.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.14 -0.975 . . . . 0.0 109.688 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -55.44 -44.03 75.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 110.797 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.2 mtt -60.32 -35.74 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.746 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' B' ' 96' ' ' LEU . 12.2 mt -93.3 -28.97 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.74 -1.225 . . . . 0.0 109.283 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.065 ' O ' ' N ' ' A' ' 55' ' ' GLY . 39.6 ttt-85 -79.07 2.86 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.299 -0.876 . . . . 0.0 111.296 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 1.059 ' NE2' HD21 ' B' ' 96' ' ' LEU . 3.4 mt-30 33.72 2.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.709 -1.244 . . . . 0.0 110.212 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 1.065 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.54 -24.82 1.43 Allowed Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.379 -0.826 . . . . 0.0 112.877 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.513 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 6.5 m-85 -59.24 -142.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.26 -1.73 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.698 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 66.4 p -142.71 -48.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -0.848 . . . . 0.0 110.999 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.698 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 35.7 p-80 -173.6 159.63 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.0 110.105 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.14 172.32 13.61 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.395 -0.815 . . . . 0.0 109.221 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -138.5 133.83 33.17 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.416 -0.803 . . . . 0.0 109.12 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.6 t -110.17 102.22 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.64 125.99 44.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.269 -0.894 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 39' ' ' SER . 31.7 m -120.55 142.83 48.99 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.26 130.59 46.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.717 -1.239 . . . . 0.0 110.066 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -55.7 -31.04 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -153.84 160.48 42.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.79 -19.7 43.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.957 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.55 -39.1 72.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.813 -1.18 . . . . 0.0 110.594 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.65 77.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 74' ' ' THR . 75.7 t80 -69.17 -45.68 69.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.969 . . . . 0.0 110.432 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.81 -28.91 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.355 -1.466 . . . . 0.0 108.645 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.355 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.694 ' CE1' HD11 ' A' ' 30' ' ' LEU . 3.5 t80 -54.46 -32.05 56.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 70' ' ' TYR . 30.9 p -75.42 -31.21 60.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.762 -1.211 . . . . 0.0 110.303 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.7 t -82.34 -0.73 47.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.115 -0.991 . . . . 0.0 110.961 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.63 ' CE1' ' NE2' ' A' ' 33' ' ' GLN . 62.1 m80 -97.8 126.36 41.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.758 -1.214 . . . . 0.0 109.61 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -41.51 -14.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.0 112.418 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.2 tp -68.73 -29.26 67.63 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 111.228 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.517 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 81.6 t60 -79.88 -42.77 23.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.046 -1.034 . . . . 0.0 110.226 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.38 -60.68 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.005 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.89 -39.2 77.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -73.24 -42.49 62.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.847 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 66.8 m -62.17 -39.86 94.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.39 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 108.69 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -70.34 -41.99 72.47 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.894 ' O ' HD13 ' A' ' 90' ' ' ILE . 25.6 t80 -45.96 -30.63 1.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 89' ' ' VAL . 17.6 m -80.77 -62.73 1.58 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.93 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.69 -0.631 . . . . 0.0 110.045 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 85' ' ' ALA . 19.4 m -103.84 10.38 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.163 -0.96 . . . . 0.0 110.786 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.894 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.1 mp -119.9 154.5 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.667 -1.271 . . . . 0.0 110.426 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' LYS . 63.8 t0 -101.37 -34.65 9.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.58 148.7 31.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -126.88 125.27 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.619 -1.3 . . . . 0.0 109.786 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 5.3 t -134.25 136.53 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -138.74 137.91 37.18 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.279 -1.513 . . . . 0.0 111.779 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.069 HD21 ' NE2' ' B' ' 54' ' ' GLN . 0.8 OUTLIER -112.13 118.09 34.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.632 -0.667 . . . . 0.0 109.333 176.277 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 56.7 t0 -123.74 126.72 47.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.044 -1.035 . . . . 0.0 108.924 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 55.3 t80 -167.86 137.72 2.17 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.019 -1.051 . . . . 0.0 110.487 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.0 Cg_exo -47.7 124.45 9.73 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.26 1.973 . . . . 0.0 112.199 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.702 HG11 ' HE1' ' B' ' 42' ' ' TRP . 76.1 t -114.19 140.44 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.939 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -109.81 78.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 109.617 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.534 ' HB2' ' CZ2' ' B' ' 42' ' ' TRP . . . -49.13 88.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.541 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.671 ' O ' HG23 ' A' ' 103' ' ' VAL . 13.1 m -149.17 116.12 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.828 . . . . 0.0 109.163 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 105' ' ' SER . 5.8 ptmt -176.43 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.362 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 107' ' ' VAL . 0.3 OUTLIER 162.05 -44.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 108.965 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.3 t -64.75 44.33 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.286 -0.884 . . . . 0.0 109.395 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 108' ' ' VAL . 3.5 t -139.77 -135.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.632 ' H ' HG12 ' A' ' 107' ' ' VAL . 11.6 p -149.89 151.16 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 109.487 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.2 115.65 26.86 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.4 m -133.29 73.2 74.43 Favored Pre-proline 0 C--N 1.303 -1.43 0 O-C-N 120.848 -1.158 . . . . 0.0 109.623 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.308 -1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 112.287 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.326 0.584 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.94 77.4 0.31 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.379 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -100.22 0.28 40.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.15 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' H ' ' B' ' 5' ' ' GLY . 15.7 m -162.55 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' B' ' 4' ' ' SER . . . -130.62 174.22 19.84 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.423 -1.37 . . . . 0.0 109.697 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.49 131.45 56.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.272 -1.134 . . . . 0.0 108.013 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 44' ' ' GLU . 10.6 ttpt -105.08 133.14 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.894 -1.129 . . . . 0.0 112.821 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' B' ' 97' ' ' ASP . 60.5 m80 -125.72 126.04 43.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.4 tt -136.12 143.43 44.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.836 -1.165 . . . . 0.0 109.45 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 11.8 p -127.62 136.68 59.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.485 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.09 128.17 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.2 159.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 117.706 -1.598 . . . . 0.0 113.043 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' B' ' 91' ' ' ASP . 11.2 mtpt -121.13 153.81 37.0 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.571 ' HB2' ' H ' ' B' ' 18' ' ' THR . 17.3 p90 -102.61 143.96 31.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.94 -1.1 . . . . 0.0 111.585 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -115.97 -29.58 6.3 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 78.7 tt0 -88.65 -55.07 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 13.6 m-20 152.03 74.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.571 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 39.5 m -62.34 109.56 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.122 0.963 . . . . 0.0 112.862 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.2 92.21 5.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.417 ' H ' HG22 ' B' ' 20' ' ' VAL . 8.6 m -57.71 -35.1 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 110.413 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.5 p-10 -66.54 -39.63 88.68 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 110.563 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.622 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 96.4 mt-10 -70.71 -32.6 69.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.66 -42.43 83.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.6 -39.2 70.43 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.2 OUTLIER -60.02 -24.86 64.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -82.16 -45.93 6.82 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.449 HD21 ' OE1' ' B' ' 41' ' ' GLU . 2.5 tt -49.0 -52.43 25.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.968 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 18.6 pt-20 -52.96 -40.24 63.54 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 40.5 m-20 -58.59 -44.01 89.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.1 OUTLIER -47.28 -46.71 25.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' B' ' 32' ' ' SER . 37.6 t -49.16 -27.77 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.91 . . . . 0.0 108.775 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 37.0 t -42.85 -48.29 5.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.63 ' NE2' ' CE1' ' B' ' 76' ' ' HIS . 8.8 mm100 -72.52 -23.45 61.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.461 -0.774 . . . . 0.0 111.509 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.779 HG22 ' O ' ' B' ' 34' ' ' ILE . 73.4 mt -82.57 23.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.009 -1.682 . . . . 0.0 110.558 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.6 -10.91 2.52 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' N ' ' B' ' 38' ' ' LYS . 44.1 p -79.93 -0.93 37.15 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.97 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.7 m 35.43 32.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.177 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' B' ' 36' ' ' THR . 20.1 mtmm -119.93 43.01 2.78 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.4 t -172.98 171.79 4.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -148.92 160.87 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.562 -1.336 . . . . 0.0 112.002 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.507 ' C ' ' HZ3' ' A' ' 104' ' ' LYS . 63.0 mt-10 -151.85 116.7 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.369 0.604 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.702 ' HE1' HG11 ' A' ' 100' ' ' VAL . 11.4 t-105 -104.62 159.27 15.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.438 ' N ' ' HZ2' ' A' ' 104' ' ' LYS . . . -118.91 151.44 17.68 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 118.695 -1.716 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.528 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 71.7 mt-10 -150.84 133.46 15.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.27 -1.136 . . . . 0.0 109.379 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 43.1 p-10 -155.47 86.62 1.08 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -78.91 155.35 29.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.365 -1.459 . . . . 0.0 109.872 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.5 mt-10 -155.51 59.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.646 -0.659 . . . . 0.0 109.338 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.415 ' O ' ' O ' ' B' ' 49' ' ' HIS . 54.1 p -172.53 138.04 0.86 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 110.142 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' B' ' 53' ' ' ARG . 43.7 m80 61.03 113.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.684 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -55.33 -44.09 75.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.821 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.42 -35.56 76.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 12.2 mt -93.46 -28.93 15.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.724 -1.235 . . . . 0.0 109.244 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 1.066 ' O ' ' N ' ' B' ' 55' ' ' GLY . 39.8 ttt-85 -79.07 2.82 19.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.394 -0.816 . . . . 0.0 111.246 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 1.069 ' NE2' HD21 ' A' ' 96' ' ' LEU . 3.3 mt-30 33.7 2.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.77 -1.206 . . . . 0.0 110.206 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 1.066 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.41 -24.76 1.39 Allowed Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.449 -0.782 . . . . 0.0 112.865 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 6.5 m-85 -59.23 -142.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.292 -1.711 . . . . 0.0 109.928 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.618 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 64.6 p -142.73 -48.3 0.33 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.618 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 35.8 p-80 -173.72 159.45 3.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.891 -1.131 . . . . 0.0 110.186 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.8 172.37 13.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 109.283 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -138.54 133.77 33.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.479 -0.763 . . . . 0.0 109.132 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -110.04 102.28 11.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.68 125.83 44.11 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.198 -0.939 . . . . 0.0 110.782 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.1 m -120.33 142.97 48.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -129.38 130.55 46.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.746 -1.221 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -55.56 -31.17 61.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -153.74 160.64 42.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.97 -19.66 45.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 111.421 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.61 -39.02 72.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.839 -1.163 . . . . 0.0 110.611 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.59 77.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.896 ' O ' HG23 ' B' ' 74' ' ' THR . 75.7 t80 -69.07 -45.89 69.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.645 -0.915 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.92 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.354 -1.466 . . . . 0.0 108.745 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.457 -0.777 . . . . 0.0 109.365 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' B' ' 30' ' ' LEU . 3.5 t80 -54.22 -32.16 55.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 111.118 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.896 HG23 ' O ' ' B' ' 70' ' ' TYR . 30.9 p -75.31 -31.34 60.63 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.761 -1.212 . . . . 0.0 110.372 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t -82.21 -0.85 47.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.097 -1.002 . . . . 0.0 110.894 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.63 ' CE1' ' NE2' ' B' ' 33' ' ' GLN . 62.3 m80 -97.66 126.49 40.91 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.829 -1.169 . . . . 0.0 109.595 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -41.64 -14.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.65 2.234 . . . . 0.0 112.454 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' B' ' 76' ' ' HIS . 8.3 tp -68.79 -29.39 67.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.422 -0.799 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 81.5 t60 -79.59 -42.83 24.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.088 . . . . 0.0 110.324 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.46 -60.69 2.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.981 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.79 -39.38 77.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.245 -0.909 . . . . 0.0 109.616 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -73.04 -42.58 62.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 66.6 m -62.15 -39.87 94.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.172 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.59 77.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.673 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.652 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -70.22 -41.88 73.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.884 ' O ' HD13 ' B' ' 90' ' ' ILE . 26.2 t80 -46.1 -30.54 1.94 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' B' ' 89' ' ' VAL . 17.6 m -80.77 -62.72 1.59 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.07 -29.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.717 -0.615 . . . . 0.0 110.084 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.652 HG22 ' O ' ' B' ' 85' ' ' ALA . 19.5 m -103.99 10.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.225 -0.922 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.884 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.1 mp -119.9 154.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.593 -1.317 . . . . 0.0 110.481 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' B' ' 13' ' ' LYS . 64.2 t0 -101.41 -34.75 9.46 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -147.59 148.53 31.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.447 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -126.82 125.29 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.569 -1.332 . . . . 0.0 109.688 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 5.1 t -134.17 136.5 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.542 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -138.69 137.98 37.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.359 -1.463 . . . . 0.0 111.854 -178.347 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 1.059 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -112.1 118.08 34.39 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.239 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 8' ' ' HIS . 56.1 t0 -123.75 126.71 46.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.16 -0.962 . . . . 0.0 108.883 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 55.9 t80 -167.71 137.79 2.24 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.525 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 88.6 Cg_exo -47.74 124.49 9.83 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.267 1.978 . . . . 0.0 112.21 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.697 HG11 ' HE1' ' A' ' 42' ' ' TRP . 76.2 t -114.24 140.38 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.99 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.86 78.6 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' ALA . . . . . 0.529 ' HB2' ' CZ2' ' A' ' 42' ' ' TRP . . . -49.06 88.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.003 . . . . 0.0 109.581 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.654 HG23 ' O ' ' B' ' 103' ' ' VAL . 13.3 m -149.11 116.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.827 . . . . 0.0 109.153 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' B' ' 105' ' ' SER . 5.9 ptmt -176.5 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 107' ' ' VAL . 0.3 OUTLIER 162.06 -44.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 8.2 t -64.59 44.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.253 -0.905 . . . . 0.0 109.456 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.619 HG12 ' H ' ' B' ' 108' ' ' VAL . 3.5 t -139.8 -135.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.619 ' H ' HG12 ' B' ' 107' ' ' VAL . 11.7 p -149.8 151.31 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -0.795 . . . . 0.0 109.503 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.3 115.6 26.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 18.8 m -133.26 73.35 74.31 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.859 -1.15 . . . . 0.0 109.666 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 C--N 1.308 -1.577 0 C-N-CA 122.815 2.344 . . . . 0.0 112.235 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.339 0.59 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.745 ' O ' HG22 ' A' ' 3' ' ' THR . . . 56.89 -148.34 0.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.317 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 81.86 -4.3 1.53 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.163 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.4 t -137.55 -98.38 0.2 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.91 175.77 20.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.722 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.51 128.94 56.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -1.115 . . . . 0.0 108.064 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HB2' HG21 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -102.72 131.04 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.947 -1.096 . . . . 0.0 112.857 -177.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -125.22 123.59 39.89 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -131.16 140.04 49.87 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.716 -1.24 . . . . 0.0 109.481 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 70.5 t -126.22 132.67 70.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.545 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 59' ' ' ALA . 1.4 t -113.0 130.53 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.18 167.17 27.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.775 -1.57 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 91' ' ' ASP . 2.2 mmmt -137.41 151.24 48.33 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.641 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 7.7 m-85 -108.07 147.3 31.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 111.637 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -127.83 -28.06 2.73 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 75.6 tt0 -87.77 -59.11 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.5 m-20 153.14 69.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 14' ' ' PHE . 31.8 m -60.02 111.71 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.063 0.935 . . . . 0.0 112.844 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.743 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.3 87.3 5.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 176.197 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.92 -32.6 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 110.487 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.3 p-10 -65.32 -37.32 86.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 96.3 mt-10 -69.79 -35.31 74.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 23' ' ' ILE . 3.2 mm -62.81 -45.22 99.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -50.24 -37.29 34.92 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -59.9 -36.29 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -78.82 -42.87 12.2 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -54.38 -59.36 4.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -1.001 . . . . 0.0 108.837 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.28 -34.89 59.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.75 -45.48 92.1 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -50.26 -44.86 53.82 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' ILE . 48.3 t -45.13 -35.41 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.243 -0.91 . . . . 0.0 108.889 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' VAL . 20.1 m -42.2 -45.86 4.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.466 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 22.4 mp0 -70.89 -23.58 62.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 111.496 176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.543 ' C ' ' H ' ' A' ' 36' ' ' THR . 22.1 mt -85.86 28.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 119.967 -1.708 . . . . 0.0 110.667 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.3 p30 -62.22 -7.2 3.84 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 38' ' ' LYS . 2.0 t -86.44 1.89 49.75 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.971 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.5 m 37.45 28.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.083 -1.011 . . . . 0.0 109.198 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 36' ' ' THR . 78.9 mttt -118.42 39.43 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.17 157.03 30.06 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.508 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 99.3 m-85 -143.95 154.0 42.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.624 -1.297 . . . . 0.0 112.013 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 55.5 mp0 -158.83 125.26 4.61 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.379 0.609 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.601 ' HE1' HG11 ' B' ' 100' ' ' VAL . 53.1 t-105 -124.02 174.33 7.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -132.63 153.31 20.58 Favored Glycine 0 N--CA 1.499 2.837 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.765 ' O ' ' CD2' ' A' ' 58' ' ' HIS . 72.8 mt-10 -147.48 137.88 23.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.204 -1.174 . . . . 0.0 109.319 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.41 144.18 48.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.568 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -149.13 122.51 9.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.502 -1.374 . . . . 0.0 109.769 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 56' ' ' PHE . 65.1 mm-40 -151.5 45.46 0.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.692 . . . . 0.0 109.335 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -124.23 121.87 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.186 -0.946 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.84 119.89 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.16 -0.963 . . . . 0.0 109.658 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.496 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 80.9 m-20 -56.38 -41.53 76.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 0.0 110.805 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG2' ' H ' ' A' ' 51' ' ' MET . 5.0 ptp -71.66 -32.01 67.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.084 . . . . 0.0 110.751 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 54' ' ' GLN . 83.7 mt -86.96 -52.54 5.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.157 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.736 ' C ' ' H ' ' A' ' 55' ' ' GLY . 15.3 ptt180 -61.93 7.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 0.0 111.219 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.54 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 3.3 mm100 53.5 -8.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.702 -1.249 . . . . 0.0 110.207 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.736 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 86.88 -21.64 18.37 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.846 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CZ ' ' NE2' ' A' ' 54' ' ' GLN . 3.2 m-85 -66.23 -128.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.247 -1.737 . . . . 0.0 109.91 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.418 HG21 ' CE2' ' A' ' 14' ' ' PHE . 4.9 t -164.85 -33.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.84 . . . . 0.0 111.002 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.765 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 5.4 t-80 -171.77 154.25 3.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.701 ' O ' ' CE1' ' A' ' 58' ' ' HIS . . . -141.56 171.4 14.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.218 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.32 121.26 35.36 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.365 -0.834 . . . . 0.0 109.087 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m -96.71 101.41 13.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.4 mtt -109.81 123.4 49.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 110.828 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.0 m -124.38 148.11 47.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.64 156.06 39.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.694 -1.254 . . . . 0.0 110.118 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.446 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 48.8 tp10 -82.91 -28.31 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 75.6 m-20 -164.65 169.23 17.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.5 ' NZ ' ' CB ' ' A' ' 67' ' ' LYS . 8.3 mtmp? -58.9 -18.94 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 111.432 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 25.4 p-10 -59.52 -40.66 87.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.771 -1.205 . . . . 0.0 110.562 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -71.3 -32.89 64.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' O ' HG22 ' A' ' 74' ' ' THR . 70.5 t80 -67.4 -44.7 78.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.522 -0.987 . . . . 0.0 110.498 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.9 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.336 -1.478 . . . . 0.0 108.657 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.88 2.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.261 -0.899 . . . . 0.0 109.345 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.2 -35.49 59.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 111.112 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.2 t -84.23 -30.11 25.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.704 -1.247 . . . . 0.0 110.29 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.6 p -68.52 -29.57 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.965 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' A' ' 78' ' ' LEU . 16.4 m-70 -76.81 127.4 84.11 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 0.0 109.562 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.3 -7.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.4 tp -70.87 -26.19 63.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.351 -0.843 . . . . 0.0 111.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.417 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.5 t60 -80.93 -42.62 21.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.049 . . . . 0.0 110.218 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.772 HG13 ' H ' ' A' ' 81' ' ' GLU . 3.7 p -64.92 -57.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.772 ' H ' HG13 ' A' ' 80' ' ' VAL . 93.2 mt-10 -58.89 -42.73 90.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 81.3 t80 -66.45 -43.36 85.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.863 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -59.89 -33.23 71.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.131 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.63 53.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.935 -1.103 . . . . 0.0 108.681 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -72.22 -43.45 64.43 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.534 ' O ' HD12 ' A' ' 90' ' ' ILE . 26.5 t80 -42.77 -29.02 0.28 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 90' ' ' ILE . 5.8 m -84.52 -61.49 1.78 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.16 -28.73 0.06 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.706 -0.621 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 87' ' ' THR . 8.9 m -97.45 13.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.196 -0.94 . . . . 0.0 110.816 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 86' ' ' PHE . 74.3 mt -123.19 156.03 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.628 -1.295 . . . . 0.0 110.45 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.0 t0 -98.64 -35.4 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' N ' HG22 ' A' ' 90' ' ' ILE . 11.1 pttp -147.63 146.04 29.19 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.7 tp -124.85 126.25 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.62 -1.3 . . . . 0.0 109.727 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t -132.07 135.44 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -139.06 134.97 33.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.303 -1.498 . . . . 0.0 111.751 -178.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.6 mp -113.82 119.08 36.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.681 -0.637 . . . . 0.0 109.303 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.37 130.29 50.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.023 -1.048 . . . . 0.0 108.96 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -172.0 140.03 1.1 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.057 -1.027 . . . . 0.0 110.486 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.91 121.38 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.296 1.998 . . . . 0.0 112.173 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' A' ' 7' ' ' LYS . 65.4 t -109.05 138.11 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.992 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.19 107.55 10.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.376 -0.828 . . . . 0.0 109.639 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -154.88 149.63 26.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.51 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 102' ' ' ALA . 3.2 m -154.91 147.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.247 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -130.27 65.77 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.348 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 106' ' ' SER . 23.2 m -51.67 -23.42 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.15 -0.969 . . . . 0.0 108.944 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' SER . 1.4 p 76.22 144.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.388 -0.82 . . . . 0.0 109.336 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.6 t 52.45 67.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 108' ' ' VAL . 13.3 p -145.16 30.65 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.55 -0.719 . . . . 0.0 109.468 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.13 161.14 0.9 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.38 151.99 95.6 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 120.823 -1.173 . . . . 0.0 109.678 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo . . . . . 0 C--N 1.308 -1.599 0 C-N-CA 122.788 2.325 . . . . 0.0 112.26 179.702 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.3 0.572 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.741 ' O ' HG22 ' B' ' 3' ' ' THR . . . 56.95 -148.32 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 109.382 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.741 HG22 ' O ' ' B' ' 2' ' ' ALA . 0.5 OUTLIER 81.78 -3.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 109.09 179.391 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t -137.73 -98.36 0.19 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.96 175.97 20.27 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.374 -1.393 . . . . 0.0 109.698 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -114.69 129.09 56.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.654 ' HB2' HG21 ' B' ' 100' ' ' VAL . 0.0 OUTLIER -102.97 130.87 50.21 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.319 1.057 . . . . 0.0 112.851 -177.274 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -124.99 123.59 40.2 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.3 tt -131.14 140.06 49.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.762 -1.211 . . . . 0.0 109.444 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 70.0 t -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.586 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' B' ' 59' ' ' ALA . 1.4 t -113.27 130.41 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.17 167.25 26.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 117.723 -1.591 . . . . 0.0 113.058 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' B' ' 91' ' ' ASP . 2.2 mmmt -137.47 151.01 48.02 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD1' ' OG1' ' B' ' 18' ' ' THR . 7.6 m-85 -107.88 147.37 31.05 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.785 -1.197 . . . . 0.0 111.57 -178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -127.99 -27.76 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 75.2 tt0 -88.19 -58.93 2.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.4 m-20 153.07 69.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.639 ' OG1' ' CD1' ' B' ' 14' ' ' PHE . 32.5 m -60.15 111.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.034 0.921 . . . . 0.0 112.927 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.753 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.28 87.34 5.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.02 -32.42 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.661 . . . . 0.0 110.433 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -65.34 -37.43 87.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.56 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 96.3 mt-10 -69.76 -35.37 74.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' B' ' 26' ' ' GLY . 3.3 mm -62.6 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -50.35 -37.04 34.9 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -60.1 -35.88 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -79.3 -42.7 11.48 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.434 HD13 ' C ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -54.31 -59.39 4.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.545 -0.973 . . . . 0.0 108.85 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.41 -34.89 59.51 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -45.56 91.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 30' ' ' LEU . 0.4 OUTLIER -50.15 -44.99 52.85 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' B' ' 34' ' ' ILE . 48.4 t -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.245 -0.909 . . . . 0.0 108.792 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.433 ' C ' ' O ' ' B' ' 31' ' ' VAL . 20.4 m -42.37 -45.64 4.38 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' B' ' 33' ' ' GLN . 22.3 mp0 -71.1 -23.55 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 111.535 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.549 HG22 ' O ' ' B' ' 34' ' ' ILE . 22.2 mt -85.79 28.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.006 -1.684 . . . . 0.0 110.571 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.4 p30 -62.36 -7.14 3.91 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.612 ' O ' ' N ' ' B' ' 38' ' ' LYS . 1.9 t -86.55 2.08 49.37 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.874 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.515 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.5 m 37.47 28.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 109.167 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' B' ' 36' ' ' THR . 78.5 mttt -118.3 39.88 3.32 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 156.72 28.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.498 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 99.3 m-85 -143.75 153.83 42.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.497 -1.377 . . . . 0.0 111.946 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.504 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 56.1 mp0 -158.76 125.23 4.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.407 0.622 . . . . 0.0 110.208 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.601 ' HE1' HG11 ' A' ' 100' ' ' VAL . 53.0 t-105 -124.01 174.69 7.44 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.558 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -133.28 152.91 20.55 Favored Glycine 0 N--CA 1.498 2.82 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.839 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.757 ' O ' ' CD2' ' B' ' 58' ' ' HIS . 71.2 mt-10 -147.2 137.87 23.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.46 143.95 48.24 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.92 122.84 9.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.386 -1.446 . . . . 0.0 109.816 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' B' ' 56' ' ' PHE . 64.9 mm-40 -151.79 45.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.665 -0.647 . . . . 0.0 109.388 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -124.12 121.7 35.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 110.172 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.92 119.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.484 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 79.4 m-20 -56.3 -41.52 76.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.838 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 4.9 ptp -71.8 -31.91 67.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.034 . . . . 0.0 110.726 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' B' ' 54' ' ' GLN . 84.0 mt -86.95 -52.45 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.712 -1.243 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.698 ' C ' ' H ' ' B' ' 55' ' ' GLY . 15.4 ptt180 -62.02 7.94 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 111.307 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.534 ' NE2' ' CZ ' ' B' ' 56' ' ' PHE . 3.3 mm100 53.53 -8.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.832 -1.168 . . . . 0.0 110.225 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.698 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 87.12 -21.48 20.17 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.468 -0.77 . . . . 0.0 112.864 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.534 ' CZ ' ' NE2' ' B' ' 54' ' ' GLN . 3.2 m-85 -66.39 -128.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.278 -1.719 . . . . 0.0 109.915 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.422 HG21 ' CE2' ' B' ' 14' ' ' PHE . 4.8 t -164.46 -34.15 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.276 -0.89 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.757 ' CD2' ' O ' ' B' ' 44' ' ' GLU . 5.4 t-80 -171.61 154.56 3.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.803 -1.186 . . . . 0.0 110.231 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.694 ' O ' ' CE1' ' B' ' 58' ' ' HIS . . . -141.98 171.09 14.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.02 121.26 35.64 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -96.65 101.48 13.1 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 38.8 mtt -109.9 123.6 49.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 110.782 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 97.1 m -124.71 147.93 48.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.53 156.03 39.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.668 -1.27 . . . . 0.0 110.058 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 50.2 tp10 -82.7 -28.64 30.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 75.5 m-20 -164.31 169.74 17.09 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.493 ' NZ ' ' CB ' ' B' ' 67' ' ' LYS . 8.2 mtmp? -59.14 -19.09 41.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 0.0 111.406 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 26.5 p-10 -59.51 -40.67 87.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.905 -1.122 . . . . 0.0 110.55 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -71.22 -32.79 65.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.505 ' O ' HG22 ' B' ' 74' ' ' THR . 71.0 t80 -67.41 -44.87 77.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.644 -0.915 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.8 -28.88 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.352 -1.468 . . . . 0.0 108.671 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.84 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -35.25 59.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 111.141 -176.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.505 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.2 t -84.51 -30.01 25.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.744 -1.223 . . . . 0.0 110.339 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 95.0 p -68.43 -29.56 68.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.12 -0.988 . . . . 0.0 110.964 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 78' ' ' LEU . 16.4 m-70 -76.97 127.53 83.54 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.4 -7.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.598 2.199 . . . . 0.0 112.48 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.4 tp -70.82 -26.38 63.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.408 -0.808 . . . . 0.0 111.178 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -80.86 -42.7 21.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 110.276 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.77 HG13 ' H ' ' B' ' 81' ' ' GLU . 3.6 p -64.8 -57.61 10.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 110.024 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.77 ' H ' HG13 ' B' ' 80' ' ' VAL . 93.2 mt-10 -58.9 -42.67 90.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.299 -0.876 . . . . 0.0 109.587 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 81.1 t80 -66.48 -43.48 85.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.818 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -59.71 -33.36 71.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.111 -0.993 . . . . 0.0 110.149 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.93 49.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 108.644 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -71.81 -43.54 65.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.548 ' O ' HD12 ' B' ' 90' ' ' ILE . 26.4 t80 -42.75 -29.2 0.29 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.471 ' O ' ' N ' ' B' ' 89' ' ' VAL . 5.4 m -84.32 -61.62 1.76 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.98 -28.67 0.06 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.681 -0.637 . . . . 0.0 110.098 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.2 m -97.69 13.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.548 HD12 ' O ' ' B' ' 86' ' ' PHE . 73.4 mt -123.39 156.1 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.651 -1.281 . . . . 0.0 110.437 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' B' ' 13' ' ' LYS . 61.8 t0 -98.54 -35.45 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.453 ' N ' HG22 ' B' ' 90' ' ' ILE . 11.2 pttp -147.66 145.71 29.04 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.43 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.7 tp -124.46 126.06 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.556 -1.34 . . . . 0.0 109.727 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 22.3 t -131.74 135.68 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.868 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -139.11 135.04 33.69 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.256 -1.527 . . . . 0.0 111.798 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.885 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.7 mp -113.86 119.04 35.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 109.33 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.22 130.48 51.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.102 -0.999 . . . . 0.0 108.97 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -171.98 140.08 1.1 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.126 -0.984 . . . . 0.0 110.538 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.86 121.18 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.308 2.005 . . . . 0.0 112.194 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' B' ' 7' ' ' LYS . 63.4 t -108.77 138.29 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 110.037 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.4 107.79 10.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.581 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' ALA . . . . . 0.486 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -155.13 149.62 26.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.486 HG13 ' O ' ' B' ' 102' ' ' ALA . 3.2 m -155.03 147.72 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.377 -0.827 . . . . 0.0 109.233 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -130.27 65.53 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.373 -179.179 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' B' ' 106' ' ' SER . 24.4 m -51.31 -23.83 4.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' B' ' 105' ' ' SER . 1.4 p 76.53 144.83 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.367 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t 52.53 67.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.636 ' O ' HG22 ' B' ' 108' ' ' VAL . 13.3 p -145.16 30.59 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.52 -0.737 . . . . 0.0 109.524 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.91 161.17 0.82 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.467 HG22 ' H ' ' B' ' 110' ' ' THR . 0.0 OUTLIER -70.4 151.83 95.61 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 120.89 -1.131 . . . . 0.0 109.659 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.721 2.281 . . . . 0.0 112.256 179.735 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 mmm . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.306 0.574 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 3' ' ' THR . . . -139.25 95.41 2.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.675 HG23 ' HB2' ' A' ' 101' ' ' ALA . 1.0 OUTLIER 155.25 -62.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.133 -178.327 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 3' ' ' THR . 2.5 t 152.35 -100.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 4' ' ' SER . . . -81.09 170.42 52.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.24 132.92 42.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 108.027 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 5.2 ttpm? -100.3 127.01 46.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 112.813 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 62' ' ' MET . 56.4 m80 -117.12 116.46 27.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -131.59 140.96 49.56 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.734 -1.229 . . . . 0.0 109.408 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.02 138.51 52.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.6 -0.687 . . . . 0.0 109.458 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.13 130.38 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.655 ' HB ' HD12 ' A' ' 90' ' ' ILE . 3.9 m -135.02 148.95 28.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 117.74 -1.584 . . . . 0.0 113.028 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.665 ' HZ2' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -120.15 151.99 38.28 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.113 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.616 ' CD2' HG21 ' A' ' 57' ' ' THR . 9.2 p90 -113.32 152.94 29.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.81 -1.181 . . . . 0.0 111.601 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -128.67 -18.05 3.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.2 mm-40 -90.33 -57.28 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 12.1 m-20 154.09 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 51.7 m -51.59 112.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.098 0.951 . . . . 0.0 112.84 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.569 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.87 90.66 2.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LEU . 29.1 m -62.85 -41.91 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.504 -0.747 . . . . 0.0 110.512 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' HG23 ' A' ' 20' ' ' VAL . 87.1 m-20 -63.43 -45.13 92.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.559 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -70.29 -33.05 71.09 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.34 -40.29 79.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.5 tp -58.84 -38.77 79.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HG3' HG21 ' B' ' 108' ' ' VAL . 3.5 ttpt -61.68 -35.07 76.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.93 -53.55 36.69 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 27' ' ' LEU . 5.8 tt -48.08 -43.84 31.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.511 -0.993 . . . . 0.0 108.813 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -54.71 -46.42 74.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.537 ' ND2' ' CE2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.66 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -47.7 -41.67 23.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.555 HG21 ' HA ' ' B' ' 105' ' ' SER . 19.3 t -54.74 -20.5 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.236 -0.915 . . . . 0.0 108.902 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 74.5 m -44.63 -42.28 7.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.533 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 46.2 mm-40 -83.84 -9.77 58.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 111.398 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 34' ' ' ILE . 45.0 mm -91.23 23.56 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 119.976 -1.702 . . . . 0.0 110.716 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.77 -8.92 1.05 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 37' ' ' VAL . 33.6 p -79.15 -2.82 42.59 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.972 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.614 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.8 m 32.13 41.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.08 -1.012 . . . . 0.0 109.135 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.0 ptmt -122.32 41.93 3.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.569 ' OG ' HD12 ' A' ' 34' ' ' ILE . 87.6 p -173.67 178.18 2.33 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 87.3 m-85 -147.01 155.0 41.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.546 -1.346 . . . . 0.0 111.929 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 46.5 mp0 -152.46 121.18 6.48 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -126.5 168.71 13.87 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.12 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.01 159.28 21.16 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.827 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.57 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 49.4 mp0 -147.78 140.59 24.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.331 -1.1 . . . . 0.0 109.392 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.3 t0 -128.46 155.7 44.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -60.22 80.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.461 -1.4 . . . . 0.0 109.747 -177.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.3 mt-10 -105.04 42.65 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.67 -0.644 . . . . 0.0 109.272 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.554 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 3.4 m -150.09 179.38 8.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.47 150.01 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 51' ' ' MET . 32.2 p-10 -43.94 -44.05 6.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.787 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.527 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 83.2 mmm -67.19 -28.96 68.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.942 -1.099 . . . . 0.0 110.713 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 95' ' ' LEU . 33.9 mt -98.29 -30.18 12.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.772 -1.205 . . . . 0.0 109.292 -178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.662 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 3.2 ptm180 -86.46 -1.73 57.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.827 . . . . 0.0 111.225 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 53' ' ' ARG . 17.0 tt0 45.96 10.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.73 -1.231 . . . . 0.0 110.149 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.662 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 58.77 -5.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.424 -0.797 . . . . 0.0 112.89 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 11.8 p90 -57.0 131.11 48.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.204 -1.762 . . . . 0.0 109.93 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.616 HG21 ' CD2' ' A' ' 14' ' ' PHE . 71.3 p -54.15 -48.1 71.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.0 110.995 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 23.7 t60 -173.0 159.19 3.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.109 . . . . 0.0 110.165 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.612 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -144.83 169.53 17.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -0.805 . . . . 0.0 109.219 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 76.6 m-85 -135.12 130.64 35.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.484 -0.76 . . . . 0.0 109.075 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 98.18 8.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.511 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.2 mtp -98.9 118.89 36.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.165 -0.96 . . . . 0.0 110.849 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -123.29 142.43 50.95 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.94 162.58 18.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.829 -1.17 . . . . 0.0 110.078 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.57 -29.97 29.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -169.76 175.0 5.44 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -58.38 -22.52 54.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 111.415 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.84 -37.56 71.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.809 -1.182 . . . . 0.0 110.617 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.08 76.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.747 ' O ' HG22 ' A' ' 74' ' ' THR . 74.0 t80 -67.14 -44.18 80.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.956 . . . . 0.0 110.417 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.76 -28.93 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.38 -1.45 . . . . 0.0 108.696 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . -64.98 -61.0 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CE1' HD11 ' A' ' 30' ' ' LEU . 2.7 t80 -63.73 -60.22 3.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.207 -0.933 . . . . 0.0 111.115 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 70' ' ' TYR . 14.8 t -49.46 -37.22 25.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.752 -1.218 . . . . 0.0 110.357 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 74' ' ' THR . 63.7 p -65.97 -11.95 51.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 0.0 111.014 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 78' ' ' LEU . 23.1 m80 -92.64 125.99 53.66 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.25 -4.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.675 2.25 . . . . 0.0 112.489 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.3 tp -74.39 -25.87 59.75 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.297 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -77.84 -45.4 24.44 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.086 -1.009 . . . . 0.0 110.247 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.756 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -63.37 -57.94 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.993 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.756 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.3 tt0 -53.59 -36.45 61.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 6.4 m-85 -74.39 -36.18 63.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.875 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -62.09 -42.9 99.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.61 -44.14 97.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 108.656 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -68.87 -44.19 73.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.482 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.03 -30.18 0.41 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' VAL . 10.9 m -82.36 -64.17 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -43.3 -24.83 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 110.099 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 85' ' ' ALA . 4.9 m -107.4 9.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 110.723 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.655 HD12 ' HB ' ' A' ' 12' ' ' VAL . 28.9 mm -131.44 164.37 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.6 -1.313 . . . . 0.0 110.504 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 90' ' ' ILE . 52.2 t0 -109.42 -33.41 6.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' NZ ' ' NZ ' ' A' ' 13' ' ' LYS . 29.2 pttt -147.84 147.57 29.94 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.605 HD12 HG12 ' A' ' 12' ' ' VAL . 4.1 tp -128.86 123.81 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.637 -1.289 . . . . 0.0 109.785 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.7 132.64 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -142.05 138.37 31.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.269 -1.519 . . . . 0.0 111.748 -178.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.875 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -116.5 119.28 35.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.719 -0.613 . . . . 0.0 109.355 177.216 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.403 ' O ' ' OG ' ' B' ' 48' ' ' SER . 62.2 t0 -111.21 117.5 33.38 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -0.989 . . . . 0.0 108.971 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 54.7 t80 -141.37 137.65 16.8 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.01 . . . . 0.0 110.465 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.55 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 31.0 Cg_endo -61.02 127.81 23.42 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.257 1.972 . . . . 0.0 112.229 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.61 117.3 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.009 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.675 ' HB2' HG23 ' A' ' 3' ' ' THR . . . -109.35 95.29 5.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.546 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.422 ' C ' HG13 ' A' ' 103' ' ' VAL . . . -65.45 69.74 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.9 m -152.88 95.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.243 -178.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' SER . 7.7 ptmm? -175.19 -126.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.396 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.578 ' HA ' HG21 ' B' ' 31' ' ' VAL . 1.5 m 63.96 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 108.899 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' LYS . 4.4 m -115.84 71.04 0.76 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.276 -0.89 . . . . 0.0 109.339 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 108' ' ' VAL . 14.3 p -119.94 -4.9 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.615 ' O ' HG22 ' A' ' 108' ' ' VAL . 9.6 p -176.58 53.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.591 -0.693 . . . . 0.0 109.447 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 108' ' ' VAL . . . -54.24 -177.53 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.5 p -134.55 69.71 72.46 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 120.865 -1.147 . . . . 0.0 109.685 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 C--N 1.308 -1.585 0 C-N-CA 122.795 2.33 . . . . 0.0 112.266 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.4 mmm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' B' ' 3' ' ' THR . . . -139.97 95.08 2.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 109.409 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.665 HG23 ' HB2' ' B' ' 101' ' ' ALA . 1.0 OUTLIER 155.5 -62.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.111 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.631 ' CB ' ' O ' ' B' ' 3' ' ' THR . 2.5 t 152.24 -100.89 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' B' ' 4' ' ' SER . . . -81.19 170.41 52.59 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.02 133.16 42.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.281 -1.129 . . . . 0.0 108.043 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' B' ' 7' ' ' LYS . 5.1 ttpm? -100.51 126.93 46.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.937 -1.102 . . . . 0.0 112.843 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 62' ' ' MET . 56.0 m80 -117.11 116.2 26.86 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -131.28 141.13 49.93 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.657 -1.277 . . . . 0.0 109.474 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.05 138.64 52.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 130.3 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.657 ' HB ' HD12 ' B' ' 90' ' ' ILE . 3.9 m -134.94 148.77 28.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.818 -1.553 . . . . 0.0 113.051 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.64 ' HZ2' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -120.11 151.91 38.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.61 ' CD2' HG21 ' B' ' 57' ' ' THR . 9.4 p90 -113.35 152.96 29.28 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.828 -1.17 . . . . 0.0 111.545 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -128.77 -18.0 3.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CG ' ' B' ' 17' ' ' ASP . 77.5 mm-40 -90.32 -57.08 2.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CG ' ' O ' ' B' ' 16' ' ' GLU . 12.7 m-20 153.73 58.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.447 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 58.6 m -52.45 112.35 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.147 0.975 . . . . 0.0 112.846 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.582 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.6 90.46 2.79 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' B' ' 24' ' ' LEU . 29.8 m -62.7 -41.93 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.683 -0.636 . . . . 0.0 110.474 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.524 ' N ' HG23 ' B' ' 20' ' ' VAL . 86.2 m-20 -63.45 -45.01 92.84 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.447 -0.783 . . . . 0.0 110.563 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -70.3 -33.26 71.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.26 -40.19 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -58.99 -38.65 79.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.426 ' HG3' HG21 ' A' ' 108' ' ' VAL . 3.5 ttpt -61.52 -35.03 76.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.44 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -64.44 -53.07 38.08 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.685 HD23 ' O ' ' B' ' 27' ' ' LEU . 5.8 tt -48.21 -43.97 32.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.577 -0.955 . . . . 0.0 108.799 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -54.49 -46.77 73.51 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' B' ' 82' ' ' PHE . 0.0 OUTLIER -52.79 -41.34 64.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.555 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -47.98 -41.35 24.98 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 105' ' ' SER . 19.3 t -54.99 -20.21 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.311 -0.868 . . . . 0.0 108.829 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.47 ' N ' ' O ' ' B' ' 29' ' ' ASN . 73.6 m -44.87 -42.34 7.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.534 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 46.1 mm-40 -83.85 -9.55 58.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.449 -0.782 . . . . 0.0 111.523 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.769 HG22 ' O ' ' B' ' 34' ' ' ILE . 44.9 mm -91.29 23.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.031 -1.668 . . . . 0.0 110.641 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -57.65 -8.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.592 ' O ' ' C ' ' B' ' 37' ' ' VAL . 34.2 p -79.06 -2.68 41.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.984 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.592 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.0 m 32.13 41.84 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.121 -0.987 . . . . 0.0 109.194 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.1 ptmt -122.24 42.15 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.573 ' OG ' HD12 ' B' ' 34' ' ' ILE . 89.2 p -173.82 177.97 2.32 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 86.5 m-85 -146.91 155.06 42.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.52 -1.362 . . . . 0.0 111.944 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' B' ' 41' ' ' GLU . 46.4 mp0 -152.42 121.11 6.47 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.364 0.602 . . . . 0.0 110.194 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.642 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.7 OUTLIER -126.48 168.83 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.09 159.48 21.22 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.807 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.584 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 49.8 mp0 -148.13 140.65 24.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.407 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' B' ' 47' ' ' GLU . 61.9 t0 -128.49 155.64 44.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.521 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -60.17 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.44 -1.413 . . . . 0.0 109.773 -177.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.5 mt-10 -104.65 42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.676 -0.64 . . . . 0.0 109.358 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 3.6 m -150.04 179.58 7.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.139 -0.975 . . . . 0.0 110.243 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.62 150.29 41.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.945 . . . . 0.0 109.701 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.3 p-10 -44.14 -43.77 7.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.858 . . . . 0.0 110.8 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.53 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 83.4 mmm -67.57 -28.95 68.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.14 -0.975 . . . . 0.0 110.75 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 95' ' ' LEU . 34.6 mt -98.32 -29.76 12.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.747 -1.221 . . . . 0.0 109.265 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' B' ' 55' ' ' GLY . 3.2 ptm180 -86.89 -1.66 57.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.394 -0.816 . . . . 0.0 111.243 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 45.99 10.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.807 -1.183 . . . . 0.0 110.194 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 59.3 -5.81 0.08 OUTLIER Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.428 -0.795 . . . . 0.0 112.881 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 11.7 p90 -56.64 131.11 47.98 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.259 -1.73 . . . . 0.0 109.899 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.61 HG21 ' CD2' ' B' ' 14' ' ' PHE . 69.9 p -54.19 -47.9 71.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.279 -0.888 . . . . 0.0 110.995 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.64 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 23.6 t60 -173.13 159.61 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.9 -1.125 . . . . 0.0 110.165 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -145.39 169.28 18.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.542 -0.724 . . . . 0.0 109.292 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 76.6 m-85 -134.91 130.64 36.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.512 -0.742 . . . . 0.0 109.081 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 97.81 8.55 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' MET . . . . . 0.515 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.8 mtp -98.62 119.1 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.198 -0.939 . . . . 0.0 110.77 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -123.43 142.63 50.79 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.0 162.99 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 110.038 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -82.98 -29.84 28.69 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -169.73 175.44 5.28 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -58.72 -22.46 57.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 111.45 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -57.08 -37.57 72.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.804 -1.185 . . . . 0.0 110.565 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 -33.1 77.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.748 ' O ' HG22 ' B' ' 74' ' ' THR . 74.5 t80 -67.01 -44.55 80.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.947 . . . . 0.0 110.405 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.81 -28.87 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.329 -1.482 . . . . 0.0 108.669 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.1 -60.91 2.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.673 ' CE1' HD11 ' B' ' 30' ' ' LEU . 2.7 t80 -63.22 -60.48 3.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 111.136 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.748 HG22 ' O ' ' B' ' 70' ' ' TYR . 14.9 t -49.47 -37.18 25.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 63.9 p -65.92 -12.04 51.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.982 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' B' ' 78' ' ' LEU . 23.1 m80 -92.6 126.27 52.71 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.898 -1.126 . . . . 0.0 109.544 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -44.6 -4.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.686 2.257 . . . . 0.0 112.424 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.3 tp -74.44 -26.22 59.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.366 -0.834 . . . . 0.0 111.18 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -77.72 -45.25 25.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.95 -1.094 . . . . 0.0 110.321 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.767 HG13 ' N ' ' B' ' 81' ' ' GLU . 7.1 p -63.19 -58.21 8.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.767 ' N ' HG13 ' B' ' 80' ' ' VAL . 84.0 tt0 -53.56 -36.36 61.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 6.4 m-85 -74.38 -36.4 63.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.872 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 87.5 p -61.79 -43.05 99.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.052 -1.03 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.97 97.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 108.622 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.632 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -69.13 -43.99 73.28 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.485 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.22 -30.0 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.6 m -82.48 -64.15 1.23 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -43.26 -24.94 0.1 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.76 -0.588 . . . . 0.0 110.12 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.632 HG22 ' O ' ' B' ' 85' ' ' ALA . 4.9 m -107.34 9.89 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 110.838 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.657 HD12 ' HB ' ' B' ' 12' ' ' VAL . 28.3 mm -131.68 164.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.628 -1.295 . . . . 0.0 110.462 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.628 ' N ' HG22 ' B' ' 90' ' ' ILE . 52.0 t0 -109.28 -33.49 6.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.491 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 28.2 pttt -147.86 147.67 30.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.608 HD12 HG12 ' B' ' 12' ' ' VAL . 4.2 tp -128.98 123.67 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.569 -1.332 . . . . 0.0 109.711 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.52 132.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.844 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -141.95 138.5 32.0 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.266 -1.521 . . . . 0.0 111.774 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.871 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.0 OUTLIER -116.55 119.27 35.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.708 -0.62 . . . . 0.0 109.334 177.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.408 ' O ' ' OG ' ' A' ' 48' ' ' SER . 62.4 t0 -111.19 117.14 32.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.04 -1.037 . . . . 0.0 108.889 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 55.6 t80 -140.87 137.89 17.62 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.057 -1.027 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 31.3 Cg_endo -61.18 127.91 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.286 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 5' ' ' GLY . 99.2 t -92.76 117.41 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 109.974 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' B' ' 3' ' ' THR . . . -109.45 95.05 5.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 109.609 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' ALA . . . . . 0.424 ' C ' HG13 ' B' ' 103' ' ' VAL . . . -65.36 70.05 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.784 HG23 ' O ' ' B' ' 103' ' ' VAL . 21.9 m -153.15 95.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' B' ' 106' ' ' SER . 7.6 ptmm? -175.09 -127.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.331 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.555 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.6 m 64.16 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 108.922 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.504 ' N ' ' O ' ' B' ' 104' ' ' LYS . 4.4 m -115.76 70.6 0.75 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.461 HG13 HG12 ' B' ' 108' ' ' VAL . 13.9 p -119.56 -5.05 10.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.632 ' O ' HG22 ' B' ' 108' ' ' VAL . 9.7 p -176.57 53.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 109.569 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' B' ' 108' ' ' VAL . . . -54.15 -177.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 46.6 p -134.45 70.26 72.61 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.846 -1.159 . . . . 0.0 109.678 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.74 2.293 . . . . 0.0 112.267 -179.938 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 64.1 mtt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.283 0.563 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 62.29 38.56 13.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 109.413 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -101.15 -7.82 22.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.111 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.7 t -145.93 -80.91 0.15 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.16 -158.97 7.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -135.76 138.15 42.38 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.164 -1.198 . . . . 0.0 108.09 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.452 ' CD ' ' CZ2' ' B' ' 42' ' ' TRP . 1.1 ttpm? -113.32 141.31 47.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.906 -1.121 . . . . 0.0 112.801 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -130.02 130.05 44.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.3 tt -135.17 144.67 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.7 -1.25 . . . . 0.0 109.485 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.8 p -128.47 135.56 62.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.434 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.38 128.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.81 157.0 32.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 117.766 -1.574 . . . . 0.0 112.994 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 91' ' ' ASP . 20.6 tptm -122.34 152.1 40.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' HB2' ' H ' ' A' ' 18' ' ' THR . 29.9 p90 -105.29 147.17 28.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.942 -1.099 . . . . 0.0 111.643 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -120.75 -24.91 5.58 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.0 mt-10 -89.38 -54.98 3.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.5 t0 150.58 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.497 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 61.0 m -58.91 110.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.112 0.958 . . . . 0.0 112.851 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.724 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -81.29 92.67 6.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.675 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 20' ' ' VAL . 11.5 m -58.72 -32.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.551 -0.718 . . . . 0.0 110.473 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.6 p-10 -66.41 -39.2 88.84 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 78.0 mm-40 -67.74 -34.2 76.38 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.71 -44.36 93.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.6 ' CD2' ' H ' ' B' ' 110' ' ' THR . 7.4 tp -53.89 -37.15 63.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.85 -32.12 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -81.9 -43.76 8.08 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.67 -58.27 8.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.482 -1.011 . . . . 0.0 108.777 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 9.3 pt-20 -51.68 -43.95 62.92 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' ' CG ' ' A' ' 28' ' ' GLU . 14.9 t-20 -61.56 -43.38 98.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.755 HD22 HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -49.95 -43.73 50.24 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.027 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 34' ' ' ILE . 39.8 t -50.8 -27.86 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.315 -0.866 . . . . 0.0 108.874 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' VAL . 46.9 t -40.61 -42.89 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.528 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 29.9 mm100 -75.75 -23.15 55.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.495 -0.753 . . . . 0.0 111.462 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.651 ' O ' HG22 ' A' ' 34' ' ' ILE . 30.9 mm -85.69 25.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.068 -1.645 . . . . 0.0 110.648 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 36' ' ' THR . 54.3 p30 -60.74 -9.01 3.39 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 38' ' ' LYS . 59.5 p -73.88 -3.2 27.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.896 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.5 m 35.65 30.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.16 -0.963 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 36' ' ' THR . 75.1 mttt -118.94 39.5 3.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 t -170.9 170.92 6.18 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -147.42 157.48 43.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.595 -1.316 . . . . 0.0 112.006 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.562 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 58.1 mt-10 -151.59 120.26 6.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.417 0.627 . . . . 0.0 110.169 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.709 ' CD1' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.49 164.55 24.58 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.709 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -134.45 174.1 21.13 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.733 -1.699 . . . . 0.0 110.766 -178.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -152.69 141.21 20.77 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -1.174 . . . . 0.0 109.371 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -105.12 140.72 37.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -135.24 103.59 5.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.374 -1.454 . . . . 0.0 109.749 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -146.97 25.6 1.13 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.651 -0.656 . . . . 0.0 109.312 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.476 ' H ' ' CB ' ' A' ' 53' ' ' ARG . 11.6 p -89.09 -106.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 m80 -92.61 148.07 22.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 51' ' ' MET . 31.5 p-10 -53.45 -43.07 67.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.365 -0.834 . . . . 0.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.522 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.9 tpt -75.42 -32.05 60.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.0 110.745 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 95' ' ' LEU . 48.9 mt -90.14 -54.53 3.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.732 -1.23 . . . . 0.0 109.305 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.76 ' C ' ' H ' ' A' ' 55' ' ' GLY . 12.5 ptt180 -62.59 1.23 0.39 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.492 ' NE2' HG11 ' B' ' 94' ' ' VAL . 0.4 OUTLIER 56.11 -17.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.803 -1.185 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.76 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 88.05 -23.16 15.29 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.511 -0.743 . . . . 0.0 112.905 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' GLY . 3.5 m-85 -61.23 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.212 -1.758 . . . . 0.0 109.903 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 58' ' ' HIS . 3.2 t -161.5 -35.99 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.315 -0.866 . . . . 0.0 110.996 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.667 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 35.1 t-80 -166.89 149.46 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.937 -1.102 . . . . 0.0 110.19 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -142.72 167.63 21.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 58' ' ' HIS . 91.3 m-85 -138.15 134.87 35.12 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.494 -0.754 . . . . 0.0 109.073 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.546 ' OG ' ' CZ3' ' A' ' 42' ' ' TRP . 1.4 m -116.45 104.64 11.64 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.7 mtt -95.32 125.45 39.96 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.143 -0.973 . . . . 0.0 110.79 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 m -118.89 140.87 49.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -127.2 128.1 45.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.742 -1.224 . . . . 0.0 110.036 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -50.96 -26.36 5.85 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -171.43 172.9 4.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.9 -19.17 60.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 111.361 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.92 -40.71 89.8 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.859 -1.15 . . . . 0.0 110.613 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.84 -29.25 59.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 74' ' ' THR . 73.5 t80 -66.1 -42.59 89.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.917 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.407 -1.433 . . . . 0.0 108.669 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.96 2.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.304 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.45 -39.39 64.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 111.159 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.0 t -79.78 -29.62 40.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.746 -1.221 . . . . 0.0 110.338 -177.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -65.44 -25.56 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 111.023 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' A' ' 78' ' ' LEU . 56.8 t-80 -79.04 125.33 83.95 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.833 -1.167 . . . . 0.0 109.661 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.43 -6.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.755 HD23 HD22 ' A' ' 30' ' ' LEU . 6.1 tp -75.84 -25.38 56.19 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 111.203 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.6 t60 -76.57 -43.0 40.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.018 -1.051 . . . . 0.0 110.241 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.733 HG13 ' N ' ' A' ' 81' ' ' GLU . 11.3 p -64.4 -54.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.733 ' N ' HG13 ' A' ' 80' ' ' VAL . 78.7 mm-40 -50.43 -30.83 13.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' CD1' ' A' ' 86' ' ' PHE . 4.2 m-85 -72.97 -37.34 67.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.879 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.6 m -63.46 -42.33 98.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.0 110.14 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.48 67.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.965 -1.084 . . . . 0.0 108.751 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.0 -43.43 82.93 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 82' ' ' PHE . 2.5 m-85 -45.0 -31.06 1.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.1 m -78.94 -63.31 1.45 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.03 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.72 -0.612 . . . . 0.0 110.064 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.4 m -111.92 6.91 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.18 -0.95 . . . . 0.0 110.803 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 34.5 mt -120.11 154.64 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.647 -1.283 . . . . 0.0 110.444 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.9 t0 -103.52 -31.42 9.96 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' NZ ' ' CE1' ' A' ' 56' ' ' PHE . 37.9 pttt -150.44 149.3 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 93' ' ' ILE . 3.8 tp -125.24 121.94 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.615 -1.303 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.496 HG11 ' NE2' ' B' ' 54' ' ' GLN . 48.8 t -129.76 133.52 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -139.49 136.86 34.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.241 -1.537 . . . . 0.0 111.752 -178.145 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.95 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.94 121.44 42.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.655 -0.653 . . . . 0.0 109.383 176.175 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 68.2 t0 -123.12 128.35 49.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.017 . . . . 0.0 108.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -164.08 139.68 4.93 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.096 -1.003 . . . . 0.0 110.505 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.03 120.68 4.4 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.292 1.995 . . . . 0.0 112.202 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -105.55 135.73 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.93 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.78 75.51 0.93 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.87 113.3 24.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 104' ' ' LYS . 16.9 m -134.42 -54.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.171 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.694 ' H ' HG23 ' A' ' 103' ' ' VAL . 26.0 mmtm 60.19 -129.75 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 0.0 109.339 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 104' ' ' LYS . 0.9 OUTLIER 72.52 -18.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.181 -0.949 . . . . 0.0 108.978 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 104' ' ' LYS . 2.0 t 168.75 -42.04 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 109.346 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 109' ' ' ALA . 53.8 t -145.11 145.25 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 108' ' ' VAL . 1.9 p -122.13 13.49 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.59 ' H ' HG12 ' A' ' 107' ' ' VAL . . . -58.07 136.79 57.23 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.59 ' H ' ' CD2' ' B' ' 24' ' ' LEU . 25.8 m -132.58 71.44 78.84 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 120.841 -1.162 . . . . 0.0 109.636 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo . . . . . 0 C--N 1.308 -1.595 0 C-N-CA 122.805 2.336 . . . . 0.0 112.178 -179.905 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' B' ' 2' ' ' ALA . 63.9 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' B' ' 1' ' ' MET . . . 62.7 38.79 11.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 0.0 109.355 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 5.5 t -101.34 -7.84 22.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.0 109.086 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t -145.94 -81.12 0.15 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.98 -158.47 7.6 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.694 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.36 137.68 40.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.279 -1.13 . . . . 0.0 108.015 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.458 ' CD ' ' CZ2' ' A' ' 42' ' ' TRP . 1.1 ttpm? -112.89 141.22 46.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.864 -1.147 . . . . 0.0 112.787 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -129.99 130.13 44.63 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.4 tt -135.45 144.54 46.51 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.798 -1.189 . . . . 0.0 109.479 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.418 ' O ' HG13 ' B' ' 10' ' ' VAL . 11.0 p -128.45 135.41 62.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.629 -0.669 . . . . 0.0 109.537 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.25 128.27 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.07 156.9 31.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 117.769 -1.572 . . . . 0.0 113.011 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' B' ' 91' ' ' ASP . 20.7 tptm -122.4 151.73 40.93 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.518 ' HB2' ' H ' ' B' ' 18' ' ' THR . 30.0 p90 -105.07 147.3 28.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.863 -1.148 . . . . 0.0 111.555 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -120.82 -25.07 5.5 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 94.9 mt-10 -89.21 -55.06 3.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.4 t0 150.5 72.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.518 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.9 m -59.11 110.3 1.02 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.105 0.955 . . . . 0.0 112.85 -176.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.729 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -81.4 92.46 6.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 175.676 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' H ' HG22 ' B' ' 20' ' ' VAL . 11.7 m -58.37 -32.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.609 -0.682 . . . . 0.0 110.43 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -66.49 -39.23 88.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.533 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 77.6 mm-40 -67.75 -34.07 76.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.74 -44.49 93.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.59 ' CD2' ' H ' ' A' ' 110' ' ' THR . 7.5 tp -53.63 -37.16 62.8 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.93 -31.95 70.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -81.96 -43.7 8.08 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -56.82 -58.04 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.589 -0.947 . . . . 0.0 108.832 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.536 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 9.4 pt-20 -51.68 -44.31 63.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.536 ' N ' ' CG ' ' B' ' 28' ' ' GLU . 15.1 t-20 -61.22 -43.31 99.08 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.761 HD22 HD23 ' B' ' 78' ' ' LEU . 1.0 OUTLIER -50.13 -43.61 51.93 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.093 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' B' ' 34' ' ' ILE . 40.6 t -51.05 -27.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.266 -0.896 . . . . 0.0 108.847 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.474 ' C ' ' O ' ' B' ' 31' ' ' VAL . 48.0 t -40.59 -43.34 1.87 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.525 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 29.9 mm100 -75.3 -23.35 57.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.425 -0.797 . . . . 0.0 111.517 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.656 HG22 ' O ' ' B' ' 34' ' ' ILE . 30.0 mm -85.45 25.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 119.995 -1.69 . . . . 0.0 110.605 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.3 p30 -60.63 -8.91 3.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' B' ' 38' ' ' LYS . 64.8 p -74.04 -3.43 29.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.963 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.554 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.6 m 36.03 30.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.13 -0.981 . . . . 0.0 109.135 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' B' ' 36' ' ' THR . 74.2 mttt -118.77 39.7 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 13.1 t -171.18 170.79 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -147.51 157.37 43.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.521 -1.362 . . . . 0.0 111.934 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.564 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 57.1 mt-10 -151.69 119.89 6.32 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.349 0.595 . . . . 0.0 110.282 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.702 ' CD1' ' N ' ' B' ' 43' ' ' GLY . 0.0 OUTLIER -130.03 164.55 24.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.07 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.702 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -134.32 174.24 21.03 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.749 -1.691 . . . . 0.0 110.885 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 0.2 OUTLIER -152.92 140.92 20.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -1.142 . . . . 0.0 109.387 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -104.99 140.42 38.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.529 ' CD ' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -135.0 103.78 5.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.388 -1.445 . . . . 0.0 109.769 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -147.07 25.68 1.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.322 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.468 ' H ' ' CB ' ' B' ' 53' ' ' ARG . 11.7 p -89.18 -106.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.932 . . . . 0.0 110.107 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' B' ' 53' ' ' ARG . 76.4 m80 -92.22 147.98 22.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.157 -0.964 . . . . 0.0 109.699 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.1 p-10 -53.36 -43.29 67.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 110.799 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 1.9 tpt -75.02 -32.34 61.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.732 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 95' ' ' LEU . 46.2 mt -90.05 -54.58 3.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.682 -1.261 . . . . 0.0 109.324 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.742 ' C ' ' H ' ' B' ' 55' ' ' GLY . 12.9 ptt180 -62.47 1.33 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.354 -0.841 . . . . 0.0 111.247 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.496 ' NE2' HG11 ' A' ' 94' ' ' VAL . 0.4 OUTLIER 56.01 -17.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.821 -1.174 . . . . 0.0 110.194 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.742 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 88.07 -22.84 16.69 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.455 -0.778 . . . . 0.0 112.795 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' B' ' 55' ' ' GLY . 3.5 m-85 -61.52 -133.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.272 -1.723 . . . . 0.0 109.962 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' B' ' 58' ' ' HIS . 3.0 t -161.56 -36.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.194 -0.941 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.651 ' HA ' ' O ' ' B' ' 44' ' ' GLU . 34.9 t-80 -166.6 149.52 6.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 0.0 110.206 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.535 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -142.68 167.76 21.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.764 . . . . 0.0 109.272 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' B' ' 58' ' ' HIS . 92.0 m-85 -138.28 134.84 34.85 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.446 -0.784 . . . . 0.0 109.094 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.539 ' OG ' ' CZ3' ' B' ' 42' ' ' TRP . 1.4 m -116.5 104.91 11.9 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 61.6 mtt -95.49 125.79 40.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.209 -0.932 . . . . 0.0 110.73 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 39.2 m -119.18 140.6 49.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -126.87 127.86 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.247 . . . . 0.0 110.029 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -50.54 -26.44 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -171.52 173.02 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.98 -19.16 60.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 111.435 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.84 90.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.827 -1.171 . . . . 0.0 110.571 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.56 59.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.594 ' O ' HG22 ' B' ' 74' ' ' THR . 74.3 t80 -65.59 -42.94 91.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.594 -0.945 . . . . 0.0 110.425 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.69 -28.99 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.38 -1.45 . . . . 0.0 108.671 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 109.356 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.0 OUTLIER -53.67 -39.23 64.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 111.221 -177.085 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.594 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.0 t -79.67 -29.64 40.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.779 -1.201 . . . . 0.0 110.341 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.6 m -65.59 -25.29 67.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.987 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' B' ' 78' ' ' LEU . 57.5 t-80 -79.19 125.08 84.12 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.29 -6.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.696 2.264 . . . . 0.0 112.433 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.761 HD23 HD22 ' B' ' 30' ' ' LEU . 6.1 tp -75.62 -25.42 56.91 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.369 -0.832 . . . . 0.0 111.233 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 2.8 t60 -76.87 -42.68 38.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.978 -1.076 . . . . 0.0 110.29 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.728 HG13 ' N ' ' B' ' 81' ' ' GLU . 11.6 p -64.52 -54.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.728 ' N ' HG13 ' B' ' 80' ' ' VAL . 79.0 mm-40 -50.4 -30.95 13.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.618 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' B' ' 86' ' ' PHE . 4.3 m-85 -72.81 -37.08 67.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.849 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.8 m -63.83 -42.28 97.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.128 -0.982 . . . . 0.0 110.082 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -50.39 67.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.029 . . . . 0.0 108.673 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.14 -43.38 82.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' B' ' 82' ' ' PHE . 2.5 m-85 -45.11 -31.01 1.24 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.539 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.7 m -78.9 -63.31 1.45 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -40.0 -24.14 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.645 -0.659 . . . . 0.0 110.074 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.3 m -111.88 7.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.198 -0.939 . . . . 0.0 110.807 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 34.5 mt -120.34 154.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.642 -1.286 . . . . 0.0 110.458 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' B' ' 13' ' ' LYS . 62.2 t0 -103.34 -31.58 9.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.447 ' NZ ' ' CE1' ' B' ' 56' ' ' PHE . 38.1 pttt -150.41 149.41 30.0 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.489 HG23 ' O ' ' B' ' 93' ' ' ILE . 3.9 tp -125.42 122.21 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.647 -1.283 . . . . 0.0 109.727 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.492 HG11 ' NE2' ' A' ' 54' ' ' GLN . 49.8 t -129.98 133.69 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.578 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -139.6 136.83 34.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.291 -1.505 . . . . 0.0 111.73 -178.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.929 HD12 ' N ' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.92 121.09 41.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.335 176.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 68.3 t0 -122.88 128.38 50.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 108.928 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -164.13 139.61 4.87 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.574 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.11 121.01 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.231 1.954 . . . . 0.0 112.294 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 18.6 t -105.96 135.57 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.002 . . . . 0.0 110.036 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.68 75.29 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.73 113.33 24.96 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.677 HG23 ' H ' ' B' ' 104' ' ' LYS . 16.8 m -134.37 -54.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.284 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.677 ' H ' HG23 ' B' ' 103' ' ' VAL . 25.9 mmtm 59.91 -129.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.396 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' B' ' 104' ' ' LYS . 0.9 OUTLIER 72.32 -18.23 0.34 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.217 -0.927 . . . . 0.0 109.02 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.518 ' H ' ' C ' ' B' ' 104' ' ' LYS . 2.0 t 168.55 -41.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.6 HG12 ' H ' ' B' ' 109' ' ' ALA . 55.1 t -145.37 144.99 21.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.445 HG13 ' O ' ' B' ' 108' ' ' VAL . 1.9 p -122.01 13.49 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.782 . . . . 0.0 109.449 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ALA . . . . . 0.6 ' H ' HG12 ' B' ' 107' ' ' VAL . . . -58.09 136.44 57.19 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.6 ' H ' ' CD2' ' A' ' 24' ' ' LEU . 26.5 m -132.25 71.94 79.13 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 120.894 -1.129 . . . . 0.0 109.625 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 C--N 1.308 -1.554 0 C-N-CA 122.712 2.275 . . . . 0.0 112.288 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' H ' ' HG3' ' A' ' 99' ' ' PRO . . . 47.45 59.77 3.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.692 HG23 ' N ' ' A' ' 4' ' ' SER . 9.8 t -63.02 -49.8 73.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.181 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.692 ' N ' HG23 ' A' ' 3' ' ' THR . 32.0 t -144.22 -95.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.04 154.05 40.61 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.635 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.05 127.27 53.26 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -1.14 . . . . 0.0 108.037 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.8 ttpm? -108.39 137.83 45.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 112.769 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -124.49 123.21 39.63 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.41 142.27 49.21 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 109.478 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.4 p -129.81 134.74 62.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.42 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.41 129.08 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 m -134.44 161.85 39.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 117.771 -1.572 . . . . 0.0 113.036 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.54 151.24 51.74 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' HB2' ' H ' ' A' ' 18' ' ' THR . 22.5 p90 -109.72 146.99 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.899 -1.125 . . . . 0.0 111.529 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -130.17 -20.24 3.08 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 79.4 mm-40 -91.18 -58.01 2.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.8 m-20 156.52 65.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.5 m -57.4 108.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.075 0.941 . . . . 0.0 112.835 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.65 87.12 3.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.034 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 21' ' ' ASP . 26.8 m -61.61 -37.73 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.524 -0.735 . . . . 0.0 110.493 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.465 ' N ' HG23 ' A' ' 20' ' ' VAL . 81.5 m-20 -66.41 -42.16 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.62 -32.48 73.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.14 -38.99 83.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.65 -35.25 60.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.37 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -60.56 -54.4 37.44 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.8 tt -51.33 -47.9 62.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.548 -0.972 . . . . 0.0 108.764 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.14 -37.26 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -61.94 -44.21 97.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.846 HD13 ' NE2' ' A' ' 33' ' ' GLN . 3.0 mm? -50.07 -47.2 53.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.4 t -50.65 -26.32 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.252 -0.905 . . . . 0.0 108.883 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 27.2 t -47.38 -44.23 24.07 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.846 ' NE2' HD13 ' A' ' 30' ' ' LEU . 12.8 pm0 -92.98 -24.32 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.541 ' C ' ' H ' ' A' ' 36' ' ' THR . 9.3 mt -71.55 26.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 119.983 -1.698 . . . . 0.0 110.631 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' GLN . 88.9 m-20 -62.84 -7.33 4.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' LYS . 50.8 p -71.93 -5.83 37.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.949 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.59 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.7 m 33.51 31.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.63 ' N ' ' O ' ' A' ' 36' ' ' THR . 6.0 mtmp? -117.35 38.61 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 72.8 m -173.63 177.29 2.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.434 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.3 m-85 -146.88 155.94 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.574 -1.329 . . . . 0.0 112.016 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 85.4 mt-10 -158.69 129.26 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.43 0.633 . . . . 0.0 110.17 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.54 177.29 8.57 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.8 162.26 22.37 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.727 -1.701 . . . . 0.0 110.816 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.628 ' N ' ' CE1' ' A' ' 58' ' ' HIS . 72.3 mt-10 -145.93 138.18 25.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -1.168 . . . . 0.0 109.438 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.14 149.28 43.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' H ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.99 81.16 0.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.396 -1.44 . . . . 0.0 109.824 -176.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -115.37 56.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.643 -0.661 . . . . 0.0 109.33 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 49' ' ' HIS . 38.5 t -150.95 83.59 1.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.203 -0.935 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.701 ' N ' HH21 ' A' ' 53' ' ' ARG . 79.1 m-70 56.83 118.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 96.6 m-20 -44.61 -33.88 1.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.339 -0.85 . . . . 0.0 110.726 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -76.94 -32.0 57.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.026 . . . . 0.0 110.714 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 95' ' ' LEU . 62.9 mt -96.32 -12.38 24.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.732 -1.23 . . . . 0.0 109.333 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.701 HH21 ' N ' ' A' ' 49' ' ' HIS . 5.9 ptp180 -95.78 2.15 53.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.311 -0.868 . . . . 0.0 111.263 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' PHE . 95.1 mm-40 44.13 19.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.82 -1.175 . . . . 0.0 110.169 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.757 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 48.75 3.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.759 0 O-C-N 121.424 -0.797 . . . . 0.0 112.914 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.757 ' O ' ' O ' ' A' ' 55' ' ' GLY . 33.2 m-85 -49.94 -143.73 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.229 -1.748 . . . . 0.0 109.987 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 93.0 m -135.93 -55.88 0.77 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.951 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.628 ' CE1' ' N ' ' A' ' 44' ' ' GLU . 13.0 t60 -168.41 152.88 6.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.879 -1.138 . . . . 0.0 110.156 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.549 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.06 115.86 10.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.231 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.29 131.67 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.118 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -121.8 122.0 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 110.749 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -122.7 143.2 49.95 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -117.73 159.81 22.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.788 -1.195 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.69 -28.91 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -174.53 -178.1 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.94 -27.09 67.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 111.453 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.02 -43.98 97.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.78 -1.2 . . . . 0.0 110.548 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.44 67.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.597 ' O ' HG22 ' A' ' 74' ' ' THR . 71.2 t80 -67.02 -45.2 78.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.982 . . . . 0.0 110.467 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.75 -28.97 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.36 -1.462 . . . . 0.0 108.671 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.347 -0.845 . . . . 0.0 109.331 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.609 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.06 -50.15 73.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 111.108 -177.274 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 8.6 t -62.63 -28.17 69.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.805 -1.184 . . . . 0.0 110.304 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -61.95 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.0 110.897 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.626 ' NE2' ' NE2' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -121.94 151.19 57.63 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.787 -1.196 . . . . 0.0 109.578 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.43 12.53 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.575 2.184 . . . . 0.0 112.433 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.685 HD22 HE22 ' A' ' 33' ' ' GLN . 0.7 OUTLIER -75.98 -29.71 58.32 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 111.251 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' SER . 35.6 t-80 -85.22 -41.65 15.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.952 -1.093 . . . . 0.0 110.282 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -57.88 -58.46 6.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.961 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.762 ' H ' HG13 ' A' ' 80' ' ' VAL . 14.9 tm-20 -58.01 -39.33 78.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.137 -0.977 . . . . 0.0 109.593 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.91 -40.74 71.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.915 . . . . 0.0 109.879 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' HIS . 86.8 p -61.56 -38.16 86.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 110.218 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.93 63.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.973 -1.079 . . . . 0.0 108.725 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.26 -40.82 77.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.476 ' O ' HD12 ' A' ' 90' ' ' ILE . 24.8 t80 -44.53 -30.49 0.9 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.0 m -83.31 -61.84 1.74 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -36.87 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.741 -0.6 . . . . 0.0 110.07 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 87' ' ' THR . 12.6 m -101.93 16.53 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 110.819 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 87' ' ' THR . 73.7 mt -124.43 159.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.655 -1.278 . . . . 0.0 110.51 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 90' ' ' ILE . 62.8 t0 -102.32 -34.53 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.462 ' N ' HG22 ' A' ' 90' ' ' ILE . 29.4 pttt -145.78 143.71 29.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 93' ' ' ILE . 4.0 tp -121.54 122.06 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.649 -1.282 . . . . 0.0 109.774 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.78 130.43 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -135.34 131.75 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.258 -1.526 . . . . 0.0 111.811 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -122.75 126.97 48.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.377 177.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -125.81 133.35 52.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.098 -1.001 . . . . 0.0 108.899 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 63.8 t80 -155.42 128.73 4.38 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.108 -0.995 . . . . 0.0 110.476 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.533 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 81.8 Cg_exo -46.08 133.58 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.308 2.006 . . . . 0.0 112.176 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.61 129.33 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -101.39 82.14 2.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.435 -0.79 . . . . 0.0 109.585 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -65.25 76.69 0.06 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.177 -0.952 . . . . 0.0 109.568 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.763 ' O ' ' C ' ' A' ' 104' ' ' LYS . 16.3 m -154.26 -28.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.436 -0.79 . . . . 0.0 109.271 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.763 ' C ' ' O ' ' A' ' 103' ' ' VAL . 55.2 mmtt -4.52 -106.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 0.0 109.396 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m 67.04 -8.99 0.4 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.095 -1.003 . . . . 0.0 108.891 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 104' ' ' LYS . 25.5 t -55.76 133.5 50.99 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.4 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 107' ' ' VAL . 14.6 p -140.76 40.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.37 138.97 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.51 -0.744 . . . . 0.0 109.486 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.2 177.33 7.9 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -137.49 70.02 53.36 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.937 -1.102 . . . . 0.0 109.642 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 C--N 1.307 -1.621 0 C-N-CA 122.814 2.343 . . . . 0.0 112.248 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.306 0.574 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.466 ' H ' ' HG3' ' B' ' 99' ' ' PRO . . . 47.36 59.89 3.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 109.434 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.684 HG23 ' N ' ' B' ' 4' ' ' SER . 9.8 t -63.16 -49.88 72.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.163 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.684 ' N ' HG23 ' B' ' 3' ' ' THR . 31.9 t -144.08 -95.65 0.11 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.84 154.23 41.24 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.26 127.13 52.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.203 -1.175 . . . . 0.0 108.021 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.534 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.8 ttpm? -108.14 137.93 45.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.96 -1.087 . . . . 0.0 112.816 -177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -124.7 123.19 39.48 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.39 142.27 49.22 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 109.475 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.436 HG13 ' O ' ' B' ' 10' ' ' VAL . 10.3 p -129.7 134.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.629 -0.67 . . . . 0.0 109.523 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.23 129.08 68.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.37 162.09 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.001 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.79 151.06 51.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.489 ' HB2' ' H ' ' B' ' 18' ' ' THR . 22.3 p90 -109.56 146.92 33.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.867 -1.146 . . . . 0.0 111.583 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.04 -20.37 3.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 79.3 mm-40 -91.08 -57.92 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.8 m-20 156.39 65.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.489 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -57.12 108.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.088 0.947 . . . . 0.0 112.86 -176.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.566 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -76.82 87.13 3.41 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 175.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.472 HG23 ' N ' ' B' ' 21' ' ' ASP . 27.1 m -61.75 -37.58 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.573 -0.704 . . . . 0.0 110.518 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.472 ' N ' HG23 ' B' ' 20' ' ' VAL . 80.7 m-20 -66.32 -42.31 88.41 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 110.552 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.59 -32.44 73.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.15 -39.0 83.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 tp -53.71 -35.19 60.89 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.43 74.96 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -60.52 -54.34 37.94 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.584 HD23 ' O ' ' B' ' 27' ' ' LEU . 1.8 tt -51.34 -47.85 62.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -55.24 -37.03 66.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -62.15 -44.04 97.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.865 HD13 ' NE2' ' B' ' 33' ' ' GLN . 3.0 mm? -50.21 -47.09 54.97 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 32' ' ' SER . 86.3 t -50.71 -26.26 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.326 -0.858 . . . . 0.0 108.879 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 27.9 t -47.34 -44.48 23.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.865 ' NE2' HD13 ' B' ' 30' ' ' LEU . 12.9 pm0 -92.75 -24.35 18.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.812 . . . . 0.0 111.54 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' B' ' 36' ' ' THR . 9.6 mt -71.66 26.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 119.976 -1.703 . . . . 0.0 110.541 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' B' ' 33' ' ' GLN . 89.6 m-20 -63.02 -7.22 4.93 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.627 ' O ' ' N ' ' B' ' 38' ' ' LYS . 49.9 p -71.83 -6.11 39.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.987 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.574 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.8 m 33.72 31.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.012 -1.055 . . . . 0.0 109.189 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' B' ' 36' ' ' THR . 5.9 mtmp? -117.39 38.65 3.51 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.541 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 72.7 m -173.66 177.26 2.55 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.6 m-85 -147.06 155.77 42.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.555 -1.341 . . . . 0.0 111.912 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 85.6 mt-10 -158.58 129.1 6.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.332 0.587 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.36 177.48 8.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.93 162.35 22.45 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 118.69 -1.719 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.637 ' N ' ' CE1' ' B' ' 58' ' ' HIS . 71.7 mt-10 -145.97 138.24 25.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -1.134 . . . . 0.0 109.34 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -121.07 149.33 42.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.568 ' H ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -71.05 81.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.412 -1.43 . . . . 0.0 109.809 -177.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -115.35 56.93 0.74 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.539 ' O ' ' O ' ' B' ' 49' ' ' HIS . 39.8 t -151.1 83.63 1.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.949 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.699 ' N ' HH21 ' B' ' 53' ' ' ARG . 78.6 m-70 56.86 118.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.121 -0.987 . . . . 0.0 109.702 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.545 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 97.4 m-20 -44.68 -33.89 2.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 110.847 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.401 ' HG2' ' H ' ' B' ' 51' ' ' MET . 2.7 ptt? -76.86 -32.0 57.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.063 -1.023 . . . . 0.0 110.751 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 95' ' ' LEU . 63.0 mt -96.29 -12.41 24.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.709 -1.245 . . . . 0.0 109.258 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.699 HH21 ' N ' ' B' ' 49' ' ' HIS . 6.1 ptp180 -95.76 1.97 53.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 111.281 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' B' ' 56' ' ' PHE . 94.9 mm-40 44.37 19.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.8 -1.187 . . . . 0.0 110.168 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.768 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 48.9 3.26 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.477 -0.764 . . . . 0.0 112.893 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' O ' ' B' ' 55' ' ' GLY . 33.0 m-85 -49.91 -143.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.252 -1.734 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 93.0 m -135.8 -55.87 0.78 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.312 -0.868 . . . . 0.0 110.964 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.637 ' CE1' ' N ' ' B' ' 44' ' ' GLU . 13.0 t60 -168.39 153.22 6.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.203 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.36 116.06 10.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.509 -0.744 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -89.42 131.68 35.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.069 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -121.89 121.3 36.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -114.95 134.66 54.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.218 -0.926 . . . . 0.0 110.757 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 40' ' ' PHE . 32.6 m -122.88 143.34 49.94 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -117.83 159.59 22.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.693 -1.254 . . . . 0.0 110.036 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.46 -29.24 46.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -174.22 -178.17 1.4 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.83 -27.12 67.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.949 . . . . 0.0 111.469 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -61.92 -44.02 97.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.782 -1.199 . . . . 0.0 110.593 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.27 -32.7 68.65 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.585 ' O ' HG22 ' B' ' 74' ' ' THR . 71.6 t80 -66.7 -45.38 78.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.939 . . . . 0.0 110.459 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.81 -28.92 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.411 -1.43 . . . . 0.0 108.697 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.421 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.08 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.325 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.596 ' O ' ' CE1' ' B' ' 76' ' ' HIS . 0.0 OUTLIER -57.06 -49.98 74.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.224 -0.923 . . . . 0.0 111.107 -177.323 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.594 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 8.6 t -62.85 -28.13 69.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 110.311 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 84.5 p -62.05 16.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.96 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.626 ' NE2' ' NE2' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -121.83 150.97 56.95 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.868 -1.145 . . . . 0.0 109.585 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.19 12.6 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.604 2.203 . . . . 0.0 112.48 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.663 HD22 HE22 ' B' ' 33' ' ' GLN . 0.7 OUTLIER -76.08 -29.72 58.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.435 -0.79 . . . . 0.0 111.22 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' B' ' 83' ' ' SER . 35.4 t-80 -85.21 -41.71 15.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.935 -1.103 . . . . 0.0 110.22 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.778 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.2 p -57.9 -58.56 5.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 110.031 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.778 ' H ' HG13 ' B' ' 80' ' ' VAL . 14.9 tm-20 -57.84 -39.4 77.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.544 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.8 -40.89 72.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 109.894 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.437 ' N ' ' O ' ' B' ' 79' ' ' HIS . 87.2 p -61.5 -38.14 86.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.24 60.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.011 -1.056 . . . . 0.0 108.675 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -41.18 78.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.466 ' O ' HD12 ' B' ' 90' ' ' ILE . 24.6 t80 -44.24 -30.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 89' ' ' VAL . 6.1 m -83.35 -61.77 1.76 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.06 -26.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.604 . . . . 0.0 110.061 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' B' ' 87' ' ' THR . 12.7 m -102.15 16.27 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.18 -0.95 . . . . 0.0 110.769 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' B' ' 87' ' ' THR . 73.4 mt -124.32 159.17 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.643 -1.285 . . . . 0.0 110.417 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.521 ' N ' HG22 ' B' ' 90' ' ' ILE . 63.0 t0 -102.3 -34.47 9.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.458 ' N ' HG22 ' B' ' 90' ' ' ILE . 29.2 pttt -145.94 143.55 29.6 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.49 ' O ' HG23 ' B' ' 93' ' ' ILE . 4.0 tp -121.4 122.2 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.64 -1.287 . . . . 0.0 109.772 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.93 130.44 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.461 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -135.37 131.67 36.64 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.307 -1.495 . . . . 0.0 111.76 -178.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.881 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -122.73 127.24 48.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.333 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -126.05 133.3 51.76 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.078 -1.014 . . . . 0.0 108.91 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 64.2 t80 -155.24 128.74 4.44 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' PRO . . . . . 0.531 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 80.5 Cg_exo -46.18 133.39 15.22 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.314 2.009 . . . . 0.0 112.241 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 74.8 t -107.42 129.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 110.007 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -101.5 81.94 2.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 109.577 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 76.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.783 ' O ' ' C ' ' B' ' 104' ' ' LYS . 16.2 m -154.22 -28.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.783 ' C ' ' O ' ' B' ' 103' ' ' VAL . 54.5 mmtt -4.54 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m 67.22 -8.97 0.42 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.149 -0.969 . . . . 0.0 108.949 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.544 ' H ' ' C ' ' B' ' 104' ' ' LYS . 26.2 t -55.83 133.27 51.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.603 HG22 ' O ' ' B' ' 107' ' ' VAL . 14.7 p -140.51 40.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.41 139.02 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.5 -0.75 . . . . 0.0 109.518 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.33 177.24 7.89 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 15.9 p -137.44 69.92 53.8 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.864 -1.147 . . . . 0.0 109.64 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.733 2.288 . . . . 0.0 112.225 -179.905 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.18 52.87 2.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 109.355 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 t -103.38 -9.85 19.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.109 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -152.78 -86.36 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.48 -159.29 7.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -142.56 142.38 32.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -1.13 . . . . 0.0 108.051 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.44 141.89 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 112.831 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -126.73 128.95 47.46 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.0 tt -135.37 142.77 45.78 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.755 -1.216 . . . . 0.0 109.436 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 12.7 p -131.11 139.5 50.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.05 127.34 72.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.05 144.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.825 -1.55 . . . . 0.0 113.068 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 37.2 tptt -111.76 150.5 30.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HB2' ' H ' ' A' ' 18' ' ' THR . 18.4 p90 -107.0 147.5 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.823 -1.173 . . . . 0.0 111.607 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.76 -26.36 4.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 65.0 tt0 -88.19 -56.94 3.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.0 p30 152.63 70.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 41.8 m -55.12 106.88 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.142 0.972 . . . . 0.0 112.821 -177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.589 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.95 88.56 1.86 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.5 m -59.53 -40.95 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.705 . . . . 0.0 110.458 -176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.551 ' N ' HG23 ' A' ' 20' ' ' VAL . 92.4 m-20 -61.01 -44.24 97.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.411 -0.806 . . . . 0.0 110.557 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.48 -39.12 62.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.5 -50.71 70.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.86 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.2 tm? -56.48 -42.61 78.53 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 24' ' ' LEU . 5.1 ttpt -60.13 -25.05 65.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.68 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -69.21 -54.82 11.89 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 27' ' ' LEU . 6.8 tt -44.33 -38.33 3.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.512 -0.993 . . . . 0.0 108.818 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -52.87 -41.82 64.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -57.41 -42.43 82.29 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.641 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -50.22 -46.29 54.48 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.849 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' SER . 34.4 t -48.91 -24.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.332 -0.855 . . . . 0.0 108.908 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 42.4 t -43.24 -43.15 4.65 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 97.0 mm-40 -76.18 -22.42 55.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 111.464 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.756 HG22 ' O ' ' A' ' 34' ' ' ILE . 71.9 mt -79.73 20.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.033 -1.667 . . . . 0.0 110.645 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.47 -10.47 1.46 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.581 ' N ' ' C ' ' A' ' 34' ' ' ILE . 35.0 p -82.24 0.44 41.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.963 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.577 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.3 m 34.94 33.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.046 -1.034 . . . . 0.0 109.117 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 mtmp? -119.61 42.01 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' PHE . 30.1 t -175.97 175.5 1.94 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.4 m-85 -150.53 159.72 44.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.591 -1.318 . . . . 0.0 111.99 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 86.1 mt-10 -159.24 130.82 6.28 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.364 0.602 . . . . 0.0 110.2 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -133.78 171.61 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' GLU . . . -134.45 168.21 23.57 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 118.672 -1.728 . . . . 0.0 110.793 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.618 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 87.4 mt-10 -156.82 152.5 26.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -1.114 . . . . 0.0 109.341 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.893 ' HA ' ' O ' ' A' ' 57' ' ' THR . 23.9 t0 -157.16 87.5 0.99 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -90.35 170.01 10.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.393 -1.442 . . . . 0.0 109.882 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.699 -0.625 . . . . 0.0 109.317 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.426 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 4.2 t -78.75 -125.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.0 110.164 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -77.63 153.9 32.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.721 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.47 -41.57 69.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 110.759 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.516 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.17 -40.61 90.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.969 -1.082 . . . . 0.0 110.737 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' B' ' 95' ' ' LEU . 44.8 mt -75.86 -64.62 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.745 -1.222 . . . . 0.0 109.303 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -67.72 18.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 0.0 111.233 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' A' ' 52' ' ' LEU . 1.7 mm100 45.33 8.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.701 -1.249 . . . . 0.0 110.164 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 70.3 -11.54 2.12 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.503 -0.748 . . . . 0.0 112.936 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' O ' ' O ' ' A' ' 55' ' ' GLY . 49.4 m-85 -53.92 -136.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.288 -1.713 . . . . 0.0 109.92 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.893 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 6.1 t -163.28 -51.45 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 110.903 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 60' ' ' PHE . 6.3 t60 -148.37 142.5 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 0.0 110.149 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.69 163.06 33.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 0.0 109.231 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 58' ' ' HIS . 94.9 m-85 -133.78 131.17 39.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.083 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' A' ' 42' ' ' TRP . 1.6 m -116.59 110.39 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.13 132.38 53.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.209 -0.932 . . . . 0.0 110.838 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -119.01 141.44 48.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.24 158.5 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.689 -1.257 . . . . 0.0 110.097 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -75.66 -26.42 57.67 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -175.39 -177.34 1.01 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -66.61 -23.73 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 111.355 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.7 -41.04 97.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.763 -1.21 . . . . 0.0 110.577 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.57 65.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.805 ' O ' HG22 ' A' ' 74' ' ' THR . 76.0 t80 -69.39 -43.22 73.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.496 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.82 -28.89 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.423 -1.423 . . . . 0.0 108.642 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.08 -60.9 2.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.299 -0.876 . . . . 0.0 109.358 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.72 -57.74 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.875 . . . . 0.0 111.145 -178.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 70' ' ' TYR . 9.2 t -57.27 -35.57 69.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.775 -1.203 . . . . 0.0 110.293 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 58.4 m -66.69 -32.94 74.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.0 110.964 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 78' ' ' LEU . 59.3 m80 -68.43 128.76 93.03 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.83 -1.169 . . . . 0.0 109.601 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.34 -8.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 112.443 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.7 tp -66.77 -28.41 68.37 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.34 -0.85 . . . . 0.0 111.291 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.75 -35.32 24.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.012 . . . . 0.0 110.247 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.97 -61.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -58.62 -38.66 78.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.604 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 78.0 t80 -68.48 -44.28 75.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.872 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 t -59.87 -35.48 74.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.968 -1.082 . . . . 0.0 108.682 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.75 -42.14 77.94 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 85' ' ' ALA . 6.5 t80 -43.53 -30.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.4 m -83.05 -61.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.84 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.639 -0.663 . . . . 0.0 110.008 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.7 m -102.69 11.37 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.19 -0.944 . . . . 0.0 110.746 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 44.8 mt -125.74 158.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.596 -1.315 . . . . 0.0 110.53 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 60.6 t0 -104.22 -32.33 9.17 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 13' ' ' LYS . 9.1 pttp -148.87 147.0 28.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.8 tp -127.43 127.58 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.579 -1.326 . . . . 0.0 109.763 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 48.3 t -132.18 135.51 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -135.6 130.28 34.19 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 111.759 -178.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.584 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.72 127.34 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.65 -0.656 . . . . 0.0 109.387 177.373 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 54.6 m-20 -123.06 125.08 44.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 108.908 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -146.7 127.26 7.01 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.053 -1.029 . . . . 0.0 110.501 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.42 123.61 9.44 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.31 2.007 . . . . 0.0 112.22 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.47 132.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.62 80.51 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 84.51 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.632 ' O ' ' O ' ' A' ' 104' ' ' LYS . 17.2 m -147.11 -22.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.177 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.632 ' O ' ' O ' ' A' ' 103' ' ' VAL . 24.8 mtmt 41.33 102.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.328 -0.858 . . . . 0.0 109.358 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -50.74 -50.8 54.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.15 -0.969 . . . . 0.0 108.934 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.1 t 45.78 29.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.385 -0.822 . . . . 0.0 109.378 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.3 t -72.32 -56.0 11.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.01 140.97 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.546 -0.721 . . . . 0.0 109.505 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -104.58 120.28 40.92 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.19 155.16 61.78 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 120.802 -1.186 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.307 -1.626 0 C-N-CA 122.825 2.35 . . . . 0.0 112.219 179.562 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' B' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.38 53.22 2.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 109.358 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 13.7 t -103.47 -10.36 18.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.85 . . . . 0.0 109.153 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t -152.44 -86.4 0.07 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.49 -159.06 7.79 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.687 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -142.81 142.37 31.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -1.136 . . . . 0.0 108.029 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.61 141.64 47.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.932 -1.105 . . . . 0.0 112.819 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.5 128.91 47.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.0 tt -135.42 142.75 45.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.789 -1.195 . . . . 0.0 109.439 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 12.5 p -131.01 139.53 50.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.627 -0.671 . . . . 0.0 109.523 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.09 127.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.03 144.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 117.738 -1.585 . . . . 0.0 113.019 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 36.8 tptt -111.92 150.42 30.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 18.4 p90 -106.91 147.36 29.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 111.575 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.6 -26.39 4.55 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 65.4 tt0 -88.18 -56.83 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.1 p30 152.45 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.459 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 40.1 m -55.38 106.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.059 0.933 . . . . 0.0 112.901 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.6 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.01 88.4 1.88 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.4 m -59.52 -40.65 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 110.434 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.528 ' N ' HG23 ' B' ' 20' ' ' VAL . 92.0 m-20 -61.22 -44.42 97.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 110.54 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -74.23 -38.99 63.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.79 -50.37 71.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.858 ' C ' HD13 ' B' ' 24' ' ' LEU . 2.2 tm? -56.86 -42.5 79.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -60.11 -25.15 65.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.688 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -69.15 -54.62 12.9 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.711 HD23 ' O ' ' B' ' 27' ' ' LEU . 6.8 tt -44.43 -38.29 3.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.551 -0.97 . . . . 0.0 108.831 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -52.96 -41.87 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.688 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.7 p30 -57.28 -42.57 81.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.638 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -50.07 -46.62 53.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' B' ' 34' ' ' ILE . 33.6 t -48.53 -24.74 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 44.2 t -43.15 -43.31 4.52 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.477 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 97.0 mm-40 -75.91 -22.74 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.429 -0.795 . . . . 0.0 111.52 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.766 HG22 ' O ' ' B' ' 34' ' ' ILE . 72.5 mt -79.3 20.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.955 -1.715 . . . . 0.0 110.586 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.57 -10.58 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.568 ' O ' ' N ' ' B' ' 38' ' ' LYS . 34.6 p -82.09 0.36 40.97 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 35.17 33.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.079 -1.013 . . . . 0.0 109.24 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.8 mtmp? -119.72 42.13 2.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.425 ' O ' ' CG ' ' B' ' 40' ' ' PHE . 30.8 t -176.04 175.21 1.96 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.454 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.9 m-85 -150.41 159.26 44.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.511 -1.368 . . . . 0.0 111.953 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 86.1 mt-10 -158.84 130.78 6.59 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.315 0.578 . . . . 0.0 110.221 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' TRP . . . . . 0.688 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.0 OUTLIER -133.7 171.6 13.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.46 168.41 23.49 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.666 -1.731 . . . . 0.0 110.751 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.615 ' O ' ' CG ' ' B' ' 58' ' ' HIS . 87.1 mt-10 -156.94 152.42 26.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -1.202 . . . . 0.0 109.41 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.888 ' HA ' ' O ' ' B' ' 57' ' ' THR . 24.4 t0 -156.99 87.85 1.01 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' H ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -90.83 170.15 10.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.368 -1.457 . . . . 0.0 109.818 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.09 0.43 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.425 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 4.7 t -78.55 -125.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 110.118 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -78.18 153.73 31.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.17 -41.79 69.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 110.822 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -66.1 -40.42 90.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.033 . . . . 0.0 110.768 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 95' ' ' LEU . 45.5 mt -76.09 -64.31 1.12 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.729 -1.232 . . . . 0.0 109.295 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.4 OUTLIER -68.12 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.38 -0.825 . . . . 0.0 111.218 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' B' ' 52' ' ' LEU . 1.7 mm100 45.13 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.735 -1.228 . . . . 0.0 110.195 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.669 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 70.42 -12.05 2.01 Favored Glycine 0 N--CA 1.5 2.914 0 O-C-N 121.496 -0.753 . . . . 0.0 112.811 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.669 ' O ' ' O ' ' B' ' 55' ' ' GLY . 49.8 m-85 -53.66 -136.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.242 -1.74 . . . . 0.0 109.916 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.888 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 6.3 t -163.0 -51.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.641 ' CD2' ' CZ ' ' B' ' 60' ' ' PHE . 6.2 t60 -148.44 142.45 25.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.938 -1.101 . . . . 0.0 110.175 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.52 163.1 33.85 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.487 -0.758 . . . . 0.0 109.294 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' B' ' 58' ' ' HIS . 95.2 m-85 -133.71 131.02 38.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.151 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' B' ' 42' ' ' TRP . 1.6 m -116.39 110.6 18.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.56 132.51 53.18 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 110.743 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -119.05 141.42 48.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.28 158.49 26.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.736 -1.228 . . . . 0.0 110.013 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -75.76 -26.48 57.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -175.28 -177.42 1.03 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.43 -23.74 66.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.69 -41.2 97.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.814 -1.179 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.28 -31.71 65.9 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.816 ' O ' HG22 ' B' ' 74' ' ' THR . 76.6 t80 -69.07 -43.53 74.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.56 -0.965 . . . . 0.0 110.474 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.88 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.47 -1.394 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.51 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.1 -60.85 2.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.632 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -57.43 -57.94 10.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 111.146 -178.538 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.816 HG22 ' O ' ' B' ' 70' ' ' TYR . 9.1 t -57.33 -35.21 69.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.368 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 58.5 m -66.93 -32.97 74.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' B' ' 78' ' ' LEU . 59.4 m80 -68.44 128.55 93.05 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.887 -1.133 . . . . 0.0 109.629 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -42.98 -8.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.644 2.229 . . . . 0.0 112.513 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.6 tp -66.56 -28.59 68.64 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.387 -0.821 . . . . 0.0 111.211 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -83.65 -35.31 24.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 110.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.05 -61.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.014 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -58.58 -38.72 78.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 77.9 t80 -68.27 -44.54 75.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.838 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -59.77 -35.24 74.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.163 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.16 60.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.978 -1.076 . . . . 0.0 108.742 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -42.15 77.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.474 ' C ' ' O ' ' B' ' 85' ' ' ALA . 6.6 t80 -43.55 -30.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.503 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.0 m -82.98 -61.87 1.75 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.78 -26.92 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.697 -0.627 . . . . 0.0 110.049 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.7 m -102.71 11.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.233 -0.917 . . . . 0.0 110.797 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 43.8 mt -126.0 158.85 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.646 -1.284 . . . . 0.0 110.384 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 60.3 t0 -104.4 -32.25 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' B' ' 13' ' ' LYS . 8.9 pttp -149.0 147.1 28.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.412 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.8 tp -127.67 127.48 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.526 -1.358 . . . . 0.0 109.746 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 48.4 t -132.12 135.28 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -135.4 130.24 34.56 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.254 -1.529 . . . . 0.0 111.792 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.599 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -118.69 127.11 53.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.645 -0.66 . . . . 0.0 109.343 177.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.573 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 55.3 m-20 -122.85 124.87 44.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.031 -1.043 . . . . 0.0 108.85 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.794 ' CD1' ' N ' ' B' ' 98' ' ' PHE . 0.0 OUTLIER -146.37 127.45 7.29 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.097 -1.002 . . . . 0.0 110.502 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.55 123.65 9.65 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.229 1.953 . . . . 0.0 112.248 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.34 132.83 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.69 80.53 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.99 84.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -0.98 . . . . 0.0 109.557 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.627 ' O ' ' O ' ' B' ' 104' ' ' LYS . 17.2 m -147.26 -22.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.196 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.627 ' O ' ' O ' ' B' ' 103' ' ' VAL . 24.5 mtmt 41.02 102.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.344 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.408 ' O ' ' C ' ' B' ' 106' ' ' SER . 15.1 m -50.89 -50.8 56.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.112 -0.993 . . . . 0.0 108.957 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.408 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.0 t 45.94 29.91 0.82 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.362 -0.836 . . . . 0.0 109.413 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t -72.29 -56.1 11.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.87 141.35 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 109.532 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -104.81 120.26 40.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.24 155.19 61.59 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 120.816 -1.177 . . . . 0.0 109.652 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 C--N 1.309 -1.54 0 C-N-CA 122.674 2.249 . . . . 0.0 112.245 179.623 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.43 64.02 1.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.381 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -113.51 4.27 16.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.15 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 100' ' ' VAL . 4.3 p -175.84 -113.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.27 173.75 19.12 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.71 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -124.92 128.99 49.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.188 -1.184 . . . . 0.0 108.07 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 20.1 ttpt -104.1 134.26 47.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.057 . . . . 0.0 112.837 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 62' ' ' MET . 85.3 t60 -127.14 125.03 40.47 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.725 -1.234 . . . . 0.0 109.454 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.46 138.05 54.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.6 -0.687 . . . . 0.0 109.444 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 t -119.4 131.64 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 93' ' ' ILE . 5.1 m -136.52 156.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 117.787 -1.565 . . . . 0.0 113.071 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -123.33 153.09 40.77 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.57 ' HB2' ' H ' ' A' ' 18' ' ' THR . 23.7 p90 -110.99 146.61 36.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -21.14 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.5 tt0 -92.82 -57.37 2.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.5 m-20 157.55 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.57 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.9 m -50.95 103.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.045 0.926 . . . . 0.0 112.854 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.89 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -71.1 82.55 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.517 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 21' ' ' ASP . 28.8 m -62.37 -40.07 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.635 -0.666 . . . . 0.0 110.458 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 20' ' ' VAL . 91.0 m-20 -66.21 -45.59 80.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 0.0 110.515 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 29.2 mp0 -68.29 -34.09 75.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.11 -43.29 88.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 20' ' ' VAL . 17.9 tp -54.29 -35.92 63.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.28 -33.9 72.99 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -61.33 -52.49 51.24 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.2 tt -46.91 -44.14 19.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.493 -1.004 . . . . 0.0 108.774 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -55.21 -37.65 67.4 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 2.0 m-80 -62.85 -46.04 89.75 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 78' ' ' LEU . 3.4 mm? -48.45 -46.49 37.92 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 32' ' ' SER . 63.1 t -51.3 -26.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.287 -0.883 . . . . 0.0 108.837 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 30.9 t -46.38 -47.97 18.65 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.652 ' NE2' HD13 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -86.94 -23.7 25.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 0.0 111.467 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.652 HD13 ' NE2' ' A' ' 33' ' ' GLN . 4.6 mm -73.25 23.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.036 -1.665 . . . . 0.0 110.618 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.0 p30 -61.8 -9.31 6.28 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' A' ' 37' ' ' VAL . 64.1 p -71.52 -4.86 29.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.971 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.4 m 32.64 36.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 ptmt -121.96 41.97 3.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 t -174.6 179.07 1.8 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 97.6 m-85 -143.98 153.4 42.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.554 -1.341 . . . . 0.0 111.998 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 61' ' ' SER . 75.5 mt-10 -156.41 124.26 5.57 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.355 0.598 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -134.74 174.15 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.24 145.42 11.7 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 118.777 -1.678 . . . . 0.0 110.832 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.573 ' O ' ' CD2' ' A' ' 58' ' ' HIS . 56.2 mp0 -148.31 164.81 32.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.233 -1.157 . . . . 0.0 109.388 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 57' ' ' THR . 21.4 t70 -113.78 161.1 17.95 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.658 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 3.0 ptmm? -62.01 83.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.43 -1.419 . . . . 0.0 109.771 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.2 mt-10 -128.79 46.87 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.622 -0.674 . . . . 0.0 109.259 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' B' ' 97' ' ' ASP . 5.9 t -142.2 78.71 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.794 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 56.2 m80 56.58 107.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.927 . . . . 0.0 109.678 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -45.66 -35.16 3.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -0.851 . . . . 0.0 110.818 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -71.4 -35.34 70.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.961 -1.087 . . . . 0.0 110.682 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' B' ' 95' ' ' LEU . 84.5 mt -78.76 -51.1 10.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.763 -1.211 . . . . 0.0 109.314 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.794 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.1 ptp180 -64.35 13.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 0.0 111.274 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.513 ' C ' ' O ' ' A' ' 53' ' ' ARG . 82.2 mm-40 37.76 32.19 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.82 -1.175 . . . . 0.0 110.129 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.777 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 59.16 1.83 1.16 Allowed Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.439 -0.788 . . . . 0.0 112.815 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.777 ' O ' ' O ' ' A' ' 55' ' ' GLY . 46.1 m-85 -48.82 -148.15 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.221 -1.753 . . . . 0.0 109.884 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 50.4 m -143.37 -56.72 0.4 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.331 -0.855 . . . . 0.0 110.957 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.632 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 15.2 t-80 -158.21 145.98 18.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.116 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -132.04 148.91 52.53 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.264 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 58' ' ' HIS . 34.8 m-85 -118.91 119.71 35.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.48 -0.762 . . . . 0.0 109.04 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 7.1 t -88.94 95.35 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.0 mtp -102.37 110.62 22.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.228 -0.92 . . . . 0.0 110.813 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -125.63 145.87 49.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.6 160.52 21.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.17 . . . . 0.0 110.068 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 85.5 tt0 -81.99 -31.95 30.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.4 m-20 -163.18 174.32 12.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.63 -27.14 62.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 111.417 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.49 -36.73 66.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.869 -1.144 . . . . 0.0 110.538 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.74 -35.35 73.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.612 ' O ' HG22 ' A' ' 74' ' ' THR . 70.4 t80 -61.68 -44.34 97.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.508 -0.995 . . . . 0.0 110.5 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.88 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.379 -1.451 . . . . 0.0 108.661 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.94 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.365 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.59 -39.94 58.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 111.129 -177.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.619 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.5 t -80.79 -29.81 36.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.725 -1.234 . . . . 0.0 110.264 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.2 t -58.13 -33.64 69.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.984 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 73' ' ' PHE . 13.9 p80 -87.84 141.91 32.0 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.632 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 10.86 1.49 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.652 2.234 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' CD2' HD22 ' A' ' 30' ' ' LEU . 3.6 tt -73.04 -26.86 61.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.801 . . . . 0.0 111.256 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 83' ' ' SER . 9.3 t-80 -85.0 -43.41 13.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.0 110.249 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.787 HG13 ' H ' ' A' ' 81' ' ' GLU . 2.8 p -56.62 -58.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.787 ' H ' HG13 ' A' ' 80' ' ' VAL . 93.5 mt-10 -58.39 -42.27 86.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.94 -39.37 72.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' HIS . 23.6 t -59.83 -38.07 81.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.142 -0.974 . . . . 0.0 110.151 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.55 72.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.923 -1.111 . . . . 0.0 108.65 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.84 -41.59 78.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 85' ' ' ALA . 22.5 t80 -45.04 -30.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 90' ' ' ILE . 3.8 m -84.68 -63.6 1.31 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.09 -27.35 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.65 -0.657 . . . . 0.0 110.089 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 87' ' ' THR . 5.4 p -98.53 16.57 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 91' ' ' ASP . 23.0 mm -130.64 164.02 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.683 -1.26 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.592 ' N ' HG22 ' A' ' 90' ' ' ILE . 40.9 t0 -103.41 -36.76 7.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 90' ' ' ILE . 21.2 pttt -146.96 146.42 30.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.65 HD12 HG12 ' A' ' 12' ' ' VAL . 4.8 tp -128.37 127.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.6 -1.313 . . . . 0.0 109.707 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.2 133.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.65 36.22 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.292 -1.505 . . . . 0.0 111.804 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -125.69 128.99 48.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.675 . . . . 0.0 109.379 177.12 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.593 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 42.8 t0 -120.01 124.61 46.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.021 -1.049 . . . . 0.0 108.893 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 97' ' ' ASP . 25.1 m-85 -142.31 148.96 49.8 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.986 -1.071 . . . . 0.0 110.531 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.83 130.12 16.4 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.244 1.963 . . . . 0.0 112.201 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.537 ' O ' ' OG ' ' A' ' 4' ' ' SER . 9.9 t -95.22 117.09 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.96 . . . . 0.0 109.994 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -91.31 75.45 6.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.21 71.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.114 -0.992 . . . . 0.0 109.563 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' SER . 29.1 m -149.78 -32.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.266 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 106' ' ' SER . 25.3 mtmt 37.68 -93.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER 66.58 -42.53 0.4 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 108.978 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 104' ' ' LYS . 9.5 m -44.4 104.18 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.277 -0.89 . . . . 0.0 109.336 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.901 HG22 ' H ' ' A' ' 108' ' ' VAL . 7.6 p -80.64 -176.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.901 ' H ' HG22 ' A' ' 107' ' ' VAL . 8.6 p -42.26 142.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.399 -0.813 . . . . 0.0 109.401 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.87 93.34 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -70.75 152.09 95.21 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 120.824 -1.172 . . . . 0.0 109.671 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo . . . . . 0 C--N 1.307 -1.637 0 C-N-CA 122.76 2.306 . . . . 0.0 112.24 179.776 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.607 ' N ' ' SD ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.42 63.83 1.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 109.428 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -113.38 3.99 16.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.101 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' B' ' 100' ' ' VAL . 4.2 p -175.64 -113.27 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.28 173.7 19.07 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -124.8 129.11 49.8 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.205 -1.174 . . . . 0.0 108.01 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 97' ' ' ASP . 20.2 ttpt -104.23 134.27 47.74 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.311 1.053 . . . . 0.0 112.822 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 85.4 t60 -127.08 125.07 40.66 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.1 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.747 -1.22 . . . . 0.0 109.487 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -130.47 138.02 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.545 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.42 131.52 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.636 HG12 HD12 ' B' ' 93' ' ' ILE . 5.2 m -136.49 156.19 35.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 117.732 -1.587 . . . . 0.0 113.053 -177.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -123.2 153.07 40.58 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.564 ' HB2' ' H ' ' B' ' 18' ' ' THR . 23.7 p90 -111.01 146.54 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 0.0 111.663 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 -21.18 2.9 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -92.96 -57.36 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.5 m-20 157.47 65.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.3 m -50.79 103.32 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.117 0.961 . . . . 0.0 112.844 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.875 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -71.29 82.47 0.75 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.535 HG23 ' N ' ' B' ' 21' ' ' ASP . 28.4 m -62.15 -40.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.585 -0.697 . . . . 0.0 110.433 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.535 ' N ' HG23 ' B' ' 20' ' ' VAL . 91.6 m-20 -66.36 -45.41 80.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.559 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 28.8 mp0 -68.43 -34.1 75.39 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.04 -43.31 89.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 20' ' ' VAL . 17.9 tp -54.14 -36.24 63.09 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.02 -34.03 72.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.582 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -61.42 -52.22 52.79 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.639 HD23 ' O ' ' B' ' 27' ' ' LEU . 2.2 tt -47.12 -43.85 20.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.533 -0.98 . . . . 0.0 108.83 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -55.54 -37.47 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 2.1 m-80 -62.9 -46.13 89.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' B' ' 78' ' ' LEU . 3.4 mm? -48.31 -46.62 36.48 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' B' ' 32' ' ' SER . 62.8 t -51.19 -26.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 108.821 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 31.0 t -46.33 -48.05 18.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.666 ' NE2' HD13 ' B' ' 34' ' ' ILE . 0.6 OUTLIER -86.97 -23.68 24.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.448 -0.782 . . . . 0.0 111.553 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.666 HD13 ' NE2' ' B' ' 33' ' ' GLN . 4.6 mm -73.16 23.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 119.984 -1.697 . . . . 0.0 110.591 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.2 p30 -61.7 -9.44 6.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.604 ' O ' ' N ' ' B' ' 38' ' ' LYS . 63.0 p -71.46 -4.73 28.2 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.948 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.596 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.3 m 32.61 36.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.044 -1.035 . . . . 0.0 109.144 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.9 ptmt -122.26 42.01 3.25 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -174.51 179.14 1.82 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.1 153.24 41.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.525 -1.359 . . . . 0.0 112.001 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 61' ' ' SER . 74.9 mt-10 -156.3 124.18 5.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.746 -0.596 . . . . 0.0 110.302 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -134.87 174.15 10.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.3 145.54 11.86 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 118.691 -1.719 . . . . 0.0 110.819 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.575 ' O ' ' CD2' ' B' ' 58' ' ' HIS . 56.8 mp0 -148.35 164.72 33.21 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -1.149 . . . . 0.0 109.408 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' B' ' 57' ' ' THR . 21.6 t70 -113.57 161.15 17.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.66 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 3.0 ptmm? -62.03 83.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.421 -1.424 . . . . 0.0 109.805 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.0 mt-10 -128.73 46.75 2.56 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 97' ' ' ASP . 6.1 t -142.13 78.9 1.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 110.179 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.787 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 56.0 m80 56.4 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 109.694 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -45.86 -35.01 4.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.38 -0.825 . . . . 0.0 110.784 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -71.49 -35.2 70.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 0.0 110.739 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' A' ' 95' ' ' LEU . 84.1 mt -78.88 -50.99 10.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.691 -1.256 . . . . 0.0 109.329 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.787 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.1 ptp180 -64.29 13.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 111.291 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' GLN . . . . . 0.514 ' C ' ' O ' ' B' ' 53' ' ' ARG . 82.2 mm-40 37.92 31.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.787 -1.196 . . . . 0.0 110.175 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.775 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 59.49 1.47 1.21 Allowed Glycine 0 N--CA 1.499 2.833 0 O-C-N 121.393 -0.817 . . . . 0.0 112.82 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' PHE . . . . . 0.775 ' O ' ' O ' ' B' ' 55' ' ' GLY . 46.6 m-85 -48.58 -148.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.296 -1.708 . . . . 0.0 109.979 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 49.3 m -143.44 -56.69 0.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.342 -0.849 . . . . 0.0 110.925 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' HIS . . . . . 0.63 ' CE1' ' CE1' ' B' ' 60' ' ' PHE . 14.8 t-80 -158.37 146.21 18.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.91 -1.119 . . . . 0.0 110.157 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.582 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -132.25 148.97 52.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CE1' ' B' ' 58' ' ' HIS . 35.6 m-85 -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.461 -0.775 . . . . 0.0 109.08 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 6.9 t -88.9 95.31 10.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.5 mtp -102.41 110.55 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.195 -0.94 . . . . 0.0 110.787 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -125.56 145.99 49.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -117.73 160.58 21.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.726 -1.234 . . . . 0.0 110.051 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 85.6 tt0 -82.06 -31.86 30.64 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.3 m-20 -163.29 174.2 12.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.58 -27.11 62.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.292 -0.88 . . . . 0.0 111.407 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -55.37 -36.89 66.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.75 -35.43 73.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.609 ' O ' HG22 ' B' ' 74' ' ' THR . 71.3 t80 -61.49 -44.66 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.604 -0.939 . . . . 0.0 110.455 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.69 -29.01 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.348 -1.47 . . . . 0.0 108.695 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.379 -0.826 . . . . 0.0 109.323 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -51.22 -40.21 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -0.921 . . . . 0.0 111.131 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.62 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.5 t -80.58 -29.96 36.95 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.742 -1.224 . . . . 0.0 110.256 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 38.5 t -57.97 -33.84 69.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.961 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.608 ' NE2' ' O ' ' B' ' 73' ' ' PHE . 13.8 p80 -87.76 141.94 32.17 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.161 . . . . 0.0 109.564 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.68 10.91 1.47 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.662 2.241 . . . . 0.0 112.427 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' B' ' 30' ' ' LEU . 3.5 tt -73.0 -27.01 61.53 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.342 -0.849 . . . . 0.0 111.243 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' SER . 9.3 t-80 -84.96 -43.26 14.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.019 -1.051 . . . . 0.0 110.25 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.777 HG13 ' H ' ' B' ' 81' ' ' GLU . 2.7 p -56.83 -58.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 110.041 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.777 ' H ' HG13 ' B' ' 80' ' ' VAL . 93.5 mt-10 -58.36 -42.49 87.09 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.643 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -70.63 -39.47 73.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.827 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.481 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.7 t -59.72 -38.25 81.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 110.108 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.63 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 108.654 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.76 -41.59 78.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' B' ' 85' ' ' ALA . 22.4 t80 -45.02 -30.88 1.14 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.495 ' O ' ' N ' ' B' ' 90' ' ' ILE . 3.8 m -84.44 -63.73 1.29 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.94 -27.51 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 110.07 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 87' ' ' THR . 5.4 p -98.57 16.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.224 -0.923 . . . . 0.0 110.818 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.601 HG22 ' N ' ' B' ' 91' ' ' ASP . 22.8 mm -130.86 164.1 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.618 -1.301 . . . . 0.0 110.497 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ASP . . . . . 0.601 ' N ' HG22 ' B' ' 90' ' ' ILE . 41.9 t0 -103.44 -36.89 7.83 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.468 ' N ' HG22 ' B' ' 90' ' ' ILE . 21.1 pttt -146.95 146.39 30.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' ILE . . . . . 0.636 HD12 HG12 ' B' ' 12' ' ' VAL . 4.8 tp -128.32 127.56 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.555 -1.341 . . . . 0.0 109.658 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.38 133.11 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.8 36.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.269 -1.52 . . . . 0.0 111.768 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.888 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -125.73 129.06 48.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.629 . . . . 0.0 109.312 177.199 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 97' ' ' ASP . . . . . 0.596 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 43.3 t0 -119.99 124.6 46.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' PHE . . . . . 0.596 ' CD1' ' O ' ' B' ' 97' ' ' ASP . 24.9 m-85 -142.29 148.91 49.7 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.098 -1.001 . . . . 0.0 110.504 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 130.05 16.41 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.28 1.987 . . . . 0.0 112.187 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.55 ' O ' ' OG ' ' B' ' 4' ' ' SER . 9.5 t -95.15 117.05 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 110.054 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -91.32 75.48 6.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 109.54 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.23 71.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.566 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' B' ' 105' ' ' SER . 29.2 m -149.84 -32.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.5 mtmt 37.71 -93.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.579 ' N ' ' O ' ' B' ' 103' ' ' VAL . 0.9 OUTLIER 66.59 -42.69 0.41 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.968 . . . . 0.0 108.941 -178.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.561 ' N ' ' O ' ' B' ' 104' ' ' LYS . 10.2 m -44.22 104.08 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.35 -0.844 . . . . 0.0 109.386 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.896 HG22 ' H ' ' B' ' 108' ' ' VAL . 7.5 p -80.49 -176.72 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.896 ' H ' HG22 ' B' ' 107' ' ' VAL . 8.5 p -41.88 142.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.408 -0.807 . . . . 0.0 109.484 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.92 93.41 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 108' ' ' VAL . 0.1 OUTLIER -70.74 152.17 95.21 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 120.881 -1.137 . . . . 0.0 109.667 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo . . . . . 0 C--N 1.307 -1.61 0 C-N-CA 122.704 2.269 . . . . 0.0 112.362 179.757 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.628 HG23 ' N ' ' A' ' 4' ' ' SER . 8.9 t -63.48 -45.57 90.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.149 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.628 ' N ' HG23 ' A' ' 3' ' ' THR . 19.9 m -139.64 -100.5 0.16 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.22 148.48 34.43 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.689 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.544 ' CZ ' ' OD1' ' A' ' 97' ' ' ASP . 34.6 t80 -114.93 128.09 56.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.268 -1.137 . . . . 0.0 108.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.695 ' HZ3' HD12 ' A' ' 9' ' ' LEU . 3.7 ttpp -113.51 142.35 46.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.919 -1.113 . . . . 0.0 112.83 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -132.79 133.42 43.38 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.695 HD12 ' HZ3' ' A' ' 7' ' ' LYS . 6.6 tt -136.63 145.84 45.33 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 109.461 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.2 p -127.14 133.43 68.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.566 HG12 ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -116.19 129.03 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 57' ' ' THR . 6.4 m -139.45 167.53 19.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.733 -1.587 . . . . 0.0 113.024 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 19.0 tptp -132.85 152.29 51.87 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.473 ' HB2' ' H ' ' A' ' 18' ' ' THR . 39.7 p90 -108.68 149.61 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.877 -1.139 . . . . 0.0 111.576 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -129.29 -22.09 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.7 mt-10 -89.27 -57.11 3.0 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.0 t0 153.83 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.473 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 64.6 m -50.93 105.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.104 0.954 . . . . 0.0 112.814 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -75.56 88.16 2.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 21' ' ' ASP . 34.7 m -64.61 -38.57 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.557 -0.714 . . . . 0.0 110.524 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 20' ' ' VAL . 82.9 m-20 -66.1 -44.63 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.425 -0.797 . . . . 0.0 110.572 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.96 -31.39 72.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mt -69.62 -37.44 74.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 13.9 tp -53.22 -37.86 62.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -34.53 74.23 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.02 -53.54 36.41 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -46.82 -47.73 20.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.497 -1.002 . . . . 0.0 108.832 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.49 -44.54 65.7 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -68.59 -49.05 62.33 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.39 -47.81 37.27 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.7 t -49.76 -26.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.268 -0.895 . . . . 0.0 108.887 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 47.0 t -41.64 -42.69 2.57 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.683 HE22 ' CG ' ' A' ' 76' ' ' HIS . 15.2 mm100 -61.23 -11.17 8.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.483 -0.76 . . . . 0.0 111.499 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 34' ' ' ILE . 41.8 mm -81.92 26.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 119.985 -1.697 . . . . 0.0 110.604 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 36' ' ' THR . 31.1 p-10 -67.38 -26.38 66.43 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.711 HG23 ' H ' ' A' ' 38' ' ' LYS . 7.5 t -79.21 1.99 22.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.968 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 21.1 m 37.83 21.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.081 -1.012 . . . . 0.0 109.187 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.711 ' H ' HG23 ' A' ' 36' ' ' THR . 83.0 mttt -120.81 41.26 3.33 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.4 m -158.12 154.75 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.503 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 98.5 m-85 -144.46 154.43 42.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.543 -1.348 . . . . 0.0 111.949 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 81.1 mt-10 -160.88 130.46 4.9 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.335 0.588 . . . . 0.0 110.223 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -130.01 175.27 9.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.8 154.0 21.97 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.574 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 17.8 mt-10 -151.1 141.85 22.77 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -1.146 . . . . 0.0 109.401 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 8.5 p30 -116.02 148.53 40.07 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.64 ' HD3' ' N ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -68.5 80.82 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.481 -1.387 . . . . 0.0 109.809 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 45' ' ' ASP . 78.2 mm-40 -96.91 54.66 1.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.298 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 49' ' ' HIS . 29.7 t -134.14 -138.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -0.934 . . . . 0.0 110.23 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.54 ' N ' ' OG ' ' A' ' 48' ' ' SER . 74.1 m80 -107.37 142.94 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -42.83 -41.11 3.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 0.0 110.798 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 ttt -71.54 -29.37 64.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.016 -1.053 . . . . 0.0 110.703 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' B' ' 95' ' ' LEU . 52.1 mt -98.25 -18.38 18.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.745 -1.222 . . . . 0.0 109.277 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.636 ' C ' ' H ' ' A' ' 55' ' ' GLY . 55.0 mtp180 -73.43 0.58 11.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 111.212 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 55.9 -4.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.797 -1.189 . . . . 0.0 110.197 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 82.53 -18.36 15.2 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.884 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CD2' HG12 ' A' ' 11' ' ' VAL . 12.0 m-85 -59.26 -128.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.246 -1.738 . . . . 0.0 109.922 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.64 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 2.5 t -164.99 -36.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.34 -0.85 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.7 t60 -169.9 153.68 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.166 . . . . 0.0 110.225 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.653 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.18 168.76 18.98 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.261 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 88.1 m-85 -129.03 126.07 38.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 109.073 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.25 14.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 mtt -104.84 117.83 35.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.172 -0.955 . . . . 0.0 110.82 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -120.31 143.24 48.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.28 159.66 23.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.691 -1.255 . . . . 0.0 110.069 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.54 -27.45 62.23 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -173.75 -174.57 0.97 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.35 -27.17 65.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 111.445 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 29.1 p-10 -58.04 -37.89 75.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.813 -1.18 . . . . 0.0 110.532 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -68.98 -37.59 83.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' ' CG2' ' A' ' 74' ' ' THR . 71.0 t80 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.507 -0.996 . . . . 0.0 110.498 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.376 -1.453 . . . . 0.0 108.677 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.91 2.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.59 ' CZ ' ' CG ' ' A' ' 79' ' ' HIS . 35.8 t80 -45.98 -35.71 4.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.9 . . . . 0.0 111.127 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -86.02 -27.25 24.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.75 -1.219 . . . . 0.0 110.332 -178.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -66.81 12.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.989 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.683 ' CG ' HE22 ' A' ' 33' ' ' GLN . 16.5 m80 -124.76 152.7 69.88 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.787 -1.195 . . . . 0.0 109.636 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.73 -6.63 15.35 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.675 2.25 . . . . 0.0 112.434 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 29' ' ' ASN . 5.8 tp -73.22 -28.01 61.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.837 . . . . 0.0 111.223 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.59 ' CG ' ' CZ ' ' A' ' 73' ' ' PHE . 2.9 t60 -82.08 -35.45 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.052 . . . . 0.0 110.281 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.53 -60.01 3.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.989 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -56.64 -38.65 72.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.612 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.41 -41.86 72.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.849 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 87' ' ' THR . 17.3 t -61.73 -39.2 90.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.167 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.31 77.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.1 -39.72 78.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 90' ' ' ILE . 28.3 t80 -45.19 -29.53 0.97 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.2 p -83.46 -62.26 1.63 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.588 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -40.09 -27.94 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.705 -0.622 . . . . 0.0 110.084 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 p -100.95 14.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.819 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 91' ' ' ASP . 22.5 mm -128.69 161.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.682 -1.261 . . . . 0.0 110.444 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 90' ' ' ILE . 62.8 t0 -104.37 -35.23 8.01 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.483 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 19.8 ptmt -145.63 146.03 31.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -125.69 123.43 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.626 -1.296 . . . . 0.0 109.799 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.65 132.4 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -138.6 135.41 34.92 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.262 -1.524 . . . . 0.0 111.766 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -121.06 124.53 45.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.638 -0.664 . . . . 0.0 109.363 176.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.544 ' OD1' ' CZ ' ' A' ' 6' ' ' PHE . 20.2 t0 -126.27 133.65 51.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.053 -1.029 . . . . 0.0 108.951 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CE1' ' CD ' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -156.62 157.77 31.07 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.109 -0.995 . . . . 0.0 110.516 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.79 127.77 13.41 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.321 2.014 . . . . 0.0 112.209 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -106.99 128.7 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -108.47 94.48 5.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.47 -0.768 . . . . 0.0 109.625 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.46 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' A' ' 101' ' ' ALA . 10.2 m -148.36 -26.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 106' ' ' SER . 25.2 mmtt -38.45 -28.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 103' ' ' VAL . 5.7 p -57.69 70.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.131 -0.98 . . . . 0.0 108.941 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 104' ' ' LYS . 8.0 t -111.21 109.82 20.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 107' ' ' VAL . 11.3 p . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.26 148.39 34.25 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.406 -1.378 . . . . 0.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.54 ' CZ ' ' OD1' ' B' ' 97' ' ' ASP . 34.4 t80 -114.77 128.2 56.17 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.249 -1.148 . . . . 0.0 108.02 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.627 ' HZ3' HD12 ' B' ' 9' ' ' LEU . 3.6 ttpp -113.55 142.4 46.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 112.822 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.406 ' HD1' ' HB2' ' B' ' 97' ' ' ASP . 70.4 t60 -132.86 133.36 43.21 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.627 HD12 ' HZ3' ' B' ' 7' ' ' LYS . 6.5 tt -136.58 145.86 45.45 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.728 -1.233 . . . . 0.0 109.458 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.45 HG13 ' O ' ' B' ' 10' ' ' VAL . 12.1 p -127.18 133.34 68.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.6 OUTLIER -116.04 129.16 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.487 ' O ' HG22 ' B' ' 57' ' ' THR . 6.3 m -139.61 167.5 19.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.017 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 19.1 tptp -132.74 152.34 51.77 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.48 ' HB2' ' H ' ' B' ' 18' ' ' THR . 39.7 p90 -108.77 149.47 28.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.85 -1.156 . . . . 0.0 111.606 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -129.11 -22.08 3.2 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.6 mt-10 -89.29 -57.12 3.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 7.9 t0 153.75 64.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 63.7 m -50.73 105.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.136 0.97 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.526 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -75.62 88.22 2.73 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.497 HG23 ' N ' ' B' ' 21' ' ' ASP . 34.9 m -64.63 -38.55 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.612 -0.68 . . . . 0.0 110.471 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' HG23 ' B' ' 20' ' ' VAL . 82.7 m-20 -66.19 -44.56 83.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 110.564 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -66.07 -31.47 72.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 mt -69.53 -37.35 74.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' B' ' 21' ' ' ASP . 13.9 tp -53.3 -37.83 62.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -34.64 74.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -63.98 -53.54 36.54 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.77 -47.64 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.982 . . . . 0.0 108.797 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -52.6 -44.55 66.06 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.3 OUTLIER -68.66 -49.04 62.27 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.51 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -48.47 -47.6 38.32 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 32' ' ' SER . 53.7 t -49.96 -26.06 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.309 -0.869 . . . . 0.0 108.832 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.3 t -42.0 -42.61 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.69 HE22 ' CG ' ' B' ' 76' ' ' HIS . 15.3 mm100 -61.07 -11.3 8.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.443 -0.786 . . . . 0.0 111.509 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.683 HG22 ' O ' ' B' ' 34' ' ' ILE . 42.1 mm -81.78 26.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 119.99 -1.693 . . . . 0.0 110.559 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 36' ' ' THR . 31.6 p-10 -67.51 -26.3 66.27 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.723 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.4 t -79.25 1.85 23.33 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.942 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 36' ' ' THR . 21.1 m 37.93 21.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 36' ' ' THR . 83.3 mttt -120.82 41.36 3.31 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.422 ' O ' HD12 ' B' ' 34' ' ' ILE . 1.4 m -158.2 154.71 27.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 98.5 m-85 -144.47 154.53 43.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.545 -1.347 . . . . 0.0 111.99 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 80.8 mt-10 -160.97 130.45 4.83 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.345 0.593 . . . . 0.0 110.2 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -130.09 175.22 9.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.75 154.07 21.99 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.828 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.568 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 17.9 mt-10 -151.12 141.72 22.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 8.1 p30 -115.91 148.67 39.77 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.633 ' HD3' ' N ' ' B' ' 57' ' ' THR . 0.0 OUTLIER -68.59 80.89 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.394 -1.441 . . . . 0.0 109.788 -176.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 45' ' ' ASP . 78.2 mm-40 -96.95 54.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.646 . . . . 0.0 109.315 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' B' ' 49' ' ' HIS . 29.6 t -134.14 -138.22 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.531 ' N ' ' OG ' ' B' ' 48' ' ' SER . 74.1 m80 -107.24 142.92 36.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.134 -0.979 . . . . 0.0 109.699 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -42.78 -41.25 3.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.78 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.9 ttt -71.42 -29.29 64.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 95' ' ' LEU . 51.5 mt -98.26 -18.46 18.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.72 -1.238 . . . . 0.0 109.279 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' B' ' 55' ' ' GLY . 55.0 mtp180 -73.42 0.58 11.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -0.844 . . . . 0.0 111.271 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 55.87 -4.06 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.832 -1.168 . . . . 0.0 110.18 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.641 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 82.77 -18.89 13.22 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.454 -0.778 . . . . 0.0 112.861 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' B' ' 11' ' ' VAL . 12.2 m-85 -58.92 -128.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.288 -1.713 . . . . 0.0 109.902 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.633 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 2.5 t -164.9 -36.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.299 -0.876 . . . . 0.0 110.992 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.652 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.7 t60 -169.91 153.77 4.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.826 -1.171 . . . . 0.0 110.214 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.652 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.21 168.77 18.95 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.461 -0.774 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.532 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 88.2 m-85 -129.01 126.12 38.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.513 -0.742 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.24 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 34.6 mtt -104.92 117.9 35.2 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.24 -0.913 . . . . 0.0 110.731 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 99.9 m -120.38 143.27 48.52 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -119.28 159.69 23.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.715 -1.241 . . . . 0.0 110.073 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.6 -27.57 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -173.57 -174.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.39 -27.33 65.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 111.422 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 29.0 p-10 -57.9 -38.03 75.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.817 -1.177 . . . . 0.0 110.574 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -68.75 -37.6 84.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.507 ' O ' ' CG2' ' B' ' 74' ' ' THR . 71.5 t80 -62.36 -46.76 87.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.574 -0.956 . . . . 0.0 110.445 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.94 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.377 -1.452 . . . . 0.0 108.732 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.585 ' CZ ' ' CG ' ' B' ' 79' ' ' HIS . 35.8 t80 -45.75 -35.76 4.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.932 . . . . 0.0 111.107 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.2 OUTLIER -86.08 -27.29 24.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.808 -1.183 . . . . 0.0 110.316 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -66.66 12.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.066 -1.021 . . . . 0.0 110.986 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.69 ' CG ' HE22 ' B' ' 33' ' ' GLN . 16.8 m80 -124.81 152.56 69.88 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 109.547 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.58 -6.63 15.48 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.644 2.229 . . . . 0.0 112.453 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.451 HD23 HD22 ' B' ' 30' ' ' LEU . 5.8 tp -73.09 -28.23 62.17 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.236 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.585 ' CG ' ' CZ ' ' B' ' 73' ' ' PHE . 2.9 t60 -81.98 -35.44 28.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.48 -60.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.987 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' B' ' 82' ' ' PHE . 22.4 pt-20 -56.59 -38.77 72.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' B' ' 81' ' ' GLU . 73.1 t80 -70.26 -41.86 72.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . 0.531 ' O ' HG23 ' B' ' 87' ' ' THR . 17.4 t -61.62 -39.42 91.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.1 -1.0 . . . . 0.0 110.15 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -49.39 77.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 108.68 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.93 -39.8 79.37 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.467 ' O ' HG12 ' B' ' 90' ' ' ILE . 28.4 t80 -45.12 -29.5 0.93 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.2 p -83.5 -62.36 1.6 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -40.01 -27.98 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.742 -0.599 . . . . 0.0 110.084 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' B' ' 87' ' ' THR . 3.9 p -100.86 14.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.234 -0.916 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 91' ' ' ASP . 22.4 mm -128.63 161.19 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.664 -1.273 . . . . 0.0 110.421 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.564 ' N ' HG22 ' B' ' 90' ' ' ILE . 62.6 t0 -104.55 -35.33 7.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.468 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 19.8 ptmt -145.53 146.14 31.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -125.78 123.32 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.597 -1.314 . . . . 0.0 109.767 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 132.38 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.519 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -138.59 135.3 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.314 -1.491 . . . . 0.0 111.737 -178.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.564 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -121.0 124.62 45.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 176.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' B' ' 6' ' ' PHE . 21.1 t0 -126.39 133.62 51.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.034 -1.041 . . . . 0.0 108.923 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -156.6 157.67 31.04 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.065 -1.022 . . . . 0.0 110.516 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.7 127.93 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.268 1.979 . . . . 0.0 112.227 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.14 128.66 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.957 . . . . 0.0 110.042 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -108.56 94.46 5.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.491 -0.756 . . . . 0.0 109.609 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.39 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.564 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.658 ' N ' ' O ' ' B' ' 101' ' ' ALA . 10.4 m -148.33 -26.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 109.23 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.4 mmtt -38.6 -28.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 103' ' ' VAL . 5.7 p -57.77 70.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.135 -0.978 . . . . 0.0 108.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.705 ' N ' ' O ' ' B' ' 104' ' ' LYS . 8.0 t -111.15 109.83 20.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.575 HG22 ' O ' ' B' ' 107' ' ' VAL . 11.3 p . . . . . 0 C--N 1.302 -1.48 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.663 HG23 ' N ' ' A' ' 4' ' ' SER . 7.6 t -147.64 -49.07 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.102 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.663 ' N ' HG23 ' A' ' 3' ' ' THR . 29.6 m -124.05 -103.76 0.37 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.01 45.24 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.737 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -136.36 135.02 38.47 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.218 -1.166 . . . . 0.0 108.036 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -99.94 127.0 46.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.93 -1.107 . . . . 0.0 112.822 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.507 ' ND1' ' OD1' ' A' ' 97' ' ' ASP . 86.3 t60 -122.61 121.18 35.84 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.6 tt -135.08 144.11 47.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.714 -1.241 . . . . 0.0 109.474 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.7 p -127.64 134.32 65.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.547 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.52 127.93 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.429 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.4 m -141.6 159.92 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 117.785 -1.566 . . . . 0.0 113.042 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -130.41 155.2 46.81 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.605 ' CD2' HG21 ' A' ' 57' ' ' THR . 11.9 p90 -111.11 153.69 25.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.13 . . . . 0.0 111.606 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -19.14 3.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 17' ' ' ASP . 13.5 tm-20 -92.63 -56.82 2.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 3.1 m-20 155.24 62.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.522 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.8 m -49.04 105.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.082 0.944 . . . . 0.0 112.849 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.85 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.98 85.5 0.7 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 21' ' ' ASP . 33.0 m -64.95 -41.02 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.527 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.547 ' N ' HG23 ' A' ' 20' ' ' VAL . 36.4 p-10 -66.51 -46.54 75.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.4 -0.812 . . . . 0.0 110.553 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.8 mp0 -66.14 -30.25 70.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mt -72.4 -41.79 64.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.4 tp -56.1 -38.59 70.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.47 -34.03 76.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -68.16 -53.3 22.86 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -44.93 -42.68 8.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.547 -0.972 . . . . 0.0 108.793 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -53.24 -42.69 66.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.674 ' ND2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -58.84 -45.2 90.63 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.674 ' N ' ' ND2' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -49.24 -45.12 44.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' ILE . 16.0 t -58.08 -20.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 108.827 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 46.8 t -44.0 -38.3 3.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.659 ' OE1' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.64 -10.74 50.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 111.39 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.659 HD13 ' OE1' ' A' ' 33' ' ' GLN . 5.4 mm -86.06 21.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.075 -1.64 . . . . 0.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 36' ' ' THR . 51.6 p30 -58.91 -9.43 1.84 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.642 ' O ' ' C ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -80.2 -1.1 39.02 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.895 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.642 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.4 m 30.26 45.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 109.217 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HZ1' ' H ' ' A' ' 69' ' ' GLY . 11.4 ptmm? -121.03 39.86 3.7 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 75.7 m -173.36 179.08 2.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -145.56 154.74 42.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.608 -1.308 . . . . 0.0 111.936 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -154.64 123.25 6.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.395 0.617 . . . . 0.0 110.234 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.615 ' CH2' ' HB3' ' B' ' 101' ' ' ALA . 67.0 t-105 -135.83 175.03 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' N ' ' CG ' ' A' ' 42' ' ' TRP . . . -132.28 160.97 23.85 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 118.711 -1.709 . . . . 0.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 41.8 mp0 -148.84 139.63 22.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -1.151 . . . . 0.0 109.336 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 47' ' ' GLU . 85.6 m-20 -113.75 147.08 38.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.671 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.5 81.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.435 -1.416 . . . . 0.0 109.806 -178.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.0 mt-10 -122.06 59.2 1.01 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' A' ' 49' ' ' HIS . 43.9 p -158.49 73.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' A' ' 48' ' ' SER . 55.9 m80 54.34 125.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -44.79 -31.51 1.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 110.757 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -30.79 52.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.992 -1.068 . . . . 0.0 110.763 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' SER . 40.6 mt -100.62 -27.63 13.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.784 -1.198 . . . . 0.0 109.336 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 46' ' ' LYS . 8.7 ptm180 -87.0 -2.45 58.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.326 -0.859 . . . . 0.0 111.25 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 49.21 13.71 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.839 -1.163 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.584 ' H ' ' HG3' ' A' ' 53' ' ' ARG . . . 57.06 -2.89 0.07 OUTLIER Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.441 -0.787 . . . . 0.0 112.89 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.525 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 45.8 p90 -57.1 124.08 17.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.233 -1.745 . . . . 0.0 109.977 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.675 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 72.1 p -54.2 -44.11 71.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 111.002 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.675 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 36.0 p-80 -170.21 154.94 5.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.826 -1.171 . . . . 0.0 110.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.48 17.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.283 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.91 126.77 38.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.494 -0.754 . . . . 0.0 109.078 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -96.09 96.24 8.71 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtt -101.83 119.11 38.26 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.165 -0.959 . . . . 0.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 m -125.67 145.31 50.22 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -121.59 163.74 18.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.701 -1.249 . . . . 0.0 110.088 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 4' ' ' SER . 85.4 tt0 -85.49 -30.9 23.09 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -157.56 164.06 37.71 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -24.29 55.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -57.18 -40.03 76.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.796 -1.19 . . . . 0.0 110.608 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.617 ' H ' ' HZ1' ' A' ' 38' ' ' LYS . . . -68.63 -40.79 85.64 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' HG22 ' A' ' 74' ' ' THR . 72.9 t80 -60.54 -46.79 88.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.988 . . . . 0.0 110.454 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.72 -28.97 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.396 -1.44 . . . . 0.0 108.677 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.02 -60.95 2.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -56.77 -39.44 74.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 111.173 -176.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.82 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.9 t -80.84 -34.08 34.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.764 -1.21 . . . . 0.0 110.295 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.1 m -68.12 -32.9 73.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 110.973 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -69.62 126.0 92.32 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.899 -1.125 . . . . 0.0 109.635 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.78 -7.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.726 2.284 . . . . 0.0 112.364 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 30' ' ' LEU . 6.1 tt -72.31 -30.99 65.3 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.363 -0.836 . . . . 0.0 111.198 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 10.9 t-160 -82.89 -29.19 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.966 -1.084 . . . . 0.0 110.275 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.53 -58.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.018 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -56.45 -38.17 71.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -71.64 -42.19 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -62.18 -39.72 93.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.102 -0.999 . . . . 0.0 110.146 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.49 77.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.955 -1.091 . . . . 0.0 108.69 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.08 -40.67 87.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 85' ' ' ALA . 15.9 t80 -45.29 -29.35 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 89' ' ' VAL . 12.2 m -81.79 -62.12 1.73 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -38.85 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.7 -0.625 . . . . 0.0 110.111 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.5 m -106.47 11.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.791 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 91' ' ' ASP . 26.4 mm -130.53 163.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.685 -1.26 . . . . 0.0 110.41 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.618 ' N ' HG22 ' A' ' 90' ' ' ILE . 22.6 t0 -124.22 -34.52 2.92 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -126.99 125.17 41.02 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.0 tp -123.54 123.14 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.691 -1.256 . . . . 0.0 109.786 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 43.7 t -130.28 133.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -137.48 135.26 36.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.278 -1.514 . . . . 0.0 111.781 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.867 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.1 mp -114.67 117.01 29.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.688 -0.632 . . . . 0.0 109.339 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.507 ' OD1' ' ND1' ' A' ' 8' ' ' HIS . 79.2 m-20 -114.63 121.77 44.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.092 -1.005 . . . . 0.0 108.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 63.1 t80 -154.61 137.22 10.03 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.077 -1.014 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 39.7 Cg_endo -63.86 141.94 80.19 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.311 2.007 . . . . 0.0 112.228 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' B' ' 42' ' ' TRP . 71.1 t -122.41 141.97 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 109.979 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.607 ' HB3' ' CH2' ' B' ' 42' ' ' TRP . . . -112.46 96.93 6.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.88 76.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.6 m -148.11 120.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.385 -0.822 . . . . 0.0 109.155 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.32 115.71 24.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.346 -0.846 . . . . 0.0 109.325 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.556 ' O ' HG12 ' A' ' 107' ' ' VAL . 22.1 m -69.88 -45.38 67.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 108.914 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' SER . 6.1 t 43.19 52.42 5.56 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.354 -0.841 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 107' ' ' VAL . 9.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.443 ' O ' ' O ' ' B' ' 65' ' ' GLU . 28.2 m . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.4 175.0 45.64 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.43 134.81 38.11 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.207 -1.172 . . . . 0.0 108.075 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -99.76 126.9 45.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.929 -1.107 . . . . 0.0 112.837 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' B' ' 97' ' ' ASP . 86.3 t60 -122.66 121.21 35.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.6 tt -135.07 144.07 47.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.694 -1.253 . . . . 0.0 109.454 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.444 HG13 ' O ' ' B' ' 10' ' ' VAL . 10.6 p -127.62 134.41 65.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.512 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.64 127.95 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.425 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.4 m -141.6 159.76 21.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.019 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -130.29 155.26 46.62 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.604 ' CD2' HG21 ' B' ' 57' ' ' THR . 12.0 p90 -111.23 153.66 25.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.827 -1.17 . . . . 0.0 111.558 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 -19.2 3.2 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 17' ' ' ASP . 13.5 tm-20 -92.49 -56.92 2.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.519 ' N ' ' OE1' ' B' ' 16' ' ' GLU . 3.1 m-20 155.21 62.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.509 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 90.2 m -49.31 105.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.095 0.95 . . . . 0.0 112.882 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.838 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -70.95 85.33 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.552 HG23 ' N ' ' B' ' 21' ' ' ASP . 32.9 m -64.84 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.616 -0.677 . . . . 0.0 110.539 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' HG23 ' B' ' 20' ' ' VAL . 36.0 p-10 -66.59 -46.41 76.05 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 110.569 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 3.9 mp0 -66.25 -30.25 70.65 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.35 -41.78 65.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -56.08 -38.6 70.9 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.34 -34.28 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.596 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -67.96 -53.43 22.98 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -44.88 -42.59 8.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.466 -1.02 . . . . 0.0 108.801 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -53.43 -42.54 67.19 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' N ' ' B' ' 30' ' ' LEU . 0.0 OUTLIER -58.91 -45.21 90.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.68 ' N ' ' ND2' ' B' ' 29' ' ' ASN . 0.5 OUTLIER -49.18 -45.28 43.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' B' ' 34' ' ' ILE . 15.8 t -57.88 -20.35 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.278 -0.889 . . . . 0.0 108.806 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.0 t -43.86 -38.41 3.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.652 ' OE1' HD13 ' B' ' 34' ' ' ILE . 0.0 OUTLIER -87.53 -10.97 50.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.502 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.652 HD13 ' OE1' ' B' ' 33' ' ' GLN . 5.3 mm -85.85 21.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 119.933 -1.73 . . . . 0.0 110.588 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 36' ' ' THR . 51.1 p30 -59.01 -9.5 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -80.18 -1.01 38.56 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.878 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.6 m 30.33 45.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.03 -1.044 . . . . 0.0 109.17 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.652 ' HZ2' ' CA ' ' B' ' 69' ' ' GLY . 11.4 ptmm? -121.12 40.0 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 74.9 m -173.39 179.17 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.61 154.73 42.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.469 -1.394 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -154.6 123.33 6.19 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.471 0.653 . . . . 0.0 110.218 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.607 ' CH2' ' HB3' ' A' ' 101' ' ' ALA . 66.7 t-105 -135.75 175.08 9.92 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' B' ' 42' ' ' TRP . . . -132.2 161.07 23.84 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.772 -1.68 . . . . 0.0 110.791 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 41.6 mp0 -148.9 139.48 22.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -1.162 . . . . 0.0 109.358 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 47' ' ' GLU . 85.2 m-20 -113.46 147.14 38.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.66 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -65.54 81.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.483 -1.385 . . . . 0.0 109.832 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.1 mt-10 -122.12 59.28 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.712 -0.618 . . . . 0.0 109.398 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' B' ' 49' ' ' HIS . 41.7 p -158.42 73.25 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' B' ' 48' ' ' SER . 55.9 m80 54.24 125.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -44.6 -31.62 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.44 -30.89 53.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.724 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' B' ' 48' ' ' SER . 41.4 mt -100.76 -27.47 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.782 -1.199 . . . . 0.0 109.247 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' O ' ' B' ' 46' ' ' LYS . 8.7 ptm180 -87.11 -2.48 58.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 111.204 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 49.32 13.64 0.08 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.782 -1.199 . . . . 0.0 110.217 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.592 ' H ' ' HG3' ' B' ' 53' ' ' ARG . . . 57.18 -3.13 0.07 OUTLIER Glycine 0 N--CA 1.498 2.797 0 O-C-N 121.47 -0.769 . . . . 0.0 112.852 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 45.9 p90 -56.96 124.17 17.72 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.279 -1.718 . . . . 0.0 109.977 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.64 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 72.1 p -54.19 -44.19 71.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.988 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.64 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 36.0 p-80 -170.21 154.82 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.119 . . . . 0.0 110.197 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.95 169.46 17.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.414 -0.804 . . . . 0.0 109.24 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.81 126.87 39.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.348 -0.845 . . . . 0.0 109.081 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 66.0 m -96.1 96.3 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtt -101.81 119.07 38.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.23 -0.919 . . . . 0.0 110.81 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -125.71 145.33 50.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.63 163.64 18.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.661 -1.274 . . . . 0.0 110.054 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 4' ' ' SER . 85.4 tt0 -85.45 -30.92 23.14 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.43 164.13 37.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -24.39 56.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 111.467 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.96 -40.23 76.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.727 -1.233 . . . . 0.0 110.563 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.652 ' CA ' ' HZ2' ' B' ' 38' ' ' LYS . . . -68.6 -40.55 85.91 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.817 ' O ' HG22 ' B' ' 74' ' ' THR . 73.4 t80 -60.77 -46.69 89.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.636 -0.92 . . . . 0.0 110.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.98 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.322 -1.486 . . . . 0.0 108.665 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.461 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.03 -60.85 2.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.788 . . . . 0.0 109.387 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.425 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.75 -39.43 73.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.889 . . . . 0.0 111.079 -177.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.817 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.9 t -80.97 -33.84 33.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.763 -1.21 . . . . 0.0 110.371 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 74.5 m -68.36 -32.82 73.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.955 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.565 ' O ' ' N ' ' B' ' 78' ' ' LEU . 0.3 OUTLIER -69.58 126.04 92.35 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.807 -1.183 . . . . 0.0 109.605 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -43.78 -7.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.642 2.228 . . . . 0.0 112.48 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.566 ' CD2' HD22 ' B' ' 30' ' ' LEU . 6.2 tt -72.51 -30.93 64.93 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.42 -0.8 . . . . 0.0 111.214 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.457 ' CD2' ' O ' ' B' ' 79' ' ' HIS . 10.9 t-160 -82.93 -29.11 29.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.956 -1.09 . . . . 0.0 110.317 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.54 -58.71 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 110.004 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -56.54 -38.2 71.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 0.0 109.531 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -71.5 -42.25 68.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 0.0 109.905 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -62.27 -39.64 93.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.0 . . . . 0.0 110.124 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.5 77.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 0.0 108.609 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.18 -40.64 86.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.456 ' O ' HG12 ' B' ' 90' ' ' ILE . 16.0 t80 -45.31 -29.3 1.0 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 12.3 m -81.8 -62.08 1.74 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.99 -26.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.643 -0.661 . . . . 0.0 110.093 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.7 m -106.58 11.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.28 -0.888 . . . . 0.0 110.828 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.62 HG22 ' N ' ' B' ' 91' ' ' ASP . 26.4 mm -130.59 163.91 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.616 -1.302 . . . . 0.0 110.494 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.62 ' N ' HG22 ' B' ' 90' ' ' ILE . 22.6 t0 -124.25 -34.55 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -127.03 125.13 40.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.0 tp -123.63 123.15 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.617 -1.302 . . . . 0.0 109.715 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 43.2 t -130.27 133.01 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.494 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -137.43 135.19 36.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.251 -1.531 . . . . 0.0 111.796 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.859 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.2 mp -114.68 116.96 29.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 109.317 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' B' ' 8' ' ' HIS . 79.8 m-20 -114.67 121.78 44.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.156 -0.965 . . . . 0.0 108.884 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 63.3 t80 -154.56 137.18 10.01 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 39.7 Cg_endo -63.93 141.89 79.53 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.27 1.98 . . . . 0.0 112.299 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' A' ' 42' ' ' TRP . 71.4 t -122.37 141.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 110.05 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.615 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . . . -112.53 96.99 6.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.439 -0.788 . . . . 0.0 109.548 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.9 76.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.091 -1.005 . . . . 0.0 109.561 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 103' ' ' VAL . 9.4 m -148.03 120.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.227 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.27 115.72 24.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.552 ' O ' HG12 ' B' ' 107' ' ' VAL . 23.2 m -69.78 -45.67 67.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.138 -0.976 . . . . 0.0 108.917 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.4 t 43.48 52.23 6.03 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.365 -0.834 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 107' ' ' VAL . 9.5 p . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.81 HG21 ' HB2' ' A' ' 101' ' ' ALA . 10.2 t -65.85 -45.7 81.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.174 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.625 ' N ' HG23 ' A' ' 3' ' ' THR . 19.7 m -136.23 -97.02 0.23 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.61 170.06 41.79 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.731 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.2 131.27 43.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.283 -1.127 . . . . 0.0 108.011 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -99.87 125.75 45.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.925 -1.109 . . . . 0.0 112.824 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 62' ' ' MET . 74.5 m80 -120.09 121.41 38.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.42 143.21 43.82 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.696 -1.252 . . . . 0.0 109.486 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 95' ' ' LEU . 14.7 p -128.67 136.12 60.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.635 -0.666 . . . . 0.0 109.492 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -114.07 126.58 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 178.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' A' ' 10' ' ' VAL . 2.1 m -138.09 154.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.813 -1.555 . . . . 0.0 113.064 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 57' ' ' THR . 43.7 mtpt -126.61 154.85 43.4 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.669 ' CD2' HG21 ' A' ' 57' ' ' THR . 16.6 p90 -111.28 152.54 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.817 -1.177 . . . . 0.0 111.641 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -128.23 -18.48 4.08 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.6 mt-10 -90.48 -56.83 3.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 4.8 p30 153.05 58.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 78.8 m -47.05 107.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.051 0.929 . . . . 0.0 112.815 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.75 87.67 2.79 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 175.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -57.97 -34.87 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.725 . . . . 0.0 110.527 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.45 -40.25 89.32 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 88.3 mt-10 -68.27 -33.33 74.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 19' ' ' LYS . 1.1 mp -63.9 -44.08 97.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.48 -34.62 61.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.51 -34.33 75.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.38 -44.92 8.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.56 -58.09 9.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.538 -0.978 . . . . 0.0 108.81 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.76 -40.82 73.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.425 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 38.7 t30 -61.23 -45.34 94.95 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.687 HD13 ' O ' ' A' ' 30' ' ' LEU . 2.8 tm? -53.91 -46.08 71.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG11 HG21 ' B' ' 107' ' ' VAL . 59.5 t -55.91 -33.8 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 108.825 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 31' ' ' VAL . 4.7 m -45.47 -39.8 7.61 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 35' ' ' ASP . 21.3 tp60 -69.34 -53.98 16.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.439 -0.788 . . . . 0.0 111.469 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.633 ' C ' ' H ' ' A' ' 36' ' ' THR . 17.4 mt -61.2 41.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.039 -1.663 . . . . 0.0 110.626 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.662 ' N ' ' O ' ' A' ' 33' ' ' GLN . 58.9 t0 -60.41 -3.81 0.74 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' A' ' 37' ' ' VAL . 45.3 p -76.9 -0.96 26.09 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.942 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 36' ' ' THR . 19.1 m 31.21 47.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 36' ' ' THR . 13.9 ptpt -124.46 42.45 3.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 t -175.63 179.45 1.41 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 93.0 m-85 -145.75 155.28 42.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.566 -1.334 . . . . 0.0 111.958 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' PHE . 71.2 mt-10 -157.06 126.52 6.08 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.356 0.598 . . . . 0.0 110.246 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.545 ' CD1' ' NZ ' ' B' ' 104' ' ' LYS . 0.1 OUTLIER -142.34 178.02 7.86 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' CE3' ' A' ' 42' ' ' TRP . . . -142.83 169.1 25.74 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.46 145.97 27.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -1.137 . . . . 0.0 109.369 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 86.5 m-20 -124.25 147.02 48.39 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.855 ' HD2' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -146.19 136.36 23.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.437 -1.414 . . . . 0.0 109.808 -174.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.73 ' O ' ' O ' ' A' ' 48' ' ' SER . 96.2 mt-10 -131.13 -0.7 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.707 -0.621 . . . . 0.0 109.343 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.73 ' O ' ' O ' ' A' ' 47' ' ' GLU . 29.7 t -49.01 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.543 ' N ' ' OG ' ' A' ' 48' ' ' SER . 76.0 m80 -70.7 152.59 43.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.461 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 88.2 m-20 -66.98 -41.65 86.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.481 ' SD ' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -69.2 -33.95 74.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.007 -1.058 . . . . 0.0 110.789 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' B' ' 95' ' ' LEU . 70.4 mt -87.26 -56.34 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.722 -1.236 . . . . 0.0 109.33 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.697 ' C ' ' H ' ' A' ' 55' ' ' GLY . 10.0 ptt180 -59.4 4.75 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 111.149 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.91 ' NE2' HD11 ' B' ' 96' ' ' LEU . 2.5 mt-30 59.64 -18.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.86 -1.15 . . . . 0.0 110.196 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.697 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 83.12 -17.27 23.89 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 121.434 -0.791 . . . . 0.0 112.921 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.855 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 6.1 p90 -60.47 117.02 4.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.275 -1.721 . . . . 0.0 109.897 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.791 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 70.1 p -51.68 -33.72 35.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.295 -0.878 . . . . 0.0 110.984 -175.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.791 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -175.44 159.93 2.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.847 -1.158 . . . . 0.0 110.114 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.51 169.28 17.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.347 -0.846 . . . . 0.0 109.249 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.36 127.5 37.72 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.484 -0.76 . . . . 0.0 109.094 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -93.15 98.49 11.33 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 8' ' ' HIS . 69.9 mtm -101.54 113.63 26.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.166 -0.958 . . . . 0.0 110.775 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.2 m -123.03 141.99 51.35 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.87 162.05 19.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.698 -1.252 . . . . 0.0 110.118 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -81.97 -30.41 31.67 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -168.13 175.36 6.63 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -65.07 -24.84 67.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 111.419 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -61.38 -44.88 96.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.777 -1.202 . . . . 0.0 110.573 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.25 -34.3 74.93 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.748 ' O ' HG22 ' A' ' 74' ' ' THR . 74.0 t80 -65.98 -46.2 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.479 -1.012 . . . . 0.0 110.485 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 75' ' ' SER . 20.9 m -70.75 -28.93 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.345 -1.472 . . . . 0.0 108.668 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.12 -60.88 2.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 0.0 109.326 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -60.96 -55.86 27.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 111.177 -177.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.748 HG22 ' O ' ' A' ' 70' ' ' TYR . 12.8 t -57.09 -34.71 68.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.729 -1.232 . . . . 0.0 110.287 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 68.8 p -69.35 -26.44 64.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -0.955 . . . . 0.0 110.967 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 72' ' ' ALA . 41.9 m80 -65.1 151.46 93.6 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.843 -1.161 . . . . 0.0 109.648 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.74 -12.7 26.73 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.641 2.227 . . . . 0.0 112.439 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.32 -28.9 63.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.361 -0.837 . . . . 0.0 111.208 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.464 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 46.1 t60 -83.23 -32.8 26.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.017 -1.052 . . . . 0.0 110.227 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.84 -60.44 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.047 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.05 -37.6 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.14 -40.26 74.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.3 t -62.6 -41.09 98.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.21 74.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.972 -1.08 . . . . 0.0 108.706 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.63 -41.26 79.69 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.467 ' C ' ' O ' ' A' ' 85' ' ' ALA . 20.0 t80 -44.6 -31.26 1.09 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.3 m -82.53 -61.68 1.82 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.17 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.712 -0.617 . . . . 0.0 110.09 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.1 m -100.53 16.35 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 110.847 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.616 ' N ' ' O ' ' A' ' 87' ' ' THR . 41.1 mt -126.68 159.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.659 -1.276 . . . . 0.0 110.409 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.517 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 52.7 t0 -102.31 -31.91 10.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.456 ' N ' HG22 ' A' ' 90' ' ' ILE . 32.2 pttt -151.9 149.44 28.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.8 tp -125.06 124.23 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.653 -1.279 . . . . 0.0 109.73 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.422 HG12 HE21 ' B' ' 54' ' ' GLN . 46.3 t -126.95 131.33 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.8 138.17 32.05 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.34 -1.475 . . . . 0.0 111.741 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.959 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.16 125.72 49.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 31.4 p-10 -120.38 124.56 45.83 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.045 . . . . 0.0 108.907 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 86.3 t80 -154.05 123.74 3.26 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.1 -1.0 . . . . 0.0 110.531 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.03 136.22 14.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.345 2.03 . . . . 0.0 112.186 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.9 t -120.77 140.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.997 . . . . 0.0 110.028 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.81 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -113.46 96.97 6.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.34 76.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.018 . . . . 0.0 109.599 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 103' ' ' VAL . 13.2 m -148.42 118.85 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 0.0 109.176 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 106' ' ' SER . 23.4 mmtm -144.73 -11.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.467 ' C ' ' O ' ' A' ' 104' ' ' LYS . 87.5 p -42.15 -24.5 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 108.93 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 104' ' ' LYS . 34.5 t -53.04 -83.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.36 -0.838 . . . . 0.0 109.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 104' ' ' LYS . 44.2 t . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.84 170.03 41.29 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.748 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.99 131.24 44.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.29 -1.123 . . . . 0.0 108.064 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -99.77 125.86 45.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.946 -1.096 . . . . 0.0 112.854 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' B' ' 62' ' ' MET . 74.4 m80 -120.22 121.09 37.95 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 tt -136.19 143.34 44.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.736 -1.227 . . . . 0.0 109.399 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' B' ' 95' ' ' LEU . 15.0 p -128.69 136.22 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.505 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' B' ' 56' ' ' PHE . 0.2 OUTLIER -114.16 126.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.431 ' CG1' HG22 ' B' ' 10' ' ' VAL . 2.1 m -138.24 153.9 27.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 117.757 -1.577 . . . . 0.0 113.016 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.434 ' HD3' ' HZ2' ' B' ' 92' ' ' LYS . 43.7 mtpt -126.4 154.68 43.27 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.674 ' CD2' HG21 ' B' ' 57' ' ' THR . 17.1 p90 -111.17 152.58 26.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.923 -1.11 . . . . 0.0 111.589 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -128.18 -18.83 4.03 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.3 mt-10 -90.12 -56.94 3.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 4.8 p30 153.13 58.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 73.0 m -47.04 107.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.131 0.967 . . . . 0.0 112.821 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.618 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.88 87.72 2.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -57.91 -34.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.567 -0.708 . . . . 0.0 110.533 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.4 p-10 -66.76 -40.08 88.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 110.51 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 88.3 mt-10 -68.28 -33.15 73.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.41 HD13 ' O ' ' B' ' 19' ' ' LYS . 1.1 mp -64.26 -43.96 97.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.27 -34.92 61.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.36 -34.43 75.29 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.26 -44.75 8.58 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -56.96 -57.98 10.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.555 -0.967 . . . . 0.0 108.799 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.8 -40.66 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.423 ' H ' ' HG3' ' B' ' 28' ' ' GLU . 38.7 t30 -61.41 -45.35 94.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.677 HD13 ' O ' ' B' ' 30' ' ' LEU . 2.8 tm? -53.87 -46.06 71.18 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 107' ' ' VAL . 60.2 t -55.69 -34.01 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.301 -0.874 . . . . 0.0 108.839 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 31' ' ' VAL . 4.7 m -45.37 -39.77 7.21 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.667 ' O ' ' N ' ' B' ' 35' ' ' ASP . 21.5 tp60 -69.49 -53.88 16.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.493 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.624 ' C ' ' H ' ' B' ' 36' ' ' THR . 17.4 mt -61.31 41.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 119.939 -1.725 . . . . 0.0 110.588 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.667 ' N ' ' O ' ' B' ' 33' ' ' GLN . 60.6 t0 -60.55 -4.26 0.87 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.624 ' H ' ' C ' ' B' ' 34' ' ' ILE . 45.6 p -76.44 -1.4 26.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.62 ' C ' ' O ' ' B' ' 36' ' ' THR . 19.0 m 31.66 47.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.015 -1.053 . . . . 0.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.444 ' HG2' ' OG1' ' B' ' 36' ' ' THR . 13.9 ptpt -124.56 42.48 3.25 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.5 t -175.56 179.39 1.44 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.434 ' O ' ' HG2' ' B' ' 41' ' ' GLU . 93.1 m-85 -145.8 155.28 42.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.582 -1.324 . . . . 0.0 111.93 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 40' ' ' PHE . 71.7 mt-10 -157.1 126.43 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.783 -0.573 . . . . 0.0 110.272 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' B' ' 43' ' ' GLY . 0.1 OUTLIER -142.23 177.95 7.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' B' ' 42' ' ' TRP . . . -142.74 168.89 25.79 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -149.31 145.65 27.14 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -1.128 . . . . 0.0 109.409 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 86.6 m-20 -123.84 147.05 47.94 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.851 ' HD2' ' O ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -146.15 136.44 23.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.349 -1.47 . . . . 0.0 109.737 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.714 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.9 mt-10 -131.1 -0.63 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.701 -0.624 . . . . 0.0 109.353 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.714 ' O ' ' O ' ' B' ' 47' ' ' GLU . 29.5 t -49.32 -151.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.204 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.513 ' N ' ' OG ' ' B' ' 48' ' ' SER . 76.1 m80 -70.63 152.41 43.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -0.994 . . . . 0.0 109.641 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.453 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 87.9 m-20 -66.69 -41.82 87.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.349 -0.844 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.482 ' SD ' ' O ' ' B' ' 51' ' ' MET . 0.4 OUTLIER -69.03 -33.95 74.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 95' ' ' LEU . 70.9 mt -87.26 -56.46 3.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.778 -1.201 . . . . 0.0 109.197 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.705 ' C ' ' H ' ' B' ' 55' ' ' GLY . 9.8 ptt180 -59.33 4.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 111.266 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.912 ' NE2' HD11 ' A' ' 96' ' ' LEU . 2.3 mt-30 59.4 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.828 -1.17 . . . . 0.0 110.219 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.705 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 83.07 -17.18 24.13 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.379 -0.826 . . . . 0.0 112.856 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.851 ' O ' ' HD2' ' B' ' 46' ' ' LYS . 6.0 p90 -60.48 117.12 4.88 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.292 -1.711 . . . . 0.0 109.951 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.74 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 69.8 p -51.73 -33.53 35.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.258 -0.901 . . . . 0.0 111.002 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.74 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 0.1 OUTLIER -175.61 159.71 2.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.787 -1.196 . . . . 0.0 110.183 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.3 169.39 17.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.504 -0.747 . . . . 0.0 109.294 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -131.3 127.7 38.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.433 -0.792 . . . . 0.0 109.093 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t -93.23 98.24 11.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . 0.415 ' O ' ' N ' ' B' ' 8' ' ' HIS . 70.2 mtm -101.35 113.59 26.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.834 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 35.8 m -122.98 142.38 50.9 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -119.16 162.0 19.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.69 -1.257 . . . . 0.0 110.035 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -82.15 -30.08 31.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -168.43 175.22 6.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -65.05 -24.61 67.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 111.474 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -61.66 -44.84 96.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.803 -1.186 . . . . 0.0 110.647 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.99 -34.31 76.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.735 ' O ' HG22 ' B' ' 74' ' ' THR . 72.9 t80 -66.14 -46.17 78.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.565 -0.962 . . . . 0.0 110.504 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.71 -28.92 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.382 -1.449 . . . . 0.0 108.666 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.08 -60.83 2.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.435 -0.791 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -60.97 -55.96 26.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 111.116 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.735 HG22 ' O ' ' B' ' 70' ' ' TYR . 13.0 t -57.05 -34.77 68.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.702 -1.249 . . . . 0.0 110.34 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 69.1 p -69.31 -26.25 64.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.088 -1.008 . . . . 0.0 110.965 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 72' ' ' ALA . 41.3 m80 -65.33 151.6 93.73 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.876 -1.14 . . . . 0.0 109.651 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.02 -12.24 25.82 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.678 2.252 . . . . 0.0 112.491 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -28.6 62.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.436 -0.79 . . . . 0.0 111.22 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.454 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 46.2 t60 -83.26 -32.84 26.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.943 -1.098 . . . . 0.0 110.249 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 66.6 t -62.91 -60.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.999 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.11 -37.52 61.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -70.21 -40.17 74.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.172 -0.955 . . . . 0.0 109.883 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.8 t -62.59 -41.2 98.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.29 74.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.973 -1.079 . . . . 0.0 108.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.52 -41.35 80.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.469 ' C ' ' O ' ' B' ' 85' ' ' ALA . 19.9 t80 -44.54 -31.37 1.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.561 ' O ' ' N ' ' B' ' 90' ' ' ILE . 6.5 m -82.53 -61.84 1.77 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.0 -29.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.681 -0.637 . . . . 0.0 110.086 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.2 m -100.67 16.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.161 -0.962 . . . . 0.0 110.843 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' B' ' 87' ' ' THR . 41.5 mt -126.73 159.23 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 0.0 110.474 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 51.9 t0 -102.48 -31.81 10.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.449 ' N ' HG22 ' B' ' 90' ' ' ILE . 32.4 pttt -152.04 149.72 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.463 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.8 tp -125.43 124.05 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.594 -1.316 . . . . 0.0 109.76 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.427 HG12 HE21 ' A' ' 54' ' ' GLN . 45.9 t -126.82 131.4 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.824 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.273 -1.517 . . . . 0.0 111.79 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.959 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -119.21 125.76 49.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.664 -0.648 . . . . 0.0 109.33 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 30.0 p-10 -120.43 124.3 45.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.065 -1.022 . . . . 0.0 108.961 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 86.1 t80 -153.79 123.91 3.36 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.091 -1.005 . . . . 0.0 110.547 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.22 136.08 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.358 2.039 . . . . 0.0 112.221 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.56 140.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 0.0 110.094 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -113.65 96.86 6.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 0.0 109.584 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.32 76.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.622 HG23 ' O ' ' B' ' 103' ' ' VAL . 13.2 m -148.49 118.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.234 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.545 ' NZ ' ' CD1' ' A' ' 42' ' ' TRP . 23.1 mmtm -144.55 -11.97 0.6 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.478 ' C ' ' O ' ' B' ' 104' ' ' LYS . 85.6 p -42.2 -24.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.152 -0.968 . . . . 0.0 108.999 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.525 ' N ' ' O ' ' B' ' 104' ' ' LYS . 33.5 t -52.93 -83.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 104' ' ' LYS . 44.8 t . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.685 HG23 ' N ' ' A' ' 4' ' ' SER . 10.1 t -153.24 -48.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.937 . . . . 0.0 109.124 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.685 ' N ' HG23 ' A' ' 3' ' ' THR . 15.2 m -59.63 -69.05 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.18 -163.63 15.4 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.76 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -110.64 135.39 51.33 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.315 -1.109 . . . . 0.0 108.015 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 5.1 ttpm? -100.44 129.43 46.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.962 -1.086 . . . . 0.0 112.88 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' MET . 78.2 t60 -121.9 120.47 34.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -132.12 141.93 49.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.702 -1.249 . . . . 0.0 109.446 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.47 139.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.654 -0.654 . . . . 0.0 109.475 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.444 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -126.64 133.74 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.3 155.95 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.069 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.701 ' HB2' ' HZ2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.8 152.26 37.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CD2' HG21 ' A' ' 57' ' ' THR . 8.9 p90 -107.88 151.51 25.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.835 -1.166 . . . . 0.0 111.565 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.13 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.6 tt0 -90.14 -56.48 3.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.8 m-20 152.63 66.86 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 65.1 m -52.46 107.0 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.087 0.946 . . . . 0.0 112.841 -176.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.629 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -72.72 85.55 1.21 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 21' ' ' ASP . 17.7 m -54.63 -37.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.3 p-10 -63.42 -36.61 84.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 110.591 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 81.6 mt-10 -72.67 -37.61 67.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.447 HD11 HG21 ' A' ' 89' ' ' VAL . 1.8 mm -58.46 -45.28 90.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -48.87 -36.25 16.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.35 -38.24 76.82 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -73.4 -25.11 73.63 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.1 tt -75.12 -60.18 2.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -1.025 . . . . 0.0 108.804 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -49.95 -31.58 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 32' ' ' SER . 75.0 m-20 -65.62 -43.5 89.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.844 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -47.22 -53.34 13.5 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.3 t -49.8 -30.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 108.856 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 10.6 t -45.15 -50.77 11.11 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.445 ' NE2' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -83.54 -9.04 59.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 111.393 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.537 ' C ' ' N ' ' A' ' 36' ' ' THR . 12.3 mt -91.72 28.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.012 -1.68 . . . . 0.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.44 -9.39 2.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 38' ' ' LYS . 10.1 t -67.55 -7.71 28.19 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.959 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.6 m 34.99 34.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.12 -0.987 . . . . 0.0 109.173 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.702 ' H ' HG23 ' A' ' 36' ' ' THR . 32.5 mtmt -123.03 47.83 1.91 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -174.35 175.05 2.69 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.17 159.05 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.522 -1.361 . . . . 0.0 112.013 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -152.11 117.25 5.23 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.306 0.574 . . . . 0.0 110.22 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' B' ' 102' ' ' ALA . 3.6 t-105 -105.74 167.16 9.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 150.27 17.13 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.73 -1.7 . . . . 0.0 110.851 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 78.0 mt-10 -152.1 143.81 23.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -1.167 . . . . 0.0 109.368 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.694 ' HA ' ' O ' ' A' ' 57' ' ' THR . 59.6 t0 -170.36 95.98 0.25 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HZ1' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -84.34 156.54 21.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.484 -1.385 . . . . 0.0 109.853 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 48' ' ' SER . 84.7 mt-10 -158.91 82.2 0.79 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.1 t 160.82 151.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.189 -0.944 . . . . 0.0 110.222 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.516 ' ND1' ' OG ' ' A' ' 48' ' ' SER . 28.8 m80 62.56 105.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.927 . . . . 0.0 109.718 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -49.8 -43.61 48.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.377 -0.827 . . . . 0.0 110.775 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.552 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 24.8 ttt -60.16 -35.58 75.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.04 -1.037 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.64 -9.62 51.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.828 -1.17 . . . . 0.0 109.283 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.951 ' O ' ' N ' ' A' ' 55' ' ' GLY . 33.2 ttp180 -84.86 36.65 0.62 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.0 111.207 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 51' ' ' MET . 78.8 mm-40 -32.66 -10.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.77 -1.206 . . . . 0.0 110.173 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.951 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 102.72 -39.74 2.67 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 121.49 -0.756 . . . . 0.0 112.911 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -52.3 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.228 -1.748 . . . . 0.0 109.903 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 70.1 p -56.84 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 110.927 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.542 ' NE2' ' CG2' ' A' ' 12' ' ' VAL . 17.6 p-80 -122.0 152.36 39.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.826 -1.171 . . . . 0.0 110.085 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB2' HG13 ' A' ' 11' ' ' VAL . . . -144.6 168.77 19.38 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -138.28 133.46 33.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.433 -0.792 . . . . 0.0 109.095 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -100.43 96.11 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 8' ' ' HIS . 53.6 mtm -96.34 121.32 38.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.111 -0.993 . . . . 0.0 110.801 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -124.74 148.07 48.28 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -125.61 155.91 40.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.795 -1.191 . . . . 0.0 110.045 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 41.4 tp10 -78.12 -26.97 48.22 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.7 m-20 -163.66 171.0 16.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -59.95 -22.17 62.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.281 -0.887 . . . . 0.0 111.438 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -58.78 -39.0 79.76 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.716 -1.24 . . . . 0.0 110.524 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.47 71.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.701 ' O ' HG22 ' A' ' 74' ' ' THR . 70.5 t80 -66.64 -44.27 82.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.561 -0.964 . . . . 0.0 110.465 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.79 -28.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.372 -1.455 . . . . 0.0 108.671 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.488 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.06 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.844 ' CE1' HD11 ' A' ' 30' ' ' LEU . 1.4 t80 -52.74 -38.7 61.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.1 t -84.16 -31.42 25.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.719 -1.238 . . . . 0.0 110.267 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 71.2 m -67.48 -33.03 74.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 111.005 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -75.36 128.02 85.14 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.898 -1.126 . . . . 0.0 109.659 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -43.67 -7.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.9 tp -64.83 -29.53 70.5 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.395 -0.815 . . . . 0.0 111.247 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -84.34 -37.11 22.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.996 -1.065 . . . . 0.0 110.239 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.73 -61.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.949 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.81 -39.15 84.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.267 -0.895 . . . . 0.0 109.559 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.32 -45.01 70.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.795 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 t -62.39 -35.02 77.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.125 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.25 65.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 108.712 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -70.83 -42.16 70.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.911 ' O ' HD13 ' A' ' 90' ' ' ILE . 18.9 t80 -45.73 -29.08 1.17 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' ' C ' ' A' ' 88' ' ' ALA . 11.2 m -82.31 -63.47 1.37 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.06 -32.34 0.09 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.624 -0.672 . . . . 0.0 110.012 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 85' ' ' ALA . 19.3 m -98.84 13.01 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.927 . . . . 0.0 110.829 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.911 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.1 mp -122.32 156.96 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.657 -1.277 . . . . 0.0 110.451 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.482 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 59.4 t0 -103.57 -36.35 7.97 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' NZ ' ' NZ ' ' A' ' 13' ' ' LYS . 30.2 pttt -147.52 147.36 30.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 93' ' ' ILE . 6.1 tp -123.42 117.73 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.608 -1.307 . . . . 0.0 109.791 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.78 127.1 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -133.79 129.2 36.24 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.365 -1.459 . . . . 0.0 111.761 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -115.69 119.36 35.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.332 176.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 61.3 t0 -125.1 131.67 53.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 108.899 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 51.9 t80 -169.26 135.36 1.4 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.06 -1.025 . . . . 0.0 110.548 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.9 Cg_exo -41.22 120.25 1.12 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.363 2.042 . . . . 0.0 112.128 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.3 143.18 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 110.019 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.12 67.78 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.682 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB2' ' CE2' ' B' ' 42' ' ' TRP . . . -56.03 98.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.054 -1.029 . . . . 0.0 109.53 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 103' ' ' VAL . 24.5 m -144.72 128.59 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 109.136 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 106' ' ' SER . 5.6 mptt -111.89 -32.29 6.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.342 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 106' ' ' SER . 1.2 m 63.42 -53.01 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 108.938 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 104' ' ' LYS . 1.4 p 73.12 148.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.0 109.348 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.477 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.57 -163.55 15.55 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.727 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -110.75 135.04 51.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.327 -1.102 . . . . 0.0 108.035 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 5.2 ttpm? -100.05 129.46 46.1 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.33 1.062 . . . . 0.0 112.778 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 77.7 t60 -121.88 120.53 34.76 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.04 142.05 49.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.762 -1.211 . . . . 0.0 109.467 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.48 139.32 51.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -126.83 133.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.538 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.23 156.3 21.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.048 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.671 ' HB2' ' HZ2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -119.95 152.33 37.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 178.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' B' ' 57' ' ' THR . 9.0 p90 -107.94 151.45 25.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.838 -1.164 . . . . 0.0 111.645 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.14 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -90.07 -56.53 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.7 m-20 152.68 66.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 64.4 m -52.35 107.09 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.991 0.901 . . . . 0.0 112.841 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.626 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -72.82 85.73 1.24 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.421 HG23 ' N ' ' B' ' 21' ' ' ASP . 17.9 m -54.87 -37.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 110.441 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.9 p-10 -63.36 -36.45 83.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.485 -0.76 . . . . 0.0 110.549 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 81.1 mt-10 -72.96 -37.77 66.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.445 HD11 HG21 ' B' ' 89' ' ' VAL . 1.8 mm -58.31 -44.96 89.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -49.13 -36.21 18.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -58.16 -38.49 76.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -73.08 -25.34 73.77 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.1 tt -74.94 -60.13 2.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.948 . . . . 0.0 108.772 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -50.2 -31.26 13.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 32' ' ' SER . 75.3 m-20 -65.86 -43.49 88.26 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.839 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.5 OUTLIER -47.25 -53.1 14.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' B' ' 32' ' ' SER . 79.4 t -50.08 -30.4 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.363 -0.835 . . . . 0.0 108.811 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 11.2 t -45.36 -50.78 11.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.441 HE22 ' CB ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -83.44 -9.25 59.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.79 . . . . 0.0 111.518 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' B' ' 36' ' ' THR . 12.7 mt -91.45 28.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.967 -1.708 . . . . 0.0 110.639 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -59.43 -9.2 2.21 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.726 HG23 ' H ' ' B' ' 38' ' ' LYS . 9.6 t -67.56 -7.87 29.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.028 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.7 m 35.31 33.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.128 -0.983 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.726 ' H ' HG23 ' B' ' 36' ' ' THR . 32.3 mtmt -122.86 47.79 1.9 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' B' ' 63' ' ' THR . 15.9 t -174.46 174.87 2.67 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.05 159.17 44.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.51 -1.369 . . . . 0.0 111.972 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -152.23 117.22 5.17 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.379 0.609 . . . . 0.0 110.225 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 102' ' ' ALA . 3.7 t-105 -105.72 167.2 9.93 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.84 150.48 17.15 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 118.734 -1.698 . . . . 0.0 110.835 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 77.6 mt-10 -152.23 143.75 23.45 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -1.105 . . . . 0.0 109.425 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' B' ' 57' ' ' THR . 59.5 t0 -170.11 95.82 0.26 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.713 ' HZ1' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -84.2 156.51 22.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.422 -1.424 . . . . 0.0 109.807 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' B' ' 48' ' ' SER . 84.3 mt-10 -158.94 82.06 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.1 t 160.94 151.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.176 -0.953 . . . . 0.0 110.192 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.516 ' ND1' ' OG ' ' B' ' 48' ' ' SER . 28.8 m80 62.8 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.682 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -49.62 -44.02 47.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.818 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.553 ' O ' ' NE2' ' B' ' 54' ' ' GLN . 24.8 ttt -59.78 -35.76 75.31 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.763 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 19.3 mt -88.65 -9.5 51.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.718 -1.239 . . . . 0.0 109.312 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.954 ' O ' ' N ' ' B' ' 55' ' ' GLY . 33.6 ttp180 -84.8 36.37 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 111.232 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' B' ' 51' ' ' MET . 78.8 mm-40 -32.48 -10.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 110.215 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.954 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 102.51 -39.63 2.71 Favored Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.425 -0.797 . . . . 0.0 112.805 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -52.34 101.57 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.554 1.677 . . . . 0.0 109.907 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 71.4 p -56.99 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 110.95 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.576 ' H ' ' HG1' ' B' ' 57' ' ' THR . 18.1 p-80 -121.97 152.12 40.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.908 -1.12 . . . . 0.0 110.127 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' B' ' 11' ' ' VAL . . . -144.38 168.72 19.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -138.24 133.69 33.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.042 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -100.56 96.19 7.2 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 53.5 mtm -96.5 121.43 38.31 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.172 -0.955 . . . . 0.0 110.73 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' B' ' 39' ' ' SER . 28.5 m -125.03 147.64 48.87 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.23 156.19 38.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.724 -1.235 . . . . 0.0 110.081 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 41.8 tp10 -78.48 -26.82 46.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.7 m-20 -163.78 170.79 16.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -59.82 -21.82 61.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 111.501 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -59.13 -38.68 80.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 110.57 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.38 69.87 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.697 ' O ' HG22 ' B' ' 74' ' ' THR . 70.6 t80 -66.59 -44.42 82.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.618 -0.93 . . . . 0.0 110.433 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.417 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.73 -28.91 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.451 -1.405 . . . . 0.0 108.707 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.491 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.09 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.297 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.839 ' CE1' HD11 ' B' ' 30' ' ' LEU . 1.4 t80 -52.59 -38.94 61.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 111.123 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.697 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.1 t -84.07 -31.32 25.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.726 -1.234 . . . . 0.0 110.281 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 71.9 m -67.53 -32.85 73.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.974 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' B' ' 78' ' ' LEU . 0.9 OUTLIER -75.53 128.09 84.7 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.885 -1.134 . . . . 0.0 109.602 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.77 -7.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 112.508 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.9 tp -64.84 -29.61 70.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.397 -0.815 . . . . 0.0 111.199 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -84.29 -37.14 22.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.238 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.68 -61.65 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 110.045 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.63 -39.21 83.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.33 -44.95 70.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.812 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 28.9 t -62.38 -35.18 78.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.1 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.29 65.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.675 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.684 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -70.79 -42.34 70.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.888 ' O ' HD13 ' B' ' 90' ' ' ILE . 19.2 t80 -45.81 -28.86 1.16 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.452 ' O ' ' C ' ' B' ' 88' ' ' ALA . 11.1 m -82.37 -63.37 1.39 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.11 -32.36 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.708 -0.62 . . . . 0.0 110.122 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.684 HG22 ' O ' ' B' ' 85' ' ' ALA . 19.1 m -98.84 12.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.874 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.888 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.1 mp -122.0 157.26 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 0.0 110.477 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 59.1 t0 -103.89 -36.21 7.88 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.435 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 30.6 pttt -147.65 147.22 29.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.554 HG23 ' O ' ' B' ' 93' ' ' ILE . 6.2 tp -123.42 117.87 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.517 -1.364 . . . . 0.0 109.721 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.86 127.24 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.59 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -133.99 129.16 35.77 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.258 -1.526 . . . . 0.0 111.73 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.462 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.5 OUTLIER -115.64 119.37 35.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.652 -0.655 . . . . 0.0 109.328 176.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 62.0 t0 -125.04 131.78 53.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 108.929 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 52.1 t80 -169.36 135.25 1.37 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.105 -0.997 . . . . 0.0 110.53 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 87.6 Cg_exo -41.2 120.1 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.264 1.976 . . . . 0.0 112.247 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.16 143.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 110.025 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.16 68.0 0.67 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.514 -0.741 . . . . 0.0 109.581 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . . . -56.12 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.623 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 103' ' ' VAL . 24.3 m -144.52 128.49 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 106' ' ' SER . 5.6 mptt -111.7 -32.43 6.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' B' ' 106' ' ' SER . 1.2 m 63.55 -53.21 0.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.13 -0.982 . . . . 0.0 108.892 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.685 ' N ' ' O ' ' B' ' 104' ' ' LYS . 1.4 p 73.24 148.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 C--N 1.302 -1.474 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.543 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 t -95.79 3.44 53.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -168.95 -89.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.28 168.68 18.35 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.671 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.62 131.57 55.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.242 -1.152 . . . . 0.0 108.022 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 25.2 ttpt -104.22 131.9 51.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.917 -1.114 . . . . 0.0 112.777 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 62' ' ' MET . 61.1 m80 -126.34 127.46 45.56 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.2 tt -135.72 142.53 45.05 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.767 -1.208 . . . . 0.0 109.496 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 4.3 p -130.66 140.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.547 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.74 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.654 ' O ' ' O ' ' A' ' 56' ' ' PHE . 3.4 m -132.38 143.39 40.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.104 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 14.2 mmtt -107.43 152.6 23.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.565 ' HB2' ' H ' ' A' ' 18' ' ' THR . 15.8 p90 -114.53 148.71 37.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.769 -1.207 . . . . 0.0 111.585 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.89 -23.43 4.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -93.05 -53.89 3.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.2 t0 150.1 67.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.565 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.3 m -49.03 105.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.13 0.967 . . . . 0.0 112.802 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.551 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -72.82 84.77 1.22 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 21' ' ' ASP . 27.8 m -58.34 -37.72 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.549 -0.72 . . . . 0.0 110.456 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 34.1 p-10 -65.29 -38.33 89.89 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.479 -0.763 . . . . 0.0 110.544 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -70.08 -34.07 72.7 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.881 HD11 HG21 ' A' ' 89' ' ' VAL . 1.4 mm -63.87 -44.07 97.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.31 -35.8 51.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -61.45 -34.59 75.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.46 -44.11 8.88 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.94 -59.24 5.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.996 . . . . 0.0 108.856 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 22.1 pt-20 -52.17 -45.41 65.1 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.533 ' N ' ' CG ' ' A' ' 28' ' ' GLU . 3.8 t30 -58.15 -43.87 87.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -49.59 -44.25 46.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 34' ' ' ILE . 20.6 t -52.4 -22.35 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.221 -0.924 . . . . 0.0 108.888 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 34.3 t -40.62 -39.53 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.55 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 62.3 mm-40 -76.26 -23.81 54.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 111.461 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 34' ' ' ILE . 75.8 mt -81.75 20.85 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.018 -1.676 . . . . 0.0 110.544 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -57.4 -6.47 0.45 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.659 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.3 t -87.93 2.96 50.33 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.943 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.9 m 35.31 35.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.073 -1.017 . . . . 0.0 109.195 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.57 ' O ' ' OG ' ' A' ' 39' ' ' SER . 65.9 mttt -115.34 39.87 2.84 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 71.0 m -173.04 175.84 3.14 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -147.3 157.41 43.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.966 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' SER . 67.6 mt-10 -154.41 120.3 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.436 0.636 . . . . 0.0 110.246 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 1.1 m95 -123.37 170.27 10.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 164.4 24.92 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 118.695 -1.717 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 50.8 tt0 -154.72 148.1 25.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -113.17 141.3 47.1 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -139.39 108.08 5.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.41 -1.431 . . . . 0.0 109.829 -178.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.5 45.81 0.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.64 -0.663 . . . . 0.0 109.287 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.483 ' CB ' HH11 ' A' ' 53' ' ' ARG . 1.4 t -144.58 121.67 11.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.131 -0.98 . . . . 0.0 110.191 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.537 ' CG ' HD12 ' A' ' 52' ' ' LEU . 7.2 m80 65.97 118.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 109.753 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.15 -29.07 70.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.81 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -85.31 -36.05 21.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.01 -1.056 . . . . 0.0 110.712 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' B' ' 95' ' ' LEU . 27.0 mt -79.66 -72.87 0.38 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.729 -1.232 . . . . 0.0 109.273 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.86 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -73.15 4.67 4.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 111.252 -176.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 53' ' ' ARG . 15.4 mm100 39.1 6.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.819 -1.176 . . . . 0.0 110.204 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 50.79 2.87 0.04 OUTLIER Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.544 -0.722 . . . . 0.0 112.933 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.763 ' O ' ' CB ' ' A' ' 57' ' ' THR . 34.4 m-85 -39.12 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.189 -1.771 . . . . 0.0 109.976 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.763 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 16.8 m 99.8 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.287 -0.883 . . . . 0.0 110.938 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.526 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 18.5 t60 -164.56 152.08 11.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.885 -1.134 . . . . 0.0 110.173 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.19 167.28 22.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.31 -0.869 . . . . 0.0 109.249 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 95.2 m-85 -135.26 130.5 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.062 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -97.65 96.98 8.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 8' ' ' HIS . 74.2 mtm -98.02 117.86 33.31 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.188 -0.945 . . . . 0.0 110.844 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -122.78 144.64 49.04 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.31 159.12 28.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.702 -1.249 . . . . 0.0 110.068 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 41.6 tp10 -82.7 -31.47 28.52 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 65' ' ' GLU . 80.6 m-20 -161.73 169.37 21.58 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.51 ' NZ ' ' CB ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -55.18 -21.66 14.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 111.437 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -56.52 -40.48 75.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.788 -1.195 . . . . 0.0 110.611 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.17 -37.59 72.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' THR . 75.1 t80 -62.63 -45.12 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.623 -0.928 . . . . 0.0 110.522 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.368 -1.457 . . . . 0.0 108.653 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' CD2' ' A' ' 76' ' ' HIS . . . -65.07 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.381 -0.825 . . . . 0.0 109.381 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.488 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -51.68 -37.74 51.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 111.134 -177.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.6 t -84.99 -33.97 22.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.802 -1.186 . . . . 0.0 110.299 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.4 t -71.34 -25.6 62.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 0.0 110.95 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.55 ' CD2' ' OE1' ' A' ' 33' ' ' GLN . 84.1 m-70 -81.01 121.35 80.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.852 -1.155 . . . . 0.0 109.604 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.36 -13.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.638 2.225 . . . . 0.0 112.457 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 HD22 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -64.0 -26.97 68.81 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.346 -0.846 . . . . 0.0 111.277 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.488 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 7.4 t-160 -81.66 -30.45 32.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.06 . . . . 0.0 110.236 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.09 -60.21 3.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.66 -40.24 62.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -66.6 -33.52 75.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.83 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 p -61.33 -43.79 98.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.105 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.48 -37.06 67.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 108.714 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.941 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -72.18 -40.53 67.87 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.613 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.28 -40.96 0.37 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' VAL . 24.3 m -81.94 -60.36 2.26 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.59 -10.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.669 -0.644 . . . . 0.0 110.047 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.941 HG22 ' O ' ' A' ' 85' ' ' ALA . 10.5 m -124.8 -7.86 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.191 -0.943 . . . . 0.0 110.853 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.652 HG13 HG23 ' A' ' 89' ' ' VAL . 65.4 mt -131.1 162.99 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.588 -1.32 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 90' ' ' ILE . 12.0 t0 -121.44 -24.01 5.51 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.73 139.02 32.76 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.4 tp -128.97 127.31 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.596 -1.315 . . . . 0.0 109.83 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 t -128.38 132.36 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -137.58 132.55 33.28 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.315 -1.49 . . . . 0.0 111.75 -178.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -115.8 121.36 42.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.723 -0.611 . . . . 0.0 109.364 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.674 ' O ' ' NE ' ' B' ' 53' ' ' ARG . 59.7 m-20 -123.75 128.3 49.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.081 -1.012 . . . . 0.0 108.869 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 99' ' ' PRO . 63.6 t80 -165.48 131.67 2.09 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.519 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 88.7 Cg_exo -47.52 133.41 20.83 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.288 1.992 . . . . 0.0 112.25 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.47 141.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.034 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -103.11 70.96 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.25 82.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.578 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 101' ' ' ALA . 29.1 m -127.53 -15.96 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 106' ' ' SER . 4.7 mptt 44.61 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -65.43 53.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 108.942 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 104' ' ' LYS . 6.3 t -83.98 38.89 0.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.636 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.11 168.88 18.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.726 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.77 131.7 55.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 25.1 ttpt -104.43 131.65 51.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.938 -1.101 . . . . 0.0 112.881 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 62' ' ' MET . 60.9 m80 -126.13 127.57 45.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.2 tt -135.77 142.56 44.96 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.741 -1.225 . . . . 0.0 109.385 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 4.2 p -130.69 140.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.56 -0.712 . . . . 0.0 109.528 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -124.77 132.85 70.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.645 ' O ' ' O ' ' B' ' 56' ' ' PHE . 3.5 m -132.73 143.18 40.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 117.762 -1.575 . . . . 0.0 112.993 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 14.2 mmtt -107.25 152.22 24.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.553 ' HB2' ' H ' ' B' ' 18' ' ' THR . 15.8 p90 -114.03 149.12 35.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.187 . . . . 0.0 111.58 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -124.0 -23.59 4.58 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.4 mt-10 -92.88 -53.96 3.94 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.1 t0 150.17 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.553 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.7 m -48.99 105.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.105 0.955 . . . . 0.0 112.887 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.562 ' H ' ' HD3' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -72.79 84.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.463 HG23 ' N ' ' B' ' 21' ' ' ASP . 27.9 m -58.41 -37.53 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 34.4 p-10 -65.52 -38.29 89.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.514 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.498 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 0.4 OUTLIER -70.05 -33.99 72.65 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.88 HD11 HG21 ' B' ' 89' ' ' VAL . 1.4 mm -63.84 -44.11 98.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.27 -35.7 50.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -61.56 -34.71 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.31 -43.71 9.32 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -57.43 -59.01 5.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.944 . . . . 0.0 108.809 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 22.3 pt-20 -52.37 -45.23 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.527 ' N ' ' CG ' ' B' ' 28' ' ' GLU . 3.8 t30 -58.22 -43.93 87.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.576 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -49.76 -43.92 48.35 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' B' ' 34' ' ' ILE . 20.8 t -52.61 -22.33 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 36.4 t -40.65 -39.48 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.552 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 62.0 mm-40 -76.28 -23.73 54.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.765 . . . . 0.0 111.497 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.79 HG22 ' O ' ' B' ' 34' ' ' ILE . 75.9 mt -81.85 20.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.014 -1.679 . . . . 0.0 110.585 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.5 p30 -57.45 -6.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.634 ' H ' ' C ' ' B' ' 34' ' ' ILE . 1.3 t -87.89 3.0 50.15 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.986 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.566 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.0 m 35.43 35.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.101 -1.0 . . . . 0.0 109.154 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.569 ' O ' ' OG ' ' B' ' 39' ' ' SER . 64.8 mttt -115.17 40.11 2.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.569 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 73.2 m -173.4 175.72 3.0 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -147.18 157.53 43.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.478 -1.389 . . . . 0.0 111.972 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' B' ' 61' ' ' SER . 67.7 mt-10 -154.54 120.5 5.25 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.356 0.598 . . . . 0.0 110.235 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.635 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 1.1 m95 -123.63 170.15 10.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.58 164.26 24.91 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 50.9 tt0 -154.48 148.07 25.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.254 -1.145 . . . . 0.0 109.354 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -113.19 141.02 47.44 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -139.35 108.04 5.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.357 -1.464 . . . . 0.0 109.889 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.38 45.54 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.689 -0.632 . . . . 0.0 109.395 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.476 ' CB ' HH11 ' B' ' 53' ' ' ARG . 1.4 t -144.24 121.94 11.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 110.166 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.533 ' CG ' HD12 ' B' ' 52' ' ' LEU . 7.2 m80 65.66 118.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.207 -0.933 . . . . 0.0 109.728 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -62.23 -29.33 70.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.332 -0.855 . . . . 0.0 110.781 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 89.5 mtp -85.23 -35.89 21.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.03 -1.044 . . . . 0.0 110.768 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' A' ' 95' ' ' LEU . 27.2 mt -79.7 -72.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.755 -1.216 . . . . 0.0 109.291 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.852 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.6 OUTLIER -73.2 4.51 4.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 111.22 -176.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.474 ' C ' ' O ' ' B' ' 53' ' ' ARG . 15.4 mm100 39.15 6.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.804 -1.185 . . . . 0.0 110.213 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.852 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 50.46 2.91 0.04 OUTLIER Glycine 0 N--CA 1.499 2.835 0 O-C-N 121.515 -0.74 . . . . 0.0 112.909 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' CB ' ' B' ' 57' ' ' THR . 33.7 m-85 -39.04 -25.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.274 -1.721 . . . . 0.0 110.004 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.768 ' CB ' ' O ' ' B' ' 56' ' ' PHE . 16.1 m 99.7 -62.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.281 -0.887 . . . . 0.0 110.982 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.52 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 18.6 t60 -164.31 152.04 12.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.862 -1.148 . . . . 0.0 110.127 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.468 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.19 167.13 22.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.536 -0.727 . . . . 0.0 109.301 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.52 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 95.2 m-85 -135.01 130.71 36.11 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.485 -0.759 . . . . 0.0 109.08 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 0.1 OUTLIER -97.66 97.06 8.71 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . 0.448 ' O ' ' N ' ' B' ' 8' ' ' HIS . 74.6 mtm -98.12 117.82 33.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.175 -0.953 . . . . 0.0 110.741 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -122.84 144.44 49.2 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.12 159.04 27.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.75 -1.219 . . . . 0.0 110.062 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' B' ' 66' ' ' ASN . 42.1 tp10 -82.57 -31.33 29.06 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' B' ' 65' ' ' GLU . 80.7 m-20 -161.93 169.6 20.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -55.25 -21.73 15.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.493 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.4 -40.76 75.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.789 -1.195 . . . . 0.0 110.534 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.89 -37.84 75.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.544 ' O ' HG22 ' B' ' 74' ' ' THR . 75.4 t80 -62.28 -45.47 93.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.592 -0.946 . . . . 0.0 110.374 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.67 -28.94 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.455 -1.403 . . . . 0.0 108.732 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' B' ' 76' ' ' HIS . . . -65.12 -60.86 2.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.315 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.491 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.1 OUTLIER -51.35 -38.1 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.86 . . . . 0.0 111.146 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.544 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.6 t -84.74 -33.99 22.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.732 -1.23 . . . . 0.0 110.324 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 36.3 t -71.29 -25.97 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.942 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.552 ' CD2' ' OE1' ' B' ' 33' ' ' GLN . 83.7 m-70 -80.63 121.32 81.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.796 -1.19 . . . . 0.0 109.557 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.39 -13.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.69 2.26 . . . . 0.0 112.413 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.544 HD23 HD22 ' B' ' 30' ' ' LEU . 0.6 OUTLIER -63.65 -27.32 69.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.776 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.491 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 7.4 t-160 -81.47 -30.32 33.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 110.301 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.18 -60.24 3.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.76 -40.06 62.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.518 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -66.56 -33.78 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.93 . . . . 0.0 109.877 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 56.6 p -61.06 -43.9 98.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.1 -1.0 . . . . 0.0 110.134 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.31 -37.26 67.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.034 -1.042 . . . . 0.0 108.72 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.926 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -72.04 -40.72 68.18 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.614 ' O ' ' HB ' ' B' ' 90' ' ' ILE . 0.0 OUTLIER -37.1 -40.89 0.33 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.541 ' O ' ' N ' ' B' ' 89' ' ' VAL . 24.6 m -82.16 -60.34 2.25 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.52 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.783 -0.573 . . . . 0.0 110.103 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.926 HG22 ' O ' ' B' ' 85' ' ' ALA . 10.4 m -124.94 -7.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 110.855 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.657 HG13 HG23 ' B' ' 89' ' ' VAL . 66.2 mt -131.04 162.89 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.618 -1.301 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.603 ' N ' HG22 ' B' ' 90' ' ' ILE . 12.0 t0 -121.28 -24.33 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.58 139.22 33.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.418 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.4 tp -129.28 127.34 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.542 -1.349 . . . . 0.0 109.755 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 60.7 t -128.35 132.52 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -137.71 132.48 32.91 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.254 -1.528 . . . . 0.0 111.783 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.443 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.4 OUTLIER -115.66 121.49 42.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.68 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 60.3 m-20 -123.73 128.23 49.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.066 -1.021 . . . . 0.0 108.934 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 99' ' ' PRO . 63.7 t80 -165.31 131.65 2.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.55 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . 0.514 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 88.2 Cg_exo -47.59 133.15 21.13 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.256 1.971 . . . . 0.0 112.225 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.22 141.28 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.049 -1.032 . . . . 0.0 110.064 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -102.88 71.11 1.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.487 -0.758 . . . . 0.0 109.602 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.46 82.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.123 -0.985 . . . . 0.0 109.574 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' B' ' 101' ' ' ALA . 29.1 m -127.65 -15.92 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.18 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' B' ' 106' ' ' SER . 4.7 mptt 44.73 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.353 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -65.34 53.97 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -0.976 . . . . 0.0 108.959 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.589 ' N ' ' O ' ' B' ' 104' ' ' LYS . 6.3 t -84.07 38.95 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.57 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.382 0.611 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.699 HG23 ' N ' ' A' ' 4' ' ' SER . 6.7 t -67.3 -51.49 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.699 ' N ' HG23 ' A' ' 3' ' ' THR . 9.7 m -140.85 -117.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.25 142.62 46.6 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.641 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -113.59 128.83 56.58 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.297 -1.119 . . . . 0.0 108.011 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -110.07 138.87 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.929 -1.107 . . . . 0.0 112.776 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.27 129.74 43.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -135.46 143.39 45.86 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.698 -1.251 . . . . 0.0 109.522 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 10.4 p -128.5 138.05 55.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.642 -0.661 . . . . 0.0 109.508 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.97 130.67 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -136.96 165.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.78 -1.568 . . . . 0.0 113.07 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 39.2 tptt -130.43 151.4 50.96 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 10.0 p90 -108.87 150.16 28.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.838 -1.164 . . . . 0.0 111.615 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.37 -22.64 5.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.9 mt-10 -91.26 -53.68 4.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.8 t0 149.39 69.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.2 m -55.85 109.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.082 0.944 . . . . 0.0 112.857 -177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.712 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.73 91.11 5.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -61.36 -33.45 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 110.453 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.8 p-10 -68.3 -41.52 80.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.451 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.703 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 70.3 tt0 -66.72 -28.32 68.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -74.46 -39.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.7 -40.41 79.42 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.703 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -60.51 -26.11 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . -81.26 -45.29 7.56 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.6 tt -49.0 -51.92 27.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.484 -1.01 . . . . 0.0 108.809 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 17.1 pt-20 -53.06 -43.29 66.57 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -57.41 -43.52 83.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -46.91 -45.35 20.49 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 34' ' ' ILE . 23.0 t -51.6 -23.37 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 108.933 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 41.9 t -42.86 -46.55 5.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.534 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 82.0 mm-40 -74.55 -20.47 59.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.374 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 34' ' ' ILE . 58.0 mt -82.62 22.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.05 -1.656 . . . . 0.0 110.643 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.8 p30 -59.46 -8.78 1.98 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 36.2 p -82.64 -0.97 49.66 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.981 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.6 m 35.59 31.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' THR . 42.0 mttm -117.66 40.76 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 34' ' ' ILE . 95.6 p -173.11 173.96 3.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.72 159.12 44.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -153.96 121.04 5.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.395 0.617 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -124.03 167.02 14.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 44' ' ' GLU . . . -125.48 157.98 19.73 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.756 -1.688 . . . . 0.0 110.823 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.654 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 73.9 mm-40 -148.35 136.9 21.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.247 -1.149 . . . . 0.0 109.397 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -111.09 141.02 45.14 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.842 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -143.42 117.26 9.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.454 -1.404 . . . . 0.0 109.763 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -153.56 -15.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.544 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -69.57 122.0 18.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 0.0 110.177 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.494 ' O ' ' O ' ' A' ' 48' ' ' SER . 48.1 m80 59.36 126.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.985 . . . . 0.0 109.678 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -67.02 -34.89 78.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.816 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.523 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -77.44 -37.94 50.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 0.0 110.687 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' B' ' 95' ' ' LEU . 19.3 mt -78.79 -71.15 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.74 -1.225 . . . . 0.0 109.266 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' A' ' 53' ' ' ARG . 3.7 mmt-85 -72.25 12.63 0.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.901 . . . . 0.0 111.258 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.53 ' CD ' HD21 ' B' ' 96' ' ' LEU . 76.1 mt-30 50.67 7.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.765 -1.209 . . . . 0.0 110.171 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.674 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 55.87 -0.42 0.12 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.361 -0.837 . . . . 0.0 112.891 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.674 ' O ' ' O ' ' A' ' 55' ' ' GLY . 4.8 m-85 -53.19 -142.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.157 -1.79 . . . . 0.0 109.914 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 35.3 m -135.82 -47.49 0.67 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.654 ' CE1' ' H ' ' A' ' 44' ' ' GLU . 27.4 t60 -172.76 160.06 4.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.96 -1.087 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.611 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.55 163.01 34.08 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.46 -0.775 . . . . 0.0 109.231 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 82.6 m-85 -133.42 129.59 37.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.499 -0.751 . . . . 0.0 109.121 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.29 98.7 8.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.6 mtt -98.68 119.68 37.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.234 -0.916 . . . . 0.0 110.76 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -119.37 140.62 50.06 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.07 125.83 44.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.083 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -50.87 -32.14 19.51 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -156.03 162.28 40.33 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -60.59 -21.83 63.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 111.493 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 34.0 p-10 -55.94 -36.43 67.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.773 -1.204 . . . . 0.0 110.532 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.18 -31.99 63.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.699 ' O ' HG22 ' A' ' 74' ' ' THR . 76.9 t80 -67.79 -44.36 77.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.973 . . . . 0.0 110.436 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.76 -28.95 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.404 -1.435 . . . . 0.0 108.686 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.05 -60.89 2.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.373 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.539 ' CE1' HD11 ' A' ' 30' ' ' LEU . 1.6 t80 -56.59 -60.13 3.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.11 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.699 HG22 ' O ' ' A' ' 70' ' ' TYR . 10.1 t -52.29 -34.46 46.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.734 -1.228 . . . . 0.0 110.3 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.3 m -77.96 -16.22 58.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.959 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 78' ' ' LEU . 22.6 m80 -79.24 132.18 63.72 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.152 . . . . 0.0 109.57 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -42.22 -12.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.697 2.264 . . . . 0.0 112.394 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.5 tp -74.44 -27.28 60.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.423 -0.798 . . . . 0.0 111.292 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.83 -45.13 21.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.957 -1.09 . . . . 0.0 110.206 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.774 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -59.44 -58.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 110.01 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.774 ' H ' HG13 ' A' ' 80' ' ' VAL . 15.2 tm-20 -51.01 -36.65 40.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.92 -32.02 73.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.758 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.05 -44.23 94.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.44 -33.28 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.921 -1.112 . . . . 0.0 108.73 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.939 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -79.42 -46.37 17.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.699 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -38.81 -40.15 0.59 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' VAL . 20.3 m -82.17 -62.53 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.86 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.676 -0.64 . . . . 0.0 110.097 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.939 HG22 ' O ' ' A' ' 85' ' ' ALA . 9.1 m -117.46 -1.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 0.0 110.771 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 91' ' ' ASP . 68.4 mt -132.93 164.02 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 110.512 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 90' ' ' ILE . 38.4 t0 -124.14 -26.82 3.94 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.422 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 18.9 ttpt -133.81 131.17 38.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -126.32 125.59 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.596 -1.315 . . . . 0.0 109.768 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.489 HG12 HE21 ' B' ' 54' ' ' GLN . 12.0 t -132.2 134.5 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -136.47 131.65 34.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.294 -1.503 . . . . 0.0 111.764 -178.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.546 HD21 ' CD ' ' B' ' 54' ' ' GLN . 0.2 OUTLIER -116.05 122.57 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.645 -0.659 . . . . 0.0 109.391 177.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.549 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 38.5 p-10 -126.11 132.49 51.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -159.81 128.72 3.08 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.087 -1.008 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.61 131.46 12.67 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.37 2.046 . . . . 0.0 112.186 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.553 HG22 ' OE2' ' B' ' 44' ' ' GLU . 96.9 t -113.42 135.37 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.96 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -107.96 88.3 2.7 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.451 -0.781 . . . . 0.0 109.56 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -57.71 73.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 102' ' ' ALA . 4.5 m -161.01 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.099 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 106' ' ' SER . 24.0 mmtm -97.7 4.57 49.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.412 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.35 -53.53 0.27 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 108.879 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 104' ' ' LYS . 20.1 m 47.17 45.01 16.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t . . . . . 0 C--N 1.301 -1.509 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.721 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.22 142.69 46.52 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.693 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -113.67 128.74 56.54 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.218 -1.166 . . . . 0.0 108.033 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -109.91 138.63 46.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.862 -1.149 . . . . 0.0 112.822 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.09 129.68 43.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.0 tt -135.35 143.45 46.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.433 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 10.3 p -128.34 137.97 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.478 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.6 OUTLIER -120.92 130.79 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 178.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.04 165.49 27.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.663 -1.615 . . . . 0.0 113.028 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 39.1 tptt -130.39 151.41 50.91 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.511 ' HB2' ' H ' ' B' ' 18' ' ' THR . 9.9 p90 -108.84 150.11 28.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.795 -1.191 . . . . 0.0 111.558 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.36 -22.82 4.98 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.9 mt-10 -91.03 -53.77 4.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.7 t0 149.47 69.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -56.0 109.76 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.129 0.966 . . . . 0.0 112.778 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.713 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.87 91.31 5.97 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.38 -33.55 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.647 . . . . 0.0 110.495 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.6 p-10 -68.13 -41.56 81.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.542 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.695 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 70.7 tt0 -66.85 -28.09 68.07 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -74.7 -39.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.62 -40.57 79.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.1 OUTLIER -60.36 -26.19 66.42 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' B' ' 25' ' ' LYS . . . -81.06 -45.47 7.56 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.502 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.6 tt -48.91 -51.98 27.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -1.032 . . . . 0.0 108.855 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 17.0 pt-20 -53.09 -43.33 66.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.0 OUTLIER -57.34 -43.47 83.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.538 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -47.1 -45.34 22.05 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 34' ' ' ILE . 23.2 t -51.47 -23.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.299 -0.876 . . . . 0.0 108.767 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 41.7 t -42.74 -46.47 5.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.527 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 81.9 mm-40 -74.57 -20.47 59.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 111.533 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.714 HG22 ' O ' ' B' ' 34' ' ' ILE . 58.1 mt -82.65 22.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.972 -1.705 . . . . 0.0 110.563 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.1 p30 -59.5 -8.88 2.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.597 ' O ' ' N ' ' B' ' 38' ' ' LYS . 36.3 p -82.52 -0.98 49.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.953 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.9 m 35.53 31.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.063 -1.023 . . . . 0.0 109.187 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.597 ' N ' ' O ' ' B' ' 36' ' ' THR . 42.2 mttm -117.64 40.73 3.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.551 ' OG ' HG23 ' B' ' 34' ' ' ILE . 95.6 p -173.07 173.94 3.56 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.525 -0.735 . . . . 0.0 109.031 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.73 158.99 44.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.521 -1.362 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -153.82 120.95 5.72 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.314 0.578 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -124.0 166.77 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' B' ' 44' ' ' GLU . . . -125.43 157.94 19.68 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.754 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.655 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 74.1 mm-40 -148.26 136.97 21.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.253 -1.146 . . . . 0.0 109.42 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -111.11 141.05 45.12 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.839 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -143.4 117.29 9.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.384 -1.448 . . . . 0.0 109.785 -178.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -153.62 -15.25 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.33 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.551 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 0.7 OUTLIER -69.62 121.87 17.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' B' ' 48' ' ' SER . 48.0 m80 59.55 126.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.076 -1.015 . . . . 0.0 109.701 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -67.07 -34.87 78.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.402 -0.811 . . . . 0.0 110.823 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.527 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -77.45 -37.89 50.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 110.749 -178.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' A' ' 95' ' ' LEU . 19.1 mt -78.75 -71.35 0.44 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.699 -1.25 . . . . 0.0 109.307 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' B' ' 53' ' ' ARG . 3.7 mmt-85 -72.06 12.59 0.4 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 111.268 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.546 ' CD ' HD21 ' A' ' 96' ' ' LEU . 76.0 mt-30 50.65 7.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.826 -1.171 . . . . 0.0 110.167 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.676 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 56.01 -0.38 0.13 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.468 -0.77 . . . . 0.0 112.865 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.676 ' O ' ' O ' ' B' ' 55' ' ' GLY . 4.7 m-85 -53.31 -142.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.323 -1.692 . . . . 0.0 109.985 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.511 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 37.5 m -135.55 -47.46 0.69 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.852 . . . . 0.0 111.003 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.655 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 27.2 t60 -172.78 160.32 4.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.624 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.81 163.07 33.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.449 -0.782 . . . . 0.0 109.282 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 82.3 m-85 -133.43 129.7 37.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.529 -0.732 . . . . 0.0 109.076 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.32 98.73 8.82 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.7 mtt -98.77 119.71 37.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.234 -0.916 . . . . 0.0 110.793 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.5 m -119.48 140.77 49.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -125.3 125.67 43.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.704 -1.247 . . . . 0.0 110.058 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.82 -32.07 19.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -156.01 162.39 40.33 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.73 -21.67 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 111.451 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 33.6 p-10 -56.06 -36.36 67.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.722 -1.236 . . . . 0.0 110.569 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -72.09 -31.99 63.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.693 ' O ' HG22 ' B' ' 74' ' ' THR . 76.6 t80 -67.78 -44.37 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.955 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.78 -28.9 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.431 -1.418 . . . . 0.0 108.691 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.532 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.465 -0.772 . . . . 0.0 109.348 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' B' ' 30' ' ' LEU . 1.6 t80 -56.59 -60.35 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.125 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 70' ' ' TYR . 10.2 t -52.03 -34.49 43.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.715 -1.24 . . . . 0.0 110.322 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 66.5 m -78.01 -16.28 58.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 0.0 110.9 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' B' ' 78' ' ' LEU . 22.8 m80 -79.23 132.15 63.8 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.874 -1.141 . . . . 0.0 109.621 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -42.12 -12.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.625 2.217 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.5 tp -74.38 -27.27 60.58 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.372 -0.83 . . . . 0.0 111.236 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.87 -44.99 21.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.029 -1.044 . . . . 0.0 110.307 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.775 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.2 p -59.55 -58.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.775 ' H ' HG13 ' B' ' 80' ' ' VAL . 15.2 tm-20 -50.91 -36.72 39.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.26 -0.9 . . . . 0.0 109.602 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.88 -31.96 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.853 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.0 -44.34 94.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.029 . . . . 0.0 110.118 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.15 70.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.928 -1.108 . . . . 0.0 108.685 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.924 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -79.39 -46.43 17.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.702 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -38.96 -40.01 0.6 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 21.0 m -82.24 -62.42 1.63 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.77 -16.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.767 -0.583 . . . . 0.0 110.126 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.924 HG22 ' O ' ' B' ' 85' ' ' ALA . 9.0 m -117.25 -1.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.166 -0.959 . . . . 0.0 110.835 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.622 HG22 ' N ' ' B' ' 91' ' ' ASP . 68.4 mt -132.99 163.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.67 -1.268 . . . . 0.0 110.457 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.622 ' N ' HG22 ' B' ' 90' ' ' ILE . 38.5 t0 -124.04 -27.0 3.94 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.495 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 18.9 ttpt -133.77 131.16 39.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.437 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -126.41 125.62 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.568 -1.333 . . . . 0.0 109.735 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.505 HG12 HE21 ' A' ' 54' ' ' GLN . 12.0 t -132.22 134.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -136.56 131.57 34.0 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.188 -1.57 . . . . 0.0 111.814 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.53 HD21 ' CD ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -116.02 122.69 45.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.701 -0.624 . . . . 0.0 109.317 177.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.551 ' O ' ' CZ ' ' A' ' 53' ' ' ARG . 38.7 p-10 -126.3 132.47 51.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.097 -1.002 . . . . 0.0 108.948 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -159.83 128.68 3.06 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.005 . . . . 0.0 110.529 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.79 131.37 13.2 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.283 1.988 . . . . 0.0 112.257 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.547 HG22 ' OE2' ' A' ' 44' ' ' GLU . 97.4 t -113.18 135.38 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -107.89 88.31 2.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 109.636 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . 0.667 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -57.63 73.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.617 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.667 HG13 ' O ' ' B' ' 102' ' ' ALA . 4.6 m -160.99 99.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 0.0 109.189 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' B' ' 106' ' ' SER . 24.1 mmtm -97.74 4.56 49.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.325 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.38 -53.46 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.147 -0.97 . . . . 0.0 108.93 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.655 ' N ' ' O ' ' B' ' 104' ' ' LYS . 20.6 m 47.13 45.04 15.94 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.338 -0.851 . . . . 0.0 109.385 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 72.2 t . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.625 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.605 ' C ' ' H ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.445 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 70.35 -26.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.145 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 2' ' ' ALA . 43.4 p -143.37 -136.85 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.37 168.56 26.96 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.73 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 131.6 47.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.173 -1.193 . . . . 0.0 108.0 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 19.7 ttpt -110.15 139.04 45.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 112.745 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -129.4 127.81 41.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.9 tt -136.47 146.3 46.15 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.761 -1.212 . . . . 0.0 109.48 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 10' ' ' VAL . 11.7 p -127.8 134.76 64.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.501 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.68 127.35 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.34 159.62 32.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.041 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 17.8 tptt -129.46 152.98 48.4 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 8.0 p90 -106.24 148.85 27.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.906 -1.121 . . . . 0.0 111.626 -177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.62 -22.92 3.52 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 85.0 tt0 -89.47 -58.17 2.62 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.3 t0 155.94 72.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.434 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m -66.15 109.75 2.73 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 112.834 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.72 92.2 5.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 20' ' ' VAL . 15.7 m -61.55 -35.97 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.1 p-10 -68.1 -41.65 81.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 65.5 tt0 -71.47 -32.68 68.57 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.22 -36.94 69.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' VAL . 12.8 tp -52.72 -39.98 62.58 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -39.58 84.2 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 29' ' ' ASN . . . -61.59 -54.36 36.37 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 60' ' ' PHE . 48.5 mt -52.63 -47.85 66.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.551 -0.97 . . . . 0.0 108.769 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.66 -39.43 61.84 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.642 ' OD1' HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.18 -42.52 99.38 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.0 mm? -49.93 -46.75 52.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.706 HG13 HD12 ' A' ' 34' ' ' ILE . 22.0 t -48.77 -25.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.283 -0.886 . . . . 0.0 108.846 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 68.5 m -42.83 -40.61 2.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.44 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 98.1 mm-40 -71.1 -17.98 62.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 111.478 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 34' ' ' ILE . 89.1 mt -80.59 18.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.024 -1.672 . . . . 0.0 110.588 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.5 -12.8 4.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 38' ' ' LYS . 4.0 t -89.28 0.52 56.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.586 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 34.24 34.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.987 -1.071 . . . . 0.0 109.157 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.0 mttt -117.54 41.75 2.76 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -177.87 179.12 0.9 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -148.33 159.84 43.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.566 -1.334 . . . . 0.0 111.955 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 76.3 mt-10 -155.96 123.76 5.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.394 0.616 . . . . 0.0 110.165 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 24.1 m95 -125.29 165.88 17.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 44' ' ' GLU . . . -161.45 150.7 20.56 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.793 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 43' ' ' GLY . 7.5 tp10 -163.66 175.19 10.83 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 11.3 p-10 -118.34 170.0 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -61.26 84.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.409 -1.432 . . . . 0.0 109.847 -178.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.6 mt-10 -107.03 42.5 1.29 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.345 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.87 -142.66 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.994 . . . . 0.0 110.193 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 50' ' ' ASP . 78.9 m80 -95.99 136.97 35.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.218 -0.927 . . . . 0.0 109.675 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' HIS . 90.8 m-20 -41.52 -35.73 0.77 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.0 110.789 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -79.02 -29.19 43.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 0.0 110.733 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.8 mt -94.31 -22.77 18.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.697 -1.252 . . . . 0.0 109.275 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 55' ' ' GLY . 2.7 ptt180 -96.08 4.01 52.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.327 -0.858 . . . . 0.0 111.218 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 53' ' ' ARG . 35.3 tt0 40.71 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.733 -1.229 . . . . 0.0 110.171 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 57.53 1.12 0.45 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 121.39 -0.819 . . . . 0.0 112.816 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 32.1 p90 -55.29 129.36 38.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.281 -1.717 . . . . 0.0 109.976 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 52.8 m -54.53 -47.55 73.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.4 ' CG ' ' N ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -164.3 150.93 11.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -179.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 58' ' ' HIS . . . -130.07 147.77 51.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.391 -0.818 . . . . 0.0 109.283 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.948 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 2.4 t80 -126.71 122.93 36.29 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.069 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -106.9 102.7 12.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.3 mtm -102.5 124.74 48.61 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.24 -0.913 . . . . 0.0 110.797 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.8 m -122.29 144.58 48.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.37 160.59 29.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.771 -1.206 . . . . 0.0 110.011 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 77.0 mt-10 -82.97 -30.84 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 29.6 m120 -150.96 160.0 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -58.21 -24.55 59.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 111.389 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -53.62 -35.42 60.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.89 85.45 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 74' ' ' THR . 71.6 t80 -62.39 -46.55 88.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.566 -0.961 . . . . 0.0 110.459 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.394 -1.441 . . . . 0.0 108.649 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.94 2.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 33' ' ' GLN . 3.8 m-85 -48.62 -36.79 16.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 111.103 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 70' ' ' TYR . 2.2 t -82.47 -27.14 32.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.759 -1.213 . . . . 0.0 110.311 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.2 p -69.34 -22.01 63.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.04 -1.038 . . . . 0.0 110.983 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 78' ' ' LEU . 78.4 m80 -85.33 130.76 50.39 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.847 -1.158 . . . . 0.0 109.579 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -45.69 -2.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.67 2.247 . . . . 0.0 112.392 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.642 HD11 ' OD1' ' A' ' 29' ' ' ASN . 8.5 tp -77.16 -31.1 55.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.423 -0.798 . . . . 0.0 111.24 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -76.9 -39.18 51.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.989 -1.069 . . . . 0.0 110.219 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.735 HG13 ' H ' ' A' ' 81' ' ' GLU . 4.0 p -62.26 -56.56 16.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.988 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.735 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.4 tt0 -49.48 -37.76 27.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.4 -29.42 70.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.256 -0.903 . . . . 0.0 109.886 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -61.87 -44.87 95.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.83 69.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.729 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.93 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -83.33 -45.39 13.81 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.703 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -36.37 -44.01 0.4 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.849 HG23 ' H ' ' A' ' 88' ' ' ALA . 3.3 t -83.36 -60.14 2.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.849 ' H ' HG23 ' A' ' 87' ' ' THR . . . -47.22 -14.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.744 -0.598 . . . . 0.0 110.093 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 85' ' ' ALA . 6.1 m -120.17 -1.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.232 -0.918 . . . . 0.0 110.809 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.565 HG13 HG23 ' A' ' 89' ' ' VAL . 61.1 mt -128.55 160.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.649 -1.282 . . . . 0.0 110.434 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.525 ' N ' HG22 ' A' ' 90' ' ' ILE . 40.3 t0 -110.34 -31.97 7.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.51 142.66 31.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.2 tp -124.35 121.11 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.62 -1.3 . . . . 0.0 109.759 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.422 ' CG1' ' CD ' ' B' ' 54' ' ' GLN . 9.0 t -127.57 132.25 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -137.15 132.98 34.73 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.319 -1.488 . . . . 0.0 111.767 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.89 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.66 119.7 36.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.636 -0.665 . . . . 0.0 109.379 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 49.9 t0 -125.61 133.24 52.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.0 108.913 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 31.4 p90 -158.06 138.11 8.81 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.102 -0.999 . . . . 0.0 110.52 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.7 122.92 6.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.594 ' O ' ' OG ' ' A' ' 4' ' ' SER . 56.7 t -85.6 109.28 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.995 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.29 89.71 3.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.42 -0.8 . . . . 0.0 109.613 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' HG13 ' A' ' 103' ' ' VAL . . . -69.85 71.06 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.511 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 103' ' ' VAL . 33.7 m -153.02 86.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.265 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 106' ' ' SER . 29.3 mmtp -95.92 4.45 52.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.342 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t 63.43 -53.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.68 ' N ' ' O ' ' A' ' 104' ' ' LYS . 7.6 t 44.32 50.51 7.81 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.649 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.596 ' OG ' ' O ' ' B' ' 100' ' ' VAL . 46.0 p . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 168.65 26.56 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.63 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.28 131.52 46.99 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -1.143 . . . . 0.0 108.012 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 19.7 ttpt -110.01 138.97 45.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.903 -1.123 . . . . 0.0 112.793 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -129.2 128.19 42.84 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.9 tt -136.86 145.91 44.95 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.724 -1.235 . . . . 0.0 109.509 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.436 HG13 ' O ' ' B' ' 10' ' ' VAL . 11.7 p -127.57 134.64 65.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.587 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.62 127.22 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.23 159.73 32.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.707 -1.597 . . . . 0.0 112.983 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 18.1 tptt -129.48 153.17 48.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 7.9 p90 -106.43 148.76 27.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.893 -1.129 . . . . 0.0 111.621 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -23.11 3.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 85.1 tt0 -89.22 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.3 t0 155.8 73.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 47.6 m -66.55 109.67 2.87 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.083 0.944 . . . . 0.0 112.862 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.678 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -79.46 92.27 5.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 175.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.427 ' H ' HG22 ' B' ' 20' ' ' VAL . 15.8 m -61.8 -35.73 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.539 -0.725 . . . . 0.0 110.445 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 28.9 p-10 -68.23 -41.5 81.14 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.58 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 64.6 tt0 -71.69 -32.47 67.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.36 -36.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.11 -39.96 63.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -39.72 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' B' ' 29' ' ' ASN . . . -61.39 -54.57 35.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.952 HD22 ' CZ ' ' B' ' 60' ' ' PHE . 47.8 mt -52.49 -47.74 66.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.525 -0.986 . . . . 0.0 108.87 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.64 -39.63 61.95 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.648 ' OD1' HD11 ' B' ' 78' ' ' LEU . 0.1 OUTLIER -62.98 -42.64 99.89 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.0 mm? -49.98 -46.65 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.708 HG13 HD12 ' B' ' 34' ' ' ILE . 22.0 t -49.05 -25.17 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.867 . . . . 0.0 108.816 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 68.4 m -43.05 -40.63 3.18 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.448 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 98.1 mm-40 -70.98 -18.08 62.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.453 -0.779 . . . . 0.0 111.526 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.828 HG22 ' O ' ' B' ' 34' ' ' ILE . 89.6 mt -80.47 18.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 119.978 -1.702 . . . . 0.0 110.568 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.64 -12.83 4.57 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.589 ' O ' ' N ' ' B' ' 38' ' ' LYS . 3.9 t -89.16 0.53 56.66 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.887 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.57 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.5 m 34.32 33.9 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.194 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' B' ' 36' ' ' THR . 65.5 mttt -117.59 42.09 2.68 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 55.6 p -177.93 179.19 0.88 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -148.34 159.65 43.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.554 -1.341 . . . . 0.0 111.95 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.502 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 77.1 mt-10 -155.79 123.84 5.74 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.335 0.588 . . . . 0.0 110.229 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' B' ' 60' ' ' PHE . 23.9 m95 -125.22 166.03 17.22 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' B' ' 44' ' ' GLU . . . -161.55 150.56 20.25 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 118.716 -1.707 . . . . 0.0 110.839 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 43' ' ' GLY . 7.6 tp10 -163.57 175.2 10.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 109.352 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 11.7 p-10 -118.44 169.92 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -61.32 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.322 -1.487 . . . . 0.0 109.809 -178.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.8 mt-10 -106.96 42.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.316 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -139.74 -142.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.138 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' B' ' 50' ' ' ASP . 79.1 m80 -95.97 136.87 35.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 49' ' ' HIS . 90.4 m-20 -41.34 -36.01 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.324 -0.86 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.5 OUTLIER -78.81 -29.35 44.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.731 -178.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.28 -22.83 18.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.691 -1.256 . . . . 0.0 109.257 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' B' ' 55' ' ' GLY . 2.7 ptt180 -95.98 4.04 52.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -0.834 . . . . 0.0 111.235 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' B' ' 53' ' ' ARG . 35.5 tt0 40.55 21.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.812 -1.18 . . . . 0.0 110.15 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 57.27 1.26 0.41 Allowed Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.356 -0.84 . . . . 0.0 112.796 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 31.5 p90 -55.45 129.47 38.87 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 119.595 1.697 . . . . 0.0 109.941 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 55.2 m -54.66 -47.57 73.41 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.301 -0.874 . . . . 0.0 110.946 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 151.06 11.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.895 -1.128 . . . . 0.0 110.17 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.18 147.77 51.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.0 109.262 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.952 ' CZ ' HD22 ' B' ' 27' ' ' LEU . 2.4 t80 -126.65 122.97 36.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.488 -0.757 . . . . 0.0 109.075 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -107.07 102.56 11.89 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.26 124.99 48.81 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.134 -0.979 . . . . 0.0 110.759 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -122.51 144.65 48.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.47 160.92 28.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.738 -1.226 . . . . 0.0 110.025 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.528 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 77.9 mt-10 -83.31 -30.73 27.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 29.6 m120 -151.01 160.21 44.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -58.27 -25.04 61.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 111.411 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -53.06 -35.75 59.86 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.816 -1.177 . . . . 0.0 110.585 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -37.1 87.71 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.458 ' O ' HG22 ' B' ' 74' ' ' THR . 71.7 t80 -62.4 -46.55 88.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.978 . . . . 0.0 110.439 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.72 -28.98 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.37 -1.456 . . . . 0.0 108.623 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.0 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' B' ' 33' ' ' GLN . 3.8 m-85 -48.54 -36.58 15.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 111.186 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.458 HG22 ' O ' ' B' ' 70' ' ' TYR . 2.1 t -82.74 -27.08 31.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.744 -1.222 . . . . 0.0 110.329 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -69.49 -21.81 63.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 0.0 111.027 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' B' ' 78' ' ' LEU . 78.3 m80 -85.35 130.81 50.17 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.861 -1.149 . . . . 0.0 109.596 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.71 -2.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.599 2.199 . . . . 0.0 112.433 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.648 HD11 ' OD1' ' B' ' 29' ' ' ASN . 8.3 tp -77.31 -31.1 54.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -76.84 -39.18 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.0 110.296 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.719 HG13 ' H ' ' B' ' 81' ' ' GLU . 4.0 p -62.41 -56.3 18.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.972 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.719 ' H ' HG13 ' B' ' 80' ' ' VAL . 84.2 tt0 -49.89 -37.37 31.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.62 -29.27 69.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.85 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 59.9 p -62.03 -44.99 95.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.71 68.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.998 -1.063 . . . . 0.0 108.641 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.956 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -83.55 -45.33 13.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.705 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -36.52 -43.91 0.42 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.836 HG23 ' H ' ' B' ' 88' ' ' ALA . 3.3 t -83.32 -60.4 2.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.836 ' H ' HG23 ' B' ' 87' ' ' THR . . . -47.04 -14.9 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.956 HG22 ' O ' ' B' ' 85' ' ' ALA . 6.3 m -119.9 -1.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -0.904 . . . . 0.0 110.835 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 61.0 mt -128.33 160.68 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.672 -1.267 . . . . 0.0 110.448 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.545 ' N ' HG22 ' B' ' 90' ' ' ILE . 40.7 t0 -110.54 -31.89 7.09 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.63 142.35 30.99 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.516 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.1 tp -124.03 121.45 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.579 -1.326 . . . . 0.0 109.661 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.431 ' CG1' ' CD ' ' A' ' 54' ' ' GLN . 9.3 t -127.83 132.42 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.553 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -137.37 132.67 33.87 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.246 -1.534 . . . . 0.0 111.777 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.891 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.43 119.78 37.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.683 -0.636 . . . . 0.0 109.294 177.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' B' ' 98' ' ' PHE . 50.2 t0 -125.69 133.23 52.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.067 -1.021 . . . . 0.0 108.861 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' B' ' 98' ' ' PHE . 31.2 p90 -158.04 137.79 8.6 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 110.555 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.37 123.1 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.313 2.008 . . . . 0.0 112.221 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.596 ' O ' ' OG ' ' B' ' 4' ' ' SER . 58.9 t -85.79 109.21 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.21 89.8 3.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . 0.41 ' C ' HG13 ' B' ' 103' ' ' VAL . . . -69.82 71.17 0.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.099 -1.001 . . . . 0.0 109.599 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.742 HG23 ' O ' ' B' ' 103' ' ' VAL . 33.8 m -153.29 85.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -0.843 . . . . 0.0 109.235 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.67 ' O ' ' N ' ' B' ' 106' ' ' SER . 29.2 mmtp -95.61 4.62 52.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.415 ' O ' ' C ' ' B' ' 106' ' ' SER . 1.8 t 63.34 -53.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 108.879 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.67 ' N ' ' O ' ' B' ' 104' ' ' LYS . 7.6 t 44.68 50.43 8.51 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.592 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.427 0.632 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 101' ' ' ALA . 8.8 t -111.5 0.21 16.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -167.25 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.1 178.15 18.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.66 127.04 55.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.276 -1.132 . . . . 0.0 107.973 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.4 ttpt -97.95 128.03 44.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.916 -1.115 . . . . 0.0 112.841 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 70' ' ' TYR . 51.6 m-70 -121.06 119.2 31.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.71 139.44 52.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.716 -1.24 . . . . 0.0 109.496 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.9 137.48 56.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.641 -0.662 . . . . 0.0 109.536 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -124.48 133.8 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 1.5 m -141.42 162.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.047 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -127.59 152.64 47.38 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 12.7 p90 -109.82 151.8 26.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.799 -1.188 . . . . 0.0 111.607 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.31 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 48.3 tp10 -92.84 -54.93 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.8 t0 152.86 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.536 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.4 m -50.22 107.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.14 0.972 . . . . 0.0 112.859 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -71.61 83.36 0.85 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 21' ' ' ASP . 27.8 m -62.83 -41.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.546 -0.721 . . . . 0.0 110.481 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.57 ' N ' HG23 ' A' ' 20' ' ' VAL . 90.3 m-20 -64.96 -44.64 88.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 110.498 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.7 -31.77 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -70.84 -43.61 76.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.2 tp -54.01 -40.04 66.66 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.92 -38.04 81.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -62.57 -51.27 57.3 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.7 tt -45.22 -44.03 10.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.461 -1.023 . . . . 0.0 108.848 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -49.87 -35.01 21.81 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 26' ' ' GLY . 14.3 m-20 -65.39 -44.32 87.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.668 HD11 ' CE1' ' A' ' 73' ' ' PHE . 1.4 mm? -48.39 -50.76 29.6 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' SER . 54.8 t -46.94 -35.7 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 108.733 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.1 t -45.36 -50.55 12.13 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -69.21 -9.15 51.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 111.47 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 34' ' ' ILE . 21.9 mm -101.35 29.07 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.04 -1.663 . . . . 0.0 110.589 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.19 -19.08 61.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.585 ' O ' ' C ' ' A' ' 37' ' ' VAL . 16.8 p -69.84 -6.85 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.585 ' C ' ' O ' ' A' ' 36' ' ' THR . 34.7 m 35.08 36.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.104 -0.998 . . . . 0.0 109.106 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -118.0 41.55 2.87 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.444 ' OG ' HG23 ' A' ' 34' ' ' ILE . 60.5 p -174.01 178.09 2.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 97.6 m-85 -145.47 153.81 41.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.594 -1.316 . . . . 0.0 111.951 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 40' ' ' PHE . 54.1 mp0 -156.99 125.41 5.68 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.421 0.629 . . . . 0.0 110.162 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -134.58 176.05 8.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.636 ' H ' ' NZ ' ' B' ' 104' ' ' LYS . . . -133.56 158.82 23.42 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 77.4 mt-10 -149.06 140.79 23.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -1.145 . . . . 0.0 109.368 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.538 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 32.4 p30 -120.62 145.36 47.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -148.62 128.84 13.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.437 -1.414 . . . . 0.0 109.794 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -161.98 51.2 0.21 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.641 -0.662 . . . . 0.0 109.32 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.2 t -91.12 -98.65 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.203 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.44 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.4 m-70 -100.69 144.67 29.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.155 -0.965 . . . . 0.0 109.708 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 87.8 m-20 -50.09 -42.97 51.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.301 -0.875 . . . . 0.0 110.674 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.3 ttt -73.55 -32.77 64.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.084 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 68.9 mt -88.67 -51.65 5.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.741 -1.224 . . . . 0.0 109.245 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.721 ' O ' ' N ' ' A' ' 55' ' ' GLY . 13.8 ptt180 -71.08 5.45 2.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 111.275 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.428 ' NE2' HG13 ' B' ' 94' ' ' VAL . 17.0 mm100 46.07 3.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.729 -1.232 . . . . 0.0 110.197 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.21 -10.07 11.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.488 -0.758 . . . . 0.0 112.864 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 55' ' ' GLY . 20.9 m-85 -59.1 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.226 -1.749 . . . . 0.0 109.99 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.724 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 81.1 p -152.86 -41.9 0.1 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.962 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.724 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 27.3 p-80 -174.33 157.81 2.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.836 -1.165 . . . . 0.0 110.145 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG13 ' A' ' 11' ' ' VAL . . . -143.69 170.91 14.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 109.287 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.05 131.67 37.29 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.128 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 t -101.67 102.15 12.78 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.9 mtt -108.08 125.1 51.18 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.146 -0.971 . . . . 0.0 110.799 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.8 m -128.4 149.36 50.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.06 131.71 45.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 110.03 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 71.7 mm-40 -52.48 -32.52 40.36 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 33.0 m120 -155.64 160.46 40.43 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -57.66 -17.93 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.99 -39.83 79.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.844 -1.16 . . . . 0.0 110.589 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.26 -33.46 73.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.615 ' CE1' ' CE1' ' A' ' 8' ' ' HIS . 76.4 t80 -67.12 -44.38 80.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.495 -1.003 . . . . 0.0 110.451 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -28.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.381 -1.45 . . . . 0.0 108.673 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.367 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.668 ' CE1' HD11 ' A' ' 30' ' ' LEU . 2.5 t80 -45.66 -34.17 3.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 111.141 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -83.41 -24.9 31.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.744 -1.223 . . . . 0.0 110.249 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.6 m -67.47 -26.0 66.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.994 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -85.47 156.0 59.42 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.878 -1.139 . . . . 0.0 109.664 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.21 3.86 2.27 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.66 2.24 . . . . 0.0 112.469 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' CD2' HD22 ' A' ' 30' ' ' LEU . 44.5 tp -77.87 -31.1 51.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.77 . . . . 0.0 111.322 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -77.7 -41.61 37.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 0.0 110.211 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.765 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.5 p -62.58 -58.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.765 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.8 tt0 -51.77 -38.72 56.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 109.638 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -69.89 -32.02 70.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 109.883 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.5 -45.06 95.16 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.48 85.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.879 -1.138 . . . . 0.0 108.751 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.829 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -77.55 -44.76 27.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -39.28 -38.78 0.55 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.3 m -81.46 -61.0 2.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.34 -13.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.63 -0.669 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 85' ' ' ALA . 13.1 m -119.27 -2.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 110.859 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -120.66 155.98 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.595 -1.316 . . . . 0.0 110.473 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.444 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 36.4 t0 -104.35 -31.58 9.47 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.433 ' H ' HG23 ' A' ' 90' ' ' ILE . 21.5 pttt -149.98 150.61 32.06 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 86' ' ' PHE . 6.0 tp -127.31 125.25 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.627 -1.295 . . . . 0.0 109.751 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.424 HG13 ' CD ' ' B' ' 54' ' ' GLN . 13.2 t -123.45 128.57 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.841 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.25 138.43 33.25 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.249 -1.532 . . . . 0.0 111.838 -178.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -122.25 123.96 42.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.637 . . . . 0.0 109.326 176.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -125.85 135.59 52.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.011 -1.056 . . . . 0.0 108.919 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -165.67 158.55 13.14 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 0.0 110.522 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.595 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 39.9 Cg_exo -58.78 114.84 2.17 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.298 1.999 . . . . 0.0 112.176 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 132.97 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.923 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -109.8 79.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -73.83 93.97 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.114 -0.991 . . . . 0.0 109.535 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.754 ' O ' ' C ' ' A' ' 104' ' ' LYS . 14.7 m -155.9 -16.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.201 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.754 ' C ' ' O ' ' A' ' 103' ' ' VAL . 31.5 mmtm -8.14 -105.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.71 -5.52 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 108.911 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 104' ' ' LYS . 45.1 t -59.71 140.56 56.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.6 p . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.19 178.12 18.44 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.433 -1.365 . . . . 0.0 109.697 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -111.76 126.69 55.33 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.276 -1.132 . . . . 0.0 107.993 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.3 ttpt -97.53 128.23 44.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.937 -1.102 . . . . 0.0 112.863 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.601 ' CE1' ' CE1' ' B' ' 70' ' ' TYR . 51.3 m-70 -121.29 119.02 31.01 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 5.9 tt -128.56 139.53 52.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.743 -1.223 . . . . 0.0 109.451 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.83 137.67 56.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.498 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.3 OUTLIER -124.77 133.86 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.623 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 1.5 m -141.5 162.04 21.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 117.745 -1.582 . . . . 0.0 113.039 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -127.57 152.66 47.35 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 12.6 p90 -109.88 151.73 26.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.798 -1.189 . . . . 0.0 111.562 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.14 3.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 48.4 tp10 -92.96 -55.04 3.5 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.7 t0 152.99 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.531 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 89.3 m -50.27 107.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.082 0.944 . . . . 0.0 112.868 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -71.51 83.23 0.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.575 HG23 ' N ' ' B' ' 21' ' ' ASP . 26.9 m -62.77 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.631 -0.668 . . . . 0.0 110.473 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.575 ' N ' HG23 ' B' ' 20' ' ' VAL . 90.0 m-20 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.456 -0.777 . . . . 0.0 110.576 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -65.5 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -70.96 -43.43 76.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.13 -40.02 67.01 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.98 -38.13 81.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -62.22 -51.59 55.61 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.544 ' O ' HD23 ' B' ' 27' ' ' LEU . 4.7 tt -45.04 -44.08 9.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.533 -0.981 . . . . 0.0 108.795 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -49.89 -34.94 21.78 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' B' ' 26' ' ' GLY . 14.3 m-20 -65.4 -44.31 87.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.664 HD11 ' CE1' ' B' ' 73' ' ' PHE . 1.4 mm? -48.37 -50.82 29.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 32' ' ' SER . 54.9 t -46.93 -35.47 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.915 . . . . 0.0 108.79 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 8.2 t -45.65 -50.48 13.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -69.28 -8.99 51.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 111.475 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 34' ' ' ILE . 21.9 mm -101.58 29.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.019 -1.675 . . . . 0.0 110.645 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -61.23 -19.27 61.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.571 ' O ' ' C ' ' B' ' 37' ' ' VAL . 16.8 p -69.59 -6.85 33.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.961 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.6 m 35.04 36.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.022 -1.049 . . . . 0.0 109.132 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.3 OUTLIER -118.09 41.68 2.86 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.445 ' OG ' HG23 ' B' ' 34' ' ' ILE . 60.3 p -174.2 177.99 2.17 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 97.7 m-85 -145.47 153.7 41.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.58 -1.325 . . . . 0.0 111.967 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' B' ' 40' ' ' PHE . 53.9 mp0 -156.92 125.11 5.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -134.2 176.18 8.83 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.648 ' H ' ' NZ ' ' A' ' 104' ' ' LYS . . . -133.74 158.74 23.42 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 118.703 -1.713 . . . . 0.0 110.782 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 77.3 mt-10 -148.98 140.83 23.66 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 32.2 p30 -120.71 145.39 47.53 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.66 128.69 13.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.404 -1.435 . . . . 0.0 109.834 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -161.91 51.36 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.622 . . . . 0.0 109.339 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -91.18 -98.83 0.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ARG . 90.4 m-70 -100.59 144.5 29.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.093 -1.004 . . . . 0.0 109.676 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' B' ' 53' ' ' ARG . 88.6 m-20 -49.92 -42.92 49.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 110.849 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.1 ttt -73.76 -32.46 63.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.029 -1.044 . . . . 0.0 110.756 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 95' ' ' LEU . 68.9 mt -88.82 -51.76 5.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.731 ' O ' ' N ' ' B' ' 55' ' ' GLY . 13.8 ptt180 -70.91 5.36 2.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.344 -0.848 . . . . 0.0 111.249 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.424 ' CD ' HG13 ' A' ' 94' ' ' VAL . 17.4 mm100 46.19 3.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.855 -1.153 . . . . 0.0 110.244 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.32 -10.12 11.96 Favored Glycine 0 N--CA 1.499 2.882 0 O-C-N 121.437 -0.79 . . . . 0.0 112.812 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' B' ' 55' ' ' GLY . 21.4 m-85 -59.19 -141.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.284 -1.715 . . . . 0.0 109.946 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.706 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 80.6 p -152.76 -41.85 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.319 -0.863 . . . . 0.0 111.024 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.706 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 27.5 p-80 -174.45 157.7 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.854 -1.154 . . . . 0.0 110.167 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.53 ' HB2' HG13 ' B' ' 11' ' ' VAL . . . -143.72 170.9 14.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.489 -0.757 . . . . 0.0 109.219 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.01 131.67 37.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 21.1 t -101.61 102.23 12.91 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 125.31 51.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.931 . . . . 0.0 110.733 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.7 m -128.59 149.28 50.7 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.05 131.64 45.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 110.095 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 72.0 mm-40 -52.17 -32.82 37.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 32.9 m120 -155.5 160.51 40.62 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -57.76 -17.87 18.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 111.466 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -57.85 -40.11 79.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.885 -1.134 . . . . 0.0 110.551 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.93 -33.6 75.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.601 ' CE1' ' CE1' ' B' ' 8' ' ' HIS . 76.2 t80 -66.99 -44.55 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.661 -0.905 . . . . 0.0 110.473 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.67 -28.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.704 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.88 2.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.664 ' CE1' HD11 ' B' ' 30' ' ' LEU . 2.5 t80 -45.66 -34.08 3.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.148 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.1 OUTLIER -83.34 -24.99 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 0.0 110.304 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -67.41 -25.86 66.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 111.032 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -85.65 156.0 58.92 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.83 -1.169 . . . . 0.0 109.579 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.17 3.91 2.23 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 112.433 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.513 ' CD2' HD22 ' B' ' 30' ' ' LEU . 44.5 tp -77.98 -31.31 50.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.429 -0.794 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -77.41 -41.79 38.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.961 -1.087 . . . . 0.0 110.289 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.781 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.6 p -62.39 -58.24 8.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.054 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.781 ' H ' HG13 ' B' ' 80' ' ' VAL . 85.0 tt0 -51.71 -38.73 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 0.0 109.593 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -69.98 -31.96 69.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.838 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.4 t -60.35 -45.36 93.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.142 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.42 85.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.987 -1.071 . . . . 0.0 108.685 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.801 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -77.53 -44.79 27.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.698 ' CE1' HD13 ' B' ' 93' ' ' ILE . 0.0 OUTLIER -39.33 -38.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.593 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.3 m -81.41 -61.1 2.04 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.12 -13.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.079 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.801 HG22 ' O ' ' B' ' 85' ' ' ALA . 13.1 m -119.21 -2.77 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.237 -0.915 . . . . 0.0 110.875 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -120.7 156.05 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.701 -1.249 . . . . 0.0 110.465 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.455 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 35.9 t0 -104.47 -31.63 9.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.435 ' H ' HG23 ' B' ' 90' ' ' ILE . 21.6 pttt -150.04 150.37 31.65 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.698 HD13 ' CE1' ' B' ' 86' ' ' PHE . 6.0 tp -127.07 125.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.491 -1.381 . . . . 0.0 109.733 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.428 HG13 ' NE2' ' A' ' 54' ' ' GLN . 12.8 t -123.55 128.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.847 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.33 138.54 33.18 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.302 -1.499 . . . . 0.0 111.791 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.4 HD12 ' N ' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -122.25 123.83 42.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -125.77 135.67 52.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.064 -1.023 . . . . 0.0 108.87 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.591 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 0.5 OUTLIER -165.62 158.52 13.21 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.132 -0.98 . . . . 0.0 110.587 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . 0.591 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 41.1 Cg_exo -58.76 114.73 2.12 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.305 2.003 . . . . 0.0 112.265 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 133.04 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.004 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 78.87 1.16 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.502 -0.749 . . . . 0.0 109.58 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . 0.471 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -73.58 94.08 2.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.12 -0.987 . . . . 0.0 109.657 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.784 ' O ' ' C ' ' B' ' 104' ' ' LYS . 14.6 m -156.0 -16.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.362 -0.836 . . . . 0.0 109.219 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.784 ' C ' ' O ' ' B' ' 103' ' ' VAL . 31.3 mmtm -8.28 -105.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.373 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.66 -5.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.935 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.557 ' H ' ' C ' ' B' ' 104' ' ' LYS . 44.4 t -59.53 140.61 56.12 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.291 -0.881 . . . . 0.0 109.419 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.538 ' O ' HG13 ' B' ' 107' ' ' VAL . 10.7 p . . . . . 0 C--N 1.302 -1.475 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.404 0.621 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 4' ' ' SER . 12.1 t -107.68 0.77 22.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.089 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.9 m -173.32 -107.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.8 -178.26 20.55 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.399 -1.382 . . . . 0.0 109.694 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -130.11 130.13 44.42 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 1.3 ttpm? -104.48 133.84 48.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.874 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -127.21 125.7 41.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.51 142.45 48.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.745 -1.222 . . . . 0.0 109.507 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 140.32 48.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.506 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.22 134.02 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.491 ' O ' HG22 ' A' ' 57' ' ' THR . 2.6 m -137.53 162.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 117.79 -1.564 . . . . 0.0 113.014 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 14' ' ' PHE . 20.7 tptp -132.21 152.8 51.14 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 18' ' ' THR . 36.3 p90 -111.65 149.44 31.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.886 -1.134 . . . . 0.0 111.597 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.45 -19.68 3.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.5 mt-10 -91.69 -56.5 3.08 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.9 t0 154.48 64.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 86.8 m -49.77 105.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.126 0.965 . . . . 0.0 112.794 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.898 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -68.65 83.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 21' ' ' ASP . 28.9 m -61.59 -42.96 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.52 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' N ' HG23 ' A' ' 20' ' ' VAL . 29.0 p-10 -65.97 -43.27 88.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 0.0 110.571 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 97.4 mt-10 -70.7 -34.12 71.61 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 89' ' ' VAL . 1.8 mm -67.32 -44.61 87.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' VAL . 15.7 tp -52.88 -38.0 61.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.08 75.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -60.63 -54.23 38.81 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.4 tt -45.83 -43.91 13.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.497 -1.002 . . . . 0.0 108.838 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' B' ' 106' ' ' SER . 71.8 mm-40 -50.86 -33.33 23.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.0 m-20 -66.54 -44.39 82.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.1 mm? -49.3 -48.28 46.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 32' ' ' SER . 94.6 t -46.97 -31.91 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.908 . . . . 0.0 108.844 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 73.7 p -45.59 -49.25 14.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 70.6 mm-40 -72.79 -12.15 60.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 111.457 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 34' ' ' ILE . 21.1 mm -96.69 24.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.043 -1.661 . . . . 0.0 110.589 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.06 -12.43 4.81 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.2 p -74.86 -1.28 21.6 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.995 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.576 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.1 m 34.61 33.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 32.1 mtmt -119.55 42.36 2.9 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 58.4 m -171.88 174.54 4.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -146.71 157.4 43.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.639 -1.288 . . . . 0.0 111.957 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.479 ' OE1' HD21 ' A' ' 27' ' ' LEU . 72.5 mt-10 -155.27 121.5 5.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.362 0.601 . . . . 0.0 110.231 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -123.95 170.2 10.85 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.97 160.0 23.72 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.72 -1.705 . . . . 0.0 110.852 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 24.1 mt-10 -150.5 145.21 25.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.251 -1.147 . . . . 0.0 109.394 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 22.5 t70 -126.53 148.03 49.77 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.877 ' HZ2' ' C ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -145.37 122.99 11.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.417 -1.427 . . . . 0.0 109.799 -178.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 48' ' ' SER . 95.4 mt-10 -133.93 3.4 3.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 47' ' ' GLU . 99.2 p -56.99 -140.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.953 . . . . 0.0 110.17 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.786 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 57.4 t-80 -74.62 160.15 31.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.691 ' N ' HH21 ' A' ' 53' ' ' ARG . 77.9 m-20 -61.2 -44.23 97.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 tpt -67.76 -33.43 74.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.013 -1.054 . . . . 0.0 110.746 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' B' ' 95' ' ' LEU . 38.0 mt -89.23 -54.43 4.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.702 -1.249 . . . . 0.0 109.323 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.786 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.3 ptp180 -64.41 2.97 0.52 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.0 111.195 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.607 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER 57.19 -12.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.75 -1.219 . . . . 0.0 110.14 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.739 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 85.24 -21.81 11.69 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.408 -0.808 . . . . 0.0 112.847 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.877 ' C ' ' HZ2' ' A' ' 46' ' ' LYS . 3.7 m-85 -57.79 -129.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.267 -1.725 . . . . 0.0 109.988 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.8 t -162.2 -33.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.629 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 15.0 t60 -172.05 154.49 3.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.104 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.629 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.9 168.01 20.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.414 -0.804 . . . . 0.0 109.251 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 96.8 m-85 -134.74 130.98 37.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.475 -0.766 . . . . 0.0 109.067 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.6 99.24 8.84 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.0 mtm -100.07 124.8 45.86 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.149 -0.97 . . . . 0.0 110.851 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.46 142.94 50.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' GLU . 94.2 m-85 -122.01 126.8 49.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.736 -1.228 . . . . 0.0 110.092 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 64' ' ' PHE . 33.6 tt0 -46.93 -30.7 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -165.81 170.59 13.74 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -57.79 -22.35 46.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 111.46 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -56.24 -40.22 73.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.822 -1.174 . . . . 0.0 110.673 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.09 62.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.645 ' O ' HG22 ' A' ' 74' ' ' THR . 71.7 t80 -63.13 -44.59 95.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.984 . . . . 0.0 110.467 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.75 -28.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.388 -1.445 . . . . 0.0 108.692 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -60.99 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -56.74 -42.57 79.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 111.09 -177.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 70' ' ' TYR . 10.0 t -75.95 -33.19 59.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.787 -1.195 . . . . 0.0 110.31 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 63.5 m -63.39 -32.76 74.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.996 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.522 ' CE1' ' OE1' ' A' ' 33' ' ' GLN . 54.5 m80 -72.03 151.91 92.76 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.861 -1.15 . . . . 0.0 109.604 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.14 4.1 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.669 2.246 . . . . 0.0 112.42 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.482 ' CD2' HD22 ' A' ' 30' ' ' LEU . 28.5 tp -76.57 -28.62 56.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.384 -0.822 . . . . 0.0 111.267 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.518 ' CD2' ' OG ' ' A' ' 83' ' ' SER . 11.2 t-160 -81.59 -41.82 20.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.987 -1.07 . . . . 0.0 110.245 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.775 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.5 p -63.12 -58.9 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 110.023 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.775 ' H ' HG13 ' A' ' 80' ' ' VAL . 48.3 tp10 -58.46 -39.61 80.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.197 -0.94 . . . . 0.0 109.627 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 85.6 t80 -69.69 -43.49 72.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.518 ' OG ' ' CD2' ' A' ' 79' ' ' HIS . 49.8 m -59.24 -36.63 75.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.113 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.22 60.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.972 -1.08 . . . . 0.0 108.666 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.9 -41.59 74.49 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.492 ' C ' ' O ' ' A' ' 85' ' ' ALA . 11.9 t80 -43.06 -30.82 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.3 m -83.21 -60.98 1.97 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.41 -24.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.682 -0.636 . . . . 0.0 110.049 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' THR . 9.0 m -105.32 11.92 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.213 -0.93 . . . . 0.0 110.834 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 47.1 mt -124.68 158.77 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.278 . . . . 0.0 110.474 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.508 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 57.5 t0 -100.05 -34.32 10.12 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 90' ' ' ILE . 38.4 pttt -149.08 147.62 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.88 131.4 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.619 -1.301 . . . . 0.0 109.744 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.0 139.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -139.44 135.18 33.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.245 -1.534 . . . . 0.0 111.739 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.898 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -117.99 123.87 46.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.382 178.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 65.7 t0 -125.47 131.15 52.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.041 -1.037 . . . . 0.0 108.939 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' B' ' 45' ' ' ASP . 44.8 t80 -160.93 138.72 7.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.036 -1.04 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.82 120.33 2.8 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.34 2.026 . . . . 0.0 112.205 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.82 144.04 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.06 125.77 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 109.609 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.06 73.55 9.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.539 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 103' ' ' VAL . 18.1 m -150.25 98.06 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.162 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 106' ' ' SER . 41.4 mmtm -134.27 -112.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.57 -12.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 108.868 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 104' ' ' LYS . 30.1 t -53.58 139.75 30.75 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.269 -0.895 . . . . 0.0 109.404 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.301 -1.511 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.83 -178.81 20.51 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.632 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.62 130.2 45.33 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.302 -1.117 . . . . 0.0 108.011 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 1.2 ttpm? -104.47 134.04 48.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.337 1.065 . . . . 0.0 112.841 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -127.41 125.63 40.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 tt -133.43 142.59 48.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 109.375 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.87 140.31 49.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.574 -0.704 . . . . 0.0 109.493 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.408 ' O ' HG22 ' B' ' 94' ' ' VAL . 0.1 OUTLIER -121.13 134.14 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.489 ' O ' HG22 ' B' ' 57' ' ' THR . 2.6 m -137.5 162.8 32.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 117.758 -1.577 . . . . 0.0 113.016 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.503 ' HD2' ' H ' ' B' ' 14' ' ' PHE . 20.6 tptp -132.17 152.96 51.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.515 ' HB2' ' H ' ' B' ' 18' ' ' THR . 36.4 p90 -111.76 149.51 31.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.78 -1.2 . . . . 0.0 111.598 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.65 -19.44 3.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.4 mt-10 -92.14 -56.17 3.16 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 8.7 t0 154.25 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.515 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 87.1 m -49.67 105.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.148 0.975 . . . . 0.0 112.876 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.887 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -68.76 83.59 0.3 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.591 HG23 ' N ' ' B' ' 21' ' ' ASP . 29.6 m -61.84 -42.89 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 110.513 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.591 ' N ' HG23 ' B' ' 20' ' ' VAL . 30.4 p-10 -65.95 -43.2 88.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.547 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 97.2 mt-10 -70.7 -34.17 71.66 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.46 HD11 HG21 ' B' ' 89' ' ' VAL . 1.8 mm -67.29 -44.51 87.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' B' ' 20' ' ' VAL . 15.7 tp -52.87 -37.94 60.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.05 75.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -60.71 -54.13 39.54 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.559 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.4 tt -45.92 -43.63 14.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 108.828 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 106' ' ' SER . 71.6 mm-40 -51.35 -33.2 28.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 26' ' ' GLY . 11.5 m-20 -66.34 -44.75 82.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.1 mm? -48.9 -48.4 42.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 94.4 t -46.9 -32.09 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 108.815 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 69.6 p -45.57 -49.37 14.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.518 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 71.1 mm-40 -72.49 -12.07 60.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 111.527 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 34' ' ' ILE . 21.2 mm -96.97 24.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.017 -1.677 . . . . 0.0 110.568 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.35 -12.02 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.575 ' O ' ' N ' ' B' ' 38' ' ' LYS . 52.6 p -75.29 -1.11 22.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.96 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 34.63 33.57 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.998 -1.064 . . . . 0.0 109.135 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' B' ' 36' ' ' THR . 32.1 mtmt -119.6 42.53 2.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 58.5 m -172.03 174.58 4.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -146.78 157.46 43.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.497 -1.377 . . . . 0.0 111.934 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.472 ' OE1' HD21 ' B' ' 27' ' ' LEU . 72.5 mt-10 -155.24 121.51 5.23 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.428 0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -123.86 170.27 10.74 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.18 159.67 23.65 Favored Glycine 0 N--CA 1.499 2.836 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.847 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 24.2 mt-10 -150.3 145.0 25.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.181 -1.188 . . . . 0.0 109.387 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 22.3 t70 -126.38 147.9 49.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.857 ' HZ2' ' C ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -145.17 123.12 12.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 0.0 109.858 -178.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.4 mt-10 -134.08 3.9 3.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.694 -0.629 . . . . 0.0 109.367 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.536 ' O ' ' O ' ' B' ' 47' ' ' GLU . 95.1 p -57.21 -140.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.179 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.762 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 57.3 t-80 -74.54 160.18 31.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 109.742 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.701 ' N ' HH21 ' B' ' 53' ' ' ARG . 77.7 m-20 -61.2 -44.2 97.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.0 110.837 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.7 tpt -67.81 -33.28 74.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.005 . . . . 0.0 110.726 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 95' ' ' LEU . 38.9 mt -89.32 -54.46 4.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.715 -1.24 . . . . 0.0 109.307 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.762 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.4 ptp180 -64.37 2.89 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 111.231 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.599 ' NE2' ' CZ ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER 57.33 -12.38 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.811 -1.18 . . . . 0.0 110.282 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.738 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 85.61 -22.04 12.3 Favored Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.43 -0.794 . . . . 0.0 112.789 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.857 ' C ' ' HZ2' ' B' ' 46' ' ' LYS . 3.6 m-85 -57.82 -129.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.327 -1.69 . . . . 0.0 109.973 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.489 HG22 ' O ' ' B' ' 12' ' ' VAL . 2.6 t -162.37 -33.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 110.985 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.617 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 15.2 t60 -171.93 154.61 3.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.832 -1.168 . . . . 0.0 110.162 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.617 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.95 167.99 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.439 -0.788 . . . . 0.0 109.341 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 96.7 m-85 -134.61 131.04 37.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 109.137 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.55 99.1 8.72 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -99.9 124.77 45.58 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.204 -0.935 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 88.4 m -123.58 143.06 50.45 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' B' ' 65' ' ' GLU . 94.3 m-85 -122.22 126.65 48.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.751 -1.218 . . . . 0.0 110.081 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' B' ' 64' ' ' PHE . 32.8 tt0 -46.62 -30.79 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -166.01 170.6 13.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.85 -22.4 47.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.886 . . . . 0.0 111.402 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -56.18 -40.26 73.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.81 -1.181 . . . . 0.0 110.653 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.57 -36.08 62.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.63 ' O ' HG22 ' B' ' 74' ' ' THR . 72.5 t80 -63.07 -44.78 94.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.532 -0.981 . . . . 0.0 110.49 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.75 -28.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.351 -1.468 . . . . 0.0 108.684 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -60.83 2.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.344 -0.847 . . . . 0.0 109.292 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.69 -42.46 79.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 111.124 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.63 HG22 ' O ' ' B' ' 70' ' ' TYR . 10.0 t -76.09 -33.14 59.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.779 -1.2 . . . . 0.0 110.381 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 65.4 m -63.47 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.062 -1.024 . . . . 0.0 110.912 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.518 ' CE1' ' OE1' ' B' ' 33' ' ' GLN . 54.1 m80 -72.34 151.63 92.06 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.82 -1.175 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.79 3.91 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.701 2.267 . . . . 0.0 112.425 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.473 ' CD2' HD22 ' B' ' 30' ' ' LEU . 28.5 tp -76.48 -28.93 56.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.373 -0.83 . . . . 0.0 111.233 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.506 ' CD2' ' OG ' ' B' ' 83' ' ' SER . 11.2 t-160 -81.37 -41.6 21.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.041 -1.037 . . . . 0.0 110.266 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.796 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.7 p -63.35 -59.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.998 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.796 ' H ' HG13 ' B' ' 80' ' ' VAL . 49.1 tp10 -58.23 -39.65 79.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.862 . . . . 0.0 109.625 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 85.5 t80 -69.43 -43.66 72.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . 0.506 ' OG ' ' CD2' ' B' ' 79' ' ' HIS . 50.9 m -59.14 -36.54 75.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.027 -1.046 . . . . 0.0 110.147 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.21 -52.98 63.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.65 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -69.99 -41.93 73.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' B' ' 85' ' ' ALA . 11.8 t80 -42.89 -30.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.545 ' O ' ' N ' ' B' ' 89' ' ' VAL . 9.4 m -83.3 -60.79 2.03 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.65 -24.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.702 -0.624 . . . . 0.0 110.06 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.0 m -105.8 12.04 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.78 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 48.0 mt -124.63 158.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.711 -1.243 . . . . 0.0 110.423 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.509 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 57.1 t0 -100.06 -34.53 10.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.445 ' N ' HG22 ' B' ' 90' ' ' ILE . 38.5 pttt -148.76 147.67 29.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.81 131.48 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.583 -1.323 . . . . 0.0 109.764 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.408 HG22 ' O ' ' B' ' 11' ' ' VAL . 2.3 m -136.93 139.51 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -139.68 135.05 32.82 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.276 -1.515 . . . . 0.0 111.773 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.885 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -117.8 124.05 47.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.7 t0 -125.64 131.56 52.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.037 -1.04 . . . . 0.0 108.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 45' ' ' ASP . 44.7 t80 -161.41 138.68 6.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.025 -1.047 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -44.69 120.35 2.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.299 2.0 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.86 143.92 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.05 125.78 25.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 109.6 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.03 73.37 9.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.039 -1.038 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.8 HG23 ' O ' ' B' ' 103' ' ' VAL . 18.2 m -149.95 98.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.219 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.635 ' C ' ' H ' ' B' ' 106' ' ' SER . 41.1 mmtm -134.52 -113.3 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.272 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.97 -13.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 108.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.635 ' H ' ' C ' ' B' ' 104' ' ' LYS . 31.1 t -53.03 139.75 27.17 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.219 -0.925 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -116.06 1.11 13.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.141 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 m -175.34 -126.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.24 173.14 31.2 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.709 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -135.78 136.36 40.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.289 -1.124 . . . . 0.0 108.005 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' B' ' 44' ' ' GLU . 20.7 ttpt -114.61 142.63 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.0 112.844 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -130.59 129.21 42.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -137.24 145.98 44.25 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.71 -1.244 . . . . 0.0 109.442 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.1 p -131.18 136.58 57.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.64 -0.663 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.53 131.14 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.46 ' CG1' HD12 ' A' ' 93' ' ' ILE . 2.1 m -142.57 162.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 117.808 -1.557 . . . . 0.0 113.043 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 91' ' ' ASP . 13.9 tptp -127.55 155.32 43.99 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.527 ' HB2' ' H ' ' A' ' 18' ' ' THR . 11.5 p90 -108.18 149.54 28.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.842 -1.162 . . . . 0.0 111.638 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -127.02 -19.28 4.43 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -90.68 -56.76 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 10.1 t0 153.51 58.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.527 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 71.9 m -46.53 106.92 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.173 0.987 . . . . 0.0 112.795 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.567 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.39 89.13 1.6 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.8 m -61.2 -39.19 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.752 . . . . 0.0 110.467 -176.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 20' ' ' VAL . 89.3 m-20 -61.58 -45.4 94.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.554 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 21.8 mp0 -73.97 -37.82 64.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.528 HD11 HG21 ' A' ' 89' ' ' VAL . 1.9 mm -66.79 -48.88 78.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.1 tm? -58.22 -41.34 83.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.61 -25.71 68.35 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.697 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -65.37 -55.48 20.73 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 27' ' ' LEU . 7.0 tt -47.5 -35.75 9.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.514 -0.992 . . . . 0.0 108.826 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -53.52 -42.94 67.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -59.97 -42.32 93.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -52.7 -46.29 67.25 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 32' ' ' SER . 38.7 t -51.97 -23.95 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.248 -0.908 . . . . 0.0 108.843 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 44.3 t -44.34 -37.26 3.21 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.552 HE21 ' CG ' ' A' ' 76' ' ' HIS . 8.6 mm100 -79.87 -4.02 50.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.792 . . . . 0.0 111.457 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 34' ' ' ILE . 6.5 mm -88.42 23.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.107 -1.62 . . . . 0.0 110.652 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.38 -16.8 16.18 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.598 ' O ' ' C ' ' A' ' 37' ' ' VAL . 43.7 p -68.27 -2.65 8.68 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.937 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 36' ' ' THR . 31.2 m 30.32 41.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.049 -1.032 . . . . 0.0 109.185 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' THR . 4.2 mtmm -122.46 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 40' ' ' PHE . 28.8 t -72.74 -176.07 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' LYS . 82.3 m-85 -153.0 167.51 28.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.629 -1.294 . . . . 0.0 111.925 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.482 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 80.6 mt-10 -159.42 127.61 5.0 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.398 0.618 . . . . 0.0 110.193 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -129.54 171.36 12.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.15 24.46 Favored Glycine 0 N--CA 1.499 2.874 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.845 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.539 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 63.9 mt-10 -151.24 147.02 26.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -1.096 . . . . 0.0 109.391 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.6 t0 -130.85 157.58 42.49 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -61.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.405 -1.434 . . . . 0.0 109.813 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.8 mt-10 -126.69 40.62 3.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.683 -0.636 . . . . 0.0 109.333 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 49' ' ' HIS . 5.3 t -147.99 76.05 1.36 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.978 . . . . 0.0 110.219 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 48' ' ' SER . 1.4 t-80 56.83 114.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.767 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 57.2 t0 -45.13 -34.87 2.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.0 110.783 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.0 mmm -75.74 -34.04 60.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' B' ' 95' ' ' LEU . 63.3 mt -89.7 -18.5 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.706 -1.246 . . . . 0.0 109.291 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' GLY . 18.0 ptt180 -101.8 7.94 41.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.244 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 53' ' ' ARG . 68.3 mm-40 38.68 27.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.789 -1.195 . . . . 0.0 110.138 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 53.37 2.71 0.12 Allowed Glycine 0 N--CA 1.499 2.836 0 O-C-N 121.416 -0.803 . . . . 0.0 112.85 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 20.4 p90 -47.82 132.07 14.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.206 -1.761 . . . . 0.0 109.936 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 98.6 m -58.18 -55.05 40.02 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.928 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.637 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 17.0 t60 -167.85 153.89 7.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.926 -1.109 . . . . 0.0 110.188 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.559 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.62 162.15 35.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.206 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 57.8 m-85 -129.2 126.17 38.58 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.493 -0.755 . . . . 0.0 109.062 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -104.57 102.91 12.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.5 mtt -102.42 120.73 41.0 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.177 -0.952 . . . . 0.0 110.816 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 m -112.02 133.66 54.05 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -119.46 121.04 38.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.689 -1.257 . . . . 0.0 110.084 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 66' ' ' ASN . 0.6 OUTLIER -47.88 -31.55 5.22 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.587 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 18.2 t-20 -157.34 162.4 39.1 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.9 -24.26 64.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 111.465 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.24 -38.39 68.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 0.0 110.573 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.525 ' O ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.63 -33.59 84.93 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.881 ' O ' HG23 ' A' ' 74' ' ' THR . 77.7 t80 -66.56 -46.98 74.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.548 -0.972 . . . . 0.0 110.489 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.93 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.427 -1.421 . . . . 0.0 108.651 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -60.64 -34.85 74.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 111.147 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 70' ' ' TYR . 41.8 p -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.712 -1.243 . . . . 0.0 110.295 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -65.38 -24.15 67.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.18 -0.95 . . . . 0.0 110.986 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.636 ' C ' ' H ' ' A' ' 78' ' ' LEU . 57.5 m80 -79.86 124.58 83.21 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.81 -1.181 . . . . 0.0 109.603 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.59 2.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.636 ' H ' ' C ' ' A' ' 76' ' ' HIS . 6.7 tp -76.37 -34.41 58.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.307 -0.871 . . . . 0.0 111.24 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 58.0 t-80 -82.66 -33.44 27.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 0.0 110.327 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.93 -60.25 2.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.79 -42.97 65.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 17.6 m-85 -72.17 -34.14 68.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.754 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 67.0 m -60.87 -43.04 98.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 110.13 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -41.96 97.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.978 -1.076 . . . . 0.0 108.673 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.666 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -68.4 -43.08 78.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.933 ' O ' HD13 ' A' ' 90' ' ' ILE . 2.7 m-85 -44.8 -30.25 0.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.1 p -82.26 -62.2 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.578 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -38.64 -28.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.654 -0.654 . . . . 0.0 110.052 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 85' ' ' ALA . 23.3 m -106.35 14.58 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 110.767 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.933 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -124.81 160.2 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.672 -1.268 . . . . 0.0 110.467 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.551 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 58.7 t0 -105.53 -35.95 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -145.95 145.29 30.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' A' ' 12' ' ' VAL . 3.0 tp -126.11 124.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.672 -1.267 . . . . 0.0 109.744 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t -127.24 130.07 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -130.98 127.22 37.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.325 -1.485 . . . . 0.0 111.759 -178.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -118.8 122.46 42.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.653 -0.654 . . . . 0.0 109.358 177.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASP . 23.1 p-10 -130.2 138.94 50.84 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.11 -0.994 . . . . 0.0 108.864 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 32.3 t80 -159.43 134.71 5.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.075 -1.015 . . . . 0.0 110.52 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 94.9 Cg_exo -42.46 125.57 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.318 2.012 . . . . 0.0 112.19 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.6 t -89.99 116.05 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.29 82.81 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.368 -0.832 . . . . 0.0 109.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -74.37 72.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 102' ' ' ALA . 5.3 m -161.91 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 25.9 mmtp -92.98 141.57 28.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.1 p -67.65 -25.3 65.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 108.958 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 106' ' ' SER . 5.9 p 61.85 50.88 4.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 100' ' ' VAL . . . -95.39 172.96 30.83 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.368 -1.396 . . . . 0.0 109.703 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -135.52 136.43 41.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.283 -1.128 . . . . 0.0 108.07 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 44' ' ' GLU . 20.7 ttpt -114.72 142.61 46.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.075 . . . . 0.0 112.809 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -130.5 129.29 42.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.1 tt -137.29 145.94 44.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.821 -1.175 . . . . 0.0 109.439 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.409 HG13 ' O ' ' B' ' 10' ' ' VAL . 11.0 p -131.2 136.66 57.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.467 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.64 131.16 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.46 ' CG1' HD12 ' B' ' 93' ' ' ILE . 2.1 m -142.68 162.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.08 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -127.6 155.27 44.11 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.545 ' HB2' ' H ' ' B' ' 18' ' ' THR . 11.5 p90 -108.2 149.48 28.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.827 -1.17 . . . . 0.0 111.59 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -127.03 -19.41 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.2 mt-10 -90.64 -56.65 3.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 9.7 t0 153.29 58.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.545 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 68.2 m -46.59 106.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.03 0.919 . . . . 0.0 112.89 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -73.42 89.35 1.63 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.8 m -61.56 -38.91 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 110.465 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.512 ' N ' HG23 ' B' ' 20' ' ' VAL . 90.6 m-20 -61.66 -45.4 94.2 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 110.512 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 21.6 mp0 -74.15 -37.59 63.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.536 HD11 HG21 ' B' ' 89' ' ' VAL . 1.9 mm -67.07 -48.94 77.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.858 ' C ' HD13 ' B' ' 24' ' ' LEU . 2.1 tm? -58.0 -41.65 83.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.4 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.703 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -65.34 -55.54 20.46 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.655 HD23 ' O ' ' B' ' 27' ' ' LEU . 7.0 tt -47.42 -35.73 8.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.541 -0.976 . . . . 0.0 108.811 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -53.49 -43.22 68.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.8 p30 -59.83 -42.23 93.06 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.61 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -52.84 -46.15 67.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' B' ' 32' ' ' SER . 38.7 t -52.0 -23.93 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.292 -0.88 . . . . 0.0 108.859 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 43.5 t -44.33 -37.39 3.28 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.558 HE21 ' CG ' ' B' ' 76' ' ' HIS . 8.6 mm100 -79.71 -4.29 51.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 111.466 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.716 HG22 ' O ' ' B' ' 34' ' ' ILE . 6.3 mm -88.24 23.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 119.947 -1.721 . . . . 0.0 110.61 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.44 -16.65 15.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' B' ' 37' ' ' VAL . 44.1 p -68.28 -2.82 9.04 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.932 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' B' ' 36' ' ' THR . 31.3 m 30.55 41.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' B' ' 40' ' ' PHE . 4.1 mtmm -122.4 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' B' ' 40' ' ' PHE . 28.9 t -72.62 -176.16 1.87 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' B' ' 38' ' ' LYS . 82.4 m-85 -152.99 167.47 29.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.542 -1.349 . . . . 0.0 111.991 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 81.0 mt-10 -159.36 127.44 4.98 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.298 0.57 . . . . 0.0 110.227 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.404 ' HE1' ' HA ' ' A' ' 102' ' ' ALA . 16.7 m-90 -129.46 171.49 12.5 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.2 162.13 24.49 Favored Glycine 0 N--CA 1.5 2.961 0 C-N-CA 118.689 -1.72 . . . . 0.0 110.768 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.544 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 63.1 mt-10 -151.3 146.84 26.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.294 -1.121 . . . . 0.0 109.392 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' B' ' 47' ' ' GLU . 63.3 t0 -130.71 157.47 42.71 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.529 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.07 80.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.378 -1.451 . . . . 0.0 109.825 -177.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -126.68 40.51 3.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.503 ' O ' ' O ' ' B' ' 49' ' ' HIS . 5.4 t -147.85 76.45 1.39 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.169 -0.957 . . . . 0.0 110.173 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.503 ' O ' ' O ' ' B' ' 48' ' ' SER . 1.4 t-80 56.59 114.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.195 -0.941 . . . . 0.0 109.676 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' NE ' ' B' ' 53' ' ' ARG . 57.9 t0 -45.14 -34.88 2.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 93.0 mmm -75.65 -33.9 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.7 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 95' ' ' LEU . 62.6 mt -89.69 -18.7 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.776 -1.202 . . . . 0.0 109.253 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' B' ' 55' ' ' GLY . 18.0 ptt180 -101.78 7.91 41.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.847 . . . . 0.0 111.26 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' B' ' 53' ' ' ARG . 68.8 mm-40 38.68 27.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.803 -1.186 . . . . 0.0 110.214 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 53.31 2.79 0.11 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.37 -0.831 . . . . 0.0 112.791 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 20.1 p90 -47.96 132.08 15.28 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.193 -1.769 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 99.7 m -57.98 -55.27 37.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.325 -0.859 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 17.3 t60 -167.77 153.9 7.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.887 -1.133 . . . . 0.0 110.193 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.543 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.62 162.07 35.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.477 -0.764 . . . . 0.0 109.287 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 57.8 m-85 -129.05 126.05 38.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.11 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -104.48 102.68 12.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 39.7 mtt -102.36 120.9 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 110.673 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 37.9 m -112.02 134.13 53.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' B' ' 64' ' ' PHE . 2.2 m-85 -119.81 121.37 38.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.741 -1.224 . . . . 0.0 109.999 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' B' ' 66' ' ' ASN . 0.6 OUTLIER -48.26 -31.47 5.96 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.581 ' H ' ' CD ' ' B' ' 65' ' ' GLU . 18.0 t-20 -157.32 162.25 39.13 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.7 -24.43 63.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.512 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -55.04 -38.67 68.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.597 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' B' ' 73' ' ' PHE . . . -66.22 -33.7 85.94 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.882 ' O ' HG23 ' B' ' 74' ' ' THR . 77.8 t80 -66.61 -47.04 73.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.566 -0.961 . . . . 0.0 110.495 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.73 -28.99 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.356 -1.465 . . . . 0.0 108.67 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.0 -60.86 2.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.338 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -60.57 -34.92 74.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.245 -0.909 . . . . 0.0 111.088 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.882 HG23 ' O ' ' B' ' 70' ' ' TYR . 42.0 p -73.86 -33.32 64.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.776 -1.203 . . . . 0.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -65.56 -24.31 67.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.0 111.053 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.635 ' C ' ' H ' ' B' ' 78' ' ' LEU . 57.6 m80 -79.58 124.62 83.68 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.829 -1.169 . . . . 0.0 109.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -46.77 2.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.609 2.206 . . . . 0.0 112.446 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.635 ' H ' ' C ' ' B' ' 76' ' ' HIS . 6.7 tp -76.42 -34.51 58.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.348 -0.845 . . . . 0.0 111.238 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.512 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 57.9 t-80 -82.47 -33.47 28.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.037 -1.039 . . . . 0.0 110.324 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.04 -60.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.92 -42.7 65.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.64 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 17.6 m-85 -72.29 -34.23 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . 0.512 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 65.3 m -60.86 -42.99 98.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.048 . . . . 0.0 110.098 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.08 97.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 108.661 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.681 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -68.39 -42.93 78.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.939 ' O ' HD13 ' B' ' 90' ' ' ILE . 2.7 m-85 -44.9 -30.22 0.96 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.1 p -82.26 -62.21 1.69 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.577 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -38.66 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.691 -0.63 . . . . 0.0 110.099 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.681 HG22 ' O ' ' B' ' 85' ' ' ALA . 23.1 m -106.22 14.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.207 -0.933 . . . . 0.0 110.829 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.939 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -124.63 160.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.7 -1.25 . . . . 0.0 110.467 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 58.3 t0 -105.46 -36.02 7.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -145.93 145.24 30.6 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' B' ' 12' ' ' VAL . 3.0 tp -126.15 124.1 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.571 -1.331 . . . . 0.0 109.798 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 14.4 t -127.29 130.2 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -131.06 126.9 37.08 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.244 -1.535 . . . . 0.0 111.809 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.554 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -118.55 122.72 43.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.443 ' OD2' ' OG ' ' A' ' 48' ' ' SER . 23.0 p-10 -130.43 138.85 50.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.175 -0.953 . . . . 0.0 108.853 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 32.2 t80 -159.42 134.6 5.75 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.048 -1.032 . . . . 0.0 110.541 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 96.5 Cg_exo -42.36 125.67 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.29 1.993 . . . . 0.0 112.244 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 5' ' ' GLY . 27.4 t -89.96 116.11 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.44 82.85 2.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . 0.675 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -74.27 71.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.602 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.675 HG13 ' O ' ' B' ' 102' ' ' ALA . 5.5 m -161.58 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.33 -0.856 . . . . 0.0 109.263 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -92.88 141.6 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 85.9 p -67.44 -25.58 65.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 108.944 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' B' ' 106' ' ' SER . 6.1 p 62.06 50.73 3.91 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.32 -0.863 . . . . 0.0 109.355 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.402 0.62 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 t -98.32 -12.24 21.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.141 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.7 m -127.79 -81.94 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.08 -168.91 16.91 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.664 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -114.43 130.76 56.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.241 -1.152 . . . . 0.0 108.09 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HZ3' ' HB3' ' B' ' 44' ' ' GLU . 21.9 ttpt -101.09 129.66 47.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.908 -1.12 . . . . 0.0 112.824 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.53 ' NE2' ' OD2' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -121.59 119.86 33.13 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 173.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 96' ' ' LEU . 6.6 tt -132.51 141.57 48.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.679 -1.263 . . . . 0.0 109.48 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 10' ' ' VAL . 9.5 p -129.35 136.11 60.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.614 -0.679 . . . . 0.0 109.523 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.27 131.0 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.843 HG12 HD12 ' A' ' 93' ' ' ILE . 35.8 m -139.32 150.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.816 -1.554 . . . . 0.0 113.095 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -127.83 154.74 45.1 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CD2' HG21 ' A' ' 57' ' ' THR . 16.2 p90 -113.04 156.8 22.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.814 -1.178 . . . . 0.0 111.615 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.36 -18.62 3.58 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.8 mt-10 -91.81 -53.49 4.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.1 t0 149.12 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -53.98 111.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.059 0.933 . . . . 0.0 112.814 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.587 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -74.07 86.36 1.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 21' ' ' ASP . 33.2 m -61.55 -42.59 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.553 -0.717 . . . . 0.0 110.547 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' N ' HG23 ' A' ' 20' ' ' VAL . 87.3 m-20 -63.45 -45.16 92.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.539 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -68.79 -34.01 74.82 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -67.94 -42.02 85.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.5 tp -58.95 -39.36 81.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -61.15 -35.48 77.21 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.656 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.44 -53.23 40.54 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -44.09 -41.44 5.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.517 -0.99 . . . . 0.0 108.821 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -51.98 -39.12 58.87 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -63.59 -44.49 93.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.649 HD22 ' CD2' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -47.15 -48.42 23.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 32' ' ' SER . 86.3 t -55.47 -24.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 0.0 108.873 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 32.2 t -43.44 -43.4 5.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.05 -10.06 48.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 111.433 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.726 HG22 ' O ' ' A' ' 34' ' ' ILE . 64.5 mt -92.5 29.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.024 -1.672 . . . . 0.0 110.626 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.91 -8.08 2.04 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.579 ' H ' ' C ' ' A' ' 34' ' ' ILE . 68.2 p -67.5 -10.24 49.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.939 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.55 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 35.3 34.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 109.219 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.3 mttt -118.17 43.94 2.33 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 63' ' ' THR . 14.2 t -176.22 177.59 1.52 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 0.0 111.914 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 64.2 mt-10 -154.33 124.07 6.66 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.366 0.603 . . . . 0.0 110.207 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.532 ' CE2' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -127.39 169.17 13.89 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.45 138.44 6.42 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.794 -1.67 . . . . 0.0 110.838 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.532 ' OE2' ' CE2' ' A' ' 42' ' ' TRP . 4.4 mp0 -124.92 172.63 9.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.209 -1.171 . . . . 0.0 109.323 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 57' ' ' THR . 57.0 t0 -167.58 94.61 0.43 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HZ1' ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.15 170.89 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.471 -1.393 . . . . 0.0 109.78 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 48' ' ' SER . 2.4 mt-10 -172.77 90.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER 163.14 147.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 0.0 110.138 -179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 48' ' ' SER . 57.5 m170 57.95 113.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.204 -0.935 . . . . 0.0 109.7 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 51' ' ' MET . 29.0 p-10 -52.53 -43.41 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.313 -0.867 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 23.2 ttt -62.56 -35.03 78.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 17.2 mt -89.08 -20.03 24.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.763 -1.211 . . . . 0.0 109.305 177.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.97 ' O ' ' N ' ' A' ' 55' ' ' GLY . 34.0 ttt-85 -83.83 42.54 0.86 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.384 -0.823 . . . . 0.0 111.217 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.561 HE21 HG11 ' B' ' 94' ' ' VAL . 34.6 tt0 -31.41 -12.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.739 -1.225 . . . . 0.0 110.195 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.97 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 105.66 -35.79 4.83 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.385 -0.822 . . . . 0.0 112.93 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -55.39 102.82 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.294 -1.709 . . . . 0.0 109.956 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.636 HG21 ' CD2' ' A' ' 14' ' ' PHE . 49.1 p -61.99 -34.48 76.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.952 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.596 ' ND1' ' OG1' ' A' ' 57' ' ' THR . 34.7 p-80 -171.74 149.9 2.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.853 -1.154 . . . . 0.0 110.182 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.35 170.87 14.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.434 -0.791 . . . . 0.0 109.26 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -138.64 134.96 34.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.494 ' HB2' ' HE1' ' A' ' 42' ' ' TRP . 10.2 t -111.22 106.24 15.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' HIS . 67.6 mtt -95.67 119.98 35.12 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.826 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.467 ' O ' ' OG ' ' A' ' 39' ' ' SER . 32.0 m -116.59 141.78 47.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -121.29 152.46 38.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.742 -1.224 . . . . 0.0 110.073 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -86.27 -23.92 26.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.519 ' ND2' ' H ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -162.47 165.86 25.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -69.15 -24.73 64.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 0.0 111.446 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.1 -40.61 98.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.825 -1.172 . . . . 0.0 110.602 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . -72.1 -33.44 62.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.655 ' O ' HG22 ' A' ' 74' ' ' THR . 25.1 t80 -66.32 -43.0 87.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.589 -0.948 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.1 m -70.84 -28.89 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.449 -1.407 . . . . 0.0 108.658 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 69' ' ' GLY . 1.1 m-85 -54.72 -35.42 63.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -0.897 . . . . 0.0 111.084 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.9 t -85.57 -28.93 24.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.739 -1.226 . . . . 0.0 110.327 -177.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 73.6 m -66.21 -34.64 78.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.997 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -61.31 151.53 76.18 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.76 -1.213 . . . . 0.0 109.61 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.07 -7.75 20.74 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.652 2.235 . . . . 0.0 112.407 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 30' ' ' LEU . 7.3 tt -76.97 -27.92 54.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.395 -0.816 . . . . 0.0 111.218 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -81.73 -35.53 29.62 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 81' ' ' GLU . 6.7 p -70.2 -56.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.006 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.726 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.96 84.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.619 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -59.17 -42.78 91.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.804 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.7 p -65.73 -30.63 71.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 110.106 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.85 -55.19 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 108.687 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.468 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -66.62 -39.35 88.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.428 ' O ' HG12 ' A' ' 90' ' ' ILE . 23.8 t80 -46.47 -25.42 0.67 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.4 m -83.56 -63.62 1.32 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.01 -33.39 0.31 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.719 -0.613 . . . . 0.0 110.067 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 85' ' ' ALA . 6.8 m -92.66 14.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -0.897 . . . . 0.0 110.815 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.636 HD12 ' HB ' ' A' ' 12' ' ' VAL . 26.5 mm -132.35 163.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.609 -1.307 . . . . 0.0 110.412 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 90' ' ' ILE . 34.7 t0 -113.9 -33.73 5.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -132.87 129.54 38.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.843 HD12 HG12 ' A' ' 12' ' ' VAL . 7.0 tp -128.79 130.44 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.579 -1.326 . . . . 0.0 109.762 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.591 HG11 HE21 ' B' ' 54' ' ' GLN . 14.4 p -146.95 148.07 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -135.85 129.86 33.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.276 -1.515 . . . . 0.0 111.804 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.901 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -112.73 119.57 38.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.669 -0.644 . . . . 0.0 109.346 178.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.53 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 54.1 t0 -128.33 135.76 50.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.052 -1.03 . . . . 0.0 108.847 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.511 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 36.3 t80 -166.76 140.64 3.24 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 110.54 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.03 106.99 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.266 1.978 . . . . 0.0 112.249 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 100' ' ' VAL . 1.9 p -88.49 128.8 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 109.952 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.76 94.71 4.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.654 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.45 150.59 25.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.091 -1.006 . . . . 0.0 109.562 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 -21.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 109.133 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.696 ' C ' ' H ' ' A' ' 106' ' ' SER . 18.0 mmtp 54.03 -141.74 0.84 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.366 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.97 -12.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 108.961 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.696 ' H ' ' C ' ' A' ' 104' ' ' LYS . 83.7 p -52.46 152.64 3.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.94 -168.98 16.89 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.684 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.5 130.52 56.75 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -1.149 . . . . 0.0 108.014 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 22.1 ttpt -100.91 129.71 46.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.975 -1.078 . . . . 0.0 112.838 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' B' ' 97' ' ' ASP . 0.3 OUTLIER -121.52 119.56 32.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.535 HD22 HD13 ' B' ' 96' ' ' LEU . 6.5 tt -132.07 141.67 49.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.713 -1.242 . . . . 0.0 109.56 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.412 ' O ' HG13 ' B' ' 10' ' ' VAL . 9.7 p -129.25 136.34 59.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.485 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.4 131.02 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.848 HG12 HD12 ' B' ' 93' ' ' ILE . 35.9 m -139.22 150.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 117.706 -1.597 . . . . 0.0 113.046 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -127.91 154.98 44.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD2' HG21 ' B' ' 57' ' ' THR . 15.4 p90 -113.34 156.68 22.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.815 -1.178 . . . . 0.0 111.596 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.27 -18.8 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.6 mt-10 -91.73 -53.65 4.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.4 t0 149.2 65.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.8 m -54.14 112.02 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.114 0.959 . . . . 0.0 112.825 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.575 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.11 86.47 1.87 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.577 HG23 ' N ' ' B' ' 21' ' ' ASP . 33.0 m -61.86 -42.42 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.622 -0.674 . . . . 0.0 110.477 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.577 ' N ' HG23 ' B' ' 20' ' ' VAL . 87.5 m-20 -63.5 -45.03 92.57 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 110.535 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -68.87 -34.43 75.43 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -67.49 -42.11 86.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' B' ' 20' ' ' VAL . 16.5 tp -58.89 -39.51 81.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -60.87 -35.67 77.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.66 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -63.29 -53.32 40.39 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 26' ' ' GLY . 5.9 tt -44.11 -41.28 5.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.989 . . . . 0.0 108.846 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -51.99 -39.07 58.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 0.7 OUTLIER -63.82 -44.17 94.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.64 HD22 ' CD2' ' B' ' 78' ' ' LEU . 0.5 OUTLIER -47.59 -47.91 28.35 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 32' ' ' SER . 84.4 t -55.84 -24.47 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 32.5 t -43.65 -43.38 5.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.07 -9.83 49.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.436 -0.79 . . . . 0.0 111.479 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.733 HG22 ' O ' ' B' ' 34' ' ' ILE . 62.8 mt -92.59 28.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.003 -1.685 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.84 -8.01 1.95 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' C ' ' B' ' 37' ' ' VAL . 66.1 p -67.61 -10.2 49.89 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.945 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.58 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.6 m 35.27 35.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.032 -1.043 . . . . 0.0 109.181 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 36' ' ' THR . 66.4 mttt -118.22 43.99 2.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' B' ' 63' ' ' THR . 14.4 t -176.27 177.7 1.48 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.02 156.0 42.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.541 -1.349 . . . . 0.0 112.007 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.452 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 63.8 mt-10 -154.09 124.23 6.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.354 0.597 . . . . 0.0 110.259 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.54 ' CE2' ' OE2' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -127.51 168.92 14.27 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.26 138.34 6.4 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.75 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.54 ' OE2' ' CE2' ' B' ' 42' ' ' TRP . 4.4 mp0 -124.71 173.16 8.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.233 -1.157 . . . . 0.0 109.434 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' B' ' 57' ' ' THR . 57.1 t0 -168.12 94.55 0.39 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HZ2' ' HA ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -89.0 170.73 10.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.446 -1.409 . . . . 0.0 109.825 179.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' B' ' 48' ' ' SER . 2.3 mt-10 -172.58 90.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER 163.46 148.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' B' ' 48' ' ' SER . 57.9 m170 57.7 113.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 109.693 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 28.7 p-10 -52.49 -43.53 65.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.781 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 23.3 ttt -62.34 -35.17 78.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 110.723 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' NZ ' ' B' ' 46' ' ' LYS . 17.0 mt -89.04 -19.91 25.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.336 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.953 ' O ' ' N ' ' B' ' 55' ' ' GLY . 34.1 ttt-85 -83.99 42.65 0.88 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -0.854 . . . . 0.0 111.194 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.591 HE21 HG11 ' A' ' 94' ' ' VAL . 34.8 tt0 -31.53 -12.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.862 -1.149 . . . . 0.0 110.274 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.953 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 105.88 -36.11 4.62 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.454 -0.779 . . . . 0.0 112.857 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.809 ' CG ' ' O ' ' B' ' 56' ' ' PHE . 0.7 OUTLIER -55.04 102.8 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.302 -1.705 . . . . 0.0 109.987 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.639 HG21 ' CD2' ' B' ' 14' ' ' PHE . 49.2 p -61.78 -34.81 76.55 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.307 -0.871 . . . . 0.0 111.015 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.575 ' HE2' HD11 ' B' ' 90' ' ' ILE . 33.9 p-80 -171.35 150.3 2.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 110.148 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.65 170.8 15.16 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.262 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -138.59 134.9 34.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.439 -0.788 . . . . 0.0 109.128 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.498 ' HB2' ' HE1' ' B' ' 42' ' ' TRP . 10.0 t -111.16 106.24 15.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . 0.475 ' N ' ' O ' ' B' ' 8' ' ' HIS . 67.7 mtt -95.57 120.33 35.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.149 -0.97 . . . . 0.0 110.833 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.507 ' O ' ' OG ' ' B' ' 39' ' ' SER . 32.5 m -116.96 141.72 47.87 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -121.27 152.1 39.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.695 -1.253 . . . . 0.0 110.047 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -85.94 -23.76 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' B' ' 69' ' ' GLY . 0.0 OUTLIER -162.65 166.08 24.98 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -69.35 -24.66 63.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 111.453 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.44 -40.29 96.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.865 -1.147 . . . . 0.0 110.604 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.553 ' O ' ' CE2' ' B' ' 73' ' ' PHE . . . -71.99 -33.78 62.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.648 ' O ' HG22 ' B' ' 74' ' ' THR . 25.2 t80 -66.15 -43.05 88.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.512 -0.993 . . . . 0.0 110.426 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.3 m -70.83 -28.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.412 -1.43 . . . . 0.0 108.626 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.99 2.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.358 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.553 ' CE2' ' O ' ' B' ' 69' ' ' GLY . 1.1 m-85 -54.6 -35.56 63.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.287 -0.883 . . . . 0.0 111.089 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.648 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.9 t -85.49 -29.0 24.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.822 -1.174 . . . . 0.0 110.347 -177.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 73.8 m -66.11 -34.78 78.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.982 . . . . 0.0 111.056 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -61.11 151.81 73.91 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.24 -7.86 21.23 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.611 2.207 . . . . 0.0 112.499 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.64 ' CD2' HD22 ' B' ' 30' ' ' LEU . 7.3 tt -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -0.797 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -81.37 -35.65 30.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 110.281 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.726 HG13 ' H ' ' B' ' 81' ' ' GLU . 6.9 p -70.26 -56.67 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.726 ' H ' HG13 ' B' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.89 84.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.15 -42.77 91.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.849 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 88.0 p -65.82 -30.55 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.991 . . . . 0.0 110.069 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.85 36.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 0.0 108.705 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.479 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -66.96 -39.24 87.2 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' B' ' 85' ' ' ALA . 24.0 t80 -46.73 -25.05 0.66 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.427 ' N ' ' C ' ' B' ' 85' ' ' ALA . 5.7 m -83.91 -63.48 1.34 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.07 -33.18 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.771 -0.581 . . . . 0.0 110.086 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 85' ' ' ALA . 7.0 m -92.89 14.83 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.173 -0.954 . . . . 0.0 110.811 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.625 HG22 ' N ' ' B' ' 91' ' ' ASP . 26.2 mm -132.43 164.16 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.651 -1.281 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.625 ' N ' HG22 ' B' ' 90' ' ' ILE . 34.8 t0 -114.07 -33.71 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -132.94 129.58 38.47 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.848 HD12 HG12 ' B' ' 12' ' ' VAL . 7.1 tp -128.83 130.56 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.516 -1.365 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.561 HG11 HE21 ' A' ' 54' ' ' GLN . 14.4 p -147.06 147.94 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.501 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -135.86 130.03 33.27 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.237 -1.54 . . . . 0.0 111.759 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.898 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.1 OUTLIER -112.85 119.42 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.325 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' B' ' 8' ' ' HIS . 54.7 t0 -128.24 135.7 50.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.107 -0.996 . . . . 0.0 108.918 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.492 ' N ' ' OD1' ' B' ' 97' ' ' ASP . 36.1 t80 -166.7 140.65 3.28 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.111 -0.993 . . . . 0.0 110.49 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.95 106.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.273 1.982 . . . . 0.0 112.264 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.441 ' H ' HG12 ' B' ' 100' ' ' VAL . 1.9 p -88.38 128.67 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.121 -0.987 . . . . 0.0 110.079 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.65 94.74 4.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.511 -0.743 . . . . 0.0 109.554 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 0.0 109.62 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.52 -21.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.21 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.703 ' C ' ' H ' ' B' ' 106' ' ' SER . 18.1 mmtp 54.45 -141.87 0.83 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.28 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.89 -12.7 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.143 -0.973 . . . . 0.0 108.916 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.703 ' H ' ' C ' ' B' ' 104' ' ' LYS . 83.5 p -52.49 152.44 3.57 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.921 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.681 ' O ' HG22 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.681 HG22 ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 74.77 -2.81 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.116 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.3 m -174.65 -129.13 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.94 168.59 26.19 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.653 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.91 128.14 47.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -1.15 . . . . 0.0 108.028 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 4.3 ttpm? -106.5 134.66 49.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 112.885 -177.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -126.17 124.48 40.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -131.76 142.03 49.65 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.678 -1.264 . . . . 0.0 109.526 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.08 138.21 53.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.482 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.83 131.69 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.19 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 117.88 -1.528 . . . . 0.0 113.071 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -127.49 147.74 50.31 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.798 ' CB ' ' H ' ' A' ' 18' ' ' THR . 17.7 t80 -111.31 158.88 18.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.0 111.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.694 ' HG3' ' H ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.42 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.694 ' H ' ' HG3' ' A' ' 15' ' ' LYS . 83.6 mt-10 -85.95 -49.99 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.457 ' H ' ' HD2' ' A' ' 14' ' ' PHE . 6.5 t0 160.31 98.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' A' ' 14' ' ' PHE . 3.4 m -51.43 153.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.121 0.963 . . . . 0.0 112.84 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.561 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -77.84 87.69 4.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.32 -33.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.507 -0.746 . . . . 0.0 110.517 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.74 -42.02 86.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.443 -0.785 . . . . 0.0 110.508 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 70.7 mm-40 -67.64 -30.31 69.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 89' ' ' VAL . 1.3 mm -70.9 -37.46 68.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -54.12 -36.87 63.71 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -35.46 80.37 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.95 -54.58 17.18 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -47.96 41.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.5 -1.0 . . . . 0.0 108.883 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.08 -43.61 70.48 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.647 ' ND2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -65.0 -47.52 77.23 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -49.27 -44.64 44.0 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.7 t -55.62 -25.02 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.28 -0.887 . . . . 0.0 108.866 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 51.0 m -43.27 -39.09 2.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.425 ' OE1' ' CG ' ' A' ' 76' ' ' HIS . 99.5 mm-40 -67.55 0.89 2.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 111.425 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 34' ' ' ILE . 72.2 mt -108.17 26.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.074 -1.641 . . . . 0.0 110.607 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -60.42 -8.42 2.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.609 ' O ' ' C ' ' A' ' 37' ' ' VAL . 29.4 p -84.21 0.23 49.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.964 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.609 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.3 m 30.26 38.99 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.29 3.59 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 t -174.07 178.27 2.16 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 91.9 m-85 -144.53 154.49 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 111.993 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.499 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 81.0 mt-10 -158.01 127.46 5.86 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.342 0.591 . . . . 0.0 110.267 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -133.43 172.59 12.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' B' ' 98' ' ' PHE . . . -131.89 163.87 23.75 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.816 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.668 ' N ' ' CE1' ' A' ' 58' ' ' HIS . 18.9 mt-10 -149.49 142.54 24.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.247 -1.149 . . . . 0.0 109.34 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.587 ' CG ' ' HD1' ' A' ' 58' ' ' HIS . 42.2 m-20 -125.63 155.79 40.22 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 81.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.395 -1.44 . . . . 0.0 109.771 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.7 mt-10 -103.04 39.33 1.57 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 97' ' ' ASP . 11.7 m -142.75 168.33 19.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 0.0 110.129 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ARG . 78.0 m80 -48.37 140.79 7.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.134 -0.979 . . . . 0.0 109.757 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 78.7 m-20 -44.48 -46.4 9.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.759 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 110.732 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 43.5 mt -102.0 -19.12 15.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.713 -1.242 . . . . 0.0 109.241 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.832 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -72.25 -5.34 35.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.905 . . . . 0.0 111.217 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.62 -8.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.827 -1.17 . . . . 0.0 110.149 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.832 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 72.77 -13.16 3.23 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.386 -0.821 . . . . 0.0 112.844 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 3.5 p90 -59.54 129.9 44.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.308 -1.701 . . . . 0.0 109.985 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.9 p -54.07 -43.04 69.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.88 . . . . 0.0 111.008 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.668 ' CE1' ' N ' ' A' ' 44' ' ' GLU . 19.0 t60 -173.36 159.4 3.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.143 . . . . 0.0 110.147 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.649 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.07 167.9 21.0 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 0.0 109.208 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 81.0 m-85 -132.94 129.48 38.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.114 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.2 m -106.6 100.72 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.9 mtm -104.79 129.14 53.1 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.19 -0.944 . . . . 0.0 110.745 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -126.48 143.44 51.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 65' ' ' GLU . 93.1 m-85 -124.5 130.13 51.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.679 -1.263 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' PHE . 84.6 tt0 -47.93 -33.82 8.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -161.54 166.37 27.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -55.27 -22.47 18.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 111.459 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD2' ' NZ ' ' A' ' 38' ' ' LYS . 22.9 t70 -53.63 -40.49 65.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.791 -1.193 . . . . 0.0 110.651 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.01 -36.16 64.55 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.647 ' O ' HG22 ' A' ' 74' ' ' THR . 56.6 t80 -64.39 -44.16 92.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.631 -0.923 . . . . 0.0 110.472 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.77 -28.9 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.331 -1.481 . . . . 0.0 108.68 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.86 2.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -59.12 -46.7 87.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 111.08 -177.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 70' ' ' TYR . 11.6 t -69.84 -36.13 75.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.747 -1.22 . . . . 0.0 110.307 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.413 ' N ' HG23 ' A' ' 74' ' ' THR . 78.0 p -65.43 -27.21 68.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -0.98 . . . . 0.0 110.941 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 55.3 m80 -72.17 151.29 92.41 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.836 -1.165 . . . . 0.0 109.562 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.98 -5.35 16.13 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 5.6 tp -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 111.198 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 83' ' ' SER . 11.1 t-160 -82.61 -40.75 20.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.074 -1.016 . . . . 0.0 110.241 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.35 -61.72 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.998 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -53.16 -38.07 62.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.612 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.647 ' CZ ' ' ND2' ' A' ' 29' ' ' ASN . 8.1 m-85 -74.37 -33.62 63.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.838 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' HIS . 21.2 t -61.23 -44.09 97.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 110.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.35 96.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.99 -1.069 . . . . 0.0 108.667 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.19 -43.42 78.14 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.22 -31.64 0.64 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 89' ' ' VAL . 22.3 m -80.43 -62.25 1.73 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.97 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.3 m -113.95 7.26 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 91' ' ' ASP . 60.9 mt -123.5 157.72 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.656 -1.277 . . . . 0.0 110.452 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.483 ' N ' HG22 ' A' ' 90' ' ' ILE . 22.5 t70 -108.37 -30.28 8.4 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -145.59 142.98 29.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' ILE . 4.0 tp -125.39 123.51 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.635 -1.29 . . . . 0.0 109.852 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 t -126.05 131.59 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -138.3 133.24 32.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.207 -1.558 . . . . 0.0 111.793 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -121.16 126.58 50.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.307 178.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 64.8 t0 -124.69 130.43 52.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.085 -1.009 . . . . 0.0 108.952 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.648 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -157.65 124.23 2.55 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.035 -1.041 . . . . 0.0 110.501 -179.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.648 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 79.8 Cg_exo -45.01 133.68 11.03 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.287 1.991 . . . . 0.0 112.235 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 4' ' ' SER . 37.2 t -110.35 133.3 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 110.001 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -110.9 94.05 4.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.463 -0.773 . . . . 0.0 109.634 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.27 69.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 109.516 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.7 m -151.45 110.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.134 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.652 ' C ' ' H ' ' A' ' 106' ' ' SER . 24.6 mmtp -125.41 1.46 7.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.44 -23.38 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.652 ' H ' ' C ' ' A' ' 104' ' ' LYS . 1.7 m 61.15 54.62 3.24 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.257 -0.902 . . . . 0.0 109.35 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.774 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' B' ' 100' ' ' VAL . 40.0 m . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.87 168.44 26.19 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.688 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.85 128.25 47.34 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.538 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 4.3 ttpm? -106.39 134.77 49.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.989 -1.07 . . . . 0.0 112.823 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -126.25 124.5 40.52 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.85 141.98 49.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.7 -1.25 . . . . 0.0 109.491 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 138.22 54.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.612 -0.68 . . . . 0.0 109.542 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.75 131.69 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.28 146.31 29.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 117.702 -1.599 . . . . 0.0 113.04 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -127.65 147.75 50.37 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.807 ' CB ' ' H ' ' B' ' 18' ' ' THR . 17.5 t80 -111.37 158.83 18.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.867 -1.146 . . . . 0.0 111.596 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.674 ' HG3' ' H ' ' B' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.674 ' H ' ' HG3' ' B' ' 15' ' ' LYS . 83.6 mt-10 -86.05 -49.95 7.41 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.466 ' H ' ' HD2' ' B' ' 14' ' ' PHE . 6.5 t0 160.35 98.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.807 ' H ' ' CB ' ' B' ' 14' ' ' PHE . 3.4 m -51.28 153.77 1.94 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.062 0.935 . . . . 0.0 112.909 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.561 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -78.01 87.6 4.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -64.24 -33.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.605 -0.684 . . . . 0.0 110.562 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 29.7 p-10 -66.71 -42.1 86.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.793 . . . . 0.0 110.56 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 70.5 mm-40 -67.64 -30.28 69.8 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.475 HD11 HG21 ' B' ' 89' ' ' VAL . 1.3 mm -70.78 -37.48 69.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -54.28 -36.64 63.86 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -35.54 80.66 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.02 -54.39 17.9 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.86 -47.7 42.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.633 -0.922 . . . . 0.0 108.855 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.44 -43.59 71.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.642 ' ND2' ' CZ ' ' B' ' 82' ' ' PHE . 0.2 OUTLIER -64.95 -47.5 77.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.6 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -49.25 -44.71 43.93 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' B' ' 32' ' ' SER . 77.4 t -55.51 -25.11 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.273 -0.892 . . . . 0.0 108.789 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 50.9 m -43.12 -39.25 2.72 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' B' ' 76' ' ' HIS . 99.5 mm-40 -67.37 0.88 2.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 111.536 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.766 HG22 ' O ' ' B' ' 34' ' ' ILE . 72.1 mt -108.18 26.64 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.043 -1.661 . . . . 0.0 110.581 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.8 p30 -60.47 -8.49 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.625 ' O ' ' C ' ' B' ' 37' ' ' VAL . 29.6 p -84.1 0.14 49.6 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.966 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.625 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.5 m 30.32 38.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.093 -1.004 . . . . 0.0 109.149 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.33 3.58 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -174.19 178.29 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 91.9 m-85 -144.59 154.39 42.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.555 -1.341 . . . . 0.0 112.002 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 81.7 mt-10 -158.01 127.57 5.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.441 0.639 . . . . 0.0 110.192 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -133.62 172.54 12.6 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 98' ' ' PHE . . . -131.93 163.8 23.78 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.725 -1.702 . . . . 0.0 110.854 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.684 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 18.4 mt-10 -149.4 142.48 24.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -1.158 . . . . 0.0 109.35 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.583 ' CG ' ' HD1' ' B' ' 58' ' ' HIS . 42.3 m-20 -125.53 155.76 40.11 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 81.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.354 -1.466 . . . . 0.0 109.743 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -103.11 39.14 1.61 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 11.9 m -142.82 168.21 20.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 110.164 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' B' ' 53' ' ' ARG . 78.0 m80 -48.26 140.78 7.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.686 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 78.1 m-20 -44.57 -46.27 9.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.773 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.4 ttt -61.76 -28.85 69.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.718 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 95' ' ' LEU . 43.3 mt -102.14 -18.98 15.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.814 ' CG ' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -72.36 -5.28 35.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 111.238 -177.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.82 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.827 -1.17 . . . . 0.0 110.204 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.814 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 73.04 -13.32 3.37 Favored Glycine 0 N--CA 1.498 2.82 0 O-C-N 121.433 -0.792 . . . . 0.0 112.83 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 3.4 p90 -59.44 129.9 44.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.328 -1.689 . . . . 0.0 109.908 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 28.8 p -53.99 -43.2 69.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 111.039 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.684 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 18.9 t60 -173.17 159.6 3.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.903 -1.123 . . . . 0.0 110.175 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.662 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.22 167.74 21.41 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.507 -0.746 . . . . 0.0 109.282 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.402 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 80.9 m-85 -132.84 129.55 38.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.443 -0.785 . . . . 0.0 109.104 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -106.55 100.95 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 56.7 mtm -105.13 129.15 53.6 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 50.4 m -126.53 143.52 51.18 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' B' ' 65' ' ' GLU . 93.3 m-85 -124.6 130.0 51.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 0.0 110.014 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 64' ' ' PHE . 84.4 tt0 -47.88 -33.67 7.84 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -161.71 166.41 26.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -55.39 -22.7 20.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 111.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.492 ' OD2' ' NZ ' ' B' ' 38' ' ' LYS . 22.6 t70 -53.23 -40.69 64.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.704 -1.248 . . . . 0.0 110.574 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.17 65.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.649 ' O ' HG22 ' B' ' 74' ' ' THR . 56.8 t80 -64.19 -44.43 91.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.921 . . . . 0.0 110.47 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.77 -28.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.331 -1.481 . . . . 0.0 108.704 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -60.94 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.309 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -58.76 -46.74 86.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 0.0 111.191 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 70' ' ' TYR . 11.6 t -69.9 -36.13 75.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.706 -1.246 . . . . 0.0 110.308 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.426 ' N ' HG23 ' B' ' 74' ' ' THR . 77.9 p -65.51 -27.08 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -0.993 . . . . 0.0 110.924 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.423 ' CG ' ' OE1' ' B' ' 33' ' ' GLN . 55.0 m80 -72.22 151.18 92.29 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.8 -1.187 . . . . 0.0 109.559 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.87 -5.12 15.52 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.632 2.221 . . . . 0.0 112.517 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' B' ' 82' ' ' PHE . 5.6 tp -73.22 -28.67 62.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.323 -0.861 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 83' ' ' SER . 11.0 t-160 -82.56 -40.69 20.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.031 -1.043 . . . . 0.0 110.226 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.45 -61.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.33 -38.02 62.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.642 ' CZ ' ' ND2' ' B' ' 29' ' ' ASN . 8.2 m-85 -74.39 -33.54 63.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 109.873 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . 0.438 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.1 t -61.32 -44.08 97.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.0 110.084 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.89 96.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.001 -1.062 . . . . 0.0 108.685 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.72 -43.13 76.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.45 -31.58 0.72 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.542 ' O ' ' N ' ' B' ' 89' ' ' VAL . 22.0 m -80.36 -62.2 1.75 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.18 -21.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.754 -0.591 . . . . 0.0 110.078 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.4 m -114.32 7.36 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.224 -0.922 . . . . 0.0 110.83 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 61.8 mt -123.5 157.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.659 -1.276 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 22.2 t70 -108.33 -30.45 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -145.63 142.97 29.56 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.472 ' O ' HG23 ' B' ' 93' ' ' ILE . 4.0 tp -125.38 123.51 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.535 -1.353 . . . . 0.0 109.753 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 t -125.99 131.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.609 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.3 OUTLIER -138.32 133.25 32.78 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.207 -1.558 . . . . 0.0 111.707 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.438 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.4 OUTLIER -121.07 126.7 50.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.695 -0.628 . . . . 0.0 109.308 178.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.1 t0 -124.8 130.34 52.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 108.943 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.658 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 0.1 OUTLIER -157.49 124.15 2.57 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.048 -1.033 . . . . 0.0 110.539 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . 0.658 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 79.7 Cg_exo -44.85 133.73 10.57 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.179 1.919 . . . . 0.0 112.274 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' B' ' 4' ' ' SER . 37.1 t -110.44 133.2 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -110.74 94.19 4.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.448 -0.783 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.37 69.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.018 . . . . 0.0 109.558 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.686 HG23 ' O ' ' B' ' 103' ' ' VAL . 21.7 m -151.44 110.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 0.0 109.246 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.637 ' C ' ' H ' ' B' ' 106' ' ' SER . 24.7 mmtp -125.45 1.39 7.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 109.381 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.48 -23.41 0.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.938 . . . . 0.0 108.94 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 104' ' ' LYS . 1.8 m 61.22 54.39 3.26 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.823 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.443 0.639 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER 73.09 -39.61 0.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.126 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.518 ' N ' HG22 ' A' ' 3' ' ' THR . 75.1 m -91.64 -132.13 0.12 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.02 177.13 20.82 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.332 -1.413 . . . . 0.0 109.655 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -114.17 131.77 56.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -107.03 137.63 44.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.908 -1.12 . . . . 0.0 112.827 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -129.95 129.13 43.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -134.33 145.04 48.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.766 -1.209 . . . . 0.0 109.498 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.3 p -126.04 133.55 68.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.436 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.28 128.89 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 57' ' ' THR . 11.5 m -139.0 161.85 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 117.779 -1.568 . . . . 0.0 113.053 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 18.3 tptm -125.2 152.22 44.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.455 ' N ' ' HG3' ' A' ' 13' ' ' LYS . 41.6 p90 -111.04 152.55 26.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.857 -1.152 . . . . 0.0 111.574 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -127.5 -24.71 3.28 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 63.2 tt0 -89.7 -53.61 4.44 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.4 t0 147.57 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 29.2 m -54.84 111.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.095 0.95 . . . . 0.0 112.889 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.698 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.07 86.41 5.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.5 m -57.82 -33.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.551 -0.718 . . . . 0.0 110.456 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -66.19 -37.57 85.93 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -70.8 -35.85 72.73 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.27 -40.82 89.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.22 -35.79 60.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HA ' ' HZ3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -56.94 -30.12 63.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -76.68 -44.93 14.13 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 tt -49.47 -56.34 10.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.568 -0.96 . . . . 0.0 108.835 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 8.0 pt-20 -51.49 -35.44 40.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 51.7 m-20 -67.2 -46.58 73.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 4.1 mm? -47.71 -51.43 21.97 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.6 t -48.91 -34.12 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 108.888 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.3 m -45.15 -50.24 11.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.79 -1.55 2.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.475 -0.766 . . . . 0.0 111.419 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 36' ' ' THR . 6.3 mt -112.37 34.06 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.997 -1.689 . . . . 0.0 110.626 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -56.31 -10.48 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.577 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.2 t -85.88 -1.57 57.4 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.03 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 35.4 m 35.6 39.96 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.034 -1.041 . . . . 0.0 109.167 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' OG ' ' A' ' 39' ' ' SER . 59.2 mttt -116.87 43.21 2.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 38.6 m -174.27 175.07 2.73 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' C ' ' CD ' ' A' ' 41' ' ' GLU . 77.3 m-85 -147.95 157.18 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.524 -1.36 . . . . 0.0 112.002 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' CD ' ' C ' ' A' ' 40' ' ' PHE . 58.7 mp0 -156.28 123.85 5.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.452 0.644 . . . . 0.0 110.172 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.52 172.25 9.85 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.97 155.56 21.04 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.798 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.582 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 76.6 mm-40 -149.12 136.65 20.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -1.127 . . . . 0.0 109.345 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.528 ' OD1' ' ND1' ' A' ' 58' ' ' HIS . 88.6 m-20 -111.43 142.87 43.12 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HZ1' ' C ' ' A' ' 58' ' ' HIS . 9.9 pttm -141.54 109.39 5.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.369 -1.457 . . . . 0.0 109.826 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -147.0 45.33 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.679 -0.638 . . . . 0.0 109.305 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 49' ' ' HIS . 10.1 t -133.16 124.44 27.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.425 ' CD2' HD12 ' A' ' 52' ' ' LEU . 58.1 m-70 60.97 116.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -60.34 -38.28 83.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.364 -0.835 . . . . 0.0 110.827 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -71.18 -35.53 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.031 -1.043 . . . . 0.0 110.729 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 54' ' ' GLN . 26.5 mt -80.68 -58.27 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.806 -1.184 . . . . 0.0 109.292 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.6 ptt180 -63.53 14.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.242 -0.911 . . . . 0.0 111.209 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 52' ' ' LEU . 24.9 mt-30 43.56 4.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.789 -1.194 . . . . 0.0 110.187 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 84.5 -16.94 32.32 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.478 -0.764 . . . . 0.0 112.844 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.482 ' CE2' ' NZ ' ' A' ' 92' ' ' LYS . 48.2 m-85 -61.94 -134.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.253 -1.733 . . . . 0.0 109.998 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 12' ' ' VAL . 4.6 t -162.89 -34.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.284 -0.885 . . . . 0.0 111.027 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.658 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 8.5 t60 -168.47 153.59 6.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 110.125 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.658 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.56 169.1 18.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.385 -0.822 . . . . 0.0 109.283 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.653 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 90.0 m-85 -132.06 128.43 38.21 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 0.0 109.083 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -100.18 99.76 10.5 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -103.07 123.08 45.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.766 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.9 m -123.12 145.62 48.43 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' ASN . 92.2 m-85 -120.92 120.33 35.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.722 -1.237 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -50.92 -24.46 3.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 64' ' ' PHE . 42.2 t-20 -171.26 171.26 5.71 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -58.91 -20.42 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 111.446 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -58.67 -41.95 87.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.835 -1.166 . . . . 0.0 110.574 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.68 -32.93 66.93 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.484 ' O ' HG22 ' A' ' 74' ' ' THR . 78.5 t80 -66.86 -44.11 81.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.927 . . . . 0.0 110.538 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.322 -1.486 . . . . 0.0 108.649 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.91 2.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.349 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -50.57 -34.78 27.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -0.871 . . . . 0.0 111.182 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.7 t -85.63 -30.15 23.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.824 -1.172 . . . . 0.0 110.294 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 t -67.41 16.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.126 -0.984 . . . . 0.0 110.971 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.474 ' H ' ' C ' ' A' ' 74' ' ' THR . 56.1 m80 -133.06 152.05 79.0 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 0.0 109.602 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.84 1.44 8.12 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.669 2.246 . . . . 0.0 112.507 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.26 -31.77 72.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.369 -0.832 . . . . 0.0 111.256 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 83' ' ' SER . 75.2 t60 -84.85 -31.84 23.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.117 -0.989 . . . . 0.0 110.237 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.13 -62.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.993 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.1 -42.46 72.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -75.13 -32.91 61.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 79' ' ' HIS . 13.7 t -63.25 -42.92 99.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.158 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.34 99.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.978 -1.076 . . . . 0.0 108.686 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -65.21 -41.8 94.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -44.66 -31.13 1.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' VAL . 18.7 m -81.68 -63.14 1.45 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.18 -28.74 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.718 -0.614 . . . . 0.0 110.057 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 85' ' ' ALA . 5.3 m -103.99 6.95 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.122 -0.986 . . . . 0.0 110.848 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 91' ' ' ASP . 28.4 mm -129.57 161.92 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.64 -1.287 . . . . 0.0 110.436 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.559 ' N ' HG22 ' A' ' 90' ' ' ILE . 61.4 t0 -121.85 -30.01 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.482 ' NZ ' ' CE2' ' A' ' 56' ' ' PHE . 18.1 ttpt -131.04 129.06 41.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' ILE . 3.4 tp -123.69 121.44 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.643 -1.286 . . . . 0.0 109.799 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.435 ' C ' HD12 ' A' ' 95' ' ' LEU . 7.5 t -131.17 134.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.823 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -143.17 141.27 31.1 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.273 -1.517 . . . . 0.0 111.755 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -117.93 118.92 33.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.649 -0.657 . . . . 0.0 109.311 177.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 39.3 p30 -128.26 136.46 51.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.059 -1.026 . . . . 0.0 108.983 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 9.3 p90 -172.48 156.14 3.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 110.481 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.19 124.87 15.16 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.293 1.995 . . . . 0.0 112.187 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.5 t -109.66 136.05 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 110.022 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.58 104.02 9.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.501 -0.75 . . . . 0.0 109.612 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.437 ' HB1' ' HZ2' ' A' ' 104' ' ' LYS . . . -167.46 160.28 13.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.001 . . . . 0.0 109.579 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.02 -10.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 109.238 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.802 ' C ' ' H ' ' A' ' 106' ' ' SER . 3.7 mmpp? 54.94 -145.72 0.61 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.322 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.53 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 108.904 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.802 ' H ' ' C ' ' A' ' 104' ' ' LYS . 75.2 m -61.62 124.64 21.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.36 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.529 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.03 176.75 21.07 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.727 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -113.85 131.99 56.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.301 -1.117 . . . . 0.0 108.029 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -107.41 137.5 45.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.988 -1.07 . . . . 0.0 112.809 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -130.03 129.18 43.34 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -134.36 145.03 48.6 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.702 -1.248 . . . . 0.0 109.53 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 10' ' ' VAL . 12.2 p -126.09 133.69 68.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.403 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.9 OUTLIER -117.45 128.63 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.5 ' O ' HG22 ' B' ' 57' ' ' THR . 11.3 m -138.92 161.56 29.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.741 -1.584 . . . . 0.0 113.026 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 18.2 tptm -124.73 152.34 43.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.452 ' N ' ' HG3' ' B' ' 13' ' ' LYS . 41.5 p90 -111.16 152.42 27.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.818 -1.176 . . . . 0.0 111.589 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -127.46 -24.73 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 62.8 tt0 -89.77 -53.64 4.42 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.5 t0 147.5 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 28.3 m -54.77 111.32 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.11 0.957 . . . . 0.0 112.857 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.704 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.4 86.13 5.78 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.32 -33.51 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.554 -0.716 . . . . 0.0 110.443 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.19 -37.77 86.41 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -70.54 -35.97 73.43 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.28 -40.71 88.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.26 -35.84 60.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' B' ' 28' ' ' GLU . 0.0 OUTLIER -56.94 -30.01 63.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -76.76 -44.78 14.15 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 1.2 tt -49.52 -56.37 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.5 -1.0 . . . . 0.0 108.824 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 8.1 pt-20 -51.49 -35.52 40.54 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 51.6 m-20 -67.17 -46.54 73.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 4.1 mm? -47.72 -51.39 22.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 32' ' ' SER . 52.1 t -48.98 -34.13 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.251 -0.906 . . . . 0.0 108.824 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 7.3 m -45.27 -49.95 12.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -64.79 -1.62 2.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 111.553 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.581 ' C ' ' N ' ' B' ' 36' ' ' THR . 6.1 mt -112.32 34.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.079 -1.638 . . . . 0.0 110.625 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -56.54 -10.61 1.01 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.581 ' N ' ' C ' ' B' ' 34' ' ' ILE . 1.2 t -85.81 -1.84 57.64 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.4 m 35.97 39.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.053 -1.029 . . . . 0.0 109.23 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.54 ' O ' ' OG ' ' B' ' 39' ' ' SER . 58.5 mttt -116.72 43.33 2.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.54 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 38.2 m -174.17 175.48 2.69 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.492 ' C ' ' CD ' ' B' ' 41' ' ' GLU . 77.1 m-85 -148.18 157.4 43.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.531 -1.356 . . . . 0.0 111.959 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.492 ' CD ' ' C ' ' B' ' 40' ' ' PHE . 58.5 mp0 -156.48 123.82 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.439 0.638 . . . . 0.0 110.194 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.5 172.11 9.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.74 155.54 20.97 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.768 -1.682 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.577 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 76.7 mm-40 -149.19 136.61 20.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -1.202 . . . . 0.0 109.392 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.534 ' OD1' ' ND1' ' B' ' 58' ' ' HIS . 90.4 m-20 -111.51 142.8 43.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.513 ' HZ1' ' C ' ' B' ' 58' ' ' HIS . 10.0 pttm -141.6 109.33 5.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.419 -1.426 . . . . 0.0 109.785 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -146.98 45.46 1.17 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.625 -0.672 . . . . 0.0 109.293 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' B' ' 49' ' ' HIS . 10.0 t -133.11 124.42 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.183 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.428 ' CD2' HD12 ' B' ' 52' ' ' LEU . 58.2 m-70 60.88 116.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.166 -0.959 . . . . 0.0 109.664 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -60.93 -38.07 84.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.747 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -71.02 -35.5 72.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.753 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' B' ' 54' ' ' GLN . 26.5 mt -80.93 -58.42 3.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.704 -1.247 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.756 ' O ' ' N ' ' B' ' 55' ' ' GLY . 17.3 ptt180 -63.33 14.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 0.0 111.222 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' B' ' 52' ' ' LEU . 24.7 mt-30 43.76 4.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.814 -1.179 . . . . 0.0 110.157 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 84.71 -16.91 33.51 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.357 -0.84 . . . . 0.0 112.861 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.486 ' CE2' ' NZ ' ' B' ' 92' ' ' LYS . 47.9 m-85 -62.08 -134.08 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.884 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.5 HG22 ' O ' ' B' ' 12' ' ' VAL . 4.6 t -163.01 -34.39 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.249 -0.907 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.671 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 8.0 t60 -168.68 153.67 6.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.846 -1.159 . . . . 0.0 110.164 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.671 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.57 169.08 18.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.483 -0.761 . . . . 0.0 109.262 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.656 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 89.8 m-85 -131.98 128.5 38.53 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.112 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 30.0 t -100.29 99.59 10.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 64.1 mtt -103.07 123.08 45.96 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.771 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 46.3 m -123.0 145.83 48.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.14 120.27 34.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.744 -1.223 . . . . 0.0 110.048 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -51.06 -24.47 3.9 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -171.07 171.55 5.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -59.29 -20.23 52.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.363 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -58.8 -41.74 87.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.804 -1.185 . . . . 0.0 110.583 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.91 -33.11 65.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.473 ' O ' HG22 ' B' ' 74' ' ' THR . 78.6 t80 -66.56 -44.31 82.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.941 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.8 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.426 -1.421 . . . . 0.0 108.731 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.12 -60.89 2.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -50.29 -35.32 26.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.258 -0.901 . . . . 0.0 111.161 -177.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.9 t -85.21 -30.44 23.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.721 -1.237 . . . . 0.0 110.353 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -67.18 16.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.115 -0.991 . . . . 0.0 110.97 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.483 ' H ' ' C ' ' B' ' 74' ' ' THR . 56.3 m80 -133.48 152.28 78.88 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.813 -1.179 . . . . 0.0 109.602 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.15 1.64 8.05 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.697 2.264 . . . . 0.0 112.445 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.5 -31.66 71.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.408 -0.808 . . . . 0.0 111.231 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' B' ' 83' ' ' SER . 75.8 t60 -84.98 -31.69 23.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.1 . . . . 0.0 110.312 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.31 -61.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.33 -42.78 74.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.573 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -74.83 -32.85 62.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 79' ' ' HIS . 13.7 t -63.41 -43.05 98.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.21 98.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 108.698 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -65.64 -41.57 92.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.468 ' O ' HG12 ' B' ' 90' ' ' ILE . 1.0 OUTLIER -44.87 -31.16 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.418 ' O ' ' C ' ' B' ' 88' ' ' ALA . 18.4 m -81.47 -63.08 1.47 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.0 -29.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.657 -0.652 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.612 HG22 ' O ' ' B' ' 85' ' ' ALA . 5.3 m -103.83 7.21 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.139 -0.976 . . . . 0.0 110.805 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.573 HG22 ' N ' ' B' ' 91' ' ' ASP . 28.0 mm -129.64 161.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.605 -1.309 . . . . 0.0 110.419 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.573 ' N ' HG22 ' B' ' 90' ' ' ILE . 62.0 t0 -121.87 -30.0 4.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.486 ' NZ ' ' CE2' ' B' ' 56' ' ' PHE . 17.5 ttpt -131.24 129.01 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.49 HG23 ' O ' ' B' ' 93' ' ' ILE . 3.4 tp -123.58 121.61 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 109.709 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.436 ' C ' HD12 ' B' ' 95' ' ' LEU . 8.0 t -131.36 134.71 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.801 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -143.1 141.18 31.17 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.349 -1.469 . . . . 0.0 111.765 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.425 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.6 OUTLIER -117.76 119.05 33.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.363 177.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 40.6 p30 -128.51 136.39 50.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.094 -1.003 . . . . 0.0 108.896 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 9.3 p90 -172.32 156.23 3.61 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.015 -1.053 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.29 124.85 15.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.316 2.011 . . . . 0.0 112.248 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.72 136.14 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 110.038 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.55 103.89 9.25 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . 0.433 ' HB1' ' NZ ' ' B' ' 104' ' ' LYS . . . -167.52 160.23 12.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.559 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.03 -10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.805 ' C ' ' H ' ' B' ' 106' ' ' SER . 3.7 mmpp? 54.89 -145.6 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.347 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.54 -26.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 108.908 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.805 ' H ' ' C ' ' B' ' 104' ' ' LYS . 75.6 m -61.51 124.87 21.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.439 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 t -100.1 0.45 40.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.162 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -162.85 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.53 174.18 19.82 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.367 -1.397 . . . . 0.0 109.696 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.5 131.52 56.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.313 -1.11 . . . . 0.0 108.014 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 10.6 ttpt -105.29 133.11 50.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.935 -1.103 . . . . 0.0 112.837 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 97' ' ' ASP . 60.5 m80 -125.6 125.97 44.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.888 -1.894 . . . . 0.0 105.888 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -136.0 143.41 44.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.43 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.9 p -127.69 136.69 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.637 -0.665 . . . . 0.0 109.486 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.2 128.12 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.08 159.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 117.848 -1.541 . . . . 0.0 113.083 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 91' ' ' ASP . 11.1 mtpt -121.16 153.87 36.96 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.566 ' HB2' ' H ' ' A' ' 18' ' ' THR . 17.1 p90 -102.61 144.03 31.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.818 -1.176 . . . . 0.0 111.604 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -116.03 -29.61 6.27 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.7 tt0 -88.54 -55.18 3.83 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.564 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 13.6 m-20 152.19 74.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.566 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 39.3 m -62.24 109.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.103 0.954 . . . . 0.0 112.876 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.694 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.14 92.22 5.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 20' ' ' VAL . 8.6 m -57.59 -35.27 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 110.475 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.1 p-10 -66.46 -39.58 88.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 110.554 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 96.4 mt-10 -70.67 -32.64 69.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.63 -42.48 83.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.49 -39.26 70.2 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -60.07 -24.73 64.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -82.42 -45.84 6.75 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.455 HD21 ' OE1' ' A' ' 41' ' ' GLU . 2.5 tt -49.05 -52.45 25.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.488 -1.007 . . . . 0.0 108.838 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 18.7 pt-20 -52.83 -40.28 63.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.1 m-20 -58.62 -43.9 89.79 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.694 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -47.33 -46.75 25.7 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' SER . 37.8 t -49.14 -27.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 108.842 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 37.4 t -42.93 -48.16 5.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.63 ' NE2' ' CE1' ' A' ' 76' ' ' HIS . 8.9 mm100 -72.8 -23.25 60.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 111.481 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.76 HG22 ' O ' ' A' ' 34' ' ' ILE . 73.2 mt -82.63 23.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.043 -1.661 . . . . 0.0 110.636 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.63 -10.89 2.53 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 43.9 p -79.94 -1.0 37.46 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.6 m 35.4 32.61 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 109.117 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 20.1 mtmm -120.02 42.71 2.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' THR . 27.7 t -172.76 171.98 4.26 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -148.83 160.98 42.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.645 -1.284 . . . . 0.0 111.943 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.526 ' C ' ' HZ3' ' B' ' 104' ' ' LYS . 63.2 mt-10 -151.91 116.71 5.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.393 0.616 . . . . 0.0 110.2 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.697 ' HE1' HG11 ' B' ' 100' ' ' VAL . 11.4 t-105 -104.66 159.2 15.96 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' HZ2' ' B' ' 104' ' ' LYS . . . -118.81 151.49 17.69 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.736 -1.697 . . . . 0.0 110.803 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' B' ' 7' ' ' LYS . 70.9 mt-10 -150.84 133.47 15.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.211 -1.17 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.6 p-10 -155.46 86.56 1.08 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -78.81 155.42 29.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.398 -1.439 . . . . 0.0 109.81 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.4 mt-10 -155.52 59.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.67 -0.644 . . . . 0.0 109.331 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 49' ' ' HIS . 54.6 p -172.37 138.2 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.131 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 m80 60.82 113.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.14 -0.975 . . . . 0.0 109.688 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -55.44 -44.03 75.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 110.797 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.2 mtt -60.32 -35.74 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.746 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' B' ' 96' ' ' LEU . 12.2 mt -93.3 -28.97 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.74 -1.225 . . . . 0.0 109.283 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.065 ' O ' ' N ' ' A' ' 55' ' ' GLY . 39.6 ttt-85 -79.07 2.86 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.299 -0.876 . . . . 0.0 111.296 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.914 ' NE2' HD11 ' B' ' 96' ' ' LEU . 8.7 mt-30 33.72 2.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.709 -1.244 . . . . 0.0 110.212 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 1.065 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.54 -24.82 1.43 Allowed Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.379 -0.826 . . . . 0.0 112.877 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.513 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 6.5 m-85 -59.24 -142.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.26 -1.73 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.698 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 66.4 p -142.71 -48.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -0.848 . . . . 0.0 110.999 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.698 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 35.7 p-80 -173.6 159.63 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.0 110.105 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.14 172.32 13.61 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.395 -0.815 . . . . 0.0 109.221 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -138.5 133.83 33.17 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.416 -0.803 . . . . 0.0 109.12 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.6 t -110.17 102.22 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.64 125.99 44.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.269 -0.894 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 39' ' ' SER . 31.7 m -120.55 142.83 48.99 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.26 130.59 46.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.717 -1.239 . . . . 0.0 110.066 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -55.7 -31.04 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -153.84 160.48 42.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.79 -19.7 43.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.957 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.55 -39.1 72.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.813 -1.18 . . . . 0.0 110.594 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.65 77.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 74' ' ' THR . 75.7 t80 -69.17 -45.68 69.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.969 . . . . 0.0 110.432 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.81 -28.91 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.355 -1.466 . . . . 0.0 108.645 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.355 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.694 ' CE1' HD11 ' A' ' 30' ' ' LEU . 3.5 t80 -54.46 -32.05 56.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 70' ' ' TYR . 30.9 p -75.42 -31.21 60.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.762 -1.211 . . . . 0.0 110.303 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.7 t -82.34 -0.73 47.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.115 -0.991 . . . . 0.0 110.961 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.63 ' CE1' ' NE2' ' A' ' 33' ' ' GLN . 62.1 m80 -97.8 126.36 41.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.758 -1.214 . . . . 0.0 109.61 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -41.51 -14.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.0 112.418 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.2 tp -68.73 -29.26 67.63 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 111.228 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.517 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 81.6 t60 -79.88 -42.77 23.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.046 -1.034 . . . . 0.0 110.226 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.38 -60.68 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.005 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.89 -39.2 77.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -73.24 -42.49 62.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.847 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 66.8 m -62.17 -39.86 94.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.39 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 108.69 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -70.34 -41.99 72.47 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.894 ' O ' HD13 ' A' ' 90' ' ' ILE . 25.6 t80 -45.96 -30.63 1.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 89' ' ' VAL . 17.6 m -80.77 -62.73 1.58 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.93 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.69 -0.631 . . . . 0.0 110.045 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 85' ' ' ALA . 19.4 m -103.84 10.38 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.163 -0.96 . . . . 0.0 110.786 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.894 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.1 mp -119.9 154.5 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.667 -1.271 . . . . 0.0 110.426 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' LYS . 63.8 t0 -101.37 -34.65 9.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.58 148.7 31.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -126.88 125.27 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.619 -1.3 . . . . 0.0 109.786 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.728 HG12 HE21 ' B' ' 54' ' ' GLN . 5.3 t -134.25 136.53 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -138.74 137.91 37.18 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.279 -1.513 . . . . 0.0 111.779 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.921 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -112.13 118.09 34.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.632 -0.667 . . . . 0.0 109.333 176.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 56.7 t0 -123.74 126.72 47.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.044 -1.035 . . . . 0.0 108.924 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 55.3 t80 -167.86 137.72 2.17 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.019 -1.051 . . . . 0.0 110.487 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.0 Cg_exo -47.7 124.45 9.73 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.26 1.973 . . . . 0.0 112.199 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.702 HG11 ' HE1' ' B' ' 42' ' ' TRP . 76.1 t -114.19 140.44 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.939 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -109.81 78.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 109.617 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.534 ' HB2' ' CZ2' ' B' ' 42' ' ' TRP . . . -49.13 88.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.541 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.671 ' O ' HG23 ' A' ' 103' ' ' VAL . 13.1 m -149.17 116.12 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.828 . . . . 0.0 109.163 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 105' ' ' SER . 5.8 ptmt -176.43 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.362 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 107' ' ' VAL . 0.3 OUTLIER 162.05 -44.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 108.965 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.3 t -64.75 44.33 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.286 -0.884 . . . . 0.0 109.395 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 105' ' ' SER . 3.5 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' H ' ' B' ' 5' ' ' GLY . 15.7 m . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' B' ' 4' ' ' SER . . . -130.62 174.22 19.84 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.423 -1.37 . . . . 0.0 109.697 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.49 131.45 56.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.272 -1.134 . . . . 0.0 108.013 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 44' ' ' GLU . 10.6 ttpt -105.08 133.14 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.894 -1.129 . . . . 0.0 112.821 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' B' ' 97' ' ' ASP . 60.5 m80 -125.72 126.04 43.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.4 tt -136.12 143.43 44.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.836 -1.165 . . . . 0.0 109.45 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 11.8 p -127.62 136.68 59.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.485 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.09 128.17 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.2 159.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 117.706 -1.598 . . . . 0.0 113.043 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' B' ' 91' ' ' ASP . 11.2 mtpt -121.13 153.81 37.0 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.571 ' HB2' ' H ' ' B' ' 18' ' ' THR . 17.3 p90 -102.61 143.96 31.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.94 -1.1 . . . . 0.0 111.585 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -115.97 -29.58 6.3 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 78.7 tt0 -88.65 -55.07 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 13.6 m-20 152.03 74.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.571 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 39.5 m -62.34 109.56 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.122 0.963 . . . . 0.0 112.862 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.2 92.21 5.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.417 ' H ' HG22 ' B' ' 20' ' ' VAL . 8.6 m -57.71 -35.1 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 110.413 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.5 p-10 -66.54 -39.63 88.68 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 110.563 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.622 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 96.4 mt-10 -70.71 -32.6 69.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.66 -42.43 83.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.6 -39.2 70.43 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.2 OUTLIER -60.02 -24.86 64.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -82.16 -45.93 6.82 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.449 HD21 ' OE1' ' B' ' 41' ' ' GLU . 2.5 tt -49.0 -52.43 25.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.968 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 18.6 pt-20 -52.96 -40.24 63.54 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 40.5 m-20 -58.59 -44.01 89.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.1 OUTLIER -47.28 -46.71 25.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' B' ' 32' ' ' SER . 37.6 t -49.16 -27.77 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.91 . . . . 0.0 108.775 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 37.0 t -42.85 -48.29 5.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.63 ' NE2' ' CE1' ' B' ' 76' ' ' HIS . 8.8 mm100 -72.52 -23.45 61.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.461 -0.774 . . . . 0.0 111.509 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.779 HG22 ' O ' ' B' ' 34' ' ' ILE . 73.4 mt -82.57 23.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.009 -1.682 . . . . 0.0 110.558 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.6 -10.91 2.52 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' N ' ' B' ' 38' ' ' LYS . 44.1 p -79.93 -0.93 37.15 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.97 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.7 m 35.43 32.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.177 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' B' ' 36' ' ' THR . 20.1 mtmm -119.93 43.01 2.78 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.4 t -172.98 171.79 4.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -148.92 160.87 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.562 -1.336 . . . . 0.0 112.002 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.507 ' C ' ' HZ3' ' A' ' 104' ' ' LYS . 63.0 mt-10 -151.85 116.7 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.369 0.604 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.702 ' HE1' HG11 ' A' ' 100' ' ' VAL . 11.4 t-105 -104.62 159.27 15.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.438 ' N ' ' HZ2' ' A' ' 104' ' ' LYS . . . -118.91 151.44 17.68 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 118.695 -1.716 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.528 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 71.7 mt-10 -150.84 133.46 15.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.27 -1.136 . . . . 0.0 109.379 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 43.1 p-10 -155.47 86.62 1.08 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -78.91 155.35 29.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.365 -1.459 . . . . 0.0 109.872 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.5 mt-10 -155.51 59.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.646 -0.659 . . . . 0.0 109.338 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.415 ' O ' ' O ' ' B' ' 49' ' ' HIS . 54.1 p -172.53 138.04 0.86 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 110.142 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' B' ' 53' ' ' ARG . 43.7 m80 61.03 113.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.684 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -55.33 -44.09 75.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.821 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.42 -35.56 76.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 12.2 mt -93.46 -28.93 15.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.724 -1.235 . . . . 0.0 109.244 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 1.066 ' O ' ' N ' ' B' ' 55' ' ' GLY . 39.8 ttt-85 -79.07 2.82 19.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.394 -0.816 . . . . 0.0 111.246 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.919 ' OE1' HD21 ' A' ' 96' ' ' LEU . 8.7 mt-30 33.7 2.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.77 -1.206 . . . . 0.0 110.206 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 1.066 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.41 -24.76 1.39 Allowed Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.449 -0.782 . . . . 0.0 112.865 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 6.5 m-85 -59.23 -142.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.292 -1.711 . . . . 0.0 109.928 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.618 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 64.6 p -142.73 -48.3 0.33 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.618 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 35.8 p-80 -173.72 159.45 3.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.891 -1.131 . . . . 0.0 110.186 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.8 172.37 13.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 109.283 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -138.54 133.77 33.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.479 -0.763 . . . . 0.0 109.132 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -110.04 102.28 11.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.68 125.83 44.11 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.198 -0.939 . . . . 0.0 110.782 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.1 m -120.33 142.97 48.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -129.38 130.55 46.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.746 -1.221 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -55.56 -31.17 61.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -153.74 160.64 42.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.97 -19.66 45.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 111.421 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.61 -39.02 72.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.839 -1.163 . . . . 0.0 110.611 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.59 77.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.896 ' O ' HG23 ' B' ' 74' ' ' THR . 75.7 t80 -69.07 -45.89 69.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.645 -0.915 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.92 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.354 -1.466 . . . . 0.0 108.745 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.457 -0.777 . . . . 0.0 109.365 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' B' ' 30' ' ' LEU . 3.5 t80 -54.22 -32.16 55.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 111.118 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.896 HG23 ' O ' ' B' ' 70' ' ' TYR . 30.9 p -75.31 -31.34 60.63 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.761 -1.212 . . . . 0.0 110.372 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t -82.21 -0.85 47.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.097 -1.002 . . . . 0.0 110.894 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.63 ' CE1' ' NE2' ' B' ' 33' ' ' GLN . 62.3 m80 -97.66 126.49 40.91 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.829 -1.169 . . . . 0.0 109.595 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -41.64 -14.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.65 2.234 . . . . 0.0 112.454 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' B' ' 76' ' ' HIS . 8.3 tp -68.79 -29.39 67.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.422 -0.799 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 81.5 t60 -79.59 -42.83 24.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.088 . . . . 0.0 110.324 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.46 -60.69 2.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.981 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.79 -39.38 77.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.245 -0.909 . . . . 0.0 109.616 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -73.04 -42.58 62.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 66.6 m -62.15 -39.87 94.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.172 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.59 77.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.673 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.652 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -70.22 -41.88 73.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.884 ' O ' HD13 ' B' ' 90' ' ' ILE . 26.2 t80 -46.1 -30.54 1.94 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' B' ' 89' ' ' VAL . 17.6 m -80.77 -62.72 1.59 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.07 -29.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.717 -0.615 . . . . 0.0 110.084 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.652 HG22 ' O ' ' B' ' 85' ' ' ALA . 19.5 m -103.99 10.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.225 -0.922 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.884 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.1 mp -119.9 154.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.593 -1.317 . . . . 0.0 110.481 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' B' ' 13' ' ' LYS . 64.2 t0 -101.41 -34.75 9.46 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -147.59 148.53 31.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.447 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -126.82 125.29 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.569 -1.332 . . . . 0.0 109.688 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.743 HG12 HE21 ' A' ' 54' ' ' GLN . 5.1 t -134.17 136.5 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.542 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -138.69 137.98 37.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.359 -1.463 . . . . 0.0 111.854 -178.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.923 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.8 OUTLIER -112.1 118.08 34.39 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 8' ' ' HIS . 56.1 t0 -123.75 126.71 46.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.16 -0.962 . . . . 0.0 108.883 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 55.9 t80 -167.71 137.79 2.24 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . 0.525 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 88.6 Cg_exo -47.74 124.49 9.83 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.267 1.978 . . . . 0.0 112.21 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.697 HG11 ' HE1' ' A' ' 42' ' ' TRP . 76.2 t -114.24 140.38 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.99 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.86 78.6 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . 0.529 ' HB2' ' CZ2' ' A' ' 42' ' ' TRP . . . -49.06 88.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.003 . . . . 0.0 109.581 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.654 HG23 ' O ' ' B' ' 103' ' ' VAL . 13.3 m -149.11 116.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.827 . . . . 0.0 109.153 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' B' ' 105' ' ' SER . 5.9 ptmt -176.5 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 107' ' ' VAL . 0.3 OUTLIER 162.06 -44.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 8.2 t -64.59 44.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.253 -0.905 . . . . 0.0 109.456 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' B' ' 105' ' ' SER . 3.5 t . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.745 ' O ' HG22 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 81.86 -4.3 1.53 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.163 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.4 t -137.55 -98.38 0.2 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.91 175.77 20.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.722 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.51 128.94 56.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -1.115 . . . . 0.0 108.064 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HB2' HG21 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -102.72 131.04 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.947 -1.096 . . . . 0.0 112.857 -177.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -125.22 123.59 39.89 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -131.16 140.04 49.87 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.716 -1.24 . . . . 0.0 109.481 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 70.5 t -126.22 132.67 70.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.545 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 59' ' ' ALA . 1.4 t -113.0 130.53 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.18 167.17 27.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.775 -1.57 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 91' ' ' ASP . 2.2 mmmt -137.41 151.24 48.33 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.641 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 7.7 m-85 -108.07 147.3 31.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 111.637 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -127.83 -28.06 2.73 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 75.6 tt0 -87.77 -59.11 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.5 m-20 153.14 69.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 14' ' ' PHE . 31.8 m -60.02 111.71 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.063 0.935 . . . . 0.0 112.844 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.743 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.3 87.3 5.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 176.197 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.92 -32.6 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 110.487 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.3 p-10 -65.32 -37.32 86.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 96.3 mt-10 -69.79 -35.31 74.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 23' ' ' ILE . 3.2 mm -62.81 -45.22 99.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -50.24 -37.29 34.92 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -59.9 -36.29 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -78.82 -42.87 12.2 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -54.38 -59.36 4.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -1.001 . . . . 0.0 108.837 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.28 -34.89 59.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.75 -45.48 92.1 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -50.26 -44.86 53.82 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' ILE . 48.3 t -45.13 -35.41 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.243 -0.91 . . . . 0.0 108.889 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' VAL . 20.1 m -42.2 -45.86 4.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.466 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 22.4 mp0 -70.89 -23.58 62.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 111.496 176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.543 ' C ' ' H ' ' A' ' 36' ' ' THR . 22.1 mt -85.86 28.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 119.967 -1.708 . . . . 0.0 110.667 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.3 p30 -62.22 -7.2 3.84 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 38' ' ' LYS . 2.0 t -86.44 1.89 49.75 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.971 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.5 m 37.45 28.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.083 -1.011 . . . . 0.0 109.198 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 36' ' ' THR . 78.9 mttt -118.42 39.43 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.17 157.03 30.06 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.508 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 99.3 m-85 -143.95 154.0 42.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.624 -1.297 . . . . 0.0 112.013 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 55.5 mp0 -158.83 125.26 4.61 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.379 0.609 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.601 ' HE1' HG11 ' B' ' 100' ' ' VAL . 53.1 t-105 -124.02 174.33 7.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -132.63 153.31 20.58 Favored Glycine 0 N--CA 1.499 2.837 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 72.8 mt-10 -147.48 137.88 23.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.204 -1.174 . . . . 0.0 109.319 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.41 144.18 48.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.568 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -149.13 122.51 9.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.502 -1.374 . . . . 0.0 109.769 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 56' ' ' PHE . 65.1 mm-40 -151.5 45.46 0.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.692 . . . . 0.0 109.335 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -124.23 121.87 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.186 -0.946 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.84 119.89 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.16 -0.963 . . . . 0.0 109.658 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.496 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 80.9 m-20 -56.38 -41.53 76.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 0.0 110.805 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG2' ' H ' ' A' ' 51' ' ' MET . 5.0 ptp -71.66 -32.01 67.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.084 . . . . 0.0 110.751 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 54' ' ' GLN . 83.7 mt -86.96 -52.54 5.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.157 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.736 ' C ' ' H ' ' A' ' 55' ' ' GLY . 15.3 ptt180 -61.93 7.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 0.0 111.219 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 52' ' ' LEU . 4.7 mm-40 53.5 -8.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.702 -1.249 . . . . 0.0 110.207 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.736 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 86.88 -21.64 18.37 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.846 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.428 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 3.2 m-85 -66.23 -128.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.247 -1.737 . . . . 0.0 109.91 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.418 HG21 ' CE2' ' A' ' 14' ' ' PHE . 4.9 t -164.85 -33.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.84 . . . . 0.0 111.002 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.645 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.8 t60 -171.77 154.25 3.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.645 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.56 171.4 14.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.218 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.32 121.26 35.36 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.365 -0.834 . . . . 0.0 109.087 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m -96.71 101.41 13.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.4 mtt -109.81 123.4 49.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 110.828 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.0 m -124.38 148.11 47.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.64 156.06 39.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.694 -1.254 . . . . 0.0 110.118 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 48.8 tp10 -82.91 -28.31 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 15.3 m120 -164.65 169.23 17.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.5 ' NZ ' ' CB ' ' A' ' 67' ' ' LYS . 8.3 mtmp? -58.9 -18.94 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 111.432 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 25.4 p-10 -59.52 -40.66 87.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.771 -1.205 . . . . 0.0 110.562 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -71.3 -32.89 64.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' O ' HG22 ' A' ' 74' ' ' THR . 70.5 t80 -67.4 -44.7 78.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.522 -0.987 . . . . 0.0 110.498 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.9 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.336 -1.478 . . . . 0.0 108.657 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.88 2.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.261 -0.899 . . . . 0.0 109.345 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.2 -35.49 59.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 111.112 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.2 t -84.23 -30.11 25.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.704 -1.247 . . . . 0.0 110.29 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.6 p -68.52 -29.57 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.965 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' A' ' 78' ' ' LEU . 16.4 m-70 -76.81 127.4 84.11 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 0.0 109.562 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.3 -7.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.4 tp -70.87 -26.19 63.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.351 -0.843 . . . . 0.0 111.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.417 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.5 t60 -80.93 -42.62 21.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.049 . . . . 0.0 110.218 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.772 HG13 ' H ' ' A' ' 81' ' ' GLU . 3.7 p -64.92 -57.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.772 ' H ' HG13 ' A' ' 80' ' ' VAL . 93.2 mt-10 -58.89 -42.73 90.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 81.3 t80 -66.45 -43.36 85.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.863 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -59.89 -33.23 71.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.131 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.63 53.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.935 -1.103 . . . . 0.0 108.681 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -72.22 -43.45 64.43 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.534 ' O ' HD12 ' A' ' 90' ' ' ILE . 26.5 t80 -42.77 -29.02 0.28 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 90' ' ' ILE . 5.8 m -84.52 -61.49 1.78 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.16 -28.73 0.06 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.706 -0.621 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 87' ' ' THR . 8.9 m -97.45 13.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.196 -0.94 . . . . 0.0 110.816 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 86' ' ' PHE . 74.3 mt -123.19 156.03 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.628 -1.295 . . . . 0.0 110.45 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.0 t0 -98.64 -35.4 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' N ' HG22 ' A' ' 90' ' ' ILE . 11.1 pttp -147.63 146.04 29.19 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.7 tp -124.85 126.25 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.62 -1.3 . . . . 0.0 109.727 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.487 HG11 ' NE2' ' B' ' 54' ' ' GLN . 22.6 t -132.07 135.44 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -139.06 134.97 33.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.303 -1.498 . . . . 0.0 111.751 -178.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.6 mp -113.82 119.08 36.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.681 -0.637 . . . . 0.0 109.303 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.37 130.29 50.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.023 -1.048 . . . . 0.0 108.96 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -172.0 140.03 1.1 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.057 -1.027 . . . . 0.0 110.486 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.91 121.38 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.296 1.998 . . . . 0.0 112.173 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' A' ' 7' ' ' LYS . 65.4 t -109.05 138.11 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.992 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.19 107.55 10.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.376 -0.828 . . . . 0.0 109.639 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -154.88 149.63 26.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.51 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 102' ' ' ALA . 3.2 m -154.91 147.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.247 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -130.27 65.77 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.348 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 106' ' ' SER . 23.2 m -51.67 -23.42 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.15 -0.969 . . . . 0.0 108.944 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' SER . 1.4 p 76.22 144.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.388 -0.82 . . . . 0.0 109.336 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.684 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.96 175.97 20.27 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.374 -1.393 . . . . 0.0 109.698 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -114.69 129.09 56.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.654 ' HB2' HG21 ' B' ' 100' ' ' VAL . 0.0 OUTLIER -102.97 130.87 50.21 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.319 1.057 . . . . 0.0 112.851 -177.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -124.99 123.59 40.2 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.3 tt -131.14 140.06 49.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.762 -1.211 . . . . 0.0 109.444 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 70.0 t -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.586 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' B' ' 59' ' ' ALA . 1.4 t -113.27 130.41 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.17 167.25 26.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 117.723 -1.591 . . . . 0.0 113.058 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' B' ' 91' ' ' ASP . 2.2 mmmt -137.47 151.01 48.02 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD1' ' OG1' ' B' ' 18' ' ' THR . 7.6 m-85 -107.88 147.37 31.05 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.785 -1.197 . . . . 0.0 111.57 -178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -127.99 -27.76 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 75.2 tt0 -88.19 -58.93 2.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.4 m-20 153.07 69.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.639 ' OG1' ' CD1' ' B' ' 14' ' ' PHE . 32.5 m -60.15 111.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.034 0.921 . . . . 0.0 112.927 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.753 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.28 87.34 5.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.02 -32.42 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.661 . . . . 0.0 110.433 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -65.34 -37.43 87.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.56 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 96.3 mt-10 -69.76 -35.37 74.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' B' ' 26' ' ' GLY . 3.3 mm -62.6 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -50.35 -37.04 34.9 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -60.1 -35.88 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -79.3 -42.7 11.48 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.434 HD13 ' C ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -54.31 -59.39 4.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.545 -0.973 . . . . 0.0 108.85 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.41 -34.89 59.51 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -45.56 91.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 30' ' ' LEU . 0.4 OUTLIER -50.15 -44.99 52.85 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' B' ' 34' ' ' ILE . 48.4 t -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.245 -0.909 . . . . 0.0 108.792 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.433 ' C ' ' O ' ' B' ' 31' ' ' VAL . 20.4 m -42.37 -45.64 4.38 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' B' ' 33' ' ' GLN . 22.3 mp0 -71.1 -23.55 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 111.535 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.549 HG22 ' O ' ' B' ' 34' ' ' ILE . 22.2 mt -85.79 28.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.006 -1.684 . . . . 0.0 110.571 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.4 p30 -62.36 -7.14 3.91 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.612 ' O ' ' N ' ' B' ' 38' ' ' LYS . 1.9 t -86.55 2.08 49.37 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.874 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.515 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.5 m 37.47 28.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 109.167 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' B' ' 36' ' ' THR . 78.5 mttt -118.3 39.88 3.32 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 156.72 28.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.498 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 99.3 m-85 -143.75 153.83 42.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.497 -1.377 . . . . 0.0 111.946 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.504 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 56.1 mp0 -158.76 125.23 4.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.407 0.622 . . . . 0.0 110.208 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.601 ' HE1' HG11 ' A' ' 100' ' ' VAL . 53.0 t-105 -124.01 174.69 7.44 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.558 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -133.28 152.91 20.55 Favored Glycine 0 N--CA 1.498 2.82 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.839 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.562 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 71.2 mt-10 -147.2 137.87 23.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.46 143.95 48.24 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.92 122.84 9.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.386 -1.446 . . . . 0.0 109.816 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' B' ' 56' ' ' PHE . 64.9 mm-40 -151.79 45.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.665 -0.647 . . . . 0.0 109.388 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -124.12 121.7 35.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 110.172 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.92 119.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.484 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 79.4 m-20 -56.3 -41.52 76.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.838 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 4.9 ptp -71.8 -31.91 67.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.034 . . . . 0.0 110.726 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' B' ' 54' ' ' GLN . 84.0 mt -86.95 -52.45 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.712 -1.243 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.698 ' C ' ' H ' ' B' ' 55' ' ' GLY . 15.4 ptt180 -62.02 7.94 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 111.307 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' B' ' 52' ' ' LEU . 4.6 mm-40 53.53 -8.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.832 -1.168 . . . . 0.0 110.225 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.698 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 87.12 -21.48 20.17 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.468 -0.77 . . . . 0.0 112.864 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.442 ' O ' ' OE2' ' B' ' 47' ' ' GLU . 3.2 m-85 -66.39 -128.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.278 -1.719 . . . . 0.0 109.915 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.422 HG21 ' CE2' ' B' ' 14' ' ' PHE . 4.8 t -164.46 -34.15 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.276 -0.89 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.648 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.9 t60 -171.61 154.56 3.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.803 -1.186 . . . . 0.0 110.231 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.648 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.98 171.09 14.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.02 121.26 35.64 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -96.65 101.48 13.1 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 38.8 mtt -109.9 123.6 49.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 110.782 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 97.1 m -124.71 147.93 48.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.53 156.03 39.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.668 -1.27 . . . . 0.0 110.058 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 50.2 tp10 -82.7 -28.64 30.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 15.6 m120 -164.31 169.74 17.09 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.493 ' NZ ' ' CB ' ' B' ' 67' ' ' LYS . 8.2 mtmp? -59.14 -19.09 41.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 0.0 111.406 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 26.5 p-10 -59.51 -40.67 87.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.905 -1.122 . . . . 0.0 110.55 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -71.22 -32.79 65.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.505 ' O ' HG22 ' B' ' 74' ' ' THR . 71.0 t80 -67.41 -44.87 77.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.644 -0.915 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.8 -28.88 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.352 -1.468 . . . . 0.0 108.671 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.84 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -35.25 59.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 111.141 -176.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.505 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.2 t -84.51 -30.01 25.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.744 -1.223 . . . . 0.0 110.339 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 95.0 p -68.43 -29.56 68.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.12 -0.988 . . . . 0.0 110.964 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 78' ' ' LEU . 16.4 m-70 -76.97 127.53 83.54 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.4 -7.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.598 2.199 . . . . 0.0 112.48 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.4 tp -70.82 -26.38 63.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.408 -0.808 . . . . 0.0 111.178 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -80.86 -42.7 21.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 110.276 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.77 HG13 ' H ' ' B' ' 81' ' ' GLU . 3.6 p -64.8 -57.61 10.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 110.024 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.77 ' H ' HG13 ' B' ' 80' ' ' VAL . 93.2 mt-10 -58.9 -42.67 90.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.299 -0.876 . . . . 0.0 109.587 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 81.1 t80 -66.48 -43.48 85.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.818 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -59.71 -33.36 71.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.111 -0.993 . . . . 0.0 110.149 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.93 49.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 108.644 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -71.81 -43.54 65.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.548 ' O ' HD12 ' B' ' 90' ' ' ILE . 26.4 t80 -42.75 -29.2 0.29 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.471 ' O ' ' N ' ' B' ' 89' ' ' VAL . 5.4 m -84.32 -61.62 1.76 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.98 -28.67 0.06 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.681 -0.637 . . . . 0.0 110.098 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.2 m -97.69 13.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.548 HD12 ' O ' ' B' ' 86' ' ' PHE . 73.4 mt -123.39 156.1 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.651 -1.281 . . . . 0.0 110.437 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' B' ' 13' ' ' LYS . 61.8 t0 -98.54 -35.45 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.453 ' N ' HG22 ' B' ' 90' ' ' ILE . 11.2 pttp -147.66 145.71 29.04 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.43 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.7 tp -124.46 126.06 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.556 -1.34 . . . . 0.0 109.727 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.485 HG11 ' NE2' ' A' ' 54' ' ' GLN . 22.3 t -131.74 135.68 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.868 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -139.11 135.04 33.69 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.256 -1.527 . . . . 0.0 111.798 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.885 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.7 mp -113.86 119.04 35.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 109.33 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.22 130.48 51.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.102 -0.999 . . . . 0.0 108.97 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -171.98 140.08 1.1 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.126 -0.984 . . . . 0.0 110.538 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.86 121.18 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.308 2.005 . . . . 0.0 112.194 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' B' ' 7' ' ' LYS . 63.4 t -108.77 138.29 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 110.037 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.4 107.79 10.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.581 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . 0.486 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -155.13 149.62 26.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.486 HG13 ' O ' ' B' ' 102' ' ' ALA . 3.2 m -155.03 147.72 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.377 -0.827 . . . . 0.0 109.233 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -130.27 65.53 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.373 -179.179 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' B' ' 106' ' ' SER . 24.4 m -51.31 -23.83 4.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' B' ' 105' ' ' SER . 1.4 p 76.53 144.83 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.367 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t . . . . . 0 C--N 1.303 -1.441 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.605 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.421 0.629 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.675 HG23 ' HB2' ' A' ' 101' ' ' ALA . 1.0 OUTLIER 155.25 -62.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.133 -178.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 3' ' ' THR . 2.5 t 152.35 -100.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 4' ' ' SER . . . -81.09 170.42 52.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.24 132.92 42.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 108.027 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 5.2 ttpm? -100.3 127.01 46.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 112.813 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 62' ' ' MET . 56.4 m80 -117.12 116.46 27.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -131.59 140.96 49.56 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.734 -1.229 . . . . 0.0 109.408 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.02 138.51 52.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.6 -0.687 . . . . 0.0 109.458 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.13 130.38 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.655 ' HB ' HD12 ' A' ' 90' ' ' ILE . 3.9 m -135.02 148.95 28.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 117.74 -1.584 . . . . 0.0 113.028 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.665 ' HZ2' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -120.15 151.99 38.28 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.616 ' CD2' HG21 ' A' ' 57' ' ' THR . 9.2 p90 -113.32 152.94 29.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.81 -1.181 . . . . 0.0 111.601 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -128.67 -18.05 3.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.2 mm-40 -90.33 -57.28 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 12.1 m-20 154.09 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 51.7 m -51.59 112.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.098 0.951 . . . . 0.0 112.84 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.569 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.87 90.66 2.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LEU . 29.1 m -62.85 -41.91 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.504 -0.747 . . . . 0.0 110.512 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' HG23 ' A' ' 20' ' ' VAL . 87.1 m-20 -63.43 -45.13 92.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.559 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -70.29 -33.05 71.09 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.34 -40.29 79.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.5 tp -58.84 -38.77 79.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.68 -35.07 76.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.93 -53.55 36.69 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 27' ' ' LEU . 5.8 tt -48.08 -43.84 31.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.511 -0.993 . . . . 0.0 108.813 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -54.71 -46.42 74.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.537 ' ND2' ' CE2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.66 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -47.7 -41.67 23.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.555 HG21 ' HA ' ' B' ' 105' ' ' SER . 19.3 t -54.74 -20.5 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.236 -0.915 . . . . 0.0 108.902 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 74.5 m -44.63 -42.28 7.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.542 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 46.2 mm-40 -83.84 -9.77 58.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 111.398 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 34' ' ' ILE . 45.0 mm -91.23 23.56 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 119.976 -1.702 . . . . 0.0 110.716 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.77 -8.92 1.05 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 37' ' ' VAL . 33.6 p -79.15 -2.82 42.59 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.972 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.614 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.8 m 32.13 41.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.08 -1.012 . . . . 0.0 109.135 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.0 ptmt -122.32 41.93 3.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.569 ' OG ' HD12 ' A' ' 34' ' ' ILE . 87.6 p -173.67 178.18 2.33 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 87.3 m-85 -147.01 155.0 41.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.546 -1.346 . . . . 0.0 111.929 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 46.5 mp0 -152.46 121.18 6.48 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -126.5 168.71 13.87 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.12 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.01 159.28 21.16 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.827 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.57 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 49.4 mp0 -147.78 140.59 24.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.331 -1.1 . . . . 0.0 109.392 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.3 t0 -128.46 155.7 44.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -60.22 80.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.461 -1.4 . . . . 0.0 109.747 -177.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.3 mt-10 -105.04 42.65 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.67 -0.644 . . . . 0.0 109.272 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.554 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 3.4 m -150.09 179.38 8.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.47 150.01 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 51' ' ' MET . 32.2 p-10 -43.94 -44.05 6.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.787 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.527 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 83.2 mmm -67.19 -28.96 68.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.942 -1.099 . . . . 0.0 110.713 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 95' ' ' LEU . 33.9 mt -98.29 -30.18 12.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.772 -1.205 . . . . 0.0 109.292 -178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.662 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 3.2 ptm180 -86.46 -1.73 57.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.827 . . . . 0.0 111.225 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.5 ' NE2' HG12 ' B' ' 94' ' ' VAL . 6.4 tt0 45.96 10.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.73 -1.231 . . . . 0.0 110.149 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.662 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 58.77 -5.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.424 -0.797 . . . . 0.0 112.89 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 11.8 p90 -57.0 131.11 48.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.204 -1.762 . . . . 0.0 109.93 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.616 HG21 ' CD2' ' A' ' 14' ' ' PHE . 71.3 p -54.15 -48.1 71.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.0 110.995 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 23.7 t60 -173.0 159.19 3.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.109 . . . . 0.0 110.165 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.612 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -144.83 169.53 17.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -0.805 . . . . 0.0 109.219 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 76.6 m-85 -135.12 130.64 35.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.484 -0.76 . . . . 0.0 109.075 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 98.18 8.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.511 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.2 mtp -98.9 118.89 36.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.165 -0.96 . . . . 0.0 110.849 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -123.29 142.43 50.95 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.94 162.58 18.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.829 -1.17 . . . . 0.0 110.078 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.57 -29.97 29.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -169.76 175.0 5.44 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -58.38 -22.52 54.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 111.415 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.84 -37.56 71.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.809 -1.182 . . . . 0.0 110.617 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.08 76.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.747 ' O ' HG22 ' A' ' 74' ' ' THR . 74.0 t80 -67.14 -44.18 80.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.956 . . . . 0.0 110.417 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.76 -28.93 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.38 -1.45 . . . . 0.0 108.696 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . -64.98 -61.0 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CE1' HD11 ' A' ' 30' ' ' LEU . 2.7 t80 -63.73 -60.22 3.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.207 -0.933 . . . . 0.0 111.115 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 70' ' ' TYR . 14.8 t -49.46 -37.22 25.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.752 -1.218 . . . . 0.0 110.357 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 74' ' ' THR . 63.7 p -65.97 -11.95 51.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 0.0 111.014 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 78' ' ' LEU . 65.2 m-70 -92.64 125.99 53.66 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.25 -4.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.675 2.25 . . . . 0.0 112.489 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.3 tp -74.39 -25.87 59.75 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.297 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -77.84 -45.4 24.44 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.086 -1.009 . . . . 0.0 110.247 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.756 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -63.37 -57.94 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.993 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.756 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.3 tt0 -53.59 -36.45 61.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 6.4 m-85 -74.39 -36.18 63.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.875 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -62.09 -42.9 99.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.61 -44.14 97.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 108.656 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -68.87 -44.19 73.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.482 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.03 -30.18 0.41 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' VAL . 10.9 m -82.36 -64.17 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -43.3 -24.83 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 110.099 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 85' ' ' ALA . 4.9 m -107.4 9.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 110.723 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.655 HD12 ' HB ' ' A' ' 12' ' ' VAL . 28.9 mm -131.44 164.37 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.6 -1.313 . . . . 0.0 110.504 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 90' ' ' ILE . 52.2 t0 -109.42 -33.41 6.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' NZ ' ' NZ ' ' A' ' 13' ' ' LYS . 29.2 pttt -147.84 147.57 29.94 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.605 HD12 HG12 ' A' ' 12' ' ' VAL . 4.1 tp -128.86 123.81 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.637 -1.289 . . . . 0.0 109.785 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG12 ' NE2' ' B' ' 54' ' ' GLN . 4.7 t -126.7 132.64 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -142.05 138.37 31.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.269 -1.519 . . . . 0.0 111.748 -178.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.875 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -116.5 119.28 35.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.719 -0.613 . . . . 0.0 109.355 177.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.403 ' O ' ' OG ' ' B' ' 48' ' ' SER . 62.2 t0 -111.21 117.5 33.38 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -0.989 . . . . 0.0 108.971 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 54.7 t80 -141.37 137.65 16.8 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.01 . . . . 0.0 110.465 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.55 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 31.0 Cg_endo -61.02 127.81 23.42 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.257 1.972 . . . . 0.0 112.229 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.61 117.3 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.009 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.675 ' HB2' HG23 ' A' ' 3' ' ' THR . . . -109.35 95.29 5.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.546 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.422 ' C ' HG13 ' A' ' 103' ' ' VAL . . . -65.45 69.74 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.9 m -152.88 95.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.243 -178.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' SER . 7.7 ptmm? -175.19 -126.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.396 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.578 ' HA ' HG21 ' B' ' 31' ' ' VAL . 1.5 m 63.96 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 108.899 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' LYS . 4.4 m -115.84 71.04 0.76 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.276 -0.89 . . . . 0.0 109.339 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 107' ' ' VAL . 14.3 p . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' B' ' 5' ' ' GLY . 2.5 t . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' B' ' 4' ' ' SER . . . -81.19 170.41 52.59 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.02 133.16 42.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.281 -1.129 . . . . 0.0 108.043 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' B' ' 7' ' ' LYS . 5.1 ttpm? -100.51 126.93 46.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.937 -1.102 . . . . 0.0 112.843 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 62' ' ' MET . 56.0 m80 -117.11 116.2 26.86 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -131.28 141.13 49.93 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.657 -1.277 . . . . 0.0 109.474 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.05 138.64 52.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 130.3 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.657 ' HB ' HD12 ' B' ' 90' ' ' ILE . 3.9 m -134.94 148.77 28.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.818 -1.553 . . . . 0.0 113.051 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.64 ' HZ2' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -120.11 151.91 38.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.61 ' CD2' HG21 ' B' ' 57' ' ' THR . 9.4 p90 -113.35 152.96 29.28 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.828 -1.17 . . . . 0.0 111.545 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -128.77 -18.0 3.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CG ' ' B' ' 17' ' ' ASP . 77.5 mm-40 -90.32 -57.08 2.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CG ' ' O ' ' B' ' 16' ' ' GLU . 12.7 m-20 153.73 58.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.447 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 58.6 m -52.45 112.35 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.147 0.975 . . . . 0.0 112.846 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.582 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.6 90.46 2.79 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' B' ' 24' ' ' LEU . 29.8 m -62.7 -41.93 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.683 -0.636 . . . . 0.0 110.474 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.524 ' N ' HG23 ' B' ' 20' ' ' VAL . 86.2 m-20 -63.45 -45.01 92.84 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.447 -0.783 . . . . 0.0 110.563 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -70.3 -33.26 71.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.26 -40.19 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -58.99 -38.65 79.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.52 -35.03 76.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.44 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -64.44 -53.07 38.08 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.685 HD23 ' O ' ' B' ' 27' ' ' LEU . 5.8 tt -48.21 -43.97 32.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.577 -0.955 . . . . 0.0 108.799 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -54.49 -46.77 73.51 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' B' ' 82' ' ' PHE . 0.0 OUTLIER -52.79 -41.34 64.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -47.98 -41.35 24.98 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 105' ' ' SER . 19.3 t -54.99 -20.21 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.311 -0.868 . . . . 0.0 108.829 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.47 ' N ' ' O ' ' B' ' 29' ' ' ASN . 73.6 m -44.87 -42.34 7.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.551 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 46.1 mm-40 -83.85 -9.55 58.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.449 -0.782 . . . . 0.0 111.523 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.769 HG22 ' O ' ' B' ' 34' ' ' ILE . 44.9 mm -91.29 23.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.031 -1.668 . . . . 0.0 110.641 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -57.65 -8.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.592 ' O ' ' C ' ' B' ' 37' ' ' VAL . 34.2 p -79.06 -2.68 41.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.984 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.592 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.0 m 32.13 41.84 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.121 -0.987 . . . . 0.0 109.194 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.1 ptmt -122.24 42.15 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.573 ' OG ' HD12 ' B' ' 34' ' ' ILE . 89.2 p -173.82 177.97 2.32 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 86.5 m-85 -146.91 155.06 42.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.52 -1.362 . . . . 0.0 111.944 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' B' ' 41' ' ' GLU . 46.4 mp0 -152.42 121.11 6.47 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.364 0.602 . . . . 0.0 110.194 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.642 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.7 OUTLIER -126.48 168.83 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.09 159.48 21.22 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.807 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.584 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 49.8 mp0 -148.13 140.65 24.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.407 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' B' ' 47' ' ' GLU . 61.9 t0 -128.49 155.64 44.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.521 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -60.17 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.44 -1.413 . . . . 0.0 109.773 -177.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.5 mt-10 -104.65 42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.676 -0.64 . . . . 0.0 109.358 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 3.6 m -150.04 179.58 7.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.139 -0.975 . . . . 0.0 110.243 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.62 150.29 41.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.945 . . . . 0.0 109.701 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.3 p-10 -44.14 -43.77 7.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.858 . . . . 0.0 110.8 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.53 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 83.4 mmm -67.57 -28.95 68.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.14 -0.975 . . . . 0.0 110.75 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 95' ' ' LEU . 34.6 mt -98.32 -29.76 12.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.747 -1.221 . . . . 0.0 109.265 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' B' ' 55' ' ' GLY . 3.2 ptm180 -86.89 -1.66 57.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.394 -0.816 . . . . 0.0 111.243 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.502 ' NE2' HG12 ' A' ' 94' ' ' VAL . 6.4 tt0 45.99 10.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.807 -1.183 . . . . 0.0 110.194 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 59.3 -5.81 0.08 OUTLIER Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.428 -0.795 . . . . 0.0 112.881 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 11.7 p90 -56.64 131.11 47.98 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.259 -1.73 . . . . 0.0 109.899 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.61 HG21 ' CD2' ' B' ' 14' ' ' PHE . 69.9 p -54.19 -47.9 71.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.279 -0.888 . . . . 0.0 110.995 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.64 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 23.6 t60 -173.13 159.61 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.9 -1.125 . . . . 0.0 110.165 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -145.39 169.28 18.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.542 -0.724 . . . . 0.0 109.292 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 76.6 m-85 -134.91 130.64 36.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.512 -0.742 . . . . 0.0 109.081 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 97.81 8.55 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . 0.515 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.8 mtp -98.62 119.1 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.198 -0.939 . . . . 0.0 110.77 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -123.43 142.63 50.79 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.0 162.99 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 110.038 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -82.98 -29.84 28.69 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -169.73 175.44 5.28 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -58.72 -22.46 57.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 111.45 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -57.08 -37.57 72.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.804 -1.185 . . . . 0.0 110.565 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 -33.1 77.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.748 ' O ' HG22 ' B' ' 74' ' ' THR . 74.5 t80 -67.01 -44.55 80.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.947 . . . . 0.0 110.405 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.81 -28.87 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.329 -1.482 . . . . 0.0 108.669 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.1 -60.91 2.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.673 ' CE1' HD11 ' B' ' 30' ' ' LEU . 2.7 t80 -63.22 -60.48 3.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 111.136 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.748 HG22 ' O ' ' B' ' 70' ' ' TYR . 14.9 t -49.47 -37.18 25.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 63.9 p -65.92 -12.04 51.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.982 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' B' ' 78' ' ' LEU . 65.2 m-70 -92.6 126.27 52.71 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.898 -1.126 . . . . 0.0 109.544 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -44.6 -4.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.686 2.257 . . . . 0.0 112.424 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.3 tp -74.44 -26.22 59.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.366 -0.834 . . . . 0.0 111.18 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -77.72 -45.25 25.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.95 -1.094 . . . . 0.0 110.321 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.767 HG13 ' N ' ' B' ' 81' ' ' GLU . 7.1 p -63.19 -58.21 8.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.767 ' N ' HG13 ' B' ' 80' ' ' VAL . 84.0 tt0 -53.56 -36.36 61.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 6.4 m-85 -74.38 -36.4 63.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.872 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 87.5 p -61.79 -43.05 99.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.052 -1.03 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.97 97.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 108.622 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.632 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -69.13 -43.99 73.28 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.485 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.22 -30.0 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.6 m -82.48 -64.15 1.23 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -43.26 -24.94 0.1 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.76 -0.588 . . . . 0.0 110.12 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.632 HG22 ' O ' ' B' ' 85' ' ' ALA . 4.9 m -107.34 9.89 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 110.838 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.657 HD12 ' HB ' ' B' ' 12' ' ' VAL . 28.3 mm -131.68 164.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.628 -1.295 . . . . 0.0 110.462 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.628 ' N ' HG22 ' B' ' 90' ' ' ILE . 52.0 t0 -109.28 -33.49 6.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.491 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 28.2 pttt -147.86 147.67 30.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.608 HD12 HG12 ' B' ' 12' ' ' VAL . 4.2 tp -128.98 123.67 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.569 -1.332 . . . . 0.0 109.711 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.5 HG12 ' NE2' ' A' ' 54' ' ' GLN . 4.6 t -126.52 132.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.844 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -141.95 138.5 32.0 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.266 -1.521 . . . . 0.0 111.774 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.871 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.0 OUTLIER -116.55 119.27 35.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.708 -0.62 . . . . 0.0 109.334 177.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.408 ' O ' ' OG ' ' A' ' 48' ' ' SER . 62.4 t0 -111.19 117.14 32.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.04 -1.037 . . . . 0.0 108.889 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 55.6 t80 -140.87 137.89 17.62 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.057 -1.027 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 31.3 Cg_endo -61.18 127.91 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.286 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 5' ' ' GLY . 99.2 t -92.76 117.41 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 109.974 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.45 95.05 5.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 109.609 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . 0.424 ' C ' HG13 ' B' ' 103' ' ' VAL . . . -65.36 70.05 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.784 HG23 ' O ' ' B' ' 103' ' ' VAL . 21.9 m -153.15 95.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' B' ' 106' ' ' SER . 7.6 ptmm? -175.09 -127.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.331 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.555 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.6 m 64.16 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 108.922 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.504 ' N ' ' O ' ' B' ' 104' ' ' LYS . 4.4 m -115.76 70.6 0.75 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.43 HG22 ' O ' ' B' ' 107' ' ' VAL . 13.9 p . . . . . 0 C--N 1.301 -1.506 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.376 0.608 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -101.15 -7.82 22.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.111 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.7 t -145.93 -80.91 0.15 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.16 -158.97 7.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -135.76 138.15 42.38 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.164 -1.198 . . . . 0.0 108.09 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.452 ' CD ' ' CZ2' ' B' ' 42' ' ' TRP . 1.1 ttpm? -113.32 141.31 47.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.906 -1.121 . . . . 0.0 112.801 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -130.02 130.05 44.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.3 tt -135.17 144.67 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.7 -1.25 . . . . 0.0 109.485 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.8 p -128.47 135.56 62.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.434 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.38 128.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.81 157.0 32.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 117.766 -1.574 . . . . 0.0 112.994 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 91' ' ' ASP . 20.6 tptm -122.34 152.1 40.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' HB2' ' H ' ' A' ' 18' ' ' THR . 29.9 p90 -105.29 147.17 28.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.942 -1.099 . . . . 0.0 111.643 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -120.75 -24.91 5.58 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.0 mt-10 -89.38 -54.98 3.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.5 t0 150.58 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.497 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 61.0 m -58.91 110.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.112 0.958 . . . . 0.0 112.851 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.724 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -81.29 92.67 6.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.675 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 20' ' ' VAL . 11.5 m -58.72 -32.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.551 -0.718 . . . . 0.0 110.473 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.6 p-10 -66.41 -39.2 88.84 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 78.0 mm-40 -67.74 -34.2 76.38 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.71 -44.36 93.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.4 tp -53.89 -37.15 63.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.85 -32.12 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -81.9 -43.76 8.08 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.67 -58.27 8.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.482 -1.011 . . . . 0.0 108.777 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 9.3 pt-20 -51.68 -43.95 62.92 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.634 HD21 HD11 ' A' ' 78' ' ' LEU . 13.7 t30 -61.56 -43.38 98.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.755 HD22 HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -49.95 -43.73 50.24 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.027 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 34' ' ' ILE . 39.8 t -50.8 -27.86 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.315 -0.866 . . . . 0.0 108.874 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' VAL . 46.9 t -40.61 -42.89 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.528 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 29.9 mm100 -75.75 -23.15 55.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.495 -0.753 . . . . 0.0 111.462 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.651 ' O ' HG22 ' A' ' 34' ' ' ILE . 30.9 mm -85.69 25.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.068 -1.645 . . . . 0.0 110.648 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 36' ' ' THR . 54.3 p30 -60.74 -9.01 3.39 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 38' ' ' LYS . 59.5 p -73.88 -3.2 27.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.896 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.5 m 35.65 30.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.16 -0.963 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 36' ' ' THR . 75.1 mttt -118.94 39.5 3.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 t -170.9 170.92 6.18 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -147.42 157.48 43.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.595 -1.316 . . . . 0.0 112.006 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.562 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 58.1 mt-10 -151.59 120.26 6.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.417 0.627 . . . . 0.0 110.169 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.709 ' CD1' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.49 164.55 24.58 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.709 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -134.45 174.1 21.13 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.733 -1.699 . . . . 0.0 110.766 -178.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -152.69 141.21 20.77 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -1.174 . . . . 0.0 109.371 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -105.12 140.72 37.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -135.24 103.59 5.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.374 -1.454 . . . . 0.0 109.749 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -146.97 25.6 1.13 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.651 -0.656 . . . . 0.0 109.312 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.476 ' H ' ' CB ' ' A' ' 53' ' ' ARG . 11.6 p -89.09 -106.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 m80 -92.61 148.07 22.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 51' ' ' MET . 31.5 p-10 -53.45 -43.07 67.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.365 -0.834 . . . . 0.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.522 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.9 tpt -75.42 -32.05 60.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.0 110.745 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 95' ' ' LEU . 48.9 mt -90.14 -54.53 3.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.732 -1.23 . . . . 0.0 109.305 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.76 ' C ' ' H ' ' A' ' 55' ' ' GLY . 12.5 ptt180 -62.59 1.23 0.39 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.492 ' NE2' HG11 ' B' ' 94' ' ' VAL . 0.4 OUTLIER 56.11 -17.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.803 -1.185 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.76 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 88.05 -23.16 15.29 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.511 -0.743 . . . . 0.0 112.905 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' GLY . 3.5 m-85 -61.23 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.212 -1.758 . . . . 0.0 109.903 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 58' ' ' HIS . 3.2 t -161.5 -35.99 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.315 -0.866 . . . . 0.0 110.996 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.667 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 35.1 t-80 -166.89 149.46 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.937 -1.102 . . . . 0.0 110.19 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -142.72 167.63 21.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 58' ' ' HIS . 91.3 m-85 -138.15 134.87 35.12 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.494 -0.754 . . . . 0.0 109.073 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.546 ' OG ' ' CZ3' ' A' ' 42' ' ' TRP . 1.4 m -116.45 104.64 11.64 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.7 mtt -95.32 125.45 39.96 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.143 -0.973 . . . . 0.0 110.79 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 m -118.89 140.87 49.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -127.2 128.1 45.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.742 -1.224 . . . . 0.0 110.036 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -50.96 -26.36 5.85 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -171.43 172.9 4.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.9 -19.17 60.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 111.361 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.92 -40.71 89.8 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.859 -1.15 . . . . 0.0 110.613 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.84 -29.25 59.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 74' ' ' THR . 73.5 t80 -66.1 -42.59 89.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.917 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.407 -1.433 . . . . 0.0 108.669 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.96 2.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.304 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.45 -39.39 64.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 111.159 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.0 t -79.78 -29.62 40.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.746 -1.221 . . . . 0.0 110.338 -177.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -65.44 -25.56 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 111.023 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' A' ' 78' ' ' LEU . 56.8 t-80 -79.04 125.33 83.95 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.833 -1.167 . . . . 0.0 109.661 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.43 -6.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.755 HD23 HD22 ' A' ' 30' ' ' LEU . 6.1 tp -75.84 -25.38 56.19 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 111.203 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.6 t60 -76.57 -43.0 40.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.018 -1.051 . . . . 0.0 110.241 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.733 HG13 ' N ' ' A' ' 81' ' ' GLU . 11.3 p -64.4 -54.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.733 ' N ' HG13 ' A' ' 80' ' ' VAL . 78.7 mm-40 -50.43 -30.83 13.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' CD1' ' A' ' 86' ' ' PHE . 4.2 m-85 -72.97 -37.34 67.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.879 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.6 m -63.46 -42.33 98.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.0 110.14 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.48 67.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.965 -1.084 . . . . 0.0 108.751 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.0 -43.43 82.93 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 82' ' ' PHE . 2.5 m-85 -45.0 -31.06 1.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.1 m -78.94 -63.31 1.45 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.03 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.72 -0.612 . . . . 0.0 110.064 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.4 m -111.92 6.91 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.18 -0.95 . . . . 0.0 110.803 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 34.5 mt -120.11 154.64 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.647 -1.283 . . . . 0.0 110.444 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.9 t0 -103.52 -31.42 9.96 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' NZ ' ' CE1' ' A' ' 56' ' ' PHE . 37.9 pttt -150.44 149.3 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 93' ' ' ILE . 3.8 tp -125.24 121.94 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.615 -1.303 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.496 HG11 ' NE2' ' B' ' 54' ' ' GLN . 48.8 t -129.76 133.52 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -139.49 136.86 34.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.241 -1.537 . . . . 0.0 111.752 -178.145 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.95 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.94 121.44 42.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.655 -0.653 . . . . 0.0 109.383 176.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 68.2 t0 -123.12 128.35 49.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.017 . . . . 0.0 108.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -164.08 139.68 4.93 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.096 -1.003 . . . . 0.0 110.505 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.03 120.68 4.4 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.292 1.995 . . . . 0.0 112.202 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -105.55 135.73 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.93 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.78 75.51 0.93 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.87 113.3 24.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 104' ' ' LYS . 16.9 m -134.42 -54.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.171 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.694 ' H ' HG23 ' A' ' 103' ' ' VAL . 26.0 mmtm 60.19 -129.75 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 0.0 109.339 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 104' ' ' LYS . 0.9 OUTLIER 72.52 -18.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.181 -0.949 . . . . 0.0 108.978 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 104' ' ' LYS . 2.0 t 168.75 -42.04 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 109.346 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.675 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.98 -158.47 7.6 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.694 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.36 137.68 40.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.279 -1.13 . . . . 0.0 108.015 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.458 ' CD ' ' CZ2' ' A' ' 42' ' ' TRP . 1.1 ttpm? -112.89 141.22 46.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.864 -1.147 . . . . 0.0 112.787 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -129.99 130.13 44.63 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.4 tt -135.45 144.54 46.51 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.798 -1.189 . . . . 0.0 109.479 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.418 ' O ' HG13 ' B' ' 10' ' ' VAL . 11.0 p -128.45 135.41 62.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.629 -0.669 . . . . 0.0 109.537 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.25 128.27 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.07 156.9 31.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 117.769 -1.572 . . . . 0.0 113.011 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' B' ' 91' ' ' ASP . 20.7 tptm -122.4 151.73 40.93 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.518 ' HB2' ' H ' ' B' ' 18' ' ' THR . 30.0 p90 -105.07 147.3 28.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.863 -1.148 . . . . 0.0 111.555 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -120.82 -25.07 5.5 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 94.9 mt-10 -89.21 -55.06 3.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.4 t0 150.5 72.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.518 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.9 m -59.11 110.3 1.02 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.105 0.955 . . . . 0.0 112.85 -176.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.729 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -81.4 92.46 6.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 175.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' H ' HG22 ' B' ' 20' ' ' VAL . 11.7 m -58.37 -32.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.609 -0.682 . . . . 0.0 110.43 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -66.49 -39.23 88.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.533 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 77.6 mm-40 -67.75 -34.07 76.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.74 -44.49 93.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -53.63 -37.16 62.8 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.93 -31.95 70.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -81.96 -43.7 8.08 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -56.82 -58.04 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.589 -0.947 . . . . 0.0 108.832 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.536 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 9.4 pt-20 -51.68 -44.31 63.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.632 HD21 HD11 ' B' ' 78' ' ' LEU . 14.7 t30 -61.22 -43.31 99.08 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.761 HD22 HD23 ' B' ' 78' ' ' LEU . 1.0 OUTLIER -50.13 -43.61 51.93 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' B' ' 34' ' ' ILE . 40.6 t -51.05 -27.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.266 -0.896 . . . . 0.0 108.847 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.474 ' C ' ' O ' ' B' ' 31' ' ' VAL . 48.0 t -40.59 -43.34 1.87 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.525 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 29.9 mm100 -75.3 -23.35 57.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.425 -0.797 . . . . 0.0 111.517 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.656 HG22 ' O ' ' B' ' 34' ' ' ILE . 30.0 mm -85.45 25.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 119.995 -1.69 . . . . 0.0 110.605 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.3 p30 -60.63 -8.91 3.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' B' ' 38' ' ' LYS . 64.8 p -74.04 -3.43 29.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.963 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.554 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.6 m 36.03 30.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.13 -0.981 . . . . 0.0 109.135 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' B' ' 36' ' ' THR . 74.2 mttt -118.77 39.7 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 13.1 t -171.18 170.79 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -147.51 157.37 43.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.521 -1.362 . . . . 0.0 111.934 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.564 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 57.1 mt-10 -151.69 119.89 6.32 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.349 0.595 . . . . 0.0 110.282 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.702 ' CD1' ' N ' ' B' ' 43' ' ' GLY . 0.0 OUTLIER -130.03 164.55 24.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.07 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . 0.702 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -134.32 174.24 21.03 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.749 -1.691 . . . . 0.0 110.885 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 0.2 OUTLIER -152.92 140.92 20.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -1.142 . . . . 0.0 109.387 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -104.99 140.42 38.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.529 ' CD ' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -135.0 103.78 5.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.388 -1.445 . . . . 0.0 109.769 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -147.07 25.68 1.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.322 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.468 ' H ' ' CB ' ' B' ' 53' ' ' ARG . 11.7 p -89.18 -106.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.932 . . . . 0.0 110.107 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' B' ' 53' ' ' ARG . 76.4 m80 -92.22 147.98 22.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.157 -0.964 . . . . 0.0 109.699 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.1 p-10 -53.36 -43.29 67.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 110.799 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 1.9 tpt -75.02 -32.34 61.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.732 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 95' ' ' LEU . 46.2 mt -90.05 -54.58 3.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.682 -1.261 . . . . 0.0 109.324 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.742 ' C ' ' H ' ' B' ' 55' ' ' GLY . 12.9 ptt180 -62.47 1.33 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.354 -0.841 . . . . 0.0 111.247 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.496 ' NE2' HG11 ' A' ' 94' ' ' VAL . 0.4 OUTLIER 56.01 -17.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.821 -1.174 . . . . 0.0 110.194 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.742 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 88.07 -22.84 16.69 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.455 -0.778 . . . . 0.0 112.795 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' B' ' 55' ' ' GLY . 3.5 m-85 -61.52 -133.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.272 -1.723 . . . . 0.0 109.962 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' B' ' 58' ' ' HIS . 3.0 t -161.56 -36.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.194 -0.941 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.651 ' HA ' ' O ' ' B' ' 44' ' ' GLU . 34.9 t-80 -166.6 149.52 6.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 0.0 110.206 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.535 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -142.68 167.76 21.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.764 . . . . 0.0 109.272 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' B' ' 58' ' ' HIS . 92.0 m-85 -138.28 134.84 34.85 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.446 -0.784 . . . . 0.0 109.094 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.539 ' OG ' ' CZ3' ' B' ' 42' ' ' TRP . 1.4 m -116.5 104.91 11.9 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 61.6 mtt -95.49 125.79 40.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.209 -0.932 . . . . 0.0 110.73 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 39.2 m -119.18 140.6 49.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -126.87 127.86 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.247 . . . . 0.0 110.029 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -50.54 -26.44 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -171.52 173.02 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.98 -19.16 60.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 111.435 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.84 90.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.827 -1.171 . . . . 0.0 110.571 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.56 59.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.594 ' O ' HG22 ' B' ' 74' ' ' THR . 74.3 t80 -65.59 -42.94 91.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.594 -0.945 . . . . 0.0 110.425 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.69 -28.99 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.38 -1.45 . . . . 0.0 108.671 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 109.356 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.0 OUTLIER -53.67 -39.23 64.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 111.221 -177.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.594 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.0 t -79.67 -29.64 40.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.779 -1.201 . . . . 0.0 110.341 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.6 m -65.59 -25.29 67.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.987 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' B' ' 78' ' ' LEU . 57.5 t-80 -79.19 125.08 84.12 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.29 -6.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.696 2.264 . . . . 0.0 112.433 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.761 HD23 HD22 ' B' ' 30' ' ' LEU . 6.1 tp -75.62 -25.42 56.91 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.369 -0.832 . . . . 0.0 111.233 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 2.8 t60 -76.87 -42.68 38.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.978 -1.076 . . . . 0.0 110.29 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.728 HG13 ' N ' ' B' ' 81' ' ' GLU . 11.6 p -64.52 -54.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.728 ' N ' HG13 ' B' ' 80' ' ' VAL . 79.0 mm-40 -50.4 -30.95 13.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.618 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' B' ' 86' ' ' PHE . 4.3 m-85 -72.81 -37.08 67.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.849 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.8 m -63.83 -42.28 97.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.128 -0.982 . . . . 0.0 110.082 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -50.39 67.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.029 . . . . 0.0 108.673 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.14 -43.38 82.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' B' ' 82' ' ' PHE . 2.5 m-85 -45.11 -31.01 1.24 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.539 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.7 m -78.9 -63.31 1.45 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -40.0 -24.14 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.645 -0.659 . . . . 0.0 110.074 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.3 m -111.88 7.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.198 -0.939 . . . . 0.0 110.807 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 34.5 mt -120.34 154.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.642 -1.286 . . . . 0.0 110.458 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' B' ' 13' ' ' LYS . 62.2 t0 -103.34 -31.58 9.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.447 ' NZ ' ' CE1' ' B' ' 56' ' ' PHE . 38.1 pttt -150.41 149.41 30.0 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.489 HG23 ' O ' ' B' ' 93' ' ' ILE . 3.9 tp -125.42 122.21 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.647 -1.283 . . . . 0.0 109.727 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.492 HG11 ' NE2' ' A' ' 54' ' ' GLN . 49.8 t -129.98 133.69 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.578 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -139.6 136.83 34.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.291 -1.505 . . . . 0.0 111.73 -178.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.929 HD12 ' N ' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.92 121.09 41.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.335 176.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 68.3 t0 -122.88 128.38 50.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 108.928 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -164.13 139.61 4.87 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.574 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.11 121.01 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.231 1.954 . . . . 0.0 112.294 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 18.6 t -105.96 135.57 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.002 . . . . 0.0 110.036 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.68 75.29 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.73 113.33 24.96 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.677 HG23 ' H ' ' B' ' 104' ' ' LYS . 16.8 m -134.37 -54.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.284 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.677 ' H ' HG23 ' B' ' 103' ' ' VAL . 25.9 mmtm 59.91 -129.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.396 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' B' ' 104' ' ' LYS . 0.9 OUTLIER 72.32 -18.23 0.34 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.217 -0.927 . . . . 0.0 109.02 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.518 ' H ' ' C ' ' B' ' 104' ' ' LYS . 2.0 t 168.55 -41.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.552 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.398 0.618 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.692 HG23 ' N ' ' A' ' 4' ' ' SER . 9.8 t -63.02 -49.8 73.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.181 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.692 ' N ' HG23 ' A' ' 3' ' ' THR . 32.0 t -144.22 -95.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.04 154.05 40.61 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.635 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.05 127.27 53.26 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -1.14 . . . . 0.0 108.037 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.8 ttpm? -108.39 137.83 45.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 112.769 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -124.49 123.21 39.63 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.41 142.27 49.21 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 109.478 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.4 p -129.81 134.74 62.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.42 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.41 129.08 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 m -134.44 161.85 39.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 117.771 -1.572 . . . . 0.0 113.036 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.54 151.24 51.74 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' HB2' ' H ' ' A' ' 18' ' ' THR . 22.5 p90 -109.72 146.99 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.899 -1.125 . . . . 0.0 111.529 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -130.17 -20.24 3.08 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 79.4 mm-40 -91.18 -58.01 2.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.8 m-20 156.52 65.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.5 m -57.4 108.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.075 0.941 . . . . 0.0 112.835 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.65 87.12 3.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 21' ' ' ASP . 26.8 m -61.61 -37.73 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.524 -0.735 . . . . 0.0 110.493 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.465 ' N ' HG23 ' A' ' 20' ' ' VAL . 81.5 m-20 -66.41 -42.16 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.62 -32.48 73.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.14 -38.99 83.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.65 -35.25 60.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.37 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -60.56 -54.4 37.44 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.8 tt -51.33 -47.9 62.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.548 -0.972 . . . . 0.0 108.764 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.14 -37.26 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -61.94 -44.21 97.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.846 HD13 ' NE2' ' A' ' 33' ' ' GLN . 3.0 mm? -50.07 -47.2 53.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.4 t -50.65 -26.32 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.252 -0.905 . . . . 0.0 108.883 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 27.2 t -47.38 -44.23 24.07 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.846 ' NE2' HD13 ' A' ' 30' ' ' LEU . 12.8 pm0 -92.98 -24.32 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.541 ' C ' ' H ' ' A' ' 36' ' ' THR . 9.3 mt -71.55 26.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 119.983 -1.698 . . . . 0.0 110.631 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' GLN . 88.9 m-20 -62.84 -7.33 4.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' LYS . 50.8 p -71.93 -5.83 37.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.949 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.59 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.7 m 33.51 31.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.63 ' N ' ' O ' ' A' ' 36' ' ' THR . 6.0 mtmp? -117.35 38.61 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 72.8 m -173.63 177.29 2.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.434 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.3 m-85 -146.88 155.94 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.574 -1.329 . . . . 0.0 112.016 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 85.4 mt-10 -158.69 129.26 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.43 0.633 . . . . 0.0 110.17 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.54 177.29 8.57 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.8 162.26 22.37 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.727 -1.701 . . . . 0.0 110.816 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.628 ' N ' ' CE1' ' A' ' 58' ' ' HIS . 72.3 mt-10 -145.93 138.18 25.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -1.168 . . . . 0.0 109.438 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.14 149.28 43.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' H ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.99 81.16 0.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.396 -1.44 . . . . 0.0 109.824 -176.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -115.37 56.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.643 -0.661 . . . . 0.0 109.33 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 49' ' ' HIS . 38.5 t -150.95 83.59 1.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.203 -0.935 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.701 ' N ' HH21 ' A' ' 53' ' ' ARG . 79.1 m-70 56.83 118.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 96.6 m-20 -44.61 -33.88 1.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.339 -0.85 . . . . 0.0 110.726 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -76.94 -32.0 57.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.026 . . . . 0.0 110.714 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 95' ' ' LEU . 62.9 mt -96.32 -12.38 24.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.732 -1.23 . . . . 0.0 109.333 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.701 HH21 ' N ' ' A' ' 49' ' ' HIS . 5.9 ptp180 -95.78 2.15 53.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.311 -0.868 . . . . 0.0 111.263 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' PHE . 95.1 mm-40 44.13 19.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.82 -1.175 . . . . 0.0 110.169 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.757 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 48.75 3.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.759 0 O-C-N 121.424 -0.797 . . . . 0.0 112.914 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.757 ' O ' ' O ' ' A' ' 55' ' ' GLY . 33.2 m-85 -49.94 -143.73 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.229 -1.748 . . . . 0.0 109.987 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 93.0 m -135.93 -55.88 0.77 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.951 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.628 ' CE1' ' N ' ' A' ' 44' ' ' GLU . 13.0 t60 -168.41 152.88 6.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.879 -1.138 . . . . 0.0 110.156 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.549 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.06 115.86 10.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.231 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.29 131.67 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.118 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -121.8 122.0 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 110.749 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -122.7 143.2 49.95 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -117.73 159.81 22.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.788 -1.195 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.69 -28.91 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -174.53 -178.1 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.94 -27.09 67.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 111.453 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.02 -43.98 97.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.78 -1.2 . . . . 0.0 110.548 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.44 67.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.597 ' O ' HG22 ' A' ' 74' ' ' THR . 71.2 t80 -67.02 -45.2 78.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.982 . . . . 0.0 110.467 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.75 -28.97 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.36 -1.462 . . . . 0.0 108.671 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.347 -0.845 . . . . 0.0 109.331 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.609 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.06 -50.15 73.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 111.108 -177.274 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 8.6 t -62.63 -28.17 69.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.805 -1.184 . . . . 0.0 110.304 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -61.95 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.0 110.897 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.626 ' NE2' ' NE2' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -121.94 151.19 57.63 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.787 -1.196 . . . . 0.0 109.578 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.43 12.53 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.575 2.184 . . . . 0.0 112.433 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.685 HD22 HE22 ' A' ' 33' ' ' GLN . 0.7 OUTLIER -75.98 -29.71 58.32 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 111.251 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' SER . 35.6 t-80 -85.22 -41.65 15.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.952 -1.093 . . . . 0.0 110.282 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -57.88 -58.46 6.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.961 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.762 ' H ' HG13 ' A' ' 80' ' ' VAL . 14.9 tm-20 -58.01 -39.33 78.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.137 -0.977 . . . . 0.0 109.593 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.91 -40.74 71.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.915 . . . . 0.0 109.879 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' HIS . 86.8 p -61.56 -38.16 86.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 110.218 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.93 63.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.973 -1.079 . . . . 0.0 108.725 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.26 -40.82 77.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.476 ' O ' HD12 ' A' ' 90' ' ' ILE . 24.8 t80 -44.53 -30.49 0.9 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.0 m -83.31 -61.84 1.74 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -36.87 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.741 -0.6 . . . . 0.0 110.07 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 87' ' ' THR . 12.6 m -101.93 16.53 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 110.819 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 87' ' ' THR . 73.7 mt -124.43 159.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.655 -1.278 . . . . 0.0 110.51 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 90' ' ' ILE . 62.8 t0 -102.32 -34.53 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.462 ' N ' HG22 ' A' ' 90' ' ' ILE . 29.4 pttt -145.78 143.71 29.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 93' ' ' ILE . 4.0 tp -121.54 122.06 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.649 -1.282 . . . . 0.0 109.774 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.78 130.43 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -135.34 131.75 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.258 -1.526 . . . . 0.0 111.811 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -122.75 126.97 48.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.377 177.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -125.81 133.35 52.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.098 -1.001 . . . . 0.0 108.899 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 63.8 t80 -155.42 128.73 4.38 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.108 -0.995 . . . . 0.0 110.476 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.533 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 81.8 Cg_exo -46.08 133.58 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.308 2.006 . . . . 0.0 112.176 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.61 129.33 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -101.39 82.14 2.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.435 -0.79 . . . . 0.0 109.585 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -65.25 76.69 0.06 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.177 -0.952 . . . . 0.0 109.568 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.763 ' O ' ' C ' ' A' ' 104' ' ' LYS . 16.3 m -154.26 -28.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.436 -0.79 . . . . 0.0 109.271 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.763 ' C ' ' O ' ' A' ' 103' ' ' VAL . 55.2 mmtt -4.52 -106.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 0.0 109.396 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m 67.04 -8.99 0.4 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.095 -1.003 . . . . 0.0 108.891 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 104' ' ' LYS . 25.5 t -55.76 133.5 50.99 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.4 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 107' ' ' VAL . 14.6 p . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.84 154.23 41.24 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.26 127.13 52.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.203 -1.175 . . . . 0.0 108.021 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.534 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.8 ttpm? -108.14 137.93 45.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.96 -1.087 . . . . 0.0 112.816 -177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -124.7 123.19 39.48 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.39 142.27 49.22 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 109.475 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.436 HG13 ' O ' ' B' ' 10' ' ' VAL . 10.3 p -129.7 134.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.629 -0.67 . . . . 0.0 109.523 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.23 129.08 68.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.37 162.09 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.001 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.79 151.06 51.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.489 ' HB2' ' H ' ' B' ' 18' ' ' THR . 22.3 p90 -109.56 146.92 33.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.867 -1.146 . . . . 0.0 111.583 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.04 -20.37 3.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 79.3 mm-40 -91.08 -57.92 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.8 m-20 156.39 65.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.489 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -57.12 108.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.088 0.947 . . . . 0.0 112.86 -176.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.566 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -76.82 87.13 3.41 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 175.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.472 HG23 ' N ' ' B' ' 21' ' ' ASP . 27.1 m -61.75 -37.58 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.573 -0.704 . . . . 0.0 110.518 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.472 ' N ' HG23 ' B' ' 20' ' ' VAL . 80.7 m-20 -66.32 -42.31 88.41 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 110.552 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.59 -32.44 73.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.15 -39.0 83.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 tp -53.71 -35.19 60.89 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.43 74.96 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -60.52 -54.34 37.94 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.584 HD23 ' O ' ' B' ' 27' ' ' LEU . 1.8 tt -51.34 -47.85 62.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -55.24 -37.03 66.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -62.15 -44.04 97.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.865 HD13 ' NE2' ' B' ' 33' ' ' GLN . 3.0 mm? -50.21 -47.09 54.97 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 32' ' ' SER . 86.3 t -50.71 -26.26 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.326 -0.858 . . . . 0.0 108.879 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 27.9 t -47.34 -44.48 23.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.865 ' NE2' HD13 ' B' ' 30' ' ' LEU . 12.9 pm0 -92.75 -24.35 18.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.812 . . . . 0.0 111.54 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' B' ' 36' ' ' THR . 9.6 mt -71.66 26.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 119.976 -1.703 . . . . 0.0 110.541 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' B' ' 33' ' ' GLN . 89.6 m-20 -63.02 -7.22 4.93 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.627 ' O ' ' N ' ' B' ' 38' ' ' LYS . 49.9 p -71.83 -6.11 39.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.987 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.574 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.8 m 33.72 31.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.012 -1.055 . . . . 0.0 109.189 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' B' ' 36' ' ' THR . 5.9 mtmp? -117.39 38.65 3.51 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.541 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 72.7 m -173.66 177.26 2.55 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.6 m-85 -147.06 155.77 42.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.555 -1.341 . . . . 0.0 111.912 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 85.6 mt-10 -158.58 129.1 6.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.332 0.587 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.36 177.48 8.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.93 162.35 22.45 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 118.69 -1.719 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.637 ' N ' ' CE1' ' B' ' 58' ' ' HIS . 71.7 mt-10 -145.97 138.24 25.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -1.134 . . . . 0.0 109.34 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -121.07 149.33 42.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.568 ' H ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -71.05 81.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.412 -1.43 . . . . 0.0 109.809 -177.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -115.35 56.93 0.74 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.539 ' O ' ' O ' ' B' ' 49' ' ' HIS . 39.8 t -151.1 83.63 1.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.949 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.699 ' N ' HH21 ' B' ' 53' ' ' ARG . 78.6 m-70 56.86 118.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.121 -0.987 . . . . 0.0 109.702 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.545 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 97.4 m-20 -44.68 -33.89 2.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 110.847 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.401 ' HG2' ' H ' ' B' ' 51' ' ' MET . 2.7 ptt? -76.86 -32.0 57.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.063 -1.023 . . . . 0.0 110.751 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 95' ' ' LEU . 63.0 mt -96.29 -12.41 24.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.709 -1.245 . . . . 0.0 109.258 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.699 HH21 ' N ' ' B' ' 49' ' ' HIS . 6.1 ptp180 -95.76 1.97 53.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 111.281 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' B' ' 56' ' ' PHE . 94.9 mm-40 44.37 19.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.8 -1.187 . . . . 0.0 110.168 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.768 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 48.9 3.26 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.477 -0.764 . . . . 0.0 112.893 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' O ' ' B' ' 55' ' ' GLY . 33.0 m-85 -49.91 -143.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.252 -1.734 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 93.0 m -135.8 -55.87 0.78 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.312 -0.868 . . . . 0.0 110.964 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.637 ' CE1' ' N ' ' B' ' 44' ' ' GLU . 13.0 t60 -168.39 153.22 6.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.203 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.36 116.06 10.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.509 -0.744 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -89.42 131.68 35.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.069 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -121.89 121.3 36.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -114.95 134.66 54.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.218 -0.926 . . . . 0.0 110.757 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 40' ' ' PHE . 32.6 m -122.88 143.34 49.94 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -117.83 159.59 22.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.693 -1.254 . . . . 0.0 110.036 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.46 -29.24 46.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -174.22 -178.17 1.4 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.83 -27.12 67.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.949 . . . . 0.0 111.469 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -61.92 -44.02 97.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.782 -1.199 . . . . 0.0 110.593 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.27 -32.7 68.65 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.585 ' O ' HG22 ' B' ' 74' ' ' THR . 71.6 t80 -66.7 -45.38 78.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.939 . . . . 0.0 110.459 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.81 -28.92 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.411 -1.43 . . . . 0.0 108.697 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.421 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.08 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.325 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.596 ' O ' ' CE1' ' B' ' 76' ' ' HIS . 0.0 OUTLIER -57.06 -49.98 74.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.224 -0.923 . . . . 0.0 111.107 -177.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.594 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 8.6 t -62.85 -28.13 69.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 110.311 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 84.5 p -62.05 16.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.96 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.626 ' NE2' ' NE2' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -121.83 150.97 56.95 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.868 -1.145 . . . . 0.0 109.585 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.19 12.6 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.604 2.203 . . . . 0.0 112.48 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.663 HD22 HE22 ' B' ' 33' ' ' GLN . 0.7 OUTLIER -76.08 -29.72 58.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.435 -0.79 . . . . 0.0 111.22 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' B' ' 83' ' ' SER . 35.4 t-80 -85.21 -41.71 15.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.935 -1.103 . . . . 0.0 110.22 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.778 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.2 p -57.9 -58.56 5.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 110.031 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.778 ' H ' HG13 ' B' ' 80' ' ' VAL . 14.9 tm-20 -57.84 -39.4 77.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.544 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.8 -40.89 72.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 109.894 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . 0.437 ' N ' ' O ' ' B' ' 79' ' ' HIS . 87.2 p -61.5 -38.14 86.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.24 60.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.011 -1.056 . . . . 0.0 108.675 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -41.18 78.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.466 ' O ' HD12 ' B' ' 90' ' ' ILE . 24.6 t80 -44.24 -30.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 89' ' ' VAL . 6.1 m -83.35 -61.77 1.76 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.06 -26.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.604 . . . . 0.0 110.061 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' B' ' 87' ' ' THR . 12.7 m -102.15 16.27 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.18 -0.95 . . . . 0.0 110.769 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' B' ' 87' ' ' THR . 73.4 mt -124.32 159.17 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.643 -1.285 . . . . 0.0 110.417 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.521 ' N ' HG22 ' B' ' 90' ' ' ILE . 63.0 t0 -102.3 -34.47 9.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.458 ' N ' HG22 ' B' ' 90' ' ' ILE . 29.2 pttt -145.94 143.55 29.6 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.49 ' O ' HG23 ' B' ' 93' ' ' ILE . 4.0 tp -121.4 122.2 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.64 -1.287 . . . . 0.0 109.772 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.93 130.44 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.461 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -135.37 131.67 36.64 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.307 -1.495 . . . . 0.0 111.76 -178.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.881 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -122.73 127.24 48.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -126.05 133.3 51.76 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.078 -1.014 . . . . 0.0 108.91 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 64.2 t80 -155.24 128.74 4.44 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . 0.531 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 80.5 Cg_exo -46.18 133.39 15.22 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.314 2.009 . . . . 0.0 112.241 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 74.8 t -107.42 129.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 110.007 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -101.5 81.94 2.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 109.577 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 76.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.783 ' O ' ' C ' ' B' ' 104' ' ' LYS . 16.2 m -154.22 -28.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.783 ' C ' ' O ' ' B' ' 103' ' ' VAL . 54.5 mmtt -4.54 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m 67.22 -8.97 0.42 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.149 -0.969 . . . . 0.0 108.949 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.544 ' H ' ' C ' ' B' ' 104' ' ' LYS . 26.2 t -55.83 133.27 51.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.603 HG22 ' O ' ' B' ' 107' ' ' VAL . 14.7 p . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 t -103.38 -9.85 19.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.109 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -152.78 -86.36 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.48 -159.29 7.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -142.56 142.38 32.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -1.13 . . . . 0.0 108.051 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.44 141.89 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 112.831 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -126.73 128.95 47.46 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.0 tt -135.37 142.77 45.78 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.755 -1.216 . . . . 0.0 109.436 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 12.7 p -131.11 139.5 50.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.05 127.34 72.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.05 144.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.825 -1.55 . . . . 0.0 113.068 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 37.2 tptt -111.76 150.5 30.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HB2' ' H ' ' A' ' 18' ' ' THR . 18.4 p90 -107.0 147.5 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.823 -1.173 . . . . 0.0 111.607 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.76 -26.36 4.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 65.0 tt0 -88.19 -56.94 3.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.0 p30 152.63 70.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 41.8 m -55.12 106.88 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.142 0.972 . . . . 0.0 112.821 -177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.589 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.95 88.56 1.86 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.5 m -59.53 -40.95 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.705 . . . . 0.0 110.458 -176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.551 ' N ' HG23 ' A' ' 20' ' ' VAL . 92.4 m-20 -61.01 -44.24 97.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.411 -0.806 . . . . 0.0 110.557 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.48 -39.12 62.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.5 -50.71 70.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.86 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.2 tm? -56.48 -42.61 78.53 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 24' ' ' LEU . 5.1 ttpt -60.13 -25.05 65.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.68 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -69.21 -54.82 11.89 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 27' ' ' LEU . 6.8 tt -44.33 -38.33 3.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.512 -0.993 . . . . 0.0 108.818 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -52.87 -41.82 64.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -57.41 -42.43 82.29 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.641 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -50.22 -46.29 54.48 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' SER . 34.4 t -48.91 -24.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.332 -0.855 . . . . 0.0 108.908 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 42.4 t -43.24 -43.15 4.65 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 97.0 mm-40 -76.18 -22.42 55.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 111.464 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.756 HG22 ' O ' ' A' ' 34' ' ' ILE . 71.9 mt -79.73 20.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.033 -1.667 . . . . 0.0 110.645 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.47 -10.47 1.46 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.581 ' N ' ' C ' ' A' ' 34' ' ' ILE . 35.0 p -82.24 0.44 41.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.963 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.577 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.3 m 34.94 33.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.046 -1.034 . . . . 0.0 109.117 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 mtmp? -119.61 42.01 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' PHE . 30.1 t -175.97 175.5 1.94 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.4 m-85 -150.53 159.72 44.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.591 -1.318 . . . . 0.0 111.99 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 86.1 mt-10 -159.24 130.82 6.28 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.364 0.602 . . . . 0.0 110.2 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -133.78 171.61 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' GLU . . . -134.45 168.21 23.57 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 118.672 -1.728 . . . . 0.0 110.793 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.618 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 87.4 mt-10 -156.82 152.5 26.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -1.114 . . . . 0.0 109.341 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.893 ' HA ' ' O ' ' A' ' 57' ' ' THR . 23.9 t0 -157.16 87.5 0.99 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -90.35 170.01 10.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.393 -1.442 . . . . 0.0 109.882 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.699 -0.625 . . . . 0.0 109.317 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.426 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 4.2 t -78.75 -125.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.0 110.164 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -77.63 153.9 32.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.721 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.47 -41.57 69.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 110.759 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.516 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.17 -40.61 90.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.969 -1.082 . . . . 0.0 110.737 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' B' ' 95' ' ' LEU . 44.8 mt -75.86 -64.62 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.745 -1.222 . . . . 0.0 109.303 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -67.72 18.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 0.0 111.233 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' A' ' 52' ' ' LEU . 1.7 mm100 45.33 8.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.701 -1.249 . . . . 0.0 110.164 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 70.3 -11.54 2.12 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.503 -0.748 . . . . 0.0 112.936 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.656 ' O ' ' O ' ' A' ' 55' ' ' GLY . 49.4 m-85 -53.92 -136.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.288 -1.713 . . . . 0.0 109.92 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.893 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 6.1 t -163.28 -51.45 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 110.903 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 60' ' ' PHE . 6.3 t60 -148.37 142.5 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 0.0 110.149 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.69 163.06 33.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 0.0 109.231 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 58' ' ' HIS . 94.9 m-85 -133.78 131.17 39.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.083 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' A' ' 42' ' ' TRP . 1.6 m -116.59 110.39 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.13 132.38 53.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.209 -0.932 . . . . 0.0 110.838 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -119.01 141.44 48.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.24 158.5 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.689 -1.257 . . . . 0.0 110.097 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -75.66 -26.42 57.67 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -175.39 -177.34 1.01 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -66.61 -23.73 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 111.355 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.7 -41.04 97.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.763 -1.21 . . . . 0.0 110.577 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.57 65.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.805 ' O ' HG22 ' A' ' 74' ' ' THR . 76.0 t80 -69.39 -43.22 73.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.496 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.82 -28.89 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.423 -1.423 . . . . 0.0 108.642 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.08 -60.9 2.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.299 -0.876 . . . . 0.0 109.358 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.72 -57.74 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.875 . . . . 0.0 111.145 -178.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 70' ' ' TYR . 9.2 t -57.27 -35.57 69.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.775 -1.203 . . . . 0.0 110.293 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 58.4 m -66.69 -32.94 74.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.0 110.964 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 78' ' ' LEU . 59.3 m80 -68.43 128.76 93.03 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.83 -1.169 . . . . 0.0 109.601 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.34 -8.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 112.443 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.7 tp -66.77 -28.41 68.37 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.34 -0.85 . . . . 0.0 111.291 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.75 -35.32 24.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.012 . . . . 0.0 110.247 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.97 -61.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -58.62 -38.66 78.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.604 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 78.0 t80 -68.48 -44.28 75.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.872 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 t -59.87 -35.48 74.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.968 -1.082 . . . . 0.0 108.682 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.75 -42.14 77.94 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 85' ' ' ALA . 6.5 t80 -43.53 -30.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.4 m -83.05 -61.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.84 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.639 -0.663 . . . . 0.0 110.008 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.7 m -102.69 11.37 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.19 -0.944 . . . . 0.0 110.746 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 44.8 mt -125.74 158.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.596 -1.315 . . . . 0.0 110.53 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 60.6 t0 -104.22 -32.33 9.17 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 13' ' ' LYS . 9.1 pttp -148.87 147.0 28.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.8 tp -127.43 127.58 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.579 -1.326 . . . . 0.0 109.763 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 48.3 t -132.18 135.51 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -135.6 130.28 34.19 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 111.759 -178.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.584 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.72 127.34 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.65 -0.656 . . . . 0.0 109.387 177.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 54.6 m-20 -123.06 125.08 44.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 108.908 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -146.7 127.26 7.01 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.053 -1.029 . . . . 0.0 110.501 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.42 123.61 9.44 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.31 2.007 . . . . 0.0 112.22 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.47 132.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.62 80.51 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 84.51 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.632 ' O ' ' O ' ' A' ' 104' ' ' LYS . 17.2 m -147.11 -22.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.177 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.632 ' O ' ' O ' ' A' ' 103' ' ' VAL . 24.8 mtmt 41.33 102.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.328 -0.858 . . . . 0.0 109.358 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -50.74 -50.8 54.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.15 -0.969 . . . . 0.0 108.934 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.1 t 45.78 29.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.385 -0.822 . . . . 0.0 109.378 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.75 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.49 -159.06 7.79 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.687 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -142.81 142.37 31.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -1.136 . . . . 0.0 108.029 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.61 141.64 47.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.932 -1.105 . . . . 0.0 112.819 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.5 128.91 47.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.0 tt -135.42 142.75 45.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.789 -1.195 . . . . 0.0 109.439 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 12.5 p -131.01 139.53 50.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.627 -0.671 . . . . 0.0 109.523 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.09 127.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.03 144.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 117.738 -1.585 . . . . 0.0 113.019 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 36.8 tptt -111.92 150.42 30.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 18.4 p90 -106.91 147.36 29.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 111.575 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.6 -26.39 4.55 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 65.4 tt0 -88.18 -56.83 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.1 p30 152.45 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.459 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 40.1 m -55.38 106.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.059 0.933 . . . . 0.0 112.901 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.6 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.01 88.4 1.88 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.4 m -59.52 -40.65 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 110.434 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.528 ' N ' HG23 ' B' ' 20' ' ' VAL . 92.0 m-20 -61.22 -44.42 97.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 110.54 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -74.23 -38.99 63.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.79 -50.37 71.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.858 ' C ' HD13 ' B' ' 24' ' ' LEU . 2.2 tm? -56.86 -42.5 79.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -60.11 -25.15 65.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.688 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -69.15 -54.62 12.9 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.711 HD23 ' O ' ' B' ' 27' ' ' LEU . 6.8 tt -44.43 -38.29 3.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.551 -0.97 . . . . 0.0 108.831 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -52.96 -41.87 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.688 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.7 p30 -57.28 -42.57 81.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.638 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -50.07 -46.62 53.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' B' ' 34' ' ' ILE . 33.6 t -48.53 -24.74 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 44.2 t -43.15 -43.31 4.52 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.477 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 97.0 mm-40 -75.91 -22.74 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.429 -0.795 . . . . 0.0 111.52 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.766 HG22 ' O ' ' B' ' 34' ' ' ILE . 72.5 mt -79.3 20.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.955 -1.715 . . . . 0.0 110.586 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.57 -10.58 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.568 ' O ' ' N ' ' B' ' 38' ' ' LYS . 34.6 p -82.09 0.36 40.97 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 35.17 33.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.079 -1.013 . . . . 0.0 109.24 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.8 mtmp? -119.72 42.13 2.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.425 ' O ' ' CG ' ' B' ' 40' ' ' PHE . 30.8 t -176.04 175.21 1.96 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.454 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.9 m-85 -150.41 159.26 44.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.511 -1.368 . . . . 0.0 111.953 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 86.1 mt-10 -158.84 130.78 6.59 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.315 0.578 . . . . 0.0 110.221 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . 0.688 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.0 OUTLIER -133.7 171.6 13.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.46 168.41 23.49 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.666 -1.731 . . . . 0.0 110.751 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.615 ' O ' ' CG ' ' B' ' 58' ' ' HIS . 87.1 mt-10 -156.94 152.42 26.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -1.202 . . . . 0.0 109.41 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.888 ' HA ' ' O ' ' B' ' 57' ' ' THR . 24.4 t0 -156.99 87.85 1.01 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' H ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -90.83 170.15 10.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.368 -1.457 . . . . 0.0 109.818 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.09 0.43 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.425 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 4.7 t -78.55 -125.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 110.118 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -78.18 153.73 31.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.17 -41.79 69.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 110.822 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -66.1 -40.42 90.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.033 . . . . 0.0 110.768 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 95' ' ' LEU . 45.5 mt -76.09 -64.31 1.12 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.729 -1.232 . . . . 0.0 109.295 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.4 OUTLIER -68.12 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.38 -0.825 . . . . 0.0 111.218 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' B' ' 52' ' ' LEU . 1.7 mm100 45.13 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.735 -1.228 . . . . 0.0 110.195 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.669 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 70.42 -12.05 2.01 Favored Glycine 0 N--CA 1.5 2.914 0 O-C-N 121.496 -0.753 . . . . 0.0 112.811 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.669 ' O ' ' O ' ' B' ' 55' ' ' GLY . 49.8 m-85 -53.66 -136.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.242 -1.74 . . . . 0.0 109.916 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.888 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 6.3 t -163.0 -51.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.641 ' CD2' ' CZ ' ' B' ' 60' ' ' PHE . 6.2 t60 -148.44 142.45 25.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.938 -1.101 . . . . 0.0 110.175 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.52 163.1 33.85 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.487 -0.758 . . . . 0.0 109.294 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' B' ' 58' ' ' HIS . 95.2 m-85 -133.71 131.02 38.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.151 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' B' ' 42' ' ' TRP . 1.6 m -116.39 110.6 18.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.56 132.51 53.18 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 110.743 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -119.05 141.42 48.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.28 158.49 26.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.736 -1.228 . . . . 0.0 110.013 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -75.76 -26.48 57.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -175.28 -177.42 1.03 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.43 -23.74 66.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.69 -41.2 97.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.814 -1.179 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.28 -31.71 65.9 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.816 ' O ' HG22 ' B' ' 74' ' ' THR . 76.6 t80 -69.07 -43.53 74.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.56 -0.965 . . . . 0.0 110.474 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.88 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.47 -1.394 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.51 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.1 -60.85 2.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.632 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -57.43 -57.94 10.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 111.146 -178.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.816 HG22 ' O ' ' B' ' 70' ' ' TYR . 9.1 t -57.33 -35.21 69.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.368 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 58.5 m -66.93 -32.97 74.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' B' ' 78' ' ' LEU . 59.4 m80 -68.44 128.55 93.05 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.887 -1.133 . . . . 0.0 109.629 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -42.98 -8.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.644 2.229 . . . . 0.0 112.513 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.6 tp -66.56 -28.59 68.64 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.387 -0.821 . . . . 0.0 111.211 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -83.65 -35.31 24.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 110.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.05 -61.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.014 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -58.58 -38.72 78.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 77.9 t80 -68.27 -44.54 75.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.838 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -59.77 -35.24 74.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.163 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.16 60.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.978 -1.076 . . . . 0.0 108.742 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -42.15 77.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.474 ' C ' ' O ' ' B' ' 85' ' ' ALA . 6.6 t80 -43.55 -30.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.503 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.0 m -82.98 -61.87 1.75 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.78 -26.92 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.697 -0.627 . . . . 0.0 110.049 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.7 m -102.71 11.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.233 -0.917 . . . . 0.0 110.797 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 43.8 mt -126.0 158.85 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.646 -1.284 . . . . 0.0 110.384 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 60.3 t0 -104.4 -32.25 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' B' ' 13' ' ' LYS . 8.9 pttp -149.0 147.1 28.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.412 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.8 tp -127.67 127.48 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.526 -1.358 . . . . 0.0 109.746 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 48.4 t -132.12 135.28 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -135.4 130.24 34.56 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.254 -1.529 . . . . 0.0 111.792 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.599 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -118.69 127.11 53.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.645 -0.66 . . . . 0.0 109.343 177.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.573 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 55.3 m-20 -122.85 124.87 44.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.031 -1.043 . . . . 0.0 108.85 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.794 ' CD1' ' N ' ' B' ' 98' ' ' PHE . 0.0 OUTLIER -146.37 127.45 7.29 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.097 -1.002 . . . . 0.0 110.502 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.55 123.65 9.65 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.229 1.953 . . . . 0.0 112.248 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.34 132.83 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.69 80.53 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.99 84.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -0.98 . . . . 0.0 109.557 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.627 ' O ' ' O ' ' B' ' 104' ' ' LYS . 17.2 m -147.26 -22.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.196 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.627 ' O ' ' O ' ' B' ' 103' ' ' VAL . 24.5 mtmt 41.02 102.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.344 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.408 ' O ' ' C ' ' B' ' 106' ' ' SER . 15.1 m -50.89 -50.8 56.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.112 -0.993 . . . . 0.0 108.957 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.408 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.0 t 45.94 29.91 0.82 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.362 -0.836 . . . . 0.0 109.413 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 C--N 1.302 -1.482 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.85 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.44 0.638 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -113.51 4.27 16.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.15 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 100' ' ' VAL . 4.3 p -175.84 -113.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.27 173.75 19.12 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.71 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -124.92 128.99 49.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.188 -1.184 . . . . 0.0 108.07 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 20.1 ttpt -104.1 134.26 47.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.057 . . . . 0.0 112.837 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 62' ' ' MET . 85.3 t60 -127.14 125.03 40.47 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.725 -1.234 . . . . 0.0 109.454 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.46 138.05 54.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.6 -0.687 . . . . 0.0 109.444 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 t -119.4 131.64 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 93' ' ' ILE . 5.1 m -136.52 156.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 117.787 -1.565 . . . . 0.0 113.071 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -123.33 153.09 40.77 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.57 ' HB2' ' H ' ' A' ' 18' ' ' THR . 23.7 p90 -110.99 146.61 36.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -21.14 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.5 tt0 -92.82 -57.37 2.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.5 m-20 157.55 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.57 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.9 m -50.95 103.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.045 0.926 . . . . 0.0 112.854 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.89 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -71.1 82.55 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 21' ' ' ASP . 28.8 m -62.37 -40.07 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.635 -0.666 . . . . 0.0 110.458 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 20' ' ' VAL . 91.0 m-20 -66.21 -45.59 80.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 0.0 110.515 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 29.2 mp0 -68.29 -34.09 75.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.11 -43.29 88.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 20' ' ' VAL . 17.9 tp -54.29 -35.92 63.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.28 -33.9 72.99 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -61.33 -52.49 51.24 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.2 tt -46.91 -44.14 19.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.493 -1.004 . . . . 0.0 108.774 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -55.21 -37.65 67.4 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 2.0 m-80 -62.85 -46.04 89.75 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 78' ' ' LEU . 3.4 mm? -48.45 -46.49 37.92 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 32' ' ' SER . 63.1 t -51.3 -26.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.287 -0.883 . . . . 0.0 108.837 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 30.9 t -46.38 -47.97 18.65 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.651 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -86.94 -23.7 25.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 0.0 111.467 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.516 ' C ' ' N ' ' A' ' 36' ' ' THR . 4.6 mm -73.25 23.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.036 -1.665 . . . . 0.0 110.618 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.0 p30 -61.8 -9.31 6.28 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' A' ' 37' ' ' VAL . 64.1 p -71.52 -4.86 29.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.971 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.4 m 32.64 36.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 ptmt -121.96 41.97 3.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 t -174.6 179.07 1.8 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 97.6 m-85 -143.98 153.4 42.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.554 -1.341 . . . . 0.0 111.998 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 61' ' ' SER . 75.5 mt-10 -156.41 124.26 5.57 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.355 0.598 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -134.74 174.15 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.24 145.42 11.7 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 118.777 -1.678 . . . . 0.0 110.832 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.573 ' O ' ' CD2' ' A' ' 58' ' ' HIS . 56.2 mp0 -148.31 164.81 32.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.233 -1.157 . . . . 0.0 109.388 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 57' ' ' THR . 21.4 t70 -113.78 161.1 17.95 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.658 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 3.0 ptmm? -62.01 83.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.43 -1.419 . . . . 0.0 109.771 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.2 mt-10 -128.79 46.87 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.622 -0.674 . . . . 0.0 109.259 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' B' ' 97' ' ' ASP . 5.9 t -142.2 78.71 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.794 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 56.2 m80 56.58 107.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.927 . . . . 0.0 109.678 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -45.66 -35.16 3.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -0.851 . . . . 0.0 110.818 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -71.4 -35.34 70.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.961 -1.087 . . . . 0.0 110.682 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' B' ' 95' ' ' LEU . 84.5 mt -78.76 -51.1 10.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.763 -1.211 . . . . 0.0 109.314 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.794 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.1 ptp180 -64.35 13.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 0.0 111.274 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.513 ' C ' ' O ' ' A' ' 53' ' ' ARG . 82.2 mm-40 37.76 32.19 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.82 -1.175 . . . . 0.0 110.129 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.777 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 59.16 1.83 1.16 Allowed Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.439 -0.788 . . . . 0.0 112.815 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.777 ' O ' ' O ' ' A' ' 55' ' ' GLY . 46.1 m-85 -48.82 -148.15 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.221 -1.753 . . . . 0.0 109.884 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 50.4 m -143.37 -56.72 0.4 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.331 -0.855 . . . . 0.0 110.957 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.632 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 15.2 t-80 -158.21 145.98 18.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.116 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -132.04 148.91 52.53 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.264 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 58' ' ' HIS . 34.8 m-85 -118.91 119.71 35.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.48 -0.762 . . . . 0.0 109.04 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 7.1 t -88.94 95.35 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.0 mtp -102.37 110.62 22.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.228 -0.92 . . . . 0.0 110.813 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -125.63 145.87 49.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.6 160.52 21.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.17 . . . . 0.0 110.068 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 85.5 tt0 -81.99 -31.95 30.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.4 m-20 -163.18 174.32 12.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.63 -27.14 62.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 111.417 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.49 -36.73 66.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.869 -1.144 . . . . 0.0 110.538 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.74 -35.35 73.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.612 ' O ' HG22 ' A' ' 74' ' ' THR . 70.4 t80 -61.68 -44.34 97.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.508 -0.995 . . . . 0.0 110.5 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.88 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.379 -1.451 . . . . 0.0 108.661 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.94 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.365 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.59 -39.94 58.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 111.129 -177.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.619 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.5 t -80.79 -29.81 36.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.725 -1.234 . . . . 0.0 110.264 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.2 t -58.13 -33.64 69.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.984 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 73' ' ' PHE . 13.9 p80 -87.84 141.91 32.0 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.632 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 10.86 1.49 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.652 2.234 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' CD2' HD22 ' A' ' 30' ' ' LEU . 3.6 tt -73.04 -26.86 61.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.801 . . . . 0.0 111.256 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 83' ' ' SER . 9.3 t-80 -85.0 -43.41 13.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.0 110.249 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.787 HG13 ' H ' ' A' ' 81' ' ' GLU . 2.8 p -56.62 -58.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.787 ' H ' HG13 ' A' ' 80' ' ' VAL . 93.5 mt-10 -58.39 -42.27 86.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.94 -39.37 72.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' HIS . 23.6 t -59.83 -38.07 81.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.142 -0.974 . . . . 0.0 110.151 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.55 72.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.923 -1.111 . . . . 0.0 108.65 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.84 -41.59 78.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 85' ' ' ALA . 22.5 t80 -45.04 -30.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 90' ' ' ILE . 3.8 m -84.68 -63.6 1.31 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.09 -27.35 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.65 -0.657 . . . . 0.0 110.089 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 87' ' ' THR . 5.4 p -98.53 16.57 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 91' ' ' ASP . 23.0 mm -130.64 164.02 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.683 -1.26 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.592 ' N ' HG22 ' A' ' 90' ' ' ILE . 40.9 t0 -103.41 -36.76 7.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 90' ' ' ILE . 21.2 pttt -146.96 146.42 30.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.65 HD12 HG12 ' A' ' 12' ' ' VAL . 4.8 tp -128.37 127.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.6 -1.313 . . . . 0.0 109.707 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.2 133.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.65 36.22 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.292 -1.505 . . . . 0.0 111.804 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -125.69 128.99 48.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.675 . . . . 0.0 109.379 177.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.593 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 42.8 t0 -120.01 124.61 46.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.021 -1.049 . . . . 0.0 108.893 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 97' ' ' ASP . 25.1 m-85 -142.31 148.96 49.8 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.986 -1.071 . . . . 0.0 110.531 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.83 130.12 16.4 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.244 1.963 . . . . 0.0 112.201 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.537 ' O ' ' OG ' ' A' ' 4' ' ' SER . 9.9 t -95.22 117.09 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.96 . . . . 0.0 109.994 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -91.31 75.45 6.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.21 71.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.114 -0.992 . . . . 0.0 109.563 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' SER . 29.1 m -149.78 -32.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.266 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 106' ' ' SER . 25.3 mtmt 37.68 -93.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER 66.58 -42.53 0.4 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 108.978 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 104' ' ' LYS . 9.5 m -44.4 104.18 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.277 -0.89 . . . . 0.0 109.336 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.323 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' B' ' 100' ' ' VAL . 4.2 p . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.28 173.7 19.07 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -124.8 129.11 49.8 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.205 -1.174 . . . . 0.0 108.01 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 97' ' ' ASP . 20.2 ttpt -104.23 134.27 47.74 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.311 1.053 . . . . 0.0 112.822 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 85.4 t60 -127.08 125.07 40.66 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.1 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.747 -1.22 . . . . 0.0 109.487 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -130.47 138.02 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.545 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.42 131.52 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.636 HG12 HD12 ' B' ' 93' ' ' ILE . 5.2 m -136.49 156.19 35.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 117.732 -1.587 . . . . 0.0 113.053 -177.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -123.2 153.07 40.58 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.564 ' HB2' ' H ' ' B' ' 18' ' ' THR . 23.7 p90 -111.01 146.54 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 0.0 111.663 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 -21.18 2.9 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -92.96 -57.36 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.5 m-20 157.47 65.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.3 m -50.79 103.32 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.117 0.961 . . . . 0.0 112.844 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.875 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -71.29 82.47 0.75 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.535 HG23 ' N ' ' B' ' 21' ' ' ASP . 28.4 m -62.15 -40.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.585 -0.697 . . . . 0.0 110.433 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.535 ' N ' HG23 ' B' ' 20' ' ' VAL . 91.6 m-20 -66.36 -45.41 80.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.559 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 28.8 mp0 -68.43 -34.1 75.39 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.04 -43.31 89.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 20' ' ' VAL . 17.9 tp -54.14 -36.24 63.09 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.02 -34.03 72.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.582 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -61.42 -52.22 52.79 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.639 HD23 ' O ' ' B' ' 27' ' ' LEU . 2.2 tt -47.12 -43.85 20.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.533 -0.98 . . . . 0.0 108.83 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -55.54 -37.47 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 2.1 m-80 -62.9 -46.13 89.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' B' ' 78' ' ' LEU . 3.4 mm? -48.31 -46.62 36.48 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' B' ' 32' ' ' SER . 62.8 t -51.19 -26.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 108.821 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 31.0 t -46.33 -48.05 18.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.654 ' O ' ' NE2' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -86.97 -23.68 24.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.448 -0.782 . . . . 0.0 111.553 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.516 HD13 ' OE1' ' B' ' 33' ' ' GLN . 4.6 mm -73.16 23.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 119.984 -1.697 . . . . 0.0 110.591 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.2 p30 -61.7 -9.44 6.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.604 ' O ' ' N ' ' B' ' 38' ' ' LYS . 63.0 p -71.46 -4.73 28.2 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.948 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.596 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.3 m 32.61 36.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.044 -1.035 . . . . 0.0 109.144 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.9 ptmt -122.26 42.01 3.25 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -174.51 179.14 1.82 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.1 153.24 41.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.525 -1.359 . . . . 0.0 112.001 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 61' ' ' SER . 74.9 mt-10 -156.3 124.18 5.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.746 -0.596 . . . . 0.0 110.302 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -134.87 174.15 10.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.3 145.54 11.86 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 118.691 -1.719 . . . . 0.0 110.819 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.575 ' O ' ' CD2' ' B' ' 58' ' ' HIS . 56.8 mp0 -148.35 164.72 33.21 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -1.149 . . . . 0.0 109.408 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' B' ' 57' ' ' THR . 21.6 t70 -113.57 161.15 17.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.66 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 3.0 ptmm? -62.03 83.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.421 -1.424 . . . . 0.0 109.805 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.0 mt-10 -128.73 46.75 2.56 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 97' ' ' ASP . 6.1 t -142.13 78.9 1.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 110.179 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.787 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 56.0 m80 56.4 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 109.694 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -45.86 -35.01 4.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.38 -0.825 . . . . 0.0 110.784 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -71.49 -35.2 70.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 0.0 110.739 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' A' ' 95' ' ' LEU . 84.1 mt -78.88 -50.99 10.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.691 -1.256 . . . . 0.0 109.329 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.787 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.1 ptp180 -64.29 13.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 111.291 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' GLN . . . . . 0.514 ' C ' ' O ' ' B' ' 53' ' ' ARG . 82.2 mm-40 37.92 31.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.787 -1.196 . . . . 0.0 110.175 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.775 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 59.49 1.47 1.21 Allowed Glycine 0 N--CA 1.499 2.833 0 O-C-N 121.393 -0.817 . . . . 0.0 112.82 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' PHE . . . . . 0.775 ' O ' ' O ' ' B' ' 55' ' ' GLY . 46.6 m-85 -48.58 -148.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.296 -1.708 . . . . 0.0 109.979 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 49.3 m -143.44 -56.69 0.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.342 -0.849 . . . . 0.0 110.925 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' HIS . . . . . 0.63 ' CE1' ' CE1' ' B' ' 60' ' ' PHE . 14.8 t-80 -158.37 146.21 18.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.91 -1.119 . . . . 0.0 110.157 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.582 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -132.25 148.97 52.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CE1' ' B' ' 58' ' ' HIS . 35.6 m-85 -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.461 -0.775 . . . . 0.0 109.08 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 6.9 t -88.9 95.31 10.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.5 mtp -102.41 110.55 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.195 -0.94 . . . . 0.0 110.787 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -125.56 145.99 49.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -117.73 160.58 21.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.726 -1.234 . . . . 0.0 110.051 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 85.6 tt0 -82.06 -31.86 30.64 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.3 m-20 -163.29 174.2 12.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.58 -27.11 62.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.292 -0.88 . . . . 0.0 111.407 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -55.37 -36.89 66.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.75 -35.43 73.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.609 ' O ' HG22 ' B' ' 74' ' ' THR . 71.3 t80 -61.49 -44.66 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.604 -0.939 . . . . 0.0 110.455 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.69 -29.01 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.348 -1.47 . . . . 0.0 108.695 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.379 -0.826 . . . . 0.0 109.323 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -51.22 -40.21 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -0.921 . . . . 0.0 111.131 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' THR . . . . . 0.62 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.5 t -80.58 -29.96 36.95 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.742 -1.224 . . . . 0.0 110.256 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 38.5 t -57.97 -33.84 69.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.961 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.608 ' NE2' ' O ' ' B' ' 73' ' ' PHE . 13.8 p80 -87.76 141.94 32.17 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.161 . . . . 0.0 109.564 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.68 10.91 1.47 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.662 2.241 . . . . 0.0 112.427 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' B' ' 30' ' ' LEU . 3.5 tt -73.0 -27.01 61.53 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.342 -0.849 . . . . 0.0 111.243 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' SER . 9.3 t-80 -84.96 -43.26 14.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.019 -1.051 . . . . 0.0 110.25 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.777 HG13 ' H ' ' B' ' 81' ' ' GLU . 2.7 p -56.83 -58.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 110.041 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.777 ' H ' HG13 ' B' ' 80' ' ' VAL . 93.5 mt-10 -58.36 -42.49 87.09 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.643 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -70.63 -39.47 73.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.827 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . 0.481 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.7 t -59.72 -38.25 81.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 110.108 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.63 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 108.654 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.76 -41.59 78.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' B' ' 85' ' ' ALA . 22.4 t80 -45.02 -30.88 1.14 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.495 ' O ' ' N ' ' B' ' 90' ' ' ILE . 3.8 m -84.44 -63.73 1.29 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.94 -27.51 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 110.07 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 87' ' ' THR . 5.4 p -98.57 16.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.224 -0.923 . . . . 0.0 110.818 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . 0.601 HG22 ' N ' ' B' ' 91' ' ' ASP . 22.8 mm -130.86 164.1 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.618 -1.301 . . . . 0.0 110.497 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . 0.601 ' N ' HG22 ' B' ' 90' ' ' ILE . 41.9 t0 -103.44 -36.89 7.83 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.468 ' N ' HG22 ' B' ' 90' ' ' ILE . 21.1 pttt -146.95 146.39 30.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . 0.636 HD12 HG12 ' B' ' 12' ' ' VAL . 4.8 tp -128.32 127.56 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.555 -1.341 . . . . 0.0 109.658 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.38 133.11 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.8 36.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.269 -1.52 . . . . 0.0 111.768 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.888 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -125.73 129.06 48.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.629 . . . . 0.0 109.312 177.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' ASP . . . . . 0.596 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 43.3 t0 -119.99 124.6 46.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' PHE . . . . . 0.596 ' CD1' ' O ' ' B' ' 97' ' ' ASP . 24.9 m-85 -142.29 148.91 49.7 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.098 -1.001 . . . . 0.0 110.504 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 130.05 16.41 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.28 1.987 . . . . 0.0 112.187 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.55 ' O ' ' OG ' ' B' ' 4' ' ' SER . 9.5 t -95.15 117.05 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 110.054 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -91.32 75.48 6.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 109.54 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.23 71.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.566 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' B' ' 105' ' ' SER . 29.2 m -149.84 -32.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.5 mtmt 37.71 -93.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.579 ' N ' ' O ' ' B' ' 103' ' ' VAL . 0.9 OUTLIER 66.59 -42.69 0.41 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.968 . . . . 0.0 108.941 -178.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.561 ' N ' ' O ' ' B' ' 104' ' ' LYS . 10.2 m -44.22 104.08 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.35 -0.844 . . . . 0.0 109.386 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.492 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' ' C ' ' A' ' 2' ' ' ALA . 74.6 mmm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 41.28 55.03 3.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.325 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.628 HG23 ' N ' ' A' ' 4' ' ' SER . 8.9 t -63.48 -45.57 90.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.149 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.628 ' N ' HG23 ' A' ' 3' ' ' THR . 19.9 m -139.64 -100.5 0.16 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.22 148.48 34.43 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.689 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.544 ' CZ ' ' OD1' ' A' ' 97' ' ' ASP . 34.6 t80 -114.93 128.09 56.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.268 -1.137 . . . . 0.0 108.032 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.695 ' HZ3' HD12 ' A' ' 9' ' ' LEU . 3.7 ttpp -113.51 142.35 46.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.919 -1.113 . . . . 0.0 112.83 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -132.79 133.42 43.38 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.695 HD12 ' HZ3' ' A' ' 7' ' ' LYS . 6.6 tt -136.63 145.84 45.33 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.75 -1.219 . . . . 0.0 109.461 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.2 p -127.14 133.43 68.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.566 HG12 ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -116.19 129.03 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 57' ' ' THR . 6.4 m -139.45 167.53 19.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.733 -1.587 . . . . 0.0 113.024 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 19.0 tptp -132.85 152.29 51.87 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.473 ' HB2' ' H ' ' A' ' 18' ' ' THR . 39.7 p90 -108.68 149.61 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.877 -1.139 . . . . 0.0 111.576 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -129.29 -22.09 3.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.7 mt-10 -89.27 -57.11 3.0 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.0 t0 153.83 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.473 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 64.6 m -50.93 105.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.104 0.954 . . . . 0.0 112.814 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -75.56 88.16 2.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 21' ' ' ASP . 34.7 m -64.61 -38.57 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.557 -0.714 . . . . 0.0 110.524 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 20' ' ' VAL . 82.9 m-20 -66.1 -44.63 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.425 -0.797 . . . . 0.0 110.572 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.96 -31.39 72.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mt -69.62 -37.44 74.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 13.9 tp -53.22 -37.86 62.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -34.53 74.23 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.02 -53.54 36.41 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -46.82 -47.73 20.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.497 -1.002 . . . . 0.0 108.832 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.49 -44.54 65.7 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -68.59 -49.05 62.33 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.39 -47.81 37.27 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.7 t -49.76 -26.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.268 -0.895 . . . . 0.0 108.887 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 47.0 t -41.64 -42.69 2.57 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.683 HE22 ' CG ' ' A' ' 76' ' ' HIS . 15.2 mm100 -61.23 -11.17 8.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.483 -0.76 . . . . 0.0 111.499 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 34' ' ' ILE . 41.8 mm -81.92 26.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 119.985 -1.697 . . . . 0.0 110.604 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 36' ' ' THR . 31.1 p-10 -67.38 -26.38 66.43 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.711 HG23 ' H ' ' A' ' 38' ' ' LYS . 7.5 t -79.21 1.99 22.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.968 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 21.1 m 37.83 21.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.081 -1.012 . . . . 0.0 109.187 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.711 ' H ' HG23 ' A' ' 36' ' ' THR . 83.0 mttt -120.81 41.26 3.33 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.4 m -158.12 154.75 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.503 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 98.5 m-85 -144.46 154.43 42.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.543 -1.348 . . . . 0.0 111.949 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 81.1 mt-10 -160.88 130.46 4.9 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.335 0.588 . . . . 0.0 110.223 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -130.01 175.27 9.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.8 154.0 21.97 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.574 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 17.8 mt-10 -151.1 141.85 22.77 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -1.146 . . . . 0.0 109.401 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 8.5 p30 -116.02 148.53 40.07 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.64 ' HD3' ' N ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -68.5 80.82 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.481 -1.387 . . . . 0.0 109.809 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 45' ' ' ASP . 78.2 mm-40 -96.91 54.66 1.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.298 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 49' ' ' HIS . 29.7 t -134.14 -138.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -0.934 . . . . 0.0 110.23 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.54 ' N ' ' OG ' ' A' ' 48' ' ' SER . 74.1 m80 -107.37 142.94 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -42.83 -41.11 3.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 0.0 110.798 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 ttt -71.54 -29.37 64.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.016 -1.053 . . . . 0.0 110.703 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' B' ' 95' ' ' LEU . 52.1 mt -98.25 -18.38 18.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.745 -1.222 . . . . 0.0 109.277 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.636 ' C ' ' H ' ' A' ' 55' ' ' GLY . 55.0 mtp180 -73.43 0.58 11.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 111.212 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 55.9 -4.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.797 -1.189 . . . . 0.0 110.197 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 82.53 -18.36 15.2 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.884 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CD2' HG12 ' A' ' 11' ' ' VAL . 12.0 m-85 -59.26 -128.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.246 -1.738 . . . . 0.0 109.922 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.64 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 2.5 t -164.99 -36.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.34 -0.85 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.7 t60 -169.9 153.68 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.166 . . . . 0.0 110.225 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.653 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.18 168.76 18.98 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.392 -0.817 . . . . 0.0 109.261 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 88.1 m-85 -129.03 126.07 38.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 109.073 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.25 14.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 mtt -104.84 117.83 35.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.172 -0.955 . . . . 0.0 110.82 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -120.31 143.24 48.46 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.28 159.66 23.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.691 -1.255 . . . . 0.0 110.069 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.54 -27.45 62.23 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -173.75 -174.57 0.97 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.35 -27.17 65.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 111.445 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 29.1 p-10 -58.04 -37.89 75.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.813 -1.18 . . . . 0.0 110.532 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -68.98 -37.59 83.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' ' CG2' ' A' ' 74' ' ' THR . 71.0 t80 -62.44 -46.5 88.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.507 -0.996 . . . . 0.0 110.498 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.376 -1.453 . . . . 0.0 108.677 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.91 2.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.59 ' CZ ' ' CG ' ' A' ' 79' ' ' HIS . 35.8 t80 -45.98 -35.71 4.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.9 . . . . 0.0 111.127 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -86.02 -27.25 24.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.75 -1.219 . . . . 0.0 110.332 -178.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -66.81 12.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.989 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.683 ' CG ' HE22 ' A' ' 33' ' ' GLN . 16.5 m80 -124.76 152.7 69.88 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.787 -1.195 . . . . 0.0 109.636 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.73 -6.63 15.35 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.675 2.25 . . . . 0.0 112.434 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 29' ' ' ASN . 5.8 tp -73.22 -28.01 61.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.837 . . . . 0.0 111.223 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.59 ' CG ' ' CZ ' ' A' ' 73' ' ' PHE . 2.9 t60 -82.08 -35.45 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.052 . . . . 0.0 110.281 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.53 -60.01 3.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.989 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -56.64 -38.65 72.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 109.612 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.41 -41.86 72.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.849 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 87' ' ' THR . 17.3 t -61.73 -39.2 90.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.167 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.31 77.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.1 -39.72 78.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 90' ' ' ILE . 28.3 t80 -45.19 -29.53 0.97 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.2 p -83.46 -62.26 1.63 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.588 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -40.09 -27.94 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.705 -0.622 . . . . 0.0 110.084 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 p -100.95 14.38 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 110.819 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 91' ' ' ASP . 22.5 mm -128.69 161.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.682 -1.261 . . . . 0.0 110.444 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 90' ' ' ILE . 62.8 t0 -104.37 -35.23 8.01 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.483 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 19.8 ptmt -145.63 146.03 31.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -125.69 123.43 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.626 -1.296 . . . . 0.0 109.799 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.65 132.4 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -138.6 135.41 34.92 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.262 -1.524 . . . . 0.0 111.766 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -121.06 124.53 45.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.638 -0.664 . . . . 0.0 109.363 176.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.544 ' OD1' ' CZ ' ' A' ' 6' ' ' PHE . 20.2 t0 -126.27 133.65 51.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.053 -1.029 . . . . 0.0 108.951 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CE1' ' CD ' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -156.62 157.77 31.07 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.109 -0.995 . . . . 0.0 110.516 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 58.9 Cg_endo -71.79 127.77 13.41 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.321 2.014 . . . . 0.0 112.209 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -106.99 128.7 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -108.47 94.48 5.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.47 -0.768 . . . . 0.0 109.625 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.46 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 109.536 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' A' ' 101' ' ' ALA . 10.2 m -148.36 -26.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 106' ' ' SER . 25.2 mmtt -38.45 -28.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 103' ' ' VAL . 5.7 p -57.69 70.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.131 -0.98 . . . . 0.0 108.941 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 104' ' ' LYS . 8.0 t -111.21 109.82 20.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.291 -0.881 . . . . 0.0 109.368 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 107' ' ' VAL . 11.3 p -91.73 30.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.27 141.36 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.538 -0.726 . . . . 0.0 109.533 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.82 132.17 32.2 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 p -70.73 152.55 95.18 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.891 -1.131 . . . . 0.0 109.617 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 C-N-CA 122.776 2.317 . . . . 0.0 112.238 179.652 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.455 ' O ' ' C ' ' B' ' 2' ' ' ALA . 74.3 mmm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' B' ' 1' ' ' MET . . . 41.39 55.06 3.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.618 HG23 ' N ' ' B' ' 4' ' ' SER . 8.9 t -63.49 -45.72 89.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.179 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.618 ' N ' HG23 ' B' ' 3' ' ' THR . 20.1 m -139.47 -100.51 0.16 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.26 148.39 34.25 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.406 -1.378 . . . . 0.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.54 ' CZ ' ' OD1' ' B' ' 97' ' ' ASP . 34.4 t80 -114.77 128.2 56.17 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.249 -1.148 . . . . 0.0 108.02 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.627 ' HZ3' HD12 ' B' ' 9' ' ' LEU . 3.6 ttpp -113.55 142.4 46.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.913 -1.117 . . . . 0.0 112.822 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.406 ' HD1' ' HB2' ' B' ' 97' ' ' ASP . 70.4 t60 -132.86 133.36 43.21 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.627 HD12 ' HZ3' ' B' ' 7' ' ' LYS . 6.5 tt -136.58 145.86 45.45 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.728 -1.233 . . . . 0.0 109.458 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.45 HG13 ' O ' ' B' ' 10' ' ' VAL . 12.1 p -127.18 133.34 68.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.6 OUTLIER -116.04 129.16 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.487 ' O ' HG22 ' B' ' 57' ' ' THR . 6.3 m -139.61 167.5 19.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 117.704 -1.598 . . . . 0.0 113.017 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 19.1 tptp -132.74 152.34 51.77 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.48 ' HB2' ' H ' ' B' ' 18' ' ' THR . 39.7 p90 -108.77 149.47 28.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.85 -1.156 . . . . 0.0 111.606 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -129.11 -22.08 3.2 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.6 mt-10 -89.29 -57.12 3.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 7.9 t0 153.75 64.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 63.7 m -50.73 105.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.136 0.97 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.526 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -75.62 88.22 2.73 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.497 HG23 ' N ' ' B' ' 21' ' ' ASP . 34.9 m -64.63 -38.55 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.612 -0.68 . . . . 0.0 110.471 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' HG23 ' B' ' 20' ' ' VAL . 82.7 m-20 -66.19 -44.56 83.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 110.564 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -66.07 -31.47 72.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.4 mt -69.53 -37.35 74.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' B' ' 21' ' ' ASP . 13.9 tp -53.3 -37.83 62.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -34.64 74.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -63.98 -53.54 36.54 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.77 -47.64 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.531 -0.982 . . . . 0.0 108.797 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -52.6 -44.55 66.06 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.3 OUTLIER -68.66 -49.04 62.27 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.51 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -48.47 -47.6 38.32 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 32' ' ' SER . 53.7 t -49.96 -26.06 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.309 -0.869 . . . . 0.0 108.832 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.3 t -42.0 -42.61 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.69 HE22 ' CG ' ' B' ' 76' ' ' HIS . 15.3 mm100 -61.07 -11.3 8.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.443 -0.786 . . . . 0.0 111.509 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.683 HG22 ' O ' ' B' ' 34' ' ' ILE . 42.1 mm -81.78 26.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 119.99 -1.693 . . . . 0.0 110.559 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 36' ' ' THR . 31.6 p-10 -67.51 -26.3 66.27 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.723 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.4 t -79.25 1.85 23.33 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.942 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 36' ' ' THR . 21.1 m 37.93 21.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 0.0 109.187 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 36' ' ' THR . 83.3 mttt -120.82 41.36 3.31 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.422 ' O ' HD12 ' B' ' 34' ' ' ILE . 1.4 m -158.2 154.71 27.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 98.5 m-85 -144.47 154.53 43.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.545 -1.347 . . . . 0.0 111.99 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 80.8 mt-10 -160.97 130.45 4.83 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.345 0.593 . . . . 0.0 110.2 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -130.09 175.22 9.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.75 154.07 21.99 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.828 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.568 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 17.9 mt-10 -151.12 141.72 22.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 8.1 p30 -115.91 148.67 39.77 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.633 ' HD3' ' N ' ' B' ' 57' ' ' THR . 0.0 OUTLIER -68.59 80.89 0.27 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.394 -1.441 . . . . 0.0 109.788 -176.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 45' ' ' ASP . 78.2 mm-40 -96.95 54.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.646 . . . . 0.0 109.315 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' B' ' 49' ' ' HIS . 29.6 t -134.14 -138.22 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.531 ' N ' ' OG ' ' B' ' 48' ' ' SER . 74.1 m80 -107.24 142.92 36.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.134 -0.979 . . . . 0.0 109.699 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -42.78 -41.25 3.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.78 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.9 ttt -71.42 -29.29 64.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.063 -1.023 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 95' ' ' LEU . 51.5 mt -98.26 -18.46 18.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.72 -1.238 . . . . 0.0 109.279 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' B' ' 55' ' ' GLY . 55.0 mtp180 -73.42 0.58 11.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -0.844 . . . . 0.0 111.271 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 55.87 -4.06 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.832 -1.168 . . . . 0.0 110.18 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.641 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 82.77 -18.89 13.22 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.454 -0.778 . . . . 0.0 112.861 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' B' ' 11' ' ' VAL . 12.2 m-85 -58.92 -128.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.288 -1.713 . . . . 0.0 109.902 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.633 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 2.5 t -164.9 -36.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.299 -0.876 . . . . 0.0 110.992 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.652 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.7 t60 -169.91 153.77 4.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.826 -1.171 . . . . 0.0 110.214 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.652 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.21 168.77 18.95 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.461 -0.774 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.532 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 88.2 m-85 -129.01 126.12 38.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.513 -0.742 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -99.82 103.24 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 34.6 mtt -104.92 117.9 35.2 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.24 -0.913 . . . . 0.0 110.731 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 99.9 m -120.38 143.27 48.52 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -119.28 159.69 23.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.715 -1.241 . . . . 0.0 110.073 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.6 -27.57 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -173.57 -174.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -59.39 -27.33 65.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 111.422 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 29.0 p-10 -57.9 -38.03 75.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.817 -1.177 . . . . 0.0 110.574 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -68.75 -37.6 84.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.507 ' O ' ' CG2' ' B' ' 74' ' ' THR . 71.5 t80 -62.36 -46.76 87.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.574 -0.956 . . . . 0.0 110.445 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.94 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.377 -1.452 . . . . 0.0 108.732 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.585 ' CZ ' ' CG ' ' B' ' 79' ' ' HIS . 35.8 t80 -45.75 -35.76 4.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.932 . . . . 0.0 111.107 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.2 OUTLIER -86.08 -27.29 24.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.808 -1.183 . . . . 0.0 110.316 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -66.66 12.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.066 -1.021 . . . . 0.0 110.986 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.69 ' CG ' HE22 ' B' ' 33' ' ' GLN . 16.8 m80 -124.81 152.56 69.88 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 109.547 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.58 -6.63 15.48 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.644 2.229 . . . . 0.0 112.453 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.451 HD23 HD22 ' B' ' 30' ' ' LEU . 5.8 tp -73.09 -28.23 62.17 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.236 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.585 ' CG ' ' CZ ' ' B' ' 73' ' ' PHE . 2.9 t60 -81.98 -35.44 28.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.48 -60.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.987 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' B' ' 82' ' ' PHE . 22.4 pt-20 -56.59 -38.77 72.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' B' ' 81' ' ' GLU . 73.1 t80 -70.26 -41.86 72.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.531 ' O ' HG23 ' B' ' 87' ' ' THR . 17.4 t -61.62 -39.42 91.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.1 -1.0 . . . . 0.0 110.15 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.44 -49.39 77.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 108.68 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.93 -39.8 79.37 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.467 ' O ' HG12 ' B' ' 90' ' ' ILE . 28.4 t80 -45.12 -29.5 0.93 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.2 p -83.5 -62.36 1.6 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -40.01 -27.98 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.742 -0.599 . . . . 0.0 110.084 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' B' ' 87' ' ' THR . 3.9 p -100.86 14.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.234 -0.916 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 91' ' ' ASP . 22.4 mm -128.63 161.19 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.664 -1.273 . . . . 0.0 110.421 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.564 ' N ' HG22 ' B' ' 90' ' ' ILE . 62.6 t0 -104.55 -35.33 7.9 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.468 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 19.8 ptmt -145.53 146.14 31.31 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -125.78 123.32 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.597 -1.314 . . . . 0.0 109.767 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.53 132.38 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.519 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -138.59 135.3 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.314 -1.491 . . . . 0.0 111.737 -178.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.564 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -121.0 124.62 45.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 176.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' B' ' 6' ' ' PHE . 21.1 t0 -126.39 133.62 51.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.034 -1.041 . . . . 0.0 108.923 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -156.6 157.67 31.04 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.065 -1.022 . . . . 0.0 110.516 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.44 ' HB3' ' H ' ' B' ' 2' ' ' ALA . 58.9 Cg_endo -71.7 127.93 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.268 1.979 . . . . 0.0 112.227 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.14 128.66 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.168 -0.957 . . . . 0.0 110.042 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -108.56 94.46 5.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.491 -0.756 . . . . 0.0 109.609 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.39 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.564 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.658 ' N ' ' O ' ' B' ' 101' ' ' ALA . 10.4 m -148.33 -26.15 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 109.23 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.4 mmtt -38.6 -28.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.856 . . . . 0.0 109.358 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 103' ' ' VAL . 5.7 p -57.77 70.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.135 -0.978 . . . . 0.0 108.912 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.705 ' N ' ' O ' ' B' ' 104' ' ' LYS . 8.0 t -111.15 109.83 20.07 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.575 HG22 ' O ' ' B' ' 107' ' ' VAL . 11.3 p -91.76 30.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -137.38 141.43 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.437 -0.79 . . . . 0.0 109.498 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.93 132.0 31.74 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -70.48 152.71 95.37 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 120.89 -1.131 . . . . 0.0 109.663 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.308 -1.604 0 C-N-CA 122.736 2.291 . . . . 0.0 112.272 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.504 ' O ' ' C ' ' A' ' 2' ' ' ALA . 61.1 mtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.346 0.593 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -38.25 110.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 109.339 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.663 HG23 ' N ' ' A' ' 4' ' ' SER . 7.6 t -147.64 -49.07 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.102 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.663 ' N ' HG23 ' A' ' 3' ' ' THR . 29.6 m -124.05 -103.76 0.37 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.01 45.24 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.737 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -136.36 135.02 38.47 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.218 -1.166 . . . . 0.0 108.036 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -99.94 127.0 46.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.93 -1.107 . . . . 0.0 112.822 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.507 ' ND1' ' OD1' ' A' ' 97' ' ' ASP . 86.3 t60 -122.61 121.18 35.84 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.6 tt -135.08 144.11 47.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.714 -1.241 . . . . 0.0 109.474 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.7 p -127.64 134.32 65.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.611 -0.68 . . . . 0.0 109.547 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.52 127.93 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.429 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.4 m -141.6 159.92 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 117.785 -1.566 . . . . 0.0 113.042 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -130.41 155.2 46.81 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.605 ' CD2' HG21 ' A' ' 57' ' ' THR . 11.9 p90 -111.11 153.69 25.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.13 . . . . 0.0 111.606 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -19.14 3.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 17' ' ' ASP . 13.5 tm-20 -92.63 -56.82 2.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 3.1 m-20 155.24 62.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.522 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.8 m -49.04 105.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.082 0.944 . . . . 0.0 112.849 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.85 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -70.98 85.5 0.7 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 21' ' ' ASP . 33.0 m -64.95 -41.02 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.527 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.547 ' N ' HG23 ' A' ' 20' ' ' VAL . 36.4 p-10 -66.51 -46.54 75.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.4 -0.812 . . . . 0.0 110.553 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 3.8 mp0 -66.14 -30.25 70.71 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mt -72.4 -41.79 64.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.4 tp -56.1 -38.59 70.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' NZ ' ' C ' ' B' ' 111' ' ' PRO . 3.3 ttpt -63.47 -34.03 76.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -68.16 -53.3 22.86 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -44.93 -42.68 8.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.547 -0.972 . . . . 0.0 108.793 178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -53.24 -42.69 66.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.674 ' ND2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -58.84 -45.2 90.63 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.674 ' N ' ' ND2' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -49.24 -45.12 44.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' ILE . 16.0 t -58.08 -20.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.235 -0.916 . . . . 0.0 108.827 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 46.8 t -44.0 -38.3 3.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.659 ' OE1' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.64 -10.74 50.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 111.39 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.659 HD13 ' OE1' ' A' ' 33' ' ' GLN . 5.4 mm -86.06 21.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.075 -1.64 . . . . 0.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 36' ' ' THR . 51.6 p30 -58.91 -9.43 1.84 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.642 ' O ' ' C ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -80.2 -1.1 39.02 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.895 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.642 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.4 m 30.26 45.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 109.217 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HZ1' ' H ' ' A' ' 69' ' ' GLY . 11.4 ptmm? -121.03 39.86 3.7 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 75.7 m -173.36 179.08 2.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -145.56 154.74 42.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.608 -1.308 . . . . 0.0 111.936 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -154.64 123.25 6.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.395 0.617 . . . . 0.0 110.234 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.615 ' CH2' ' HB3' ' B' ' 101' ' ' ALA . 67.0 t-105 -135.83 175.03 9.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' N ' ' CG ' ' A' ' 42' ' ' TRP . . . -132.28 160.97 23.85 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 118.711 -1.709 . . . . 0.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 41.8 mp0 -148.84 139.63 22.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -1.151 . . . . 0.0 109.336 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 47' ' ' GLU . 85.6 m-20 -113.75 147.08 38.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.671 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.5 81.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.435 -1.416 . . . . 0.0 109.806 -178.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.0 mt-10 -122.06 59.2 1.01 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' A' ' 49' ' ' HIS . 43.9 p -158.49 73.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' A' ' 48' ' ' SER . 55.9 m80 54.34 125.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -44.79 -31.51 1.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 110.757 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.57 -30.79 52.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.992 -1.068 . . . . 0.0 110.763 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' SER . 40.6 mt -100.62 -27.63 13.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.784 -1.198 . . . . 0.0 109.336 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 46' ' ' LYS . 8.7 ptm180 -87.0 -2.45 58.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.326 -0.859 . . . . 0.0 111.25 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 49.21 13.71 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.839 -1.163 . . . . 0.0 110.167 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.584 ' H ' ' HG3' ' A' ' 53' ' ' ARG . . . 57.06 -2.89 0.07 OUTLIER Glycine 0 N--CA 1.498 2.808 0 O-C-N 121.441 -0.787 . . . . 0.0 112.89 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.525 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 45.8 p90 -57.1 124.08 17.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.233 -1.745 . . . . 0.0 109.977 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.675 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 72.1 p -54.2 -44.11 71.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 111.002 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.675 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 36.0 p-80 -170.21 154.94 5.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.826 -1.171 . . . . 0.0 110.151 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.06 169.48 17.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.283 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -129.91 126.77 38.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.494 -0.754 . . . . 0.0 109.078 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -96.09 96.24 8.71 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtt -101.83 119.11 38.26 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.165 -0.959 . . . . 0.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 m -125.67 145.31 50.22 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -121.59 163.74 18.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.701 -1.249 . . . . 0.0 110.088 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 4' ' ' SER . 85.4 tt0 -85.49 -30.9 23.09 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -157.56 164.06 37.71 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -24.29 55.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.944 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -57.18 -40.03 76.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.796 -1.19 . . . . 0.0 110.608 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.617 ' H ' ' HZ1' ' A' ' 38' ' ' LYS . . . -68.63 -40.79 85.64 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' HG22 ' A' ' 74' ' ' THR . 72.9 t80 -60.54 -46.79 88.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.988 . . . . 0.0 110.454 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.72 -28.97 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.396 -1.44 . . . . 0.0 108.677 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.02 -60.95 2.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -56.77 -39.44 74.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 111.173 -176.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.82 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.9 t -80.84 -34.08 34.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.764 -1.21 . . . . 0.0 110.295 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.1 m -68.12 -32.9 73.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 110.973 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -69.62 126.0 92.32 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.899 -1.125 . . . . 0.0 109.635 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.78 -7.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.726 2.284 . . . . 0.0 112.364 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 30' ' ' LEU . 6.1 tt -72.31 -30.99 65.3 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.363 -0.836 . . . . 0.0 111.198 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 10.9 t-160 -82.89 -29.19 29.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.966 -1.084 . . . . 0.0 110.275 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.53 -58.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.018 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -56.45 -38.17 71.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -71.64 -42.19 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -62.18 -39.72 93.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.102 -0.999 . . . . 0.0 110.146 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.49 77.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.955 -1.091 . . . . 0.0 108.69 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.08 -40.67 87.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' C ' ' O ' ' A' ' 85' ' ' ALA . 15.9 t80 -45.29 -29.35 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 89' ' ' VAL . 12.2 m -81.79 -62.12 1.73 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -38.85 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.7 -0.625 . . . . 0.0 110.111 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.5 m -106.47 11.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.791 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 91' ' ' ASP . 26.4 mm -130.53 163.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.685 -1.26 . . . . 0.0 110.41 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.618 ' N ' HG22 ' A' ' 90' ' ' ILE . 22.6 t0 -124.22 -34.52 2.92 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -126.99 125.17 41.02 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.0 tp -123.54 123.14 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.691 -1.256 . . . . 0.0 109.786 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 43.7 t -130.28 133.01 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -137.48 135.26 36.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.278 -1.514 . . . . 0.0 111.781 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.867 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.1 mp -114.67 117.01 29.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.688 -0.632 . . . . 0.0 109.339 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.507 ' OD1' ' ND1' ' A' ' 8' ' ' HIS . 79.2 m-20 -114.63 121.77 44.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.092 -1.005 . . . . 0.0 108.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 63.1 t80 -154.61 137.22 10.03 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.077 -1.014 . . . . 0.0 110.507 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 39.7 Cg_endo -63.86 141.94 80.19 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.311 2.007 . . . . 0.0 112.228 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' B' ' 42' ' ' TRP . 71.1 t -122.41 141.97 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 109.979 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.607 ' HB3' ' CH2' ' B' ' 42' ' ' TRP . . . -112.46 96.93 6.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.88 76.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.6 m -148.11 120.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.385 -0.822 . . . . 0.0 109.155 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.32 115.71 24.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.346 -0.846 . . . . 0.0 109.325 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.556 ' O ' HG12 ' A' ' 107' ' ' VAL . 22.1 m -69.88 -45.38 67.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 108.914 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' SER . 6.1 t 43.19 52.42 5.56 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.354 -0.841 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 107' ' ' VAL . 9.7 p -177.19 51.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 108' ' ' VAL . 8.6 p -168.06 43.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.567 -0.708 . . . . 0.0 109.465 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.03 75.99 0.66 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 p -76.28 153.56 84.16 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 120.921 -1.112 . . . . 0.0 109.661 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.47 ' C ' ' NZ ' ' B' ' 25' ' ' LYS . 75.3 Cg_endo . . . . . 0 C--N 1.309 -1.546 0 C-N-CA 122.736 2.291 . . . . 0.0 112.255 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.481 ' O ' ' C ' ' B' ' 2' ' ' ALA . 61.5 mtt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.289 0.566 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' B' ' 1' ' ' MET . . . -38.3 110.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -0.927 . . . . 0.0 109.288 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.665 HG23 ' N ' ' B' ' 4' ' ' SER . 7.7 t -147.82 -48.83 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 109.143 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.665 ' N ' HG23 ' B' ' 3' ' ' THR . 28.2 m -124.36 -103.97 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.4 175.0 45.64 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.43 134.81 38.11 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.207 -1.172 . . . . 0.0 108.075 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -99.76 126.9 45.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.929 -1.107 . . . . 0.0 112.837 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' B' ' 97' ' ' ASP . 86.3 t60 -122.66 121.21 35.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.6 tt -135.07 144.07 47.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.694 -1.253 . . . . 0.0 109.454 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.444 HG13 ' O ' ' B' ' 10' ' ' VAL . 10.6 p -127.62 134.41 65.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.512 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.64 127.95 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.425 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.4 m -141.6 159.76 21.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.019 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -130.29 155.26 46.62 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.604 ' CD2' HG21 ' B' ' 57' ' ' THR . 12.0 p90 -111.23 153.66 25.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.827 -1.17 . . . . 0.0 111.558 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 -19.2 3.2 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 17' ' ' ASP . 13.5 tm-20 -92.49 -56.92 2.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.519 ' N ' ' OE1' ' B' ' 16' ' ' GLU . 3.1 m-20 155.21 62.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.509 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 90.2 m -49.31 105.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.095 0.95 . . . . 0.0 112.882 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.838 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -70.95 85.33 0.69 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.552 HG23 ' N ' ' B' ' 21' ' ' ASP . 32.9 m -64.84 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.616 -0.677 . . . . 0.0 110.539 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' HG23 ' B' ' 20' ' ' VAL . 36.0 p-10 -66.59 -46.41 76.05 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 110.569 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 3.9 mp0 -66.25 -30.25 70.65 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mt -72.35 -41.78 65.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -56.08 -38.6 70.9 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.47 ' NZ ' ' C ' ' A' ' 111' ' ' PRO . 3.3 ttpt -63.34 -34.28 77.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.596 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -67.96 -53.43 22.98 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -44.88 -42.59 8.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.466 -1.02 . . . . 0.0 108.801 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -53.43 -42.54 67.19 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' N ' ' B' ' 30' ' ' LEU . 0.0 OUTLIER -58.91 -45.21 90.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.68 ' N ' ' ND2' ' B' ' 29' ' ' ASN . 0.5 OUTLIER -49.18 -45.28 43.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' B' ' 34' ' ' ILE . 15.8 t -57.88 -20.35 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.278 -0.889 . . . . 0.0 108.806 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 47.0 t -43.86 -38.41 3.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.652 ' OE1' HD13 ' B' ' 34' ' ' ILE . 0.0 OUTLIER -87.53 -10.97 50.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.502 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.652 HD13 ' OE1' ' B' ' 33' ' ' GLN . 5.3 mm -85.85 21.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 119.933 -1.73 . . . . 0.0 110.588 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 36' ' ' THR . 51.1 p30 -59.01 -9.5 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' B' ' 37' ' ' VAL . 0.1 OUTLIER -80.18 -1.01 38.56 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.878 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.6 m 30.33 45.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.03 -1.044 . . . . 0.0 109.17 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.652 ' HZ2' ' CA ' ' B' ' 69' ' ' GLY . 11.4 ptmm? -121.12 40.0 3.68 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 74.9 m -173.39 179.17 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.61 154.73 42.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.469 -1.394 . . . . 0.0 111.983 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -154.6 123.33 6.19 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.471 0.653 . . . . 0.0 110.218 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.607 ' CH2' ' HB3' ' A' ' 101' ' ' ALA . 66.7 t-105 -135.75 175.08 9.92 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' B' ' 42' ' ' TRP . . . -132.2 161.07 23.84 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 118.772 -1.68 . . . . 0.0 110.791 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 41.6 mp0 -148.9 139.48 22.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -1.162 . . . . 0.0 109.358 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 47' ' ' GLU . 85.2 m-20 -113.46 147.14 38.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.66 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -65.54 81.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.483 -1.385 . . . . 0.0 109.832 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.1 mt-10 -122.12 59.28 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.712 -0.618 . . . . 0.0 109.398 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.623 ' O ' ' O ' ' B' ' 49' ' ' HIS . 41.7 p -158.42 73.25 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 110.184 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.623 ' O ' ' O ' ' B' ' 48' ' ' SER . 55.9 m80 54.24 125.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -44.6 -31.62 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 110.822 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.44 -30.89 53.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.724 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' B' ' 48' ' ' SER . 41.4 mt -100.76 -27.47 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.782 -1.199 . . . . 0.0 109.247 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.66 ' NH2' ' O ' ' B' ' 46' ' ' LYS . 8.7 ptm180 -87.11 -2.48 58.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 111.204 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 49.32 13.64 0.08 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.782 -1.199 . . . . 0.0 110.217 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.592 ' H ' ' HG3' ' B' ' 53' ' ' ARG . . . 57.18 -3.13 0.07 OUTLIER Glycine 0 N--CA 1.498 2.797 0 O-C-N 121.47 -0.769 . . . . 0.0 112.852 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 45.9 p90 -56.96 124.17 17.72 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.279 -1.718 . . . . 0.0 109.977 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.64 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 72.1 p -54.19 -44.19 71.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.988 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.64 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 36.0 p-80 -170.21 154.82 5.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.909 -1.119 . . . . 0.0 110.197 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.95 169.46 17.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.414 -0.804 . . . . 0.0 109.24 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.81 126.87 39.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.348 -0.845 . . . . 0.0 109.081 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 66.0 m -96.1 96.3 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtt -101.81 119.07 38.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.23 -0.919 . . . . 0.0 110.81 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -125.71 145.33 50.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.63 163.64 18.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.661 -1.274 . . . . 0.0 110.054 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 4' ' ' SER . 85.4 tt0 -85.45 -30.92 23.14 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -157.43 164.13 37.79 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -24.39 56.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 111.467 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.96 -40.23 76.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.727 -1.233 . . . . 0.0 110.563 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.652 ' CA ' ' HZ2' ' B' ' 38' ' ' LYS . . . -68.6 -40.55 85.91 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.817 ' O ' HG22 ' B' ' 74' ' ' THR . 73.4 t80 -60.77 -46.69 89.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.636 -0.92 . . . . 0.0 110.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.98 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.322 -1.486 . . . . 0.0 108.665 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.461 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.03 -60.85 2.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.788 . . . . 0.0 109.387 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.425 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.75 -39.43 73.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -0.889 . . . . 0.0 111.079 -177.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.817 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.9 t -80.97 -33.84 33.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.763 -1.21 . . . . 0.0 110.371 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 74.5 m -68.36 -32.82 73.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.955 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.565 ' O ' ' N ' ' B' ' 78' ' ' LEU . 0.3 OUTLIER -69.58 126.04 92.35 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.807 -1.183 . . . . 0.0 109.605 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -43.78 -7.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.642 2.228 . . . . 0.0 112.48 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.566 ' CD2' HD22 ' B' ' 30' ' ' LEU . 6.2 tt -72.51 -30.93 64.93 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.42 -0.8 . . . . 0.0 111.214 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.457 ' CD2' ' O ' ' B' ' 79' ' ' HIS . 10.9 t-160 -82.93 -29.11 29.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.956 -1.09 . . . . 0.0 110.317 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.54 -58.71 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 110.004 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -56.54 -38.2 71.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 0.0 109.531 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -71.5 -42.25 68.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 0.0 109.905 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -62.27 -39.64 93.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.0 . . . . 0.0 110.124 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.5 77.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 0.0 108.609 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.18 -40.64 86.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.456 ' O ' HG12 ' B' ' 90' ' ' ILE . 16.0 t80 -45.31 -29.3 1.0 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 12.3 m -81.8 -62.08 1.74 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.99 -26.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.643 -0.661 . . . . 0.0 110.093 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.7 m -106.58 11.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.28 -0.888 . . . . 0.0 110.828 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.62 HG22 ' N ' ' B' ' 91' ' ' ASP . 26.4 mm -130.59 163.91 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.616 -1.302 . . . . 0.0 110.494 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.62 ' N ' HG22 ' B' ' 90' ' ' ILE . 22.6 t0 -124.25 -34.55 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -127.03 125.13 40.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.0 tp -123.63 123.15 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.617 -1.302 . . . . 0.0 109.715 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 43.2 t -130.27 133.01 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.494 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -137.43 135.19 36.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.251 -1.531 . . . . 0.0 111.796 -178.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.859 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.2 mp -114.68 116.96 29.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.657 -0.652 . . . . 0.0 109.317 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' B' ' 8' ' ' HIS . 79.8 m-20 -114.67 121.78 44.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.156 -0.965 . . . . 0.0 108.884 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 63.3 t80 -154.56 137.18 10.01 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 39.7 Cg_endo -63.93 141.89 79.53 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.27 1.98 . . . . 0.0 112.299 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' A' ' 42' ' ' TRP . 71.4 t -122.37 141.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.134 -0.979 . . . . 0.0 110.05 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.615 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . . . -112.53 96.99 6.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.439 -0.788 . . . . 0.0 109.548 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.9 76.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.091 -1.005 . . . . 0.0 109.561 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 103' ' ' VAL . 9.4 m -148.03 120.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.227 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -120.27 115.72 24.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.359 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.552 ' O ' HG12 ' B' ' 107' ' ' VAL . 23.2 m -69.78 -45.67 67.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.138 -0.976 . . . . 0.0 108.917 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.409 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.4 t 43.48 52.23 6.03 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.365 -0.834 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 107' ' ' VAL . 9.5 p -177.09 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.73 ' O ' HG22 ' B' ' 108' ' ' VAL . 8.5 p -167.94 43.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.509 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.9 75.9 0.63 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.285 -0.884 . . . . 0.0 108.636 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 1.7 p -76.28 153.57 84.17 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 120.864 -1.148 . . . . 0.0 109.625 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.468 ' C ' ' NZ ' ' A' ' 25' ' ' LYS . 74.9 Cg_endo . . . . . 0 C--N 1.308 -1.571 0 C-N-CA 122.731 2.287 . . . . 0.0 112.228 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' O ' ' C ' ' A' ' 2' ' ' ALA . 25.4 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.303 0.573 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 44.57 64.1 1.46 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.362 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.81 HG21 ' HB2' ' A' ' 101' ' ' ALA . 10.2 t -65.85 -45.7 81.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.174 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.625 ' N ' HG23 ' A' ' 3' ' ' THR . 19.7 m -136.23 -97.02 0.23 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.61 170.06 41.79 Favored Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.731 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.2 131.27 43.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.283 -1.127 . . . . 0.0 108.011 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -99.87 125.75 45.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.925 -1.109 . . . . 0.0 112.824 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 62' ' ' MET . 74.5 m80 -120.09 121.41 38.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.42 143.21 43.82 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.696 -1.252 . . . . 0.0 109.486 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 95' ' ' LEU . 14.7 p -128.67 136.12 60.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.635 -0.666 . . . . 0.0 109.492 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -114.07 126.58 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 178.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' A' ' 10' ' ' VAL . 2.1 m -138.09 154.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.813 -1.555 . . . . 0.0 113.064 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 57' ' ' THR . 43.7 mtpt -126.61 154.85 43.4 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.669 ' CD2' HG21 ' A' ' 57' ' ' THR . 16.6 p90 -111.28 152.54 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.817 -1.177 . . . . 0.0 111.641 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -128.23 -18.48 4.08 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.6 mt-10 -90.48 -56.83 3.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 4.8 p30 153.05 58.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 89' ' ' VAL . 78.8 m -47.05 107.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.051 0.929 . . . . 0.0 112.815 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.75 87.67 2.79 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 175.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -57.97 -34.87 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.725 . . . . 0.0 110.527 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.45 -40.25 89.32 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 88.3 mt-10 -68.27 -33.33 74.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 19' ' ' LYS . 1.1 mp -63.9 -44.08 97.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.48 -34.62 61.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.51 -34.33 75.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.38 -44.92 8.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.56 -58.09 9.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.538 -0.978 . . . . 0.0 108.81 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' B' ' 108' ' ' VAL . 0.7 OUTLIER -55.76 -40.82 73.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 38.7 t30 -61.23 -45.34 94.95 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.687 HD13 ' O ' ' A' ' 30' ' ' LEU . 2.8 tm? -53.91 -46.08 71.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG11 HG21 ' B' ' 107' ' ' VAL . 59.5 t -55.91 -33.8 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 108.825 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 31' ' ' VAL . 4.7 m -45.47 -39.8 7.61 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 35' ' ' ASP . 21.3 tp60 -69.34 -53.98 16.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.439 -0.788 . . . . 0.0 111.469 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.633 ' C ' ' H ' ' A' ' 36' ' ' THR . 17.4 mt -61.2 41.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.039 -1.663 . . . . 0.0 110.626 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.662 ' N ' ' O ' ' A' ' 33' ' ' GLN . 58.9 t0 -60.41 -3.81 0.74 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' A' ' 37' ' ' VAL . 45.3 p -76.9 -0.96 26.09 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.942 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 36' ' ' THR . 19.1 m 31.21 47.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 36' ' ' THR . 13.9 ptpt -124.46 42.45 3.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 t -175.63 179.45 1.41 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 93.0 m-85 -145.75 155.28 42.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.566 -1.334 . . . . 0.0 111.958 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' PHE . 71.2 mt-10 -157.06 126.52 6.08 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.356 0.598 . . . . 0.0 110.246 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.545 ' CD1' ' NZ ' ' B' ' 104' ' ' LYS . 0.1 OUTLIER -142.34 178.02 7.86 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' CE3' ' A' ' 42' ' ' TRP . . . -142.83 169.1 25.74 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.46 145.97 27.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -1.137 . . . . 0.0 109.369 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 86.5 m-20 -124.25 147.02 48.39 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.855 ' HD2' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -146.19 136.36 23.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.437 -1.414 . . . . 0.0 109.808 -174.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.73 ' O ' ' O ' ' A' ' 48' ' ' SER . 96.2 mt-10 -131.13 -0.7 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.707 -0.621 . . . . 0.0 109.343 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.73 ' O ' ' O ' ' A' ' 47' ' ' GLU . 29.7 t -49.01 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.543 ' N ' ' OG ' ' A' ' 48' ' ' SER . 76.0 m80 -70.7 152.59 43.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.461 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 88.2 m-20 -66.98 -41.65 86.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.481 ' SD ' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -69.2 -33.95 74.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.007 -1.058 . . . . 0.0 110.789 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' B' ' 95' ' ' LEU . 70.4 mt -87.26 -56.34 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.722 -1.236 . . . . 0.0 109.33 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.697 ' C ' ' H ' ' A' ' 55' ' ' GLY . 10.0 ptt180 -59.4 4.75 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 111.149 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.91 ' NE2' HD11 ' B' ' 96' ' ' LEU . 2.5 mt-30 59.64 -18.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.86 -1.15 . . . . 0.0 110.196 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.697 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 83.12 -17.27 23.89 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 121.434 -0.791 . . . . 0.0 112.921 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.855 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 6.1 p90 -60.47 117.02 4.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.275 -1.721 . . . . 0.0 109.897 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.791 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 70.1 p -51.68 -33.72 35.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.295 -0.878 . . . . 0.0 110.984 -175.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.791 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -175.44 159.93 2.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.847 -1.158 . . . . 0.0 110.114 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.51 169.28 17.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.347 -0.846 . . . . 0.0 109.249 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.36 127.5 37.72 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.484 -0.76 . . . . 0.0 109.094 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -93.15 98.49 11.33 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.446 ' O ' ' N ' ' A' ' 8' ' ' HIS . 69.9 mtm -101.54 113.63 26.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.166 -0.958 . . . . 0.0 110.775 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.2 m -123.03 141.99 51.35 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.87 162.05 19.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.698 -1.252 . . . . 0.0 110.118 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -81.97 -30.41 31.67 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -168.13 175.36 6.63 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -65.07 -24.84 67.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 111.419 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -61.38 -44.88 96.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.777 -1.202 . . . . 0.0 110.573 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.25 -34.3 74.93 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.748 ' O ' HG22 ' A' ' 74' ' ' THR . 74.0 t80 -65.98 -46.2 78.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.479 -1.012 . . . . 0.0 110.485 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 75' ' ' SER . 20.9 m -70.75 -28.93 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.345 -1.472 . . . . 0.0 108.668 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.12 -60.88 2.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.387 -0.82 . . . . 0.0 109.326 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -60.96 -55.86 27.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 111.177 -177.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.748 HG22 ' O ' ' A' ' 70' ' ' TYR . 12.8 t -57.09 -34.71 68.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.729 -1.232 . . . . 0.0 110.287 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 68.8 p -69.35 -26.44 64.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -0.955 . . . . 0.0 110.967 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 72' ' ' ALA . 41.9 m80 -65.1 151.46 93.6 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.843 -1.161 . . . . 0.0 109.648 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.74 -12.7 26.73 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.641 2.227 . . . . 0.0 112.439 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.32 -28.9 63.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.361 -0.837 . . . . 0.0 111.208 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.464 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 46.1 t60 -83.23 -32.8 26.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.017 -1.052 . . . . 0.0 110.227 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.84 -60.44 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.047 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.05 -37.6 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.14 -40.26 74.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.3 t -62.6 -41.09 98.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.21 74.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.972 -1.08 . . . . 0.0 108.706 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.63 -41.26 79.69 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.467 ' C ' ' O ' ' A' ' 85' ' ' ALA . 20.0 t80 -44.6 -31.26 1.09 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.3 m -82.53 -61.68 1.82 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.17 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.712 -0.617 . . . . 0.0 110.09 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 87' ' ' THR . 6.1 m -100.53 16.35 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 110.847 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.616 ' N ' ' O ' ' A' ' 87' ' ' THR . 41.1 mt -126.68 159.21 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.659 -1.276 . . . . 0.0 110.409 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.517 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 52.7 t0 -102.31 -31.91 10.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' N ' HG22 ' A' ' 90' ' ' ILE . 32.2 pttt -151.9 149.44 28.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.8 tp -125.06 124.23 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.653 -1.279 . . . . 0.0 109.73 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG12 HE21 ' B' ' 54' ' ' GLN . 46.3 t -126.95 131.33 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.8 138.17 32.05 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.34 -1.475 . . . . 0.0 111.741 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.959 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.16 125.72 49.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 31.4 p-10 -120.38 124.56 45.83 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.045 . . . . 0.0 108.907 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 86.3 t80 -154.05 123.74 3.26 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.1 -1.0 . . . . 0.0 110.531 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.03 136.22 14.05 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.345 2.03 . . . . 0.0 112.186 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.9 t -120.77 140.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.997 . . . . 0.0 110.028 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.81 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -113.46 96.97 6.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.34 76.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.07 -1.018 . . . . 0.0 109.599 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 103' ' ' VAL . 13.2 m -148.42 118.85 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 0.0 109.176 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 106' ' ' SER . 23.4 mmtm -144.73 -11.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.467 ' C ' ' O ' ' A' ' 104' ' ' LYS . 87.5 p -42.15 -24.5 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 108.93 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 104' ' ' LYS . 34.5 t -53.04 -83.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.36 -0.838 . . . . 0.0 109.359 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 104' ' ' LYS . 44.2 t 42.9 87.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' B' ' 28' ' ' GLU . 78.9 t -129.89 119.1 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.612 -0.68 . . . . 0.0 109.49 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.96 157.54 33.09 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -69.6 151.2 96.67 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 120.839 -1.163 . . . . 0.0 109.634 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo . . . . . 0 C--N 1.307 -1.641 0 C-N-CA 122.843 2.362 . . . . 0.0 112.259 179.909 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.04 64.26 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.804 HG21 ' HB2' ' B' ' 101' ' ' ALA . 10.4 t -65.99 -45.98 79.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.895 . . . . 0.0 109.147 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.624 ' N ' HG23 ' B' ' 3' ' ' THR . 19.9 m -135.92 -96.92 0.23 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.84 170.03 41.29 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.748 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.99 131.24 44.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.29 -1.123 . . . . 0.0 108.064 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -99.77 125.86 45.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.946 -1.096 . . . . 0.0 112.854 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' B' ' 62' ' ' MET . 74.4 m80 -120.22 121.09 37.95 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 tt -136.19 143.34 44.34 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.736 -1.227 . . . . 0.0 109.399 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' B' ' 95' ' ' LEU . 15.0 p -128.69 136.22 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.505 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' B' ' 56' ' ' PHE . 0.2 OUTLIER -114.16 126.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.431 ' CG1' HG22 ' B' ' 10' ' ' VAL . 2.1 m -138.24 153.9 27.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 117.757 -1.577 . . . . 0.0 113.016 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.434 ' HD3' ' HZ2' ' B' ' 92' ' ' LYS . 43.7 mtpt -126.4 154.68 43.27 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.674 ' CD2' HG21 ' B' ' 57' ' ' THR . 17.1 p90 -111.17 152.58 26.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.923 -1.11 . . . . 0.0 111.589 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -128.18 -18.83 4.03 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.3 mt-10 -90.12 -56.94 3.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 4.8 p30 153.13 58.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 73.0 m -47.04 107.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.131 0.967 . . . . 0.0 112.821 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.618 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.88 87.72 2.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.7 m -57.91 -34.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.567 -0.708 . . . . 0.0 110.533 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.4 p-10 -66.76 -40.08 88.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 110.51 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 88.3 mt-10 -68.28 -33.15 73.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.41 HD13 ' O ' ' B' ' 19' ' ' LYS . 1.1 mp -64.26 -43.96 97.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.27 -34.92 61.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -61.36 -34.43 75.29 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.26 -44.75 8.58 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -56.96 -57.98 10.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.555 -0.967 . . . . 0.0 108.799 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 108' ' ' VAL . 0.7 OUTLIER -55.8 -40.66 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.423 ' H ' ' HG3' ' B' ' 28' ' ' GLU . 38.7 t30 -61.41 -45.35 94.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.677 HD13 ' O ' ' B' ' 30' ' ' LEU . 2.8 tm? -53.87 -46.06 71.18 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 107' ' ' VAL . 60.2 t -55.69 -34.01 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.301 -0.874 . . . . 0.0 108.839 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 31' ' ' VAL . 4.7 m -45.37 -39.77 7.21 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.667 ' O ' ' N ' ' B' ' 35' ' ' ASP . 21.5 tp60 -69.49 -53.88 16.98 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.493 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.624 ' C ' ' H ' ' B' ' 36' ' ' THR . 17.4 mt -61.31 41.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 119.939 -1.725 . . . . 0.0 110.588 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.667 ' N ' ' O ' ' B' ' 33' ' ' GLN . 60.6 t0 -60.55 -4.26 0.87 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.624 ' H ' ' C ' ' B' ' 34' ' ' ILE . 45.6 p -76.44 -1.4 26.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.983 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.62 ' C ' ' O ' ' B' ' 36' ' ' THR . 19.0 m 31.66 47.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.015 -1.053 . . . . 0.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.444 ' HG2' ' OG1' ' B' ' 36' ' ' THR . 13.9 ptpt -124.56 42.48 3.25 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.5 t -175.56 179.39 1.44 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.434 ' O ' ' HG2' ' B' ' 41' ' ' GLU . 93.1 m-85 -145.8 155.28 42.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.582 -1.324 . . . . 0.0 111.93 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 40' ' ' PHE . 71.7 mt-10 -157.1 126.43 6.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.783 -0.573 . . . . 0.0 110.272 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' B' ' 43' ' ' GLY . 0.1 OUTLIER -142.23 177.95 7.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' B' ' 42' ' ' TRP . . . -142.74 168.89 25.79 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 118.694 -1.717 . . . . 0.0 110.816 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -149.31 145.65 27.14 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -1.128 . . . . 0.0 109.409 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 86.6 m-20 -123.84 147.05 47.94 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.851 ' HD2' ' O ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -146.15 136.44 23.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.349 -1.47 . . . . 0.0 109.737 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.714 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.9 mt-10 -131.1 -0.63 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.701 -0.624 . . . . 0.0 109.353 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.714 ' O ' ' O ' ' B' ' 47' ' ' GLU . 29.5 t -49.32 -151.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.204 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.513 ' N ' ' OG ' ' B' ' 48' ' ' SER . 76.1 m80 -70.63 152.41 43.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -0.994 . . . . 0.0 109.641 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.453 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 87.9 m-20 -66.69 -41.82 87.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.349 -0.844 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.482 ' SD ' ' O ' ' B' ' 51' ' ' MET . 0.4 OUTLIER -69.03 -33.95 74.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 95' ' ' LEU . 70.9 mt -87.26 -56.46 3.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.778 -1.201 . . . . 0.0 109.197 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.705 ' C ' ' H ' ' B' ' 55' ' ' GLY . 9.8 ptt180 -59.33 4.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 111.266 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.912 ' NE2' HD11 ' A' ' 96' ' ' LEU . 2.3 mt-30 59.4 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.828 -1.17 . . . . 0.0 110.219 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.705 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 83.07 -17.18 24.13 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.379 -0.826 . . . . 0.0 112.856 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.851 ' O ' ' HD2' ' B' ' 46' ' ' LYS . 6.0 p90 -60.48 117.12 4.88 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.292 -1.711 . . . . 0.0 109.951 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.74 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 69.8 p -51.73 -33.53 35.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.258 -0.901 . . . . 0.0 111.002 -175.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.74 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 0.1 OUTLIER -175.61 159.71 2.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.787 -1.196 . . . . 0.0 110.183 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.3 169.39 17.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.504 -0.747 . . . . 0.0 109.294 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -131.3 127.7 38.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.433 -0.792 . . . . 0.0 109.093 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t -93.23 98.24 11.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . 0.415 ' O ' ' N ' ' B' ' 8' ' ' HIS . 70.2 mtm -101.35 113.59 26.8 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.834 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 35.8 m -122.98 142.38 50.9 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -119.16 162.0 19.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.69 -1.257 . . . . 0.0 110.035 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -82.15 -30.08 31.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -168.43 175.22 6.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -65.05 -24.61 67.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 111.474 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -61.66 -44.84 96.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.803 -1.186 . . . . 0.0 110.647 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.99 -34.31 76.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.735 ' O ' HG22 ' B' ' 74' ' ' THR . 72.9 t80 -66.14 -46.17 78.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.565 -0.962 . . . . 0.0 110.504 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.71 -28.92 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.382 -1.449 . . . . 0.0 108.666 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.08 -60.83 2.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.435 -0.791 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -60.97 -55.96 26.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 111.116 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.735 HG22 ' O ' ' B' ' 70' ' ' TYR . 13.0 t -57.05 -34.77 68.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.702 -1.249 . . . . 0.0 110.34 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 69.1 p -69.31 -26.25 64.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.088 -1.008 . . . . 0.0 110.965 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 72' ' ' ALA . 41.3 m80 -65.33 151.6 93.73 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.876 -1.14 . . . . 0.0 109.651 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.02 -12.24 25.82 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.678 2.252 . . . . 0.0 112.491 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -28.6 62.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.436 -0.79 . . . . 0.0 111.22 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.454 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 46.2 t60 -83.26 -32.84 26.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.943 -1.098 . . . . 0.0 110.249 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 66.6 t -62.91 -60.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.999 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.11 -37.52 61.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -70.21 -40.17 74.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.172 -0.955 . . . . 0.0 109.883 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.8 t -62.59 -41.2 98.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.29 74.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.973 -1.079 . . . . 0.0 108.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.52 -41.35 80.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.469 ' C ' ' O ' ' B' ' 85' ' ' ALA . 19.9 t80 -44.54 -31.37 1.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.561 ' O ' ' N ' ' B' ' 90' ' ' ILE . 6.5 m -82.53 -61.84 1.77 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.0 -29.24 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.681 -0.637 . . . . 0.0 110.086 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 87' ' ' THR . 6.2 m -100.67 16.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.161 -0.962 . . . . 0.0 110.843 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' B' ' 87' ' ' THR . 41.5 mt -126.73 159.23 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.669 -1.269 . . . . 0.0 110.474 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 51.9 t0 -102.48 -31.81 10.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.449 ' N ' HG22 ' B' ' 90' ' ' ILE . 32.4 pttt -152.04 149.72 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.463 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.8 tp -125.43 124.05 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.594 -1.316 . . . . 0.0 109.76 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.427 HG12 HE21 ' A' ' 54' ' ' GLN . 45.9 t -126.82 131.4 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.824 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.273 -1.517 . . . . 0.0 111.79 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.959 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -119.21 125.76 49.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.664 -0.648 . . . . 0.0 109.33 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 30.0 p-10 -120.43 124.3 45.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.065 -1.022 . . . . 0.0 108.961 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 86.1 t80 -153.79 123.91 3.36 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.091 -1.005 . . . . 0.0 110.547 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.22 136.08 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.358 2.039 . . . . 0.0 112.221 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.56 140.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 0.0 110.094 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.804 ' HB2' HG21 ' B' ' 3' ' ' THR . . . -113.65 96.86 6.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 0.0 109.584 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.32 76.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.622 HG23 ' O ' ' B' ' 103' ' ' VAL . 13.2 m -148.49 118.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.234 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.545 ' NZ ' ' CD1' ' A' ' 42' ' ' TRP . 23.1 mmtm -144.55 -11.97 0.6 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.478 ' C ' ' O ' ' B' ' 104' ' ' LYS . 85.6 p -42.2 -24.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.152 -0.968 . . . . 0.0 108.999 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.525 ' N ' ' O ' ' B' ' 104' ' ' LYS . 33.5 t -52.93 -83.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 104' ' ' LYS . 44.8 t 42.9 87.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.441 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 79.0 t -129.93 119.2 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 109.49 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.09 157.55 33.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.452 HG22 ' H ' ' B' ' 110' ' ' THR . 0.0 OUTLIER -69.6 150.93 96.74 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 120.799 -1.188 . . . . 0.0 109.706 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo . . . . . 0 C--N 1.307 -1.611 0 C-N-CA 122.759 2.306 . . . . 0.0 112.213 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' H2 ' ' N ' ' A' ' 101' ' ' ALA . 65.1 mtt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.266 0.555 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 176.02 69.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 109.341 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.685 HG23 ' N ' ' A' ' 4' ' ' SER . 10.1 t -153.24 -48.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.937 . . . . 0.0 109.124 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.685 ' N ' HG23 ' A' ' 3' ' ' THR . 15.2 m -59.63 -69.05 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.18 -163.63 15.4 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.365 -1.397 . . . . 0.0 109.76 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -110.64 135.39 51.33 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.315 -1.109 . . . . 0.0 108.015 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 5.1 ttpm? -100.44 129.43 46.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.962 -1.086 . . . . 0.0 112.88 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' MET . 78.2 t60 -121.9 120.47 34.58 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 tt -132.12 141.93 49.32 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.702 -1.249 . . . . 0.0 109.446 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.47 139.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.654 -0.654 . . . . 0.0 109.475 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.444 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -126.64 133.74 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.3 155.95 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.069 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.701 ' HB2' ' HZ2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.8 152.26 37.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CD2' HG21 ' A' ' 57' ' ' THR . 8.9 p90 -107.88 151.51 25.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.835 -1.166 . . . . 0.0 111.565 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.13 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.6 tt0 -90.14 -56.48 3.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.8 m-20 152.63 66.86 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 65.1 m -52.46 107.0 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.087 0.946 . . . . 0.0 112.841 -176.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.629 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -72.72 85.55 1.21 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 21' ' ' ASP . 17.7 m -54.63 -37.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.3 p-10 -63.42 -36.61 84.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 110.591 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 81.6 mt-10 -72.67 -37.61 67.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.447 HD11 HG21 ' A' ' 89' ' ' VAL . 1.8 mm -58.46 -45.28 90.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -48.87 -36.25 16.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.35 -38.24 76.82 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -73.4 -25.11 73.63 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 2.1 tt -75.12 -60.18 2.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -1.025 . . . . 0.0 108.804 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' B' ' 110' ' ' THR . 24.2 pt-20 -49.95 -31.58 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 32' ' ' SER . 75.0 m-20 -65.62 -43.5 89.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.844 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -47.22 -53.34 13.5 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.3 t -49.8 -30.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 108.856 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 10.6 t -45.15 -50.77 11.11 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.445 ' NE2' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -83.54 -9.04 59.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 111.393 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.537 ' C ' ' N ' ' A' ' 36' ' ' THR . 12.3 mt -91.72 28.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.012 -1.68 . . . . 0.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.44 -9.39 2.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 38' ' ' LYS . 10.1 t -67.55 -7.71 28.19 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.959 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.6 m 34.99 34.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.12 -0.987 . . . . 0.0 109.173 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.702 ' H ' HG23 ' A' ' 36' ' ' THR . 32.5 mtmt -123.03 47.83 1.91 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -174.35 175.05 2.69 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.17 159.05 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.522 -1.361 . . . . 0.0 112.013 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -152.11 117.25 5.23 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.306 0.574 . . . . 0.0 110.22 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' B' ' 102' ' ' ALA . 3.6 t-105 -105.74 167.16 9.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 150.27 17.13 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.73 -1.7 . . . . 0.0 110.851 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 78.0 mt-10 -152.1 143.81 23.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -1.167 . . . . 0.0 109.368 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.694 ' HA ' ' O ' ' A' ' 57' ' ' THR . 59.6 t0 -170.36 95.98 0.25 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HZ1' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -84.34 156.54 21.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.484 -1.385 . . . . 0.0 109.853 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 48' ' ' SER . 84.7 mt-10 -158.91 82.2 0.79 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.1 t 160.82 151.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.189 -0.944 . . . . 0.0 110.222 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.516 ' ND1' ' OG ' ' A' ' 48' ' ' SER . 28.8 m80 62.56 105.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.927 . . . . 0.0 109.718 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -49.8 -43.61 48.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.377 -0.827 . . . . 0.0 110.775 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.552 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 24.8 ttt -60.16 -35.58 75.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.04 -1.037 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.64 -9.62 51.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.828 -1.17 . . . . 0.0 109.283 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.951 ' O ' ' N ' ' A' ' 55' ' ' GLY . 33.2 ttp180 -84.86 36.65 0.62 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.0 111.207 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 51' ' ' MET . 78.8 mm-40 -32.66 -10.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.77 -1.206 . . . . 0.0 110.173 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.951 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 102.72 -39.74 2.67 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 121.49 -0.756 . . . . 0.0 112.911 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -52.3 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.228 -1.748 . . . . 0.0 109.903 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 70.1 p -56.84 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 110.927 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.542 ' NE2' ' CG2' ' A' ' 12' ' ' VAL . 17.6 p-80 -122.0 152.36 39.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.826 -1.171 . . . . 0.0 110.085 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB2' HG13 ' A' ' 11' ' ' VAL . . . -144.6 168.77 19.38 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -138.28 133.46 33.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.433 -0.792 . . . . 0.0 109.095 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m -100.43 96.11 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 8' ' ' HIS . 53.6 mtm -96.34 121.32 38.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.111 -0.993 . . . . 0.0 110.801 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -124.74 148.07 48.28 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -125.61 155.91 40.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.795 -1.191 . . . . 0.0 110.045 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 41.4 tp10 -78.12 -26.97 48.22 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.7 m-20 -163.66 171.0 16.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -59.95 -22.17 62.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.281 -0.887 . . . . 0.0 111.438 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -58.78 -39.0 79.76 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.716 -1.24 . . . . 0.0 110.524 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.47 71.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.701 ' O ' HG22 ' A' ' 74' ' ' THR . 70.5 t80 -66.64 -44.27 82.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.561 -0.964 . . . . 0.0 110.465 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.79 -28.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.372 -1.455 . . . . 0.0 108.671 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.488 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.06 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.844 ' CE1' HD11 ' A' ' 30' ' ' LEU . 1.4 t80 -52.74 -38.7 61.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.1 t -84.16 -31.42 25.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.719 -1.238 . . . . 0.0 110.267 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 71.2 m -67.48 -33.03 74.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 111.005 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -75.36 128.02 85.14 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.898 -1.126 . . . . 0.0 109.659 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -43.67 -7.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.9 tp -64.83 -29.53 70.5 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.395 -0.815 . . . . 0.0 111.247 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -84.34 -37.11 22.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.996 -1.065 . . . . 0.0 110.239 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.73 -61.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.949 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.81 -39.15 84.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.267 -0.895 . . . . 0.0 109.559 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.32 -45.01 70.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.795 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 t -62.39 -35.02 77.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.125 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.25 65.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 108.712 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -70.83 -42.16 70.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.911 ' O ' HD13 ' A' ' 90' ' ' ILE . 18.9 t80 -45.73 -29.08 1.17 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' ' C ' ' A' ' 88' ' ' ALA . 11.2 m -82.31 -63.47 1.37 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.06 -32.34 0.09 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.624 -0.672 . . . . 0.0 110.012 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 85' ' ' ALA . 19.3 m -98.84 13.01 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.927 . . . . 0.0 110.829 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.911 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.1 mp -122.32 156.96 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.657 -1.277 . . . . 0.0 110.451 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.482 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 59.4 t0 -103.57 -36.35 7.97 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' NZ ' ' NZ ' ' A' ' 13' ' ' LYS . 30.2 pttt -147.52 147.36 30.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 93' ' ' ILE . 6.1 tp -123.42 117.73 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.608 -1.307 . . . . 0.0 109.791 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.78 127.1 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -133.79 129.2 36.24 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.365 -1.459 . . . . 0.0 111.761 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -115.69 119.36 35.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.332 176.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 61.3 t0 -125.1 131.67 53.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 108.899 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 51.9 t80 -169.26 135.36 1.4 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.06 -1.025 . . . . 0.0 110.548 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.9 Cg_exo -41.22 120.25 1.12 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.363 2.042 . . . . 0.0 112.128 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.3 143.18 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 110.019 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.507 ' N ' ' H2 ' ' A' ' 1' ' ' MET . . . -113.12 67.78 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.682 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB2' ' CE2' ' B' ' 42' ' ' TRP . . . -56.03 98.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.054 -1.029 . . . . 0.0 109.53 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 103' ' ' VAL . 24.5 m -144.72 128.59 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 109.136 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 106' ' ' SER . 5.6 mptt -111.89 -32.29 6.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.342 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 106' ' ' SER . 1.2 m 63.42 -53.01 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 108.938 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 104' ' ' LYS . 1.4 p 73.12 148.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.0 109.348 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.3 t 49.65 66.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.48 152.1 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.735 . . . . 0.0 109.425 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.36 137.68 40.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.498 ' N ' ' OE2' ' B' ' 28' ' ' GLU . 29.5 m -132.92 71.53 77.95 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 120.843 -1.161 . . . . 0.0 109.63 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 C--N 1.308 -1.559 0 C-N-CA 122.769 2.313 . . . . 0.0 112.225 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.521 ' H3 ' ' HB3' ' B' ' 101' ' ' ALA . 64.8 mtt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.303 0.573 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' B' ' 1' ' ' MET . . . 175.93 69.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 109.354 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.671 HG23 ' N ' ' B' ' 4' ' ' SER . 10.2 t -153.29 -48.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.065 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.671 ' N ' HG23 ' B' ' 3' ' ' THR . 15.6 m -59.78 -68.68 0.26 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.57 -163.55 15.55 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.727 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -110.75 135.04 51.93 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.327 -1.102 . . . . 0.0 108.035 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 5.2 ttpm? -100.05 129.46 46.1 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.33 1.062 . . . . 0.0 112.778 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 77.7 t60 -121.88 120.53 34.76 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.04 142.05 49.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.762 -1.211 . . . . 0.0 109.467 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.48 139.32 51.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -126.83 133.65 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.538 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.23 156.3 21.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.048 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.671 ' HB2' ' HZ2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -119.95 152.33 37.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 178.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' B' ' 57' ' ' THR . 9.0 p90 -107.94 151.45 25.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.838 -1.164 . . . . 0.0 111.645 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -126.14 -23.79 3.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -90.07 -56.53 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.7 m-20 152.68 66.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 64.4 m -52.35 107.09 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.991 0.901 . . . . 0.0 112.841 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.626 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -72.82 85.73 1.24 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.421 HG23 ' N ' ' B' ' 21' ' ' ASP . 17.9 m -54.87 -37.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 110.441 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.9 p-10 -63.36 -36.45 83.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.485 -0.76 . . . . 0.0 110.549 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 81.1 mt-10 -72.96 -37.77 66.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.445 HD11 HG21 ' B' ' 89' ' ' VAL . 1.8 mm -58.31 -44.96 89.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 tp -49.13 -36.21 18.51 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -58.16 -38.49 76.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -73.08 -25.34 73.77 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 2.1 tt -74.94 -60.13 2.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.948 . . . . 0.0 108.772 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.498 ' OE2' ' N ' ' A' ' 110' ' ' THR . 24.4 pt-20 -50.2 -31.26 13.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 32' ' ' SER . 75.3 m-20 -65.86 -43.49 88.26 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.839 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.5 OUTLIER -47.25 -53.1 14.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' B' ' 32' ' ' SER . 79.4 t -50.08 -30.4 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.363 -0.835 . . . . 0.0 108.811 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 11.2 t -45.36 -50.78 11.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.441 HE22 ' CB ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -83.44 -9.25 59.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.79 . . . . 0.0 111.518 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' B' ' 36' ' ' THR . 12.7 mt -91.45 28.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.967 -1.708 . . . . 0.0 110.639 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -59.43 -9.2 2.21 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.726 HG23 ' H ' ' B' ' 38' ' ' LYS . 9.6 t -67.56 -7.87 29.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.028 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.565 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.7 m 35.31 33.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.128 -0.983 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.726 ' H ' HG23 ' B' ' 36' ' ' THR . 32.3 mtmt -122.86 47.79 1.9 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' B' ' 63' ' ' THR . 15.9 t -174.46 174.87 2.67 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -148.05 159.17 44.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.51 -1.369 . . . . 0.0 111.972 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -152.23 117.22 5.17 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.379 0.609 . . . . 0.0 110.225 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 102' ' ' ALA . 3.7 t-105 -105.72 167.2 9.93 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.84 150.48 17.15 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 118.734 -1.698 . . . . 0.0 110.835 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 77.6 mt-10 -152.23 143.75 23.45 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -1.105 . . . . 0.0 109.425 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' B' ' 57' ' ' THR . 59.5 t0 -170.11 95.82 0.26 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.713 ' HZ1' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -84.2 156.51 22.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.422 -1.424 . . . . 0.0 109.807 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' B' ' 48' ' ' SER . 84.3 mt-10 -158.94 82.06 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.1 t 160.94 151.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.176 -0.953 . . . . 0.0 110.192 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.516 ' ND1' ' OG ' ' B' ' 48' ' ' SER . 28.8 m80 62.8 105.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.682 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -49.62 -44.02 47.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.818 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.553 ' O ' ' NE2' ' B' ' 54' ' ' GLN . 24.8 ttt -59.78 -35.76 75.31 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.763 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 19.3 mt -88.65 -9.5 51.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.718 -1.239 . . . . 0.0 109.312 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.954 ' O ' ' N ' ' B' ' 55' ' ' GLY . 33.6 ttp180 -84.8 36.37 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 0.0 111.232 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' B' ' 51' ' ' MET . 78.8 mm-40 -32.48 -10.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 110.215 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.954 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 102.51 -39.63 2.71 Favored Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.425 -0.797 . . . . 0.0 112.805 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -52.34 101.57 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.554 1.677 . . . . 0.0 109.907 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 71.4 p -56.99 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 110.95 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.576 ' H ' ' HG1' ' B' ' 57' ' ' THR . 18.1 p-80 -121.97 152.12 40.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.908 -1.12 . . . . 0.0 110.127 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' B' ' 11' ' ' VAL . . . -144.38 168.72 19.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.475 -0.765 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -138.24 133.69 33.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.042 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -100.56 96.19 7.2 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 53.5 mtm -96.5 121.43 38.31 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.172 -0.955 . . . . 0.0 110.73 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' B' ' 39' ' ' SER . 28.5 m -125.03 147.64 48.87 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.23 156.19 38.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.724 -1.235 . . . . 0.0 110.081 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 41.8 tp10 -78.48 -26.82 46.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.7 m-20 -163.78 170.79 16.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -59.82 -21.82 61.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.912 . . . . 0.0 111.501 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -59.13 -38.68 80.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 110.57 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.38 69.87 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.697 ' O ' HG22 ' B' ' 74' ' ' THR . 70.6 t80 -66.59 -44.42 82.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.618 -0.93 . . . . 0.0 110.433 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.417 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.73 -28.91 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.451 -1.405 . . . . 0.0 108.707 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.491 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.09 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.442 -0.786 . . . . 0.0 109.297 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.839 ' CE1' HD11 ' B' ' 30' ' ' LEU . 1.4 t80 -52.59 -38.94 61.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 111.123 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.697 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.1 t -84.07 -31.32 25.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.726 -1.234 . . . . 0.0 110.281 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 71.9 m -67.53 -32.85 73.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.974 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' B' ' 78' ' ' LEU . 0.9 OUTLIER -75.53 128.09 84.7 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.885 -1.134 . . . . 0.0 109.602 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -43.77 -7.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 112.508 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.9 tp -64.84 -29.61 70.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.397 -0.815 . . . . 0.0 111.199 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -84.29 -37.14 22.05 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.238 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.68 -61.65 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 110.045 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.63 -39.21 83.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -69.33 -44.95 70.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.812 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 28.9 t -62.38 -35.18 78.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.1 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.29 65.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.675 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.684 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -70.79 -42.34 70.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.888 ' O ' HD13 ' B' ' 90' ' ' ILE . 19.2 t80 -45.81 -28.86 1.16 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.452 ' O ' ' C ' ' B' ' 88' ' ' ALA . 11.1 m -82.37 -63.37 1.39 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.11 -32.36 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.708 -0.62 . . . . 0.0 110.122 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.684 HG22 ' O ' ' B' ' 85' ' ' ALA . 19.1 m -98.84 12.78 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 110.874 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.888 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.1 mp -122.0 157.26 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.671 -1.268 . . . . 0.0 110.477 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 59.1 t0 -103.89 -36.21 7.88 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.435 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 30.6 pttt -147.65 147.22 29.77 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.554 HG23 ' O ' ' B' ' 93' ' ' ILE . 6.2 tp -123.42 117.87 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.517 -1.364 . . . . 0.0 109.721 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.86 127.24 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.59 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -133.99 129.16 35.77 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.258 -1.526 . . . . 0.0 111.73 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.462 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.5 OUTLIER -115.64 119.37 35.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.652 -0.655 . . . . 0.0 109.328 176.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 62.0 t0 -125.04 131.78 53.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 108.929 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 52.1 t80 -169.36 135.25 1.37 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.105 -0.997 . . . . 0.0 110.53 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 87.6 Cg_exo -41.2 120.1 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.264 1.976 . . . . 0.0 112.247 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.16 143.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 110.025 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.521 ' HB3' ' H3 ' ' B' ' 1' ' ' MET . . . -113.16 68.0 0.67 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.514 -0.741 . . . . 0.0 109.581 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . . . -56.12 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.623 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 103' ' ' VAL . 24.3 m -144.52 128.49 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 106' ' ' SER . 5.6 mptt -111.7 -32.43 6.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' B' ' 106' ' ' SER . 1.2 m 63.55 -53.21 0.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.13 -0.982 . . . . 0.0 108.892 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.685 ' N ' ' O ' ' B' ' 104' ' ' LYS . 1.4 p 73.24 148.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t 49.5 66.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.34 152.23 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.513 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.46 137.64 40.61 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.484 ' N ' ' OE2' ' A' ' 28' ' ' GLU . 28.7 m -132.79 71.41 78.4 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 120.821 -1.175 . . . . 0.0 109.657 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 C--N 1.308 -1.564 0 C-N-CA 122.785 2.323 . . . . 0.0 112.233 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.288 0.566 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.77 64.97 1.65 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 109.38 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 t -95.79 3.44 53.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -168.95 -89.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.28 168.68 18.35 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.671 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.62 131.57 55.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.242 -1.152 . . . . 0.0 108.022 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 25.2 ttpt -104.22 131.9 51.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.917 -1.114 . . . . 0.0 112.777 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 62' ' ' MET . 61.1 m80 -126.34 127.46 45.56 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.2 tt -135.72 142.53 45.05 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.767 -1.208 . . . . 0.0 109.496 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 4.3 p -130.66 140.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.547 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.74 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.654 ' O ' ' O ' ' A' ' 56' ' ' PHE . 3.4 m -132.38 143.39 40.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.104 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 14.2 mmtt -107.43 152.6 23.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.565 ' HB2' ' H ' ' A' ' 18' ' ' THR . 15.8 p90 -114.53 148.71 37.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.769 -1.207 . . . . 0.0 111.585 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.89 -23.43 4.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -93.05 -53.89 3.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.2 t0 150.1 67.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.565 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.3 m -49.03 105.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.13 0.967 . . . . 0.0 112.802 -176.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.551 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -72.82 84.77 1.22 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 21' ' ' ASP . 27.8 m -58.34 -37.72 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.549 -0.72 . . . . 0.0 110.456 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 34.1 p-10 -65.29 -38.33 89.89 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.479 -0.763 . . . . 0.0 110.544 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -70.08 -34.07 72.7 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.881 HD11 HG21 ' A' ' 89' ' ' VAL . 1.4 mm -63.87 -44.07 97.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.31 -35.8 51.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -61.45 -34.59 75.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -80.46 -44.11 8.88 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.94 -59.24 5.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.996 . . . . 0.0 108.856 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 22.1 pt-20 -52.17 -45.41 65.1 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.533 ' N ' ' CG ' ' A' ' 28' ' ' GLU . 3.8 t30 -58.15 -43.87 87.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -49.59 -44.25 46.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 34' ' ' ILE . 20.6 t -52.4 -22.35 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.221 -0.924 . . . . 0.0 108.888 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 34.3 t -40.62 -39.53 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 62.3 mm-40 -76.26 -23.81 54.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.478 -0.764 . . . . 0.0 111.461 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 34' ' ' ILE . 75.8 mt -81.75 20.85 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.018 -1.676 . . . . 0.0 110.544 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -57.4 -6.47 0.45 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.659 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.3 t -87.93 2.96 50.33 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.943 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.9 m 35.31 35.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.073 -1.017 . . . . 0.0 109.195 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.57 ' O ' ' OG ' ' A' ' 39' ' ' SER . 65.9 mttt -115.34 39.87 2.84 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 71.0 m -173.04 175.84 3.14 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -147.3 157.41 43.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.966 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' SER . 67.6 mt-10 -154.41 120.3 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.436 0.636 . . . . 0.0 110.246 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 1.1 m95 -123.37 170.27 10.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 164.4 24.92 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 118.695 -1.717 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 50.8 tt0 -154.72 148.1 25.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -113.17 141.3 47.1 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -139.39 108.08 5.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.41 -1.431 . . . . 0.0 109.829 -178.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.5 45.81 0.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.64 -0.663 . . . . 0.0 109.287 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.483 ' CB ' HH11 ' A' ' 53' ' ' ARG . 1.4 t -144.58 121.67 11.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.131 -0.98 . . . . 0.0 110.191 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.537 ' CG ' HD12 ' A' ' 52' ' ' LEU . 7.2 m80 65.97 118.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 109.753 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.15 -29.07 70.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.81 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -85.31 -36.05 21.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.01 -1.056 . . . . 0.0 110.712 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' B' ' 95' ' ' LEU . 27.0 mt -79.66 -72.87 0.38 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.729 -1.232 . . . . 0.0 109.273 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.86 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -73.15 4.67 4.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 111.252 -176.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 53' ' ' ARG . 15.4 mm100 39.1 6.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.819 -1.176 . . . . 0.0 110.204 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 50.79 2.87 0.04 OUTLIER Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.544 -0.722 . . . . 0.0 112.933 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.763 ' O ' ' CB ' ' A' ' 57' ' ' THR . 34.4 m-85 -39.12 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.189 -1.771 . . . . 0.0 109.976 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.763 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 16.8 m 99.8 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.287 -0.883 . . . . 0.0 110.938 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.526 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 18.5 t60 -164.56 152.08 11.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.885 -1.134 . . . . 0.0 110.173 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.19 167.28 22.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.31 -0.869 . . . . 0.0 109.249 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 95.2 m-85 -135.26 130.5 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.49 -0.756 . . . . 0.0 109.062 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -97.65 96.98 8.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 8' ' ' HIS . 74.2 mtm -98.02 117.86 33.31 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.188 -0.945 . . . . 0.0 110.844 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -122.78 144.64 49.04 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.31 159.12 28.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.702 -1.249 . . . . 0.0 110.068 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 41.6 tp10 -82.7 -31.47 28.52 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 65' ' ' GLU . 80.6 m-20 -161.73 169.37 21.58 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.51 ' NZ ' ' CB ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -55.18 -21.66 14.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 111.437 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -56.52 -40.48 75.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.788 -1.195 . . . . 0.0 110.611 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.17 -37.59 72.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' THR . 75.1 t80 -62.63 -45.12 94.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.623 -0.928 . . . . 0.0 110.522 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.368 -1.457 . . . . 0.0 108.653 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' O ' ' CD2' ' A' ' 76' ' ' HIS . . . -65.07 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.381 -0.825 . . . . 0.0 109.381 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.488 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -51.68 -37.74 51.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 111.134 -177.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.6 t -84.99 -33.97 22.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.802 -1.186 . . . . 0.0 110.299 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.4 t -71.34 -25.6 62.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 0.0 110.95 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.55 ' CD2' ' OE1' ' A' ' 33' ' ' GLN . 84.1 m-70 -81.01 121.35 80.65 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.852 -1.155 . . . . 0.0 109.604 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.36 -13.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.638 2.225 . . . . 0.0 112.457 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 HD22 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -64.0 -26.97 68.81 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.346 -0.846 . . . . 0.0 111.277 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.488 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 7.4 t-160 -81.66 -30.45 32.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.06 . . . . 0.0 110.236 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.09 -60.21 3.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.66 -40.24 62.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -66.6 -33.52 75.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.83 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 p -61.33 -43.79 98.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.144 -0.973 . . . . 0.0 110.105 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.48 -37.06 67.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 108.714 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.941 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -72.18 -40.53 67.87 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.613 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.28 -40.96 0.37 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' VAL . 24.3 m -81.94 -60.36 2.26 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.59 -10.24 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.669 -0.644 . . . . 0.0 110.047 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.941 HG22 ' O ' ' A' ' 85' ' ' ALA . 10.5 m -124.8 -7.86 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.191 -0.943 . . . . 0.0 110.853 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.652 HG13 HG23 ' A' ' 89' ' ' VAL . 65.4 mt -131.1 162.99 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.588 -1.32 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 90' ' ' ILE . 12.0 t0 -121.44 -24.01 5.51 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.73 139.02 32.76 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.4 tp -128.97 127.31 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.596 -1.315 . . . . 0.0 109.83 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 t -128.38 132.36 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -137.58 132.55 33.28 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.315 -1.49 . . . . 0.0 111.75 -178.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -115.8 121.36 42.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.723 -0.611 . . . . 0.0 109.364 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.674 ' O ' ' NE ' ' B' ' 53' ' ' ARG . 59.7 m-20 -123.75 128.3 49.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.081 -1.012 . . . . 0.0 108.869 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 99' ' ' PRO . 63.6 t80 -165.48 131.67 2.09 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.519 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 88.7 Cg_exo -47.52 133.41 20.83 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.288 1.992 . . . . 0.0 112.25 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.47 141.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 110.034 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -103.11 70.96 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.25 82.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.578 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 101' ' ' ALA . 29.1 m -127.53 -15.96 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.395 -0.816 . . . . 0.0 109.184 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 106' ' ' SER . 4.7 mptt 44.61 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -65.43 53.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 108.942 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 104' ' ' LYS . 6.3 t -83.98 38.89 0.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 108' ' ' VAL . 9.7 p -91.44 -44.22 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.593 ' N ' HG13 ' A' ' 107' ' ' VAL . 7.1 p -144.38 140.72 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.553 -0.717 . . . . 0.0 109.519 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.94 119.5 38.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -77.78 152.73 80.47 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 120.937 -1.102 . . . . 0.0 109.629 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.813 2.342 . . . . 0.0 112.245 179.695 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.314 0.578 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.8 65.14 1.6 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.88 . . . . 0.0 109.33 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -95.92 3.74 53.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 109.166 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m -169.37 -89.95 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -126.11 168.88 18.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.726 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -111.77 131.7 55.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 25.1 ttpt -104.43 131.65 51.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.938 -1.101 . . . . 0.0 112.881 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 62' ' ' MET . 60.9 m80 -126.13 127.57 45.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.2 tt -135.77 142.56 44.96 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.741 -1.225 . . . . 0.0 109.385 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 4.2 p -130.69 140.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.56 -0.712 . . . . 0.0 109.528 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -124.77 132.85 70.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.645 ' O ' ' O ' ' B' ' 56' ' ' PHE . 3.5 m -132.73 143.18 40.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 117.762 -1.575 . . . . 0.0 112.993 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 14.2 mmtt -107.25 152.22 24.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.553 ' HB2' ' H ' ' B' ' 18' ' ' THR . 15.8 p90 -114.03 149.12 35.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.801 -1.187 . . . . 0.0 111.58 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -124.0 -23.59 4.58 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.4 mt-10 -92.88 -53.96 3.94 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.1 t0 150.17 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.553 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.7 m -48.99 105.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.105 0.955 . . . . 0.0 112.887 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.562 ' H ' ' HD3' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -72.79 84.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.463 HG23 ' N ' ' B' ' 21' ' ' ASP . 27.9 m -58.41 -37.53 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.498 -0.751 . . . . 0.0 110.43 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 34.4 p-10 -65.52 -38.29 89.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.514 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.498 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 0.4 OUTLIER -70.05 -33.99 72.65 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.88 HD11 HG21 ' B' ' 89' ' ' VAL . 1.4 mm -63.84 -44.11 98.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.27 -35.7 50.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -61.56 -34.71 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -80.31 -43.71 9.32 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -57.43 -59.01 5.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.944 . . . . 0.0 108.809 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 22.3 pt-20 -52.37 -45.23 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.527 ' N ' ' CG ' ' B' ' 28' ' ' GLU . 3.8 t30 -58.22 -43.93 87.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.576 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -49.76 -43.92 48.35 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' B' ' 34' ' ' ILE . 20.8 t -52.61 -22.33 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 36.4 t -40.65 -39.48 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.552 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 62.0 mm-40 -76.28 -23.73 54.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.765 . . . . 0.0 111.497 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.79 HG22 ' O ' ' B' ' 34' ' ' ILE . 75.9 mt -81.85 20.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.014 -1.679 . . . . 0.0 110.585 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.5 p30 -57.45 -6.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.634 ' H ' ' C ' ' B' ' 34' ' ' ILE . 1.3 t -87.89 3.0 50.15 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.986 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.566 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.0 m 35.43 35.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.101 -1.0 . . . . 0.0 109.154 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.569 ' O ' ' OG ' ' B' ' 39' ' ' SER . 64.8 mttt -115.17 40.11 2.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.569 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 73.2 m -173.4 175.72 3.0 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -147.18 157.53 43.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.478 -1.389 . . . . 0.0 111.972 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' B' ' 61' ' ' SER . 67.7 mt-10 -154.54 120.5 5.25 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.356 0.598 . . . . 0.0 110.235 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.635 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 1.1 m95 -123.63 170.15 10.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.58 164.26 24.91 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 50.9 tt0 -154.48 148.07 25.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.254 -1.145 . . . . 0.0 109.354 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -113.19 141.02 47.44 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -139.35 108.04 5.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.357 -1.464 . . . . 0.0 109.889 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -151.38 45.54 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.689 -0.632 . . . . 0.0 109.395 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.476 ' CB ' HH11 ' B' ' 53' ' ' ARG . 1.4 t -144.24 121.94 11.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 110.166 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.533 ' CG ' HD12 ' B' ' 52' ' ' LEU . 7.2 m80 65.66 118.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.207 -0.933 . . . . 0.0 109.728 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -62.23 -29.33 70.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.332 -0.855 . . . . 0.0 110.781 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 89.5 mtp -85.23 -35.89 21.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.03 -1.044 . . . . 0.0 110.768 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' A' ' 95' ' ' LEU . 27.2 mt -79.7 -72.74 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.755 -1.216 . . . . 0.0 109.291 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.852 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.6 OUTLIER -73.2 4.51 4.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 111.22 -176.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.474 ' C ' ' O ' ' B' ' 53' ' ' ARG . 15.4 mm100 39.15 6.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.804 -1.185 . . . . 0.0 110.213 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.852 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 50.46 2.91 0.04 OUTLIER Glycine 0 N--CA 1.499 2.835 0 O-C-N 121.515 -0.74 . . . . 0.0 112.909 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' CB ' ' B' ' 57' ' ' THR . 33.7 m-85 -39.04 -25.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.274 -1.721 . . . . 0.0 110.004 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.768 ' CB ' ' O ' ' B' ' 56' ' ' PHE . 16.1 m 99.7 -62.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.281 -0.887 . . . . 0.0 110.982 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.52 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 18.6 t60 -164.31 152.04 12.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.862 -1.148 . . . . 0.0 110.127 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.468 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.19 167.13 22.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.536 -0.727 . . . . 0.0 109.301 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.52 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 95.2 m-85 -135.01 130.71 36.11 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.485 -0.759 . . . . 0.0 109.08 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 0.1 OUTLIER -97.66 97.06 8.71 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . 0.448 ' O ' ' N ' ' B' ' 8' ' ' HIS . 74.6 mtm -98.12 117.82 33.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.175 -0.953 . . . . 0.0 110.741 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -122.84 144.44 49.2 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.12 159.04 27.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.75 -1.219 . . . . 0.0 110.062 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' B' ' 66' ' ' ASN . 42.1 tp10 -82.57 -31.33 29.06 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' B' ' 65' ' ' GLU . 80.7 m-20 -161.93 169.6 20.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' B' ' 67' ' ' LYS . 0.0 OUTLIER -55.25 -21.73 15.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.493 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.4 -40.76 75.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.789 -1.195 . . . . 0.0 110.534 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.89 -37.84 75.08 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.544 ' O ' HG22 ' B' ' 74' ' ' THR . 75.4 t80 -62.28 -45.47 93.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.592 -0.946 . . . . 0.0 110.374 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.67 -28.94 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.455 -1.403 . . . . 0.0 108.732 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' B' ' 76' ' ' HIS . . . -65.12 -60.86 2.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.315 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.491 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.1 OUTLIER -51.35 -38.1 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.86 . . . . 0.0 111.146 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.544 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.6 t -84.74 -33.99 22.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.732 -1.23 . . . . 0.0 110.324 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 36.3 t -71.29 -25.97 62.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.942 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.552 ' CD2' ' OE1' ' B' ' 33' ' ' GLN . 83.7 m-70 -80.63 121.32 81.12 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.796 -1.19 . . . . 0.0 109.557 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.39 -13.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.69 2.26 . . . . 0.0 112.413 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.544 HD23 HD22 ' B' ' 30' ' ' LEU . 0.6 OUTLIER -63.65 -27.32 69.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.776 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.491 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 7.4 t-160 -81.47 -30.32 33.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 110.301 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.18 -60.24 3.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.76 -40.06 62.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.518 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -66.56 -33.78 76.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.93 . . . . 0.0 109.877 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 56.6 p -61.06 -43.9 98.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.1 -1.0 . . . . 0.0 110.134 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.31 -37.26 67.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.034 -1.042 . . . . 0.0 108.72 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.926 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -72.04 -40.72 68.18 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.614 ' O ' ' HB ' ' B' ' 90' ' ' ILE . 0.0 OUTLIER -37.1 -40.89 0.33 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.541 ' O ' ' N ' ' B' ' 89' ' ' VAL . 24.6 m -82.16 -60.34 2.25 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -48.52 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.783 -0.573 . . . . 0.0 110.103 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.926 HG22 ' O ' ' B' ' 85' ' ' ALA . 10.4 m -124.94 -7.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.233 -0.917 . . . . 0.0 110.855 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.657 HG13 HG23 ' B' ' 89' ' ' VAL . 66.2 mt -131.04 162.89 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.618 -1.301 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.603 ' N ' HG22 ' B' ' 90' ' ' ILE . 12.0 t0 -121.28 -24.33 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -141.58 139.22 33.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.418 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.4 tp -129.28 127.34 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.542 -1.349 . . . . 0.0 109.755 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 60.7 t -128.35 132.52 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.604 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -137.71 132.48 32.91 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.254 -1.528 . . . . 0.0 111.783 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.443 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.4 OUTLIER -115.66 121.49 42.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.68 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 60.3 m-20 -123.73 128.23 49.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.066 -1.021 . . . . 0.0 108.934 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 99' ' ' PRO . 63.7 t80 -165.31 131.65 2.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.55 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.514 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 88.2 Cg_exo -47.59 133.15 21.13 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.256 1.971 . . . . 0.0 112.225 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.22 141.28 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.049 -1.032 . . . . 0.0 110.064 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -102.88 71.11 1.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.487 -0.758 . . . . 0.0 109.602 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.46 82.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.123 -0.985 . . . . 0.0 109.574 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' B' ' 101' ' ' ALA . 29.1 m -127.65 -15.92 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.18 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' B' ' 106' ' ' SER . 4.7 mptt 44.73 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.353 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -65.34 53.97 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -0.976 . . . . 0.0 108.959 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.589 ' N ' ' O ' ' B' ' 104' ' ' LYS . 6.3 t -84.07 38.95 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.583 HG13 ' N ' ' B' ' 108' ' ' VAL . 9.8 p -91.49 -44.18 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.583 ' N ' HG13 ' B' ' 107' ' ' VAL . 7.2 p -144.45 140.62 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.508 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.71 119.6 39.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -77.71 152.76 80.68 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 120.841 -1.162 . . . . 0.0 109.613 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.775 2.317 . . . . 0.0 112.262 179.765 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.536 ' H3 ' ' HG2' ' A' ' 99' ' ' PRO . 7.9 ptp . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.483 ' H ' ' HG3' ' A' ' 99' ' ' PRO . . . 46.91 62.84 2.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.979 . . . . 0.0 109.423 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.699 HG23 ' N ' ' A' ' 4' ' ' SER . 6.7 t -67.3 -51.49 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.699 ' N ' HG23 ' A' ' 3' ' ' THR . 9.7 m -140.85 -117.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.25 142.62 46.6 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.641 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -113.59 128.83 56.58 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.297 -1.119 . . . . 0.0 108.011 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -110.07 138.87 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.929 -1.107 . . . . 0.0 112.776 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.27 129.74 43.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -135.46 143.39 45.86 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.698 -1.251 . . . . 0.0 109.522 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 10.4 p -128.5 138.05 55.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.642 -0.661 . . . . 0.0 109.508 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.97 130.67 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -136.96 165.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.78 -1.568 . . . . 0.0 113.07 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 39.2 tptt -130.43 151.4 50.96 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 10.0 p90 -108.87 150.16 28.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.838 -1.164 . . . . 0.0 111.615 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.37 -22.64 5.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.9 mt-10 -91.26 -53.68 4.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.8 t0 149.39 69.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.2 m -55.85 109.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.082 0.944 . . . . 0.0 112.857 -177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.712 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.73 91.11 5.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -61.36 -33.45 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 110.453 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.8 p-10 -68.3 -41.52 80.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.451 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.703 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 70.3 tt0 -66.72 -28.32 68.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -74.46 -39.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.7 -40.41 79.42 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.703 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -60.51 -26.11 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . -81.26 -45.29 7.56 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.6 tt -49.0 -51.92 27.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.484 -1.01 . . . . 0.0 108.809 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 17.1 pt-20 -53.06 -43.29 66.57 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -57.41 -43.52 83.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -46.91 -45.35 20.49 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 34' ' ' ILE . 23.0 t -51.6 -23.37 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 108.933 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 41.9 t -42.86 -46.55 5.34 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.534 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 82.0 mm-40 -74.55 -20.47 59.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.374 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 34' ' ' ILE . 58.0 mt -82.62 22.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.05 -1.656 . . . . 0.0 110.643 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.8 p30 -59.46 -8.78 1.98 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 36.2 p -82.64 -0.97 49.66 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.981 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.6 m 35.59 31.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' THR . 42.0 mttm -117.66 40.76 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 34' ' ' ILE . 95.6 p -173.11 173.96 3.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.72 159.12 44.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -153.96 121.04 5.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.395 0.617 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -124.03 167.02 14.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' O ' ' CD ' ' A' ' 44' ' ' GLU . . . -125.48 157.98 19.73 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.756 -1.688 . . . . 0.0 110.823 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.654 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 73.9 mm-40 -148.35 136.9 21.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.247 -1.149 . . . . 0.0 109.397 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -111.09 141.02 45.14 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.842 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -143.42 117.26 9.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.454 -1.404 . . . . 0.0 109.763 -178.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -153.56 -15.22 0.14 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.544 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -69.57 122.0 18.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.993 . . . . 0.0 110.177 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.494 ' O ' ' O ' ' A' ' 48' ' ' SER . 48.1 m80 59.36 126.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.985 . . . . 0.0 109.678 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -67.02 -34.89 78.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.816 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.523 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -77.44 -37.94 50.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 0.0 110.687 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' B' ' 95' ' ' LEU . 19.3 mt -78.79 -71.15 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.74 -1.225 . . . . 0.0 109.266 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' A' ' 53' ' ' ARG . 3.7 mmt-85 -72.25 12.63 0.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.901 . . . . 0.0 111.258 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.53 ' CD ' HD21 ' B' ' 96' ' ' LEU . 76.1 mt-30 50.67 7.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.765 -1.209 . . . . 0.0 110.171 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.674 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 55.87 -0.42 0.12 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.361 -0.837 . . . . 0.0 112.891 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.674 ' O ' ' O ' ' A' ' 55' ' ' GLY . 4.8 m-85 -53.19 -142.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.157 -1.79 . . . . 0.0 109.914 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 46' ' ' LYS . 35.3 m -135.82 -47.49 0.67 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.415 -0.803 . . . . 0.0 110.96 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.654 ' CE1' ' H ' ' A' ' 44' ' ' GLU . 27.4 t60 -172.76 160.06 4.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.96 -1.087 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.611 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.55 163.01 34.08 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.46 -0.775 . . . . 0.0 109.231 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.641 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 82.6 m-85 -133.42 129.59 37.52 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.499 -0.751 . . . . 0.0 109.121 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.29 98.7 8.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.6 mtt -98.68 119.68 37.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.234 -0.916 . . . . 0.0 110.76 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -119.37 140.62 50.06 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.07 125.83 44.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.083 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -50.87 -32.14 19.51 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -156.03 162.28 40.33 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -60.59 -21.83 63.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 111.493 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 34.0 p-10 -55.94 -36.43 67.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.773 -1.204 . . . . 0.0 110.532 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -72.18 -31.99 63.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.699 ' O ' HG22 ' A' ' 74' ' ' THR . 76.9 t80 -67.79 -44.36 77.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.973 . . . . 0.0 110.436 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.76 -28.95 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.404 -1.435 . . . . 0.0 108.686 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.05 -60.89 2.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 0.0 109.373 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.539 ' CE1' HD11 ' A' ' 30' ' ' LEU . 1.6 t80 -56.59 -60.13 3.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.11 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.699 HG22 ' O ' ' A' ' 70' ' ' TYR . 10.1 t -52.29 -34.46 46.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.734 -1.228 . . . . 0.0 110.3 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.3 m -77.96 -16.22 58.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.959 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 78' ' ' LEU . 22.6 m80 -79.24 132.18 63.72 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.856 -1.152 . . . . 0.0 109.57 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -42.22 -12.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.697 2.264 . . . . 0.0 112.394 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.5 tp -74.44 -27.28 60.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.423 -0.798 . . . . 0.0 111.292 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.83 -45.13 21.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.957 -1.09 . . . . 0.0 110.206 -177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.774 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -59.44 -58.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 110.01 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.774 ' H ' HG13 ' A' ' 80' ' ' VAL . 15.2 tm-20 -51.01 -36.65 40.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.92 -32.02 73.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.758 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.05 -44.23 94.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.44 -33.28 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.921 -1.112 . . . . 0.0 108.73 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.939 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -79.42 -46.37 17.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.699 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -38.81 -40.15 0.59 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 89' ' ' VAL . 20.3 m -82.17 -62.53 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.86 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.676 -0.64 . . . . 0.0 110.097 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.939 HG22 ' O ' ' A' ' 85' ' ' ALA . 9.1 m -117.46 -1.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 0.0 110.771 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 91' ' ' ASP . 68.4 mt -132.93 164.02 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 110.512 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 90' ' ' ILE . 38.4 t0 -124.14 -26.82 3.94 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' NZ ' ' CZ ' ' A' ' 56' ' ' PHE . 18.9 ttpt -133.81 131.17 38.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -126.32 125.59 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.596 -1.315 . . . . 0.0 109.768 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.489 HG12 HE21 ' B' ' 54' ' ' GLN . 12.0 t -132.2 134.5 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -136.47 131.65 34.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.294 -1.503 . . . . 0.0 111.764 -178.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.546 HD21 ' CD ' ' B' ' 54' ' ' GLN . 0.2 OUTLIER -116.05 122.57 45.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.645 -0.659 . . . . 0.0 109.391 177.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.549 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 38.5 p-10 -126.11 132.49 51.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -159.81 128.72 3.08 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.087 -1.008 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.536 ' HG2' ' H3 ' ' A' ' 1' ' ' MET . 80.5 Cg_exo -45.61 131.46 12.67 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.37 2.046 . . . . 0.0 112.186 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.553 HG22 ' OE2' ' B' ' 44' ' ' GLU . 96.9 t -113.42 135.37 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.96 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -107.96 88.3 2.7 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.451 -0.781 . . . . 0.0 109.56 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -57.71 73.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 102' ' ' ALA . 4.5 m -161.01 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 109.099 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 106' ' ' SER . 24.0 mmtm -97.7 4.57 49.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.412 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.35 -53.53 0.27 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 108.879 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 104' ' ' LYS . 20.1 m 47.17 45.01 16.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.358 -0.839 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -84.83 -41.62 16.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.3 m -112.4 49.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.573 -0.704 . . . . 0.0 109.508 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.78 83.88 3.38 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.39 161.79 48.3 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 120.901 -1.124 . . . . 0.0 109.671 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 C--N 1.308 -1.576 0 C-N-CA 122.707 2.271 . . . . 0.0 112.277 179.651 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.556 ' H3 ' ' HG2' ' B' ' 99' ' ' PRO . 7.9 ptp . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.322 0.582 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.472 ' H ' ' HG3' ' B' ' 99' ' ' PRO . . . 47.05 62.86 2.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.302 -0.874 . . . . 0.0 109.366 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.69 HG23 ' N ' ' B' ' 4' ' ' SER . 6.7 t -67.36 -51.52 51.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -0.859 . . . . 0.0 109.138 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.69 ' N ' HG23 ' B' ' 3' ' ' THR . 9.5 m -140.82 -117.35 0.12 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.22 142.69 46.52 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.693 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -113.67 128.74 56.54 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.218 -1.166 . . . . 0.0 108.033 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -109.91 138.63 46.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.862 -1.149 . . . . 0.0 112.822 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -130.09 129.68 43.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.0 tt -135.35 143.45 46.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.796 -1.19 . . . . 0.0 109.433 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 10.3 p -128.34 137.97 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.603 -0.686 . . . . 0.0 109.478 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.6 OUTLIER -120.92 130.79 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 178.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.04 165.49 27.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.663 -1.615 . . . . 0.0 113.028 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 39.1 tptt -130.39 151.41 50.91 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.511 ' HB2' ' H ' ' B' ' 18' ' ' THR . 9.9 p90 -108.84 150.11 28.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.795 -1.191 . . . . 0.0 111.558 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -123.36 -22.82 4.98 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.9 mt-10 -91.03 -53.77 4.24 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.7 t0 149.47 69.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -56.0 109.76 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.129 0.966 . . . . 0.0 112.778 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.713 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.87 91.31 5.97 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.38 -33.55 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.647 . . . . 0.0 110.495 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.6 p-10 -68.13 -41.56 81.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 110.542 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.695 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 70.7 tt0 -66.85 -28.09 68.07 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -74.7 -39.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tp -57.62 -40.57 79.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.1 OUTLIER -60.36 -26.19 66.42 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' B' ' 25' ' ' LYS . . . -81.06 -45.47 7.56 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.502 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.6 tt -48.91 -51.98 27.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -1.032 . . . . 0.0 108.855 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 17.0 pt-20 -53.09 -43.33 66.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.0 OUTLIER -57.34 -43.47 83.46 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.538 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -47.1 -45.34 22.05 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 34' ' ' ILE . 23.2 t -51.47 -23.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.299 -0.876 . . . . 0.0 108.767 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 41.7 t -42.74 -46.47 5.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.527 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 81.9 mm-40 -74.57 -20.47 59.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 111.533 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.714 HG22 ' O ' ' B' ' 34' ' ' ILE . 58.1 mt -82.65 22.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.972 -1.705 . . . . 0.0 110.563 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.1 p30 -59.5 -8.88 2.06 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.597 ' O ' ' N ' ' B' ' 38' ' ' LYS . 36.3 p -82.52 -0.98 49.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.953 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.544 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.9 m 35.53 31.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.063 -1.023 . . . . 0.0 109.187 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.597 ' N ' ' O ' ' B' ' 36' ' ' THR . 42.2 mttm -117.64 40.73 3.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.551 ' OG ' HG23 ' B' ' 34' ' ' ILE . 95.6 p -173.07 173.94 3.56 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.525 -0.735 . . . . 0.0 109.031 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -148.73 158.99 44.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.521 -1.362 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -153.82 120.95 5.72 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.314 0.578 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -124.0 166.77 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' B' ' 44' ' ' GLU . . . -125.43 157.94 19.68 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.742 -1.694 . . . . 0.0 110.754 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.655 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 74.1 mm-40 -148.26 136.97 21.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.253 -1.146 . . . . 0.0 109.42 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -111.11 141.05 45.12 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.839 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -143.4 117.29 9.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.384 -1.448 . . . . 0.0 109.785 -178.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -153.62 -15.25 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.33 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.551 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 0.7 OUTLIER -69.62 121.87 17.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' B' ' 48' ' ' SER . 48.0 m80 59.55 126.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.076 -1.015 . . . . 0.0 109.701 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -67.07 -34.87 78.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.402 -0.811 . . . . 0.0 110.823 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.527 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -77.45 -37.89 50.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 110.749 -178.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.684 ' O ' ' O ' ' A' ' 95' ' ' LEU . 19.1 mt -78.75 -71.35 0.44 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.699 -1.25 . . . . 0.0 109.307 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' B' ' 53' ' ' ARG . 3.7 mmt-85 -72.06 12.59 0.4 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 111.268 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.546 ' CD ' HD21 ' A' ' 96' ' ' LEU . 76.0 mt-30 50.65 7.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.826 -1.171 . . . . 0.0 110.167 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.676 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 56.01 -0.38 0.13 Allowed Glycine 0 N--CA 1.498 2.817 0 O-C-N 121.468 -0.77 . . . . 0.0 112.865 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.676 ' O ' ' O ' ' B' ' 55' ' ' GLY . 4.7 m-85 -53.31 -142.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.323 -1.692 . . . . 0.0 109.985 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.511 ' N ' ' HD3' ' B' ' 46' ' ' LYS . 37.5 m -135.55 -47.46 0.69 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.852 . . . . 0.0 111.003 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.655 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 27.2 t60 -172.78 160.32 4.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.624 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.81 163.07 33.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.449 -0.782 . . . . 0.0 109.282 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 82.3 m-85 -133.43 129.7 37.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.529 -0.732 . . . . 0.0 109.076 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -102.32 98.73 8.82 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 67.7 mtt -98.77 119.71 37.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.234 -0.916 . . . . 0.0 110.793 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.5 m -119.48 140.77 49.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -125.3 125.67 43.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.704 -1.247 . . . . 0.0 110.058 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.82 -32.07 19.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -156.01 162.39 40.33 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.73 -21.67 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 111.451 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 33.6 p-10 -56.06 -36.36 67.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.722 -1.236 . . . . 0.0 110.569 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -72.09 -31.99 63.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.693 ' O ' HG22 ' B' ' 74' ' ' THR . 76.6 t80 -67.78 -44.37 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.955 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.78 -28.9 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.431 -1.418 . . . . 0.0 108.691 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.532 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.465 -0.772 . . . . 0.0 109.348 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' B' ' 30' ' ' LEU . 1.6 t80 -56.59 -60.35 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.125 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 70' ' ' TYR . 10.2 t -52.03 -34.49 43.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.715 -1.24 . . . . 0.0 110.322 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 66.5 m -78.01 -16.28 58.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 0.0 110.9 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' B' ' 78' ' ' LEU . 22.8 m80 -79.23 132.15 63.8 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.874 -1.141 . . . . 0.0 109.621 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -42.12 -12.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.625 2.217 . . . . 0.0 112.435 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.5 tp -74.38 -27.27 60.58 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.372 -0.83 . . . . 0.0 111.236 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -78.87 -44.99 21.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.029 -1.044 . . . . 0.0 110.307 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.775 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.2 p -59.55 -58.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.775 ' H ' HG13 ' B' ' 80' ' ' VAL . 15.2 tm-20 -50.91 -36.72 39.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.26 -0.9 . . . . 0.0 109.602 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.88 -31.96 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.853 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.3 t -60.0 -44.34 94.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.029 . . . . 0.0 110.118 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.15 70.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.928 -1.108 . . . . 0.0 108.685 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.924 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -79.39 -46.43 17.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.702 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -38.96 -40.01 0.6 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.52 ' O ' ' N ' ' B' ' 89' ' ' VAL . 21.0 m -82.24 -62.42 1.63 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.77 -16.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.767 -0.583 . . . . 0.0 110.126 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.924 HG22 ' O ' ' B' ' 85' ' ' ALA . 9.0 m -117.25 -1.49 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.166 -0.959 . . . . 0.0 110.835 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.622 HG22 ' N ' ' B' ' 91' ' ' ASP . 68.4 mt -132.99 163.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.67 -1.268 . . . . 0.0 110.457 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.622 ' N ' HG22 ' B' ' 90' ' ' ILE . 38.5 t0 -124.04 -27.0 3.94 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.495 ' NZ ' ' CZ ' ' B' ' 56' ' ' PHE . 18.9 ttpt -133.77 131.16 39.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.437 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -126.41 125.62 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.568 -1.333 . . . . 0.0 109.735 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.505 HG12 HE21 ' A' ' 54' ' ' GLN . 12.0 t -132.22 134.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.691 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -136.56 131.57 34.0 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.188 -1.57 . . . . 0.0 111.814 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.53 HD21 ' CD ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -116.02 122.69 45.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.701 -0.624 . . . . 0.0 109.317 177.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.551 ' O ' ' CZ ' ' A' ' 53' ' ' ARG . 38.7 p-10 -126.3 132.47 51.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.097 -1.002 . . . . 0.0 108.948 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -159.83 128.68 3.06 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.005 . . . . 0.0 110.529 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.556 ' HG2' ' H3 ' ' B' ' 1' ' ' MET . 80.1 Cg_exo -45.79 131.37 13.2 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.283 1.988 . . . . 0.0 112.257 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.547 HG22 ' OE2' ' A' ' 44' ' ' GLU . 97.4 t -113.18 135.38 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -107.89 88.31 2.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.447 -0.783 . . . . 0.0 109.636 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . 0.667 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -57.63 73.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.617 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.667 HG13 ' O ' ' B' ' 102' ' ' ALA . 4.6 m -160.99 99.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 0.0 109.189 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' B' ' 106' ' ' SER . 24.1 mmtm -97.74 4.56 49.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.325 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.6 t 64.38 -53.46 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.147 -0.97 . . . . 0.0 108.93 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.655 ' N ' ' O ' ' B' ' 104' ' ' LYS . 20.6 m 47.13 45.04 15.94 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.338 -0.851 . . . . 0.0 109.385 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 72.2 t -84.95 -41.67 15.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 9.7 m -112.3 49.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.472 -0.768 . . . . 0.0 109.53 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.82 83.81 3.41 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.35 161.74 48.66 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.853 -1.154 . . . . 0.0 109.609 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 C-N-CA 122.775 2.317 . . . . 0.0 112.252 179.688 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.542 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 7.3 ptm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.277 0.561 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.605 ' C ' ' H ' ' A' ' 4' ' ' SER . . . 66.11 -138.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 109.365 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.445 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 70.35 -26.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.145 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 2' ' ' ALA . 43.4 p -143.37 -136.85 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.37 168.56 26.96 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.73 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.463 ' HZ ' ' H2 ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -129.22 131.6 47.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.173 -1.193 . . . . 0.0 108.0 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 19.7 ttpt -110.15 139.04 45.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 112.745 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -129.4 127.81 41.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.9 tt -136.47 146.3 46.15 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.761 -1.212 . . . . 0.0 109.48 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 10' ' ' VAL . 11.7 p -127.8 134.76 64.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.501 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.68 127.35 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.34 159.62 32.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.041 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 17.8 tptt -129.46 152.98 48.4 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 8.0 p90 -106.24 148.85 27.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.906 -1.121 . . . . 0.0 111.626 -177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.62 -22.92 3.52 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 85.0 tt0 -89.47 -58.17 2.62 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.3 t0 155.94 72.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.434 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m -66.15 109.75 2.73 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 112.834 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.72 92.2 5.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 20' ' ' VAL . 15.7 m -61.55 -35.97 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.1 p-10 -68.1 -41.65 81.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 65.5 tt0 -71.47 -32.68 68.57 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.22 -36.94 69.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 20' ' ' VAL . 12.8 tp -52.72 -39.98 62.58 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -39.58 84.2 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 29' ' ' ASN . . . -61.59 -54.36 36.37 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 60' ' ' PHE . 48.5 mt -52.63 -47.85 66.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.551 -0.97 . . . . 0.0 108.769 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.66 -39.43 61.84 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.642 ' OD1' HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.18 -42.52 99.38 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.0 mm? -49.93 -46.75 52.35 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.706 HG13 HD12 ' A' ' 34' ' ' ILE . 22.0 t -48.77 -25.54 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.283 -0.886 . . . . 0.0 108.846 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 68.5 m -42.83 -40.61 2.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.44 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 98.1 mm-40 -71.1 -17.98 62.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 111.478 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 34' ' ' ILE . 89.1 mt -80.59 18.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.024 -1.672 . . . . 0.0 110.588 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.5 -12.8 4.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 38' ' ' LYS . 4.0 t -89.28 0.52 56.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.586 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 34.24 34.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.987 -1.071 . . . . 0.0 109.157 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.0 mttt -117.54 41.75 2.76 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.5 p -177.87 179.12 0.9 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -148.33 159.84 43.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.566 -1.334 . . . . 0.0 111.955 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 76.3 mt-10 -155.96 123.76 5.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.394 0.616 . . . . 0.0 110.165 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 24.1 m95 -125.29 165.88 17.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 44' ' ' GLU . . . -161.45 150.7 20.56 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.735 -1.697 . . . . 0.0 110.793 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 43' ' ' GLY . 7.5 tp10 -163.66 175.19 10.83 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 11.3 p-10 -118.34 170.0 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -61.26 84.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.409 -1.432 . . . . 0.0 109.847 -178.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.6 mt-10 -107.03 42.5 1.29 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.345 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.87 -142.66 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.994 . . . . 0.0 110.193 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 50' ' ' ASP . 78.9 m80 -95.99 136.97 35.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.218 -0.927 . . . . 0.0 109.675 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' HIS . 90.8 m-20 -41.52 -35.73 0.77 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.0 110.789 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -79.02 -29.19 43.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 0.0 110.733 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.8 mt -94.31 -22.77 18.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.697 -1.252 . . . . 0.0 109.275 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 55' ' ' GLY . 2.7 ptt180 -96.08 4.01 52.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.327 -0.858 . . . . 0.0 111.218 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 53' ' ' ARG . 35.3 tt0 40.71 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.733 -1.229 . . . . 0.0 110.171 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 57.53 1.12 0.45 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 121.39 -0.819 . . . . 0.0 112.816 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 32.1 p90 -55.29 129.36 38.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.281 -1.717 . . . . 0.0 109.976 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 52.8 m -54.53 -47.55 73.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.4 ' CG ' ' N ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -164.3 150.93 11.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.931 -1.106 . . . . 0.0 110.162 -179.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 58' ' ' HIS . . . -130.07 147.77 51.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.391 -0.818 . . . . 0.0 109.283 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.948 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 2.4 t80 -126.71 122.93 36.29 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.069 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -106.9 102.7 12.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.3 mtm -102.5 124.74 48.61 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.24 -0.913 . . . . 0.0 110.797 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.8 m -122.29 144.58 48.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.37 160.59 29.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.771 -1.206 . . . . 0.0 110.011 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 77.0 mt-10 -82.97 -30.84 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 29.6 m120 -150.96 160.0 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -58.21 -24.55 59.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 111.389 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -53.62 -35.42 60.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.89 85.45 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 74' ' ' THR . 71.6 t80 -62.39 -46.55 88.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.566 -0.961 . . . . 0.0 110.459 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.75 -28.96 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.394 -1.441 . . . . 0.0 108.649 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.94 2.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 33' ' ' GLN . 3.8 m-85 -48.62 -36.79 16.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 111.103 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 70' ' ' TYR . 2.2 t -82.47 -27.14 32.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.759 -1.213 . . . . 0.0 110.311 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.2 p -69.34 -22.01 63.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.04 -1.038 . . . . 0.0 110.983 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 78' ' ' LEU . 78.4 m80 -85.33 130.76 50.39 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.847 -1.158 . . . . 0.0 109.579 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -45.69 -2.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.67 2.247 . . . . 0.0 112.392 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.642 HD11 ' OD1' ' A' ' 29' ' ' ASN . 8.5 tp -77.16 -31.1 55.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.423 -0.798 . . . . 0.0 111.24 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -76.9 -39.18 51.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.989 -1.069 . . . . 0.0 110.219 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.735 HG13 ' H ' ' A' ' 81' ' ' GLU . 4.0 p -62.26 -56.56 16.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.988 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.735 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.4 tt0 -49.48 -37.76 27.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.4 -29.42 70.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.256 -0.903 . . . . 0.0 109.886 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -61.87 -44.87 95.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.6 -32.83 69.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.729 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.93 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -83.33 -45.39 13.81 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.703 ' C ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -36.37 -44.01 0.4 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.849 HG23 ' H ' ' A' ' 88' ' ' ALA . 3.3 t -83.36 -60.14 2.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.849 ' H ' HG23 ' A' ' 87' ' ' THR . . . -47.22 -14.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.744 -0.598 . . . . 0.0 110.093 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 85' ' ' ALA . 6.1 m -120.17 -1.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.232 -0.918 . . . . 0.0 110.809 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.565 HG13 HG23 ' A' ' 89' ' ' VAL . 61.1 mt -128.55 160.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.649 -1.282 . . . . 0.0 110.434 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.525 ' N ' HG22 ' A' ' 90' ' ' ILE . 40.3 t0 -110.34 -31.97 7.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.51 142.66 31.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.2 tp -124.35 121.11 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.62 -1.3 . . . . 0.0 109.759 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.422 ' CG1' ' CD ' ' B' ' 54' ' ' GLN . 9.0 t -127.57 132.25 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -137.15 132.98 34.73 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.319 -1.488 . . . . 0.0 111.767 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.89 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.66 119.7 36.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.636 -0.665 . . . . 0.0 109.379 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 49.9 t0 -125.61 133.24 52.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.0 108.913 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 31.4 p90 -158.06 138.11 8.81 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.102 -0.999 . . . . 0.0 110.52 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.7 122.92 6.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.315 2.01 . . . . 0.0 112.218 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.594 ' O ' ' OG ' ' A' ' 4' ' ' SER . 56.7 t -85.6 109.28 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.995 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.29 89.71 3.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.42 -0.8 . . . . 0.0 109.613 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' HG13 ' A' ' 103' ' ' VAL . . . -69.85 71.06 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.104 -0.997 . . . . 0.0 109.511 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 103' ' ' VAL . 33.7 m -153.02 86.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.265 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 106' ' ' SER . 29.3 mmtp -95.92 4.45 52.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.342 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t 63.43 -53.04 0.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.68 ' N ' ' O ' ' A' ' 104' ' ' LYS . 7.6 t 44.32 50.51 7.81 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 108' ' ' VAL . 11.6 p -104.83 -38.55 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.48 ' N ' HG13 ' A' ' 107' ' ' VAL . 12.3 p -143.86 141.59 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.544 -0.722 . . . . 0.0 109.487 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' HB2' ' OG ' ' B' ' 32' ' ' SER . . . -102.46 108.05 19.24 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.3 p -71.1 150.91 94.8 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 120.9 -1.125 . . . . 0.0 109.659 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo . . . . . 0 C--N 1.308 -1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 112.215 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.535 ' O ' ' HB3' ' B' ' 2' ' ' ALA . 7.3 ptm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' B' ' 4' ' ' SER . . . 65.79 -138.03 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.269 -0.894 . . . . 0.0 109.366 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.409 ' CB ' ' O ' ' B' ' 2' ' ' ALA . 0.4 OUTLIER 70.41 -26.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.599 ' H ' ' C ' ' B' ' 2' ' ' ALA . 46.0 p -143.47 -136.57 0.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 168.65 26.56 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.63 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.467 ' HZ ' ' H2 ' ' B' ' 1' ' ' MET . 0.2 OUTLIER -129.28 131.52 46.99 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -1.143 . . . . 0.0 108.012 178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 19.7 ttpt -110.01 138.97 45.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.903 -1.123 . . . . 0.0 112.793 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -129.2 128.19 42.84 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.9 tt -136.86 145.91 44.95 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.724 -1.235 . . . . 0.0 109.509 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.436 HG13 ' O ' ' B' ' 10' ' ' VAL . 11.7 p -127.57 134.64 65.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.587 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.62 127.22 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.23 159.73 32.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.707 -1.597 . . . . 0.0 112.983 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 18.1 tptt -129.48 153.17 48.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 7.9 p90 -106.43 148.76 27.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.893 -1.129 . . . . 0.0 111.621 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.6 -23.11 3.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 85.1 tt0 -89.22 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.3 t0 155.8 73.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 47.6 m -66.55 109.67 2.87 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.083 0.944 . . . . 0.0 112.862 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.678 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -79.46 92.27 5.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 175.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.427 ' H ' HG22 ' B' ' 20' ' ' VAL . 15.8 m -61.8 -35.73 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.539 -0.725 . . . . 0.0 110.445 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 28.9 p-10 -68.23 -41.5 81.14 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.58 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 64.6 tt0 -71.69 -32.47 67.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.36 -36.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.11 -39.96 63.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -39.72 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' B' ' 29' ' ' ASN . . . -61.39 -54.57 35.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.952 HD22 ' CZ ' ' B' ' 60' ' ' PHE . 47.8 mt -52.49 -47.74 66.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.525 -0.986 . . . . 0.0 108.87 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.64 -39.63 61.95 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.648 ' OD1' HD11 ' B' ' 78' ' ' LEU . 0.1 OUTLIER -62.98 -42.64 99.89 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.0 mm? -49.98 -46.65 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.708 HG13 HD12 ' B' ' 34' ' ' ILE . 22.0 t -49.05 -25.17 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.867 . . . . 0.0 108.816 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 68.4 m -43.05 -40.63 3.18 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.448 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 98.1 mm-40 -70.98 -18.08 62.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.453 -0.779 . . . . 0.0 111.526 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.828 HG22 ' O ' ' B' ' 34' ' ' ILE . 89.6 mt -80.47 18.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 119.978 -1.702 . . . . 0.0 110.568 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.64 -12.83 4.57 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.589 ' O ' ' N ' ' B' ' 38' ' ' LYS . 3.9 t -89.16 0.53 56.66 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.887 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.57 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.5 m 34.32 33.9 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.194 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' B' ' 36' ' ' THR . 65.5 mttt -117.59 42.09 2.68 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 55.6 p -177.93 179.19 0.88 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -148.34 159.65 43.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.554 -1.341 . . . . 0.0 111.95 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.502 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 77.1 mt-10 -155.79 123.84 5.74 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.335 0.588 . . . . 0.0 110.229 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' B' ' 60' ' ' PHE . 23.9 m95 -125.22 166.03 17.22 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' B' ' 44' ' ' GLU . . . -161.55 150.56 20.25 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 118.716 -1.707 . . . . 0.0 110.839 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 43' ' ' GLY . 7.6 tp10 -163.57 175.2 10.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 109.352 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' B' ' 45' ' ' ASP . 11.7 p-10 -118.44 169.92 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -61.32 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.322 -1.487 . . . . 0.0 109.809 -178.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.8 mt-10 -106.96 42.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.316 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -139.74 -142.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 110.138 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' B' ' 50' ' ' ASP . 79.1 m80 -95.97 136.87 35.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 49' ' ' HIS . 90.4 m-20 -41.34 -36.01 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.324 -0.86 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.5 OUTLIER -78.81 -29.35 44.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.731 -178.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.28 -22.83 18.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.691 -1.256 . . . . 0.0 109.257 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' B' ' 55' ' ' GLY . 2.7 ptt180 -95.98 4.04 52.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -0.834 . . . . 0.0 111.235 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' B' ' 53' ' ' ARG . 35.5 tt0 40.55 21.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.812 -1.18 . . . . 0.0 110.15 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 57.27 1.26 0.41 Allowed Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.356 -0.84 . . . . 0.0 112.796 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 31.5 p90 -55.45 129.47 38.87 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 119.595 1.697 . . . . 0.0 109.941 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 55.2 m -54.66 -47.57 73.41 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.301 -0.874 . . . . 0.0 110.946 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 151.06 11.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.895 -1.128 . . . . 0.0 110.17 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.18 147.77 51.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.0 109.262 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.952 ' CZ ' HD22 ' B' ' 27' ' ' LEU . 2.4 t80 -126.65 122.97 36.48 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.488 -0.757 . . . . 0.0 109.075 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -107.07 102.56 11.89 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.26 124.99 48.81 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.134 -0.979 . . . . 0.0 110.759 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.8 m -122.51 144.65 48.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.47 160.92 28.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.738 -1.226 . . . . 0.0 110.025 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.528 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 77.9 mt-10 -83.31 -30.73 27.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 29.6 m120 -151.01 160.21 44.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -58.27 -25.04 61.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 111.411 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -53.06 -35.75 59.86 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.816 -1.177 . . . . 0.0 110.585 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -37.1 87.71 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.458 ' O ' HG22 ' B' ' 74' ' ' THR . 71.7 t80 -62.4 -46.55 88.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.978 . . . . 0.0 110.439 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.72 -28.98 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.37 -1.456 . . . . 0.0 108.623 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.0 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.794 . . . . 0.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' B' ' 33' ' ' GLN . 3.8 m-85 -48.54 -36.58 15.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 111.186 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.458 HG22 ' O ' ' B' ' 70' ' ' TYR . 2.1 t -82.74 -27.08 31.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.744 -1.222 . . . . 0.0 110.329 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -69.49 -21.81 63.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 0.0 111.027 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' B' ' 78' ' ' LEU . 78.3 m80 -85.35 130.81 50.17 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.861 -1.149 . . . . 0.0 109.596 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.71 -2.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.599 2.199 . . . . 0.0 112.433 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.648 HD11 ' OD1' ' B' ' 29' ' ' ASN . 8.3 tp -77.31 -31.1 54.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -76.84 -39.18 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.0 110.296 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.719 HG13 ' H ' ' B' ' 81' ' ' GLU . 4.0 p -62.41 -56.3 18.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.972 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.719 ' H ' HG13 ' B' ' 80' ' ' VAL . 84.2 tt0 -49.89 -37.37 31.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.524 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.62 -29.27 69.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.85 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 59.9 p -62.03 -44.99 95.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -0.937 . . . . 0.0 110.194 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.71 68.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.998 -1.063 . . . . 0.0 108.641 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.956 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -83.55 -45.33 13.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.705 ' C ' ' CD1' ' B' ' 86' ' ' PHE . 0.0 OUTLIER -36.52 -43.91 0.42 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.836 HG23 ' H ' ' B' ' 88' ' ' ALA . 3.3 t -83.32 -60.4 2.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.836 ' H ' HG23 ' B' ' 87' ' ' THR . . . -47.04 -14.9 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.956 HG22 ' O ' ' B' ' 85' ' ' ALA . 6.3 m -119.9 -1.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.254 -0.904 . . . . 0.0 110.835 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 61.0 mt -128.33 160.68 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.672 -1.267 . . . . 0.0 110.448 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.545 ' N ' HG22 ' B' ' 90' ' ' ILE . 40.7 t0 -110.54 -31.89 7.09 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -143.63 142.35 30.99 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.516 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.1 tp -124.03 121.45 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.579 -1.326 . . . . 0.0 109.661 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.431 ' CG1' ' CD ' ' A' ' 54' ' ' GLN . 9.3 t -127.83 132.42 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.553 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -137.37 132.67 33.87 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.246 -1.534 . . . . 0.0 111.777 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.891 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.43 119.78 37.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.683 -0.636 . . . . 0.0 109.294 177.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' B' ' 98' ' ' PHE . 50.2 t0 -125.69 133.23 52.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.067 -1.021 . . . . 0.0 108.861 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' B' ' 98' ' ' PHE . 31.2 p90 -158.04 137.79 8.6 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 110.555 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.37 123.1 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.313 2.008 . . . . 0.0 112.221 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.596 ' O ' ' OG ' ' B' ' 4' ' ' SER . 58.9 t -85.79 109.21 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.21 89.8 3.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . 0.41 ' C ' HG13 ' B' ' 103' ' ' VAL . . . -69.82 71.17 0.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.099 -1.001 . . . . 0.0 109.599 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.742 HG23 ' O ' ' B' ' 103' ' ' VAL . 33.8 m -153.29 85.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -0.843 . . . . 0.0 109.235 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.67 ' O ' ' N ' ' B' ' 106' ' ' SER . 29.2 mmtp -95.61 4.62 52.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.415 ' O ' ' C ' ' B' ' 106' ' ' SER . 1.8 t 63.34 -53.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.078 -1.014 . . . . 0.0 108.879 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.67 ' N ' ' O ' ' B' ' 104' ' ' LYS . 7.6 t 44.68 50.43 8.51 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.48 HG13 ' N ' ' B' ' 108' ' ' VAL . 11.8 p -104.96 -38.26 4.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.48 ' N ' HG13 ' B' ' 107' ' ' VAL . 12.3 p -144.08 141.59 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 109.434 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.45 107.99 19.16 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.2 p -71.14 151.0 94.71 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.844 -1.16 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo . . . . . 0 C--N 1.308 -1.584 0 C-N-CA 122.743 2.295 . . . . 0.0 112.255 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.732 ' O ' ' C ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.314 0.578 . . . . 0.0 109.511 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.732 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -15.44 91.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.168 -0.957 . . . . 0.0 109.336 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 1' ' ' MET . 8.8 t -111.5 0.21 16.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -167.25 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.1 178.15 18.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.66 127.04 55.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.276 -1.132 . . . . 0.0 107.973 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.4 ttpt -97.95 128.03 44.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.916 -1.115 . . . . 0.0 112.841 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.615 ' CE1' ' CE1' ' A' ' 70' ' ' TYR . 51.6 m-70 -121.06 119.2 31.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.71 139.44 52.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.716 -1.24 . . . . 0.0 109.496 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.9 137.48 56.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.641 -0.662 . . . . 0.0 109.536 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -124.48 133.8 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 1.5 m -141.42 162.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 117.799 -1.56 . . . . 0.0 113.047 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -127.59 152.64 47.38 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 12.7 p90 -109.82 151.8 26.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.799 -1.188 . . . . 0.0 111.607 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.31 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 48.3 tp10 -92.84 -54.93 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.8 t0 152.86 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.536 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 89.4 m -50.22 107.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.14 0.972 . . . . 0.0 112.859 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -71.61 83.36 0.85 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 176.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 21' ' ' ASP . 27.8 m -62.83 -41.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.546 -0.721 . . . . 0.0 110.481 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.57 ' N ' HG23 ' A' ' 20' ' ' VAL . 90.3 m-20 -64.96 -44.64 88.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 110.498 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -65.7 -31.77 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -70.84 -43.61 76.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.2 tp -54.01 -40.04 66.66 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.92 -38.04 81.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -62.57 -51.27 57.3 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.7 tt -45.22 -44.03 10.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.461 -1.023 . . . . 0.0 108.848 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -49.87 -35.01 21.81 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 26' ' ' GLY . 14.3 m-20 -65.39 -44.32 87.87 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.668 HD11 ' CE1' ' A' ' 73' ' ' PHE . 1.4 mm? -48.39 -50.76 29.6 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' SER . 54.8 t -46.94 -35.7 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 108.733 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.1 t -45.36 -50.55 12.13 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -69.21 -9.15 51.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 111.47 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 34' ' ' ILE . 21.9 mm -101.35 29.07 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.04 -1.663 . . . . 0.0 110.589 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.19 -19.08 61.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.585 ' O ' ' C ' ' A' ' 37' ' ' VAL . 16.8 p -69.84 -6.85 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.585 ' C ' ' O ' ' A' ' 36' ' ' THR . 34.7 m 35.08 36.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.104 -0.998 . . . . 0.0 109.106 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -118.0 41.55 2.87 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.444 ' OG ' HG23 ' A' ' 34' ' ' ILE . 60.5 p -174.01 178.09 2.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 97.6 m-85 -145.47 153.81 41.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.594 -1.316 . . . . 0.0 111.951 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 40' ' ' PHE . 54.1 mp0 -156.99 125.41 5.68 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.421 0.629 . . . . 0.0 110.162 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -134.58 176.05 8.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.636 ' H ' ' NZ ' ' B' ' 104' ' ' LYS . . . -133.56 158.82 23.42 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.794 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 77.4 mt-10 -149.06 140.79 23.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -1.145 . . . . 0.0 109.368 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' O ' ' CD2' ' B' ' 98' ' ' PHE . 32.4 p30 -120.62 145.36 47.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' CD ' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -148.62 128.84 13.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.437 -1.414 . . . . 0.0 109.794 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -161.98 51.2 0.21 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.641 -0.662 . . . . 0.0 109.32 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.2 t -91.12 -98.65 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.203 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.44 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.4 m-70 -100.69 144.67 29.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.155 -0.965 . . . . 0.0 109.708 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 87.8 m-20 -50.09 -42.97 51.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.301 -0.875 . . . . 0.0 110.674 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.3 ttt -73.55 -32.77 64.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.084 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 68.9 mt -88.67 -51.65 5.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.741 -1.224 . . . . 0.0 109.245 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.721 ' O ' ' N ' ' A' ' 55' ' ' GLY . 13.8 ptt180 -71.08 5.45 2.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 111.275 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.428 ' NE2' HG13 ' B' ' 94' ' ' VAL . 17.0 mm100 46.07 3.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.729 -1.232 . . . . 0.0 110.197 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.21 -10.07 11.46 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 121.488 -0.758 . . . . 0.0 112.864 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 55' ' ' GLY . 20.9 m-85 -59.1 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.226 -1.749 . . . . 0.0 109.99 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.724 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 81.1 p -152.86 -41.9 0.1 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.962 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.724 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 27.3 p-80 -174.33 157.81 2.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.836 -1.165 . . . . 0.0 110.145 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG13 ' A' ' 11' ' ' VAL . . . -143.69 170.91 14.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 109.287 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.05 131.67 37.29 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.128 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 t -101.67 102.15 12.78 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.9 mtt -108.08 125.1 51.18 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.146 -0.971 . . . . 0.0 110.799 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.8 m -128.4 149.36 50.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.06 131.71 45.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 110.03 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 71.7 mm-40 -52.48 -32.52 40.36 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 33.0 m120 -155.64 160.46 40.43 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -57.66 -17.93 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 111.36 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.99 -39.83 79.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.844 -1.16 . . . . 0.0 110.589 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.26 -33.46 73.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.615 ' CE1' ' CE1' ' A' ' 8' ' ' HIS . 76.4 t80 -67.12 -44.38 80.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.495 -1.003 . . . . 0.0 110.451 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -28.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.381 -1.45 . . . . 0.0 108.673 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.87 2.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.367 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.668 ' CE1' HD11 ' A' ' 30' ' ' LEU . 2.5 t80 -45.66 -34.17 3.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 111.141 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -83.41 -24.9 31.72 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.744 -1.223 . . . . 0.0 110.249 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.6 m -67.47 -26.0 66.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.994 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -85.47 156.0 59.42 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.878 -1.139 . . . . 0.0 109.664 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.21 3.86 2.27 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.66 2.24 . . . . 0.0 112.469 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' CD2' HD22 ' A' ' 30' ' ' LEU . 44.5 tp -77.87 -31.1 51.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.467 -0.77 . . . . 0.0 111.322 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -77.7 -41.61 37.34 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 0.0 110.211 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.765 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.5 p -62.58 -58.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.765 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.8 tt0 -51.77 -38.72 56.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 109.638 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -69.89 -32.02 70.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 109.883 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.5 -45.06 95.16 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.48 85.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.879 -1.138 . . . . 0.0 108.751 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.829 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -77.55 -44.76 27.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -39.28 -38.78 0.55 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.3 m -81.46 -61.0 2.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.34 -13.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.63 -0.669 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 85' ' ' ALA . 13.1 m -119.27 -2.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 110.859 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -120.66 155.98 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.595 -1.316 . . . . 0.0 110.473 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.444 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 36.4 t0 -104.35 -31.58 9.47 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.433 ' H ' HG23 ' A' ' 90' ' ' ILE . 21.5 pttt -149.98 150.61 32.06 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 86' ' ' PHE . 6.0 tp -127.31 125.25 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.627 -1.295 . . . . 0.0 109.751 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.424 HG13 ' CD ' ' B' ' 54' ' ' GLN . 13.2 t -123.45 128.57 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.841 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -141.25 138.43 33.25 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.249 -1.532 . . . . 0.0 111.838 -178.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -122.25 123.96 42.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.637 . . . . 0.0 109.326 176.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -125.85 135.59 52.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.011 -1.056 . . . . 0.0 108.919 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -165.67 158.55 13.14 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 0.0 110.522 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.595 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 39.9 Cg_exo -58.78 114.84 2.17 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.298 1.999 . . . . 0.0 112.176 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 132.97 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.923 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -109.8 79.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.644 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -73.83 93.97 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.114 -0.991 . . . . 0.0 109.535 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.754 ' O ' ' C ' ' A' ' 104' ' ' LYS . 14.7 m -155.9 -16.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.201 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.754 ' C ' ' O ' ' A' ' 103' ' ' VAL . 31.5 mmtm -8.14 -105.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.345 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.71 -5.52 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 108.911 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 104' ' ' LYS . 45.1 t -59.71 140.56 56.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 107' ' ' VAL . 10.6 p -148.71 42.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.91 151.03 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.0 109.445 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.34 163.04 26.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 110' ' ' THR . 6.5 p -142.67 68.67 19.79 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 120.82 -1.175 . . . . 0.0 109.599 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo . . . . . 0 C--N 1.308 -1.575 0 C-N-CA 122.763 2.309 . . . . 0.0 112.226 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.745 ' O ' ' C ' ' B' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.745 ' C ' ' O ' ' B' ' 1' ' ' MET . . . -15.51 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 109.311 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.572 ' N ' ' O ' ' B' ' 1' ' ' MET . 8.9 t -111.56 0.17 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.226 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -167.36 -87.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.19 178.12 18.44 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.433 -1.365 . . . . 0.0 109.697 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -111.76 126.69 55.33 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.276 -1.132 . . . . 0.0 107.993 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.3 ttpt -97.53 128.23 44.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.937 -1.102 . . . . 0.0 112.863 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.601 ' CE1' ' CE1' ' B' ' 70' ' ' TYR . 51.3 m-70 -121.29 119.02 31.01 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 5.9 tt -128.56 139.53 52.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.743 -1.223 . . . . 0.0 109.451 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.83 137.67 56.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.498 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' B' ' 59' ' ' ALA . 0.3 OUTLIER -124.77 133.86 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.623 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 1.5 m -141.5 162.04 21.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 117.745 -1.582 . . . . 0.0 113.039 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -127.57 152.66 47.35 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 12.6 p90 -109.88 151.73 26.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.798 -1.189 . . . . 0.0 111.562 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -129.28 -20.14 3.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 48.4 tp10 -92.96 -55.04 3.5 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.7 t0 152.99 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.531 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 89.3 m -50.27 107.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.082 0.944 . . . . 0.0 112.868 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -71.51 83.23 0.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.575 HG23 ' N ' ' B' ' 21' ' ' ASP . 26.9 m -62.77 -41.95 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.631 -0.668 . . . . 0.0 110.473 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.575 ' N ' HG23 ' B' ' 20' ' ' VAL . 90.0 m-20 -64.85 -44.84 88.45 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.456 -0.777 . . . . 0.0 110.576 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -65.5 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -70.96 -43.43 76.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.13 -40.02 67.01 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -59.98 -38.13 81.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -62.22 -51.59 55.61 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.544 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.7 tt -45.04 -44.08 9.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.533 -0.981 . . . . 0.0 108.795 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -49.89 -34.94 21.78 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' B' ' 26' ' ' GLY . 14.3 m-20 -65.4 -44.31 87.85 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.664 HD11 ' CE1' ' B' ' 73' ' ' PHE . 1.4 mm? -48.37 -50.82 29.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 32' ' ' SER . 54.9 t -46.93 -35.47 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.915 . . . . 0.0 108.79 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 8.2 t -45.65 -50.48 13.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -69.28 -8.99 51.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 111.475 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 34' ' ' ILE . 21.9 mm -101.58 29.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.019 -1.675 . . . . 0.0 110.645 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -61.23 -19.27 61.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.571 ' O ' ' C ' ' B' ' 37' ' ' VAL . 16.8 p -69.59 -6.85 33.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.961 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 34.6 m 35.04 36.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.022 -1.049 . . . . 0.0 109.132 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.3 OUTLIER -118.09 41.68 2.86 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.445 ' OG ' HG23 ' B' ' 34' ' ' ILE . 60.3 p -174.2 177.99 2.17 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 97.7 m-85 -145.47 153.7 41.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.58 -1.325 . . . . 0.0 111.967 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' B' ' 40' ' ' PHE . 53.9 mp0 -156.92 125.11 5.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -134.2 176.18 8.83 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.648 ' H ' ' NZ ' ' A' ' 104' ' ' LYS . . . -133.74 158.74 23.42 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 118.703 -1.713 . . . . 0.0 110.782 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 77.3 mt-10 -148.98 140.83 23.66 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 98' ' ' PHE . 32.2 p30 -120.71 145.39 47.53 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.66 128.69 13.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.404 -1.435 . . . . 0.0 109.834 -177.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -161.91 51.36 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.704 -0.622 . . . . 0.0 109.339 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -91.18 -98.83 0.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ARG . 90.4 m-70 -100.59 144.5 29.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.093 -1.004 . . . . 0.0 109.676 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' B' ' 53' ' ' ARG . 88.6 m-20 -49.92 -42.92 49.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 110.849 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.1 ttt -73.76 -32.46 63.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.029 -1.044 . . . . 0.0 110.756 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 95' ' ' LEU . 68.9 mt -88.82 -51.76 5.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.275 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.731 ' O ' ' N ' ' B' ' 55' ' ' GLY . 13.8 ptt180 -70.91 5.36 2.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.344 -0.848 . . . . 0.0 111.249 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.424 ' CD ' HG13 ' A' ' 94' ' ' VAL . 17.4 mm100 46.19 3.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.855 -1.153 . . . . 0.0 110.244 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.32 -10.12 11.96 Favored Glycine 0 N--CA 1.499 2.882 0 O-C-N 121.437 -0.79 . . . . 0.0 112.812 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' B' ' 55' ' ' GLY . 21.4 m-85 -59.19 -141.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.284 -1.715 . . . . 0.0 109.946 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.706 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 80.6 p -152.76 -41.85 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.319 -0.863 . . . . 0.0 111.024 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.706 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 27.5 p-80 -174.45 157.7 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.854 -1.154 . . . . 0.0 110.167 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.53 ' HB2' HG13 ' B' ' 11' ' ' VAL . . . -143.72 170.9 14.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.489 -0.757 . . . . 0.0 109.219 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.01 131.67 37.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 21.1 t -101.61 102.23 12.91 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 62.8 mtt -108.27 125.31 51.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.931 . . . . 0.0 110.733 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.7 m -128.59 149.28 50.7 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.05 131.64 45.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 110.095 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.523 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 72.0 mm-40 -52.17 -32.82 37.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 32.9 m120 -155.5 160.51 40.62 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -57.76 -17.87 18.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 111.466 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -57.85 -40.11 79.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.885 -1.134 . . . . 0.0 110.551 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.93 -33.6 75.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.601 ' CE1' ' CE1' ' B' ' 8' ' ' HIS . 76.2 t80 -66.99 -44.55 80.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.661 -0.905 . . . . 0.0 110.473 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.67 -28.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.704 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.88 2.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.664 ' CE1' HD11 ' B' ' 30' ' ' LEU . 2.5 t80 -45.66 -34.08 3.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.292 -0.88 . . . . 0.0 111.148 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' B' ' 70' ' ' TYR . 0.1 OUTLIER -83.34 -24.99 31.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 0.0 110.304 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -67.41 -25.86 66.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 111.032 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -85.65 156.0 58.92 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.83 -1.169 . . . . 0.0 109.579 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.17 3.91 2.23 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 112.433 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.513 ' CD2' HD22 ' B' ' 30' ' ' LEU . 44.5 tp -77.98 -31.31 50.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.429 -0.794 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -77.41 -41.79 38.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.961 -1.087 . . . . 0.0 110.289 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.781 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.6 p -62.39 -58.24 8.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.054 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.781 ' H ' HG13 ' B' ' 80' ' ' VAL . 85.0 tt0 -51.71 -38.73 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.885 . . . . 0.0 109.593 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -69.98 -31.96 69.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.838 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.4 t -60.35 -45.36 93.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.142 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.42 85.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.987 -1.071 . . . . 0.0 108.685 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.801 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -77.53 -44.79 27.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.698 ' CE1' HD13 ' B' ' 93' ' ' ILE . 0.0 OUTLIER -39.33 -38.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.593 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.3 m -81.41 -61.1 2.04 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -45.12 -13.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.079 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.801 HG22 ' O ' ' B' ' 85' ' ' ALA . 13.1 m -119.21 -2.77 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.237 -0.915 . . . . 0.0 110.875 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -120.7 156.05 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.701 -1.249 . . . . 0.0 110.465 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.455 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 35.9 t0 -104.47 -31.63 9.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.435 ' H ' HG23 ' B' ' 90' ' ' ILE . 21.6 pttt -150.04 150.37 31.65 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.698 HD13 ' CE1' ' B' ' 86' ' ' PHE . 6.0 tp -127.07 125.43 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.491 -1.381 . . . . 0.0 109.733 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.428 HG13 ' NE2' ' A' ' 54' ' ' GLN . 12.8 t -123.55 128.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.847 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -141.33 138.54 33.18 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.302 -1.499 . . . . 0.0 111.791 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.4 HD12 ' N ' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -122.25 123.83 42.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -125.77 135.67 52.3 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.064 -1.023 . . . . 0.0 108.87 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.591 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 0.5 OUTLIER -165.62 158.52 13.21 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.132 -0.98 . . . . 0.0 110.587 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.591 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 41.1 Cg_exo -58.76 114.73 2.12 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.305 2.003 . . . . 0.0 112.265 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.79 133.04 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.004 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' B' ' 3' ' ' THR . . . -109.87 78.87 1.16 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.502 -0.749 . . . . 0.0 109.58 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . 0.471 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -73.58 94.08 2.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.12 -0.987 . . . . 0.0 109.657 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.784 ' O ' ' C ' ' B' ' 104' ' ' LYS . 14.6 m -156.0 -16.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.362 -0.836 . . . . 0.0 109.219 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.784 ' C ' ' O ' ' B' ' 103' ' ' VAL . 31.3 mmtm -8.28 -105.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.373 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 63.66 -5.58 0.27 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.935 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.557 ' H ' ' C ' ' B' ' 104' ' ' LYS . 44.4 t -59.53 140.61 56.12 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.291 -0.881 . . . . 0.0 109.419 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.538 ' O ' HG13 ' B' ' 107' ' ' VAL . 10.7 p -148.78 42.95 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.95 151.07 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.48 -0.762 . . . . 0.0 109.452 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.3 163.16 26.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.466 ' O ' ' OG1' ' B' ' 110' ' ' THR . 6.6 p -142.82 68.56 18.98 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 120.874 -1.142 . . . . 0.0 109.658 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo . . . . . 0 C--N 1.308 -1.575 0 C-N-CA 122.731 2.287 . . . . 0.0 112.234 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.301 0.572 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.26 66.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.368 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.404 ' O ' ' OG ' ' A' ' 4' ' ' SER . 12.1 t -107.68 0.77 22.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.089 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.9 m -173.32 -107.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.8 -178.26 20.55 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.399 -1.382 . . . . 0.0 109.694 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -130.11 130.13 44.42 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 1.3 ttpm? -104.48 133.84 48.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.874 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -127.21 125.7 41.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.51 142.45 48.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.745 -1.222 . . . . 0.0 109.507 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 140.32 48.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.506 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.22 134.02 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.491 ' O ' HG22 ' A' ' 57' ' ' THR . 2.6 m -137.53 162.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 117.79 -1.564 . . . . 0.0 113.014 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 14' ' ' PHE . 20.7 tptp -132.21 152.8 51.14 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 18' ' ' THR . 36.3 p90 -111.65 149.44 31.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.886 -1.134 . . . . 0.0 111.597 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.45 -19.68 3.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.5 mt-10 -91.69 -56.5 3.08 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 8.9 t0 154.48 64.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 86.8 m -49.77 105.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.126 0.965 . . . . 0.0 112.794 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.898 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -68.65 83.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 21' ' ' ASP . 28.9 m -61.59 -42.96 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.52 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' N ' HG23 ' A' ' 20' ' ' VAL . 29.0 p-10 -65.97 -43.27 88.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 0.0 110.571 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 97.4 mt-10 -70.7 -34.12 71.61 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 89' ' ' VAL . 1.8 mm -67.32 -44.61 87.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' VAL . 15.7 tp -52.88 -38.0 61.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.08 75.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 29' ' ' ASN . . . -60.63 -54.23 38.81 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 27' ' ' LEU . 4.4 tt -45.83 -43.91 13.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.497 -1.002 . . . . 0.0 108.838 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' B' ' 106' ' ' SER . 71.8 mm-40 -50.86 -33.33 23.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 26' ' ' GLY . 12.0 m-20 -66.54 -44.39 82.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 2.1 mm? -49.3 -48.28 46.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 32' ' ' SER . 94.6 t -46.97 -31.91 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.908 . . . . 0.0 108.844 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 73.7 p -45.59 -49.25 14.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 70.6 mm-40 -72.79 -12.15 60.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 111.457 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 34' ' ' ILE . 21.1 mm -96.69 24.23 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.043 -1.661 . . . . 0.0 110.589 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.06 -12.43 4.81 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.2 p -74.86 -1.28 21.6 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.995 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.576 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.1 m 34.61 33.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 32.1 mtmt -119.55 42.36 2.9 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 58.4 m -171.88 174.54 4.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -146.71 157.4 43.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.639 -1.288 . . . . 0.0 111.957 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.479 ' OE1' HD21 ' A' ' 27' ' ' LEU . 72.5 mt-10 -155.27 121.5 5.21 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.362 0.601 . . . . 0.0 110.231 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -123.95 170.2 10.85 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.97 160.0 23.72 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.72 -1.705 . . . . 0.0 110.852 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 7' ' ' LYS . 24.1 mt-10 -150.5 145.21 25.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.251 -1.147 . . . . 0.0 109.394 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 22.5 t70 -126.53 148.03 49.77 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.877 ' HZ2' ' C ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -145.37 122.99 11.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.417 -1.427 . . . . 0.0 109.799 -178.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 48' ' ' SER . 95.4 mt-10 -133.93 3.4 3.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 47' ' ' GLU . 99.2 p -56.99 -140.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.953 . . . . 0.0 110.17 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.786 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 57.4 t-80 -74.62 160.15 31.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.691 ' N ' HH21 ' A' ' 53' ' ' ARG . 77.9 m-20 -61.2 -44.23 97.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 tpt -67.76 -33.43 74.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.013 -1.054 . . . . 0.0 110.746 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' B' ' 95' ' ' LEU . 38.0 mt -89.23 -54.43 4.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.702 -1.249 . . . . 0.0 109.323 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.786 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.3 ptp180 -64.41 2.97 0.52 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.0 111.195 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.607 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER 57.19 -12.09 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.75 -1.219 . . . . 0.0 110.14 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.739 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 85.24 -21.81 11.69 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.408 -0.808 . . . . 0.0 112.847 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.877 ' C ' ' HZ2' ' A' ' 46' ' ' LYS . 3.7 m-85 -57.79 -129.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.267 -1.725 . . . . 0.0 109.988 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.8 t -162.2 -33.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.344 -0.847 . . . . 0.0 110.96 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.629 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 15.0 t60 -172.05 154.49 3.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.104 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.629 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.9 168.01 20.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.414 -0.804 . . . . 0.0 109.251 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 96.8 m-85 -134.74 130.98 37.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.475 -0.766 . . . . 0.0 109.067 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.6 99.24 8.84 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.0 mtm -100.07 124.8 45.86 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.149 -0.97 . . . . 0.0 110.851 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.46 142.94 50.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' GLU . 94.2 m-85 -122.01 126.8 49.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.736 -1.228 . . . . 0.0 110.092 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 64' ' ' PHE . 33.6 tt0 -46.93 -30.7 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -165.81 170.59 13.74 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -57.79 -22.35 46.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 111.46 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -56.24 -40.22 73.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.822 -1.174 . . . . 0.0 110.673 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.09 62.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.645 ' O ' HG22 ' A' ' 74' ' ' THR . 71.7 t80 -63.13 -44.59 95.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.984 . . . . 0.0 110.467 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.75 -28.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.388 -1.445 . . . . 0.0 108.692 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 -60.99 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 109.336 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -56.74 -42.57 79.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.884 . . . . 0.0 111.09 -177.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 70' ' ' TYR . 10.0 t -75.95 -33.19 59.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.787 -1.195 . . . . 0.0 110.31 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 63.5 m -63.39 -32.76 74.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.996 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.522 ' CE1' ' OE1' ' A' ' 33' ' ' GLN . 54.5 m80 -72.03 151.91 92.76 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.861 -1.15 . . . . 0.0 109.604 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.14 4.1 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.669 2.246 . . . . 0.0 112.42 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.482 ' CD2' HD22 ' A' ' 30' ' ' LEU . 28.5 tp -76.57 -28.62 56.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.384 -0.822 . . . . 0.0 111.267 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.518 ' CD2' ' OG ' ' A' ' 83' ' ' SER . 11.2 t-160 -81.59 -41.82 20.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.987 -1.07 . . . . 0.0 110.245 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.775 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.5 p -63.12 -58.9 5.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 110.023 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.775 ' H ' HG13 ' A' ' 80' ' ' VAL . 48.3 tp10 -58.46 -39.61 80.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.197 -0.94 . . . . 0.0 109.627 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 85.6 t80 -69.69 -43.49 72.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.827 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.518 ' OG ' ' CD2' ' A' ' 79' ' ' HIS . 49.8 m -59.24 -36.63 75.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.11 -0.994 . . . . 0.0 110.113 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.22 60.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.972 -1.08 . . . . 0.0 108.666 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.9 -41.59 74.49 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.492 ' C ' ' O ' ' A' ' 85' ' ' ALA . 11.9 t80 -43.06 -30.82 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.3 m -83.21 -60.98 1.97 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.41 -24.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.682 -0.636 . . . . 0.0 110.049 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' THR . 9.0 m -105.32 11.92 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.213 -0.93 . . . . 0.0 110.834 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 47.1 mt -124.68 158.77 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.278 . . . . 0.0 110.474 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.508 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 57.5 t0 -100.05 -34.32 10.12 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 90' ' ' ILE . 38.4 pttt -149.08 147.62 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.88 131.4 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.619 -1.301 . . . . 0.0 109.744 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.0 139.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -139.44 135.18 33.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.245 -1.534 . . . . 0.0 111.739 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.898 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -117.99 123.87 46.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.382 178.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 65.7 t0 -125.47 131.15 52.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.041 -1.037 . . . . 0.0 108.939 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' B' ' 45' ' ' ASP . 44.8 t80 -160.93 138.72 7.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.036 -1.04 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.82 120.33 2.8 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.34 2.026 . . . . 0.0 112.205 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.82 144.04 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.962 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.06 125.77 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.824 . . . . 0.0 109.609 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.06 73.55 9.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.105 -0.997 . . . . 0.0 109.539 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 103' ' ' VAL . 18.1 m -150.25 98.06 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.162 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 106' ' ' SER . 41.4 mmtm -134.27 -112.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.57 -12.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.103 -0.998 . . . . 0.0 108.868 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 104' ' ' LYS . 30.1 t -53.58 139.75 30.75 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.269 -0.895 . . . . 0.0 109.404 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.93 138.38 53.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.71 ' O ' HG22 ' A' ' 108' ' ' VAL . 5.8 p 178.47 59.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.465 -0.772 . . . . 0.0 109.495 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.455 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . . . -83.9 109.36 17.52 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.9 m -135.87 70.15 64.56 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 120.84 -1.162 . . . . 0.0 109.641 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--N 1.309 -1.549 0 C-N-CA 122.782 2.322 . . . . 0.0 112.223 179.963 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.86 67.26 1.03 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 109.357 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -108.02 0.82 22.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 109.047 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 38.2 m -173.55 -107.35 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.83 -178.81 20.51 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.632 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.62 130.2 45.33 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.302 -1.117 . . . . 0.0 108.011 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 1.2 ttpm? -104.47 134.04 48.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.337 1.065 . . . . 0.0 112.841 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -127.41 125.63 40.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 tt -133.43 142.59 48.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.729 -1.232 . . . . 0.0 109.375 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.87 140.31 49.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.574 -0.704 . . . . 0.0 109.493 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.408 ' O ' HG22 ' B' ' 94' ' ' VAL . 0.1 OUTLIER -121.13 134.14 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.489 ' O ' HG22 ' B' ' 57' ' ' THR . 2.6 m -137.5 162.8 32.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 117.758 -1.577 . . . . 0.0 113.016 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.503 ' HD2' ' H ' ' B' ' 14' ' ' PHE . 20.6 tptp -132.17 152.96 51.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.515 ' HB2' ' H ' ' B' ' 18' ' ' THR . 36.4 p90 -111.76 149.51 31.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.78 -1.2 . . . . 0.0 111.598 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -130.65 -19.44 3.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 95.4 mt-10 -92.14 -56.17 3.16 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 8.7 t0 154.25 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.515 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 87.1 m -49.67 105.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.148 0.975 . . . . 0.0 112.876 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.887 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -68.76 83.59 0.3 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.591 HG23 ' N ' ' B' ' 21' ' ' ASP . 29.6 m -61.84 -42.89 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 110.513 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.591 ' N ' HG23 ' B' ' 20' ' ' VAL . 30.4 p-10 -65.95 -43.2 88.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.547 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 97.2 mt-10 -70.7 -34.17 71.66 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.46 HD11 HG21 ' B' ' 89' ' ' VAL . 1.8 mm -67.29 -44.51 87.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' B' ' 20' ' ' VAL . 15.7 tp -52.87 -37.94 60.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -60.53 -35.05 75.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 29' ' ' ASN . . . -60.71 -54.13 39.54 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.559 HD23 ' O ' ' B' ' 27' ' ' LEU . 4.4 tt -45.92 -43.63 14.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.574 -0.957 . . . . 0.0 108.828 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 106' ' ' SER . 71.6 mm-40 -51.35 -33.2 28.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 26' ' ' GLY . 11.5 m-20 -66.34 -44.75 82.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 2.1 mm? -48.9 -48.4 42.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 94.4 t -46.9 -32.09 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 108.815 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 69.6 p -45.57 -49.37 14.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.518 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 71.1 mm-40 -72.49 -12.07 60.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 111.527 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 34' ' ' ILE . 21.2 mm -96.97 24.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.017 -1.677 . . . . 0.0 110.568 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.35 -12.02 5.14 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.575 ' O ' ' N ' ' B' ' 38' ' ' LYS . 52.6 p -75.29 -1.11 22.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.96 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 34.63 33.57 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.998 -1.064 . . . . 0.0 109.135 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' B' ' 36' ' ' THR . 32.1 mtmt -119.6 42.53 2.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 58.5 m -172.03 174.58 4.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -146.78 157.46 43.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.497 -1.377 . . . . 0.0 111.934 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.472 ' OE1' HD21 ' B' ' 27' ' ' LEU . 72.5 mt-10 -155.24 121.51 5.23 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.428 0.633 . . . . 0.0 110.221 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -123.86 170.27 10.74 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.18 159.67 23.65 Favored Glycine 0 N--CA 1.499 2.836 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.847 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 24.2 mt-10 -150.3 145.0 25.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.181 -1.188 . . . . 0.0 109.387 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 22.3 t70 -126.38 147.9 49.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.857 ' HZ2' ' C ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER -145.17 123.12 12.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 0.0 109.858 -178.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' B' ' 48' ' ' SER . 95.4 mt-10 -134.08 3.9 3.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.694 -0.629 . . . . 0.0 109.367 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.536 ' O ' ' O ' ' B' ' 47' ' ' GLU . 95.1 p -57.21 -140.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.179 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.762 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 57.3 t-80 -74.54 160.18 31.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 109.742 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.701 ' N ' HH21 ' B' ' 53' ' ' ARG . 77.7 m-20 -61.2 -44.2 97.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.0 110.837 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 1.7 tpt -67.81 -33.28 74.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.005 . . . . 0.0 110.726 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 95' ' ' LEU . 38.9 mt -89.32 -54.46 4.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.715 -1.24 . . . . 0.0 109.307 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.762 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.4 ptp180 -64.37 2.89 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 111.231 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.599 ' NE2' ' CZ ' ' B' ' 56' ' ' PHE . 0.0 OUTLIER 57.33 -12.38 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.811 -1.18 . . . . 0.0 110.282 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.738 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 85.61 -22.04 12.3 Favored Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.43 -0.794 . . . . 0.0 112.789 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.857 ' C ' ' HZ2' ' B' ' 46' ' ' LYS . 3.6 m-85 -57.82 -129.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.327 -1.69 . . . . 0.0 109.973 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.489 HG22 ' O ' ' B' ' 12' ' ' VAL . 2.6 t -162.37 -33.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 110.985 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.617 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 15.2 t60 -171.93 154.61 3.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.832 -1.168 . . . . 0.0 110.162 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.617 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.95 167.99 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.439 -0.788 . . . . 0.0 109.341 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.55 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 96.7 m-85 -134.61 131.04 37.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 109.137 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -105.55 99.1 8.72 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -99.9 124.77 45.58 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.204 -0.935 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 88.4 m -123.58 143.06 50.45 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' B' ' 65' ' ' GLU . 94.3 m-85 -122.22 126.65 48.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.751 -1.218 . . . . 0.0 110.081 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' B' ' 64' ' ' PHE . 32.8 tt0 -46.62 -30.79 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -166.01 170.6 13.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.85 -22.4 47.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.886 . . . . 0.0 111.402 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -56.18 -40.26 73.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.81 -1.181 . . . . 0.0 110.653 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.57 -36.08 62.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.63 ' O ' HG22 ' B' ' 74' ' ' THR . 72.5 t80 -63.07 -44.78 94.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.532 -0.981 . . . . 0.0 110.49 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.0 m -70.75 -28.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.351 -1.468 . . . . 0.0 108.684 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -60.83 2.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.344 -0.847 . . . . 0.0 109.292 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -56.69 -42.46 79.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 111.124 -177.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.63 HG22 ' O ' ' B' ' 70' ' ' TYR . 10.0 t -76.09 -33.14 59.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.779 -1.2 . . . . 0.0 110.381 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 65.4 m -63.47 -32.41 73.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.062 -1.024 . . . . 0.0 110.912 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.518 ' CE1' ' OE1' ' B' ' 33' ' ' GLN . 54.1 m80 -72.34 151.63 92.06 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 120.82 -1.175 . . . . 0.0 109.555 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.79 3.91 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.701 2.267 . . . . 0.0 112.425 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.473 ' CD2' HD22 ' B' ' 30' ' ' LEU . 28.5 tp -76.48 -28.93 56.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.373 -0.83 . . . . 0.0 111.233 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.506 ' CD2' ' OG ' ' B' ' 83' ' ' SER . 11.2 t-160 -81.37 -41.6 21.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.041 -1.037 . . . . 0.0 110.266 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.796 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.7 p -63.35 -59.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.998 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.796 ' H ' HG13 ' B' ' 80' ' ' VAL . 49.1 tp10 -58.23 -39.65 79.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -0.862 . . . . 0.0 109.625 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 85.5 t80 -69.43 -43.66 72.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.506 ' OG ' ' CD2' ' B' ' 79' ' ' HIS . 50.9 m -59.14 -36.54 75.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.027 -1.046 . . . . 0.0 110.147 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.21 -52.98 63.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.975 -1.078 . . . . 0.0 108.65 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -69.99 -41.93 73.76 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' B' ' 85' ' ' ALA . 11.8 t80 -42.89 -30.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.545 ' O ' ' N ' ' B' ' 89' ' ' VAL . 9.4 m -83.3 -60.79 2.03 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.65 -24.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.702 -0.624 . . . . 0.0 110.06 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.0 m -105.8 12.04 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.78 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 48.0 mt -124.63 158.81 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.711 -1.243 . . . . 0.0 110.423 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.509 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 57.1 t0 -100.06 -34.53 10.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.445 ' N ' HG22 ' B' ' 90' ' ' ILE . 38.5 pttt -148.76 147.67 29.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 tp -128.81 131.48 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.583 -1.323 . . . . 0.0 109.764 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.408 HG22 ' O ' ' B' ' 11' ' ' VAL . 2.3 m -136.93 139.51 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -139.68 135.05 32.82 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.276 -1.515 . . . . 0.0 111.773 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.885 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -117.8 124.05 47.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.7 t0 -125.64 131.56 52.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.037 -1.04 . . . . 0.0 108.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 45' ' ' ASP . 44.7 t80 -161.41 138.68 6.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.025 -1.047 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -44.69 120.35 2.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.299 2.0 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.86 143.92 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.05 125.78 25.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 109.6 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.03 73.37 9.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.039 -1.038 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.8 HG23 ' O ' ' B' ' 103' ' ' VAL . 18.2 m -149.95 98.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.219 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.635 ' C ' ' H ' ' B' ' 106' ' ' SER . 41.1 mmtm -134.52 -113.3 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.272 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m 63.97 -13.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 108.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.635 ' H ' ' C ' ' B' ' 104' ' ' LYS . 31.1 t -53.03 139.75 27.17 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.219 -0.925 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -130.88 138.37 53.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.699 ' O ' HG22 ' B' ' 108' ' ' VAL . 5.6 p 178.41 59.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.544 -0.723 . . . . 0.0 109.463 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . 0.453 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . . . -83.96 109.38 17.58 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 20.5 m -135.83 70.11 64.82 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 120.86 -1.15 . . . . 0.0 109.567 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 C--N 1.307 -1.62 0 C-N-CA 122.768 2.312 . . . . 0.0 112.248 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.277 0.56 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.77 58.04 4.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.347 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -116.06 1.11 13.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.141 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 m -175.34 -126.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 100' ' ' VAL . . . -95.24 173.14 31.2 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.709 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -135.78 136.36 40.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.289 -1.124 . . . . 0.0 108.005 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' B' ' 44' ' ' GLU . 20.7 ttpt -114.61 142.63 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.0 112.844 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -130.59 129.21 42.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.0 tt -137.24 145.98 44.25 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.71 -1.244 . . . . 0.0 109.442 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.1 p -131.18 136.58 57.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.64 -0.663 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.53 131.14 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.46 ' CG1' HD12 ' A' ' 93' ' ' ILE . 2.1 m -142.57 162.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 117.808 -1.557 . . . . 0.0 113.043 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 91' ' ' ASP . 13.9 tptp -127.55 155.32 43.99 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.527 ' HB2' ' H ' ' A' ' 18' ' ' THR . 11.5 p90 -108.18 149.54 28.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.842 -1.162 . . . . 0.0 111.638 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -127.02 -19.28 4.43 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.3 mt-10 -90.68 -56.76 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 10.1 t0 153.51 58.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.527 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 71.9 m -46.53 106.92 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.173 0.987 . . . . 0.0 112.795 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.567 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.39 89.13 1.6 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.8 m -61.2 -39.19 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.752 . . . . 0.0 110.467 -176.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 20' ' ' VAL . 89.3 m-20 -61.58 -45.4 94.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.554 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 21.8 mp0 -73.97 -37.82 64.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.528 HD11 HG21 ' A' ' 89' ' ' VAL . 1.9 mm -66.79 -48.88 78.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.1 tm? -58.22 -41.34 83.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.61 -25.71 68.35 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.697 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -65.37 -55.48 20.73 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 27' ' ' LEU . 7.0 tt -47.5 -35.75 9.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.514 -0.992 . . . . 0.0 108.826 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -53.52 -42.94 67.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -59.97 -42.32 93.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -52.7 -46.29 67.25 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 32' ' ' SER . 38.7 t -51.97 -23.95 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.248 -0.908 . . . . 0.0 108.843 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 44.3 t -44.34 -37.26 3.21 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.552 HE21 ' CG ' ' A' ' 76' ' ' HIS . 8.6 mm100 -79.87 -4.02 50.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.792 . . . . 0.0 111.457 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 34' ' ' ILE . 6.5 mm -88.42 23.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.107 -1.62 . . . . 0.0 110.652 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.38 -16.8 16.18 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.598 ' O ' ' C ' ' A' ' 37' ' ' VAL . 43.7 p -68.27 -2.65 8.68 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.937 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 36' ' ' THR . 31.2 m 30.32 41.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.049 -1.032 . . . . 0.0 109.185 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' THR . 4.2 mtmm -122.46 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 40' ' ' PHE . 28.8 t -72.74 -176.07 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' LYS . 82.3 m-85 -153.0 167.51 28.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.629 -1.294 . . . . 0.0 111.925 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.482 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 80.6 mt-10 -159.42 127.61 5.0 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.398 0.618 . . . . 0.0 110.193 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -129.54 171.36 12.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.15 24.46 Favored Glycine 0 N--CA 1.499 2.874 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.845 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.539 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 63.9 mt-10 -151.24 147.02 26.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -1.096 . . . . 0.0 109.391 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.6 t0 -130.85 157.58 42.49 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -61.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.405 -1.434 . . . . 0.0 109.813 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.8 mt-10 -126.69 40.62 3.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.683 -0.636 . . . . 0.0 109.333 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 49' ' ' HIS . 5.3 t -147.99 76.05 1.36 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.134 -0.978 . . . . 0.0 110.219 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 48' ' ' SER . 1.4 t-80 56.83 114.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.767 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 57.2 t0 -45.13 -34.87 2.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.0 110.783 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.0 mmm -75.74 -34.04 60.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' B' ' 95' ' ' LEU . 63.3 mt -89.7 -18.5 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.706 -1.246 . . . . 0.0 109.291 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' GLY . 18.0 ptt180 -101.8 7.94 41.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.244 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 53' ' ' ARG . 68.3 mm-40 38.68 27.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.789 -1.195 . . . . 0.0 110.138 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 53.37 2.71 0.12 Allowed Glycine 0 N--CA 1.499 2.836 0 O-C-N 121.416 -0.803 . . . . 0.0 112.85 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 20.4 p90 -47.82 132.07 14.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.206 -1.761 . . . . 0.0 109.936 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 98.6 m -58.18 -55.05 40.02 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.928 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.637 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 17.0 t60 -167.85 153.89 7.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.926 -1.109 . . . . 0.0 110.188 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.559 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.62 162.15 35.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.206 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 57.8 m-85 -129.2 126.17 38.58 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.493 -0.755 . . . . 0.0 109.062 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -104.57 102.91 12.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.5 mtt -102.42 120.73 41.0 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.177 -0.952 . . . . 0.0 110.816 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 m -112.02 133.66 54.05 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -119.46 121.04 38.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.689 -1.257 . . . . 0.0 110.084 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 66' ' ' ASN . 0.6 OUTLIER -47.88 -31.55 5.22 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.587 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 18.2 t-20 -157.34 162.4 39.1 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -59.9 -24.26 64.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 111.465 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.24 -38.39 68.42 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 0.0 110.573 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.525 ' O ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.63 -33.59 84.93 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.881 ' O ' HG23 ' A' ' 74' ' ' THR . 77.7 t80 -66.56 -46.98 74.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.548 -0.972 . . . . 0.0 110.489 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.93 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.427 -1.421 . . . . 0.0 108.651 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -60.64 -34.85 74.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 111.147 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 70' ' ' TYR . 41.8 p -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.712 -1.243 . . . . 0.0 110.295 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -65.38 -24.15 67.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.18 -0.95 . . . . 0.0 110.986 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.636 ' C ' ' H ' ' A' ' 78' ' ' LEU . 57.5 m80 -79.86 124.58 83.21 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.81 -1.181 . . . . 0.0 109.603 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.59 2.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.584 2.189 . . . . 0.0 112.519 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.636 ' H ' ' C ' ' A' ' 76' ' ' HIS . 6.7 tp -76.37 -34.41 58.9 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.307 -0.871 . . . . 0.0 111.24 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 58.0 t-80 -82.66 -33.44 27.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 0.0 110.327 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.93 -60.25 2.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.79 -42.97 65.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 17.6 m-85 -72.17 -34.14 68.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.754 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 67.0 m -60.87 -43.04 98.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 110.13 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.13 -41.96 97.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.978 -1.076 . . . . 0.0 108.673 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.666 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -68.4 -43.08 78.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.933 ' O ' HD13 ' A' ' 90' ' ' ILE . 2.7 m-85 -44.8 -30.25 0.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 1.1 p -82.26 -62.2 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.578 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -38.64 -28.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.654 -0.654 . . . . 0.0 110.052 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 85' ' ' ALA . 23.3 m -106.35 14.58 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 110.767 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.933 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.2 mp -124.81 160.2 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.672 -1.268 . . . . 0.0 110.467 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.551 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 58.7 t0 -105.53 -35.95 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -145.95 145.29 30.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' A' ' 12' ' ' VAL . 3.0 tp -126.11 124.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.672 -1.267 . . . . 0.0 109.744 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t -127.24 130.07 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -130.98 127.22 37.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.325 -1.485 . . . . 0.0 111.759 -178.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -118.8 122.46 42.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.653 -0.654 . . . . 0.0 109.358 177.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASP . 23.1 p-10 -130.2 138.94 50.84 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.11 -0.994 . . . . 0.0 108.864 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 32.3 t80 -159.43 134.71 5.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.075 -1.015 . . . . 0.0 110.52 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 94.9 Cg_exo -42.46 125.57 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.318 2.012 . . . . 0.0 112.19 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' GLY . 28.6 t -89.99 116.05 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.29 82.81 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.368 -0.832 . . . . 0.0 109.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -74.37 72.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 102' ' ' ALA . 5.3 m -161.91 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 25.9 mmtp -92.98 141.57 28.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.1 p -67.65 -25.3 65.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 108.958 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 106' ' ' SER . 5.9 p 61.85 50.88 4.02 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.83 135.88 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.0 t -51.54 140.47 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.533 -0.73 . . . . 0.0 109.467 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.76 100.48 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.2 p -134.53 69.75 72.52 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.918 -1.114 . . . . 0.0 109.611 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo . . . . . 0 C--N 1.307 -1.606 0 C-N-CA 122.812 2.342 . . . . 0.0 112.283 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.95 57.8 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.365 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.408 ' O ' ' OG ' ' B' ' 4' ' ' SER . 7.4 t -115.86 0.69 13.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.133 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 3' ' ' THR . 31.2 m -175.07 -126.23 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 100' ' ' VAL . . . -95.39 172.96 30.83 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.368 -1.396 . . . . 0.0 109.703 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -135.52 136.43 41.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.283 -1.128 . . . . 0.0 108.07 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 44' ' ' GLU . 20.7 ttpt -114.72 142.61 46.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.981 -1.075 . . . . 0.0 112.809 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -130.5 129.29 42.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.1 tt -137.29 145.94 44.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.821 -1.175 . . . . 0.0 109.439 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.409 HG13 ' O ' ' B' ' 10' ' ' VAL . 11.0 p -131.2 136.66 57.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.467 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.64 131.16 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.46 ' CG1' HD12 ' B' ' 93' ' ' ILE . 2.1 m -142.68 162.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.08 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -127.6 155.27 44.11 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.545 ' HB2' ' H ' ' B' ' 18' ' ' THR . 11.5 p90 -108.2 149.48 28.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.827 -1.17 . . . . 0.0 111.59 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -127.03 -19.41 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.2 mt-10 -90.64 -56.65 3.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 9.7 t0 153.29 58.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.545 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 68.2 m -46.59 106.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.03 0.919 . . . . 0.0 112.89 -177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -73.42 89.35 1.63 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.8 m -61.56 -38.91 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 110.465 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.512 ' N ' HG23 ' B' ' 20' ' ' VAL . 90.6 m-20 -61.66 -45.4 94.2 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 110.512 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 21.6 mp0 -74.15 -37.59 63.98 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.536 HD11 HG21 ' B' ' 89' ' ' VAL . 1.9 mm -67.07 -48.94 77.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.858 ' C ' HD13 ' B' ' 24' ' ' LEU . 2.1 tm? -58.0 -41.65 83.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.4 -25.74 68.42 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.703 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -65.34 -55.54 20.46 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.971 -2.052 . . . . 0.0 107.971 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.655 HD23 ' O ' ' B' ' 27' ' ' LEU . 7.0 tt -47.42 -35.73 8.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.541 -0.976 . . . . 0.0 108.811 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -53.49 -43.22 68.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.8 p30 -59.83 -42.23 93.06 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.61 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -52.84 -46.15 67.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' B' ' 32' ' ' SER . 38.7 t -52.0 -23.93 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.292 -0.88 . . . . 0.0 108.859 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 43.5 t -44.33 -37.39 3.28 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.558 HE21 ' CG ' ' B' ' 76' ' ' HIS . 8.6 mm100 -79.71 -4.29 51.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.516 -0.74 . . . . 0.0 111.466 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.716 HG22 ' O ' ' B' ' 34' ' ' ILE . 6.3 mm -88.24 23.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 119.947 -1.721 . . . . 0.0 110.61 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -58.44 -16.65 15.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.637 ' O ' ' C ' ' B' ' 37' ' ' VAL . 44.1 p -68.28 -2.82 9.04 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.932 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' B' ' 36' ' ' THR . 31.3 m 30.55 41.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' B' ' 40' ' ' PHE . 4.1 mtmm -122.4 -65.73 1.09 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' B' ' 40' ' ' PHE . 28.9 t -72.62 -176.16 1.87 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' B' ' 38' ' ' LYS . 82.4 m-85 -152.99 167.47 29.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.542 -1.349 . . . . 0.0 111.991 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 81.0 mt-10 -159.36 127.44 4.98 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.298 0.57 . . . . 0.0 110.227 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.404 ' HE1' ' HA ' ' A' ' 102' ' ' ALA . 16.7 m-90 -129.46 171.49 12.5 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.2 162.13 24.49 Favored Glycine 0 N--CA 1.5 2.961 0 C-N-CA 118.689 -1.72 . . . . 0.0 110.768 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.544 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 63.1 mt-10 -151.3 146.84 26.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.294 -1.121 . . . . 0.0 109.392 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' B' ' 47' ' ' GLU . 63.3 t0 -130.71 157.47 42.71 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.529 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -61.07 80.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.378 -1.451 . . . . 0.0 109.825 -177.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -126.68 40.51 3.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.503 ' O ' ' O ' ' B' ' 49' ' ' HIS . 5.4 t -147.85 76.45 1.39 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.169 -0.957 . . . . 0.0 110.173 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.503 ' O ' ' O ' ' B' ' 48' ' ' SER . 1.4 t-80 56.59 114.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.195 -0.941 . . . . 0.0 109.676 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' NE ' ' B' ' 53' ' ' ARG . 57.9 t0 -45.14 -34.88 2.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 110.839 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 93.0 mmm -75.65 -33.9 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.7 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 95' ' ' LEU . 62.6 mt -89.69 -18.7 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.776 -1.202 . . . . 0.0 109.253 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' B' ' 55' ' ' GLY . 18.0 ptt180 -101.78 7.91 41.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.847 . . . . 0.0 111.26 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' B' ' 53' ' ' ARG . 68.8 mm-40 38.68 27.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.803 -1.186 . . . . 0.0 110.214 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 53.31 2.79 0.11 Allowed Glycine 0 N--CA 1.498 2.787 0 O-C-N 121.37 -0.831 . . . . 0.0 112.791 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' B' ' 56' ' ' PHE . 20.1 p90 -47.96 132.08 15.28 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.193 -1.769 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 99.7 m -57.98 -55.27 37.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.325 -0.859 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 17.3 t60 -167.77 153.9 7.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.887 -1.133 . . . . 0.0 110.193 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.543 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.62 162.07 35.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.477 -0.764 . . . . 0.0 109.287 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 57.8 m-85 -129.05 126.05 38.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.11 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -104.48 102.68 12.32 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 39.7 mtt -102.36 120.9 41.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 110.673 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 37.9 m -112.02 134.13 53.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' B' ' 64' ' ' PHE . 2.2 m-85 -119.81 121.37 38.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.741 -1.224 . . . . 0.0 109.999 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' B' ' 66' ' ' ASN . 0.6 OUTLIER -48.26 -31.47 5.96 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.581 ' H ' ' CD ' ' B' ' 65' ' ' GLU . 18.0 t-20 -157.32 162.25 39.13 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -59.7 -24.43 63.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.512 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -55.04 -38.67 68.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.597 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.524 ' O ' ' CD2' ' B' ' 73' ' ' PHE . . . -66.22 -33.7 85.94 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.882 ' O ' HG23 ' B' ' 74' ' ' THR . 77.8 t80 -66.61 -47.04 73.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.566 -0.961 . . . . 0.0 110.495 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.73 -28.99 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.356 -1.465 . . . . 0.0 108.67 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.0 -60.86 2.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.338 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -60.57 -34.92 74.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.245 -0.909 . . . . 0.0 111.088 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.882 HG23 ' O ' ' B' ' 70' ' ' TYR . 42.0 p -73.86 -33.32 64.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.776 -1.203 . . . . 0.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -65.56 -24.31 67.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.112 -0.992 . . . . 0.0 111.053 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.635 ' C ' ' H ' ' B' ' 78' ' ' LEU . 57.6 m80 -79.58 124.62 83.68 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.829 -1.169 . . . . 0.0 109.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -46.77 2.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.609 2.206 . . . . 0.0 112.446 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.635 ' H ' ' C ' ' B' ' 76' ' ' HIS . 6.7 tp -76.42 -34.51 58.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.348 -0.845 . . . . 0.0 111.238 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.512 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 57.9 t-80 -82.47 -33.47 28.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.037 -1.039 . . . . 0.0 110.324 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.04 -60.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.96 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.92 -42.7 65.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.64 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 17.6 m-85 -72.29 -34.23 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.878 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.512 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 65.3 m -60.86 -42.99 98.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.048 . . . . 0.0 110.098 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.08 97.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.037 -1.039 . . . . 0.0 108.661 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.681 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -68.39 -42.93 78.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.939 ' O ' HD13 ' B' ' 90' ' ' ILE . 2.7 m-85 -44.9 -30.22 0.96 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' B' ' 88' ' ' ALA . 1.1 p -82.26 -62.21 1.69 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.577 ' N ' ' OG1' ' B' ' 87' ' ' THR . . . -38.66 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.691 -0.63 . . . . 0.0 110.099 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.681 HG22 ' O ' ' B' ' 85' ' ' ALA . 23.1 m -106.22 14.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.207 -0.933 . . . . 0.0 110.829 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.939 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.2 mp -124.63 160.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.7 -1.25 . . . . 0.0 110.467 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 58.3 t0 -105.46 -36.02 7.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -145.93 145.24 30.6 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' B' ' 12' ' ' VAL . 3.0 tp -126.15 124.1 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.571 -1.331 . . . . 0.0 109.798 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 14.4 t -127.29 130.2 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -131.06 126.9 37.08 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.244 -1.535 . . . . 0.0 111.809 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.554 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -118.55 122.72 43.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.443 ' OD2' ' OG ' ' A' ' 48' ' ' SER . 23.0 p-10 -130.43 138.85 50.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.175 -0.953 . . . . 0.0 108.853 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 32.2 t80 -159.42 134.6 5.75 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.048 -1.032 . . . . 0.0 110.541 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 96.5 Cg_exo -42.36 125.67 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.29 1.993 . . . . 0.0 112.244 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 5' ' ' GLY . 27.4 t -89.96 116.11 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.44 82.85 2.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.568 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . 0.675 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -74.27 71.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.602 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.675 HG13 ' O ' ' B' ' 102' ' ' ALA . 5.5 m -161.58 78.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.33 -0.856 . . . . 0.0 109.263 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -92.88 141.6 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.417 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 85.9 p -67.44 -25.58 65.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.159 -0.963 . . . . 0.0 108.944 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' B' ' 106' ' ' SER . 6.1 p 62.06 50.73 3.91 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.32 -0.863 . . . . 0.0 109.355 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.78 136.15 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.442 ' H ' HG23 ' B' ' 108' ' ' VAL . 15.5 t -51.92 140.52 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.429 -0.794 . . . . 0.0 109.501 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.69 100.39 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 17.2 p -134.47 69.64 72.8 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.82 -1.175 . . . . 0.0 109.634 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo . . . . . 0 C--N 1.308 -1.582 0 C-N-CA 122.76 2.307 . . . . 0.0 112.219 179.938 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.279 0.562 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.54 57.53 6.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 109.375 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 t -98.32 -12.24 21.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.141 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.7 m -127.79 -81.94 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.08 -168.91 16.91 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.664 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -114.43 130.76 56.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.241 -1.152 . . . . 0.0 108.09 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HZ3' ' HB3' ' B' ' 44' ' ' GLU . 21.9 ttpt -101.09 129.66 47.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.908 -1.12 . . . . 0.0 112.824 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.53 ' NE2' ' OD2' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -121.59 119.86 33.13 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 173.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 96' ' ' LEU . 6.6 tt -132.51 141.57 48.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.679 -1.263 . . . . 0.0 109.48 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 10' ' ' VAL . 9.5 p -129.35 136.11 60.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.614 -0.679 . . . . 0.0 109.523 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.27 131.0 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.843 HG12 HD12 ' A' ' 93' ' ' ILE . 35.8 m -139.32 150.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.816 -1.554 . . . . 0.0 113.095 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -127.83 154.74 45.1 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CD2' HG21 ' A' ' 57' ' ' THR . 16.2 p90 -113.04 156.8 22.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.814 -1.178 . . . . 0.0 111.615 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.36 -18.62 3.58 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 96.8 mt-10 -91.81 -53.49 4.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 6.1 t0 149.12 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -53.98 111.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.059 0.933 . . . . 0.0 112.814 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.587 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -74.07 86.36 1.85 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 177.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 21' ' ' ASP . 33.2 m -61.55 -42.59 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.553 -0.717 . . . . 0.0 110.547 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' N ' HG23 ' A' ' 20' ' ' VAL . 87.3 m-20 -63.45 -45.16 92.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.539 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -68.79 -34.01 74.82 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -67.94 -42.02 85.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' VAL . 16.5 tp -58.95 -39.36 81.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -61.15 -35.48 77.21 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.656 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.44 -53.23 40.54 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -44.09 -41.44 5.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.517 -0.99 . . . . 0.0 108.821 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -51.98 -39.12 58.87 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -63.59 -44.49 93.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.649 HD22 ' CD2' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -47.15 -48.42 23.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 32' ' ' SER . 86.3 t -55.47 -24.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.248 -0.908 . . . . 0.0 108.873 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 32.2 t -43.44 -43.4 5.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.05 -10.06 48.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.444 -0.785 . . . . 0.0 111.433 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.726 HG22 ' O ' ' A' ' 34' ' ' ILE . 64.5 mt -92.5 29.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.024 -1.672 . . . . 0.0 110.626 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.91 -8.08 2.04 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.579 ' H ' ' C ' ' A' ' 34' ' ' ILE . 68.2 p -67.5 -10.24 49.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.939 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.55 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.7 m 35.3 34.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 109.219 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' THR . 65.3 mttt -118.17 43.94 2.33 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 63' ' ' THR . 14.2 t -176.22 177.59 1.52 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.614 -1.304 . . . . 0.0 111.914 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 64.2 mt-10 -154.33 124.07 6.66 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.366 0.603 . . . . 0.0 110.207 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.532 ' CE2' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -127.39 169.17 13.89 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.45 138.44 6.42 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 118.794 -1.67 . . . . 0.0 110.838 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' OE2' ' CE2' ' A' ' 42' ' ' TRP . 4.4 mp0 -124.92 172.63 9.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.209 -1.171 . . . . 0.0 109.323 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 57' ' ' THR . 57.0 t0 -167.58 94.61 0.43 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HZ1' ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.15 170.89 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.471 -1.393 . . . . 0.0 109.78 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 48' ' ' SER . 2.4 mt-10 -172.77 90.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER 163.14 147.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 0.0 110.138 -179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 48' ' ' SER . 57.5 m170 57.95 113.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.204 -0.935 . . . . 0.0 109.7 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 51' ' ' MET . 29.0 p-10 -52.53 -43.41 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.313 -0.867 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 23.2 ttt -62.56 -35.03 78.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 17.2 mt -89.08 -20.03 24.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.763 -1.211 . . . . 0.0 109.305 177.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.97 ' O ' ' N ' ' A' ' 55' ' ' GLY . 34.0 ttt-85 -83.83 42.54 0.86 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.384 -0.823 . . . . 0.0 111.217 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.561 HE21 HG11 ' B' ' 94' ' ' VAL . 34.6 tt0 -31.41 -12.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.739 -1.225 . . . . 0.0 110.195 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.97 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 105.66 -35.79 4.83 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.385 -0.822 . . . . 0.0 112.93 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -55.39 102.82 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.294 -1.709 . . . . 0.0 109.956 -179.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.636 HG21 ' CD2' ' A' ' 14' ' ' PHE . 49.1 p -61.99 -34.48 76.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.952 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.596 ' ND1' ' OG1' ' A' ' 57' ' ' THR . 34.7 p-80 -171.74 149.9 2.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.853 -1.154 . . . . 0.0 110.182 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.35 170.87 14.97 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.434 -0.791 . . . . 0.0 109.26 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -138.64 134.96 34.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.494 ' HB2' ' HE1' ' A' ' 42' ' ' TRP . 10.2 t -111.22 106.24 15.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' HIS . 67.6 mtt -95.67 119.98 35.12 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.826 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.467 ' O ' ' OG ' ' A' ' 39' ' ' SER . 32.0 m -116.59 141.78 47.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -121.29 152.46 38.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.742 -1.224 . . . . 0.0 110.073 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -86.27 -23.92 26.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.519 ' ND2' ' H ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -162.47 165.86 25.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -69.15 -24.73 64.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 0.0 111.446 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -63.1 -40.61 98.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.825 -1.172 . . . . 0.0 110.602 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . -72.1 -33.44 62.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.655 ' O ' HG22 ' A' ' 74' ' ' THR . 25.1 t80 -66.32 -43.0 87.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.589 -0.948 . . . . 0.0 110.51 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.1 m -70.84 -28.89 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.449 -1.407 . . . . 0.0 108.658 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.89 2.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 109.383 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 69' ' ' GLY . 1.1 m-85 -54.72 -35.42 63.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -0.897 . . . . 0.0 111.084 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' TYR . 4.9 t -85.57 -28.93 24.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.739 -1.226 . . . . 0.0 110.327 -177.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 73.6 m -66.21 -34.64 78.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.997 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -61.31 151.53 76.18 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.76 -1.213 . . . . 0.0 109.61 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.07 -7.75 20.74 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.652 2.235 . . . . 0.0 112.407 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 30' ' ' LEU . 7.3 tt -76.97 -27.92 54.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.395 -0.816 . . . . 0.0 111.218 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -81.73 -35.53 29.62 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 81' ' ' GLU . 6.7 p -70.2 -56.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.006 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.726 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.96 84.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.619 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -59.17 -42.78 91.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.804 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.7 p -65.73 -30.63 71.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 110.106 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.85 -55.19 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.033 -1.042 . . . . 0.0 108.687 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.468 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -66.62 -39.35 88.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.428 ' O ' HG12 ' A' ' 90' ' ' ILE . 23.8 t80 -46.47 -25.42 0.67 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.4 m -83.56 -63.62 1.32 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.01 -33.39 0.31 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.719 -0.613 . . . . 0.0 110.067 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 85' ' ' ALA . 6.8 m -92.66 14.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -0.897 . . . . 0.0 110.815 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.636 HD12 ' HB ' ' A' ' 12' ' ' VAL . 26.5 mm -132.35 163.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.609 -1.307 . . . . 0.0 110.412 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 90' ' ' ILE . 34.7 t0 -113.9 -33.73 5.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -132.87 129.54 38.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.843 HD12 HG12 ' A' ' 12' ' ' VAL . 7.0 tp -128.79 130.44 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.579 -1.326 . . . . 0.0 109.762 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.591 HG11 HE21 ' B' ' 54' ' ' GLN . 14.4 p -146.95 148.07 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -135.85 129.86 33.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.276 -1.515 . . . . 0.0 111.804 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.901 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -112.73 119.57 38.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.669 -0.644 . . . . 0.0 109.346 178.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.53 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 54.1 t0 -128.33 135.76 50.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.052 -1.03 . . . . 0.0 108.847 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.511 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 36.3 t80 -166.76 140.64 3.24 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 110.54 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.03 106.99 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.266 1.978 . . . . 0.0 112.249 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 100' ' ' VAL . 1.9 p -88.49 128.8 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 109.952 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.76 94.71 4.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.654 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.45 150.59 25.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.091 -1.006 . . . . 0.0 109.562 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 -21.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 109.133 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.696 ' C ' ' H ' ' A' ' 106' ' ' SER . 18.0 mmtp 54.03 -141.74 0.84 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.366 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.97 -12.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 108.961 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.696 ' H ' ' C ' ' A' ' 104' ' ' LYS . 83.7 p -52.46 152.64 3.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.28 -0.887 . . . . 0.0 109.378 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.756 HG13 HG12 ' A' ' 108' ' ' VAL . 7.4 p -140.29 166.03 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.756 HG12 HG13 ' A' ' 107' ' ' VAL . 5.1 p 32.53 72.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.733 . . . . 0.0 109.545 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.8 174.01 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.6 m -70.72 132.78 86.89 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 120.848 -1.158 . . . . 0.0 109.673 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 C--N 1.308 -1.574 0 C-N-CA 122.795 2.33 . . . . 0.0 112.228 179.659 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.32 0.581 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.43 57.67 5.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 0.0 109.339 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.5 t -98.48 -12.26 21.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.106 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.8 m -127.76 -82.02 0.6 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.94 -168.98 16.89 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.684 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.5 130.52 56.75 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -1.149 . . . . 0.0 108.014 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 22.1 ttpt -100.91 129.71 46.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.975 -1.078 . . . . 0.0 112.838 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' B' ' 97' ' ' ASP . 0.3 OUTLIER -121.52 119.56 32.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.535 HD22 HD13 ' B' ' 96' ' ' LEU . 6.5 tt -132.07 141.67 49.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.713 -1.242 . . . . 0.0 109.56 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.412 ' O ' HG13 ' B' ' 10' ' ' VAL . 9.7 p -129.25 136.34 59.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 109.485 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.4 131.02 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.848 HG12 HD12 ' B' ' 93' ' ' ILE . 35.9 m -139.22 150.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 117.706 -1.597 . . . . 0.0 113.046 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -127.91 154.98 44.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD2' HG21 ' B' ' 57' ' ' THR . 15.4 p90 -113.34 156.68 22.97 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.815 -1.178 . . . . 0.0 111.596 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -129.27 -18.8 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 96.6 mt-10 -91.73 -53.65 4.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 6.4 t0 149.2 65.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.8 m -54.14 112.02 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.114 0.959 . . . . 0.0 112.825 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.575 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.11 86.47 1.87 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.577 HG23 ' N ' ' B' ' 21' ' ' ASP . 33.0 m -61.86 -42.42 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.622 -0.674 . . . . 0.0 110.477 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.577 ' N ' HG23 ' B' ' 20' ' ' VAL . 87.5 m-20 -63.5 -45.03 92.57 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 110.535 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -68.87 -34.43 75.43 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -67.49 -42.11 86.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' B' ' 20' ' ' VAL . 16.5 tp -58.89 -39.51 81.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -60.87 -35.67 77.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.66 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -63.29 -53.32 40.39 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 26' ' ' GLY . 5.9 tt -44.11 -41.28 5.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.989 . . . . 0.0 108.846 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -51.99 -39.07 58.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 0.7 OUTLIER -63.82 -44.17 94.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.64 HD22 ' CD2' ' B' ' 78' ' ' LEU . 0.5 OUTLIER -47.59 -47.91 28.35 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 32' ' ' SER . 84.4 t -55.84 -24.47 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 32.5 t -43.65 -43.38 5.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -89.07 -9.83 49.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.436 -0.79 . . . . 0.0 111.479 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.733 HG22 ' O ' ' B' ' 34' ' ' ILE . 62.8 mt -92.59 28.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.003 -1.685 . . . . 0.0 110.604 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.84 -8.01 1.95 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' C ' ' B' ' 37' ' ' VAL . 66.1 p -67.61 -10.2 49.89 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.945 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.58 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.6 m 35.27 35.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.032 -1.043 . . . . 0.0 109.181 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 36' ' ' THR . 66.4 mttt -118.22 43.99 2.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' B' ' 63' ' ' THR . 14.4 t -176.27 177.7 1.48 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.02 156.0 42.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.541 -1.349 . . . . 0.0 112.007 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.452 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 63.8 mt-10 -154.09 124.23 6.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.354 0.597 . . . . 0.0 110.259 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.54 ' CE2' ' OE2' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -127.51 168.92 14.27 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.26 138.34 6.4 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.75 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.54 ' OE2' ' CE2' ' B' ' 42' ' ' TRP . 4.4 mp0 -124.71 173.16 8.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.233 -1.157 . . . . 0.0 109.434 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' B' ' 57' ' ' THR . 57.1 t0 -168.12 94.55 0.39 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HZ2' ' HA ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -89.0 170.73 10.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.446 -1.409 . . . . 0.0 109.825 179.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' B' ' 48' ' ' SER . 2.3 mt-10 -172.58 90.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER 163.46 148.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' B' ' 48' ' ' SER . 57.9 m170 57.7 113.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 109.693 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 28.7 p-10 -52.49 -43.53 65.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.781 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 23.3 ttt -62.34 -35.17 78.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 110.723 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.522 ' O ' ' NZ ' ' B' ' 46' ' ' LYS . 17.0 mt -89.04 -19.91 25.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.336 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.953 ' O ' ' N ' ' B' ' 55' ' ' GLY . 34.1 ttt-85 -83.99 42.65 0.88 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.334 -0.854 . . . . 0.0 111.194 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.591 HE21 HG11 ' A' ' 94' ' ' VAL . 34.8 tt0 -31.53 -12.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.862 -1.149 . . . . 0.0 110.274 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.953 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 105.88 -36.11 4.62 Favored Glycine 0 N--CA 1.498 2.775 0 O-C-N 121.454 -0.779 . . . . 0.0 112.857 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.809 ' CG ' ' O ' ' B' ' 56' ' ' PHE . 0.7 OUTLIER -55.04 102.8 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.302 -1.705 . . . . 0.0 109.987 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.639 HG21 ' CD2' ' B' ' 14' ' ' PHE . 49.2 p -61.78 -34.81 76.55 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.307 -0.871 . . . . 0.0 111.015 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.575 ' HE2' HD11 ' B' ' 90' ' ' ILE . 33.9 p-80 -171.35 150.3 2.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 110.148 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.65 170.8 15.16 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.262 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -138.59 134.9 34.4 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.439 -0.788 . . . . 0.0 109.128 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.498 ' HB2' ' HE1' ' B' ' 42' ' ' TRP . 10.0 t -111.16 106.24 15.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . 0.475 ' N ' ' O ' ' B' ' 8' ' ' HIS . 67.7 mtt -95.57 120.33 35.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.149 -0.97 . . . . 0.0 110.833 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.507 ' O ' ' OG ' ' B' ' 39' ' ' SER . 32.5 m -116.96 141.72 47.87 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -121.27 152.1 39.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.695 -1.253 . . . . 0.0 110.047 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -85.94 -23.76 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' B' ' 69' ' ' GLY . 0.0 OUTLIER -162.65 166.08 24.98 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -69.35 -24.66 63.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 111.453 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.44 -40.29 96.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.865 -1.147 . . . . 0.0 110.604 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.553 ' O ' ' CE2' ' B' ' 73' ' ' PHE . . . -71.99 -33.78 62.34 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.648 ' O ' HG22 ' B' ' 74' ' ' THR . 25.2 t80 -66.15 -43.05 88.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.512 -0.993 . . . . 0.0 110.426 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.3 m -70.83 -28.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.412 -1.43 . . . . 0.0 108.626 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.99 2.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.358 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.553 ' CE2' ' O ' ' B' ' 69' ' ' GLY . 1.1 m-85 -54.6 -35.56 63.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.287 -0.883 . . . . 0.0 111.089 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.648 HG22 ' O ' ' B' ' 70' ' ' TYR . 4.9 t -85.49 -29.0 24.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.822 -1.174 . . . . 0.0 110.347 -177.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 73.8 m -66.11 -34.78 78.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.982 . . . . 0.0 111.056 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -61.11 151.81 73.91 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.24 -7.86 21.23 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.611 2.207 . . . . 0.0 112.499 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.64 ' CD2' HD22 ' B' ' 30' ' ' LEU . 7.3 tt -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -0.797 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -81.37 -35.65 30.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 110.281 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.726 HG13 ' H ' ' B' ' 81' ' ' GLU . 6.9 p -70.26 -56.67 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 110.049 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.726 ' H ' HG13 ' B' ' 80' ' ' VAL . 84.4 tt0 -57.99 -41.89 84.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.15 -42.77 91.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.849 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 88.0 p -65.82 -30.55 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.991 . . . . 0.0 110.069 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.93 -54.85 36.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 0.0 108.705 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.479 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -66.96 -39.24 87.2 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' B' ' 85' ' ' ALA . 24.0 t80 -46.73 -25.05 0.66 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.427 ' N ' ' C ' ' B' ' 85' ' ' ALA . 5.7 m -83.91 -63.48 1.34 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.07 -33.18 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.771 -0.581 . . . . 0.0 110.086 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 85' ' ' ALA . 7.0 m -92.89 14.83 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.173 -0.954 . . . . 0.0 110.811 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.625 HG22 ' N ' ' B' ' 91' ' ' ASP . 26.2 mm -132.43 164.16 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.651 -1.281 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.625 ' N ' HG22 ' B' ' 90' ' ' ILE . 34.8 t0 -114.07 -33.71 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -132.94 129.58 38.47 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.848 HD12 HG12 ' B' ' 12' ' ' VAL . 7.1 tp -128.83 130.56 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.516 -1.365 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.561 HG11 HE21 ' A' ' 54' ' ' GLN . 14.4 p -147.06 147.94 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.501 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -135.86 130.03 33.27 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.237 -1.54 . . . . 0.0 111.759 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.898 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.1 OUTLIER -112.85 119.42 37.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.325 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' B' ' 8' ' ' HIS . 54.7 t0 -128.24 135.7 50.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.107 -0.996 . . . . 0.0 108.918 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.492 ' N ' ' OD1' ' B' ' 97' ' ' ASP . 36.1 t80 -166.7 140.65 3.28 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.111 -0.993 . . . . 0.0 110.49 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.95 106.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.273 1.982 . . . . 0.0 112.264 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.441 ' H ' HG12 ' B' ' 100' ' ' VAL . 1.9 p -88.38 128.67 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.121 -0.987 . . . . 0.0 110.079 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -122.65 94.74 4.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.511 -0.743 . . . . 0.0 109.554 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 0.0 109.62 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.52 -21.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.21 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.703 ' C ' ' H ' ' B' ' 106' ' ' SER . 18.1 mmtp 54.45 -141.87 0.83 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.28 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m 59.89 -12.7 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.143 -0.973 . . . . 0.0 108.916 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.703 ' H ' ' C ' ' B' ' 104' ' ' LYS . 83.5 p -52.49 152.44 3.57 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.738 HG13 HG12 ' B' ' 108' ' ' VAL . 7.4 p -140.16 165.57 21.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.738 HG12 HG13 ' B' ' 107' ' ' VAL . 5.0 p 32.96 72.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.61 174.26 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.293 -0.879 . . . . 0.0 108.635 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 22.0 m -71.07 132.69 86.27 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 120.8 -1.187 . . . . 0.0 109.606 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 0 C--N 1.307 -1.623 0 C-N-CA 122.796 2.33 . . . . 0.0 112.267 179.708 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.686 ' O ' ' N ' ' A' ' 3' ' ' THR . 7.4 ptp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.31 0.576 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.681 ' O ' HG22 ' A' ' 3' ' ' THR . . . 60.0 -62.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.362 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.686 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.5 OUTLIER 74.77 -2.81 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.116 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 3' ' ' THR . 38.3 m -174.65 -129.13 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.94 168.59 26.19 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.653 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.91 128.14 47.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -1.15 . . . . 0.0 108.028 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 4.3 ttpm? -106.5 134.66 49.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 112.885 -177.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -126.17 124.48 40.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -131.76 142.03 49.65 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.678 -1.264 . . . . 0.0 109.526 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.08 138.21 53.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.482 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.83 131.69 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.19 145.98 29.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 117.88 -1.528 . . . . 0.0 113.071 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -127.49 147.74 50.31 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.798 ' CB ' ' H ' ' A' ' 18' ' ' THR . 17.7 t80 -111.31 158.88 18.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.801 -1.187 . . . . 0.0 111.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.694 ' HG3' ' H ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.42 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.694 ' H ' ' HG3' ' A' ' 15' ' ' LYS . 83.6 mt-10 -85.95 -49.99 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.457 ' H ' ' HD2' ' A' ' 14' ' ' PHE . 6.5 t0 160.31 98.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' A' ' 14' ' ' PHE . 3.4 m -51.43 153.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.121 0.963 . . . . 0.0 112.84 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.561 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -77.84 87.69 4.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.32 -33.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.507 -0.746 . . . . 0.0 110.517 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 29.8 p-10 -66.74 -42.02 86.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.443 -0.785 . . . . 0.0 110.508 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 70.7 mm-40 -67.64 -30.31 69.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 89' ' ' VAL . 1.3 mm -70.9 -37.46 68.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -54.12 -36.87 63.71 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -35.46 80.37 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.95 -54.58 17.18 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -47.96 41.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.5 -1.0 . . . . 0.0 108.883 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.08 -43.61 70.48 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.647 ' ND2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -65.0 -47.52 77.23 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -49.27 -44.64 44.0 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' SER . 78.7 t -55.62 -25.02 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.28 -0.887 . . . . 0.0 108.866 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 29' ' ' ASN . 51.0 m -43.27 -39.09 2.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.425 ' OE1' ' CG ' ' A' ' 76' ' ' HIS . 99.5 mm-40 -67.55 0.89 2.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 111.425 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 34' ' ' ILE . 72.2 mt -108.17 26.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.074 -1.641 . . . . 0.0 110.607 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 36' ' ' THR . 53.4 p30 -60.42 -8.42 2.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.609 ' O ' ' C ' ' A' ' 37' ' ' VAL . 29.4 p -84.21 0.23 49.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.964 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.609 ' C ' ' O ' ' A' ' 36' ' ' THR . 29.3 m 30.26 38.99 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.29 3.59 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 t -174.07 178.27 2.16 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 91.9 m-85 -144.53 154.49 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 111.993 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.499 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 81.0 mt-10 -158.01 127.46 5.86 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.342 0.591 . . . . 0.0 110.267 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -133.43 172.59 12.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' B' ' 98' ' ' PHE . . . -131.89 163.87 23.75 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.816 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.668 ' N ' ' CE1' ' A' ' 58' ' ' HIS . 18.9 mt-10 -149.49 142.54 24.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.247 -1.149 . . . . 0.0 109.34 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.587 ' CG ' ' HD1' ' A' ' 58' ' ' HIS . 42.2 m-20 -125.63 155.79 40.22 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 81.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.395 -1.44 . . . . 0.0 109.771 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 45' ' ' ASP . 95.7 mt-10 -103.04 39.33 1.57 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 97' ' ' ASP . 11.7 m -142.75 168.33 19.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 0.0 110.129 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' ARG . 78.0 m80 -48.37 140.79 7.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.134 -0.979 . . . . 0.0 109.757 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 78.7 m-20 -44.48 -46.4 9.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.759 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.7 ttt -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.057 . . . . 0.0 110.732 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' B' ' 95' ' ' LEU . 43.5 mt -102.0 -19.12 15.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.713 -1.242 . . . . 0.0 109.241 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.832 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -72.25 -5.34 35.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.905 . . . . 0.0 111.217 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.62 -8.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.827 -1.17 . . . . 0.0 110.149 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.832 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 72.77 -13.16 3.23 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.386 -0.821 . . . . 0.0 112.844 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 3.5 p90 -59.54 129.9 44.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.308 -1.701 . . . . 0.0 109.985 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.9 p -54.07 -43.04 69.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.88 . . . . 0.0 111.008 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.668 ' CE1' ' N ' ' A' ' 44' ' ' GLU . 19.0 t60 -173.36 159.4 3.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.143 . . . . 0.0 110.147 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.649 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -143.07 167.9 21.0 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 0.0 109.208 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 81.0 m-85 -132.94 129.48 38.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.114 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.2 m -106.6 100.72 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.9 mtm -104.79 129.14 53.1 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.19 -0.944 . . . . 0.0 110.745 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -126.48 143.44 51.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 65' ' ' GLU . 93.1 m-85 -124.5 130.13 51.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.679 -1.263 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' PHE . 84.6 tt0 -47.93 -33.82 8.21 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -161.54 166.37 27.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -55.27 -22.47 18.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 111.459 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD2' ' NZ ' ' A' ' 38' ' ' LYS . 22.9 t70 -53.63 -40.49 65.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.791 -1.193 . . . . 0.0 110.651 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.01 -36.16 64.55 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.647 ' O ' HG22 ' A' ' 74' ' ' THR . 56.6 t80 -64.39 -44.16 92.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.631 -0.923 . . . . 0.0 110.472 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.77 -28.9 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.331 -1.481 . . . . 0.0 108.68 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.86 2.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.382 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -59.12 -46.7 87.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 111.08 -177.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 70' ' ' TYR . 11.6 t -69.84 -36.13 75.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.747 -1.22 . . . . 0.0 110.307 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.413 ' N ' HG23 ' A' ' 74' ' ' THR . 78.0 p -65.43 -27.21 68.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -0.98 . . . . 0.0 110.941 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CG ' ' OE1' ' A' ' 33' ' ' GLN . 55.3 m80 -72.17 151.29 92.41 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.836 -1.165 . . . . 0.0 109.562 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.98 -5.35 16.13 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.603 2.202 . . . . 0.0 112.388 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 5.6 tp -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 111.198 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 83' ' ' SER . 11.1 t-160 -82.61 -40.75 20.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.074 -1.016 . . . . 0.0 110.241 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.35 -61.72 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.998 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -53.16 -38.07 62.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.612 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.647 ' CZ ' ' ND2' ' A' ' 29' ' ' ASN . 8.1 m-85 -74.37 -33.62 63.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.838 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 79' ' ' HIS . 21.2 t -61.23 -44.09 97.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 110.166 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.35 96.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.99 -1.069 . . . . 0.0 108.667 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.19 -43.42 78.14 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.22 -31.64 0.64 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 89' ' ' VAL . 22.3 m -80.43 -62.25 1.73 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.97 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 110.034 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.3 m -113.95 7.26 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 91' ' ' ASP . 60.9 mt -123.5 157.72 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.656 -1.277 . . . . 0.0 110.452 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.483 ' N ' HG22 ' A' ' 90' ' ' ILE . 22.5 t70 -108.37 -30.28 8.4 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -145.59 142.98 29.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' ILE . 4.0 tp -125.39 123.51 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.635 -1.29 . . . . 0.0 109.852 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 t -126.05 131.59 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -138.3 133.24 32.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.207 -1.558 . . . . 0.0 111.793 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -121.16 126.58 50.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.307 178.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 64.8 t0 -124.69 130.43 52.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.085 -1.009 . . . . 0.0 108.952 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.648 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -157.65 124.23 2.55 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.035 -1.041 . . . . 0.0 110.501 -179.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.648 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 79.8 Cg_exo -45.01 133.68 11.03 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.287 1.991 . . . . 0.0 112.235 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 4' ' ' SER . 37.2 t -110.35 133.3 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 110.001 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -110.9 94.05 4.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.463 -0.773 . . . . 0.0 109.634 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.27 69.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 0.0 109.516 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.7 m -151.45 110.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.442 -0.786 . . . . 0.0 109.134 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.652 ' C ' ' H ' ' A' ' 106' ' ' SER . 24.6 mmtp -125.41 1.46 7.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.44 -23.38 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.652 ' H ' ' C ' ' A' ' 104' ' ' LYS . 1.7 m 61.15 54.62 3.24 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.257 -0.902 . . . . 0.0 109.35 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.656 HG12 HG12 ' A' ' 108' ' ' VAL . 5.4 t -142.31 -123.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.934 HG13 ' H ' ' A' ' 109' ' ' ALA . 2.8 p -140.05 -103.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 109.5 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.934 ' H ' HG13 ' A' ' 108' ' ' VAL . . . -136.39 157.13 47.52 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -72.36 154.51 91.88 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 120.876 -1.14 . . . . 0.0 109.639 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.781 2.321 . . . . 0.0 112.29 179.63 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.677 ' O ' ' N ' ' B' ' 3' ' ' THR . 7.3 ptp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.677 ' O ' HG22 ' B' ' 3' ' ' THR . . . 59.89 -62.22 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.677 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.5 OUTLIER 74.8 -2.94 2.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.877 . . . . 0.0 109.149 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' B' ' 3' ' ' THR . 40.0 m -174.48 -129.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.87 168.44 26.19 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.688 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.85 128.25 47.34 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.538 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 4.3 ttpm? -106.39 134.77 49.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.989 -1.07 . . . . 0.0 112.823 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -126.25 124.5 40.52 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.85 141.98 49.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.7 -1.25 . . . . 0.0 109.491 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 138.22 54.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.612 -0.68 . . . . 0.0 109.542 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.75 131.69 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.28 146.31 29.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 117.702 -1.599 . . . . 0.0 113.04 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -127.65 147.75 50.37 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.807 ' CB ' ' H ' ' B' ' 18' ' ' THR . 17.5 t80 -111.37 158.83 18.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.867 -1.146 . . . . 0.0 111.596 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.674 ' HG3' ' H ' ' B' ' 16' ' ' GLU . 0.2 OUTLIER -43.83 -73.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.674 ' H ' ' HG3' ' B' ' 15' ' ' LYS . 83.6 mt-10 -86.05 -49.95 7.41 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.466 ' H ' ' HD2' ' B' ' 14' ' ' PHE . 6.5 t0 160.35 98.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.807 ' H ' ' CB ' ' B' ' 14' ' ' PHE . 3.4 m -51.28 153.77 1.94 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.062 0.935 . . . . 0.0 112.909 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.561 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -78.01 87.6 4.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -64.24 -33.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.605 -0.684 . . . . 0.0 110.562 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 29.7 p-10 -66.71 -42.1 86.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.793 . . . . 0.0 110.56 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 70.5 mm-40 -67.64 -30.28 69.8 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.475 HD11 HG21 ' B' ' 89' ' ' VAL . 1.3 mm -70.78 -37.48 69.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -54.28 -36.64 63.86 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -35.54 80.66 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.02 -54.39 17.9 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.86 -47.7 42.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.633 -0.922 . . . . 0.0 108.855 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.44 -43.59 71.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.642 ' ND2' ' CZ ' ' B' ' 82' ' ' PHE . 0.2 OUTLIER -64.95 -47.5 77.43 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.6 HD13 ' O ' ' B' ' 30' ' ' LEU . 0.6 OUTLIER -49.25 -44.71 43.93 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' B' ' 32' ' ' SER . 77.4 t -55.51 -25.11 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.273 -0.892 . . . . 0.0 108.789 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' B' ' 29' ' ' ASN . 50.9 m -43.12 -39.25 2.72 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' B' ' 76' ' ' HIS . 99.5 mm-40 -67.37 0.88 2.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 111.536 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.766 HG22 ' O ' ' B' ' 34' ' ' ILE . 72.1 mt -108.18 26.64 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.043 -1.661 . . . . 0.0 110.581 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 36' ' ' THR . 53.8 p30 -60.47 -8.49 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.625 ' O ' ' C ' ' B' ' 37' ' ' VAL . 29.6 p -84.1 0.14 49.6 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.966 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.625 ' C ' ' O ' ' B' ' 36' ' ' THR . 29.5 m 30.32 38.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.093 -1.004 . . . . 0.0 109.149 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' B' ' 36' ' ' THR . 0.1 OUTLIER -120.95 40.33 3.58 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -174.19 178.29 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 91.9 m-85 -144.59 154.39 42.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.555 -1.341 . . . . 0.0 112.002 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 81.7 mt-10 -158.01 127.57 5.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.441 0.639 . . . . 0.0 110.192 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -133.62 172.54 12.6 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 98' ' ' PHE . . . -131.93 163.8 23.78 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 118.725 -1.702 . . . . 0.0 110.854 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.684 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 18.4 mt-10 -149.4 142.48 24.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -1.158 . . . . 0.0 109.35 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.583 ' CG ' ' HD1' ' B' ' 58' ' ' HIS . 42.3 m-20 -125.53 155.76 40.11 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 81.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.354 -1.466 . . . . 0.0 109.743 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' B' ' 45' ' ' ASP . 95.7 mt-10 -103.11 39.14 1.61 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 11.9 m -142.82 168.21 20.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 110.164 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' B' ' 53' ' ' ARG . 78.0 m80 -48.26 140.78 7.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.0 109.686 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.523 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 78.1 m-20 -44.57 -46.27 9.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.773 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 24.4 ttt -61.76 -28.85 69.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.718 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 95' ' ' LEU . 43.3 mt -102.14 -18.98 15.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.814 ' CG ' ' H ' ' B' ' 55' ' ' GLY . 0.0 OUTLIER -72.36 -5.28 35.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 111.238 -177.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.82 -8.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.827 -1.17 . . . . 0.0 110.204 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.814 ' H ' ' CG ' ' B' ' 53' ' ' ARG . . . 73.04 -13.32 3.37 Favored Glycine 0 N--CA 1.498 2.82 0 O-C-N 121.433 -0.792 . . . . 0.0 112.83 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 3.4 p90 -59.44 129.9 44.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.328 -1.689 . . . . 0.0 109.908 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 28.8 p -53.99 -43.2 69.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 111.039 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.684 ' CE1' ' H ' ' B' ' 44' ' ' GLU . 18.9 t60 -173.17 159.6 3.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.903 -1.123 . . . . 0.0 110.175 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.662 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -143.22 167.74 21.41 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.507 -0.746 . . . . 0.0 109.282 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.402 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 80.9 m-85 -132.84 129.55 38.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.443 -0.785 . . . . 0.0 109.104 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -106.55 100.95 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 56.7 mtm -105.13 129.15 53.6 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 50.4 m -126.53 143.52 51.18 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' B' ' 65' ' ' GLU . 93.3 m-85 -124.6 130.0 51.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 0.0 110.014 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 64' ' ' PHE . 84.4 tt0 -47.88 -33.67 7.84 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' B' ' 66' ' ' ASN . 0.9 OUTLIER -161.71 166.41 26.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -55.39 -22.7 20.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 111.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.492 ' OD2' ' NZ ' ' B' ' 38' ' ' LYS . 22.6 t70 -53.23 -40.69 64.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.704 -1.248 . . . . 0.0 110.574 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.17 65.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.649 ' O ' HG22 ' B' ' 74' ' ' THR . 56.8 t80 -64.19 -44.43 91.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.921 . . . . 0.0 110.47 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.77 -28.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.331 -1.481 . . . . 0.0 108.704 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -60.94 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.309 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -58.76 -46.74 86.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 0.0 111.191 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 70' ' ' TYR . 11.6 t -69.9 -36.13 75.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.706 -1.246 . . . . 0.0 110.308 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.426 ' N ' HG23 ' B' ' 74' ' ' THR . 77.9 p -65.51 -27.08 68.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -0.993 . . . . 0.0 110.924 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.423 ' CG ' ' OE1' ' B' ' 33' ' ' GLN . 55.0 m80 -72.22 151.18 92.29 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.8 -1.187 . . . . 0.0 109.559 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.87 -5.12 15.52 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.632 2.221 . . . . 0.0 112.517 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' B' ' 82' ' ' PHE . 5.6 tp -73.22 -28.67 62.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.323 -0.861 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 83' ' ' SER . 11.0 t-160 -82.56 -40.69 20.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.031 -1.043 . . . . 0.0 110.226 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.45 -61.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.33 -38.02 62.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.642 ' CZ ' ' ND2' ' B' ' 29' ' ' ASN . 8.2 m-85 -74.39 -33.54 63.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 109.873 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.438 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.1 t -61.32 -44.08 97.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.0 110.084 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.89 96.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.001 -1.062 . . . . 0.0 108.685 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.72 -43.13 76.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.45 -31.58 0.72 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.542 ' O ' ' N ' ' B' ' 89' ' ' VAL . 22.0 m -80.36 -62.2 1.75 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.18 -21.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.754 -0.591 . . . . 0.0 110.078 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.4 m -114.32 7.36 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.224 -0.922 . . . . 0.0 110.83 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 61.8 mt -123.5 157.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.659 -1.276 . . . . 0.0 110.488 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 22.2 t70 -108.33 -30.45 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -145.63 142.97 29.56 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.472 ' O ' HG23 ' B' ' 93' ' ' ILE . 4.0 tp -125.38 123.51 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.535 -1.353 . . . . 0.0 109.753 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 t -125.99 131.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.609 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.3 OUTLIER -138.32 133.25 32.78 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.207 -1.558 . . . . 0.0 111.707 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.438 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.4 OUTLIER -121.07 126.7 50.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.695 -0.628 . . . . 0.0 109.308 178.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 65.1 t0 -124.8 130.34 52.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 108.943 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.658 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 0.1 OUTLIER -157.49 124.15 2.57 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.048 -1.033 . . . . 0.0 110.539 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.658 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 79.7 Cg_exo -44.85 133.73 10.57 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.179 1.919 . . . . 0.0 112.274 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' B' ' 4' ' ' SER . 37.1 t -110.44 133.2 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -110.74 94.19 4.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.448 -0.783 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.37 69.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.07 -1.018 . . . . 0.0 109.558 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.686 HG23 ' O ' ' B' ' 103' ' ' VAL . 21.7 m -151.44 110.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 0.0 109.246 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.637 ' C ' ' H ' ' B' ' 106' ' ' SER . 24.7 mmtp -125.45 1.39 7.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 109.381 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.48 -23.41 0.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.938 . . . . 0.0 108.94 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 104' ' ' LYS . 1.8 m 61.22 54.39 3.26 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.643 HG12 HG12 ' B' ' 108' ' ' VAL . 5.2 t -142.16 -123.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.938 HG13 ' H ' ' B' ' 109' ' ' ALA . 2.8 p -139.97 -103.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.474 -0.766 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . 0.938 ' H ' HG13 ' B' ' 108' ' ' VAL . . . -136.42 157.28 47.16 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.427 HG22 ' H ' ' B' ' 110' ' ' THR . 0.1 OUTLIER -72.48 154.68 91.64 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 120.926 -1.109 . . . . 0.0 109.583 -179.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 C-N-CA 122.786 2.324 . . . . 0.0 112.223 179.641 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.719 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 24.1 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 76.9 -155.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 109.339 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER 73.09 -39.61 0.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.126 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.518 ' N ' HG22 ' A' ' 3' ' ' THR . 75.1 m -91.64 -132.13 0.12 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.02 177.13 20.82 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.332 -1.413 . . . . 0.0 109.655 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -114.17 131.77 56.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -107.03 137.63 44.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.908 -1.12 . . . . 0.0 112.827 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -129.95 129.13 43.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -134.33 145.04 48.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.766 -1.209 . . . . 0.0 109.498 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.3 p -126.04 133.55 68.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.436 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.28 128.89 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 57' ' ' THR . 11.5 m -139.0 161.85 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 117.779 -1.568 . . . . 0.0 113.053 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 14' ' ' PHE . 18.3 tptm -125.2 152.22 44.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.455 ' N ' ' HG3' ' A' ' 13' ' ' LYS . 41.6 p90 -111.04 152.55 26.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.857 -1.152 . . . . 0.0 111.574 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -127.5 -24.71 3.28 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 63.2 tt0 -89.7 -53.61 4.44 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.4 t0 147.57 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 29.2 m -54.84 111.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.095 0.95 . . . . 0.0 112.889 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.698 ' H ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.07 86.41 5.53 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.5 m -57.82 -33.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.551 -0.718 . . . . 0.0 110.456 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -66.19 -37.57 85.93 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -70.8 -35.85 72.73 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.27 -40.82 89.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.22 -35.79 60.32 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HA ' ' HZ3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -56.94 -30.12 63.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -76.68 -44.93 14.13 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 tt -49.47 -56.34 10.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.568 -0.96 . . . . 0.0 108.835 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 8.0 pt-20 -51.49 -35.44 40.13 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 51.7 m-20 -67.2 -46.58 73.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 4.1 mm? -47.71 -51.43 21.97 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' SER . 53.6 t -48.91 -34.12 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.26 -0.9 . . . . 0.0 108.888 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 8.3 m -45.15 -50.24 11.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.79 -1.55 2.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.475 -0.766 . . . . 0.0 111.419 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 36' ' ' THR . 6.3 mt -112.37 34.06 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 119.997 -1.689 . . . . 0.0 110.626 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -56.31 -10.48 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.577 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.2 t -85.88 -1.57 57.4 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.03 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' C ' ' O ' ' A' ' 36' ' ' THR . 35.4 m 35.6 39.96 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.034 -1.041 . . . . 0.0 109.167 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' OG ' ' A' ' 39' ' ' SER . 59.2 mttt -116.87 43.21 2.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 38.6 m -174.27 175.07 2.73 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' C ' ' CD ' ' A' ' 41' ' ' GLU . 77.3 m-85 -147.95 157.18 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.524 -1.36 . . . . 0.0 112.002 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' CD ' ' C ' ' A' ' 40' ' ' PHE . 58.7 mp0 -156.28 123.85 5.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.452 0.644 . . . . 0.0 110.172 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.52 172.25 9.85 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.97 155.56 21.04 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.798 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.582 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 76.6 mm-40 -149.12 136.65 20.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -1.127 . . . . 0.0 109.345 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.528 ' OD1' ' ND1' ' A' ' 58' ' ' HIS . 88.6 m-20 -111.43 142.87 43.12 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HZ1' ' C ' ' A' ' 58' ' ' HIS . 9.9 pttm -141.54 109.39 5.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.369 -1.457 . . . . 0.0 109.826 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -147.0 45.33 1.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.679 -0.638 . . . . 0.0 109.305 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 49' ' ' HIS . 10.1 t -133.16 124.44 27.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.119 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.425 ' CD2' HD12 ' A' ' 52' ' ' LEU . 58.1 m-70 60.97 116.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -60.34 -38.28 83.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.364 -0.835 . . . . 0.0 110.827 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.5 ptt? -71.18 -35.53 71.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.031 -1.043 . . . . 0.0 110.729 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 54' ' ' GLN . 26.5 mt -80.68 -58.27 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.806 -1.184 . . . . 0.0 109.292 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.6 ptt180 -63.53 14.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.242 -0.911 . . . . 0.0 111.209 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 52' ' ' LEU . 24.9 mt-30 43.56 4.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.789 -1.194 . . . . 0.0 110.187 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 84.5 -16.94 32.32 Favored Glycine 0 N--CA 1.498 2.809 0 O-C-N 121.478 -0.764 . . . . 0.0 112.844 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.482 ' CE2' ' NZ ' ' A' ' 92' ' ' LYS . 48.2 m-85 -61.94 -134.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.253 -1.733 . . . . 0.0 109.998 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 12' ' ' VAL . 4.6 t -162.89 -34.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.284 -0.885 . . . . 0.0 111.027 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.658 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 8.5 t60 -168.47 153.59 6.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 110.125 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.658 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -142.56 169.1 18.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.385 -0.822 . . . . 0.0 109.283 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.653 ' CZ ' ' NE2' ' A' ' 58' ' ' HIS . 90.0 m-85 -132.06 128.43 38.21 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.415 -0.803 . . . . 0.0 109.083 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -100.18 99.76 10.5 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -103.07 123.08 45.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.766 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.9 m -123.12 145.62 48.43 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' ASN . 92.2 m-85 -120.92 120.33 35.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.722 -1.237 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -50.92 -24.46 3.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 64' ' ' PHE . 42.2 t-20 -171.26 171.26 5.71 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -58.91 -20.42 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 111.446 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -58.67 -41.95 87.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.835 -1.166 . . . . 0.0 110.574 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.68 -32.93 66.93 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.484 ' O ' HG22 ' A' ' 74' ' ' THR . 78.5 t80 -66.86 -44.11 81.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.927 . . . . 0.0 110.538 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.322 -1.486 . . . . 0.0 108.649 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.91 2.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.349 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -50.57 -34.78 27.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -0.871 . . . . 0.0 111.182 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.51 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.7 t -85.63 -30.15 23.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.824 -1.172 . . . . 0.0 110.294 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 t -67.41 16.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.126 -0.984 . . . . 0.0 110.971 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.474 ' H ' ' C ' ' A' ' 74' ' ' THR . 56.1 m80 -133.06 152.05 79.0 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 0.0 109.602 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.84 1.44 8.12 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.669 2.246 . . . . 0.0 112.507 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.26 -31.77 72.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.369 -0.832 . . . . 0.0 111.256 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 83' ' ' SER . 75.2 t60 -84.85 -31.84 23.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.117 -0.989 . . . . 0.0 110.237 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.13 -62.08 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.993 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.1 -42.46 72.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -75.13 -32.91 61.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 79' ' ' HIS . 13.7 t -63.25 -42.92 99.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.158 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.34 99.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.978 -1.076 . . . . 0.0 108.686 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -65.21 -41.8 94.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -44.66 -31.13 1.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' VAL . 18.7 m -81.68 -63.14 1.45 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -41.18 -28.74 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.718 -0.614 . . . . 0.0 110.057 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 85' ' ' ALA . 5.3 m -103.99 6.95 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.122 -0.986 . . . . 0.0 110.848 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 91' ' ' ASP . 28.4 mm -129.57 161.92 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.64 -1.287 . . . . 0.0 110.436 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.559 ' N ' HG22 ' A' ' 90' ' ' ILE . 61.4 t0 -121.85 -30.01 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.482 ' NZ ' ' CE2' ' A' ' 56' ' ' PHE . 18.1 ttpt -131.04 129.06 41.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' ILE . 3.4 tp -123.69 121.44 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.643 -1.286 . . . . 0.0 109.799 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.435 ' C ' HD12 ' A' ' 95' ' ' LEU . 7.5 t -131.17 134.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.823 ' N ' HD12 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -143.17 141.27 31.1 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.273 -1.517 . . . . 0.0 111.755 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -117.93 118.92 33.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.649 -0.657 . . . . 0.0 109.311 177.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 39.3 p30 -128.26 136.46 51.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.059 -1.026 . . . . 0.0 108.983 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' B' ' 45' ' ' ASP . 9.3 p90 -172.48 156.14 3.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 110.481 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.19 124.87 15.16 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.293 1.995 . . . . 0.0 112.187 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.5 t -109.66 136.05 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.985 . . . . 0.0 110.022 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.58 104.02 9.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.501 -0.75 . . . . 0.0 109.612 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' HB1' ' HZ2' ' A' ' 104' ' ' LYS . . . -167.46 160.28 13.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.001 . . . . 0.0 109.579 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.02 -10.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -0.778 . . . . 0.0 109.238 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.802 ' C ' ' H ' ' A' ' 106' ' ' SER . 3.7 mmpp? 54.94 -145.72 0.61 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.322 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.53 -26.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 108.904 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.802 ' H ' ' C ' ' A' ' 104' ' ' LYS . 75.2 m -61.62 124.64 21.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.361 -0.837 . . . . 0.0 109.36 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.7 p -129.71 140.45 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.672 ' O ' HG22 ' A' ' 108' ' ' VAL . 2.3 p 160.97 77.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.518 -0.739 . . . . 0.0 109.401 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.1 116.77 23.66 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 p -70.35 150.89 95.81 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 120.898 -1.126 . . . . 0.0 109.675 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 122.873 2.382 . . . . 0.0 112.231 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.712 ' O ' ' HB3' ' B' ' 2' ' ' ALA . 24.1 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.324 0.583 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' B' ' 1' ' ' MET . . . 76.8 -155.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 109.313 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.528 HG22 ' N ' ' B' ' 4' ' ' SER . 0.4 OUTLIER 73.09 -39.68 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.141 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.528 ' N ' HG22 ' B' ' 3' ' ' THR . 74.9 m -91.66 -132.25 0.12 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.03 176.75 21.07 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.442 -1.361 . . . . 0.0 109.727 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -113.85 131.99 56.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.301 -1.117 . . . . 0.0 108.029 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -107.41 137.5 45.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.988 -1.07 . . . . 0.0 112.809 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -130.03 129.18 43.34 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -134.36 145.03 48.6 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.702 -1.248 . . . . 0.0 109.53 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 10' ' ' VAL . 12.2 p -126.09 133.69 68.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.63 -0.669 . . . . 0.0 109.481 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.403 HG12 ' CD2' ' B' ' 56' ' ' PHE . 0.9 OUTLIER -117.45 128.63 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.5 ' O ' HG22 ' B' ' 57' ' ' THR . 11.3 m -138.92 161.56 29.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.741 -1.584 . . . . 0.0 113.026 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' B' ' 14' ' ' PHE . 18.2 tptm -124.73 152.34 43.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.452 ' N ' ' HG3' ' B' ' 13' ' ' LYS . 41.5 p90 -111.16 152.42 27.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.818 -1.176 . . . . 0.0 111.589 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -127.46 -24.73 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 62.8 tt0 -89.77 -53.64 4.42 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.5 t0 147.5 69.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 28.3 m -54.77 111.32 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.11 0.957 . . . . 0.0 112.857 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.704 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.4 86.13 5.78 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.32 -33.51 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.554 -0.716 . . . . 0.0 110.443 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.19 -37.77 86.41 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -70.54 -35.97 73.43 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -62.28 -40.71 88.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 tp -53.26 -35.84 60.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' B' ' 28' ' ' GLU . 0.0 OUTLIER -56.94 -30.01 63.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -76.76 -44.78 14.15 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' B' ' 30' ' ' LEU . 1.2 tt -49.52 -56.37 10.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.5 -1.0 . . . . 0.0 108.824 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 8.1 pt-20 -51.49 -35.52 40.54 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 51.6 m-20 -67.17 -46.54 73.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 4.1 mm? -47.72 -51.39 22.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 32' ' ' SER . 52.1 t -48.98 -34.13 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.251 -0.906 . . . . 0.0 108.824 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 7.3 m -45.27 -49.95 12.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -64.79 -1.62 2.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.503 -0.748 . . . . 0.0 111.553 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.581 ' C ' ' N ' ' B' ' 36' ' ' THR . 6.1 mt -112.32 34.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.079 -1.638 . . . . 0.0 110.625 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -56.54 -10.61 1.01 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.581 ' N ' ' C ' ' B' ' 34' ' ' ILE . 1.2 t -85.81 -1.84 57.64 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.4 m 35.97 39.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.053 -1.029 . . . . 0.0 109.23 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.54 ' O ' ' OG ' ' B' ' 39' ' ' SER . 58.5 mttt -116.72 43.33 2.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.54 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 38.2 m -174.17 175.48 2.69 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.492 ' C ' ' CD ' ' B' ' 41' ' ' GLU . 77.1 m-85 -148.18 157.4 43.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.531 -1.356 . . . . 0.0 111.959 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.492 ' CD ' ' C ' ' B' ' 40' ' ' PHE . 58.5 mp0 -156.48 123.82 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.439 0.638 . . . . 0.0 110.194 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -125.5 172.11 9.96 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.74 155.54 20.97 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.768 -1.682 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.577 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 76.7 mm-40 -149.19 136.61 20.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.156 -1.202 . . . . 0.0 109.392 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.534 ' OD1' ' ND1' ' B' ' 58' ' ' HIS . 90.4 m-20 -111.51 142.8 43.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.513 ' HZ1' ' C ' ' B' ' 58' ' ' HIS . 10.0 pttm -141.6 109.33 5.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.419 -1.426 . . . . 0.0 109.785 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -146.98 45.46 1.17 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.625 -0.672 . . . . 0.0 109.293 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' B' ' 49' ' ' HIS . 10.0 t -133.11 124.42 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.183 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.428 ' CD2' HD12 ' B' ' 52' ' ' LEU . 58.2 m-70 60.88 116.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.166 -0.959 . . . . 0.0 109.664 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -60.93 -38.07 84.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.747 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -71.02 -35.5 72.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.753 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' B' ' 54' ' ' GLN . 26.5 mt -80.93 -58.42 3.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.704 -1.247 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.756 ' O ' ' N ' ' B' ' 55' ' ' GLY . 17.3 ptt180 -63.33 14.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 0.0 111.222 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' B' ' 52' ' ' LEU . 24.7 mt-30 43.76 4.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.814 -1.179 . . . . 0.0 110.157 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 84.71 -16.91 33.51 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.357 -0.84 . . . . 0.0 112.861 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.486 ' CE2' ' NZ ' ' B' ' 92' ' ' LYS . 47.9 m-85 -62.08 -134.08 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.303 -1.704 . . . . 0.0 109.884 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.5 HG22 ' O ' ' B' ' 12' ' ' VAL . 4.6 t -163.01 -34.39 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.249 -0.907 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.671 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 8.0 t60 -168.68 153.67 6.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.846 -1.159 . . . . 0.0 110.164 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.671 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -142.57 169.08 18.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.483 -0.761 . . . . 0.0 109.262 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.656 ' CZ ' ' NE2' ' B' ' 58' ' ' HIS . 89.8 m-85 -131.98 128.5 38.53 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.48 -0.762 . . . . 0.0 109.112 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 30.0 t -100.29 99.59 10.28 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 64.1 mtt -103.07 123.08 45.96 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.179 -0.95 . . . . 0.0 110.771 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 46.3 m -123.0 145.83 48.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -121.14 120.27 34.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.744 -1.223 . . . . 0.0 110.048 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -51.06 -24.47 3.9 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -171.07 171.55 5.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -59.29 -20.23 52.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 0.0 111.363 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -58.8 -41.74 87.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.804 -1.185 . . . . 0.0 110.583 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.91 -33.11 65.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.473 ' O ' HG22 ' B' ' 74' ' ' THR . 78.6 t80 -66.56 -44.31 82.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.941 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.75 -28.8 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.426 -1.421 . . . . 0.0 108.731 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.12 -60.89 2.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -50.29 -35.32 26.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.258 -0.901 . . . . 0.0 111.161 -177.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.9 t -85.21 -30.44 23.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.721 -1.237 . . . . 0.0 110.353 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -67.18 16.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.115 -0.991 . . . . 0.0 110.97 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.483 ' H ' ' C ' ' B' ' 74' ' ' THR . 56.3 m80 -133.48 152.28 78.88 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.813 -1.179 . . . . 0.0 109.602 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.15 1.64 8.05 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.697 2.264 . . . . 0.0 112.445 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.5 -31.66 71.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.408 -0.808 . . . . 0.0 111.231 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' B' ' 83' ' ' SER . 75.8 t60 -84.98 -31.69 23.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.1 . . . . 0.0 110.312 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.31 -61.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -55.33 -42.78 74.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 109.573 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -74.83 -32.85 62.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 79' ' ' HIS . 13.7 t -63.41 -43.05 98.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.21 98.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 108.698 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -65.64 -41.57 92.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.468 ' O ' HG12 ' B' ' 90' ' ' ILE . 1.0 OUTLIER -44.87 -31.16 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.418 ' O ' ' C ' ' B' ' 88' ' ' ALA . 18.4 m -81.47 -63.08 1.47 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -41.0 -29.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.657 -0.652 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.612 HG22 ' O ' ' B' ' 85' ' ' ALA . 5.3 m -103.83 7.21 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.139 -0.976 . . . . 0.0 110.805 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.573 HG22 ' N ' ' B' ' 91' ' ' ASP . 28.0 mm -129.64 161.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.605 -1.309 . . . . 0.0 110.419 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.573 ' N ' HG22 ' B' ' 90' ' ' ILE . 62.0 t0 -121.87 -30.0 4.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.486 ' NZ ' ' CE2' ' B' ' 56' ' ' PHE . 17.5 ttpt -131.24 129.01 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.49 HG23 ' O ' ' B' ' 93' ' ' ILE . 3.4 tp -123.58 121.61 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 109.709 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.436 ' C ' HD12 ' B' ' 95' ' ' LEU . 8.0 t -131.36 134.71 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.801 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -143.1 141.18 31.17 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.349 -1.469 . . . . 0.0 111.765 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.425 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.6 OUTLIER -117.76 119.05 33.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.689 -0.632 . . . . 0.0 109.363 177.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' B' ' 97' ' ' ASP . 40.6 p30 -128.51 136.39 50.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.094 -1.003 . . . . 0.0 108.896 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 45' ' ' ASP . 9.3 p90 -172.32 156.23 3.61 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.015 -1.053 . . . . 0.0 110.466 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.29 124.85 15.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.316 2.011 . . . . 0.0 112.248 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.72 136.14 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 110.038 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.55 103.89 9.25 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.569 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . 0.433 ' HB1' ' NZ ' ' B' ' 104' ' ' LYS . . . -167.52 160.23 12.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.559 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.03 -10.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.805 ' C ' ' H ' ' B' ' 106' ' ' SER . 3.7 mmpp? 54.89 -145.6 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.347 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.7 m 56.54 -26.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 108.908 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.805 ' H ' ' C ' ' B' ' 104' ' ' LYS . 75.6 m -61.51 124.87 21.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.567 ' O ' ' HB ' ' B' ' 108' ' ' VAL . 7.3 p -129.98 140.5 48.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.684 HG22 ' O ' ' B' ' 108' ' ' VAL . 2.3 p 160.9 77.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.533 -0.729 . . . . 0.0 109.52 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.84 116.92 23.57 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.3 p -70.6 151.06 95.5 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 120.804 -1.185 . . . . 0.0 109.676 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo . . . . . 0 C--N 1.307 -1.637 0 C-N-CA 122.775 2.317 . . . . 0.0 112.279 179.674 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.25 77.22 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.967 . . . . 0.0 109.319 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 t -100.1 0.45 40.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.162 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -162.85 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.53 174.18 19.82 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.367 -1.397 . . . . 0.0 109.696 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.5 131.52 56.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.313 -1.11 . . . . 0.0 108.014 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 10.6 ttpt -105.29 133.11 50.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.935 -1.103 . . . . 0.0 112.837 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 97' ' ' ASP . 60.5 m80 -125.6 125.97 44.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.888 -1.894 . . . . 0.0 105.888 175.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -136.0 143.41 44.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.43 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.9 p -127.69 136.69 59.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.637 -0.665 . . . . 0.0 109.486 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.2 128.12 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' A' ' 58' ' ' HIS . 2.2 m -141.08 159.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 117.848 -1.541 . . . . 0.0 113.083 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 91' ' ' ASP . 11.1 mtpt -121.16 153.87 36.96 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.566 ' HB2' ' H ' ' A' ' 18' ' ' THR . 17.1 p90 -102.61 144.03 31.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.818 -1.176 . . . . 0.0 111.604 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -116.03 -29.61 6.27 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.564 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.7 tt0 -88.54 -55.18 3.83 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.564 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 13.6 m-20 152.19 74.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.566 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 39.3 m -62.24 109.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.103 0.954 . . . . 0.0 112.876 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.694 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.14 92.22 5.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 20' ' ' VAL . 8.6 m -57.59 -35.27 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 110.475 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 32.1 p-10 -66.46 -39.58 88.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 110.554 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 96.4 mt-10 -70.67 -32.64 69.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.63 -42.48 83.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.49 -39.26 70.2 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -60.07 -24.73 64.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -82.42 -45.84 6.75 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.455 HD21 ' OE1' ' A' ' 41' ' ' GLU . 2.5 tt -49.05 -52.45 25.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.488 -1.007 . . . . 0.0 108.838 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 18.7 pt-20 -52.83 -40.28 63.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.1 m-20 -58.62 -43.9 89.79 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.694 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -47.33 -46.75 25.7 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' SER . 37.8 t -49.14 -27.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 108.842 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 37.4 t -42.93 -48.16 5.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.63 ' NE2' ' CE1' ' A' ' 76' ' ' HIS . 8.9 mm100 -72.8 -23.25 60.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 111.481 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.76 HG22 ' O ' ' A' ' 34' ' ' ILE . 73.2 mt -82.63 23.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.043 -1.661 . . . . 0.0 110.636 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.63 -10.89 2.53 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 38' ' ' LYS . 43.9 p -79.94 -1.0 37.46 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.6 m 35.4 32.61 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.998 -1.064 . . . . 0.0 109.117 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 36' ' ' THR . 20.1 mtmm -120.02 42.71 2.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' THR . 27.7 t -172.76 171.98 4.26 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -148.83 160.98 42.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.645 -1.284 . . . . 0.0 111.943 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.526 ' C ' ' HZ3' ' B' ' 104' ' ' LYS . 63.2 mt-10 -151.91 116.71 5.14 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.393 0.616 . . . . 0.0 110.2 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.697 ' HE1' HG11 ' B' ' 100' ' ' VAL . 11.4 t-105 -104.66 159.2 15.96 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' HZ2' ' B' ' 104' ' ' LYS . . . -118.81 151.49 17.69 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 118.736 -1.697 . . . . 0.0 110.803 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' B' ' 7' ' ' LYS . 70.9 mt-10 -150.84 133.47 15.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.211 -1.17 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.6 p-10 -155.46 86.56 1.08 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -78.81 155.42 29.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.398 -1.439 . . . . 0.0 109.81 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.4 mt-10 -155.52 59.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.67 -0.644 . . . . 0.0 109.331 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 49' ' ' HIS . 54.6 p -172.37 138.2 0.91 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.131 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 m80 60.82 113.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.14 -0.975 . . . . 0.0 109.688 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -55.44 -44.03 75.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 110.797 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.2 mtt -60.32 -35.74 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.046 -1.034 . . . . 0.0 110.746 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' B' ' 96' ' ' LEU . 12.2 mt -93.3 -28.97 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.74 -1.225 . . . . 0.0 109.283 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.065 ' O ' ' N ' ' A' ' 55' ' ' GLY . 39.6 ttt-85 -79.07 2.86 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.299 -0.876 . . . . 0.0 111.296 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.914 ' NE2' HD11 ' B' ' 96' ' ' LEU . 8.7 mt-30 33.72 2.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.709 -1.244 . . . . 0.0 110.212 -176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 1.065 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 75.54 -24.82 1.43 Allowed Glycine 0 N--CA 1.497 2.739 0 O-C-N 121.379 -0.826 . . . . 0.0 112.877 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.513 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 6.5 m-85 -59.24 -142.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.26 -1.73 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.698 ' HG1' ' CE1' ' A' ' 58' ' ' HIS . 66.4 p -142.71 -48.32 0.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -0.848 . . . . 0.0 110.999 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.698 ' CE1' ' HG1' ' A' ' 57' ' ' THR . 35.7 p-80 -173.6 159.63 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.0 110.105 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.14 172.32 13.61 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.395 -0.815 . . . . 0.0 109.221 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -138.5 133.83 33.17 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.416 -0.803 . . . . 0.0 109.12 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.6 t -110.17 102.22 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.64 125.99 44.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.269 -0.894 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 39' ' ' SER . 31.7 m -120.55 142.83 48.99 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -129.26 130.59 46.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.717 -1.239 . . . . 0.0 110.066 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -55.7 -31.04 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -153.84 160.48 42.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.79 -19.7 43.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.957 . . . . 0.0 111.392 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.55 -39.1 72.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.813 -1.18 . . . . 0.0 110.594 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.65 77.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 74' ' ' THR . 75.7 t80 -69.17 -45.68 69.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.969 . . . . 0.0 110.432 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.81 -28.91 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.355 -1.466 . . . . 0.0 108.645 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.355 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.694 ' CE1' HD11 ' A' ' 30' ' ' LEU . 3.5 t80 -54.46 -32.05 56.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.326 -0.859 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 70' ' ' TYR . 30.9 p -75.42 -31.21 60.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.762 -1.211 . . . . 0.0 110.303 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.7 t -82.34 -0.73 47.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.115 -0.991 . . . . 0.0 110.961 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.63 ' CE1' ' NE2' ' A' ' 33' ' ' GLN . 62.1 m80 -97.8 126.36 41.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.758 -1.214 . . . . 0.0 109.61 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -41.51 -14.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.0 112.418 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.2 tp -68.73 -29.26 67.63 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.395 -0.816 . . . . 0.0 111.228 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.517 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 81.6 t60 -79.88 -42.77 23.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.046 -1.034 . . . . 0.0 110.226 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.38 -60.68 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.005 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.89 -39.2 77.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -73.24 -42.49 62.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.847 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 79' ' ' HIS . 66.8 m -62.17 -39.86 94.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.39 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 108.69 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -70.34 -41.99 72.47 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.894 ' O ' HD13 ' A' ' 90' ' ' ILE . 25.6 t80 -45.96 -30.63 1.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 89' ' ' VAL . 17.6 m -80.77 -62.73 1.58 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -37.93 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.69 -0.631 . . . . 0.0 110.045 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 85' ' ' ALA . 19.4 m -103.84 10.38 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.163 -0.96 . . . . 0.0 110.786 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.894 HD13 ' O ' ' A' ' 86' ' ' PHE . 1.1 mp -119.9 154.5 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.667 -1.271 . . . . 0.0 110.426 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' LYS . 63.8 t0 -101.37 -34.65 9.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.58 148.7 31.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' ILE . 2.9 tp -126.88 125.27 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.619 -1.3 . . . . 0.0 109.786 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.728 HG12 HE21 ' B' ' 54' ' ' GLN . 5.3 t -134.25 136.53 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -138.74 137.91 37.18 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.279 -1.513 . . . . 0.0 111.779 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.921 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -112.13 118.09 34.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.632 -0.667 . . . . 0.0 109.333 176.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 8' ' ' HIS . 56.7 t0 -123.74 126.72 47.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.044 -1.035 . . . . 0.0 108.924 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 99' ' ' PRO . 55.3 t80 -167.86 137.72 2.17 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.019 -1.051 . . . . 0.0 110.487 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 89.0 Cg_exo -47.7 124.45 9.73 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.26 1.973 . . . . 0.0 112.199 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.702 HG11 ' HE1' ' B' ' 42' ' ' TRP . 76.1 t -114.19 140.44 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.939 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -109.81 78.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.437 -0.789 . . . . 0.0 109.617 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.534 ' HB2' ' CZ2' ' B' ' 42' ' ' TRP . . . -49.13 88.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.167 -0.958 . . . . 0.0 109.541 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.671 ' O ' HG23 ' A' ' 103' ' ' VAL . 13.1 m -149.17 116.12 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.828 . . . . 0.0 109.163 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 105' ' ' SER . 5.8 ptmt -176.43 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.362 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 107' ' ' VAL . 0.3 OUTLIER 162.05 -44.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 108.965 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.3 t -64.75 44.33 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.286 -0.884 . . . . 0.0 109.395 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 108' ' ' VAL . 3.5 t -139.77 -135.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.632 ' H ' HG12 ' A' ' 107' ' ' VAL . 11.6 p -149.89 151.16 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 109.487 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.2 115.65 26.86 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.4 m -133.29 73.2 74.43 Favored Pre-proline 0 C--N 1.303 -1.43 0 O-C-N 120.848 -1.158 . . . . 0.0 109.623 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 C--N 1.308 -1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 112.287 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.326 0.584 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.94 77.4 0.31 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.379 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -100.22 0.28 40.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.15 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' H ' ' B' ' 5' ' ' GLY . 15.7 m -162.55 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' B' ' 4' ' ' SER . . . -130.62 174.22 19.84 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.423 -1.37 . . . . 0.0 109.697 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.49 131.45 56.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.272 -1.134 . . . . 0.0 108.013 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 44' ' ' GLU . 10.6 ttpt -105.08 133.14 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.894 -1.129 . . . . 0.0 112.821 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' B' ' 97' ' ' ASP . 60.5 m80 -125.72 126.04 43.97 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.4 tt -136.12 143.43 44.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.836 -1.165 . . . . 0.0 109.45 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 11.8 p -127.62 136.68 59.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.485 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.09 128.17 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.48 ' CG2' ' NE2' ' B' ' 58' ' ' HIS . 2.2 m -141.2 159.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 117.706 -1.598 . . . . 0.0 113.043 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' B' ' 91' ' ' ASP . 11.2 mtpt -121.13 153.81 37.0 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.571 ' HB2' ' H ' ' B' ' 18' ' ' THR . 17.3 p90 -102.61 143.96 31.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.94 -1.1 . . . . 0.0 111.585 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -115.97 -29.58 6.3 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 78.7 tt0 -88.65 -55.07 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 13.6 m-20 152.03 74.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.571 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 39.5 m -62.34 109.56 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.122 0.963 . . . . 0.0 112.862 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.2 92.21 5.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.417 ' H ' HG22 ' B' ' 20' ' ' VAL . 8.6 m -57.71 -35.1 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 110.413 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 31.5 p-10 -66.54 -39.63 88.68 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 110.563 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.622 ' O ' ' HG3' ' B' ' 25' ' ' LYS . 96.4 mt-10 -70.71 -32.6 69.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -68.66 -42.43 83.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -55.6 -39.2 70.43 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' B' ' 22' ' ' GLU . 0.2 OUTLIER -60.02 -24.86 64.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -82.16 -45.93 6.82 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.449 HD21 ' OE1' ' B' ' 41' ' ' GLU . 2.5 tt -49.0 -52.43 25.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.968 . . . . 0.0 108.797 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' B' ' 25' ' ' LYS . 18.6 pt-20 -52.96 -40.24 63.54 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 40.5 m-20 -58.59 -44.01 89.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.1 OUTLIER -47.28 -46.71 25.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' B' ' 32' ' ' SER . 37.6 t -49.16 -27.77 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.91 . . . . 0.0 108.775 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 37.0 t -42.85 -48.29 5.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.63 ' NE2' ' CE1' ' B' ' 76' ' ' HIS . 8.8 mm100 -72.52 -23.45 61.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.461 -0.774 . . . . 0.0 111.509 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.779 HG22 ' O ' ' B' ' 34' ' ' ILE . 73.4 mt -82.57 23.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.009 -1.682 . . . . 0.0 110.558 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.6 -10.91 2.52 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.58 ' O ' ' N ' ' B' ' 38' ' ' LYS . 44.1 p -79.93 -0.93 37.15 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.97 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.7 m 35.43 32.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.177 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' B' ' 36' ' ' THR . 20.1 mtmm -119.93 43.01 2.78 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.4 t -172.98 171.79 4.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -148.92 160.87 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.562 -1.336 . . . . 0.0 112.002 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.507 ' C ' ' HZ3' ' A' ' 104' ' ' LYS . 63.0 mt-10 -151.85 116.7 5.16 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.369 0.604 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.702 ' HE1' HG11 ' A' ' 100' ' ' VAL . 11.4 t-105 -104.62 159.27 15.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.438 ' N ' ' HZ2' ' A' ' 104' ' ' LYS . . . -118.91 151.44 17.68 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 118.695 -1.716 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.528 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 71.7 mt-10 -150.84 133.46 15.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.27 -1.136 . . . . 0.0 109.379 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' B' ' 45' ' ' ASP . 43.1 p-10 -155.47 86.62 1.08 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -78.91 155.35 29.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.365 -1.459 . . . . 0.0 109.872 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.5 mt-10 -155.51 59.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.646 -0.659 . . . . 0.0 109.338 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.415 ' O ' ' O ' ' B' ' 49' ' ' HIS . 54.1 p -172.53 138.04 0.86 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 110.142 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' B' ' 53' ' ' ARG . 43.7 m80 61.03 113.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.684 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -55.33 -44.09 75.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.821 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 64.3 mtt -60.42 -35.56 76.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 12.2 mt -93.46 -28.93 15.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.724 -1.235 . . . . 0.0 109.244 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 1.066 ' O ' ' N ' ' B' ' 55' ' ' GLY . 39.8 ttt-85 -79.07 2.82 19.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.394 -0.816 . . . . 0.0 111.246 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.919 ' OE1' HD21 ' A' ' 96' ' ' LEU . 8.7 mt-30 33.7 2.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.77 -1.206 . . . . 0.0 110.206 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 1.066 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 75.41 -24.76 1.39 Allowed Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.449 -0.782 . . . . 0.0 112.865 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.518 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 6.5 m-85 -59.23 -142.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.292 -1.711 . . . . 0.0 109.928 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.618 ' HG1' ' CE1' ' B' ' 58' ' ' HIS . 64.6 p -142.73 -48.3 0.33 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.618 ' CE1' ' HG1' ' B' ' 57' ' ' THR . 35.8 p-80 -173.72 159.45 3.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.891 -1.131 . . . . 0.0 110.186 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.8 172.37 13.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.477 -0.764 . . . . 0.0 109.283 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -138.54 133.77 33.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.479 -0.763 . . . . 0.0 109.132 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -110.04 102.28 11.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 66.0 mtt -98.68 125.83 44.11 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.198 -0.939 . . . . 0.0 110.782 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.1 m -120.33 142.97 48.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -129.38 130.55 46.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.746 -1.221 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -55.56 -31.17 61.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -153.74 160.64 42.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -58.97 -19.66 45.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 111.421 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.61 -39.02 72.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.839 -1.163 . . . . 0.0 110.611 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.59 77.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.896 ' O ' HG23 ' B' ' 74' ' ' THR . 75.7 t80 -69.07 -45.89 69.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.645 -0.915 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.92 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.354 -1.466 . . . . 0.0 108.745 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.457 -0.777 . . . . 0.0 109.365 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' B' ' 30' ' ' LEU . 3.5 t80 -54.22 -32.16 55.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 111.118 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.896 HG23 ' O ' ' B' ' 70' ' ' TYR . 30.9 p -75.31 -31.34 60.63 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.761 -1.212 . . . . 0.0 110.372 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t -82.21 -0.85 47.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.097 -1.002 . . . . 0.0 110.894 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.63 ' CE1' ' NE2' ' B' ' 33' ' ' GLN . 62.3 m80 -97.66 126.49 40.91 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.829 -1.169 . . . . 0.0 109.595 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -41.64 -14.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.65 2.234 . . . . 0.0 112.454 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' B' ' 76' ' ' HIS . 8.3 tp -68.79 -29.39 67.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.422 -0.799 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.515 ' CE1' ' OG ' ' B' ' 83' ' ' SER . 81.5 t60 -79.59 -42.83 24.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.088 . . . . 0.0 110.324 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.46 -60.69 2.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.981 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.79 -39.38 77.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.245 -0.909 . . . . 0.0 109.616 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -73.04 -42.58 62.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' B' ' 79' ' ' HIS . 66.6 m -62.15 -39.87 94.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.172 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.59 77.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.673 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.652 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -70.22 -41.88 73.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.884 ' O ' HD13 ' B' ' 90' ' ' ILE . 26.2 t80 -46.1 -30.54 1.94 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' B' ' 89' ' ' VAL . 17.6 m -80.77 -62.72 1.59 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -38.07 -29.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.717 -0.615 . . . . 0.0 110.084 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.652 HG22 ' O ' ' B' ' 85' ' ' ALA . 19.5 m -103.99 10.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.225 -0.922 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.884 HD13 ' O ' ' B' ' 86' ' ' PHE . 1.1 mp -119.9 154.54 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.593 -1.317 . . . . 0.0 110.481 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' B' ' 13' ' ' LYS . 64.2 t0 -101.41 -34.75 9.46 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -147.59 148.53 31.23 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.447 ' O ' HG23 ' B' ' 93' ' ' ILE . 2.9 tp -126.82 125.29 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.569 -1.332 . . . . 0.0 109.688 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.743 HG12 HE21 ' A' ' 54' ' ' GLN . 5.1 t -134.17 136.5 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.542 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.1 OUTLIER -138.69 137.98 37.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.359 -1.463 . . . . 0.0 111.854 -178.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.923 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.8 OUTLIER -112.1 118.08 34.39 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 8' ' ' HIS . 56.1 t0 -123.75 126.71 46.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.16 -0.962 . . . . 0.0 108.883 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' B' ' 99' ' ' PRO . 55.9 t80 -167.71 137.79 2.24 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.001 -1.062 . . . . 0.0 110.538 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.525 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 88.6 Cg_exo -47.74 124.49 9.83 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.267 1.978 . . . . 0.0 112.21 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.697 HG11 ' HE1' ' A' ' 42' ' ' TRP . 76.2 t -114.24 140.38 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.99 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -109.86 78.6 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . 0.529 ' HB2' ' CZ2' ' A' ' 42' ' ' TRP . . . -49.06 88.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.096 -1.003 . . . . 0.0 109.581 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.654 HG23 ' O ' ' B' ' 103' ' ' VAL . 13.3 m -149.11 116.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.827 . . . . 0.0 109.153 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' B' ' 105' ' ' SER . 5.9 ptmt -176.5 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 107' ' ' VAL . 0.3 OUTLIER 162.06 -44.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 8.2 t -64.59 44.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.253 -0.905 . . . . 0.0 109.456 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.619 HG12 ' H ' ' B' ' 108' ' ' VAL . 3.5 t -139.8 -135.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.619 ' H ' HG12 ' B' ' 107' ' ' VAL . 11.7 p -149.8 151.31 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -0.795 . . . . 0.0 109.503 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.3 115.6 26.89 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 18.8 m -133.26 73.35 74.31 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.859 -1.15 . . . . 0.0 109.666 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 C--N 1.308 -1.577 0 C-N-CA 122.815 2.344 . . . . 0.0 112.235 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.339 0.59 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.745 ' O ' HG22 ' A' ' 3' ' ' THR . . . 56.89 -148.34 0.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.317 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 81.86 -4.3 1.53 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.163 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.4 t -137.55 -98.38 0.2 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.91 175.77 20.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.722 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.51 128.94 56.59 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -1.115 . . . . 0.0 108.064 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HB2' HG21 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -102.72 131.04 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.947 -1.096 . . . . 0.0 112.857 -177.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -125.22 123.59 39.89 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.4 tt -131.16 140.04 49.87 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.716 -1.24 . . . . 0.0 109.481 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 70.5 t -126.22 132.67 70.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.545 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 59' ' ' ALA . 1.4 t -113.0 130.53 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.18 167.17 27.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.775 -1.57 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 91' ' ' ASP . 2.2 mmmt -137.41 151.24 48.33 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.641 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 7.7 m-85 -108.07 147.3 31.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 111.637 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -127.83 -28.06 2.73 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 75.6 tt0 -87.77 -59.11 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 3.5 m-20 153.14 69.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.641 ' OG1' ' CD1' ' A' ' 14' ' ' PHE . 31.8 m -60.02 111.71 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.063 0.935 . . . . 0.0 112.844 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.743 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -80.3 87.3 5.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 176.197 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.92 -32.6 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 0.0 110.487 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.3 p-10 -65.32 -37.32 86.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 96.3 mt-10 -69.79 -35.31 74.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 23' ' ' ILE . 3.2 mm -62.81 -45.22 99.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -50.24 -37.29 34.92 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -59.9 -36.29 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . -78.82 -42.87 12.2 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -54.38 -59.36 4.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.498 -1.001 . . . . 0.0 108.837 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.28 -34.89 59.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.75 -45.48 92.1 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -50.26 -44.86 53.82 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' ILE . 48.3 t -45.13 -35.41 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.243 -0.91 . . . . 0.0 108.889 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' VAL . 20.1 m -42.2 -45.86 4.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.466 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 22.4 mp0 -70.89 -23.58 62.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.433 -0.792 . . . . 0.0 111.496 176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.543 ' C ' ' H ' ' A' ' 36' ' ' THR . 22.1 mt -85.86 28.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 119.967 -1.708 . . . . 0.0 110.667 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.3 p30 -62.22 -7.2 3.84 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 38' ' ' LYS . 2.0 t -86.44 1.89 49.75 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.971 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' A' ' 36' ' ' THR . 22.5 m 37.45 28.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.083 -1.011 . . . . 0.0 109.198 178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 36' ' ' THR . 78.9 mttt -118.42 39.43 3.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.17 157.03 30.06 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.508 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 99.3 m-85 -143.95 154.0 42.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.624 -1.297 . . . . 0.0 112.013 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 55.5 mp0 -158.83 125.26 4.61 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.379 0.609 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.601 ' HE1' HG11 ' B' ' 100' ' ' VAL . 53.1 t-105 -124.02 174.33 7.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -132.63 153.31 20.58 Favored Glycine 0 N--CA 1.499 2.837 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' O ' ' ND1' ' A' ' 58' ' ' HIS . 72.8 mt-10 -147.48 137.88 23.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.204 -1.174 . . . . 0.0 109.319 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.41 144.18 48.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.568 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -149.13 122.51 9.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.502 -1.374 . . . . 0.0 109.769 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 56' ' ' PHE . 65.1 mm-40 -151.5 45.46 0.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.592 -0.692 . . . . 0.0 109.335 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -124.23 121.87 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.186 -0.946 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.84 119.89 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.16 -0.963 . . . . 0.0 109.658 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.496 ' OD1' ' CZ ' ' A' ' 53' ' ' ARG . 80.9 m-20 -56.38 -41.53 76.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 0.0 110.805 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG2' ' H ' ' A' ' 51' ' ' MET . 5.0 ptp -71.66 -32.01 67.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.084 . . . . 0.0 110.751 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 54' ' ' GLN . 83.7 mt -86.96 -52.54 5.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.157 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.736 ' C ' ' H ' ' A' ' 55' ' ' GLY . 15.3 ptt180 -61.93 7.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 0.0 111.219 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' H ' ' C ' ' A' ' 52' ' ' LEU . 4.7 mm-40 53.5 -8.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.702 -1.249 . . . . 0.0 110.207 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.736 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 86.88 -21.64 18.37 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.437 -0.789 . . . . 0.0 112.846 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.428 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 3.2 m-85 -66.23 -128.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.247 -1.737 . . . . 0.0 109.91 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.418 HG21 ' CE2' ' A' ' 14' ' ' PHE . 4.9 t -164.85 -33.92 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.84 . . . . 0.0 111.002 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.645 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 7.8 t60 -171.77 154.25 3.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.645 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -141.56 171.4 14.11 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.218 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.32 121.26 35.36 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.365 -0.834 . . . . 0.0 109.087 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m -96.71 101.41 13.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 39.4 mtt -109.81 123.4 49.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 110.828 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.0 m -124.38 148.11 47.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.64 156.06 39.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.694 -1.254 . . . . 0.0 110.118 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 48.8 tp10 -82.91 -28.31 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 65' ' ' GLU . 15.3 m120 -164.65 169.23 17.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.5 ' NZ ' ' CB ' ' A' ' 67' ' ' LYS . 8.3 mtmp? -58.9 -18.94 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 111.432 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 25.4 p-10 -59.52 -40.66 87.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.771 -1.205 . . . . 0.0 110.562 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 68' ' ' ASP . . . -71.3 -32.89 64.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' O ' HG22 ' A' ' 74' ' ' THR . 70.5 t80 -67.4 -44.7 78.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.522 -0.987 . . . . 0.0 110.498 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.8 -28.9 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.336 -1.478 . . . . 0.0 108.657 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.88 2.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.261 -0.899 . . . . 0.0 109.345 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.2 -35.49 59.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 111.112 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.2 t -84.23 -30.11 25.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.704 -1.247 . . . . 0.0 110.29 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.6 p -68.52 -29.57 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.965 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' A' ' 78' ' ' LEU . 16.4 m-70 -76.81 127.4 84.11 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 0.0 109.562 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -44.3 -7.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 76' ' ' HIS . 2.4 tp -70.87 -26.19 63.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.351 -0.843 . . . . 0.0 111.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.417 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.5 t60 -80.93 -42.62 21.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.049 . . . . 0.0 110.218 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.772 HG13 ' H ' ' A' ' 81' ' ' GLU . 3.7 p -64.92 -57.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.772 ' H ' HG13 ' A' ' 80' ' ' VAL . 93.2 mt-10 -58.89 -42.73 90.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 81.3 t80 -66.45 -43.36 85.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.863 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -59.89 -33.23 71.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.131 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.63 53.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.935 -1.103 . . . . 0.0 108.681 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -72.22 -43.45 64.43 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.534 ' O ' HD12 ' A' ' 90' ' ' ILE . 26.5 t80 -42.77 -29.02 0.28 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 90' ' ' ILE . 5.8 m -84.52 -61.49 1.78 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.16 -28.73 0.06 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.706 -0.621 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 87' ' ' THR . 8.9 m -97.45 13.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.196 -0.94 . . . . 0.0 110.816 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 86' ' ' PHE . 74.3 mt -123.19 156.03 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.628 -1.295 . . . . 0.0 110.45 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.0 t0 -98.64 -35.4 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' N ' HG22 ' A' ' 90' ' ' ILE . 11.1 pttp -147.63 146.04 29.19 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.7 tp -124.85 126.25 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.62 -1.3 . . . . 0.0 109.727 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.487 HG11 ' NE2' ' B' ' 54' ' ' GLN . 22.6 t -132.07 135.44 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -139.06 134.97 33.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.303 -1.498 . . . . 0.0 111.751 -178.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.6 mp -113.82 119.08 36.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.681 -0.637 . . . . 0.0 109.303 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.37 130.29 50.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.023 -1.048 . . . . 0.0 108.96 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -172.0 140.03 1.1 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.057 -1.027 . . . . 0.0 110.486 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.91 121.38 5.78 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.296 1.998 . . . . 0.0 112.173 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' A' ' 7' ' ' LYS . 65.4 t -109.05 138.11 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.992 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.19 107.55 10.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.376 -0.828 . . . . 0.0 109.639 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -154.88 149.63 26.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.51 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 102' ' ' ALA . 3.2 m -154.91 147.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.247 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -130.27 65.77 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.348 -179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 106' ' ' SER . 23.2 m -51.67 -23.42 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.15 -0.969 . . . . 0.0 108.944 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' SER . 1.4 p 76.22 144.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.388 -0.82 . . . . 0.0 109.336 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.6 t 52.45 67.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 108' ' ' VAL . 13.3 p -145.16 30.65 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.55 -0.719 . . . . 0.0 109.468 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.13 161.14 0.9 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.38 151.99 95.6 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 120.823 -1.173 . . . . 0.0 109.678 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo . . . . . 0 C--N 1.308 -1.599 0 C-N-CA 122.788 2.325 . . . . 0.0 112.26 179.702 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.3 0.572 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.741 ' O ' HG22 ' B' ' 3' ' ' THR . . . 56.95 -148.32 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 109.382 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.741 HG22 ' O ' ' B' ' 2' ' ' ALA . 0.5 OUTLIER 81.78 -3.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 109.09 179.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t -137.73 -98.36 0.19 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.96 175.97 20.27 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.374 -1.393 . . . . 0.0 109.698 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -114.69 129.09 56.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.654 ' HB2' HG21 ' B' ' 100' ' ' VAL . 0.0 OUTLIER -102.97 130.87 50.21 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.319 1.057 . . . . 0.0 112.851 -177.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -124.99 123.59 40.2 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.3 tt -131.14 140.06 49.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.762 -1.211 . . . . 0.0 109.444 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 70.0 t -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.615 -0.678 . . . . 0.0 109.586 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' B' ' 59' ' ' ALA . 1.4 t -113.27 130.41 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.17 167.25 26.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 117.723 -1.591 . . . . 0.0 113.058 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' B' ' 91' ' ' ASP . 2.2 mmmt -137.47 151.01 48.02 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.639 ' CD1' ' OG1' ' B' ' 18' ' ' THR . 7.6 m-85 -107.88 147.37 31.05 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.785 -1.197 . . . . 0.0 111.57 -178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -127.99 -27.76 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 75.2 tt0 -88.19 -58.93 2.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 3.4 m-20 153.07 69.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.639 ' OG1' ' CD1' ' B' ' 14' ' ' PHE . 32.5 m -60.15 111.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.034 0.921 . . . . 0.0 112.927 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.753 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -80.28 87.34 5.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.02 -32.42 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.643 -0.661 . . . . 0.0 110.433 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -65.34 -37.43 87.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.56 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 96.3 mt-10 -69.76 -35.37 74.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' B' ' 26' ' ' GLY . 3.3 mm -62.6 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -50.35 -37.04 34.9 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -60.1 -35.88 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 23' ' ' ILE . . . -79.3 -42.7 11.48 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.434 HD13 ' C ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -54.31 -59.39 4.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.545 -0.973 . . . . 0.0 108.85 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -53.41 -34.89 59.51 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -45.56 91.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 30' ' ' LEU . 0.4 OUTLIER -50.15 -44.99 52.85 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' B' ' 34' ' ' ILE . 48.4 t -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.245 -0.909 . . . . 0.0 108.792 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.433 ' C ' ' O ' ' B' ' 31' ' ' VAL . 20.4 m -42.37 -45.64 4.38 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' B' ' 33' ' ' GLN . 22.3 mp0 -71.1 -23.55 62.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 111.535 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.549 HG22 ' O ' ' B' ' 34' ' ' ILE . 22.2 mt -85.79 28.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.006 -1.684 . . . . 0.0 110.571 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.4 p30 -62.36 -7.14 3.91 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.612 ' O ' ' N ' ' B' ' 38' ' ' LYS . 1.9 t -86.55 2.08 49.37 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.874 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.515 ' C ' ' O ' ' B' ' 36' ' ' THR . 22.5 m 37.47 28.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 109.167 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' B' ' 36' ' ' THR . 78.5 mttt -118.3 39.88 3.32 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.61 156.72 28.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.498 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 99.3 m-85 -143.75 153.83 42.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.497 -1.377 . . . . 0.0 111.946 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.504 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 56.1 mp0 -158.76 125.23 4.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.407 0.622 . . . . 0.0 110.208 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.601 ' HE1' HG11 ' A' ' 100' ' ' VAL . 53.0 t-105 -124.01 174.69 7.44 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.558 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -133.28 152.91 20.55 Favored Glycine 0 N--CA 1.498 2.82 0 C-N-CA 118.684 -1.722 . . . . 0.0 110.839 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.562 ' O ' ' ND1' ' B' ' 58' ' ' HIS . 71.2 mt-10 -147.2 137.87 23.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.46 143.95 48.24 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -148.92 122.84 9.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.386 -1.446 . . . . 0.0 109.816 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' B' ' 56' ' ' PHE . 64.9 mm-40 -151.79 45.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.665 -0.647 . . . . 0.0 109.388 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -124.12 121.7 35.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 110.172 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.92 119.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.484 ' OD1' ' CZ ' ' B' ' 53' ' ' ARG . 79.4 m-20 -56.3 -41.52 76.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.838 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 4.9 ptp -71.8 -31.91 67.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.034 . . . . 0.0 110.726 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' B' ' 54' ' ' GLN . 84.0 mt -86.95 -52.45 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.712 -1.243 . . . . 0.0 109.302 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.698 ' C ' ' H ' ' B' ' 55' ' ' GLY . 15.4 ptt180 -62.02 7.94 0.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 111.307 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' B' ' 52' ' ' LEU . 4.6 mm-40 53.53 -8.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.832 -1.168 . . . . 0.0 110.225 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.698 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 87.12 -21.48 20.17 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.468 -0.77 . . . . 0.0 112.864 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.442 ' O ' ' OE2' ' B' ' 47' ' ' GLU . 3.2 m-85 -66.39 -128.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.278 -1.719 . . . . 0.0 109.915 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.422 HG21 ' CE2' ' B' ' 14' ' ' PHE . 4.8 t -164.46 -34.15 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.276 -0.89 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.648 ' CD2' ' N ' ' B' ' 59' ' ' ALA . 7.9 t60 -171.61 154.56 3.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.803 -1.186 . . . . 0.0 110.231 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.648 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -141.98 171.09 14.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.529 -0.732 . . . . 0.0 109.306 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.02 121.26 35.64 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -96.65 101.48 13.1 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 38.8 mtt -109.9 123.6 49.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 110.782 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 97.1 m -124.71 147.93 48.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.53 156.03 39.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.668 -1.27 . . . . 0.0 110.058 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' B' ' 66' ' ' ASN . 50.2 tp10 -82.7 -28.64 30.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 65' ' ' GLU . 15.6 m120 -164.31 169.74 17.09 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.493 ' NZ ' ' CB ' ' B' ' 67' ' ' LYS . 8.2 mtmp? -59.14 -19.09 41.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.214 -0.929 . . . . 0.0 111.406 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 69' ' ' GLY . 26.5 p-10 -59.51 -40.67 87.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.905 -1.122 . . . . 0.0 110.55 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' B' ' 68' ' ' ASP . . . -71.22 -32.79 65.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.505 ' O ' HG22 ' B' ' 74' ' ' THR . 71.0 t80 -67.41 -44.87 77.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.644 -0.915 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.8 -28.88 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.352 -1.468 . . . . 0.0 108.671 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -60.84 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -35.25 59.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 111.141 -176.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.505 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.2 t -84.51 -30.01 25.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.744 -1.223 . . . . 0.0 110.339 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 95.0 p -68.43 -29.56 68.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.12 -0.988 . . . . 0.0 110.964 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 78' ' ' LEU . 16.4 m-70 -76.97 127.53 83.54 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.4 -7.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.598 2.199 . . . . 0.0 112.48 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' B' ' 76' ' ' HIS . 2.4 tp -70.82 -26.38 63.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.408 -0.808 . . . . 0.0 111.178 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -80.86 -42.7 21.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 110.276 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.77 HG13 ' H ' ' B' ' 81' ' ' GLU . 3.6 p -64.8 -57.61 10.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 110.024 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.77 ' H ' HG13 ' B' ' 80' ' ' VAL . 93.2 mt-10 -58.9 -42.67 90.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.299 -0.876 . . . . 0.0 109.587 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 81.1 t80 -66.48 -43.48 85.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.818 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 26.6 t -59.71 -33.36 71.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.111 -0.993 . . . . 0.0 110.149 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.93 49.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 108.644 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -71.81 -43.54 65.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.548 ' O ' HD12 ' B' ' 90' ' ' ILE . 26.4 t80 -42.75 -29.2 0.29 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.471 ' O ' ' N ' ' B' ' 89' ' ' VAL . 5.4 m -84.32 -61.62 1.76 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.98 -28.67 0.06 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.681 -0.637 . . . . 0.0 110.098 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' B' ' 87' ' ' THR . 9.2 m -97.69 13.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.548 HD12 ' O ' ' B' ' 86' ' ' PHE . 73.4 mt -123.39 156.1 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.651 -1.281 . . . . 0.0 110.437 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' B' ' 13' ' ' LYS . 61.8 t0 -98.54 -35.45 10.23 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.453 ' N ' HG22 ' B' ' 90' ' ' ILE . 11.2 pttp -147.66 145.71 29.04 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.43 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.7 tp -124.46 126.06 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.556 -1.34 . . . . 0.0 109.727 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.485 HG11 ' NE2' ' A' ' 54' ' ' GLN . 22.3 t -131.74 135.68 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.868 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -139.11 135.04 33.69 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.256 -1.527 . . . . 0.0 111.798 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.885 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.7 mp -113.86 119.04 35.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 109.33 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -126.22 130.48 51.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.102 -0.999 . . . . 0.0 108.97 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -171.98 140.08 1.1 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.126 -0.984 . . . . 0.0 110.538 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.86 121.18 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.308 2.005 . . . . 0.0 112.194 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' B' ' 7' ' ' LYS . 63.4 t -108.77 138.29 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 110.037 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.4 107.79 10.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.503 -0.748 . . . . 0.0 109.581 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . 0.486 ' O ' HG13 ' B' ' 103' ' ' VAL . . . -155.13 149.62 26.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.486 HG13 ' O ' ' B' ' 102' ' ' ALA . 3.2 m -155.03 147.72 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.377 -0.827 . . . . 0.0 109.233 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -130.27 65.53 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.373 -179.179 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' B' ' 106' ' ' SER . 24.4 m -51.31 -23.83 4.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' B' ' 105' ' ' SER . 1.4 p 76.53 144.83 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.367 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t 52.53 67.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.636 ' O ' HG22 ' B' ' 108' ' ' VAL . 13.3 p -145.16 30.59 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.52 -0.737 . . . . 0.0 109.524 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.91 161.17 0.82 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.467 HG22 ' H ' ' B' ' 110' ' ' THR . 0.0 OUTLIER -70.4 151.83 95.61 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 120.89 -1.131 . . . . 0.0 109.659 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.721 2.281 . . . . 0.0 112.256 179.735 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 mmm . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.306 0.574 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 3' ' ' THR . . . -139.25 95.41 2.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.675 HG23 ' HB2' ' A' ' 101' ' ' ALA . 1.0 OUTLIER 155.25 -62.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.133 -178.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 3' ' ' THR . 2.5 t 152.35 -100.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 4' ' ' SER . . . -81.09 170.42 52.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.24 132.92 42.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 108.027 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 5.2 ttpm? -100.3 127.01 46.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 112.813 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 62' ' ' MET . 56.4 m80 -117.12 116.46 27.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 6.7 tt -131.59 140.96 49.56 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.734 -1.229 . . . . 0.0 109.408 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.02 138.51 52.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.6 -0.687 . . . . 0.0 109.458 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.13 130.38 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.655 ' HB ' HD12 ' A' ' 90' ' ' ILE . 3.9 m -135.02 148.95 28.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 117.74 -1.584 . . . . 0.0 113.028 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.665 ' HZ2' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -120.15 151.99 38.28 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.616 ' CD2' HG21 ' A' ' 57' ' ' THR . 9.2 p90 -113.32 152.94 29.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.81 -1.181 . . . . 0.0 111.601 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -128.67 -18.05 3.96 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CG ' ' A' ' 17' ' ' ASP . 78.2 mm-40 -90.33 -57.28 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 12.1 m-20 154.09 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 51.7 m -51.59 112.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.098 0.951 . . . . 0.0 112.84 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.569 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.87 90.66 2.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LEU . 29.1 m -62.85 -41.91 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.504 -0.747 . . . . 0.0 110.512 -176.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' HG23 ' A' ' 20' ' ' VAL . 87.1 m-20 -63.43 -45.13 92.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.559 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -70.29 -33.05 71.09 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.34 -40.29 79.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 20' ' ' VAL . 14.5 tp -58.84 -38.77 79.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HG3' HG21 ' B' ' 108' ' ' VAL . 3.5 ttpt -61.68 -35.07 76.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -63.93 -53.55 36.69 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 27' ' ' LEU . 5.8 tt -48.08 -43.84 31.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.511 -0.993 . . . . 0.0 108.813 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -54.71 -46.42 74.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.537 ' ND2' ' CE2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.66 HD11 ' CE1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -47.7 -41.67 23.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.555 HG21 ' HA ' ' B' ' 105' ' ' SER . 19.3 t -54.74 -20.5 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.236 -0.915 . . . . 0.0 108.902 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 74.5 m -44.63 -42.28 7.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.542 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 46.2 mm-40 -83.84 -9.77 58.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 111.398 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 34' ' ' ILE . 45.0 mm -91.23 23.56 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 119.976 -1.702 . . . . 0.0 110.716 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.77 -8.92 1.05 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 37' ' ' VAL . 33.6 p -79.15 -2.82 42.59 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.972 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.614 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.8 m 32.13 41.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.08 -1.012 . . . . 0.0 109.135 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.0 ptmt -122.32 41.93 3.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.569 ' OG ' HD12 ' A' ' 34' ' ' ILE . 87.6 p -173.67 178.18 2.33 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 87.3 m-85 -147.01 155.0 41.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.546 -1.346 . . . . 0.0 111.929 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 46.5 mp0 -152.46 121.18 6.48 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -126.5 168.71 13.87 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.12 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.01 159.28 21.16 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 118.738 -1.696 . . . . 0.0 110.827 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.57 ' H ' ' CE1' ' A' ' 58' ' ' HIS . 49.4 mp0 -147.78 140.59 24.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.331 -1.1 . . . . 0.0 109.392 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 47' ' ' GLU . 62.3 t0 -128.46 155.7 44.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' O ' ' NH2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -60.22 80.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.461 -1.4 . . . . 0.0 109.747 -177.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.3 mt-10 -105.04 42.65 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.67 -0.644 . . . . 0.0 109.272 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.554 ' O ' ' NE ' ' A' ' 53' ' ' ARG . 3.4 m -150.09 179.38 8.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.47 150.01 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 51' ' ' MET . 32.2 p-10 -43.94 -44.05 6.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.787 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.527 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 83.2 mmm -67.19 -28.96 68.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.942 -1.099 . . . . 0.0 110.713 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 95' ' ' LEU . 33.9 mt -98.29 -30.18 12.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.772 -1.205 . . . . 0.0 109.292 -178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.662 ' CG ' ' H ' ' A' ' 55' ' ' GLY . 3.2 ptm180 -86.46 -1.73 57.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.827 . . . . 0.0 111.225 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.5 ' NE2' HG12 ' B' ' 94' ' ' VAL . 6.4 tt0 45.96 10.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.73 -1.231 . . . . 0.0 110.149 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.662 ' H ' ' CG ' ' A' ' 53' ' ' ARG . . . 58.77 -5.16 0.07 OUTLIER Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.424 -0.797 . . . . 0.0 112.89 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 11.8 p90 -57.0 131.11 48.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.204 -1.762 . . . . 0.0 109.93 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.616 HG21 ' CD2' ' A' ' 14' ' ' PHE . 71.3 p -54.15 -48.1 71.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.0 110.995 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.633 ' NE2' ' CE1' ' A' ' 60' ' ' PHE . 23.7 t60 -173.0 159.19 3.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.109 . . . . 0.0 110.165 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.612 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -144.83 169.53 17.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -0.805 . . . . 0.0 109.219 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' NE2' ' A' ' 58' ' ' HIS . 76.6 m-85 -135.12 130.64 35.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.484 -0.76 . . . . 0.0 109.075 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 98.18 8.87 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.511 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.2 mtp -98.9 118.89 36.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.165 -0.96 . . . . 0.0 110.849 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -123.29 142.43 50.95 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -119.94 162.58 18.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.829 -1.17 . . . . 0.0 110.078 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.57 -29.97 29.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -169.76 175.0 5.44 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -58.38 -22.52 54.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 111.415 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.84 -37.56 71.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.809 -1.182 . . . . 0.0 110.617 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.08 76.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.747 ' O ' HG22 ' A' ' 74' ' ' THR . 74.0 t80 -67.14 -44.18 80.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.575 -0.956 . . . . 0.0 110.417 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.76 -28.93 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.38 -1.45 . . . . 0.0 108.696 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . -64.98 -61.0 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CE1' HD11 ' A' ' 30' ' ' LEU . 2.7 t80 -63.73 -60.22 3.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.207 -0.933 . . . . 0.0 111.115 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 70' ' ' TYR . 14.8 t -49.46 -37.22 25.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.752 -1.218 . . . . 0.0 110.357 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 74' ' ' THR . 63.7 p -65.97 -11.95 51.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.118 -0.989 . . . . 0.0 111.014 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 78' ' ' LEU . 65.2 m-70 -92.64 125.99 53.66 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.25 -4.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.675 2.25 . . . . 0.0 112.489 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.3 tp -74.39 -25.87 59.75 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.297 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -77.84 -45.4 24.44 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.086 -1.009 . . . . 0.0 110.247 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.756 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -63.37 -57.94 9.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.993 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.756 ' H ' HG13 ' A' ' 80' ' ' VAL . 84.3 tt0 -53.59 -36.45 61.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CE2' ' ND2' ' A' ' 29' ' ' ASN . 6.4 m-85 -74.39 -36.18 63.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.875 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -62.09 -42.9 99.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.61 -44.14 97.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 108.656 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -68.87 -44.19 73.82 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.482 ' C ' ' O ' ' A' ' 85' ' ' ALA . 2.5 m-85 -43.03 -30.18 0.41 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' VAL . 10.9 m -82.36 -64.17 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -43.3 -24.83 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 110.099 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 85' ' ' ALA . 4.9 m -107.4 9.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 110.723 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.655 HD12 ' HB ' ' A' ' 12' ' ' VAL . 28.9 mm -131.44 164.37 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.6 -1.313 . . . . 0.0 110.504 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 90' ' ' ILE . 52.2 t0 -109.42 -33.41 6.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' NZ ' ' NZ ' ' A' ' 13' ' ' LYS . 29.2 pttt -147.84 147.57 29.94 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.605 HD12 HG12 ' A' ' 12' ' ' VAL . 4.1 tp -128.86 123.81 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.637 -1.289 . . . . 0.0 109.785 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG12 ' NE2' ' B' ' 54' ' ' GLN . 4.7 t -126.7 132.64 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -142.05 138.37 31.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.269 -1.519 . . . . 0.0 111.748 -178.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.875 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -116.5 119.28 35.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.719 -0.613 . . . . 0.0 109.355 177.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.403 ' O ' ' OG ' ' B' ' 48' ' ' SER . 62.2 t0 -111.21 117.5 33.38 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -0.989 . . . . 0.0 108.971 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 99' ' ' PRO . 54.7 t80 -141.37 137.65 16.8 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.01 . . . . 0.0 110.465 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.55 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 31.0 Cg_endo -61.02 127.81 23.42 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.257 1.972 . . . . 0.0 112.229 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.61 117.3 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.009 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.675 ' HB2' HG23 ' A' ' 3' ' ' THR . . . -109.35 95.29 5.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.546 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.422 ' C ' HG13 ' A' ' 103' ' ' VAL . . . -65.45 69.74 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.098 -1.001 . . . . 0.0 109.562 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.9 m -152.88 95.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.243 -178.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' SER . 7.7 ptmm? -175.19 -126.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.396 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.578 ' HA ' HG21 ' B' ' 31' ' ' VAL . 1.5 m 63.96 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 108.899 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' LYS . 4.4 m -115.84 71.04 0.76 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.276 -0.89 . . . . 0.0 109.339 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 108' ' ' VAL . 14.3 p -119.94 -4.9 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.615 ' O ' HG22 ' A' ' 108' ' ' VAL . 9.6 p -176.58 53.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.591 -0.693 . . . . 0.0 109.447 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 108' ' ' VAL . . . -54.24 -177.53 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.5 p -134.55 69.71 72.46 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 120.865 -1.147 . . . . 0.0 109.685 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 C--N 1.308 -1.585 0 C-N-CA 122.795 2.33 . . . . 0.0 112.266 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.4 mmm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' B' ' 3' ' ' THR . . . -139.97 95.08 2.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 109.409 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.665 HG23 ' HB2' ' B' ' 101' ' ' ALA . 1.0 OUTLIER 155.5 -62.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.111 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.631 ' CB ' ' O ' ' B' ' 3' ' ' THR . 2.5 t 152.24 -100.89 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' B' ' 4' ' ' SER . . . -81.19 170.41 52.59 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.02 133.16 42.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.281 -1.129 . . . . 0.0 108.043 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' B' ' 7' ' ' LYS . 5.1 ttpm? -100.51 126.93 46.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.937 -1.102 . . . . 0.0 112.843 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 62' ' ' MET . 56.0 m80 -117.11 116.2 26.86 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 6.8 tt -131.28 141.13 49.93 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.657 -1.277 . . . . 0.0 109.474 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.05 138.64 52.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 130.3 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.657 ' HB ' HD12 ' B' ' 90' ' ' ILE . 3.9 m -134.94 148.77 28.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 117.818 -1.553 . . . . 0.0 113.051 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.64 ' HZ2' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -120.11 151.91 38.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.61 ' CD2' HG21 ' B' ' 57' ' ' THR . 9.4 p90 -113.35 152.96 29.28 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.828 -1.17 . . . . 0.0 111.545 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -128.77 -18.0 3.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.561 ' O ' ' CG ' ' B' ' 17' ' ' ASP . 77.5 mm-40 -90.32 -57.08 2.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.561 ' CG ' ' O ' ' B' ' 16' ' ' GLU . 12.7 m-20 153.73 58.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.447 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 58.6 m -52.45 112.35 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.147 0.975 . . . . 0.0 112.846 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.582 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -75.6 90.46 2.79 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' B' ' 24' ' ' LEU . 29.8 m -62.7 -41.93 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.683 -0.636 . . . . 0.0 110.474 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.524 ' N ' HG23 ' B' ' 20' ' ' VAL . 86.2 m-20 -63.45 -45.01 92.84 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.447 -0.783 . . . . 0.0 110.563 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -70.3 -33.26 71.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mm -69.26 -40.19 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' B' ' 20' ' ' VAL . 14.3 tp -58.99 -38.65 79.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.426 ' HG3' HG21 ' A' ' 108' ' ' VAL . 3.5 ttpt -61.52 -35.03 76.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.44 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -64.44 -53.07 38.08 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.909 -2.077 . . . . 0.0 107.909 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.685 HD23 ' O ' ' B' ' 27' ' ' LEU . 5.8 tt -48.21 -43.97 32.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.577 -0.955 . . . . 0.0 108.799 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -54.49 -46.77 73.51 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' B' ' 82' ' ' PHE . 0.0 OUTLIER -52.79 -41.34 64.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -47.98 -41.35 24.98 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 105' ' ' SER . 19.3 t -54.99 -20.21 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.311 -0.868 . . . . 0.0 108.829 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.47 ' N ' ' O ' ' B' ' 29' ' ' ASN . 73.6 m -44.87 -42.34 7.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.551 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 46.1 mm-40 -83.85 -9.55 58.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.449 -0.782 . . . . 0.0 111.523 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.769 HG22 ' O ' ' B' ' 34' ' ' ILE . 44.9 mm -91.29 23.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.031 -1.668 . . . . 0.0 110.641 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -57.65 -8.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.592 ' O ' ' C ' ' B' ' 37' ' ' VAL . 34.2 p -79.06 -2.68 41.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.984 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.592 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.0 m 32.13 41.84 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.121 -0.987 . . . . 0.0 109.194 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.1 ptmt -122.24 42.15 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.573 ' OG ' HD12 ' B' ' 34' ' ' ILE . 89.2 p -173.82 177.97 2.32 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' B' ' 41' ' ' GLU . 86.5 m-85 -146.91 155.06 42.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.52 -1.362 . . . . 0.0 111.944 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' B' ' 41' ' ' GLU . 46.4 mp0 -152.42 121.11 6.47 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.364 0.602 . . . . 0.0 110.194 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.642 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.7 OUTLIER -126.48 168.83 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.09 159.48 21.22 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.807 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.584 ' H ' ' CE1' ' B' ' 58' ' ' HIS . 49.8 mp0 -148.13 140.65 24.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.407 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' B' ' 47' ' ' GLU . 61.9 t0 -128.49 155.64 44.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.521 ' O ' ' NH2' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -60.17 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.44 -1.413 . . . . 0.0 109.773 -177.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.5 mt-10 -104.65 42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.676 -0.64 . . . . 0.0 109.358 177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.56 ' O ' ' CZ ' ' B' ' 53' ' ' ARG . 3.6 m -150.04 179.58 7.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.139 -0.975 . . . . 0.0 110.243 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -62.62 150.29 41.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.945 . . . . 0.0 109.701 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.3 p-10 -44.14 -43.77 7.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.858 . . . . 0.0 110.8 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.53 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 83.4 mmm -67.57 -28.95 68.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.14 -0.975 . . . . 0.0 110.75 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 95' ' ' LEU . 34.6 mt -98.32 -29.76 12.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.747 -1.221 . . . . 0.0 109.265 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' B' ' 55' ' ' GLY . 3.2 ptm180 -86.89 -1.66 57.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.394 -0.816 . . . . 0.0 111.243 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.502 ' NE2' HG12 ' A' ' 94' ' ' VAL . 6.4 tt0 45.99 10.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.807 -1.183 . . . . 0.0 110.194 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' B' ' 53' ' ' ARG . . . 59.3 -5.81 0.08 OUTLIER Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.428 -0.795 . . . . 0.0 112.881 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' B' ' 56' ' ' PHE . 11.7 p90 -56.64 131.11 47.98 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.259 -1.73 . . . . 0.0 109.899 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.61 HG21 ' CD2' ' B' ' 14' ' ' PHE . 69.9 p -54.19 -47.9 71.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.279 -0.888 . . . . 0.0 110.995 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.64 ' NE2' ' CE1' ' B' ' 60' ' ' PHE . 23.6 t60 -173.13 159.61 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.9 -1.125 . . . . 0.0 110.165 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.623 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -145.39 169.28 18.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.542 -0.724 . . . . 0.0 109.292 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' NE2' ' B' ' 58' ' ' HIS . 76.6 m-85 -134.91 130.64 36.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.512 -0.742 . . . . 0.0 109.081 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -100.28 97.81 8.55 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . 0.515 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.8 mtp -98.62 119.1 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.198 -0.939 . . . . 0.0 110.77 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -123.43 142.63 50.79 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.0 162.99 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 110.038 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -82.98 -29.84 28.69 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -169.73 175.44 5.28 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -58.72 -22.46 57.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 111.45 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -57.08 -37.57 72.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.804 -1.185 . . . . 0.0 110.565 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 -33.1 77.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.748 ' O ' HG22 ' B' ' 74' ' ' THR . 74.5 t80 -67.01 -44.55 80.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.947 . . . . 0.0 110.405 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.81 -28.87 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.329 -1.482 . . . . 0.0 108.669 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.1 -60.91 2.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.673 ' CE1' HD11 ' B' ' 30' ' ' LEU . 2.7 t80 -63.22 -60.48 3.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.267 -0.896 . . . . 0.0 111.136 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.748 HG22 ' O ' ' B' ' 70' ' ' TYR . 14.9 t -49.47 -37.18 25.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 63.9 p -65.92 -12.04 51.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.982 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' B' ' 78' ' ' LEU . 65.2 m-70 -92.6 126.27 52.71 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.898 -1.126 . . . . 0.0 109.544 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -44.6 -4.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.686 2.257 . . . . 0.0 112.424 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.3 tp -74.44 -26.22 59.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.366 -0.834 . . . . 0.0 111.18 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -77.72 -45.25 25.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.95 -1.094 . . . . 0.0 110.321 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.767 HG13 ' N ' ' B' ' 81' ' ' GLU . 7.1 p -63.19 -58.21 8.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.767 ' N ' HG13 ' B' ' 80' ' ' VAL . 84.0 tt0 -53.56 -36.36 61.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' B' ' 29' ' ' ASN . 6.4 m-85 -74.38 -36.4 63.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.872 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 87.5 p -61.79 -43.05 99.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.052 -1.03 . . . . 0.0 110.182 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.97 97.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 108.622 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.632 ' O ' HG22 ' B' ' 89' ' ' VAL . . . -69.13 -43.99 73.28 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.485 ' C ' ' O ' ' B' ' 85' ' ' ALA . 2.5 m-85 -43.22 -30.0 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.6 m -82.48 -64.15 1.23 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -43.26 -24.94 0.1 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.76 -0.588 . . . . 0.0 110.12 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.632 HG22 ' O ' ' B' ' 85' ' ' ALA . 4.9 m -107.34 9.89 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 110.838 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.657 HD12 ' HB ' ' B' ' 12' ' ' VAL . 28.3 mm -131.68 164.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.628 -1.295 . . . . 0.0 110.462 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.628 ' N ' HG22 ' B' ' 90' ' ' ILE . 52.0 t0 -109.28 -33.49 6.83 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.491 ' NZ ' ' HZ2' ' B' ' 13' ' ' LYS . 28.2 pttt -147.86 147.67 30.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.608 HD12 HG12 ' B' ' 12' ' ' VAL . 4.2 tp -128.98 123.67 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.569 -1.332 . . . . 0.0 109.711 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.5 HG12 ' NE2' ' A' ' 54' ' ' GLN . 4.6 t -126.52 132.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.844 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -141.95 138.5 32.0 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.266 -1.521 . . . . 0.0 111.774 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.871 ' N ' HD12 ' B' ' 96' ' ' LEU . 1.0 OUTLIER -116.55 119.27 35.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.708 -0.62 . . . . 0.0 109.334 177.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.408 ' O ' ' OG ' ' A' ' 48' ' ' SER . 62.4 t0 -111.19 117.14 32.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.04 -1.037 . . . . 0.0 108.889 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' B' ' 99' ' ' PRO . 55.6 t80 -140.87 137.89 17.62 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.057 -1.027 . . . . 0.0 110.519 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.553 ' O ' ' CE1' ' B' ' 98' ' ' PHE . 31.3 Cg_endo -61.18 127.91 23.56 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.286 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' B' ' 5' ' ' GLY . 99.2 t -92.76 117.41 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 109.974 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' B' ' 3' ' ' THR . . . -109.45 95.05 5.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 109.609 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . 0.424 ' C ' HG13 ' B' ' 103' ' ' VAL . . . -65.36 70.05 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.784 HG23 ' O ' ' B' ' 103' ' ' VAL . 21.9 m -153.15 95.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' B' ' 106' ' ' SER . 7.6 ptmm? -175.09 -127.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.331 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.555 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.6 m 64.16 -74.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 108.922 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.504 ' N ' ' O ' ' B' ' 104' ' ' LYS . 4.4 m -115.76 70.6 0.75 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.461 HG13 HG12 ' B' ' 108' ' ' VAL . 13.9 p -119.56 -5.05 10.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.632 ' O ' HG22 ' B' ' 108' ' ' VAL . 9.7 p -176.57 53.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 109.569 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' B' ' 108' ' ' VAL . . . -54.15 -177.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 46.6 p -134.45 70.26 72.61 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.846 -1.159 . . . . 0.0 109.678 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.74 2.293 . . . . 0.0 112.267 -179.938 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 64.1 mtt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.283 0.563 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 62.29 38.56 13.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 109.413 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -101.15 -7.82 22.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.111 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.7 t -145.93 -80.91 0.15 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.16 -158.97 7.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -135.76 138.15 42.38 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.164 -1.198 . . . . 0.0 108.09 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.452 ' CD ' ' CZ2' ' B' ' 42' ' ' TRP . 1.1 ttpm? -113.32 141.31 47.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.906 -1.121 . . . . 0.0 112.801 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -130.02 130.05 44.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.3 tt -135.17 144.67 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.7 -1.25 . . . . 0.0 109.485 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.8 p -128.47 135.56 62.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.434 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.38 128.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -137.81 157.0 32.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 117.766 -1.574 . . . . 0.0 112.994 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 91' ' ' ASP . 20.6 tptm -122.34 152.1 40.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' HB2' ' H ' ' A' ' 18' ' ' THR . 29.9 p90 -105.29 147.17 28.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.942 -1.099 . . . . 0.0 111.643 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -120.75 -24.91 5.58 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 95.0 mt-10 -89.38 -54.98 3.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.5 t0 150.58 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.497 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 61.0 m -58.91 110.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.112 0.958 . . . . 0.0 112.851 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.724 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -81.29 92.67 6.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.675 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 20' ' ' VAL . 11.5 m -58.72 -32.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.551 -0.718 . . . . 0.0 110.473 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' GLU . 30.6 p-10 -66.41 -39.2 88.84 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 78.0 mm-40 -67.74 -34.2 76.38 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.71 -44.36 93.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.6 ' CD2' ' H ' ' B' ' 110' ' ' THR . 7.4 tp -53.89 -37.15 63.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.85 -32.12 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 30' ' ' LEU . . . -81.9 -43.76 8.08 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -56.67 -58.27 8.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.482 -1.011 . . . . 0.0 108.777 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 29' ' ' ASN . 9.3 pt-20 -51.68 -43.95 62.92 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.634 HD21 HD11 ' A' ' 78' ' ' LEU . 13.7 t30 -61.56 -43.38 98.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.755 HD22 HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -49.95 -43.73 50.24 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.027 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 34' ' ' ILE . 39.8 t -50.8 -27.86 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.315 -0.866 . . . . 0.0 108.874 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' VAL . 46.9 t -40.61 -42.89 1.79 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.528 ' OE1' ' CD2' ' A' ' 76' ' ' HIS . 29.9 mm100 -75.75 -23.15 55.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.495 -0.753 . . . . 0.0 111.462 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 34' ' ' ILE . 30.9 mm -85.69 25.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.068 -1.645 . . . . 0.0 110.648 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 36' ' ' THR . 54.3 p30 -60.74 -9.01 3.39 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 38' ' ' LYS . 59.5 p -73.88 -3.2 27.37 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.896 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 36' ' ' THR . 30.5 m 35.65 30.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.16 -0.963 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 36' ' ' THR . 75.1 mttt -118.94 39.5 3.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 t -170.9 170.92 6.18 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -147.42 157.48 43.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.595 -1.316 . . . . 0.0 112.006 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.562 ' O ' ' NZ ' ' B' ' 104' ' ' LYS . 58.1 mt-10 -151.59 120.26 6.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.417 0.627 . . . . 0.0 110.169 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.709 ' CD1' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.49 164.55 24.58 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.709 ' N ' ' CD1' ' A' ' 42' ' ' TRP . . . -134.45 174.1 21.13 Favored Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.733 -1.699 . . . . 0.0 110.766 -178.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -152.69 141.21 20.77 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -1.174 . . . . 0.0 109.371 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -105.12 140.72 37.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -135.24 103.59 5.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.374 -1.454 . . . . 0.0 109.749 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -146.97 25.6 1.13 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.651 -0.656 . . . . 0.0 109.312 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.476 ' H ' ' CB ' ' A' ' 53' ' ' ARG . 11.6 p -89.09 -106.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 53' ' ' ARG . 76.6 m80 -92.61 148.07 22.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 109.664 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 51' ' ' MET . 31.5 p-10 -53.45 -43.07 67.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.365 -0.834 . . . . 0.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.522 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.9 tpt -75.42 -32.05 60.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.0 110.745 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 95' ' ' LEU . 48.9 mt -90.14 -54.53 3.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.732 -1.23 . . . . 0.0 109.305 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.76 ' C ' ' H ' ' A' ' 55' ' ' GLY . 12.5 ptt180 -62.59 1.23 0.39 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.492 ' NE2' HG11 ' B' ' 94' ' ' VAL . 0.4 OUTLIER 56.11 -17.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.803 -1.185 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.76 ' H ' ' C ' ' A' ' 53' ' ' ARG . . . 88.05 -23.16 15.29 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.511 -0.743 . . . . 0.0 112.905 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' GLY . 3.5 m-85 -61.23 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.212 -1.758 . . . . 0.0 109.903 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 58' ' ' HIS . 3.2 t -161.5 -35.99 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.315 -0.866 . . . . 0.0 110.996 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.667 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 35.1 t-80 -166.89 149.46 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.937 -1.102 . . . . 0.0 110.19 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -142.72 167.63 21.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 58' ' ' HIS . 91.3 m-85 -138.15 134.87 35.12 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.494 -0.754 . . . . 0.0 109.073 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.546 ' OG ' ' CZ3' ' A' ' 42' ' ' TRP . 1.4 m -116.45 104.64 11.64 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.7 mtt -95.32 125.45 39.96 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.143 -0.973 . . . . 0.0 110.79 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 m -118.89 140.87 49.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -127.2 128.1 45.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.742 -1.224 . . . . 0.0 110.036 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -50.96 -26.36 5.85 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -171.43 172.9 4.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.9 -19.17 60.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 111.361 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.92 -40.71 89.8 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.859 -1.15 . . . . 0.0 110.613 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.84 -29.25 59.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 74' ' ' THR . 73.5 t80 -66.1 -42.59 89.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.917 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.78 -28.92 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.407 -1.433 . . . . 0.0 108.669 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.96 2.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.304 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -53.45 -39.39 64.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 111.159 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 70' ' ' TYR . 5.0 t -79.78 -29.62 40.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.746 -1.221 . . . . 0.0 110.338 -177.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -65.44 -25.56 67.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.0 111.023 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' A' ' 78' ' ' LEU . 56.8 t-80 -79.04 125.33 83.95 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.833 -1.167 . . . . 0.0 109.661 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.43 -6.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.658 2.239 . . . . 0.0 112.439 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.755 HD23 HD22 ' A' ' 30' ' ' LEU . 6.1 tp -75.84 -25.38 56.19 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 111.203 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' A' ' 73' ' ' PHE . 2.6 t60 -76.57 -43.0 40.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.018 -1.051 . . . . 0.0 110.241 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.733 HG13 ' N ' ' A' ' 81' ' ' GLU . 11.3 p -64.4 -54.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.733 ' N ' HG13 ' A' ' 80' ' ' VAL . 78.7 mm-40 -50.43 -30.83 13.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.644 178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' CD1' ' A' ' 86' ' ' PHE . 4.2 m-85 -72.97 -37.34 67.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.879 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.6 m -63.46 -42.33 98.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.0 110.14 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.48 67.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.965 -1.084 . . . . 0.0 108.751 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -67.0 -43.43 82.93 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 82' ' ' PHE . 2.5 m-85 -45.0 -31.06 1.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 89' ' ' VAL . 23.1 m -78.94 -63.31 1.45 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.03 -24.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.72 -0.612 . . . . 0.0 110.064 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.4 m -111.92 6.91 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.18 -0.95 . . . . 0.0 110.803 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 34.5 mt -120.11 154.64 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.647 -1.283 . . . . 0.0 110.444 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' LYS . 61.9 t0 -103.52 -31.42 9.96 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' NZ ' ' CE1' ' A' ' 56' ' ' PHE . 37.9 pttt -150.44 149.3 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.8 tp -125.24 121.94 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.615 -1.303 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.496 HG11 ' NE2' ' B' ' 54' ' ' GLN . 48.8 t -129.76 133.52 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -139.49 136.86 34.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.241 -1.537 . . . . 0.0 111.752 -178.145 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.95 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -115.94 121.44 42.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.655 -0.653 . . . . 0.0 109.383 176.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 7' ' ' LYS . 68.2 t0 -123.12 128.35 49.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.017 . . . . 0.0 108.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -164.08 139.68 4.93 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.096 -1.003 . . . . 0.0 110.505 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.03 120.68 4.4 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.292 1.995 . . . . 0.0 112.202 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -105.55 135.73 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.93 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.78 75.51 0.93 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.87 113.3 24.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 104' ' ' LYS . 16.9 m -134.42 -54.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.171 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.694 ' H ' HG23 ' A' ' 103' ' ' VAL . 26.0 mmtm 60.19 -129.75 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 0.0 109.339 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 104' ' ' LYS . 0.9 OUTLIER 72.52 -18.54 0.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.181 -0.949 . . . . 0.0 108.978 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 104' ' ' LYS . 2.0 t 168.75 -42.04 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.348 -0.845 . . . . 0.0 109.346 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 109' ' ' ALA . 53.8 t -145.11 145.25 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 108' ' ' VAL . 1.9 p -122.13 13.49 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.59 ' H ' HG12 ' A' ' 107' ' ' VAL . . . -58.07 136.79 57.23 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.59 ' H ' ' CD2' ' B' ' 24' ' ' LEU . 25.8 m -132.58 71.44 78.84 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 120.841 -1.162 . . . . 0.0 109.636 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo . . . . . 0 C--N 1.308 -1.595 0 C-N-CA 122.805 2.336 . . . . 0.0 112.178 -179.905 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' B' ' 2' ' ' ALA . 63.9 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' B' ' 1' ' ' MET . . . 62.7 38.79 11.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 0.0 109.355 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 5.5 t -101.34 -7.84 22.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.0 109.086 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t -145.94 -81.12 0.15 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.98 -158.47 7.6 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.694 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -136.36 137.68 40.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.279 -1.13 . . . . 0.0 108.015 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.458 ' CD ' ' CZ2' ' A' ' 42' ' ' TRP . 1.1 ttpm? -112.89 141.22 46.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.864 -1.147 . . . . 0.0 112.787 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -129.99 130.13 44.63 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.4 tt -135.45 144.54 46.51 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.798 -1.189 . . . . 0.0 109.479 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.418 ' O ' HG13 ' B' ' 10' ' ' VAL . 11.0 p -128.45 135.41 62.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.629 -0.669 . . . . 0.0 109.537 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.25 128.27 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.07 156.9 31.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 117.769 -1.572 . . . . 0.0 113.011 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' B' ' 91' ' ' ASP . 20.7 tptm -122.4 151.73 40.93 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.518 ' HB2' ' H ' ' B' ' 18' ' ' THR . 30.0 p90 -105.07 147.3 28.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.863 -1.148 . . . . 0.0 111.555 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -120.82 -25.07 5.5 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 94.9 mt-10 -89.21 -55.06 3.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.4 t0 150.5 72.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.518 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.9 m -59.11 110.3 1.02 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.105 0.955 . . . . 0.0 112.85 -176.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.729 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -81.4 92.46 6.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 175.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' H ' HG22 ' B' ' 20' ' ' VAL . 11.7 m -58.37 -32.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.609 -0.682 . . . . 0.0 110.43 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 30.3 p-10 -66.49 -39.23 88.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 110.533 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 77.6 mm-40 -67.75 -34.07 76.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mt -65.74 -44.49 93.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.59 ' CD2' ' H ' ' A' ' 110' ' ' THR . 7.5 tp -53.63 -37.16 62.8 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -59.93 -31.95 70.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' B' ' 30' ' ' LEU . . . -81.96 -43.7 8.08 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -56.82 -58.04 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.589 -0.947 . . . . 0.0 108.832 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.536 ' CG ' ' N ' ' B' ' 29' ' ' ASN . 9.4 pt-20 -51.68 -44.31 63.06 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.632 HD21 HD11 ' B' ' 78' ' ' LEU . 14.7 t30 -61.22 -43.31 99.08 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.761 HD22 HD23 ' B' ' 78' ' ' LEU . 1.0 OUTLIER -50.13 -43.61 51.93 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' B' ' 34' ' ' ILE . 40.6 t -51.05 -27.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.266 -0.896 . . . . 0.0 108.847 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.474 ' C ' ' O ' ' B' ' 31' ' ' VAL . 48.0 t -40.59 -43.34 1.87 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.525 ' OE1' ' CD2' ' B' ' 76' ' ' HIS . 29.9 mm100 -75.3 -23.35 57.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.425 -0.797 . . . . 0.0 111.517 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.656 HG22 ' O ' ' B' ' 34' ' ' ILE . 30.0 mm -85.45 25.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 119.995 -1.69 . . . . 0.0 110.605 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 54.3 p30 -60.63 -8.91 3.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.594 ' O ' ' N ' ' B' ' 38' ' ' LYS . 64.8 p -74.04 -3.43 29.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.963 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.554 ' C ' ' O ' ' B' ' 36' ' ' THR . 30.6 m 36.03 30.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.13 -0.981 . . . . 0.0 109.135 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' B' ' 36' ' ' THR . 74.2 mttt -118.77 39.7 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 13.1 t -171.18 170.79 5.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -147.51 157.37 43.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.521 -1.362 . . . . 0.0 111.934 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.564 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . 57.1 mt-10 -151.69 119.89 6.32 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.349 0.595 . . . . 0.0 110.282 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.702 ' CD1' ' N ' ' B' ' 43' ' ' GLY . 0.0 OUTLIER -130.03 164.55 24.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.07 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.702 ' N ' ' CD1' ' B' ' 42' ' ' TRP . . . -134.32 174.24 21.03 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 118.749 -1.691 . . . . 0.0 110.885 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' B' ' 58' ' ' HIS . 0.2 OUTLIER -152.92 140.92 20.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -1.142 . . . . 0.0 109.387 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -104.99 140.42 38.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -135.0 103.78 5.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.388 -1.445 . . . . 0.0 109.769 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -147.07 25.68 1.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.322 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.468 ' H ' ' CB ' ' B' ' 53' ' ' ARG . 11.7 p -89.18 -106.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.932 . . . . 0.0 110.107 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' B' ' 53' ' ' ARG . 76.4 m80 -92.22 147.98 22.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.157 -0.964 . . . . 0.0 109.699 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 51' ' ' MET . 31.1 p-10 -53.36 -43.29 67.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 110.799 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' OD1' ' B' ' 50' ' ' ASP . 1.9 tpt -75.02 -32.34 61.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.732 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 95' ' ' LEU . 46.2 mt -90.05 -54.58 3.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.682 -1.261 . . . . 0.0 109.324 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.742 ' C ' ' H ' ' B' ' 55' ' ' GLY . 12.9 ptt180 -62.47 1.33 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.354 -0.841 . . . . 0.0 111.247 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.496 ' NE2' HG11 ' A' ' 94' ' ' VAL . 0.4 OUTLIER 56.01 -17.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.821 -1.174 . . . . 0.0 110.194 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.742 ' H ' ' C ' ' B' ' 53' ' ' ARG . . . 88.07 -22.84 16.69 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 121.455 -0.778 . . . . 0.0 112.795 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' B' ' 55' ' ' GLY . 3.5 m-85 -61.52 -133.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.272 -1.723 . . . . 0.0 109.962 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' B' ' 58' ' ' HIS . 3.0 t -161.56 -36.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.194 -0.941 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.651 ' HA ' ' O ' ' B' ' 44' ' ' GLU . 34.9 t-80 -166.6 149.52 6.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 0.0 110.206 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.535 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -142.68 167.76 21.31 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.764 . . . . 0.0 109.272 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' B' ' 58' ' ' HIS . 92.0 m-85 -138.28 134.84 34.85 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.446 -0.784 . . . . 0.0 109.094 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.539 ' OG ' ' CZ3' ' B' ' 42' ' ' TRP . 1.4 m -116.5 104.91 11.9 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 61.6 mtt -95.49 125.79 40.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.209 -0.932 . . . . 0.0 110.73 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 39.2 m -119.18 140.6 49.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -126.87 127.86 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.247 . . . . 0.0 110.029 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -50.54 -26.44 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -171.52 173.02 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -60.98 -19.16 60.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 111.435 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.84 90.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.827 -1.171 . . . . 0.0 110.571 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.56 59.16 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.594 ' O ' HG22 ' B' ' 74' ' ' THR . 74.3 t80 -65.59 -42.94 91.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.594 -0.945 . . . . 0.0 110.425 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.69 -28.99 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.38 -1.45 . . . . 0.0 108.671 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.9 2.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 109.356 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' B' ' 79' ' ' HIS . 0.0 OUTLIER -53.67 -39.23 64.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 111.221 -177.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.594 HG22 ' O ' ' B' ' 70' ' ' TYR . 5.0 t -79.67 -29.64 40.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.779 -1.201 . . . . 0.0 110.341 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 72.6 m -65.59 -25.29 67.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.987 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' B' ' 78' ' ' LEU . 57.5 t-80 -79.19 125.08 84.12 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 109.639 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.29 -6.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.696 2.264 . . . . 0.0 112.433 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.761 HD23 HD22 ' B' ' 30' ' ' LEU . 6.1 tp -75.62 -25.42 56.91 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.369 -0.832 . . . . 0.0 111.233 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.44 ' CG ' ' CE1' ' B' ' 73' ' ' PHE . 2.8 t60 -76.87 -42.68 38.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.978 -1.076 . . . . 0.0 110.29 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.728 HG13 ' N ' ' B' ' 81' ' ' GLU . 11.6 p -64.52 -54.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.728 ' N ' HG13 ' B' ' 80' ' ' VAL . 79.0 mm-40 -50.4 -30.95 13.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.618 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' B' ' 86' ' ' PHE . 4.3 m-85 -72.81 -37.08 67.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.967 . . . . 0.0 109.849 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 19.8 m -63.83 -42.28 97.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.128 -0.982 . . . . 0.0 110.082 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.52 -50.39 67.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.029 . . . . 0.0 108.673 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -67.14 -43.38 82.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' B' ' 82' ' ' PHE . 2.5 m-85 -45.11 -31.01 1.24 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.539 ' O ' ' N ' ' B' ' 89' ' ' VAL . 23.7 m -78.9 -63.31 1.45 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -40.0 -24.14 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.645 -0.659 . . . . 0.0 110.074 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 87' ' ' THR . 4.3 m -111.88 7.18 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.198 -0.939 . . . . 0.0 110.807 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 34.5 mt -120.34 154.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.642 -1.286 . . . . 0.0 110.458 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' B' ' 13' ' ' LYS . 62.2 t0 -103.34 -31.58 9.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.447 ' NZ ' ' CE1' ' B' ' 56' ' ' PHE . 38.1 pttt -150.41 149.41 30.0 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.489 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.9 tp -125.42 122.21 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.647 -1.283 . . . . 0.0 109.727 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.492 HG11 ' NE2' ' A' ' 54' ' ' GLN . 49.8 t -129.98 133.69 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.578 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.4 OUTLIER -139.6 136.83 34.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.291 -1.505 . . . . 0.0 111.73 -178.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.929 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -115.92 121.09 41.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.335 176.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 7' ' ' LYS . 68.3 t0 -122.88 128.38 50.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 108.928 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -164.13 139.61 4.87 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.095 -1.003 . . . . 0.0 110.574 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.11 121.01 4.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.231 1.954 . . . . 0.0 112.294 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 18.6 t -105.96 135.57 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.002 . . . . 0.0 110.036 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.68 75.29 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.73 113.33 24.96 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.677 HG23 ' H ' ' B' ' 104' ' ' LYS . 16.8 m -134.37 -54.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.284 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.677 ' H ' HG23 ' B' ' 103' ' ' VAL . 25.9 mmtm 59.91 -129.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.396 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' B' ' 104' ' ' LYS . 0.9 OUTLIER 72.32 -18.23 0.34 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.217 -0.927 . . . . 0.0 109.02 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.518 ' H ' ' C ' ' B' ' 104' ' ' LYS . 2.0 t 168.55 -41.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.6 HG12 ' H ' ' B' ' 109' ' ' ALA . 55.1 t -145.37 144.99 21.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.445 HG13 ' O ' ' B' ' 108' ' ' VAL . 1.9 p -122.01 13.49 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.782 . . . . 0.0 109.449 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . 0.6 ' H ' HG12 ' B' ' 107' ' ' VAL . . . -58.09 136.44 57.19 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.6 ' H ' ' CD2' ' A' ' 24' ' ' LEU . 26.5 m -132.25 71.94 79.13 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 120.894 -1.129 . . . . 0.0 109.625 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 C--N 1.308 -1.554 0 C-N-CA 122.712 2.275 . . . . 0.0 112.288 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' H ' ' HG3' ' A' ' 99' ' ' PRO . . . 47.45 59.77 3.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.692 HG23 ' N ' ' A' ' 4' ' ' SER . 9.8 t -63.02 -49.8 73.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.181 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.692 ' N ' HG23 ' A' ' 3' ' ' THR . 32.0 t -144.22 -95.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.04 154.05 40.61 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.345 -1.407 . . . . 0.0 109.635 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.05 127.27 53.26 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.263 -1.14 . . . . 0.0 108.037 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' B' ' 44' ' ' GLU . 3.8 ttpm? -108.39 137.83 45.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 112.769 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -124.49 123.21 39.63 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.41 142.27 49.21 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 109.478 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 10' ' ' VAL . 10.4 p -129.81 134.74 62.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.42 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.41 129.08 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 m -134.44 161.85 39.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 117.771 -1.572 . . . . 0.0 113.036 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.54 151.24 51.74 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' HB2' ' H ' ' A' ' 18' ' ' THR . 22.5 p90 -109.72 146.99 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.899 -1.125 . . . . 0.0 111.529 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -130.17 -20.24 3.08 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 79.4 mm-40 -91.18 -58.01 2.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.8 m-20 156.52 65.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 90.5 m -57.4 108.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.075 0.941 . . . . 0.0 112.835 -176.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.65 87.12 3.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 21' ' ' ASP . 26.8 m -61.61 -37.73 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.524 -0.735 . . . . 0.0 110.493 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.465 ' N ' HG23 ' A' ' 20' ' ' VAL . 81.5 m-20 -66.41 -42.16 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.62 -32.48 73.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.14 -38.99 83.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.65 -35.25 60.8 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.37 74.82 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -60.56 -54.4 37.44 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.8 tt -51.33 -47.9 62.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.548 -0.972 . . . . 0.0 108.764 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.14 -37.26 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -61.94 -44.21 97.25 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.846 HD13 ' NE2' ' A' ' 33' ' ' GLN . 3.0 mm? -50.07 -47.2 53.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.4 t -50.65 -26.32 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.252 -0.905 . . . . 0.0 108.883 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 27.2 t -47.38 -44.23 24.07 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.846 ' NE2' HD13 ' A' ' 30' ' ' LEU . 12.8 pm0 -92.98 -24.32 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.541 ' C ' ' H ' ' A' ' 36' ' ' THR . 9.3 mt -71.55 26.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 119.983 -1.698 . . . . 0.0 110.631 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' GLN . 88.9 m-20 -62.84 -7.33 4.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' LYS . 50.8 p -71.93 -5.83 37.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.949 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.59 ' C ' ' O ' ' A' ' 36' ' ' THR . 32.7 m 33.51 31.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.63 ' N ' ' O ' ' A' ' 36' ' ' THR . 6.0 mtmp? -117.35 38.61 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' A' ' 38' ' ' LYS . 72.8 m -173.63 177.29 2.55 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.434 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.3 m-85 -146.88 155.94 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.574 -1.329 . . . . 0.0 112.016 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 85.4 mt-10 -158.69 129.26 6.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.43 0.633 . . . . 0.0 110.17 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.54 177.29 8.57 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.8 162.26 22.37 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.727 -1.701 . . . . 0.0 110.816 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.628 ' N ' ' CE1' ' A' ' 58' ' ' HIS . 72.3 mt-10 -145.93 138.18 25.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -1.168 . . . . 0.0 109.438 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.14 149.28 43.02 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' H ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -70.99 81.16 0.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.396 -1.44 . . . . 0.0 109.824 -176.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -115.37 56.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.643 -0.661 . . . . 0.0 109.33 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 49' ' ' HIS . 38.5 t -150.95 83.59 1.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.203 -0.935 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.701 ' N ' HH21 ' A' ' 53' ' ' ARG . 79.1 m-70 56.83 118.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 96.6 m-20 -44.61 -33.88 1.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.339 -0.85 . . . . 0.0 110.726 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -76.94 -32.0 57.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.059 -1.026 . . . . 0.0 110.714 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 95' ' ' LEU . 62.9 mt -96.32 -12.38 24.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.732 -1.23 . . . . 0.0 109.333 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.701 HH21 ' N ' ' A' ' 49' ' ' HIS . 5.9 ptp180 -95.78 2.15 53.67 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.311 -0.868 . . . . 0.0 111.263 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' PHE . 95.1 mm-40 44.13 19.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.82 -1.175 . . . . 0.0 110.169 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.757 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 48.75 3.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.759 0 O-C-N 121.424 -0.797 . . . . 0.0 112.914 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.757 ' O ' ' O ' ' A' ' 55' ' ' GLY . 33.2 m-85 -49.94 -143.73 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.229 -1.748 . . . . 0.0 109.987 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 93.0 m -135.93 -55.88 0.77 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.951 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.628 ' CE1' ' N ' ' A' ' 44' ' ' GLU . 13.0 t60 -168.41 152.88 6.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.879 -1.138 . . . . 0.0 110.156 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.549 ' N ' ' CD2' ' A' ' 58' ' ' HIS . . . -139.06 115.86 10.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.231 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.29 131.67 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.118 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -121.8 122.0 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 110.749 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.4 m -122.7 143.2 49.95 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -117.73 159.81 22.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.788 -1.195 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.69 -28.91 45.28 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -174.53 -178.1 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.94 -27.09 67.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 111.453 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.02 -43.98 97.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.78 -1.2 . . . . 0.0 110.548 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.44 67.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.597 ' O ' HG22 ' A' ' 74' ' ' THR . 71.2 t80 -67.02 -45.2 78.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.531 -0.982 . . . . 0.0 110.467 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.75 -28.97 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.36 -1.462 . . . . 0.0 108.671 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.06 -60.95 2.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.347 -0.845 . . . . 0.0 109.331 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.609 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.06 -50.15 73.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 111.108 -177.274 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' A' ' 73' ' ' PHE . 8.6 t -62.63 -28.17 69.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.805 -1.184 . . . . 0.0 110.304 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -61.95 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.0 110.897 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.626 ' NE2' ' NE2' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -121.94 151.19 57.63 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.787 -1.196 . . . . 0.0 109.578 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.43 12.53 1.82 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.575 2.184 . . . . 0.0 112.433 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.685 HD22 HE22 ' A' ' 33' ' ' GLN . 0.7 OUTLIER -75.98 -29.71 58.32 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 111.251 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' SER . 35.6 t-80 -85.22 -41.65 15.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.952 -1.093 . . . . 0.0 110.282 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 ' H ' ' A' ' 81' ' ' GLU . 7.2 p -57.88 -58.46 6.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.961 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.762 ' H ' HG13 ' A' ' 80' ' ' VAL . 14.9 tm-20 -58.01 -39.33 78.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.137 -0.977 . . . . 0.0 109.593 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.91 -40.74 71.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.915 . . . . 0.0 109.879 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' HIS . 86.8 p -61.56 -38.16 86.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.132 -0.98 . . . . 0.0 110.218 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.93 63.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.973 -1.079 . . . . 0.0 108.725 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -69.26 -40.82 77.6 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.476 ' O ' HD12 ' A' ' 90' ' ' ILE . 24.8 t80 -44.53 -30.49 0.9 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 90' ' ' ILE . 6.0 m -83.31 -61.84 1.74 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -36.87 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.741 -0.6 . . . . 0.0 110.07 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 87' ' ' THR . 12.6 m -101.93 16.53 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 110.819 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 87' ' ' THR . 73.7 mt -124.43 159.14 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.655 -1.278 . . . . 0.0 110.51 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 90' ' ' ILE . 62.8 t0 -102.32 -34.53 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.462 ' N ' HG22 ' A' ' 90' ' ' ILE . 29.4 pttt -145.78 143.71 29.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 93' ' ' ILE . 4.0 tp -121.54 122.06 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.649 -1.282 . . . . 0.0 109.774 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.78 130.43 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -135.34 131.75 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.258 -1.526 . . . . 0.0 111.811 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -122.75 126.97 48.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.651 -0.655 . . . . 0.0 109.377 177.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -125.81 133.35 52.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.098 -1.001 . . . . 0.0 108.899 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 99' ' ' PRO . 63.8 t80 -155.42 128.73 4.38 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.108 -0.995 . . . . 0.0 110.476 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.533 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 81.8 Cg_exo -46.08 133.58 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.308 2.006 . . . . 0.0 112.176 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.61 129.33 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -101.39 82.14 2.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.435 -0.79 . . . . 0.0 109.585 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -65.25 76.69 0.06 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.177 -0.952 . . . . 0.0 109.568 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.763 ' O ' ' C ' ' A' ' 104' ' ' LYS . 16.3 m -154.26 -28.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.436 -0.79 . . . . 0.0 109.271 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.763 ' C ' ' O ' ' A' ' 103' ' ' VAL . 55.2 mmtt -4.52 -106.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 0.0 109.396 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m 67.04 -8.99 0.4 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.095 -1.003 . . . . 0.0 108.891 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 104' ' ' LYS . 25.5 t -55.76 133.5 50.99 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.239 -0.913 . . . . 0.0 109.4 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 107' ' ' VAL . 14.6 p -140.76 40.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.37 138.97 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.51 -0.744 . . . . 0.0 109.486 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.2 177.33 7.9 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -137.49 70.02 53.36 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.937 -1.102 . . . . 0.0 109.642 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 C--N 1.307 -1.621 0 C-N-CA 122.814 2.343 . . . . 0.0 112.248 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.306 0.574 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.466 ' H ' ' HG3' ' B' ' 99' ' ' PRO . . . 47.36 59.89 3.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 109.434 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.684 HG23 ' N ' ' B' ' 4' ' ' SER . 9.8 t -63.16 -49.88 72.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.163 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.684 ' N ' HG23 ' B' ' 3' ' ' THR . 31.9 t -144.08 -95.65 0.11 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.84 154.23 41.24 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -119.26 127.13 52.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.203 -1.175 . . . . 0.0 108.021 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.534 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 3.8 ttpm? -108.14 137.93 45.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.96 -1.087 . . . . 0.0 112.816 -177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -124.7 123.19 39.48 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.39 142.27 49.22 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 109.475 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.436 HG13 ' O ' ' B' ' 10' ' ' VAL . 10.3 p -129.7 134.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.629 -0.67 . . . . 0.0 109.523 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.23 129.08 68.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.37 162.09 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.001 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -131.79 151.06 51.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.489 ' HB2' ' H ' ' B' ' 18' ' ' THR . 22.3 p90 -109.56 146.92 33.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.867 -1.146 . . . . 0.0 111.583 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -130.04 -20.37 3.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 79.3 mm-40 -91.08 -57.92 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.8 m-20 156.39 65.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.489 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 91.6 m -57.12 108.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.088 0.947 . . . . 0.0 112.86 -176.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.566 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -76.82 87.13 3.41 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 175.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.472 HG23 ' N ' ' B' ' 21' ' ' ASP . 27.1 m -61.75 -37.58 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.573 -0.704 . . . . 0.0 110.518 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.472 ' N ' HG23 ' B' ' 20' ' ' VAL . 80.7 m-20 -66.32 -42.31 88.41 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 110.552 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.59 -32.44 73.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.15 -39.0 83.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 tp -53.71 -35.19 60.89 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -35.43 74.96 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -60.52 -54.34 37.94 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.584 HD23 ' O ' ' B' ' 27' ' ' LEU . 1.8 tt -51.34 -47.85 62.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.802 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -55.24 -37.03 66.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -62.15 -44.04 97.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.865 HD13 ' NE2' ' B' ' 33' ' ' GLN . 3.0 mm? -50.21 -47.09 54.97 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 32' ' ' SER . 86.3 t -50.71 -26.26 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.326 -0.858 . . . . 0.0 108.879 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 27.9 t -47.34 -44.48 23.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.865 ' NE2' HD13 ' B' ' 30' ' ' LEU . 12.9 pm0 -92.75 -24.35 18.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.812 . . . . 0.0 111.54 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' B' ' 36' ' ' THR . 9.6 mt -71.66 26.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 119.976 -1.703 . . . . 0.0 110.541 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' B' ' 33' ' ' GLN . 89.6 m-20 -63.02 -7.22 4.93 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.627 ' O ' ' N ' ' B' ' 38' ' ' LYS . 49.9 p -71.83 -6.11 39.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.987 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.574 ' C ' ' O ' ' B' ' 36' ' ' THR . 32.8 m 33.72 31.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.012 -1.055 . . . . 0.0 109.189 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' B' ' 36' ' ' THR . 5.9 mtmp? -117.39 38.65 3.51 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.541 ' OG ' ' O ' ' B' ' 38' ' ' LYS . 72.7 m -173.66 177.26 2.55 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.6 m-85 -147.06 155.77 42.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.555 -1.341 . . . . 0.0 111.912 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 85.6 mt-10 -158.58 129.1 6.09 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.332 0.587 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -143.36 177.48 8.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.93 162.35 22.45 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 118.69 -1.719 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.637 ' N ' ' CE1' ' B' ' 58' ' ' HIS . 71.7 mt-10 -145.97 138.24 25.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -1.134 . . . . 0.0 109.34 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -121.07 149.33 42.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.568 ' H ' ' CD ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -71.05 81.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.412 -1.43 . . . . 0.0 109.809 -177.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -115.35 56.93 0.74 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.539 ' O ' ' O ' ' B' ' 49' ' ' HIS . 39.8 t -151.1 83.63 1.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.181 -0.949 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.699 ' N ' HH21 ' B' ' 53' ' ' ARG . 78.6 m-70 56.86 118.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.121 -0.987 . . . . 0.0 109.702 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.545 ' OD1' ' NH1' ' B' ' 53' ' ' ARG . 97.4 m-20 -44.68 -33.89 2.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 110.847 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.401 ' HG2' ' H ' ' B' ' 51' ' ' MET . 2.7 ptt? -76.86 -32.0 57.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.063 -1.023 . . . . 0.0 110.751 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 95' ' ' LEU . 63.0 mt -96.29 -12.41 24.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.709 -1.245 . . . . 0.0 109.258 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.699 HH21 ' N ' ' B' ' 49' ' ' HIS . 6.1 ptp180 -95.76 1.97 53.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 111.281 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' B' ' 56' ' ' PHE . 94.9 mm-40 44.37 19.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.8 -1.187 . . . . 0.0 110.168 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.768 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 48.9 3.26 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.477 -0.764 . . . . 0.0 112.893 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.768 ' O ' ' O ' ' B' ' 55' ' ' GLY . 33.0 m-85 -49.91 -143.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.252 -1.734 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 93.0 m -135.8 -55.87 0.78 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.312 -0.868 . . . . 0.0 110.964 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.637 ' CE1' ' N ' ' B' ' 44' ' ' GLU . 13.0 t60 -168.39 153.22 6.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.203 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' B' ' 58' ' ' HIS . . . -139.36 116.06 10.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.509 -0.744 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -89.42 131.68 35.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.396 -0.815 . . . . 0.0 109.069 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -121.89 121.3 36.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -114.95 134.66 54.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.218 -0.926 . . . . 0.0 110.757 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 40' ' ' PHE . 32.6 m -122.88 143.34 49.94 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -117.83 159.59 22.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.693 -1.254 . . . . 0.0 110.036 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.46 -29.24 46.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -174.22 -178.17 1.4 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.83 -27.12 67.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.949 . . . . 0.0 111.469 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -61.92 -44.02 97.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.782 -1.199 . . . . 0.0 110.593 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.27 -32.7 68.65 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.585 ' O ' HG22 ' B' ' 74' ' ' THR . 71.6 t80 -66.7 -45.38 78.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.939 . . . . 0.0 110.459 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -70.81 -28.92 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.411 -1.43 . . . . 0.0 108.697 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.421 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . -65.08 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.325 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.596 ' O ' ' CE1' ' B' ' 76' ' ' HIS . 0.0 OUTLIER -57.06 -49.98 74.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.224 -0.923 . . . . 0.0 111.107 -177.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.594 ' N ' ' CG ' ' B' ' 73' ' ' PHE . 8.6 t -62.85 -28.13 69.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 110.311 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 72' ' ' ALA . 84.5 p -62.05 16.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.96 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.626 ' NE2' ' NE2' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -121.83 150.97 56.95 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.868 -1.145 . . . . 0.0 109.585 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.19 12.6 1.74 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.604 2.203 . . . . 0.0 112.48 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.663 HD22 HE22 ' B' ' 33' ' ' GLN . 0.7 OUTLIER -76.08 -29.72 58.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.435 -0.79 . . . . 0.0 111.22 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' B' ' 83' ' ' SER . 35.4 t-80 -85.21 -41.71 15.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.935 -1.103 . . . . 0.0 110.22 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.778 HG13 ' H ' ' B' ' 81' ' ' GLU . 7.2 p -57.9 -58.56 5.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 110.031 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.778 ' H ' HG13 ' B' ' 80' ' ' VAL . 14.9 tm-20 -57.84 -39.4 77.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.544 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -70.8 -40.89 72.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 109.894 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.437 ' N ' ' O ' ' B' ' 79' ' ' HIS . 87.2 p -61.5 -38.14 86.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.24 60.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.011 -1.056 . . . . 0.0 108.675 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -41.18 78.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.466 ' O ' HD12 ' B' ' 90' ' ' ILE . 24.6 t80 -44.24 -30.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 89' ' ' VAL . 6.1 m -83.35 -61.77 1.76 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -37.06 -26.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.604 . . . . 0.0 110.061 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' B' ' 87' ' ' THR . 12.7 m -102.15 16.27 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.18 -0.95 . . . . 0.0 110.769 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' B' ' 87' ' ' THR . 73.4 mt -124.32 159.17 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.643 -1.285 . . . . 0.0 110.417 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.521 ' N ' HG22 ' B' ' 90' ' ' ILE . 63.0 t0 -102.3 -34.47 9.2 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.458 ' N ' HG22 ' B' ' 90' ' ' ILE . 29.2 pttt -145.94 143.55 29.6 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.49 ' O ' HG23 ' B' ' 93' ' ' ILE . 4.0 tp -121.4 122.2 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.64 -1.287 . . . . 0.0 109.772 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.93 130.44 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.461 HD12 ' N ' ' B' ' 95' ' ' LEU . 0.0 OUTLIER -135.37 131.67 36.64 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.307 -1.495 . . . . 0.0 111.76 -178.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.881 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -122.73 127.24 48.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -126.05 133.3 51.76 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.078 -1.014 . . . . 0.0 108.91 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' B' ' 99' ' ' PRO . 64.2 t80 -155.24 128.74 4.44 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . 0.531 ' O ' ' CE2' ' B' ' 98' ' ' PHE . 80.5 Cg_exo -46.18 133.39 15.22 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.314 2.009 . . . . 0.0 112.241 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 74.8 t -107.42 129.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 110.007 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -101.5 81.94 2.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 109.577 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 76.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.783 ' O ' ' C ' ' B' ' 104' ' ' LYS . 16.2 m -154.22 -28.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 0.0 109.197 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.783 ' C ' ' O ' ' B' ' 103' ' ' VAL . 54.5 mmtt -4.54 -106.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.387 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m 67.22 -8.97 0.42 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.149 -0.969 . . . . 0.0 108.949 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.544 ' H ' ' C ' ' B' ' 104' ' ' LYS . 26.2 t -55.83 133.27 51.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.603 HG22 ' O ' ' B' ' 107' ' ' VAL . 14.7 p -140.51 40.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.41 139.02 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.5 -0.75 . . . . 0.0 109.518 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.33 177.24 7.89 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 15.9 p -137.44 69.92 53.8 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.864 -1.147 . . . . 0.0 109.64 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.733 2.288 . . . . 0.0 112.225 -179.905 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.18 52.87 2.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 109.355 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 t -103.38 -9.85 19.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.109 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -152.78 -86.36 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.48 -159.29 7.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -142.56 142.38 32.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.278 -1.13 . . . . 0.0 108.051 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.44 141.89 47.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 112.831 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -126.73 128.95 47.46 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 7.0 tt -135.37 142.77 45.78 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.755 -1.216 . . . . 0.0 109.436 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 12.7 p -131.11 139.5 50.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.05 127.34 72.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.05 144.17 36.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.825 -1.55 . . . . 0.0 113.068 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 55' ' ' GLY . 37.2 tptt -111.76 150.5 30.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HB2' ' H ' ' A' ' 18' ' ' THR . 18.4 p90 -107.0 147.5 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.823 -1.173 . . . . 0.0 111.607 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.76 -26.36 4.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 65.0 tt0 -88.19 -56.94 3.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 5.0 p30 152.63 70.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 41.8 m -55.12 106.88 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.142 0.972 . . . . 0.0 112.821 -177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.589 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.95 88.56 1.86 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 24' ' ' LEU . 31.5 m -59.53 -40.95 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.705 . . . . 0.0 110.458 -176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.551 ' N ' HG23 ' A' ' 20' ' ' VAL . 92.4 m-20 -61.01 -44.24 97.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.411 -0.806 . . . . 0.0 110.557 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.48 -39.12 62.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.5 -50.71 70.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.86 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.2 tm? -56.48 -42.61 78.53 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 24' ' ' LEU . 5.1 ttpt -60.13 -25.05 65.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.68 ' O ' ' ND2' ' A' ' 29' ' ' ASN . . . -69.21 -54.82 11.89 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 27' ' ' LEU . 6.8 tt -44.33 -38.33 3.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.512 -0.993 . . . . 0.0 108.818 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -52.87 -41.82 64.68 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.68 ' ND2' ' O ' ' A' ' 26' ' ' GLY . 1.7 p30 -57.41 -42.43 82.29 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.641 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -50.22 -46.29 54.48 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' SER . 34.4 t -48.91 -24.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.332 -0.855 . . . . 0.0 108.908 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 42.4 t -43.24 -43.15 4.65 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 76' ' ' HIS . 97.0 mm-40 -76.18 -22.42 55.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -0.802 . . . . 0.0 111.464 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.756 HG22 ' O ' ' A' ' 34' ' ' ILE . 71.9 mt -79.73 20.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.033 -1.667 . . . . 0.0 110.645 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.47 -10.47 1.46 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.581 ' N ' ' C ' ' A' ' 34' ' ' ILE . 35.0 p -82.24 0.44 41.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.963 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.577 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.3 m 34.94 33.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.046 -1.034 . . . . 0.0 109.117 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 mtmp? -119.61 42.01 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' PHE . 30.1 t -175.97 175.5 1.94 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 77.4 m-85 -150.53 159.72 44.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.591 -1.318 . . . . 0.0 111.99 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 40' ' ' PHE . 86.1 mt-10 -159.24 130.82 6.28 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.364 0.602 . . . . 0.0 110.2 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -133.78 171.61 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' GLU . . . -134.45 168.21 23.57 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 118.672 -1.728 . . . . 0.0 110.793 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.618 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 87.4 mt-10 -156.82 152.5 26.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.306 -1.114 . . . . 0.0 109.341 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.893 ' HA ' ' O ' ' A' ' 57' ' ' THR . 23.9 t0 -157.16 87.5 0.99 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -90.35 170.01 10.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.393 -1.442 . . . . 0.0 109.882 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.699 -0.625 . . . . 0.0 109.317 176.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.426 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 4.2 t -78.75 -125.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.0 110.164 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -77.63 153.9 32.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.721 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -71.47 -41.57 69.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 110.759 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.516 ' N ' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.17 -40.61 90.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.969 -1.082 . . . . 0.0 110.737 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' B' ' 95' ' ' LEU . 44.8 mt -75.86 -64.62 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.745 -1.222 . . . . 0.0 109.303 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -67.72 18.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 0.0 111.233 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' A' ' 52' ' ' LEU . 1.7 mm100 45.33 8.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.701 -1.249 . . . . 0.0 110.164 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 70.3 -11.54 2.12 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.503 -0.748 . . . . 0.0 112.936 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' O ' ' O ' ' A' ' 55' ' ' GLY . 49.4 m-85 -53.92 -136.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.288 -1.713 . . . . 0.0 109.92 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.893 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 6.1 t -163.28 -51.45 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.305 -0.872 . . . . 0.0 110.903 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 60' ' ' PHE . 6.3 t60 -148.37 142.5 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.87 -1.144 . . . . 0.0 110.149 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.69 163.06 33.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 0.0 109.231 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 58' ' ' HIS . 94.9 m-85 -133.78 131.17 39.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.083 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' A' ' 42' ' ' TRP . 1.6 m -116.59 110.39 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.13 132.38 53.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.209 -0.932 . . . . 0.0 110.838 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -119.01 141.44 48.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.24 158.5 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.689 -1.257 . . . . 0.0 110.097 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -75.66 -26.42 57.67 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -175.39 -177.34 1.01 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -66.61 -23.73 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 111.355 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.7 -41.04 97.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.763 -1.21 . . . . 0.0 110.577 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.57 65.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.805 ' O ' HG22 ' A' ' 74' ' ' THR . 76.0 t80 -69.39 -43.22 73.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.496 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' OG ' ' A' ' 75' ' ' SER . 21.0 m -70.82 -28.89 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.423 -1.423 . . . . 0.0 108.642 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' ' ND1' ' A' ' 76' ' ' HIS . . . -65.08 -60.9 2.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.299 -0.876 . . . . 0.0 109.358 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CG ' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -57.72 -57.74 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.875 . . . . 0.0 111.145 -178.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 70' ' ' TYR . 9.2 t -57.27 -35.57 69.93 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.775 -1.203 . . . . 0.0 110.293 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 58.4 m -66.69 -32.94 74.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.0 110.964 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 78' ' ' LEU . 59.3 m80 -68.43 128.76 93.03 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.83 -1.169 . . . . 0.0 109.601 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.34 -8.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 112.443 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 76' ' ' HIS . 6.7 tp -66.77 -28.41 68.37 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.34 -0.85 . . . . 0.0 111.291 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.75 -35.32 24.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.012 . . . . 0.0 110.247 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.97 -61.32 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -58.62 -38.66 78.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.604 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' A' ' 86' ' ' PHE . 78.0 t80 -68.48 -44.28 75.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.872 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.5 t -59.87 -35.48 74.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.968 -1.082 . . . . 0.0 108.682 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.75 -42.14 77.94 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 85' ' ' ALA . 6.5 t80 -43.53 -30.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 89' ' ' VAL . 9.4 m -83.05 -61.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -39.84 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.639 -0.663 . . . . 0.0 110.008 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.7 m -102.69 11.37 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.19 -0.944 . . . . 0.0 110.746 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 91' ' ' ASP . 44.8 mt -125.74 158.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.596 -1.315 . . . . 0.0 110.53 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 60.6 t0 -104.22 -32.33 9.17 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 13' ' ' LYS . 9.1 pttp -148.87 147.0 28.19 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 93' ' ' ILE . 3.8 tp -127.43 127.58 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.579 -1.326 . . . . 0.0 109.763 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 48.3 t -132.18 135.51 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -135.6 130.28 34.19 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 111.759 -178.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.584 ' H ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.72 127.34 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.65 -0.656 . . . . 0.0 109.387 177.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.567 ' O ' ' NH1' ' B' ' 53' ' ' ARG . 54.6 m-20 -123.06 125.08 44.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 108.908 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -146.7 127.26 7.01 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.053 -1.029 . . . . 0.0 110.501 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -48.42 123.61 9.44 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.31 2.007 . . . . 0.0 112.22 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.47 132.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.62 80.51 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 84.51 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.632 ' O ' ' O ' ' A' ' 104' ' ' LYS . 17.2 m -147.11 -22.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.177 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.632 ' O ' ' O ' ' A' ' 103' ' ' VAL . 24.8 mtmt 41.33 102.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.328 -0.858 . . . . 0.0 109.358 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -50.74 -50.8 54.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.15 -0.969 . . . . 0.0 108.934 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.1 t 45.78 29.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.385 -0.822 . . . . 0.0 109.378 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.3 t -72.32 -56.0 11.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.01 140.97 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.546 -0.721 . . . . 0.0 109.505 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -104.58 120.28 40.92 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.19 155.16 61.78 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 120.802 -1.186 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.307 -1.626 0 C-N-CA 122.825 2.35 . . . . 0.0 112.219 179.562 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' B' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.38 53.22 2.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 109.358 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 13.7 t -103.47 -10.36 18.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.85 . . . . 0.0 109.153 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t -152.44 -86.4 0.07 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.49 -159.06 7.79 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.687 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -142.81 142.37 31.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -1.136 . . . . 0.0 108.029 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.61 141.64 47.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.932 -1.105 . . . . 0.0 112.819 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -126.5 128.91 47.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' LEU . 7.0 tt -135.42 142.75 45.68 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.789 -1.195 . . . . 0.0 109.439 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' B' ' 94' ' ' VAL . 12.5 p -131.01 139.53 50.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.627 -0.671 . . . . 0.0 109.523 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.09 127.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.03 144.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 117.738 -1.585 . . . . 0.0 113.019 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' B' ' 55' ' ' GLY . 36.8 tptt -111.92 150.42 30.51 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' B' ' 14' ' ' PHE . 18.4 p90 -106.91 147.36 29.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 111.575 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -122.6 -26.39 4.55 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 65.4 tt0 -88.18 -56.83 3.16 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 5.1 p30 152.45 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.459 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 40.1 m -55.38 106.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.059 0.933 . . . . 0.0 112.901 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.6 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -74.01 88.4 1.88 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' B' ' 24' ' ' LEU . 31.4 m -59.52 -40.65 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 110.434 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.528 ' N ' HG23 ' B' ' 20' ' ' VAL . 92.0 m-20 -61.22 -44.42 97.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 110.54 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -74.23 -38.99 63.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -65.79 -50.37 71.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.858 ' C ' HD13 ' B' ' 24' ' ' LEU . 2.2 tm? -56.86 -42.5 79.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -60.11 -25.15 65.21 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.688 ' O ' ' ND2' ' B' ' 29' ' ' ASN . . . -69.15 -54.62 12.9 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.711 HD23 ' O ' ' B' ' 27' ' ' LEU . 6.8 tt -44.43 -38.29 3.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.551 -0.97 . . . . 0.0 108.831 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -52.96 -41.87 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.688 ' ND2' ' O ' ' B' ' 26' ' ' GLY . 1.7 p30 -57.28 -42.57 81.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.638 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -50.07 -46.62 53.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' B' ' 34' ' ' ILE . 33.6 t -48.53 -24.74 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 44.2 t -43.15 -43.31 4.52 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.477 ' OE1' ' CE1' ' B' ' 76' ' ' HIS . 97.0 mm-40 -75.91 -22.74 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.429 -0.795 . . . . 0.0 111.52 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.766 HG22 ' O ' ' B' ' 34' ' ' ILE . 72.5 mt -79.3 20.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.955 -1.715 . . . . 0.0 110.586 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.57 -10.58 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.568 ' O ' ' N ' ' B' ' 38' ' ' LYS . 34.6 p -82.09 0.36 40.97 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.944 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' B' ' 36' ' ' THR . 33.2 m 35.17 33.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.079 -1.013 . . . . 0.0 109.24 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.8 mtmp? -119.72 42.13 2.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.425 ' O ' ' CG ' ' B' ' 40' ' ' PHE . 30.8 t -176.04 175.21 1.96 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.454 ' O ' ' CG ' ' B' ' 41' ' ' GLU . 77.9 m-85 -150.41 159.26 44.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.511 -1.368 . . . . 0.0 111.953 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' B' ' 40' ' ' PHE . 86.1 mt-10 -158.84 130.78 6.59 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.315 0.578 . . . . 0.0 110.221 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . 0.688 ' CD1' ' N ' ' B' ' 42' ' ' TRP . 0.0 OUTLIER -133.7 171.6 13.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.46 168.41 23.49 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 118.666 -1.731 . . . . 0.0 110.751 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.615 ' O ' ' CG ' ' B' ' 58' ' ' HIS . 87.1 mt-10 -156.94 152.42 26.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -1.202 . . . . 0.0 109.41 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.888 ' HA ' ' O ' ' B' ' 57' ' ' THR . 24.4 t0 -156.99 87.85 1.01 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' H ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -90.83 170.15 10.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.368 -1.457 . . . . 0.0 109.818 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 88.7 mt-10 -155.11 24.09 0.43 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.425 ' H ' ' HG3' ' B' ' 53' ' ' ARG . 4.7 t -78.55 -125.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.108 -0.995 . . . . 0.0 110.118 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -78.18 153.73 31.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.17 -41.79 69.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 110.822 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' B' ' 51' ' ' MET . 0.0 OUTLIER -66.1 -40.42 90.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.033 . . . . 0.0 110.768 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 95' ' ' LEU . 45.5 mt -76.09 -64.31 1.12 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.729 -1.232 . . . . 0.0 109.295 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' B' ' 55' ' ' GLY . 0.4 OUTLIER -68.12 18.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.38 -0.825 . . . . 0.0 111.218 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' B' ' 52' ' ' LEU . 1.7 mm100 45.13 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.735 -1.228 . . . . 0.0 110.195 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.669 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 70.42 -12.05 2.01 Favored Glycine 0 N--CA 1.5 2.914 0 O-C-N 121.496 -0.753 . . . . 0.0 112.811 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.669 ' O ' ' O ' ' B' ' 55' ' ' GLY . 49.8 m-85 -53.66 -136.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.242 -1.74 . . . . 0.0 109.916 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.888 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 6.3 t -163.0 -51.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.641 ' CD2' ' CZ ' ' B' ' 60' ' ' PHE . 6.2 t60 -148.44 142.45 25.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.938 -1.101 . . . . 0.0 110.175 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.52 163.1 33.85 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.487 -0.758 . . . . 0.0 109.294 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' B' ' 58' ' ' HIS . 95.2 m-85 -133.71 131.02 38.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.437 -0.79 . . . . 0.0 109.151 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.429 ' O ' ' CD1' ' B' ' 42' ' ' TRP . 1.6 m -116.39 110.6 18.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -107.56 132.51 53.18 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -0.897 . . . . 0.0 110.743 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -119.05 141.42 48.75 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.28 158.49 26.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.736 -1.228 . . . . 0.0 110.013 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -75.76 -26.48 57.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -175.28 -177.42 1.03 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.43 -23.74 66.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.69 -41.2 97.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.814 -1.179 . . . . 0.0 110.638 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.28 -31.71 65.9 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.816 ' O ' HG22 ' B' ' 74' ' ' THR . 76.6 t80 -69.07 -43.53 74.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.56 -0.965 . . . . 0.0 110.474 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' B' ' 75' ' ' SER . 21.1 m -70.76 -28.88 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.47 -1.394 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.51 ' O ' ' ND1' ' B' ' 76' ' ' HIS . . . -65.1 -60.85 2.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.632 ' CG ' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -57.43 -57.94 10.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 111.146 -178.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.816 HG22 ' O ' ' B' ' 70' ' ' TYR . 9.1 t -57.33 -35.21 69.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.368 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' B' ' 71' ' ' VAL . 58.5 m -66.93 -32.97 74.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.571 ' O ' ' N ' ' B' ' 78' ' ' LEU . 59.4 m80 -68.44 128.55 93.05 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.887 -1.133 . . . . 0.0 109.629 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -42.98 -8.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.644 2.229 . . . . 0.0 112.513 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' B' ' 76' ' ' HIS . 6.6 tp -66.56 -28.59 68.64 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.387 -0.821 . . . . 0.0 111.211 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -83.65 -35.31 24.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 110.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.05 -61.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.014 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -58.58 -38.72 78.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.426 ' CE2' ' CD1' ' B' ' 86' ' ' PHE . 77.9 t80 -68.27 -44.54 75.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.838 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -59.77 -35.24 74.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.163 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.16 60.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.978 -1.076 . . . . 0.0 108.742 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.87 -42.15 77.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.474 ' C ' ' O ' ' B' ' 85' ' ' ALA . 6.6 t80 -43.55 -30.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.503 ' O ' ' N ' ' B' ' 89' ' ' VAL . 10.0 m -82.98 -61.87 1.75 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.78 -26.92 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.697 -0.627 . . . . 0.0 110.049 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.7 m -102.71 11.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.233 -0.917 . . . . 0.0 110.797 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' B' ' 91' ' ' ASP . 43.8 mt -126.0 158.85 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.646 -1.284 . . . . 0.0 110.384 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.504 ' N ' ' CG2' ' B' ' 90' ' ' ILE . 60.3 t0 -104.4 -32.25 9.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' B' ' 13' ' ' LYS . 8.9 pttp -149.0 147.1 28.17 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.412 ' O ' HG23 ' B' ' 93' ' ' ILE . 3.8 tp -127.67 127.48 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.526 -1.358 . . . . 0.0 109.746 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 10' ' ' VAL . 48.4 t -132.12 135.28 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -135.4 130.24 34.56 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.254 -1.529 . . . . 0.0 111.792 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.599 ' H ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -118.69 127.11 53.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.645 -0.66 . . . . 0.0 109.343 177.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.573 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 55.3 m-20 -122.85 124.87 44.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.031 -1.043 . . . . 0.0 108.85 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.794 ' CD1' ' N ' ' B' ' 98' ' ' PHE . 0.0 OUTLIER -146.37 127.45 7.29 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.097 -1.002 . . . . 0.0 110.502 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.55 123.65 9.65 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.229 1.953 . . . . 0.0 112.248 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.34 132.83 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.69 80.53 1.47 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.99 84.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -0.98 . . . . 0.0 109.557 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.627 ' O ' ' O ' ' B' ' 104' ' ' LYS . 17.2 m -147.26 -22.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.196 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.627 ' O ' ' O ' ' B' ' 103' ' ' VAL . 24.5 mtmt 41.02 102.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.344 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.408 ' O ' ' C ' ' B' ' 106' ' ' SER . 15.1 m -50.89 -50.8 56.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.112 -0.993 . . . . 0.0 108.957 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.408 ' C ' ' O ' ' B' ' 105' ' ' SER . 6.0 t 45.94 29.91 0.82 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.362 -0.836 . . . . 0.0 109.413 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 78.4 t -72.29 -56.1 11.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.87 141.35 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 109.532 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -104.81 120.26 40.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.24 155.19 61.59 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 120.816 -1.177 . . . . 0.0 109.652 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 C--N 1.309 -1.54 0 C-N-CA 122.674 2.249 . . . . 0.0 112.245 179.623 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.43 64.02 1.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.381 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -113.51 4.27 16.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.15 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 100' ' ' VAL . 4.3 p -175.84 -113.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.27 173.75 19.12 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.71 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -124.92 128.99 49.48 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.188 -1.184 . . . . 0.0 108.07 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 20.1 ttpt -104.1 134.26 47.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.008 -1.057 . . . . 0.0 112.837 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 62' ' ' MET . 85.3 t60 -127.14 125.03 40.47 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.09 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.725 -1.234 . . . . 0.0 109.454 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.46 138.05 54.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.6 -0.687 . . . . 0.0 109.444 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 t -119.4 131.64 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 93' ' ' ILE . 5.1 m -136.52 156.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 117.787 -1.565 . . . . 0.0 113.071 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -123.33 153.09 40.77 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.57 ' HB2' ' H ' ' A' ' 18' ' ' THR . 23.7 p90 -110.99 146.61 36.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -21.14 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 17' ' ' ASP . 84.5 tt0 -92.82 -57.37 2.68 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 16' ' ' GLU . 2.5 m-20 157.55 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.57 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 60.9 m -50.95 103.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.045 0.926 . . . . 0.0 112.854 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.89 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -71.1 82.55 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 21' ' ' ASP . 28.8 m -62.37 -40.07 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.635 -0.666 . . . . 0.0 110.458 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 20' ' ' VAL . 91.0 m-20 -66.21 -45.59 80.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 0.0 110.515 -178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 29.2 mp0 -68.29 -34.09 75.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.11 -43.29 88.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 20' ' ' VAL . 17.9 tp -54.29 -35.92 63.12 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.28 -33.9 72.99 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 29' ' ' ASN . . . -61.33 -52.49 51.24 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 27' ' ' LEU . 2.2 tt -46.91 -44.14 19.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.493 -1.004 . . . . 0.0 108.774 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -55.21 -37.65 67.4 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 2.0 m-80 -62.85 -46.04 89.75 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 78' ' ' LEU . 3.4 mm? -48.45 -46.49 37.92 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 32' ' ' SER . 63.1 t -51.3 -26.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.287 -0.883 . . . . 0.0 108.837 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 29' ' ' ASN . 30.9 t -46.38 -47.97 18.65 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.651 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -86.94 -23.7 25.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 0.0 111.467 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.516 ' C ' ' N ' ' A' ' 36' ' ' THR . 4.6 mm -73.25 23.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.036 -1.665 . . . . 0.0 110.618 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 36' ' ' THR . 55.0 p30 -61.8 -9.31 6.28 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.617 ' O ' ' C ' ' A' ' 37' ' ' VAL . 64.1 p -71.52 -4.86 29.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.971 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.617 ' C ' ' O ' ' A' ' 36' ' ' THR . 33.4 m 32.64 36.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.087 -1.008 . . . . 0.0 109.141 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 36' ' ' THR . 3.8 ptmt -121.96 41.97 3.24 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.9 t -174.6 179.07 1.8 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 97.6 m-85 -143.98 153.4 42.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.554 -1.341 . . . . 0.0 111.998 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 61' ' ' SER . 75.5 mt-10 -156.41 124.26 5.57 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.355 0.598 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -134.74 174.15 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.24 145.42 11.7 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 118.777 -1.678 . . . . 0.0 110.832 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.573 ' O ' ' CD2' ' A' ' 58' ' ' HIS . 56.2 mp0 -148.31 164.81 32.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.233 -1.157 . . . . 0.0 109.388 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 57' ' ' THR . 21.4 t70 -113.78 161.1 17.95 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.658 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 3.0 ptmm? -62.01 83.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.43 -1.419 . . . . 0.0 109.771 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' ASP . 96.2 mt-10 -128.79 46.87 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.622 -0.674 . . . . 0.0 109.259 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' B' ' 97' ' ' ASP . 5.9 t -142.2 78.71 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.794 ' C ' ' HE ' ' A' ' 53' ' ' ARG . 56.2 m80 56.58 107.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.927 . . . . 0.0 109.678 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -45.66 -35.16 3.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -0.851 . . . . 0.0 110.818 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -71.4 -35.34 70.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.961 -1.087 . . . . 0.0 110.682 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' B' ' 95' ' ' LEU . 84.5 mt -78.76 -51.1 10.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.763 -1.211 . . . . 0.0 109.314 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.794 ' HE ' ' C ' ' A' ' 49' ' ' HIS . 2.1 ptp180 -64.35 13.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 0.0 111.274 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.513 ' C ' ' O ' ' A' ' 53' ' ' ARG . 82.2 mm-40 37.76 32.19 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.82 -1.175 . . . . 0.0 110.129 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.777 ' O ' ' O ' ' A' ' 56' ' ' PHE . . . 59.16 1.83 1.16 Allowed Glycine 0 N--CA 1.499 2.847 0 O-C-N 121.439 -0.788 . . . . 0.0 112.815 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.777 ' O ' ' O ' ' A' ' 55' ' ' GLY . 46.1 m-85 -48.82 -148.15 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.221 -1.753 . . . . 0.0 109.884 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 50.4 m -143.37 -56.72 0.4 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.331 -0.855 . . . . 0.0 110.957 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.632 ' CE1' ' CE1' ' A' ' 60' ' ' PHE . 15.2 t-80 -158.21 145.98 18.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.884 -1.135 . . . . 0.0 110.116 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' N ' ' ND1' ' A' ' 58' ' ' HIS . . . -132.04 148.91 52.53 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.264 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 58' ' ' HIS . 34.8 m-85 -118.91 119.71 35.14 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.48 -0.762 . . . . 0.0 109.04 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 7.1 t -88.94 95.35 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 8' ' ' HIS . 84.0 mtp -102.37 110.62 22.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.228 -0.92 . . . . 0.0 110.813 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -125.63 145.87 49.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.6 160.52 21.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.829 -1.17 . . . . 0.0 110.068 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 85.5 tt0 -81.99 -31.95 30.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 65' ' ' GLU . 78.4 m-20 -163.18 174.32 12.3 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.63 -27.14 62.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 111.417 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.49 -36.73 66.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.869 -1.144 . . . . 0.0 110.538 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.74 -35.35 73.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.612 ' O ' HG22 ' A' ' 74' ' ' THR . 70.4 t80 -61.68 -44.34 97.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.508 -0.995 . . . . 0.0 110.5 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.1 m -70.78 -28.88 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.379 -1.451 . . . . 0.0 108.661 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.07 -60.94 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.365 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.59 -39.94 58.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 111.129 -177.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.619 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 3.5 t -80.79 -29.81 36.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.725 -1.234 . . . . 0.0 110.264 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.2 t -58.13 -33.64 69.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.984 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 73' ' ' PHE . 13.9 p80 -87.84 141.91 32.0 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.632 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 10.86 1.49 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.652 2.234 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' CD2' HD22 ' A' ' 30' ' ' LEU . 3.6 tt -73.04 -26.86 61.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -0.801 . . . . 0.0 111.256 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 83' ' ' SER . 9.3 t-80 -85.0 -43.41 13.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.0 110.249 -177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.787 HG13 ' H ' ' A' ' 81' ' ' GLU . 2.8 p -56.62 -58.1 6.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.012 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.787 ' H ' HG13 ' A' ' 80' ' ' VAL . 93.5 mt-10 -58.39 -42.27 86.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -70.94 -39.37 72.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' HIS . 23.6 t -59.83 -38.07 81.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.142 -0.974 . . . . 0.0 110.151 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.55 72.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.923 -1.111 . . . . 0.0 108.65 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 86' ' ' PHE . . . -68.84 -41.59 78.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 85' ' ' ALA . 22.5 t80 -45.04 -30.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 90' ' ' ILE . 3.8 m -84.68 -63.6 1.31 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' THR . . . -40.09 -27.35 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.65 -0.657 . . . . 0.0 110.089 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 87' ' ' THR . 5.4 p -98.53 16.57 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 91' ' ' ASP . 23.0 mm -130.64 164.02 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.683 -1.26 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.592 ' N ' HG22 ' A' ' 90' ' ' ILE . 40.9 t0 -103.41 -36.76 7.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 90' ' ' ILE . 21.2 pttt -146.96 146.42 30.09 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.65 HD12 HG12 ' A' ' 12' ' ' VAL . 4.8 tp -128.37 127.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.6 -1.313 . . . . 0.0 109.707 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.2 133.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.65 36.22 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.292 -1.505 . . . . 0.0 111.804 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.895 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -125.69 128.99 48.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.621 -0.675 . . . . 0.0 109.379 177.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.593 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 42.8 t0 -120.01 124.61 46.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.021 -1.049 . . . . 0.0 108.893 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 97' ' ' ASP . 25.1 m-85 -142.31 148.96 49.8 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.986 -1.071 . . . . 0.0 110.531 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.83 130.12 16.4 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.244 1.963 . . . . 0.0 112.201 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.537 ' O ' ' OG ' ' A' ' 4' ' ' SER . 9.9 t -95.22 117.09 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.96 . . . . 0.0 109.994 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 103' ' ' VAL . . . -91.31 75.45 6.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.21 71.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.114 -0.992 . . . . 0.0 109.563 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' SER . 29.1 m -149.78 -32.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.266 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 106' ' ' SER . 25.3 mtmt 37.68 -93.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER 66.58 -42.53 0.4 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 108.978 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 104' ' ' LYS . 9.5 m -44.4 104.18 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.277 -0.89 . . . . 0.0 109.336 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.901 HG22 ' H ' ' A' ' 108' ' ' VAL . 7.6 p -80.64 -176.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.901 ' H ' HG22 ' A' ' 107' ' ' VAL . 8.6 p -42.26 142.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.399 -0.813 . . . . 0.0 109.401 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.87 93.34 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -70.75 152.09 95.21 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 120.824 -1.172 . . . . 0.0 109.671 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo . . . . . 0 C--N 1.307 -1.637 0 C-N-CA 122.76 2.306 . . . . 0.0 112.24 179.776 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.607 ' N ' ' SD ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.42 63.83 1.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 109.428 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -113.38 3.99 16.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.101 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' B' ' 100' ' ' VAL . 4.2 p -175.64 -113.27 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.28 173.7 19.07 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -124.8 129.11 49.8 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.205 -1.174 . . . . 0.0 108.01 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 97' ' ' ASP . 20.2 ttpt -104.23 134.27 47.74 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.311 1.053 . . . . 0.0 112.822 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' B' ' 62' ' ' MET . 85.4 t60 -127.08 125.07 40.66 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.1 145.98 44.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.747 -1.22 . . . . 0.0 109.487 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -130.47 138.02 54.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.616 -0.678 . . . . 0.0 109.545 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.42 131.52 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.636 HG12 HD12 ' B' ' 93' ' ' ILE . 5.2 m -136.49 156.19 35.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 117.732 -1.587 . . . . 0.0 113.053 -177.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -123.2 153.07 40.58 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.564 ' HB2' ' H ' ' B' ' 18' ' ' THR . 23.7 p90 -111.01 146.54 36.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 0.0 111.663 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.37 -21.18 2.9 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' B' ' 17' ' ' ASP . 84.7 tt0 -92.96 -57.36 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 16' ' ' GLU . 2.5 m-20 157.47 65.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' B' ' 14' ' ' PHE . 60.3 m -50.79 103.32 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.117 0.961 . . . . 0.0 112.844 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.875 ' CD ' ' H ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -71.29 82.47 0.75 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.535 HG23 ' N ' ' B' ' 21' ' ' ASP . 28.4 m -62.15 -40.11 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.585 -0.697 . . . . 0.0 110.433 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.535 ' N ' HG23 ' B' ' 20' ' ' VAL . 91.6 m-20 -66.36 -45.41 80.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.559 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' B' ' 22' ' ' GLU . 28.8 mp0 -68.43 -34.1 75.39 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.04 -43.31 89.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 20' ' ' VAL . 17.9 tp -54.14 -36.24 63.09 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -60.02 -34.03 72.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.582 ' O ' ' HB2' ' B' ' 29' ' ' ASN . . . -61.42 -52.22 52.79 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.639 HD23 ' O ' ' B' ' 27' ' ' LEU . 2.2 tt -47.12 -43.85 20.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.533 -0.98 . . . . 0.0 108.83 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -55.54 -37.47 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB2' ' O ' ' B' ' 26' ' ' GLY . 2.1 m-80 -62.9 -46.13 89.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' B' ' 78' ' ' LEU . 3.4 mm? -48.31 -46.62 36.48 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' B' ' 32' ' ' SER . 62.8 t -51.19 -26.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 108.821 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' B' ' 29' ' ' ASN . 31.0 t -46.33 -48.05 18.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.654 ' O ' ' NE2' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -86.97 -23.68 24.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.448 -0.782 . . . . 0.0 111.553 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.516 HD13 ' OE1' ' B' ' 33' ' ' GLN . 4.6 mm -73.16 23.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 119.984 -1.697 . . . . 0.0 110.591 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' B' ' 36' ' ' THR . 55.2 p30 -61.7 -9.44 6.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.604 ' O ' ' N ' ' B' ' 38' ' ' LYS . 63.0 p -71.46 -4.73 28.2 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.948 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.596 ' C ' ' O ' ' B' ' 36' ' ' THR . 35.3 m 32.61 36.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.044 -1.035 . . . . 0.0 109.144 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' B' ' 36' ' ' THR . 3.9 ptmt -122.26 42.01 3.25 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -174.51 179.14 1.82 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.1 153.24 41.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.525 -1.359 . . . . 0.0 112.001 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 61' ' ' SER . 74.9 mt-10 -156.3 124.18 5.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.746 -0.596 . . . . 0.0 110.302 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -134.87 174.15 10.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.3 145.54 11.86 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 118.691 -1.719 . . . . 0.0 110.819 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.575 ' O ' ' CD2' ' B' ' 58' ' ' HIS . 56.8 mp0 -148.35 164.72 33.21 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -1.149 . . . . 0.0 109.408 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' B' ' 57' ' ' THR . 21.6 t70 -113.57 161.15 17.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.66 ' CG ' ' O ' ' B' ' 46' ' ' LYS . 3.0 ptmm? -62.03 83.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.421 -1.424 . . . . 0.0 109.805 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' B' ' 45' ' ' ASP . 96.0 mt-10 -128.73 46.75 2.56 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 97' ' ' ASP . 6.1 t -142.13 78.9 1.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 110.179 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.787 ' C ' ' HE ' ' B' ' 53' ' ' ARG . 56.0 m80 56.4 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 109.694 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -45.86 -35.01 4.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.38 -0.825 . . . . 0.0 110.784 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -71.49 -35.2 70.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 0.0 110.739 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' A' ' 95' ' ' LEU . 84.1 mt -78.88 -50.99 10.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.691 -1.256 . . . . 0.0 109.329 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.787 ' HE ' ' C ' ' B' ' 49' ' ' HIS . 2.1 ptp180 -64.29 13.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 111.291 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' GLN . . . . . 0.514 ' C ' ' O ' ' B' ' 53' ' ' ARG . 82.2 mm-40 37.92 31.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.787 -1.196 . . . . 0.0 110.175 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.775 ' O ' ' O ' ' B' ' 56' ' ' PHE . . . 59.49 1.47 1.21 Allowed Glycine 0 N--CA 1.499 2.833 0 O-C-N 121.393 -0.817 . . . . 0.0 112.82 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' PHE . . . . . 0.775 ' O ' ' O ' ' B' ' 55' ' ' GLY . 46.6 m-85 -48.58 -148.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.296 -1.708 . . . . 0.0 109.979 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 45' ' ' ASP . 49.3 m -143.44 -56.69 0.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.342 -0.849 . . . . 0.0 110.925 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' HIS . . . . . 0.63 ' CE1' ' CE1' ' B' ' 60' ' ' PHE . 14.8 t-80 -158.37 146.21 18.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.91 -1.119 . . . . 0.0 110.157 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.582 ' N ' ' ND1' ' B' ' 58' ' ' HIS . . . -132.25 148.97 52.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' CE1' ' B' ' 58' ' ' HIS . 35.6 m-85 -118.89 119.69 35.09 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.461 -0.775 . . . . 0.0 109.08 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 41' ' ' GLU . 6.9 t -88.9 95.31 10.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . 0.44 ' O ' ' N ' ' B' ' 8' ' ' HIS . 83.5 mtp -102.41 110.55 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.195 -0.94 . . . . 0.0 110.787 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -125.56 145.99 49.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -117.73 160.58 21.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.726 -1.234 . . . . 0.0 110.051 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' B' ' 66' ' ' ASN . 85.6 tt0 -82.06 -31.86 30.64 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' B' ' 65' ' ' GLU . 78.3 m-20 -163.29 174.2 12.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -57.58 -27.11 62.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.292 -0.88 . . . . 0.0 111.407 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -55.37 -36.89 66.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.75 -35.43 73.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.609 ' O ' HG22 ' B' ' 74' ' ' THR . 71.3 t80 -61.49 -44.66 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.604 -0.939 . . . . 0.0 110.455 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.69 -29.01 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.348 -1.47 . . . . 0.0 108.695 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -60.88 2.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.379 -0.826 . . . . 0.0 109.323 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -51.22 -40.21 58.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -0.921 . . . . 0.0 111.131 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.62 ' N ' ' CD1' ' B' ' 73' ' ' PHE . 3.5 t -80.58 -29.96 36.95 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.742 -1.224 . . . . 0.0 110.256 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 38.5 t -57.97 -33.84 69.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.961 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.608 ' NE2' ' O ' ' B' ' 73' ' ' PHE . 13.8 p80 -87.76 141.94 32.17 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.161 . . . . 0.0 109.564 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.68 10.91 1.47 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.662 2.241 . . . . 0.0 112.427 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' B' ' 30' ' ' LEU . 3.5 tt -73.0 -27.01 61.53 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.342 -0.849 . . . . 0.0 111.243 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' SER . 9.3 t-80 -84.96 -43.26 14.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.019 -1.051 . . . . 0.0 110.25 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.777 HG13 ' H ' ' B' ' 81' ' ' GLU . 2.7 p -56.83 -58.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 110.041 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.777 ' H ' HG13 ' B' ' 80' ' ' VAL . 93.5 mt-10 -58.36 -42.49 87.09 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.282 -0.886 . . . . 0.0 109.643 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -70.63 -39.47 73.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.827 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.481 ' N ' ' O ' ' B' ' 79' ' ' HIS . 22.7 t -59.72 -38.25 81.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 110.108 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.63 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.055 . . . . 0.0 108.654 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' B' ' 86' ' ' PHE . . . -68.76 -41.59 78.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' B' ' 85' ' ' ALA . 22.4 t80 -45.02 -30.88 1.14 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.495 ' O ' ' N ' ' B' ' 90' ' ' ILE . 3.8 m -84.44 -63.73 1.29 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' B' ' 87' ' ' THR . . . -39.94 -27.51 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 110.07 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 87' ' ' THR . 5.4 p -98.57 16.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.224 -0.923 . . . . 0.0 110.818 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.601 HG22 ' N ' ' B' ' 91' ' ' ASP . 22.8 mm -130.86 164.1 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.618 -1.301 . . . . 0.0 110.497 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . 0.601 ' N ' HG22 ' B' ' 90' ' ' ILE . 41.9 t0 -103.44 -36.89 7.83 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.468 ' N ' HG22 ' B' ' 90' ' ' ILE . 21.1 pttt -146.95 146.39 30.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . 0.636 HD12 HG12 ' B' ' 12' ' ' VAL . 4.8 tp -128.32 127.56 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.555 -1.341 . . . . 0.0 109.658 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.38 133.11 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.637 ' O ' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -137.36 134.8 36.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.269 -1.52 . . . . 0.0 111.768 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.888 ' N ' HD12 ' B' ' 96' ' ' LEU . 0.0 OUTLIER -125.73 129.06 48.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.629 . . . . 0.0 109.312 177.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . 0.596 ' O ' ' CD1' ' B' ' 98' ' ' PHE . 43.3 t0 -119.99 124.6 46.34 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . 0.596 ' CD1' ' O ' ' B' ' 97' ' ' ASP . 24.9 m-85 -142.29 148.91 49.7 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.098 -1.001 . . . . 0.0 110.504 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 130.05 16.41 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.28 1.987 . . . . 0.0 112.187 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.55 ' O ' ' OG ' ' B' ' 4' ' ' SER . 9.5 t -95.15 117.05 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -0.953 . . . . 0.0 110.054 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 103' ' ' VAL . . . -91.32 75.48 6.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.524 -0.735 . . . . 0.0 109.54 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.23 71.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.566 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' B' ' 105' ' ' SER . 29.2 m -149.84 -32.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 106' ' ' SER . 25.5 mtmt 37.71 -93.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.579 ' N ' ' O ' ' B' ' 103' ' ' VAL . 0.9 OUTLIER 66.59 -42.69 0.41 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.968 . . . . 0.0 108.941 -178.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.561 ' N ' ' O ' ' B' ' 104' ' ' LYS . 10.2 m -44.22 104.08 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.35 -0.844 . . . . 0.0 109.386 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.896 HG22 ' H ' ' B' ' 108' ' ' VAL . 7.5 p -80.49 -176.72 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.896 ' H ' HG22 ' B' ' 107' ' ' VAL . 8.5 p -41.88 142.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.408 -0.807 . . . . 0.0 109.484 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.92 93.41 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 108' ' ' VAL . 0.1 OUTLIER -70.74 152.17 95.21 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 120.881 -1.137 . . . . 0.0 109.667 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo . . . . . 0 C--N 1.307 -1.61 0 C-N-CA 122.704 2.269 . . . . 0.0 112.362 179.757 . . . . . . . . 0 0 . 1 stop_ save_